data_2m6l_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m6l _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.61 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.06 -2.34 58.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.373 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.481 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.5 179.18 1.22 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.469 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.5 Cg_exo -60.8 145.38 99.06 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.729 2.286 . . . . 0.0 112.166 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.61 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 34.9 ptt-85 -156.29 -179.47 8.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.579 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -116.18 137.44 52.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.323 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.69 146.88 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.322 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.5 p -119.93 135.81 54.76 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.807 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.16 -143.65 0.32 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.19 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.45 -37.14 86.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.445 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.481 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.31 -66.51 0.22 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.484 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.62 142.35 45.68 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 p -112.06 131.4 55.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.89 0.376 . . . . 0.0 110.391 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -118.98 128.81 54.74 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.499 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.0 m -85.62 130.28 34.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.143 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 70.0 mt -96.25 78.76 3.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.317 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.54 -32.15 73.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.471 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.6 109.77 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.044 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -123.3 91.37 49.85 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.199 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.636 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.2 Cg_exo -57.07 148.92 65.88 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.738 2.292 . . . . 0.0 111.773 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.28 83.11 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.631 0.582 . . . . 0.0 111.047 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.636 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.64 67.09 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.129 0.49 . . . . 0.0 110.261 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.45 130.82 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.515 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.9 t -122.84 147.01 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.085 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.9 t -136.24 143.8 44.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.644 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.606 ' HG1' ' N ' ' A' ' 50' ' ' SER . 28.3 p -99.08 -59.25 1.76 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.53 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.606 ' N ' ' HG1' ' A' ' 49' ' ' THR . 87.1 p -79.3 155.27 28.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.695 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -74.22 -21.85 17.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.62 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.4 ' O ' ' OG ' ' A' ' 56' ' ' SER . 99.8 m -60.37 -51.98 67.21 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.486 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.8 mt -66.29 -42.52 88.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.502 0.668 . . . . 0.0 110.951 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.0 m -43.44 -53.76 5.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.076 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.13 -37.36 72.53 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.6 m -62.77 -44.63 95.68 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.367 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.0 mt -65.98 -42.17 90.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.43 0.633 . . . . 0.0 110.69 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 tp -62.59 -40.13 95.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.467 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.29 -36.16 77.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.05 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 pt -90.75 28.61 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.177 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.59 51.39 11.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.825 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.72 75.14 26.12 Favored Pre-proline 0 C--N 1.333 -0.15 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.97 151.24 86.12 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.718 2.278 . . . . 0.0 112.16 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -113.63 137.29 47.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.306 0.574 . . . . 0.0 110.23 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.407 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.1 pt -69.06 -43.69 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.373 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.481 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.2 130.94 53.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.987 0.423 . . . . 0.0 110.597 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.525 ' O ' ' O ' ' A' ' 97' ' ' ARG . 30.8 p -155.41 168.88 25.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.346 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.77 -177.33 21.7 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.44 172.57 12.53 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.857 0.36 . . . . 0.0 110.556 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.7 p -132.47 -113.0 0.23 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.348 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.03 179.98 0.9 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.211 -178.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.7 Cg_exo -60.89 57.93 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 123.027 2.485 . . . . 0.0 112.187 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.4 t-20 -64.28 -34.13 77.41 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 118.606 -0.712 . . . . 0.0 110.584 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 45.1 m-20 93.91 -36.21 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.617 1.198 . . . . 0.0 109.753 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -62.7 -39.9 95.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.224 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.17 -25.83 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.804 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.32 -171.18 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.649 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -73.94 -153.88 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.833 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.8 p-10 -52.74 -7.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.658 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.3 114.89 23.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.556 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.88 70.11 1.35 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.467 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.1 m-85 -143.25 147.91 35.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.941 0.4 . . . . 0.0 110.819 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -85.76 -98.62 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.125 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.1 mtt-85 -63.88 -42.71 97.43 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.236 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.5 tt0 91.72 53.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.286 0.991 . . . . 0.0 110.917 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -103.4 -9.0 19.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.404 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.467 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.5 p -64.66 -34.0 77.26 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.167 0.508 . . . . 0.0 110.777 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.531 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.79 -24.57 1.47 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.56 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.25 -46.04 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.048 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.27 -48.43 81.47 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.98 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.73 -38.21 89.62 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.347 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.95 -32.08 52.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.218 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.551 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.4 mmt-85 -90.09 1.9 55.85 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.686 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.36 -49.43 0.2 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 124.412 1.07 . . . . 0.0 110.366 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.613 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 83.2 mt -46.48 154.73 0.27 Allowed 'General case' 0 CA--C 1.485 -1.549 0 CA-C-O 117.068 -1.444 . . . . 0.0 108.966 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.613 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 120.82 92.68 0.0 OUTLIER 'General case' 0 C--N 1.359 1.001 0 O-C-N 125.958 2.036 . . . . 0.0 110.527 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.525 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.6 143.47 42.31 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.227 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.8 mt -132.47 27.03 4.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.692 0.282 . . . . 0.0 110.436 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.48 138.18 34.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.027 0.441 . . . . 0.0 110.491 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.519 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.6 mt -137.15 164.91 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.385 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.519 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.25 -28.59 1.81 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -152.54 70.99 7.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.193 0.521 . . . . 0.0 110.287 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.04 145.42 98.43 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.711 2.274 . . . . 0.0 112.075 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.1 t -134.78 136.59 42.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.035 0.445 . . . . 0.0 110.507 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.29 -38.17 81.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.702 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.25 -42.09 96.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.57 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.27 -41.48 98.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.515 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 64.9 t -63.67 -43.56 98.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.947 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.25 78.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.336 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.34 -18.67 59.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.502 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.76 -6.42 58.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.52 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 75.8 mtp 47.74 55.83 17.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.599 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.9 Cg_endo -70.49 150.02 63.11 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.841 2.361 . . . . 0.0 112.044 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -101.4 -75.9 0.58 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.404 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.6 tp -108.38 113.7 26.98 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.218 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.0 mt -102.64 126.77 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.404 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.5 mt -109.73 133.68 52.86 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.084 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.28 139.08 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.496 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 121' ' ' THR . 91.5 p -83.17 168.33 16.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.68 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -37.46 80.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.454 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.418 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -140.06 158.89 43.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.43 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.18 177.36 33.26 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.16 -33.82 87.11 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.61 151.84 44.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.874 0.369 . . . . 0.0 110.588 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.1 t -63.03 141.06 58.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.288 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.04 9.85 11.3 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.697 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.9 mp -61.22 -39.18 89.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.056 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.629 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.76 -36.01 23.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.647 0.737 . . . . 0.0 110.704 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -70.59 -35.61 73.1 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.488 0.661 . . . . 0.0 110.828 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -42.85 -63.03 0.86 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.332 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.629 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.89 -42.62 90.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.97 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.11 -33.18 73.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.083 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.2 mt -72.86 -40.74 65.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.24 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.51 -48.61 80.24 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.139 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 m -53.29 -42.25 66.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.105 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.78 -42.93 93.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.998 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.55 156.38 5.23 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.581 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -39.63 107.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.581 2.188 . . . . 0.0 112.347 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 89.8 m -110.11 120.81 43.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.234 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.45 152.67 31.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.125 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 tt -129.39 131.44 67.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.38 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.9 mt -115.17 128.12 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.384 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.2 t30 -101.6 103.61 14.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.262 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.5 p90 -100.96 -11.36 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.774 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.4 p-10 -64.79 -33.81 76.86 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.705 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.6 p-10 -98.08 7.8 45.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.63 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.7 155.41 50.44 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.543 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.404 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -74.93 165.68 24.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.668 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.598 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.84 -48.75 80.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.185 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -53.7 -41.96 67.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.918 0.39 . . . . 0.0 110.012 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.6 t -62.58 -41.14 98.76 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.391 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.8 tp -60.64 -44.13 96.75 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.315 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.7 tp -61.5 -43.42 98.9 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.226 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -54.99 -44.79 74.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.659 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.42 -40.68 97.35 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.893 0.377 . . . . 0.0 110.355 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.425 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -62.2 -42.35 99.21 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.387 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.05 -41.02 95.36 Favored Glycine 0 C--N 1.315 -0.587 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.42 -46.13 64.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.949 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.6 -44.05 96.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.816 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 156' ' ' LEU . 32.4 p -93.02 -8.74 42.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.595 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.93 26.63 72.32 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -101.99 50.96 0.83 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.814 0.34 . . . . 0.0 110.721 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -69.67 -39.46 76.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.751 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.58 -47.08 86.98 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.268 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -60.02 -39.24 85.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.332 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.13 -40.87 98.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.277 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.91 -28.69 70.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.07 0.462 . . . . 0.0 110.571 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.03 -54.24 8.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.221 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -65.51 -42.1 92.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.439 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.9 mt -62.35 -43.78 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.434 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.72 -57.53 10.64 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.082 0.468 . . . . 0.0 110.509 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.89 -34.05 69.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.342 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -80.76 -37.15 30.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.075 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.5 m-20 -55.56 -41.45 73.31 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.245 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.75 -42.23 99.58 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.727 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.3 -37.83 88.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.227 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.6 mt -62.5 -42.24 99.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.737 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.04 -52.59 63.35 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.096 0.474 . . . . 0.0 110.7 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.37 -41.75 88.99 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.592 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.92 95.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.623 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.23 -32.43 73.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.381 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.09 -22.38 18.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.762 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.629 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.0 tt0 -64.85 -41.01 96.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.64 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.6 pt -77.16 136.6 24.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.623 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -127.15 108.22 10.71 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.218 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.08 126.0 0.34 Allowed Pre-proline 0 N--CA 1.446 -0.669 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.588 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.7 Cg_exo -44.04 152.61 0.37 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.664 2.242 . . . . 0.0 112.606 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.19 141.88 53.76 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.59 2.193 . . . . 0.0 112.456 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.547 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.16 147.2 2.19 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.648 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.46 155.23 67.5 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.745 2.297 . . . . 0.0 112.299 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.522 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.63 163.12 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.362 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.522 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 2.2 t -143.58 170.16 16.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.912 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.515 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -147.86 137.42 22.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.208 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 37.7 pt -134.26 146.51 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.603 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.92 131.98 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.305 0.574 . . . . 0.0 110.57 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.411 ' HH ' ' CG1' ' A' ' 272' ' ' ILE . 52.4 p90 -152.85 156.43 38.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.379 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.0 m -122.08 122.92 40.36 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.934 0.397 . . . . 0.0 110.329 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.486 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.78 -26.55 67.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.534 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -74.12 -50.02 21.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.079 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -75.75 -13.46 60.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.506 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.486 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 78.1 m80 49.94 46.21 24.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.529 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.6 t -131.14 144.86 51.7 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.317 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -109.4 106.08 15.71 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.204 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -116.46 129.69 56.35 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.14 0.495 . . . . 0.0 110.307 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.7 tt -112.36 146.19 38.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.719 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.45 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.9 t90 -99.34 128.68 45.48 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.141 0.496 . . . . 0.0 109.959 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.702 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -94.82 154.08 39.91 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.107 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.6 Cg_endo -67.71 -17.97 47.79 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.736 2.291 . . . . 0.0 111.897 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.702 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -49.43 -18.92 0.45 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.402 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.45 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.1 p -75.5 164.57 26.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.488 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.9 -27.89 65.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.532 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.61 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.8 mt-30 -63.76 -41.19 98.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.64 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.44 -44.28 97.82 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.55 -38.94 92.74 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 120.989 0.423 . . . . 0.0 110.461 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.28 -41.26 98.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.062 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 71.7 mt -63.6 -47.06 82.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.635 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.34 -31.75 55.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.91 -18.25 62.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.526 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 90.0 mt -88.11 -8.75 54.99 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.651 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.64 2.1 55.34 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -88.46 153.29 21.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.755 0.312 . . . . 0.0 110.436 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.3 p -116.05 128.63 55.85 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.078 0.466 . . . . 0.0 110.384 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.33 146.33 23.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.901 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.456 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.24 151.36 45.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.432 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.37 131.88 42.32 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.394 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.622 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.3 93.71 27.73 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.002 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.717 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.1 Cg_exo -55.63 138.78 81.9 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.574 2.182 . . . . 0.0 111.435 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.56 -25.61 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.551 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.717 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.63 -49.89 28.03 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.596 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.9 mt -55.23 -37.16 66.8 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -65.54 35.65 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.909 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.596 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.47 88.32 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.773 0.32 . . . . 0.0 110.852 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.2 p -81.44 -13.4 58.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.377 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.86 -40.76 11.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.604 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.0 t -66.64 -17.02 64.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.644 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.01 44.0 26.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.485 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.29 -148.21 8.05 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.68 142.5 48.42 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.888 0.375 . . . . 0.0 110.352 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.11 149.55 28.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.334 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -102.43 -150.12 0.4 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.26 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 55.48 -92.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.575 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.475 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.3 tt -127.2 174.13 11.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.498 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.475 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 88.2 mt -121.57 140.84 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.798 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.36 170.53 8.57 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.4 mt -146.88 149.53 33.44 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.253 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.19 -39.32 97.78 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.09 2.96 4.08 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -78.48 -57.32 3.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 110.621 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.19 -36.81 83.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.084 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.8 mp -53.31 -67.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.05 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.84 -42.55 68.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.13 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.67 17.72 0.15 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.659 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.99 47.85 0.26 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 7.8 mp 39.53 -110.17 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.601 0.238 . . . . 0.0 110.637 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.456 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -61.2 -44.15 97.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.326 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.15 8.14 84.19 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.86 -13.34 20.11 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.774 -0.251 . . . . 0.0 110.69 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.425 ' HG ' ' N ' ' A' ' 259' ' ' LEU . 5.9 t 176.89 142.74 0.08 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.174 0.511 . . . . 0.0 110.51 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.425 ' N ' ' HG ' ' A' ' 258' ' ' SER . 9.3 tt -147.96 125.72 11.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.1 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -98.92 143.42 29.24 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 120.917 0.389 . . . . 0.0 110.785 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.4 mt -94.7 106.26 18.23 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.55 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.436 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.0 t80 -101.98 -11.82 18.65 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.122 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.5 86.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.923 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.46 172.99 45.8 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.451 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.7 m-20 -73.9 -112.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.771 0.32 . . . . 0.0 110.701 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.05 -28.72 67.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.766 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.24 -43.59 92.4 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.159 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.48 -44.26 94.91 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.406 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.78 -59.77 4.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.158 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.29 -43.32 61.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.166 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.26 -43.42 74.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.163 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.411 ' CG1' ' HH ' ' A' ' 196' ' ' TYR . 93.2 mt -64.48 -43.63 96.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.651 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -56.43 -37.43 70.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.138 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.64 0.63 19.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.266 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -114.85 91.35 25.8 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.196 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.28 -27.22 29.78 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.773 2.315 . . . . 0.0 111.729 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.51 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.4 -41.2 98.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.585 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.428 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.25 5.12 52.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.291 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.79 -35.18 69.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.722 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -79.65 4.63 15.47 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.472 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.544 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.61 121.46 81.04 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.639 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -47.65 -37.48 27.3 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.349 2.032 . . . . 0.0 112.586 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.544 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -59.1 -43.71 91.89 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 63.0 t -65.87 -43.85 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.92 0.391 . . . . 0.0 110.287 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.68 -40.53 95.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.53 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.445 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 48.0 t-20 -89.84 -12.69 38.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.515 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 61.99 32.55 17.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.88 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.14 43.94 1.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.359 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.38 135.59 41.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.42 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.68 132.14 56.77 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.492 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.507 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.68 88.01 7.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.71 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.45 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.5 mt -64.07 -40.64 96.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.96 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.436 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.33 167.99 34.93 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.51 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 75.7 p -75.93 -25.67 56.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 110.716 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.536 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.1 tp10 -67.45 -34.86 78.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.352 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.496 ' O ' ' CG2' ' A' ' 296' ' ' THR . 95.4 m -73.36 25.12 0.07 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.671 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.61 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 59.4 t80 -58.34 -51.15 71.03 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 68.6 mmt-85 -111.79 154.84 24.47 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 44.1 tp -115.92 125.2 52.27 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 41.6 t0 -147.79 165.67 29.85 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.585 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -48.99 -38.26 22.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.597 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -71.79 -65.17 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.458 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.6 p -60.84 -32.86 72.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.126 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.75 -25.19 26.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.585 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.8 mtt -63.54 -40.99 98.44 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 120.91 0.386 . . . . 0.0 111.01 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -79.03 -44.01 23.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.977 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 77.5 t -65.94 -43.24 92.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.417 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.43 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 54.5 tp -60.66 -46.94 88.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.622 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -69.51 -39.62 77.47 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.466 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.507 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.0 ttt180 -61.94 -38.36 88.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.146 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.1 mt -86.82 4.09 42.54 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.834 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.629 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.3 tttt -112.71 -11.45 13.52 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.174 0.512 . . . . 0.0 110.29 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.04 85.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.624 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.02 -48.64 80.88 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.331 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.868 -1.063 . . . . 0.0 109.992 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.61 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.36 -2.63 57.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.383 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.476 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.09 179.03 1.26 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.452 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.9 Cg_exo -60.85 145.46 98.97 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.558 2.172 . . . . 0.0 112.171 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.61 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.29 -179.76 8.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.624 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.14 137.0 52.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.372 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -124.23 146.67 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.314 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -119.76 135.61 54.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.759 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.15 -143.98 0.32 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.143 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.21 -37.35 86.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.533 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.89 -66.99 0.23 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.532 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.47 142.56 45.14 Favored Glycine 0 C--O 1.224 -0.48 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.0 p -112.28 131.26 55.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.922 0.392 . . . . 0.0 110.26 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -118.7 128.86 54.9 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.545 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.1 m -85.44 130.43 34.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.198 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.1 mt -96.49 78.81 3.02 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.16 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.6 -32.06 73.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.501 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.75 108.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.024 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -122.11 90.79 48.98 Favored Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.245 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.636 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.0 Cg_exo -56.96 148.6 66.93 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.708 2.272 . . . . 0.0 111.652 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.13 82.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.574 0.546 . . . . 0.0 111.056 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.636 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.76 67.16 0.87 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.302 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.05 131.14 35.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.461 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.3 t -122.78 147.38 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.154 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.3 t -136.18 143.94 44.7 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.556 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.547 ' HG1' ' H ' ' A' ' 50' ' ' SER . 17.2 p -99.45 -59.39 1.73 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.492 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.547 ' H ' ' HG1' ' A' ' 49' ' ' THR . 86.6 p -79.4 155.06 28.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.93 0.395 . . . . 0.0 110.671 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 68.9 t -73.47 -21.9 18.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.598 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.404 ' O ' ' OG ' ' A' ' 56' ' ' SER . 95.6 m -60.52 -51.74 68.13 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.384 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.9 mt -66.13 -42.62 88.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.496 0.665 . . . . 0.0 110.911 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.1 m -43.86 -54.16 5.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.996 -178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.63 -37.11 77.01 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 52' ' ' THR . 7.0 m -63.2 -44.36 95.57 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.217 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.3 mt -65.73 -42.25 91.27 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.274 0.559 . . . . 0.0 110.544 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.93 -39.68 95.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.431 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.2 78.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.078 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.5 pt -90.62 27.31 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.251 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 57.12 51.27 10.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.835 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.23 76.08 32.79 Favored Pre-proline 0 C--O 1.227 -0.081 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.66 149.42 90.93 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.634 2.223 . . . . 0.0 112.089 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -112.41 136.3 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.302 0.572 . . . . 0.0 110.161 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -68.97 -43.75 81.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.448 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.15 130.51 52.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.114 0.483 . . . . 0.0 110.613 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.6 p -155.28 168.83 25.78 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.305 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.6 -177.38 21.8 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.37 172.51 12.6 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.776 0.322 . . . . 0.0 110.601 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.9 p -133.81 -110.92 0.22 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.532 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.22 179.78 0.91 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.149 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.7 Cg_exo -60.91 58.88 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.892 2.395 . . . . 0.0 112.139 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.7 t-20 -64.07 -34.44 78.03 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.693 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.5 m-20 94.34 -36.73 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 125.018 1.449 . . . . 0.0 109.778 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -63.06 -40.53 97.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.083 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -73.7 -26.56 21.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.933 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.68 -172.37 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.64 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.44 -152.91 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.809 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.3 p-10 -54.74 -6.54 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.684 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -87.37 114.11 23.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.956 0.408 . . . . 0.0 110.487 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.67 71.67 1.31 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.495 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.3 m-85 -143.02 148.7 37.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.795 0.331 . . . . 0.0 110.968 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.526 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.5 mp -86.5 -99.06 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.91 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.61 -43.55 96.55 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 119.027 -0.511 . . . . 0.0 110.141 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.529 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.8 tt0 91.77 52.37 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 124.487 1.117 . . . . 0.0 111.156 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -103.48 -8.58 20.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.449 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.495 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.5 p -65.29 -33.39 75.86 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.323 0.582 . . . . 0.0 110.819 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.529 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.1 mttt -48.86 -23.88 1.25 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.531 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.6 t -69.88 -45.78 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.299 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.49 -48.27 81.84 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.065 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.58 -38.5 90.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.303 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.84 -33.2 55.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.177 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.539 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.3 mmt-85 -88.88 1.86 54.68 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.619 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.43 -49.42 0.19 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.616 1.197 . . . . 0.0 110.347 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.598 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.8 mt -46.48 154.14 0.31 Allowed 'General case' 0 CA--C 1.485 -1.551 0 CA-C-O 117.082 -1.437 . . . . 0.0 108.67 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.598 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.1 91.89 0.0 OUTLIER 'General case' 0 C--N 1.363 1.16 0 O-C-N 125.944 2.028 . . . . 0.0 110.677 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.531 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.85 143.14 44.02 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.046 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.6 mt -132.15 26.47 4.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.492 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.03 137.6 34.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.942 0.401 . . . . 0.0 110.579 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.513 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.6 mt -136.82 164.63 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.383 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.513 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.88 -28.82 1.72 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -151.95 70.65 7.87 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.038 0.447 . . . . 0.0 110.26 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.14 145.41 98.54 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.686 2.257 . . . . 0.0 112.059 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.4 t -135.01 137.09 42.66 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.467 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.99 -38.1 82.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.701 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.44 -41.92 96.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.629 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.25 -41.38 98.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.386 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.75 -43.57 98.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.745 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.1 77.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.326 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.52 -18.85 60.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.489 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.63 -6.56 58.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.47 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.1 mtp 47.77 55.76 17.08 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.686 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.3 Cg_endo -70.0 149.56 65.51 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.927 2.418 . . . . 0.0 112.016 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.38 -72.81 0.67 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.42 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.2 tp -111.76 114.22 27.08 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.8 mt -103.16 126.87 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.344 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 mt -110.22 134.27 52.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.951 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.415 HG23 HD12 ' A' ' 118' ' ' ILE . 96.9 mt -120.57 139.09 48.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.612 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 121' ' ' THR . 87.4 p -82.77 167.94 17.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.839 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.51 -37.27 80.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.38 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.419 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -139.91 158.6 43.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.457 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.45 177.12 33.6 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.15 -33.76 86.89 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.74 151.7 44.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.898 0.38 . . . . 0.0 110.58 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.4 t -63.48 141.14 58.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.284 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.51 10.44 11.13 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.654 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.7 mp -61.1 -39.48 90.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.994 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.63 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.44 -36.12 24.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.662 0.744 . . . . 0.0 110.681 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.8 mt -70.52 -35.61 73.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.83 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -43.04 -62.81 0.93 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.485 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.63 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.86 -42.63 90.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.932 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -62.09 -33.34 74.25 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.019 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.0 mt -72.57 -40.96 66.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.49 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.78 -48.27 81.83 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.131 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 65.7 m -53.61 -42.32 67.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.93 -43.12 92.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.889 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.42 153.39 5.25 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.591 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -39.05 107.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.519 2.146 . . . . 0.0 112.152 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 98.9 m -109.52 121.58 45.5 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.258 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.9 mp -113.85 152.58 30.51 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.182 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 tt -128.34 131.03 69.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.287 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.28 128.02 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.441 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.0 t30 -100.7 104.75 16.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.221 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.419 ' O ' ' O ' ' A' ' 147' ' ' LYS . 45.7 p90 -100.77 -11.74 19.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.919 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.1 p-10 -64.79 -33.93 77.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.848 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -99.52 7.45 45.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.758 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.9 mttm -134.71 152.04 51.46 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.856 0.36 . . . . 0.0 110.637 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.424 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -75.75 166.31 23.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.658 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.594 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.5 t90 -59.32 -48.11 82.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.244 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -54.26 -43.88 71.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.897 0.38 . . . . 0.0 110.061 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.8 t -62.97 -41.06 99.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.126 0.489 . . . . 0.0 110.343 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.0 -43.92 98.17 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.008 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 53.3 tp -61.58 -42.97 99.63 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.14 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.5 m -55.29 -45.34 76.2 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.12 -40.71 96.83 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.181 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -62.31 -42.54 99.45 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.341 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.54 -40.73 94.3 Favored Glycine 0 C--N 1.315 -0.62 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.24 -46.16 65.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.982 0.42 . . . . 0.0 111.016 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.73 -43.98 96.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.942 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 156' ' ' LEU . 32.8 p -92.89 -9.29 40.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.575 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.28 26.06 72.52 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -101.93 50.91 0.83 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.811 0.339 . . . . 0.0 110.809 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.51 -39.22 77.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.717 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.7 -46.87 87.76 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.414 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -60.03 -39.17 84.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.156 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.46 97.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.149 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.17 -29.15 70.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.149 0.499 . . . . 0.0 110.565 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -73.48 -54.44 8.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.149 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -64.86 -42.01 95.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.443 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 174' ' ' ASP . 81.0 mt -62.27 -43.84 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.527 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.34 -58.23 8.43 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.096 0.474 . . . . 0.0 110.738 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.08 -33.99 67.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.217 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -80.54 -36.3 33.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.123 0.487 . . . . 0.0 111.098 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.1 m-20 -55.34 -41.98 73.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.137 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.25 -41.98 98.92 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.785 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -64.88 -38.24 90.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.31 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.49 -42.35 99.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.646 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.83 -53.23 58.74 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.729 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.3 -41.9 89.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.575 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.75 -40.0 95.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.616 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.3 -32.64 74.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.44 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.32 -21.89 18.71 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.843 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.636 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.2 tt0 -64.5 -41.68 96.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.757 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.9 pt -76.07 134.82 28.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.22 106.91 9.56 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.4 pp -176.5 127.88 0.34 Allowed Pre-proline 0 N--CA 1.446 -0.637 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.527 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.2 Cg_exo -43.53 151.79 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.599 2.199 . . . . 0.0 112.594 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.41 142.21 53.69 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.655 2.237 . . . . 0.0 112.385 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.54 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -170.93 146.99 2.24 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.648 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.04 154.76 70.05 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.646 2.231 . . . . 0.0 112.153 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.518 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.59 162.93 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.416 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.53 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.2 t -143.45 169.93 16.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.919 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.53 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -147.88 137.37 22.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.154 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.5 pt -134.16 146.39 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.707 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.25 131.63 58.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.185 0.517 . . . . 0.0 110.49 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -151.65 154.62 36.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.32 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 89.7 m -121.75 122.64 39.97 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.014 0.435 . . . . 0.0 110.179 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.57 -25.73 66.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.463 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.11 -49.1 20.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.088 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.75 -9.05 58.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.38 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.0 m80 46.13 43.68 11.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.505 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.4 t -136.55 145.22 44.76 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.413 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.29 113.75 26.46 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.231 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.95 133.7 55.48 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.112 0.482 . . . . 0.0 110.304 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.6 tt -112.53 146.24 38.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.781 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.466 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 13.6 t90 -99.3 128.19 45.39 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.708 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -94.38 153.36 40.47 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.174 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.51 -18.41 48.99 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.924 2.416 . . . . 0.0 111.829 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.708 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.6 mt-10 -50.07 -18.86 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.369 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.466 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.0 p -75.26 168.17 20.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.485 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.45 -35.77 76.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.419 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.3 mt-30 -56.62 -40.7 75.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.743 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.92 -43.3 98.2 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.4 mt-30 -63.98 -40.65 96.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.944 0.402 . . . . 0.0 110.373 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.594 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.1 mmm -61.74 -41.79 98.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.195 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 69.9 mt -63.33 -48.34 78.41 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.843 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -54.4 -32.07 56.39 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -70.63 -18.81 62.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.621 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.96 -7.8 56.59 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.749 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.14 2.86 55.86 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -88.32 152.06 22.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.0 110.558 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.6 p -114.73 127.81 55.95 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.099 0.476 . . . . 0.0 110.387 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.24 145.67 24.31 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.901 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.456 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.64 150.55 46.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.453 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.32 131.71 43.96 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.318 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.62 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.69 92.77 25.63 Favored Pre-proline 0 N--CA 1.464 0.275 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.049 -179.445 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.711 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.8 Cg_exo -55.58 139.4 82.67 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.534 2.156 . . . . 0.0 111.392 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.71 -25.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.588 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.711 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.11 -49.04 29.06 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.583 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.6 mt -55.16 -37.01 66.45 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -66.38 35.89 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.837 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.583 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.56 87.71 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.794 0.33 . . . . 0.0 110.778 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.4 p -81.53 -14.9 56.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.449 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -90.94 -41.33 11.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.612 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.81 -16.79 64.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.696 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 56.01 43.4 27.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.439 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.37 -147.7 7.4 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.58 142.94 50.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.969 0.414 . . . . 0.0 110.233 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.3 149.61 28.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.312 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -100.65 -152.0 0.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.255 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 56.31 -91.74 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.722 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.512 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.91 175.14 9.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.648 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.512 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.6 mt -121.44 140.79 44.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.816 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.16 168.59 9.96 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.303 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.0 mt -147.22 150.97 35.91 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.464 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.7 -39.0 97.05 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.11 4.3 4.61 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.51 -57.95 3.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.933 0.397 . . . . 0.0 110.594 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -62.39 -37.18 84.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.109 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.0 -67.36 0.26 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.918 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -54.06 -41.77 68.52 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.06 18.12 0.15 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.684 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.98 47.72 0.26 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.3 mp 39.07 -109.82 0.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.696 0.284 . . . . 0.0 110.664 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.456 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.9 m120 -61.21 -44.26 97.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.372 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 83.98 8.18 84.43 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -99.29 -12.58 20.22 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.739 -0.271 . . . . 0.0 110.671 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.8 t 176.48 142.31 0.07 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.097 0.475 . . . . 0.0 110.488 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.3 tt -147.79 126.16 12.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.201 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -99.25 142.95 30.08 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.035 0.445 . . . . 0.0 110.621 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.63 106.54 18.52 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.433 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.474 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 93.2 t80 -102.23 -12.55 17.92 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.007 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.4 90.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.813 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.29 173.8 46.18 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.452 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -74.59 -112.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.691 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.57 -28.45 67.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.753 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -59.81 -43.86 94.28 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.913 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -63.72 -44.1 94.6 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.318 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.69 -59.38 4.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.181 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.81 -43.1 62.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.054 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.51 -43.94 76.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.129 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.9 mt -64.05 -43.55 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.962 0.411 . . . . 0.0 110.707 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -57.1 -37.67 72.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.067 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.14 0.8 20.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.278 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -114.73 91.14 24.47 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.248 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.83 -27.35 27.02 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.824 2.35 . . . . 0.0 111.619 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.51 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -41.26 98.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.637 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.8 mp -95.18 4.8 53.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.314 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.49 -35.61 70.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.711 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.37 4.56 14.98 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.436 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.541 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.71 121.54 81.52 Favored Pre-proline 0 N--CA 1.438 -1.033 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.581 -179.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.56 -37.71 27.03 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.242 1.961 . . . . 0.0 112.542 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.541 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -58.91 -43.8 91.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.59 -43.77 93.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.351 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.67 -40.65 95.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.534 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.0 t-20 -89.59 -12.4 39.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.647 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 61.92 31.97 18.0 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.78 44.38 1.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.329 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.77 135.47 43.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.455 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -116.2 132.58 56.62 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.468 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.495 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.9 87.92 6.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.775 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.461 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.1 mt -63.68 -41.74 98.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.817 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.474 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.47 166.45 34.66 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.1 p -75.59 -26.07 57.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.879 0.371 . . . . 0.0 110.823 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.541 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.2 tp10 -68.04 -34.25 76.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.444 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.486 ' O ' ' CG2' ' A' ' 296' ' ' THR . 98.0 m -72.47 20.59 0.07 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.688 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.541 ' H ' ' C ' ' A' ' 295' ' ' GLU . 49.0 t80 -57.54 -51.12 70.77 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.951 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.1 mmt-85 -107.43 149.26 28.11 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 41.0 tp -115.91 126.23 53.63 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 123.411 0.444 . . . . 0.0 110.888 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 42.0 t0 -149.55 166.91 27.81 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.554 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.57 -37.99 29.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.435 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -71.71 -64.99 0.82 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.604 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.8 p -60.96 -32.66 72.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.973 0.416 . . . . 0.0 111.183 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.93 -25.37 28.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.6 mtt -63.61 -41.21 98.33 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 120.984 0.421 . . . . 0.0 110.999 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -77.92 -44.42 27.03 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.052 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.85 -43.1 93.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.409 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.429 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.7 tp -60.36 -46.63 89.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.317 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -70.51 -39.22 74.22 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.559 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.495 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 73.4 ttt180 -61.42 -38.26 86.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.219 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.35 4.27 43.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.833 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.636 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.0 tttt -111.65 -11.84 13.96 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.136 0.493 . . . . 0.0 110.323 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.24 -37.25 84.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.68 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -61.15 -48.34 82.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.358 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.023 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.23 -2.71 58.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.395 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.481 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.67 178.91 1.29 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.468 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.9 Cg_exo -60.84 144.84 99.63 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.749 2.299 . . . . 0.0 112.204 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.4 ptt-85 -155.76 -179.48 8.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.57 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.74 136.5 53.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.34 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.35 147.32 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.452 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.2 p -120.5 136.01 54.9 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.7 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.1 p30 -98.97 -143.7 0.32 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.254 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.62 -37.27 86.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.509 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.53 -67.43 0.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.527 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.0 142.66 43.98 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.1 p -112.42 131.17 55.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.924 0.392 . . . . 0.0 110.397 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -118.99 129.31 55.08 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.547 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 m -86.16 131.24 34.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.982 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.3 mt -96.51 78.96 3.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.421 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.83 -32.67 74.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.491 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 t 176.78 110.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.103 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -123.79 91.11 50.04 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.228 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.3 Cg_exo -56.91 149.11 63.25 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.697 2.265 . . . . 0.0 111.765 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.22 81.99 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.602 0.564 . . . . 0.0 110.986 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.39 66.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.092 0.473 . . . . 0.0 110.236 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.2 mt -77.36 131.17 35.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.573 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.0 t -122.6 148.07 26.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.17 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 t -136.62 143.62 43.63 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.607 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.616 ' HG1' ' H ' ' A' ' 50' ' ' SER . 26.9 p -99.3 -59.31 1.75 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.557 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.616 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.3 p -79.52 156.37 27.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.63 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.5 t -74.88 -21.51 16.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.636 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.7 m -60.2 -51.88 67.68 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.455 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.7 mt -66.46 -42.3 87.79 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.36 0.6 . . . . 0.0 110.906 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.22 -54.41 4.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.145 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.0 -38.78 74.45 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 m -62.38 -43.6 98.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.884 0.373 . . . . 0.0 110.357 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.1 mt -65.28 -42.65 92.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.403 0.621 . . . . 0.0 110.719 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 tp -63.07 -38.65 92.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.221 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.64 -36.52 81.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.948 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -91.58 27.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.027 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.419 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 98.6 m-20 57.22 52.45 8.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.253 0.345 . . . . 0.0 110.789 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.72 75.39 31.31 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.049 0.452 . . . . 0.0 109.989 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.96 148.49 93.42 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.735 2.29 . . . . 0.0 112.177 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -112.75 135.97 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.195 0.521 . . . . 0.0 110.275 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.85 -43.3 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.192 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.68 130.85 53.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 110.55 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.9 p -155.14 168.42 27.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.461 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.37 -177.71 21.94 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.46 172.46 12.68 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.878 0.371 . . . . 0.0 110.541 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.1 p -132.9 -112.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.269 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.31 179.91 0.9 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.274 -178.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.7 Cg_exo -61.16 57.87 0.1 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.015 2.476 . . . . 0.0 112.126 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.8 t-20 -64.36 -33.41 75.79 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.878 -0.582 . . . . 0.0 110.571 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 43.9 m-20 93.71 -35.5 0.02 OUTLIER 'General case' 0 C--N 1.345 0.383 0 O-C-N 124.322 1.014 . . . . 0.0 109.948 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -63.27 -39.97 96.09 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.283 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -74.31 -25.43 19.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.7 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.16 -170.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.65 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.66 -155.24 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.828 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.8 p-10 -51.57 -7.95 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.641 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.53 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -85.42 115.23 23.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.564 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.23 70.71 1.33 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -144.64 148.55 34.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 110.69 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.8 mp -86.29 -98.63 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.266 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.8 -42.97 97.59 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.179 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.592 ' NE2' ' HZ2' ' A' ' 88' ' ' LYS . 35.7 tt0 91.88 52.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 124.136 0.898 . . . . 0.0 110.784 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -102.41 -8.92 20.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.446 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.9 p -64.78 -34.25 77.89 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.131 0.491 . . . . 0.0 110.648 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.592 ' HZ2' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.57 -24.62 1.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.6 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 81.9 t -69.29 -45.55 78.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.925 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.31 81.76 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.155 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.33 -38.22 88.63 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.276 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.51 -33.87 56.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.292 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.57 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.2 mmt-85 -88.76 0.99 55.97 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.67 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 57.2 mttp 83.02 -47.61 0.14 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 124.25 0.968 . . . . 0.0 110.316 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.5 mt -47.2 153.18 0.5 Allowed 'General case' 0 CA--C 1.49 -1.359 0 CA-C-O 117.604 -1.189 . . . . 0.0 109.124 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.644 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 122.31 91.72 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 O-C-N 125.54 1.775 . . . . 0.0 110.469 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -74.81 142.59 44.21 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.963 0.411 . . . . 0.0 110.299 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 mt -131.65 26.41 4.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.741 0.305 . . . . 0.0 110.464 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.06 137.29 34.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.946 0.403 . . . . 0.0 110.479 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.52 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 90.7 mt -137.17 164.94 28.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.354 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.52 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.21 -28.73 1.82 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.03 70.6 7.79 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.25 0.548 . . . . 0.0 110.348 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.97 145.25 98.8 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.808 2.339 . . . . 0.0 112.041 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.8 t -134.85 137.11 42.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.541 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.89 -38.44 83.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.665 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.28 -42.21 96.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.501 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.6 98.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.526 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.54 -43.36 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.037 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.07 -35.17 77.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.376 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.31 -18.74 60.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.495 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.6 -6.46 58.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.561 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.5 mtp 47.87 55.74 17.11 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.627 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.14 149.35 64.34 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.791 2.327 . . . . 0.0 112.121 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.41 -72.76 0.67 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.481 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.6 tp -111.33 113.15 25.41 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.367 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.8 mt -102.19 126.56 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.451 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.6 mt -110.57 134.0 52.79 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.173 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.55 140.22 45.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.446 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 121' ' ' THR . 94.8 p -83.61 167.2 17.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.665 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.58 -36.66 79.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.472 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.426 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.7 t -138.24 157.71 45.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.471 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.36 174.63 34.16 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.29 -33.98 87.77 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -123.57 150.98 43.41 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.92 0.391 . . . . 0.0 110.562 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.6 t -63.57 140.16 58.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.291 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.94 11.44 11.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.631 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.1 -39.25 89.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.098 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.627 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.82 -35.53 24.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.564 0.697 . . . . 0.0 110.705 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -71.11 -35.04 71.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.408 0.623 . . . . 0.0 110.787 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -43.07 -63.19 0.85 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.171 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.627 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.1 p-10 -65.89 -42.81 89.79 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.535 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -61.78 -32.6 72.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.114 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 129' ' ' LEU . 67.6 mt -73.83 -40.3 63.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.187 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.29 -49.31 77.59 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.195 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.5 m -52.62 -42.66 64.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.313 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.08 -42.97 92.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.993 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.31 152.61 5.03 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.623 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -38.58 107.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.677 2.252 . . . . 0.0 112.317 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.404 ' HG1' ' CB ' ' A' ' 133' ' ' LEU . 94.2 m -109.35 120.95 44.08 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.293 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.54 153.64 29.69 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.225 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 tt -130.49 128.93 64.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.376 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.1 mt -110.42 122.84 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.574 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.538 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 53.8 t30 -101.11 106.35 17.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.349 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -100.17 0.45 40.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.897 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -65.52 -34.93 79.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.585 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.0 p-10 -101.29 9.5 41.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -133.85 148.08 51.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.537 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.409 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 22.5 p -77.69 169.05 18.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.579 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.598 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.6 t90 -58.71 -49.74 76.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.087 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -54.41 -46.15 73.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.011 0.434 . . . . 0.0 110.144 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.9 t -63.24 -40.79 98.43 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.345 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.4 tp -60.83 -44.37 97.03 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.367 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.2 -43.49 98.79 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.202 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -54.21 -45.8 72.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.772 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.8 -39.92 93.41 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.854 0.359 . . . . 0.0 110.268 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.439 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.2 mm? -61.9 -42.25 98.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.059 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.8 -38.87 94.81 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.21 -45.75 65.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.963 0.411 . . . . 0.0 110.798 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.72 -44.15 96.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.715 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -92.86 -9.28 40.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.53 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.0 26.51 72.35 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -102.31 50.11 0.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.831 0.348 . . . . 0.0 110.704 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.21 -39.14 78.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.691 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.67 -47.4 85.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.256 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.419 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 86.6 mt-30 -59.99 -39.66 86.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.335 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.59 -40.89 98.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.328 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.15 -29.47 70.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.995 0.426 . . . . 0.0 110.542 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.09 -54.13 8.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.121 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -64.44 -42.79 95.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.474 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.9 mt -62.62 -43.72 98.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.499 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.71 -60.8 3.12 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.255 0.55 . . . . 0.0 110.402 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.23 -34.31 63.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.271 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -80.29 -34.96 36.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.937 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.2 m-20 -55.02 -41.53 71.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.185 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.18 -41.71 98.59 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.575 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.04 -37.74 88.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.269 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.23 -42.6 99.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.796 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.69 -53.04 61.46 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.19 0.519 . . . . 0.0 110.668 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.37 -41.45 89.44 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.544 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.28 -39.9 94.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.644 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.52 -33.23 74.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.365 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -93.21 -21.55 19.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.714 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.626 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -65.21 -41.44 94.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.667 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 30.7 pt -77.48 133.94 29.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.05 0.452 . . . . 0.0 110.696 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -128.09 107.03 9.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.302 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.59 127.76 0.33 Allowed Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.556 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.445 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.3 Cg_exo -43.72 151.7 0.39 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.702 2.268 . . . . 0.0 112.598 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.63 142.51 53.49 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.629 2.219 . . . . 0.0 112.416 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.542 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.61 146.89 2.39 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.659 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.27 154.62 69.4 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.753 2.302 . . . . 0.0 112.29 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.529 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.98 163.4 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.42 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.529 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 1.9 t -143.4 169.97 16.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.896 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.447 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.18 137.4 22.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.964 0.412 . . . . 0.0 110.159 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 38.0 pt -133.98 145.53 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.639 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -131.97 131.5 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.143 0.497 . . . . 0.0 110.548 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -152.62 156.04 38.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.418 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 199' ' ' ALA . 88.4 m -121.57 122.51 39.83 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.947 0.404 . . . . 0.0 110.331 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.496 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.41 -26.26 66.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.414 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.1 -48.74 22.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.014 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.83 -10.09 59.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.414 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.496 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.6 m80 45.88 46.65 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.563 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.0 t -132.16 143.09 49.73 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.402 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -108.08 107.26 17.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.296 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -116.96 130.1 56.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.099 0.476 . . . . 0.0 110.352 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.5 tt -112.03 145.77 39.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.603 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.453 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 9.1 t90 -98.44 127.53 44.41 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.09 0.472 . . . . 0.0 110.043 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.71 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -92.08 153.18 43.26 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.156 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.04 -17.59 45.94 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.822 2.348 . . . . 0.0 111.923 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.71 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -50.19 -19.13 0.7 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.429 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.453 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.4 p -74.52 163.71 27.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.497 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.38 -27.73 64.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.458 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.492 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.5 mt-30 -63.37 -42.74 98.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.628 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.69 -43.58 98.9 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.409 ' OE1' ' C ' ' A' ' 148' ' ' SER . 74.7 mt-30 -63.75 -38.85 92.64 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.865 0.364 . . . . 0.0 110.46 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 85.9 mmm -62.27 -41.52 98.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.251 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.1 -49.25 72.96 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.628 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -52.36 -33.36 42.68 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -71.06 -20.43 62.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.491 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 75.0 mt -87.56 -6.45 58.32 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.63 -6.73 57.45 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -77.74 148.25 34.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.754 0.311 . . . . 0.0 110.622 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.7 p -113.02 126.78 55.87 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.093 0.473 . . . . 0.0 110.331 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -91.94 145.86 24.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.925 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.472 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.88 150.26 46.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.462 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.17 131.4 44.02 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.396 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.627 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.53 93.48 27.75 Favored Pre-proline 0 C--O 1.235 0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.998 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.721 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.7 Cg_exo -55.25 138.37 79.27 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.652 2.234 . . . . 0.0 111.54 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.44 -24.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.537 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.721 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.62 -50.13 21.36 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.586 ' C ' ' H ' ' A' ' 232' ' ' ALA . 98.5 mt -54.55 -35.98 63.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.769 0.318 . . . . 0.0 110.278 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.94 36.2 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.744 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.99 87.68 0.01 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.757 0.313 . . . . 0.0 110.873 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.3 p -81.61 -13.47 57.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.423 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -91.67 -39.48 11.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.544 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.7 t -66.63 -16.84 64.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.613 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.03 43.86 26.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.437 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 178.79 -146.45 7.3 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.22 142.21 50.13 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.925 0.393 . . . . 0.0 110.303 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.18 149.58 28.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.384 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -102.41 -149.36 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.31 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 54.94 -93.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.648 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.484 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 13.0 tt -126.65 173.75 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.581 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.484 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 95.1 mt -121.75 140.6 45.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.767 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.77 172.29 7.35 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.336 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 67.2 mt -146.82 149.08 32.61 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.09 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -62.89 -39.49 98.09 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.94 2.07 3.93 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -78.62 -57.54 3.71 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.93 0.395 . . . . 0.0 110.694 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -62.36 -36.74 83.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.236 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 6.1 mp -53.84 -67.07 0.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.936 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.53 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.79 -42.24 68.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.215 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.01 18.09 0.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.652 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.07 46.91 0.24 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 7.6 mp 39.83 -110.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.637 0.256 . . . . 0.0 110.608 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.472 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 10.8 m120 -60.77 -44.52 96.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.427 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.46 8.03 83.83 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -98.7 -12.54 20.91 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.778 -0.248 . . . . 0.0 110.636 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.1 t 175.75 143.06 0.06 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 110.487 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -147.99 125.9 11.99 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.051 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -98.93 143.44 29.22 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 120.882 0.372 . . . . 0.0 110.867 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.7 mt -94.62 106.3 18.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.584 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.453 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.1 t80 -101.86 -13.15 17.78 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.223 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.03 -40.39 91.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.821 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.64 173.15 45.86 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.457 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.9 m-20 -74.19 -112.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 0.0 110.74 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.76 -28.78 67.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.701 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.84 -44.13 90.89 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.314 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.56 -44.36 94.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.405 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.42 -59.81 3.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.223 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.35 -43.23 61.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.187 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.86 74.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.159 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.2 mt -64.35 -43.57 97.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.64 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.72 -37.58 71.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.246 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.06 0.88 19.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.27 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -114.99 91.13 25.51 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.179 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.01 -27.28 28.08 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.785 2.323 . . . . 0.0 111.81 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -41.24 98.9 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.559 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.9 mp -95.34 5.01 52.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.306 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.03 -35.28 69.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.679 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.21 4.62 14.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.516 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.541 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.82 121.17 80.38 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.618 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -47.53 -37.45 26.34 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.432 2.088 . . . . 0.0 112.46 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.541 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.89 -43.58 90.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.826 0.346 . . . . 0.0 110.235 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.89 -43.76 92.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.291 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.86 -40.53 95.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.494 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 48.0 t-20 -89.64 -12.87 38.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.607 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.39 32.43 16.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.801 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.98 44.03 1.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.409 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.03 135.56 42.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.429 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.97 131.81 56.86 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.459 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.495 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.71 88.73 6.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.708 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.469 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.2 mt -63.95 -41.44 97.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.851 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.453 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.62 165.86 33.86 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.521 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 77.7 p -75.73 -25.62 56.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.831 0.348 . . . . 0.0 110.731 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.4 tp10 -68.29 -33.99 75.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.457 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.495 ' O ' ' CG2' ' A' ' 296' ' ' THR . 97.3 m -73.04 21.53 0.07 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.597 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.543 ' H ' ' C ' ' A' ' 295' ' ' GLU . 50.4 t80 -57.66 -50.86 71.78 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.994 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.3 mmt-85 -108.97 150.89 27.06 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.5 tp -115.48 125.03 52.57 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.765 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 304' ' ' ALA . 40.7 t0 -148.04 165.85 29.54 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.569 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -49.36 -38.19 27.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.524 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -70.72 -65.63 0.71 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.212 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -61.04 -32.96 72.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.021 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 300' ' ' ASP . . . -53.6 -25.7 18.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.495 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.6 mtt -63.7 -40.73 97.51 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 120.835 0.35 . . . . 0.0 110.979 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -78.01 -44.66 25.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.941 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.2 -42.83 91.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.407 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.43 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 47.8 tp -59.57 -47.56 85.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.468 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -69.92 -39.32 76.22 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.606 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.495 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.1 ttt180 -61.77 -37.9 86.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.181 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.6 mt -87.76 4.82 42.85 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.626 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.58 -11.74 13.54 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.018 0.437 . . . . 0.0 110.288 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.95 -36.96 85.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.614 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -61.01 -49.11 78.73 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.434 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.099 179.875 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.614 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -90.37 -2.62 57.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.394 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.476 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.51 178.87 1.3 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.485 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.5 Cg_exo -60.79 145.11 99.47 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.556 2.17 . . . . 0.0 112.191 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.614 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.5 ptt-85 -155.99 -179.77 8.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.609 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -115.6 136.35 53.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.292 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -124.07 146.28 29.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.369 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.9 p -119.84 135.6 54.8 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.714 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.6 p30 -98.43 -144.41 0.31 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.296 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.36 -36.54 84.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.473 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.489 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -147.53 -70.4 0.23 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.593 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.77 144.09 41.68 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.0 p -112.58 130.05 56.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.783 0.325 . . . . 0.0 110.369 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -114.71 129.26 56.66 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.599 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -86.61 130.63 34.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.308 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 70.8 mt -97.84 78.71 2.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.2 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.03 -32.53 74.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.511 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.4 t 178.05 109.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.076 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -123.87 90.76 50.37 Favored Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.218 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.1 Cg_exo -56.66 149.3 59.68 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.709 2.272 . . . . 0.0 111.646 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.3 82.51 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.491 0.494 . . . . 0.0 110.997 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.57 66.84 0.88 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.303 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.2 mt -77.38 131.2 35.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.433 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.8 t -122.46 147.64 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.231 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.5 t -136.51 144.03 44.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.576 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.671 ' HG1' ' H ' ' A' ' 50' ' ' SER . 18.9 p -100.37 -58.9 1.81 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.46 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.671 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.5 p -79.43 155.49 28.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.901 0.381 . . . . 0.0 110.642 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.6 t -74.2 -21.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.696 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.2 m -60.27 -51.7 68.41 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.456 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.4 mt -66.32 -42.62 87.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.532 0.682 . . . . 0.0 110.859 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.3 m -43.29 -54.58 4.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.198 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.91 -38.73 75.36 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.1 m -62.52 -43.73 98.09 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.172 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 48.2 mt -65.31 -42.57 92.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.052 0.453 . . . . 0.0 110.665 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.7 tp -62.95 -38.67 91.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.254 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.69 -36.45 80.92 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.068 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.4 pt -91.34 27.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.081 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 56.99 52.15 9.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.744 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.04 75.34 35.18 Favored Pre-proline 0 C--N 1.334 -0.081 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.34 148.66 92.67 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.596 2.197 . . . . 0.0 112.041 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -112.21 135.76 50.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 121.22 0.533 . . . . 0.0 110.229 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.4 pt -69.73 -43.38 80.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.219 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.8 130.41 52.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.013 0.435 . . . . 0.0 110.599 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.9 p -155.09 168.8 25.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.354 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.48 -177.73 21.86 Favored Glycine 0 N--CA 1.465 0.572 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.36 171.46 13.7 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.7 0.286 . . . . 0.0 110.575 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.0 p -133.82 -110.71 0.22 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.498 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.35 179.78 0.91 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.244 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.1 Cg_exo -60.94 58.51 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.912 2.408 . . . . 0.0 112.089 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.544 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 56.7 t-20 -64.0 -35.23 80.02 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.699 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 48.0 m-20 95.31 -37.15 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.979 1.425 . . . . 0.0 109.986 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -62.69 -40.51 97.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.264 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -72.97 -26.53 23.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.815 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.86 -171.9 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.717 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.513 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -74.33 -153.13 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.805 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.6 p-10 -54.03 -6.86 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.608 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.77 114.06 23.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.962 0.41 . . . . 0.0 110.484 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.48 72.21 1.3 Allowed Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.457 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.4 m-85 -143.87 148.44 35.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 110.806 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.522 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -85.68 -99.24 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.065 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.67 -43.46 96.62 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.377 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.542 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 36.0 tt0 92.08 52.62 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.314 1.009 . . . . 0.0 111.016 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -103.01 -9.16 20.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.507 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.457 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.52 -34.06 77.36 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.136 0.493 . . . . 0.0 110.686 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.542 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.3 -24.67 1.27 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.491 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.94 -45.36 77.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.14 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.3 -48.69 80.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.224 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.49 -38.42 89.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.28 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.55 -32.95 52.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.292 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.562 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.51 1.19 56.25 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 118.868 -0.586 . . . . 0.0 110.681 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 83.16 -48.37 0.14 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.535 1.147 . . . . 0.0 110.348 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.629 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.1 mt -46.81 152.73 0.47 Allowed 'General case' 0 CA--C 1.49 -1.351 0 CA-C-O 117.632 -1.175 . . . . 0.0 108.951 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.629 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.0 tt0 122.25 91.32 0.0 OUTLIER 'General case' 0 C--N 1.358 0.967 0 O-C-N 125.515 1.76 . . . . 0.0 110.66 -178.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.52 143.04 44.72 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.201 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.9 mt -132.08 26.25 4.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.427 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -139.69 136.52 34.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.577 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.514 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 91.5 mt -136.62 164.72 30.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.45 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.514 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.76 -28.88 1.73 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -151.46 70.72 8.25 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.053 0.454 . . . . 0.0 110.354 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.99 145.3 98.69 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.612 2.208 . . . . 0.0 112.016 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.9 t -135.69 137.65 41.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.537 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.08 -38.12 82.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.68 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.27 -42.26 96.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.576 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.07 -41.56 98.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.429 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.57 -43.47 98.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.935 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.09 -35.11 77.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.439 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.34 -19.0 61.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.554 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.54 -6.58 58.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.478 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.4 mtp 47.68 55.81 17.07 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.663 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.8 Cg_endo -70.05 149.4 64.98 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.919 2.412 . . . . 0.0 112.034 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.27 -71.68 0.7 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.43 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.0 tp -112.89 113.62 25.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.221 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.7 mt -102.17 126.85 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.289 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 mt -110.82 133.75 53.1 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.042 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.61 140.18 45.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.6 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 121' ' ' THR . 95.6 p -83.28 167.44 17.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.783 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.94 79.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.475 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.422 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.6 t -138.44 158.02 45.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.471 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.5 175.34 34.16 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.24 -33.91 87.5 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -124.09 150.95 44.43 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.593 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.5 t -63.71 140.68 58.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.306 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.56 11.63 10.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.674 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.7 mp -60.87 -39.58 89.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.165 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.633 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.6 -35.63 24.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.587 0.708 . . . . 0.0 110.596 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.4 mt -70.92 -35.12 72.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.867 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -43.28 -62.82 0.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.298 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.633 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.2 p-10 -65.91 -42.95 89.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.801 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -61.8 -32.85 73.18 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.06 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 129' ' ' LEU . 67.6 mt -73.4 -40.52 64.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.459 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.55 -48.45 80.85 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.278 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.1 m -53.24 -42.11 66.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.33 -42.81 91.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.612 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.11 152.27 5.06 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.673 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -39.11 106.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.572 2.182 . . . . 0.0 111.986 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 95.2 m -108.89 122.06 46.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.323 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.94 154.47 28.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.282 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 tt -130.23 129.22 65.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.474 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 93.1 mt -110.66 122.93 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.503 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.537 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 52.7 t30 -101.45 105.14 16.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.363 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -98.0 -0.19 45.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.004 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.2 p-10 -65.23 -35.04 79.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.028 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.594 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.1 p-10 -101.76 8.51 41.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -133.13 146.82 51.95 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.889 0.376 . . . . 0.0 110.565 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.427 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 21.1 p -78.61 170.41 16.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.545 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.597 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 88.1 t90 -58.31 -49.54 76.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.247 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -54.75 -47.39 73.91 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.22 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.8 t -63.33 -40.81 98.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.121 0.486 . . . . 0.0 110.264 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.01 -44.11 97.9 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.224 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 53.6 tp -61.1 -42.85 99.27 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.314 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.6 m -55.35 -46.39 76.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.666 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.44 -40.1 93.24 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.253 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.1 mm? -61.84 -42.18 98.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.962 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.42 -38.92 95.42 Favored Glycine 0 C--N 1.317 -0.523 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.56 -45.02 66.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.402 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.64 -43.99 96.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.76 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -94.01 -8.48 39.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.563 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.83 25.83 71.97 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -102.81 51.17 0.81 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.787 0.327 . . . . 0.0 110.818 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.23 -38.73 78.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.117 0.484 . . . . 0.0 110.744 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.87 -46.99 87.55 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.392 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -61.37 -39.17 89.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.296 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.1 -40.57 98.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.309 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.73 -28.06 69.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.23 0.538 . . . . 0.0 110.458 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -75.2 -52.76 10.15 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.174 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.72 -42.92 97.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.45 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 174' ' ' ASP . 86.7 mt -62.83 -43.83 99.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.594 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.47 -61.09 2.78 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.15 0.5 . . . . 0.0 110.56 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.63 -35.4 63.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.228 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -79.59 -35.14 40.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.106 0.479 . . . . 0.0 111.265 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.4 m-20 -55.33 -40.67 71.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.297 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.45 -41.87 99.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.631 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.36 -38.08 88.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.31 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 77.3 mt -62.27 -42.58 99.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.711 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.83 -53.25 58.44 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.053 0.454 . . . . 0.0 110.729 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.41 -41.39 89.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.587 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.72 94.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.624 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.08 -32.71 74.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.332 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -94.05 -21.88 18.87 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.764 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.631 ' NE2' ' HZ2' ' A' ' 312' ' ' LYS . 52.1 tt0 -64.79 -41.88 95.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.72 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.5 pt -76.33 134.43 28.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.684 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.58 106.52 9.22 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.184 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.5 127.92 0.34 Allowed Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.586 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.445 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.9 Cg_exo -43.57 151.69 0.36 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.615 2.21 . . . . 0.0 112.508 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.68 142.33 52.68 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.806 2.337 . . . . 0.0 112.299 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.39 146.68 2.46 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.664 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.02 154.01 71.38 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.716 2.277 . . . . 0.0 112.122 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.521 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.41 162.86 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.434 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.566 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.0 t -143.5 169.64 17.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.805 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.566 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -147.74 137.38 22.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.276 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.5 pt -134.24 146.25 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.652 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.47 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.88 131.52 59.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.081 0.467 . . . . 0.0 110.504 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -151.63 154.69 36.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.391 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.2 m -121.97 122.85 40.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.973 0.416 . . . . 0.0 110.268 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.42 -25.76 66.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.424 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.401 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.31 -49.15 20.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.105 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.23 -10.79 60.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.5 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.1 m80 47.93 42.95 17.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.495 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.1 t -136.47 145.35 45.07 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.386 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.22 113.92 26.76 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.296 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.89 133.62 55.52 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.359 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.41 146.18 38.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.721 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.48 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.4 t90 -99.69 127.93 45.8 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.021 0.438 . . . . 0.0 109.952 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.706 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -93.12 153.69 41.69 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.947 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.401 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.2 Cg_endo -67.58 -18.33 48.6 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.895 2.397 . . . . 0.0 111.931 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.706 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -49.6 -18.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.504 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.48 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.0 p -75.61 167.51 21.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.485 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.46 -35.13 75.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.447 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.2 mt-30 -56.42 -41.33 76.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.676 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.35 -42.89 97.63 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.483 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.7 mt-30 -63.59 -40.45 96.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.881 0.372 . . . . 0.0 110.302 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.597 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.2 mmm -61.87 -41.58 98.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.182 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.59 -49.95 71.34 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.661 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -52.92 -32.36 45.04 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -71.94 -19.89 61.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.54 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 64.4 mt -87.46 -6.45 58.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.57 3.94 57.24 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -89.28 151.39 22.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.711 0.291 . . . . 0.0 110.553 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.6 p -114.44 127.63 55.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.994 0.426 . . . . 0.0 110.402 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.563 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.97 144.71 25.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.905 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.468 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.23 150.71 47.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.416 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.79 131.36 44.62 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.298 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.626 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.82 92.49 25.34 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.123 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.715 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.8 Cg_exo -55.24 138.9 80.52 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.603 2.202 . . . . 0.0 111.47 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.65 -25.03 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.662 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.715 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.92 -49.68 27.3 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.586 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -54.66 -36.76 64.94 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.59 35.82 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.845 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.02 87.47 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.837 0.351 . . . . 0.0 110.684 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.3 p -81.25 -14.23 57.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.486 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.45 -40.85 11.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.565 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.9 t -66.76 -16.52 64.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.639 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.1 43.64 26.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.518 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.31 -145.55 6.68 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -123.27 143.05 50.31 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 110.349 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.1 ttt-85 -151.49 148.82 28.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.36 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -100.24 -152.62 0.43 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.274 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 56.46 -92.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.593 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.509 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.56 175.09 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.635 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.509 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -120.72 140.29 45.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.769 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.01 169.03 9.71 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.406 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.8 mt -147.59 150.61 34.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.317 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.85 -38.82 96.68 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.39 3.81 4.62 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -77.24 -58.02 3.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.877 0.37 . . . . 0.0 110.678 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.36 -36.62 82.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.255 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.45 -67.44 0.25 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.828 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.74 -42.11 67.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.22 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.74 18.17 0.14 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.742 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.41 47.96 0.21 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.3 mp 39.19 -110.22 0.09 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.734 0.302 . . . . 0.0 110.631 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.468 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.1 m120 -60.97 -44.87 96.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.467 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.61 8.39 83.06 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -99.4 -12.26 20.41 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.607 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.6 t 176.15 142.46 0.07 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.073 0.463 . . . . 0.0 110.555 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -148.17 125.74 11.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.058 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -98.97 142.9 29.88 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.024 0.44 . . . . 0.0 110.567 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.5 mt -94.47 106.62 18.61 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.533 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.477 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 93.0 t80 -102.66 -11.95 18.05 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.199 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.75 -39.89 88.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.8 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.13 173.82 46.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.456 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 96.3 m-20 -74.98 -112.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.799 0.333 . . . . 0.0 110.658 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.83 -28.44 67.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.753 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.55 -43.97 93.39 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.031 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.34 -44.47 94.8 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.433 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.53 -59.51 4.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.243 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.6 -43.19 62.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.128 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.39 -44.08 75.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.2 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.4 mt -64.19 -43.61 97.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.949 0.404 . . . . 0.0 110.735 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -56.8 -37.68 71.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.121 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.31 1.03 19.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.386 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -114.64 91.29 24.71 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.423 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.79 -27.54 27.38 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.836 2.357 . . . . 0.0 111.696 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.39 -41.32 98.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.63 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.8 mp -95.32 4.83 53.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.251 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.71 -35.58 70.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.697 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.62 4.68 15.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.428 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.553 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.74 121.71 82.2 Favored Pre-proline 0 N--CA 1.441 -0.916 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.575 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.34 -38.21 26.15 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.32 2.014 . . . . 0.0 112.446 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.553 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -58.83 -43.77 90.76 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.821 0.343 . . . . 0.0 110.077 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.96 -43.64 92.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.373 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.85 -40.75 95.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.576 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.446 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 48.6 t-20 -89.27 -12.59 40.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.648 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.3 mtmt 62.52 31.92 16.79 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -88.67 44.7 1.23 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.391 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.6 134.95 46.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.515 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -116.25 132.38 56.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.468 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.495 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.52 88.22 6.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.693 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.468 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.8 mt -63.88 -41.61 97.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.772 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.477 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.83 167.15 34.51 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.2 p -75.6 -25.66 57.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.822 0.344 . . . . 0.0 110.711 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.6 tp10 -68.09 -34.54 76.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.512 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.492 ' O ' ' CG2' ' A' ' 296' ' ' THR . 98.6 m -72.5 17.68 0.11 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.598 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.513 ' O ' ' NE2' ' A' ' 212' ' ' GLN . 47.8 t80 -56.89 -51.28 69.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.115 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 -106.09 147.4 28.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.062 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.3 tp -115.27 125.61 53.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 123.461 0.476 . . . . 0.0 110.796 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 304' ' ' ALA . 42.5 t0 -149.62 166.75 28.36 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.52 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -49.5 -38.13 29.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.476 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -71.51 -64.92 0.83 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.24 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -61.28 -32.53 72.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.948 0.404 . . . . 0.0 110.944 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 300' ' ' ASP . . . -54.56 -25.8 28.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.393 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.7 mtt -63.57 -41.11 98.41 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.898 0.38 . . . . 0.0 110.811 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.6 -44.59 27.87 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.848 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 77.4 t -66.12 -42.87 92.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.434 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 48.4 tp -59.88 -46.87 87.94 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.374 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -70.72 -39.12 73.58 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.463 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.495 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.2 ttt180 -61.56 -38.06 86.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.273 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.59 4.62 43.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.914 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.631 ' HZ2' ' NE2' ' A' ' 183' ' ' GLN . 87.0 tttt -111.95 -12.27 13.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.118 0.485 . . . . 0.0 110.423 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.55 -37.01 84.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.678 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.02 -48.73 80.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.387 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.228 179.771 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -90.1 -2.69 58.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.406 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.04 1.25 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.489 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.2 Cg_exo -60.78 145.09 99.5 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.75 2.3 . . . . 0.0 112.168 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.04 -179.65 8.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.585 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.61 136.06 53.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.311 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -123.34 146.24 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.358 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.0 p -120.35 136.42 54.71 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.767 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 53.1 p30 -100.03 -142.99 0.33 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.2 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -62.87 -37.19 85.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.513 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.464 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -152.01 -59.99 0.16 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.413 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -60.52 139.82 48.11 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.7 p -111.83 129.98 55.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.916 0.388 . . . . 0.0 110.461 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.97 128.84 53.94 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.523 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.8 m -85.45 130.62 34.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.222 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.9 mt -96.27 79.04 3.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.311 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.55 -32.03 73.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.485 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.01 109.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.063 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -121.73 91.31 48.59 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.226 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.8 Cg_exo -57.05 148.95 65.58 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.759 2.306 . . . . 0.0 111.787 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.72 82.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 O-C-N 123.566 0.541 . . . . 0.0 110.983 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.24 66.95 0.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.111 0.482 . . . . 0.0 110.233 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.75 130.74 35.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.589 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.5 t -122.71 146.07 28.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.106 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 t -135.85 143.47 45.12 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.624 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.557 ' HG1' ' H ' ' A' ' 50' ' ' SER . 25.5 p -99.24 -59.31 1.75 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.51 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.557 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.8 p -79.37 154.62 28.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.638 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.4 t -73.98 -21.72 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.573 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.404 ' O ' ' OG ' ' A' ' 56' ' ' SER . 99.8 m -60.28 -52.0 67.12 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.477 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.45 -42.34 87.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.368 0.604 . . . . 0.0 110.943 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.22 -53.93 4.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.099 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.1 -37.48 72.86 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 52' ' ' THR . 5.8 m -62.76 -44.6 95.77 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-O 120.848 0.356 . . . . 0.0 110.424 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.6 mt -66.19 -41.95 89.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.477 0.656 . . . . 0.0 110.728 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.57 -40.34 96.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.431 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.93 -35.71 75.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.976 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.7 pt -91.51 28.44 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.138 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.72 51.42 11.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.851 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.45 75.02 27.89 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.984 0.421 . . . . 0.0 109.941 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.17 151.3 85.94 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.765 2.31 . . . . 0.0 112.263 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.59 137.3 47.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.207 0.527 . . . . 0.0 110.235 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.417 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -69.13 -43.7 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.218 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.03 130.86 53.17 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.959 0.409 . . . . 0.0 110.548 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.529 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.1 p -155.59 168.96 25.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.408 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.86 -177.38 21.64 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.06 172.21 12.95 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.976 0.417 . . . . 0.0 110.498 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.8 p -134.05 -110.38 0.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.402 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.18 179.74 0.92 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.323 -179.018 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.5 Cg_exo -60.99 58.93 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 123.03 2.487 . . . . 0.0 112.088 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 56.7 t-20 -64.22 -35.16 79.92 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.586 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.602 HD22 ' HG1' ' A' ' 294' ' ' THR . 46.2 m-20 94.91 -37.67 0.01 OUTLIER 'General case' 0 C--N 1.346 0.454 0 O-C-N 124.377 1.048 . . . . 0.0 109.938 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -62.7 -40.08 96.02 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.244 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -73.88 -26.77 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.724 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.76 -172.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.627 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.64 -152.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.742 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.6 p-10 -54.76 -6.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.681 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.516 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -87.06 113.68 23.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.609 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.25 73.06 1.27 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.506 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.2 m-85 -143.94 148.58 35.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.825 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -85.84 -99.36 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.086 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.09 -42.95 96.76 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.142 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.548 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.2 tt0 91.6 53.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.088 0.867 . . . . 0.0 110.834 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -103.47 -9.21 19.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.453 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.506 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.2 p -64.9 -33.78 76.84 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.112 0.482 . . . . 0.0 110.664 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.548 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.62 -23.8 1.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.554 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.5 t -69.52 -46.0 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.978 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.35 81.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.117 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.72 -38.2 89.54 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.284 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.66 -32.16 50.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.226 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.572 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.5 mmt-85 -90.12 1.7 56.1 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 119.204 -0.426 . . . . 0.0 110.609 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 82.85 -49.11 0.16 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.212 0.945 . . . . 0.0 110.322 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.642 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.3 mt -46.49 153.96 0.33 Allowed 'General case' 0 CA--C 1.49 -1.34 0 CA-C-O 117.587 -1.197 . . . . 0.0 109.148 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.642 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.2 tt0 121.23 92.19 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 O-C-N 125.558 1.786 . . . . 0.0 110.529 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.529 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.21 143.46 43.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.218 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -132.12 26.95 4.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.733 0.301 . . . . 0.0 110.462 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.54 138.42 34.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.959 0.409 . . . . 0.0 110.469 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.521 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.6 mt -137.3 165.02 28.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.351 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.521 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.29 -28.59 1.81 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.95 70.95 7.15 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.188 0.518 . . . . 0.0 110.358 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.24 145.69 98.0 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 122.803 2.335 . . . . 0.0 112.032 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.2 t -134.38 136.64 43.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.568 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.14 82.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.716 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.5 -41.94 96.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.507 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.47 98.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.514 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.66 -43.35 98.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.06 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.99 -35.17 77.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.311 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -18.52 60.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.468 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.5 -6.34 58.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.526 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.0 mtp 48.0 55.74 17.17 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.651 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.15 149.12 63.94 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.777 2.318 . . . . 0.0 112.114 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -101.2 -73.37 0.65 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.46 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.3 tp -110.84 112.63 24.62 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.324 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -101.13 125.99 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.446 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.2 mt -109.5 133.27 53.28 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.149 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.22 139.48 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.484 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 121' ' ' THR . 92.9 p -83.42 168.41 16.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.648 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.56 80.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.44 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.426 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -139.51 159.18 42.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.424 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.2 177.01 33.46 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.94 87.5 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.77 151.98 44.42 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.962 0.41 . . . . 0.0 110.527 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.6 t -62.97 141.07 58.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.362 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.66 10.15 10.96 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.647 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.7 mp -60.98 -39.18 88.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.061 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.68 -35.91 24.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.54 0.686 . . . . 0.0 110.671 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.5 mt -70.83 -35.57 72.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.458 0.647 . . . . 0.0 110.774 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -42.78 -62.86 0.89 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.265 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.83 -42.61 90.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.994 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -62.33 -32.97 73.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.129 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.8 mt -73.48 -40.71 63.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.19 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.41 -48.66 79.96 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.206 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.7 m -53.28 -42.16 66.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.208 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.01 -43.04 92.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.002 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.62 154.08 5.34 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.625 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -39.13 107.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.666 2.244 . . . . 0.0 112.298 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 94.5 m -109.75 121.4 45.14 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.252 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.28 152.82 30.75 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.252 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 tt -128.27 131.42 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.359 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.29 127.42 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.397 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.88 103.6 14.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.364 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.9 p90 -101.12 -11.32 19.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.782 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.91 -33.47 76.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.622 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.2 p-10 -98.35 7.57 46.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.643 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.7 mttm -135.33 155.35 50.75 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.568 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.0 p -74.54 165.47 25.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.687 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.584 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -59.86 -48.7 80.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.298 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -53.86 -41.93 68.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.918 0.389 . . . . 0.0 110.081 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.4 t -62.42 -40.82 97.77 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.402 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 tp -60.66 -43.87 97.12 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.355 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.0 tp -61.39 -43.07 99.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.861 0.363 . . . . 0.0 110.14 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.2 m -55.54 -45.3 77.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.716 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.49 -40.6 97.24 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 120.877 0.37 . . . . 0.0 110.395 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.433 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -62.02 -42.34 99.06 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.233 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.77 -41.05 95.93 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.72 -46.21 63.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.968 0.413 . . . . 0.0 110.894 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.6 mt -64.52 -44.05 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.819 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 156' ' ' LEU . 31.8 p -93.23 -8.75 41.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.6 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.09 25.05 72.07 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -101.72 51.73 0.83 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.787 0.327 . . . . 0.0 110.681 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.79 -38.92 76.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.698 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.5 -46.92 87.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.187 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -61.37 -39.04 89.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.375 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.16 -40.45 97.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.362 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.3 -27.8 69.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.542 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.77 -53.71 8.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.171 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.75 -43.31 96.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.468 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 174' ' ' ASP . 86.7 mt -63.05 -43.9 99.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.676 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.33 -61.51 2.5 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.12 0.486 . . . . 0.0 110.484 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -54.81 -35.22 63.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.365 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -79.44 -34.72 41.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.114 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.3 m-20 -56.9 -40.01 75.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.926 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.83 -42.39 99.71 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.733 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.82 -37.74 87.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.294 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.41 -42.5 99.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.7 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.0 -53.14 59.79 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.128 0.489 . . . . 0.0 110.711 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.44 -41.41 89.16 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.548 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.26 -39.82 94.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.622 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.3 -32.33 73.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.338 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.21 -21.88 18.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.745 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.638 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -65.02 -41.42 95.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.698 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 pt -77.58 136.33 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.679 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.46 108.65 11.0 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.274 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.18 126.15 0.33 Allowed Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.89 152.18 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.724 2.283 . . . . 0.0 112.586 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.13 141.71 53.5 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.676 2.25 . . . . 0.0 112.469 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -170.96 147.07 2.24 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.669 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.13 154.5 70.15 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.734 2.289 . . . . 0.0 112.265 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.44 163.18 28.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.419 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.528 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.1 t -143.65 170.05 16.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.857 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.528 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -147.79 137.45 22.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.226 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.3 pt -134.03 146.01 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.603 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.72 131.68 59.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.133 0.492 . . . . 0.0 110.457 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -152.01 155.11 37.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.419 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.2 m -122.25 122.93 40.27 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.916 0.389 . . . . 0.0 110.382 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.37 -25.84 66.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.569 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.24 -49.17 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.086 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.59 -12.87 61.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.472 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.7 m80 50.43 41.55 25.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.439 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.9 t -136.27 144.79 44.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.339 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.5 114.31 27.62 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.35 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.1 m-20 -119.86 133.4 55.6 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.067 0.46 . . . . 0.0 110.372 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -111.98 146.32 38.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.756 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.449 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 12.3 t90 -99.29 129.54 45.52 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.062 0.458 . . . . 0.0 110.026 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.708 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.43 153.72 39.5 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.082 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.66 -18.29 48.12 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.791 2.328 . . . . 0.0 111.888 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.708 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -49.11 -18.71 0.35 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.45 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.449 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.1 p -75.65 165.23 25.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.496 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.14 -28.19 66.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.545 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.1 mt-30 -63.61 -41.43 98.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.17 -44.67 97.15 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.5 -38.92 92.7 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.981 0.42 . . . . 0.0 110.567 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.584 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.1 mmm -62.28 -41.36 98.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.114 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.5 mt -63.67 -47.05 82.8 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.648 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.48 -31.95 56.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.057 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -70.74 -18.14 62.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.543 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 91.4 mt -88.63 -8.67 54.24 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.692 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.85 2.52 55.12 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -88.57 152.46 21.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.768 0.318 . . . . 0.0 110.565 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.2 p -115.35 128.15 55.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.101 0.477 . . . . 0.0 110.378 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.46 146.02 24.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.852 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.455 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.64 151.16 46.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.463 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.9 131.59 42.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.408 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.63 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.56 93.4 27.59 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.061 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.716 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.0 Cg_exo -55.61 139.16 82.58 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.588 2.192 . . . . 0.0 111.519 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.86 -25.47 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.507 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.716 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.66 -49.88 27.9 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.583 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -53.99 -37.07 63.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.771 0.32 . . . . 0.0 110.19 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -66.71 35.96 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.815 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.583 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.32 88.13 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.4 p -81.72 -14.36 56.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.335 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -91.37 -41.41 10.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.564 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.7 t -66.88 -16.62 64.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.682 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.1 43.54 26.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.495 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.63 -147.99 7.63 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -121.75 143.11 49.57 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.953 0.406 . . . . 0.0 110.354 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -151.97 149.43 28.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.349 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -100.83 -151.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.313 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 55.87 -91.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.609 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.51 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.4 tt -126.67 175.12 9.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.559 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.51 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.8 mt -121.73 141.42 42.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.841 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.68 169.16 9.46 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.259 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.2 mt -147.73 150.83 35.02 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.181 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.58 -39.04 97.18 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.33 3.98 4.6 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -77.33 -58.03 3.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.001 0.429 . . . . 0.0 110.649 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.15 -36.86 83.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.221 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.36 -67.76 0.22 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.747 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.45 -42.17 66.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.248 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.11 17.92 0.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.672 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.99 48.59 0.29 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.42 -109.83 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.647 0.26 . . . . 0.0 110.744 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.455 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 12.0 m120 -60.96 -44.82 96.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.454 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.41 8.09 83.82 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -99.1 -12.95 20.05 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.783 -0.245 . . . . 0.0 110.646 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.426 ' HG ' ' N ' ' A' ' 259' ' ' LEU . 5.0 t 176.69 142.57 0.07 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.121 0.486 . . . . 0.0 110.514 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.426 ' N ' ' HG ' ' A' ' 258' ' ' SER . 9.2 tt -147.94 125.94 12.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.074 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -99.08 143.1 29.73 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 120.927 0.394 . . . . 0.0 110.79 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.4 mt -94.49 106.35 18.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.632 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.455 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.4 t80 -101.96 -12.29 18.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.163 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.22 -40.14 90.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.862 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.67 174.19 46.4 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.466 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.6 m-20 -74.67 -113.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 0.0 110.662 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.65 -28.61 67.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.743 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.04 -44.11 91.72 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.245 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.53 -44.28 94.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.398 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.56 -59.81 4.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.208 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.39 -43.34 61.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.151 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.34 -43.92 75.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.23 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.41 -43.6 97.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.682 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -56.55 -37.44 70.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.207 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.76 1.09 18.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.297 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -115.04 91.21 26.07 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.174 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.21 -27.11 28.86 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.803 2.336 . . . . 0.0 111.767 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.33 -41.06 98.87 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.641 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.22 4.93 53.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.371 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.63 -35.21 70.35 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.75 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.59 4.56 15.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.512 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.75 121.39 81.03 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.592 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -47.67 -37.67 27.77 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.46 2.107 . . . . 0.0 112.453 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.554 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -59.06 -43.75 91.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.788 0.328 . . . . 0.0 110.211 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.85 -43.75 93.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.251 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.72 -40.52 95.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.449 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.76 -12.43 39.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.534 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.2 mtmt 61.99 31.56 17.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.39 44.01 1.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.384 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.04 135.91 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.497 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.47 132.87 56.56 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.428 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.15 87.75 7.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.723 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.468 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.3 mt -64.01 -41.25 97.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.92 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.455 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.98 168.45 34.97 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.602 ' HG1' HD22 ' A' ' 74' ' ' ASN . 73.0 p -76.05 -25.81 55.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.858 0.361 . . . . 0.0 110.731 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.528 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.1 tp10 -67.61 -34.18 76.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.465 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.494 ' O ' ' CG2' ' A' ' 296' ' ' THR . 97.0 m -73.52 20.47 0.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.648 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.557 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 57.0 t80 -57.63 -51.13 70.77 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.942 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 65.2 mmt-85 -108.28 149.72 28.26 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.4 tp -115.32 125.35 53.14 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.805 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 42.2 t0 -149.11 166.46 28.69 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.552 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -49.24 -38.16 25.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.61 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -71.54 -65.21 0.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.371 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -60.93 -32.86 72.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.47 -25.65 26.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.566 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.6 mtt -63.33 -40.87 98.5 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 120.865 0.364 . . . . 0.0 110.944 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.77 -44.22 23.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 78.8 t -66.17 -43.03 92.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.403 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.3 tp -60.23 -47.06 87.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.466 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -69.83 -39.9 76.19 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.035 0.445 . . . . 0.0 110.744 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.498 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.2 ttt180 -61.61 -38.19 86.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.198 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.11 4.45 42.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.767 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.638 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -112.47 -11.51 13.62 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.045 0.45 . . . . 0.0 110.259 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.97 85.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.644 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.1 -48.87 79.67 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.339 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.042 179.947 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.44 -2.76 57.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.444 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.49 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.41 178.98 1.27 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.536 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.3 Cg_exo -60.75 144.82 99.61 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.652 2.235 . . . . 0.0 112.212 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.69 -179.75 8.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.608 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.58 136.69 52.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.392 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.1 tp -124.55 146.28 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.361 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.8 p -119.81 136.09 54.6 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.779 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.9 p30 -98.74 -144.17 0.32 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.273 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.56 -36.63 84.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.47 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.486 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.9 ttt85 -147.32 -70.59 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.565 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.81 144.07 41.81 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.2 p -112.68 130.08 56.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 0.0 110.397 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -114.8 129.65 56.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.686 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.9 m -86.83 130.6 34.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.342 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.1 mt -97.41 79.06 2.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.437 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -65.94 -32.55 74.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.53 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 t 177.09 109.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.155 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -123.36 91.59 49.64 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.324 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.3 Cg_exo -56.81 149.0 62.9 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.71 2.273 . . . . 0.0 111.82 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.69 83.05 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.933 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.48 67.27 0.89 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.316 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.59 130.69 35.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.637 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.4 t -123.04 146.31 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.108 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 t -136.16 143.84 44.68 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.626 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.626 ' HG1' ' N ' ' A' ' 50' ' ' SER . 27.7 p -99.35 -59.35 1.74 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.523 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.626 ' N ' ' HG1' ' A' ' 49' ' ' THR . 86.2 p -79.36 155.03 28.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.585 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.5 t -74.36 -21.67 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.582 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.41 ' O ' ' OG ' ' A' ' 56' ' ' SER . 99.7 m -60.23 -52.09 66.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.537 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -66.62 -42.45 86.8 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.243 0.544 . . . . 0.0 110.759 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.8 m -42.88 -54.07 4.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.234 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.34 -37.24 70.51 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.0 m -62.85 -44.62 95.64 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 120.848 0.356 . . . . 0.0 110.428 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.9 mt -66.51 -41.93 88.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.306 0.574 . . . . 0.0 110.732 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.3 tp -62.5 -40.44 96.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.25 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.81 -36.05 75.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.928 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.7 pt -91.06 29.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.103 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 56.43 51.51 11.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.899 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.41 75.79 22.13 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.909 0.385 . . . . 0.0 109.98 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.15 152.11 83.35 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.783 2.322 . . . . 0.0 112.28 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.86 137.54 46.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.104 0.478 . . . . 0.0 110.33 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.419 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.5 pt -69.14 -43.65 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.241 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.1 131.21 53.33 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.948 0.404 . . . . 0.0 110.595 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.5 p -155.57 168.94 25.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.409 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.98 -177.28 21.56 Favored Glycine 0 N--CA 1.464 0.505 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.14 172.31 12.83 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.919 0.39 . . . . 0.0 110.507 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 p -132.35 -112.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.947 0.403 . . . . 0.0 110.462 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.18 179.76 0.93 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.344 -179.185 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.6 Cg_exo -60.8 57.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.962 2.441 . . . . 0.0 112.132 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.7 t-20 -64.41 -33.54 76.09 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.522 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.567 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.6 m-20 93.76 -36.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.08 0.862 . . . . 0.0 109.94 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -62.43 -39.48 93.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.265 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -74.69 -25.68 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.623 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.19 -171.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.86 -153.75 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.758 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.1 p-10 -52.78 -7.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.687 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.52 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.49 115.17 23.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.653 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.94 69.85 1.35 Allowed Glycine 0 CA--C 1.521 0.42 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.449 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.2 m-85 -143.16 147.51 35.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.815 0.341 . . . . 0.0 110.832 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.528 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.3 mp -85.61 -98.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.185 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.1 -42.64 96.84 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.122 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.0 tt0 91.51 53.14 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.866 0.729 . . . . 0.0 110.878 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -103.13 -9.05 19.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.447 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.449 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.79 -33.74 76.69 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.058 0.456 . . . . 0.0 110.65 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.55 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.18 -23.85 1.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.613 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.53 -46.0 76.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.936 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.41 -48.19 82.34 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.237 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.65 -38.26 89.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.292 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.78 -32.31 52.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.238 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.594 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.3 mmt-85 -90.19 1.65 56.21 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.57 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 56.9 mttp 82.64 -49.55 0.18 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.954 0.784 . . . . 0.0 110.29 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.671 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.7 mt -45.87 154.52 0.23 Allowed 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 118.16 -0.924 . . . . 0.0 109.453 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.671 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 120.77 92.68 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 O-C-N 125.066 1.479 . . . . 0.0 110.462 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.76 143.45 42.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.992 0.425 . . . . 0.0 110.249 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.5 mt -132.38 27.21 4.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 110.517 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.35 138.04 34.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.557 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 91.7 mt -137.25 164.96 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.386 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.523 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.02 -28.53 1.85 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.69 70.82 7.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.078 0.466 . . . . 0.0 110.36 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.89 145.19 98.9 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.754 2.303 . . . . 0.0 112.066 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.2 t -133.99 136.13 43.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.549 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.95 -38.17 82.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.673 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.25 -41.95 96.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.514 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.37 -41.41 98.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.527 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.0 t -63.84 -43.4 97.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.068 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.13 -35.05 77.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.323 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.75 -18.41 59.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.485 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.75 -6.39 58.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.498 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 68.0 mtp 47.57 56.06 17.21 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.584 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.13 149.43 64.51 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.786 2.324 . . . . 0.0 112.034 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.11 -73.88 0.63 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.433 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.9 tp -110.56 112.35 24.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.262 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.9 mt -100.72 126.33 54.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.022 0.439 . . . . 0.0 110.437 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.8 mt -109.16 132.83 53.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.272 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.418 HG23 HD12 ' A' ' 118' ' ' ILE . 96.9 mt -120.0 139.3 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.511 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 121' ' ' THR . 87.0 p -83.55 168.38 16.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.579 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.1 -37.52 80.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.424 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.429 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -140.14 159.32 42.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.511 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.46 178.38 32.96 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.21 -33.74 86.92 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -125.6 152.67 44.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.899 0.381 . . . . 0.0 110.556 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 33.3 t -63.4 141.27 58.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.408 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.68 10.46 11.01 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.578 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.416 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -60.93 -38.97 87.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.113 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.88 -36.12 23.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.431 0.634 . . . . 0.0 110.629 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.1 mt -70.93 -35.57 72.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.373 0.606 . . . . 0.0 110.79 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -42.69 -62.8 0.9 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.201 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -66.17 -42.69 88.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.043 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.24 -32.58 73.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.267 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 129' ' ' LEU . 74.1 mt -73.9 -41.06 62.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.078 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -58.24 -48.98 78.69 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.301 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.0 m -52.95 -42.37 65.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.353 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.96 -42.65 92.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.985 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.44 153.97 5.47 Favored Pre-proline 0 N--CA 1.453 -0.281 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.581 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -39.74 106.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.669 2.246 . . . . 0.0 112.179 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 95.6 m -110.07 122.76 48.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.382 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -115.05 153.68 30.25 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.304 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 tt -129.44 131.81 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.395 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.16 127.79 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.513 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.21 104.37 15.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.298 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.2 p90 -101.57 -11.17 19.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.805 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.576 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.73 -33.66 76.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.722 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.576 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.7 p-10 -98.41 8.03 45.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.573 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.61 155.18 50.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.582 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.409 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.45 165.94 24.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.64 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.595 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.8 t90 -59.72 -49.12 78.99 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.23 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -53.51 -42.39 67.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 110.109 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.8 t -62.85 -40.99 99.15 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.328 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 48.9 tp -60.64 -44.19 96.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.366 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.37 -43.6 98.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.206 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.5 m -54.71 -44.64 73.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.875 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.79 -40.74 98.26 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.905 0.383 . . . . 0.0 110.379 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -62.03 -42.38 99.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.165 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.94 -41.21 95.5 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.66 -45.81 64.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.908 0.385 . . . . 0.0 110.831 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.55 -44.0 96.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.811 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -93.34 -8.34 42.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.583 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.5 26.67 71.95 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -101.76 51.41 0.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.818 0.342 . . . . 0.0 110.679 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.8 -39.38 76.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.707 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.61 -47.41 85.67 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.297 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -59.92 -39.47 85.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.35 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.9 -40.97 99.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.368 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.52 70.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.566 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.17 -54.37 7.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.1 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -65.57 -42.19 92.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.477 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.6 mt -62.36 -43.77 98.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.566 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.66 -57.16 12.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.931 0.396 . . . . 0.0 110.551 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -58.48 -32.76 69.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.345 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -82.1 -36.56 27.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.772 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.6 m-20 -56.13 -41.41 75.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.155 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.99 -42.25 99.79 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.595 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.45 -37.78 87.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.281 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.9 mt -62.5 -42.23 99.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.654 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.06 -52.91 62.03 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.013 0.435 . . . . 0.0 110.668 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.4 -41.77 88.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.565 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.98 95.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.563 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.31 -31.94 73.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.424 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.54 -22.51 18.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.766 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.65 -41.25 96.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.616 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.0 pt -76.72 136.52 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.626 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.89 108.1 10.68 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.282 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.83 125.43 0.3 Allowed Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.505 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.451 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.7 Cg_exo -43.77 152.35 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.741 2.294 . . . . 0.0 112.484 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.89 141.81 55.06 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.634 2.223 . . . . 0.0 112.396 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.19 147.25 2.18 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.578 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.0 154.32 70.94 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.779 2.319 . . . . 0.0 112.324 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.27 163.15 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.42 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.524 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 1.9 t -144.07 170.68 15.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.799 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.515 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.63 137.7 21.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.312 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 40.0 pt -134.31 146.96 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.675 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.28 131.83 58.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.102 0.477 . . . . 0.0 110.482 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -152.09 155.12 37.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.473 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.4 m -122.79 122.93 39.88 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.412 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.47 -25.67 66.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.579 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.419 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.33 -48.86 21.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.007 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.34 -9.41 58.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.467 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.2 m80 46.51 42.11 10.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.444 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -135.93 145.75 46.58 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.399 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.94 114.3 27.12 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.321 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.79 133.37 55.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 110.442 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -111.81 146.22 38.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.712 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.439 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.3 t90 -99.42 129.38 45.6 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.074 0.464 . . . . 0.0 110.056 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.705 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.02 153.42 39.84 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.073 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.85 -17.87 46.99 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.762 2.308 . . . . 0.0 111.962 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.705 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -49.14 -18.9 0.37 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.486 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.439 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.6 p -75.71 164.71 26.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.531 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.93 -27.95 65.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.504 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.6 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.9 mt-30 -63.65 -41.19 98.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.643 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.66 -44.37 97.95 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.45 -38.8 92.29 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.983 0.42 . . . . 0.0 110.464 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.595 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.0 mmm -62.14 -41.31 98.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.177 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.7 mt -63.63 -47.17 82.42 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.672 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.13 -31.95 53.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.114 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.85 -18.3 62.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.557 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 90.9 mt -87.87 -9.13 54.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.559 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.19 1.6 54.34 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -88.16 153.77 20.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.835 0.35 . . . . 0.0 110.519 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 p -116.31 128.74 55.82 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.071 0.463 . . . . 0.0 110.384 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.555 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.62 146.3 23.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.866 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.455 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.95 151.72 45.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.463 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.88 131.47 42.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.443 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.635 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.73 93.07 26.93 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.132 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.717 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.9 Cg_exo -55.43 139.21 81.77 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.597 2.198 . . . . 0.0 111.59 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.01 -26.07 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.486 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.717 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.36 -50.25 27.88 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.586 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.4 mt -53.71 -37.15 63.0 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -66.76 36.14 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.731 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 38.98 88.72 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.847 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.5 p -81.28 -13.87 58.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.377 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.98 -41.84 10.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.626 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.7 t -66.74 -16.94 64.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.636 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 55.74 44.01 26.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.453 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.67 -149.24 8.32 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.95 142.84 48.38 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.912 0.387 . . . . 0.0 110.369 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.01 149.56 29.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.391 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -101.31 -151.59 0.42 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.343 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 55.96 -92.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.631 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.515 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.4 tt -126.84 175.52 8.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.613 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.515 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.4 mt -122.72 142.04 40.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.759 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.86 169.65 9.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.329 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 58.7 mt -148.01 150.8 34.63 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.49 -39.05 97.26 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.1 4.03 4.69 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -77.55 -58.04 3.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.896 0.379 . . . . 0.0 110.596 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -62.11 -36.61 82.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.264 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.36 -67.76 0.23 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.661 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.54 -42.48 67.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.264 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.63 17.42 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.56 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.02 48.83 0.3 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.53 -110.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.587 0.232 . . . . 0.0 110.704 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.455 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.9 m120 -60.8 -44.8 96.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.572 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.28 8.01 84.16 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.95 -13.58 19.89 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.628 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.1 t 177.25 142.55 0.08 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.007 0.432 . . . . 0.0 110.492 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 tt -148.22 124.81 11.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.052 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -98.09 143.63 28.43 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 120.854 0.359 . . . . 0.0 110.699 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.5 mt -95.13 106.49 18.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.659 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.442 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.8 t80 -101.75 -12.27 18.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.279 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.37 -40.73 89.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.83 173.06 45.72 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.453 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -73.71 -113.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.814 0.34 . . . . 0.0 110.739 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.66 -28.62 67.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.715 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.9 -44.03 91.13 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.179 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.63 -44.22 94.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.336 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.71 -60.21 3.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.227 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.93 -43.54 60.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.165 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.27 -43.58 74.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.268 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.64 -43.63 96.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.648 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -56.28 -37.5 69.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.189 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.54 0.9 18.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.328 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -114.99 91.4 26.6 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.227 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.21 -27.28 29.54 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.809 2.34 . . . . 0.0 111.778 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.514 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -40.96 98.78 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.621 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.33 5.31 52.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.328 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.07 -35.37 69.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.009 0.433 . . . . 0.0 110.707 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.36 4.36 15.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.601 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.554 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.76 121.15 80.17 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.531 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -47.2 -37.89 24.53 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.479 2.119 . . . . 0.0 112.397 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.554 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -58.98 -43.74 91.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.846 0.355 . . . . 0.0 110.311 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.5 t -66.18 -43.68 91.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.337 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.89 -40.6 95.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.537 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.5 t-20 -89.64 -12.89 38.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.502 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 62.47 32.28 16.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.79 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.01 43.84 1.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.376 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.22 135.63 41.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.544 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.84 132.38 56.71 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.465 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.07 89.15 7.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.735 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.457 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.8 mt -63.88 -40.98 97.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.784 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.79 165.34 33.26 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 71.7 p -75.47 -25.75 57.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 110.673 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.535 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.8 tp10 -68.36 -33.85 75.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.384 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.508 ' O ' ' CG2' ' A' ' 296' ' ' THR . 95.7 m -73.68 25.17 0.07 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.711 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.6 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 37.7 t80 -58.57 -50.75 72.68 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.4 mmt-85 -110.82 153.84 24.81 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 45.0 tp -115.67 125.1 52.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.721 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 44.7 t0 -147.98 165.66 30.05 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.531 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.16 -38.13 24.55 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.544 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.03 -65.83 0.69 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.29 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.91 -32.75 72.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.35 -25.25 23.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.627 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.5 mtt -63.72 -40.73 97.47 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 120.889 0.376 . . . . 0.0 111.01 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -79.1 -44.13 22.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 79.0 t -66.15 -42.88 92.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.469 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.9 tp -60.1 -47.13 87.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.455 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.04 -39.31 75.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.58 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.2 ttt180 -61.85 -38.66 89.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.252 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -86.67 4.57 39.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.772 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.92 -11.16 13.46 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.048 0.451 . . . . 0.0 110.31 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.1 85.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.578 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.84 -48.88 79.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.422 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.178 179.701 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.612 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.68 -3.15 57.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.425 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.489 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -143.88 179.2 1.23 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.53 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 37.6 Cg_exo -60.55 144.57 99.54 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.779 2.32 . . . . 0.0 112.161 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.612 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.3 ptt-85 -155.85 179.96 8.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.571 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -116.03 137.22 52.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.346 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.83 146.17 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.46 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.8 p -119.9 136.27 54.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.744 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.7 p30 -98.33 -144.51 0.31 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.267 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.58 -36.39 83.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.481 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -147.04 -70.68 0.23 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.508 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.59 144.15 41.11 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.7 p -112.61 129.82 56.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 110.385 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -114.86 129.9 56.79 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.643 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 m -87.74 131.53 34.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.159 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.8 mt -99.02 79.64 2.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.655 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.16 -32.01 73.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.475 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 t 176.98 109.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.182 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -124.32 91.66 49.23 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.306 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.4 Cg_exo -56.64 149.04 61.05 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.792 2.328 . . . . 0.0 111.917 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.44 82.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.599 0.562 . . . . 0.0 110.923 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.0 mtm180 -151.62 67.23 0.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.24 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.84 130.99 35.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.667 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.16 147.74 27.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.149 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 t -136.22 143.96 44.63 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.703 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.515 ' HG1' ' H ' ' A' ' 50' ' ' SER . 16.9 p -99.65 -59.33 1.74 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.524 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.515 ' H ' ' HG1' ' A' ' 49' ' ' THR . 86.6 p -79.41 154.94 28.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.596 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.5 t -73.72 -21.76 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.517 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.413 ' O ' ' OG ' ' A' ' 56' ' ' SER . 99.8 m -60.17 -52.03 67.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.535 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 mt -66.41 -42.32 87.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.208 0.527 . . . . 0.0 110.862 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.7 m -43.52 -54.27 4.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.091 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.63 -36.65 76.35 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.3 m -63.32 -44.38 95.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 0.0 110.423 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.7 mt -66.02 -42.13 90.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.484 0.659 . . . . 0.0 110.593 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tp -62.83 -40.17 96.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.367 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.52 -36.16 77.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.065 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -90.99 27.66 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.168 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 57.02 51.51 10.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.944 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.81 75.92 29.86 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.036 0.446 . . . . 0.0 109.932 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -63.53 149.38 91.16 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.752 2.302 . . . . 0.0 112.214 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -112.71 137.11 46.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.198 0.523 . . . . 0.0 110.281 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.5 pt -69.51 -43.7 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.145 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.22 131.21 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.929 0.395 . . . . 0.0 110.59 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.2 p -155.78 168.67 26.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.467 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.7 -177.41 21.74 Favored Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.07 172.3 12.83 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.483 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.4 p -134.13 -110.27 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.396 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.43 179.6 0.94 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.348 -179.045 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.2 Cg_exo -60.79 58.87 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.996 2.464 . . . . 0.0 112.129 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 56.3 t-20 -64.37 -34.91 79.25 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.498 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 46.7 m-20 95.04 -38.14 0.01 OUTLIER 'General case' 0 C--N 1.346 0.448 0 O-C-N 124.016 0.822 . . . . 0.0 109.875 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.45 -39.84 94.67 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.018 0.437 . . . . 0.0 110.228 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.2 p -73.79 -26.5 21.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.693 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.97 -172.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.568 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.7 p30 -74.22 -152.88 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.757 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.7 p-10 -54.49 -6.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.701 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.515 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.94 113.66 22.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.589 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.48 72.74 1.28 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.485 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.2 m-85 -143.99 148.62 35.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.885 0.374 . . . . 0.0 110.817 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.527 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.3 mp -85.75 -99.16 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.139 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.04 -42.94 96.89 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.201 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.566 ' NE2' ' HZ1' ' A' ' 88' ' ' LYS . 35.5 tt0 91.65 52.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.953 0.783 . . . . 0.0 110.925 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -103.43 -8.99 19.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.365 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.485 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.92 -33.58 76.35 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.108 0.48 . . . . 0.0 110.669 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.566 ' HZ1' ' NE2' ' A' ' 85' ' ' GLN . 97.9 mttt -48.85 -23.55 1.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.671 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.7 t -70.02 -46.14 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.815 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.16 -48.63 80.7 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.107 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.63 -38.18 89.23 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.41 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.76 -32.31 51.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.261 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.583 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.9 mmt-85 -89.79 1.81 55.68 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.617 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 82.64 -49.5 0.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.015 0.822 . . . . 0.0 110.319 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.655 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.6 mt -46.06 154.48 0.25 Allowed 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 117.702 -1.142 . . . . 0.0 109.407 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.655 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 120.72 92.36 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 O-C-N 125.439 1.712 . . . . 0.0 110.479 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.533 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.11 143.02 43.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.084 0.468 . . . . 0.0 110.259 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -132.07 26.71 4.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.856 0.36 . . . . 0.0 110.533 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.33 138.14 34.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.013 0.435 . . . . 0.0 110.549 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.522 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 93.3 mt -137.16 164.79 29.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.398 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.63 -28.91 1.75 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -151.94 70.75 7.88 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.177 0.513 . . . . 0.0 110.258 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.87 145.29 98.64 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.777 2.318 . . . . 0.0 112.057 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.8 t -134.98 136.49 42.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.549 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.97 -38.17 82.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.657 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.51 -42.07 96.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.506 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.08 -41.59 98.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.516 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.77 -43.29 97.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.064 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.17 -35.09 77.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.263 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -18.29 59.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.506 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.72 -6.1 58.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.505 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.417 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 70.4 mtp 47.83 55.73 17.09 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.608 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.0 Cg_endo -70.25 149.16 63.4 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.744 2.296 . . . . 0.0 112.116 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.48 -72.99 0.66 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.429 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.6 tp -111.25 113.54 26.11 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.342 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.4 mt -102.67 126.95 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.576 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.5 mt -110.06 133.85 52.76 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.225 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.33 139.65 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.468 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 121' ' ' THR . 89.6 p -83.48 167.84 17.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.688 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -37.25 79.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.47 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.423 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -139.61 158.6 43.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.472 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.11 176.97 33.4 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.75 86.91 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.95 152.27 44.38 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.926 0.394 . . . . 0.0 110.505 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.0 t -63.47 140.93 58.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.355 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.62 10.5 11.07 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.611 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.418 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.04 -38.89 87.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.14 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.97 -35.86 23.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.542 0.687 . . . . 0.0 110.668 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.9 mt -70.98 -35.34 72.09 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.444 0.64 . . . . 0.0 110.733 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -42.81 -63.0 0.86 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.239 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.87 -42.71 90.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.049 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.07 -32.63 73.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.3 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.9 mt -73.9 -40.7 62.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.987 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.28 -49.22 77.92 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.21 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.3 m -52.89 -42.48 65.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.246 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.59 -42.87 93.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.131 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.73 153.94 5.19 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.65 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -39.38 106.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.661 2.241 . . . . 0.0 112.354 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 97.1 m -109.97 122.22 47.06 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.332 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.5 153.44 29.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.225 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 tt -129.04 131.5 68.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.393 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.413 HG22 HD11 ' A' ' 142' ' ' ILE . 96.5 mt -114.88 127.6 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.475 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.496 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 55.3 t30 -100.65 104.45 15.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.311 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 147' ' ' LYS . 50.0 p90 -100.92 -11.18 19.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.809 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.0 p-10 -64.74 -33.53 76.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.728 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.1 p-10 -98.87 8.13 45.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.591 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.441 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.27 153.04 52.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.487 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.405 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.8 p -75.37 166.05 24.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.649 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.598 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.7 t90 -59.46 -48.91 79.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.127 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -54.28 -43.07 70.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.91 0.386 . . . . 0.0 110.114 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.1 t -62.78 -40.9 98.75 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.366 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.69 -44.37 96.62 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.241 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.35 -42.88 99.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.853 0.359 . . . . 0.0 110.192 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.0 m -55.86 -44.9 78.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.773 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.81 -40.3 96.93 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 120.908 0.385 . . . . 0.0 110.439 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.9 -42.27 98.88 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.287 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.81 -40.45 95.6 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.52 -45.54 65.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.908 0.385 . . . . 0.0 110.792 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.71 -44.03 96.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.742 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -93.44 -8.4 41.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.596 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.67 26.5 72.04 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -101.35 50.76 0.85 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.813 0.339 . . . . 0.0 110.589 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -69.65 -39.68 76.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.667 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.58 -47.59 84.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.208 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -59.62 -39.78 85.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.268 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.15 99.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.296 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.56 -28.59 69.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.604 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.47 -54.22 7.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.016 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -65.61 -42.36 91.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.458 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.8 mt -62.38 -43.9 98.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.522 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.67 -57.67 10.19 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.079 0.466 . . . . 0.0 110.377 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.91 -33.75 69.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.482 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -81.39 -36.35 29.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.755 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.4 m-20 -55.33 -41.87 73.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.982 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.54 -42.03 99.26 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.664 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.22 -38.23 89.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.348 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.5 mt -62.5 -42.25 99.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.733 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.11 -53.06 60.72 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.12 0.486 . . . . 0.0 110.657 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.09 -42.0 89.91 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.642 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.71 -40.06 95.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.666 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.28 -31.9 73.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.37 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.92 -22.16 18.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.662 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.635 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.7 tt0 -64.63 -41.33 96.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.599 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.5 pt -75.2 136.2 25.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.6 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -125.99 106.95 9.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.312 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -177.2 125.56 0.29 Allowed Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.57 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.8 Cg_exo -43.9 152.39 0.36 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.772 2.315 . . . . 0.0 112.56 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.87 141.93 55.54 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.658 2.239 . . . . 0.0 112.468 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.25 147.46 2.2 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.585 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.03 154.45 70.59 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.764 2.309 . . . . 0.0 112.362 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.525 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.47 163.12 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.194 0.521 . . . . 0.0 110.386 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.539 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.0 t -143.65 170.3 16.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.932 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.539 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.47 137.56 21.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.995 0.426 . . . . 0.0 110.111 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.6 pt -134.4 147.14 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.657 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.56 132.04 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.157 0.503 . . . . 0.0 110.492 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -151.95 154.84 36.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.423 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.7 m -121.82 122.62 39.87 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.947 0.403 . . . . 0.0 110.344 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.93 -25.48 66.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.646 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.405 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.86 -49.65 19.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.91 -9.53 58.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.409 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.8 m80 46.97 43.74 14.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.436 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.7 t -135.78 145.11 46.2 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.347 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.47 113.49 25.96 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.26 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.1 m-20 -119.86 133.26 55.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.384 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.5 tt -112.02 146.35 38.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.757 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.452 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.1 t90 -99.35 128.85 45.51 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.104 0.478 . . . . 0.0 110.067 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.675 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -94.65 154.04 40.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.174 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.68 -17.98 47.91 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.662 2.241 . . . . 0.0 111.94 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.675 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -49.35 -18.79 0.42 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.405 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.452 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 84.6 p -75.42 164.73 26.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.507 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.89 -28.14 65.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.461 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.556 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.4 mt-30 -63.67 -41.74 98.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.669 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.65 -44.67 96.67 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.441 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.1 mt-30 -64.45 -38.9 92.63 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 122.448 -0.442 . . . . 0.0 110.672 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.06 -41.19 97.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.276 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.61 -47.42 81.47 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.997 0.427 . . . . 0.0 110.502 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -53.82 -32.15 51.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.193 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -70.92 -19.0 62.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.555 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 92.6 mt -87.48 -8.89 55.9 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.63 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.83 2.72 55.15 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.9 152.67 21.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.339 . . . . 0.0 110.532 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 7.8 p -115.57 128.19 55.78 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.063 0.459 . . . . 0.0 110.305 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.41 146.52 23.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.959 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.458 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.07 151.1 45.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.447 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.64 131.56 43.28 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.475 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.63 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.57 93.42 27.67 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.073 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.718 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.3 Cg_exo -55.52 138.99 82.02 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.629 2.219 . . . . 0.0 111.617 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.82 -25.51 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.482 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.718 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.57 -49.82 28.78 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.582 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.1 mt -54.05 -36.97 63.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.71 36.09 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.72 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.582 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.14 86.73 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.9 p -79.61 -15.04 58.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.34 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -92.37 -41.4 10.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.59 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -65.98 -17.72 64.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.621 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 56.18 43.32 26.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.466 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.23 -148.31 7.67 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.87 142.81 49.88 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.958 0.408 . . . . 0.0 110.336 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.06 149.57 28.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.328 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -100.79 -151.86 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.308 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.5 t0 55.9 -92.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.673 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.51 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.48 175.41 8.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.601 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.51 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.7 mt -122.32 141.72 41.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.766 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.7 169.17 9.45 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.226 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.8 mt -147.66 150.86 35.17 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.191 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.64 -38.82 96.83 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.82 4.2 4.78 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -77.45 -58.22 3.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.945 0.402 . . . . 0.0 110.558 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.17 -36.64 82.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.416 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.17 -67.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.777 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.72 -42.27 67.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.102 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.72 17.38 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.645 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.34 49.13 0.34 Allowed Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.411 -0.675 . . . . 0.0 111.411 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 253' ' ' GLY . 8.4 mp 37.85 -109.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.635 0.255 . . . . 0.0 110.825 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.458 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.7 m120 -60.65 -45.2 95.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.493 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.82 7.85 83.48 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.04 -13.04 20.04 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.745 -0.268 . . . . 0.0 110.696 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.4 t 176.86 142.89 0.08 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.063 0.458 . . . . 0.0 110.458 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 tt -148.35 125.43 11.4 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.087 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -98.76 143.43 29.12 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 120.916 0.389 . . . . 0.0 110.837 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.6 mt -94.88 106.47 18.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.674 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.9 t80 -101.88 -12.02 18.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.261 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.24 89.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.834 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.54 173.86 46.16 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.443 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.5 m-20 -74.44 -113.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.759 0.314 . . . . 0.0 110.734 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.74 -28.4 67.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.66 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.96 -44.14 91.44 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.27 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.68 -44.14 94.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.341 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.48 -60.38 3.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.273 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.92 -43.53 60.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.174 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.47 -43.81 75.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.252 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.1 mt -64.54 -43.6 96.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.629 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -56.52 -37.66 70.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.2 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.66 1.19 17.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.272 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -115.0 91.28 26.16 Favored Pre-proline 0 CA--C 1.528 0.134 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.118 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.97 -27.17 27.38 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.768 2.312 . . . . 0.0 111.875 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.41 -41.26 98.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.526 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.15 5.12 52.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.407 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.96 -35.38 69.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.595 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.58 4.35 16.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.516 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.562 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.66 121.51 81.33 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.615 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -47.31 -38.13 25.82 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.487 2.125 . . . . 0.0 112.533 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.562 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.86 -43.95 90.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.812 0.339 . . . . 0.0 110.391 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.73 -43.63 93.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.293 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.83 -40.64 95.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.454 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 44.8 t-20 -89.73 -12.14 40.27 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.549 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.4 mtmt 61.73 31.3 18.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.965 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -88.17 43.78 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.435 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.43 136.09 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.453 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.59 132.8 56.59 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.452 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.1 88.49 7.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.752 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.464 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.5 mt -64.0 -41.41 97.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.891 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.46 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.42 167.26 33.76 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.4 p -75.71 -25.97 57.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.852 0.358 . . . . 0.0 110.747 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -67.77 -33.91 75.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.533 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.494 ' O ' ' CG2' ' A' ' 296' ' ' THR . 97.1 m -73.72 20.41 0.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.674 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.556 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 55.0 t80 -57.26 -51.19 70.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.939 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 68.4 mmt-85 -108.38 150.12 27.79 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 44.1 tp -115.54 125.78 53.43 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.811 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 42.7 t0 -149.56 166.72 28.36 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.598 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -49.16 -37.97 24.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.631 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.83 -65.21 0.79 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.388 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -60.92 -32.76 72.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.7 -25.22 25.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.688 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.3 mtt -63.66 -40.98 98.2 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.871 0.367 . . . . 0.0 111.057 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.85 -43.94 24.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.03 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 78.9 t -66.34 -42.85 91.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.328 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.6 tp -60.06 -47.13 87.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.505 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.99 -39.4 75.95 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.578 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.9 ttt180 -61.96 -38.24 87.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.208 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -87.14 4.31 42.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.68 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.635 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -113.07 -11.06 13.39 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.025 0.441 . . . . 0.0 110.283 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.3 86.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.559 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.66 -48.66 80.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.361 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 117.885 -1.055 . . . . 0.0 110.038 179.907 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.14 -2.36 58.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.442 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.488 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.06 1.24 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.533 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.93 145.26 99.32 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.774 2.316 . . . . 0.0 112.165 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.15 -179.1 7.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.6 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.0 137.0 52.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.323 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -124.57 146.73 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.443 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.4 p -119.97 135.99 54.7 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.704 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.28 -143.53 0.32 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.309 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.49 -37.15 86.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.487 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.476 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.1 ttt85 -149.31 -66.26 0.22 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.533 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.5 142.16 45.57 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 p -112.07 131.3 55.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 0.0 110.409 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -119.06 129.09 54.91 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.547 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -85.62 130.26 34.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.273 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.1 mt -95.97 78.86 3.21 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.353 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.51 -32.07 73.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.479 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 175.97 109.78 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.143 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -122.72 91.53 49.54 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.277 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.654 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.5 Cg_exo -56.97 148.92 65.0 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.818 2.345 . . . . 0.0 111.816 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.52 82.78 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.654 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.38 67.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.097 0.475 . . . . 0.0 110.279 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.19 130.73 35.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.582 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.7 t -122.78 146.91 27.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.202 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.2 t -136.26 143.48 44.28 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.62 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.487 ' HG1' ' H ' ' A' ' 50' ' ' SER . 25.6 p -99.18 -59.5 1.71 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.618 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.487 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.0 p -79.18 155.13 28.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.611 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.0 t -74.23 -21.83 17.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.571 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.411 ' O ' ' OG ' ' A' ' 56' ' ' SER . 95.9 m -60.13 -52.25 66.13 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.553 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.8 mt -66.63 -42.33 86.93 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.249 0.547 . . . . 0.0 110.877 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.6 m -42.88 -54.06 4.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.265 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.47 -37.48 69.32 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.2 m -62.48 -44.68 95.81 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.82 0.343 . . . . 0.0 110.443 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.2 -41.99 89.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.385 0.612 . . . . 0.0 110.703 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.2 tp -62.68 -40.34 96.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.284 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.17 -35.82 76.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.899 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.6 pt -91.36 28.85 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.021 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 56.57 51.61 10.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.798 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.2 75.58 23.14 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.984 0.421 . . . . 0.0 110.054 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.53 151.41 85.67 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.723 2.282 . . . . 0.0 112.256 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.56 137.32 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.121 0.486 . . . . 0.0 110.335 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.417 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.9 pt -69.42 -43.45 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.178 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.1 131.17 53.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 110.522 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.0 p -155.77 168.98 25.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.481 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.24 -177.12 21.43 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.54 172.91 12.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 110.56 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.1 p -132.9 -112.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.29 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.26 179.76 0.93 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.328 -179.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.5 Cg_exo -60.93 57.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 123.032 2.488 . . . . 0.0 112.151 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.7 t-20 -64.43 -33.69 76.47 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.606 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 43.4 m-20 93.6 -36.27 0.02 OUTLIER 'General case' 0 C--N 1.344 0.332 0 O-C-N 124.014 0.822 . . . . 0.0 109.993 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -62.64 -39.38 93.67 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.299 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.88 -25.29 18.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.73 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.38 -171.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.597 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.46 -153.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.752 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.1 p-10 -52.36 -7.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.706 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.522 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.36 114.86 23.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.531 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.85 69.98 1.35 Allowed Glycine 0 CA--C 1.522 0.469 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.47 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.9 m-85 -143.23 147.39 34.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.968 0.414 . . . . 0.0 110.673 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.525 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.3 mp -85.49 -98.3 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.205 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.36 -42.57 96.15 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.205 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.64 53.65 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.894 0.746 . . . . 0.0 110.791 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -103.9 -8.77 19.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.429 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.47 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -65.18 -33.79 76.85 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.175 0.512 . . . . 0.0 110.649 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.548 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.84 -24.24 1.37 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.568 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.9 t -69.5 -45.68 77.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.876 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.23 -48.57 80.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.117 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.73 -38.09 89.13 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.379 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.82 -32.42 52.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.281 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.591 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.5 mmt-85 -89.87 1.77 55.8 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.588 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.54 -49.51 0.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 124.036 0.835 . . . . 0.0 110.412 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.669 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.17 154.92 0.23 Allowed 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.443 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.669 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 120.66 92.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 125.133 1.521 . . . . 0.0 110.501 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.531 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.61 143.56 42.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.291 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.8 mt -132.58 27.15 4.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.494 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.55 138.39 34.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.541 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.526 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 91.6 mt -137.5 165.14 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.427 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.526 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.22 -28.71 1.82 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -152.59 70.87 7.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.121 0.486 . . . . 0.0 110.396 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.97 145.38 98.49 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.789 2.326 . . . . 0.0 112.048 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.8 t -134.47 136.37 43.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.036 0.446 . . . . 0.0 110.522 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.26 -38.17 81.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.673 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.45 -42.29 96.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.511 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.94 -41.73 98.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.481 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.51 -43.19 98.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.146 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.04 -35.07 77.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.345 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.5 -18.4 58.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.476 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.96 -6.33 58.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.486 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.418 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 75.9 mtp 47.76 55.77 17.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.66 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.14 149.4 64.4 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.807 2.338 . . . . 0.0 112.093 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.16 -74.01 0.63 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.503 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.8 tp -110.45 113.09 25.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.368 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -101.68 126.39 55.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.5 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.2 mt -109.7 133.53 53.02 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.248 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.56 140.02 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.587 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 121' ' ' THR . 88.8 p -83.62 168.68 16.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.641 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.08 -37.61 80.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.432 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.429 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -139.96 159.38 42.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.476 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.2 177.49 33.2 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.14 -33.77 86.93 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -124.87 151.93 44.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.822 0.344 . . . . 0.0 110.603 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.5 t -63.14 141.01 58.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.307 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.46 10.46 11.17 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.559 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.07 -39.03 88.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.072 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.04 -35.99 23.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.361 0.6 . . . . 0.0 110.696 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.8 mt -70.83 -35.45 72.47 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.428 0.632 . . . . 0.0 110.72 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.76 -63.28 0.81 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.158 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.6 p-10 -65.89 -42.72 89.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.4 mt-30 -62.01 -32.66 73.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.164 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.3 mt -74.01 -40.35 62.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.051 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.23 -49.12 78.2 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.208 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.1 m -52.59 -42.56 64.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.216 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.77 -42.98 93.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.08 154.81 5.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.632 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.29 106.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.709 2.273 . . . . 0.0 112.339 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 95.0 m -110.07 121.19 44.67 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.31 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.0 153.03 30.06 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.296 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 tt -129.09 131.22 68.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.413 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.92 127.85 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.443 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.477 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.8 t30 -101.38 103.62 14.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.34 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.3 p90 -101.14 -11.37 19.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.769 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.2 p-10 -64.77 -33.63 76.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.66 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.8 p-10 -98.12 7.79 45.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.603 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.449 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.64 155.6 50.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.564 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.3 p -74.96 165.71 24.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.664 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.592 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.4 t90 -59.85 -48.88 79.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.286 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.51 -41.95 66.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.088 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.2 t -62.73 -41.01 98.96 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.406 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.6 tp -60.59 -44.28 96.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.376 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.36 -43.56 98.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.211 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.0 m -54.87 -44.93 74.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.837 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.39 -40.94 98.12 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.837 0.351 . . . . 0.0 110.331 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.444 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -61.89 -42.48 99.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.157 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.9 -40.89 95.64 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.41 -46.16 64.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.899 0.381 . . . . 0.0 110.816 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.74 -44.02 96.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.735 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -92.97 -8.69 42.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.553 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.8 26.62 72.2 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -101.8 51.07 0.84 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 110.667 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -69.91 -39.38 76.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.644 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.57 -47.26 86.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.248 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -59.88 -39.36 85.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.341 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.14 99.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.322 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.71 -28.52 70.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.974 0.416 . . . . 0.0 110.576 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.39 -54.25 7.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.058 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -65.55 -42.17 92.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.518 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.466 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.3 mt -62.35 -43.86 98.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.488 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.75 -57.73 9.93 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.021 0.439 . . . . 0.0 110.453 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.78 -33.86 68.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.35 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -81.46 -36.28 29.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.811 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.2 m-20 -55.6 -41.59 73.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.238 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.64 -42.42 99.59 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.688 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.29 -38.01 88.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.366 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.25 -42.23 99.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.68 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.8 62.53 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.044 0.45 . . . . 0.0 110.66 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.19 -41.92 89.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.559 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.86 95.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.56 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.42 -31.99 73.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.379 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.63 -22.21 18.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.729 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.633 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.83 -41.16 95.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.651 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.8 pt -77.01 136.73 23.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.574 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.01 108.29 10.81 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.291 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.76 125.5 0.3 Allowed Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.512 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.6 Cg_exo -43.81 152.18 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.775 2.316 . . . . 0.0 112.499 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.79 141.82 55.61 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.61 2.206 . . . . 0.0 112.461 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.33 147.08 2.1 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.592 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.02 154.58 70.43 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.741 2.294 . . . . 0.0 112.292 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.35 163.13 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.4 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.615 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 1.9 t -143.97 170.76 15.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.817 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.615 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -149.12 137.99 21.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.237 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.4 pt -134.45 146.9 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.639 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 204' ' ' ASN . 3.0 p -133.08 131.76 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.145 0.498 . . . . 0.0 110.505 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -151.99 155.13 37.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.466 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.5 m -121.95 122.65 39.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.938 0.399 . . . . 0.0 110.392 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.25 -25.96 66.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.6 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.37 -48.69 21.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.066 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.7 -12.2 60.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.387 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.0 m80 49.74 41.69 22.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.491 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.3 t -136.45 144.97 44.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.407 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.88 114.38 27.67 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.295 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.73 133.24 55.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.064 0.459 . . . . 0.0 110.352 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -111.74 146.16 38.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.686 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.446 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 10.0 t90 -99.62 129.56 45.78 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.082 0.468 . . . . 0.0 110.089 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.703 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.01 153.76 39.78 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.144 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.407 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.4 Cg_endo -67.82 -18.11 47.22 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.741 2.294 . . . . 0.0 111.972 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.703 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -49.01 -18.83 0.33 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.507 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.446 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.6 p -75.61 165.05 25.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.521 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.15 -27.95 66.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.472 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.605 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.3 mt-30 -63.78 -41.28 97.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.642 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.55 -44.64 97.53 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.449 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.25 -38.9 92.69 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.004 0.43 . . . . 0.0 110.633 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.592 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.0 mmm -61.99 -41.21 97.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.159 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 74.8 mt -63.6 -47.22 82.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.949 0.404 . . . . 0.0 110.645 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.94 -32.09 52.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.049 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.94 -18.62 62.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.518 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 90.9 mt -88.01 -8.49 55.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.659 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.42 2.3 55.58 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -88.57 153.18 21.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.513 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.1 p -116.13 128.62 55.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.049 0.452 . . . . 0.0 110.421 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.555 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.74 146.14 23.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.831 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.454 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.65 151.65 45.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.526 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.68 131.4 43.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.347 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.635 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.57 93.3 27.15 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.121 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.717 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.6 Cg_exo -55.55 139.05 82.21 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.629 2.219 . . . . 0.0 111.635 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.05 -25.73 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.474 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.717 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.55 -50.11 27.46 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.587 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.8 mt -53.82 -37.31 63.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 0.0 110.252 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -66.73 36.06 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.769 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.1 88.46 0.01 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.829 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 86.7 p -81.02 -13.62 58.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.393 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -92.39 -41.49 10.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.548 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.92 -16.91 64.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.669 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.75 43.95 27.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.504 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.78 -148.67 8.03 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.63 142.98 48.92 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.996 0.426 . . . . 0.0 110.331 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.19 149.64 28.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.35 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -101.46 -151.69 0.42 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.305 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 56.19 -92.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.635 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.51 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.83 175.23 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.629 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.51 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.2 mt -122.4 141.79 41.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.676 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.98 169.55 9.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.285 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.7 mt -148.01 151.11 35.2 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.106 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.52 -39.05 97.23 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.97 4.21 4.7 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -77.57 -58.07 3.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.903 0.382 . . . . 0.0 110.577 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -62.1 -36.71 82.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.301 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.26 -67.75 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.748 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.31 -42.49 66.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.231 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.02 17.66 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.678 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.1 49.03 0.31 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.28 -109.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.609 0.242 . . . . 0.0 110.715 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.454 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.8 m120 -60.68 -45.06 95.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.47 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.4 7.96 84.02 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.85 -13.6 20.0 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.821 -0.223 . . . . 0.0 110.617 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.0 t 177.2 142.57 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.996 0.427 . . . . 0.0 110.5 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 tt -148.05 125.34 11.54 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.998 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -98.66 143.31 29.18 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.8 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.6 mt -94.5 106.38 18.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.626 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.439 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.2 t80 -101.4 -12.5 18.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.254 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.66 90.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.749 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.32 173.63 46.03 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.46 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -73.91 -112.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.797 0.332 . . . . 0.0 110.72 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -68.02 -28.52 67.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.666 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -58.76 -44.12 90.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.386 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.64 -44.29 94.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.333 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.54 -60.31 3.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.267 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -50.95 -43.36 60.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.229 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.56 75.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.267 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.5 mt -64.56 -43.67 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.607 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -56.27 -37.34 69.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.241 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.54 0.79 18.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.28 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -115.22 91.24 27.05 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.242 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.26 -26.87 28.42 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.814 2.343 . . . . 0.0 111.84 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.5 -40.95 98.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.564 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.35 5.21 52.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.435 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.1 -35.07 69.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.717 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.6 4.65 15.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.538 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.551 HD22 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.99 120.99 80.03 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.559 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -47.24 -37.53 24.26 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.501 2.134 . . . . 0.0 112.451 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.551 ' H ' HD22 ' A' ' 281' ' ' LEU . . . -59.1 -43.74 91.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.818 0.342 . . . . 0.0 110.323 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.91 -43.7 92.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.377 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.85 -40.54 95.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.483 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.437 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 44.3 t-20 -89.54 -12.72 39.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.601 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 62.03 31.37 17.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.809 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.37 43.72 1.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.417 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.95 136.02 38.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.489 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -116.77 132.36 56.71 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.466 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.41 88.24 7.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.668 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.458 ' O ' ' OG1' ' A' ' 296' ' ' THR . 89.0 mt -63.83 -40.85 97.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.821 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.439 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.6 167.24 34.14 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.51 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 76.3 p -75.68 -25.76 57.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.854 0.359 . . . . 0.0 110.746 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.54 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.0 tp10 -67.8 -34.62 77.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.427 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.503 ' O ' ' CG2' ' A' ' 296' ' ' THR . 94.6 m -73.53 25.44 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.714 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.605 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 60.8 t80 -58.18 -51.2 70.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.342 -0.39 . . . . 0.0 109.986 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 66.4 mmt-85 -112.02 155.24 24.11 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 45.5 tp -116.01 125.14 52.08 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.748 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 45.2 t0 -147.58 165.52 30.14 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.551 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -49.07 -38.1 23.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.512 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.71 -65.28 0.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.232 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -61.01 -32.79 72.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.51 -25.48 25.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.601 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.5 mtt -63.38 -41.09 98.77 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 120.924 0.392 . . . . 0.0 110.918 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.17 -43.91 22.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.978 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 76.0 t -66.29 -42.88 91.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.417 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 52.1 tp -60.31 -47.23 86.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.546 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -69.74 -39.6 76.66 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.516 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.6 ttt180 -62.06 -38.24 88.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.217 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.6 mt -87.12 4.5 42.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.741 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.633 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.3 tttt -112.86 -11.23 13.48 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.038 0.447 . . . . 0.0 110.355 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.03 85.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.638 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.94 -48.82 80.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.366 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.134 179.804 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -89.63 -2.49 58.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.391 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.2 179.01 1.25 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.521 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.6 Cg_exo -60.66 145.13 99.39 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.718 2.279 . . . . 0.0 112.171 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.82 -179.4 8.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.655 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.91 137.4 52.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.39 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -125.05 147.11 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.437 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 79.1 p -120.24 136.26 54.71 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.788 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.18 -143.83 0.32 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.199 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -63.53 -37.23 86.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.441 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.57 -67.19 0.23 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.475 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.44 142.59 45.05 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.2 p -112.16 131.45 55.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 110.377 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -119.13 129.51 55.07 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.517 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 m -86.64 131.33 34.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.871 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.3 mt -96.96 79.37 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.496 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.75 -31.79 72.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.521 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.77 109.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.117 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -122.06 92.18 48.87 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.386 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 37.3 Cg_exo -57.08 148.72 67.28 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.724 2.283 . . . . 0.0 111.782 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.85 83.0 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 O-C-N 123.491 0.495 . . . . 0.0 110.927 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.49 67.11 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.293 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.09 130.75 35.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.604 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.1 t -122.62 146.47 27.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.067 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 t -135.88 143.47 45.05 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.679 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.632 ' HG1' ' H ' ' A' ' 50' ' ' SER . 29.6 p -99.06 -59.77 1.66 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.599 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.632 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.3 p -79.25 155.33 28.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.659 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.8 t -74.06 -22.07 18.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.488 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.409 ' O ' ' OG ' ' A' ' 56' ' ' SER . 98.2 m -60.27 -52.05 66.92 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.484 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.6 mt -66.43 -42.18 88.09 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.312 0.577 . . . . 0.0 110.881 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.0 m -43.7 -53.78 5.56 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.19 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.22 -37.28 71.63 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.5 m -62.77 -44.61 95.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.826 0.346 . . . . 0.0 110.517 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.0 mt -66.22 -42.05 89.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.397 0.617 . . . . 0.0 110.652 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.57 -40.44 96.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.354 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.09 -35.77 75.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.066 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.4 pt -91.36 28.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.256 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.53 51.68 10.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.875 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.4 75.83 22.13 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.924 0.393 . . . . 0.0 109.962 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.67 151.46 85.55 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.733 2.289 . . . . 0.0 112.382 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.48 136.87 48.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.185 0.517 . . . . 0.0 110.267 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -69.06 -43.58 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.299 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.03 131.18 53.42 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.025 0.44 . . . . 0.0 110.598 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.8 p -155.7 168.82 25.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.433 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.98 -177.07 21.57 Favored Glycine 0 N--CA 1.464 0.524 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.53 172.68 12.4 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 110.527 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 p -132.8 -112.52 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.96 0.41 . . . . 0.0 110.36 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.28 179.69 0.94 Allowed Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.368 -179.103 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.8 Cg_exo -60.91 58.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.978 2.452 . . . . 0.0 112.094 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.3 t-20 -64.57 -33.66 76.43 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.526 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.2 m-20 93.8 -36.76 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.064 0.852 . . . . 0.0 109.923 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -62.57 -39.48 93.81 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.24 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.1 p -74.35 -25.66 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.715 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.16 -171.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.617 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.514 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.86 -154.2 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.76 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 38.0 p-10 -52.53 -7.54 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.669 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.514 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.16 115.17 23.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.545 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.99 69.54 1.36 Allowed Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.415 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.3 m-85 -143.12 147.37 34.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.937 0.399 . . . . 0.0 110.752 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.525 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -85.15 -98.47 0.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.204 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.0 -42.73 97.08 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.16 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.553 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.0 tt0 91.62 53.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.97 0.794 . . . . 0.0 110.907 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -103.27 -8.7 20.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.369 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.415 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 77.8 p -65.06 -33.85 77.03 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.1 0.476 . . . . 0.0 110.589 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.542 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.1 mttt -48.88 -24.05 1.32 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.644 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.45 -46.0 77.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.921 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.4 -48.42 81.31 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.071 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.57 -38.24 89.33 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.272 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.83 -32.52 53.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.272 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.586 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.7 mmt-85 -89.98 1.57 56.13 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.566 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.586 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.8 -49.24 0.17 Allowed 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.999 0.812 . . . . 0.0 110.3 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.659 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.28 154.21 0.29 Allowed 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.259 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.659 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 121.01 92.39 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 125.287 1.617 . . . . 0.0 110.476 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.7 mtp180 -75.47 143.43 42.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.057 0.456 . . . . 0.0 110.354 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.2 mt -132.44 27.07 4.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.461 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.36 138.23 34.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.548 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.525 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 91.7 mt -137.43 165.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.358 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.525 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.5 -28.81 1.77 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.55 70.96 7.46 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.15 0.5 . . . . 0.0 110.373 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.89 145.27 98.71 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.714 2.276 . . . . 0.0 112.075 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.9 t -134.4 136.37 43.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.485 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.81 -38.22 83.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.669 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.37 -42.28 96.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.496 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.49 98.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.494 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.3 t -63.65 -43.4 98.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.029 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.07 77.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.32 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.66 -18.69 60.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.464 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.36 -6.42 58.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.566 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 77.9 mtp 47.74 55.82 17.11 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.56 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.12 149.18 64.26 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.768 2.312 . . . . 0.0 112.109 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.28 -74.05 0.63 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.406 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.5 tp -110.3 113.13 25.55 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.264 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.3 mt -101.93 126.19 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.481 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.7 mt -109.19 133.28 53.22 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.202 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.16 139.31 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.533 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 121' ' ' THR . 89.9 p -83.57 168.54 16.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.677 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.21 -37.42 80.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.437 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.426 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.9 t -139.85 158.89 43.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.477 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.16 177.67 33.08 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.89 87.36 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -125.15 152.03 45.0 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.954 0.407 . . . . 0.0 110.555 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.3 t -63.34 141.24 58.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.36 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.84 10.54 10.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.684 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.9 mp -61.27 -39.02 88.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.973 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.74 -36.09 23.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.467 0.651 . . . . 0.0 110.612 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.2 mt -70.93 -35.34 72.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.447 0.641 . . . . 0.0 110.756 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -42.81 -62.68 0.94 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.27 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.7 p-10 -65.98 -42.59 89.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.067 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.4 -32.81 73.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.14 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.7 mt -73.44 -40.91 63.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.136 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.43 -48.78 79.58 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.167 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.0 m -53.01 -42.7 65.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.241 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.7 -43.2 93.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.106 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.47 154.27 5.56 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.599 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -39.24 106.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.624 2.216 . . . . 0.0 112.377 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 94.3 m -110.22 121.4 45.18 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.983 0.421 . . . . 0.0 110.218 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.37 152.89 30.78 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.233 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 tt -129.09 131.38 68.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.428 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.01 127.9 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.553 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.2 t30 -101.74 103.65 14.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.278 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.2 p90 -101.19 -11.22 19.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.797 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.7 -33.74 76.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.631 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.571 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.6 p-10 -98.09 7.96 45.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.661 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.94 155.6 50.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.503 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.401 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.0 165.7 24.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.689 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.59 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.91 -48.52 81.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.244 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.79 -42.02 67.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.1 t -62.6 -41.17 98.81 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.356 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.4 tp -60.58 -44.35 96.32 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.441 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.45 -43.42 98.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.164 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -54.99 -44.87 74.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.797 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.67 -40.63 97.66 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.837 0.351 . . . . 0.0 110.289 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.439 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -62.03 -42.53 99.27 Favored 'General case' 0 CA--C 1.51 -0.558 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.245 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.01 -41.1 95.4 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.3 -46.17 64.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.953 0.406 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.66 -44.06 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.826 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 156' ' ' LEU . 32.7 p -93.01 -8.86 41.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.567 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.93 26.9 72.4 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -102.06 50.65 0.84 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.849 0.357 . . . . 0.0 110.694 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -69.57 -39.44 77.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.677 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.78 -47.23 86.54 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.292 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -59.78 -39.57 85.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.275 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.94 -40.91 99.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.259 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.68 -28.89 70.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.522 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.04 -54.24 8.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.197 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -65.49 -42.16 92.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.494 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.4 mt -62.43 -43.77 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.524 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.62 -57.61 10.44 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.971 0.415 . . . . 0.0 110.515 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.66 -33.34 68.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.366 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -81.58 -36.52 28.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.856 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 170' ' ' ILE . 58.0 m-20 -55.46 -41.95 73.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.411 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.72 -42.17 99.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.646 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.34 -37.89 88.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.222 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.5 mt -62.43 -42.31 99.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.715 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.93 62.0 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.078 0.466 . . . . 0.0 110.677 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.36 -41.72 89.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.519 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.05 95.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.55 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.26 -32.15 73.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.409 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.65 -22.38 18.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.681 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.56 -41.23 96.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.651 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.6 pt -76.95 136.46 24.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.659 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -126.83 108.27 10.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.291 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -177.04 125.81 0.3 Allowed Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.492 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.1 Cg_exo -44.02 152.44 0.38 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.806 2.337 . . . . 0.0 112.468 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.85 141.83 55.31 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.68 2.253 . . . . 0.0 112.48 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.55 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.16 146.98 2.14 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.602 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.06 154.57 70.3 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.817 2.345 . . . . 0.0 112.272 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.38 163.22 29.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.472 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.671 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.0 t -144.03 170.75 15.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.829 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.671 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -148.61 137.71 21.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.225 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.0 pt -134.45 147.14 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.617 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.43 132.05 57.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.148 0.499 . . . . 0.0 110.482 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -151.95 154.87 36.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.398 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.0 m -122.31 122.94 40.24 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.64 -25.83 66.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.623 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.404 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.22 -48.99 20.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.035 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.99 -11.03 60.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.373 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 76.8 m80 48.59 41.74 17.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.467 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.6 t -136.31 144.97 44.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.391 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.19 114.36 27.54 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.278 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.6 m-20 -119.79 133.41 55.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 110.376 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -111.81 146.24 37.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.79 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.447 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.6 t90 -99.26 129.94 45.52 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.083 0.468 . . . . 0.0 109.997 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.702 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.55 153.72 39.42 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.126 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.4 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.9 Cg_endo -67.95 -17.97 46.47 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.811 2.341 . . . . 0.0 111.852 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.702 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -49.24 -19.16 0.44 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.397 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.447 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.1 p -75.44 164.72 26.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.502 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.95 -27.72 65.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.504 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.585 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.0 mt-30 -63.85 -41.22 97.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.582 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.69 -44.52 97.81 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.41 -38.86 92.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.995 0.426 . . . . 0.0 110.578 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.59 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.1 mmm -62.24 -41.18 98.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.063 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.1 mt -63.78 -46.65 84.25 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.646 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.7 -31.84 58.58 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.7 -18.77 62.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.537 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 90.4 mt -87.39 -9.4 54.86 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.664 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.51 1.71 53.36 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -88.34 153.84 20.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.884 0.373 . . . . 0.0 110.469 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.0 p -116.41 128.84 55.86 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.071 0.462 . . . . 0.0 110.471 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.65 146.33 23.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.864 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.452 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.82 151.41 45.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.516 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.56 131.41 43.32 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.43 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.632 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.61 93.53 28.35 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.095 -179.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.715 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.0 Cg_exo -55.85 139.07 83.62 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.556 2.171 . . . . 0.0 111.521 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.1 -26.05 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.503 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.715 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.18 -50.03 30.11 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.583 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.7 mt -53.99 -37.05 63.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -66.73 36.09 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.794 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.583 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.0 88.38 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.949 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 81.5 p -80.98 -14.08 58.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.398 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.85 -41.82 10.41 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.597 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.2 t -66.64 -16.96 64.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.621 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.76 44.01 26.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.507 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.75 -149.21 8.32 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.09 142.75 48.61 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.013 0.435 . . . . 0.0 110.339 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -151.95 149.61 29.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.368 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -101.32 -151.67 0.42 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.319 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.03 -92.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.689 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.515 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.85 175.38 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.596 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.515 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.2 mt -122.69 141.85 41.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.815 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.87 169.61 9.1 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.31 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.4 mt -147.82 150.9 35.04 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.21 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.65 -38.98 97.06 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.1 3.97 4.71 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -77.49 -57.98 3.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.897 0.38 . . . . 0.0 110.651 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -62.09 -36.73 82.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.196 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 9.9 mp -52.38 -67.59 0.24 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.725 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.66 -42.24 67.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.154 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.92 17.42 0.17 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.649 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.37 48.76 0.33 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.31 -109.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.621 0.248 . . . . 0.0 110.753 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.452 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.7 m120 -60.94 -44.58 97.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.521 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.15 7.89 84.56 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.92 -13.54 19.94 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.748 -0.266 . . . . 0.0 110.732 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.415 ' HG ' ' N ' ' A' ' 259' ' ' LEU . 6.5 t 177.08 142.52 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.131 0.491 . . . . 0.0 110.504 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.415 ' N ' ' HG ' ' A' ' 258' ' ' SER . 9.2 tt -147.95 125.47 11.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.106 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -98.42 143.72 28.56 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 120.937 0.399 . . . . 0.0 110.711 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.2 mt -95.22 106.28 18.29 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.727 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.442 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.0 t80 -101.79 -11.81 18.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.221 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.96 -40.75 87.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.831 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.9 173.2 45.81 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.472 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -74.06 -113.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 110.709 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.28 -28.76 68.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.725 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.01 -43.89 91.61 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.27 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -63.62 -44.33 94.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.31 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.65 -60.02 3.75 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.266 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.09 -43.38 61.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.102 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.43 -43.57 75.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.161 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.56 -43.66 96.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.615 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -56.22 -37.59 69.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.156 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.5 0.93 18.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.259 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -115.12 91.51 27.63 Favored Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.167 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.4 -27.09 30.13 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.846 2.364 . . . . 0.0 111.717 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.41 -41.2 98.72 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.558 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.431 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.9 mp -95.1 4.9 53.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.432 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.08 70.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.703 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -79.97 4.53 16.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.615 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.553 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.64 121.29 80.49 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.536 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -47.49 -37.65 26.38 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.408 2.072 . . . . 0.0 112.424 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.553 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -59.03 -43.63 91.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.792 0.329 . . . . 0.0 110.289 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.05 -43.86 92.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.279 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.82 -40.65 95.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.519 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.9 t-20 -89.54 -12.92 38.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.541 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.35 32.7 16.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.49 43.87 1.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.341 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.48 135.67 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.539 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.72 132.62 56.64 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.469 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.32 89.01 7.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.7 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.456 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.1 mt -63.9 -41.11 97.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.783 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.95 165.57 34.09 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.52 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 76.5 p -75.44 -25.74 57.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.865 0.364 . . . . 0.0 110.665 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -68.35 -34.49 76.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.345 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.505 ' O ' ' CG2' ' A' ' 296' ' ' THR . 95.3 m -72.98 25.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.722 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.585 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 39.6 t80 -58.53 -50.36 74.05 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.1 mmt-85 -111.05 153.48 25.56 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 44.9 tp -115.53 125.03 52.51 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.691 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 41.4 t0 -147.88 165.71 29.81 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.614 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -49.3 -38.16 26.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.509 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -71.23 -65.47 0.74 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.421 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -60.96 -32.73 72.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.962 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.4 -25.61 25.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.634 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.6 mtt -63.5 -41.02 98.55 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 120.905 0.383 . . . . 0.0 111.003 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -78.7 -44.03 24.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.067 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.18 -42.99 92.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.352 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.9 tp -60.14 -47.27 86.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.481 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -69.7 -39.66 76.79 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.634 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.4 ttt180 -61.63 -38.67 88.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.19 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -86.84 4.42 41.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.759 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.59 -11.19 13.61 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.018 0.437 . . . . 0.0 110.28 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.83 -37.12 85.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.632 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.19 -48.63 80.65 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.326 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.975 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.618 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.75 -2.4 58.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.38 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.484 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.12 179.06 1.24 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.047 0.451 . . . . 0.0 110.514 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.6 Cg_exo -60.98 145.1 99.57 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.773 2.316 . . . . 0.0 112.169 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.618 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.77 -179.31 8.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.553 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.7 136.88 52.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.355 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.0 tp -124.64 147.44 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.372 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.4 p -120.39 136.1 54.83 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.767 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.5 -143.47 0.33 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.25 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.41 -37.3 86.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.477 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.1 -66.85 0.22 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.467 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.64 142.48 45.61 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.2 p -112.2 131.71 55.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.951 0.405 . . . . 0.0 110.401 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.15 128.89 54.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.53 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.2 m -85.49 130.36 34.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.237 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.8 mt -95.71 78.75 3.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.306 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.6 -32.19 73.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.493 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 176.03 109.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.099 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -122.55 91.59 49.35 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.28 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.2 Cg_exo -56.95 148.54 67.19 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.794 2.329 . . . . 0.0 111.869 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.15 82.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.595 0.56 . . . . 0.0 111.022 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.43 66.82 0.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.227 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.85 130.83 35.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.697 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.7 t -122.57 147.43 26.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.079 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 t -136.62 143.74 43.69 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.65 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.69 ' HG1' ' H ' ' A' ' 50' ' ' SER . 26.7 p -99.22 -59.48 1.72 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.572 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.69 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.0 p -79.01 155.46 28.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.688 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.3 t -74.43 -21.9 17.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.557 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.407 ' O ' ' OG ' ' A' ' 56' ' ' SER . 89.2 m -60.22 -51.87 67.72 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.503 -178.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.4 mt -66.56 -42.4 87.15 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.319 0.58 . . . . 0.0 110.905 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.5 m -43.37 -53.83 5.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.065 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.27 -37.84 71.35 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.7 m -62.5 -44.45 96.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.846 0.355 . . . . 0.0 110.34 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.5 mt -65.99 -42.14 90.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.464 0.65 . . . . 0.0 110.714 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tp -62.57 -40.13 95.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.453 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.11 77.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.134 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.3 pt -90.9 28.29 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.208 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.81 51.82 10.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.939 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.83 75.75 24.45 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.974 0.416 . . . . 0.0 109.889 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.18 150.63 87.93 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.781 2.32 . . . . 0.0 112.213 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -113.36 136.88 48.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.198 0.523 . . . . 0.0 110.282 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.412 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.25 -43.55 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.307 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.11 131.19 53.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.006 0.431 . . . . 0.0 110.553 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.6 p -155.46 168.61 26.54 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.399 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.69 -177.42 21.75 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.77 172.86 12.2 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 120.881 0.372 . . . . 0.0 110.518 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.7 p -132.41 -113.16 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.374 . . . . 0.0 110.312 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.87 179.85 0.92 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.353 -179.02 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.8 Cg_exo -61.23 57.74 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.988 2.458 . . . . 0.0 112.137 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.545 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 60.4 t-20 -64.37 -33.38 75.71 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.468 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 42.7 m-20 93.76 -35.68 0.02 OUTLIER 'General case' 0 C--N 1.345 0.403 0 O-C-N 124.182 0.926 . . . . 0.0 109.804 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.6 mtp85 -63.05 -39.86 95.98 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.989 0.423 . . . . 0.0 110.267 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -74.73 -25.33 18.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.738 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.03 -171.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.599 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -73.3 -154.16 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.787 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.2 p-10 -52.11 -7.71 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.684 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -86.34 115.1 23.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.594 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.18 70.06 1.34 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.446 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.4 m-85 -143.57 147.46 34.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.931 0.396 . . . . 0.0 110.784 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.527 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.3 mp -85.57 -98.48 0.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.137 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.87 -42.74 97.44 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.129 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.569 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.6 tt0 91.68 53.13 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.066 0.854 . . . . 0.0 110.892 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -102.95 -9.31 19.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.419 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.446 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.54 -34.26 77.82 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.173 0.511 . . . . 0.0 110.664 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.569 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.1 mttt -48.91 -24.79 1.61 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.597 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.2 -45.66 79.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.792 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.25 -48.47 81.28 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.038 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.48 -38.35 89.52 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.364 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.67 -33.0 53.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.176 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.572 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.1 mmt-85 -89.72 1.47 56.03 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.598 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.92 -49.13 0.16 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 124.159 0.912 . . . . 0.0 110.288 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.64 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.1 mt -46.52 153.79 0.34 Allowed 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 117.403 -1.284 . . . . 0.0 109.264 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.64 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 121.62 92.62 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 O-C-N 125.625 1.828 . . . . 0.0 110.431 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.533 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.7 143.29 42.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.122 0.487 . . . . 0.0 110.276 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.3 mt -132.42 27.06 4.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.453 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.37 138.07 34.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.036 0.446 . . . . 0.0 110.512 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 91.9 mt -137.17 164.98 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.401 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.523 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.13 -28.63 1.83 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -153.01 70.93 7.1 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.167 0.508 . . . . 0.0 110.232 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.12 145.48 98.37 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.715 2.277 . . . . 0.0 112.089 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.5 t -134.2 136.61 43.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.563 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.35 82.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.649 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.31 -42.18 96.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.512 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.57 98.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.478 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.66 -43.31 98.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.961 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.2 77.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.26 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.48 -18.7 60.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.438 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.39 -6.44 58.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.523 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 72.4 mtp 47.94 55.85 17.23 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.617 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.16 148.99 63.72 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.798 2.332 . . . . 0.0 112.098 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.15 -73.04 0.66 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.501 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.9 tp -111.32 113.64 26.26 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.313 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.4 mt -102.6 126.37 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.537 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.3 mt -109.77 134.06 52.44 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.143 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.77 139.87 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.496 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 121' ' ' THR . 92.4 p -83.4 168.45 16.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.707 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.16 -37.4 80.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.41 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.425 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.9 t -139.99 159.21 42.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.433 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.27 177.28 33.37 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.24 -33.87 87.36 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.57 151.74 44.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.904 0.383 . . . . 0.0 110.543 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -63.39 140.85 58.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.32 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.54 10.66 11.16 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.657 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.18 -39.04 88.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.092 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.633 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.86 23.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.586 0.708 . . . . 0.0 110.611 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.0 mt -70.76 -35.65 72.72 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.531 0.681 . . . . 0.0 110.764 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.88 -62.96 0.88 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.273 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.633 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.89 -42.64 90.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.046 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -62.17 -32.77 73.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.177 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.5 mt -73.48 -40.9 63.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.24 -48.85 79.11 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.16 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.3 m -52.9 -42.58 65.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.199 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.74 -43.05 93.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.107 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.75 153.89 5.15 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.62 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -39.12 106.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.664 2.243 . . . . 0.0 112.406 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 96.8 m -110.33 121.52 45.47 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.244 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.02 152.96 30.19 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.26 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 tt -128.9 131.0 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.309 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.79 127.78 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.432 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.3 103.75 14.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.278 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 147' ' ' LYS . 45.5 p90 -101.45 -11.2 19.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.783 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.69 -33.61 76.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.666 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -98.21 7.79 45.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.525 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.76 155.46 50.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.527 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.7 p -74.89 165.71 24.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.709 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -60.05 -48.65 80.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.197 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.79 -42.02 67.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.923 0.392 . . . . 0.0 110.027 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.8 t -62.63 -41.11 98.83 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.358 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 tp -60.7 -44.17 96.89 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.353 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.4 tp -61.5 -43.22 99.26 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.101 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -55.31 -44.88 76.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.52 -40.65 97.44 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.894 0.378 . . . . 0.0 110.327 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.431 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -61.95 -42.46 99.14 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.31 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.88 -40.62 95.54 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.58 -45.86 64.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.926 0.393 . . . . 0.0 110.855 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.67 -44.04 96.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.85 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.3 p -93.19 -8.61 41.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.588 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.78 26.34 72.08 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -101.47 50.75 0.85 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.768 0.318 . . . . 0.0 110.67 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.58 -39.36 77.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.659 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.5 -47.17 86.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.234 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -60.19 -39.45 86.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.308 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.1 99.37 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.307 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.94 -28.69 70.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.994 0.426 . . . . 0.0 110.602 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.19 -54.24 8.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.15 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -65.55 -42.25 92.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.477 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.454 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.3 mt -62.45 -43.94 98.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.492 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.48 -58.96 5.71 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.14 0.495 . . . . 0.0 110.48 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -56.51 -34.16 66.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.448 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -80.79 -36.21 32.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.886 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.7 m-20 -55.1 -42.26 72.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.095 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.42 -41.82 98.98 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.686 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.05 -38.19 90.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.285 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.38 -42.11 99.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.771 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.47 63.87 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.084 0.469 . . . . 0.0 110.677 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.35 -41.79 89.02 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.601 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.06 -39.94 95.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.566 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.12 -32.43 73.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.361 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.24 -21.97 18.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.668 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.625 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.67 -41.35 96.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.64 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 pt -76.59 135.92 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.677 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.93 107.79 10.39 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.273 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.67 125.97 0.31 Allowed Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.541 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 73.9 Cg_exo -43.72 152.24 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.781 2.32 . . . . 0.0 112.601 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.87 141.98 55.75 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.573 2.182 . . . . 0.0 112.484 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.547 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.22 147.32 2.19 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.628 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.34 154.85 68.79 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.735 2.29 . . . . 0.0 112.284 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.525 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.56 163.27 28.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.419 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.675 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.0 t -143.84 170.8 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.959 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.675 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -148.92 137.92 21.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.93 0.395 . . . . 0.0 110.195 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 40.1 pt -134.47 147.37 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.692 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -133.2 131.95 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.098 0.475 . . . . 0.0 110.501 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -151.99 155.08 37.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.442 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 89.6 m -122.33 122.84 40.0 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.96 0.41 . . . . 0.0 110.366 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.2 -25.78 65.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.613 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.49 -48.46 22.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.069 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.07 -11.21 60.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.386 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.6 m80 48.25 41.55 16.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.485 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.3 t -135.89 145.22 46.08 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.42 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.94 114.02 27.03 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.233 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.63 133.13 55.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 110.351 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -111.77 146.24 37.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.772 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.442 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 10.3 t90 -99.36 129.77 45.59 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.096 0.475 . . . . 0.0 109.973 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.678 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.59 153.81 39.37 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.306 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.414 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.8 Cg_endo -67.76 -18.39 47.56 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.716 2.277 . . . . 0.0 111.954 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.678 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -49.1 -18.44 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.4 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.442 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.3 p -76.42 164.69 25.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.508 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.78 -27.64 65.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.514 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.603 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.1 mt-30 -63.75 -41.1 98.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.77 -44.48 97.93 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.63 -38.63 91.68 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.961 0.41 . . . . 0.0 110.575 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.3 mmm -62.16 -41.35 98.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.082 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.71 -46.91 83.28 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.534 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.5 -31.91 56.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.073 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.79 -18.68 62.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.449 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.61 -9.31 54.64 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.61 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.29 1.9 54.04 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -88.34 153.77 20.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 110.516 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.3 p -116.56 129.02 55.94 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.119 0.485 . . . . 0.0 110.331 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -93.02 146.21 23.79 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.927 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.454 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.41 151.48 46.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.49 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.39 131.41 43.63 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.397 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.54 93.3 27.01 Favored Pre-proline 0 C--O 1.234 0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.077 -179.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.716 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.6 Cg_exo -55.75 138.96 82.94 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.569 2.179 . . . . 0.0 111.527 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.84 -25.59 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.46 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.716 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.26 -49.96 29.96 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.58 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.0 mt -54.0 -36.8 63.34 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.85 36.42 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.814 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.58 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.75 86.94 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.905 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.1 p -79.4 -15.39 57.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.405 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -92.19 -41.29 10.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.627 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -66.03 -17.94 65.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.605 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.17 43.37 26.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.468 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.49 -147.76 7.46 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.97 142.66 50.08 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.026 0.441 . . . . 0.0 110.294 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.43 149.82 28.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.353 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -101.3 -151.55 0.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.347 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.4 t0 56.16 -91.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.652 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.519 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.85 175.35 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.559 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.519 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 93.4 mt -122.29 141.76 41.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.833 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.81 169.02 9.53 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.221 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.5 mt -147.68 151.07 35.53 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.266 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.69 -39.0 97.06 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.06 4.0 4.72 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.27 -58.06 3.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.996 0.426 . . . . 0.0 110.578 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -62.22 -36.93 83.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.212 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.21 -67.61 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.778 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.71 -42.13 67.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.132 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.0 17.71 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.607 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.25 48.46 0.31 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.47 -109.79 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.605 0.24 . . . . 0.0 110.7 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.454 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.8 m120 -60.9 -44.59 96.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.42 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.21 7.95 84.38 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -98.91 -13.33 20.05 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.713 -0.286 . . . . 0.0 110.693 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.423 ' HG ' ' N ' ' A' ' 259' ' ' LEU . 5.6 t 177.03 142.71 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.089 0.471 . . . . 0.0 110.498 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.423 ' N ' ' HG ' ' A' ' 258' ' ' SER . 9.2 tt -148.06 125.49 11.64 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.176 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -98.65 143.26 29.23 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 120.923 0.392 . . . . 0.0 110.809 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.9 mt -94.42 106.32 18.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.678 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.451 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.9 t80 -101.58 -11.55 19.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.108 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.43 87.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.874 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.74 174.12 46.32 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.475 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.4 m-20 -74.35 -113.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.741 0.305 . . . . 0.0 110.772 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.78 -28.69 67.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.708 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.03 -43.93 91.68 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.271 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.72 -44.26 94.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.377 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.52 -60.14 3.59 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.247 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.11 -43.26 61.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.17 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.53 -43.68 75.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.2 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.2 mt -64.47 -43.65 96.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.664 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -56.31 -37.39 69.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.162 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.77 0.95 18.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.197 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -115.05 91.31 26.5 Favored Pre-proline 0 CA--C 1.529 0.147 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.148 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.29 -27.2 29.76 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.796 2.33 . . . . 0.0 111.832 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.36 -41.02 98.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.569 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.45 5.22 52.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.349 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.97 -35.21 69.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.695 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.58 4.56 15.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.527 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.546 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.58 121.33 80.51 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.566 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -47.6 -37.69 27.25 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.397 2.065 . . . . 0.0 112.558 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.546 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.94 -43.57 91.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.856 0.36 . . . . 0.0 110.305 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.88 -43.89 92.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.285 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.91 -40.59 95.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.444 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.437 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.7 t-20 -89.32 -12.93 39.13 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.529 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.5 mtmt 62.32 31.94 17.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.893 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -89.01 43.87 1.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.046 0.45 . . . . 0.0 110.313 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.51 135.87 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.444 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -116.61 132.55 56.65 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.485 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.1 87.84 7.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.769 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.456 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.5 mt -63.86 -41.23 97.83 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.866 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.451 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.46 167.65 34.58 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.516 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 71.2 p -75.53 -25.69 57.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.845 0.355 . . . . 0.0 110.763 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.4 tp10 -67.84 -34.86 77.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.452 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.499 ' O ' ' CG2' ' A' ' 296' ' ' THR . 95.7 m -73.27 24.59 0.06 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.65 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.603 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 65.5 t80 -58.23 -51.18 70.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 58.9 mmt-85 -112.17 155.1 24.5 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 46.1 tp -116.3 125.64 52.43 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 42.0 t0 -147.29 165.3 30.52 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.573 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -49.41 -38.2 28.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.548 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -72.23 -64.8 0.87 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.509 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.3 -32.11 70.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.984 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.66 -25.3 26.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.571 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.6 mtt -63.08 -41.18 99.35 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 120.965 0.412 . . . . 0.0 110.953 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -78.33 -44.79 24.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.095 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 73.6 t -66.0 -43.06 92.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.435 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.441 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 52.7 tp -60.26 -47.37 86.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.548 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.94 -39.39 76.11 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.635 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.1 ttt180 -61.96 -38.07 87.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.233 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.8 mt -87.38 4.61 42.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.794 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.625 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.3 tttt -112.87 -11.7 13.4 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.045 0.45 . . . . 0.0 110.284 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.04 -37.31 86.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.539 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.95 -48.69 80.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.379 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.022 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.56 -2.53 57.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.43 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.488 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.61 179.03 1.25 Allowed Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.457 -179.658 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.7 Cg_exo -60.81 144.7 99.6 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.796 2.331 . . . . 0.0 112.183 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.98 -179.65 8.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.596 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.61 136.27 53.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.317 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -123.91 146.65 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.333 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.3 p -119.91 136.0 54.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.77 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.1 p30 -99.42 -143.62 0.33 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.225 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -63.4 -37.19 86.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.593 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.9 ttt85 -149.3 -66.62 0.22 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.501 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.29 142.1 45.16 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.8 p -112.15 131.03 55.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.934 0.397 . . . . 0.0 110.437 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -118.92 129.08 54.99 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.542 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.6 m -85.67 130.64 34.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.214 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.1 mt -96.0 78.77 3.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.343 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.81 -32.0 73.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.473 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.12 108.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.164 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -121.65 91.4 48.52 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.304 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.652 ' O ' ' N ' ' A' ' 45' ' ' ARG . 37.1 Cg_exo -57.0 148.59 67.44 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.738 2.292 . . . . 0.0 111.824 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.69 82.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.556 0.535 . . . . 0.0 111.018 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.14 66.85 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.046 0.45 . . . . 0.0 110.251 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.44 131.0 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.614 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.7 t -122.89 145.54 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.146 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -135.52 143.32 45.7 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.623 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.443 ' HG1' ' H ' ' A' ' 50' ' ' SER . 26.0 p -99.26 -59.19 1.77 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.552 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.443 ' H ' ' HG1' ' A' ' 49' ' ' THR . 86.9 p -79.52 154.97 28.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.647 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.8 t -74.58 -21.79 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.57 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.5 m -60.12 -52.18 66.45 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.434 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.6 -42.4 86.94 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.245 0.545 . . . . 0.0 110.873 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -42.82 -53.64 4.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.153 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.45 -37.75 69.56 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.9 m -62.56 -44.62 95.88 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.884 0.373 . . . . 0.0 110.459 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.19 -41.94 89.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.38 0.61 . . . . 0.0 110.739 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.65 -40.15 96.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.324 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.03 -35.91 76.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.94 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.4 pt -91.31 28.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.118 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.54 51.64 10.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.819 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.02 75.93 23.12 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.95 0.405 . . . . 0.0 110.003 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.4 151.77 84.06 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.746 2.298 . . . . 0.0 112.265 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.85 137.42 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.149 0.499 . . . . 0.0 110.316 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.419 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.5 pt -69.26 -43.61 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.219 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.78 130.96 53.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.926 0.393 . . . . 0.0 110.547 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.5 p -155.75 168.99 25.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.44 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.75 -177.44 21.71 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.67 171.86 13.3 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 120.943 0.402 . . . . 0.0 110.531 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 p -133.45 -111.02 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.426 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.498 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.91 179.61 0.95 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.303 -179.171 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.6 Cg_exo -60.88 58.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.953 2.436 . . . . 0.0 112.129 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.1 t-20 -64.24 -35.21 80.09 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.483 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 48.3 m-20 95.26 -37.65 0.01 OUTLIER 'General case' 0 C--N 1.345 0.401 0 O-C-N 124.113 0.883 . . . . 0.0 110.008 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -62.61 -39.87 95.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.2 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.9 p -73.81 -26.41 21.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.689 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -50.06 -172.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.547 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.05 -152.79 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.711 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.7 p-10 -54.37 -6.66 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.685 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -86.92 113.82 23.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.559 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.15 72.73 1.28 Allowed Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.499 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.2 m-85 -143.84 148.05 34.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 0.0 110.809 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.3 mp -85.25 -99.47 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.109 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.554 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.86 -43.11 97.09 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.252 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.4 tt0 91.74 52.8 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.916 0.76 . . . . 0.0 110.861 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -103.32 -9.21 19.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.457 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.499 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.3 p -64.79 -33.86 76.98 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.049 0.452 . . . . 0.0 110.679 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.554 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.66 -23.67 1.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.516 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.3 t -69.7 -45.88 76.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.889 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.23 -48.6 80.74 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.165 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.67 -38.12 89.11 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.337 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.63 -32.51 51.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.218 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.588 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.3 mmt-85 -89.76 1.62 55.88 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.575 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.84 -49.08 0.16 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 124.045 0.841 . . . . 0.0 110.331 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.662 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.7 mt -46.49 154.3 0.3 Allowed 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 117.89 -1.053 . . . . 0.0 109.349 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.662 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 121.17 92.36 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 125.313 1.633 . . . . 0.0 110.502 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.39 143.26 42.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.251 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.9 mt -131.77 26.83 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.758 0.313 . . . . 0.0 110.481 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.42 138.08 34.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.969 0.414 . . . . 0.0 110.506 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.522 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.0 mt -137.17 165.19 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.432 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.04 -28.51 1.85 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -153.01 70.65 7.07 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.178 0.513 . . . . 0.0 110.362 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.12 145.52 98.28 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.772 2.315 . . . . 0.0 112.053 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.5 t -134.1 137.0 44.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.59 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.2 -38.17 81.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.666 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.41 -42.23 96.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.529 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.7 98.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.503 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 64.2 t -63.72 -43.33 97.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.066 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.65 -35.32 77.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.332 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.8 -18.36 59.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.484 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.52 -6.44 58.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.508 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.413 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.9 mtp 48.15 55.78 17.26 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.588 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.05 148.98 64.39 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.844 2.363 . . . . 0.0 112.133 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.28 -73.1 0.66 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.424 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.7 tp -111.33 112.42 24.18 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.305 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.4 mt -100.55 126.07 54.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.476 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.4 mt -109.36 133.16 53.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.203 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.55 139.55 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.526 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 121' ' ' THR . 89.9 p -83.43 168.25 16.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.673 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.23 -37.48 80.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.494 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.433 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.9 t -139.03 158.96 43.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.502 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.44 176.8 33.71 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.83 87.16 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.93 151.55 45.28 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.876 0.369 . . . . 0.0 110.604 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.2 t -62.93 141.17 58.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.291 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.05 10.51 10.77 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.664 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.07 -39.07 88.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.031 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.83 -35.7 24.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.452 0.644 . . . . 0.0 110.654 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.3 mt -71.11 -35.31 71.73 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.437 0.637 . . . . 0.0 110.772 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -42.87 -62.93 0.89 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.185 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.76 -42.82 90.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -62.12 -32.65 73.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.204 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.8 mt -74.03 -40.46 62.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.054 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.16 -48.81 79.13 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.209 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.3 m -52.88 -42.44 65.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.194 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.15 -43.05 92.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.103 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.35 153.37 5.3 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.632 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -39.18 107.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.643 2.229 . . . . 0.0 112.326 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 98.3 m -109.09 121.38 45.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.285 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.36 152.89 30.76 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.26 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 tt -128.95 131.45 68.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.365 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.407 HG22 HD11 ' A' ' 142' ' ' ILE . 96.6 mt -115.07 127.72 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.493 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.4 t30 -101.86 103.67 14.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.324 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 49.6 p90 -101.23 -11.27 19.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.751 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.9 p-10 -64.78 -33.44 76.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.652 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.577 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.1 p-10 -98.31 7.41 46.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.584 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.14 155.35 50.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.572 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.408 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.2 p -74.65 165.7 24.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.664 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.588 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -59.99 -48.86 79.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.281 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -53.84 -41.99 68.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.104 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.2 t -62.49 -40.82 97.92 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.451 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 48.7 tp -60.61 -43.75 97.1 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.297 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.4 -43.2 99.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.826 0.346 . . . . 0.0 110.213 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.7 m -55.63 -45.37 77.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.833 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.35 -40.76 97.43 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-O 120.847 0.356 . . . . 0.0 110.377 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -61.88 -42.38 98.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.184 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.63 -40.76 96.1 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.77 -46.15 63.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.941 0.401 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.52 -43.98 96.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.766 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.2 p -93.21 -8.49 42.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.585 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.69 25.32 71.63 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -101.8 52.09 0.83 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.779 0.323 . . . . 0.0 110.623 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.84 -39.07 76.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.629 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.3 -47.17 86.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.262 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -61.33 -38.97 88.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.413 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.4 97.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.324 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.41 -27.69 69.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.491 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.77 -53.75 8.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.207 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -63.78 -43.51 96.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.458 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.1 mt -63.08 -43.88 99.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.654 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.35 -61.62 2.41 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.118 0.485 . . . . 0.0 110.377 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.66 -35.08 63.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.457 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -79.6 -34.77 40.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.004 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.6 m-20 -56.49 -40.12 74.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.112 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.95 -42.41 99.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.686 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.79 -37.72 87.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.309 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.44 -42.45 99.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.737 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.09 -53.17 59.18 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.059 0.457 . . . . 0.0 110.679 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.12 -41.77 90.08 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.562 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.93 95.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.647 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.17 -32.26 73.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.419 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.3 -21.97 18.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.719 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.637 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.94 -41.4 95.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.68 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 pt -77.48 136.14 24.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.666 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.26 108.69 11.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.351 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.5 126.14 0.32 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.559 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.457 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.4 Cg_exo -43.68 152.02 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.742 2.295 . . . . 0.0 112.598 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.03 141.66 53.81 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.605 2.203 . . . . 0.0 112.465 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.12 147.34 2.23 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.62 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.28 154.62 69.37 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.74 2.293 . . . . 0.0 112.26 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.52 163.2 28.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.446 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.524 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 2.0 t -143.82 170.1 16.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.853 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.484 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.51 137.75 21.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.238 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.7 pt -134.29 146.71 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.288 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.654 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.76 131.77 59.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.099 0.476 . . . . 0.0 110.53 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -152.05 155.11 37.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.369 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 90.5 m -122.62 122.92 39.98 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.924 0.393 . . . . 0.0 110.401 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.11 -25.71 65.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.601 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.42 -48.97 20.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.091 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.62 -13.25 61.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.442 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.3 m80 50.72 41.36 26.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.503 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 43.3 t -136.32 144.68 44.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.344 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.14 114.18 27.47 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.315 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.1 m-20 -119.74 133.35 55.65 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.972 0.415 . . . . 0.0 110.372 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.3 tt -112.07 146.32 38.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.735 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.457 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.2 t90 -99.5 129.8 45.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.108 0.48 . . . . 0.0 110.059 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.707 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.48 154.14 39.37 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.086 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.7 Cg_endo -67.8 -17.93 47.26 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.742 2.295 . . . . 0.0 111.933 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.707 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -49.56 -18.43 0.43 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.457 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.457 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.6 p -75.83 165.26 25.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.523 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.26 -28.17 66.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.491 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.526 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.51 -41.63 98.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.705 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.84 -44.95 96.59 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.44 -39.01 93.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.949 0.404 . . . . 0.0 110.612 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.588 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.4 mmm -62.08 -41.31 98.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.226 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.71 -47.14 82.33 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.64 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.33 -32.05 55.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.095 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.71 -18.3 62.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.496 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 91.1 mt -88.53 -8.6 54.53 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.691 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.74 2.43 55.25 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -88.55 152.63 21.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.0 110.499 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.2 p -115.5 128.32 55.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.077 0.465 . . . . 0.0 110.42 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.52 146.1 23.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.899 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.455 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.37 151.05 46.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.49 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.76 131.47 43.0 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.463 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.632 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.62 93.41 27.93 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.142 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.718 ' C ' ' H ' ' A' ' 229' ' ' GLY . 47.5 Cg_exo -55.65 139.16 82.79 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.62 2.213 . . . . 0.0 111.558 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.99 -25.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.445 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.718 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.71 -49.81 27.97 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.587 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.0 mt -53.97 -37.14 63.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.56 35.99 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.782 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.2 88.18 0.01 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.844 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.9 p -81.33 -14.31 57.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.356 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.64 -41.19 10.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.567 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.8 t -66.84 -16.72 64.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.607 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.06 43.53 26.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.469 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.91 -147.1 7.25 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -122.49 143.16 49.88 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.994 0.426 . . . . 0.0 110.389 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -151.97 149.47 28.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.453 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -100.72 -151.94 0.42 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.392 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 55.92 -92.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.648 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.512 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.54 175.08 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.565 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.512 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.5 mt -121.83 141.43 42.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.726 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.75 169.22 9.4 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.281 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.4 mt -147.83 150.85 34.95 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.182 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.65 -38.95 97.01 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.15 4.13 4.64 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.37 -58.15 3.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.922 0.392 . . . . 0.0 110.579 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -62.13 -36.86 83.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.271 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.28 -67.81 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.722 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.33 -42.11 66.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.185 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.14 18.12 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.64 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.79 48.61 0.27 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.41 -109.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.6 0.238 . . . . 0.0 110.726 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.455 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 12.0 m120 -60.89 -44.72 96.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.425 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.41 8.13 83.76 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -99.13 -12.74 20.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.58 0.229 . . . . 0.0 110.715 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.8 t 176.37 142.42 0.07 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.062 0.458 . . . . 0.0 110.533 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -147.88 125.39 11.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.03 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -98.6 143.03 29.44 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 120.85 0.357 . . . . 0.0 110.817 178.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.1 mt -94.33 106.5 18.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.675 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.463 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.3 t80 -102.28 -11.65 18.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.25 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.08 -40.15 86.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.804 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.11 173.68 46.14 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.474 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.0 m-20 -74.45 -112.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.347 . . . . 0.0 110.618 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.13 -28.72 67.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.728 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.85 -44.17 90.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.296 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -63.35 -44.54 94.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.353 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.34 -59.92 3.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.29 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.16 -43.32 61.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.221 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.38 -43.92 75.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.216 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.4 mt -64.42 -43.63 97.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.589 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -56.71 -37.43 70.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.172 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.96 1.03 18.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.251 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.0 91.35 26.43 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.195 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.01 -27.19 27.75 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.743 2.296 . . . . 0.0 111.87 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.514 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.34 -41.19 98.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.634 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.9 mp -95.21 5.11 52.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.41 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.72 -35.09 70.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.683 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.8 4.7 15.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.528 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.95 121.08 80.32 Favored Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.556 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -47.27 -37.8 24.94 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.507 2.138 . . . . 0.0 112.487 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.55 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.9 -43.82 91.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.294 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.82 -43.72 93.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.303 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.6 -40.52 95.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.539 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -90.32 -11.94 39.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.53 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.86 32.38 18.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.884 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.77 44.0 1.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.385 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.34 135.74 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.566 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.44 133.03 56.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.435 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.497 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.69 87.95 7.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.686 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.471 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.9 mt -63.91 -41.47 97.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.834 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.16 167.93 34.42 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.8 p -75.9 -25.82 56.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.84 0.352 . . . . 0.0 110.691 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.533 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.4 tp10 -67.84 -34.32 76.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.39 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.497 ' O ' ' CG2' ' A' ' 296' ' ' THR . 97.1 m -73.14 19.7 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.631 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.533 ' H ' ' C ' ' A' ' 295' ' ' GLU . 53.1 t80 -57.25 -51.08 70.8 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.058 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 68.5 mmt-85 -108.05 149.36 28.53 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 42.3 tp -115.46 125.57 53.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.756 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 304' ' ' ALA . 42.6 t0 -149.37 166.61 28.52 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.632 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -49.15 -38.14 24.47 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.588 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.82 -65.15 0.8 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.231 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.86 -32.79 72.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 300' ' ' ASP . . . -54.44 -26.01 28.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.659 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.6 mtt -63.36 -41.04 98.8 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 120.851 0.357 . . . . 0.0 110.908 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.26 -44.41 25.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.914 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.17 -42.89 92.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.425 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.436 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.3 tp -59.86 -47.49 85.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.505 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -69.64 -39.56 77.05 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.027 0.441 . . . . 0.0 110.723 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.497 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.2 ttt180 -61.7 -38.43 87.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.203 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -87.14 4.9 40.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.785 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.637 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.65 -11.77 13.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.04 0.448 . . . . 0.0 110.266 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.74 -37.08 85.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.642 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.99 -48.78 80.24 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.386 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.057 179.855 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.85 -2.46 58.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.413 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.9 179.08 1.24 Allowed Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.556 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.1 Cg_exo -60.9 145.11 99.52 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.781 2.321 . . . . 0.0 112.165 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.03 -179.21 7.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.589 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.81 136.67 52.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.342 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.39 147.29 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.362 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.9 p -120.39 136.12 54.82 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.27 -143.57 0.32 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.191 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -63.46 -37.18 86.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.526 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.05 -66.96 0.22 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.412 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.32 142.4 44.96 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.7 p -112.24 131.44 55.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.907 0.384 . . . . 0.0 110.435 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -119.22 129.06 54.76 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.518 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.0 m -85.68 130.36 34.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.225 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.8 mt -95.94 78.88 3.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.32 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.9 -31.91 73.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.491 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 176.06 108.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.05 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -121.89 91.56 48.77 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.312 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.646 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.3 Cg_exo -56.94 148.77 65.7 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.787 2.325 . . . . 0.0 111.862 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.64 82.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.607 0.567 . . . . 0.0 111.044 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.646 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.16 66.71 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.229 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.7 130.65 36.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.63 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.9 t -122.91 146.34 28.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.027 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -135.96 144.3 45.32 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.406 ' HG1' ' N ' ' A' ' 50' ' ' SER . 20.8 p -100.13 -59.28 1.74 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.619 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.406 ' N ' ' HG1' ' A' ' 49' ' ' THR . 86.5 p -79.21 154.78 28.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.653 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.2 t -74.0 -22.01 18.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.578 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.405 ' O ' ' OG ' ' A' ' 56' ' ' SER . 97.4 m -60.24 -51.89 67.62 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.559 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -66.45 -42.42 87.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.196 0.522 . . . . 0.0 110.855 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.1 m -43.38 -53.74 5.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.048 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.41 -37.64 69.88 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.5 m -62.51 -44.66 95.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.896 0.379 . . . . 0.0 110.324 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.0 mt -66.16 -42.01 89.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.535 0.683 . . . . 0.0 110.704 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.63 -40.21 96.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.398 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.79 75.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.07 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 pt -91.36 28.91 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.229 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.5 51.66 10.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.881 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.35 75.55 22.71 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.91 151.88 84.22 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.742 2.295 . . . . 0.0 112.136 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.82 137.48 46.86 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 CA-C-O 121.172 0.51 . . . . 0.0 110.236 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.22 -43.63 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.317 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.483 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.97 131.12 53.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.051 0.453 . . . . 0.0 110.552 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.53 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.0 p -155.62 168.84 25.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.493 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.82 -177.25 21.67 Favored Glycine 0 N--CA 1.464 0.544 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.72 172.76 12.32 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.0 0.428 . . . . 0.0 110.486 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 p -132.59 -112.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.339 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.17 179.9 0.91 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.359 -179.131 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.8 Cg_exo -60.89 57.59 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.973 2.449 . . . . 0.0 112.154 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.6 t-20 -63.87 -33.36 75.52 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.407 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 43.6 m-20 93.42 -36.64 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.014 0.821 . . . . 0.0 109.855 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -62.65 -39.51 94.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.019 0.438 . . . . 0.0 110.145 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 77' ' ' ALA . 15.0 p -74.29 -25.65 19.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.758 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.36 -171.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.545 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -74.12 -154.13 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.845 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.2 p-10 -52.52 -7.4 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.665 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.521 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.19 115.02 23.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.977 0.418 . . . . 0.0 110.631 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.82 70.16 1.35 Allowed Glycine 0 CA--C 1.52 0.39 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.3 m-85 -143.47 148.18 35.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 110.793 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.526 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -86.08 -98.42 0.07 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.135 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.89 -42.84 97.37 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.183 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.547 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.3 tt0 91.53 52.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.991 0.807 . . . . 0.0 110.858 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -102.86 -9.48 19.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.429 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.419 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.3 p -64.24 -33.85 76.75 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.149 0.5 . . . . 0.0 110.691 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.546 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.12 -23.96 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.66 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.39 -45.99 77.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.27 -48.33 81.9 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.043 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.65 -38.11 89.0 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.374 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.82 -32.72 53.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.161 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.574 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.94 1.71 55.93 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.523 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.65 -49.38 0.18 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.115 0.884 . . . . 0.0 110.265 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.5 mt -46.16 154.65 0.25 Allowed 'General case' 0 CA--C 1.49 -1.336 0 CA-C-O 117.475 -1.25 . . . . 0.0 109.343 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.644 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 120.95 92.57 0.0 OUTLIER 'General case' 0 C--N 1.353 0.735 0 O-C-N 125.563 1.79 . . . . 0.0 110.46 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.53 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.7 mtp180 -75.7 143.36 42.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.14 0.495 . . . . 0.0 110.265 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.5 mt -132.43 27.12 4.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 0.0 110.461 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.21 137.7 34.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.003 0.43 . . . . 0.0 110.49 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 91.8 mt -137.29 165.09 28.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.391 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.524 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.08 -28.46 1.84 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.35 70.84 7.59 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.191 0.52 . . . . 0.0 110.208 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -60.0 145.3 98.71 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 C-N-CA 122.751 2.3 . . . . 0.0 112.066 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.7 t -134.73 136.81 42.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.553 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.12 81.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.711 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.26 -42.33 96.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.52 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.86 -41.61 98.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.546 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.4 t -63.5 -43.42 98.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.99 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.06 77.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.23 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.76 -18.9 61.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.478 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.38 -6.57 58.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 81.9 mtp 47.8 55.97 17.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.59 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.3 Cg_endo -70.37 149.36 62.87 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.807 2.338 . . . . 0.0 112.101 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.22 -72.94 0.66 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.454 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.2 tp -111.56 113.01 25.14 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.324 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.1 mt -101.27 126.46 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.584 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.7 mt -109.52 133.47 53.05 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.225 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.68 139.65 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.493 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 121' ' ' THR . 88.4 p -83.45 168.56 16.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.671 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.42 80.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.381 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.431 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.8 t -139.53 158.94 43.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.943 0.402 . . . . 0.0 110.453 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.29 176.92 33.56 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.21 -33.71 86.82 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.77 151.52 45.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.925 0.393 . . . . 0.0 110.507 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.1 t -63.06 140.98 58.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.339 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.69 10.42 11.0 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.642 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.09 -39.16 88.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.081 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.79 -35.98 23.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.588 0.709 . . . . 0.0 110.705 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.4 mt -70.83 -35.54 72.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.528 0.68 . . . . 0.0 110.732 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -42.81 -62.83 0.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.317 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.81 -42.78 90.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.06 -179.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -62.03 -32.73 73.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.24 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.3 mt -73.77 -40.64 63.31 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.102 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.29 -48.76 79.47 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.153 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.1 m -53.05 -42.5 65.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.097 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.88 -43.09 93.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.937 0.399 . . . . 0.0 111.099 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.32 153.47 5.36 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.674 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -39.25 107.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.65 2.233 . . . . 0.0 112.445 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 97.8 m -109.65 121.64 45.67 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.24 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -113.96 152.6 30.64 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.256 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 tt -128.98 131.4 68.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.321 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.14 127.89 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.491 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.472 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 57.0 t30 -101.56 103.8 14.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.265 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.6 p90 -101.38 -11.21 19.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.816 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.75 -33.65 76.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.682 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.9 p-10 -98.3 7.66 45.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.612 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.448 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.46 155.39 50.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.51 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.403 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.8 p -74.86 165.64 24.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.641 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.86 -48.77 80.35 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.247 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.66 -41.95 67.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.028 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.3 t -62.65 -41.08 98.86 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.385 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.5 tp -60.61 -44.38 96.36 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.393 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.3 tp -61.41 -43.43 98.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.145 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -55.07 -44.88 75.2 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.43 -40.78 97.68 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.943 0.402 . . . . 0.0 110.469 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -62.03 -42.47 99.2 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.305 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.21 -40.91 95.02 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.5 -45.96 64.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.832 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.75 -44.04 96.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.794 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.4 p -93.03 -8.81 41.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.622 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.01 26.58 72.38 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -101.54 50.63 0.85 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.807 0.337 . . . . 0.0 110.703 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.45 -39.61 77.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.617 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.4 -47.26 86.13 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.252 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -59.94 -39.55 85.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.314 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.77 98.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.278 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.0 -28.61 70.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.614 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.18 -54.26 8.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.067 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -65.49 -42.27 92.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.456 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.459 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.6 mt -62.35 -43.98 98.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.502 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.66 -58.35 7.8 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.037 0.446 . . . . 0.0 110.344 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.05 -34.05 67.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.471 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -81.01 -36.35 30.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.875 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -55.61 -41.84 74.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.03 -178.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.7 -42.1 99.47 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.684 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.29 -38.05 89.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.288 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.47 -42.23 99.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.674 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.08 -52.79 62.48 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.091 0.472 . . . . 0.0 110.664 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.32 -41.75 89.23 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.588 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.89 95.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.611 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.34 -32.13 73.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.426 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.62 -22.26 18.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.693 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.636 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.77 -41.26 96.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.652 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.3 pt -76.56 136.45 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.698 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.72 107.91 10.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.224 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.82 125.69 0.3 Allowed Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.45 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.452 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.2 Cg_exo -43.96 152.38 0.37 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.757 2.305 . . . . 0.0 112.623 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.75 141.85 55.88 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.589 2.193 . . . . 0.0 112.466 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.01 147.44 2.29 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.622 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.31 154.32 69.71 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.782 2.321 . . . . 0.0 112.303 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.522 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.39 163.15 29.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.438 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.582 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.1 t -143.91 170.73 15.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.915 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.582 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.36 137.75 22.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.238 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 40.1 pt -134.24 146.89 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.672 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.03 131.87 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.168 0.508 . . . . 0.0 110.488 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -152.12 155.25 37.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.388 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 90.6 m -122.69 123.16 40.49 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.917 0.389 . . . . 0.0 110.341 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.5 -25.66 66.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.649 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.59 -48.94 20.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.038 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.18 -13.62 61.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.435 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 76.5 m80 51.05 40.92 26.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.518 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.9 t -136.48 143.96 44.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.422 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -109.56 114.54 28.25 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.287 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.3 m-20 -119.8 133.32 55.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.128 0.49 . . . . 0.0 110.346 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -111.97 146.41 37.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.787 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.449 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.6 t90 -99.47 129.61 45.66 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.142 0.496 . . . . 0.0 109.996 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.707 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.14 153.89 39.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.225 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.7 Cg_endo -67.8 -18.04 47.3 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.647 2.231 . . . . 0.0 111.958 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.707 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -49.29 -18.7 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.441 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.449 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.6 p -75.63 164.65 26.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.486 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.91 -27.94 65.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.503 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.579 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.9 mt-30 -63.82 -41.33 97.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.586 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.37 -44.61 97.4 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.448 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.2 mt-30 -64.51 -38.75 92.11 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 122.524 -0.398 . . . . 0.0 110.575 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.2 mmm -62.16 -41.08 97.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.167 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.3 mt -63.59 -47.02 83.18 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.464 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.31 -31.91 55.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.155 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -70.84 -18.24 62.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.558 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.17 -9.11 54.16 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.617 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.18 1.97 54.41 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -88.43 153.22 21.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 110.467 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 p -116.12 128.73 55.91 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.129 0.49 . . . . 0.0 110.348 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.66 146.24 23.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.897 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.75 151.26 46.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.402 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.43 131.44 43.57 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.425 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.631 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.62 93.37 27.72 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.032 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.716 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.7 Cg_exo -55.65 139.0 82.62 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.575 2.183 . . . . 0.0 111.518 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.84 -25.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.483 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.716 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -69.94 -50.1 31.18 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.581 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.5 mt -53.94 -36.92 63.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.814 0.34 . . . . 0.0 110.123 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -66.7 36.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.829 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.581 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.88 86.81 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.948 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.3 p -79.09 -15.24 58.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.325 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.58 -41.04 10.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.616 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.1 t -66.21 -18.0 65.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.546 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.14 43.48 26.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.435 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.52 -148.22 7.71 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.68 142.79 49.81 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.002 0.429 . . . . 0.0 110.294 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.41 149.93 29.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.317 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -101.21 -151.55 0.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.369 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 56.0 -91.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.646 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.519 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.84 175.42 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.648 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.519 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.1 mt -122.54 141.78 41.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.83 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.76 169.29 9.35 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.327 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.5 mt -147.65 151.01 35.46 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.289 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.63 -38.95 97.02 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.95 4.13 4.74 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -77.37 -58.1 3.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.986 0.422 . . . . 0.0 110.595 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -62.11 -36.69 82.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.232 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.44 -67.53 0.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.55 -42.21 67.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.1 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.29 17.67 0.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.62 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.17 48.62 0.31 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.5 mp 38.65 -109.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.6 0.238 . . . . 0.0 110.736 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.453 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.9 m120 -60.95 -44.75 96.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.427 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.42 7.97 83.98 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.88 -13.51 20.0 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.743 -0.269 . . . . 0.0 110.65 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.423 ' HG ' ' N ' ' A' ' 259' ' ' LEU . 5.7 t 176.97 142.7 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.122 0.487 . . . . 0.0 110.479 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.423 ' N ' ' HG ' ' A' ' 258' ' ' SER . 9.2 tt -148.13 125.21 11.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.14 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -98.31 143.52 28.7 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 120.898 0.38 . . . . 0.0 110.763 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.87 106.55 18.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.688 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.4 t80 -101.79 -12.21 18.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.157 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.47 -40.86 89.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.853 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.79 173.22 45.87 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.009 -0.837 . . . . 0.0 111.009 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.461 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.4 m-20 -73.85 -113.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 110.758 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.89 -28.69 67.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.711 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.9 -43.9 91.11 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.237 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.57 -44.17 94.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.408 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.73 -60.09 3.68 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.217 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.08 -43.34 61.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.142 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.48 -43.62 75.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.144 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.6 mt -64.59 -43.66 96.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.6 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -56.07 -37.49 69.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.16 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.72 0.94 18.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.185 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -114.98 91.14 25.49 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.147 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.19 -27.09 28.69 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.756 2.304 . . . . 0.0 111.848 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.45 -40.97 98.55 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.592 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.35 5.11 52.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.352 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.87 -35.19 69.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.687 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.65 4.5 15.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.53 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.548 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.67 121.17 80.07 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -47.32 -37.66 25.12 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.469 2.113 . . . . 0.0 112.512 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.548 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -59.05 -43.82 91.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.804 0.335 . . . . 0.0 110.273 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.5 t -65.86 -43.77 93.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.299 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -65.03 -40.66 95.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.428 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.9 t-20 -89.49 -12.73 39.22 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.575 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.7 mtmt 62.16 32.07 17.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -88.9 43.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.101 0.477 . . . . 0.0 110.332 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.13 135.81 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.419 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.8 132.3 56.73 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.403 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.13 89.05 7.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.765 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.458 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.8 mt -63.9 -41.23 97.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.877 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.444 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.79 165.64 33.84 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 69.0 p -75.47 -25.83 57.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.888 0.375 . . . . 0.0 110.813 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.0 tp10 -68.23 -33.84 75.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.439 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.503 ' O ' ' CG2' ' A' ' 296' ' ' THR . 96.7 m -73.53 24.45 0.07 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.67 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.579 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 43.7 t80 -58.28 -50.7 72.66 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 76.9 mmt-85 -110.8 153.17 25.75 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 43.6 tp -115.49 125.34 52.94 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.819 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 41.1 t0 -148.16 165.77 29.89 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.605 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -49.38 -38.05 27.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.567 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -70.92 -65.76 0.7 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.449 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -60.97 -32.72 72.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.056 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.22 -25.58 23.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.678 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.7 mtt -63.51 -40.83 98.08 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 120.872 0.368 . . . . 0.0 111.081 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.75 -44.24 23.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.108 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 78.6 t -66.14 -42.91 92.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.409 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.3 tp -60.29 -47.01 87.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.48 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -70.0 -39.33 75.93 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.598 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.498 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.7 ttt180 -61.79 -38.29 87.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.166 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.5 mt -87.07 4.45 42.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.71 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.636 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.78 -11.3 13.5 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 110.264 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.12 85.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.552 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.85 -48.61 81.01 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.296 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.964 179.971 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.614 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.34 -2.46 57.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.412 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.89 179.04 1.25 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.0 Cg_exo -60.73 144.61 99.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.71 2.273 . . . . 0.0 112.194 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.614 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.58 -179.87 8.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.621 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.63 136.52 52.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.318 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.12 147.07 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.368 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.6 p -120.25 136.08 54.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 110.745 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.6 -143.43 0.33 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.269 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.41 -37.27 86.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.504 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.474 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.17 -66.84 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.486 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.62 142.38 45.65 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.0 p -112.26 131.41 55.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.908 0.385 . . . . 0.0 110.45 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -118.8 128.96 54.96 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.561 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.5 m -85.35 130.33 34.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.237 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.7 mt -95.68 78.9 3.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.324 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.53 -31.94 73.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.493 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.79 109.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.073 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -122.05 91.66 48.9 Favored Pre-proline 0 C--O 1.233 0.203 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.296 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.646 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.2 Cg_exo -56.94 148.76 65.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.766 2.311 . . . . 0.0 111.874 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.61 82.75 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 O-C-N 123.587 0.554 . . . . 0.0 110.991 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.646 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.45 67.03 0.89 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.244 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.14 130.66 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.665 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.66 146.68 27.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.047 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.9 t -136.28 143.87 44.45 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.697 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.561 ' HG1' ' H ' ' A' ' 50' ' ' SER . 28.2 p -99.26 -59.2 1.77 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.584 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.561 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.2 p -79.46 155.39 28.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.632 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.6 t -74.3 -21.86 17.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.567 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.407 ' O ' ' OG ' ' A' ' 56' ' ' SER . 97.4 m -60.28 -52.01 67.11 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.456 -178.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.29 -42.54 88.23 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.375 0.607 . . . . 0.0 110.879 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.0 m -43.38 -53.93 5.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.086 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.31 -37.75 70.89 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.7 m -62.51 -44.67 95.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.805 0.336 . . . . 0.0 110.277 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt -66.14 -41.98 89.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.464 0.649 . . . . 0.0 110.761 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.53 -40.19 95.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.476 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.14 -36.0 76.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.135 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.9 pt -91.07 28.7 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.239 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.72 51.48 10.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.861 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.94 75.66 23.97 Favored Pre-proline 0 C--N 1.332 -0.167 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.68 151.44 85.64 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.743 2.295 . . . . 0.0 112.17 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.61 137.18 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.191 0.519 . . . . 0.0 110.25 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.7 pt -69.09 -43.69 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.339 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.95 130.97 53.43 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.933 0.396 . . . . 0.0 110.581 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.53 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.8 p -155.51 168.79 25.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.429 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.78 -177.45 21.69 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.54 172.88 12.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.944 0.402 . . . . 0.0 110.523 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.6 p -133.03 -112.11 0.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.404 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.36 179.79 0.92 Allowed Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.346 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.3 Cg_exo -61.2 57.86 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.943 2.428 . . . . 0.0 112.117 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.8 t-20 -63.97 -33.98 76.95 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.51 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.3 m-20 94.01 -36.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.176 0.923 . . . . 0.0 109.808 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.2 mtp85 -62.99 -40.1 96.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.258 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 77' ' ' ALA . 15.0 p -74.43 -25.92 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.744 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.21 -171.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.608 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -73.69 -153.87 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.819 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.1 p-10 -52.79 -7.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.751 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.22 114.59 23.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.619 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.81 71.04 1.33 Allowed Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.444 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.0 m-85 -143.75 148.23 35.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.861 0.362 . . . . 0.0 110.812 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.527 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.5 mp -86.07 -98.66 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.031 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.99 -42.83 97.06 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.227 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.561 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.7 tt0 91.7 53.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.994 0.809 . . . . 0.0 110.887 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -103.12 -9.22 19.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.36 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.444 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.49 -34.19 77.64 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.079 0.466 . . . . 0.0 110.625 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.561 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.1 mttt -48.91 -23.76 1.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.562 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.9 t -69.53 -45.93 77.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.41 -48.38 81.46 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.055 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.63 -38.21 89.35 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.276 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.71 -32.25 51.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.173 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.575 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 83.2 mmt-85 -90.16 1.67 56.17 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.575 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.76 -49.18 0.17 Allowed 'General case' 0 N--CA 1.465 0.305 0 O-C-N 124.169 0.918 . . . . 0.0 110.288 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.1 mt -46.54 154.21 0.31 Allowed 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 117.503 -1.237 . . . . 0.0 109.274 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.644 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.32 92.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 O-C-N 125.569 1.793 . . . . 0.0 110.431 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.53 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.59 143.51 42.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.123 0.487 . . . . 0.0 110.228 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 mt -132.37 27.18 4.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.769 0.319 . . . . 0.0 110.471 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.48 138.25 34.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.015 0.436 . . . . 0.0 110.495 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.522 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 93.1 mt -137.3 165.04 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.367 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.0 -28.57 1.85 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -153.16 70.93 7.01 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.13 0.49 . . . . 0.0 110.292 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.08 145.48 98.34 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.724 2.282 . . . . 0.0 112.075 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.7 t -134.05 136.37 43.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.05 -38.29 82.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.63 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.28 -42.03 96.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.53 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.4 98.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.523 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -63.74 -43.54 98.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.946 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.13 77.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.237 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.68 -18.6 60.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.427 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.6 -6.61 58.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.509 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.5 mtp 47.93 56.02 17.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.609 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.4 Cg_endo -70.23 149.09 63.35 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.834 2.356 . . . . 0.0 112.112 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -100.75 -74.11 0.62 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.564 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.1 tp -110.45 113.32 25.87 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.296 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.9 mt -101.78 126.38 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.508 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.1 mt -109.79 133.55 53.02 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.183 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.26 139.62 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.563 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.2 p -83.45 168.41 16.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.701 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.42 80.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.459 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.2 t -139.58 158.97 43.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.436 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.01 176.65 33.41 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.33 -33.82 87.34 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.48 151.57 44.43 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.881 0.372 . . . . 0.0 110.537 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.5 t -63.1 140.57 58.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.316 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.39 10.5 11.23 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.677 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.06 -38.97 88.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.049 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.99 -35.92 23.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.554 0.692 . . . . 0.0 110.645 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.9 mt -70.69 -35.65 72.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.495 0.664 . . . . 0.0 110.726 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -42.8 -62.93 0.88 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.375 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.74 -42.65 90.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.102 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -62.14 -32.97 73.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.209 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.5 mt -73.29 -40.95 64.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.038 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.42 -48.85 79.32 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.145 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.4 m -52.94 -42.32 65.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.247 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.11 -42.93 92.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.928 0.394 . . . . 0.0 111.043 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.53 154.37 5.55 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.621 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -39.63 107.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.621 2.214 . . . . 0.0 112.335 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 93.8 m -110.09 121.13 44.54 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.255 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -113.88 152.74 30.31 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.223 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 tt -128.8 131.39 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.391 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.13 127.75 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.469 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.9 t30 -101.52 103.23 14.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.243 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 147' ' ' LYS . 44.5 p90 -100.96 -11.09 20.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.812 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.5 p-10 -64.8 -33.56 76.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.703 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.7 p-10 -98.47 8.12 45.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.601 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.443 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.8 155.51 50.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.51 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.404 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.8 p -74.99 165.85 24.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.705 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.4 t90 -60.01 -48.8 80.22 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.246 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.5 -42.19 67.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.921 0.391 . . . . 0.0 110.103 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.7 t -62.54 -40.81 97.99 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.406 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.62 -43.91 96.93 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.282 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.8 tp -61.45 -43.25 99.2 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.111 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.5 m -55.01 -45.27 75.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.53 -40.67 97.52 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.855 0.359 . . . . 0.0 110.338 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -62.02 -42.37 99.09 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.302 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.07 -41.18 95.25 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.61 -46.03 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.952 0.406 . . . . 0.0 110.975 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.53 -44.05 96.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.887 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 156' ' ' LEU . 31.8 p -93.31 -8.54 41.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.597 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.89 25.46 71.92 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -102.12 51.83 0.82 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.8 0.333 . . . . 0.0 110.699 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.76 -39.23 76.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.664 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.28 -46.94 87.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.173 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -61.36 -39.02 89.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.315 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.4 -40.46 97.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.311 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.62 69.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.018 0.437 . . . . 0.0 110.545 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.77 -53.61 8.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.158 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -64.11 -43.25 95.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.406 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.2 mt -62.98 -43.89 99.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.717 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.46 -61.38 2.57 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.128 0.489 . . . . 0.0 110.461 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.71 -35.11 63.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.451 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -79.6 -35.24 39.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.957 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.4 m-20 -56.29 -40.66 74.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.255 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.01 -42.37 99.81 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.684 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.64 -37.83 87.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.287 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.42 -42.16 99.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.736 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.05 -52.78 62.56 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.128 0.489 . . . . 0.0 110.694 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.46 -41.47 89.02 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.609 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.8 94.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.633 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.01 -32.53 73.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.43 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.03 -21.93 18.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.696 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -65.11 -41.03 95.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.734 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -77.45 136.32 24.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.74 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.28 108.56 10.97 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.258 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.44 125.96 0.32 Allowed Pre-proline 0 C--O 1.24 0.555 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.529 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.1 Cg_exo -43.92 152.21 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.824 2.349 . . . . 0.0 112.533 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.26 142.12 54.16 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.678 2.252 . . . . 0.0 112.472 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.44 147.26 2.09 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.607 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.85 154.29 71.3 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.726 2.284 . . . . 0.0 112.293 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.521 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.12 162.99 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.452 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.521 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 2.1 t -143.83 170.57 15.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.948 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.471 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.77 137.84 21.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.0 110.166 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 40.0 pt -134.33 146.99 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.695 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.94 131.86 59.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.161 0.505 . . . . 0.0 110.468 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -152.22 155.45 37.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.363 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 90.6 m -123.05 123.23 40.39 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.939 0.4 . . . . 0.0 110.331 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.78 66.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.635 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.23 -49.28 19.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.1 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.89 -11.65 60.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.403 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.5 m80 48.84 41.98 19.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.485 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.9 t -136.16 143.48 44.49 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.363 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -109.86 114.18 27.53 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.29 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.94 133.63 55.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.05 0.452 . . . . 0.0 110.445 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.05 146.45 37.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.787 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.446 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.4 t90 -99.8 129.78 45.94 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.127 0.489 . . . . 0.0 109.939 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.705 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.54 153.82 39.41 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.281 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.417 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.0 Cg_endo -67.62 -18.37 48.39 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.72 2.28 . . . . 0.0 111.912 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.705 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.3 mt-10 -48.92 -18.28 0.27 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.401 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.446 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.4 p -76.2 165.35 25.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.499 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.35 -28.34 66.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.484 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.613 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.0 mt-30 -63.57 -41.13 98.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.617 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.31 -44.52 97.43 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.443 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.8 mt-30 -64.57 -39.05 93.05 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.886 0.374 . . . . 0.0 110.496 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.19 -41.31 98.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.107 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 70.5 mt -63.59 -47.05 83.03 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.588 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -54.63 -31.77 57.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.112 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.7 -18.38 62.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.539 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 90.0 mt -87.94 -9.1 54.62 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.609 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.27 2.34 54.14 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -88.59 153.43 21.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.359 . . . . 0.0 110.549 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.0 p -115.98 128.52 55.8 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.154 0.502 . . . . 0.0 110.307 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.4 145.88 24.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.944 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.451 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.66 151.59 45.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.503 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.17 131.72 42.5 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.385 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.73 93.36 28.19 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.063 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.717 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.5 Cg_exo -55.38 138.91 81.15 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.571 2.181 . . . . 0.0 111.539 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.78 -25.78 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.505 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.717 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.18 -50.16 29.42 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.59 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.7 mt -54.48 -37.11 64.86 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.18 35.89 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.898 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.59 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.3 88.24 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.909 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.3 p -81.68 -13.91 57.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.323 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.64 -41.45 10.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.577 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.4 t -67.02 -16.66 64.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.649 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.95 43.81 26.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.461 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 180.0 -148.5 8.0 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.55 143.02 48.82 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.001 0.429 . . . . 0.0 110.313 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -151.95 149.48 28.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.273 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -101.14 -151.86 0.42 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.33 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.06 -91.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.664 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.507 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.8 tt -127.08 175.29 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.545 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.507 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.1 mt -122.17 141.63 41.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.84 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.55 169.13 9.51 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.207 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.3 mt -147.69 150.72 34.87 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.241 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.67 -39.01 97.08 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.21 4.07 4.63 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.49 -57.98 3.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.949 0.404 . . . . 0.0 110.566 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.25 -36.27 81.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.326 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.52 -67.72 0.23 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.735 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.4 -42.29 66.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.241 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.06 17.85 0.16 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.681 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.76 48.59 0.26 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.62 -109.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.59 0.233 . . . . 0.0 110.728 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.451 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.8 m120 -61.08 -44.57 97.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.406 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.25 8.15 84.01 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -99.2 -13.05 19.9 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.75 -0.265 . . . . 0.0 110.69 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.41 ' HG ' ' N ' ' A' ' 259' ' ' LEU . 5.3 t 176.79 142.34 0.08 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.112 0.482 . . . . 0.0 110.454 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.41 ' N ' ' HG ' ' A' ' 258' ' ' SER . 9.2 tt -147.9 125.4 11.69 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.165 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -98.67 143.02 29.51 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 120.894 0.378 . . . . 0.0 110.775 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.9 mt -94.15 106.29 18.27 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.664 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.441 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.3 t80 -101.48 -11.88 18.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.129 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.3 87.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.84 174.14 46.32 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.451 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -74.41 -113.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.799 0.333 . . . . 0.0 110.786 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.45 -28.61 68.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.702 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.1 -44.1 91.91 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.172 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.89 -44.02 94.28 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.383 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.81 -60.27 3.47 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.233 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.15 -43.39 61.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.13 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.57 75.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.139 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.7 mt -64.45 -43.67 96.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.657 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -56.46 -37.5 70.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.139 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.82 0.91 18.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.223 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -114.9 91.35 26.04 Favored Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.164 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.2 -27.19 29.11 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.802 2.335 . . . . 0.0 111.786 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.36 -41.25 98.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.545 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.15 4.99 53.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.343 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.75 -35.16 70.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.719 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.83 4.73 15.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.558 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.552 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.89 121.32 81.04 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.6 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -47.58 -37.44 26.68 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.411 2.074 . . . . 0.0 112.523 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.552 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -59.12 -43.73 91.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.777 0.323 . . . . 0.0 110.244 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.89 -43.79 92.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.33 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -64.81 -40.65 95.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.424 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.8 t-20 -89.54 -12.78 38.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.588 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.8 mtmt 62.11 32.27 17.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.96 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -89.07 43.87 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.072 0.463 . . . . 0.0 110.352 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.44 135.85 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.453 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -116.53 132.45 56.68 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.44 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.503 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.79 87.22 7.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.751 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.452 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.5 mt -64.04 -40.77 97.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.441 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.58 169.35 35.54 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.508 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 72.4 p -76.35 -25.78 55.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.819 0.343 . . . . 0.0 110.699 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.535 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.7 tp10 -67.24 -34.82 78.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.398 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.496 ' O ' ' CG2' ' A' ' 296' ' ' THR . 93.2 m -73.59 25.01 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.758 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.613 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 64.2 t80 -58.27 -51.25 70.55 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 61.2 mmt-85 -112.16 154.96 24.72 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 44.3 tp -115.54 124.4 50.95 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 41.9 t0 -147.42 165.58 29.81 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.583 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -49.0 -38.51 23.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.624 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -71.5 -65.37 0.76 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.523 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.73 -32.87 72.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.082 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.64 -25.29 25.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.697 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.7 mtt -63.35 -41.0 98.83 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 120.894 0.378 . . . . 0.0 111.018 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.34 -43.99 22.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.987 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 75.1 t -65.81 -43.22 93.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.398 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 56.5 tp -60.65 -47.28 86.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.494 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -69.39 -39.64 77.87 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.725 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.503 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.2 ttt180 -62.13 -38.39 88.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.207 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.2 mt -86.86 3.88 43.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.84 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -112.57 -11.29 13.6 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.064 0.459 . . . . 0.0 110.315 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.07 -37.0 85.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.515 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.01 -48.74 80.4 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.414 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.09 179.829 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.647 ' H ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.15 -2.05 58.02 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.369 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.484 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.08 179.04 1.24 Allowed Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.499 -179.625 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.0 Cg_exo -61.04 145.2 99.33 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.769 2.313 . . . . 0.0 112.226 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.647 ' NH1' ' H ' ' A' ' 24' ' ' ALA . 35.4 ptt-85 -156.41 -178.95 7.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.601 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.91 136.68 52.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.281 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -123.97 146.68 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.378 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.8 p -119.8 135.94 54.66 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.736 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.41 -143.53 0.33 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.295 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -63.28 -37.06 85.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.598 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.88 -65.56 0.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.518 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.84 141.95 46.47 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 p -112.02 131.19 55.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.922 0.392 . . . . 0.0 110.36 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -119.08 128.87 54.73 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.51 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.1 m -85.45 130.13 34.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.201 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.0 mt -96.03 78.67 3.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.432 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.52 -31.69 72.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.466 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.28 109.98 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.172 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -122.99 91.35 49.91 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.196 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.645 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.9 Cg_exo -57.01 148.99 64.96 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.756 2.304 . . . . 0.0 111.784 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.79 82.89 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 O-C-N 123.603 0.564 . . . . 0.0 110.928 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.645 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.28 67.09 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.289 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.1 130.69 35.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.549 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.5 t -122.79 146.51 27.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.124 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.4 t -136.04 144.16 45.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.63 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 p -100.48 -58.87 1.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.564 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.2 p -79.43 154.78 28.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.598 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.8 t -74.07 -21.81 18.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.629 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.402 ' O ' ' OG ' ' A' ' 56' ' ' SER . 94.7 m -60.31 -52.1 66.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.474 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.3 mt -66.5 -42.2 87.74 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.347 0.594 . . . . 0.0 111.003 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.2 m -43.32 -54.06 4.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.143 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.26 -37.84 71.42 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.7 m -62.28 -44.5 96.37 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.956 0.407 . . . . 0.0 110.645 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.9 mt -66.2 -42.18 89.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.459 0.647 . . . . 0.0 110.737 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.63 -40.25 96.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.371 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.21 -36.03 76.76 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.914 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.6 pt -91.2 28.89 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.042 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.6 51.63 10.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.777 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.0 75.34 24.23 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.949 0.404 . . . . 0.0 109.998 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.44 151.57 85.0 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.743 2.295 . . . . 0.0 112.246 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.77 137.37 47.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.181 0.515 . . . . 0.0 110.245 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.4 pt -69.34 -43.61 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.163 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.482 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.9 130.87 53.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.915 0.388 . . . . 0.0 110.544 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.53 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.0 p -155.64 168.98 25.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.456 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.98 -177.04 21.58 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.58 172.65 12.46 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 120.934 0.397 . . . . 0.0 110.513 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.6 p -132.68 -112.49 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.276 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.41 179.84 0.91 Allowed Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.326 -179.115 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.3 Cg_exo -60.93 57.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 123.054 2.503 . . . . 0.0 112.214 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.1 t-20 -64.41 -33.82 76.75 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.487 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.8 m-20 93.85 -36.09 0.02 OUTLIER 'General case' 0 C--N 1.346 0.435 0 O-C-N 124.08 0.862 . . . . 0.0 109.966 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -63.1 -39.39 94.55 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.218 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 77' ' ' ALA . 15.0 p -74.71 -25.29 18.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.692 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.35 -171.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.588 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.7 p30 -74.08 -153.66 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.765 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.0 p-10 -52.77 -7.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.639 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.521 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.37 115.06 23.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.582 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.85 69.69 1.36 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.469 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.9 m-85 -142.96 147.53 35.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.958 0.409 . . . . 0.0 110.704 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.528 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.3 mp -85.29 -98.4 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.313 178.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.548 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.4 -42.5 96.06 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.108 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.548 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.5 tt0 91.69 53.05 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.075 0.859 . . . . 0.0 110.79 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.24 -9.09 19.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.466 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.469 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.0 p -64.64 -34.04 77.35 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.118 0.485 . . . . 0.0 110.653 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.532 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.66 -23.9 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.553 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.53 -46.02 76.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.881 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.24 -48.49 81.24 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.073 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.68 -38.09 89.0 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.357 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.68 -32.58 52.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.248 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.575 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.1 mmt-85 -89.69 1.67 55.75 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.695 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 56.9 mttp 82.69 -49.05 0.17 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 124.115 0.885 . . . . 0.0 110.31 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.649 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.71 154.79 0.29 Allowed 'General case' 0 CA--C 1.49 -1.327 0 CA-C-O 117.592 -1.194 . . . . 0.0 109.253 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.649 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 120.85 92.47 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 O-C-N 125.462 1.726 . . . . 0.0 110.542 -178.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.53 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.39 143.44 42.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.108 0.48 . . . . 0.0 110.244 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.4 mt -132.4 26.95 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.0 110.47 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.52 138.15 34.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.441 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.522 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 91.4 mt -137.31 165.01 28.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.391 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.15 -28.8 1.82 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.408 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -152.18 70.13 7.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.201 0.524 . . . . 0.0 110.348 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.03 145.44 98.39 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 122.663 2.242 . . . . 0.0 112.126 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.0 t -134.81 137.35 43.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.521 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.22 -38.07 81.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.716 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.27 -42.29 96.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.547 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.52 98.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.558 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.2 t -63.58 -43.41 98.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.057 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.13 77.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.294 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.52 -18.62 59.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.463 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.58 -6.62 58.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.576 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 64.3 mtp 48.17 55.87 17.34 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.609 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.37 149.23 62.66 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.716 2.277 . . . . 0.0 112.111 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.13 -73.21 0.65 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.468 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.0 tp -111.02 112.65 24.62 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.44 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.8 mt -101.11 126.06 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.469 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.6 mt -109.59 133.64 52.87 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.294 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -121.01 140.17 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.472 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 121' ' ' THR . 89.6 p -83.5 168.68 16.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.64 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.43 80.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.433 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.426 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.1 t -140.15 159.09 42.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.963 0.411 . . . . 0.0 110.416 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.3 177.66 33.2 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.26 -33.79 87.15 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -124.84 151.72 44.9 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.904 0.383 . . . . 0.0 110.567 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.2 t -63.36 141.2 58.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.355 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.74 10.67 11.02 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.577 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.31 -39.07 89.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.071 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.634 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.9 -35.72 23.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.516 0.675 . . . . 0.0 110.709 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.5 mt -71.0 -35.42 72.06 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.473 0.654 . . . . 0.0 110.727 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -42.74 -63.19 0.82 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.132 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.634 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.83 -42.64 90.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -61.99 -32.91 73.42 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.424 0.453 . . . . 0.0 110.17 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.9 mt -73.8 -40.24 63.53 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.22 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.17 -49.13 78.08 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.15 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 78.9 m -52.36 -42.74 64.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.314 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.37 -43.26 94.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.141 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.99 154.85 5.3 Favored Pre-proline 0 N--CA 1.453 -0.285 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.646 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -39.19 106.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.696 2.264 . . . . 0.0 112.356 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 95.4 m -110.09 121.5 45.41 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.169 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.26 152.93 30.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.257 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 tt -129.01 129.11 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.382 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.4 mt -112.54 127.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.498 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.11 103.34 14.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.3 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 147' ' ' LYS . 44.0 p90 -101.04 -11.17 19.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.703 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.2 p-10 -64.72 -33.77 76.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.619 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.7 p-10 -98.27 8.1 45.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.597 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.83 155.62 50.05 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.499 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.1 165.91 24.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.594 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.09 -48.62 80.94 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.22 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.76 -42.03 67.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.992 0.425 . . . . 0.0 110.084 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.0 t -62.63 -40.63 97.58 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.435 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.9 tp -60.62 -43.88 96.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.417 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.9 tp -61.45 -43.19 99.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.188 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.2 m -54.94 -45.17 74.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.806 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.5 -40.72 97.62 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-O 120.889 0.376 . . . . 0.0 110.381 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.95 -42.33 98.99 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.249 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.05 -41.03 95.36 Favored Glycine 0 C--N 1.316 -0.533 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.85 -46.0 63.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.94 0.4 . . . . 0.0 110.807 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.61 -44.03 96.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.741 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 156' ' ' LEU . 31.6 p -93.27 -8.64 41.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.546 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.8 25.16 71.71 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -102.15 52.49 0.81 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.72 0.295 . . . . 0.0 110.593 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -70.04 -39.11 75.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.696 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.16 -47.01 86.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.165 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -61.38 -38.91 88.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.434 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.38 97.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.413 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.45 -27.67 69.15 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.537 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.82 -53.77 8.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.17 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -63.55 -43.56 96.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.448 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 174' ' ' ASP . 85.7 mt -63.01 -43.78 99.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.658 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.08 -61.65 2.42 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.112 0.482 . . . . 0.0 110.383 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.54 -35.09 62.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.425 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -79.6 -35.05 40.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.891 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.3 m-20 -56.68 -40.43 75.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.96 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.94 -42.61 99.86 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.769 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.85 -37.52 86.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.303 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.26 -42.36 99.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.702 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -53.0 61.77 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.168 0.509 . . . . 0.0 110.645 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.25 -41.69 89.6 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.597 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.31 -39.68 94.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.5 -32.36 73.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.302 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.93 -22.12 18.79 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.647 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.631 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -65.22 -40.91 94.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.632 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.1 pt -78.45 136.45 23.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.568 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.53 109.45 11.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.277 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.48 125.8 0.32 Allowed Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.518 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.4 Cg_exo -43.92 152.29 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.713 2.276 . . . . 0.0 112.598 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.16 142.0 54.28 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.612 2.208 . . . . 0.0 112.461 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.37 147.4 2.14 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.602 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.15 154.74 69.67 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.805 2.337 . . . . 0.0 112.296 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.27 163.23 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.405 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.549 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.1 t -144.1 170.41 16.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.793 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.549 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.83 137.89 21.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.017 0.437 . . . . 0.0 110.226 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.44 146.72 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.574 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.98 131.73 58.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.128 0.49 . . . . 0.0 110.474 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -151.92 154.89 36.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.357 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 87.2 m -122.08 122.62 39.68 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.961 0.41 . . . . 0.0 110.371 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.32 -25.98 66.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.613 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -74.72 -49.02 22.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.007 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.38 -11.04 60.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.285 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.8 m80 48.6 42.47 19.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.452 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.6 t -136.43 145.7 45.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.386 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.44 114.18 27.12 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.311 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.72 133.32 55.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.08 0.467 . . . . 0.0 110.343 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.3 tt -112.13 146.43 38.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.671 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.451 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 10.9 t90 -99.77 130.23 45.96 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.104 0.478 . . . . 0.0 110.148 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.708 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.65 153.88 39.31 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.133 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.412 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.2 Cg_endo -67.76 -18.05 47.51 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.663 2.242 . . . . 0.0 111.95 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.708 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -48.99 -18.57 0.3 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.405 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.451 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.6 p -75.96 165.11 25.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.543 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.22 -28.04 66.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.516 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.616 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.3 mt-30 -63.76 -41.21 98.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.669 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.12 -44.75 97.02 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.8 mt-30 -64.6 -38.71 91.94 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 120.99 0.424 . . . . 0.0 110.649 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.14 -41.15 98.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.11 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.81 -46.74 83.76 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.644 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.59 -31.73 57.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.089 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.88 -18.12 62.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.57 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.25 -8.49 55.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.612 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.39 2.05 55.61 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -88.41 153.36 21.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.512 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 7.9 p -116.09 128.72 55.91 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.055 0.455 . . . . 0.0 110.308 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.62 145.97 24.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.802 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.68 151.5 45.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.534 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.72 131.53 43.12 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.526 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.632 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.55 93.22 26.67 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.049 -179.689 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.716 ' C ' ' H ' ' A' ' 229' ' ' GLY . 47.6 Cg_exo -55.59 139.25 82.59 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.56 2.173 . . . . 0.0 111.612 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.04 -25.64 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.459 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.716 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.54 -49.78 29.2 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.579 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.8 mt -53.87 -37.01 63.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 0.0 110.197 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.92 36.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.777 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.579 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.85 86.85 0.01 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.861 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.3 p -79.42 -15.17 58.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.411 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.38 -41.12 10.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.616 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.8 t -66.06 -17.78 64.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.65 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.25 43.22 26.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.508 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.48 -147.27 7.21 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.96 143.01 50.19 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.955 0.407 . . . . 0.0 110.323 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -152.51 149.85 28.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.391 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -100.95 -151.75 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.398 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 66.9 t0 55.99 -91.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.555 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.506 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.96 175.25 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.54 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.506 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 93.0 mt -122.3 141.73 41.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.693 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.77 168.97 9.57 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.244 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.3 mt -147.73 150.9 35.16 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.154 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.53 -39.21 97.4 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.32 4.01 4.6 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.28 -58.06 3.49 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.011 0.434 . . . . 0.0 110.636 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.2 -37.04 83.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.271 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.14 -67.69 0.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.784 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.43 -42.07 66.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.145 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.16 17.96 0.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.724 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.92 48.13 0.26 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.83 -109.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.663 0.268 . . . . 0.0 110.675 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.453 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.8 m120 -60.71 -44.87 96.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.502 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.26 8.13 84.03 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -99.02 -13.19 19.98 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.672 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.6 t 176.8 142.45 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.079 0.466 . . . . 0.0 110.423 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -147.93 125.42 11.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.983 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -98.57 142.94 29.53 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 120.877 0.37 . . . . 0.0 110.88 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.9 mt -93.88 106.26 18.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.655 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.429 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.2 t80 -101.48 -12.27 18.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.215 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.4 -40.62 89.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.833 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.43 173.73 46.09 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.448 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -74.09 -112.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.811 0.339 . . . . 0.0 110.683 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.88 -28.74 67.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.689 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -58.85 -43.95 90.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.371 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.8 -44.32 93.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.357 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.48 -60.17 3.56 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.247 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.31 -43.55 61.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.084 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.16 -43.6 74.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.229 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.4 mt -64.62 -43.63 96.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.597 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -56.23 -37.48 69.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.211 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.87 1.25 18.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.277 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -114.94 91.33 26.13 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.213 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.31 -27.25 30.1 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.753 2.302 . . . . 0.0 111.841 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.38 -41.17 98.77 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.591 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.43 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.9 mp -95.07 5.12 52.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.362 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.87 -35.13 69.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.713 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.53 4.52 15.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.52 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.543 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.91 120.91 79.38 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.61 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -47.41 -37.43 25.4 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.478 2.119 . . . . 0.0 112.493 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.543 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -59.01 -43.84 91.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.758 0.313 . . . . 0.0 110.356 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.96 -43.7 92.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.344 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.81 -40.7 95.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.445 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.437 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.9 t-20 -89.42 -12.86 39.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.625 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.7 mtmt 62.18 32.36 17.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -89.15 43.87 1.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.074 0.464 . . . . 0.0 110.353 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.51 135.89 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.448 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.78 132.37 56.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.491 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.504 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.67 87.49 7.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.674 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.456 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.9 mt -64.02 -40.69 96.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.971 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.429 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.72 168.85 35.0 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.51 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 77.8 p -76.13 -25.89 55.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 0.0 110.698 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.536 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.1 tp10 -67.27 -34.6 77.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.524 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.497 ' O ' ' CG2' ' A' ' 296' ' ' THR . 95.7 m -73.66 25.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.601 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.616 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 61.8 t80 -58.13 -51.13 70.99 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 64.4 mmt-85 -112.3 155.13 24.6 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 45.2 tp -115.88 124.77 51.48 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.766 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 41.7 t0 -147.79 165.79 29.5 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -49.13 -38.55 25.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.579 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -71.53 -65.31 0.77 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.267 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -60.79 -32.75 72.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.913 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.88 -25.19 27.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.549 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.1 mtt -63.08 -41.42 99.43 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.88 0.371 . . . . 0.0 110.857 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.18 -43.85 23.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.997 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.04 -43.18 92.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.414 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 56.0 tp -60.55 -47.04 87.92 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.549 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -69.84 -39.85 76.18 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.546 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.504 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.3 ttt180 -62.06 -37.97 87.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.133 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.3 mt -87.19 4.32 42.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.795 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.631 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.5 tttt -112.59 -11.51 13.56 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.042 0.448 . . . . 0.0 110.263 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.9 84.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.66 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.02 -48.78 80.2 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.332 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.898 -1.048 . . . . 0.0 110.097 179.941 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.47 -2.1 57.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.298 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.94 179.09 1.23 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.991 0.424 . . . . 0.0 110.481 -179.65 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.6 Cg_exo -60.95 144.91 99.68 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.814 2.343 . . . . 0.0 112.149 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.96 -179.3 8.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.597 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.68 136.66 52.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.388 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.36 147.11 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.297 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.8 p -120.18 135.99 54.78 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.41 -143.38 0.32 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.233 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -63.52 -37.13 86.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.549 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.477 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.54 -66.12 0.22 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.546 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.48 141.99 45.68 Favored Glycine 0 CA--C 1.519 0.309 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.4 p -112.19 131.23 55.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.939 0.4 . . . . 0.0 110.4 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.21 128.9 54.65 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.532 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -85.49 130.3 34.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.227 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.0 mt -95.74 78.86 3.3 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.287 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.28 -32.31 73.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.55 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 175.88 110.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.075 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -123.05 91.7 49.66 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.322 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.645 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.1 Cg_exo -56.95 148.82 65.44 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.769 2.313 . . . . 0.0 111.864 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.42 82.78 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 O-C-N 123.59 0.557 . . . . 0.0 111.017 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.645 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.45 67.07 0.89 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.133 0.492 . . . . 0.0 110.183 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.17 130.78 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.709 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.85 146.59 27.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.034 0.445 . . . . 0.0 110.015 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -136.38 143.91 44.28 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.693 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.561 ' HG1' ' H ' ' A' ' 50' ' ' SER . 28.1 p -99.31 -59.5 1.71 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.647 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.561 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.0 p -78.95 155.61 28.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.706 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -74.65 -21.84 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.55 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.402 ' O ' ' OG ' ' A' ' 56' ' ' SER . 94.7 m -60.36 -51.88 67.63 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.459 -178.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.5 mt -66.3 -42.62 88.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.207 0.527 . . . . 0.0 110.85 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.15 -53.9 4.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.005 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.39 -38.12 70.24 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.7 m -62.21 -44.55 96.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 110.203 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.3 mt -66.27 -42.03 89.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.443 0.64 . . . . 0.0 110.756 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.59 -40.12 95.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.495 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.97 -35.91 76.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.183 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.7 pt -91.2 28.69 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.295 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.58 51.52 11.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.98 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.74 75.52 25.38 Favored Pre-proline 0 C--N 1.331 -0.208 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.34 151.15 86.64 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.793 2.328 . . . . 0.0 112.199 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -113.59 137.26 47.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.223 0.535 . . . . 0.0 110.208 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.417 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.0 pt -69.21 -43.65 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.326 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.483 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.02 131.07 53.46 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.964 0.411 . . . . 0.0 110.564 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.526 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.4 p -155.68 168.72 26.25 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.501 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.96 -176.97 21.59 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.37 172.54 12.56 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 121.01 0.433 . . . . 0.0 110.44 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.9 p -133.13 -111.84 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 110.349 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.49 179.68 0.94 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.348 -179.143 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.7 Cg_exo -61.34 57.89 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.975 2.45 . . . . 0.0 112.094 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.5 t-20 -64.19 -34.13 77.37 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 118.894 -0.574 . . . . 0.0 110.398 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.5 m-20 94.06 -36.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.103 0.877 . . . . 0.0 109.838 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -62.9 -39.84 95.73 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.179 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.49 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -74.27 -25.71 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.758 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.68 -171.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.575 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.26 -153.68 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.864 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.0 p-10 -52.72 -7.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.677 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.523 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.25 114.6 23.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.618 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.61 70.36 1.34 Allowed Glycine 0 C--O 1.225 -0.428 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.479 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.9 m-85 -143.18 147.93 35.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.824 0.345 . . . . 0.0 110.961 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.523 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.5 mp -85.94 -98.4 0.07 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.995 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.1 mtt-85 -64.28 -42.69 96.3 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.08 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.4 tt0 91.49 53.43 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.057 0.848 . . . . 0.0 110.954 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.38 -9.1 19.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.391 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.479 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.2 p -64.71 -33.99 77.27 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.165 0.507 . . . . 0.0 110.681 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.538 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.85 -24.27 1.39 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.59 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.4 t -69.13 -46.11 78.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.936 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.21 -48.49 81.26 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.964 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.69 -38.17 89.35 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.302 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.82 -32.28 52.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.095 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.571 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.7 mmt-85 -90.04 1.82 55.89 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.585 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.6 -49.34 0.18 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 124.102 0.876 . . . . 0.0 110.192 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.638 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.5 mt -46.42 154.88 0.25 Allowed 'General case' 0 CA--C 1.49 -1.345 0 CA-C-O 117.365 -1.302 . . . . 0.0 109.275 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.638 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 120.76 92.48 0.0 OUTLIER 'General case' 0 C--N 1.354 0.764 0 O-C-N 125.699 1.875 . . . . 0.0 110.464 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.526 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.34 143.54 42.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.098 0.475 . . . . 0.0 110.311 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.5 mt -132.52 27.2 4.4 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.147 -0.346 . . . . 0.0 110.428 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -140.6 138.46 34.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.015 0.436 . . . . 0.0 110.542 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.5 mt -137.37 164.99 28.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.418 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.523 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.34 -28.71 1.8 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -153.23 70.87 6.95 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.166 0.508 . . . . 0.0 110.288 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.22 145.58 98.22 Favored 'Trans proline' 0 C--N 1.301 -1.936 0 C-N-CA 122.719 2.279 . . . . 0.0 112.108 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.4 t -133.99 136.55 44.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.481 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.38 83.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.683 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.38 -42.17 96.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.52 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.53 98.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.581 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.6 t -63.68 -43.45 98.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.925 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.81 -35.12 77.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.233 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.55 -18.61 59.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.38 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -86.67 -6.85 58.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.562 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.409 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.6 mtp 48.1 56.09 17.47 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.627 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.0 Cg_endo -70.12 149.23 64.28 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.766 2.31 . . . . 0.0 112.122 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.04 -73.47 0.64 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.43 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.4 tp -111.03 112.84 24.94 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.26 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.1 mt -101.13 126.19 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.556 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.5 mt -109.58 133.42 53.12 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.198 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.46 139.7 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.506 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 121' ' ' THR . 94.4 p -83.42 168.42 16.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.692 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.12 -37.41 79.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.402 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.429 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.2 t -139.38 159.07 43.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.932 0.396 . . . . 0.0 110.475 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.07 176.33 33.55 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.13 -33.84 87.14 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.7 151.53 44.88 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 110.523 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.9 t -63.06 140.82 58.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.359 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.7 10.44 11.0 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.607 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.418 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.08 -39.13 88.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.099 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.68 -35.86 24.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.59 0.709 . . . . 0.0 110.721 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.2 mt -70.8 -35.62 72.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.642 0.734 . . . . 0.0 110.738 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -42.84 -62.71 0.94 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.408 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.64 -42.66 91.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -62.1 -33.02 73.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.301 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.1 mt -73.3 -40.77 64.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.145 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.8 t -58.53 -48.58 80.36 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.013 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.8 m -52.9 -42.35 65.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.302 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.15 -43.03 92.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.082 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.4 154.15 5.58 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.659 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -39.37 107.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.639 2.226 . . . . 0.0 112.422 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 93.8 m -110.13 120.88 43.85 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.037 0.446 . . . . 0.0 110.238 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -113.62 152.78 29.89 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.292 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.7 tt -128.75 131.04 68.82 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.268 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.81 127.79 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.504 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.9 t30 -101.79 103.53 14.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.302 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 147' ' ' LYS . 45.3 p90 -101.05 -11.29 19.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.862 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.74 -33.73 76.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.671 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -98.29 7.86 45.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.548 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.6 155.54 50.29 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.538 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.404 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.07 165.8 24.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.715 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.05 -48.69 80.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.152 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -53.7 -42.2 67.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.002 0.429 . . . . 0.0 110.063 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.2 t -62.49 -40.89 98.15 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.362 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 tp -60.59 -43.95 96.79 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.261 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.0 tp -61.27 -43.43 98.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.139 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 m -55.03 -45.37 75.17 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.59 -40.58 97.36 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.891 0.377 . . . . 0.0 110.446 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.97 -42.29 98.96 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.343 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.19 -40.89 95.05 Favored Glycine 0 C--N 1.315 -0.587 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.72 -45.91 64.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.0 mt -64.61 -44.0 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.794 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.6 p -93.35 -8.56 41.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.587 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.85 25.37 71.85 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -102.06 52.26 0.82 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.769 0.319 . . . . 0.0 110.663 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.87 -39.23 76.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.575 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.15 -46.95 87.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.243 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -61.41 -39.12 89.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.35 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.27 -40.32 97.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.257 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.49 -27.51 69.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.545 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.95 -53.81 8.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.059 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -63.88 -43.24 96.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.47 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.9 mt -63.07 -43.86 99.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.726 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.18 -61.52 2.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.146 0.498 . . . . 0.0 110.403 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.65 -35.32 63.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.466 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -79.21 -35.19 42.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.963 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.1 m-20 -56.98 -40.1 75.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.146 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.08 -42.64 99.68 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.828 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.74 -37.76 87.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.285 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.29 -42.33 99.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.715 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.07 -52.76 62.61 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.073 0.463 . . . . 0.0 110.639 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.41 -41.56 89.1 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.624 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.33 -39.65 94.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.671 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.29 -32.49 73.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.306 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.95 -21.99 18.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.657 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.633 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -65.02 -40.9 95.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.726 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.8 pt -78.1 136.47 24.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.727 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.37 109.31 11.65 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.214 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.8 125.66 0.3 Allowed Pre-proline 0 C--O 1.242 0.666 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.495 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.4 Cg_exo -43.88 152.36 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.786 2.324 . . . . 0.0 112.618 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.13 142.29 55.41 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.554 2.17 . . . . 0.0 112.504 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.3 147.07 2.11 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.626 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.91 154.6 70.64 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.75 2.3 . . . . 0.0 112.307 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.29 163.2 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.487 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.639 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.1 t -144.02 170.35 16.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.889 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.639 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.01 137.65 22.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.253 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.37 146.75 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.65 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.46 132.26 57.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.168 0.509 . . . . 0.0 110.497 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -152.12 155.15 37.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.439 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.8 m -122.34 123.06 40.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.957 0.408 . . . . 0.0 110.364 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.51 -25.76 66.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.631 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.12 -49.18 20.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.084 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.12 -12.18 60.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.413 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.4 m80 49.47 41.95 21.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.496 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.1 t -135.97 144.76 45.57 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.328 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.5 113.97 27.02 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.258 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.474 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.8 133.33 55.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.039 0.447 . . . . 0.0 110.362 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.5 tt -111.92 146.32 37.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.45 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 12.5 t90 -99.11 129.74 45.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.175 0.512 . . . . 0.0 109.932 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.703 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.74 153.87 39.25 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.294 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.2 Cg_endo -67.59 -18.15 48.47 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.671 2.247 . . . . 0.0 111.957 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.703 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -49.37 -18.83 0.43 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.36 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.45 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.9 p -75.39 164.59 26.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.536 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.99 -27.84 65.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.559 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.623 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.2 mt-30 -63.99 -41.0 97.63 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.589 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.26 -44.54 97.36 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.6 mt-30 -64.59 -38.71 91.96 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.022 0.439 . . . . 0.0 110.557 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.2 mmm -62.18 -41.21 98.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.103 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.3 mt -63.7 -47.09 82.58 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.525 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.27 -31.84 54.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.355 . . . . 0.0 110.193 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.02 -18.32 62.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.472 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 90.5 mt -87.94 -8.67 55.38 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.626 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.57 2.13 55.42 Favored Glycine 0 N--CA 1.464 0.503 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -88.4 153.29 21.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.939 0.4 . . . . 0.0 110.464 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.3 p -115.93 128.7 55.97 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.143 0.497 . . . . 0.0 110.334 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.555 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.71 145.89 24.07 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.948 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.451 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.46 151.49 46.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.423 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.65 131.59 43.3 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.461 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.7 93.29 27.74 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.062 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.716 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.5 Cg_exo -55.52 139.13 82.15 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.556 2.171 . . . . 0.0 111.58 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.76 -25.69 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.477 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.716 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.13 -50.07 30.2 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.582 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.7 mt -54.17 -36.93 63.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.68 35.99 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.819 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.582 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.08 88.31 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.003 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 79.5 p -81.23 -14.15 57.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.31 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.8 -41.57 10.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.685 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.1 t -66.7 -16.92 64.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.647 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 55.94 43.76 26.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.439 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.74 -148.45 7.9 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.91 142.94 49.24 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.0 0.428 . . . . 0.0 110.327 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.14 149.56 28.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.278 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -101.19 -151.85 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.297 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.12 -92.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.624 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.511 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.67 175.24 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.596 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.511 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.5 mt -122.37 141.62 42.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.56 169.05 9.56 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.264 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.0 mt -147.63 150.86 35.21 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.224 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.69 -38.98 97.03 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.18 3.87 4.7 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -77.18 -58.04 3.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.958 0.409 . . . . 0.0 110.631 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -62.25 -36.85 83.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.249 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.24 -67.74 0.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.67 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.68 -42.08 67.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.135 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.97 17.8 0.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.644 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.88 48.5 0.27 Allowed Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.45 -109.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.596 0.236 . . . . 0.0 110.754 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.451 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 12.0 m120 -61.12 -44.65 97.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.469 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.31 8.05 84.06 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -98.93 -13.25 20.07 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.668 -0.313 . . . . 0.0 110.697 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.419 ' HG ' ' N ' ' A' ' 259' ' ' LEU . 5.8 t 176.96 142.53 0.08 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.087 0.47 . . . . 0.0 110.434 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.419 ' N ' ' HG ' ' A' ' 258' ' ' SER . 9.1 tt -147.84 125.62 11.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.191 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -98.68 143.15 29.37 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 120.899 0.381 . . . . 0.0 110.778 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.1 mt -94.44 106.3 18.28 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.672 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.435 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.58 -11.69 19.05 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.171 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.14 -40.66 86.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.27 173.69 46.1 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.442 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.5 m-20 -74.02 -112.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.352 . . . . 0.0 110.856 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.76 -28.75 67.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.731 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.11 -44.01 91.95 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.147 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.68 -44.2 94.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.308 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.72 -59.93 3.88 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.201 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.32 -43.58 61.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.982 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.32 -43.63 75.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.181 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.7 mt -64.57 -43.62 96.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.581 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.4 -37.51 70.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.113 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.92 1.24 18.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.179 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -114.73 91.46 25.72 Favored Pre-proline 0 CA--C 1.528 0.11 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.179 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.33 -27.32 30.54 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.801 2.334 . . . . 0.0 111.811 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.42 -41.14 98.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.575 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.43 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.9 mp -95.14 5.04 52.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.346 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.58 -35.08 70.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.645 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.99 4.43 17.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.512 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.541 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.73 120.9 78.88 Favored Pre-proline 0 N--CA 1.441 -0.884 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.512 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.37 -37.47 25.19 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.41 2.074 . . . . 0.0 112.635 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.541 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -59.02 -43.65 91.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.75 0.31 . . . . 0.0 110.352 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.99 -43.75 92.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.301 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.89 -40.64 95.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.422 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.8 t-20 -89.51 -12.86 38.79 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.516 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.23 32.08 17.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.88 44.01 1.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.115 0.484 . . . . 0.0 110.367 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.78 135.63 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.529 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -116.64 132.51 56.67 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.386 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.506 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.5 87.31 7.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.834 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.453 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.6 mt -63.97 -40.77 97.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.919 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.435 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.94 168.84 35.59 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.508 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 77.0 p -76.07 -25.88 55.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.901 0.382 . . . . 0.0 110.781 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.536 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.8 tp10 -67.37 -34.7 77.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.357 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.497 ' O ' ' CG2' ' A' ' 296' ' ' THR . 94.7 m -73.49 25.1 0.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.748 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.623 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 63.2 t80 -58.26 -51.07 71.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 63.5 mmt-85 -112.42 155.0 24.93 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 43.9 tp -115.72 124.92 52.04 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 42.2 t0 -148.04 165.89 29.42 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.533 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -49.08 -38.64 25.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.659 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -71.05 -65.61 0.72 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.54 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -60.61 -32.93 72.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.079 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.62 -24.97 23.75 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.811 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.9 mtt -63.23 -41.18 99.07 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 120.948 0.404 . . . . 0.0 111.105 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.54 -43.89 22.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.064 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 77.3 t -65.81 -43.24 93.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.417 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 55.4 tp -60.82 -46.96 88.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.518 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -69.83 -39.65 76.33 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.663 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.506 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.5 ttt180 -62.09 -38.15 87.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.136 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.03 3.97 43.85 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.753 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.633 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.5 tttt -112.78 -11.06 13.54 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.114 0.483 . . . . 0.0 110.189 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.23 -36.95 85.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.549 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.95 -48.7 80.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.395 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.003 179.9 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.06 -2.63 58.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.415 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.72 179.16 1.22 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.498 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.3 Cg_exo -60.87 144.94 99.66 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.76 2.307 . . . . 0.0 112.203 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.613 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.78 -179.7 8.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.581 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.51 136.14 53.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.333 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -123.94 146.82 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.395 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.6 p -120.02 135.98 54.73 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.812 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.25 -143.61 0.32 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.259 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.65 -36.98 85.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.437 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.22 -66.96 0.22 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.523 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.27 142.3 44.93 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.3 p -112.18 131.24 55.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.934 0.397 . . . . 0.0 110.324 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.08 128.94 54.79 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.541 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.9 m -85.55 130.64 34.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.178 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.0 mt -95.83 78.63 3.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.271 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.04 -32.18 73.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.493 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.43 108.87 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.086 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -122.25 91.56 49.09 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.194 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.644 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.1 Cg_exo -56.97 148.67 66.6 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.802 2.334 . . . . 0.0 111.827 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.79 82.67 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 O-C-N 123.57 0.544 . . . . 0.0 111.028 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.644 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.28 67.07 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.226 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.0 130.85 35.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.609 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.5 t -122.61 145.86 28.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.08 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -135.66 143.45 45.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.63 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.0 p -99.34 -59.54 1.7 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.594 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.7 p -79.07 155.12 28.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.668 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.9 t -74.41 -21.72 17.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.569 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.5 m -60.36 -52.04 66.94 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.518 -178.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.5 mt -66.51 -42.37 87.43 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.363 0.601 . . . . 0.0 110.956 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -43.21 -53.63 4.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.083 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.3 -37.69 71.01 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -62.58 -44.48 96.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.893 0.378 . . . . 0.0 110.393 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt -66.25 -42.14 88.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.547 0.689 . . . . 0.0 110.769 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tp -62.62 -40.09 95.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.439 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.07 -35.75 75.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.006 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.4 pt -91.6 28.92 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.16 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.35 51.65 11.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.816 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.86 75.71 24.32 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.98 151.5 85.61 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.775 2.317 . . . . 0.0 112.289 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.45 137.15 47.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.219 0.533 . . . . 0.0 110.251 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.1 pt -69.2 -43.63 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.243 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.08 130.92 53.24 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.97 0.414 . . . . 0.0 110.505 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.4 p -155.39 168.84 25.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.464 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.55 -177.53 21.83 Favored Glycine 0 N--CA 1.464 0.564 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.99 172.07 13.12 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.009 0.433 . . . . 0.0 110.458 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.2 p -133.49 -111.34 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.321 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.636 ' HG1' ' N ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -102.56 179.65 0.95 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.348 -179.044 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.636 ' N ' ' HG1' ' A' ' 71' ' ' THR . 39.2 Cg_exo -60.97 58.71 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.059 2.506 . . . . 0.0 112.108 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.543 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.2 t-20 -64.35 -34.94 79.31 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 118.669 -0.681 . . . . 0.0 110.521 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 45.8 m-20 95.07 -37.58 0.01 OUTLIER 'General case' 0 C--N 1.349 0.557 0 O-C-N 124.332 1.02 . . . . 0.0 109.857 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -62.54 -39.89 95.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.025 0.44 . . . . 0.0 110.261 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -73.93 -26.45 21.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.678 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.83 -172.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.518 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.2 p30 -73.77 -152.79 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.787 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.0 p-10 -54.61 -6.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.683 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.515 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.93 113.74 22.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.585 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.23 72.92 1.27 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.492 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.2 m-85 -143.87 148.67 35.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.897 0.38 . . . . 0.0 110.825 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.527 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.3 mp -86.0 -99.14 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.172 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.541 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.04 -43.28 96.02 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.143 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.57 ' NE2' ' HZ1' ' A' ' 88' ' ' LYS . 35.8 tt0 91.8 52.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.117 0.886 . . . . 0.0 110.919 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -103.12 -8.9 20.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.347 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.492 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.2 p -65.05 -33.97 77.31 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.164 0.507 . . . . 0.0 110.727 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.57 ' HZ1' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.49 -24.17 1.2 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.624 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.5 t -69.55 -45.84 77.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.1 -48.74 80.29 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.071 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.77 -38.2 89.66 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.348 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -53.7 -32.45 51.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.207 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.569 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.9 mmt-85 -90.02 1.71 56.0 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 119.19 -0.433 . . . . 0.0 110.579 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.569 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.85 -49.41 0.16 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.232 0.957 . . . . 0.0 110.351 179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.636 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.9 mt -46.32 154.01 0.31 Allowed 'General case' 0 CA--C 1.489 -1.39 0 CA-C-O 117.331 -1.319 . . . . 0.0 109.139 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.636 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.6 tt0 121.37 92.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 O-C-N 125.754 1.909 . . . . 0.0 110.538 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.48 143.09 42.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.115 0.483 . . . . 0.0 110.279 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 mt -131.91 26.81 4.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.8 0.333 . . . . 0.0 110.443 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.16 137.56 34.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.974 0.416 . . . . 0.0 110.525 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 91.9 mt -136.99 165.19 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.42 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.523 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.13 -28.44 1.84 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -153.32 70.85 6.89 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.192 0.52 . . . . 0.0 110.281 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.94 145.55 98.04 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.759 2.306 . . . . 0.0 112.135 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.3 t -134.06 136.72 44.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.981 0.42 . . . . 0.0 110.541 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.96 -38.3 82.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.642 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.27 -42.29 96.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.518 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.12 -41.44 98.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.561 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.67 -43.34 98.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.05 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.13 77.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.295 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -18.62 60.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.489 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.51 -6.6 58.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.524 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 78.7 mtp 47.91 55.98 17.3 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.596 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.31 149.27 63.1 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.755 2.303 . . . . 0.0 112.083 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.38 -72.56 0.68 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.498 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.7 tp -111.7 112.7 24.58 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.321 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.3 mt -101.09 126.37 54.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.567 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.2 mt -110.07 133.7 52.93 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.156 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -121.17 139.97 46.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.517 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 121' ' ' THR . 89.7 p -83.34 168.43 16.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.705 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -37.48 80.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.418 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.43 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.9 t -139.47 159.0 43.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.434 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.15 176.94 33.44 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.02 -34.0 87.49 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.88 151.56 45.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.927 0.394 . . . . 0.0 110.531 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.3 t -63.16 141.06 58.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.291 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.09 10.94 10.84 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.625 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.29 -38.93 88.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.007 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.632 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.81 -35.7 24.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.594 0.711 . . . . 0.0 110.605 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.0 mt -71.14 -35.42 71.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.52 0.676 . . . . 0.0 110.8 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.9 t80 -42.89 -62.95 0.88 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.19 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.632 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.3 p-10 -65.67 -42.64 91.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.988 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -62.24 -32.58 73.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.124 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.5 mt -73.94 -40.54 62.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.15 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.23 -48.87 79.03 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.221 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.6 m -52.69 -42.78 65.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.212 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.96 -43.07 92.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.221 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.04 152.63 5.27 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.66 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -39.02 107.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.627 2.218 . . . . 0.0 112.421 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 94.2 m -109.43 121.02 44.27 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.239 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.9 mp -113.6 152.68 30.01 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.12 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 tt -128.53 131.05 69.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.36 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.406 HG22 HD11 ' A' ' 142' ' ' ILE . 96.6 mt -114.99 127.79 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.463 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.99 103.76 14.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.324 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.3 p90 -101.36 -11.42 19.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.772 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.4 p-10 -64.82 -33.48 76.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.673 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.1 p-10 -98.17 7.59 46.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.585 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.44 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.56 155.48 50.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.507 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -74.43 165.39 25.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.67 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.549 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 90.8 t90 -60.0 -48.52 81.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.255 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -53.95 -41.73 68.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.99 0.424 . . . . 0.0 110.061 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.9 t -62.55 -40.84 98.1 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.401 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 tp -60.61 -43.93 96.87 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.338 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.0 tp -61.37 -42.97 99.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 0.0 110.261 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -55.79 -45.25 78.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.679 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.44 -40.6 97.13 Favored 'General case' 0 C--O 1.228 -0.044 0 CA-C-O 120.938 0.399 . . . . 0.0 110.388 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.93 -42.34 98.99 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.321 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.77 -40.72 95.8 Favored Glycine 0 C--N 1.316 -0.575 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.89 -45.85 63.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.937 0.399 . . . . 0.0 110.899 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.0 mt -64.49 -44.13 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.742 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.5 p -93.47 -8.15 42.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.538 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.65 25.0 71.47 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -101.35 52.24 0.84 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.817 0.341 . . . . 0.0 110.653 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.7 -39.02 77.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.668 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.47 -47.12 86.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.201 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -61.41 -39.02 89.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.357 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.4 97.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.068 0.461 . . . . 0.0 110.355 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.19 -27.71 69.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.541 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.71 -53.57 9.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.192 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.98 -43.26 96.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.461 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 174' ' ' ASP . 86.9 mt -63.08 -43.86 99.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.687 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.45 -61.72 2.33 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.173 0.511 . . . . 0.0 110.369 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.45 -34.99 62.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.448 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -79.66 -35.37 39.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.056 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.0 m-20 -56.0 -41.15 74.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.128 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.92 -42.25 99.73 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.756 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.3 -37.93 88.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.29 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.41 -42.26 99.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.752 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.8 -52.97 62.01 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.132 0.491 . . . . 0.0 110.704 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.45 -41.78 88.61 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.649 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.03 -40.0 95.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.7 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.32 -32.4 73.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.349 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.16 -21.69 18.93 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.684 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.0 tt0 -64.86 -41.36 95.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.642 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.0 pt -77.23 135.58 26.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.656 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.02 108.62 11.09 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.27 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.86 126.83 0.31 Allowed Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.548 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.9 Cg_exo -43.75 152.09 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.749 2.3 . . . . 0.0 112.609 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.2 142.09 54.42 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.598 2.198 . . . . 0.0 112.487 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.547 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.12 147.32 2.23 Favored Pre-proline 0 N--CA 1.446 -0.631 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.62 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.2 154.46 69.92 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.71 2.274 . . . . 0.0 112.293 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.42 163.14 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.417 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.631 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.1 t -143.75 170.46 15.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.905 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.631 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.64 137.65 21.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.961 0.41 . . . . 0.0 110.141 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.3 pt -134.08 146.46 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.623 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.9 131.74 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.182 0.515 . . . . 0.0 110.485 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -151.73 154.59 36.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.404 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 84.8 m -121.86 122.54 39.66 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.996 0.427 . . . . 0.0 110.382 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.76 -25.5 66.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.551 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -74.45 -50.0 20.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.071 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.53 -10.74 60.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.398 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.3 m80 48.61 43.26 20.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.475 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.1 t -136.07 145.24 45.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.323 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.19 113.77 26.52 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.297 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.9 133.65 55.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.07 0.462 . . . . 0.0 110.301 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.23 146.43 38.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.72 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.463 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.8 t90 -99.36 129.86 45.6 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.152 0.501 . . . . 0.0 110.024 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.652 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.67 154.37 39.18 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.211 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.9 Cg_endo -67.64 -18.22 48.24 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.702 2.268 . . . . 0.0 111.925 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.652 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -49.2 -18.72 0.37 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.431 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.463 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.6 p -75.73 164.99 25.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.559 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.07 -27.94 66.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.529 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.52 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.8 mt-30 -63.56 -41.59 98.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.675 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.05 -44.87 96.85 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.38 -38.97 92.9 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.952 0.406 . . . . 0.0 110.642 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.549 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.4 mmm -62.23 -41.39 98.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.148 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 70.9 mt -63.78 -47.15 82.08 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.641 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.51 -31.97 57.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.075 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -70.7 -18.28 62.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.493 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 93.5 mt -88.61 -8.3 54.92 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.656 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.47 2.64 55.52 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -88.54 152.33 21.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.346 . . . . 0.0 110.543 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.2 p -115.15 128.12 55.99 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.117 0.484 . . . . 0.0 110.337 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.52 145.7 24.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.454 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.38 151.41 46.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.43 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.31 131.81 42.34 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.409 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.627 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.52 93.54 28.01 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.078 -179.57 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.717 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.4 Cg_exo -55.62 138.99 82.45 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.553 2.169 . . . . 0.0 111.493 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.77 -25.42 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.463 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.717 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.83 -49.55 28.42 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.587 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.8 mt -54.61 -37.18 65.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 0.0 110.098 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.29 35.8 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.837 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.38 88.35 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 82.6 p -81.83 -14.12 56.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.307 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.53 -40.89 11.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.582 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 24.7 t -66.86 -16.87 64.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.643 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.99 43.6 26.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.45 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.94 -147.44 7.43 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.02 142.95 49.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.035 0.445 . . . . 0.0 110.291 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.23 149.69 28.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.361 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -101.3 -151.35 0.41 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.294 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 55.76 -92.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.611 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.502 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.3 tt -126.56 174.8 9.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.604 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.502 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.7 mt -121.4 141.09 43.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.781 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.42 168.85 9.73 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.224 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.8 mt -147.57 150.85 35.26 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.191 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.75 -38.76 96.66 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.05 4.27 4.65 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.47 -58.03 3.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.94 0.4 . . . . 0.0 110.571 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.42 -36.6 82.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.282 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.2 mp -52.29 -67.64 0.23 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.808 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.67 -42.11 67.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.072 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.84 17.97 0.15 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.698 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.77 48.32 0.26 Allowed Glycine 0 N--CA 1.464 0.564 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.36 -109.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.595 0.236 . . . . 0.0 110.741 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.454 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.8 m120 -60.74 -44.95 96.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.484 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.54 8.23 83.41 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -99.53 -12.24 20.31 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.751 -0.264 . . . . 0.0 110.732 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.7 t 176.2 142.47 0.07 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.096 0.474 . . . . 0.0 110.482 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 tt -148.06 126.04 12.04 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.077 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -99.06 142.89 29.97 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 120.893 0.378 . . . . 0.0 110.907 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.45 106.61 18.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.596 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.47 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.8 t80 -102.3 -12.1 18.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.203 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.66 -40.32 88.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.833 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.22 173.45 45.92 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.495 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.4 m-20 -74.49 -113.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.772 0.32 . . . . 0.0 110.77 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.27 -28.69 68.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.635 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.06 -44.19 91.81 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.306 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.64 -44.29 94.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.379 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.54 -60.09 3.66 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.174 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.21 -43.41 61.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.219 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.45 -43.87 75.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.159 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.6 mt -64.31 -43.62 97.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.651 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -56.84 -37.49 71.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.21 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.03 0.93 19.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.249 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -114.83 91.53 26.45 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.086 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.14 -27.26 28.91 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.743 2.295 . . . . 0.0 111.823 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.27 -41.37 99.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.63 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.8 mp -95.01 4.87 53.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.324 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.7 -35.24 70.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.667 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.72 4.59 15.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.51 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.555 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.82 121.51 81.6 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.563 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -47.72 -37.76 28.31 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.415 2.076 . . . . 0.0 112.553 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.555 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -58.94 -43.7 91.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.803 0.335 . . . . 0.0 110.266 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.7 -43.78 93.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.286 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.91 -40.6 95.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.43 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.4 -12.48 40.19 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.569 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.25 31.69 17.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.891 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -88.64 44.22 1.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.419 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.91 135.58 43.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.436 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.23 132.87 56.54 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.452 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.42 87.6 6.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.72 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.463 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.1 mt -63.95 -41.33 97.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.983 0.421 . . . . 0.0 110.906 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.47 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.91 168.6 35.04 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 77.2 p -75.89 -25.79 56.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.834 0.35 . . . . 0.0 110.705 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.533 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -67.71 -34.55 77.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.484 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.495 ' O ' ' CG2' ' A' ' 296' ' ' THR . 98.5 m -72.96 19.38 0.09 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.596 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.533 ' H ' ' C ' ' A' ' 295' ' ' GLU . 52.0 t80 -57.36 -50.88 71.56 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.049 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 69.8 mmt-85 -108.15 148.98 29.11 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.1 tp -115.54 125.87 53.54 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.696 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 42.6 t0 -149.32 166.7 28.18 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.651 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -49.45 -38.22 28.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.597 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -72.6 -64.61 0.92 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.925 0.393 . . . . 0.0 111.381 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.26 -31.49 70.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.889 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -55.54 -25.05 35.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.523 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.7 mtt -63.08 -41.52 99.43 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 120.923 0.392 . . . . 0.0 110.809 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.16 -44.28 26.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.018 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 78.6 t -66.16 -43.08 92.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.415 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.439 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.5 tp -60.37 -47.3 86.66 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.529 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -69.8 -39.69 76.4 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.675 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.498 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 70.6 ttt180 -61.76 -37.92 86.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.218 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.72 4.79 42.78 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.769 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -112.58 -12.09 13.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.045 0.45 . . . . 0.0 110.246 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.22 85.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.574 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.87 -48.63 80.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.328 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.025 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -90.16 -2.81 58.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.369 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.09 179.22 1.22 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.513 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.6 Cg_exo -60.92 145.16 99.46 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.815 2.343 . . . . 0.0 112.179 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.35 -179.38 8.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.571 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -116.33 137.15 52.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.98 0.419 . . . . 0.0 110.329 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -123.99 146.61 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.349 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -120.28 136.4 54.68 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.771 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 53.1 p30 -99.81 -143.16 0.33 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.133 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -62.87 -36.87 84.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.399 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.468 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -152.23 -59.76 0.15 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.446 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -60.75 140.27 48.06 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.1 p -111.78 130.21 55.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.925 0.393 . . . . 0.0 110.404 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -120.05 128.62 53.68 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.509 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.2 m -85.5 130.14 34.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.205 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.7 mt -96.29 78.61 3.08 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.343 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.46 -31.83 73.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.556 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.75 109.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.976 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -122.75 91.2 49.74 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.287 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.643 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -57.15 148.63 68.44 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.82 2.347 . . . . 0.0 111.876 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.28 82.77 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.653 0.595 . . . . 0.0 110.999 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.643 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.67 67.0 0.88 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.142 0.496 . . . . 0.0 110.229 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -77.07 130.93 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.752 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.6 t -122.58 147.72 26.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.047 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.0 t -136.55 143.97 43.97 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.666 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.672 ' HG1' ' H ' ' A' ' 50' ' ' SER . 18.2 p -99.71 -58.8 1.84 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.557 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.672 ' H ' ' HG1' ' A' ' 49' ' ' THR . 88.4 p -79.43 155.25 28.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.637 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.0 t -74.05 -21.94 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.569 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.403 ' O ' ' OG ' ' A' ' 56' ' ' SER . 97.6 m -60.26 -51.92 67.48 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.516 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 mt -66.21 -42.68 88.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.172 0.511 . . . . 0.0 110.897 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.3 m -43.16 -53.96 4.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.959 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.0 -37.55 73.86 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.1 m -62.86 -44.22 96.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.87 0.366 . . . . 0.0 110.244 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.5 mt -65.86 -42.33 90.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.602 0.715 . . . . 0.0 110.679 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tp -62.93 -39.69 95.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.519 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.0 77.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.235 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.2 pt -91.36 28.09 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.257 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.79 51.83 10.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.011 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.16 76.07 27.62 Favored Pre-proline 0 C--O 1.225 -0.189 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.02 149.6 90.14 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.742 2.294 . . . . 0.0 112.108 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -112.57 136.61 48.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-O 121.233 0.539 . . . . 0.0 110.256 179.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.3 pt -69.3 -43.73 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.369 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.16 131.15 53.27 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.989 0.423 . . . . 0.0 110.628 -178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.5 p -155.65 168.6 26.64 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.38 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.34 -177.24 21.98 Favored Glycine 0 N--CA 1.465 0.593 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.42 172.04 13.25 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 121.067 0.46 . . . . 0.0 110.434 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.8 p -133.38 -111.37 0.23 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.001 0.429 . . . . 0.0 110.346 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.94 179.73 0.93 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.356 -179.019 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.0 Cg_exo -61.02 58.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 123.032 2.488 . . . . 0.0 112.14 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.535 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.7 t-20 -64.38 -34.23 77.68 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 118.716 -0.659 . . . . 0.0 110.423 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.4 m-20 94.6 -37.27 0.01 OUTLIER 'General case' 0 C--N 1.348 0.543 0 O-C-N 124.156 0.91 . . . . 0.0 109.684 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -62.73 -40.07 96.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.029 0.442 . . . . 0.0 110.203 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -73.99 -26.16 20.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.714 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.75 -172.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.539 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.54 -153.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.79 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.3 p-10 -54.21 -6.85 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.707 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.515 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.01 114.19 23.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.647 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.42 72.06 1.3 Allowed Glycine 0 C--O 1.225 -0.446 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.487 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.3 m-85 -143.58 148.13 35.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.913 0.387 . . . . 0.0 110.839 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.525 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.5 mp -85.89 -98.77 0.07 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.076 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.86 -43.39 96.23 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.14 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.556 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.8 tt0 91.65 52.69 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 124.143 0.902 . . . . 0.0 110.919 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -103.33 -8.53 20.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.387 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.487 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -65.52 -33.31 75.63 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.198 0.523 . . . . 0.0 110.687 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.556 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.24 -24.26 1.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.629 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.8 t -69.57 -46.02 76.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.842 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.24 -48.51 81.12 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.984 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.61 -38.23 89.38 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.367 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.71 -32.86 53.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.144 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.565 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.79 1.71 55.8 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.554 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 83.03 -49.38 0.15 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.141 0.901 . . . . 0.0 110.275 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.628 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.1 mt -46.23 153.72 0.31 Allowed 'General case' 0 CA--C 1.486 -1.483 0 CA-C-O 117.127 -1.416 . . . . 0.0 109.257 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.628 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.35 92.06 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 O-C-N 125.896 1.998 . . . . 0.0 110.525 -178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.01 142.83 43.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.174 0.512 . . . . 0.0 110.212 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.8 mt -131.96 26.52 4.6 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.041 -0.412 . . . . 0.0 110.443 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -140.03 137.5 34.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.032 0.444 . . . . 0.0 110.516 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.7 mt -136.82 164.7 29.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.352 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.518 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.76 -28.76 1.74 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.08 70.67 7.77 Favored Pre-proline 0 N--CA 1.464 0.256 0 CA-C-O 121.195 0.521 . . . . 0.0 110.206 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.98 145.29 98.7 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.743 2.295 . . . . 0.0 112.087 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.1 t -135.03 137.11 42.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.507 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.0 -38.35 82.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.697 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.19 -42.23 96.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.512 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.91 -41.61 98.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.545 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.46 -43.35 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.96 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.04 -35.17 77.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.022 0.439 . . . . 0.0 110.216 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.58 -18.96 61.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.459 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.32 -6.55 58.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.537 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.413 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 68.9 mtp 47.65 55.87 17.11 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.661 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.5 Cg_endo -70.34 149.64 63.48 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.755 2.303 . . . . 0.0 112.132 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.48 -72.78 0.67 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.451 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.5 tp -111.61 113.93 26.65 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.348 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.0 mt -102.96 126.79 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 120.935 0.398 . . . . 0.0 110.566 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.2 mt -110.33 134.16 52.56 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.111 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.65 139.72 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.501 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 121' ' ' THR . 91.1 p -83.22 167.78 17.37 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.708 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.34 -37.25 80.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.43 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.418 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.6 t -139.57 158.6 43.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.439 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.59 176.64 33.87 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.68 86.88 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.34 151.38 44.41 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.919 0.39 . . . . 0.0 110.547 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.4 t -63.56 140.89 58.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.268 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.55 10.65 11.15 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.618 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.2 -39.07 88.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.171 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.628 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.75 -35.9 24.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.614 0.721 . . . . 0.0 110.667 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.8 mt -70.98 -35.26 72.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.525 0.678 . . . . 0.0 110.74 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.9 -62.98 0.87 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.339 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.628 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.72 -42.73 90.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -61.97 -32.64 73.1 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.509 0.506 . . . . 0.0 110.222 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.4 mt -73.75 -40.56 63.41 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.49 -49.03 78.82 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.137 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.8 m -52.98 -42.52 65.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.237 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.91 -43.08 93.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.991 0.424 . . . . 0.0 111.208 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.06 152.89 5.36 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.677 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -38.92 107.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.673 2.249 . . . . 0.0 112.488 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.403 ' HG1' ' CB ' ' A' ' 133' ' ' LEU . 96.8 m -109.61 121.44 45.22 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.041 0.448 . . . . 0.0 110.181 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -113.83 152.68 30.33 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.254 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 tt -128.06 131.16 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.38 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.34 127.75 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.49 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 54.4 t30 -100.15 104.57 16.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.176 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -100.28 -12.02 19.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.014 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.8 p-10 -65.16 -34.08 77.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.81 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.581 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.8 p-10 -99.34 7.92 45.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.585 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -134.05 151.44 51.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.56 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.42 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.8 p -75.87 166.31 23.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.635 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.595 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.0 t90 -59.26 -48.76 80.43 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.101 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -54.24 -44.12 71.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.989 0.423 . . . . 0.0 110.04 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.3 t -63.05 -40.8 98.78 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.344 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 62.7 tp -60.62 -44.52 96.23 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.287 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.6 tp -61.56 -42.51 98.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.192 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.9 m -55.55 -46.14 77.17 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.83 -40.6 95.87 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.962 0.41 . . . . 0.0 110.337 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -62.12 -42.51 99.3 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.41 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.27 -40.11 94.62 Favored Glycine 0 C--O 1.222 -0.608 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.34 -45.9 65.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.931 0.396 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.83 -44.1 96.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.2 p -92.95 -9.3 40.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.61 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.18 26.37 72.49 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -101.97 50.73 0.84 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.822 0.344 . . . . 0.0 110.694 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.63 -39.27 77.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.667 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.5 -47.21 86.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.223 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -59.84 -39.54 85.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.209 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.16 -40.82 98.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.059 0.457 . . . . 0.0 110.259 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.83 -29.03 70.42 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.966 0.412 . . . . 0.0 110.616 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -73.94 -54.39 8.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.076 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -64.67 -42.02 95.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.419 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.4 mt -62.3 -43.93 98.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.531 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.99 -59.67 4.76 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.136 0.493 . . . . 0.0 110.253 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -55.91 -34.15 65.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.48 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -80.17 -36.18 35.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.798 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.2 m-20 -54.66 -42.02 70.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.926 -178.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.98 -41.39 97.97 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.62 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -64.93 -38.21 90.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.322 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.33 -42.45 99.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.804 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.84 -53.38 56.67 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.149 0.5 . . . . 0.0 110.685 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.22 -41.82 89.55 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.694 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.7 -40.31 96.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.697 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.03 -32.54 73.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.39 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.2 -21.53 19.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.736 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.63 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.2 tt0 -64.7 -41.93 95.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.763 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.1 pt -75.98 133.76 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.043 0.449 . . . . 0.0 110.723 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -127.51 106.11 8.95 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.317 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.3 128.27 0.35 Allowed Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.576 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.447 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.5 Cg_exo -43.44 151.3 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.812 2.342 . . . . 0.0 112.667 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.66 142.43 53.06 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.577 2.185 . . . . 0.0 112.517 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.544 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -170.97 147.29 2.28 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.672 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.9 153.96 71.77 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.761 2.308 . . . . 0.0 112.299 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.521 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.21 163.05 29.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.228 0.537 . . . . 0.0 110.415 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.646 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.1 t -143.52 169.82 16.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.949 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.646 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -148.03 137.59 22.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.987 0.422 . . . . 0.0 110.11 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.5 pt -134.22 146.34 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.76 131.9 59.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.198 0.523 . . . . 0.0 110.471 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -151.86 154.77 36.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.409 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.0 m -121.64 122.78 40.39 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 110.358 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.6 -25.61 66.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.638 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.401 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.95 -49.43 20.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.966 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.75 -12.03 60.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.34 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.7 m80 49.59 42.35 22.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.435 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.8 t -136.39 145.29 45.17 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.354 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.84 114.39 27.7 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.268 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.93 133.37 55.59 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.108 0.48 . . . . 0.0 110.289 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.07 146.4 38.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.793 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.475 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 12.9 t90 -99.69 127.99 45.8 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.187 0.518 . . . . 0.0 109.86 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.539 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -93.46 153.67 41.35 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.401 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.74 -18.57 47.72 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.655 2.237 . . . . 0.0 111.977 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.539 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -50.13 -18.35 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.343 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.475 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.6 p -75.36 167.8 21.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.484 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.24 -35.62 75.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.429 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.5 mt-30 -56.74 -41.12 76.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.698 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.42 -42.99 97.77 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.503 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 73.1 mt-30 -63.91 -39.95 95.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 122.279 -0.541 . . . . 0.0 110.745 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.595 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.4 mmm -61.83 -41.54 97.91 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.196 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 77.5 mt -63.46 -49.79 72.26 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 121.16 0.505 . . . . 0.0 110.404 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.38 -32.66 50.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 0.0 110.076 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.18 -20.07 62.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.578 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 67.1 mt -87.39 -6.53 58.42 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.58 3.89 57.24 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -88.63 149.81 23.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 0.0 110.527 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.5 p -112.96 126.83 55.91 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.211 0.529 . . . . 0.0 110.191 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.565 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.87 145.61 24.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.061 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.461 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.9 150.51 46.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.398 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.61 131.29 44.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.385 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.626 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.67 92.97 26.18 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.996 -179.535 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.718 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.1 Cg_exo -55.6 139.13 82.53 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.542 2.161 . . . . 0.0 111.582 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.51 -24.62 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.483 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.718 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.07 -49.59 26.77 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.581 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -54.57 -36.91 64.88 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.63 36.06 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.82 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.581 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.68 87.4 0.01 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.879 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.5 p -80.81 -14.73 57.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.334 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.42 -41.11 11.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.668 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.2 t -66.85 -16.65 64.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.585 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.01 43.74 26.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.431 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.77 -146.87 7.22 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.57 143.42 49.75 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.026 0.441 . . . . 0.0 110.296 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -151.75 149.26 28.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.279 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -100.36 -152.83 0.43 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.317 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.6 t0 56.44 -91.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.671 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.519 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.67 175.39 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.594 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.519 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.8 mt -121.41 141.04 43.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.842 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.41 168.98 9.65 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.14 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.0 mt -147.3 150.69 35.27 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.278 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.69 -39.04 97.09 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.56 3.75 4.55 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.0 -58.31 3.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.959 0.409 . . . . 0.0 110.562 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -62.06 -36.92 83.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.209 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.18 -67.66 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.79 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.6 -42.02 67.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.091 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.15 18.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.689 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.44 47.53 0.2 Allowed Glycine 0 N--CA 1.466 0.642 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.3 mp 39.23 -109.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.569 0.223 . . . . 0.0 110.684 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.461 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.5 m120 -60.98 -44.99 96.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.367 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.78 8.04 83.26 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -99.22 -12.47 20.38 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.709 -0.289 . . . . 0.0 110.687 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.4 t 176.38 142.65 0.07 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.085 0.469 . . . . 0.0 110.449 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -148.16 125.77 11.77 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.207 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -98.63 143.04 29.45 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 120.885 0.374 . . . . 0.0 110.958 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.0 mt -94.39 106.77 18.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.659 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.472 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 93.0 t80 -102.23 -12.95 17.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.117 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -65.87 -40.45 91.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.892 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.18 173.48 45.95 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.492 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -74.27 -112.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.76 0.314 . . . . 0.0 110.749 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.93 -28.77 67.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.673 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.2 -44.05 92.23 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.259 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.5 -44.49 94.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.327 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.45 -59.67 4.15 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.12 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.35 -43.41 61.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.069 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.74 74.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.194 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.3 -43.61 97.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.592 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -56.57 -37.77 71.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.074 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.32 0.99 20.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.168 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -115.07 91.28 26.48 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.094 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.05 -27.22 28.16 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.786 2.324 . . . . 0.0 111.897 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -41.27 98.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.536 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.9 mp -95.44 4.91 52.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.347 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.76 -35.31 70.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.644 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.82 4.77 15.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.489 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.541 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.68 121.2 80.22 Favored Pre-proline 0 N--CA 1.44 -0.937 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.587 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -47.55 -37.48 26.53 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.41 2.073 . . . . 0.0 112.628 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.541 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.72 -43.48 90.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.747 0.308 . . . . 0.0 110.245 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.85 -43.74 93.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.246 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.86 -40.62 95.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.335 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.46 -12.6 39.68 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.603 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 62.01 31.64 17.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.003 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.42 44.33 1.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.136 0.493 . . . . 0.0 110.327 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.4 135.82 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.439 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.65 132.42 56.69 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.4 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.49 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.83 88.39 6.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.77 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.474 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.9 mt -63.83 -41.74 97.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.983 0.42 . . . . 0.0 110.832 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.472 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.85 165.94 34.56 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 76.8 p -75.62 -25.99 57.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.846 0.355 . . . . 0.0 110.703 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.3 tp10 -68.4 -34.03 75.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.442 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.494 ' O ' ' CG2' ' A' ' 296' ' ' THR . 99.4 m -72.26 18.82 0.08 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.558 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.543 ' H ' ' C ' ' A' ' 295' ' ' GLU . 48.1 t80 -56.93 -51.03 70.76 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.873 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -107.09 148.15 29.13 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 41.0 tp -115.52 126.11 53.86 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.842 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 304' ' ' ALA . 42.0 t0 -149.55 166.83 28.04 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.672 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -49.28 -38.03 25.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.631 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -71.75 -64.91 0.84 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.47 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.9 -32.94 72.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.979 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 300' ' ' ASP . . . -54.47 -25.52 25.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.66 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.2 mtt -63.56 -41.07 98.43 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 120.906 0.384 . . . . 0.0 111.06 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -77.65 -44.61 27.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.084 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 79.6 t -66.12 -42.88 92.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.346 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.43 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 48.3 tp -59.92 -47.05 87.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.449 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -70.19 -39.55 75.15 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.134 0.492 . . . . 0.0 110.897 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.492 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 73.9 ttt180 -61.28 -37.79 84.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.197 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -88.06 5.06 42.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.689 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.63 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.0 tttt -112.23 -11.84 13.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.075 0.464 . . . . 0.0 110.303 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.26 85.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.53 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.97 -48.73 80.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.339 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.941 -179.964 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.655 ' H ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -89.89 -2.68 58.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.417 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.493 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.15 1.23 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.501 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.493 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.8 Cg_exo -60.81 144.89 99.64 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.86 2.373 . . . . 0.0 112.123 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.655 ' NH1' ' H ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.83 -179.48 8.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.592 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.77 137.0 52.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.371 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.71 146.99 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.383 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -120.03 136.14 54.67 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.791 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.36 -143.48 0.32 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.225 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.66 -37.08 86.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.458 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.21 -66.62 0.22 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.435 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.6 142.39 45.59 Favored Glycine 0 CA--C 1.519 0.294 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.6 p -112.17 131.36 55.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 110.443 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -119.1 129.1 54.88 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.485 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.9 m -85.76 130.37 34.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.225 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.3 mt -95.91 79.07 3.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.439 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.61 -31.96 73.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.71 109.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.986 0.422 . . . . 0.0 110.121 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -122.49 91.92 49.19 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.435 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.9 Cg_exo -56.7 148.67 63.9 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.804 2.336 . . . . 0.0 111.953 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.58 82.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.591 0.557 . . . . 0.0 110.979 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.5 66.84 0.89 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.271 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.06 130.58 36.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.812 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.7 t -122.61 146.71 27.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.061 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.0 t -135.96 143.96 45.16 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.77 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.68 ' HG1' ' H ' ' A' ' 50' ' ' SER . 28.5 p -99.5 -59.4 1.73 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.624 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.68 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.2 p -79.28 155.07 28.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.651 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.3 t -74.05 -21.91 18.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.529 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.413 ' O ' ' OG ' ' A' ' 56' ' ' SER . 96.4 m -60.23 -52.07 66.85 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.536 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.38 -42.6 87.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.102 0.477 . . . . 0.0 110.787 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.9 m -43.14 -54.07 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.029 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.33 -37.05 70.53 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.8 m -62.88 -44.71 95.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.867 0.365 . . . . 0.0 110.252 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.0 mt -66.37 -41.9 88.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.487 0.661 . . . . 0.0 110.75 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -62.61 -40.33 96.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.431 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.04 -35.61 75.48 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.202 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -91.54 28.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.253 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.45 51.67 11.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.32 75.7 22.57 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.0 0.429 . . . . 0.0 109.919 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.61 151.35 85.96 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.825 2.35 . . . . 0.0 112.16 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -113.42 137.31 46.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.182 0.515 . . . . 0.0 110.274 179.772 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.418 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.4 pt -69.42 -43.4 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.359 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.03 131.17 53.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.96 0.41 . . . . 0.0 110.594 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.8 p -155.64 168.49 26.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.489 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.66 -177.16 21.78 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.92 172.85 12.24 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 110.449 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 p -133.16 -111.93 0.23 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.001 0.429 . . . . 0.0 110.428 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.43 179.68 0.94 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.509 -179.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.7 Cg_exo -60.97 58.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.965 2.443 . . . . 0.0 112.099 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.1 t-20 -64.43 -33.73 76.54 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.485 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 42.5 m-20 94.07 -36.96 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.875 0.734 . . . . 0.0 109.808 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -62.75 -39.73 95.06 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.188 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.35 -25.54 19.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.669 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.31 -171.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.428 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.14 -153.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.87 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.5 p-10 -52.72 -7.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.749 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.52 114.88 23.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.648 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.95 69.69 1.36 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.434 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.1 m-85 -143.05 147.15 34.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 110.813 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.527 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -84.92 -98.58 0.06 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.11 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.556 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.06 -42.48 97.0 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.13 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.556 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 34.8 tt0 91.29 52.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.841 0.713 . . . . 0.0 111.076 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -102.8 -9.25 20.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.374 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.434 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.3 p -64.36 -34.11 77.39 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.138 0.494 . . . . 0.0 110.695 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.532 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.05 -23.61 1.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.677 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.92 -45.97 75.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.746 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.26 -48.55 80.9 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.009 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.37 -38.34 89.2 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.446 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.57 -32.74 52.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.175 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.593 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.4 mmt-85 -90.1 1.75 56.03 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.535 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 56.9 mttp 82.84 -49.38 0.17 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.838 0.711 . . . . 0.0 110.318 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.664 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.3 mt -45.86 154.01 0.25 Allowed 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 117.733 -1.127 . . . . 0.0 109.598 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.664 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.22 92.62 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 125.387 1.679 . . . . 0.0 110.521 -178.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.543 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.65 143.17 42.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.249 0.547 . . . . 0.0 110.244 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.9 mt -132.23 27.04 4.5 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 122.013 -0.429 . . . . 0.0 110.454 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.32 137.94 34.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.03 0.443 . . . . 0.0 110.559 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.525 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 91.2 mt -137.33 165.1 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.356 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.525 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 144.58 -28.48 1.91 Allowed Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.22 70.45 7.63 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.13 0.49 . . . . 0.0 110.172 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.93 145.23 98.83 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.751 2.301 . . . . 0.0 112.098 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.5 t -134.57 136.59 43.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.97 0.414 . . . . 0.0 110.544 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.37 83.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.63 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.14 -42.41 96.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.527 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.6 98.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.525 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.7 -43.41 98.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.03 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.23 -35.03 77.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.181 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.59 -18.73 60.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.407 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.61 -6.47 58.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.531 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 70.3 mtp 47.59 56.06 17.22 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.596 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.1 149.33 64.57 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.737 2.291 . . . . 0.0 112.12 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.24 -74.0 0.63 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.43 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.8 tp -110.22 112.91 25.17 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.268 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.4 mt -101.82 126.26 55.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.694 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 mt -109.51 133.7 52.77 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.276 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.406 HG23 HD12 ' A' ' 118' ' ' ILE . 96.8 mt -120.54 139.44 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.594 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 121' ' ' THR . 90.5 p -83.43 168.58 16.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.793 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.24 -37.43 80.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.427 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.428 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -139.74 158.99 43.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.488 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.15 177.43 33.19 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.19 -33.9 87.38 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -125.12 151.98 45.01 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.9 0.381 . . . . 0.0 110.522 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.4 t -63.14 140.99 58.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.369 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.43 10.32 11.16 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.649 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.01 -38.79 87.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.244 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.638 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.2 -35.89 23.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.449 0.643 . . . . 0.0 110.628 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.1 mt -71.05 -35.51 71.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.504 0.668 . . . . 0.0 110.673 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -42.68 -62.71 0.92 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.356 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.638 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.91 -42.73 89.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.159 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -62.08 -32.69 73.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.338 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.3 mt -73.75 -40.98 63.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.898 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.27 -48.84 79.17 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.19 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.2 m -53.2 -42.48 66.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.182 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.81 -42.94 93.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.022 0.439 . . . . 0.0 111.158 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.64 154.57 5.53 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.657 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -39.39 106.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.647 2.232 . . . . 0.0 112.496 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 95.7 m -110.5 121.35 45.09 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.093 0.473 . . . . 0.0 110.199 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.22 153.28 29.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.286 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 tt -129.29 131.55 67.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.404 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.16 128.03 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.056 0.455 . . . . 0.0 110.512 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.62 103.56 14.38 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.197 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.8 p90 -101.15 -11.21 19.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.872 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.2 p-10 -64.84 -33.41 75.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.703 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.571 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.3 p-10 -98.38 8.0 45.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.567 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.45 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.88 155.62 50.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.466 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.403 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.8 p -75.01 165.62 24.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.668 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.59 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.88 -48.62 80.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.217 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.54 -42.02 67.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.001 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.4 t -62.74 -41.06 99.01 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.37 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.6 tp -60.59 -44.41 96.29 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.406 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.37 -43.41 98.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.166 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.0 m -55.07 -44.93 75.26 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.35 -40.74 97.38 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.967 0.413 . . . . 0.0 110.507 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.446 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.94 -42.54 99.23 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.311 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.13 -40.85 95.16 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.57 -45.99 64.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.937 0.398 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.75 -43.98 96.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.837 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -93.07 -8.83 41.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.632 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.96 26.63 72.34 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.69 50.59 0.85 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.807 0.337 . . . . 0.0 110.678 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -69.44 -39.48 77.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.648 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.46 -47.2 86.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.274 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -60.13 -39.38 86.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.163 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.98 99.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.246 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.92 -28.5 70.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.591 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.29 -54.27 8.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.895 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -65.48 -42.28 92.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.366 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.9 mt -62.36 -43.84 98.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.566 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.57 -58.36 7.83 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.999 0.428 . . . . 0.0 110.356 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.13 -33.55 67.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.589 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -81.34 -36.5 29.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.774 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -55.63 -42.29 74.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.023 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.28 -42.23 99.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.74 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.27 -37.98 88.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.295 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.51 -42.12 99.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.729 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.13 -52.98 61.69 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.045 0.45 . . . . 0.0 110.667 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.22 -41.91 89.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.665 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.7 -40.02 95.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.592 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.38 -31.91 73.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.434 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.77 -22.4 18.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.67 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.75 -41.27 96.03 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.668 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.0 pt -76.24 136.27 25.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.657 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.47 107.83 10.62 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.29 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -177.16 125.8 0.29 Allowed Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.472 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.4 Cg_exo -44.04 152.38 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.864 2.376 . . . . 0.0 112.509 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.8 141.91 55.85 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.612 2.208 . . . . 0.0 112.446 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.27 147.14 2.13 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.548 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.08 154.34 70.57 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.811 2.34 . . . . 0.0 112.312 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.52 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.05 162.99 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.235 0.54 . . . . 0.0 110.403 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.665 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.0 t -143.72 170.33 16.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.927 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.665 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -148.66 137.75 21.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 110.126 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.4 pt -134.54 147.2 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.661 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.02 132.15 58.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.115 0.483 . . . . 0.0 110.488 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -152.44 155.72 38.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.444 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 88.8 m -123.25 123.48 40.85 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.945 0.402 . . . . 0.0 110.375 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.63 -25.64 66.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.626 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.69 -48.96 19.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.006 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.61 -12.06 60.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.497 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.1 m80 49.28 41.02 19.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.526 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.3 t -135.84 143.65 45.23 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.385 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -109.83 114.29 27.74 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.24 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.82 133.36 55.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.016 0.436 . . . . 0.0 110.488 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -111.87 146.62 37.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.834 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.451 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 10.0 t90 -99.97 129.65 46.06 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.186 0.517 . . . . 0.0 109.869 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.713 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -94.85 153.73 39.94 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.39 179.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.3 Cg_endo -67.77 -18.06 47.44 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.755 2.303 . . . . 0.0 111.975 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.713 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -49.27 -19.12 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.369 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.451 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.5 p -75.4 164.41 26.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.497 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.78 -27.66 65.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.526 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.61 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.0 mt-30 -63.88 -41.03 97.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.556 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.81 -44.48 97.96 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.45 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.1 mt-30 -64.49 -38.77 92.17 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 122.299 -0.53 . . . . 0.0 110.697 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.59 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.3 mmm -61.93 -41.24 97.72 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.209 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.56 -47.31 82.09 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.022 0.439 . . . . 0.0 110.437 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.91 -31.97 51.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.866 0.365 . . . . 0.0 110.268 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -70.9 -18.63 62.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.508 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 90.3 mt -87.65 -9.12 55.11 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.602 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.16 1.84 54.46 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -88.42 153.55 21.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.904 0.383 . . . . 0.0 110.468 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 7.3 p -116.4 128.87 55.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.14 0.495 . . . . 0.0 110.41 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.557 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.48 146.3 23.79 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.916 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.453 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.93 151.5 45.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.488 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.49 131.51 43.51 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.428 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.72 93.44 28.53 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.05 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.716 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.2 Cg_exo -55.38 138.78 80.84 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.545 2.163 . . . . 0.0 111.679 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.98 -26.05 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.457 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.716 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.03 -50.11 30.57 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.586 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.5 mt -54.43 -37.07 64.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.45 36.24 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.74 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.3 86.31 0.02 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.878 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.5 p -79.2 -15.08 58.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.382 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -92.6 -41.01 10.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.603 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.9 t -66.13 -17.86 64.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.645 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 56.16 43.3 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.492 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.34 -148.34 7.72 Favored Glycine 0 CA--C 1.519 0.289 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.58 142.75 49.8 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 110.347 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -152.36 149.89 29.12 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.296 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -101.28 -151.33 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.348 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 55.81 -92.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.672 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.511 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.85 175.38 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.627 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.511 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.8 mt -122.5 141.81 41.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.65 169.32 9.35 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.23 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.3 mt -147.52 150.94 35.5 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.264 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.93 -38.85 96.67 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.35 3.77 4.65 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -77.34 -58.13 3.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.924 0.392 . . . . 0.0 110.538 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -62.14 -36.34 81.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.308 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.55 -67.51 0.25 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.86 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.75 -42.37 68.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.081 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.7 17.59 0.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.669 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.86 48.47 0.27 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.394 -0.683 . . . . 0.0 111.394 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.3 mp 38.82 -109.98 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.593 0.235 . . . . 0.0 110.712 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.453 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.6 m120 -60.86 -44.93 96.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.475 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.47 7.99 83.87 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -98.91 -13.66 19.91 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.647 -0.325 . . . . 0.0 110.66 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.4 t 177.25 142.78 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.087 0.47 . . . . 0.0 110.42 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 tt -148.13 125.34 11.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.165 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -98.28 143.63 28.56 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 120.865 0.364 . . . . 0.0 110.83 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.7 mt -95.18 106.67 18.71 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.794 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.437 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.7 t80 -102.26 -12.1 18.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.158 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.44 -40.4 89.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.886 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.0 173.3 45.86 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.461 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.3 m-20 -74.07 -113.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.756 0.312 . . . . 0.0 110.704 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.72 -28.81 67.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.686 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.1 -43.86 91.9 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.225 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.32 -44.55 94.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.316 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.56 -59.98 3.8 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.189 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -51.02 -43.38 60.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.151 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.47 -43.41 75.51 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.19 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.53 -43.68 96.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.629 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.25 -37.55 69.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.098 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.48 0.79 18.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.131 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -115.21 91.7 28.81 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.148 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.35 -27.07 29.73 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.748 2.299 . . . . 0.0 111.95 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.515 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.55 -41.06 98.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.503 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.434 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.33 5.24 52.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.381 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.13 -35.08 69.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.585 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.93 4.53 16.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.51 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.553 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.64 121.25 80.33 Favored Pre-proline 0 N--CA 1.445 -0.7 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.549 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -47.14 -38.0 24.3 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.483 2.122 . . . . 0.0 112.529 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.553 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -58.8 -43.66 90.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.704 0.288 . . . . 0.0 110.37 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.0 -43.62 92.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.355 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.92 -40.78 95.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.415 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.6 t-20 -89.65 -12.41 39.7 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.588 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.2 mtmt 61.94 32.19 17.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.995 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.76 43.97 1.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.061 0.457 . . . . 0.0 110.307 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.68 135.67 41.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.503 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.78 132.69 56.63 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.447 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.15 89.16 7.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.732 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.453 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.8 mt -63.82 -41.05 97.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.021 0.438 . . . . 0.0 110.856 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.437 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.2 165.02 33.52 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.516 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 74.1 p -75.28 -25.71 58.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.94 0.4 . . . . 0.0 110.771 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.3 tp10 -68.42 -34.03 75.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.393 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.506 ' O ' ' CG2' ' A' ' 296' ' ' THR . 96.6 m -73.35 24.84 0.07 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.736 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.61 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 39.7 t80 -58.07 -50.66 72.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.433 ' CZ ' ' CE2' ' A' ' 297' ' ' PHE . 80.0 mmt-85 -111.19 154.01 24.99 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 44.8 tp -115.44 124.98 52.51 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.814 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 41.8 t0 -147.69 165.55 30.13 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.619 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -49.34 -37.88 26.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.57 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -71.12 -65.6 0.72 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.504 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -61.01 -32.91 72.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.975 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.19 -25.55 23.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.743 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.2 mtt -63.6 -40.9 98.11 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 120.829 0.347 . . . . 0.0 111.07 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.76 -43.94 24.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.195 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.34 -42.85 91.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.357 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.1 tp -60.22 -46.96 87.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.464 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -70.07 -39.47 75.62 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.054 0.454 . . . . 0.0 110.759 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.9 ttt180 -61.75 -38.29 87.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.248 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.12 4.39 42.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.607 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -112.77 -11.01 13.55 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.091 0.472 . . . . 0.0 110.347 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.41 -37.09 85.95 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.487 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.84 -48.71 80.58 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.457 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.006 179.868 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.618 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.02 -2.52 58.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.464 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.8 179.03 1.25 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.552 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.96 144.97 99.69 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.84 2.36 . . . . 0.0 112.092 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.618 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.68 -179.58 8.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.601 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.73 136.84 52.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.358 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.0 tp -124.53 147.5 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.396 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -120.35 135.97 54.85 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 110.742 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.27 -143.5 0.32 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.194 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.54 -37.11 86.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.417 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.09 -67.21 0.22 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.507 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.54 142.72 45.18 Favored Glycine 0 C--O 1.228 -0.275 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.9 p -112.29 131.57 55.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.962 0.41 . . . . 0.0 110.481 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -118.94 128.92 54.86 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.507 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.2 m -85.41 130.35 34.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.247 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.3 mt -95.59 78.54 3.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.405 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.69 -32.17 73.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.52 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.5 109.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.121 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -122.74 91.47 49.59 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.326 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.94 148.67 66.31 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.818 2.345 . . . . 0.0 111.894 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -40.71 82.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 O-C-N 123.657 0.598 . . . . 0.0 111.008 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.44 66.85 0.89 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.266 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.22 130.74 35.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.752 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.2 t -122.61 146.95 27.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.041 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 t -136.23 143.62 44.42 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.718 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.71 ' HG1' ' H ' ' A' ' 50' ' ' SER . 25.8 p -99.38 -59.25 1.76 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.526 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.71 ' H ' ' HG1' ' A' ' 49' ' ' THR . 85.8 p -79.35 155.57 28.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.646 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.5 t -74.46 -21.97 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.591 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.412 ' O ' ' OG ' ' A' ' 56' ' ' SER . 73.7 m -60.25 -52.15 66.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.575 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.35 -42.53 87.93 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.173 0.511 . . . . 0.0 110.939 177.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.4 m -42.92 -54.07 4.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.041 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.47 -37.69 69.39 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.2 m -62.36 -44.63 96.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 110.299 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.4 mt -66.3 -41.98 88.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.445 0.641 . . . . 0.0 110.756 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -62.55 -40.17 95.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.442 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.19 -35.83 76.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.133 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 pt -91.41 29.06 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.266 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.42 51.92 10.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.887 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.4 75.67 22.35 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.961 0.41 . . . . 0.0 109.906 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.73 151.45 85.65 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.837 2.358 . . . . 0.0 112.162 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -113.58 137.16 47.65 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-O 121.214 0.53 . . . . 0.0 110.255 179.743 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.7 pt -69.48 -43.38 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.305 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.9 131.08 53.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.603 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.535 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.1 p -155.54 168.66 26.42 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.422 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.68 -177.2 21.76 Favored Glycine 0 N--CA 1.463 0.496 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.8 172.66 12.48 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.954 0.407 . . . . 0.0 110.538 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 p -132.26 -113.17 0.23 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.421 . . . . 0.0 110.359 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.77 179.72 0.95 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.408 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.1 Cg_exo -61.31 57.48 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 123.069 2.513 . . . . 0.0 112.091 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 60.4 t-20 -64.3 -33.07 74.97 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.462 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.3 m-20 93.65 -35.55 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.962 0.789 . . . . 0.0 109.795 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -63.23 -39.74 95.47 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.987 0.422 . . . . 0.0 110.173 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.79 -25.19 18.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.719 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -48.96 -171.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.555 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -73.72 -153.84 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.787 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 36.4 p-10 -52.34 -7.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.726 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.52 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -86.51 114.99 23.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.003 0.43 . . . . 0.0 110.59 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.07 70.2 1.34 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.453 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.3 m-85 -143.57 147.46 34.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.825 0.345 . . . . 0.0 110.823 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.525 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -85.82 -98.58 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.136 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.551 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.82 -42.71 97.58 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.114 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.591 ' NE2' ' HZ3' ' A' ' 88' ' ' LYS . 35.4 tt0 91.61 52.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.962 0.789 . . . . 0.0 110.907 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -102.53 -9.27 20.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.33 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.453 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.56 -34.17 77.63 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.043 0.449 . . . . 0.0 110.631 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.591 ' HZ3' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.2 -24.36 1.71 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.614 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.42 -45.64 78.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.753 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.45 -48.3 81.76 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.037 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.52 -38.24 89.17 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.36 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.53 -32.98 52.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.155 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.581 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.86 1.46 56.15 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.493 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.581 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.98 -48.98 0.15 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.984 0.803 . . . . 0.0 110.208 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.651 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.5 153.83 0.34 Allowed 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 117.65 -1.167 . . . . 0.0 109.307 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.651 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.59 92.46 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 O-C-N 125.482 1.739 . . . . 0.0 110.491 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.52 143.19 42.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.138 0.494 . . . . 0.0 110.321 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.3 mt -132.24 27.1 4.5 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.122 -0.361 . . . . 0.0 110.362 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -140.31 137.83 34.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.045 0.45 . . . . 0.0 110.524 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.5 mt -136.99 165.02 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.447 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.523 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 144.97 -28.61 1.85 Allowed Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -152.61 70.79 7.39 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.153 0.501 . . . . 0.0 110.355 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.08 145.43 98.46 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.75 2.3 . . . . 0.0 112.06 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.7 t -134.56 136.77 43.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.514 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.37 82.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.635 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.11 -42.24 96.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.483 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.15 -41.62 98.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.48 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.59 -43.45 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.043 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.3 78.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.195 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.44 -18.7 60.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.413 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.52 -6.53 58.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.486 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 73.8 mtp 48.09 55.94 17.35 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.616 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.12 149.13 64.17 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.808 2.339 . . . . 0.0 112.129 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.32 -73.05 0.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.5 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.5 tp -111.35 113.48 25.98 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.313 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.4 mt -102.3 126.64 56.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.567 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 mt -110.19 133.94 52.72 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.262 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.98 139.95 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.474 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 121' ' ' THR . 87.6 p -83.5 168.67 16.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.741 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.46 80.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.442 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.424 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.1 t -139.94 159.21 42.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.423 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.31 177.29 33.4 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.28 -33.81 87.25 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.53 151.53 44.57 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.575 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.4 t -63.55 140.93 58.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.298 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.66 10.7 11.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.666 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.04 -39.05 88.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.187 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.01 -35.91 23.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.445 0.64 . . . . 0.0 110.576 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -70.8 -35.48 72.56 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.54 0.686 . . . . 0.0 110.784 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -42.91 -62.99 0.87 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.289 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.61 -42.84 91.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.132 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -61.95 -32.73 73.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.257 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.1 mt -73.82 -40.69 63.17 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.032 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.31 -48.98 78.78 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.186 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.5 m -53.0 -42.39 65.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.187 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.89 -43.04 93.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.089 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.43 153.61 5.33 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.633 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -39.15 106.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.687 2.258 . . . . 0.0 112.393 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 93.4 m -109.94 121.35 45.04 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.191 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -113.71 152.82 29.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.269 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 tt -129.13 131.17 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.326 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.16 128.17 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.073 0.463 . . . . 0.0 110.497 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.476 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.61 103.57 14.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.23 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.4 p90 -101.34 -11.35 19.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.832 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 48.9 p-10 -64.67 -33.52 76.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.639 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.566 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.2 p-10 -98.37 7.7 45.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.596 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.447 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.49 155.72 50.05 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.539 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.6 p -74.94 165.68 24.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.643 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.3 t90 -60.12 -48.76 80.38 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.256 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -53.42 -41.82 66.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.89 0.376 . . . . 0.0 110.064 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.1 t -62.82 -41.13 99.17 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.334 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.7 tp -60.7 -44.4 96.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.331 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.1 tp -61.4 -43.54 98.69 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.168 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -54.85 -45.03 74.48 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.44 -40.56 96.99 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.936 0.398 . . . . 0.0 110.492 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.96 -42.47 99.16 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.368 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.1 -40.85 95.22 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.59 -45.98 64.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.891 0.377 . . . . 0.0 110.842 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.8 mt -64.68 -43.96 96.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.893 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.3 p -92.99 -8.79 42.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.621 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.84 26.96 72.35 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -101.98 50.71 0.84 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 110.716 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.48 -39.23 77.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.635 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.66 -47.24 86.39 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.3 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -60.14 -39.47 86.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.225 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.96 99.31 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.292 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.92 -28.62 70.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.649 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.21 -54.3 8.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.048 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -65.47 -42.28 92.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.449 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.455 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.3 mt -62.52 -43.8 98.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.473 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.62 -59.08 5.43 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.067 0.46 . . . . 0.0 110.392 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -56.25 -34.2 66.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.568 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -80.87 -36.31 31.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.798 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.3 m-20 -54.98 -42.15 72.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.147 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.54 -41.92 99.2 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.639 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.08 -38.26 90.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.259 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.33 -42.19 99.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.692 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -52.81 62.52 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.135 0.493 . . . . 0.0 110.689 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.09 -41.99 89.94 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.673 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.87 -40.01 95.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.591 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.17 -32.27 73.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.379 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.3 -22.06 18.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.632 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.625 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.6 tt0 -64.75 -41.28 96.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.657 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.8 pt -77.02 136.05 25.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.668 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.2 108.05 10.55 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.27 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.59 126.05 0.32 Allowed Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.458 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.7 152.23 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.796 2.331 . . . . 0.0 112.66 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.04 141.89 54.53 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.624 2.216 . . . . 0.0 112.479 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.42 147.24 2.1 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.605 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.32 155.1 68.35 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.772 2.315 . . . . 0.0 112.356 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.526 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.78 163.26 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.207 0.527 . . . . 0.0 110.371 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.668 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.2 t -143.61 170.05 16.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.894 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.668 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.17 137.47 22.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.067 0.46 . . . . 0.0 110.03 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.0 pt -134.28 146.67 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.637 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.55 131.75 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.348 0.594 . . . . 0.0 110.488 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.437 ' HH ' ' CG1' ' A' ' 272' ' ' ILE . 52.4 p90 -152.78 156.17 38.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.425 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 199' ' ' ALA . 88.4 m -122.17 122.88 40.21 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.878 0.37 . . . . 0.0 110.307 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.523 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.8 -26.32 67.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.591 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.404 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.68 -49.5 21.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.69 -10.44 59.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.449 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.523 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.9 m80 46.28 47.05 13.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.455 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -130.97 143.76 50.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.414 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -108.57 105.32 14.9 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.169 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.6 m-20 -115.95 128.79 56.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.148 0.499 . . . . 0.0 110.321 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.7 tt -111.84 146.32 37.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.465 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.2 t90 -99.55 128.55 45.66 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.131 0.491 . . . . 0.0 109.905 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.709 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -94.41 154.22 40.31 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.293 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.71 -18.09 47.81 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.726 2.284 . . . . 0.0 111.981 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.709 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -49.65 -19.26 0.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.472 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.465 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 87.0 p -74.76 164.44 26.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.483 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.98 -27.77 65.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.518 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.583 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.67 -41.45 98.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.634 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.07 -44.29 97.43 Favored Glycine 0 C--N 1.331 0.286 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.447 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.5 mt-30 -64.52 -38.77 92.16 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 122.4 -0.471 . . . . 0.0 110.683 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.3 mmm -62.12 -41.34 98.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.16 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.6 mt -63.59 -47.36 81.77 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.534 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.24 -31.83 54.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 0.0 110.113 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.97 -18.33 62.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.493 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 92.1 mt -88.37 -8.55 54.86 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.568 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.42 2.88 55.57 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -89.02 152.56 21.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 0.0 110.445 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.3 p -115.35 128.23 55.94 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.132 0.491 . . . . 0.0 110.334 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.555 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.16 146.75 23.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.038 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.46 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.4 151.28 45.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.487 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.07 131.69 42.65 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.39 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.38 93.78 28.46 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.095 -179.667 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.721 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.2 Cg_exo -55.47 138.73 81.11 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.607 2.205 . . . . 0.0 111.568 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.53 -25.49 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.471 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.721 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.68 -49.95 27.46 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.601 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.1 mt -55.15 -37.37 66.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.851 0.358 . . . . 0.0 110.086 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -65.54 35.53 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.84 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.601 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.45 88.3 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 86.2 p -82.26 -13.83 56.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.325 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.32 -40.67 11.35 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.611 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.2 t -66.71 -16.95 64.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.593 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.99 43.69 26.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.457 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.91 -148.08 7.81 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.61 142.25 49.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.998 0.427 . . . . 0.0 110.274 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.0 149.54 29.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.342 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -102.02 -150.35 0.4 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.346 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.68 -93.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.616 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.483 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.0 tt -126.57 174.58 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.604 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.483 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 87.4 mt -121.7 140.94 44.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.902 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.28 170.33 8.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.169 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.5 mt -146.94 149.51 33.33 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.15 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.35 -39.25 97.58 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.19 3.06 4.01 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -78.33 -57.64 3.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.948 0.404 . . . . 0.0 110.583 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -61.99 -36.89 82.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.245 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.7 mp -53.13 -67.42 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.022 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.72 -42.7 68.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.145 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.38 17.85 0.13 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.685 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.79 47.59 0.23 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 7.9 mp 39.71 -110.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.595 0.236 . . . . 0.0 110.651 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.46 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -60.92 -44.52 97.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.441 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.5 8.11 83.64 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -98.7 -13.31 20.32 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.779 -0.248 . . . . 0.0 110.712 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.0 t 176.85 142.84 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 110.478 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -147.89 125.49 11.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.108 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -98.83 143.64 28.93 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 120.92 0.391 . . . . 0.0 110.758 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.9 mt -94.91 106.31 18.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.724 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.451 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.9 -11.81 18.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.219 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.91 86.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.897 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.25 172.69 45.56 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.469 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -73.81 -113.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.0 110.72 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.44 -28.86 68.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.74 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.01 -43.9 91.6 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.275 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -63.53 -44.39 94.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.386 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.57 -59.81 4.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.187 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.21 -43.44 61.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.067 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.42 74.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.267 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.437 ' CG1' ' HH ' ' A' ' 196' ' ' TYR . 91.3 mt -64.66 -43.53 96.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.58 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -56.34 -37.61 70.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.133 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.75 0.85 19.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.149 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.08 91.17 26.08 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.127 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.21 -27.09 28.8 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.724 2.283 . . . . 0.0 111.912 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.46 -41.02 98.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.557 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.3 5.48 51.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.418 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.18 -35.21 68.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.658 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.55 4.5 15.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.495 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.6 121.46 81.02 Favored Pre-proline 0 N--CA 1.444 -0.764 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.541 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -47.46 -37.93 26.61 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.51 2.14 . . . . 0.0 112.556 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.553 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.66 -43.7 89.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.738 0.304 . . . . 0.0 110.292 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.04 -43.52 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.325 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.17 -40.86 97.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.441 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.413 ' ND2' ' CG ' ' A' ' 288' ' ' GLN . 58.0 t30 -90.99 -11.22 39.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.704 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.2 mtmt 61.1 32.66 19.68 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.481 0.488 . . . . 0.0 111.001 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . 0.413 ' CG ' ' ND2' ' A' ' 286' ' ' ASN . 97.1 mm-40 -88.11 43.9 1.16 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.361 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.5 135.83 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.534 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.88 132.15 56.77 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.373 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.6 88.65 7.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.762 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.466 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.1 mt -64.0 -41.13 97.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.003 0.43 . . . . 0.0 110.892 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.451 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.25 166.39 34.04 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 70.3 p -75.29 -25.53 58.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.835 0.35 . . . . 0.0 110.719 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.538 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.3 tp10 -68.33 -33.91 75.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.535 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.499 ' O ' ' CG2' ' A' ' 296' ' ' THR . 97.7 m -73.62 23.42 0.07 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.617 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.583 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 59.3 t80 -58.04 -51.23 70.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 66.1 mmt-85 -111.05 153.88 25.01 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 44.2 tp -116.13 125.6 52.57 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.449 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 41.7 t0 -147.43 165.43 30.27 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.561 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -49.37 -38.09 27.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.607 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -72.14 -64.86 0.86 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.52 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.32 -32.0 70.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.012 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.39 -25.36 24.13 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.614 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.8 mtt -63.37 -41.0 98.78 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 120.879 0.371 . . . . 0.0 110.782 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -78.23 -44.78 24.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 79.3 t -65.9 -43.04 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.448 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.439 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 51.2 tp -60.36 -47.16 87.25 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.606 -178.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.11 -39.61 75.4 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.736 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.7 ttt180 -61.64 -38.13 86.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.154 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.2 mt -87.63 4.74 42.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.72 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.625 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.72 -11.87 13.45 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.004 0.431 . . . . 0.0 110.334 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.12 -37.24 86.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.522 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.01 -48.73 80.46 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.383 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 . . . . . 0 C--O 1.221 -0.408 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.008 179.899 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.25 -2.61 58.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.437 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.27 179.07 1.25 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.488 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.4 Cg_exo -60.78 145.29 99.18 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.794 2.329 . . . . 0.0 112.174 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.5 -179.36 8.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.585 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.3 137.01 52.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.405 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -123.99 147.09 28.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.366 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.7 p -119.98 135.95 54.72 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.78 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.39 -143.61 0.33 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.291 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.54 -37.29 86.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.456 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.477 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.82 -67.25 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.46 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.31 142.64 44.7 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.1 p -112.4 131.4 55.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.96 0.409 . . . . 0.0 110.397 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -119.01 129.16 54.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.442 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.7 m -85.63 130.78 34.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.289 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 70.3 mt -96.79 78.83 2.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.281 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.96 -31.84 72.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.561 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.56 107.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.148 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -120.74 91.19 47.11 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.414 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.658 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.3 Cg_exo -56.94 148.57 66.86 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.765 2.31 . . . . 0.0 111.842 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.62 82.41 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.577 0.548 . . . . 0.0 111.001 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.658 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.37 66.87 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.253 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -76.62 131.06 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.745 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.76 147.25 27.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.028 0.442 . . . . 0.0 110.066 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 t -136.33 144.12 44.48 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.654 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.677 ' HG1' ' H ' ' A' ' 50' ' ' SER . 19.7 p -100.09 -59.09 1.77 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.584 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.677 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.1 p -79.25 155.02 28.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -74.07 -21.85 18.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.565 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.411 ' O ' ' OG ' ' A' ' 56' ' ' SER . 96.9 m -60.13 -52.07 66.92 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.542 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.6 mt -66.49 -42.4 87.51 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.131 0.491 . . . . 0.0 110.798 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -43.35 -53.9 5.01 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.074 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.04 -37.39 73.39 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.1 m -62.93 -44.28 96.5 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 110.38 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.8 mt -66.04 -42.05 90.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.396 0.617 . . . . 0.0 110.662 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 tp -62.88 -39.91 95.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.271 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.45 -36.1 77.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.177 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.8 pt -91.18 27.9 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.27 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.4 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 99.0 m-20 56.94 51.75 10.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.972 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.17 76.06 27.59 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.944 0.402 . . . . 0.0 110.001 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.87 149.56 90.37 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.811 2.341 . . . . 0.0 112.281 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -112.52 136.6 48.24 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-O 121.136 0.493 . . . . 0.0 110.281 179.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.3 pt -69.48 -43.4 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.32 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.51 131.39 52.82 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.946 0.403 . . . . 0.0 110.648 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.54 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.3 p -155.84 168.83 25.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.458 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.35 -177.39 21.97 Favored Glycine 0 N--CA 1.463 0.499 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.5 172.38 12.8 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.015 0.436 . . . . 0.0 110.482 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.7 p -133.33 -111.57 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 0.0 110.491 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.8 179.62 0.95 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.448 -179.221 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.4 Cg_exo -60.86 58.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.894 2.396 . . . . 0.0 112.076 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.4 t-20 -64.42 -33.98 77.12 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.5 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.6 m-20 94.29 -36.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.869 0.731 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -62.89 -39.96 96.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.937 0.398 . . . . 0.0 110.224 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -74.49 -26.0 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.675 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.59 -172.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.612 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.3 p30 -73.73 -152.75 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.771 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 36.9 p-10 -54.46 -6.6 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.726 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.59 114.19 23.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.548 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.53 71.73 1.31 Allowed Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.509 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.3 m-85 -143.19 148.21 36.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.74 0.305 . . . . 0.0 110.908 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.532 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -86.04 -98.64 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.961 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.558 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.08 -43.3 95.83 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.183 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.558 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 36.0 tt0 91.85 52.64 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.875 0.734 . . . . 0.0 110.961 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -103.47 -9.02 19.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.377 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.509 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -65.23 -33.25 75.56 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.02 0.438 . . . . 0.0 110.604 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.549 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 97.9 mttt -49.09 -24.51 1.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.619 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.6 t -69.67 -45.92 76.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.31 -48.47 81.22 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.111 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -38.38 90.17 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.364 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.8 -32.64 53.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.23 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.596 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.2 mmt-85 -89.91 1.72 55.89 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.468 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.95 -49.93 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.897 0.748 . . . . 0.0 110.294 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.668 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.1 mt -45.55 153.86 0.23 Allowed 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.456 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.668 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 121.01 92.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 125.218 1.574 . . . . 0.0 110.458 -178.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.54 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.28 142.72 43.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.201 0.524 . . . . 0.0 110.191 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.4 mt -131.71 26.75 4.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.467 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -140.11 137.52 34.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 110.51 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.522 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 93.0 mt -136.84 164.88 29.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.406 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 144.97 -28.4 1.86 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.469 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.71 70.62 7.29 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.101 0.477 . . . . 0.0 110.327 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.07 145.31 98.72 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.687 2.258 . . . . 0.0 112.215 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.7 t -133.8 136.11 44.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.527 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.74 -38.42 83.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.662 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.48 -41.99 96.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.52 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.11 -41.54 98.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.516 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -63.64 -43.29 98.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.976 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.1 77.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.284 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.76 -18.37 59.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.454 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.77 -6.39 58.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.508 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.416 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 75.2 mtp 47.93 55.79 17.17 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.614 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.6 Cg_endo -69.94 149.36 65.63 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.88 2.386 . . . . 0.0 112.114 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.76 -73.05 0.66 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.488 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.6 tp -111.43 114.21 27.18 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.267 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -103.49 126.97 57.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.525 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 mt -110.71 134.51 52.4 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.184 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.12 140.15 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.555 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 121' ' ' THR . 90.7 p -83.57 168.02 16.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.689 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.31 -37.26 80.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.472 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.427 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.7 t -139.19 158.4 44.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.486 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.3 177.0 33.54 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.71 86.99 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -125.28 151.7 45.64 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.913 0.387 . . . . 0.0 110.551 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.9 t -63.29 141.34 58.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.379 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.18 10.7 10.72 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.631 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.15 -38.97 88.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.15 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.7 -35.97 24.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.432 0.634 . . . . 0.0 110.633 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.2 mt -70.98 -35.1 71.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.486 0.66 . . . . 0.0 110.72 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -42.88 -62.94 0.88 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.285 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.61 -42.84 91.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.066 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -62.11 -32.29 72.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.242 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.4 mt -74.28 -40.64 62.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.969 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.44 -49.09 78.55 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.275 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.7 m -52.92 -42.85 65.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.157 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.18 -43.06 92.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -168.83 151.71 5.09 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.71 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -38.61 107.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.621 2.214 . . . . 0.0 112.387 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 97.2 m -109.75 121.64 45.69 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.2 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.0 153.34 29.53 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.309 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.46 131.11 69.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.371 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 142' ' ' ILE . 96.5 mt -115.18 128.19 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.571 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 54.6 t30 -100.77 104.94 16.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.227 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.411 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.4 p90 -100.71 -11.94 19.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.893 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.0 p-10 -64.95 -33.69 76.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.742 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -99.29 7.91 45.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.542 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.411 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.8 mttm -134.57 151.84 51.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.869 0.366 . . . . 0.0 110.529 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.427 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.7 p -75.82 166.26 23.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.597 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.4 t90 -59.25 -48.62 80.94 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.276 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -54.44 -44.1 72.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.03 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.4 t -62.96 -40.7 98.5 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.202 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 63.4 tp -60.92 -44.34 97.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.3 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 49.2 tp -61.49 -42.98 99.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.198 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.8 m -55.9 -45.7 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.741 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.23 -40.56 96.55 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.836 0.35 . . . . 0.0 110.394 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.452 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -62.03 -42.5 99.24 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.222 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.73 -40.06 95.56 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.42 -45.95 64.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.8 -44.0 96.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.5 p -92.77 -9.09 41.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.704 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.93 26.29 72.22 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -101.22 50.47 0.86 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.776 0.322 . . . . 0.0 110.629 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.48 -39.17 77.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.658 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.9 -47.45 85.73 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.213 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.4 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 88.0 mt-30 -59.97 -39.27 85.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.162 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.92 98.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.238 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.88 -29.13 70.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.558 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -73.86 -54.41 8.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.059 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -64.86 -42.13 95.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.455 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 174' ' ' ASP . 78.4 mt -62.43 -43.82 98.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.487 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.28 -58.71 6.72 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.009 0.433 . . . . 0.0 110.368 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -56.61 -33.57 66.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.37 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -81.1 -36.12 30.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.78 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.1 m-20 -54.84 -42.35 71.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.062 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.17 -41.77 98.64 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.696 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.0 -38.02 89.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.383 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.45 -42.48 99.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.653 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.75 -53.06 61.14 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.132 0.492 . . . . 0.0 110.752 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.48 -41.76 88.48 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.618 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.09 95.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.67 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.14 -32.63 74.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.418 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.06 -21.47 19.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.728 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.63 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.3 tt0 -64.87 -41.58 95.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.733 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.0 pt -76.5 133.9 30.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.675 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.71 106.46 9.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.4 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.59 128.37 0.34 Allowed Pre-proline 0 C--O 1.238 0.479 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.553 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.3 Cg_exo -43.65 151.42 0.4 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.839 2.359 . . . . 0.0 112.497 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.67 142.18 52.22 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.611 2.208 . . . . 0.0 112.421 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.542 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.72 147.17 2.39 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.542 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.15 153.93 70.93 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.787 2.325 . . . . 0.0 112.278 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.525 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.47 163.23 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.159 0.504 . . . . 0.0 110.45 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.587 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.1 t -143.75 169.93 16.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.832 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.587 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -147.68 137.4 22.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.3 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.2 pt -134.19 146.03 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.592 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -133.39 132.01 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.054 0.454 . . . . 0.0 110.517 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -151.82 154.45 36.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.48 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 90.0 m -121.56 122.69 40.23 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.955 0.407 . . . . 0.0 110.368 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.74 -25.59 66.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.595 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -74.96 -49.66 19.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.992 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.01 -11.53 60.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.403 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.6 m80 49.14 42.47 21.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.495 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.0 t -135.94 144.98 45.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.319 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.82 114.12 27.22 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.375 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -120.18 133.71 55.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.986 0.422 . . . . 0.0 110.399 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.18 146.53 37.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.74 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.468 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 13.3 t90 -99.38 127.96 45.46 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.101 0.477 . . . . 0.0 109.987 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.71 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -93.7 153.42 41.14 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.264 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.9 -18.29 46.81 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.648 2.232 . . . . 0.0 111.962 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.71 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -50.01 -18.75 0.59 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.368 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.468 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.1 p -75.21 167.7 21.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.476 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.11 -35.56 75.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.3 mt-30 -56.64 -41.19 76.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.763 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.37 -43.04 97.68 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.492 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.4 mt-30 -63.75 -40.08 95.84 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 122.549 -0.383 . . . . 0.0 110.542 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.597 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.2 mmm -61.56 -41.87 98.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.376 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.56 -49.88 71.67 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.473 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.11 -33.06 50.62 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -71.09 -20.21 62.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.558 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 65.9 mt -87.28 -6.42 58.55 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.74 3.52 57.16 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -88.34 149.85 23.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.93 0.395 . . . . 0.0 110.507 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.0 p -112.78 126.49 55.47 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.127 0.489 . . . . 0.0 110.355 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.568 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.79 145.84 24.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.999 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.464 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.06 150.77 46.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.438 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.86 131.21 44.43 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.502 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.634 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.69 93.25 27.51 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.118 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.721 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.6 Cg_exo -55.77 138.99 83.15 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.655 2.236 . . . . 0.0 111.561 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.75 -25.13 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.399 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.721 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.75 -49.91 27.2 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.589 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.1 mt -54.37 -37.01 64.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.54 35.92 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.801 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.58 87.92 0.01 OUTLIER 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.864 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 82.3 p -81.64 -14.28 56.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.351 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.51 -41.8 10.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.609 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.9 -16.91 64.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.587 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.91 43.69 27.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.504 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.21 -149.62 8.44 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -120.29 142.79 48.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.976 0.417 . . . . 0.0 110.36 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.24 149.76 29.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.366 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -101.21 -151.7 0.42 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.358 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 56.21 -91.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.688 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.526 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.3 tt -127.08 175.61 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.597 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.526 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.6 mt -122.23 141.68 41.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.81 169.26 9.36 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.255 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.3 mt -147.57 150.71 34.99 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.223 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.57 -39.06 97.21 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.33 3.74 4.67 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.11 -58.44 3.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.911 0.386 . . . . 0.0 110.568 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -61.95 -36.57 81.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.29 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 9.9 mp -52.3 -67.8 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.757 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.42 -42.21 66.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.148 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.87 18.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.657 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.75 47.64 0.23 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.3 mp 39.13 -110.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.521 0.201 . . . . 0.0 110.743 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.464 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.8 m120 -60.9 -44.98 96.37 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.473 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.78 8.1 83.17 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -99.14 -12.57 20.36 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.805 -0.232 . . . . 0.0 110.642 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.3 t 176.24 142.65 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.052 0.453 . . . . 0.0 110.493 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -148.1 125.47 11.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.156 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -98.37 143.03 29.27 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 120.848 0.356 . . . . 0.0 110.837 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.2 mt -94.41 106.52 18.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.674 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.469 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.87 -12.74 18.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.149 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.79 90.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.895 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.9 173.2 45.81 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.472 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 87.5 m-20 -74.07 -113.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 110.723 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.15 -28.91 68.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.765 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.08 -44.09 91.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.187 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.51 -44.45 94.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.318 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.32 -59.78 4.0 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.25 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.25 -43.47 61.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.111 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.2 -43.84 74.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.244 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.1 mt -64.39 -43.58 97.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.679 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -56.59 -37.67 70.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.163 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.28 1.17 19.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.212 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -115.04 91.47 27.13 Favored Pre-proline 0 C--O 1.231 0.114 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.17 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.14 -27.33 29.18 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.821 2.347 . . . . 0.0 111.864 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.515 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.4 -41.17 98.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.55 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.9 mp -95.24 4.75 53.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.396 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.71 -35.31 70.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.099 0.476 . . . . 0.0 110.673 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.76 4.62 15.8 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.624 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.555 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.79 121.15 80.26 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.565 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -47.64 -37.35 26.96 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.464 2.11 . . . . 0.0 112.472 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.555 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.88 -43.35 90.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.319 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.04 -43.8 92.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.303 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -64.95 -40.76 95.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.341 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.3 t-20 -89.15 -13.16 39.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.577 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.5 mtmt 62.66 32.05 16.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.93 44.51 1.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.292 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.68 135.4 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.551 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.6 132.41 56.69 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.398 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.49 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.83 88.69 6.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.786 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.469 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.4 mt -63.87 -41.72 97.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.78 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.469 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.82 165.9 34.41 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 75.5 p -75.61 -25.92 57.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.719 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.542 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -68.29 -33.97 75.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.552 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.498 ' O ' ' CG2' ' A' ' 296' ' ' THR . 98.7 m -72.62 19.85 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.668 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.542 ' H ' ' C ' ' A' ' 295' ' ' GLU . 49.1 t80 -57.28 -51.01 71.1 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.014 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 70.9 mmt-85 -107.85 149.18 28.58 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 41.1 tp -115.67 126.26 53.9 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.862 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 304' ' ' ALA . 42.6 t0 -149.74 166.67 28.71 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.611 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -49.21 -38.04 24.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.613 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.65 -65.11 0.8 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.454 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -60.71 -32.82 72.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.974 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 300' ' ' ASP . . . -54.49 -25.21 24.1 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.3 mtt -63.67 -41.02 98.23 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 120.811 0.339 . . . . 0.0 110.945 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -78.37 -44.36 25.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.988 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 79.7 t -65.97 -42.93 92.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.431 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.436 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.8 tp -60.01 -46.92 87.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.448 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -70.61 -39.48 73.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.988 0.423 . . . . 0.0 110.603 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.49 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 73.6 ttt180 -61.35 -38.0 85.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.319 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.8 mt -87.76 4.91 42.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.698 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.63 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.22 -11.71 13.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.041 0.448 . . . . 0.0 110.337 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.79 -37.1 85.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.489 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.96 -48.75 80.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.435 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.958 179.872 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.612 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -90.3 -2.39 58.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.441 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.93 179.04 1.25 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.525 -179.67 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.0 Cg_exo -60.74 144.81 99.61 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.802 2.334 . . . . 0.0 112.191 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.612 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.4 ptt-85 -156.09 -179.46 8.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.597 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.62 136.19 53.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.322 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -123.78 146.53 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.432 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.8 p -119.78 135.99 54.63 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.719 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.1 p30 -99.28 -143.5 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.328 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.8 p -63.66 -37.0 85.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.42 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.31 -66.78 0.22 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.437 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.06 142.12 44.65 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.6 p -112.09 131.23 55.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.411 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -119.2 129.17 54.83 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.498 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.1 m -85.62 130.3 34.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.301 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.4 mt -95.69 78.58 3.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.399 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.82 -32.03 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.482 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.27 108.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.204 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -121.97 91.31 48.85 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.322 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.658 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.1 Cg_exo -56.94 148.8 65.48 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.782 2.321 . . . . 0.0 111.888 179.049 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.82 82.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.487 0.492 . . . . 0.0 110.922 -179.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.658 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.09 66.79 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.277 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.45 130.93 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.748 -179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.1 t -122.82 145.57 29.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.191 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.9 t -135.13 143.59 46.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.681 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.2 p -99.54 -59.26 1.75 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.576 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.4 p -79.74 155.11 28.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.593 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -74.58 -21.9 17.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.46 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.404 ' O ' ' OG ' ' A' ' 56' ' ' SER . 97.2 m -59.9 -52.32 65.92 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.508 -178.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.0 mt -66.53 -42.35 87.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.129 0.49 . . . . 0.0 110.8 178.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.6 m -42.91 -53.73 4.55 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.169 -178.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.46 -37.34 69.42 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 178.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 52' ' ' THR . 5.6 m -62.79 -44.62 95.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.955 0.407 . . . . 0.0 110.484 -179.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.5 mt -66.37 -41.85 88.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.367 0.603 . . . . 0.0 110.683 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tp -62.5 -40.25 96.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.297 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.98 -35.75 75.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.033 -178.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.6 pt -91.57 28.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.163 -179.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.38 51.78 10.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.795 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.86 75.91 24.0 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.999 0.428 . . . . 0.0 110.05 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.19 151.27 86.03 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.739 2.293 . . . . 0.0 112.3 -178.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.51 137.48 46.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.156 0.503 . . . . 0.0 110.339 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.3 pt -69.41 -43.56 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.129 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.96 131.09 53.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.958 0.408 . . . . 0.0 110.613 -178.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.1 p -155.8 169.03 25.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.515 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.87 -177.43 21.63 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.01 172.19 12.96 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 120.979 0.418 . . . . 0.0 110.444 179.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.9 p -133.76 -110.72 0.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.364 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.95 179.53 0.96 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.421 -179.202 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.7 Cg_exo -60.89 58.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.011 2.474 . . . . 0.0 112.079 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.4 t-20 -64.29 -35.03 79.52 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.52 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 47.2 m-20 94.96 -37.66 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.926 0.766 . . . . 0.0 110.031 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.64 -40.01 95.67 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.256 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.5 p -73.94 -26.44 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.697 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.9 -172.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.504 -179.402 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -73.88 -152.51 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.72 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.3 p-10 -54.78 -6.33 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.674 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.4 113.56 23.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.634 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.4 72.66 1.28 Allowed Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.498 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.1 m-85 -143.68 148.56 35.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.919 0.39 . . . . 0.0 110.759 179.264 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.3 mp -85.76 -99.15 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.136 178.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.564 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.28 -42.74 96.27 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.322 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.564 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.3 tt0 91.5 52.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.772 0.67 . . . . 0.0 110.951 178.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.45 -9.25 19.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.412 179.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.498 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.0 p -64.74 -33.78 76.78 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.112 0.482 . . . . 0.0 110.643 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.55 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 97.9 mttt -48.66 -23.35 1.0 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.591 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.8 t -70.05 -45.87 74.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.789 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.25 -48.65 80.49 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.183 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.61 -38.15 89.08 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.382 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.64 -32.39 51.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.237 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.605 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.5 mmt-85 -89.98 1.68 56.0 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.547 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.89 -49.1 0.16 Allowed 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.816 0.697 . . . . 0.0 110.342 179.141 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.683 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.9 mt -46.3 154.05 0.3 Allowed 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.557 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.683 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 121.12 92.26 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.029 1.456 . . . . 0.0 110.543 -178.579 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.537 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.3 143.3 43.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.078 0.466 . . . . 0.0 110.287 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 mt -131.92 26.97 4.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.847 0.356 . . . . 0.0 110.479 -179.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.48 138.15 34.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.004 0.431 . . . . 0.0 110.481 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.525 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.8 mt -137.19 165.15 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.429 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.525 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.11 -28.55 1.84 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.469 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -153.21 70.64 6.93 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.039 0.447 . . . . 0.0 110.391 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.15 145.53 98.28 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.801 2.334 . . . . 0.0 112.011 -179.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.1 t -134.04 136.81 44.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.57 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.33 82.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.656 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.42 -42.28 96.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.476 -179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.71 98.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.484 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.4 t -63.66 -43.18 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.136 179.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.74 -35.23 77.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.249 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.82 -18.28 59.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.432 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.7 -6.53 58.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.523 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.413 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 66.9 mtp 48.04 55.96 17.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.623 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.9 Cg_endo -70.22 149.1 63.45 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.771 2.314 . . . . 0.0 112.134 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.36 -72.87 0.67 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.539 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.2 tp -111.42 112.4 24.12 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.377 179.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 75.6 mt -100.59 126.03 54.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.516 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.9 mt -109.38 133.0 53.6 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.287 -179.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.47 139.61 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.573 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 121' ' ' THR . 87.5 p -83.44 168.38 16.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.705 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.41 80.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.483 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.431 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.8 t -139.33 158.87 43.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.96 0.409 . . . . 0.0 110.446 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.16 177.04 33.41 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.91 87.39 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.97 151.62 45.25 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.906 0.384 . . . . 0.0 110.546 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.1 t -63.18 141.27 58.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.398 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.51 10.93 10.54 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.659 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.14 -38.83 87.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.099 -179.404 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.64 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.86 -35.79 23.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.377 0.608 . . . . 0.0 110.579 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.7 mt -71.06 -35.17 71.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.396 0.617 . . . . 0.0 110.691 179.333 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -42.94 -62.82 0.92 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.229 -178.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.64 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.87 -42.63 90.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.997 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.18 -32.28 72.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.266 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.4 mt -74.41 -40.54 61.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 178.686 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.93 -48.86 78.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.219 -179.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.5 m -52.66 -42.68 64.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.215 179.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.06 -43.05 92.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.173 179.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.36 153.21 5.22 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.622 -179.128 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -39.03 107.33 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.664 2.243 . . . . 0.0 112.435 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 93.8 m -108.72 121.01 44.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.287 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.03 152.52 30.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.343 -179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 tt -129.0 131.51 68.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.42 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.11 127.68 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.55 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.8 t30 -101.83 103.86 14.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.359 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 147' ' ' LYS . 49.1 p90 -101.29 -11.31 19.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.801 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.7 p-10 -64.77 -33.52 76.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.728 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.577 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.8 p-10 -98.33 7.68 45.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.568 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.34 155.44 50.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.508 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.3 p -74.66 165.69 24.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.615 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.571 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 90.9 t90 -60.04 -48.7 80.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.38 -179.189 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.87 -41.87 67.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.005 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.9 t -62.6 -40.77 97.98 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.484 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 48.4 tp -60.62 -43.94 96.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.417 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.1 tp -61.47 -42.96 99.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.21 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.5 m -55.75 -45.31 78.09 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.4 -40.69 97.32 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.881 0.372 . . . . 0.0 110.408 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.96 -42.38 99.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.158 179.233 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.65 -40.72 96.04 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.87 -46.04 63.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.853 0.359 . . . . 0.0 110.829 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.62 -44.03 96.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.795 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.5 p -93.01 -8.79 41.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.676 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.76 25.19 71.67 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -101.87 52.01 0.82 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.658 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.92 -39.03 76.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.685 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.28 -47.08 86.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.252 -179.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -61.4 -38.93 88.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.291 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.43 97.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.41 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.48 -27.54 69.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.507 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.92 -53.78 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.134 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.66 -43.49 96.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.441 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.0 mt -63.06 -43.85 99.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.7 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.3 -61.65 2.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.064 0.459 . . . . 0.0 110.392 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -54.61 -35.08 63.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.44 -179.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -79.75 -34.46 39.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.909 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 170' ' ' ILE . 50.2 m-20 -56.83 -40.14 75.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.805 -178.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.89 -42.45 99.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.937 0.399 . . . . 0.0 110.709 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.68 -37.96 87.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.292 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.33 -42.49 99.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.704 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.95 -53.29 57.76 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.081 0.467 . . . . 0.0 110.694 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.27 -41.66 89.56 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.633 179.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.76 94.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.68 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.22 -32.21 73.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.379 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -94.49 -21.67 18.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.615 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.631 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.94 -41.63 95.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.631 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.4 pt -77.52 136.09 25.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.745 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.24 108.95 11.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.338 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.74 126.38 0.31 Allowed Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.519 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.462 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.9 Cg_exo -43.88 152.13 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.76 2.307 . . . . 0.0 112.519 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.18 141.72 53.26 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.627 2.218 . . . . 0.0 112.354 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.37 147.22 2.11 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.497 179.402 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.21 154.46 69.88 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.764 2.31 . . . . 0.0 112.254 178.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.527 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.5 163.07 28.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.437 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.65 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.1 t -143.76 170.1 16.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.899 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.65 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -148.0 137.48 22.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.948 0.404 . . . . 0.0 110.315 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.2 146.08 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.607 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.71 131.61 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.109 0.48 . . . . 0.0 110.497 178.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -151.94 154.8 36.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.406 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 90.0 m -122.05 122.82 40.17 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.945 0.402 . . . . 0.0 110.393 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.33 -25.64 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.618 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.39 -48.86 21.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.04 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.03 -11.73 60.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.414 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.4 m80 49.19 42.19 21.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.478 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.1 t -136.5 145.58 45.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.373 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.15 114.24 27.34 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.348 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.89 133.33 55.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.036 0.446 . . . . 0.0 110.376 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.3 tt -112.03 146.38 38.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.713 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.455 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 12.2 t90 -99.37 130.01 45.61 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.121 0.486 . . . . 0.0 110.096 179.246 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.707 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.89 153.95 39.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.097 -179.854 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.71 -18.22 47.84 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.796 2.33 . . . . 0.0 111.93 178.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.707 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -49.11 -18.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.405 -179.275 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.455 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.5 p -75.97 164.98 25.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.497 179.648 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.96 -27.99 65.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.51 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.528 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.69 -41.56 98.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.763 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.91 -44.86 96.73 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.8 mt-30 -64.57 -38.81 92.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.957 0.408 . . . . 0.0 110.709 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.571 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.3 mmm -62.03 -41.44 98.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.229 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.4 mt -63.79 -47.25 81.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.912 0.387 . . . . 0.0 110.607 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.16 -32.07 54.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.154 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -70.79 -18.29 62.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.58 179.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 91.8 mt -88.7 -8.61 54.25 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.641 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.67 2.75 55.32 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -88.48 151.91 22.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.509 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 7.8 p -114.95 127.83 55.92 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.052 0.453 . . . . 0.0 110.427 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.56 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.35 146.13 23.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.962 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.456 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.56 151.07 46.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.524 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.65 131.65 43.34 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.487 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.633 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.62 93.73 29.37 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.139 -179.789 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.723 ' C ' ' H ' ' A' ' 229' ' ' GLY . 47.3 Cg_exo -55.63 138.72 81.74 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.673 2.249 . . . . 0.0 111.59 179.153 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.75 -25.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.444 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.723 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.47 -49.77 29.65 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.578 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -53.46 -36.43 61.61 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -67.16 36.57 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.725 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.578 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.63 86.67 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.831 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.3 p -78.83 -15.72 58.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.53 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.22 -40.77 10.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.626 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.9 t -66.2 -17.73 64.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.573 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.41 43.25 26.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.418 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.85 -146.6 6.98 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -123.39 143.21 50.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.96 0.409 . . . . 0.0 110.335 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.07 149.61 29.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.422 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -100.5 -152.17 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.391 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 55.9 -91.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.567 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.517 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.65 175.46 8.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.564 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.517 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.9 mt -122.16 141.76 41.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.734 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -100.0 169.12 9.41 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.328 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.5 mt -147.83 151.18 35.52 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.133 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.78 -39.01 97.01 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.19 4.1 4.63 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.23 -58.38 3.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.939 0.399 . . . . 0.0 110.573 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -61.98 -36.97 83.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.313 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.19 -67.73 0.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.813 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.46 -42.09 66.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.153 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.12 18.06 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.637 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.92 48.34 0.27 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.57 -110.0 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.667 0.27 . . . . 0.0 110.717 -178.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.456 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 12.3 m120 -60.62 -45.35 94.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.471 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.88 8.15 82.93 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.23 -12.61 20.24 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.799 -0.236 . . . . 0.0 110.631 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.6 t 176.2 142.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.063 0.459 . . . . 0.0 110.553 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -147.85 125.31 11.67 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.047 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -98.43 142.98 29.38 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 120.88 0.371 . . . . 0.0 110.781 178.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.3 mt -94.17 106.43 18.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.652 -179.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.468 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.2 t80 -101.96 -11.41 18.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.182 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.42 -40.33 85.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.788 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.39 173.75 46.11 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.499 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.5 m-20 -74.44 -113.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.756 0.312 . . . . 0.0 110.71 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.62 -28.57 67.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.685 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.01 -44.21 91.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.313 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.68 -44.4 93.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.354 179.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.38 -60.16 3.56 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.295 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.02 -43.34 60.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.227 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.39 -43.92 75.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.258 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.0 mt -64.55 -43.71 96.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.598 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -56.27 -37.72 70.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.268 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.94 1.22 18.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.316 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -115.04 91.14 25.77 Favored Pre-proline 0 CA--C 1.528 0.122 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.207 -179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.98 -27.18 27.45 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.818 2.345 . . . . 0.0 111.879 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.516 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.45 -41.08 98.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.565 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.31 5.03 52.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.459 -179.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.95 -35.01 69.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.735 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.87 4.74 15.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.541 -178.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.567 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.88 121.39 81.27 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.561 179.918 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -47.53 -37.8 26.9 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.539 2.159 . . . . 0.0 112.427 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.567 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.72 -43.72 90.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.38 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.89 -43.69 92.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.335 179.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.67 -40.6 95.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.49 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.7 t-20 -89.84 -12.19 39.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.563 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.4 mtmt 61.85 31.85 18.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.959 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.47 44.15 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.34 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.18 135.82 41.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.465 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.5 132.34 56.7 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.521 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.2 87.97 6.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.728 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.473 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.0 mt -63.94 -41.35 97.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.885 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.468 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.21 167.89 34.44 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 75.5 p -75.89 -25.82 56.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.381 . . . . 0.0 110.797 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.533 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.6 tp10 -67.9 -34.18 76.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.489 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.499 ' O ' ' CG2' ' A' ' 296' ' ' THR . 97.0 m -73.24 19.9 0.09 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.69 -179.142 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.533 ' H ' ' C ' ' A' ' 295' ' ' GLU . 53.0 t80 -57.24 -51.14 70.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.018 -179.543 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -108.22 149.41 28.62 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 41.5 tp -115.26 125.26 53.1 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.672 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 304' ' ' ALA . 42.5 t0 -149.08 166.29 29.18 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.624 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -49.08 -38.19 23.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.632 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -71.96 -64.99 0.83 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.262 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -60.81 -32.52 71.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.864 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 300' ' ' ASP . . . -54.85 -25.6 29.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.617 -179.049 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.8 mtt -63.23 -41.23 99.09 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 120.9 0.381 . . . . 0.0 110.883 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.19 -44.4 25.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.994 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.14 -42.88 92.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.397 179.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.443 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.4 tp -59.89 -47.46 85.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.451 -178.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -69.85 -39.72 76.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.047 0.451 . . . . 0.0 110.888 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.499 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 72.2 ttt180 -61.52 -38.19 86.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.29 -179.048 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.2 mt -87.48 5.04 41.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.658 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.631 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.66 -11.78 13.49 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.049 0.452 . . . . 0.0 110.259 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.84 -37.16 85.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.56 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.82 -48.88 79.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.427 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.022 179.786 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.618 ' H ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.45 -2.83 57.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.481 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.46 179.12 1.24 Allowed Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.477 -179.722 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.4 Cg_exo -60.52 144.42 99.52 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.79 2.326 . . . . 0.0 112.235 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.618 ' NH1' ' H ' ' A' ' 24' ' ' ALA . 35.5 ptt-85 -155.75 -179.9 8.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.55 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.58 136.77 52.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.042 0.448 . . . . 0.0 110.312 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.1 tp -124.41 146.2 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.39 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -119.54 135.97 54.55 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.805 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.9 p30 -98.71 -144.11 0.32 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.17 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.65 -36.49 84.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.405 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -147.58 -70.27 0.23 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.43 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.81 144.12 41.77 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.263 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.8 p -112.8 129.84 56.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.914 0.387 . . . . 0.0 110.451 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -114.68 129.66 56.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.683 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.9 m -86.95 130.68 34.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.35 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 70.4 mt -97.61 78.87 2.67 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.434 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.8 -32.58 74.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.544 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 t 177.15 109.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.118 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -124.52 91.5 49.4 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.39 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.62 149.27 59.46 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.865 2.377 . . . . 0.0 111.962 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -40.22 82.36 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.624 0.578 . . . . 0.0 110.998 -179.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.69 66.66 0.87 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.477 . . . . 0.0 110.18 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -77.28 131.23 35.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.4 t -122.65 147.86 26.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.104 0.478 . . . . 0.0 110.073 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.9 t -136.17 143.61 44.54 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.725 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.667 ' HG1' ' N ' ' A' ' 50' ' ' SER . 27.2 p -99.26 -59.96 1.62 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.618 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.667 ' N ' ' HG1' ' A' ' 49' ' ' THR . 87.1 p -79.07 156.14 28.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.64 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 68.9 t -74.59 -21.55 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.572 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.4 ' O ' ' OG ' ' A' ' 56' ' ' SER . 100.0 m -60.15 -51.99 67.24 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.513 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.0 mt -66.28 -42.44 88.41 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.817 177.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.23 -54.36 4.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.998 -178.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.11 -38.77 73.29 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.304 -0.719 . . . . 0.0 111.304 178.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.6 m -62.29 -43.67 98.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.934 0.397 . . . . 0.0 110.199 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.7 mt -65.46 -42.41 92.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.502 0.668 . . . . 0.0 110.684 179.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.6 tp -63.08 -38.74 92.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.263 -179.348 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.59 -36.65 81.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.224 -178.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -91.22 27.6 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.148 -179.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.419 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 90.6 m-20 57.11 52.46 9.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.123 179.41 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.79 76.48 28.94 Favored Pre-proline 0 C--O 1.225 -0.223 0 CA-C-O 121.039 0.447 . . . . 0.0 109.891 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.67 148.2 92.32 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.733 2.289 . . . . 0.0 112.08 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -112.67 136.27 49.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.126 0.489 . . . . 0.0 110.395 179.724 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -70.11 -43.05 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.189 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.76 131.04 53.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.979 0.419 . . . . 0.0 110.637 -178.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.542 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.3 p -155.58 168.42 27.19 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.424 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.61 -177.26 21.81 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.57 172.43 12.75 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 121.081 0.467 . . . . 0.0 110.422 179.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.2 p -132.95 -112.09 0.23 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.452 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.63 179.7 0.93 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.497 -179.245 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.5 Cg_exo -60.83 57.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.966 2.444 . . . . 0.0 112.157 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.4 t-20 -64.42 -33.51 76.03 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.417 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.2 m-20 93.91 -36.17 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.779 0.675 . . . . 0.0 109.899 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -63.21 -39.72 95.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.203 179.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.33 -25.3 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.688 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.24 -170.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.468 -179.354 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.83 -154.91 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.878 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 38.3 p-10 -51.44 -7.92 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.823 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.531 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -85.68 114.99 23.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.693 179.59 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.38 70.87 1.32 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -144.87 148.07 33.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.924 0.392 . . . . 0.0 110.752 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.51 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.9 mp -85.92 -98.46 0.07 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.178 178.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.0 -42.53 97.13 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.176 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.4 tt0 91.47 53.03 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.868 0.73 . . . . 0.0 110.877 179.037 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -102.69 -9.55 19.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.331 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.5 p -63.88 -34.42 77.92 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.05 0.452 . . . . 0.0 110.703 -179.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.557 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.13 -23.86 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.59 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.0 t -70.11 -45.21 76.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.592 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.42 -48.53 80.79 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.923 -179.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.04 -38.38 88.49 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.436 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.31 -34.36 57.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.251 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.594 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.6 mmt-85 -88.43 1.08 55.48 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.608 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.5 mttp 83.17 -47.94 0.14 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.845 0.715 . . . . 0.0 110.315 179.163 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.668 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.4 mt -46.68 153.3 0.4 Allowed 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 117.817 -1.087 . . . . 0.0 109.606 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.668 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.6 tt0 122.03 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 O-C-N 125.318 1.636 . . . . 0.0 110.452 -178.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.84 142.85 44.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.204 0.526 . . . . 0.0 110.337 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.2 mt -131.95 26.61 4.6 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.096 -0.377 . . . . 0.0 110.49 -179.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.09 137.46 34.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.576 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.521 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.0 mt -136.99 164.86 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.411 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.521 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.48 -28.83 1.78 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.35 70.5 7.54 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 121.134 0.492 . . . . 0.0 110.219 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.15 145.32 98.74 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.783 2.322 . . . . 0.0 112.098 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.9 t -134.45 137.12 43.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.584 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.56 83.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.655 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.32 -42.0 96.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.485 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.08 -41.79 98.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.466 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.7 -43.21 97.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.063 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.23 -35.27 78.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.218 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.26 -18.3 57.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.433 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -87.09 -6.06 58.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.483 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 70.3 mtp 47.71 55.99 17.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.621 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.0 Cg_endo -70.08 149.26 64.57 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.784 2.323 . . . . 0.0 112.067 179.556 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.24 -72.39 0.68 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.579 179.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.2 tp -111.91 113.22 25.4 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.399 179.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.8 mt -102.0 126.9 55.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.0 0.429 . . . . 0.0 110.587 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.3 mt -110.74 133.72 53.1 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.212 -179.297 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.4 139.92 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.559 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 121' ' ' THR . 95.7 p -83.6 167.41 17.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.683 179.695 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.59 -36.85 79.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.455 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.422 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.4 t -138.2 157.78 45.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.456 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.55 175.4 34.17 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.55 -33.61 87.03 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.38 151.42 44.42 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.97 0.414 . . . . 0.0 110.513 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.5 t -63.53 140.53 58.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.389 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.05 10.93 10.86 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.648 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -60.96 -38.92 87.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.219 -179.428 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.634 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.14 -35.58 23.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.445 0.641 . . . . 0.0 110.577 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.3 mt -71.16 -35.16 71.56 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.457 0.646 . . . . 0.0 110.654 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -43.02 -62.82 0.93 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.215 -178.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.634 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.5 p-10 -65.98 -42.93 89.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.021 -179.162 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.3 mt-30 -61.73 -32.38 72.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.343 -179.524 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.7 mt -74.38 -40.49 62.05 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.922 178.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.09 -49.09 78.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.277 -179.104 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 m -52.92 -42.56 65.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.211 179.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.83 -42.72 92.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.152 179.26 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.54 153.16 5.05 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.628 -179.335 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -39.04 106.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.679 2.253 . . . . 0.0 112.393 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 98.1 m -109.36 121.89 46.16 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.416 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.86 154.07 29.3 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.264 -179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 tt -130.38 129.23 64.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.409 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 92.9 mt -110.6 122.71 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.024 0.44 . . . . 0.0 110.614 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.544 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 54.2 t30 -101.17 106.91 18.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.256 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -100.76 0.25 38.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.847 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.4 p-10 -65.61 -34.77 78.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.959 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -101.88 10.22 39.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.728 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -133.99 148.31 51.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.909 0.385 . . . . 0.0 110.49 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.409 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 22.9 p -77.61 168.82 19.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.623 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.6 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.1 t90 -58.7 -49.87 75.99 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.064 -179.009 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -54.46 -46.17 73.26 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.944 0.402 . . . . 0.0 110.048 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 40.1 t -63.07 -40.77 98.67 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.14 0.495 . . . . 0.0 110.314 178.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.0 tp -60.72 -44.54 96.48 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.309 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.89 -43.5 98.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.113 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.9 m -54.51 -45.85 73.39 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.86 -40.1 94.2 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.853 0.358 . . . . 0.0 110.364 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -61.59 -42.2 98.52 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.115 179.234 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.84 -38.8 94.68 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.148 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.52 -45.08 66.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.962 0.41 . . . . 0.0 110.712 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.69 -44.11 96.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.789 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.8 p -93.41 -8.69 41.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.533 -178.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.5 27.08 72.17 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -102.54 50.27 0.83 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.66 -179.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -69.31 -39.03 78.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.622 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.56 -47.26 86.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.31 -179.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.419 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 86.4 mt-30 -60.5 -39.33 87.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.213 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.51 -41.02 98.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.278 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.31 -29.28 70.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.607 179.334 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.18 -54.46 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.855 179.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -64.22 -42.89 96.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.431 -179.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 174' ' ' ASP . 82.0 mt -62.59 -43.77 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.483 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.6 -61.11 2.76 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.2 0.524 . . . . 0.0 110.201 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.77 -34.51 62.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.521 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -80.33 -34.84 36.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.761 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -55.26 -41.71 72.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.059 -178.686 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.2 -41.8 98.7 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.662 179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.14 -37.87 88.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.313 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.33 -42.39 99.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.756 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.8 -52.95 62.08 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.112 0.482 . . . . 0.0 110.59 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.34 -41.43 89.57 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.601 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.28 -39.78 94.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.615 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.64 -33.08 74.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.369 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.54 -21.49 19.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.612 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.628 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -65.18 -41.43 94.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.694 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 30.9 pt -76.98 133.83 30.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.802 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -127.55 107.05 9.6 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.298 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.93 127.39 0.31 Allowed Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.483 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.78 151.99 0.38 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.865 2.377 . . . . 0.0 112.53 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.52 142.39 53.67 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.599 2.199 . . . . 0.0 112.368 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.545 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.78 146.86 2.3 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.548 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.0 153.9 71.65 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.855 2.37 . . . . 0.0 112.37 178.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.527 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.37 163.11 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 110.475 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.622 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.0 t -143.93 170.72 15.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.032 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.622 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.74 137.8 21.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.074 0.464 . . . . 0.0 110.098 179.388 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.9 pt -134.39 146.64 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.691 179.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.44 131.68 60.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.1 0.476 . . . . 0.0 110.472 178.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -152.09 154.84 36.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.431 179.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 89.5 m -122.02 122.71 39.93 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.921 0.391 . . . . 0.0 110.341 179.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.89 -25.34 66.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.662 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.12 -49.34 19.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.899 179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.16 -11.49 60.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.345 -179.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.2 m80 49.21 42.57 21.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.483 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.0 t -136.42 144.56 44.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.33 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.79 114.54 27.96 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.293 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -120.41 133.95 55.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.048 0.451 . . . . 0.0 110.405 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.3 tt -112.4 146.75 37.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.778 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.45 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 9.4 t90 -100.51 129.28 46.44 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.177 0.513 . . . . 0.0 109.962 179.335 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.703 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -93.27 153.75 41.53 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.164 179.976 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.406 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.8 Cg_endo -67.77 -18.05 47.44 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.685 2.256 . . . . 0.0 112.057 178.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.703 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -48.74 -18.92 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.468 -179.214 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.45 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 84.8 p -74.84 163.89 27.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.551 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.5 -28.24 65.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.478 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.507 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.2 mt-30 -63.55 -42.86 98.35 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.577 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.0 -43.74 97.89 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.409 ' OE1' ' C ' ' A' ' 148' ' ' SER . 74.8 mt-30 -63.68 -38.52 91.42 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 122.271 -0.546 . . . . 0.0 110.629 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.6 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 85.6 mmm -61.99 -41.66 98.28 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.26 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 82.2 mt -63.83 -49.73 71.67 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.136 0.493 . . . . 0.0 110.257 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -51.96 -33.91 39.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.845 0.355 . . . . 0.0 110.241 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -70.88 -20.74 62.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.519 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 75.1 mt -87.61 -6.32 58.34 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 -179.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.87 -7.04 57.19 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -77.06 147.6 36.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.854 0.359 . . . . 0.0 110.614 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.4 p -112.58 126.67 55.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.133 0.492 . . . . 0.0 110.284 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.41 145.49 24.43 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.995 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.468 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.23 150.59 47.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.448 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -129.98 130.81 45.51 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.379 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.633 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.96 92.79 27.08 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.192 -179.716 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.722 ' C ' ' H ' ' A' ' 229' ' ' GLY . 43.3 Cg_exo -55.61 139.11 82.55 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.581 2.188 . . . . 0.0 111.676 178.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.55 -25.42 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.485 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.722 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.14 -50.2 29.42 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.575 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -53.58 -35.89 61.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.892 0.377 . . . . 0.0 110.132 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -67.57 36.65 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.715 179.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.575 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.16 86.33 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.813 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.1 p -79.02 -16.07 57.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.4 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -91.66 -40.67 11.16 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.622 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -66.22 -17.35 64.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.594 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.56 43.22 26.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.462 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.78 -146.17 6.87 Favored Glycine 0 CA--C 1.519 0.292 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -123.39 143.37 50.17 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.961 0.41 . . . . 0.0 110.262 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -151.86 149.32 28.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -100.25 -152.35 0.42 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.43 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.86 -91.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.693 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.511 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.4 tt -126.31 175.1 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.617 -179.427 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.511 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.4 mt -121.7 141.22 43.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.698 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.58 169.35 9.35 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.256 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.7 mt -147.73 151.02 35.38 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.204 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.91 -38.76 96.56 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.96 4.14 4.73 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -77.3 -58.34 3.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.98 0.419 . . . . 0.0 110.522 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -62.04 -36.81 82.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.314 -179.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.42 -67.63 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.746 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.43 -42.2 66.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.149 -179.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.13 17.99 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.641 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.82 48.58 0.27 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.48 -109.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.516 0.198 . . . . 0.0 110.787 -178.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.468 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.3 m120 -60.58 -45.52 93.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.528 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 85.18 7.9 82.51 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -99.04 -12.66 20.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.598 0.237 . . . . 0.0 110.658 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.4 t 176.23 142.88 0.07 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.067 0.46 . . . . 0.0 110.44 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 tt -148.36 125.35 11.33 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -98.29 143.14 29.09 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 120.873 0.368 . . . . 0.0 110.861 178.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.9 mt -94.35 106.75 18.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.762 -179.174 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.454 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.9 t80 -102.1 -12.63 17.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.173 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.36 89.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.88 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.74 173.19 45.86 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.493 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -74.06 -112.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 0.0 110.74 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.81 -28.97 68.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.693 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.81 -43.95 90.69 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.261 -178.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.44 -44.52 94.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.304 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.36 -60.05 3.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.198 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.96 -43.47 60.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.211 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.26 -43.58 74.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.247 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.3 mt -64.57 -43.53 96.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.548 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.45 -37.65 70.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.2 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.14 1.02 19.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.218 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -115.03 91.41 26.83 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.078 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.05 -27.27 28.27 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.769 2.312 . . . . 0.0 111.984 179.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.515 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.51 -41.09 98.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.584 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.428 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.9 mp -95.52 5.02 52.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.4 -179.269 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.9 -34.89 69.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.647 179.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -80.12 4.85 16.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.494 -178.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.555 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -69.04 121.23 80.98 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.511 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -47.38 -37.58 25.39 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.513 2.142 . . . . 0.0 112.562 -179.53 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.555 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.6 -43.38 89.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.759 0.314 . . . . 0.0 110.372 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.09 -43.51 92.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.309 179.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -65.06 -40.72 95.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.349 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 44.4 t-20 -89.31 -12.99 39.0 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.59 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 62.19 31.64 17.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.912 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.53 44.29 1.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.157 0.503 . . . . 0.0 110.366 179.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.79 135.69 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.446 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.93 132.25 56.75 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.457 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.493 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.3 88.71 6.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.756 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.466 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.7 mt -63.87 -41.39 97.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 179.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.454 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.52 165.66 33.26 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.524 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 77.5 p -75.56 -25.83 57.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.885 0.374 . . . . 0.0 110.791 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.0 tp10 -68.43 -33.71 74.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.483 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.497 ' O ' ' CG2' ' A' ' 296' ' ' THR . 97.2 m -73.06 21.54 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.696 -179.174 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.543 ' H ' ' C ' ' A' ' 295' ' ' GLU . 51.7 t80 -57.41 -51.02 71.1 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 70.4 mmt-85 -109.35 151.15 27.0 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 39.0 tp -115.57 125.13 52.59 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.934 0.397 . . . . 0.0 110.69 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 304' ' ' ALA . 40.6 t0 -147.94 165.75 29.75 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.631 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -49.35 -37.95 26.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.499 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -70.8 -65.67 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.235 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -61.11 -33.04 72.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 300' ' ' ASP . . . -53.44 -25.6 16.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.575 -179.08 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.1 mtt -63.7 -40.85 97.82 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 120.874 0.368 . . . . 0.0 111.035 179.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -78.08 -44.69 25.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.115 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 75.1 t -66.11 -42.76 91.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.383 179.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.431 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 48.6 tp -59.62 -47.31 86.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.465 -178.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -70.32 -39.26 74.89 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.016 0.436 . . . . 0.0 110.729 179.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.493 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 72.5 ttt180 -61.66 -38.05 86.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.251 -178.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.0 mt -87.74 5.16 41.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.624 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.628 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.88 -11.59 13.42 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.016 0.436 . . . . 0.0 110.333 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.08 -37.07 85.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.486 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.78 -48.89 79.77 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.396 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 C--O 1.222 -0.365 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.002 179.836 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.612 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.05 -2.32 58.1 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.371 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.489 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.8 179.15 1.23 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.502 -179.682 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.79 144.98 99.65 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.851 2.367 . . . . 0.0 112.197 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.612 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.99 -179.32 8.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.562 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -115.94 136.77 52.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.327 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.23 146.99 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.369 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.5 p -120.02 135.97 54.73 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.734 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.39 -143.34 0.32 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.259 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.65 -37.04 85.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.536 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.42 -66.48 0.22 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.393 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.52 142.33 45.47 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.331 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.5 p -112.2 131.54 55.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.917 0.389 . . . . 0.0 110.459 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -119.38 128.98 54.57 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.546 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.8 m -85.57 130.15 34.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.191 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.3 mt -95.62 78.69 3.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.496 179.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.73 -31.74 72.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.596 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 175.97 109.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.983 0.42 . . . . 0.0 110.109 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -122.58 91.41 49.46 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-O 120.752 0.311 . . . . 0.0 110.381 -179.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.647 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.59 148.42 64.2 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.797 2.331 . . . . 0.0 112.067 178.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -40.64 82.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.634 0.584 . . . . 0.0 110.963 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.647 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.51 66.92 0.89 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.222 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.21 130.56 36.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.819 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.7 t -122.49 146.69 27.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.016 -179.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 t -135.97 143.7 44.98 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.742 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.598 ' HG1' ' H ' ' A' ' 50' ' ' SER . 26.5 p -99.35 -59.28 1.75 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.564 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.598 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.3 p -79.35 155.09 28.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.583 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.4 t -74.1 -21.84 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.548 179.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.408 ' O ' ' OG ' ' A' ' 56' ' ' SER . 98.3 m -60.28 -52.09 66.76 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.499 -178.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.4 mt -66.26 -42.76 88.06 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.8 177.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.1 m -42.87 -54.18 4.3 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.968 -178.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.23 -37.17 71.48 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 178.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.6 m -62.84 -44.79 95.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.915 0.388 . . . . 0.0 110.16 -179.237 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt -66.48 -41.91 88.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.521 0.677 . . . . 0.0 110.701 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 tp -62.75 -40.46 97.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.401 -179.264 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.93 76.08 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.158 -179.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -91.15 28.92 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.176 -179.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.54 51.74 10.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.971 179.409 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.56 76.05 21.3 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.07 151.66 84.96 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.74 2.293 . . . . 0.0 112.032 -178.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -113.44 137.48 46.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.242 0.544 . . . . 0.0 110.237 179.706 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.3 pt -69.47 -43.54 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.307 179.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.13 131.35 53.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.947 0.403 . . . . 0.0 110.526 -178.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.536 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.7 p -155.86 168.65 26.53 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.462 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.42 -177.32 21.93 Favored Glycine 0 N--CA 1.464 0.513 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.17 171.99 13.27 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.088 0.47 . . . . 0.0 110.36 179.383 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.7 p -131.94 -113.48 0.23 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.981 0.419 . . . . 0.0 110.269 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.99 179.82 0.93 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.407 -179.148 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.5 Cg_exo -60.7 57.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 123.031 2.488 . . . . 0.0 112.18 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.8 t-20 -64.42 -33.64 76.33 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 119.081 -0.485 . . . . 0.0 110.345 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.6 m-20 94.03 -36.74 0.02 OUTLIER 'General case' 0 C--N 1.346 0.448 0 O-C-N 123.832 0.707 . . . . 0.0 109.806 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -62.51 -39.7 94.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.191 179.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.499 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.25 -25.48 19.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.762 179.374 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.52 -171.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.456 -179.201 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.05 -154.08 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.815 -179.599 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 38.2 p-10 -52.49 -7.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.769 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.1 mm-40 -86.32 115.0 23.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.674 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.02 69.92 1.35 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.416 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.3 m-85 -143.45 147.72 35.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.971 0.415 . . . . 0.0 110.768 179.141 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.526 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -85.66 -98.29 0.07 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.185 178.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.25 -42.42 96.52 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.036 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.547 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.17 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.988 0.805 . . . . 0.0 110.996 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -102.86 -8.79 20.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.322 179.306 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.416 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.6 p -64.87 -33.82 76.92 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.132 0.492 . . . . 0.0 110.763 -179.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.537 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.36 -23.4 1.45 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.682 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 73.4 t -70.02 -45.86 74.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.688 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.64 80.4 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.891 -179.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.36 -38.29 88.96 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.927 0.394 . . . . 0.0 110.509 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.64 -32.34 51.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.185 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.576 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.7 mmt-85 -90.3 1.95 56.0 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.622 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.55 -49.58 0.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.942 0.776 . . . . 0.0 110.223 179.181 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.646 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.0 mt -45.81 154.65 0.21 Allowed 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 117.451 -1.262 . . . . 0.0 109.441 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.646 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 120.8 92.6 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 O-C-N 125.676 1.86 . . . . 0.0 110.471 -178.532 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.536 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.57 143.25 42.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.238 0.542 . . . . 0.0 110.294 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.7 mt -132.42 27.1 4.44 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.976 -0.453 . . . . 0.0 110.391 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.25 137.77 34.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.065 0.46 . . . . 0.0 110.516 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.522 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 93.1 mt -137.01 165.01 28.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.331 179.581 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.2 -28.57 1.82 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -152.98 71.08 7.13 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 121.203 0.525 . . . . 0.0 110.262 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.17 145.54 98.27 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.803 2.335 . . . . 0.0 112.027 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.9 t -134.56 136.85 43.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.597 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.22 81.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.651 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.14 -42.38 96.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.518 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.99 -41.65 98.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.5 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.71 -43.23 97.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.05 179.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.17 -35.09 77.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.994 0.426 . . . . 0.0 110.146 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.7 -18.8 61.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.451 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.63 -6.48 58.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.529 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 63.1 mtp 47.22 56.22 17.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.613 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.34 149.9 63.9 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.763 2.309 . . . . 0.0 112.106 179.413 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.14 -74.25 0.62 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.454 179.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.4 tp -110.2 113.33 25.93 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.372 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.4 mt -102.04 126.26 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 120.955 0.407 . . . . 0.0 110.661 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.1 mt -109.58 133.95 52.5 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.22 -179.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.85 139.63 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.496 -179.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 121' ' ' THR . 88.4 p -83.38 168.5 16.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.799 179.623 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.13 -37.52 80.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.443 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.428 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -139.79 159.16 42.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.012 0.434 . . . . 0.0 110.381 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.22 176.96 33.49 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.71 86.99 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -124.82 151.51 45.12 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.925 0.393 . . . . 0.0 110.508 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.3 t -63.26 140.81 58.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.333 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.62 10.37 11.04 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.676 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -60.83 -38.87 86.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.258 -179.367 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.67 23.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.562 0.696 . . . . 0.0 110.613 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.9 mt -71.11 -35.44 71.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.587 0.708 . . . . 0.0 110.631 179.359 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -42.81 -62.84 0.9 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.353 -178.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.85 -42.84 89.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.7 mt-30 -61.99 -32.54 73.01 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.493 0.495 . . . . 0.0 110.427 -179.594 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.7 mt -73.91 -40.95 62.79 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.803 178.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.13 -48.86 78.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.153 -178.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.5 m -53.31 -42.38 66.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.036 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.12 -42.61 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.943 0.401 . . . . 0.0 111.199 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.64 154.24 5.39 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.665 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -39.48 106.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.622 2.215 . . . . 0.0 112.589 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 95.4 m -110.08 121.4 45.18 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.115 0.483 . . . . 0.0 110.264 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -113.99 152.84 30.32 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.2 -179.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 tt -128.91 131.55 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.353 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.8 mt -115.31 128.02 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.488 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.6 t30 -101.6 103.92 14.77 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.206 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.2 p90 -101.38 -11.18 19.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.823 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.5 p-10 -64.83 -33.5 76.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.704 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -98.45 7.59 45.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.531 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.31 155.45 50.58 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.467 -179.418 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.6 p -75.05 165.68 24.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.695 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.589 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.85 -48.85 80.01 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.166 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -53.5 -42.05 66.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.929 0.395 . . . . 0.0 110.132 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.1 t -62.73 -41.05 98.98 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.36 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.9 tp -60.5 -44.54 95.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.374 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.8 tp -61.34 -43.33 99.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.235 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.6 m -55.02 -44.94 75.03 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.34 -40.67 97.14 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 120.928 0.394 . . . . 0.0 110.488 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -62.02 -42.45 99.18 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.418 178.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.24 -40.86 94.94 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.68 -45.92 64.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.894 0.378 . . . . 0.0 110.781 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.78 -43.99 96.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.798 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 156' ' ' LEU . 32.7 p -93.13 -8.7 41.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.581 -178.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.88 26.64 72.28 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -101.75 50.85 0.84 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 110.65 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -69.55 -39.75 77.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.591 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.16 -47.26 85.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.3 -179.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -60.22 -39.3 86.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.136 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.07 -40.87 98.96 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 121.064 0.459 . . . . 0.0 110.279 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.02 -28.31 70.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.685 179.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.35 -54.35 7.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.894 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -65.51 -42.17 92.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.366 -179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.3 mt -62.4 -43.83 98.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.481 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.3 -58.32 8.15 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.026 0.441 . . . . 0.0 110.216 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.28 -33.1 67.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.689 -179.03 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -81.53 -36.71 28.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.676 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.1 m-20 -55.92 -41.99 75.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.933 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.49 -42.24 99.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.911 0.386 . . . . 0.0 110.774 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.28 -37.94 88.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.279 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.37 -42.19 99.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.791 179.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.15 -52.91 61.93 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.169 0.509 . . . . 0.0 110.628 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.1 -41.81 90.11 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.75 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.99 95.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.652 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.26 -32.07 73.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.429 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.62 -22.38 18.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.679 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.79 -41.38 95.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.67 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.0 pt -76.93 136.53 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.72 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.1 108.09 10.6 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.245 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.63 126.01 0.31 Allowed Pre-proline 0 C--O 1.241 0.611 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.562 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.451 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.94 152.46 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.823 2.349 . . . . 0.0 112.596 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.35 142.15 53.85 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.541 2.161 . . . . 0.0 112.428 179.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.38 147.32 2.13 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.573 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.19 154.82 69.38 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.81 2.34 . . . . 0.0 112.392 178.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.525 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.52 163.29 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.185 0.517 . . . . 0.0 110.484 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.662 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.1 t -143.62 170.34 16.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.955 179.457 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.662 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -148.2 137.44 22.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.946 0.403 . . . . 0.0 110.105 179.434 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 38.4 pt -134.14 146.51 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.726 179.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.71 131.77 59.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.257 0.551 . . . . 0.0 110.502 178.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.447 ' HH ' ' CG1' ' A' ' 272' ' ' ILE . 52.3 p90 -153.01 156.68 39.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.476 179.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 89.3 m -121.98 122.86 40.3 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.915 0.388 . . . . 0.0 110.358 179.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.517 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -61.06 -26.17 67.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.69 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -74.56 -49.25 22.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.872 179.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -77.42 -9.95 59.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.409 -179.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.9 m80 45.91 47.58 12.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.512 -179.635 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.2 t -130.76 143.0 50.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.968 0.413 . . . . 0.0 110.32 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -108.44 105.62 15.36 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.162 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.7 m-20 -116.39 129.2 56.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.159 0.504 . . . . 0.0 110.321 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.6 tt -111.92 146.46 37.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.806 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.451 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.5 t90 -99.61 128.73 45.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.207 0.527 . . . . 0.0 109.891 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.652 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -94.52 153.94 40.24 Favored Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.379 179.805 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.67 -17.74 47.95 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.682 2.254 . . . . 0.0 112.049 178.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.652 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.3 mt-10 -49.75 -18.89 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.342 -179.091 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.451 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.4 p -75.44 164.6 26.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.495 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.92 -27.88 65.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.496 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.574 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.7 mt-30 -63.73 -41.39 98.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.609 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.32 -44.45 97.52 Favored Glycine 0 C--N 1.332 0.337 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.49 -38.84 92.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 122.119 -0.636 . . . . 0.0 110.796 179.576 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.3 mmm -61.84 -41.27 97.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.279 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.3 mt -63.53 -47.63 80.84 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.055 0.455 . . . . 0.0 110.386 179.221 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.63 -32.07 49.87 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.872 0.368 . . . . 0.0 110.405 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.96 -17.91 62.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.473 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 90.7 mt -88.4 -9.14 53.62 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.575 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.1 2.37 54.65 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -88.72 153.0 21.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 110.453 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.2 p -115.86 128.44 55.81 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.149 0.499 . . . . 0.0 110.355 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.557 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.09 146.74 23.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.915 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.459 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.42 151.17 45.46 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.413 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.9 131.73 42.98 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.432 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.625 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.52 93.33 27.05 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.002 -179.453 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.721 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.2 Cg_exo -55.0 138.66 78.88 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.604 2.203 . . . . 0.0 111.71 178.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.38 -25.51 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.508 -179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.721 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.64 -49.93 27.79 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.598 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.1 mt -55.15 -37.05 66.47 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.034 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -65.66 35.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.816 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.598 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.45 88.34 0.01 OUTLIER 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 85.1 p -81.82 -13.65 57.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.297 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.73 -40.84 11.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.6 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 29.3 t -66.64 -17.03 64.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.591 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.8 43.86 27.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.444 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.93 -148.74 8.14 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.65 142.03 48.81 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.963 0.411 . . . . 0.0 110.288 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.03 149.51 28.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.241 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -102.38 -149.86 0.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.307 179.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.41 -92.91 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.636 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.484 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.4 tt -126.68 174.43 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.56 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.484 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 88.2 mt -122.31 141.27 43.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.839 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.48 170.6 8.5 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.19 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 67.1 mt -146.71 149.61 33.77 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.12 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.26 -39.35 97.76 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.01 3.22 4.05 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -78.64 -57.46 3.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.949 0.404 . . . . 0.0 110.482 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -62.14 -36.91 83.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.163 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.7 mp -52.88 -67.46 0.25 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.985 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.8 -42.49 68.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.094 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.67 17.45 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.666 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.15 48.33 0.29 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.1 mp 38.97 -109.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.505 0.193 . . . . 0.0 110.769 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.459 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -60.79 -44.71 96.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.349 -179.572 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.46 8.07 83.77 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -98.8 -13.64 20.05 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 122.685 -0.303 . . . . 0.0 110.661 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.423 ' HG ' ' N ' ' A' ' 259' ' ' LEU . 6.0 t 177.25 142.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.072 0.463 . . . . 0.0 110.445 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.423 ' N ' ' HG ' ' A' ' 258' ' ' SER . 9.2 tt -147.98 125.45 11.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.14 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -98.55 143.84 28.53 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 120.902 0.382 . . . . 0.0 110.922 178.133 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.8 mt -95.24 106.38 18.41 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.73 -179.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.45 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.5 t80 -102.31 -11.4 18.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.114 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.61 -40.64 84.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.815 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.27 172.68 45.54 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.453 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 90.8 m-20 -73.72 -113.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.846 0.355 . . . . 0.0 110.794 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.35 -28.99 68.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.7 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.04 -43.71 91.68 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.251 -178.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -63.43 -44.48 94.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.31 179.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.6 -59.88 3.93 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.136 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.94 -43.55 60.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.233 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.32 -43.34 74.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.23 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.447 ' CG1' ' HH ' ' A' ' 196' ' ' TYR . 91.2 mt -64.68 -43.61 96.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.634 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -55.97 -37.75 69.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.135 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.5 1.03 17.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.241 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -114.93 91.11 25.16 Favored Pre-proline 0 N--CA 1.464 0.256 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.161 -179.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.96 -27.3 27.81 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.764 2.309 . . . . 0.0 112.02 179.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.69 -40.93 98.01 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.545 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.25 5.39 51.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.327 -179.187 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.36 -35.04 68.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.527 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.72 4.49 16.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.472 -178.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.551 HD22 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.62 121.1 79.76 Favored Pre-proline 0 N--CA 1.442 -0.868 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.566 -179.983 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.27 -37.74 24.87 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.503 2.135 . . . . 0.0 112.643 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.551 ' H ' HD22 ' A' ' 281' ' ' LEU . . . -58.89 -43.84 91.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.803 0.335 . . . . 0.0 110.398 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.98 -43.48 92.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.356 179.345 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.07 -40.57 94.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.382 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.443 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.9 t-20 -89.73 -12.59 38.94 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.501 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.12 32.31 17.49 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.395 0.435 . . . . 0.0 110.992 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.04 43.69 1.16 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.126 0.489 . . . . 0.0 110.334 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.23 135.82 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.488 -179.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -116.87 132.44 56.7 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.469 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.19 88.93 7.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.709 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.458 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.8 mt -63.88 -41.05 97.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.869 179.478 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.45 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.75 165.55 33.58 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 72.1 p -75.38 -25.75 57.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 110.824 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.54 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.2 tp10 -68.26 -33.94 75.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.414 -179.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.503 ' O ' ' CG2' ' A' ' 296' ' ' THR . 96.7 m -73.37 24.33 0.07 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.698 -179.026 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.574 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 43.0 t80 -58.28 -50.93 71.84 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.22 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -110.4 152.9 25.71 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.085 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 44.1 tp -115.53 125.11 52.6 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 120.893 0.377 . . . . 0.0 110.723 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 40.9 t0 -148.04 165.76 29.81 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.652 179.517 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -49.32 -37.74 25.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.642 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -71.35 -65.6 0.73 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.487 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.88 -32.99 72.41 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.041 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.25 -25.49 23.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.703 -179.104 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.4 mtt -63.57 -40.8 97.91 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 120.892 0.377 . . . . 0.0 111.097 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.63 -44.27 24.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.188 179.524 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.23 -42.82 91.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.308 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 51.0 tp -60.19 -47.11 87.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.464 -178.512 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -69.96 -39.24 76.13 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.593 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.5 ttt180 -61.89 -38.18 87.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.235 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.6 mt -87.26 4.67 41.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.625 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.9 -10.95 13.49 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.046 0.451 . . . . 0.0 110.221 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.29 86.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.432 179.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.81 -48.82 80.06 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.41 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.029 179.915 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.3 -2.46 58.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.43 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.493 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.05 1.25 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.537 -179.682 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.493 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.8 Cg_exo -60.75 144.93 99.63 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.806 2.337 . . . . 0.0 112.203 179.718 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.95 -179.53 8.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.635 -179.74 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.81 136.84 52.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.389 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.44 147.07 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.418 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 79.2 p -120.03 136.07 54.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.733 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.47 -143.34 0.33 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.266 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -63.67 -37.19 86.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.472 179.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.25 -66.53 0.22 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.416 179.637 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.43 142.22 45.36 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.0 p -112.17 131.53 55.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.949 0.404 . . . . 0.0 110.485 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -119.23 129.05 54.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.588 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.9 m -85.46 130.19 34.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.307 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.5 mt -95.51 78.75 3.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.373 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.73 -31.9 73.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.579 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.65 109.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.984 0.421 . . . . 0.0 110.119 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -122.35 91.81 49.12 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.416 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.7 Cg_exo -56.68 148.35 65.63 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.826 2.35 . . . . 0.0 111.956 178.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.4 82.66 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.526 0.516 . . . . 0.0 110.961 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.6 mtm180 -151.41 66.87 0.89 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.062 0.458 . . . . 0.0 110.263 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.38 130.69 35.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.77 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.6 147.01 26.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.151 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.8 t -136.27 143.83 44.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.025 0.441 . . . . 0.0 110.639 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.626 ' HG1' ' N ' ' A' ' 50' ' ' SER . 26.1 p -99.53 -59.65 1.68 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.62 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.626 ' N ' ' HG1' ' A' ' 49' ' ' THR . 87.3 p -78.91 155.25 29.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.675 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.8 t -74.42 -21.8 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.546 179.446 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.412 ' O ' ' OG ' ' A' ' 56' ' ' SER . 97.8 m -60.11 -52.28 66.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.506 -178.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.4 -42.59 87.62 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.723 177.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.0 m -42.91 -54.17 4.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.035 -178.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.31 -37.18 70.78 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.5 m -62.85 -44.69 95.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.906 0.384 . . . . 0.0 110.336 -179.358 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.9 mt -66.35 -41.84 88.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.426 0.632 . . . . 0.0 110.781 179.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.59 -40.44 96.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.333 -179.319 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.17 -35.76 76.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.185 -178.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -91.27 28.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.237 -179.24 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.53 51.76 10.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.009 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.17 75.53 23.32 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.996 0.427 . . . . 0.0 109.995 -179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.36 150.98 87.27 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.794 2.329 . . . . 0.0 112.121 -178.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -113.17 137.27 46.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 CA-C-O 121.13 0.49 . . . . 0.0 110.356 179.814 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.0 pt -69.52 -43.49 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.219 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.06 131.25 53.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.522 -178.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.7 p -155.67 168.72 26.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.547 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.89 -177.21 21.62 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.33 172.55 12.54 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 121.043 0.449 . . . . 0.0 110.439 179.336 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.4 p -132.76 -112.43 0.23 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.991 0.424 . . . . 0.0 110.396 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.31 179.66 0.95 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.427 -179.185 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.3 Cg_exo -60.9 58.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.977 2.452 . . . . 0.0 112.07 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.572 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.0 t-20 -64.52 -33.84 76.83 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.438 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.3 m-20 93.92 -36.74 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.736 0.648 . . . . 0.0 109.926 -179.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -62.61 -39.58 94.24 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.256 179.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.499 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.9 p -74.55 -25.44 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.606 179.467 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.41 -171.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.449 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -74.03 -153.65 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.805 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.9 p-10 -52.82 -7.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.675 -179.405 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.525 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.5 114.8 23.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.623 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.03 70.0 1.35 Allowed Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.435 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.1 m-85 -143.31 147.36 34.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.917 0.389 . . . . 0.0 110.769 179.15 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.528 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -85.33 -98.44 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.12 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.563 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.11 -42.81 96.74 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.123 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.563 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.55 53.0 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.771 0.669 . . . . 0.0 110.856 178.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -102.92 -9.63 19.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.407 179.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.435 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.4 p -64.05 -34.11 77.28 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.047 0.451 . . . . 0.0 110.683 -179.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.541 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.96 -23.38 1.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.668 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.1 t -70.12 -45.72 75.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.713 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.58 80.65 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.048 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.37 -38.26 88.86 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.431 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.66 -32.65 52.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.166 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.606 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.8 mmt-85 -89.91 1.5 56.16 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.587 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.94 -49.19 0.16 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.761 0.663 . . . . 0.0 110.213 179.122 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.682 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.6 mt -46.05 154.08 0.27 Allowed 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.69 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.682 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.6 tt0 121.26 92.57 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 125.115 1.509 . . . . 0.0 110.445 -178.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.65 143.35 42.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.0 110.337 179.345 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.8 mt -132.41 27.25 4.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.879 0.371 . . . . 0.0 110.426 -179.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.31 137.86 34.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.525 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 91.7 mt -137.16 165.13 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.369 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.525 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.16 -28.76 1.82 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -153.0 70.93 7.11 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.124 0.488 . . . . 0.0 110.333 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.96 145.41 98.4 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.792 2.328 . . . . 0.0 112.058 -179.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.0 t -134.37 136.96 43.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.573 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.28 82.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.576 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.02 -42.34 97.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.569 -179.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.88 -41.65 98.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.55 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -63.7 -43.32 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.107 179.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.91 -35.18 77.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.274 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.78 -18.68 60.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.42 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.65 -6.78 58.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.538 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 68.6 mtp 47.48 56.25 17.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.648 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.28 149.44 63.57 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.759 2.306 . . . . 0.0 112.064 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.09 -73.5 0.64 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.529 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.6 tp -111.01 113.57 26.21 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.271 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.0 mt -102.16 126.63 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.6 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.7 mt -109.84 133.91 52.63 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.278 -179.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.99 139.98 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.522 -179.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 121' ' ' THR . 91.1 p -83.68 168.62 16.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.71 179.814 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.25 -37.41 80.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.472 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.422 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -139.98 158.86 43.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.453 -179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -155.94 177.07 33.21 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.22 -33.71 86.83 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.84 151.4 45.3 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.891 0.376 . . . . 0.0 110.54 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -63.29 140.93 58.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.326 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.78 10.64 10.99 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.647 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -60.97 -38.89 87.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.168 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.2 -35.75 23.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.375 0.607 . . . . 0.0 110.538 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.3 mt -71.0 -35.21 71.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.41 0.624 . . . . 0.0 110.697 179.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -42.8 -63.03 0.85 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.319 -178.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.2 p-10 -65.67 -42.85 90.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.091 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.545 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -61.91 -32.62 73.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.314 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.5 mt -73.95 -40.79 62.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 178.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -57.99 -49.23 77.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.169 -179.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 75.2 m -52.46 -42.67 64.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.263 179.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.3 -42.87 91.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 111.022 179.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.4 153.48 5.3 Favored Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.676 -179.336 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -39.41 107.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.675 2.25 . . . . 0.0 112.435 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 97.2 m -109.61 121.68 45.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.074 0.464 . . . . 0.0 110.258 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.05 152.55 30.84 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.299 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 tt -128.87 131.24 68.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.474 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.99 128.01 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.527 -179.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.8 t30 -101.82 103.87 14.6 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.2 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.6 p90 -101.51 -10.85 19.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.888 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.77 -33.24 75.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.704 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.6 p-10 -98.8 8.05 45.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.583 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.442 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.87 155.56 50.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.534 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -75.08 165.93 24.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.69 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.596 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.3 t90 -60.01 -48.65 80.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.278 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.36 -42.41 66.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.116 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.8 t -62.84 -41.11 99.21 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.348 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.8 tp -60.5 -44.45 95.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.317 -179.621 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.9 tp -61.26 -43.74 98.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.205 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 m -54.7 -45.22 73.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.708 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.14 -40.93 97.61 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.878 0.37 . . . . 0.0 110.455 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.68 -42.4 98.87 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.206 179.117 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.16 -40.6 95.0 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.508 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.75 -46.01 63.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.874 0.369 . . . . 0.0 110.847 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.74 -43.92 96.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.735 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -93.18 -8.66 41.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.632 -179.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.01 26.58 72.37 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.66 50.72 0.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 110.708 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.64 -39.47 77.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.584 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.45 -47.3 86.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.357 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -59.82 -39.56 85.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.317 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.88 -40.99 99.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.297 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.1 -28.66 70.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.601 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.29 -54.51 7.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.873 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -65.0 -42.43 94.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.533 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.454 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.1 mt -62.33 -43.91 98.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.53 -179.508 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.19 -60.8 3.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.967 0.413 . . . . 0.0 110.415 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.9 -34.0 62.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.619 -179.183 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -81.1 -35.84 31.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.762 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.7 m-20 -55.28 -41.95 72.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.124 -178.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.47 -42.04 99.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.643 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.04 -38.27 90.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.363 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.36 -42.1 99.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.672 179.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.06 -53.27 57.84 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.068 0.461 . . . . 0.0 110.682 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.22 -41.85 89.53 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.635 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.0 95.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.615 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.42 -31.56 72.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.434 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -95.03 -22.68 17.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.611 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.635 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.7 tt0 -64.85 -41.42 95.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.582 -179.55 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.2 pt -76.22 135.99 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.719 -179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -126.1 108.1 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.292 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.6 pp -177.3 125.2 0.28 Allowed Pre-proline 0 C--O 1.239 0.502 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.497 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.5 Cg_exo -44.03 152.47 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.898 2.399 . . . . 0.0 112.429 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.8 141.73 55.2 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.622 2.215 . . . . 0.0 112.352 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.46 147.25 2.08 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.511 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.9 154.38 71.04 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.856 2.371 . . . . 0.0 112.328 178.661 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.52 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.14 162.91 30.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.134 0.492 . . . . 0.0 110.449 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.625 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.1 t -144.03 170.72 15.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.999 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.625 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.61 137.73 21.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.938 0.399 . . . . 0.0 110.245 179.382 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.5 pt -134.44 147.16 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.726 179.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -132.89 131.73 59.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 110.467 178.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.404 ' HH ' ' CG1' ' A' ' 272' ' ' ILE . 54.6 p90 -152.32 155.37 37.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.379 179.316 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 90.4 m -122.82 122.93 39.87 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.972 0.415 . . . . 0.0 110.425 179.45 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.79 -25.55 66.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.571 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.23 -48.88 21.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.925 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.81 -11.77 60.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.516 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.8 m80 49.4 41.63 21.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.582 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.8 t -136.29 144.76 44.92 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.408 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.96 114.47 27.81 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.393 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.9 133.56 55.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 0.0 110.347 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.3 tt -112.27 146.91 37.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.771 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.452 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.6 t90 -100.42 131.14 46.5 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.196 0.522 . . . . 0.0 109.965 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.698 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.66 153.94 39.29 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.244 -179.959 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.406 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.9 Cg_endo -67.87 -17.99 46.93 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.736 2.29 . . . . 0.0 111.985 178.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.698 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -49.19 -18.69 0.37 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.388 -179.148 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.452 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 84.1 p -75.5 164.66 26.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.518 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.11 -27.92 66.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.473 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.589 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.5 mt-30 -64.03 -41.22 97.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.605 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.24 -45.06 96.77 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.83 -38.86 92.4 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 122.438 -0.448 . . . . 0.0 110.731 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.596 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.1 mmm -62.03 -41.71 98.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.262 179.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 45.5 mt -63.43 -46.87 84.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.019 0.438 . . . . 0.0 110.325 179.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.94 -31.56 60.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.346 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.16 -17.52 63.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.496 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.54 -9.34 52.68 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.576 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.58 1.78 50.01 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -88.46 154.42 20.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.843 0.354 . . . . 0.0 110.567 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.2 p -116.35 128.7 55.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.132 0.492 . . . . 0.0 110.387 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.557 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.5 mm? -91.76 146.14 24.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.999 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.454 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.52 151.88 44.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.405 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.36 131.53 41.98 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.571 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.632 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.45 93.45 27.24 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.238 -179.815 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.719 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.9 Cg_exo -55.22 139.14 80.74 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.604 2.203 . . . . 0.0 111.758 178.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.0 -26.32 0.05 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.427 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.719 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.24 -50.3 28.27 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.586 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -53.65 -37.19 62.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.176 -179.385 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -66.77 36.09 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.709 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.02 88.32 0.01 OUTLIER 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.932 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 79.5 p -81.21 -14.18 57.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.36 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.9 -41.29 10.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.565 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.84 -16.98 64.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.633 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 55.72 43.68 27.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.539 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.5 -148.62 7.91 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.88 142.59 49.54 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.956 0.408 . . . . 0.0 110.382 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -151.91 149.44 28.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.352 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -101.22 -151.49 0.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.316 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.75 -92.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.655 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.508 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.6 tt -126.58 175.18 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.532 -179.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.508 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -122.79 141.91 41.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.809 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.65 169.32 9.36 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.279 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.7 mt -147.96 150.97 35.0 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.176 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.91 -38.99 96.89 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.41 4.12 4.52 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -77.43 -58.25 3.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.485 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -61.85 -36.89 82.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.518 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.35 -67.86 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.635 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.36 -42.32 66.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.159 -179.515 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.04 17.56 0.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.635 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.71 49.13 0.27 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.5 mp 38.23 -109.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.565 0.222 . . . . 0.0 110.67 -178.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.454 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.9 m120 -60.37 -45.24 94.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.635 -179.742 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.55 7.87 83.89 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.338 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.95 -13.24 20.05 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.669 -0.312 . . . . 0.0 110.743 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.2 t 176.87 142.61 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.97 0.414 . . . . 0.0 110.465 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 tt -148.2 125.09 11.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.094 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -98.27 143.34 28.86 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.841 0.353 . . . . 0.0 110.758 178.276 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.7 mt -94.91 106.78 18.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.807 -179.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.441 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.1 t80 -101.98 -12.52 18.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.209 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.07 -40.95 91.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.857 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.5 173.03 45.82 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.474 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 93.5 m-20 -73.7 -112.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.678 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -68.2 -28.83 67.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.614 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.96 -43.95 91.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.278 -178.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.39 -44.66 94.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.371 179.171 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.47 -60.16 3.57 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.378 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.83 -43.68 59.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.21 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.28 -43.38 74.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.205 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.404 ' CG1' ' HH ' ' A' ' 196' ' ' TYR . 91.9 mt -64.75 -43.67 96.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.563 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -56.1 -37.51 69.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.182 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.23 0.84 17.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.238 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -115.17 91.13 26.37 Favored Pre-proline 0 N--CA 1.46 0.073 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.25 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.98 -27.07 27.11 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.847 2.365 . . . . 0.0 111.959 179.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.52 -40.94 98.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.513 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.436 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.1 mp -95.2 5.49 51.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.443 -179.143 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.19 -34.59 68.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.631 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -79.97 4.5 16.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.569 -178.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.558 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.96 121.1 80.4 Favored Pre-proline 0 N--CA 1.446 -0.645 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.462 -179.974 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -47.29 -37.65 24.83 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.463 2.108 . . . . 0.0 112.499 -179.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.558 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -59.06 -43.96 91.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.769 0.318 . . . . 0.0 110.446 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.08 -43.54 92.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.358 179.281 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.44 -40.99 96.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.428 -179.319 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -90.27 -11.54 40.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.69 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.62 32.8 18.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.965 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -89.0 43.85 1.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.096 0.474 . . . . 0.0 110.366 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.52 135.82 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.451 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -116.73 132.55 56.66 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.387 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.06 89.17 7.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.732 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.458 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.3 mt -63.9 -40.88 97.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.441 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.03 165.27 33.67 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.51 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 74.4 p -75.43 -25.72 57.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.878 0.37 . . . . 0.0 110.679 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.8 tp10 -68.53 -33.7 74.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.454 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.508 ' O ' ' CG2' ' A' ' 296' ' ' THR . 95.8 m -73.59 24.96 0.07 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.74 -179.148 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.589 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 40.2 t80 -58.32 -50.72 72.62 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.387 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.416 ' CZ ' ' CE2' ' A' ' 297' ' ' PHE . 79.3 mmt-85 -111.03 153.95 24.88 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 46.3 tp -115.77 125.17 52.4 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.757 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 41.5 t0 -147.93 165.68 29.94 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.656 179.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.26 -37.94 25.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.641 -179.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -71.36 -65.58 0.73 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.403 -179.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.84 -32.85 72.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.269 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.19 -25.58 23.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.797 -179.057 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.6 mtt -63.54 -40.91 98.24 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.05 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.0 -43.93 23.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.979 179.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 79.8 t -66.35 -42.76 91.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.403 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.436 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.3 tp -60.17 -47.06 87.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.48 -178.737 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -70.07 -39.32 75.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.958 0.408 . . . . 0.0 110.584 179.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.7 ttt180 -61.87 -38.43 88.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.232 -178.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.09 4.49 41.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.622 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.635 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.67 -11.2 13.57 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.103 0.478 . . . . 0.0 110.435 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.21 -37.28 86.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.51 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.68 -48.83 80.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.363 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.221 -0.405 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.069 179.769 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.11 -2.54 58.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.44 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.5 179.16 1.23 Allowed Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.49 -179.66 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.4 Cg_exo -60.72 145.07 99.52 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.84 2.36 . . . . 0.0 112.142 179.611 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.613 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.25 -179.44 8.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.631 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.19 136.95 52.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.362 179.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.05 147.17 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.402 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.4 p -120.18 136.05 54.76 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.062 0.458 . . . . 0.0 110.78 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.9 p30 -99.21 -143.8 0.32 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.244 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.52 -37.04 85.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.522 179.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.481 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.76 -67.69 0.23 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.422 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.12 142.71 44.21 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.2 p -112.51 131.22 55.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.895 0.378 . . . . 0.0 110.418 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -118.6 129.2 55.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.559 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.8 m -85.67 130.58 34.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.247 -179.808 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 70.0 mt -96.69 78.76 2.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 110.433 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.84 -31.68 72.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.603 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.51 107.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 110.089 -179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -121.13 91.32 47.95 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.42 -179.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.655 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.6 Cg_exo -56.73 148.54 64.95 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.801 2.334 . . . . 0.0 111.953 178.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.61 82.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.627 0.579 . . . . 0.0 110.951 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.655 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.41 66.85 0.89 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.071 0.462 . . . . 0.0 110.192 -179.465 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -76.83 130.98 35.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.803 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.9 t -122.63 147.33 26.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.028 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.7 t -136.4 144.11 44.33 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.745 179.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.644 ' HG1' ' N ' ' A' ' 50' ' ' SER . 17.5 p -100.03 -59.04 1.78 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.549 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.644 ' N ' ' HG1' ' A' ' 49' ' ' THR . 87.3 p -79.2 155.07 28.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.612 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.0 t -74.11 -21.83 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.472 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.406 ' O ' ' OG ' ' A' ' 56' ' ' SER . 95.2 m -60.31 -51.93 67.43 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.478 -178.433 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -66.4 -42.75 87.41 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.759 177.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.9 m -42.99 -54.07 4.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.911 -178.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.08 -37.46 73.0 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 178.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.5 m -62.89 -44.26 96.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.886 0.374 . . . . 0.0 110.164 -179.292 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.5 mt -66.14 -42.21 89.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.544 0.687 . . . . 0.0 110.639 179.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.97 -39.78 95.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.379 -179.122 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.49 -35.81 76.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.231 -179.078 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.6 pt -91.5 27.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.317 -179.311 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.82 51.95 10.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.053 179.554 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.34 76.19 26.41 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 121.021 0.438 . . . . 0.0 109.839 -179.653 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.24 149.63 89.88 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.8 2.333 . . . . 0.0 112.09 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -112.4 136.66 47.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 CA-C-O 121.127 0.489 . . . . 0.0 110.34 179.696 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -69.57 -43.45 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.358 179.317 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.49 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.35 131.35 53.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.032 0.444 . . . . 0.0 110.601 -179.008 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.536 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.4 p -155.94 168.68 26.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.47 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.32 -177.35 21.99 Favored Glycine 0 N--CA 1.463 0.456 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.35 172.07 13.19 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 121.04 0.448 . . . . 0.0 110.452 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 p -133.25 -111.39 0.23 Allowed 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.018 0.437 . . . . 0.0 110.453 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.94 179.62 0.94 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.44 -179.195 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.8 Cg_exo -60.89 58.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.926 2.418 . . . . 0.0 112.156 179.518 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.8 t-20 -64.42 -34.19 77.6 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.361 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 45.1 m-20 94.76 -37.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.824 0.703 . . . . 0.0 109.814 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -62.76 -40.22 96.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.218 179.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.3 p -74.08 -25.98 20.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.758 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.84 -172.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.433 -179.219 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.87 -152.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.777 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.3 p-10 -54.36 -6.66 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.759 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.516 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.48 114.14 23.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.629 179.731 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.52 72.14 1.3 Allowed Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.5 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.2 m-85 -143.54 148.27 35.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.874 0.369 . . . . 0.0 110.899 179.236 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.531 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -85.96 -98.81 0.07 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.026 178.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.555 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.94 -43.26 96.39 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.177 179.291 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.555 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.8 tt0 91.66 52.55 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.913 0.758 . . . . 0.0 111.052 179.176 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -103.49 -8.63 19.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.335 179.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.5 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.3 p -65.33 -33.38 75.84 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.063 0.459 . . . . 0.0 110.672 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.552 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.12 -24.18 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.695 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.2 t -69.86 -45.93 75.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.765 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.14 -48.77 80.06 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.043 -179.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.48 -38.32 89.4 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.454 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.72 -32.62 52.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.136 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.591 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 83.7 mmt-85 -90.1 1.8 55.98 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.538 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.94 -49.79 0.16 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.865 0.728 . . . . 0.0 110.235 179.176 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.66 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.4 mt -45.54 153.75 0.23 Allowed 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 117.673 -1.156 . . . . 0.0 109.561 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.66 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 121.05 92.27 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 O-C-N 125.444 1.715 . . . . 0.0 110.456 -178.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.536 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.02 142.77 43.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.219 0.533 . . . . 0.0 110.262 179.34 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 mt -131.81 26.59 4.65 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.04 -0.413 . . . . 0.0 110.415 -179.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -139.97 137.27 34.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.045 0.45 . . . . 0.0 110.531 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.521 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 93.1 mt -136.72 164.89 29.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.361 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.521 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.22 -28.48 1.82 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.76 70.5 7.24 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.108 0.48 . . . . 0.0 110.259 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.1 145.32 98.72 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 122.768 2.312 . . . . 0.0 112.123 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.9 t -134.08 136.68 44.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.556 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.62 -38.54 84.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.665 179.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.35 -41.98 96.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.48 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.65 98.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.473 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.53 -43.22 98.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.077 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.01 -35.12 77.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.223 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.69 -18.69 60.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.401 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.66 -6.51 58.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.5 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.8 mtp 47.61 55.99 17.18 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.594 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.28 149.82 64.17 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.767 2.312 . . . . 0.0 112.126 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.9 -72.77 0.67 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.452 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.7 tp -111.67 114.19 27.05 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.388 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.3 mt -103.36 126.91 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 120.964 0.411 . . . . 0.0 110.608 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.0 mt -110.63 134.21 52.63 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.214 -179.401 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.86 140.12 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.572 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 121' ' ' THR . 91.0 p -83.48 168.25 16.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.788 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.5 -37.13 80.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.47 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.419 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.7 t -139.49 158.35 44.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.466 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.15 176.88 33.46 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.31 -34.0 87.87 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -179.541 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.82 151.52 45.11 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.91 0.386 . . . . 0.0 110.552 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.8 t -63.23 141.07 58.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.334 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.89 10.59 10.9 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.644 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -60.92 -38.98 87.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.235 -179.372 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.87 -35.74 23.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.479 0.657 . . . . 0.0 110.587 179.84 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.2 mt -71.16 -35.18 71.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.492 0.663 . . . . 0.0 110.614 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -42.95 -62.85 0.91 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.322 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.69 -42.96 90.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.058 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -61.86 -32.34 72.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.402 -179.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.2 mt -74.23 -40.64 62.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.869 178.637 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.42 -49.09 78.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.163 -178.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.9 m -53.04 -42.67 65.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.941 0.4 . . . . 0.0 110.142 179.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.53 -42.83 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 120.948 0.404 . . . . 0.0 111.218 179.023 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -168.6 151.4 5.18 Favored Pre-proline 0 N--CA 1.452 -0.369 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.726 -179.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -38.78 107.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.716 2.277 . . . . 0.0 112.493 179.717 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 98.4 m -109.35 121.71 45.77 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.047 0.451 . . . . 0.0 110.265 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.13 153.51 29.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.32 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.77 131.62 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.402 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.36 127.82 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 121.074 0.464 . . . . 0.0 110.535 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.2 t30 -100.99 105.1 16.28 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.149 179.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.9 p90 -101.28 -11.58 19.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.898 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.0 p-10 -64.82 -33.64 76.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.805 -179.656 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.2 p-10 -99.37 7.82 45.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.601 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.9 mttm -134.79 152.35 51.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.525 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.424 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.9 p -75.42 165.97 24.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.677 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.596 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.3 t90 -59.09 -48.49 81.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.23 -179.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -54.37 -43.68 71.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.043 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.1 t -62.9 -41.09 99.31 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.255 178.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.8 tp -60.81 -44.53 96.74 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.185 -179.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.49 -42.75 99.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.153 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.8 m -55.63 -45.46 77.58 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.49 -40.13 95.7 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 120.892 0.377 . . . . 0.0 110.505 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.446 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.5 mm? -61.99 -42.51 99.22 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.324 179.058 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.16 -40.04 94.79 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.508 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.57 -45.9 64.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 110.849 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.87 -44.06 96.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.845 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.9 p -92.98 -9.1 41.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.643 -178.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.16 26.02 72.39 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -101.17 50.38 0.86 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.811 0.338 . . . . 0.0 110.649 -179.506 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -69.43 -39.56 77.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.628 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.53 -47.35 85.89 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.294 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -60.01 -39.16 84.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.099 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.04 -40.76 98.69 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.214 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.04 -28.86 70.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.56 179.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.12 -54.46 7.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.904 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -64.78 -42.23 95.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.406 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.2 mt -62.48 -43.8 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.483 -179.508 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.95 -60.15 4.06 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.024 0.44 . . . . 0.0 110.311 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.22 -34.01 63.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.552 -179.229 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -80.7 -36.11 32.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.731 179.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.8 m-20 -54.79 -42.44 71.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.005 -178.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.01 -41.75 98.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.719 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -64.97 -38.02 89.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.355 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.53 -42.29 99.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.753 179.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.91 -52.97 61.91 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.066 0.46 . . . . 0.0 110.686 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.41 -41.79 88.75 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.711 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.74 -40.24 96.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.664 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.06 -32.81 74.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.477 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.07 -21.3 19.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.704 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.632 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.3 tt0 -64.89 -41.62 95.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.743 -179.56 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.3 pt -76.47 133.93 29.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.071 0.462 . . . . 0.0 110.716 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -127.83 106.43 9.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.417 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.58 128.31 0.34 Allowed Pre-proline 0 C--O 1.24 0.553 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.521 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.49 151.37 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.869 2.38 . . . . 0.0 112.577 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.83 142.57 52.61 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.587 2.192 . . . . 0.0 112.411 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.542 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.89 147.19 2.3 Favored Pre-proline 0 N--CA 1.448 -0.555 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.574 179.395 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.99 153.8 71.85 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.879 2.386 . . . . 0.0 112.317 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.19 163.09 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.167 0.508 . . . . 0.0 110.454 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.642 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.1 t -143.5 169.76 17.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.958 179.462 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.642 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -147.84 137.48 22.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.147 179.505 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.8 pt -134.35 146.58 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.693 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -133.41 132.15 57.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.129 0.49 . . . . 0.0 110.43 178.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -152.05 154.85 36.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.398 179.158 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 89.8 m -121.95 122.88 40.39 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.961 0.41 . . . . 0.0 110.355 179.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.87 -25.34 66.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.656 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.19 -49.58 18.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.02 -10.9 60.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.416 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.0 m80 48.4 42.72 18.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.489 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.9 t -136.37 145.05 44.93 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.355 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.12 114.42 27.66 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.324 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -120.19 133.71 55.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.984 0.421 . . . . 0.0 110.387 179.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.24 146.68 37.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.052 0.453 . . . . 0.0 110.762 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.465 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 12.4 t90 -99.73 127.93 45.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.195 0.521 . . . . 0.0 109.862 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.707 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -93.5 153.47 41.33 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.427 179.904 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.71 -18.56 47.92 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.629 2.219 . . . . 0.0 112.005 178.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.707 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -49.86 -18.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.419 -179.121 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.465 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.3 p -75.27 167.77 21.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.491 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.64 75.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.481 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.3 mt-30 -56.52 -41.38 76.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.722 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.22 -43.07 97.45 Favored Glycine 0 C--O 1.235 0.201 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.49 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.4 mt-30 -63.81 -39.87 95.26 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 122.231 -0.57 . . . . 0.0 110.82 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.596 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.3 mmm -61.77 -41.7 98.04 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.277 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 77.3 mt -63.31 -50.2 70.98 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.197 0.522 . . . . 0.0 110.328 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.69 -33.03 45.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.862 0.363 . . . . 0.0 110.227 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.15 -19.99 62.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.562 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 66.2 mt -87.41 -6.44 58.44 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.819 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.63 3.56 57.27 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -88.47 149.96 23.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.912 0.386 . . . . 0.0 110.519 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.1 p -113.01 126.67 55.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.137 0.494 . . . . 0.0 110.332 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.568 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.63 145.91 24.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.078 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.464 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.05 150.5 46.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.44 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.52 131.25 45.0 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.466 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.632 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -114.02 92.94 27.87 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.004 -179.552 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.719 ' C ' ' H ' ' A' ' 229' ' ' GLY . 44.5 Cg_exo -55.52 139.12 82.11 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.544 2.162 . . . . 0.0 111.693 178.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.68 -25.05 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.448 -179.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.719 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.82 -49.79 27.37 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.584 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.1 mt -54.43 -36.97 64.6 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.62 36.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.804 179.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.584 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.52 87.85 0.01 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.93 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.1 p -80.88 -14.32 58.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.318 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.77 -41.41 10.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.616 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.1 t -66.99 -16.74 64.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.584 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.78 43.97 26.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.467 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.98 -148.58 8.03 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.81 143.19 48.98 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.971 0.415 . . . . 0.0 110.316 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -151.98 149.6 29.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.328 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -101.05 -152.21 0.43 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.299 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.3 -92.14 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.626 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.522 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.4 tt -126.81 175.58 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.612 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.522 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.0 mt -122.21 141.46 42.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 -179.431 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.61 169.29 9.39 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.243 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.6 mt -147.38 150.69 35.18 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.277 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.72 -38.96 96.99 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.53 3.62 4.6 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.07 -58.33 3.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.966 0.412 . . . . 0.0 110.518 -179.743 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -61.95 -36.75 82.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.203 -179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.24 -67.72 0.23 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.849 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.56 -42.32 67.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.109 -179.394 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.81 18.19 0.14 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.664 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.63 47.85 0.23 Allowed Glycine 0 N--CA 1.464 0.555 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.3 mp 39.06 -110.07 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.501 0.191 . . . . 0.0 110.74 -178.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.464 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.8 m120 -60.84 -45.18 95.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.421 -179.482 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.95 8.05 82.96 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -99.16 -12.92 20.02 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.757 -0.261 . . . . 0.0 110.597 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.9 t 176.79 142.75 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.101 0.477 . . . . 0.0 110.417 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -148.17 125.6 11.65 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.137 179.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -98.52 143.33 29.05 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 120.915 0.388 . . . . 0.0 110.838 178.236 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.3 mt -94.65 106.55 18.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.782 -179.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.466 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.8 t80 -101.95 -12.52 18.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.13 179.582 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.7 90.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.87 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.02 173.36 45.9 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -179.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.496 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -74.01 -112.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.762 0.315 . . . . 0.0 110.768 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.74 -28.78 67.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.658 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.06 -44.06 91.81 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.236 -178.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.43 -44.49 94.42 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.288 179.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.47 -59.96 3.81 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.189 -179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.95 -43.52 60.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.159 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.31 -43.64 75.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.243 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.5 mt -64.49 -43.57 96.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.577 179.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -56.48 -37.72 70.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.152 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.22 1.02 19.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.199 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -114.83 91.49 26.25 Favored Pre-proline 0 N--CA 1.462 0.135 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.176 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.09 -27.32 28.79 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.715 2.277 . . . . 0.0 111.966 179.318 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.515 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.42 -41.08 98.7 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.545 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.424 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.9 mp -95.5 5.06 52.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.354 -179.14 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.83 -35.14 69.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.601 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -80.17 4.74 16.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.507 -178.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.552 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.73 121.11 80.0 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.57 -179.996 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.43 -37.71 26.0 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.492 2.128 . . . . 0.0 112.58 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.552 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.66 -43.4 89.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.765 0.317 . . . . 0.0 110.397 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.92 -43.67 92.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.357 179.204 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -65.1 -40.64 94.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.31 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 44.5 t-20 -89.08 -13.1 39.38 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.554 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 62.29 31.19 17.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.037 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.32 44.2 1.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.176 0.513 . . . . 0.0 110.346 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.93 135.75 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.514 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -116.65 132.41 56.69 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.439 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.492 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.09 88.68 6.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.808 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.47 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.8 mt -63.93 -41.65 97.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.021 0.439 . . . . 0.0 110.781 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.466 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.79 165.87 34.28 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 71.2 p -75.47 -25.82 57.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.9 0.381 . . . . 0.0 110.756 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.542 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.1 tp10 -68.59 -33.82 74.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.478 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.496 ' O ' ' CG2' ' A' ' 296' ' ' THR . 99.0 m -72.65 19.67 0.08 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.129 0.49 . . . . 0.0 110.677 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.542 ' H ' ' C ' ' A' ' 295' ' ' GLU . 49.6 t80 -57.1 -51.23 70.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.925 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 70.8 mmt-85 -107.65 149.05 28.56 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.7 tp -115.61 126.19 53.87 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.842 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 304' ' ' ALA . 42.7 t0 -149.74 166.87 28.12 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.618 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -49.29 -38.05 26.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.649 -179.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -71.65 -65.21 0.79 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.462 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.61 -32.83 71.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.021 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 300' ' ' ASP . . . -54.57 -25.42 26.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.735 -179.125 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.8 mtt -63.49 -41.15 98.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.827 0.346 . . . . 0.0 111.053 179.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.96 -44.48 26.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.102 179.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 79.8 t -66.15 -42.73 91.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.365 179.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.3 tp -59.9 -47.09 87.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.514 -178.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -70.57 -39.23 74.01 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.73 179.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.496 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 73.3 ttt180 -61.5 -37.84 85.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.257 -178.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.3 mt -87.95 5.05 42.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.664 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.632 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.4 -11.71 13.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.03 0.443 . . . . 0.0 110.314 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.82 -37.29 86.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.394 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.92 -48.92 79.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.46 -179.653 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.992 179.886 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -90.1 -2.18 58.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.464 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.494 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.02 179.04 1.24 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.504 -179.638 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.81 145.01 99.64 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.827 2.351 . . . . 0.0 112.18 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.3 ptt-85 -156.37 -179.1 7.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.615 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.78 136.15 53.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.984 0.421 . . . . 0.0 110.371 179.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -123.41 146.64 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.409 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.8 p -119.72 135.87 54.66 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.818 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.5 p30 -99.4 -143.47 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.26 179.877 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -63.62 -37.11 86.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.526 179.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.36 -66.76 0.22 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.431 179.719 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.21 142.2 44.9 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.42 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.7 p -112.27 131.49 55.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 0.0 110.488 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -119.1 128.98 54.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.611 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -85.38 130.15 34.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.247 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.6 mt -95.67 78.51 3.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.39 179.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.73 -31.65 72.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.589 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.23 109.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.155 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -122.18 91.08 49.11 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.414 -179.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.661 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.63 148.81 62.36 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.8 2.334 . . . . 0.0 112.049 178.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.92 82.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.506 0.504 . . . . 0.0 110.999 -179.252 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.661 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.1 66.86 0.91 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.292 -179.604 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.87 130.69 35.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.822 -179.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.73 146.23 28.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.061 -179.62 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.9 t -136.1 143.76 44.77 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.778 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.544 ' HG1' ' H ' ' A' ' 50' ' ' SER . 24.8 p -99.53 -59.05 1.79 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.579 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.544 ' H ' ' HG1' ' A' ' 49' ' ' THR . 86.9 p -79.29 155.11 28.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.627 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.3 t -74.61 -21.72 17.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.514 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.405 ' O ' ' OG ' ' A' ' 56' ' ' SER . 99.8 m -60.28 -52.2 66.29 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.518 -178.537 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.34 -42.9 87.45 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.622 177.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.0 m -42.49 -54.04 4.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.985 -178.719 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.48 -37.36 69.18 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 178.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.3 m -62.67 -44.93 95.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.815 0.34 . . . . 0.0 110.107 -179.25 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.6 mt -66.41 -41.76 88.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.433 0.635 . . . . 0.0 110.714 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.56 -40.49 97.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.283 -179.284 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.77 -35.65 75.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.236 -178.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.2 pt -91.45 28.9 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.284 -179.375 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.29 51.58 11.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.019 179.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.03 75.57 23.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 0.0 109.94 -179.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.96 151.48 85.68 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.848 2.365 . . . . 0.0 112.064 -178.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.38 137.44 46.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-O 121.126 0.489 . . . . 0.0 110.319 179.826 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.421 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.9 pt -69.35 -43.49 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.263 179.597 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.09 131.22 53.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.044 0.45 . . . . 0.0 110.534 -179.049 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.3 p -155.91 168.8 26.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.522 -179.717 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.63 -177.18 21.8 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.03 171.92 13.34 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 121.094 0.473 . . . . 0.0 110.451 179.39 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.7 p -133.54 -110.86 0.23 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.004 0.43 . . . . 0.0 110.516 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.86 179.6 0.95 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.494 -179.312 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.0 Cg_exo -60.75 58.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.891 2.394 . . . . 0.0 112.082 179.557 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.3 t-20 -64.39 -35.19 80.11 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.445 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 47.4 m-20 94.93 -37.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.692 0.62 . . . . 0.0 109.889 -179.365 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.54 -39.86 94.95 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.199 179.109 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.6 p -73.96 -26.55 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.621 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.96 -172.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.383 -179.367 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -74.1 -152.63 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.765 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.8 p-10 -54.56 -6.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.724 -179.429 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.88 113.32 22.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.678 179.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.33 73.31 1.26 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.615 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.498 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.2 m-85 -144.24 148.33 34.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.817 0.342 . . . . 0.0 110.901 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -85.71 -99.38 0.07 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.022 178.836 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.564 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.17 -42.84 96.55 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.088 179.255 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.564 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.5 52.91 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.672 0.607 . . . . 0.0 111.042 179.025 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -103.57 -9.02 19.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.32 179.274 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.498 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.98 -33.74 76.77 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.097 0.475 . . . . 0.0 110.701 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.551 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 97.9 mttt -48.83 -23.22 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.72 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.5 t -70.18 -45.9 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.705 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.09 -48.82 79.92 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.978 -179.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.38 -38.34 89.2 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.379 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.67 -32.4 51.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.202 -179.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.608 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.91 1.61 56.02 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.49 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.99 -49.43 0.16 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.729 0.643 . . . . 0.0 110.229 179.209 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.686 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 79.5 mt -45.88 153.85 0.27 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 118.209 -0.901 . . . . 0.0 109.758 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.686 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.3 tt0 121.24 92.17 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.966 1.416 . . . . 0.0 110.472 -178.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.26 143.24 43.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.277 0.561 . . . . 0.0 110.269 179.416 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -131.97 27.03 4.59 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 122.053 -0.404 . . . . 0.0 110.443 -179.399 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.33 137.94 34.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.456 . . . . 0.0 110.514 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 93.7 mt -137.03 165.06 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.395 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.524 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 144.91 -28.44 1.87 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -152.85 70.69 7.19 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.06 0.457 . . . . 0.0 110.271 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.11 145.37 98.6 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 122.744 2.296 . . . . 0.0 112.114 -179.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.4 t -134.27 136.87 43.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.533 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.12 -38.33 82.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.547 179.725 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.25 -42.35 96.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.499 -179.45 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.67 98.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.544 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.4 t -63.68 -43.25 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.108 179.451 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.08 -35.08 77.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.137 -179.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.73 -18.49 59.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.376 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.75 -6.51 58.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.506 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.8 mtp 47.85 56.14 17.4 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.659 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.8 Cg_endo -70.28 149.29 63.35 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.8 2.334 . . . . 0.0 112.07 179.465 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -101.24 -73.38 0.65 Allowed 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.471 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.0 tp -111.02 112.39 24.18 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.269 179.632 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 75.9 mt -100.59 126.1 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.645 -179.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.9 mt -109.42 133.38 53.13 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.268 -179.428 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.56 139.61 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.585 -179.559 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 121' ' ' THR . 91.2 p -83.5 168.24 16.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.714 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.09 -37.43 79.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.488 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.425 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -139.59 159.0 43.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.442 -179.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.27 177.22 33.41 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.2 -33.73 86.87 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 -179.684 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -125.07 151.7 45.31 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 110.519 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -63.12 141.2 58.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.334 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.72 10.03 10.89 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.666 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.7 mp -60.71 -38.97 86.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.305 -179.383 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.641 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.79 23.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.355 0.598 . . . . 0.0 110.568 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.9 mt -71.03 -35.29 71.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.482 0.658 . . . . 0.0 110.625 179.403 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.3 t80 -42.73 -62.72 0.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.355 -178.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.641 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.77 -42.83 90.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.176 -179.244 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -62.0 -32.57 73.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.417 -179.718 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 129' ' ' LEU . 71.2 mt -74.17 -40.79 62.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.792 178.745 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.1 -49.02 78.39 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.169 -179.094 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.3 m -53.06 -42.08 65.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.975 0.417 . . . . 0.0 110.155 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.56 -42.57 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 120.95 0.405 . . . . 0.0 111.081 179.241 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.78 153.61 5.01 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.661 -179.338 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -39.06 106.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.658 2.239 . . . . 0.0 112.491 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 95.1 m -109.37 121.32 44.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.129 0.49 . . . . 0.0 110.278 179.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.1 153.07 30.12 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.365 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 tt -128.96 131.56 68.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.343 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.29 127.88 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.605 -179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.9 t30 -101.9 103.67 14.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.174 179.847 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.9 p90 -101.15 -11.23 19.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.875 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.84 -33.26 75.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.731 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.5 p-10 -98.6 8.19 45.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.56 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.442 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.91 155.62 50.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.521 -179.413 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.408 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -74.86 165.83 24.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.626 -179.818 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.584 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -60.02 -48.95 79.61 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.264 -179.22 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -53.56 -42.06 67.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.17 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.0 t -62.47 -40.83 97.92 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.358 178.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 48.0 tp -60.64 -43.97 96.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.275 -179.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.5 tp -61.32 -43.25 99.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.063 179.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -55.41 -45.58 76.69 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.32 -40.73 97.29 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.895 0.379 . . . . 0.0 110.509 179.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.8 -42.42 98.99 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.238 179.046 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.86 -40.88 95.72 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 179.522 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.93 -45.74 63.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 0.0 110.84 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.1 mt -64.78 -43.99 96.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.839 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -93.29 -8.55 41.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.633 -179.066 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.76 25.37 71.74 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -101.88 51.98 0.82 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.831 0.348 . . . . 0.0 110.673 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -69.74 -39.09 76.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.593 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.25 -47.2 86.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.34 -179.416 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -61.35 -39.15 89.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.232 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.23 -40.46 97.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.347 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.43 -27.17 68.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.567 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -75.32 -53.71 8.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.842 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.88 -43.26 96.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.422 -179.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.3 mt -63.06 -43.89 99.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.73 -179.705 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.37 -61.76 2.32 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.062 0.458 . . . . 0.0 110.356 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -54.55 -35.05 62.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.565 -179.153 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -79.62 -34.99 40.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.822 179.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -56.6 -40.12 74.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.009 -178.642 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.88 -42.37 99.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.692 179.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.79 -37.75 87.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.315 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.45 -42.28 99.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.713 179.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.17 -53.32 56.99 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.017 0.436 . . . . 0.0 110.613 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.3 -41.4 89.81 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.633 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.24 -39.95 95.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.601 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.19 -32.16 73.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.471 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.52 -21.75 18.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.63 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.636 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.96 -41.57 95.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.717 -179.625 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -77.58 136.08 25.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.746 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.1 108.97 11.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.333 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.9 126.13 0.3 Allowed Pre-proline 0 C--O 1.238 0.473 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.501 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.461 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.7 Cg_exo -43.73 152.16 0.36 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.891 2.394 . . . . 0.0 112.483 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.99 141.68 54.11 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.579 2.186 . . . . 0.0 112.341 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.16 147.07 2.16 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.602 179.374 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.2 154.19 70.36 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.897 2.398 . . . . 0.0 112.269 178.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.526 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.4 163.24 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.151 0.501 . . . . 0.0 110.477 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.526 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 2.1 t -144.08 170.26 16.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.157 0.503 . . . . 0.0 110.851 179.68 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.456 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -147.82 137.4 22.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.213 179.536 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.28 146.56 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.728 179.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.29 132.09 58.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.152 0.501 . . . . 0.0 110.418 178.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -152.09 154.73 36.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.377 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 197' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.6 m -122.15 123.01 40.54 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.904 0.383 . . . . 0.0 110.408 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.38 -25.43 65.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.679 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.407 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.53 -49.0 20.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.5 -9.85 59.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.499 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.6 m80 46.5 42.76 11.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.582 -179.602 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 t -135.89 145.77 46.69 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.421 179.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.33 113.92 26.73 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.393 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -120.06 133.58 55.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.438 . . . . 0.0 110.377 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.3 tt -112.33 146.72 37.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.794 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.452 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.5 t90 -99.58 129.8 45.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.22 0.533 . . . . 0.0 109.864 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.701 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.62 153.85 39.34 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.292 179.935 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.1 Cg_endo -67.61 -18.3 48.41 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.705 2.27 . . . . 0.0 111.986 178.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.701 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -49.16 -18.72 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.414 -179.23 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.452 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.1 p -75.7 165.04 25.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.496 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.01 -28.3 66.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.508 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.543 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.47 -41.45 98.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.673 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.85 -44.89 96.66 Favored Glycine 0 C--N 1.331 0.276 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.43 -38.98 92.92 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 122.231 -0.57 . . . . 0.0 110.703 179.67 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.584 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.7 mmm -61.93 -41.41 97.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.246 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.58 -47.72 80.33 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.99 0.424 . . . . 0.0 110.44 179.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.73 -32.01 50.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.882 0.373 . . . . 0.0 110.379 179.715 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -70.89 -18.13 62.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.493 179.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 91.5 mt -88.62 -8.67 54.27 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.651 -179.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.61 2.64 55.37 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -88.59 152.26 21.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.929 0.395 . . . . 0.0 110.504 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.1 p -115.11 127.99 55.94 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.118 0.485 . . . . 0.0 110.397 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.56 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.36 146.15 23.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.943 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.455 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.84 151.66 45.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.529 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.1 131.74 42.65 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.546 179.811 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.634 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.79 93.53 29.27 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.099 -179.713 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.723 ' C ' ' H ' ' A' ' 229' ' ' GLY . 44.5 Cg_exo -55.14 138.95 80.18 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.61 2.207 . . . . 0.0 111.769 178.775 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.6 -25.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.481 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.723 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.79 -49.95 26.8 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.805 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.586 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -53.94 -37.21 63.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 -179.273 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -66.62 35.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.83 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.09 88.36 0.01 OUTLIER 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.913 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.2 p -81.94 -14.33 56.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.337 -179.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.34 -41.43 10.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.618 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.2 t -66.91 -16.67 64.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.616 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.09 43.47 26.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.495 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.56 -148.44 7.84 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.37 143.23 49.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.959 0.409 . . . . 0.0 110.358 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.1 ttt-85 -151.95 149.43 28.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.312 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -100.71 -152.09 0.42 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.372 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.4 t0 56.1 -91.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.517 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.0 tt -126.54 175.43 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.631 -179.508 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.517 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.0 mt -122.14 141.7 41.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 -179.44 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.79 169.33 9.32 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.266 -179.774 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.2 mt -147.9 150.76 34.7 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.183 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.75 -38.91 96.88 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.19 4.07 4.64 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.3 -58.24 3.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 110.539 -179.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -62.1 -36.88 83.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.281 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.3 -67.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.736 -179.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.47 -42.23 67.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.19 -179.617 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.06 18.09 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.617 179.787 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.69 48.63 0.26 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.29 -109.91 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.485 0.183 . . . . 0.0 110.746 -178.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.455 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.9 m120 -60.78 -45.25 95.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.463 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.95 8.17 82.78 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 179.255 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.32 -12.75 20.05 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.725 -0.279 . . . . 0.0 110.673 -179.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.4 t 176.6 142.49 0.07 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.013 0.435 . . . . 0.0 110.446 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.0 tt -148.17 125.19 11.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -98.27 142.93 29.32 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 120.91 0.386 . . . . 0.0 110.694 178.313 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.3 mt -94.23 106.58 18.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.805 -179.323 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.463 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.3 t80 -101.91 -11.73 18.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.15 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.99 -40.2 87.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.84 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.81 173.97 46.17 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.459 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -74.39 -112.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.789 0.328 . . . . 0.0 110.798 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.83 -28.74 67.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.671 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.95 -44.18 91.4 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.24 -178.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.56 -44.4 94.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.317 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.47 -60.09 3.65 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.194 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.8 -43.74 58.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.143 179.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.91 75.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.242 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.1 mt -64.46 -43.62 96.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.587 179.56 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -56.57 -37.87 71.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.137 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.82 1.11 18.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.208 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.0 91.2 25.82 Favored Pre-proline 0 N--CA 1.461 0.104 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.164 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.86 -27.17 26.56 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.796 2.331 . . . . 0.0 112.034 179.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.516 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.58 -41.01 98.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.468 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.38 5.33 51.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.414 -179.21 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.06 -34.82 69.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.588 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -80.26 4.71 16.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.485 -178.819 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.56 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.91 121.11 80.36 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.555 179.921 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -47.15 -37.87 24.19 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.521 2.148 . . . . 0.0 112.533 -179.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.56 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -58.86 -43.77 90.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.469 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.98 -43.47 92.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.387 179.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -64.86 -40.67 95.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.439 -179.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -90.02 -12.25 39.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.504 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 62.16 32.54 17.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.989 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -89.08 43.97 1.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.079 0.466 . . . . 0.0 110.278 179.52 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.13 135.87 41.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.587 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.6 132.56 56.65 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.37 179.618 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.499 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.56 87.86 7.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.762 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.47 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.3 mt -63.97 -41.31 97.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.782 179.433 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.12 168.14 34.73 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.7 p -75.97 -25.89 56.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.756 179.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.3 tp10 -67.79 -33.92 75.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.471 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.5 ' O ' ' CG2' ' A' ' 296' ' ' THR . 97.4 m -73.47 19.9 0.1 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.076 0.465 . . . . 0.0 110.78 -179.148 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.543 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 55.3 t80 -57.26 -51.38 69.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.853 -179.369 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 67.4 mmt-85 -108.0 149.51 28.3 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.5 tp -115.34 125.39 53.18 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.851 179.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 304' ' ' ALA . 42.4 t0 -149.06 166.41 28.79 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.567 179.537 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -49.29 -37.95 25.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.663 -179.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -71.89 -65.11 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.376 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.65 -32.74 71.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.983 -179.491 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 300' ' ' ASP . . . -54.7 -25.51 27.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.786 -179.102 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.5 mtt -63.32 -40.79 98.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.851 0.358 . . . . 0.0 111.027 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.89 -44.03 23.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.982 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 74.5 t -66.26 -42.79 91.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.381 179.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.441 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 51.7 tp -60.23 -47.1 87.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.495 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -70.17 -39.48 75.25 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.987 0.422 . . . . 0.0 110.672 179.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.499 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.3 ttt180 -61.67 -38.24 87.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.275 -179.043 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.4 4.75 41.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.61 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.636 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.3 tttt -112.82 -11.18 13.5 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.964 0.411 . . . . 0.0 110.264 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.15 -37.18 86.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.388 179.737 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.75 -48.91 79.66 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.465 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.157 179.66 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -89.94 -2.58 58.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.423 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.68 179.23 1.21 Allowed Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.524 -179.673 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.4 Cg_exo -60.87 145.0 99.67 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.818 2.345 . . . . 0.0 112.141 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.613 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.92 -179.56 8.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.639 -179.735 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.93 137.02 52.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.961 0.41 . . . . 0.0 110.313 179.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -124.43 147.05 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.346 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.5 p -120.03 136.11 54.68 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.779 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.46 -143.49 0.33 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.248 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.55 -37.39 87.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.453 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.476 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.93 -66.61 0.23 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.442 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.55 142.46 45.42 Favored Glycine 0 CA--C 1.518 0.277 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 -179.38 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.7 p -112.3 131.38 55.55 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.569 -0.371 . . . . 0.0 110.465 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -119.07 129.06 54.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.56 -179.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.5 m -85.6 130.43 34.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.223 -179.834 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.6 mt -95.95 78.82 3.22 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.388 179.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.71 -31.78 72.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.56 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 176.1 109.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.032 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -122.41 91.51 49.25 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.412 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.647 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.3 Cg_exo -56.89 148.55 66.58 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.79 2.327 . . . . 0.0 111.956 178.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.48 82.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.679 0.612 . . . . 0.0 110.97 -179.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.647 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.6 66.93 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.055 0.455 . . . . 0.0 110.173 -179.389 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.23 130.69 35.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.3 t -122.42 146.55 27.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.046 0.451 . . . . 0.0 109.993 -179.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.2 t -135.81 143.77 45.36 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.038 0.447 . . . . 0.0 110.729 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.709 ' HG1' ' H ' ' A' ' 50' ' ' SER . 27.2 p -99.37 -59.53 1.7 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.619 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.709 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.5 p -79.25 155.22 28.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.654 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.7 t -74.11 -21.92 18.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.486 179.355 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.41 ' O ' ' OG ' ' A' ' 56' ' ' SER . 98.1 m -60.33 -52.13 66.59 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.488 -178.406 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.9 mt -66.24 -42.72 88.2 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.759 177.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.1 m -43.24 -53.83 4.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.905 -178.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.37 -37.23 70.21 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 178.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.8 m -62.75 -44.69 95.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.853 0.359 . . . . 0.0 110.141 -179.221 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.0 mt -66.46 -41.9 88.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.497 0.665 . . . . 0.0 110.739 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -62.56 -40.49 96.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.489 -179.392 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.92 -35.86 75.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.287 -179.084 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.5 pt -91.16 28.89 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.352 -179.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.45 51.75 10.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.058 179.56 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.49 76.04 21.51 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.03 151.53 85.46 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.836 2.357 . . . . 0.0 112.076 -178.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -113.37 137.46 46.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-O 121.176 0.512 . . . . 0.0 110.293 179.671 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.1 pt -69.46 -43.62 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.321 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.12 131.44 53.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.037 0.446 . . . . 0.0 110.569 -178.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.536 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.0 p -155.77 168.59 26.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.445 -179.715 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.47 -177.22 21.9 Favored Glycine 0 N--CA 1.463 0.471 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.97 172.77 12.35 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 121.078 0.466 . . . . 0.0 110.437 179.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 p -132.42 -112.92 0.23 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.104 0.478 . . . . 0.0 110.376 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.98 179.72 0.94 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.406 -179.198 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.5 Cg_exo -60.86 57.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.968 2.446 . . . . 0.0 112.145 179.554 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.1 t-20 -64.25 -33.16 75.16 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.382 -179.731 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 42.6 m-20 93.47 -36.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.757 0.661 . . . . 0.0 109.805 -179.524 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -62.62 -39.64 94.45 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.216 179.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.34 -25.53 19.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.684 179.384 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.31 -170.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.436 -179.232 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.03 -154.35 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.856 -179.627 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.8 p-10 -52.31 -7.56 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.757 -179.567 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -85.95 114.92 23.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.676 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.97 70.4 1.34 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -143.84 147.99 34.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.844 0.354 . . . . 0.0 110.841 179.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.525 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.5 mp -85.82 -98.46 0.07 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.082 178.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.551 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.18 -42.52 96.65 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.052 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.607 ' NE2' ' HZ1' ' A' ' 88' ' ' LYS . 35.2 tt0 91.38 52.83 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.895 0.747 . . . . 0.0 111.024 179.205 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -102.88 -9.38 19.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.313 179.37 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.2 p -64.31 -33.91 76.93 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.139 0.495 . . . . 0.0 110.699 -179.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.607 ' HZ1' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.21 -23.39 1.31 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.678 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.3 t -69.84 -45.95 75.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 179.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.23 -48.62 80.65 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.924 -179.324 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.4 -38.4 89.48 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.379 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.59 -33.07 53.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.134 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.584 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.5 mmt-85 -89.66 1.74 55.64 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.554 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.68 -49.34 0.18 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.862 0.726 . . . . 0.0 110.197 179.126 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.655 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.8 mt -45.9 154.4 0.24 Allowed 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 117.538 -1.22 . . . . 0.0 109.524 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.655 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.1 tt0 121.07 92.63 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 O-C-N 125.566 1.791 . . . . 0.0 110.443 -178.595 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.536 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.57 142.94 42.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.252 0.548 . . . . 0.0 110.312 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -131.94 26.98 4.6 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.0 -0.438 . . . . 0.0 110.437 -179.344 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.24 137.9 34.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.022 0.439 . . . . 0.0 110.589 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.5 mt -137.16 165.01 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.332 179.629 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.523 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 144.9 -28.43 1.87 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.58 70.51 7.37 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-O 121.079 0.466 . . . . 0.0 110.095 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.92 145.33 98.57 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 122.668 2.245 . . . . 0.0 112.133 -179.651 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.9 t -134.35 136.73 43.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.559 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.37 81.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.63 179.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.12 -42.23 96.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.51 -179.408 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.62 98.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.491 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.6 -43.35 98.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.004 179.479 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.08 77.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.132 -179.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.69 -18.75 60.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.362 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.66 -6.55 58.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.491 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.8 mtp 47.53 56.1 17.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.644 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.8 Cg_endo -70.03 149.46 65.19 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.791 2.327 . . . . 0.0 112.098 179.516 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.03 -73.61 0.64 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.519 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.6 tp -111.02 113.44 25.99 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.293 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -102.08 126.57 56.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 120.962 0.411 . . . . 0.0 110.64 -179.8 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.3 mt -109.92 133.96 52.6 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.266 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.73 139.6 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.558 -179.567 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 121' ' ' THR . 87.9 p -83.4 168.37 16.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.716 179.673 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.47 80.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.389 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.428 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -139.91 159.13 42.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.94 0.4 . . . . 0.0 110.432 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.23 176.82 33.54 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.29 -33.59 86.57 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.56 151.46 44.71 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.928 0.394 . . . . 0.0 110.507 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.0 t -63.33 140.78 58.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.331 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.55 10.35 11.08 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.591 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.418 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.01 -38.94 87.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.253 -179.283 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.97 -35.89 23.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.522 0.677 . . . . 0.0 110.605 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -70.96 -35.44 72.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.546 0.688 . . . . 0.0 110.659 179.394 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.83 -62.81 0.91 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.411 -178.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.65 -42.86 90.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.195 -179.402 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -61.98 -32.71 73.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.367 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.0 mt -73.58 -41.06 63.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.864 178.642 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.18 -48.87 78.98 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.122 -178.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.8 m -52.97 -42.5 65.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.961 0.41 . . . . 0.0 110.186 179.474 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.14 -42.84 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 120.934 0.397 . . . . 0.0 111.18 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.33 153.51 5.38 Favored Pre-proline 0 N--CA 1.452 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.655 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -39.29 107.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.682 2.255 . . . . 0.0 112.516 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 97.0 m -109.73 121.4 45.14 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.116 0.484 . . . . 0.0 110.281 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -113.56 152.44 30.27 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.279 -179.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 tt -128.77 131.22 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.351 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.09 127.9 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.099 0.476 . . . . 0.0 110.52 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.8 t30 -101.43 103.81 14.74 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.161 179.822 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.0 p90 -101.35 -11.13 19.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.875 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.5 p-10 -64.89 -33.54 76.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.768 -179.718 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -98.4 7.72 45.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.503 -179.546 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.448 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.55 155.62 50.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.484 -179.358 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.2 p -75.02 165.75 24.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.675 -179.778 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.589 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.02 -48.8 80.22 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.188 -179.1 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -53.41 -42.0 66.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 110.094 -179.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.4 t -62.74 -41.04 99.0 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.366 178.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.6 tp -60.66 -44.42 96.48 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.325 -179.469 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.0 tp -61.47 -43.49 98.77 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.079 179.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.0 m -54.91 -45.04 74.69 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.18 -40.86 97.43 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.88 0.371 . . . . 0.0 110.46 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.86 -42.51 99.13 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.388 178.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.27 -40.78 94.86 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.51 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.54 -46.05 64.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.389 . . . . 0.0 110.842 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.79 -44.02 96.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.847 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 156' ' ' LEU . 32.8 p -92.86 -8.89 42.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.622 -179.026 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.88 26.61 72.27 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -101.85 50.91 0.84 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.844 0.354 . . . . 0.0 110.693 -179.572 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.56 -39.59 77.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.622 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.37 -47.12 86.63 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.288 -179.293 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -60.07 -39.49 86.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.145 -179.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.97 99.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.247 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.88 -28.26 69.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.622 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.56 -54.18 7.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.898 179.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -65.54 -42.19 92.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.402 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.2 mt -62.43 -43.77 98.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.496 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.58 -58.15 8.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.984 0.421 . . . . 0.0 110.372 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.47 -33.35 67.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.597 -179.016 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -81.35 -36.72 29.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.756 179.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.7 m-20 -55.79 -42.01 74.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.867 -178.437 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.4 -42.19 99.24 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.919 0.39 . . . . 0.0 110.801 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.26 -38.06 89.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.237 179.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.41 -42.2 99.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.718 179.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.19 -53.01 61.38 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.07 0.462 . . . . 0.0 110.67 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.02 -41.8 90.5 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.674 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.95 95.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.28 -32.09 73.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.382 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -94.62 -22.35 18.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.688 -179.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.635 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.76 -41.33 95.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.676 -179.554 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -76.45 136.37 24.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.69 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.72 107.91 10.59 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.246 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.73 125.95 0.31 Allowed Pre-proline 0 C--O 1.239 0.55 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.465 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.452 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.6 Cg_exo -44.02 152.35 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.872 2.381 . . . . 0.0 112.553 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.09 141.98 54.6 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.556 2.171 . . . . 0.0 112.385 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.35 147.33 2.14 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.52 179.301 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.28 154.62 69.37 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.813 2.342 . . . . 0.0 112.348 178.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.42 163.15 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.207 0.527 . . . . 0.0 110.42 179.799 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.648 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.2 t -143.56 170.11 16.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.008 179.453 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.648 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -147.75 137.32 22.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.949 0.404 . . . . 0.0 110.185 179.448 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 38.7 pt -134.16 146.55 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.682 179.528 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.95 132.04 59.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.261 0.553 . . . . 0.0 110.468 178.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.431 ' HH ' ' CG1' ' A' ' 272' ' ' ILE . 52.4 p90 -153.31 156.96 39.37 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.43 179.21 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.4 m -122.8 123.31 40.74 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.944 0.402 . . . . 0.0 110.418 179.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.474 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -61.09 -25.95 67.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.583 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -74.66 -50.0 19.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.972 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.24 -11.11 59.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.548 -179.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.474 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 80.6 m80 47.11 47.39 16.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.563 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.6 t -131.47 144.75 51.38 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.277 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -109.76 106.19 15.72 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.235 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -116.76 129.61 56.21 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.177 0.513 . . . . 0.0 110.301 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.7 tt -112.1 146.54 37.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.813 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.457 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 12.1 t90 -99.49 128.46 45.6 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.203 0.525 . . . . 0.0 109.851 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.703 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -94.41 153.88 40.37 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.37 179.758 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.5 Cg_endo -67.59 -18.08 48.43 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.651 2.234 . . . . 0.0 112.003 178.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.703 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.7 mt-10 -49.6 -18.55 0.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.332 -179.165 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.457 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.9 p -75.56 164.15 26.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.474 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.71 -28.1 65.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.533 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.571 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.0 mt-30 -63.65 -41.25 98.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.656 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.57 -44.44 97.78 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -179.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.448 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.1 mt-30 -64.3 -38.81 92.35 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 122.212 -0.581 . . . . 0.0 110.712 179.588 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.2 mmm -61.99 -41.31 97.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.188 179.819 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 74.1 mt -63.49 -47.71 80.61 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.031 0.443 . . . . 0.0 110.392 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.66 -32.06 50.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.909 0.385 . . . . 0.0 110.273 179.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -71.01 -17.96 62.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.48 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.77 -8.4 54.5 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.617 -179.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.44 2.58 55.55 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.811 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -88.68 152.2 21.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.953 0.406 . . . . 0.0 110.429 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.9 p -115.18 127.97 55.88 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.183 0.516 . . . . 0.0 110.356 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -91.94 146.63 23.59 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.011 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.457 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.38 151.18 45.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.477 179.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.1 131.77 42.67 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.5 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.626 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.54 93.53 28.01 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.079 -179.52 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.725 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.5 Cg_exo -55.31 138.77 80.5 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.599 2.199 . . . . 0.0 111.633 179.034 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.27 -25.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.478 -179.621 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.725 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.45 -50.11 28.07 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.819 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.594 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.4 mt -54.76 -36.67 65.08 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.122 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -65.95 36.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.783 179.431 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.594 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.51 86.25 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.953 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.2 p -79.27 -15.14 58.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.346 -179.809 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -92.4 -40.25 10.98 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.678 179.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -66.03 -18.03 65.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.598 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.16 43.44 26.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.41 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.89 -148.16 7.79 Favored Glycine 0 CA--C 1.518 0.262 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.97 142.31 49.89 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 110.316 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.48 149.92 29.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.313 179.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -102.18 -149.95 0.4 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.3 179.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 55.29 -92.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.696 -179.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.49 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.1 tt -126.94 174.65 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.635 -179.495 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.49 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.0 mt -122.31 141.29 43.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.039 0.447 . . . . 0.0 110.899 -179.562 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.58 170.62 8.47 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.196 -179.787 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.3 mt -146.75 149.6 33.71 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.259 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.19 -39.38 97.86 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.07 3.14 4.04 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -78.5 -57.59 3.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.964 0.412 . . . . 0.0 110.517 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -62.07 -36.88 82.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.203 -179.651 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.6 mp -52.98 -67.57 0.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.0 179.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.515 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.61 -42.53 67.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.112 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.74 17.74 0.15 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.656 179.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.0 48.05 0.27 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.1 mp 39.25 -109.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.534 0.207 . . . . 0.0 110.721 -178.623 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.457 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -60.83 -44.67 96.61 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.381 -179.57 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.6 7.96 83.69 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.336 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.93 -13.34 20.02 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.689 -0.301 . . . . 0.0 110.667 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.1 t 177.06 142.89 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.083 0.468 . . . . 0.0 110.427 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -148.2 125.3 11.41 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.197 179.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -98.47 143.65 28.68 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 120.892 0.377 . . . . 0.0 110.808 178.326 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.06 106.62 18.63 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.78 -179.264 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.2 t80 -102.3 -11.41 18.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.116 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.57 -40.55 84.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.875 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.28 172.71 45.57 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.599 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.472 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 94.8 m-20 -73.9 -113.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.784 0.326 . . . . 0.0 110.723 -179.745 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.67 -28.94 68.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.661 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.11 -43.62 91.91 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.104 -178.762 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.55 -44.4 94.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.299 179.299 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.63 -59.99 3.8 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.133 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -51.02 -43.58 60.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.115 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.31 -43.23 74.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.179 -179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.431 ' CG1' ' HH ' ' A' ' 196' ' ' TYR . 92.0 mt -64.67 -43.57 96.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.641 179.541 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -55.96 -37.61 69.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.149 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.76 1.0 18.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.158 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -114.96 91.41 26.49 Favored Pre-proline 0 N--CA 1.461 0.114 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.121 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.24 -27.29 29.81 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.798 2.332 . . . . 0.0 111.917 179.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.514 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.5 -40.98 98.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.484 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.432 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.37 5.22 52.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.349 -179.132 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.95 -35.12 69.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.622 179.557 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -80.06 4.69 16.34 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.521 -178.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.76 121.17 80.27 Favored Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.541 179.967 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -47.28 -37.68 24.8 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.427 2.085 . . . . 0.0 112.611 -179.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.554 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.84 -43.75 90.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.747 0.308 . . . . 0.0 110.404 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.01 -43.64 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.285 179.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.87 -40.66 95.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.376 -179.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.8 t-20 -89.78 -12.55 38.93 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.592 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 61.87 32.18 18.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.069 -179.743 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.78 43.84 1.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.136 0.493 . . . . 0.0 110.308 179.537 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.11 135.85 39.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.487 -179.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.9 132.19 56.76 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.412 179.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.02 89.12 7.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.796 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.46 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.2 mt -64.05 -41.11 97.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.45 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.444 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.52 165.76 33.44 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.514 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 74.3 p -75.46 -25.87 57.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.887 0.375 . . . . 0.0 110.785 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.538 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.9 tp10 -68.27 -33.76 74.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.439 -179.737 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.5 ' O ' ' CG2' ' A' ' 296' ' ' THR . 95.8 m -73.59 23.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.751 -179.144 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.571 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 49.4 t80 -58.0 -50.86 71.95 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.102 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 75.0 mmt-85 -110.7 152.97 25.92 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.108 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 41.9 tp -115.48 125.54 53.2 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.989 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 41.3 t0 -148.03 165.55 30.44 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.581 179.46 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -49.35 -37.71 25.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.655 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.29 -65.54 0.73 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.58 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.96 -32.85 72.37 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.058 -179.536 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.13 -25.61 23.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.8 -179.166 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.7 mtt -63.55 -40.7 97.68 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 120.854 0.359 . . . . 0.0 111.135 179.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.64 -44.1 24.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.188 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.37 -42.87 91.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.353 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.431 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.1 tp -60.24 -47.12 87.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.507 -178.488 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -69.67 -39.36 77.07 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.069 0.462 . . . . 0.0 110.796 179.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.7 ttt180 -61.89 -38.44 88.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.218 -178.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.01 4.29 42.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.594 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.635 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.3 tttt -112.84 -10.94 13.52 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.073 0.463 . . . . 0.0 110.314 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.35 86.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.427 179.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.86 -48.7 80.59 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.403 -179.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.064 179.86 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -90.22 -2.56 58.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.428 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.7 179.13 1.23 Allowed Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.588 -179.711 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.0 Cg_exo -60.86 144.79 99.63 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.81 2.34 . . . . 0.0 112.206 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.9 -179.56 8.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.562 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -115.7 136.44 53.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.355 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.28 147.63 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.386 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.3 p -120.65 136.26 54.88 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.814 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.32 -143.34 0.32 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.239 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.8 -36.95 85.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.484 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.0 -67.67 0.22 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.436 179.676 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.16 142.53 44.46 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.295 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.4 p -112.18 131.8 55.26 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.552 -0.381 . . . . 0.0 110.513 -179.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.12 128.9 54.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.591 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.3 m -85.39 130.14 34.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.223 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.8 mt -95.37 78.43 3.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.4 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.81 -32.27 73.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.532 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.61 108.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.993 0.425 . . . . 0.0 110.157 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -122.69 91.59 49.48 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-O 120.767 0.317 . . . . 0.0 110.404 -179.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.655 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.6 Cg_exo -56.67 148.68 63.46 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.742 2.295 . . . . 0.0 111.993 178.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.26 82.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.677 0.61 . . . . 0.0 110.988 -179.196 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.655 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.57 66.88 0.88 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.261 -179.377 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.56 131.06 35.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.817 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.68 148.27 26.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.056 0.455 . . . . 0.0 110.077 -179.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.7 t -136.78 143.68 43.34 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.776 179.75 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.581 ' HG1' ' H ' ' A' ' 50' ' ' SER . 25.5 p -99.3 -59.03 1.8 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.572 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.581 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.0 p -79.16 155.43 28.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.587 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 68.8 t -74.51 -21.72 17.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.484 179.357 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.408 ' O ' ' OG ' ' A' ' 56' ' ' SER . 90.1 m -60.4 -52.1 66.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.524 -178.464 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.37 -42.7 87.61 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.754 177.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.3 m -42.9 -53.89 4.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.948 -178.585 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.15 -37.41 72.29 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 178.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 52' ' ' THR . 5.8 m -62.8 -44.34 96.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.941 0.4 . . . . 0.0 110.152 -179.321 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.6 mt -66.09 -42.05 89.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.505 0.669 . . . . 0.0 110.683 179.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.88 -40.04 96.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.393 -179.266 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.88 -36.1 78.34 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.348 -178.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.3 pt -90.92 27.81 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.27 -179.199 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.89 52.03 9.91 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.391 0.432 . . . . 0.0 111.097 179.568 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.2 75.82 27.83 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.32 148.95 92.46 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.859 2.373 . . . . 0.0 112.12 -178.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -112.5 136.58 48.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-O 121.188 0.518 . . . . 0.0 110.308 179.807 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.68 -43.5 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.251 179.352 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.13 131.26 53.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.948 0.404 . . . . 0.0 110.605 -178.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.5 p -155.55 168.43 27.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.501 -179.796 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.81 -177.37 21.67 Favored Glycine 0 N--CA 1.463 0.453 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.04 173.16 11.88 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.062 0.458 . . . . 0.0 110.402 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.6 p -133.22 -111.79 0.23 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.982 0.42 . . . . 0.0 110.4 -179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.64 179.71 0.93 Allowed Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.466 -179.247 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.3 Cg_exo -60.93 58.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 123.018 2.479 . . . . 0.0 112.089 179.463 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.0 t-20 -64.45 -33.8 76.73 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.412 -179.647 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.2 m-20 93.85 -36.13 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.788 0.68 . . . . 0.0 109.769 -179.632 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -63.22 -40.09 96.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.235 179.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.3 p -74.42 -25.37 19.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.742 179.326 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.25 -171.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.463 -179.208 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.524 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.56 -153.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 38.0 p-10 -52.15 -7.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.751 -179.594 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.524 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.1 mm-40 -86.33 114.81 23.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.619 179.707 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.79 70.61 1.34 Allowed Glycine 0 CA--C 1.52 0.379 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.472 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.1 m-85 -143.55 147.85 35.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.925 0.393 . . . . 0.0 110.802 179.233 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.527 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -85.98 -98.34 0.07 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.035 178.874 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.558 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.3 -42.49 96.35 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.132 179.354 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.561 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.3 tt0 91.55 53.29 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.851 0.719 . . . . 0.0 111.033 179.195 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -103.15 -9.43 19.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.345 179.261 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.472 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.5 p -64.06 -34.58 78.35 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.059 0.457 . . . . 0.0 110.732 -179.805 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.561 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.71 -24.31 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.624 179.704 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.95 -45.62 76.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.58 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.89 -49.03 79.11 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.976 -179.368 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.44 -38.15 88.64 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.412 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.46 -32.8 51.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.135 -179.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.593 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.97 1.55 56.13 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.555 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 83.11 -48.98 0.15 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.743 0.652 . . . . 0.0 110.245 179.146 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.664 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.1 mt -46.51 153.64 0.35 Allowed 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 117.732 -1.128 . . . . 0.0 109.546 -179.872 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.664 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.3 tt0 121.64 92.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 125.359 1.662 . . . . 0.0 110.476 -178.634 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.42 143.16 42.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.245 0.545 . . . . 0.0 110.288 179.313 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.1 mt -132.42 26.95 4.44 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 122.02 -0.425 . . . . 0.0 110.479 -179.365 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.44 138.31 34.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 0.0 110.485 -179.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.1 mt -137.28 164.84 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.359 179.51 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.524 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.14 -29.0 1.82 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.2 70.64 7.67 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.17 0.51 . . . . 0.0 110.241 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.07 145.37 98.59 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 C-N-CA 122.795 2.33 . . . . 0.0 112.046 -179.53 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.2 t -134.66 136.68 42.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.574 179.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.63 83.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.619 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.01 -42.21 97.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.493 -179.415 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.07 -41.55 98.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.563 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.61 -43.43 98.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.994 179.487 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.15 77.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.174 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.31 -18.8 60.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.459 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.59 -6.62 58.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.523 -179.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 73.5 mtp 47.91 56.04 17.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.548 179.993 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.22 149.27 63.73 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.834 2.356 . . . . 0.0 112.1 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.31 -72.8 0.67 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.506 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.2 tp -111.56 113.9 26.62 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.386 179.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.9 mt -103.05 126.89 57.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 120.993 0.425 . . . . 0.0 110.572 -179.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.6 mt -110.11 134.29 52.33 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.251 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.84 139.92 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.499 -179.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.515 ' HG ' ' CB ' ' A' ' 50' ' ' SER . 90.3 p -83.51 168.13 16.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.776 179.722 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.09 79.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.431 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.429 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -139.61 158.71 43.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.432 -179.823 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.26 175.74 33.87 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.22 -33.62 86.54 Favored Glycine 0 CA--C 1.518 0.279 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -123.97 151.13 44.0 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.904 0.383 . . . . 0.0 110.585 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.4 t -63.52 140.08 58.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.389 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.1 10.82 11.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.656 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -60.99 -38.85 87.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.251 -179.394 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.633 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.32 -35.71 23.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.407 0.622 . . . . 0.0 110.587 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.4 mt -70.98 -35.42 72.1 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.51 0.671 . . . . 0.0 110.668 179.379 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -42.76 -63.0 0.86 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.348 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.633 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.7 p-10 -65.88 -42.83 89.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.114 -179.25 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.3 mt-30 -61.76 -32.8 73.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.362 -179.603 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.4 mt -73.62 -40.78 63.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 178.651 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.23 -49.2 77.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.165 -178.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.9 m -52.7 -42.7 65.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.186 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.09 -42.78 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 120.967 0.413 . . . . 0.0 111.144 179.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.58 153.36 5.09 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.632 -179.362 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -39.12 107.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.629 2.219 . . . . 0.0 112.538 179.65 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 98.3 m -110.04 121.35 45.06 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.095 0.474 . . . . 0.0 110.289 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -113.94 153.05 29.93 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.29 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 tt -130.36 129.25 64.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.398 179.714 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.5 mt -111.74 126.72 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.626 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.513 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 57.0 t30 -100.9 103.81 15.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.149 179.711 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -100.88 -6.31 24.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.956 -179.741 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.2 p-10 -65.34 -33.39 75.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.728 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.584 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -100.37 9.18 43.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.618 -179.366 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.436 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.7 mttm -135.48 153.31 51.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.461 -179.39 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.9 p -75.81 166.55 23.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.624 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.597 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.8 t90 -59.89 -48.93 79.7 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.194 -179.095 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.85 -43.41 69.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.88 0.371 . . . . 0.0 110.087 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.0 t -62.88 -41.02 99.24 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.28 178.573 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 49.9 tp -60.68 -44.49 96.44 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.298 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.0 tp -61.04 -43.59 98.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.136 179.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -54.53 -45.02 73.28 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.37 -40.15 95.5 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.96 0.41 . . . . 0.0 110.398 179.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.444 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.79 -42.46 99.03 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.189 179.164 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.75 -40.09 95.54 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.362 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.43 -45.64 65.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.352 . . . . 0.0 110.762 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.84 -43.99 96.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.1 p -93.39 -8.95 40.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.632 -178.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.13 26.01 72.35 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -101.78 50.48 0.85 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.735 0.302 . . . . 0.0 110.65 -179.509 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.48 -39.29 77.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.625 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.39 -47.2 86.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.327 -179.452 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -60.23 -39.61 87.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.226 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.11 99.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.01 0.433 . . . . 0.0 110.245 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.03 -28.58 70.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.591 179.489 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.59 -54.12 8.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.885 179.407 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -65.26 -42.5 93.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.395 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 174' ' ' ASP . 81.2 mt -62.61 -43.94 98.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.54 -179.388 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.11 -61.06 2.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.088 0.471 . . . . 0.0 110.403 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.8 -34.52 62.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.605 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -80.41 -35.9 34.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.812 179.576 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.8 m-20 -55.08 -42.07 72.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.997 -178.658 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.42 -41.94 99.07 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.746 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.0 -38.21 90.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.316 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.46 -41.92 99.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.728 179.397 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.88 -52.81 62.61 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.097 0.475 . . . . 0.0 110.68 179.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.21 -41.75 89.69 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.674 179.408 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.92 95.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.592 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.36 -32.28 73.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.05 -22.16 18.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.589 -179.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.636 ' NE2' ' HZ2' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.82 -41.06 96.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.698 -179.593 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -76.89 135.94 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.749 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -126.85 108.33 10.91 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.257 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.62 125.75 0.31 Allowed Pre-proline 0 C--O 1.239 0.551 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.495 179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.6 Cg_exo -43.94 152.4 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.848 2.365 . . . . 0.0 112.585 -179.862 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.09 141.75 53.82 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.604 2.203 . . . . 0.0 112.382 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.3 147.31 2.16 Favored Pre-proline 0 N--CA 1.448 -0.528 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.563 179.315 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.11 154.22 70.63 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.839 2.36 . . . . 0.0 112.33 178.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.37 163.08 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.27 0.557 . . . . 0.0 110.42 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.639 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.1 t -143.77 170.39 15.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.97 179.593 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.639 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -148.17 137.6 22.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 0.0 110.182 179.432 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 40.6 pt -134.37 147.02 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.73 179.596 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.484 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -133.55 132.05 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.21 0.529 . . . . 0.0 110.436 178.772 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -152.1 155.04 37.1 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.382 179.14 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.7 m -122.26 122.89 40.16 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.952 0.406 . . . . 0.0 110.405 179.469 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.88 -25.36 66.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.678 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.45 -49.37 19.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.876 179.635 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.26 -9.81 59.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.393 -179.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.6 m80 46.85 43.39 13.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.544 -179.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -136.39 144.65 44.65 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.31 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.9 113.92 26.86 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.336 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.95 133.41 55.57 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.096 0.474 . . . . 0.0 110.405 179.824 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.5 tt -112.06 146.48 37.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.014 0.435 . . . . 0.0 110.728 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.456 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 13.6 t90 -99.67 129.88 45.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.14 0.495 . . . . 0.0 109.919 179.434 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.697 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.64 154.02 39.29 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.333 179.896 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.8 Cg_endo -67.54 -18.3 48.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.752 2.302 . . . . 0.0 111.976 178.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.697 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.6 mt-10 -49.54 -18.38 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.344 -179.148 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.456 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.4 p -75.59 164.34 26.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.51 179.664 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.83 -27.95 65.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.45 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.575 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.1 mt-30 -63.98 -41.26 97.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.61 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.04 -45.05 96.62 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -179.52 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.436 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.63 -38.71 91.94 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 122.236 -0.567 . . . . 0.0 110.783 179.54 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.597 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.7 mmm -62.14 -41.78 98.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.312 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 48.5 mt -63.5 -47.14 82.96 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.143 0.497 . . . . 0.0 110.259 179.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -54.77 -31.64 58.97 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.894 0.378 . . . . 0.0 110.411 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -70.26 -17.7 63.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.451 179.573 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.82 -9.23 52.52 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.585 -179.492 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.98 2.68 51.98 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.756 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.86 153.03 21.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.5 p -115.36 128.12 55.87 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.11 0.481 . . . . 0.0 110.323 -179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.5 mm? -91.75 146.6 23.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.032 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.456 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.81 151.62 44.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.41 179.709 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -133.06 132.1 41.4 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.465 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.63 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.42 93.96 29.42 Favored Pre-proline 0 C--O 1.235 0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.066 -179.633 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.723 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.3 Cg_exo -55.12 138.86 79.91 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.582 2.188 . . . . 0.0 111.662 178.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.6 -25.27 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.504 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.723 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.17 -49.58 26.24 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.729 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.59 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.8 mt -54.58 -37.34 65.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.093 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.33 35.75 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.767 179.376 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.59 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.48 88.02 0.01 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.926 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 81.1 p -81.0 -13.81 58.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.31 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.16 -40.71 10.86 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.604 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.7 t -67.04 -16.6 64.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.559 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.69 43.94 27.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.473 -179.589 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.61 -147.05 7.37 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.06 143.45 49.5 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.96 0.41 . . . . 0.0 110.343 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.08 149.61 29.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.338 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -101.02 -152.08 0.42 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.319 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.5 t0 56.02 -92.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.672 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.503 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.1 tt -126.49 175.13 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.661 -179.591 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.503 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -121.62 141.24 42.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.827 -179.392 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.48 168.8 9.75 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.16 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.3 mt -147.47 150.91 35.5 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.281 179.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.99 -38.74 96.48 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.09 4.3 4.63 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.63 -58.1 3.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.901 0.381 . . . . 0.0 110.466 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.15 -36.45 81.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.332 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.36 -67.8 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.842 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.32 -42.06 66.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.182 -179.362 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.29 18.03 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.629 179.816 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.59 48.46 0.24 Allowed Glycine 0 N--CA 1.465 0.591 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.62 -109.84 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.467 0.175 . . . . 0.0 110.745 -178.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.456 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 12.0 m120 -60.68 -45.18 95.12 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.534 -179.555 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.82 8.17 83.01 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.258 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.37 -12.71 20.04 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 122.744 -0.268 . . . . 0.0 110.7 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.5 t 176.44 142.44 0.07 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.077 0.465 . . . . 0.0 110.436 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 tt -148.1 125.34 11.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.161 179.593 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -98.38 143.19 29.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 120.899 0.38 . . . . 0.0 110.944 178.153 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.8 mt -94.52 106.66 18.65 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.718 -179.257 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.446 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.82 -12.36 18.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.101 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.58 89.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.872 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.37 173.66 46.04 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.657 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.5 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -73.98 -112.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 110.798 -179.824 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.95 -28.61 67.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.707 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.98 -44.12 91.53 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.202 -178.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.75 -44.24 94.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.308 179.3 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.51 -60.24 3.48 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.167 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -50.9 -43.56 59.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.169 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.27 -43.72 74.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.211 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.7 mt -64.57 -43.56 96.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.635 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -56.39 -37.68 70.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.168 -179.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.8 1.07 18.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.19 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -115.25 91.1 26.64 Favored Pre-proline 0 N--CA 1.462 0.134 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.129 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.99 -26.99 26.88 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.746 2.297 . . . . 0.0 111.976 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.54 -41.09 98.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.495 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.43 5.28 52.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.401 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.17 -34.84 68.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.536 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -80.11 4.74 16.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.526 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.555 HD22 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.9 121.28 80.94 Favored Pre-proline 0 N--CA 1.445 -0.721 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.566 179.999 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -47.22 -37.79 24.51 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.446 2.097 . . . . 0.0 112.618 -179.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.555 ' H ' HD22 ' A' ' 281' ' ' LEU . . . -58.88 -43.8 90.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.705 0.288 . . . . 0.0 110.403 179.764 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.93 -43.56 92.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.345 179.306 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.84 -40.68 95.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.327 -179.217 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -90.09 -12.06 39.5 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.572 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.69 32.84 18.29 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.393 0.433 . . . . 0.0 111.035 -179.801 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -89.3 43.87 1.17 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.17 0.509 . . . . 0.0 110.348 179.476 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.54 135.96 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.533 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -116.7 132.55 56.66 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.385 179.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.502 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.57 88.09 7.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.733 179.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.455 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.5 mt -64.06 -40.82 97.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 179.322 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.446 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.64 167.54 34.82 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.515 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 73.8 p -75.55 -25.73 57.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.803 0.335 . . . . 0.0 110.689 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.542 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.4 tp10 -67.89 -34.56 76.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.491 -179.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.501 ' O ' ' CG2' ' A' ' 296' ' ' THR . 96.7 m -73.36 24.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.649 -179.106 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.575 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 56.7 t80 -58.04 -51.17 70.79 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.348 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.0 mmt-85 -111.77 154.54 24.9 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.073 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 45.0 tp -115.89 124.99 52.03 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.97 0.414 . . . . 0.0 110.824 179.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 44.4 t0 -147.22 165.37 30.27 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.59 179.552 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.4 -38.41 28.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.617 -179.463 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -71.81 -65.1 0.81 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.527 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -60.08 -32.27 70.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.926 -179.501 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.19 -25.27 21.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.684 -179.14 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.7 mtt -63.1 -41.27 99.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.975 0.417 . . . . 0.0 110.977 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.27 -44.52 25.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.207 179.427 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 78.7 t -66.12 -42.88 92.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.465 179.703 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.443 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 52.1 tp -60.36 -47.25 86.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.524 -178.522 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -70.09 -39.54 75.49 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.696 179.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.502 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 70.2 ttt180 -61.89 -37.79 85.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.36 -178.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -87.8 4.81 42.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.723 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.636 ' HZ2' ' NE2' ' A' ' 183' ' ' GLN . 87.6 tttt -113.2 -11.99 13.18 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.052 0.453 . . . . 0.0 110.357 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.3 86.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.449 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.91 -48.8 80.15 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.431 -179.644 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.059 179.8 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.608 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.86 -2.7 58.26 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.463 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.55 179.14 1.23 Allowed Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.561 -179.65 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.4 Cg_exo -60.75 145.0 99.64 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.799 2.333 . . . . 0.0 112.171 179.634 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.608 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.03 -179.52 8.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.596 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.97 136.94 52.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.013 0.435 . . . . 0.0 110.383 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.22 147.06 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.342 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.6 p -119.93 135.88 54.73 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.073 0.463 . . . . 0.0 110.699 179.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.42 -143.44 0.33 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.252 179.893 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.61 -37.11 86.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.485 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.4 -66.68 0.22 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.416 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.52 142.47 45.35 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -179.357 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 78.4 p -112.29 131.61 55.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 0.0 110.447 -179.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -119.2 129.03 54.76 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.526 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.1 m -85.56 130.18 34.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.217 -179.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.1 mt -95.7 78.5 3.3 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.463 179.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.64 -31.73 72.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.579 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.35 109.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.018 0.437 . . . . 0.0 110.089 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -122.35 91.15 49.3 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.485 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.4 Cg_exo -56.74 148.48 65.36 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.831 2.354 . . . . 0.0 112.002 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.46 82.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.566 0.542 . . . . 0.0 110.975 -179.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.55 66.84 0.88 Allowed 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 121.094 0.473 . . . . 0.0 110.221 -179.422 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.4 130.74 35.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.803 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.42 146.61 27.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.057 -179.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.7 t -135.87 143.78 45.23 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.772 179.79 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.713 ' HG1' ' H ' ' A' ' 50' ' ' SER . 26.9 p -99.57 -59.36 1.73 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.588 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.713 ' H ' ' HG1' ' A' ' 49' ' ' THR . 86.1 p -79.22 155.17 28.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.66 179.924 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.7 t -74.2 -21.89 17.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.474 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.407 ' O ' ' OG ' ' A' ' 56' ' ' SER . 99.3 m -60.28 -52.19 66.31 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.549 -178.399 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.34 -42.72 87.75 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.756 177.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.1 m -42.94 -53.83 4.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.9 -178.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.32 -37.19 70.68 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 178.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.3 m -62.78 -44.78 95.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.871 0.367 . . . . 0.0 110.141 -179.214 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.9 mt -66.45 -41.94 88.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.51 0.671 . . . . 0.0 110.711 179.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.65 -40.48 97.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.427 -179.363 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.9 -35.67 75.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.303 -179.046 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -91.34 28.65 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.314 -179.388 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.51 51.81 10.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.084 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.34 76.04 21.98 Favored Pre-proline 0 N--CA 1.463 0.199 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.77 151.21 86.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.864 2.376 . . . . 0.0 112.102 -178.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -113.18 137.47 46.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 121.155 0.502 . . . . 0.0 110.292 179.683 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.43 -43.55 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.395 179.344 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.25 131.48 53.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.033 0.444 . . . . 0.0 110.562 -179.008 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.6 p -155.7 168.51 26.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.437 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.36 -177.37 21.96 Favored Glycine 0 N--CA 1.463 0.475 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.52 172.25 12.98 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 121.165 0.507 . . . . 0.0 110.453 179.263 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 p -132.17 -113.14 0.23 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.037 0.446 . . . . 0.0 110.406 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.64 179.58 0.97 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.399 -179.185 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.9 Cg_exo -61.04 57.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.997 2.465 . . . . 0.0 112.146 179.417 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.2 t-20 -64.1 -33.18 75.19 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.286 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.5 m-20 93.8 -36.62 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.674 0.609 . . . . 0.0 109.825 -179.527 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -62.51 -39.71 94.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.009 0.433 . . . . 0.0 110.225 179.279 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.505 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.26 -25.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.703 179.353 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.15 -171.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.444 -179.227 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.77 -154.15 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.843 -179.708 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 38.1 p-10 -52.46 -7.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.742 -179.557 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.13 114.87 23.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.679 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.23 70.05 1.34 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.428 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.4 m-85 -143.59 147.45 34.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.866 0.365 . . . . 0.0 110.856 179.161 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.525 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.5 mp -85.41 -98.2 0.07 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.126 178.859 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.3 -42.38 96.39 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.076 179.543 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.553 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.23 52.5 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.875 0.734 . . . . 0.0 111.027 179.205 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -102.6 -9.12 20.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.332 179.338 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.428 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.3 p -64.56 -33.86 76.9 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.183 0.515 . . . . 0.0 110.74 -179.728 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.539 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.29 -23.29 1.33 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 179.666 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.0 t -70.08 -45.83 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.689 179.698 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.29 -48.63 80.52 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.216 0.532 . . . . 0.0 109.963 -179.384 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.52 -38.2 89.01 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.425 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.71 -32.89 53.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.041 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.585 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.9 mmt-85 -89.87 1.77 55.8 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.453 -179.811 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.585 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.76 -49.38 0.17 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.903 0.752 . . . . 0.0 110.228 179.125 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.658 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.2 mt -45.97 154.3 0.25 Allowed 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 117.621 -1.181 . . . . 0.0 109.566 -179.768 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.658 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.9 tt0 121.16 92.65 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 O-C-N 125.461 1.726 . . . . 0.0 110.51 -178.511 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.69 142.93 42.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.242 0.544 . . . . 0.0 110.291 179.296 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.3 mt -132.05 27.15 4.55 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.973 -0.454 . . . . 0.0 110.44 -179.346 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.39 137.97 34.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.042 0.448 . . . . 0.0 110.583 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.9 mt -137.17 165.12 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.319 179.594 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.524 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 144.94 -28.51 1.86 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -152.96 70.89 7.14 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 121.119 0.485 . . . . 0.0 110.132 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.1 145.42 98.48 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 122.743 2.295 . . . . 0.0 112.126 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.9 t -134.27 136.75 43.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.543 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.27 81.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.643 179.652 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.25 -42.3 96.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.511 -179.385 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.92 -41.7 98.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.49 -179.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.56 -43.43 98.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.991 179.485 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.02 77.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.145 -179.636 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.62 -18.82 61.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.383 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.6 -6.68 58.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.461 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.41 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.4 mtp 47.57 56.3 17.39 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.568 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.8 Cg_endo -70.33 149.5 63.38 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.751 2.301 . . . . 0.0 112.098 179.5 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.04 -73.64 0.64 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.492 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.3 tp -111.07 113.6 26.25 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 110.295 179.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.6 mt -101.97 126.75 55.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 120.966 0.413 . . . . 0.0 110.714 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.5 mt -109.84 133.5 53.09 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.211 -179.43 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.5 139.43 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.55 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 121' ' ' THR . 87.4 p -83.32 168.39 16.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.851 179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.4 -37.3 80.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.397 179.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.424 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.3 t -139.96 158.87 43.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.968 0.414 . . . . 0.0 110.415 -179.818 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.23 176.97 33.49 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.26 -33.81 87.2 Favored Glycine 0 CA--C 1.518 0.251 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -124.58 151.3 44.95 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 110.547 -179.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.0 t -63.24 140.88 58.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.333 -179.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.48 10.37 11.14 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.659 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.7 mp -60.92 -39.0 87.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.273 -179.374 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.84 23.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.469 0.652 . . . . 0.0 110.594 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.5 mt -70.99 -35.4 72.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.517 0.675 . . . . 0.0 110.613 179.398 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -42.77 -62.91 0.88 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.424 -178.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.7 p-10 -65.63 -42.92 90.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 -179.301 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -61.89 -32.6 72.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.399 -179.609 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.4 mt -73.9 -40.8 62.9 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.78 178.672 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.04 -49.0 78.39 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.114 -178.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.9 m -53.02 -42.37 65.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.955 0.407 . . . . 0.0 110.144 179.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.21 -42.7 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 120.909 0.385 . . . . 0.0 111.252 179.044 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.64 153.81 5.22 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.681 -179.401 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -39.25 107.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.702 2.268 . . . . 0.0 112.519 179.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 96.2 m -109.56 121.08 44.4 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.152 0.501 . . . . 0.0 110.272 179.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -113.59 152.24 30.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.294 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 tt -128.77 131.43 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.3 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.8 mt -115.27 127.97 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.553 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.51 103.85 14.74 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.151 179.766 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 147' ' ' LYS . 48.4 p90 -101.3 -11.11 19.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.895 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.92 -33.49 76.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.708 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.0 p-10 -98.21 7.57 46.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.589 -179.622 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.44 155.56 50.34 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.415 -179.38 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.2 p -74.9 165.82 24.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.63 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.589 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.05 -48.83 80.08 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.19 -179.073 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.46 -41.92 66.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.351 . . . . 0.0 110.082 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.6 t -62.69 -41.03 98.89 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.399 178.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.74 -44.51 96.59 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.285 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.33 -43.47 98.83 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.106 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.0 m -55.16 -44.99 75.67 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.17 -40.66 96.78 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 120.948 0.404 . . . . 0.0 110.545 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -61.94 -42.5 99.17 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.378 178.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.19 -40.8 95.03 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.548 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.76 -46.03 63.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.786 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.68 -44.05 96.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 156' ' ' LEU . 32.0 p -92.95 -8.9 41.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.661 -179.023 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.41 26.39 72.71 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -101.74 50.32 0.85 Allowed 'General case' 0 N--CA 1.463 0.214 0 O-C-N 122.638 -0.331 . . . . 0.0 110.68 -179.576 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -69.46 -39.63 77.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.694 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.32 -47.08 86.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.301 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -60.2 -39.42 86.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.129 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.96 99.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.181 179.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.11 -28.39 70.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.67 179.476 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.3 -54.38 7.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.863 179.357 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -65.35 -42.22 93.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.376 -179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.4 mt -62.31 -43.88 98.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.559 -179.418 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.48 -59.23 5.26 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.992 0.425 . . . . 0.0 110.308 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -56.28 -33.99 66.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.572 -179.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -80.73 -36.37 32.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.815 179.524 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.8 m-20 -55.45 -42.22 73.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.91 -178.419 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.17 -42.13 98.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.8 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.08 -38.15 89.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.306 179.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.8 mt -62.44 -42.25 99.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.746 179.452 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.19 -52.84 62.17 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.026 0.441 . . . . 0.0 110.622 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.24 -41.85 89.44 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.641 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.95 95.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.641 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.34 -31.95 73.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.48 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.57 -22.26 18.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.635 -179.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.632 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.84 -41.35 95.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.597 -179.497 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.6 pt -76.73 136.13 25.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.741 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.87 107.98 10.59 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.265 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.71 125.87 0.31 Allowed Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.487 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.5 Cg_exo -43.8 152.42 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.794 2.33 . . . . 0.0 112.58 -179.804 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.18 141.95 54.0 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.536 2.157 . . . . 0.0 112.397 179.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.32 147.46 2.18 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.555 179.323 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.37 154.55 69.12 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.797 2.331 . . . . 0.0 112.272 178.52 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.526 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.57 163.3 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.232 0.539 . . . . 0.0 110.408 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.672 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.2 t -143.56 170.17 16.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.025 179.454 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.672 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -147.94 137.31 22.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.997 0.427 . . . . 0.0 110.127 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 38.0 pt -134.17 146.84 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.7 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -133.01 131.97 58.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.285 0.564 . . . . 0.0 110.439 178.775 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -152.98 156.42 38.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.362 179.202 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 197' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 199' ' ' ALA . 85.0 m -122.36 123.12 40.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.906 0.384 . . . . 0.0 110.418 179.416 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.522 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.78 -26.18 67.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.608 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.423 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.89 -49.23 21.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.68 -10.37 59.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.503 -179.703 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.522 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.5 m80 45.84 46.59 12.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 t -130.8 143.51 50.79 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.012 0.434 . . . . 0.0 110.334 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -108.23 105.62 15.42 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.18 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -116.2 128.98 56.07 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.288 0.566 . . . . 0.0 110.29 179.714 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.7 tt -111.82 146.45 37.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.816 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.452 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.7 t90 -99.5 128.33 45.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.205 0.526 . . . . 0.0 109.795 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.716 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -94.22 153.8 40.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.434 179.772 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.62 -17.97 48.26 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.674 2.249 . . . . 0.0 112.018 178.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.716 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -49.84 -18.59 0.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.392 -179.189 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.452 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.7 p -75.49 164.7 26.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 179.577 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.96 -28.05 65.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.576 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.561 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.5 mt-30 -63.66 -41.4 98.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.59 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.36 -44.48 97.53 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.41 -38.89 92.61 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 122.167 -0.607 . . . . 0.0 110.739 179.67 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.0 mmm -61.83 -41.35 97.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.273 179.716 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.5 -47.75 80.44 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.095 0.474 . . . . 0.0 110.407 179.271 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.63 -32.07 49.83 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.913 0.387 . . . . 0.0 110.413 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -70.84 -18.22 62.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.501 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.61 -8.7 54.23 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.558 -179.469 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.85 2.78 55.13 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.78 151.86 22.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.94 0.4 . . . . 0.0 110.432 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.3 p -114.87 127.8 55.92 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.178 0.513 . . . . 0.0 110.387 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.05 146.79 23.45 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.929 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.459 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.45 151.26 45.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.456 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.96 131.66 42.81 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.519 179.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.626 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.6 93.65 28.89 Favored Pre-proline 0 C--O 1.235 0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.055 -179.529 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.725 ' C ' ' H ' ' A' ' 229' ' ' GLY . 44.8 Cg_exo -55.17 138.55 79.38 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.618 2.212 . . . . 0.0 111.703 178.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.36 -25.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.521 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.725 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.44 -50.19 27.68 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 179.802 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.597 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -55.13 -36.93 66.28 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.101 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -65.77 35.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.806 179.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.597 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.14 88.66 0.01 OUTLIER 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.949 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 87.7 p -82.41 -13.6 56.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.331 -179.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.41 -40.95 11.15 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.633 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 31.9 t -66.65 -16.82 64.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.622 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.79 43.88 27.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.482 -179.599 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.95 -148.75 8.14 Favored Glycine 0 CA--C 1.518 0.245 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.82 142.17 48.86 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.916 0.389 . . . . 0.0 110.267 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -151.93 149.47 28.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.349 179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -102.11 -150.31 0.4 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.344 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.81 -93.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.64 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.488 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.0 tt -126.4 174.72 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.64 -179.589 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.488 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 89.5 mt -122.12 141.2 43.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -99.62 170.5 8.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.189 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 70.0 mt -146.69 149.69 33.93 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.229 179.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.22 -39.41 97.86 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.17 3.22 3.98 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -78.72 -57.42 3.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.937 0.399 . . . . 0.0 110.484 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -62.03 -36.81 82.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.242 -179.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.7 mp -53.06 -67.45 0.25 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.014 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.8 -42.71 68.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.126 -179.297 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.31 17.64 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.701 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.9 47.81 0.25 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 7.9 mp 39.47 -110.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.532 0.206 . . . . 0.0 110.699 -178.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.459 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.7 m120 -60.76 -44.57 96.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.35 -179.563 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.4 7.92 84.09 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.413 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.87 -13.5 20.03 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.761 -0.258 . . . . 0.0 110.678 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.7 t 177.21 142.94 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 0.0 110.448 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -148.19 125.49 11.55 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.161 179.56 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -98.71 143.66 28.83 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 120.914 0.388 . . . . 0.0 110.847 178.269 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.9 mt -95.06 106.67 18.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.736 -179.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.442 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.1 t80 -101.91 -12.63 18.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.122 179.596 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.4 -41.04 89.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.82 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.36 172.86 45.69 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.469 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -73.59 -113.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.75 0.31 . . . . 0.0 110.815 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.6 -28.84 68.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.644 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.11 -43.64 91.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.16 -178.801 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.68 -44.28 94.18 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.267 179.248 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.6 -59.98 3.8 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.111 -179.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.96 -43.52 60.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.112 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.38 -43.33 75.06 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.199 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.2 mt -64.62 -43.61 96.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.674 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -55.94 -37.84 69.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.132 -179.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.48 0.78 18.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.182 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -115.04 90.99 25.21 Favored Pre-proline 0 N--CA 1.463 0.177 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.123 -179.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.09 -27.08 27.89 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.704 2.27 . . . . 0.0 111.979 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.514 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.48 -40.92 98.37 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.518 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.1 mp -95.53 5.59 51.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.343 -179.214 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.39 -34.84 68.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.612 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.86 4.59 16.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.495 -178.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.547 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.75 121.13 80.09 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.607 -179.979 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -47.28 -37.6 24.7 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.431 2.087 . . . . 0.0 112.635 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.547 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.84 -43.78 90.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.756 0.313 . . . . 0.0 110.4 179.724 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.03 -43.51 92.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.346 179.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.74 -40.64 95.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.383 -179.191 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -90.22 -12.19 38.77 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.1 mtmt 61.74 32.81 18.2 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.371 0.419 . . . . 0.0 111.024 -179.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -89.04 43.67 1.16 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.13 0.491 . . . . 0.0 110.295 179.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.22 136.02 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.44 -179.661 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -117.02 132.28 56.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.391 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.78 89.14 7.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.819 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.463 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.3 mt -63.97 -41.16 97.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.993 0.425 . . . . 0.0 110.811 179.521 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.02 165.22 33.58 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.511 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 67.6 p -75.26 -25.77 58.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.968 0.413 . . . . 0.0 110.822 179.778 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.542 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -68.39 -33.83 74.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.504 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.505 ' O ' ' CG2' ' A' ' 296' ' ' THR . 95.8 m -73.39 24.72 0.07 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.797 -179.076 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.561 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 44.0 t80 -58.71 -50.85 72.35 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.256 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 77.1 mmt-85 -110.64 153.09 25.7 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 179.135 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 42.7 tp -115.4 124.88 52.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.883 0.373 . . . . 0.0 110.816 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 40.6 t0 -147.73 165.53 30.22 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.592 179.572 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -49.4 -37.92 27.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.533 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.32 -65.45 0.75 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.871 0.367 . . . . 0.0 111.582 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.87 -32.76 72.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.013 -179.504 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.5 -25.66 26.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.724 -179.153 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.5 mtt -63.37 -40.83 98.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.874 0.369 . . . . 0.0 111.145 179.694 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.41 -44.24 25.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.103 179.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 78.2 t -66.34 -42.89 91.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.347 179.652 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.438 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.3 tp -60.02 -47.22 86.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.446 -178.516 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -69.82 -39.28 76.59 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.07 0.462 . . . . 0.0 110.811 179.074 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.9 ttt180 -61.87 -38.33 87.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.219 -178.936 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.27 4.61 42.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.57 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.632 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -112.85 -11.25 13.48 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.066 0.46 . . . . 0.0 110.367 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.35 86.89 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.466 179.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.82 -48.81 80.12 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.39 -179.608 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.222 -0.379 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.012 179.912 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.36 -2.55 57.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.372 -179.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.493 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.62 179.05 1.25 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.521 -179.701 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.493 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.8 Cg_exo -60.73 144.74 99.59 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.814 2.343 . . . . 0.0 112.153 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.87 -179.57 8.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.632 -179.851 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.76 136.42 53.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.046 0.45 . . . . 0.0 110.364 179.765 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.08 147.26 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.382 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.9 p -120.3 136.1 54.79 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.813 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.21 -143.52 0.32 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.248 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.7 -37.03 85.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.47 179.623 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.482 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.15 -67.04 0.22 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.418 179.783 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.21 142.5 44.61 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.436 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.7 p -112.64 131.21 55.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.991 0.424 . . . . 0.0 110.463 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -118.96 129.14 55.0 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.54 -179.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.3 m -85.63 130.83 34.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.226 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.2 mt -96.24 78.7 3.11 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.343 179.678 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -65.93 -32.11 73.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.574 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.62 108.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.106 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -121.93 91.21 48.8 Favored Pre-proline 0 C--O 1.233 0.189 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.45 -179.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.663 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.2 Cg_exo -56.75 148.29 66.7 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.798 2.332 . . . . 0.0 111.982 178.98 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.18 82.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.695 0.622 . . . . 0.0 111.002 -179.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.663 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.47 66.72 0.89 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.263 -179.4 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.95 130.98 35.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.851 -179.742 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.75 147.7 26.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.062 0.458 . . . . 0.0 110.013 -179.678 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.2 t -136.62 144.03 43.86 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.753 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.625 ' HG1' ' N ' ' A' ' 50' ' ' SER . 27.1 p -99.45 -59.53 1.7 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.628 179.86 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.625 ' N ' ' HG1' ' A' ' 49' ' ' THR . 86.8 p -79.08 155.64 28.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.623 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.1 t -74.26 -21.65 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.532 179.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.41 ' O ' ' OG ' ' A' ' 56' ' ' SER . 95.4 m -60.34 -52.01 67.08 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.547 -178.502 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.16 -42.7 88.61 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.718 177.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.8 m -43.26 -54.38 4.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.884 -178.54 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.88 -37.36 74.89 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 178.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.8 m -62.91 -44.49 95.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.872 0.368 . . . . 0.0 110.163 -179.304 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.3 mt -66.07 -41.95 90.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.505 0.669 . . . . 0.0 110.663 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.04 -39.95 96.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.344 -179.251 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.48 -35.91 77.02 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.295 -178.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.9 pt -91.14 27.64 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.374 -179.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.403 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 98.8 m-20 57.08 51.93 9.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.084 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.48 76.39 25.25 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.98 149.46 90.49 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.877 2.385 . . . . 0.0 112.146 -178.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -112.43 136.71 47.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 121.115 0.483 . . . . 0.0 110.35 179.661 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.0 pt -69.67 -43.46 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.249 179.439 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.491 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.13 131.27 53.28 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.963 0.411 . . . . 0.0 110.608 -178.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.4 p -155.92 168.63 26.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.531 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.16 -177.43 22.09 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.26 171.92 13.38 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 121.102 0.477 . . . . 0.0 110.425 179.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.3 p -133.81 -110.51 0.22 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.008 0.432 . . . . 0.0 110.583 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.498 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.11 179.62 0.94 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.566 -179.323 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.4 Cg_exo -60.72 58.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.944 2.429 . . . . 0.0 112.126 179.512 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.3 t-20 -64.31 -34.88 79.15 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.48 -179.789 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.566 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 45.9 m-20 95.04 -38.07 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.671 0.607 . . . . 0.0 109.759 -179.436 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 -62.54 -39.88 95.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.99 0.424 . . . . 0.0 110.142 179.234 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -73.6 -26.55 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.693 179.326 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -50.04 -171.77 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.463 -179.381 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -74.38 -153.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 -179.785 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.3 p-10 -54.37 -6.77 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.675 -179.432 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.516 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.9 113.93 23.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.671 179.793 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.39 72.39 1.29 Allowed Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.473 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.3 m-85 -143.8 148.1 35.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.862 0.363 . . . . 0.0 110.876 179.244 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.53 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.6 mp -85.99 -98.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.939 178.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.92 -43.38 96.11 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.113 179.395 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.37 52.53 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.794 0.684 . . . . 0.0 111.147 179.195 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.78 -8.63 19.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.347 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.473 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.0 p -65.45 -33.22 75.43 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.05 0.452 . . . . 0.0 110.65 -179.596 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.523 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.87 -23.24 1.02 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.717 179.639 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.4 t -70.13 -45.81 74.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.708 179.708 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.75 80.09 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.974 -179.441 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.41 -38.37 89.41 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.39 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.65 -32.78 52.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.208 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.599 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.5 mmt-85 -89.8 1.81 55.69 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.406 -179.802 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 82.68 -49.18 0.17 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.7 0.625 . . . . 0.0 110.246 179.152 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.673 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.3 mt -45.96 154.11 0.26 Allowed 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.542 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.673 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 121.2 92.05 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 125.17 1.543 . . . . 0.0 110.477 -178.683 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.543 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.92 142.56 44.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.282 0.563 . . . . 0.0 110.368 179.374 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.2 mt -131.6 26.59 4.72 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 122.016 -0.428 . . . . 0.0 110.379 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -139.8 136.96 34.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.06 0.457 . . . . 0.0 110.596 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.52 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 93.7 mt -136.52 164.69 30.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.393 179.592 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.52 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.19 -28.49 1.83 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.56 70.72 7.42 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 121.08 0.466 . . . . 0.0 110.182 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.08 145.41 98.5 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.705 2.27 . . . . 0.0 112.098 -179.481 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.5 t -134.59 136.91 43.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.509 179.776 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.35 82.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.57 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.2 -42.38 96.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.603 -179.439 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.91 -41.68 98.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.544 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.57 -43.35 98.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.987 179.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.17 -35.04 77.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.206 -179.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.81 -18.71 60.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.363 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.51 -6.4 58.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.457 -179.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.4 mtp 47.54 56.0 17.15 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.576 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.9 Cg_endo -70.33 149.61 63.5 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.816 2.344 . . . . 0.0 112.049 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.46 -73.72 0.64 Allowed 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.46 179.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.1 tp -110.61 113.72 26.55 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.27 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.3 mt -102.84 126.83 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.614 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.1 mt -110.57 134.18 52.63 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.275 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.68 140.05 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.57 -179.574 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 121' ' ' THR . 92.2 p -83.44 168.19 16.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.8 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.5 79.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.455 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.419 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.6 t -139.99 159.2 42.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.398 -179.85 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.18 176.82 33.49 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.31 -33.67 86.83 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.49 151.67 44.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.858 0.361 . . . . 0.0 110.565 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.8 t -63.39 140.64 58.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.336 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.39 10.35 11.19 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.622 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -60.75 -39.0 87.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.253 -179.368 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.97 -35.9 23.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.358 0.599 . . . . 0.0 110.594 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.0 mt -70.89 -35.43 72.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.47 0.653 . . . . 0.0 110.607 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -42.78 -62.92 0.88 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.453 -178.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.82 -42.75 90.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.244 -179.395 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -61.83 -32.6 72.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.402 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.2 mt -73.88 -40.82 62.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.879 178.665 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -58.24 -49.18 77.99 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.231 -179.041 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.8 m -53.01 -42.49 65.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.896 0.379 . . . . 0.0 110.089 179.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.18 -42.82 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 120.927 0.394 . . . . 0.0 111.154 179.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.4 153.39 5.26 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.684 -179.395 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -39.08 107.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.666 2.244 . . . . 0.0 112.537 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 94.1 m -109.68 121.08 44.4 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.115 0.483 . . . . 0.0 110.246 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -113.76 153.08 29.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.32 -179.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 tt -128.58 131.45 68.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.383 179.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.41 128.17 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.605 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.501 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 53.6 t30 -99.59 104.02 15.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.133 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.416 ' O ' ' O ' ' A' ' 147' ' ' LYS . 50.8 p90 -98.87 -12.39 20.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.969 -179.705 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.6 p-10 -64.93 -33.89 77.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.798 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.592 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.7 p-10 -99.23 6.89 46.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.596 -179.376 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.8 mttm -133.71 149.59 51.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.559 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.423 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -76.43 167.31 22.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.618 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.603 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.2 t90 -59.07 -48.3 82.1 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.166 -179.158 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -54.4 -45.99 73.04 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 40.4 t -63.42 -40.8 98.14 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.094 0.473 . . . . 0.0 110.2 178.429 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.5 tp -61.04 -44.67 97.05 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.119 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.49 -42.71 99.21 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.207 179.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.5 m -55.78 -45.61 78.14 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.39 -40.4 96.37 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.812 0.339 . . . . 0.0 110.445 179.766 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -61.81 -42.54 99.14 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.312 178.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.78 -40.0 95.45 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.425 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.36 -45.61 65.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.922 0.391 . . . . 0.0 110.843 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.9 mt -65.02 -43.88 96.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.82 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.3 p -92.89 -9.11 41.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.656 -179.049 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.96 26.42 72.28 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -101.72 50.76 0.84 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.883 0.373 . . . . 0.0 110.668 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.53 -39.31 77.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.608 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.37 -47.36 85.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.36 -179.448 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.403 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 87.3 mt-30 -60.3 -39.3 86.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.112 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.05 99.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.186 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.07 -28.39 70.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.607 179.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.21 -54.42 7.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.939 179.405 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -65.5 -41.98 92.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.561 -179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 174' ' ' ASP . 78.9 mt -62.31 -43.92 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.549 -179.319 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.91 -57.85 9.39 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 120.995 0.426 . . . . 0.0 110.416 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -57.56 -33.83 68.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.619 -179.134 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -81.15 -36.43 30.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.774 179.648 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.4 m-20 -55.72 -41.64 74.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.095 -178.672 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.49 -42.1 99.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.631 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.19 -38.35 90.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.255 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.45 -42.02 99.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.76 179.498 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.18 -53.16 59.29 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.091 0.472 . . . . 0.0 110.628 179.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -65.87 -42.08 90.82 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.722 179.502 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.51 -39.45 94.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.669 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.7 -32.06 73.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.4 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -95.34 -21.96 18.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.617 -179.677 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.64 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.38 -41.77 96.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.685 -179.494 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.4 pt -74.53 135.55 27.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.016 0.436 . . . . 0.0 110.707 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.29 106.2 9.35 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.346 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -178.02 127.51 0.28 Allowed Pre-proline 0 C--O 1.239 0.53 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.513 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.447 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.7 Cg_exo -43.53 151.81 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.892 2.395 . . . . 0.0 112.53 -179.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.44 142.81 55.46 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.608 2.205 . . . . 0.0 112.343 179.672 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.545 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -171.66 147.14 1.99 Allowed Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.527 179.327 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.13 155.29 68.49 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.887 2.391 . . . . 0.0 112.34 178.676 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.59 163.14 28.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.201 0.524 . . . . 0.0 110.409 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.67 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.2 t -143.3 169.36 17.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.031 179.455 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.67 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -147.41 137.1 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.365 . . . . 0.0 110.177 179.525 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 38.0 pt -134.08 146.12 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.759 179.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.491 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -133.32 132.11 58.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.286 0.565 . . . . 0.0 110.431 178.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -153.07 156.55 38.94 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.403 179.193 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 197' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.4 m -121.84 122.93 40.57 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.41 179.556 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.467 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.94 -26.09 67.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.606 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.404 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.77 -49.56 20.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.974 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -75.79 -13.22 60.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.471 -179.65 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.467 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 78.4 m80 49.56 46.51 23.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.621 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.5 t -131.59 146.04 52.01 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.075 0.464 . . . . 0.0 110.247 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.21 106.05 15.33 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.234 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -116.36 129.19 56.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.09 0.471 . . . . 0.0 110.276 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.7 tt -111.95 146.32 38.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.017 0.437 . . . . 0.0 110.889 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.456 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 17.4 t90 -98.73 128.86 45.11 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.139 0.495 . . . . 0.0 109.912 179.442 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.699 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -96.05 153.55 39.12 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.229 179.909 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.8 -18.25 47.35 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.748 2.299 . . . . 0.0 111.981 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.699 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -49.9 -19.16 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.437 -179.273 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.456 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.7 p -75.86 167.63 21.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.449 179.61 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.46 74.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.453 -179.682 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.506 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.2 mt-30 -56.55 -40.68 75.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.756 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.31 -43.71 97.09 Favored Glycine 0 C--N 1.329 0.165 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.532 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.512 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.2 mt-30 -64.32 -40.57 96.16 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 122.341 -0.505 . . . . 0.0 110.796 -179.896 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.603 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.3 mmm -62.02 -42.46 99.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.499 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 39.7 mt -62.91 -49.21 75.69 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.049 0.452 . . . . 0.0 110.432 179.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.67 -31.52 62.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 110.441 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -69.48 -17.47 63.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.541 179.792 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.0 mt -87.3 -11.5 49.32 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.616 -179.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 105.19 1.32 41.43 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.723 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -88.2 156.1 19.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.923 0.392 . . . . 0.0 110.692 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 7.1 p -116.39 128.59 55.65 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.183 0.516 . . . . 0.0 110.201 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.566 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.6 mm? -90.53 146.81 23.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.993 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.458 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -71.62 150.47 44.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.414 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.5 131.94 42.15 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.575 179.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.623 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.03 94.2 28.83 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.984 -179.579 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.727 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.8 Cg_exo -55.19 138.57 79.49 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.651 2.234 . . . . 0.0 111.602 178.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.28 -25.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.46 -179.59 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.727 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.07 -49.67 26.42 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.601 ' C ' ' H ' ' A' ' 232' ' ' ALA . 98.1 mt -54.89 -37.29 66.13 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.127 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -65.71 35.52 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.775 179.37 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.601 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.78 87.82 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.5 p -81.38 -13.86 57.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.382 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.73 -40.41 11.27 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.628 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 26.9 t -66.93 -16.62 64.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.573 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.83 43.82 27.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.488 -179.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.4 -146.52 7.16 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.23 142.98 49.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.947 0.404 . . . . 0.0 110.397 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -151.82 149.37 28.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.034 0.445 . . . . 0.0 110.28 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -101.22 -151.3 0.41 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.348 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 55.67 -92.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.712 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.492 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.0 tt -126.57 174.63 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.618 -179.469 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.492 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -121.69 140.96 44.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.476 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.28 170.33 8.73 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.307 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.1 mt -146.82 149.55 33.53 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.191 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.42 -39.3 97.58 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.22 3.06 4.0 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -78.29 -57.73 3.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.935 0.398 . . . . 0.0 110.463 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -62.06 -37.06 83.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.297 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.7 mp -52.71 -67.78 0.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.74 -42.46 68.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.133 -179.283 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.39 17.69 0.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.668 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.05 48.0 0.27 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.1 mp 39.06 -110.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.493 0.187 . . . . 0.0 110.696 -178.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.458 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 12.0 m120 -60.66 -44.58 96.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.42 -179.639 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.32 7.85 84.33 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.329 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -98.67 -13.41 20.31 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.763 -0.257 . . . . 0.0 110.69 -179.795 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.5 t 177.03 142.72 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.132 0.492 . . . . 0.0 110.382 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 tt -147.71 125.46 11.88 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.288 179.55 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -98.61 143.7 28.71 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 120.927 0.394 . . . . 0.0 110.731 178.405 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.2 mt -95.12 106.33 18.33 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.773 -179.255 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.481 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.8 t80 -102.45 -12.26 17.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.112 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.53 -40.04 88.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.883 179.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.16 173.61 46.07 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.463 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 96.5 m-20 -74.43 -113.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 0.0 110.769 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.5 -29.16 68.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.693 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.9 -43.81 91.1 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.112 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.36 -44.68 94.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.271 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.46 -59.95 3.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.197 -179.792 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -51.02 -43.64 60.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.082 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.12 -43.75 74.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.156 -179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.8 mt -64.41 -43.65 97.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.579 179.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -56.63 -37.9 71.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.144 -179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.5 1.03 17.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.179 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -115.17 91.24 26.83 Favored Pre-proline 0 N--CA 1.461 0.089 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.176 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.12 -26.93 27.6 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.748 2.299 . . . . 0.0 111.975 179.329 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.515 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.55 -40.82 98.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.577 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.9 mp -95.16 5.57 51.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.381 -179.022 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.03 -35.14 69.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.618 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.63 4.27 16.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.492 -178.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.68 120.69 77.39 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.575 179.953 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -47.27 -37.66 24.7 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.446 2.097 . . . . 0.0 112.6 -179.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.553 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.93 -43.63 91.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.43 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.83 -43.61 93.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.337 179.241 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.9 -40.58 95.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.396 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.8 -12.28 39.65 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.508 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.81 31.66 18.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.051 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.44 44.04 1.17 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.128 0.49 . . . . 0.0 110.308 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.8 136.13 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.563 -179.704 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.66 132.5 56.67 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.361 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.496 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.35 88.66 6.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.794 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.465 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.1 mt -63.82 -41.51 97.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.697 179.533 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.481 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.5 165.13 34.28 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.789 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.7 p -75.53 -26.09 57.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.551 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.4 tp10 -68.67 -33.77 74.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.394 -179.699 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.507 ' O ' ' CG2' ' A' ' 296' ' ' THR . 98.1 m -72.47 22.19 0.06 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.215 0.531 . . . . 0.0 110.761 -179.351 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.551 ' H ' ' C ' ' A' ' 295' ' ' GLU . 49.1 t80 -57.86 -51.0 71.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.851 -179.253 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.9 mmt-85 -108.02 150.03 27.66 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 44.7 tp -116.46 127.31 54.47 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.77 179.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 304' ' ' ALA . 42.6 t0 -150.99 167.82 26.45 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.675 179.631 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.4 ' CE2' ' CE ' ' A' ' 305' ' ' MET . 91.4 t80 -49.3 -38.09 26.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.622 -179.54 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.16 -65.63 0.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.588 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.64 -33.03 72.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.028 -179.479 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 300' ' ' ASP . . . -54.17 -25.31 21.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.782 -179.125 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 305' ' ' MET . . . . . 0.4 ' CE ' ' CE2' ' A' ' 301' ' ' TYR . 61.3 mtt -63.57 -41.09 98.4 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.933 0.397 . . . . 0.0 111.158 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.96 -43.88 23.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.181 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 77.9 t -66.21 -42.86 91.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.405 179.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.2 tp -60.34 -46.76 88.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.48 -178.555 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -70.47 -39.47 74.22 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.098 0.475 . . . . 0.0 110.805 179.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.496 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 73.6 ttt180 -61.56 -37.53 84.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.292 -179.029 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.6 mt -87.99 4.18 45.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.642 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.64 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 86.9 tttt -112.2 -11.26 13.77 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.003 0.43 . . . . 0.0 110.396 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.17 86.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.406 179.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.82 -48.89 79.75 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.474 -179.703 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.005 179.877 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.61 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.06 -2.34 58.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.373 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.481 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.5 179.18 1.22 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.469 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.5 Cg_exo -60.8 145.38 99.06 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.729 2.286 . . . . 0.0 112.166 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.61 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 34.9 ptt-85 -156.29 -179.47 8.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.579 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -116.18 137.44 52.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.323 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.69 146.88 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.322 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.5 p -119.93 135.81 54.76 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.807 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.16 -143.65 0.32 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.19 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.45 -37.14 86.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.445 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.481 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.31 -66.51 0.22 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.484 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.62 142.35 45.68 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 p -112.06 131.4 55.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.89 0.376 . . . . 0.0 110.391 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -118.98 128.81 54.74 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.499 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.0 m -85.62 130.28 34.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.143 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 70.0 mt -96.25 78.76 3.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.317 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.54 -32.15 73.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.471 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.6 109.77 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.044 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -123.3 91.37 49.85 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.199 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.636 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.2 Cg_exo -57.07 148.92 65.88 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.738 2.292 . . . . 0.0 111.773 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.28 83.11 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.631 0.582 . . . . 0.0 111.047 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.636 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.64 67.09 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.129 0.49 . . . . 0.0 110.261 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.45 130.82 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.515 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.9 t -122.84 147.01 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.085 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.9 t -136.24 143.8 44.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.644 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.606 ' HG1' ' N ' ' A' ' 50' ' ' SER . 28.3 p -99.08 -59.25 1.76 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.53 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.606 ' N ' ' HG1' ' A' ' 49' ' ' THR . 87.1 p -79.3 155.27 28.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.695 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -74.22 -21.85 17.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.62 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.4 ' O ' ' OG ' ' A' ' 56' ' ' SER . 99.8 m -60.37 -51.98 67.21 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.486 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.8 mt -66.29 -42.52 88.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.502 0.668 . . . . 0.0 110.951 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.0 m -43.44 -53.76 5.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.076 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.13 -37.36 72.53 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.6 m -62.77 -44.63 95.68 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.367 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.0 mt -65.98 -42.17 90.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.43 0.633 . . . . 0.0 110.69 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 tp -62.59 -40.13 95.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.467 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.29 -36.16 77.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.05 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 pt -90.75 28.61 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.177 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.59 51.39 11.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.825 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.72 75.14 26.12 Favored Pre-proline 0 C--N 1.333 -0.15 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.97 151.24 86.12 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.718 2.278 . . . . 0.0 112.16 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -113.63 137.29 47.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.306 0.574 . . . . 0.0 110.23 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.407 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.1 pt -69.06 -43.69 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.373 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.481 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.2 130.94 53.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.987 0.423 . . . . 0.0 110.597 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.525 ' O ' ' O ' ' A' ' 97' ' ' ARG . 30.8 p -155.41 168.88 25.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.346 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.77 -177.33 21.7 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.44 172.57 12.53 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.857 0.36 . . . . 0.0 110.556 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.7 p -132.47 -113.0 0.23 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.348 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.03 179.98 0.9 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.211 -178.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.7 Cg_exo -60.89 57.93 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 123.027 2.485 . . . . 0.0 112.187 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.4 t-20 -64.28 -34.13 77.41 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 118.606 -0.712 . . . . 0.0 110.584 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 45.1 m-20 93.91 -36.21 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.617 1.198 . . . . 0.0 109.753 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -62.7 -39.9 95.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.224 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.17 -25.83 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.804 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.32 -171.18 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.649 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -73.94 -153.88 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.833 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.8 p-10 -52.74 -7.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.658 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.3 114.89 23.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.556 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.88 70.11 1.35 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.467 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.1 m-85 -143.25 147.91 35.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.941 0.4 . . . . 0.0 110.819 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -85.76 -98.62 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.125 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.1 mtt-85 -63.88 -42.71 97.43 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.236 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.5 tt0 91.72 53.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.286 0.991 . . . . 0.0 110.917 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -103.4 -9.0 19.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.404 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.467 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.5 p -64.66 -34.0 77.26 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.167 0.508 . . . . 0.0 110.777 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.531 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.79 -24.57 1.47 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.56 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.25 -46.04 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.048 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.27 -48.43 81.47 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.98 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.73 -38.21 89.62 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.347 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.95 -32.08 52.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.218 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.551 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.4 mmt-85 -90.09 1.9 55.85 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.686 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.36 -49.43 0.2 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 124.412 1.07 . . . . 0.0 110.366 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.613 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 83.2 mt -46.48 154.73 0.27 Allowed 'General case' 0 CA--C 1.485 -1.549 0 CA-C-O 117.068 -1.444 . . . . 0.0 108.966 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.613 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 120.82 92.68 0.0 OUTLIER 'General case' 0 C--N 1.359 1.001 0 O-C-N 125.958 2.036 . . . . 0.0 110.527 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.525 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.6 143.47 42.31 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.227 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.8 mt -132.47 27.03 4.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.692 0.282 . . . . 0.0 110.436 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.48 138.18 34.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.027 0.441 . . . . 0.0 110.491 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.519 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.6 mt -137.15 164.91 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.385 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.519 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.25 -28.59 1.81 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -152.54 70.99 7.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.193 0.521 . . . . 0.0 110.287 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.04 145.42 98.43 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.711 2.274 . . . . 0.0 112.075 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.1 t -134.78 136.59 42.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.035 0.445 . . . . 0.0 110.507 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.29 -38.17 81.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.702 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.25 -42.09 96.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.57 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.27 -41.48 98.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.515 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 64.9 t -63.67 -43.56 98.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.947 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.25 78.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.336 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.34 -18.67 59.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.502 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.76 -6.42 58.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.52 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 75.8 mtp 47.74 55.83 17.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.599 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.9 Cg_endo -70.49 150.02 63.11 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.841 2.361 . . . . 0.0 112.044 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -101.4 -75.9 0.58 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.404 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.6 tp -108.38 113.7 26.98 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.218 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.0 mt -102.64 126.77 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.404 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.5 mt -109.73 133.68 52.86 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.084 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.28 139.08 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.496 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 121' ' ' THR . 91.5 p -83.17 168.33 16.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.68 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -37.46 80.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.454 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.418 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -140.06 158.89 43.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.43 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.18 177.36 33.26 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.16 -33.82 87.11 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.61 151.84 44.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.874 0.369 . . . . 0.0 110.588 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.1 t -63.03 141.06 58.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.288 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.04 9.85 11.3 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.697 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.9 mp -61.22 -39.18 89.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.056 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.629 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.76 -36.01 23.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.647 0.737 . . . . 0.0 110.704 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -70.59 -35.61 73.1 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.488 0.661 . . . . 0.0 110.828 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -42.85 -63.03 0.86 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.332 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.629 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.89 -42.62 90.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.97 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.11 -33.18 73.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.083 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.2 mt -72.86 -40.74 65.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.24 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.51 -48.61 80.24 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.139 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 m -53.29 -42.25 66.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.105 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.78 -42.93 93.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.998 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.55 156.38 5.23 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.581 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -39.63 107.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.581 2.188 . . . . 0.0 112.347 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 89.8 m -110.11 120.81 43.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.234 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.45 152.67 31.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.125 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 tt -129.39 131.44 67.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.38 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.9 mt -115.17 128.12 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.384 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.2 t30 -101.6 103.61 14.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.262 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.5 p90 -100.96 -11.36 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.774 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.4 p-10 -64.79 -33.81 76.86 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.705 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.6 p-10 -98.08 7.8 45.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.63 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.7 155.41 50.44 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.543 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.404 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -74.93 165.68 24.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.668 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.598 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.84 -48.75 80.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.185 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -53.7 -41.96 67.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.918 0.39 . . . . 0.0 110.012 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.6 t -62.58 -41.14 98.76 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.391 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.8 tp -60.64 -44.13 96.75 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.315 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.7 tp -61.5 -43.42 98.9 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.226 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -54.99 -44.79 74.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.659 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.42 -40.68 97.35 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.893 0.377 . . . . 0.0 110.355 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.425 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -62.2 -42.35 99.21 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.387 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.05 -41.02 95.36 Favored Glycine 0 C--N 1.315 -0.587 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.42 -46.13 64.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.949 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.6 -44.05 96.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.816 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 156' ' ' LEU . 32.4 p -93.02 -8.74 42.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.595 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.93 26.63 72.32 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -101.99 50.96 0.83 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.814 0.34 . . . . 0.0 110.721 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -69.67 -39.46 76.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.751 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.58 -47.08 86.98 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.268 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -60.02 -39.24 85.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.332 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.13 -40.87 98.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.277 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.91 -28.69 70.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.07 0.462 . . . . 0.0 110.571 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.03 -54.24 8.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.221 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -65.51 -42.1 92.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.439 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.9 mt -62.35 -43.78 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.434 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.72 -57.53 10.64 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.082 0.468 . . . . 0.0 110.509 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.89 -34.05 69.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.342 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -80.76 -37.15 30.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.075 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.5 m-20 -55.56 -41.45 73.31 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.245 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.75 -42.23 99.58 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.727 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.3 -37.83 88.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.227 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.6 mt -62.5 -42.24 99.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.737 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.04 -52.59 63.35 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.096 0.474 . . . . 0.0 110.7 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.37 -41.75 88.99 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.592 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.92 95.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.623 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.23 -32.43 73.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.381 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.09 -22.38 18.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.762 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.629 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.0 tt0 -64.85 -41.01 96.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.64 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.6 pt -77.16 136.6 24.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.623 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -127.15 108.22 10.71 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.218 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.08 126.0 0.34 Allowed Pre-proline 0 N--CA 1.446 -0.669 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.588 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.7 Cg_exo -44.04 152.61 0.37 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.664 2.242 . . . . 0.0 112.606 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.19 141.88 53.76 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.59 2.193 . . . . 0.0 112.456 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.547 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.16 147.2 2.19 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.648 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.46 155.23 67.5 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.745 2.297 . . . . 0.0 112.299 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.522 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.63 163.12 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.362 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.522 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 2.2 t -143.58 170.16 16.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.912 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.515 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -147.86 137.42 22.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.208 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 37.7 pt -134.26 146.51 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.603 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.92 131.98 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.305 0.574 . . . . 0.0 110.57 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.411 ' HH ' ' CG1' ' A' ' 272' ' ' ILE . 52.4 p90 -152.85 156.43 38.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.379 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.0 m -122.08 122.92 40.36 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.934 0.397 . . . . 0.0 110.329 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.486 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.78 -26.55 67.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.534 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -74.12 -50.02 21.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.079 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -75.75 -13.46 60.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.506 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.486 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 78.1 m80 49.94 46.21 24.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.529 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.6 t -131.14 144.86 51.7 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.317 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -109.4 106.08 15.71 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.204 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -116.46 129.69 56.35 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.14 0.495 . . . . 0.0 110.307 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.7 tt -112.36 146.19 38.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.719 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.45 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.9 t90 -99.34 128.68 45.48 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.141 0.496 . . . . 0.0 109.959 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.702 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -94.82 154.08 39.91 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.107 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.6 Cg_endo -67.71 -17.97 47.79 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.736 2.291 . . . . 0.0 111.897 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.702 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -49.43 -18.92 0.45 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.402 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.45 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.1 p -75.5 164.57 26.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.488 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.9 -27.89 65.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.532 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.61 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.8 mt-30 -63.76 -41.19 98.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.64 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.44 -44.28 97.82 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.55 -38.94 92.74 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 120.989 0.423 . . . . 0.0 110.461 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.28 -41.26 98.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.062 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 71.7 mt -63.6 -47.06 82.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.635 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.34 -31.75 55.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.91 -18.25 62.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.526 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 90.0 mt -88.11 -8.75 54.99 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.651 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.64 2.1 55.34 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -88.46 153.29 21.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.755 0.312 . . . . 0.0 110.436 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.3 p -116.05 128.63 55.85 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.078 0.466 . . . . 0.0 110.384 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.33 146.33 23.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.901 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.456 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.24 151.36 45.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.432 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.37 131.88 42.32 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.394 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.622 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.3 93.71 27.73 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.002 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.717 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.1 Cg_exo -55.63 138.78 81.9 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.574 2.182 . . . . 0.0 111.435 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.56 -25.61 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.551 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.717 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.63 -49.89 28.03 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.596 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.9 mt -55.23 -37.16 66.8 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -65.54 35.65 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.909 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.596 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.47 88.32 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.773 0.32 . . . . 0.0 110.852 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.2 p -81.44 -13.4 58.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.377 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.86 -40.76 11.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.604 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.0 t -66.64 -17.02 64.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.644 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.01 44.0 26.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.485 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.29 -148.21 8.05 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.68 142.5 48.42 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.888 0.375 . . . . 0.0 110.352 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.11 149.55 28.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.334 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -102.43 -150.12 0.4 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.26 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 55.48 -92.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.575 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.475 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.3 tt -127.2 174.13 11.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.498 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.475 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 88.2 mt -121.57 140.84 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.798 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.36 170.53 8.57 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.4 mt -146.88 149.53 33.44 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.253 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.19 -39.32 97.78 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.09 2.96 4.08 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -78.48 -57.32 3.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 110.621 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.19 -36.81 83.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.084 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.8 mp -53.31 -67.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.05 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.84 -42.55 68.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.13 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.67 17.72 0.15 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.659 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.99 47.85 0.26 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 7.8 mp 39.53 -110.17 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.601 0.238 . . . . 0.0 110.637 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.456 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -61.2 -44.15 97.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.326 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.15 8.14 84.19 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.86 -13.34 20.11 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.774 -0.251 . . . . 0.0 110.69 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.425 ' HG ' ' N ' ' A' ' 259' ' ' LEU . 5.9 t 176.89 142.74 0.08 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.174 0.511 . . . . 0.0 110.51 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.425 ' N ' ' HG ' ' A' ' 258' ' ' SER . 9.3 tt -147.96 125.72 11.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.1 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -98.92 143.42 29.24 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 120.917 0.389 . . . . 0.0 110.785 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.4 mt -94.7 106.26 18.23 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.55 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.436 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.0 t80 -101.98 -11.82 18.65 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.122 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.5 86.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.923 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.46 172.99 45.8 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.451 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.7 m-20 -73.9 -112.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.771 0.32 . . . . 0.0 110.701 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.05 -28.72 67.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.766 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.24 -43.59 92.4 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.159 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.48 -44.26 94.91 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.406 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.78 -59.77 4.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.158 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.29 -43.32 61.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.166 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.26 -43.42 74.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.163 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.411 ' CG1' ' HH ' ' A' ' 196' ' ' TYR . 93.2 mt -64.48 -43.63 96.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.651 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -56.43 -37.43 70.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.138 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.64 0.63 19.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.266 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -114.85 91.35 25.8 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.196 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.28 -27.22 29.78 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.773 2.315 . . . . 0.0 111.729 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.51 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.4 -41.2 98.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.585 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.428 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.25 5.12 52.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.291 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.79 -35.18 69.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.722 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -79.65 4.63 15.47 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.472 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.544 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.61 121.46 81.04 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.639 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -47.65 -37.48 27.3 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.349 2.032 . . . . 0.0 112.586 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.544 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -59.1 -43.71 91.89 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 63.0 t -65.87 -43.85 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.92 0.391 . . . . 0.0 110.287 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.68 -40.53 95.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.53 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.445 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 48.0 t-20 -89.84 -12.69 38.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.515 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 61.99 32.55 17.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.88 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.14 43.94 1.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.359 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.38 135.59 41.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.42 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.68 132.14 56.77 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.492 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.507 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.68 88.01 7.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.71 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.45 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.5 mt -64.07 -40.64 96.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.96 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.436 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.33 167.99 34.93 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.51 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 75.7 p -75.93 -25.67 56.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 110.716 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.536 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.1 tp10 -67.45 -34.86 78.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.352 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.496 ' O ' ' CG2' ' A' ' 296' ' ' THR . 95.4 m -73.36 25.12 0.07 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.671 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.61 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 59.4 t80 -58.34 -51.15 71.03 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 68.6 mmt-85 -111.79 154.84 24.47 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 44.1 tp -115.92 125.2 52.27 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 41.6 t0 -147.79 165.67 29.85 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.585 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -48.99 -38.26 22.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.597 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -71.79 -65.17 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.458 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.6 p -60.84 -32.86 72.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.126 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.75 -25.19 26.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.585 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.8 mtt -63.54 -40.99 98.44 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 120.91 0.386 . . . . 0.0 111.01 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -79.03 -44.01 23.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.977 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 77.5 t -65.94 -43.24 92.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.417 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.43 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 54.5 tp -60.66 -46.94 88.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.622 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -69.51 -39.62 77.47 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.466 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.507 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.0 ttt180 -61.94 -38.36 88.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.146 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.1 mt -86.82 4.09 42.54 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.834 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.629 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.3 tttt -112.71 -11.45 13.52 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.174 0.512 . . . . 0.0 110.29 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.04 85.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.624 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.02 -48.64 80.88 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.331 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.868 -1.063 . . . . 0.0 109.992 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.61 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.36 -2.63 57.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.383 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.476 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.09 179.03 1.26 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.452 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.9 Cg_exo -60.85 145.46 98.97 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.558 2.172 . . . . 0.0 112.171 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.61 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.29 -179.76 8.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.624 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.14 137.0 52.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.372 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -124.23 146.67 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.314 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -119.76 135.61 54.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.759 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.15 -143.98 0.32 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.143 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.21 -37.35 86.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.533 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.89 -66.99 0.23 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.532 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.47 142.56 45.14 Favored Glycine 0 C--O 1.224 -0.48 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.0 p -112.28 131.26 55.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.922 0.392 . . . . 0.0 110.26 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -118.7 128.86 54.9 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.545 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.1 m -85.44 130.43 34.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.198 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.1 mt -96.49 78.81 3.02 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.16 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.6 -32.06 73.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.501 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.75 108.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.024 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -122.11 90.79 48.98 Favored Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.245 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.636 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.0 Cg_exo -56.96 148.6 66.93 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.708 2.272 . . . . 0.0 111.652 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.13 82.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.574 0.546 . . . . 0.0 111.056 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.636 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.76 67.16 0.87 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.302 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.05 131.14 35.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.461 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.3 t -122.78 147.38 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.154 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.3 t -136.18 143.94 44.7 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.556 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.547 ' HG1' ' H ' ' A' ' 50' ' ' SER . 17.2 p -99.45 -59.39 1.73 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.492 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.547 ' H ' ' HG1' ' A' ' 49' ' ' THR . 86.6 p -79.4 155.06 28.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.93 0.395 . . . . 0.0 110.671 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 68.9 t -73.47 -21.9 18.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.598 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.404 ' O ' ' OG ' ' A' ' 56' ' ' SER . 95.6 m -60.52 -51.74 68.13 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.384 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.9 mt -66.13 -42.62 88.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.496 0.665 . . . . 0.0 110.911 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.1 m -43.86 -54.16 5.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.996 -178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.63 -37.11 77.01 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 52' ' ' THR . 7.0 m -63.2 -44.36 95.57 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.217 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.3 mt -65.73 -42.25 91.27 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.274 0.559 . . . . 0.0 110.544 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.93 -39.68 95.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.431 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.2 78.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.078 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.5 pt -90.62 27.31 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.251 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 57.12 51.27 10.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.835 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.23 76.08 32.79 Favored Pre-proline 0 C--O 1.227 -0.081 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.66 149.42 90.93 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.634 2.223 . . . . 0.0 112.089 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -112.41 136.3 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.302 0.572 . . . . 0.0 110.161 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -68.97 -43.75 81.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.448 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.15 130.51 52.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.114 0.483 . . . . 0.0 110.613 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.6 p -155.28 168.83 25.78 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.305 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.6 -177.38 21.8 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.37 172.51 12.6 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.776 0.322 . . . . 0.0 110.601 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.9 p -133.81 -110.92 0.22 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.532 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.22 179.78 0.91 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.149 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.7 Cg_exo -60.91 58.88 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.892 2.395 . . . . 0.0 112.139 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.7 t-20 -64.07 -34.44 78.03 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.693 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.5 m-20 94.34 -36.73 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 125.018 1.449 . . . . 0.0 109.778 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -63.06 -40.53 97.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.083 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -73.7 -26.56 21.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.933 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.68 -172.37 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.64 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.44 -152.91 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.809 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.3 p-10 -54.74 -6.54 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.684 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -87.37 114.11 23.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.956 0.408 . . . . 0.0 110.487 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.67 71.67 1.31 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.495 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.3 m-85 -143.02 148.7 37.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.795 0.331 . . . . 0.0 110.968 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.526 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.5 mp -86.5 -99.06 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.91 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.61 -43.55 96.55 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 119.027 -0.511 . . . . 0.0 110.141 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.529 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.8 tt0 91.77 52.37 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 124.487 1.117 . . . . 0.0 111.156 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -103.48 -8.58 20.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.449 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.495 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.5 p -65.29 -33.39 75.86 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.323 0.582 . . . . 0.0 110.819 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.529 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.1 mttt -48.86 -23.88 1.25 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.531 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.6 t -69.88 -45.78 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.299 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.49 -48.27 81.84 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.065 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.58 -38.5 90.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.303 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.84 -33.2 55.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.177 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.539 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.3 mmt-85 -88.88 1.86 54.68 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.619 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.43 -49.42 0.19 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.616 1.197 . . . . 0.0 110.347 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.598 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.8 mt -46.48 154.14 0.31 Allowed 'General case' 0 CA--C 1.485 -1.551 0 CA-C-O 117.082 -1.437 . . . . 0.0 108.67 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.598 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.1 91.89 0.0 OUTLIER 'General case' 0 C--N 1.363 1.16 0 O-C-N 125.944 2.028 . . . . 0.0 110.677 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.531 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.85 143.14 44.02 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.046 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.6 mt -132.15 26.47 4.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.492 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.03 137.6 34.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.942 0.401 . . . . 0.0 110.579 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.513 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.6 mt -136.82 164.63 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.383 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.513 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.88 -28.82 1.72 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -151.95 70.65 7.87 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.038 0.447 . . . . 0.0 110.26 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.14 145.41 98.54 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.686 2.257 . . . . 0.0 112.059 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.4 t -135.01 137.09 42.66 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.467 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.99 -38.1 82.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.701 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.44 -41.92 96.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.629 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.25 -41.38 98.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.386 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.75 -43.57 98.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.745 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.1 77.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.326 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.52 -18.85 60.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.489 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.63 -6.56 58.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.47 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.1 mtp 47.77 55.76 17.08 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.686 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.3 Cg_endo -70.0 149.56 65.51 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.927 2.418 . . . . 0.0 112.016 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.38 -72.81 0.67 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.42 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.2 tp -111.76 114.22 27.08 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.8 mt -103.16 126.87 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.344 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 mt -110.22 134.27 52.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.951 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.415 HG23 HD12 ' A' ' 118' ' ' ILE . 96.9 mt -120.57 139.09 48.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.612 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 121' ' ' THR . 87.4 p -82.77 167.94 17.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.839 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.51 -37.27 80.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.38 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.419 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -139.91 158.6 43.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.457 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.45 177.12 33.6 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.15 -33.76 86.89 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.74 151.7 44.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.898 0.38 . . . . 0.0 110.58 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.4 t -63.48 141.14 58.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.284 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.51 10.44 11.13 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.654 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.7 mp -61.1 -39.48 90.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.994 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.63 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.44 -36.12 24.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.662 0.744 . . . . 0.0 110.681 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.8 mt -70.52 -35.61 73.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.83 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -43.04 -62.81 0.93 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.485 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.63 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.86 -42.63 90.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.932 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -62.09 -33.34 74.25 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.019 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.0 mt -72.57 -40.96 66.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.49 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.78 -48.27 81.83 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.131 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 65.7 m -53.61 -42.32 67.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.93 -43.12 92.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.889 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.42 153.39 5.25 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.591 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -39.05 107.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.519 2.146 . . . . 0.0 112.152 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 98.9 m -109.52 121.58 45.5 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.258 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.9 mp -113.85 152.58 30.51 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.182 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 tt -128.34 131.03 69.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.287 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.28 128.02 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.441 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.0 t30 -100.7 104.75 16.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.221 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.419 ' O ' ' O ' ' A' ' 147' ' ' LYS . 45.7 p90 -100.77 -11.74 19.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.919 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.1 p-10 -64.79 -33.93 77.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.848 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -99.52 7.45 45.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.758 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.9 mttm -134.71 152.04 51.46 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.856 0.36 . . . . 0.0 110.637 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.424 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -75.75 166.31 23.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.658 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.594 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.5 t90 -59.32 -48.11 82.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.244 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -54.26 -43.88 71.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.897 0.38 . . . . 0.0 110.061 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.8 t -62.97 -41.06 99.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.126 0.489 . . . . 0.0 110.343 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.0 -43.92 98.17 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.008 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 53.3 tp -61.58 -42.97 99.63 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.14 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.5 m -55.29 -45.34 76.2 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.12 -40.71 96.83 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.181 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -62.31 -42.54 99.45 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.341 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.54 -40.73 94.3 Favored Glycine 0 C--N 1.315 -0.62 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.24 -46.16 65.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.982 0.42 . . . . 0.0 111.016 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.73 -43.98 96.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.942 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 156' ' ' LEU . 32.8 p -92.89 -9.29 40.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.575 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.28 26.06 72.52 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -101.93 50.91 0.83 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.811 0.339 . . . . 0.0 110.809 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.51 -39.22 77.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.717 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.7 -46.87 87.76 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.414 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -60.03 -39.17 84.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.156 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.46 97.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.149 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.17 -29.15 70.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.149 0.499 . . . . 0.0 110.565 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -73.48 -54.44 8.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.149 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -64.86 -42.01 95.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.443 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 174' ' ' ASP . 81.0 mt -62.27 -43.84 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.527 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.34 -58.23 8.43 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.096 0.474 . . . . 0.0 110.738 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.08 -33.99 67.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.217 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -80.54 -36.3 33.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.123 0.487 . . . . 0.0 111.098 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.1 m-20 -55.34 -41.98 73.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.137 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.25 -41.98 98.92 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.785 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -64.88 -38.24 90.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.31 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.49 -42.35 99.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.646 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.83 -53.23 58.74 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.729 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.3 -41.9 89.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.575 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.75 -40.0 95.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.616 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.3 -32.64 74.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.44 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.32 -21.89 18.71 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.843 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.636 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.2 tt0 -64.5 -41.68 96.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.757 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.9 pt -76.07 134.82 28.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.22 106.91 9.56 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.4 pp -176.5 127.88 0.34 Allowed Pre-proline 0 N--CA 1.446 -0.637 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.527 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.2 Cg_exo -43.53 151.79 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.599 2.199 . . . . 0.0 112.594 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.41 142.21 53.69 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.655 2.237 . . . . 0.0 112.385 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.54 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -170.93 146.99 2.24 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.648 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.04 154.76 70.05 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.646 2.231 . . . . 0.0 112.153 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.518 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.59 162.93 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.416 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.53 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.2 t -143.45 169.93 16.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.919 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.53 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -147.88 137.37 22.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.154 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.5 pt -134.16 146.39 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.707 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.25 131.63 58.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.185 0.517 . . . . 0.0 110.49 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -151.65 154.62 36.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.32 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 89.7 m -121.75 122.64 39.97 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.014 0.435 . . . . 0.0 110.179 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.57 -25.73 66.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.463 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.11 -49.1 20.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.088 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.75 -9.05 58.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.38 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.0 m80 46.13 43.68 11.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.505 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.4 t -136.55 145.22 44.76 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.413 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.29 113.75 26.46 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.231 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.95 133.7 55.48 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.112 0.482 . . . . 0.0 110.304 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.6 tt -112.53 146.24 38.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.781 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.466 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 13.6 t90 -99.3 128.19 45.39 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.708 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -94.38 153.36 40.47 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.174 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.51 -18.41 48.99 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.924 2.416 . . . . 0.0 111.829 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.708 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.6 mt-10 -50.07 -18.86 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.369 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.466 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.0 p -75.26 168.17 20.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.485 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.45 -35.77 76.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.419 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.3 mt-30 -56.62 -40.7 75.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.743 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.92 -43.3 98.2 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.4 mt-30 -63.98 -40.65 96.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.944 0.402 . . . . 0.0 110.373 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.594 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.1 mmm -61.74 -41.79 98.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.195 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 69.9 mt -63.33 -48.34 78.41 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.843 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -54.4 -32.07 56.39 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -70.63 -18.81 62.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.621 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.96 -7.8 56.59 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.749 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.14 2.86 55.86 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -88.32 152.06 22.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.0 110.558 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.6 p -114.73 127.81 55.95 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.099 0.476 . . . . 0.0 110.387 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.24 145.67 24.31 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.901 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.456 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.64 150.55 46.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.453 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.32 131.71 43.96 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.318 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.62 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.69 92.77 25.63 Favored Pre-proline 0 N--CA 1.464 0.275 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.049 -179.445 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.711 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.8 Cg_exo -55.58 139.4 82.67 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.534 2.156 . . . . 0.0 111.392 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.71 -25.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.588 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.711 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.11 -49.04 29.06 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.583 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.6 mt -55.16 -37.01 66.45 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -66.38 35.89 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.837 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.583 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.56 87.71 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.794 0.33 . . . . 0.0 110.778 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.4 p -81.53 -14.9 56.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.449 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -90.94 -41.33 11.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.612 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.81 -16.79 64.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.696 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 56.01 43.4 27.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.439 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.37 -147.7 7.4 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.58 142.94 50.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.969 0.414 . . . . 0.0 110.233 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.3 149.61 28.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.312 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -100.65 -152.0 0.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.255 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 56.31 -91.74 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.722 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.512 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.91 175.14 9.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.648 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.512 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.6 mt -121.44 140.79 44.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.816 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.16 168.59 9.96 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.303 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.0 mt -147.22 150.97 35.91 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.464 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.7 -39.0 97.05 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.11 4.3 4.61 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.51 -57.95 3.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.933 0.397 . . . . 0.0 110.594 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -62.39 -37.18 84.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.109 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.0 -67.36 0.26 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.918 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -54.06 -41.77 68.52 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.06 18.12 0.15 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.684 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.98 47.72 0.26 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.3 mp 39.07 -109.82 0.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.696 0.284 . . . . 0.0 110.664 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.456 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.9 m120 -61.21 -44.26 97.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.372 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 83.98 8.18 84.43 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -99.29 -12.58 20.22 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.739 -0.271 . . . . 0.0 110.671 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.8 t 176.48 142.31 0.07 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.097 0.475 . . . . 0.0 110.488 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.3 tt -147.79 126.16 12.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.201 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -99.25 142.95 30.08 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.035 0.445 . . . . 0.0 110.621 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.63 106.54 18.52 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.433 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.474 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 93.2 t80 -102.23 -12.55 17.92 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.007 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.4 90.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.813 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.29 173.8 46.18 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.452 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -74.59 -112.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.691 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.57 -28.45 67.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.753 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -59.81 -43.86 94.28 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.913 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -63.72 -44.1 94.6 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.318 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.69 -59.38 4.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.181 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.81 -43.1 62.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.054 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.51 -43.94 76.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.129 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.9 mt -64.05 -43.55 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.962 0.411 . . . . 0.0 110.707 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -57.1 -37.67 72.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.067 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.14 0.8 20.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.278 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -114.73 91.14 24.47 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.248 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.83 -27.35 27.02 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.824 2.35 . . . . 0.0 111.619 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.51 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -41.26 98.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.637 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.8 mp -95.18 4.8 53.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.314 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.49 -35.61 70.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.711 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.37 4.56 14.98 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.436 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.541 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.71 121.54 81.52 Favored Pre-proline 0 N--CA 1.438 -1.033 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.581 -179.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.56 -37.71 27.03 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.242 1.961 . . . . 0.0 112.542 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.541 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -58.91 -43.8 91.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.59 -43.77 93.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.351 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.67 -40.65 95.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.534 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.0 t-20 -89.59 -12.4 39.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.647 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 61.92 31.97 18.0 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.78 44.38 1.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.329 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.77 135.47 43.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.455 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -116.2 132.58 56.62 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.468 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.495 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.9 87.92 6.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.775 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.461 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.1 mt -63.68 -41.74 98.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.817 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.474 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.47 166.45 34.66 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.1 p -75.59 -26.07 57.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.879 0.371 . . . . 0.0 110.823 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.541 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.2 tp10 -68.04 -34.25 76.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.444 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.486 ' O ' ' CG2' ' A' ' 296' ' ' THR . 98.0 m -72.47 20.59 0.07 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.688 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.541 ' H ' ' C ' ' A' ' 295' ' ' GLU . 49.0 t80 -57.54 -51.12 70.77 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.951 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.1 mmt-85 -107.43 149.26 28.11 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 41.0 tp -115.91 126.23 53.63 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 123.411 0.444 . . . . 0.0 110.888 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 42.0 t0 -149.55 166.91 27.81 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.554 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.57 -37.99 29.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.435 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -71.71 -64.99 0.82 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.604 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.8 p -60.96 -32.66 72.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.973 0.416 . . . . 0.0 111.183 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.93 -25.37 28.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.6 mtt -63.61 -41.21 98.33 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 120.984 0.421 . . . . 0.0 110.999 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -77.92 -44.42 27.03 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.052 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.85 -43.1 93.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.409 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.429 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.7 tp -60.36 -46.63 89.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.317 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -70.51 -39.22 74.22 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.559 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.495 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 73.4 ttt180 -61.42 -38.26 86.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.219 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.35 4.27 43.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.833 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.636 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.0 tttt -111.65 -11.84 13.96 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.136 0.493 . . . . 0.0 110.323 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.24 -37.25 84.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.68 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -61.15 -48.34 82.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.358 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.023 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.23 -2.71 58.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.395 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.481 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.67 178.91 1.29 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.468 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.9 Cg_exo -60.84 144.84 99.63 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.749 2.299 . . . . 0.0 112.204 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.4 ptt-85 -155.76 -179.48 8.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.57 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.74 136.5 53.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.34 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.35 147.32 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.452 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.2 p -120.5 136.01 54.9 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.7 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.1 p30 -98.97 -143.7 0.32 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.254 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.62 -37.27 86.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.509 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.53 -67.43 0.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.527 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.0 142.66 43.98 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.1 p -112.42 131.17 55.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.924 0.392 . . . . 0.0 110.397 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -118.99 129.31 55.08 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.547 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 m -86.16 131.24 34.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.982 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.3 mt -96.51 78.96 3.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.421 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.83 -32.67 74.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.491 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 t 176.78 110.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.103 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -123.79 91.11 50.04 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.228 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.3 Cg_exo -56.91 149.11 63.25 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.697 2.265 . . . . 0.0 111.765 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.22 81.99 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.602 0.564 . . . . 0.0 110.986 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.39 66.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.092 0.473 . . . . 0.0 110.236 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.2 mt -77.36 131.17 35.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.573 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.0 t -122.6 148.07 26.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.17 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 t -136.62 143.62 43.63 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.607 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.616 ' HG1' ' H ' ' A' ' 50' ' ' SER . 26.9 p -99.3 -59.31 1.75 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.557 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.616 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.3 p -79.52 156.37 27.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.63 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.5 t -74.88 -21.51 16.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.636 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.7 m -60.2 -51.88 67.68 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.455 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.7 mt -66.46 -42.3 87.79 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.36 0.6 . . . . 0.0 110.906 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.22 -54.41 4.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.145 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.0 -38.78 74.45 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 m -62.38 -43.6 98.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.884 0.373 . . . . 0.0 110.357 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.1 mt -65.28 -42.65 92.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.403 0.621 . . . . 0.0 110.719 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 tp -63.07 -38.65 92.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.221 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.64 -36.52 81.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.948 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -91.58 27.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.027 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.419 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 98.6 m-20 57.22 52.45 8.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.253 0.345 . . . . 0.0 110.789 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.72 75.39 31.31 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.049 0.452 . . . . 0.0 109.989 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.96 148.49 93.42 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.735 2.29 . . . . 0.0 112.177 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -112.75 135.97 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.195 0.521 . . . . 0.0 110.275 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.85 -43.3 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.192 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.68 130.85 53.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 110.55 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.9 p -155.14 168.42 27.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.461 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.37 -177.71 21.94 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.46 172.46 12.68 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.878 0.371 . . . . 0.0 110.541 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.1 p -132.9 -112.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.269 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.31 179.91 0.9 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.274 -178.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.7 Cg_exo -61.16 57.87 0.1 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.015 2.476 . . . . 0.0 112.126 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.8 t-20 -64.36 -33.41 75.79 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.878 -0.582 . . . . 0.0 110.571 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 43.9 m-20 93.71 -35.5 0.02 OUTLIER 'General case' 0 C--N 1.345 0.383 0 O-C-N 124.322 1.014 . . . . 0.0 109.948 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -63.27 -39.97 96.09 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.283 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -74.31 -25.43 19.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.7 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.16 -170.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.65 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.66 -155.24 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.828 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.8 p-10 -51.57 -7.95 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.641 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.53 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -85.42 115.23 23.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.564 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.23 70.71 1.33 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -144.64 148.55 34.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 110.69 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.8 mp -86.29 -98.63 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.266 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.8 -42.97 97.59 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.179 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.592 ' NE2' ' HZ2' ' A' ' 88' ' ' LYS . 35.7 tt0 91.88 52.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 124.136 0.898 . . . . 0.0 110.784 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -102.41 -8.92 20.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.446 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.9 p -64.78 -34.25 77.89 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.131 0.491 . . . . 0.0 110.648 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.592 ' HZ2' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.57 -24.62 1.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.6 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 81.9 t -69.29 -45.55 78.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.925 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.31 81.76 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.155 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.33 -38.22 88.63 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.276 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.51 -33.87 56.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.292 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.57 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.2 mmt-85 -88.76 0.99 55.97 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.67 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 57.2 mttp 83.02 -47.61 0.14 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 124.25 0.968 . . . . 0.0 110.316 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.5 mt -47.2 153.18 0.5 Allowed 'General case' 0 CA--C 1.49 -1.359 0 CA-C-O 117.604 -1.189 . . . . 0.0 109.124 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.644 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 122.31 91.72 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 O-C-N 125.54 1.775 . . . . 0.0 110.469 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -74.81 142.59 44.21 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.963 0.411 . . . . 0.0 110.299 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 mt -131.65 26.41 4.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.741 0.305 . . . . 0.0 110.464 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.06 137.29 34.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.946 0.403 . . . . 0.0 110.479 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.52 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 90.7 mt -137.17 164.94 28.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.354 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.52 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.21 -28.73 1.82 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.03 70.6 7.79 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.25 0.548 . . . . 0.0 110.348 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.97 145.25 98.8 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.808 2.339 . . . . 0.0 112.041 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.8 t -134.85 137.11 42.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.541 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.89 -38.44 83.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.665 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.28 -42.21 96.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.501 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.6 98.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.526 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.54 -43.36 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.037 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.07 -35.17 77.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.376 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.31 -18.74 60.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.495 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.6 -6.46 58.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.561 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.5 mtp 47.87 55.74 17.11 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.627 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.14 149.35 64.34 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.791 2.327 . . . . 0.0 112.121 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.41 -72.76 0.67 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.481 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.6 tp -111.33 113.15 25.41 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.367 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.8 mt -102.19 126.56 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.451 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.6 mt -110.57 134.0 52.79 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.173 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.55 140.22 45.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.446 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 121' ' ' THR . 94.8 p -83.61 167.2 17.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.665 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.58 -36.66 79.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.472 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.426 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.7 t -138.24 157.71 45.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.471 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.36 174.63 34.16 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.29 -33.98 87.77 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -123.57 150.98 43.41 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.92 0.391 . . . . 0.0 110.562 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.6 t -63.57 140.16 58.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.291 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.94 11.44 11.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.631 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.1 -39.25 89.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.098 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.627 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.82 -35.53 24.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.564 0.697 . . . . 0.0 110.705 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -71.11 -35.04 71.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.408 0.623 . . . . 0.0 110.787 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -43.07 -63.19 0.85 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.171 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.627 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.1 p-10 -65.89 -42.81 89.79 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.535 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -61.78 -32.6 72.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.114 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 129' ' ' LEU . 67.6 mt -73.83 -40.3 63.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.187 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.29 -49.31 77.59 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.195 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.5 m -52.62 -42.66 64.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.313 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.08 -42.97 92.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.993 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.31 152.61 5.03 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.623 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -38.58 107.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.677 2.252 . . . . 0.0 112.317 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.404 ' HG1' ' CB ' ' A' ' 133' ' ' LEU . 94.2 m -109.35 120.95 44.08 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.293 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.54 153.64 29.69 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.225 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 tt -130.49 128.93 64.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.376 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.1 mt -110.42 122.84 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.574 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.538 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 53.8 t30 -101.11 106.35 17.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.349 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -100.17 0.45 40.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.897 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -65.52 -34.93 79.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.585 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.0 p-10 -101.29 9.5 41.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -133.85 148.08 51.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.537 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.409 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 22.5 p -77.69 169.05 18.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.579 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.598 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.6 t90 -58.71 -49.74 76.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.087 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -54.41 -46.15 73.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.011 0.434 . . . . 0.0 110.144 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.9 t -63.24 -40.79 98.43 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.345 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.4 tp -60.83 -44.37 97.03 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.367 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.2 -43.49 98.79 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.202 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -54.21 -45.8 72.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.772 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.8 -39.92 93.41 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.854 0.359 . . . . 0.0 110.268 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.439 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.2 mm? -61.9 -42.25 98.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.059 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.8 -38.87 94.81 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.21 -45.75 65.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.963 0.411 . . . . 0.0 110.798 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.72 -44.15 96.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.715 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -92.86 -9.28 40.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.53 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.0 26.51 72.35 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -102.31 50.11 0.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.831 0.348 . . . . 0.0 110.704 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.21 -39.14 78.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.691 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.67 -47.4 85.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.256 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.419 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 86.6 mt-30 -59.99 -39.66 86.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.335 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.59 -40.89 98.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.328 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.15 -29.47 70.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.995 0.426 . . . . 0.0 110.542 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.09 -54.13 8.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.121 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -64.44 -42.79 95.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.474 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.9 mt -62.62 -43.72 98.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.499 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.71 -60.8 3.12 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.255 0.55 . . . . 0.0 110.402 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.23 -34.31 63.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.271 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -80.29 -34.96 36.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.937 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.2 m-20 -55.02 -41.53 71.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.185 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.18 -41.71 98.59 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.575 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.04 -37.74 88.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.269 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.23 -42.6 99.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.796 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.69 -53.04 61.46 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.19 0.519 . . . . 0.0 110.668 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.37 -41.45 89.44 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.544 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.28 -39.9 94.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.644 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.52 -33.23 74.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.365 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -93.21 -21.55 19.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.714 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.626 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -65.21 -41.44 94.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.667 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 30.7 pt -77.48 133.94 29.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.05 0.452 . . . . 0.0 110.696 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -128.09 107.03 9.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.302 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.59 127.76 0.33 Allowed Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.556 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.445 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.3 Cg_exo -43.72 151.7 0.39 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.702 2.268 . . . . 0.0 112.598 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.63 142.51 53.49 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.629 2.219 . . . . 0.0 112.416 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.542 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.61 146.89 2.39 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.659 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.27 154.62 69.4 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.753 2.302 . . . . 0.0 112.29 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.529 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.98 163.4 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.42 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.529 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 1.9 t -143.4 169.97 16.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.896 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.447 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.18 137.4 22.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.964 0.412 . . . . 0.0 110.159 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 38.0 pt -133.98 145.53 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.639 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -131.97 131.5 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.143 0.497 . . . . 0.0 110.548 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -152.62 156.04 38.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.418 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 199' ' ' ALA . 88.4 m -121.57 122.51 39.83 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.947 0.404 . . . . 0.0 110.331 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.496 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.41 -26.26 66.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.414 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.1 -48.74 22.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.014 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.83 -10.09 59.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.414 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.496 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.6 m80 45.88 46.65 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.563 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.0 t -132.16 143.09 49.73 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.402 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -108.08 107.26 17.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.296 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -116.96 130.1 56.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.099 0.476 . . . . 0.0 110.352 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.5 tt -112.03 145.77 39.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.603 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.453 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 9.1 t90 -98.44 127.53 44.41 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.09 0.472 . . . . 0.0 110.043 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.71 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -92.08 153.18 43.26 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.156 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.04 -17.59 45.94 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.822 2.348 . . . . 0.0 111.923 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.71 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -50.19 -19.13 0.7 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.429 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.453 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.4 p -74.52 163.71 27.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.497 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.38 -27.73 64.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.458 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.492 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.5 mt-30 -63.37 -42.74 98.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.628 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.69 -43.58 98.9 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.409 ' OE1' ' C ' ' A' ' 148' ' ' SER . 74.7 mt-30 -63.75 -38.85 92.64 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.865 0.364 . . . . 0.0 110.46 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 85.9 mmm -62.27 -41.52 98.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.251 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.1 -49.25 72.96 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.628 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -52.36 -33.36 42.68 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -71.06 -20.43 62.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.491 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 75.0 mt -87.56 -6.45 58.32 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.63 -6.73 57.45 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -77.74 148.25 34.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.754 0.311 . . . . 0.0 110.622 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.7 p -113.02 126.78 55.87 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.093 0.473 . . . . 0.0 110.331 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -91.94 145.86 24.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.925 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.472 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.88 150.26 46.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.462 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.17 131.4 44.02 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.396 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.627 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.53 93.48 27.75 Favored Pre-proline 0 C--O 1.235 0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.998 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.721 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.7 Cg_exo -55.25 138.37 79.27 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.652 2.234 . . . . 0.0 111.54 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.44 -24.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.537 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.721 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.62 -50.13 21.36 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.586 ' C ' ' H ' ' A' ' 232' ' ' ALA . 98.5 mt -54.55 -35.98 63.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.769 0.318 . . . . 0.0 110.278 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.94 36.2 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.744 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.99 87.68 0.01 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.757 0.313 . . . . 0.0 110.873 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.3 p -81.61 -13.47 57.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.423 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -91.67 -39.48 11.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.544 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.7 t -66.63 -16.84 64.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.613 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.03 43.86 26.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.437 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 178.79 -146.45 7.3 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.22 142.21 50.13 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.925 0.393 . . . . 0.0 110.303 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.18 149.58 28.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.384 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -102.41 -149.36 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.31 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 54.94 -93.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.648 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.484 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 13.0 tt -126.65 173.75 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.581 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.484 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 95.1 mt -121.75 140.6 45.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.767 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.77 172.29 7.35 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.336 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 67.2 mt -146.82 149.08 32.61 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.09 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -62.89 -39.49 98.09 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.94 2.07 3.93 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -78.62 -57.54 3.71 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.93 0.395 . . . . 0.0 110.694 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -62.36 -36.74 83.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.236 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 6.1 mp -53.84 -67.07 0.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.936 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.53 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.79 -42.24 68.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.215 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.01 18.09 0.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.652 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.07 46.91 0.24 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 7.6 mp 39.83 -110.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.637 0.256 . . . . 0.0 110.608 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.472 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 10.8 m120 -60.77 -44.52 96.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.427 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.46 8.03 83.83 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -98.7 -12.54 20.91 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.778 -0.248 . . . . 0.0 110.636 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.1 t 175.75 143.06 0.06 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 110.487 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -147.99 125.9 11.99 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.051 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -98.93 143.44 29.22 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 120.882 0.372 . . . . 0.0 110.867 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.7 mt -94.62 106.3 18.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.584 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.453 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.1 t80 -101.86 -13.15 17.78 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.223 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.03 -40.39 91.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.821 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.64 173.15 45.86 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.457 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.9 m-20 -74.19 -112.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 0.0 110.74 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.76 -28.78 67.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.701 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.84 -44.13 90.89 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.314 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.56 -44.36 94.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.405 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.42 -59.81 3.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.223 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.35 -43.23 61.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.187 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.86 74.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.159 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.2 mt -64.35 -43.57 97.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.64 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.72 -37.58 71.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.246 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.06 0.88 19.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.27 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -114.99 91.13 25.51 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.179 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.01 -27.28 28.08 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.785 2.323 . . . . 0.0 111.81 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -41.24 98.9 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.559 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.9 mp -95.34 5.01 52.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.306 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.03 -35.28 69.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.679 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.21 4.62 14.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.516 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.541 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.82 121.17 80.38 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.618 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -47.53 -37.45 26.34 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.432 2.088 . . . . 0.0 112.46 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.541 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.89 -43.58 90.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.826 0.346 . . . . 0.0 110.235 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.89 -43.76 92.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.291 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.86 -40.53 95.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.494 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 48.0 t-20 -89.64 -12.87 38.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.607 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.39 32.43 16.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.801 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.98 44.03 1.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.409 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.03 135.56 42.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.429 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.97 131.81 56.86 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.459 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.495 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.71 88.73 6.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.708 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.469 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.2 mt -63.95 -41.44 97.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.851 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.453 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.62 165.86 33.86 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.521 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 77.7 p -75.73 -25.62 56.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.831 0.348 . . . . 0.0 110.731 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.4 tp10 -68.29 -33.99 75.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.457 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.495 ' O ' ' CG2' ' A' ' 296' ' ' THR . 97.3 m -73.04 21.53 0.07 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.597 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.543 ' H ' ' C ' ' A' ' 295' ' ' GLU . 50.4 t80 -57.66 -50.86 71.78 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.994 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.3 mmt-85 -108.97 150.89 27.06 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.5 tp -115.48 125.03 52.57 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.765 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 304' ' ' ALA . 40.7 t0 -148.04 165.85 29.54 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.569 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -49.36 -38.19 27.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.524 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -70.72 -65.63 0.71 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.212 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -61.04 -32.96 72.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.021 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 300' ' ' ASP . . . -53.6 -25.7 18.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.495 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.6 mtt -63.7 -40.73 97.51 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 120.835 0.35 . . . . 0.0 110.979 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -78.01 -44.66 25.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.941 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.2 -42.83 91.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.407 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.43 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 47.8 tp -59.57 -47.56 85.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.468 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -69.92 -39.32 76.22 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.606 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.495 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.1 ttt180 -61.77 -37.9 86.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.181 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.6 mt -87.76 4.82 42.85 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.626 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.58 -11.74 13.54 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.018 0.437 . . . . 0.0 110.288 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.95 -36.96 85.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.614 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -61.01 -49.11 78.73 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.434 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.099 179.875 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.614 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -90.37 -2.62 57.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.394 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.476 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.51 178.87 1.3 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.485 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.5 Cg_exo -60.79 145.11 99.47 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.556 2.17 . . . . 0.0 112.191 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.614 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.5 ptt-85 -155.99 -179.77 8.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.609 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -115.6 136.35 53.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.292 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -124.07 146.28 29.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.369 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.9 p -119.84 135.6 54.8 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.714 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.6 p30 -98.43 -144.41 0.31 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.296 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.36 -36.54 84.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.473 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.489 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -147.53 -70.4 0.23 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.593 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.77 144.09 41.68 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.0 p -112.58 130.05 56.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.783 0.325 . . . . 0.0 110.369 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -114.71 129.26 56.66 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.599 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -86.61 130.63 34.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.308 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 70.8 mt -97.84 78.71 2.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.2 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.03 -32.53 74.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.511 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.4 t 178.05 109.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.076 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -123.87 90.76 50.37 Favored Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.218 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.1 Cg_exo -56.66 149.3 59.68 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.709 2.272 . . . . 0.0 111.646 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.3 82.51 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.491 0.494 . . . . 0.0 110.997 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.57 66.84 0.88 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.303 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.2 mt -77.38 131.2 35.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.433 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.8 t -122.46 147.64 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.231 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.5 t -136.51 144.03 44.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.576 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.671 ' HG1' ' H ' ' A' ' 50' ' ' SER . 18.9 p -100.37 -58.9 1.81 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.46 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.671 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.5 p -79.43 155.49 28.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.901 0.381 . . . . 0.0 110.642 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.6 t -74.2 -21.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.696 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.2 m -60.27 -51.7 68.41 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.456 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.4 mt -66.32 -42.62 87.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.532 0.682 . . . . 0.0 110.859 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.3 m -43.29 -54.58 4.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.198 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.91 -38.73 75.36 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.1 m -62.52 -43.73 98.09 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.172 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 48.2 mt -65.31 -42.57 92.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.052 0.453 . . . . 0.0 110.665 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.7 tp -62.95 -38.67 91.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.254 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.69 -36.45 80.92 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.068 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.4 pt -91.34 27.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.081 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 56.99 52.15 9.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.744 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.04 75.34 35.18 Favored Pre-proline 0 C--N 1.334 -0.081 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.34 148.66 92.67 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.596 2.197 . . . . 0.0 112.041 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -112.21 135.76 50.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 121.22 0.533 . . . . 0.0 110.229 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.4 pt -69.73 -43.38 80.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.219 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.8 130.41 52.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.013 0.435 . . . . 0.0 110.599 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.9 p -155.09 168.8 25.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.354 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.48 -177.73 21.86 Favored Glycine 0 N--CA 1.465 0.572 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.36 171.46 13.7 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.7 0.286 . . . . 0.0 110.575 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.0 p -133.82 -110.71 0.22 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.498 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.35 179.78 0.91 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.244 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.1 Cg_exo -60.94 58.51 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.912 2.408 . . . . 0.0 112.089 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.544 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 56.7 t-20 -64.0 -35.23 80.02 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.699 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 48.0 m-20 95.31 -37.15 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.979 1.425 . . . . 0.0 109.986 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -62.69 -40.51 97.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.264 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -72.97 -26.53 23.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.815 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.86 -171.9 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.717 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.513 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -74.33 -153.13 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.805 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.6 p-10 -54.03 -6.86 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.608 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.77 114.06 23.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.962 0.41 . . . . 0.0 110.484 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.48 72.21 1.3 Allowed Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.457 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.4 m-85 -143.87 148.44 35.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 110.806 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.522 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -85.68 -99.24 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.065 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.67 -43.46 96.62 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.377 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.542 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 36.0 tt0 92.08 52.62 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.314 1.009 . . . . 0.0 111.016 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -103.01 -9.16 20.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.507 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.457 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.52 -34.06 77.36 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.136 0.493 . . . . 0.0 110.686 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.542 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.3 -24.67 1.27 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.491 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.94 -45.36 77.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.14 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.3 -48.69 80.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.224 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.49 -38.42 89.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.28 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.55 -32.95 52.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.292 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.562 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.51 1.19 56.25 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 118.868 -0.586 . . . . 0.0 110.681 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 83.16 -48.37 0.14 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.535 1.147 . . . . 0.0 110.348 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.629 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.1 mt -46.81 152.73 0.47 Allowed 'General case' 0 CA--C 1.49 -1.351 0 CA-C-O 117.632 -1.175 . . . . 0.0 108.951 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.629 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.0 tt0 122.25 91.32 0.0 OUTLIER 'General case' 0 C--N 1.358 0.967 0 O-C-N 125.515 1.76 . . . . 0.0 110.66 -178.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.52 143.04 44.72 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.201 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.9 mt -132.08 26.25 4.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.427 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -139.69 136.52 34.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.577 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.514 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 91.5 mt -136.62 164.72 30.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.45 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.514 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.76 -28.88 1.73 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -151.46 70.72 8.25 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.053 0.454 . . . . 0.0 110.354 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.99 145.3 98.69 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.612 2.208 . . . . 0.0 112.016 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.9 t -135.69 137.65 41.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.537 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.08 -38.12 82.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.68 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.27 -42.26 96.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.576 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.07 -41.56 98.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.429 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.57 -43.47 98.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.935 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.09 -35.11 77.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.439 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.34 -19.0 61.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.554 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.54 -6.58 58.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.478 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.4 mtp 47.68 55.81 17.07 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.663 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.8 Cg_endo -70.05 149.4 64.98 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.919 2.412 . . . . 0.0 112.034 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.27 -71.68 0.7 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.43 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.0 tp -112.89 113.62 25.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.221 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.7 mt -102.17 126.85 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.289 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 mt -110.82 133.75 53.1 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.042 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.61 140.18 45.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.6 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 121' ' ' THR . 95.6 p -83.28 167.44 17.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.783 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.94 79.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.475 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.422 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.6 t -138.44 158.02 45.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.471 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.5 175.34 34.16 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.24 -33.91 87.5 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -124.09 150.95 44.43 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.593 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.5 t -63.71 140.68 58.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.306 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.56 11.63 10.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.674 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.7 mp -60.87 -39.58 89.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.165 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.633 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.6 -35.63 24.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.587 0.708 . . . . 0.0 110.596 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.4 mt -70.92 -35.12 72.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.867 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -43.28 -62.82 0.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.298 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.633 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.2 p-10 -65.91 -42.95 89.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.801 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -61.8 -32.85 73.18 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.06 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 129' ' ' LEU . 67.6 mt -73.4 -40.52 64.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.459 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.55 -48.45 80.85 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.278 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.1 m -53.24 -42.11 66.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.33 -42.81 91.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.612 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.11 152.27 5.06 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.673 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -39.11 106.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.572 2.182 . . . . 0.0 111.986 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 95.2 m -108.89 122.06 46.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.323 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.94 154.47 28.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.282 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 tt -130.23 129.22 65.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.474 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 93.1 mt -110.66 122.93 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.503 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.537 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 52.7 t30 -101.45 105.14 16.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.363 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -98.0 -0.19 45.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.004 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.2 p-10 -65.23 -35.04 79.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.028 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.594 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.1 p-10 -101.76 8.51 41.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -133.13 146.82 51.95 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.889 0.376 . . . . 0.0 110.565 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.427 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 21.1 p -78.61 170.41 16.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.545 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.597 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 88.1 t90 -58.31 -49.54 76.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.247 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -54.75 -47.39 73.91 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.22 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.8 t -63.33 -40.81 98.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.121 0.486 . . . . 0.0 110.264 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.01 -44.11 97.9 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.224 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 53.6 tp -61.1 -42.85 99.27 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.314 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.6 m -55.35 -46.39 76.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.666 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.44 -40.1 93.24 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.253 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.1 mm? -61.84 -42.18 98.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.962 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.42 -38.92 95.42 Favored Glycine 0 C--N 1.317 -0.523 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.56 -45.02 66.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.402 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.64 -43.99 96.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.76 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -94.01 -8.48 39.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.563 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.83 25.83 71.97 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -102.81 51.17 0.81 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.787 0.327 . . . . 0.0 110.818 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.23 -38.73 78.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.117 0.484 . . . . 0.0 110.744 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.87 -46.99 87.55 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.392 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -61.37 -39.17 89.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.296 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.1 -40.57 98.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.309 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.73 -28.06 69.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.23 0.538 . . . . 0.0 110.458 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -75.2 -52.76 10.15 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.174 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.72 -42.92 97.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.45 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 174' ' ' ASP . 86.7 mt -62.83 -43.83 99.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.594 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.47 -61.09 2.78 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.15 0.5 . . . . 0.0 110.56 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.63 -35.4 63.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.228 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -79.59 -35.14 40.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.106 0.479 . . . . 0.0 111.265 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.4 m-20 -55.33 -40.67 71.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.297 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.45 -41.87 99.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.631 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.36 -38.08 88.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.31 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 77.3 mt -62.27 -42.58 99.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.711 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.83 -53.25 58.44 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.053 0.454 . . . . 0.0 110.729 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.41 -41.39 89.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.587 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.72 94.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.624 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.08 -32.71 74.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.332 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -94.05 -21.88 18.87 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.764 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.631 ' NE2' ' HZ2' ' A' ' 312' ' ' LYS . 52.1 tt0 -64.79 -41.88 95.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.72 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.5 pt -76.33 134.43 28.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.684 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.58 106.52 9.22 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.184 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.5 127.92 0.34 Allowed Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.586 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.445 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.9 Cg_exo -43.57 151.69 0.36 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.615 2.21 . . . . 0.0 112.508 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.68 142.33 52.68 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.806 2.337 . . . . 0.0 112.299 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.39 146.68 2.46 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.664 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.02 154.01 71.38 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.716 2.277 . . . . 0.0 112.122 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.521 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.41 162.86 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.434 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.566 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.0 t -143.5 169.64 17.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.805 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.566 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -147.74 137.38 22.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.276 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.5 pt -134.24 146.25 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.652 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.47 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.88 131.52 59.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.081 0.467 . . . . 0.0 110.504 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -151.63 154.69 36.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.391 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.2 m -121.97 122.85 40.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.973 0.416 . . . . 0.0 110.268 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.42 -25.76 66.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.424 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.401 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.31 -49.15 20.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.105 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.23 -10.79 60.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.5 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.1 m80 47.93 42.95 17.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.495 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.1 t -136.47 145.35 45.07 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.386 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.22 113.92 26.76 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.296 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.89 133.62 55.52 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.359 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.41 146.18 38.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.721 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.48 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.4 t90 -99.69 127.93 45.8 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.021 0.438 . . . . 0.0 109.952 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.706 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -93.12 153.69 41.69 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.947 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.401 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.2 Cg_endo -67.58 -18.33 48.6 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.895 2.397 . . . . 0.0 111.931 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.706 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -49.6 -18.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.504 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.48 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.0 p -75.61 167.51 21.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.485 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.46 -35.13 75.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.447 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.2 mt-30 -56.42 -41.33 76.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.676 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.35 -42.89 97.63 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.483 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.7 mt-30 -63.59 -40.45 96.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.881 0.372 . . . . 0.0 110.302 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.597 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.2 mmm -61.87 -41.58 98.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.182 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.59 -49.95 71.34 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.661 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -52.92 -32.36 45.04 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -71.94 -19.89 61.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.54 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 64.4 mt -87.46 -6.45 58.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.57 3.94 57.24 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -89.28 151.39 22.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.711 0.291 . . . . 0.0 110.553 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.6 p -114.44 127.63 55.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.994 0.426 . . . . 0.0 110.402 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.563 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.97 144.71 25.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.905 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.468 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.23 150.71 47.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.416 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.79 131.36 44.62 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.298 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.626 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.82 92.49 25.34 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.123 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.715 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.8 Cg_exo -55.24 138.9 80.52 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.603 2.202 . . . . 0.0 111.47 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.65 -25.03 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.662 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.715 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.92 -49.68 27.3 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.586 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -54.66 -36.76 64.94 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.59 35.82 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.845 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.02 87.47 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.837 0.351 . . . . 0.0 110.684 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.3 p -81.25 -14.23 57.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.486 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.45 -40.85 11.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.565 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.9 t -66.76 -16.52 64.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.639 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.1 43.64 26.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.518 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.31 -145.55 6.68 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -123.27 143.05 50.31 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 110.349 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.1 ttt-85 -151.49 148.82 28.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.36 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -100.24 -152.62 0.43 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.274 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 56.46 -92.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.593 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.509 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.56 175.09 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.635 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.509 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -120.72 140.29 45.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.769 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.01 169.03 9.71 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.406 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.8 mt -147.59 150.61 34.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.317 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.85 -38.82 96.68 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.39 3.81 4.62 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -77.24 -58.02 3.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.877 0.37 . . . . 0.0 110.678 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.36 -36.62 82.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.255 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.45 -67.44 0.25 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.828 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.74 -42.11 67.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.22 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.74 18.17 0.14 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.742 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.41 47.96 0.21 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.3 mp 39.19 -110.22 0.09 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.734 0.302 . . . . 0.0 110.631 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.468 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.1 m120 -60.97 -44.87 96.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.467 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.61 8.39 83.06 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -99.4 -12.26 20.41 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.607 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.6 t 176.15 142.46 0.07 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.073 0.463 . . . . 0.0 110.555 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -148.17 125.74 11.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.058 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -98.97 142.9 29.88 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.024 0.44 . . . . 0.0 110.567 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.5 mt -94.47 106.62 18.61 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.533 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.477 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 93.0 t80 -102.66 -11.95 18.05 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.199 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.75 -39.89 88.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.8 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.13 173.82 46.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.456 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 96.3 m-20 -74.98 -112.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.799 0.333 . . . . 0.0 110.658 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.83 -28.44 67.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.753 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.55 -43.97 93.39 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.031 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.34 -44.47 94.8 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.433 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.53 -59.51 4.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.243 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.6 -43.19 62.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.128 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.39 -44.08 75.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.2 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.4 mt -64.19 -43.61 97.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.949 0.404 . . . . 0.0 110.735 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -56.8 -37.68 71.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.121 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.31 1.03 19.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.386 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -114.64 91.29 24.71 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.423 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.79 -27.54 27.38 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.836 2.357 . . . . 0.0 111.696 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.39 -41.32 98.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.63 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.8 mp -95.32 4.83 53.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.251 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.71 -35.58 70.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.697 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.62 4.68 15.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.428 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.553 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.74 121.71 82.2 Favored Pre-proline 0 N--CA 1.441 -0.916 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.575 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.34 -38.21 26.15 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.32 2.014 . . . . 0.0 112.446 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.553 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -58.83 -43.77 90.76 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.821 0.343 . . . . 0.0 110.077 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.96 -43.64 92.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.373 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.85 -40.75 95.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.576 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.446 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 48.6 t-20 -89.27 -12.59 40.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.648 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.3 mtmt 62.52 31.92 16.79 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -88.67 44.7 1.23 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.391 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.6 134.95 46.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.515 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -116.25 132.38 56.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.468 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.495 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.52 88.22 6.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.693 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.468 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.8 mt -63.88 -41.61 97.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.772 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.477 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.83 167.15 34.51 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.2 p -75.6 -25.66 57.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.822 0.344 . . . . 0.0 110.711 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.6 tp10 -68.09 -34.54 76.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.512 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.492 ' O ' ' CG2' ' A' ' 296' ' ' THR . 98.6 m -72.5 17.68 0.11 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.598 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.513 ' O ' ' NE2' ' A' ' 212' ' ' GLN . 47.8 t80 -56.89 -51.28 69.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.115 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 -106.09 147.4 28.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.062 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.3 tp -115.27 125.61 53.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 123.461 0.476 . . . . 0.0 110.796 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 304' ' ' ALA . 42.5 t0 -149.62 166.75 28.36 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.52 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -49.5 -38.13 29.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.476 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -71.51 -64.92 0.83 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.24 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -61.28 -32.53 72.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.948 0.404 . . . . 0.0 110.944 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 300' ' ' ASP . . . -54.56 -25.8 28.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.393 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.7 mtt -63.57 -41.11 98.41 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.898 0.38 . . . . 0.0 110.811 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.6 -44.59 27.87 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.848 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 77.4 t -66.12 -42.87 92.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.434 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 48.4 tp -59.88 -46.87 87.94 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.374 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -70.72 -39.12 73.58 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.463 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.495 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.2 ttt180 -61.56 -38.06 86.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.273 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.59 4.62 43.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.914 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.631 ' HZ2' ' NE2' ' A' ' 183' ' ' GLN . 87.0 tttt -111.95 -12.27 13.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.118 0.485 . . . . 0.0 110.423 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.55 -37.01 84.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.678 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.02 -48.73 80.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.387 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.228 179.771 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -90.1 -2.69 58.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.406 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.04 1.25 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.489 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.2 Cg_exo -60.78 145.09 99.5 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.75 2.3 . . . . 0.0 112.168 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.04 -179.65 8.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.585 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.61 136.06 53.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.311 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -123.34 146.24 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.358 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.0 p -120.35 136.42 54.71 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.767 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 53.1 p30 -100.03 -142.99 0.33 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.2 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -62.87 -37.19 85.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.513 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.464 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -152.01 -59.99 0.16 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.413 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -60.52 139.82 48.11 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.7 p -111.83 129.98 55.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.916 0.388 . . . . 0.0 110.461 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.97 128.84 53.94 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.523 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.8 m -85.45 130.62 34.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.222 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.9 mt -96.27 79.04 3.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.311 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.55 -32.03 73.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.485 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.01 109.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.063 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -121.73 91.31 48.59 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.226 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.8 Cg_exo -57.05 148.95 65.58 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.759 2.306 . . . . 0.0 111.787 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.72 82.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 O-C-N 123.566 0.541 . . . . 0.0 110.983 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.24 66.95 0.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.111 0.482 . . . . 0.0 110.233 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.75 130.74 35.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.589 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.5 t -122.71 146.07 28.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.106 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 t -135.85 143.47 45.12 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.624 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.557 ' HG1' ' H ' ' A' ' 50' ' ' SER . 25.5 p -99.24 -59.31 1.75 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.51 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.557 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.8 p -79.37 154.62 28.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.638 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.4 t -73.98 -21.72 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.573 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.404 ' O ' ' OG ' ' A' ' 56' ' ' SER . 99.8 m -60.28 -52.0 67.12 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.477 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.45 -42.34 87.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.368 0.604 . . . . 0.0 110.943 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.22 -53.93 4.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.099 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.1 -37.48 72.86 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 52' ' ' THR . 5.8 m -62.76 -44.6 95.77 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-O 120.848 0.356 . . . . 0.0 110.424 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.6 mt -66.19 -41.95 89.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.477 0.656 . . . . 0.0 110.728 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.57 -40.34 96.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.431 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.93 -35.71 75.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.976 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.7 pt -91.51 28.44 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.138 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.72 51.42 11.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.851 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.45 75.02 27.89 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.984 0.421 . . . . 0.0 109.941 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.17 151.3 85.94 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.765 2.31 . . . . 0.0 112.263 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.59 137.3 47.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.207 0.527 . . . . 0.0 110.235 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.417 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -69.13 -43.7 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.218 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.03 130.86 53.17 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.959 0.409 . . . . 0.0 110.548 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.529 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.1 p -155.59 168.96 25.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.408 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.86 -177.38 21.64 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.06 172.21 12.95 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.976 0.417 . . . . 0.0 110.498 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.8 p -134.05 -110.38 0.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.402 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.18 179.74 0.92 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.323 -179.018 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.5 Cg_exo -60.99 58.93 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 123.03 2.487 . . . . 0.0 112.088 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 56.7 t-20 -64.22 -35.16 79.92 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.586 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.602 HD22 ' HG1' ' A' ' 294' ' ' THR . 46.2 m-20 94.91 -37.67 0.01 OUTLIER 'General case' 0 C--N 1.346 0.454 0 O-C-N 124.377 1.048 . . . . 0.0 109.938 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -62.7 -40.08 96.02 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.244 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -73.88 -26.77 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.724 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.76 -172.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.627 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.64 -152.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.742 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.6 p-10 -54.76 -6.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.681 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.516 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -87.06 113.68 23.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.609 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.25 73.06 1.27 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.506 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.2 m-85 -143.94 148.58 35.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.825 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -85.84 -99.36 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.086 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.09 -42.95 96.76 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.142 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.548 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.2 tt0 91.6 53.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.088 0.867 . . . . 0.0 110.834 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -103.47 -9.21 19.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.453 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.506 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.2 p -64.9 -33.78 76.84 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.112 0.482 . . . . 0.0 110.664 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.548 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.62 -23.8 1.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.554 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.5 t -69.52 -46.0 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.978 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.35 81.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.117 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.72 -38.2 89.54 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.284 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.66 -32.16 50.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.226 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.572 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.5 mmt-85 -90.12 1.7 56.1 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 119.204 -0.426 . . . . 0.0 110.609 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 82.85 -49.11 0.16 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.212 0.945 . . . . 0.0 110.322 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.642 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.3 mt -46.49 153.96 0.33 Allowed 'General case' 0 CA--C 1.49 -1.34 0 CA-C-O 117.587 -1.197 . . . . 0.0 109.148 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.642 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.2 tt0 121.23 92.19 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 O-C-N 125.558 1.786 . . . . 0.0 110.529 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.529 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.21 143.46 43.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.218 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -132.12 26.95 4.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.733 0.301 . . . . 0.0 110.462 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.54 138.42 34.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.959 0.409 . . . . 0.0 110.469 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.521 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.6 mt -137.3 165.02 28.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.351 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.521 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.29 -28.59 1.81 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.95 70.95 7.15 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.188 0.518 . . . . 0.0 110.358 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.24 145.69 98.0 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 122.803 2.335 . . . . 0.0 112.032 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.2 t -134.38 136.64 43.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.568 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.14 82.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.716 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.5 -41.94 96.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.507 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.47 98.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.514 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.66 -43.35 98.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.06 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.99 -35.17 77.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.311 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -18.52 60.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.468 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.5 -6.34 58.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.526 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.0 mtp 48.0 55.74 17.17 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.651 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.15 149.12 63.94 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.777 2.318 . . . . 0.0 112.114 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -101.2 -73.37 0.65 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.46 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.3 tp -110.84 112.63 24.62 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.324 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -101.13 125.99 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.446 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.2 mt -109.5 133.27 53.28 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.149 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.22 139.48 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.484 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 121' ' ' THR . 92.9 p -83.42 168.41 16.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.648 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.56 80.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.44 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.426 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -139.51 159.18 42.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.424 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.2 177.01 33.46 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.94 87.5 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.77 151.98 44.42 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.962 0.41 . . . . 0.0 110.527 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.6 t -62.97 141.07 58.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.362 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.66 10.15 10.96 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.647 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.7 mp -60.98 -39.18 88.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.061 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.68 -35.91 24.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.54 0.686 . . . . 0.0 110.671 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.5 mt -70.83 -35.57 72.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.458 0.647 . . . . 0.0 110.774 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -42.78 -62.86 0.89 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.265 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.83 -42.61 90.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.994 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -62.33 -32.97 73.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.129 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.8 mt -73.48 -40.71 63.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.19 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.41 -48.66 79.96 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.206 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.7 m -53.28 -42.16 66.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.208 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.01 -43.04 92.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.002 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.62 154.08 5.34 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.625 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -39.13 107.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.666 2.244 . . . . 0.0 112.298 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 94.5 m -109.75 121.4 45.14 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.252 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.28 152.82 30.75 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.252 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 tt -128.27 131.42 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.359 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.29 127.42 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.397 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.88 103.6 14.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.364 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.9 p90 -101.12 -11.32 19.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.782 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.91 -33.47 76.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.622 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.2 p-10 -98.35 7.57 46.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.643 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.7 mttm -135.33 155.35 50.75 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.568 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.0 p -74.54 165.47 25.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.687 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.584 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -59.86 -48.7 80.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.298 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -53.86 -41.93 68.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.918 0.389 . . . . 0.0 110.081 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.4 t -62.42 -40.82 97.77 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.402 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 tp -60.66 -43.87 97.12 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.355 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.0 tp -61.39 -43.07 99.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.861 0.363 . . . . 0.0 110.14 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.2 m -55.54 -45.3 77.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.716 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.49 -40.6 97.24 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 120.877 0.37 . . . . 0.0 110.395 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.433 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -62.02 -42.34 99.06 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.233 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.77 -41.05 95.93 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.72 -46.21 63.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.968 0.413 . . . . 0.0 110.894 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.6 mt -64.52 -44.05 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.819 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 156' ' ' LEU . 31.8 p -93.23 -8.75 41.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.6 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.09 25.05 72.07 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -101.72 51.73 0.83 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.787 0.327 . . . . 0.0 110.681 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.79 -38.92 76.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.698 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.5 -46.92 87.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.187 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -61.37 -39.04 89.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.375 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.16 -40.45 97.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.362 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.3 -27.8 69.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.542 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.77 -53.71 8.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.171 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.75 -43.31 96.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.468 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 174' ' ' ASP . 86.7 mt -63.05 -43.9 99.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.676 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.33 -61.51 2.5 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.12 0.486 . . . . 0.0 110.484 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -54.81 -35.22 63.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.365 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -79.44 -34.72 41.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.114 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.3 m-20 -56.9 -40.01 75.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.926 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.83 -42.39 99.71 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.733 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.82 -37.74 87.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.294 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.41 -42.5 99.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.7 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.0 -53.14 59.79 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.128 0.489 . . . . 0.0 110.711 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.44 -41.41 89.16 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.548 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.26 -39.82 94.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.622 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.3 -32.33 73.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.338 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.21 -21.88 18.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.745 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.638 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -65.02 -41.42 95.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.698 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 pt -77.58 136.33 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.679 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.46 108.65 11.0 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.274 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.18 126.15 0.33 Allowed Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.89 152.18 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.724 2.283 . . . . 0.0 112.586 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.13 141.71 53.5 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.676 2.25 . . . . 0.0 112.469 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -170.96 147.07 2.24 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.669 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.13 154.5 70.15 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.734 2.289 . . . . 0.0 112.265 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.44 163.18 28.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.419 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.528 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.1 t -143.65 170.05 16.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.857 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.528 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -147.79 137.45 22.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.226 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.3 pt -134.03 146.01 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.603 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.72 131.68 59.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.133 0.492 . . . . 0.0 110.457 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -152.01 155.11 37.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.419 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.2 m -122.25 122.93 40.27 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.916 0.389 . . . . 0.0 110.382 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.37 -25.84 66.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.569 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.24 -49.17 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.086 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.59 -12.87 61.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.472 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.7 m80 50.43 41.55 25.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.439 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.9 t -136.27 144.79 44.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.339 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.5 114.31 27.62 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.35 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.1 m-20 -119.86 133.4 55.6 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.067 0.46 . . . . 0.0 110.372 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -111.98 146.32 38.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.756 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.449 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 12.3 t90 -99.29 129.54 45.52 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.062 0.458 . . . . 0.0 110.026 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.708 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.43 153.72 39.5 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.082 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.66 -18.29 48.12 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.791 2.328 . . . . 0.0 111.888 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.708 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -49.11 -18.71 0.35 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.45 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.449 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.1 p -75.65 165.23 25.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.496 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.14 -28.19 66.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.545 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.1 mt-30 -63.61 -41.43 98.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.17 -44.67 97.15 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.5 -38.92 92.7 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.981 0.42 . . . . 0.0 110.567 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.584 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.1 mmm -62.28 -41.36 98.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.114 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.5 mt -63.67 -47.05 82.8 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.648 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.48 -31.95 56.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.057 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -70.74 -18.14 62.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.543 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 91.4 mt -88.63 -8.67 54.24 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.692 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.85 2.52 55.12 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -88.57 152.46 21.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.768 0.318 . . . . 0.0 110.565 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.2 p -115.35 128.15 55.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.101 0.477 . . . . 0.0 110.378 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.46 146.02 24.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.852 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.455 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.64 151.16 46.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.463 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.9 131.59 42.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.408 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.63 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.56 93.4 27.59 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.061 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.716 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.0 Cg_exo -55.61 139.16 82.58 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.588 2.192 . . . . 0.0 111.519 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.86 -25.47 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.507 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.716 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.66 -49.88 27.9 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.583 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -53.99 -37.07 63.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.771 0.32 . . . . 0.0 110.19 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -66.71 35.96 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.815 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.583 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.32 88.13 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.4 p -81.72 -14.36 56.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.335 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -91.37 -41.41 10.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.564 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.7 t -66.88 -16.62 64.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.682 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.1 43.54 26.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.495 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.63 -147.99 7.63 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -121.75 143.11 49.57 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.953 0.406 . . . . 0.0 110.354 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -151.97 149.43 28.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.349 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -100.83 -151.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.313 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 55.87 -91.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.609 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.51 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.4 tt -126.67 175.12 9.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.559 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.51 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.8 mt -121.73 141.42 42.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.841 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.68 169.16 9.46 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.259 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.2 mt -147.73 150.83 35.02 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.181 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.58 -39.04 97.18 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.33 3.98 4.6 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -77.33 -58.03 3.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.001 0.429 . . . . 0.0 110.649 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.15 -36.86 83.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.221 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.36 -67.76 0.22 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.747 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.45 -42.17 66.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.248 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.11 17.92 0.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.672 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.99 48.59 0.29 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.42 -109.83 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.647 0.26 . . . . 0.0 110.744 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.455 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 12.0 m120 -60.96 -44.82 96.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.454 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.41 8.09 83.82 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -99.1 -12.95 20.05 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.783 -0.245 . . . . 0.0 110.646 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.426 ' HG ' ' N ' ' A' ' 259' ' ' LEU . 5.0 t 176.69 142.57 0.07 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.121 0.486 . . . . 0.0 110.514 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.426 ' N ' ' HG ' ' A' ' 258' ' ' SER . 9.2 tt -147.94 125.94 12.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.074 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -99.08 143.1 29.73 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 120.927 0.394 . . . . 0.0 110.79 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.4 mt -94.49 106.35 18.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.632 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.455 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.4 t80 -101.96 -12.29 18.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.163 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.22 -40.14 90.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.862 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.67 174.19 46.4 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.466 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.6 m-20 -74.67 -113.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 0.0 110.662 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.65 -28.61 67.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.743 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.04 -44.11 91.72 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.245 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.53 -44.28 94.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.398 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.56 -59.81 4.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.208 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.39 -43.34 61.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.151 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.34 -43.92 75.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.23 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.41 -43.6 97.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.682 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -56.55 -37.44 70.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.207 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.76 1.09 18.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.297 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -115.04 91.21 26.07 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.174 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.21 -27.11 28.86 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.803 2.336 . . . . 0.0 111.767 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.33 -41.06 98.87 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.641 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.22 4.93 53.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.371 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.63 -35.21 70.35 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.75 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.59 4.56 15.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.512 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.75 121.39 81.03 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.592 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -47.67 -37.67 27.77 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.46 2.107 . . . . 0.0 112.453 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.554 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -59.06 -43.75 91.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.788 0.328 . . . . 0.0 110.211 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.85 -43.75 93.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.251 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.72 -40.52 95.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.449 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.76 -12.43 39.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.534 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.2 mtmt 61.99 31.56 17.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.39 44.01 1.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.384 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.04 135.91 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.497 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.47 132.87 56.56 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.428 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.15 87.75 7.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.723 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.468 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.3 mt -64.01 -41.25 97.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.92 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.455 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.98 168.45 34.97 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.602 ' HG1' HD22 ' A' ' 74' ' ' ASN . 73.0 p -76.05 -25.81 55.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.858 0.361 . . . . 0.0 110.731 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.528 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.1 tp10 -67.61 -34.18 76.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.465 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.494 ' O ' ' CG2' ' A' ' 296' ' ' THR . 97.0 m -73.52 20.47 0.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.648 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.557 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 57.0 t80 -57.63 -51.13 70.77 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.942 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 65.2 mmt-85 -108.28 149.72 28.26 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.4 tp -115.32 125.35 53.14 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.805 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 42.2 t0 -149.11 166.46 28.69 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.552 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -49.24 -38.16 25.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.61 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -71.54 -65.21 0.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.371 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -60.93 -32.86 72.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.47 -25.65 26.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.566 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.6 mtt -63.33 -40.87 98.5 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 120.865 0.364 . . . . 0.0 110.944 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.77 -44.22 23.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 78.8 t -66.17 -43.03 92.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.403 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.3 tp -60.23 -47.06 87.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.466 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -69.83 -39.9 76.19 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.035 0.445 . . . . 0.0 110.744 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.498 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.2 ttt180 -61.61 -38.19 86.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.198 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.11 4.45 42.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.767 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.638 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -112.47 -11.51 13.62 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.045 0.45 . . . . 0.0 110.259 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.97 85.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.644 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.1 -48.87 79.67 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.339 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.042 179.947 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.44 -2.76 57.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.444 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.49 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.41 178.98 1.27 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.536 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.3 Cg_exo -60.75 144.82 99.61 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.652 2.235 . . . . 0.0 112.212 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.69 -179.75 8.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.608 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.58 136.69 52.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.392 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.1 tp -124.55 146.28 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.361 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.8 p -119.81 136.09 54.6 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.779 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.9 p30 -98.74 -144.17 0.32 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.273 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.56 -36.63 84.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.47 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.486 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.9 ttt85 -147.32 -70.59 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.565 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.81 144.07 41.81 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.2 p -112.68 130.08 56.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 0.0 110.397 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -114.8 129.65 56.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.686 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.9 m -86.83 130.6 34.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.342 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.1 mt -97.41 79.06 2.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.437 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -65.94 -32.55 74.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.53 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 t 177.09 109.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.155 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -123.36 91.59 49.64 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.324 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.3 Cg_exo -56.81 149.0 62.9 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.71 2.273 . . . . 0.0 111.82 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.69 83.05 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.933 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.48 67.27 0.89 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.316 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.59 130.69 35.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.637 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.4 t -123.04 146.31 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.108 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 t -136.16 143.84 44.68 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.626 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.626 ' HG1' ' N ' ' A' ' 50' ' ' SER . 27.7 p -99.35 -59.35 1.74 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.523 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.626 ' N ' ' HG1' ' A' ' 49' ' ' THR . 86.2 p -79.36 155.03 28.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.585 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.5 t -74.36 -21.67 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.582 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.41 ' O ' ' OG ' ' A' ' 56' ' ' SER . 99.7 m -60.23 -52.09 66.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.537 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -66.62 -42.45 86.8 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.243 0.544 . . . . 0.0 110.759 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.8 m -42.88 -54.07 4.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.234 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.34 -37.24 70.51 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.0 m -62.85 -44.62 95.64 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 120.848 0.356 . . . . 0.0 110.428 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.9 mt -66.51 -41.93 88.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.306 0.574 . . . . 0.0 110.732 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.3 tp -62.5 -40.44 96.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.25 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.81 -36.05 75.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.928 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.7 pt -91.06 29.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.103 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 56.43 51.51 11.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.899 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.41 75.79 22.13 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.909 0.385 . . . . 0.0 109.98 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.15 152.11 83.35 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.783 2.322 . . . . 0.0 112.28 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.86 137.54 46.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.104 0.478 . . . . 0.0 110.33 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.419 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.5 pt -69.14 -43.65 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.241 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.1 131.21 53.33 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.948 0.404 . . . . 0.0 110.595 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.5 p -155.57 168.94 25.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.409 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.98 -177.28 21.56 Favored Glycine 0 N--CA 1.464 0.505 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.14 172.31 12.83 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.919 0.39 . . . . 0.0 110.507 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 p -132.35 -112.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.947 0.403 . . . . 0.0 110.462 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.18 179.76 0.93 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.344 -179.185 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.6 Cg_exo -60.8 57.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.962 2.441 . . . . 0.0 112.132 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.7 t-20 -64.41 -33.54 76.09 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.522 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.567 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.6 m-20 93.76 -36.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.08 0.862 . . . . 0.0 109.94 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -62.43 -39.48 93.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.265 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -74.69 -25.68 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.623 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.19 -171.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.86 -153.75 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.758 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.1 p-10 -52.78 -7.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.687 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.52 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.49 115.17 23.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.653 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.94 69.85 1.35 Allowed Glycine 0 CA--C 1.521 0.42 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.449 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.2 m-85 -143.16 147.51 35.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.815 0.341 . . . . 0.0 110.832 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.528 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.3 mp -85.61 -98.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.185 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.1 -42.64 96.84 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.122 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.0 tt0 91.51 53.14 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.866 0.729 . . . . 0.0 110.878 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -103.13 -9.05 19.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.447 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.449 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.79 -33.74 76.69 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.058 0.456 . . . . 0.0 110.65 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.55 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.18 -23.85 1.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.613 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.53 -46.0 76.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.936 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.41 -48.19 82.34 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.237 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.65 -38.26 89.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.292 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.78 -32.31 52.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.238 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.594 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.3 mmt-85 -90.19 1.65 56.21 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.57 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 56.9 mttp 82.64 -49.55 0.18 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.954 0.784 . . . . 0.0 110.29 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.671 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.7 mt -45.87 154.52 0.23 Allowed 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 118.16 -0.924 . . . . 0.0 109.453 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.671 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 120.77 92.68 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 O-C-N 125.066 1.479 . . . . 0.0 110.462 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.76 143.45 42.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.992 0.425 . . . . 0.0 110.249 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.5 mt -132.38 27.21 4.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 110.517 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.35 138.04 34.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.557 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 91.7 mt -137.25 164.96 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.386 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.523 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.02 -28.53 1.85 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.69 70.82 7.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.078 0.466 . . . . 0.0 110.36 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.89 145.19 98.9 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.754 2.303 . . . . 0.0 112.066 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.2 t -133.99 136.13 43.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.549 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.95 -38.17 82.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.673 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.25 -41.95 96.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.514 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.37 -41.41 98.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.527 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.0 t -63.84 -43.4 97.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.068 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.13 -35.05 77.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.323 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.75 -18.41 59.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.485 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.75 -6.39 58.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.498 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 68.0 mtp 47.57 56.06 17.21 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.584 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.13 149.43 64.51 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.786 2.324 . . . . 0.0 112.034 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.11 -73.88 0.63 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.433 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.9 tp -110.56 112.35 24.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.262 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.9 mt -100.72 126.33 54.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.022 0.439 . . . . 0.0 110.437 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.8 mt -109.16 132.83 53.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.272 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.418 HG23 HD12 ' A' ' 118' ' ' ILE . 96.9 mt -120.0 139.3 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.511 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 121' ' ' THR . 87.0 p -83.55 168.38 16.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.579 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.1 -37.52 80.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.424 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.429 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -140.14 159.32 42.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.511 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.46 178.38 32.96 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.21 -33.74 86.92 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -125.6 152.67 44.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.899 0.381 . . . . 0.0 110.556 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 33.3 t -63.4 141.27 58.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.408 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.68 10.46 11.01 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.578 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.416 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -60.93 -38.97 87.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.113 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.88 -36.12 23.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.431 0.634 . . . . 0.0 110.629 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.1 mt -70.93 -35.57 72.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.373 0.606 . . . . 0.0 110.79 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -42.69 -62.8 0.9 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.201 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -66.17 -42.69 88.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.043 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.24 -32.58 73.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.267 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 129' ' ' LEU . 74.1 mt -73.9 -41.06 62.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.078 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -58.24 -48.98 78.69 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.301 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.0 m -52.95 -42.37 65.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.353 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.96 -42.65 92.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.985 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.44 153.97 5.47 Favored Pre-proline 0 N--CA 1.453 -0.281 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.581 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -39.74 106.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.669 2.246 . . . . 0.0 112.179 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 95.6 m -110.07 122.76 48.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.382 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -115.05 153.68 30.25 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.304 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 tt -129.44 131.81 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.395 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.16 127.79 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.513 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.21 104.37 15.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.298 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.2 p90 -101.57 -11.17 19.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.805 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.576 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.73 -33.66 76.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.722 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.576 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.7 p-10 -98.41 8.03 45.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.573 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.61 155.18 50.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.582 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.409 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.45 165.94 24.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.64 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.595 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.8 t90 -59.72 -49.12 78.99 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.23 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -53.51 -42.39 67.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 110.109 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.8 t -62.85 -40.99 99.15 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.328 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 48.9 tp -60.64 -44.19 96.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.366 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.37 -43.6 98.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.206 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.5 m -54.71 -44.64 73.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.875 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.79 -40.74 98.26 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.905 0.383 . . . . 0.0 110.379 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -62.03 -42.38 99.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.165 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.94 -41.21 95.5 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.66 -45.81 64.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.908 0.385 . . . . 0.0 110.831 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.55 -44.0 96.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.811 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -93.34 -8.34 42.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.583 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.5 26.67 71.95 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -101.76 51.41 0.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.818 0.342 . . . . 0.0 110.679 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.8 -39.38 76.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.707 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.61 -47.41 85.67 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.297 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -59.92 -39.47 85.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.35 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.9 -40.97 99.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.368 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.52 70.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.566 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.17 -54.37 7.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.1 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -65.57 -42.19 92.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.477 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.6 mt -62.36 -43.77 98.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.566 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.66 -57.16 12.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.931 0.396 . . . . 0.0 110.551 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -58.48 -32.76 69.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.345 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -82.1 -36.56 27.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.772 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.6 m-20 -56.13 -41.41 75.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.155 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.99 -42.25 99.79 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.595 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.45 -37.78 87.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.281 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.9 mt -62.5 -42.23 99.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.654 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.06 -52.91 62.03 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.013 0.435 . . . . 0.0 110.668 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.4 -41.77 88.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.565 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.98 95.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.563 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.31 -31.94 73.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.424 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.54 -22.51 18.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.766 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.65 -41.25 96.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.616 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.0 pt -76.72 136.52 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.626 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.89 108.1 10.68 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.282 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.83 125.43 0.3 Allowed Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.505 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.451 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.7 Cg_exo -43.77 152.35 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.741 2.294 . . . . 0.0 112.484 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.89 141.81 55.06 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.634 2.223 . . . . 0.0 112.396 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.19 147.25 2.18 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.578 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.0 154.32 70.94 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.779 2.319 . . . . 0.0 112.324 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.27 163.15 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.42 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.524 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 1.9 t -144.07 170.68 15.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.799 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.515 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.63 137.7 21.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.312 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 40.0 pt -134.31 146.96 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.675 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.28 131.83 58.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.102 0.477 . . . . 0.0 110.482 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -152.09 155.12 37.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.473 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.4 m -122.79 122.93 39.88 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.412 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.47 -25.67 66.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.579 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.419 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.33 -48.86 21.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.007 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.34 -9.41 58.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.467 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.2 m80 46.51 42.11 10.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.444 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -135.93 145.75 46.58 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.399 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.94 114.3 27.12 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.321 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.79 133.37 55.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 110.442 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -111.81 146.22 38.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.712 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.439 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.3 t90 -99.42 129.38 45.6 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.074 0.464 . . . . 0.0 110.056 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.705 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.02 153.42 39.84 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.073 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.85 -17.87 46.99 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.762 2.308 . . . . 0.0 111.962 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.705 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -49.14 -18.9 0.37 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.486 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.439 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.6 p -75.71 164.71 26.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.531 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.93 -27.95 65.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.504 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.6 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.9 mt-30 -63.65 -41.19 98.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.643 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.66 -44.37 97.95 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.45 -38.8 92.29 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.983 0.42 . . . . 0.0 110.464 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.595 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.0 mmm -62.14 -41.31 98.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.177 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.7 mt -63.63 -47.17 82.42 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.672 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.13 -31.95 53.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.114 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.85 -18.3 62.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.557 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 90.9 mt -87.87 -9.13 54.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.559 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.19 1.6 54.34 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -88.16 153.77 20.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.835 0.35 . . . . 0.0 110.519 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 p -116.31 128.74 55.82 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.071 0.463 . . . . 0.0 110.384 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.555 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.62 146.3 23.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.866 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.455 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.95 151.72 45.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.463 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.88 131.47 42.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.443 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.635 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.73 93.07 26.93 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.132 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.717 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.9 Cg_exo -55.43 139.21 81.77 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.597 2.198 . . . . 0.0 111.59 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.01 -26.07 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.486 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.717 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.36 -50.25 27.88 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.586 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.4 mt -53.71 -37.15 63.0 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -66.76 36.14 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.731 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 38.98 88.72 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.847 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.5 p -81.28 -13.87 58.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.377 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.98 -41.84 10.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.626 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.7 t -66.74 -16.94 64.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.636 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 55.74 44.01 26.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.453 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.67 -149.24 8.32 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.95 142.84 48.38 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.912 0.387 . . . . 0.0 110.369 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.01 149.56 29.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.391 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -101.31 -151.59 0.42 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.343 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 55.96 -92.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.631 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.515 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.4 tt -126.84 175.52 8.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.613 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.515 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.4 mt -122.72 142.04 40.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.759 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.86 169.65 9.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.329 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 58.7 mt -148.01 150.8 34.63 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.49 -39.05 97.26 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.1 4.03 4.69 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -77.55 -58.04 3.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.896 0.379 . . . . 0.0 110.596 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -62.11 -36.61 82.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.264 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.36 -67.76 0.23 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.661 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.54 -42.48 67.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.264 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.63 17.42 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.56 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.02 48.83 0.3 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.53 -110.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.587 0.232 . . . . 0.0 110.704 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.455 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.9 m120 -60.8 -44.8 96.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.572 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.28 8.01 84.16 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.95 -13.58 19.89 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.628 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.1 t 177.25 142.55 0.08 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.007 0.432 . . . . 0.0 110.492 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 tt -148.22 124.81 11.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.052 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -98.09 143.63 28.43 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 120.854 0.359 . . . . 0.0 110.699 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.5 mt -95.13 106.49 18.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.659 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.442 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.8 t80 -101.75 -12.27 18.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.279 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.37 -40.73 89.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.83 173.06 45.72 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.453 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -73.71 -113.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.814 0.34 . . . . 0.0 110.739 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.66 -28.62 67.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.715 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.9 -44.03 91.13 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.179 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.63 -44.22 94.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.336 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.71 -60.21 3.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.227 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.93 -43.54 60.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.165 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.27 -43.58 74.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.268 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.64 -43.63 96.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.648 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -56.28 -37.5 69.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.189 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.54 0.9 18.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.328 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -114.99 91.4 26.6 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.227 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.21 -27.28 29.54 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.809 2.34 . . . . 0.0 111.778 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.514 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -40.96 98.78 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.621 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.33 5.31 52.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.328 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.07 -35.37 69.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.009 0.433 . . . . 0.0 110.707 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.36 4.36 15.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.601 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.554 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.76 121.15 80.17 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.531 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -47.2 -37.89 24.53 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.479 2.119 . . . . 0.0 112.397 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.554 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -58.98 -43.74 91.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.846 0.355 . . . . 0.0 110.311 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.5 t -66.18 -43.68 91.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.337 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.89 -40.6 95.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.537 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.5 t-20 -89.64 -12.89 38.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.502 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 62.47 32.28 16.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.79 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.01 43.84 1.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.376 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.22 135.63 41.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.544 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.84 132.38 56.71 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.465 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.07 89.15 7.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.735 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.457 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.8 mt -63.88 -40.98 97.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.784 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.79 165.34 33.26 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 71.7 p -75.47 -25.75 57.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 110.673 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.535 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.8 tp10 -68.36 -33.85 75.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.384 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.508 ' O ' ' CG2' ' A' ' 296' ' ' THR . 95.7 m -73.68 25.17 0.07 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.711 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.6 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 37.7 t80 -58.57 -50.75 72.68 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.4 mmt-85 -110.82 153.84 24.81 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 45.0 tp -115.67 125.1 52.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.721 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 44.7 t0 -147.98 165.66 30.05 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.531 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.16 -38.13 24.55 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.544 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.03 -65.83 0.69 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.29 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.91 -32.75 72.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.35 -25.25 23.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.627 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.5 mtt -63.72 -40.73 97.47 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 120.889 0.376 . . . . 0.0 111.01 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -79.1 -44.13 22.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 79.0 t -66.15 -42.88 92.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.469 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.9 tp -60.1 -47.13 87.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.455 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.04 -39.31 75.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.58 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.2 ttt180 -61.85 -38.66 89.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.252 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -86.67 4.57 39.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.772 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.92 -11.16 13.46 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.048 0.451 . . . . 0.0 110.31 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.1 85.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.578 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.84 -48.88 79.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.422 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.178 179.701 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.612 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.68 -3.15 57.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.425 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.489 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -143.88 179.2 1.23 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.53 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 37.6 Cg_exo -60.55 144.57 99.54 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.779 2.32 . . . . 0.0 112.161 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.612 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.3 ptt-85 -155.85 179.96 8.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.571 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -116.03 137.22 52.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.346 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.83 146.17 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.46 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.8 p -119.9 136.27 54.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.744 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.7 p30 -98.33 -144.51 0.31 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.267 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.58 -36.39 83.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.481 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -147.04 -70.68 0.23 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.508 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.59 144.15 41.11 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.7 p -112.61 129.82 56.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 110.385 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -114.86 129.9 56.79 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.643 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 m -87.74 131.53 34.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.159 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.8 mt -99.02 79.64 2.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.655 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.16 -32.01 73.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.475 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 t 176.98 109.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.182 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -124.32 91.66 49.23 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.306 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.4 Cg_exo -56.64 149.04 61.05 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.792 2.328 . . . . 0.0 111.917 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.44 82.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.599 0.562 . . . . 0.0 110.923 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.0 mtm180 -151.62 67.23 0.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.24 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.84 130.99 35.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.667 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.16 147.74 27.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.149 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 t -136.22 143.96 44.63 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.703 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.515 ' HG1' ' H ' ' A' ' 50' ' ' SER . 16.9 p -99.65 -59.33 1.74 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.524 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.515 ' H ' ' HG1' ' A' ' 49' ' ' THR . 86.6 p -79.41 154.94 28.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.596 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.5 t -73.72 -21.76 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.517 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.413 ' O ' ' OG ' ' A' ' 56' ' ' SER . 99.8 m -60.17 -52.03 67.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.535 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 mt -66.41 -42.32 87.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.208 0.527 . . . . 0.0 110.862 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.7 m -43.52 -54.27 4.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.091 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.63 -36.65 76.35 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.3 m -63.32 -44.38 95.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 0.0 110.423 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.7 mt -66.02 -42.13 90.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.484 0.659 . . . . 0.0 110.593 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tp -62.83 -40.17 96.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.367 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.52 -36.16 77.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.065 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -90.99 27.66 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.168 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 57.02 51.51 10.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.944 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.81 75.92 29.86 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.036 0.446 . . . . 0.0 109.932 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -63.53 149.38 91.16 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.752 2.302 . . . . 0.0 112.214 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -112.71 137.11 46.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.198 0.523 . . . . 0.0 110.281 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.5 pt -69.51 -43.7 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.145 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.22 131.21 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.929 0.395 . . . . 0.0 110.59 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.2 p -155.78 168.67 26.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.467 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.7 -177.41 21.74 Favored Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.07 172.3 12.83 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.483 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.4 p -134.13 -110.27 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.396 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.43 179.6 0.94 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.348 -179.045 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.2 Cg_exo -60.79 58.87 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.996 2.464 . . . . 0.0 112.129 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 56.3 t-20 -64.37 -34.91 79.25 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.498 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 46.7 m-20 95.04 -38.14 0.01 OUTLIER 'General case' 0 C--N 1.346 0.448 0 O-C-N 124.016 0.822 . . . . 0.0 109.875 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.45 -39.84 94.67 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.018 0.437 . . . . 0.0 110.228 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.2 p -73.79 -26.5 21.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.693 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.97 -172.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.568 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.7 p30 -74.22 -152.88 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.757 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.7 p-10 -54.49 -6.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.701 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.515 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.94 113.66 22.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.589 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.48 72.74 1.28 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.485 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.2 m-85 -143.99 148.62 35.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.885 0.374 . . . . 0.0 110.817 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.527 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.3 mp -85.75 -99.16 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.139 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.04 -42.94 96.89 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.201 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.566 ' NE2' ' HZ1' ' A' ' 88' ' ' LYS . 35.5 tt0 91.65 52.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.953 0.783 . . . . 0.0 110.925 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -103.43 -8.99 19.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.365 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.485 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.92 -33.58 76.35 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.108 0.48 . . . . 0.0 110.669 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.566 ' HZ1' ' NE2' ' A' ' 85' ' ' GLN . 97.9 mttt -48.85 -23.55 1.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.671 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.7 t -70.02 -46.14 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.815 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.16 -48.63 80.7 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.107 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.63 -38.18 89.23 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.41 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.76 -32.31 51.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.261 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.583 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.9 mmt-85 -89.79 1.81 55.68 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.617 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 82.64 -49.5 0.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.015 0.822 . . . . 0.0 110.319 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.655 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.6 mt -46.06 154.48 0.25 Allowed 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 117.702 -1.142 . . . . 0.0 109.407 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.655 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 120.72 92.36 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 O-C-N 125.439 1.712 . . . . 0.0 110.479 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.533 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.11 143.02 43.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.084 0.468 . . . . 0.0 110.259 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -132.07 26.71 4.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.856 0.36 . . . . 0.0 110.533 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.33 138.14 34.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.013 0.435 . . . . 0.0 110.549 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.522 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 93.3 mt -137.16 164.79 29.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.398 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.63 -28.91 1.75 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -151.94 70.75 7.88 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.177 0.513 . . . . 0.0 110.258 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.87 145.29 98.64 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.777 2.318 . . . . 0.0 112.057 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.8 t -134.98 136.49 42.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.549 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.97 -38.17 82.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.657 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.51 -42.07 96.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.506 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.08 -41.59 98.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.516 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.77 -43.29 97.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.064 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.17 -35.09 77.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.263 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -18.29 59.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.506 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.72 -6.1 58.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.505 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.417 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 70.4 mtp 47.83 55.73 17.09 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.608 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.0 Cg_endo -70.25 149.16 63.4 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.744 2.296 . . . . 0.0 112.116 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.48 -72.99 0.66 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.429 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.6 tp -111.25 113.54 26.11 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.342 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.4 mt -102.67 126.95 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.576 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.5 mt -110.06 133.85 52.76 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.225 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.33 139.65 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.468 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 121' ' ' THR . 89.6 p -83.48 167.84 17.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.688 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -37.25 79.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.47 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.423 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -139.61 158.6 43.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.472 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.11 176.97 33.4 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.75 86.91 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.95 152.27 44.38 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.926 0.394 . . . . 0.0 110.505 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.0 t -63.47 140.93 58.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.355 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.62 10.5 11.07 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.611 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.418 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.04 -38.89 87.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.14 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.97 -35.86 23.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.542 0.687 . . . . 0.0 110.668 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.9 mt -70.98 -35.34 72.09 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.444 0.64 . . . . 0.0 110.733 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -42.81 -63.0 0.86 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.239 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.87 -42.71 90.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.049 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.07 -32.63 73.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.3 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.9 mt -73.9 -40.7 62.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.987 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.28 -49.22 77.92 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.21 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.3 m -52.89 -42.48 65.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.246 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.59 -42.87 93.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.131 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.73 153.94 5.19 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.65 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -39.38 106.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.661 2.241 . . . . 0.0 112.354 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 97.1 m -109.97 122.22 47.06 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.332 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.5 153.44 29.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.225 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 tt -129.04 131.5 68.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.393 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.413 HG22 HD11 ' A' ' 142' ' ' ILE . 96.5 mt -114.88 127.6 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.475 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.496 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 55.3 t30 -100.65 104.45 15.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.311 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 147' ' ' LYS . 50.0 p90 -100.92 -11.18 19.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.809 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.0 p-10 -64.74 -33.53 76.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.728 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.1 p-10 -98.87 8.13 45.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.591 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.441 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.27 153.04 52.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.487 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.405 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.8 p -75.37 166.05 24.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.649 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.598 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.7 t90 -59.46 -48.91 79.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.127 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -54.28 -43.07 70.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.91 0.386 . . . . 0.0 110.114 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.1 t -62.78 -40.9 98.75 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.366 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.69 -44.37 96.62 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.241 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.35 -42.88 99.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.853 0.359 . . . . 0.0 110.192 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.0 m -55.86 -44.9 78.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.773 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.81 -40.3 96.93 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 120.908 0.385 . . . . 0.0 110.439 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.9 -42.27 98.88 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.287 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.81 -40.45 95.6 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.52 -45.54 65.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.908 0.385 . . . . 0.0 110.792 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.71 -44.03 96.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.742 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -93.44 -8.4 41.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.596 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.67 26.5 72.04 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -101.35 50.76 0.85 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.813 0.339 . . . . 0.0 110.589 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -69.65 -39.68 76.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.667 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.58 -47.59 84.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.208 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -59.62 -39.78 85.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.268 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.15 99.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.296 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.56 -28.59 69.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.604 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.47 -54.22 7.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.016 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -65.61 -42.36 91.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.458 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.8 mt -62.38 -43.9 98.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.522 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.67 -57.67 10.19 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.079 0.466 . . . . 0.0 110.377 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.91 -33.75 69.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.482 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -81.39 -36.35 29.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.755 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.4 m-20 -55.33 -41.87 73.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.982 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.54 -42.03 99.26 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.664 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.22 -38.23 89.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.348 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.5 mt -62.5 -42.25 99.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.733 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.11 -53.06 60.72 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.12 0.486 . . . . 0.0 110.657 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.09 -42.0 89.91 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.642 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.71 -40.06 95.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.666 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.28 -31.9 73.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.37 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.92 -22.16 18.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.662 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.635 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.7 tt0 -64.63 -41.33 96.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.599 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.5 pt -75.2 136.2 25.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.6 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -125.99 106.95 9.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.312 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -177.2 125.56 0.29 Allowed Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.57 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.8 Cg_exo -43.9 152.39 0.36 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.772 2.315 . . . . 0.0 112.56 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.87 141.93 55.54 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.658 2.239 . . . . 0.0 112.468 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.25 147.46 2.2 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.585 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.03 154.45 70.59 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.764 2.309 . . . . 0.0 112.362 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.525 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.47 163.12 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.194 0.521 . . . . 0.0 110.386 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.539 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.0 t -143.65 170.3 16.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.932 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.539 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.47 137.56 21.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.995 0.426 . . . . 0.0 110.111 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.6 pt -134.4 147.14 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.657 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.56 132.04 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.157 0.503 . . . . 0.0 110.492 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -151.95 154.84 36.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.423 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.7 m -121.82 122.62 39.87 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.947 0.403 . . . . 0.0 110.344 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.93 -25.48 66.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.646 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.405 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.86 -49.65 19.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.91 -9.53 58.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.409 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.8 m80 46.97 43.74 14.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.436 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.7 t -135.78 145.11 46.2 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.347 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.47 113.49 25.96 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.26 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.1 m-20 -119.86 133.26 55.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.384 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.5 tt -112.02 146.35 38.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.757 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.452 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.1 t90 -99.35 128.85 45.51 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.104 0.478 . . . . 0.0 110.067 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.675 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -94.65 154.04 40.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.174 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.68 -17.98 47.91 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.662 2.241 . . . . 0.0 111.94 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.675 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -49.35 -18.79 0.42 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.405 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.452 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 84.6 p -75.42 164.73 26.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.507 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.89 -28.14 65.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.461 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.556 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.4 mt-30 -63.67 -41.74 98.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.669 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.65 -44.67 96.67 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.441 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.1 mt-30 -64.45 -38.9 92.63 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 122.448 -0.442 . . . . 0.0 110.672 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.06 -41.19 97.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.276 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.61 -47.42 81.47 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.997 0.427 . . . . 0.0 110.502 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -53.82 -32.15 51.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.193 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -70.92 -19.0 62.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.555 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 92.6 mt -87.48 -8.89 55.9 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.63 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.83 2.72 55.15 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.9 152.67 21.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.339 . . . . 0.0 110.532 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 7.8 p -115.57 128.19 55.78 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.063 0.459 . . . . 0.0 110.305 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.41 146.52 23.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.959 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.458 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.07 151.1 45.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.447 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.64 131.56 43.28 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.475 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.63 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.57 93.42 27.67 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.073 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.718 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.3 Cg_exo -55.52 138.99 82.02 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.629 2.219 . . . . 0.0 111.617 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.82 -25.51 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.482 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.718 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.57 -49.82 28.78 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.582 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.1 mt -54.05 -36.97 63.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.71 36.09 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.72 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.582 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.14 86.73 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.9 p -79.61 -15.04 58.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.34 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -92.37 -41.4 10.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.59 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -65.98 -17.72 64.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.621 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 56.18 43.32 26.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.466 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.23 -148.31 7.67 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.87 142.81 49.88 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.958 0.408 . . . . 0.0 110.336 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.06 149.57 28.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.328 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -100.79 -151.86 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.308 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.5 t0 55.9 -92.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.673 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.51 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.48 175.41 8.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.601 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.51 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.7 mt -122.32 141.72 41.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.766 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.7 169.17 9.45 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.226 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.8 mt -147.66 150.86 35.17 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.191 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.64 -38.82 96.83 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.82 4.2 4.78 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -77.45 -58.22 3.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.945 0.402 . . . . 0.0 110.558 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.17 -36.64 82.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.416 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.17 -67.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.777 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.72 -42.27 67.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.102 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.72 17.38 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.645 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.34 49.13 0.34 Allowed Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.411 -0.675 . . . . 0.0 111.411 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 253' ' ' GLY . 8.4 mp 37.85 -109.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.635 0.255 . . . . 0.0 110.825 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.458 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.7 m120 -60.65 -45.2 95.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.493 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.82 7.85 83.48 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.04 -13.04 20.04 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.745 -0.268 . . . . 0.0 110.696 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.4 t 176.86 142.89 0.08 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.063 0.458 . . . . 0.0 110.458 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 tt -148.35 125.43 11.4 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.087 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -98.76 143.43 29.12 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 120.916 0.389 . . . . 0.0 110.837 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.6 mt -94.88 106.47 18.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.674 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.9 t80 -101.88 -12.02 18.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.261 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.24 89.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.834 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.54 173.86 46.16 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.443 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.5 m-20 -74.44 -113.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.759 0.314 . . . . 0.0 110.734 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.74 -28.4 67.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.66 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.96 -44.14 91.44 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.27 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.68 -44.14 94.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.341 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.48 -60.38 3.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.273 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.92 -43.53 60.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.174 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.47 -43.81 75.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.252 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.1 mt -64.54 -43.6 96.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.629 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -56.52 -37.66 70.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.2 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.66 1.19 17.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.272 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -115.0 91.28 26.16 Favored Pre-proline 0 CA--C 1.528 0.134 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.118 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.97 -27.17 27.38 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.768 2.312 . . . . 0.0 111.875 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.41 -41.26 98.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.526 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.15 5.12 52.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.407 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.96 -35.38 69.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.595 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.58 4.35 16.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.516 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.562 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.66 121.51 81.33 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.615 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -47.31 -38.13 25.82 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.487 2.125 . . . . 0.0 112.533 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.562 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.86 -43.95 90.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.812 0.339 . . . . 0.0 110.391 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.73 -43.63 93.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.293 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.83 -40.64 95.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.454 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 44.8 t-20 -89.73 -12.14 40.27 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.549 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.4 mtmt 61.73 31.3 18.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.965 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -88.17 43.78 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.435 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.43 136.09 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.453 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.59 132.8 56.59 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.452 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.1 88.49 7.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.752 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.464 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.5 mt -64.0 -41.41 97.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.891 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.46 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.42 167.26 33.76 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.4 p -75.71 -25.97 57.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.852 0.358 . . . . 0.0 110.747 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -67.77 -33.91 75.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.533 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.494 ' O ' ' CG2' ' A' ' 296' ' ' THR . 97.1 m -73.72 20.41 0.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.674 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.556 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 55.0 t80 -57.26 -51.19 70.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.939 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 68.4 mmt-85 -108.38 150.12 27.79 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 44.1 tp -115.54 125.78 53.43 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.811 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 42.7 t0 -149.56 166.72 28.36 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.598 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -49.16 -37.97 24.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.631 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.83 -65.21 0.79 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.388 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -60.92 -32.76 72.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.7 -25.22 25.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.688 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.3 mtt -63.66 -40.98 98.2 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.871 0.367 . . . . 0.0 111.057 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.85 -43.94 24.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.03 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 78.9 t -66.34 -42.85 91.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.328 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.6 tp -60.06 -47.13 87.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.505 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.99 -39.4 75.95 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.578 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.9 ttt180 -61.96 -38.24 87.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.208 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -87.14 4.31 42.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.68 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.635 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -113.07 -11.06 13.39 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.025 0.441 . . . . 0.0 110.283 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.3 86.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.559 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.66 -48.66 80.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.361 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 117.885 -1.055 . . . . 0.0 110.038 179.907 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.14 -2.36 58.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.442 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.488 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.06 1.24 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.533 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.93 145.26 99.32 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.774 2.316 . . . . 0.0 112.165 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.15 -179.1 7.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.6 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.0 137.0 52.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.323 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -124.57 146.73 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.443 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.4 p -119.97 135.99 54.7 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.704 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.28 -143.53 0.32 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.309 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.49 -37.15 86.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.487 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.476 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.1 ttt85 -149.31 -66.26 0.22 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.533 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.5 142.16 45.57 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 p -112.07 131.3 55.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 0.0 110.409 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -119.06 129.09 54.91 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.547 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -85.62 130.26 34.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.273 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.1 mt -95.97 78.86 3.21 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.353 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.51 -32.07 73.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.479 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 175.97 109.78 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.143 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -122.72 91.53 49.54 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.277 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.654 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.5 Cg_exo -56.97 148.92 65.0 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.818 2.345 . . . . 0.0 111.816 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.52 82.78 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.654 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.38 67.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.097 0.475 . . . . 0.0 110.279 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.19 130.73 35.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.582 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.7 t -122.78 146.91 27.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.202 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.2 t -136.26 143.48 44.28 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.62 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.487 ' HG1' ' H ' ' A' ' 50' ' ' SER . 25.6 p -99.18 -59.5 1.71 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.618 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.487 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.0 p -79.18 155.13 28.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.611 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.0 t -74.23 -21.83 17.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.571 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.411 ' O ' ' OG ' ' A' ' 56' ' ' SER . 95.9 m -60.13 -52.25 66.13 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.553 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.8 mt -66.63 -42.33 86.93 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.249 0.547 . . . . 0.0 110.877 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.6 m -42.88 -54.06 4.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.265 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.47 -37.48 69.32 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.2 m -62.48 -44.68 95.81 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.82 0.343 . . . . 0.0 110.443 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.2 -41.99 89.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.385 0.612 . . . . 0.0 110.703 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.2 tp -62.68 -40.34 96.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.284 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.17 -35.82 76.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.899 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.6 pt -91.36 28.85 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.021 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 56.57 51.61 10.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.798 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.2 75.58 23.14 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.984 0.421 . . . . 0.0 110.054 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.53 151.41 85.67 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.723 2.282 . . . . 0.0 112.256 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.56 137.32 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.121 0.486 . . . . 0.0 110.335 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.417 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.9 pt -69.42 -43.45 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.178 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.1 131.17 53.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 110.522 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.0 p -155.77 168.98 25.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.481 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.24 -177.12 21.43 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.54 172.91 12.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 110.56 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.1 p -132.9 -112.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.29 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.26 179.76 0.93 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.328 -179.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.5 Cg_exo -60.93 57.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 123.032 2.488 . . . . 0.0 112.151 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.7 t-20 -64.43 -33.69 76.47 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.606 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 43.4 m-20 93.6 -36.27 0.02 OUTLIER 'General case' 0 C--N 1.344 0.332 0 O-C-N 124.014 0.822 . . . . 0.0 109.993 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -62.64 -39.38 93.67 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.299 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.88 -25.29 18.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.73 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.38 -171.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.597 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.46 -153.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.752 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.1 p-10 -52.36 -7.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.706 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.522 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.36 114.86 23.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.531 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.85 69.98 1.35 Allowed Glycine 0 CA--C 1.522 0.469 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.47 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.9 m-85 -143.23 147.39 34.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.968 0.414 . . . . 0.0 110.673 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.525 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.3 mp -85.49 -98.3 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.205 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.36 -42.57 96.15 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.205 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.64 53.65 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.894 0.746 . . . . 0.0 110.791 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -103.9 -8.77 19.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.429 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.47 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -65.18 -33.79 76.85 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.175 0.512 . . . . 0.0 110.649 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.548 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.84 -24.24 1.37 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.568 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.9 t -69.5 -45.68 77.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.876 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.23 -48.57 80.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.117 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.73 -38.09 89.13 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.379 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.82 -32.42 52.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.281 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.591 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.5 mmt-85 -89.87 1.77 55.8 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.588 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.54 -49.51 0.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 124.036 0.835 . . . . 0.0 110.412 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.669 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.17 154.92 0.23 Allowed 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.443 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.669 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 120.66 92.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 125.133 1.521 . . . . 0.0 110.501 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.531 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.61 143.56 42.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.291 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.8 mt -132.58 27.15 4.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.494 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.55 138.39 34.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.541 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.526 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 91.6 mt -137.5 165.14 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.427 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.526 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.22 -28.71 1.82 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -152.59 70.87 7.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.121 0.486 . . . . 0.0 110.396 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.97 145.38 98.49 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.789 2.326 . . . . 0.0 112.048 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.8 t -134.47 136.37 43.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.036 0.446 . . . . 0.0 110.522 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.26 -38.17 81.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.673 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.45 -42.29 96.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.511 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.94 -41.73 98.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.481 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.51 -43.19 98.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.146 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.04 -35.07 77.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.345 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.5 -18.4 58.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.476 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.96 -6.33 58.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.486 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.418 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 75.9 mtp 47.76 55.77 17.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.66 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.14 149.4 64.4 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.807 2.338 . . . . 0.0 112.093 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.16 -74.01 0.63 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.503 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.8 tp -110.45 113.09 25.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.368 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -101.68 126.39 55.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.5 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.2 mt -109.7 133.53 53.02 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.248 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.56 140.02 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.587 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 121' ' ' THR . 88.8 p -83.62 168.68 16.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.641 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.08 -37.61 80.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.432 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.429 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -139.96 159.38 42.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.476 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.2 177.49 33.2 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.14 -33.77 86.93 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -124.87 151.93 44.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.822 0.344 . . . . 0.0 110.603 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.5 t -63.14 141.01 58.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.307 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.46 10.46 11.17 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.559 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.07 -39.03 88.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.072 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.04 -35.99 23.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.361 0.6 . . . . 0.0 110.696 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.8 mt -70.83 -35.45 72.47 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.428 0.632 . . . . 0.0 110.72 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.76 -63.28 0.81 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.158 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.6 p-10 -65.89 -42.72 89.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.4 mt-30 -62.01 -32.66 73.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.164 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.3 mt -74.01 -40.35 62.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.051 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.23 -49.12 78.2 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.208 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.1 m -52.59 -42.56 64.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.216 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.77 -42.98 93.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.08 154.81 5.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.632 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.29 106.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.709 2.273 . . . . 0.0 112.339 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 95.0 m -110.07 121.19 44.67 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.31 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.0 153.03 30.06 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.296 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 tt -129.09 131.22 68.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.413 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.92 127.85 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.443 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.477 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.8 t30 -101.38 103.62 14.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.34 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.3 p90 -101.14 -11.37 19.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.769 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.2 p-10 -64.77 -33.63 76.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.66 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.8 p-10 -98.12 7.79 45.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.603 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.449 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.64 155.6 50.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.564 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.3 p -74.96 165.71 24.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.664 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.592 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.4 t90 -59.85 -48.88 79.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.286 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.51 -41.95 66.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.088 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.2 t -62.73 -41.01 98.96 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.406 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.6 tp -60.59 -44.28 96.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.376 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.36 -43.56 98.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.211 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.0 m -54.87 -44.93 74.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.837 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.39 -40.94 98.12 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.837 0.351 . . . . 0.0 110.331 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.444 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -61.89 -42.48 99.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.157 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.9 -40.89 95.64 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.41 -46.16 64.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.899 0.381 . . . . 0.0 110.816 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.74 -44.02 96.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.735 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -92.97 -8.69 42.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.553 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.8 26.62 72.2 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -101.8 51.07 0.84 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 110.667 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -69.91 -39.38 76.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.644 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.57 -47.26 86.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.248 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -59.88 -39.36 85.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.341 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.14 99.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.322 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.71 -28.52 70.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.974 0.416 . . . . 0.0 110.576 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.39 -54.25 7.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.058 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -65.55 -42.17 92.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.518 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.466 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.3 mt -62.35 -43.86 98.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.488 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.75 -57.73 9.93 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.021 0.439 . . . . 0.0 110.453 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.78 -33.86 68.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.35 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -81.46 -36.28 29.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.811 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.2 m-20 -55.6 -41.59 73.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.238 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.64 -42.42 99.59 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.688 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.29 -38.01 88.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.366 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.25 -42.23 99.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.68 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.8 62.53 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.044 0.45 . . . . 0.0 110.66 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.19 -41.92 89.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.559 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.86 95.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.56 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.42 -31.99 73.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.379 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.63 -22.21 18.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.729 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.633 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.83 -41.16 95.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.651 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.8 pt -77.01 136.73 23.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.574 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.01 108.29 10.81 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.291 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.76 125.5 0.3 Allowed Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.512 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.6 Cg_exo -43.81 152.18 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.775 2.316 . . . . 0.0 112.499 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.79 141.82 55.61 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.61 2.206 . . . . 0.0 112.461 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.33 147.08 2.1 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.592 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.02 154.58 70.43 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.741 2.294 . . . . 0.0 112.292 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.35 163.13 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.4 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.615 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 1.9 t -143.97 170.76 15.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.817 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.615 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -149.12 137.99 21.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.237 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.4 pt -134.45 146.9 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.639 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 204' ' ' ASN . 3.0 p -133.08 131.76 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.145 0.498 . . . . 0.0 110.505 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -151.99 155.13 37.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.466 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.5 m -121.95 122.65 39.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.938 0.399 . . . . 0.0 110.392 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.25 -25.96 66.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.6 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.37 -48.69 21.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.066 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.7 -12.2 60.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.387 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.0 m80 49.74 41.69 22.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.491 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.3 t -136.45 144.97 44.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.407 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.88 114.38 27.67 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.295 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.73 133.24 55.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.064 0.459 . . . . 0.0 110.352 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -111.74 146.16 38.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.686 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.446 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 10.0 t90 -99.62 129.56 45.78 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.082 0.468 . . . . 0.0 110.089 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.703 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.01 153.76 39.78 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.144 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.407 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.4 Cg_endo -67.82 -18.11 47.22 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.741 2.294 . . . . 0.0 111.972 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.703 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -49.01 -18.83 0.33 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.507 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.446 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.6 p -75.61 165.05 25.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.521 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.15 -27.95 66.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.472 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.605 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.3 mt-30 -63.78 -41.28 97.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.642 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.55 -44.64 97.53 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.449 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.25 -38.9 92.69 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.004 0.43 . . . . 0.0 110.633 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.592 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.0 mmm -61.99 -41.21 97.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.159 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 74.8 mt -63.6 -47.22 82.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.949 0.404 . . . . 0.0 110.645 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.94 -32.09 52.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.049 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.94 -18.62 62.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.518 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 90.9 mt -88.01 -8.49 55.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.659 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.42 2.3 55.58 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -88.57 153.18 21.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.513 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.1 p -116.13 128.62 55.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.049 0.452 . . . . 0.0 110.421 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.555 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.74 146.14 23.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.831 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.454 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.65 151.65 45.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.526 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.68 131.4 43.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.347 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.635 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.57 93.3 27.15 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.121 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.717 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.6 Cg_exo -55.55 139.05 82.21 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.629 2.219 . . . . 0.0 111.635 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.05 -25.73 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.474 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.717 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.55 -50.11 27.46 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.587 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.8 mt -53.82 -37.31 63.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 0.0 110.252 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -66.73 36.06 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.769 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.1 88.46 0.01 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.829 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 86.7 p -81.02 -13.62 58.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.393 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -92.39 -41.49 10.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.548 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.92 -16.91 64.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.669 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.75 43.95 27.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.504 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.78 -148.67 8.03 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.63 142.98 48.92 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.996 0.426 . . . . 0.0 110.331 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.19 149.64 28.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.35 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -101.46 -151.69 0.42 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.305 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 56.19 -92.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.635 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.51 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.83 175.23 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.629 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.51 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.2 mt -122.4 141.79 41.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.676 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.98 169.55 9.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.285 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.7 mt -148.01 151.11 35.2 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.106 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.52 -39.05 97.23 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.97 4.21 4.7 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -77.57 -58.07 3.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.903 0.382 . . . . 0.0 110.577 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -62.1 -36.71 82.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.301 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.26 -67.75 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.748 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.31 -42.49 66.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.231 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.02 17.66 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.678 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.1 49.03 0.31 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.28 -109.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.609 0.242 . . . . 0.0 110.715 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.454 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.8 m120 -60.68 -45.06 95.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.47 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.4 7.96 84.02 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.85 -13.6 20.0 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.821 -0.223 . . . . 0.0 110.617 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.0 t 177.2 142.57 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.996 0.427 . . . . 0.0 110.5 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 tt -148.05 125.34 11.54 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.998 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -98.66 143.31 29.18 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.8 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.6 mt -94.5 106.38 18.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.626 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.439 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.2 t80 -101.4 -12.5 18.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.254 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.66 90.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.749 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.32 173.63 46.03 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.46 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -73.91 -112.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.797 0.332 . . . . 0.0 110.72 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -68.02 -28.52 67.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.666 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -58.76 -44.12 90.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.386 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.64 -44.29 94.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.333 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.54 -60.31 3.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.267 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -50.95 -43.36 60.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.229 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.56 75.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.267 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.5 mt -64.56 -43.67 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.607 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -56.27 -37.34 69.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.241 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.54 0.79 18.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.28 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -115.22 91.24 27.05 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.242 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.26 -26.87 28.42 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.814 2.343 . . . . 0.0 111.84 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.5 -40.95 98.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.564 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.35 5.21 52.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.435 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.1 -35.07 69.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.717 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.6 4.65 15.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.538 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.551 HD22 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.99 120.99 80.03 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.559 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -47.24 -37.53 24.26 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.501 2.134 . . . . 0.0 112.451 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.551 ' H ' HD22 ' A' ' 281' ' ' LEU . . . -59.1 -43.74 91.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.818 0.342 . . . . 0.0 110.323 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.91 -43.7 92.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.377 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.85 -40.54 95.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.483 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.437 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 44.3 t-20 -89.54 -12.72 39.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.601 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 62.03 31.37 17.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.809 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.37 43.72 1.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.417 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.95 136.02 38.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.489 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -116.77 132.36 56.71 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.466 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.41 88.24 7.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.668 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.458 ' O ' ' OG1' ' A' ' 296' ' ' THR . 89.0 mt -63.83 -40.85 97.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.821 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.439 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.6 167.24 34.14 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.51 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 76.3 p -75.68 -25.76 57.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.854 0.359 . . . . 0.0 110.746 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.54 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.0 tp10 -67.8 -34.62 77.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.427 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.503 ' O ' ' CG2' ' A' ' 296' ' ' THR . 94.6 m -73.53 25.44 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.714 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.605 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 60.8 t80 -58.18 -51.2 70.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.342 -0.39 . . . . 0.0 109.986 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 66.4 mmt-85 -112.02 155.24 24.11 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 45.5 tp -116.01 125.14 52.08 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.748 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 45.2 t0 -147.58 165.52 30.14 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.551 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -49.07 -38.1 23.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.512 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.71 -65.28 0.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.232 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -61.01 -32.79 72.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.51 -25.48 25.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.601 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.5 mtt -63.38 -41.09 98.77 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 120.924 0.392 . . . . 0.0 110.918 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.17 -43.91 22.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.978 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 76.0 t -66.29 -42.88 91.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.417 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 52.1 tp -60.31 -47.23 86.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.546 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -69.74 -39.6 76.66 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.516 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.6 ttt180 -62.06 -38.24 88.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.217 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.6 mt -87.12 4.5 42.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.741 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.633 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.3 tttt -112.86 -11.23 13.48 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.038 0.447 . . . . 0.0 110.355 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.03 85.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.638 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.94 -48.82 80.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.366 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.134 179.804 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -89.63 -2.49 58.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.391 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.2 179.01 1.25 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.521 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.6 Cg_exo -60.66 145.13 99.39 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.718 2.279 . . . . 0.0 112.171 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.82 -179.4 8.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.655 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.91 137.4 52.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.39 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -125.05 147.11 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.437 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 79.1 p -120.24 136.26 54.71 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.788 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.18 -143.83 0.32 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.199 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -63.53 -37.23 86.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.441 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.57 -67.19 0.23 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.475 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.44 142.59 45.05 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.2 p -112.16 131.45 55.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 110.377 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -119.13 129.51 55.07 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.517 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 m -86.64 131.33 34.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.871 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.3 mt -96.96 79.37 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.496 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.75 -31.79 72.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.521 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.77 109.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.117 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -122.06 92.18 48.87 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.386 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 37.3 Cg_exo -57.08 148.72 67.28 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.724 2.283 . . . . 0.0 111.782 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.85 83.0 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 O-C-N 123.491 0.495 . . . . 0.0 110.927 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.49 67.11 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.293 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.09 130.75 35.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.604 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.1 t -122.62 146.47 27.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.067 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 t -135.88 143.47 45.05 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.679 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.632 ' HG1' ' H ' ' A' ' 50' ' ' SER . 29.6 p -99.06 -59.77 1.66 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.599 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.632 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.3 p -79.25 155.33 28.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.659 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.8 t -74.06 -22.07 18.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.488 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.409 ' O ' ' OG ' ' A' ' 56' ' ' SER . 98.2 m -60.27 -52.05 66.92 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.484 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.6 mt -66.43 -42.18 88.09 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.312 0.577 . . . . 0.0 110.881 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.0 m -43.7 -53.78 5.56 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.19 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.22 -37.28 71.63 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.5 m -62.77 -44.61 95.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.826 0.346 . . . . 0.0 110.517 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.0 mt -66.22 -42.05 89.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.397 0.617 . . . . 0.0 110.652 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.57 -40.44 96.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.354 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.09 -35.77 75.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.066 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.4 pt -91.36 28.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.256 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.53 51.68 10.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.875 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.4 75.83 22.13 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.924 0.393 . . . . 0.0 109.962 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.67 151.46 85.55 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.733 2.289 . . . . 0.0 112.382 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.48 136.87 48.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.185 0.517 . . . . 0.0 110.267 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -69.06 -43.58 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.299 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.03 131.18 53.42 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.025 0.44 . . . . 0.0 110.598 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.8 p -155.7 168.82 25.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.433 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.98 -177.07 21.57 Favored Glycine 0 N--CA 1.464 0.524 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.53 172.68 12.4 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 110.527 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 p -132.8 -112.52 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.96 0.41 . . . . 0.0 110.36 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.28 179.69 0.94 Allowed Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.368 -179.103 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.8 Cg_exo -60.91 58.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.978 2.452 . . . . 0.0 112.094 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.3 t-20 -64.57 -33.66 76.43 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.526 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.2 m-20 93.8 -36.76 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.064 0.852 . . . . 0.0 109.923 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -62.57 -39.48 93.81 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.24 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.1 p -74.35 -25.66 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.715 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.16 -171.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.617 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.514 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.86 -154.2 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.76 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 38.0 p-10 -52.53 -7.54 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.669 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.514 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.16 115.17 23.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.545 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.99 69.54 1.36 Allowed Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.415 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.3 m-85 -143.12 147.37 34.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.937 0.399 . . . . 0.0 110.752 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.525 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -85.15 -98.47 0.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.204 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.0 -42.73 97.08 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.16 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.553 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.0 tt0 91.62 53.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.97 0.794 . . . . 0.0 110.907 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -103.27 -8.7 20.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.369 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.415 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 77.8 p -65.06 -33.85 77.03 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.1 0.476 . . . . 0.0 110.589 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.542 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.1 mttt -48.88 -24.05 1.32 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.644 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.45 -46.0 77.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.921 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.4 -48.42 81.31 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.071 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.57 -38.24 89.33 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.272 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.83 -32.52 53.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.272 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.586 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.7 mmt-85 -89.98 1.57 56.13 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.566 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.586 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.8 -49.24 0.17 Allowed 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.999 0.812 . . . . 0.0 110.3 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.659 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.28 154.21 0.29 Allowed 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.259 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.659 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 121.01 92.39 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 125.287 1.617 . . . . 0.0 110.476 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.7 mtp180 -75.47 143.43 42.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.057 0.456 . . . . 0.0 110.354 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.2 mt -132.44 27.07 4.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.461 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.36 138.23 34.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.548 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.525 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 91.7 mt -137.43 165.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.358 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.525 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.5 -28.81 1.77 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.55 70.96 7.46 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.15 0.5 . . . . 0.0 110.373 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.89 145.27 98.71 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.714 2.276 . . . . 0.0 112.075 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.9 t -134.4 136.37 43.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.485 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.81 -38.22 83.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.669 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.37 -42.28 96.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.496 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.49 98.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.494 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.3 t -63.65 -43.4 98.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.029 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.07 77.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.32 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.66 -18.69 60.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.464 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.36 -6.42 58.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.566 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 77.9 mtp 47.74 55.82 17.11 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.56 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.12 149.18 64.26 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.768 2.312 . . . . 0.0 112.109 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.28 -74.05 0.63 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.406 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.5 tp -110.3 113.13 25.55 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.264 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.3 mt -101.93 126.19 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.481 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.7 mt -109.19 133.28 53.22 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.202 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.16 139.31 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.533 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 121' ' ' THR . 89.9 p -83.57 168.54 16.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.677 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.21 -37.42 80.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.437 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.426 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.9 t -139.85 158.89 43.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.477 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.16 177.67 33.08 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.89 87.36 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -125.15 152.03 45.0 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.954 0.407 . . . . 0.0 110.555 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.3 t -63.34 141.24 58.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.36 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.84 10.54 10.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.684 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.9 mp -61.27 -39.02 88.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.973 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.74 -36.09 23.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.467 0.651 . . . . 0.0 110.612 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.2 mt -70.93 -35.34 72.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.447 0.641 . . . . 0.0 110.756 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -42.81 -62.68 0.94 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.27 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.7 p-10 -65.98 -42.59 89.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.067 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.4 -32.81 73.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.14 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.7 mt -73.44 -40.91 63.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.136 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.43 -48.78 79.58 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.167 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.0 m -53.01 -42.7 65.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.241 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.7 -43.2 93.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.106 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.47 154.27 5.56 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.599 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -39.24 106.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.624 2.216 . . . . 0.0 112.377 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 94.3 m -110.22 121.4 45.18 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.983 0.421 . . . . 0.0 110.218 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.37 152.89 30.78 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.233 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 tt -129.09 131.38 68.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.428 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.01 127.9 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.553 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.2 t30 -101.74 103.65 14.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.278 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.2 p90 -101.19 -11.22 19.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.797 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.7 -33.74 76.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.631 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.571 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.6 p-10 -98.09 7.96 45.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.661 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.94 155.6 50.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.503 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.401 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.0 165.7 24.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.689 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.59 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.91 -48.52 81.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.244 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.79 -42.02 67.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.1 t -62.6 -41.17 98.81 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.356 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.4 tp -60.58 -44.35 96.32 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.441 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.45 -43.42 98.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.164 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -54.99 -44.87 74.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.797 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.67 -40.63 97.66 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.837 0.351 . . . . 0.0 110.289 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.439 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -62.03 -42.53 99.27 Favored 'General case' 0 CA--C 1.51 -0.558 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.245 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.01 -41.1 95.4 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.3 -46.17 64.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.953 0.406 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.66 -44.06 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.826 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 156' ' ' LEU . 32.7 p -93.01 -8.86 41.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.567 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.93 26.9 72.4 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -102.06 50.65 0.84 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.849 0.357 . . . . 0.0 110.694 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -69.57 -39.44 77.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.677 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.78 -47.23 86.54 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.292 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -59.78 -39.57 85.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.275 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.94 -40.91 99.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.259 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.68 -28.89 70.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.522 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.04 -54.24 8.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.197 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -65.49 -42.16 92.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.494 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.4 mt -62.43 -43.77 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.524 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.62 -57.61 10.44 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.971 0.415 . . . . 0.0 110.515 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.66 -33.34 68.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.366 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -81.58 -36.52 28.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.856 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 170' ' ' ILE . 58.0 m-20 -55.46 -41.95 73.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.411 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.72 -42.17 99.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.646 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.34 -37.89 88.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.222 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.5 mt -62.43 -42.31 99.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.715 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.93 62.0 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.078 0.466 . . . . 0.0 110.677 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.36 -41.72 89.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.519 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.05 95.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.55 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.26 -32.15 73.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.409 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.65 -22.38 18.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.681 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.56 -41.23 96.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.651 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.6 pt -76.95 136.46 24.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.659 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -126.83 108.27 10.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.291 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -177.04 125.81 0.3 Allowed Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.492 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.1 Cg_exo -44.02 152.44 0.38 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.806 2.337 . . . . 0.0 112.468 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.85 141.83 55.31 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.68 2.253 . . . . 0.0 112.48 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.55 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.16 146.98 2.14 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.602 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.06 154.57 70.3 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.817 2.345 . . . . 0.0 112.272 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.38 163.22 29.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.472 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.671 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.0 t -144.03 170.75 15.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.829 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.671 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -148.61 137.71 21.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.225 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.0 pt -134.45 147.14 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.617 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.43 132.05 57.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.148 0.499 . . . . 0.0 110.482 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -151.95 154.87 36.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.398 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.0 m -122.31 122.94 40.24 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.64 -25.83 66.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.623 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.404 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.22 -48.99 20.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.035 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.99 -11.03 60.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.373 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 76.8 m80 48.59 41.74 17.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.467 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.6 t -136.31 144.97 44.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.391 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.19 114.36 27.54 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.278 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.6 m-20 -119.79 133.41 55.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 110.376 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -111.81 146.24 37.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.79 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.447 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.6 t90 -99.26 129.94 45.52 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.083 0.468 . . . . 0.0 109.997 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.702 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.55 153.72 39.42 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.126 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.4 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.9 Cg_endo -67.95 -17.97 46.47 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.811 2.341 . . . . 0.0 111.852 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.702 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -49.24 -19.16 0.44 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.397 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.447 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.1 p -75.44 164.72 26.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.502 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.95 -27.72 65.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.504 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.585 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.0 mt-30 -63.85 -41.22 97.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.582 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.69 -44.52 97.81 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.41 -38.86 92.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.995 0.426 . . . . 0.0 110.578 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.59 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.1 mmm -62.24 -41.18 98.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.063 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.1 mt -63.78 -46.65 84.25 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.646 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.7 -31.84 58.58 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.7 -18.77 62.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.537 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 90.4 mt -87.39 -9.4 54.86 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.664 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.51 1.71 53.36 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -88.34 153.84 20.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.884 0.373 . . . . 0.0 110.469 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.0 p -116.41 128.84 55.86 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.071 0.462 . . . . 0.0 110.471 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.65 146.33 23.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.864 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.452 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.82 151.41 45.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.516 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.56 131.41 43.32 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.43 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.632 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.61 93.53 28.35 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.095 -179.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.715 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.0 Cg_exo -55.85 139.07 83.62 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.556 2.171 . . . . 0.0 111.521 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.1 -26.05 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.503 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.715 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.18 -50.03 30.11 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.583 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.7 mt -53.99 -37.05 63.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -66.73 36.09 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.794 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.583 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.0 88.38 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.949 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 81.5 p -80.98 -14.08 58.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.398 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.85 -41.82 10.41 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.597 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.2 t -66.64 -16.96 64.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.621 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.76 44.01 26.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.507 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.75 -149.21 8.32 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.09 142.75 48.61 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.013 0.435 . . . . 0.0 110.339 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -151.95 149.61 29.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.368 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -101.32 -151.67 0.42 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.319 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.03 -92.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.689 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.515 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.85 175.38 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.596 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.515 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.2 mt -122.69 141.85 41.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.815 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.87 169.61 9.1 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.31 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.4 mt -147.82 150.9 35.04 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.21 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.65 -38.98 97.06 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.1 3.97 4.71 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -77.49 -57.98 3.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.897 0.38 . . . . 0.0 110.651 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -62.09 -36.73 82.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.196 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 9.9 mp -52.38 -67.59 0.24 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.725 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.66 -42.24 67.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.154 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.92 17.42 0.17 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.649 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.37 48.76 0.33 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.31 -109.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.621 0.248 . . . . 0.0 110.753 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.452 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.7 m120 -60.94 -44.58 97.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.521 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.15 7.89 84.56 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.92 -13.54 19.94 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.748 -0.266 . . . . 0.0 110.732 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.415 ' HG ' ' N ' ' A' ' 259' ' ' LEU . 6.5 t 177.08 142.52 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.131 0.491 . . . . 0.0 110.504 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.415 ' N ' ' HG ' ' A' ' 258' ' ' SER . 9.2 tt -147.95 125.47 11.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.106 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -98.42 143.72 28.56 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 120.937 0.399 . . . . 0.0 110.711 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.2 mt -95.22 106.28 18.29 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.727 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.442 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.0 t80 -101.79 -11.81 18.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.221 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.96 -40.75 87.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.831 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.9 173.2 45.81 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.472 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -74.06 -113.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 110.709 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.28 -28.76 68.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.725 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.01 -43.89 91.61 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.27 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -63.62 -44.33 94.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.31 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.65 -60.02 3.75 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.266 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.09 -43.38 61.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.102 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.43 -43.57 75.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.161 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.56 -43.66 96.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.615 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -56.22 -37.59 69.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.156 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.5 0.93 18.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.259 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -115.12 91.51 27.63 Favored Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.167 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.4 -27.09 30.13 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.846 2.364 . . . . 0.0 111.717 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.41 -41.2 98.72 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.558 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.431 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.9 mp -95.1 4.9 53.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.432 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.08 70.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.703 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -79.97 4.53 16.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.615 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.553 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.64 121.29 80.49 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.536 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -47.49 -37.65 26.38 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.408 2.072 . . . . 0.0 112.424 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.553 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -59.03 -43.63 91.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.792 0.329 . . . . 0.0 110.289 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.05 -43.86 92.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.279 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.82 -40.65 95.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.519 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.9 t-20 -89.54 -12.92 38.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.541 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.35 32.7 16.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.49 43.87 1.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.341 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.48 135.67 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.539 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.72 132.62 56.64 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.469 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.32 89.01 7.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.7 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.456 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.1 mt -63.9 -41.11 97.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.783 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.95 165.57 34.09 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.52 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 76.5 p -75.44 -25.74 57.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.865 0.364 . . . . 0.0 110.665 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -68.35 -34.49 76.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.345 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.505 ' O ' ' CG2' ' A' ' 296' ' ' THR . 95.3 m -72.98 25.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.722 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.585 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 39.6 t80 -58.53 -50.36 74.05 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.1 mmt-85 -111.05 153.48 25.56 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 44.9 tp -115.53 125.03 52.51 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.691 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 41.4 t0 -147.88 165.71 29.81 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.614 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -49.3 -38.16 26.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.509 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -71.23 -65.47 0.74 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.421 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -60.96 -32.73 72.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.962 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.4 -25.61 25.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.634 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.6 mtt -63.5 -41.02 98.55 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 120.905 0.383 . . . . 0.0 111.003 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -78.7 -44.03 24.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.067 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.18 -42.99 92.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.352 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.9 tp -60.14 -47.27 86.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.481 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -69.7 -39.66 76.79 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.634 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.4 ttt180 -61.63 -38.67 88.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.19 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -86.84 4.42 41.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.759 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.59 -11.19 13.61 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.018 0.437 . . . . 0.0 110.28 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.83 -37.12 85.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.632 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.19 -48.63 80.65 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.326 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.975 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.618 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.75 -2.4 58.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.38 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.484 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.12 179.06 1.24 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.047 0.451 . . . . 0.0 110.514 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.6 Cg_exo -60.98 145.1 99.57 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.773 2.316 . . . . 0.0 112.169 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.618 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.77 -179.31 8.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.553 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.7 136.88 52.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.355 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.0 tp -124.64 147.44 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.372 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.4 p -120.39 136.1 54.83 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.767 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.5 -143.47 0.33 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.25 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.41 -37.3 86.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.477 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.1 -66.85 0.22 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.467 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.64 142.48 45.61 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.2 p -112.2 131.71 55.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.951 0.405 . . . . 0.0 110.401 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.15 128.89 54.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.53 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.2 m -85.49 130.36 34.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.237 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.8 mt -95.71 78.75 3.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.306 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.6 -32.19 73.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.493 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 176.03 109.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.099 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -122.55 91.59 49.35 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.28 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.2 Cg_exo -56.95 148.54 67.19 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.794 2.329 . . . . 0.0 111.869 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.15 82.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.595 0.56 . . . . 0.0 111.022 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.43 66.82 0.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.227 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.85 130.83 35.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.697 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.7 t -122.57 147.43 26.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.079 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 t -136.62 143.74 43.69 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.65 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.69 ' HG1' ' H ' ' A' ' 50' ' ' SER . 26.7 p -99.22 -59.48 1.72 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.572 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.69 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.0 p -79.01 155.46 28.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.688 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.3 t -74.43 -21.9 17.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.557 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.407 ' O ' ' OG ' ' A' ' 56' ' ' SER . 89.2 m -60.22 -51.87 67.72 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.503 -178.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.4 mt -66.56 -42.4 87.15 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.319 0.58 . . . . 0.0 110.905 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.5 m -43.37 -53.83 5.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.065 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.27 -37.84 71.35 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.7 m -62.5 -44.45 96.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.846 0.355 . . . . 0.0 110.34 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.5 mt -65.99 -42.14 90.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.464 0.65 . . . . 0.0 110.714 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tp -62.57 -40.13 95.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.453 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.11 77.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.134 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.3 pt -90.9 28.29 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.208 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.81 51.82 10.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.939 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.83 75.75 24.45 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.974 0.416 . . . . 0.0 109.889 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.18 150.63 87.93 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.781 2.32 . . . . 0.0 112.213 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -113.36 136.88 48.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.198 0.523 . . . . 0.0 110.282 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.412 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.25 -43.55 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.307 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.11 131.19 53.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.006 0.431 . . . . 0.0 110.553 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.6 p -155.46 168.61 26.54 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.399 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.69 -177.42 21.75 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.77 172.86 12.2 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 120.881 0.372 . . . . 0.0 110.518 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.7 p -132.41 -113.16 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.374 . . . . 0.0 110.312 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.87 179.85 0.92 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.353 -179.02 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.8 Cg_exo -61.23 57.74 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.988 2.458 . . . . 0.0 112.137 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.545 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 60.4 t-20 -64.37 -33.38 75.71 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.468 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 42.7 m-20 93.76 -35.68 0.02 OUTLIER 'General case' 0 C--N 1.345 0.403 0 O-C-N 124.182 0.926 . . . . 0.0 109.804 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.6 mtp85 -63.05 -39.86 95.98 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.989 0.423 . . . . 0.0 110.267 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -74.73 -25.33 18.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.738 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.03 -171.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.599 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -73.3 -154.16 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.787 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.2 p-10 -52.11 -7.71 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.684 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -86.34 115.1 23.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.594 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.18 70.06 1.34 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.446 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.4 m-85 -143.57 147.46 34.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.931 0.396 . . . . 0.0 110.784 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.527 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.3 mp -85.57 -98.48 0.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.137 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.87 -42.74 97.44 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.129 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.569 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.6 tt0 91.68 53.13 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.066 0.854 . . . . 0.0 110.892 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -102.95 -9.31 19.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.419 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.446 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.54 -34.26 77.82 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.173 0.511 . . . . 0.0 110.664 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.569 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.1 mttt -48.91 -24.79 1.61 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.597 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.2 -45.66 79.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.792 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.25 -48.47 81.28 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.038 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.48 -38.35 89.52 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.364 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.67 -33.0 53.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.176 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.572 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.1 mmt-85 -89.72 1.47 56.03 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.598 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.92 -49.13 0.16 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 124.159 0.912 . . . . 0.0 110.288 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.64 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.1 mt -46.52 153.79 0.34 Allowed 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 117.403 -1.284 . . . . 0.0 109.264 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.64 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 121.62 92.62 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 O-C-N 125.625 1.828 . . . . 0.0 110.431 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.533 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.7 143.29 42.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.122 0.487 . . . . 0.0 110.276 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.3 mt -132.42 27.06 4.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.453 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.37 138.07 34.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.036 0.446 . . . . 0.0 110.512 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 91.9 mt -137.17 164.98 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.401 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.523 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.13 -28.63 1.83 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -153.01 70.93 7.1 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.167 0.508 . . . . 0.0 110.232 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.12 145.48 98.37 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.715 2.277 . . . . 0.0 112.089 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.5 t -134.2 136.61 43.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.563 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.35 82.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.649 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.31 -42.18 96.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.512 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.57 98.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.478 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.66 -43.31 98.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.961 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.2 77.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.26 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.48 -18.7 60.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.438 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.39 -6.44 58.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.523 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 72.4 mtp 47.94 55.85 17.23 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.617 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.16 148.99 63.72 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.798 2.332 . . . . 0.0 112.098 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.15 -73.04 0.66 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.501 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.9 tp -111.32 113.64 26.26 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.313 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.4 mt -102.6 126.37 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.537 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.3 mt -109.77 134.06 52.44 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.143 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.77 139.87 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.496 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 121' ' ' THR . 92.4 p -83.4 168.45 16.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.707 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.16 -37.4 80.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.41 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.425 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.9 t -139.99 159.21 42.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.433 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.27 177.28 33.37 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.24 -33.87 87.36 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.57 151.74 44.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.904 0.383 . . . . 0.0 110.543 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -63.39 140.85 58.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.32 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.54 10.66 11.16 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.657 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.18 -39.04 88.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.092 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.633 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.86 23.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.586 0.708 . . . . 0.0 110.611 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.0 mt -70.76 -35.65 72.72 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.531 0.681 . . . . 0.0 110.764 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.88 -62.96 0.88 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.273 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.633 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.89 -42.64 90.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.046 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -62.17 -32.77 73.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.177 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.5 mt -73.48 -40.9 63.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.24 -48.85 79.11 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.16 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.3 m -52.9 -42.58 65.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.199 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.74 -43.05 93.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.107 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.75 153.89 5.15 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.62 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -39.12 106.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.664 2.243 . . . . 0.0 112.406 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 96.8 m -110.33 121.52 45.47 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.244 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.02 152.96 30.19 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.26 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 tt -128.9 131.0 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.309 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.79 127.78 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.432 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.3 103.75 14.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.278 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 147' ' ' LYS . 45.5 p90 -101.45 -11.2 19.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.783 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.69 -33.61 76.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.666 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -98.21 7.79 45.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.525 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.76 155.46 50.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.527 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.7 p -74.89 165.71 24.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.709 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -60.05 -48.65 80.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.197 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.79 -42.02 67.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.923 0.392 . . . . 0.0 110.027 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.8 t -62.63 -41.11 98.83 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.358 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 tp -60.7 -44.17 96.89 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.353 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.4 tp -61.5 -43.22 99.26 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.101 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -55.31 -44.88 76.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.52 -40.65 97.44 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.894 0.378 . . . . 0.0 110.327 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.431 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -61.95 -42.46 99.14 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.31 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.88 -40.62 95.54 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.58 -45.86 64.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.926 0.393 . . . . 0.0 110.855 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.67 -44.04 96.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.85 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.3 p -93.19 -8.61 41.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.588 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.78 26.34 72.08 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -101.47 50.75 0.85 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.768 0.318 . . . . 0.0 110.67 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.58 -39.36 77.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.659 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.5 -47.17 86.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.234 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -60.19 -39.45 86.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.308 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.1 99.37 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.307 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.94 -28.69 70.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.994 0.426 . . . . 0.0 110.602 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.19 -54.24 8.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.15 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -65.55 -42.25 92.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.477 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.454 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.3 mt -62.45 -43.94 98.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.492 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.48 -58.96 5.71 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.14 0.495 . . . . 0.0 110.48 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -56.51 -34.16 66.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.448 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -80.79 -36.21 32.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.886 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.7 m-20 -55.1 -42.26 72.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.095 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.42 -41.82 98.98 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.686 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.05 -38.19 90.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.285 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.38 -42.11 99.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.771 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.47 63.87 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.084 0.469 . . . . 0.0 110.677 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.35 -41.79 89.02 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.601 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.06 -39.94 95.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.566 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.12 -32.43 73.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.361 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.24 -21.97 18.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.668 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.625 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.67 -41.35 96.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.64 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 pt -76.59 135.92 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.677 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.93 107.79 10.39 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.273 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.67 125.97 0.31 Allowed Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.541 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 73.9 Cg_exo -43.72 152.24 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.781 2.32 . . . . 0.0 112.601 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.87 141.98 55.75 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.573 2.182 . . . . 0.0 112.484 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.547 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.22 147.32 2.19 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.628 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.34 154.85 68.79 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.735 2.29 . . . . 0.0 112.284 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.525 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.56 163.27 28.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.419 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.675 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.0 t -143.84 170.8 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.959 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.675 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -148.92 137.92 21.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.93 0.395 . . . . 0.0 110.195 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 40.1 pt -134.47 147.37 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.692 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -133.2 131.95 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.098 0.475 . . . . 0.0 110.501 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -151.99 155.08 37.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.442 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 89.6 m -122.33 122.84 40.0 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.96 0.41 . . . . 0.0 110.366 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.2 -25.78 65.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.613 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.49 -48.46 22.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.069 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.07 -11.21 60.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.386 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.6 m80 48.25 41.55 16.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.485 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.3 t -135.89 145.22 46.08 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.42 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.94 114.02 27.03 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.233 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.63 133.13 55.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 110.351 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -111.77 146.24 37.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.772 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.442 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 10.3 t90 -99.36 129.77 45.59 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.096 0.475 . . . . 0.0 109.973 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.678 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.59 153.81 39.37 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.306 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.414 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.8 Cg_endo -67.76 -18.39 47.56 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.716 2.277 . . . . 0.0 111.954 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.678 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -49.1 -18.44 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.4 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.442 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.3 p -76.42 164.69 25.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.508 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.78 -27.64 65.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.514 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.603 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.1 mt-30 -63.75 -41.1 98.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.77 -44.48 97.93 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.63 -38.63 91.68 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.961 0.41 . . . . 0.0 110.575 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.3 mmm -62.16 -41.35 98.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.082 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.71 -46.91 83.28 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.534 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.5 -31.91 56.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.073 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.79 -18.68 62.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.449 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.61 -9.31 54.64 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.61 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.29 1.9 54.04 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -88.34 153.77 20.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 110.516 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.3 p -116.56 129.02 55.94 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.119 0.485 . . . . 0.0 110.331 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -93.02 146.21 23.79 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.927 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.454 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.41 151.48 46.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.49 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.39 131.41 43.63 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.397 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.54 93.3 27.01 Favored Pre-proline 0 C--O 1.234 0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.077 -179.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.716 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.6 Cg_exo -55.75 138.96 82.94 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.569 2.179 . . . . 0.0 111.527 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.84 -25.59 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.46 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.716 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.26 -49.96 29.96 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.58 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.0 mt -54.0 -36.8 63.34 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.85 36.42 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.814 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.58 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.75 86.94 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.905 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.1 p -79.4 -15.39 57.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.405 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -92.19 -41.29 10.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.627 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -66.03 -17.94 65.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.605 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.17 43.37 26.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.468 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.49 -147.76 7.46 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.97 142.66 50.08 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.026 0.441 . . . . 0.0 110.294 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.43 149.82 28.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.353 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -101.3 -151.55 0.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.347 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.4 t0 56.16 -91.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.652 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.519 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.85 175.35 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.559 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.519 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 93.4 mt -122.29 141.76 41.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.833 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.81 169.02 9.53 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.221 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.5 mt -147.68 151.07 35.53 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.266 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.69 -39.0 97.06 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.06 4.0 4.72 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.27 -58.06 3.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.996 0.426 . . . . 0.0 110.578 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -62.22 -36.93 83.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.212 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.21 -67.61 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.778 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.71 -42.13 67.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.132 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.0 17.71 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.607 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.25 48.46 0.31 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.47 -109.79 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.605 0.24 . . . . 0.0 110.7 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.454 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.8 m120 -60.9 -44.59 96.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.42 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.21 7.95 84.38 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -98.91 -13.33 20.05 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.713 -0.286 . . . . 0.0 110.693 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.423 ' HG ' ' N ' ' A' ' 259' ' ' LEU . 5.6 t 177.03 142.71 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.089 0.471 . . . . 0.0 110.498 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.423 ' N ' ' HG ' ' A' ' 258' ' ' SER . 9.2 tt -148.06 125.49 11.64 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.176 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -98.65 143.26 29.23 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 120.923 0.392 . . . . 0.0 110.809 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.9 mt -94.42 106.32 18.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.678 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.451 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.9 t80 -101.58 -11.55 19.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.108 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.43 87.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.874 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.74 174.12 46.32 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.475 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.4 m-20 -74.35 -113.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.741 0.305 . . . . 0.0 110.772 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.78 -28.69 67.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.708 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.03 -43.93 91.68 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.271 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.72 -44.26 94.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.377 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.52 -60.14 3.59 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.247 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.11 -43.26 61.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.17 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.53 -43.68 75.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.2 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.2 mt -64.47 -43.65 96.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.664 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -56.31 -37.39 69.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.162 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.77 0.95 18.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.197 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -115.05 91.31 26.5 Favored Pre-proline 0 CA--C 1.529 0.147 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.148 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.29 -27.2 29.76 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.796 2.33 . . . . 0.0 111.832 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.36 -41.02 98.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.569 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.45 5.22 52.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.349 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.97 -35.21 69.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.695 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.58 4.56 15.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.527 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.546 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.58 121.33 80.51 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.566 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -47.6 -37.69 27.25 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.397 2.065 . . . . 0.0 112.558 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.546 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.94 -43.57 91.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.856 0.36 . . . . 0.0 110.305 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.88 -43.89 92.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.285 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.91 -40.59 95.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.444 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.437 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.7 t-20 -89.32 -12.93 39.13 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.529 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.5 mtmt 62.32 31.94 17.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.893 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -89.01 43.87 1.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.046 0.45 . . . . 0.0 110.313 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.51 135.87 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.444 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -116.61 132.55 56.65 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.485 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.1 87.84 7.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.769 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.456 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.5 mt -63.86 -41.23 97.83 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.866 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.451 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.46 167.65 34.58 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.516 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 71.2 p -75.53 -25.69 57.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.845 0.355 . . . . 0.0 110.763 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.4 tp10 -67.84 -34.86 77.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.452 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.499 ' O ' ' CG2' ' A' ' 296' ' ' THR . 95.7 m -73.27 24.59 0.06 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.65 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.603 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 65.5 t80 -58.23 -51.18 70.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 58.9 mmt-85 -112.17 155.1 24.5 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 46.1 tp -116.3 125.64 52.43 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 42.0 t0 -147.29 165.3 30.52 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.573 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -49.41 -38.2 28.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.548 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -72.23 -64.8 0.87 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.509 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.3 -32.11 70.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.984 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.66 -25.3 26.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.571 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.6 mtt -63.08 -41.18 99.35 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 120.965 0.412 . . . . 0.0 110.953 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -78.33 -44.79 24.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.095 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 73.6 t -66.0 -43.06 92.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.435 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.441 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 52.7 tp -60.26 -47.37 86.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.548 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.94 -39.39 76.11 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.635 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.1 ttt180 -61.96 -38.07 87.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.233 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.8 mt -87.38 4.61 42.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.794 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.625 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.3 tttt -112.87 -11.7 13.4 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.045 0.45 . . . . 0.0 110.284 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.04 -37.31 86.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.539 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.95 -48.69 80.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.379 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.022 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.56 -2.53 57.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.43 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.488 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.61 179.03 1.25 Allowed Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.457 -179.658 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.7 Cg_exo -60.81 144.7 99.6 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.796 2.331 . . . . 0.0 112.183 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.98 -179.65 8.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.596 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.61 136.27 53.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.317 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -123.91 146.65 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.333 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.3 p -119.91 136.0 54.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.77 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.1 p30 -99.42 -143.62 0.33 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.225 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -63.4 -37.19 86.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.593 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.9 ttt85 -149.3 -66.62 0.22 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.501 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.29 142.1 45.16 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.8 p -112.15 131.03 55.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.934 0.397 . . . . 0.0 110.437 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -118.92 129.08 54.99 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.542 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.6 m -85.67 130.64 34.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.214 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.1 mt -96.0 78.77 3.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.343 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.81 -32.0 73.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.473 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.12 108.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.164 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -121.65 91.4 48.52 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.304 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.652 ' O ' ' N ' ' A' ' 45' ' ' ARG . 37.1 Cg_exo -57.0 148.59 67.44 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.738 2.292 . . . . 0.0 111.824 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.69 82.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.556 0.535 . . . . 0.0 111.018 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.14 66.85 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.046 0.45 . . . . 0.0 110.251 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.44 131.0 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.614 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.7 t -122.89 145.54 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.146 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -135.52 143.32 45.7 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.623 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.443 ' HG1' ' H ' ' A' ' 50' ' ' SER . 26.0 p -99.26 -59.19 1.77 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.552 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.443 ' H ' ' HG1' ' A' ' 49' ' ' THR . 86.9 p -79.52 154.97 28.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.647 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.8 t -74.58 -21.79 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.57 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.5 m -60.12 -52.18 66.45 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.434 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.6 -42.4 86.94 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.245 0.545 . . . . 0.0 110.873 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -42.82 -53.64 4.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.153 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.45 -37.75 69.56 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.9 m -62.56 -44.62 95.88 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.884 0.373 . . . . 0.0 110.459 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.19 -41.94 89.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.38 0.61 . . . . 0.0 110.739 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.65 -40.15 96.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.324 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.03 -35.91 76.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.94 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.4 pt -91.31 28.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.118 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.54 51.64 10.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.819 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.02 75.93 23.12 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.95 0.405 . . . . 0.0 110.003 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.4 151.77 84.06 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.746 2.298 . . . . 0.0 112.265 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.85 137.42 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.149 0.499 . . . . 0.0 110.316 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.419 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.5 pt -69.26 -43.61 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.219 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.78 130.96 53.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.926 0.393 . . . . 0.0 110.547 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.5 p -155.75 168.99 25.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.44 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.75 -177.44 21.71 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.67 171.86 13.3 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 120.943 0.402 . . . . 0.0 110.531 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 p -133.45 -111.02 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.426 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.498 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.91 179.61 0.95 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.303 -179.171 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.6 Cg_exo -60.88 58.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.953 2.436 . . . . 0.0 112.129 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.1 t-20 -64.24 -35.21 80.09 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.483 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 48.3 m-20 95.26 -37.65 0.01 OUTLIER 'General case' 0 C--N 1.345 0.401 0 O-C-N 124.113 0.883 . . . . 0.0 110.008 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -62.61 -39.87 95.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.2 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.9 p -73.81 -26.41 21.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.689 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -50.06 -172.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.547 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.05 -152.79 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.711 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.7 p-10 -54.37 -6.66 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.685 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -86.92 113.82 23.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.559 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.15 72.73 1.28 Allowed Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.499 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.2 m-85 -143.84 148.05 34.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 0.0 110.809 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.3 mp -85.25 -99.47 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.109 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.554 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.86 -43.11 97.09 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.252 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.4 tt0 91.74 52.8 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.916 0.76 . . . . 0.0 110.861 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -103.32 -9.21 19.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.457 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.499 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.3 p -64.79 -33.86 76.98 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.049 0.452 . . . . 0.0 110.679 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.554 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.66 -23.67 1.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.516 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.3 t -69.7 -45.88 76.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.889 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.23 -48.6 80.74 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.165 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.67 -38.12 89.11 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.337 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.63 -32.51 51.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.218 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.588 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.3 mmt-85 -89.76 1.62 55.88 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.575 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.84 -49.08 0.16 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 124.045 0.841 . . . . 0.0 110.331 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.662 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.7 mt -46.49 154.3 0.3 Allowed 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 117.89 -1.053 . . . . 0.0 109.349 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.662 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 121.17 92.36 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 125.313 1.633 . . . . 0.0 110.502 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.39 143.26 42.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.251 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.9 mt -131.77 26.83 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.758 0.313 . . . . 0.0 110.481 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.42 138.08 34.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.969 0.414 . . . . 0.0 110.506 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.522 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.0 mt -137.17 165.19 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.432 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.04 -28.51 1.85 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -153.01 70.65 7.07 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.178 0.513 . . . . 0.0 110.362 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.12 145.52 98.28 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.772 2.315 . . . . 0.0 112.053 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.5 t -134.1 137.0 44.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.59 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.2 -38.17 81.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.666 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.41 -42.23 96.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.529 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.7 98.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.503 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 64.2 t -63.72 -43.33 97.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.066 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.65 -35.32 77.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.332 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.8 -18.36 59.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.484 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.52 -6.44 58.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.508 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.413 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.9 mtp 48.15 55.78 17.26 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.588 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.05 148.98 64.39 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.844 2.363 . . . . 0.0 112.133 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.28 -73.1 0.66 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.424 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.7 tp -111.33 112.42 24.18 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.305 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.4 mt -100.55 126.07 54.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.476 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.4 mt -109.36 133.16 53.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.203 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.55 139.55 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.526 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 121' ' ' THR . 89.9 p -83.43 168.25 16.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.673 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.23 -37.48 80.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.494 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.433 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.9 t -139.03 158.96 43.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.502 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.44 176.8 33.71 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.83 87.16 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.93 151.55 45.28 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.876 0.369 . . . . 0.0 110.604 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.2 t -62.93 141.17 58.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.291 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.05 10.51 10.77 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.664 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.07 -39.07 88.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.031 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.83 -35.7 24.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.452 0.644 . . . . 0.0 110.654 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.3 mt -71.11 -35.31 71.73 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.437 0.637 . . . . 0.0 110.772 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -42.87 -62.93 0.89 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.185 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.76 -42.82 90.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -62.12 -32.65 73.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.204 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.8 mt -74.03 -40.46 62.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.054 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.16 -48.81 79.13 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.209 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.3 m -52.88 -42.44 65.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.194 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.15 -43.05 92.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.103 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.35 153.37 5.3 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.632 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -39.18 107.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.643 2.229 . . . . 0.0 112.326 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 98.3 m -109.09 121.38 45.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.285 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.36 152.89 30.76 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.26 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 tt -128.95 131.45 68.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.365 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.407 HG22 HD11 ' A' ' 142' ' ' ILE . 96.6 mt -115.07 127.72 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.493 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.4 t30 -101.86 103.67 14.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.324 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 49.6 p90 -101.23 -11.27 19.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.751 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.9 p-10 -64.78 -33.44 76.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.652 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.577 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.1 p-10 -98.31 7.41 46.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.584 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.14 155.35 50.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.572 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.408 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.2 p -74.65 165.7 24.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.664 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.588 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -59.99 -48.86 79.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.281 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -53.84 -41.99 68.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.104 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.2 t -62.49 -40.82 97.92 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.451 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 48.7 tp -60.61 -43.75 97.1 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.297 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.4 -43.2 99.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.826 0.346 . . . . 0.0 110.213 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.7 m -55.63 -45.37 77.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.833 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.35 -40.76 97.43 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-O 120.847 0.356 . . . . 0.0 110.377 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -61.88 -42.38 98.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.184 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.63 -40.76 96.1 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.77 -46.15 63.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.941 0.401 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.52 -43.98 96.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.766 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.2 p -93.21 -8.49 42.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.585 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.69 25.32 71.63 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -101.8 52.09 0.83 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.779 0.323 . . . . 0.0 110.623 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.84 -39.07 76.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.629 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.3 -47.17 86.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.262 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -61.33 -38.97 88.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.413 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.4 97.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.324 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.41 -27.69 69.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.491 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.77 -53.75 8.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.207 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -63.78 -43.51 96.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.458 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.1 mt -63.08 -43.88 99.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.654 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.35 -61.62 2.41 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.118 0.485 . . . . 0.0 110.377 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.66 -35.08 63.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.457 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -79.6 -34.77 40.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.004 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.6 m-20 -56.49 -40.12 74.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.112 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.95 -42.41 99.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.686 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.79 -37.72 87.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.309 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.44 -42.45 99.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.737 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.09 -53.17 59.18 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.059 0.457 . . . . 0.0 110.679 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.12 -41.77 90.08 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.562 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.93 95.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.647 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.17 -32.26 73.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.419 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.3 -21.97 18.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.719 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.637 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.94 -41.4 95.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.68 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 pt -77.48 136.14 24.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.666 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.26 108.69 11.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.351 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.5 126.14 0.32 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.559 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.457 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.4 Cg_exo -43.68 152.02 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.742 2.295 . . . . 0.0 112.598 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.03 141.66 53.81 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.605 2.203 . . . . 0.0 112.465 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.12 147.34 2.23 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.62 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.28 154.62 69.37 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.74 2.293 . . . . 0.0 112.26 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.52 163.2 28.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.446 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.524 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 2.0 t -143.82 170.1 16.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.853 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.484 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.51 137.75 21.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.238 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.7 pt -134.29 146.71 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.288 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.654 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.76 131.77 59.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.099 0.476 . . . . 0.0 110.53 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -152.05 155.11 37.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.369 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 90.5 m -122.62 122.92 39.98 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.924 0.393 . . . . 0.0 110.401 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.11 -25.71 65.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.601 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.42 -48.97 20.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.091 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.62 -13.25 61.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.442 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.3 m80 50.72 41.36 26.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.503 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 43.3 t -136.32 144.68 44.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.344 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.14 114.18 27.47 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.315 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.1 m-20 -119.74 133.35 55.65 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.972 0.415 . . . . 0.0 110.372 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.3 tt -112.07 146.32 38.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.735 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.457 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.2 t90 -99.5 129.8 45.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.108 0.48 . . . . 0.0 110.059 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.707 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.48 154.14 39.37 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.086 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.7 Cg_endo -67.8 -17.93 47.26 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.742 2.295 . . . . 0.0 111.933 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.707 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -49.56 -18.43 0.43 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.457 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.457 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.6 p -75.83 165.26 25.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.523 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.26 -28.17 66.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.491 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.526 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.51 -41.63 98.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.705 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.84 -44.95 96.59 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.44 -39.01 93.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.949 0.404 . . . . 0.0 110.612 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.588 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.4 mmm -62.08 -41.31 98.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.226 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.71 -47.14 82.33 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.64 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.33 -32.05 55.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.095 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.71 -18.3 62.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.496 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 91.1 mt -88.53 -8.6 54.53 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.691 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.74 2.43 55.25 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -88.55 152.63 21.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.0 110.499 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.2 p -115.5 128.32 55.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.077 0.465 . . . . 0.0 110.42 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.52 146.1 23.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.899 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.455 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.37 151.05 46.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.49 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.76 131.47 43.0 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.463 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.632 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.62 93.41 27.93 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.142 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.718 ' C ' ' H ' ' A' ' 229' ' ' GLY . 47.5 Cg_exo -55.65 139.16 82.79 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.62 2.213 . . . . 0.0 111.558 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.99 -25.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.445 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.718 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.71 -49.81 27.97 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.587 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.0 mt -53.97 -37.14 63.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.56 35.99 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.782 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.2 88.18 0.01 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.844 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.9 p -81.33 -14.31 57.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.356 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.64 -41.19 10.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.567 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.8 t -66.84 -16.72 64.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.607 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.06 43.53 26.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.469 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.91 -147.1 7.25 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -122.49 143.16 49.88 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.994 0.426 . . . . 0.0 110.389 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -151.97 149.47 28.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.453 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -100.72 -151.94 0.42 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.392 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 55.92 -92.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.648 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.512 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.54 175.08 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.565 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.512 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.5 mt -121.83 141.43 42.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.726 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.75 169.22 9.4 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.281 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.4 mt -147.83 150.85 34.95 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.182 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.65 -38.95 97.01 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.15 4.13 4.64 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.37 -58.15 3.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.922 0.392 . . . . 0.0 110.579 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -62.13 -36.86 83.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.271 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.28 -67.81 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.722 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.33 -42.11 66.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.185 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.14 18.12 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.64 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.79 48.61 0.27 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.41 -109.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.6 0.238 . . . . 0.0 110.726 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.455 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 12.0 m120 -60.89 -44.72 96.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.425 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.41 8.13 83.76 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -99.13 -12.74 20.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.58 0.229 . . . . 0.0 110.715 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.8 t 176.37 142.42 0.07 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.062 0.458 . . . . 0.0 110.533 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -147.88 125.39 11.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.03 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -98.6 143.03 29.44 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 120.85 0.357 . . . . 0.0 110.817 178.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.1 mt -94.33 106.5 18.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.675 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.463 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.3 t80 -102.28 -11.65 18.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.25 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.08 -40.15 86.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.804 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.11 173.68 46.14 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.474 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.0 m-20 -74.45 -112.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.347 . . . . 0.0 110.618 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.13 -28.72 67.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.728 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.85 -44.17 90.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.296 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -63.35 -44.54 94.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.353 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.34 -59.92 3.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.29 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.16 -43.32 61.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.221 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.38 -43.92 75.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.216 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.4 mt -64.42 -43.63 97.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.589 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -56.71 -37.43 70.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.172 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.96 1.03 18.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.251 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.0 91.35 26.43 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.195 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.01 -27.19 27.75 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.743 2.296 . . . . 0.0 111.87 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.514 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.34 -41.19 98.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.634 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.9 mp -95.21 5.11 52.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.41 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.72 -35.09 70.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.683 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.8 4.7 15.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.528 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.95 121.08 80.32 Favored Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.556 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -47.27 -37.8 24.94 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.507 2.138 . . . . 0.0 112.487 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.55 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.9 -43.82 91.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.294 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.82 -43.72 93.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.303 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.6 -40.52 95.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.539 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -90.32 -11.94 39.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.53 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.86 32.38 18.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.884 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.77 44.0 1.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.385 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.34 135.74 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.566 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.44 133.03 56.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.435 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.497 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.69 87.95 7.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.686 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.471 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.9 mt -63.91 -41.47 97.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.834 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.16 167.93 34.42 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.8 p -75.9 -25.82 56.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.84 0.352 . . . . 0.0 110.691 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.533 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.4 tp10 -67.84 -34.32 76.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.39 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.497 ' O ' ' CG2' ' A' ' 296' ' ' THR . 97.1 m -73.14 19.7 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.631 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.533 ' H ' ' C ' ' A' ' 295' ' ' GLU . 53.1 t80 -57.25 -51.08 70.8 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.058 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 68.5 mmt-85 -108.05 149.36 28.53 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 42.3 tp -115.46 125.57 53.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.756 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 304' ' ' ALA . 42.6 t0 -149.37 166.61 28.52 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.632 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -49.15 -38.14 24.47 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.588 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.82 -65.15 0.8 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.231 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.86 -32.79 72.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 300' ' ' ASP . . . -54.44 -26.01 28.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.659 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.6 mtt -63.36 -41.04 98.8 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 120.851 0.357 . . . . 0.0 110.908 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.26 -44.41 25.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.914 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.17 -42.89 92.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.425 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.436 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.3 tp -59.86 -47.49 85.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.505 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -69.64 -39.56 77.05 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.027 0.441 . . . . 0.0 110.723 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.497 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.2 ttt180 -61.7 -38.43 87.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.203 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -87.14 4.9 40.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.785 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.637 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.65 -11.77 13.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.04 0.448 . . . . 0.0 110.266 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.74 -37.08 85.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.642 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.99 -48.78 80.24 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.386 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.057 179.855 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.85 -2.46 58.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.413 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.9 179.08 1.24 Allowed Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.556 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.1 Cg_exo -60.9 145.11 99.52 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.781 2.321 . . . . 0.0 112.165 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.03 -179.21 7.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.589 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.81 136.67 52.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.342 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.39 147.29 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.362 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.9 p -120.39 136.12 54.82 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.27 -143.57 0.32 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.191 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -63.46 -37.18 86.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.526 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.05 -66.96 0.22 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.412 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.32 142.4 44.96 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.7 p -112.24 131.44 55.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.907 0.384 . . . . 0.0 110.435 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -119.22 129.06 54.76 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.518 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.0 m -85.68 130.36 34.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.225 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.8 mt -95.94 78.88 3.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.32 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.9 -31.91 73.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.491 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 176.06 108.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.05 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -121.89 91.56 48.77 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.312 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.646 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.3 Cg_exo -56.94 148.77 65.7 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.787 2.325 . . . . 0.0 111.862 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.64 82.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.607 0.567 . . . . 0.0 111.044 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.646 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.16 66.71 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.229 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.7 130.65 36.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.63 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.9 t -122.91 146.34 28.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.027 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -135.96 144.3 45.32 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.406 ' HG1' ' N ' ' A' ' 50' ' ' SER . 20.8 p -100.13 -59.28 1.74 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.619 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.406 ' N ' ' HG1' ' A' ' 49' ' ' THR . 86.5 p -79.21 154.78 28.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.653 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.2 t -74.0 -22.01 18.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.578 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.405 ' O ' ' OG ' ' A' ' 56' ' ' SER . 97.4 m -60.24 -51.89 67.62 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.559 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -66.45 -42.42 87.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.196 0.522 . . . . 0.0 110.855 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.1 m -43.38 -53.74 5.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.048 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.41 -37.64 69.88 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.5 m -62.51 -44.66 95.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.896 0.379 . . . . 0.0 110.324 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.0 mt -66.16 -42.01 89.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.535 0.683 . . . . 0.0 110.704 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.63 -40.21 96.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.398 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.79 75.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.07 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 pt -91.36 28.91 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.229 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.5 51.66 10.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.881 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.35 75.55 22.71 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.91 151.88 84.22 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.742 2.295 . . . . 0.0 112.136 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.82 137.48 46.86 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 CA-C-O 121.172 0.51 . . . . 0.0 110.236 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.22 -43.63 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.317 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.483 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.97 131.12 53.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.051 0.453 . . . . 0.0 110.552 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.53 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.0 p -155.62 168.84 25.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.493 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.82 -177.25 21.67 Favored Glycine 0 N--CA 1.464 0.544 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.72 172.76 12.32 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.0 0.428 . . . . 0.0 110.486 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 p -132.59 -112.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.339 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.17 179.9 0.91 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.359 -179.131 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.8 Cg_exo -60.89 57.59 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.973 2.449 . . . . 0.0 112.154 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.6 t-20 -63.87 -33.36 75.52 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.407 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 43.6 m-20 93.42 -36.64 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.014 0.821 . . . . 0.0 109.855 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -62.65 -39.51 94.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.019 0.438 . . . . 0.0 110.145 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 77' ' ' ALA . 15.0 p -74.29 -25.65 19.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.758 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.36 -171.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.545 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -74.12 -154.13 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.845 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.2 p-10 -52.52 -7.4 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.665 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.521 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.19 115.02 23.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.977 0.418 . . . . 0.0 110.631 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.82 70.16 1.35 Allowed Glycine 0 CA--C 1.52 0.39 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.3 m-85 -143.47 148.18 35.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 110.793 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.526 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -86.08 -98.42 0.07 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.135 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.89 -42.84 97.37 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.183 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.547 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.3 tt0 91.53 52.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.991 0.807 . . . . 0.0 110.858 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -102.86 -9.48 19.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.429 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.419 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.3 p -64.24 -33.85 76.75 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.149 0.5 . . . . 0.0 110.691 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.546 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.12 -23.96 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.66 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.39 -45.99 77.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.27 -48.33 81.9 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.043 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.65 -38.11 89.0 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.374 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.82 -32.72 53.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.161 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.574 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.94 1.71 55.93 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.523 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.65 -49.38 0.18 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.115 0.884 . . . . 0.0 110.265 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.5 mt -46.16 154.65 0.25 Allowed 'General case' 0 CA--C 1.49 -1.336 0 CA-C-O 117.475 -1.25 . . . . 0.0 109.343 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.644 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 120.95 92.57 0.0 OUTLIER 'General case' 0 C--N 1.353 0.735 0 O-C-N 125.563 1.79 . . . . 0.0 110.46 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.53 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.7 mtp180 -75.7 143.36 42.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.14 0.495 . . . . 0.0 110.265 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.5 mt -132.43 27.12 4.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 0.0 110.461 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.21 137.7 34.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.003 0.43 . . . . 0.0 110.49 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 91.8 mt -137.29 165.09 28.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.391 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.524 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.08 -28.46 1.84 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.35 70.84 7.59 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.191 0.52 . . . . 0.0 110.208 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -60.0 145.3 98.71 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 C-N-CA 122.751 2.3 . . . . 0.0 112.066 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.7 t -134.73 136.81 42.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.553 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.12 81.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.711 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.26 -42.33 96.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.52 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.86 -41.61 98.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.546 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.4 t -63.5 -43.42 98.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.99 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.06 77.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.23 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.76 -18.9 61.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.478 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.38 -6.57 58.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 81.9 mtp 47.8 55.97 17.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.59 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.3 Cg_endo -70.37 149.36 62.87 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.807 2.338 . . . . 0.0 112.101 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.22 -72.94 0.66 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.454 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.2 tp -111.56 113.01 25.14 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.324 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.1 mt -101.27 126.46 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.584 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.7 mt -109.52 133.47 53.05 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.225 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.68 139.65 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.493 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 121' ' ' THR . 88.4 p -83.45 168.56 16.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.671 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.42 80.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.381 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.431 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.8 t -139.53 158.94 43.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.943 0.402 . . . . 0.0 110.453 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.29 176.92 33.56 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.21 -33.71 86.82 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.77 151.52 45.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.925 0.393 . . . . 0.0 110.507 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.1 t -63.06 140.98 58.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.339 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.69 10.42 11.0 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.642 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.09 -39.16 88.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.081 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.79 -35.98 23.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.588 0.709 . . . . 0.0 110.705 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.4 mt -70.83 -35.54 72.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.528 0.68 . . . . 0.0 110.732 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -42.81 -62.83 0.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.317 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.81 -42.78 90.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.06 -179.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -62.03 -32.73 73.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.24 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.3 mt -73.77 -40.64 63.31 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.102 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.29 -48.76 79.47 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.153 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.1 m -53.05 -42.5 65.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.097 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.88 -43.09 93.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.937 0.399 . . . . 0.0 111.099 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.32 153.47 5.36 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.674 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -39.25 107.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.65 2.233 . . . . 0.0 112.445 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 97.8 m -109.65 121.64 45.67 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.24 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -113.96 152.6 30.64 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.256 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 tt -128.98 131.4 68.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.321 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.14 127.89 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.491 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.472 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 57.0 t30 -101.56 103.8 14.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.265 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.6 p90 -101.38 -11.21 19.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.816 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.75 -33.65 76.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.682 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.9 p-10 -98.3 7.66 45.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.612 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.448 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.46 155.39 50.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.51 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.403 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.8 p -74.86 165.64 24.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.641 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.86 -48.77 80.35 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.247 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.66 -41.95 67.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.028 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.3 t -62.65 -41.08 98.86 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.385 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.5 tp -60.61 -44.38 96.36 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.393 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.3 tp -61.41 -43.43 98.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.145 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -55.07 -44.88 75.2 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.43 -40.78 97.68 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.943 0.402 . . . . 0.0 110.469 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -62.03 -42.47 99.2 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.305 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.21 -40.91 95.02 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.5 -45.96 64.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.832 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.75 -44.04 96.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.794 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.4 p -93.03 -8.81 41.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.622 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.01 26.58 72.38 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -101.54 50.63 0.85 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.807 0.337 . . . . 0.0 110.703 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.45 -39.61 77.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.617 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.4 -47.26 86.13 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.252 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -59.94 -39.55 85.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.314 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.77 98.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.278 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.0 -28.61 70.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.614 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.18 -54.26 8.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.067 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -65.49 -42.27 92.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.456 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.459 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.6 mt -62.35 -43.98 98.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.502 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.66 -58.35 7.8 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.037 0.446 . . . . 0.0 110.344 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.05 -34.05 67.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.471 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -81.01 -36.35 30.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.875 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -55.61 -41.84 74.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.03 -178.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.7 -42.1 99.47 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.684 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.29 -38.05 89.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.288 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.47 -42.23 99.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.674 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.08 -52.79 62.48 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.091 0.472 . . . . 0.0 110.664 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.32 -41.75 89.23 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.588 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.89 95.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.611 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.34 -32.13 73.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.426 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.62 -22.26 18.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.693 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.636 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.77 -41.26 96.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.652 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.3 pt -76.56 136.45 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.698 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.72 107.91 10.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.224 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.82 125.69 0.3 Allowed Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.45 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.452 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.2 Cg_exo -43.96 152.38 0.37 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.757 2.305 . . . . 0.0 112.623 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.75 141.85 55.88 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.589 2.193 . . . . 0.0 112.466 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.01 147.44 2.29 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.622 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.31 154.32 69.71 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.782 2.321 . . . . 0.0 112.303 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.522 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.39 163.15 29.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.438 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.582 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.1 t -143.91 170.73 15.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.915 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.582 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.36 137.75 22.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.238 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 40.1 pt -134.24 146.89 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.672 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.03 131.87 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.168 0.508 . . . . 0.0 110.488 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -152.12 155.25 37.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.388 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 90.6 m -122.69 123.16 40.49 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.917 0.389 . . . . 0.0 110.341 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.5 -25.66 66.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.649 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.59 -48.94 20.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.038 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.18 -13.62 61.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.435 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 76.5 m80 51.05 40.92 26.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.518 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.9 t -136.48 143.96 44.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.422 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -109.56 114.54 28.25 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.287 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.3 m-20 -119.8 133.32 55.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.128 0.49 . . . . 0.0 110.346 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -111.97 146.41 37.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.787 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.449 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.6 t90 -99.47 129.61 45.66 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.142 0.496 . . . . 0.0 109.996 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.707 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.14 153.89 39.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.225 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.7 Cg_endo -67.8 -18.04 47.3 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.647 2.231 . . . . 0.0 111.958 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.707 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -49.29 -18.7 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.441 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.449 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.6 p -75.63 164.65 26.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.486 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.91 -27.94 65.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.503 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.579 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.9 mt-30 -63.82 -41.33 97.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.586 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.37 -44.61 97.4 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.448 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.2 mt-30 -64.51 -38.75 92.11 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 122.524 -0.398 . . . . 0.0 110.575 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.2 mmm -62.16 -41.08 97.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.167 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.3 mt -63.59 -47.02 83.18 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.464 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.31 -31.91 55.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.155 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -70.84 -18.24 62.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.558 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.17 -9.11 54.16 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.617 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.18 1.97 54.41 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -88.43 153.22 21.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 110.467 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 p -116.12 128.73 55.91 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.129 0.49 . . . . 0.0 110.348 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.66 146.24 23.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.897 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.75 151.26 46.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.402 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.43 131.44 43.57 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.425 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.631 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.62 93.37 27.72 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.032 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.716 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.7 Cg_exo -55.65 139.0 82.62 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.575 2.183 . . . . 0.0 111.518 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.84 -25.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.483 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.716 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -69.94 -50.1 31.18 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.581 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.5 mt -53.94 -36.92 63.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.814 0.34 . . . . 0.0 110.123 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -66.7 36.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.829 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.581 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.88 86.81 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.948 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.3 p -79.09 -15.24 58.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.325 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.58 -41.04 10.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.616 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.1 t -66.21 -18.0 65.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.546 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.14 43.48 26.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.435 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.52 -148.22 7.71 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.68 142.79 49.81 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.002 0.429 . . . . 0.0 110.294 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.41 149.93 29.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.317 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -101.21 -151.55 0.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.369 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 56.0 -91.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.646 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.519 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.84 175.42 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.648 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.519 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.1 mt -122.54 141.78 41.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.83 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.76 169.29 9.35 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.327 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.5 mt -147.65 151.01 35.46 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.289 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.63 -38.95 97.02 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.95 4.13 4.74 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -77.37 -58.1 3.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.986 0.422 . . . . 0.0 110.595 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -62.11 -36.69 82.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.232 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.44 -67.53 0.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.55 -42.21 67.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.1 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.29 17.67 0.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.62 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.17 48.62 0.31 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.5 mp 38.65 -109.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.6 0.238 . . . . 0.0 110.736 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.453 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.9 m120 -60.95 -44.75 96.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.427 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.42 7.97 83.98 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.88 -13.51 20.0 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.743 -0.269 . . . . 0.0 110.65 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.423 ' HG ' ' N ' ' A' ' 259' ' ' LEU . 5.7 t 176.97 142.7 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.122 0.487 . . . . 0.0 110.479 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.423 ' N ' ' HG ' ' A' ' 258' ' ' SER . 9.2 tt -148.13 125.21 11.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.14 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -98.31 143.52 28.7 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 120.898 0.38 . . . . 0.0 110.763 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.87 106.55 18.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.688 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.4 t80 -101.79 -12.21 18.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.157 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.47 -40.86 89.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.853 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.79 173.22 45.87 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.009 -0.837 . . . . 0.0 111.009 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.461 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.4 m-20 -73.85 -113.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 110.758 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.89 -28.69 67.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.711 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.9 -43.9 91.11 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.237 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.57 -44.17 94.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.408 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.73 -60.09 3.68 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.217 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.08 -43.34 61.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.142 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.48 -43.62 75.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.144 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.6 mt -64.59 -43.66 96.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.6 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -56.07 -37.49 69.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.16 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.72 0.94 18.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.185 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -114.98 91.14 25.49 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.147 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.19 -27.09 28.69 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.756 2.304 . . . . 0.0 111.848 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.45 -40.97 98.55 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.592 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.35 5.11 52.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.352 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.87 -35.19 69.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.687 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.65 4.5 15.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.53 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.548 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.67 121.17 80.07 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -47.32 -37.66 25.12 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.469 2.113 . . . . 0.0 112.512 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.548 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -59.05 -43.82 91.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.804 0.335 . . . . 0.0 110.273 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.5 t -65.86 -43.77 93.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.299 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -65.03 -40.66 95.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.428 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.9 t-20 -89.49 -12.73 39.22 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.575 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.7 mtmt 62.16 32.07 17.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -88.9 43.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.101 0.477 . . . . 0.0 110.332 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.13 135.81 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.419 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.8 132.3 56.73 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.403 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.13 89.05 7.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.765 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.458 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.8 mt -63.9 -41.23 97.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.877 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.444 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.79 165.64 33.84 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 69.0 p -75.47 -25.83 57.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.888 0.375 . . . . 0.0 110.813 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.0 tp10 -68.23 -33.84 75.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.439 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.503 ' O ' ' CG2' ' A' ' 296' ' ' THR . 96.7 m -73.53 24.45 0.07 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.67 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.579 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 43.7 t80 -58.28 -50.7 72.66 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 76.9 mmt-85 -110.8 153.17 25.75 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 43.6 tp -115.49 125.34 52.94 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.819 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 41.1 t0 -148.16 165.77 29.89 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.605 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -49.38 -38.05 27.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.567 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -70.92 -65.76 0.7 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.449 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -60.97 -32.72 72.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.056 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.22 -25.58 23.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.678 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.7 mtt -63.51 -40.83 98.08 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 120.872 0.368 . . . . 0.0 111.081 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.75 -44.24 23.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.108 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 78.6 t -66.14 -42.91 92.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.409 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.3 tp -60.29 -47.01 87.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.48 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -70.0 -39.33 75.93 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.598 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.498 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.7 ttt180 -61.79 -38.29 87.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.166 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.5 mt -87.07 4.45 42.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.71 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.636 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.78 -11.3 13.5 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 110.264 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.12 85.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.552 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.85 -48.61 81.01 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.296 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.964 179.971 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.614 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.34 -2.46 57.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.412 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.89 179.04 1.25 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.0 Cg_exo -60.73 144.61 99.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.71 2.273 . . . . 0.0 112.194 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.614 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.58 -179.87 8.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.621 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.63 136.52 52.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.318 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.12 147.07 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.368 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.6 p -120.25 136.08 54.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 110.745 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.6 -143.43 0.33 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.269 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.41 -37.27 86.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.504 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.474 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.17 -66.84 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.486 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.62 142.38 45.65 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.0 p -112.26 131.41 55.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.908 0.385 . . . . 0.0 110.45 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -118.8 128.96 54.96 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.561 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.5 m -85.35 130.33 34.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.237 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.7 mt -95.68 78.9 3.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.324 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.53 -31.94 73.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.493 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.79 109.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.073 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -122.05 91.66 48.9 Favored Pre-proline 0 C--O 1.233 0.203 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.296 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.646 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.2 Cg_exo -56.94 148.76 65.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.766 2.311 . . . . 0.0 111.874 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.61 82.75 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 O-C-N 123.587 0.554 . . . . 0.0 110.991 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.646 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.45 67.03 0.89 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.244 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.14 130.66 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.665 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.66 146.68 27.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.047 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.9 t -136.28 143.87 44.45 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.697 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.561 ' HG1' ' H ' ' A' ' 50' ' ' SER . 28.2 p -99.26 -59.2 1.77 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.584 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.561 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.2 p -79.46 155.39 28.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.632 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.6 t -74.3 -21.86 17.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.567 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.407 ' O ' ' OG ' ' A' ' 56' ' ' SER . 97.4 m -60.28 -52.01 67.11 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.456 -178.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.29 -42.54 88.23 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.375 0.607 . . . . 0.0 110.879 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.0 m -43.38 -53.93 5.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.086 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.31 -37.75 70.89 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.7 m -62.51 -44.67 95.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.805 0.336 . . . . 0.0 110.277 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt -66.14 -41.98 89.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.464 0.649 . . . . 0.0 110.761 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.53 -40.19 95.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.476 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.14 -36.0 76.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.135 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.9 pt -91.07 28.7 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.239 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.72 51.48 10.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.861 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.94 75.66 23.97 Favored Pre-proline 0 C--N 1.332 -0.167 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.68 151.44 85.64 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.743 2.295 . . . . 0.0 112.17 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.61 137.18 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.191 0.519 . . . . 0.0 110.25 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.7 pt -69.09 -43.69 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.339 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.95 130.97 53.43 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.933 0.396 . . . . 0.0 110.581 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.53 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.8 p -155.51 168.79 25.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.429 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.78 -177.45 21.69 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.54 172.88 12.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.944 0.402 . . . . 0.0 110.523 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.6 p -133.03 -112.11 0.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.404 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.36 179.79 0.92 Allowed Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.346 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.3 Cg_exo -61.2 57.86 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.943 2.428 . . . . 0.0 112.117 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.8 t-20 -63.97 -33.98 76.95 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.51 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.3 m-20 94.01 -36.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.176 0.923 . . . . 0.0 109.808 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.2 mtp85 -62.99 -40.1 96.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.258 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 77' ' ' ALA . 15.0 p -74.43 -25.92 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.744 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.21 -171.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.608 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -73.69 -153.87 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.819 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.1 p-10 -52.79 -7.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.751 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.22 114.59 23.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.619 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.81 71.04 1.33 Allowed Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.444 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.0 m-85 -143.75 148.23 35.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.861 0.362 . . . . 0.0 110.812 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.527 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.5 mp -86.07 -98.66 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.031 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.99 -42.83 97.06 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.227 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.561 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.7 tt0 91.7 53.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.994 0.809 . . . . 0.0 110.887 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -103.12 -9.22 19.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.36 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.444 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.49 -34.19 77.64 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.079 0.466 . . . . 0.0 110.625 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.561 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.1 mttt -48.91 -23.76 1.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.562 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.9 t -69.53 -45.93 77.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.41 -48.38 81.46 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.055 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.63 -38.21 89.35 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.276 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.71 -32.25 51.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.173 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.575 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 83.2 mmt-85 -90.16 1.67 56.17 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.575 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.76 -49.18 0.17 Allowed 'General case' 0 N--CA 1.465 0.305 0 O-C-N 124.169 0.918 . . . . 0.0 110.288 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.1 mt -46.54 154.21 0.31 Allowed 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 117.503 -1.237 . . . . 0.0 109.274 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.644 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.32 92.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 O-C-N 125.569 1.793 . . . . 0.0 110.431 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.53 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.59 143.51 42.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.123 0.487 . . . . 0.0 110.228 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 mt -132.37 27.18 4.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.769 0.319 . . . . 0.0 110.471 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.48 138.25 34.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.015 0.436 . . . . 0.0 110.495 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.522 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 93.1 mt -137.3 165.04 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.367 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.0 -28.57 1.85 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -153.16 70.93 7.01 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.13 0.49 . . . . 0.0 110.292 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.08 145.48 98.34 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.724 2.282 . . . . 0.0 112.075 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.7 t -134.05 136.37 43.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.05 -38.29 82.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.63 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.28 -42.03 96.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.53 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.4 98.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.523 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -63.74 -43.54 98.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.946 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.13 77.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.237 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.68 -18.6 60.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.427 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.6 -6.61 58.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.509 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.5 mtp 47.93 56.02 17.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.609 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.4 Cg_endo -70.23 149.09 63.35 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.834 2.356 . . . . 0.0 112.112 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -100.75 -74.11 0.62 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.564 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.1 tp -110.45 113.32 25.87 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.296 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.9 mt -101.78 126.38 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.508 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.1 mt -109.79 133.55 53.02 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.183 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.26 139.62 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.563 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.2 p -83.45 168.41 16.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.701 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.42 80.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.459 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.2 t -139.58 158.97 43.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.436 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.01 176.65 33.41 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.33 -33.82 87.34 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.48 151.57 44.43 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.881 0.372 . . . . 0.0 110.537 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.5 t -63.1 140.57 58.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.316 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.39 10.5 11.23 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.677 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.06 -38.97 88.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.049 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.99 -35.92 23.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.554 0.692 . . . . 0.0 110.645 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.9 mt -70.69 -35.65 72.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.495 0.664 . . . . 0.0 110.726 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -42.8 -62.93 0.88 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.375 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.74 -42.65 90.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.102 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -62.14 -32.97 73.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.209 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.5 mt -73.29 -40.95 64.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.038 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.42 -48.85 79.32 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.145 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.4 m -52.94 -42.32 65.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.247 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.11 -42.93 92.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.928 0.394 . . . . 0.0 111.043 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.53 154.37 5.55 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.621 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -39.63 107.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.621 2.214 . . . . 0.0 112.335 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 93.8 m -110.09 121.13 44.54 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.255 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -113.88 152.74 30.31 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.223 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 tt -128.8 131.39 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.391 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.13 127.75 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.469 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.9 t30 -101.52 103.23 14.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.243 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 147' ' ' LYS . 44.5 p90 -100.96 -11.09 20.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.812 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.5 p-10 -64.8 -33.56 76.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.703 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.7 p-10 -98.47 8.12 45.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.601 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.443 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.8 155.51 50.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.51 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.404 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.8 p -74.99 165.85 24.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.705 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.4 t90 -60.01 -48.8 80.22 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.246 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.5 -42.19 67.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.921 0.391 . . . . 0.0 110.103 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.7 t -62.54 -40.81 97.99 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.406 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.62 -43.91 96.93 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.282 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.8 tp -61.45 -43.25 99.2 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.111 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.5 m -55.01 -45.27 75.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.53 -40.67 97.52 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.855 0.359 . . . . 0.0 110.338 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -62.02 -42.37 99.09 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.302 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.07 -41.18 95.25 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.61 -46.03 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.952 0.406 . . . . 0.0 110.975 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.53 -44.05 96.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.887 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 156' ' ' LEU . 31.8 p -93.31 -8.54 41.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.597 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.89 25.46 71.92 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -102.12 51.83 0.82 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.8 0.333 . . . . 0.0 110.699 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.76 -39.23 76.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.664 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.28 -46.94 87.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.173 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -61.36 -39.02 89.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.315 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.4 -40.46 97.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.311 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.62 69.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.018 0.437 . . . . 0.0 110.545 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.77 -53.61 8.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.158 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -64.11 -43.25 95.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.406 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.2 mt -62.98 -43.89 99.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.717 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.46 -61.38 2.57 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.128 0.489 . . . . 0.0 110.461 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.71 -35.11 63.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.451 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -79.6 -35.24 39.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.957 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.4 m-20 -56.29 -40.66 74.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.255 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.01 -42.37 99.81 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.684 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.64 -37.83 87.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.287 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.42 -42.16 99.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.736 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.05 -52.78 62.56 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.128 0.489 . . . . 0.0 110.694 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.46 -41.47 89.02 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.609 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.8 94.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.633 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.01 -32.53 73.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.43 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.03 -21.93 18.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.696 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -65.11 -41.03 95.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.734 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -77.45 136.32 24.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.74 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.28 108.56 10.97 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.258 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.44 125.96 0.32 Allowed Pre-proline 0 C--O 1.24 0.555 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.529 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.1 Cg_exo -43.92 152.21 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.824 2.349 . . . . 0.0 112.533 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.26 142.12 54.16 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.678 2.252 . . . . 0.0 112.472 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.44 147.26 2.09 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.607 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.85 154.29 71.3 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.726 2.284 . . . . 0.0 112.293 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.521 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.12 162.99 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.452 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.521 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 2.1 t -143.83 170.57 15.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.948 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.471 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.77 137.84 21.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.0 110.166 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 40.0 pt -134.33 146.99 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.695 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.94 131.86 59.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.161 0.505 . . . . 0.0 110.468 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -152.22 155.45 37.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.363 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 90.6 m -123.05 123.23 40.39 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.939 0.4 . . . . 0.0 110.331 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.78 66.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.635 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.23 -49.28 19.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.1 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.89 -11.65 60.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.403 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.5 m80 48.84 41.98 19.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.485 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.9 t -136.16 143.48 44.49 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.363 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -109.86 114.18 27.53 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.29 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.94 133.63 55.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.05 0.452 . . . . 0.0 110.445 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.05 146.45 37.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.787 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.446 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.4 t90 -99.8 129.78 45.94 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.127 0.489 . . . . 0.0 109.939 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.705 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.54 153.82 39.41 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.281 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.417 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.0 Cg_endo -67.62 -18.37 48.39 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.72 2.28 . . . . 0.0 111.912 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.705 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.3 mt-10 -48.92 -18.28 0.27 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.401 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.446 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.4 p -76.2 165.35 25.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.499 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.35 -28.34 66.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.484 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.613 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.0 mt-30 -63.57 -41.13 98.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.617 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.31 -44.52 97.43 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.443 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.8 mt-30 -64.57 -39.05 93.05 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.886 0.374 . . . . 0.0 110.496 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.19 -41.31 98.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.107 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 70.5 mt -63.59 -47.05 83.03 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.588 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -54.63 -31.77 57.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.112 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.7 -18.38 62.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.539 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 90.0 mt -87.94 -9.1 54.62 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.609 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.27 2.34 54.14 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -88.59 153.43 21.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.359 . . . . 0.0 110.549 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.0 p -115.98 128.52 55.8 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.154 0.502 . . . . 0.0 110.307 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.4 145.88 24.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.944 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.451 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.66 151.59 45.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.503 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.17 131.72 42.5 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.385 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.73 93.36 28.19 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.063 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.717 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.5 Cg_exo -55.38 138.91 81.15 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.571 2.181 . . . . 0.0 111.539 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.78 -25.78 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.505 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.717 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.18 -50.16 29.42 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.59 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.7 mt -54.48 -37.11 64.86 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.18 35.89 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.898 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.59 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.3 88.24 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.909 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.3 p -81.68 -13.91 57.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.323 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.64 -41.45 10.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.577 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.4 t -67.02 -16.66 64.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.649 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.95 43.81 26.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.461 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 180.0 -148.5 8.0 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.55 143.02 48.82 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.001 0.429 . . . . 0.0 110.313 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -151.95 149.48 28.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.273 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -101.14 -151.86 0.42 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.33 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.06 -91.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.664 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.507 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.8 tt -127.08 175.29 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.545 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.507 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.1 mt -122.17 141.63 41.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.84 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.55 169.13 9.51 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.207 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.3 mt -147.69 150.72 34.87 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.241 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.67 -39.01 97.08 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.21 4.07 4.63 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.49 -57.98 3.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.949 0.404 . . . . 0.0 110.566 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.25 -36.27 81.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.326 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.52 -67.72 0.23 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.735 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.4 -42.29 66.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.241 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.06 17.85 0.16 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.681 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.76 48.59 0.26 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.62 -109.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.59 0.233 . . . . 0.0 110.728 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.451 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.8 m120 -61.08 -44.57 97.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.406 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.25 8.15 84.01 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -99.2 -13.05 19.9 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.75 -0.265 . . . . 0.0 110.69 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.41 ' HG ' ' N ' ' A' ' 259' ' ' LEU . 5.3 t 176.79 142.34 0.08 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.112 0.482 . . . . 0.0 110.454 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.41 ' N ' ' HG ' ' A' ' 258' ' ' SER . 9.2 tt -147.9 125.4 11.69 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.165 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -98.67 143.02 29.51 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 120.894 0.378 . . . . 0.0 110.775 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.9 mt -94.15 106.29 18.27 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.664 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.441 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.3 t80 -101.48 -11.88 18.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.129 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.3 87.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.84 174.14 46.32 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.451 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -74.41 -113.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.799 0.333 . . . . 0.0 110.786 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.45 -28.61 68.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.702 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.1 -44.1 91.91 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.172 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.89 -44.02 94.28 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.383 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.81 -60.27 3.47 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.233 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.15 -43.39 61.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.13 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.57 75.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.139 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.7 mt -64.45 -43.67 96.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.657 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -56.46 -37.5 70.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.139 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.82 0.91 18.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.223 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -114.9 91.35 26.04 Favored Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.164 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.2 -27.19 29.11 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.802 2.335 . . . . 0.0 111.786 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.36 -41.25 98.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.545 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.15 4.99 53.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.343 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.75 -35.16 70.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.719 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.83 4.73 15.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.558 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.552 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.89 121.32 81.04 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.6 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -47.58 -37.44 26.68 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.411 2.074 . . . . 0.0 112.523 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.552 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -59.12 -43.73 91.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.777 0.323 . . . . 0.0 110.244 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.89 -43.79 92.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.33 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -64.81 -40.65 95.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.424 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.8 t-20 -89.54 -12.78 38.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.588 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.8 mtmt 62.11 32.27 17.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.96 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -89.07 43.87 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.072 0.463 . . . . 0.0 110.352 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.44 135.85 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.453 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -116.53 132.45 56.68 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.44 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.503 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.79 87.22 7.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.751 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.452 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.5 mt -64.04 -40.77 97.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.441 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.58 169.35 35.54 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.508 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 72.4 p -76.35 -25.78 55.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.819 0.343 . . . . 0.0 110.699 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.535 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.7 tp10 -67.24 -34.82 78.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.398 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.496 ' O ' ' CG2' ' A' ' 296' ' ' THR . 93.2 m -73.59 25.01 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.758 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.613 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 64.2 t80 -58.27 -51.25 70.55 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 61.2 mmt-85 -112.16 154.96 24.72 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 44.3 tp -115.54 124.4 50.95 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 41.9 t0 -147.42 165.58 29.81 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.583 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -49.0 -38.51 23.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.624 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -71.5 -65.37 0.76 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.523 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.73 -32.87 72.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.082 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.64 -25.29 25.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.697 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.7 mtt -63.35 -41.0 98.83 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 120.894 0.378 . . . . 0.0 111.018 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.34 -43.99 22.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.987 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 75.1 t -65.81 -43.22 93.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.398 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 56.5 tp -60.65 -47.28 86.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.494 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -69.39 -39.64 77.87 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.725 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.503 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.2 ttt180 -62.13 -38.39 88.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.207 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.2 mt -86.86 3.88 43.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.84 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -112.57 -11.29 13.6 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.064 0.459 . . . . 0.0 110.315 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.07 -37.0 85.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.515 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.01 -48.74 80.4 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.414 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.09 179.829 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.647 ' H ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.15 -2.05 58.02 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.369 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.484 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.08 179.04 1.24 Allowed Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.499 -179.625 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.0 Cg_exo -61.04 145.2 99.33 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.769 2.313 . . . . 0.0 112.226 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.647 ' NH1' ' H ' ' A' ' 24' ' ' ALA . 35.4 ptt-85 -156.41 -178.95 7.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.601 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.91 136.68 52.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.281 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -123.97 146.68 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.378 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.8 p -119.8 135.94 54.66 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.736 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.41 -143.53 0.33 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.295 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -63.28 -37.06 85.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.598 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.88 -65.56 0.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.518 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.84 141.95 46.47 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 p -112.02 131.19 55.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.922 0.392 . . . . 0.0 110.36 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -119.08 128.87 54.73 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.51 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.1 m -85.45 130.13 34.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.201 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.0 mt -96.03 78.67 3.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.432 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.52 -31.69 72.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.466 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.28 109.98 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.172 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -122.99 91.35 49.91 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.196 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.645 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.9 Cg_exo -57.01 148.99 64.96 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.756 2.304 . . . . 0.0 111.784 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.79 82.89 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 O-C-N 123.603 0.564 . . . . 0.0 110.928 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.645 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.28 67.09 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.289 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.1 130.69 35.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.549 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.5 t -122.79 146.51 27.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.124 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.4 t -136.04 144.16 45.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.63 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 p -100.48 -58.87 1.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.564 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.2 p -79.43 154.78 28.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.598 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.8 t -74.07 -21.81 18.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.629 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.402 ' O ' ' OG ' ' A' ' 56' ' ' SER . 94.7 m -60.31 -52.1 66.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.474 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.3 mt -66.5 -42.2 87.74 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.347 0.594 . . . . 0.0 111.003 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.2 m -43.32 -54.06 4.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.143 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.26 -37.84 71.42 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.7 m -62.28 -44.5 96.37 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.956 0.407 . . . . 0.0 110.645 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.9 mt -66.2 -42.18 89.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.459 0.647 . . . . 0.0 110.737 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.63 -40.25 96.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.371 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.21 -36.03 76.76 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.914 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.6 pt -91.2 28.89 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.042 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.6 51.63 10.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.777 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.0 75.34 24.23 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.949 0.404 . . . . 0.0 109.998 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.44 151.57 85.0 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.743 2.295 . . . . 0.0 112.246 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.77 137.37 47.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.181 0.515 . . . . 0.0 110.245 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.4 pt -69.34 -43.61 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.163 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.482 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.9 130.87 53.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.915 0.388 . . . . 0.0 110.544 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.53 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.0 p -155.64 168.98 25.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.456 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.98 -177.04 21.58 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.58 172.65 12.46 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 120.934 0.397 . . . . 0.0 110.513 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.6 p -132.68 -112.49 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.276 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.41 179.84 0.91 Allowed Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.326 -179.115 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.3 Cg_exo -60.93 57.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 123.054 2.503 . . . . 0.0 112.214 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.1 t-20 -64.41 -33.82 76.75 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.487 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.8 m-20 93.85 -36.09 0.02 OUTLIER 'General case' 0 C--N 1.346 0.435 0 O-C-N 124.08 0.862 . . . . 0.0 109.966 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -63.1 -39.39 94.55 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.218 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 77' ' ' ALA . 15.0 p -74.71 -25.29 18.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.692 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.35 -171.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.588 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.7 p30 -74.08 -153.66 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.765 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.0 p-10 -52.77 -7.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.639 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.521 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.37 115.06 23.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.582 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.85 69.69 1.36 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.469 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.9 m-85 -142.96 147.53 35.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.958 0.409 . . . . 0.0 110.704 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.528 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.3 mp -85.29 -98.4 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.313 178.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.548 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.4 -42.5 96.06 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.108 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.548 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.5 tt0 91.69 53.05 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.075 0.859 . . . . 0.0 110.79 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.24 -9.09 19.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.466 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.469 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.0 p -64.64 -34.04 77.35 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.118 0.485 . . . . 0.0 110.653 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.532 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.66 -23.9 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.553 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.53 -46.02 76.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.881 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.24 -48.49 81.24 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.073 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.68 -38.09 89.0 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.357 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.68 -32.58 52.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.248 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.575 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.1 mmt-85 -89.69 1.67 55.75 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.695 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 56.9 mttp 82.69 -49.05 0.17 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 124.115 0.885 . . . . 0.0 110.31 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.649 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.71 154.79 0.29 Allowed 'General case' 0 CA--C 1.49 -1.327 0 CA-C-O 117.592 -1.194 . . . . 0.0 109.253 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.649 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 120.85 92.47 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 O-C-N 125.462 1.726 . . . . 0.0 110.542 -178.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.53 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.39 143.44 42.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.108 0.48 . . . . 0.0 110.244 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.4 mt -132.4 26.95 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.0 110.47 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.52 138.15 34.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.441 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.522 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 91.4 mt -137.31 165.01 28.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.391 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.15 -28.8 1.82 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.408 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -152.18 70.13 7.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.201 0.524 . . . . 0.0 110.348 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.03 145.44 98.39 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 122.663 2.242 . . . . 0.0 112.126 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.0 t -134.81 137.35 43.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.521 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.22 -38.07 81.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.716 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.27 -42.29 96.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.547 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.52 98.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.558 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.2 t -63.58 -43.41 98.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.057 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.13 77.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.294 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.52 -18.62 59.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.463 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.58 -6.62 58.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.576 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 64.3 mtp 48.17 55.87 17.34 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.609 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.37 149.23 62.66 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.716 2.277 . . . . 0.0 112.111 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.13 -73.21 0.65 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.468 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.0 tp -111.02 112.65 24.62 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.44 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.8 mt -101.11 126.06 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.469 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.6 mt -109.59 133.64 52.87 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.294 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -121.01 140.17 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.472 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 121' ' ' THR . 89.6 p -83.5 168.68 16.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.64 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.43 80.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.433 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.426 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.1 t -140.15 159.09 42.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.963 0.411 . . . . 0.0 110.416 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.3 177.66 33.2 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.26 -33.79 87.15 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -124.84 151.72 44.9 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.904 0.383 . . . . 0.0 110.567 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.2 t -63.36 141.2 58.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.355 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.74 10.67 11.02 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.577 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.31 -39.07 89.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.071 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.634 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.9 -35.72 23.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.516 0.675 . . . . 0.0 110.709 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.5 mt -71.0 -35.42 72.06 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.473 0.654 . . . . 0.0 110.727 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -42.74 -63.19 0.82 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.132 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.634 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.83 -42.64 90.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -61.99 -32.91 73.42 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.424 0.453 . . . . 0.0 110.17 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.9 mt -73.8 -40.24 63.53 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.22 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.17 -49.13 78.08 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.15 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 78.9 m -52.36 -42.74 64.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.314 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.37 -43.26 94.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.141 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.99 154.85 5.3 Favored Pre-proline 0 N--CA 1.453 -0.285 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.646 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -39.19 106.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.696 2.264 . . . . 0.0 112.356 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 95.4 m -110.09 121.5 45.41 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.169 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.26 152.93 30.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.257 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 tt -129.01 129.11 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.382 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.4 mt -112.54 127.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.498 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.11 103.34 14.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.3 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 147' ' ' LYS . 44.0 p90 -101.04 -11.17 19.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.703 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.2 p-10 -64.72 -33.77 76.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.619 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.7 p-10 -98.27 8.1 45.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.597 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.83 155.62 50.05 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.499 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.1 165.91 24.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.594 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.09 -48.62 80.94 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.22 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.76 -42.03 67.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.992 0.425 . . . . 0.0 110.084 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.0 t -62.63 -40.63 97.58 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.435 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.9 tp -60.62 -43.88 96.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.417 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.9 tp -61.45 -43.19 99.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.188 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.2 m -54.94 -45.17 74.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.806 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.5 -40.72 97.62 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-O 120.889 0.376 . . . . 0.0 110.381 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.95 -42.33 98.99 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.249 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.05 -41.03 95.36 Favored Glycine 0 C--N 1.316 -0.533 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.85 -46.0 63.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.94 0.4 . . . . 0.0 110.807 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.61 -44.03 96.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.741 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 156' ' ' LEU . 31.6 p -93.27 -8.64 41.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.546 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.8 25.16 71.71 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -102.15 52.49 0.81 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.72 0.295 . . . . 0.0 110.593 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -70.04 -39.11 75.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.696 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.16 -47.01 86.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.165 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -61.38 -38.91 88.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.434 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.38 97.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.413 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.45 -27.67 69.15 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.537 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.82 -53.77 8.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.17 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -63.55 -43.56 96.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.448 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 174' ' ' ASP . 85.7 mt -63.01 -43.78 99.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.658 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.08 -61.65 2.42 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.112 0.482 . . . . 0.0 110.383 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.54 -35.09 62.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.425 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -79.6 -35.05 40.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.891 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.3 m-20 -56.68 -40.43 75.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.96 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.94 -42.61 99.86 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.769 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.85 -37.52 86.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.303 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.26 -42.36 99.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.702 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -53.0 61.77 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.168 0.509 . . . . 0.0 110.645 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.25 -41.69 89.6 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.597 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.31 -39.68 94.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.5 -32.36 73.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.302 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.93 -22.12 18.79 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.647 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.631 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -65.22 -40.91 94.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.632 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.1 pt -78.45 136.45 23.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.568 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.53 109.45 11.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.277 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.48 125.8 0.32 Allowed Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.518 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.4 Cg_exo -43.92 152.29 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.713 2.276 . . . . 0.0 112.598 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.16 142.0 54.28 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.612 2.208 . . . . 0.0 112.461 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.37 147.4 2.14 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.602 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.15 154.74 69.67 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.805 2.337 . . . . 0.0 112.296 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.27 163.23 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.405 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.549 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.1 t -144.1 170.41 16.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.793 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.549 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.83 137.89 21.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.017 0.437 . . . . 0.0 110.226 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.44 146.72 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.574 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.98 131.73 58.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.128 0.49 . . . . 0.0 110.474 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -151.92 154.89 36.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.357 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 87.2 m -122.08 122.62 39.68 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.961 0.41 . . . . 0.0 110.371 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.32 -25.98 66.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.613 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -74.72 -49.02 22.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.007 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.38 -11.04 60.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.285 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.8 m80 48.6 42.47 19.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.452 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.6 t -136.43 145.7 45.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.386 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.44 114.18 27.12 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.311 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.72 133.32 55.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.08 0.467 . . . . 0.0 110.343 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.3 tt -112.13 146.43 38.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.671 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.451 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 10.9 t90 -99.77 130.23 45.96 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.104 0.478 . . . . 0.0 110.148 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.708 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.65 153.88 39.31 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.133 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.412 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.2 Cg_endo -67.76 -18.05 47.51 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.663 2.242 . . . . 0.0 111.95 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.708 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -48.99 -18.57 0.3 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.405 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.451 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.6 p -75.96 165.11 25.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.543 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.22 -28.04 66.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.516 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.616 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.3 mt-30 -63.76 -41.21 98.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.669 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.12 -44.75 97.02 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.8 mt-30 -64.6 -38.71 91.94 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 120.99 0.424 . . . . 0.0 110.649 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.14 -41.15 98.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.11 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.81 -46.74 83.76 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.644 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.59 -31.73 57.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.089 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.88 -18.12 62.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.57 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.25 -8.49 55.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.612 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.39 2.05 55.61 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -88.41 153.36 21.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.512 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 7.9 p -116.09 128.72 55.91 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.055 0.455 . . . . 0.0 110.308 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.62 145.97 24.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.802 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.68 151.5 45.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.534 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.72 131.53 43.12 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.526 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.632 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.55 93.22 26.67 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.049 -179.689 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.716 ' C ' ' H ' ' A' ' 229' ' ' GLY . 47.6 Cg_exo -55.59 139.25 82.59 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.56 2.173 . . . . 0.0 111.612 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.04 -25.64 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.459 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.716 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.54 -49.78 29.2 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.579 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.8 mt -53.87 -37.01 63.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 0.0 110.197 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.92 36.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.777 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.579 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.85 86.85 0.01 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.861 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.3 p -79.42 -15.17 58.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.411 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.38 -41.12 10.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.616 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.8 t -66.06 -17.78 64.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.65 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.25 43.22 26.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.508 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.48 -147.27 7.21 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.96 143.01 50.19 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.955 0.407 . . . . 0.0 110.323 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -152.51 149.85 28.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.391 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -100.95 -151.75 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.398 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 66.9 t0 55.99 -91.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.555 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.506 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.96 175.25 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.54 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.506 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 93.0 mt -122.3 141.73 41.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.693 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.77 168.97 9.57 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.244 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.3 mt -147.73 150.9 35.16 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.154 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.53 -39.21 97.4 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.32 4.01 4.6 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.28 -58.06 3.49 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.011 0.434 . . . . 0.0 110.636 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.2 -37.04 83.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.271 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.14 -67.69 0.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.784 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.43 -42.07 66.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.145 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.16 17.96 0.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.724 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.92 48.13 0.26 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.83 -109.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.663 0.268 . . . . 0.0 110.675 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.453 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.8 m120 -60.71 -44.87 96.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.502 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.26 8.13 84.03 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -99.02 -13.19 19.98 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.672 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.6 t 176.8 142.45 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.079 0.466 . . . . 0.0 110.423 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -147.93 125.42 11.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.983 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -98.57 142.94 29.53 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 120.877 0.37 . . . . 0.0 110.88 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.9 mt -93.88 106.26 18.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.655 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.429 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.2 t80 -101.48 -12.27 18.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.215 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.4 -40.62 89.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.833 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.43 173.73 46.09 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.448 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -74.09 -112.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.811 0.339 . . . . 0.0 110.683 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.88 -28.74 67.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.689 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -58.85 -43.95 90.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.371 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.8 -44.32 93.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.357 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.48 -60.17 3.56 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.247 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.31 -43.55 61.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.084 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.16 -43.6 74.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.229 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.4 mt -64.62 -43.63 96.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.597 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -56.23 -37.48 69.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.211 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.87 1.25 18.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.277 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -114.94 91.33 26.13 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.213 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.31 -27.25 30.1 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.753 2.302 . . . . 0.0 111.841 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.38 -41.17 98.77 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.591 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.43 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.9 mp -95.07 5.12 52.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.362 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.87 -35.13 69.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.713 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.53 4.52 15.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.52 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.543 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.91 120.91 79.38 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.61 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -47.41 -37.43 25.4 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.478 2.119 . . . . 0.0 112.493 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.543 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -59.01 -43.84 91.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.758 0.313 . . . . 0.0 110.356 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.96 -43.7 92.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.344 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.81 -40.7 95.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.445 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.437 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.9 t-20 -89.42 -12.86 39.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.625 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.7 mtmt 62.18 32.36 17.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -89.15 43.87 1.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.074 0.464 . . . . 0.0 110.353 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.51 135.89 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.448 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.78 132.37 56.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.491 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.504 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.67 87.49 7.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.674 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.456 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.9 mt -64.02 -40.69 96.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.971 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.429 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.72 168.85 35.0 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.51 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 77.8 p -76.13 -25.89 55.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 0.0 110.698 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.536 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.1 tp10 -67.27 -34.6 77.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.524 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.497 ' O ' ' CG2' ' A' ' 296' ' ' THR . 95.7 m -73.66 25.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.601 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.616 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 61.8 t80 -58.13 -51.13 70.99 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 64.4 mmt-85 -112.3 155.13 24.6 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 45.2 tp -115.88 124.77 51.48 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.766 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 41.7 t0 -147.79 165.79 29.5 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -49.13 -38.55 25.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.579 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -71.53 -65.31 0.77 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.267 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -60.79 -32.75 72.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.913 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.88 -25.19 27.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.549 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.1 mtt -63.08 -41.42 99.43 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.88 0.371 . . . . 0.0 110.857 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.18 -43.85 23.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.997 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.04 -43.18 92.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.414 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 56.0 tp -60.55 -47.04 87.92 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.549 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -69.84 -39.85 76.18 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.546 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.504 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.3 ttt180 -62.06 -37.97 87.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.133 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.3 mt -87.19 4.32 42.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.795 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.631 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.5 tttt -112.59 -11.51 13.56 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.042 0.448 . . . . 0.0 110.263 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.9 84.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.66 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.02 -48.78 80.2 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.332 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.898 -1.048 . . . . 0.0 110.097 179.941 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.47 -2.1 57.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.298 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.94 179.09 1.23 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.991 0.424 . . . . 0.0 110.481 -179.65 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.6 Cg_exo -60.95 144.91 99.68 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.814 2.343 . . . . 0.0 112.149 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.96 -179.3 8.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.597 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.68 136.66 52.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.388 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.36 147.11 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.297 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.8 p -120.18 135.99 54.78 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.41 -143.38 0.32 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.233 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -63.52 -37.13 86.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.549 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.477 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.54 -66.12 0.22 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.546 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.48 141.99 45.68 Favored Glycine 0 CA--C 1.519 0.309 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.4 p -112.19 131.23 55.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.939 0.4 . . . . 0.0 110.4 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.21 128.9 54.65 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.532 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -85.49 130.3 34.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.227 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.0 mt -95.74 78.86 3.3 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.287 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.28 -32.31 73.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.55 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 175.88 110.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.075 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -123.05 91.7 49.66 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.322 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.645 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.1 Cg_exo -56.95 148.82 65.44 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.769 2.313 . . . . 0.0 111.864 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.42 82.78 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 O-C-N 123.59 0.557 . . . . 0.0 111.017 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.645 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.45 67.07 0.89 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.133 0.492 . . . . 0.0 110.183 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.17 130.78 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.709 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.85 146.59 27.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.034 0.445 . . . . 0.0 110.015 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -136.38 143.91 44.28 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.693 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.561 ' HG1' ' H ' ' A' ' 50' ' ' SER . 28.1 p -99.31 -59.5 1.71 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.647 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.561 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.0 p -78.95 155.61 28.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.706 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -74.65 -21.84 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.55 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.402 ' O ' ' OG ' ' A' ' 56' ' ' SER . 94.7 m -60.36 -51.88 67.63 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.459 -178.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.5 mt -66.3 -42.62 88.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.207 0.527 . . . . 0.0 110.85 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.15 -53.9 4.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.005 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.39 -38.12 70.24 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.7 m -62.21 -44.55 96.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 110.203 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.3 mt -66.27 -42.03 89.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.443 0.64 . . . . 0.0 110.756 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.59 -40.12 95.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.495 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.97 -35.91 76.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.183 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.7 pt -91.2 28.69 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.295 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.58 51.52 11.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.98 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.74 75.52 25.38 Favored Pre-proline 0 C--N 1.331 -0.208 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.34 151.15 86.64 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.793 2.328 . . . . 0.0 112.199 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -113.59 137.26 47.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.223 0.535 . . . . 0.0 110.208 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.417 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.0 pt -69.21 -43.65 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.326 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.483 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.02 131.07 53.46 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.964 0.411 . . . . 0.0 110.564 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.526 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.4 p -155.68 168.72 26.25 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.501 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.96 -176.97 21.59 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.37 172.54 12.56 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 121.01 0.433 . . . . 0.0 110.44 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.9 p -133.13 -111.84 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 110.349 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.49 179.68 0.94 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.348 -179.143 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.7 Cg_exo -61.34 57.89 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.975 2.45 . . . . 0.0 112.094 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.5 t-20 -64.19 -34.13 77.37 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 118.894 -0.574 . . . . 0.0 110.398 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.5 m-20 94.06 -36.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.103 0.877 . . . . 0.0 109.838 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -62.9 -39.84 95.73 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.179 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.49 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -74.27 -25.71 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.758 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.68 -171.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.575 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.26 -153.68 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.864 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.0 p-10 -52.72 -7.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.677 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.523 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.25 114.6 23.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.618 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.61 70.36 1.34 Allowed Glycine 0 C--O 1.225 -0.428 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.479 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.9 m-85 -143.18 147.93 35.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.824 0.345 . . . . 0.0 110.961 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.523 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.5 mp -85.94 -98.4 0.07 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.995 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.1 mtt-85 -64.28 -42.69 96.3 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.08 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.4 tt0 91.49 53.43 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.057 0.848 . . . . 0.0 110.954 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.38 -9.1 19.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.391 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.479 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.2 p -64.71 -33.99 77.27 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.165 0.507 . . . . 0.0 110.681 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.538 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.85 -24.27 1.39 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.59 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.4 t -69.13 -46.11 78.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.936 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.21 -48.49 81.26 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.964 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.69 -38.17 89.35 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.302 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.82 -32.28 52.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.095 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.571 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.7 mmt-85 -90.04 1.82 55.89 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.585 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.6 -49.34 0.18 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 124.102 0.876 . . . . 0.0 110.192 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.638 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.5 mt -46.42 154.88 0.25 Allowed 'General case' 0 CA--C 1.49 -1.345 0 CA-C-O 117.365 -1.302 . . . . 0.0 109.275 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.638 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 120.76 92.48 0.0 OUTLIER 'General case' 0 C--N 1.354 0.764 0 O-C-N 125.699 1.875 . . . . 0.0 110.464 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.526 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.34 143.54 42.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.098 0.475 . . . . 0.0 110.311 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.5 mt -132.52 27.2 4.4 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.147 -0.346 . . . . 0.0 110.428 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -140.6 138.46 34.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.015 0.436 . . . . 0.0 110.542 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.5 mt -137.37 164.99 28.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.418 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.523 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.34 -28.71 1.8 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -153.23 70.87 6.95 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.166 0.508 . . . . 0.0 110.288 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.22 145.58 98.22 Favored 'Trans proline' 0 C--N 1.301 -1.936 0 C-N-CA 122.719 2.279 . . . . 0.0 112.108 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.4 t -133.99 136.55 44.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.481 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.38 83.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.683 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.38 -42.17 96.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.52 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.53 98.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.581 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.6 t -63.68 -43.45 98.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.925 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.81 -35.12 77.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.233 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.55 -18.61 59.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.38 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -86.67 -6.85 58.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.562 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.409 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.6 mtp 48.1 56.09 17.47 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.627 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.0 Cg_endo -70.12 149.23 64.28 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.766 2.31 . . . . 0.0 112.122 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.04 -73.47 0.64 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.43 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.4 tp -111.03 112.84 24.94 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.26 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.1 mt -101.13 126.19 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.556 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.5 mt -109.58 133.42 53.12 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.198 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.46 139.7 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.506 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 121' ' ' THR . 94.4 p -83.42 168.42 16.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.692 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.12 -37.41 79.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.402 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.429 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.2 t -139.38 159.07 43.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.932 0.396 . . . . 0.0 110.475 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.07 176.33 33.55 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.13 -33.84 87.14 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.7 151.53 44.88 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 110.523 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.9 t -63.06 140.82 58.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.359 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.7 10.44 11.0 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.607 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.418 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.08 -39.13 88.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.099 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.68 -35.86 24.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.59 0.709 . . . . 0.0 110.721 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.2 mt -70.8 -35.62 72.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.642 0.734 . . . . 0.0 110.738 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -42.84 -62.71 0.94 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.408 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.64 -42.66 91.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -62.1 -33.02 73.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.301 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.1 mt -73.3 -40.77 64.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.145 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.8 t -58.53 -48.58 80.36 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.013 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.8 m -52.9 -42.35 65.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.302 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.15 -43.03 92.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.082 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.4 154.15 5.58 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.659 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -39.37 107.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.639 2.226 . . . . 0.0 112.422 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 93.8 m -110.13 120.88 43.85 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.037 0.446 . . . . 0.0 110.238 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -113.62 152.78 29.89 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.292 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.7 tt -128.75 131.04 68.82 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.268 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.81 127.79 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.504 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.9 t30 -101.79 103.53 14.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.302 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 147' ' ' LYS . 45.3 p90 -101.05 -11.29 19.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.862 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.74 -33.73 76.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.671 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -98.29 7.86 45.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.548 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.6 155.54 50.29 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.538 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.404 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.07 165.8 24.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.715 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.05 -48.69 80.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.152 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -53.7 -42.2 67.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.002 0.429 . . . . 0.0 110.063 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.2 t -62.49 -40.89 98.15 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.362 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 tp -60.59 -43.95 96.79 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.261 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.0 tp -61.27 -43.43 98.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.139 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 m -55.03 -45.37 75.17 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.59 -40.58 97.36 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.891 0.377 . . . . 0.0 110.446 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.97 -42.29 98.96 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.343 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.19 -40.89 95.05 Favored Glycine 0 C--N 1.315 -0.587 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.72 -45.91 64.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.0 mt -64.61 -44.0 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.794 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.6 p -93.35 -8.56 41.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.587 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.85 25.37 71.85 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -102.06 52.26 0.82 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.769 0.319 . . . . 0.0 110.663 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.87 -39.23 76.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.575 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.15 -46.95 87.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.243 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -61.41 -39.12 89.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.35 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.27 -40.32 97.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.257 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.49 -27.51 69.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.545 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.95 -53.81 8.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.059 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -63.88 -43.24 96.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.47 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.9 mt -63.07 -43.86 99.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.726 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.18 -61.52 2.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.146 0.498 . . . . 0.0 110.403 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.65 -35.32 63.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.466 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -79.21 -35.19 42.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.963 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.1 m-20 -56.98 -40.1 75.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.146 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.08 -42.64 99.68 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.828 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.74 -37.76 87.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.285 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.29 -42.33 99.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.715 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.07 -52.76 62.61 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.073 0.463 . . . . 0.0 110.639 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.41 -41.56 89.1 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.624 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.33 -39.65 94.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.671 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.29 -32.49 73.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.306 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.95 -21.99 18.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.657 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.633 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -65.02 -40.9 95.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.726 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.8 pt -78.1 136.47 24.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.727 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.37 109.31 11.65 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.214 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.8 125.66 0.3 Allowed Pre-proline 0 C--O 1.242 0.666 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.495 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.4 Cg_exo -43.88 152.36 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.786 2.324 . . . . 0.0 112.618 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.13 142.29 55.41 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.554 2.17 . . . . 0.0 112.504 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.3 147.07 2.11 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.626 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.91 154.6 70.64 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.75 2.3 . . . . 0.0 112.307 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.29 163.2 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.487 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.639 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.1 t -144.02 170.35 16.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.889 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.639 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.01 137.65 22.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.253 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.37 146.75 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.65 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.46 132.26 57.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.168 0.509 . . . . 0.0 110.497 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -152.12 155.15 37.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.439 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.8 m -122.34 123.06 40.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.957 0.408 . . . . 0.0 110.364 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.51 -25.76 66.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.631 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.12 -49.18 20.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.084 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.12 -12.18 60.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.413 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.4 m80 49.47 41.95 21.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.496 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.1 t -135.97 144.76 45.57 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.328 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.5 113.97 27.02 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.258 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.474 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.8 133.33 55.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.039 0.447 . . . . 0.0 110.362 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.5 tt -111.92 146.32 37.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.45 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 12.5 t90 -99.11 129.74 45.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.175 0.512 . . . . 0.0 109.932 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.703 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.74 153.87 39.25 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.294 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.2 Cg_endo -67.59 -18.15 48.47 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.671 2.247 . . . . 0.0 111.957 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.703 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -49.37 -18.83 0.43 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.36 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.45 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.9 p -75.39 164.59 26.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.536 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.99 -27.84 65.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.559 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.623 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.2 mt-30 -63.99 -41.0 97.63 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.589 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.26 -44.54 97.36 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.6 mt-30 -64.59 -38.71 91.96 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.022 0.439 . . . . 0.0 110.557 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.2 mmm -62.18 -41.21 98.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.103 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.3 mt -63.7 -47.09 82.58 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.525 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.27 -31.84 54.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.355 . . . . 0.0 110.193 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.02 -18.32 62.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.472 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 90.5 mt -87.94 -8.67 55.38 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.626 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.57 2.13 55.42 Favored Glycine 0 N--CA 1.464 0.503 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -88.4 153.29 21.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.939 0.4 . . . . 0.0 110.464 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.3 p -115.93 128.7 55.97 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.143 0.497 . . . . 0.0 110.334 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.555 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.71 145.89 24.07 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.948 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.451 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.46 151.49 46.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.423 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.65 131.59 43.3 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.461 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.7 93.29 27.74 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.062 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.716 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.5 Cg_exo -55.52 139.13 82.15 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.556 2.171 . . . . 0.0 111.58 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.76 -25.69 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.477 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.716 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.13 -50.07 30.2 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.582 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.7 mt -54.17 -36.93 63.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.68 35.99 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.819 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.582 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.08 88.31 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.003 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 79.5 p -81.23 -14.15 57.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.31 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.8 -41.57 10.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.685 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.1 t -66.7 -16.92 64.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.647 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 55.94 43.76 26.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.439 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.74 -148.45 7.9 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.91 142.94 49.24 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.0 0.428 . . . . 0.0 110.327 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.14 149.56 28.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.278 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -101.19 -151.85 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.297 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.12 -92.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.624 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.511 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.67 175.24 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.596 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.511 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.5 mt -122.37 141.62 42.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.56 169.05 9.56 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.264 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.0 mt -147.63 150.86 35.21 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.224 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.69 -38.98 97.03 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.18 3.87 4.7 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -77.18 -58.04 3.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.958 0.409 . . . . 0.0 110.631 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -62.25 -36.85 83.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.249 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.24 -67.74 0.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.67 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.68 -42.08 67.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.135 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.97 17.8 0.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.644 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.88 48.5 0.27 Allowed Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.45 -109.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.596 0.236 . . . . 0.0 110.754 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.451 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 12.0 m120 -61.12 -44.65 97.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.469 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.31 8.05 84.06 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -98.93 -13.25 20.07 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.668 -0.313 . . . . 0.0 110.697 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.419 ' HG ' ' N ' ' A' ' 259' ' ' LEU . 5.8 t 176.96 142.53 0.08 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.087 0.47 . . . . 0.0 110.434 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.419 ' N ' ' HG ' ' A' ' 258' ' ' SER . 9.1 tt -147.84 125.62 11.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.191 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -98.68 143.15 29.37 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 120.899 0.381 . . . . 0.0 110.778 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.1 mt -94.44 106.3 18.28 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.672 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.435 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.58 -11.69 19.05 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.171 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.14 -40.66 86.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.27 173.69 46.1 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.442 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.5 m-20 -74.02 -112.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.352 . . . . 0.0 110.856 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.76 -28.75 67.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.731 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.11 -44.01 91.95 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.147 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.68 -44.2 94.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.308 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.72 -59.93 3.88 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.201 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.32 -43.58 61.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.982 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.32 -43.63 75.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.181 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.7 mt -64.57 -43.62 96.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.581 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.4 -37.51 70.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.113 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.92 1.24 18.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.179 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -114.73 91.46 25.72 Favored Pre-proline 0 CA--C 1.528 0.11 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.179 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.33 -27.32 30.54 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.801 2.334 . . . . 0.0 111.811 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.42 -41.14 98.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.575 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.43 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.9 mp -95.14 5.04 52.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.346 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.58 -35.08 70.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.645 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.99 4.43 17.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.512 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.541 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.73 120.9 78.88 Favored Pre-proline 0 N--CA 1.441 -0.884 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.512 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.37 -37.47 25.19 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.41 2.074 . . . . 0.0 112.635 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.541 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -59.02 -43.65 91.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.75 0.31 . . . . 0.0 110.352 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.99 -43.75 92.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.301 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.89 -40.64 95.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.422 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.8 t-20 -89.51 -12.86 38.79 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.516 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.23 32.08 17.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.88 44.01 1.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.115 0.484 . . . . 0.0 110.367 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.78 135.63 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.529 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -116.64 132.51 56.67 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.386 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.506 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.5 87.31 7.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.834 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.453 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.6 mt -63.97 -40.77 97.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.919 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.435 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.94 168.84 35.59 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.508 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 77.0 p -76.07 -25.88 55.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.901 0.382 . . . . 0.0 110.781 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.536 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.8 tp10 -67.37 -34.7 77.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.357 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.497 ' O ' ' CG2' ' A' ' 296' ' ' THR . 94.7 m -73.49 25.1 0.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.748 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.623 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 63.2 t80 -58.26 -51.07 71.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 63.5 mmt-85 -112.42 155.0 24.93 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 43.9 tp -115.72 124.92 52.04 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 42.2 t0 -148.04 165.89 29.42 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.533 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -49.08 -38.64 25.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.659 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -71.05 -65.61 0.72 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.54 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -60.61 -32.93 72.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.079 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.62 -24.97 23.75 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.811 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.9 mtt -63.23 -41.18 99.07 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 120.948 0.404 . . . . 0.0 111.105 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.54 -43.89 22.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.064 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 77.3 t -65.81 -43.24 93.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.417 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 55.4 tp -60.82 -46.96 88.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.518 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -69.83 -39.65 76.33 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.663 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.506 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.5 ttt180 -62.09 -38.15 87.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.136 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.03 3.97 43.85 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.753 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.633 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.5 tttt -112.78 -11.06 13.54 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.114 0.483 . . . . 0.0 110.189 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.23 -36.95 85.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.549 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.95 -48.7 80.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.395 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.003 179.9 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.06 -2.63 58.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.415 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.72 179.16 1.22 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.498 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.3 Cg_exo -60.87 144.94 99.66 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.76 2.307 . . . . 0.0 112.203 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.613 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.78 -179.7 8.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.581 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.51 136.14 53.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.333 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -123.94 146.82 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.395 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.6 p -120.02 135.98 54.73 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.812 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.25 -143.61 0.32 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.259 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.65 -36.98 85.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.437 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.22 -66.96 0.22 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.523 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.27 142.3 44.93 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.3 p -112.18 131.24 55.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.934 0.397 . . . . 0.0 110.324 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.08 128.94 54.79 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.541 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.9 m -85.55 130.64 34.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.178 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.0 mt -95.83 78.63 3.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.271 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.04 -32.18 73.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.493 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.43 108.87 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.086 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -122.25 91.56 49.09 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.194 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.644 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.1 Cg_exo -56.97 148.67 66.6 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.802 2.334 . . . . 0.0 111.827 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.79 82.67 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 O-C-N 123.57 0.544 . . . . 0.0 111.028 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.644 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.28 67.07 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.226 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.0 130.85 35.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.609 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.5 t -122.61 145.86 28.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.08 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -135.66 143.45 45.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.63 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.0 p -99.34 -59.54 1.7 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.594 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.7 p -79.07 155.12 28.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.668 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.9 t -74.41 -21.72 17.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.569 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.5 m -60.36 -52.04 66.94 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.518 -178.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.5 mt -66.51 -42.37 87.43 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.363 0.601 . . . . 0.0 110.956 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -43.21 -53.63 4.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.083 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.3 -37.69 71.01 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -62.58 -44.48 96.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.893 0.378 . . . . 0.0 110.393 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt -66.25 -42.14 88.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.547 0.689 . . . . 0.0 110.769 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tp -62.62 -40.09 95.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.439 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.07 -35.75 75.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.006 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.4 pt -91.6 28.92 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.16 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.35 51.65 11.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.816 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.86 75.71 24.32 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.98 151.5 85.61 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.775 2.317 . . . . 0.0 112.289 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.45 137.15 47.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.219 0.533 . . . . 0.0 110.251 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.1 pt -69.2 -43.63 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.243 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.08 130.92 53.24 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.97 0.414 . . . . 0.0 110.505 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.4 p -155.39 168.84 25.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.464 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.55 -177.53 21.83 Favored Glycine 0 N--CA 1.464 0.564 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.99 172.07 13.12 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.009 0.433 . . . . 0.0 110.458 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.2 p -133.49 -111.34 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.321 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.636 ' HG1' ' N ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -102.56 179.65 0.95 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.348 -179.044 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.636 ' N ' ' HG1' ' A' ' 71' ' ' THR . 39.2 Cg_exo -60.97 58.71 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.059 2.506 . . . . 0.0 112.108 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.543 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.2 t-20 -64.35 -34.94 79.31 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 118.669 -0.681 . . . . 0.0 110.521 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 45.8 m-20 95.07 -37.58 0.01 OUTLIER 'General case' 0 C--N 1.349 0.557 0 O-C-N 124.332 1.02 . . . . 0.0 109.857 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -62.54 -39.89 95.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.025 0.44 . . . . 0.0 110.261 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -73.93 -26.45 21.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.678 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.83 -172.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.518 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.2 p30 -73.77 -152.79 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.787 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.0 p-10 -54.61 -6.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.683 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.515 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.93 113.74 22.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.585 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.23 72.92 1.27 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.492 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.2 m-85 -143.87 148.67 35.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.897 0.38 . . . . 0.0 110.825 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.527 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.3 mp -86.0 -99.14 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.172 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.541 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.04 -43.28 96.02 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.143 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.57 ' NE2' ' HZ1' ' A' ' 88' ' ' LYS . 35.8 tt0 91.8 52.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.117 0.886 . . . . 0.0 110.919 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -103.12 -8.9 20.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.347 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.492 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.2 p -65.05 -33.97 77.31 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.164 0.507 . . . . 0.0 110.727 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.57 ' HZ1' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.49 -24.17 1.2 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.624 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.5 t -69.55 -45.84 77.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.1 -48.74 80.29 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.071 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.77 -38.2 89.66 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.348 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -53.7 -32.45 51.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.207 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.569 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.9 mmt-85 -90.02 1.71 56.0 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 119.19 -0.433 . . . . 0.0 110.579 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.569 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.85 -49.41 0.16 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.232 0.957 . . . . 0.0 110.351 179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.636 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.9 mt -46.32 154.01 0.31 Allowed 'General case' 0 CA--C 1.489 -1.39 0 CA-C-O 117.331 -1.319 . . . . 0.0 109.139 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.636 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.6 tt0 121.37 92.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 O-C-N 125.754 1.909 . . . . 0.0 110.538 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.48 143.09 42.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.115 0.483 . . . . 0.0 110.279 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 mt -131.91 26.81 4.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.8 0.333 . . . . 0.0 110.443 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.16 137.56 34.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.974 0.416 . . . . 0.0 110.525 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 91.9 mt -136.99 165.19 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.42 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.523 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.13 -28.44 1.84 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -153.32 70.85 6.89 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.192 0.52 . . . . 0.0 110.281 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.94 145.55 98.04 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.759 2.306 . . . . 0.0 112.135 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.3 t -134.06 136.72 44.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.981 0.42 . . . . 0.0 110.541 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.96 -38.3 82.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.642 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.27 -42.29 96.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.518 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.12 -41.44 98.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.561 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.67 -43.34 98.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.05 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.13 77.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.295 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -18.62 60.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.489 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.51 -6.6 58.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.524 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 78.7 mtp 47.91 55.98 17.3 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.596 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.31 149.27 63.1 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.755 2.303 . . . . 0.0 112.083 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.38 -72.56 0.68 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.498 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.7 tp -111.7 112.7 24.58 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.321 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.3 mt -101.09 126.37 54.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.567 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.2 mt -110.07 133.7 52.93 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.156 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -121.17 139.97 46.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.517 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 121' ' ' THR . 89.7 p -83.34 168.43 16.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.705 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -37.48 80.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.418 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.43 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.9 t -139.47 159.0 43.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.434 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.15 176.94 33.44 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.02 -34.0 87.49 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.88 151.56 45.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.927 0.394 . . . . 0.0 110.531 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.3 t -63.16 141.06 58.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.291 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.09 10.94 10.84 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.625 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.29 -38.93 88.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.007 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.632 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.81 -35.7 24.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.594 0.711 . . . . 0.0 110.605 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.0 mt -71.14 -35.42 71.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.52 0.676 . . . . 0.0 110.8 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.9 t80 -42.89 -62.95 0.88 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.19 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.632 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.3 p-10 -65.67 -42.64 91.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.988 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -62.24 -32.58 73.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.124 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.5 mt -73.94 -40.54 62.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.15 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.23 -48.87 79.03 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.221 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.6 m -52.69 -42.78 65.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.212 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.96 -43.07 92.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.221 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.04 152.63 5.27 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.66 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -39.02 107.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.627 2.218 . . . . 0.0 112.421 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 94.2 m -109.43 121.02 44.27 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.239 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.9 mp -113.6 152.68 30.01 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.12 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 tt -128.53 131.05 69.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.36 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.406 HG22 HD11 ' A' ' 142' ' ' ILE . 96.6 mt -114.99 127.79 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.463 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.99 103.76 14.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.324 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.3 p90 -101.36 -11.42 19.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.772 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.4 p-10 -64.82 -33.48 76.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.673 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.1 p-10 -98.17 7.59 46.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.585 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.44 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.56 155.48 50.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.507 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -74.43 165.39 25.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.67 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.549 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 90.8 t90 -60.0 -48.52 81.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.255 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -53.95 -41.73 68.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.99 0.424 . . . . 0.0 110.061 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.9 t -62.55 -40.84 98.1 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.401 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 tp -60.61 -43.93 96.87 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.338 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.0 tp -61.37 -42.97 99.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 0.0 110.261 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -55.79 -45.25 78.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.679 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.44 -40.6 97.13 Favored 'General case' 0 C--O 1.228 -0.044 0 CA-C-O 120.938 0.399 . . . . 0.0 110.388 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.93 -42.34 98.99 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.321 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.77 -40.72 95.8 Favored Glycine 0 C--N 1.316 -0.575 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.89 -45.85 63.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.937 0.399 . . . . 0.0 110.899 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.0 mt -64.49 -44.13 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.742 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.5 p -93.47 -8.15 42.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.538 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.65 25.0 71.47 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -101.35 52.24 0.84 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.817 0.341 . . . . 0.0 110.653 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.7 -39.02 77.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.668 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.47 -47.12 86.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.201 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -61.41 -39.02 89.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.357 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.4 97.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.068 0.461 . . . . 0.0 110.355 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.19 -27.71 69.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.541 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.71 -53.57 9.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.192 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.98 -43.26 96.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.461 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 174' ' ' ASP . 86.9 mt -63.08 -43.86 99.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.687 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.45 -61.72 2.33 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.173 0.511 . . . . 0.0 110.369 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.45 -34.99 62.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.448 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -79.66 -35.37 39.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.056 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.0 m-20 -56.0 -41.15 74.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.128 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.92 -42.25 99.73 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.756 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.3 -37.93 88.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.29 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.41 -42.26 99.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.752 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.8 -52.97 62.01 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.132 0.491 . . . . 0.0 110.704 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.45 -41.78 88.61 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.649 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.03 -40.0 95.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.7 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.32 -32.4 73.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.349 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.16 -21.69 18.93 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.684 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.0 tt0 -64.86 -41.36 95.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.642 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.0 pt -77.23 135.58 26.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.656 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.02 108.62 11.09 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.27 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.86 126.83 0.31 Allowed Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.548 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.9 Cg_exo -43.75 152.09 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.749 2.3 . . . . 0.0 112.609 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.2 142.09 54.42 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.598 2.198 . . . . 0.0 112.487 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.547 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.12 147.32 2.23 Favored Pre-proline 0 N--CA 1.446 -0.631 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.62 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.2 154.46 69.92 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.71 2.274 . . . . 0.0 112.293 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.42 163.14 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.417 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.631 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.1 t -143.75 170.46 15.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.905 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.631 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.64 137.65 21.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.961 0.41 . . . . 0.0 110.141 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.3 pt -134.08 146.46 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.623 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.9 131.74 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.182 0.515 . . . . 0.0 110.485 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -151.73 154.59 36.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.404 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 84.8 m -121.86 122.54 39.66 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.996 0.427 . . . . 0.0 110.382 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.76 -25.5 66.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.551 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -74.45 -50.0 20.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.071 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.53 -10.74 60.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.398 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.3 m80 48.61 43.26 20.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.475 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.1 t -136.07 145.24 45.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.323 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.19 113.77 26.52 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.297 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.9 133.65 55.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.07 0.462 . . . . 0.0 110.301 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.23 146.43 38.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.72 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.463 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.8 t90 -99.36 129.86 45.6 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.152 0.501 . . . . 0.0 110.024 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.652 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.67 154.37 39.18 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.211 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.9 Cg_endo -67.64 -18.22 48.24 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.702 2.268 . . . . 0.0 111.925 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.652 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -49.2 -18.72 0.37 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.431 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.463 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.6 p -75.73 164.99 25.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.559 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.07 -27.94 66.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.529 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.52 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.8 mt-30 -63.56 -41.59 98.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.675 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.05 -44.87 96.85 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.38 -38.97 92.9 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.952 0.406 . . . . 0.0 110.642 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.549 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.4 mmm -62.23 -41.39 98.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.148 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 70.9 mt -63.78 -47.15 82.08 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.641 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.51 -31.97 57.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.075 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -70.7 -18.28 62.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.493 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 93.5 mt -88.61 -8.3 54.92 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.656 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.47 2.64 55.52 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -88.54 152.33 21.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.346 . . . . 0.0 110.543 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.2 p -115.15 128.12 55.99 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.117 0.484 . . . . 0.0 110.337 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.52 145.7 24.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.454 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.38 151.41 46.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.43 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.31 131.81 42.34 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.409 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.627 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.52 93.54 28.01 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.078 -179.57 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.717 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.4 Cg_exo -55.62 138.99 82.45 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.553 2.169 . . . . 0.0 111.493 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.77 -25.42 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.463 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.717 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.83 -49.55 28.42 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.587 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.8 mt -54.61 -37.18 65.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 0.0 110.098 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.29 35.8 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.837 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.38 88.35 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 82.6 p -81.83 -14.12 56.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.307 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.53 -40.89 11.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.582 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 24.7 t -66.86 -16.87 64.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.643 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.99 43.6 26.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.45 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.94 -147.44 7.43 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.02 142.95 49.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.035 0.445 . . . . 0.0 110.291 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.23 149.69 28.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.361 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -101.3 -151.35 0.41 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.294 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 55.76 -92.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.611 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.502 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.3 tt -126.56 174.8 9.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.604 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.502 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.7 mt -121.4 141.09 43.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.781 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.42 168.85 9.73 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.224 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.8 mt -147.57 150.85 35.26 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.191 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.75 -38.76 96.66 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.05 4.27 4.65 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.47 -58.03 3.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.94 0.4 . . . . 0.0 110.571 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.42 -36.6 82.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.282 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.2 mp -52.29 -67.64 0.23 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.808 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.67 -42.11 67.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.072 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.84 17.97 0.15 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.698 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.77 48.32 0.26 Allowed Glycine 0 N--CA 1.464 0.564 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.36 -109.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.595 0.236 . . . . 0.0 110.741 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.454 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.8 m120 -60.74 -44.95 96.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.484 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.54 8.23 83.41 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -99.53 -12.24 20.31 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.751 -0.264 . . . . 0.0 110.732 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.7 t 176.2 142.47 0.07 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.096 0.474 . . . . 0.0 110.482 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 tt -148.06 126.04 12.04 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.077 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -99.06 142.89 29.97 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 120.893 0.378 . . . . 0.0 110.907 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.45 106.61 18.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.596 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.47 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.8 t80 -102.3 -12.1 18.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.203 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.66 -40.32 88.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.833 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.22 173.45 45.92 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.495 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.4 m-20 -74.49 -113.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.772 0.32 . . . . 0.0 110.77 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.27 -28.69 68.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.635 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.06 -44.19 91.81 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.306 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.64 -44.29 94.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.379 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.54 -60.09 3.66 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.174 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.21 -43.41 61.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.219 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.45 -43.87 75.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.159 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.6 mt -64.31 -43.62 97.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.651 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -56.84 -37.49 71.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.21 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.03 0.93 19.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.249 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -114.83 91.53 26.45 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.086 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.14 -27.26 28.91 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.743 2.295 . . . . 0.0 111.823 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.27 -41.37 99.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.63 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.8 mp -95.01 4.87 53.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.324 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.7 -35.24 70.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.667 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.72 4.59 15.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.51 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.555 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.82 121.51 81.6 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.563 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -47.72 -37.76 28.31 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.415 2.076 . . . . 0.0 112.553 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.555 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -58.94 -43.7 91.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.803 0.335 . . . . 0.0 110.266 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.7 -43.78 93.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.286 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.91 -40.6 95.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.43 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.4 -12.48 40.19 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.569 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.25 31.69 17.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.891 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -88.64 44.22 1.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.419 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.91 135.58 43.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.436 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.23 132.87 56.54 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.452 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.42 87.6 6.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.72 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.463 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.1 mt -63.95 -41.33 97.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.983 0.421 . . . . 0.0 110.906 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.47 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.91 168.6 35.04 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 77.2 p -75.89 -25.79 56.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.834 0.35 . . . . 0.0 110.705 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.533 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -67.71 -34.55 77.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.484 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.495 ' O ' ' CG2' ' A' ' 296' ' ' THR . 98.5 m -72.96 19.38 0.09 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.596 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.533 ' H ' ' C ' ' A' ' 295' ' ' GLU . 52.0 t80 -57.36 -50.88 71.56 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.049 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 69.8 mmt-85 -108.15 148.98 29.11 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.1 tp -115.54 125.87 53.54 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.696 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 42.6 t0 -149.32 166.7 28.18 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.651 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -49.45 -38.22 28.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.597 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -72.6 -64.61 0.92 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.925 0.393 . . . . 0.0 111.381 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.26 -31.49 70.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.889 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -55.54 -25.05 35.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.523 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.7 mtt -63.08 -41.52 99.43 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 120.923 0.392 . . . . 0.0 110.809 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.16 -44.28 26.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.018 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 78.6 t -66.16 -43.08 92.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.415 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.439 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.5 tp -60.37 -47.3 86.66 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.529 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -69.8 -39.69 76.4 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.675 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.498 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 70.6 ttt180 -61.76 -37.92 86.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.218 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.72 4.79 42.78 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.769 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -112.58 -12.09 13.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.045 0.45 . . . . 0.0 110.246 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.22 85.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.574 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.87 -48.63 80.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.328 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.025 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -90.16 -2.81 58.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.369 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.09 179.22 1.22 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.513 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.6 Cg_exo -60.92 145.16 99.46 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.815 2.343 . . . . 0.0 112.179 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.35 -179.38 8.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.571 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -116.33 137.15 52.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.98 0.419 . . . . 0.0 110.329 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -123.99 146.61 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.349 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -120.28 136.4 54.68 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.771 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 53.1 p30 -99.81 -143.16 0.33 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.133 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -62.87 -36.87 84.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.399 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.468 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -152.23 -59.76 0.15 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.446 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -60.75 140.27 48.06 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.1 p -111.78 130.21 55.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.925 0.393 . . . . 0.0 110.404 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -120.05 128.62 53.68 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.509 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.2 m -85.5 130.14 34.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.205 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.7 mt -96.29 78.61 3.08 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.343 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.46 -31.83 73.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.556 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.75 109.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.976 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -122.75 91.2 49.74 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.287 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.643 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -57.15 148.63 68.44 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.82 2.347 . . . . 0.0 111.876 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.28 82.77 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.653 0.595 . . . . 0.0 110.999 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.643 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.67 67.0 0.88 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.142 0.496 . . . . 0.0 110.229 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -77.07 130.93 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.752 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.6 t -122.58 147.72 26.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.047 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.0 t -136.55 143.97 43.97 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.666 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.672 ' HG1' ' H ' ' A' ' 50' ' ' SER . 18.2 p -99.71 -58.8 1.84 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.557 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.672 ' H ' ' HG1' ' A' ' 49' ' ' THR . 88.4 p -79.43 155.25 28.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.637 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.0 t -74.05 -21.94 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.569 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.403 ' O ' ' OG ' ' A' ' 56' ' ' SER . 97.6 m -60.26 -51.92 67.48 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.516 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 mt -66.21 -42.68 88.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.172 0.511 . . . . 0.0 110.897 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.3 m -43.16 -53.96 4.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.959 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.0 -37.55 73.86 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.1 m -62.86 -44.22 96.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.87 0.366 . . . . 0.0 110.244 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.5 mt -65.86 -42.33 90.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.602 0.715 . . . . 0.0 110.679 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tp -62.93 -39.69 95.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.519 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.0 77.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.235 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.2 pt -91.36 28.09 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.257 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.79 51.83 10.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.011 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.16 76.07 27.62 Favored Pre-proline 0 C--O 1.225 -0.189 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.02 149.6 90.14 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.742 2.294 . . . . 0.0 112.108 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -112.57 136.61 48.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-O 121.233 0.539 . . . . 0.0 110.256 179.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.3 pt -69.3 -43.73 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.369 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.16 131.15 53.27 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.989 0.423 . . . . 0.0 110.628 -178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.5 p -155.65 168.6 26.64 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.38 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.34 -177.24 21.98 Favored Glycine 0 N--CA 1.465 0.593 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.42 172.04 13.25 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 121.067 0.46 . . . . 0.0 110.434 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.8 p -133.38 -111.37 0.23 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.001 0.429 . . . . 0.0 110.346 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.94 179.73 0.93 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.356 -179.019 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.0 Cg_exo -61.02 58.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 123.032 2.488 . . . . 0.0 112.14 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.535 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.7 t-20 -64.38 -34.23 77.68 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 118.716 -0.659 . . . . 0.0 110.423 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.4 m-20 94.6 -37.27 0.01 OUTLIER 'General case' 0 C--N 1.348 0.543 0 O-C-N 124.156 0.91 . . . . 0.0 109.684 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -62.73 -40.07 96.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.029 0.442 . . . . 0.0 110.203 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -73.99 -26.16 20.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.714 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.75 -172.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.539 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.54 -153.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.79 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.3 p-10 -54.21 -6.85 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.707 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.515 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.01 114.19 23.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.647 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.42 72.06 1.3 Allowed Glycine 0 C--O 1.225 -0.446 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.487 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.3 m-85 -143.58 148.13 35.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.913 0.387 . . . . 0.0 110.839 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.525 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.5 mp -85.89 -98.77 0.07 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.076 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.86 -43.39 96.23 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.14 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.556 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.8 tt0 91.65 52.69 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 124.143 0.902 . . . . 0.0 110.919 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -103.33 -8.53 20.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.387 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.487 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -65.52 -33.31 75.63 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.198 0.523 . . . . 0.0 110.687 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.556 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.24 -24.26 1.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.629 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.8 t -69.57 -46.02 76.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.842 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.24 -48.51 81.12 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.984 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.61 -38.23 89.38 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.367 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.71 -32.86 53.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.144 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.565 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.79 1.71 55.8 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.554 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 83.03 -49.38 0.15 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.141 0.901 . . . . 0.0 110.275 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.628 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.1 mt -46.23 153.72 0.31 Allowed 'General case' 0 CA--C 1.486 -1.483 0 CA-C-O 117.127 -1.416 . . . . 0.0 109.257 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.628 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.35 92.06 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 O-C-N 125.896 1.998 . . . . 0.0 110.525 -178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.01 142.83 43.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.174 0.512 . . . . 0.0 110.212 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.8 mt -131.96 26.52 4.6 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.041 -0.412 . . . . 0.0 110.443 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -140.03 137.5 34.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.032 0.444 . . . . 0.0 110.516 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.7 mt -136.82 164.7 29.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.352 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.518 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.76 -28.76 1.74 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.08 70.67 7.77 Favored Pre-proline 0 N--CA 1.464 0.256 0 CA-C-O 121.195 0.521 . . . . 0.0 110.206 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.98 145.29 98.7 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.743 2.295 . . . . 0.0 112.087 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.1 t -135.03 137.11 42.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.507 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.0 -38.35 82.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.697 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.19 -42.23 96.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.512 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.91 -41.61 98.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.545 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.46 -43.35 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.96 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.04 -35.17 77.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.022 0.439 . . . . 0.0 110.216 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.58 -18.96 61.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.459 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.32 -6.55 58.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.537 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.413 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 68.9 mtp 47.65 55.87 17.11 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.661 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.5 Cg_endo -70.34 149.64 63.48 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.755 2.303 . . . . 0.0 112.132 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.48 -72.78 0.67 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.451 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.5 tp -111.61 113.93 26.65 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.348 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.0 mt -102.96 126.79 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 120.935 0.398 . . . . 0.0 110.566 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.2 mt -110.33 134.16 52.56 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.111 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.65 139.72 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.501 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 121' ' ' THR . 91.1 p -83.22 167.78 17.37 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.708 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.34 -37.25 80.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.43 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.418 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.6 t -139.57 158.6 43.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.439 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.59 176.64 33.87 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.68 86.88 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.34 151.38 44.41 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.919 0.39 . . . . 0.0 110.547 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.4 t -63.56 140.89 58.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.268 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.55 10.65 11.15 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.618 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.2 -39.07 88.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.171 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.628 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.75 -35.9 24.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.614 0.721 . . . . 0.0 110.667 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.8 mt -70.98 -35.26 72.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.525 0.678 . . . . 0.0 110.74 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.9 -62.98 0.87 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.339 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.628 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.72 -42.73 90.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -61.97 -32.64 73.1 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.509 0.506 . . . . 0.0 110.222 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.4 mt -73.75 -40.56 63.41 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.49 -49.03 78.82 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.137 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.8 m -52.98 -42.52 65.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.237 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.91 -43.08 93.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.991 0.424 . . . . 0.0 111.208 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.06 152.89 5.36 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.677 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -38.92 107.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.673 2.249 . . . . 0.0 112.488 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.403 ' HG1' ' CB ' ' A' ' 133' ' ' LEU . 96.8 m -109.61 121.44 45.22 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.041 0.448 . . . . 0.0 110.181 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -113.83 152.68 30.33 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.254 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 tt -128.06 131.16 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.38 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.34 127.75 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.49 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 54.4 t30 -100.15 104.57 16.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.176 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -100.28 -12.02 19.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.014 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.8 p-10 -65.16 -34.08 77.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.81 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.581 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.8 p-10 -99.34 7.92 45.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.585 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -134.05 151.44 51.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.56 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.42 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.8 p -75.87 166.31 23.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.635 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.595 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.0 t90 -59.26 -48.76 80.43 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.101 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -54.24 -44.12 71.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.989 0.423 . . . . 0.0 110.04 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.3 t -63.05 -40.8 98.78 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.344 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 62.7 tp -60.62 -44.52 96.23 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.287 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.6 tp -61.56 -42.51 98.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.192 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.9 m -55.55 -46.14 77.17 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.83 -40.6 95.87 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.962 0.41 . . . . 0.0 110.337 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -62.12 -42.51 99.3 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.41 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.27 -40.11 94.62 Favored Glycine 0 C--O 1.222 -0.608 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.34 -45.9 65.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.931 0.396 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.83 -44.1 96.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.2 p -92.95 -9.3 40.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.61 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.18 26.37 72.49 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -101.97 50.73 0.84 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.822 0.344 . . . . 0.0 110.694 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.63 -39.27 77.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.667 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.5 -47.21 86.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.223 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -59.84 -39.54 85.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.209 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.16 -40.82 98.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.059 0.457 . . . . 0.0 110.259 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.83 -29.03 70.42 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.966 0.412 . . . . 0.0 110.616 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -73.94 -54.39 8.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.076 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -64.67 -42.02 95.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.419 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.4 mt -62.3 -43.93 98.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.531 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.99 -59.67 4.76 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.136 0.493 . . . . 0.0 110.253 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -55.91 -34.15 65.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.48 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -80.17 -36.18 35.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.798 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.2 m-20 -54.66 -42.02 70.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.926 -178.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.98 -41.39 97.97 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.62 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -64.93 -38.21 90.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.322 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.33 -42.45 99.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.804 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.84 -53.38 56.67 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.149 0.5 . . . . 0.0 110.685 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.22 -41.82 89.55 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.694 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.7 -40.31 96.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.697 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.03 -32.54 73.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.39 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.2 -21.53 19.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.736 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.63 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.2 tt0 -64.7 -41.93 95.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.763 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.1 pt -75.98 133.76 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.043 0.449 . . . . 0.0 110.723 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -127.51 106.11 8.95 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.317 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.3 128.27 0.35 Allowed Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.576 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.447 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.5 Cg_exo -43.44 151.3 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.812 2.342 . . . . 0.0 112.667 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.66 142.43 53.06 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.577 2.185 . . . . 0.0 112.517 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.544 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -170.97 147.29 2.28 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.672 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.9 153.96 71.77 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.761 2.308 . . . . 0.0 112.299 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.521 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.21 163.05 29.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.228 0.537 . . . . 0.0 110.415 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.646 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.1 t -143.52 169.82 16.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.949 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.646 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -148.03 137.59 22.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.987 0.422 . . . . 0.0 110.11 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.5 pt -134.22 146.34 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.76 131.9 59.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.198 0.523 . . . . 0.0 110.471 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -151.86 154.77 36.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.409 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.0 m -121.64 122.78 40.39 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 110.358 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.6 -25.61 66.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.638 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.401 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.95 -49.43 20.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.966 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.75 -12.03 60.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.34 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.7 m80 49.59 42.35 22.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.435 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.8 t -136.39 145.29 45.17 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.354 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.84 114.39 27.7 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.268 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.93 133.37 55.59 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.108 0.48 . . . . 0.0 110.289 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.07 146.4 38.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.793 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.475 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 12.9 t90 -99.69 127.99 45.8 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.187 0.518 . . . . 0.0 109.86 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.539 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -93.46 153.67 41.35 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.401 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.74 -18.57 47.72 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.655 2.237 . . . . 0.0 111.977 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.539 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -50.13 -18.35 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.343 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.475 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.6 p -75.36 167.8 21.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.484 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.24 -35.62 75.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.429 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.5 mt-30 -56.74 -41.12 76.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.698 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.42 -42.99 97.77 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.503 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 73.1 mt-30 -63.91 -39.95 95.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 122.279 -0.541 . . . . 0.0 110.745 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.595 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.4 mmm -61.83 -41.54 97.91 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.196 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 77.5 mt -63.46 -49.79 72.26 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 121.16 0.505 . . . . 0.0 110.404 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.38 -32.66 50.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 0.0 110.076 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.18 -20.07 62.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.578 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 67.1 mt -87.39 -6.53 58.42 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.58 3.89 57.24 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -88.63 149.81 23.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 0.0 110.527 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.5 p -112.96 126.83 55.91 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.211 0.529 . . . . 0.0 110.191 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.565 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.87 145.61 24.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.061 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.461 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.9 150.51 46.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.398 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.61 131.29 44.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.385 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.626 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.67 92.97 26.18 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.996 -179.535 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.718 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.1 Cg_exo -55.6 139.13 82.53 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.542 2.161 . . . . 0.0 111.582 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.51 -24.62 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.483 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.718 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.07 -49.59 26.77 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.581 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -54.57 -36.91 64.88 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.63 36.06 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.82 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.581 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.68 87.4 0.01 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.879 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.5 p -80.81 -14.73 57.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.334 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.42 -41.11 11.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.668 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.2 t -66.85 -16.65 64.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.585 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.01 43.74 26.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.431 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.77 -146.87 7.22 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.57 143.42 49.75 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.026 0.441 . . . . 0.0 110.296 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -151.75 149.26 28.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.279 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -100.36 -152.83 0.43 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.317 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.6 t0 56.44 -91.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.671 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.519 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.67 175.39 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.594 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.519 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.8 mt -121.41 141.04 43.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.842 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.41 168.98 9.65 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.14 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.0 mt -147.3 150.69 35.27 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.278 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.69 -39.04 97.09 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.56 3.75 4.55 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.0 -58.31 3.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.959 0.409 . . . . 0.0 110.562 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -62.06 -36.92 83.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.209 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.18 -67.66 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.79 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.6 -42.02 67.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.091 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.15 18.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.689 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.44 47.53 0.2 Allowed Glycine 0 N--CA 1.466 0.642 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.3 mp 39.23 -109.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.569 0.223 . . . . 0.0 110.684 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.461 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.5 m120 -60.98 -44.99 96.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.367 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.78 8.04 83.26 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -99.22 -12.47 20.38 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.709 -0.289 . . . . 0.0 110.687 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.4 t 176.38 142.65 0.07 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.085 0.469 . . . . 0.0 110.449 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -148.16 125.77 11.77 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.207 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -98.63 143.04 29.45 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 120.885 0.374 . . . . 0.0 110.958 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.0 mt -94.39 106.77 18.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.659 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.472 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 93.0 t80 -102.23 -12.95 17.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.117 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -65.87 -40.45 91.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.892 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.18 173.48 45.95 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.492 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -74.27 -112.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.76 0.314 . . . . 0.0 110.749 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.93 -28.77 67.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.673 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.2 -44.05 92.23 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.259 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.5 -44.49 94.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.327 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.45 -59.67 4.15 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.12 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.35 -43.41 61.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.069 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.74 74.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.194 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.3 -43.61 97.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.592 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -56.57 -37.77 71.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.074 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.32 0.99 20.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.168 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -115.07 91.28 26.48 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.094 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.05 -27.22 28.16 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.786 2.324 . . . . 0.0 111.897 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -41.27 98.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.536 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.9 mp -95.44 4.91 52.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.347 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.76 -35.31 70.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.644 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.82 4.77 15.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.489 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.541 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.68 121.2 80.22 Favored Pre-proline 0 N--CA 1.44 -0.937 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.587 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -47.55 -37.48 26.53 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.41 2.073 . . . . 0.0 112.628 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.541 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.72 -43.48 90.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.747 0.308 . . . . 0.0 110.245 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.85 -43.74 93.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.246 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.86 -40.62 95.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.335 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.46 -12.6 39.68 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.603 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 62.01 31.64 17.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.003 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.42 44.33 1.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.136 0.493 . . . . 0.0 110.327 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.4 135.82 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.439 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.65 132.42 56.69 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.4 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.49 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.83 88.39 6.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.77 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.474 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.9 mt -63.83 -41.74 97.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.983 0.42 . . . . 0.0 110.832 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.472 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.85 165.94 34.56 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 76.8 p -75.62 -25.99 57.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.846 0.355 . . . . 0.0 110.703 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.3 tp10 -68.4 -34.03 75.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.442 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.494 ' O ' ' CG2' ' A' ' 296' ' ' THR . 99.4 m -72.26 18.82 0.08 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.558 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.543 ' H ' ' C ' ' A' ' 295' ' ' GLU . 48.1 t80 -56.93 -51.03 70.76 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.873 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -107.09 148.15 29.13 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 41.0 tp -115.52 126.11 53.86 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.842 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 304' ' ' ALA . 42.0 t0 -149.55 166.83 28.04 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.672 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -49.28 -38.03 25.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.631 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -71.75 -64.91 0.84 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.47 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.9 -32.94 72.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.979 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 300' ' ' ASP . . . -54.47 -25.52 25.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.66 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.2 mtt -63.56 -41.07 98.43 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 120.906 0.384 . . . . 0.0 111.06 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -77.65 -44.61 27.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.084 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 79.6 t -66.12 -42.88 92.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.346 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.43 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 48.3 tp -59.92 -47.05 87.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.449 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -70.19 -39.55 75.15 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.134 0.492 . . . . 0.0 110.897 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.492 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 73.9 ttt180 -61.28 -37.79 84.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.197 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -88.06 5.06 42.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.689 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.63 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.0 tttt -112.23 -11.84 13.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.075 0.464 . . . . 0.0 110.303 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.26 85.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.53 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.97 -48.73 80.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.339 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.941 -179.964 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.655 ' H ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -89.89 -2.68 58.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.417 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.493 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.15 1.23 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.501 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.493 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.8 Cg_exo -60.81 144.89 99.64 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.86 2.373 . . . . 0.0 112.123 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.655 ' NH1' ' H ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.83 -179.48 8.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.592 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.77 137.0 52.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.371 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.71 146.99 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.383 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -120.03 136.14 54.67 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.791 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.36 -143.48 0.32 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.225 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.66 -37.08 86.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.458 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.21 -66.62 0.22 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.435 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.6 142.39 45.59 Favored Glycine 0 CA--C 1.519 0.294 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.6 p -112.17 131.36 55.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 110.443 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -119.1 129.1 54.88 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.485 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.9 m -85.76 130.37 34.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.225 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.3 mt -95.91 79.07 3.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.439 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.61 -31.96 73.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.71 109.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.986 0.422 . . . . 0.0 110.121 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -122.49 91.92 49.19 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.435 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.9 Cg_exo -56.7 148.67 63.9 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.804 2.336 . . . . 0.0 111.953 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.58 82.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.591 0.557 . . . . 0.0 110.979 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.5 66.84 0.89 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.271 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.06 130.58 36.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.812 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.7 t -122.61 146.71 27.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.061 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.0 t -135.96 143.96 45.16 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.77 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.68 ' HG1' ' H ' ' A' ' 50' ' ' SER . 28.5 p -99.5 -59.4 1.73 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.624 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.68 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.2 p -79.28 155.07 28.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.651 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.3 t -74.05 -21.91 18.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.529 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.413 ' O ' ' OG ' ' A' ' 56' ' ' SER . 96.4 m -60.23 -52.07 66.85 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.536 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.38 -42.6 87.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.102 0.477 . . . . 0.0 110.787 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.9 m -43.14 -54.07 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.029 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.33 -37.05 70.53 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.8 m -62.88 -44.71 95.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.867 0.365 . . . . 0.0 110.252 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.0 mt -66.37 -41.9 88.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.487 0.661 . . . . 0.0 110.75 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -62.61 -40.33 96.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.431 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.04 -35.61 75.48 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.202 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -91.54 28.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.253 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.45 51.67 11.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.32 75.7 22.57 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.0 0.429 . . . . 0.0 109.919 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.61 151.35 85.96 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.825 2.35 . . . . 0.0 112.16 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -113.42 137.31 46.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.182 0.515 . . . . 0.0 110.274 179.772 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.418 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.4 pt -69.42 -43.4 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.359 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.03 131.17 53.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.96 0.41 . . . . 0.0 110.594 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.8 p -155.64 168.49 26.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.489 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.66 -177.16 21.78 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.92 172.85 12.24 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 110.449 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 p -133.16 -111.93 0.23 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.001 0.429 . . . . 0.0 110.428 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.43 179.68 0.94 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.509 -179.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.7 Cg_exo -60.97 58.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.965 2.443 . . . . 0.0 112.099 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.1 t-20 -64.43 -33.73 76.54 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.485 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 42.5 m-20 94.07 -36.96 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.875 0.734 . . . . 0.0 109.808 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -62.75 -39.73 95.06 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.188 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.35 -25.54 19.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.669 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.31 -171.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.428 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.14 -153.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.87 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.5 p-10 -52.72 -7.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.749 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.52 114.88 23.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.648 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.95 69.69 1.36 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.434 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.1 m-85 -143.05 147.15 34.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 110.813 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.527 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -84.92 -98.58 0.06 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.11 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.556 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.06 -42.48 97.0 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.13 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.556 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 34.8 tt0 91.29 52.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.841 0.713 . . . . 0.0 111.076 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -102.8 -9.25 20.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.374 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.434 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.3 p -64.36 -34.11 77.39 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.138 0.494 . . . . 0.0 110.695 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.532 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.05 -23.61 1.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.677 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.92 -45.97 75.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.746 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.26 -48.55 80.9 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.009 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.37 -38.34 89.2 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.446 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.57 -32.74 52.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.175 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.593 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.4 mmt-85 -90.1 1.75 56.03 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.535 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 56.9 mttp 82.84 -49.38 0.17 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.838 0.711 . . . . 0.0 110.318 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.664 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.3 mt -45.86 154.01 0.25 Allowed 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 117.733 -1.127 . . . . 0.0 109.598 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.664 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.22 92.62 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 125.387 1.679 . . . . 0.0 110.521 -178.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.543 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.65 143.17 42.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.249 0.547 . . . . 0.0 110.244 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.9 mt -132.23 27.04 4.5 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 122.013 -0.429 . . . . 0.0 110.454 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.32 137.94 34.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.03 0.443 . . . . 0.0 110.559 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.525 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 91.2 mt -137.33 165.1 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.356 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.525 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 144.58 -28.48 1.91 Allowed Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.22 70.45 7.63 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.13 0.49 . . . . 0.0 110.172 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.93 145.23 98.83 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.751 2.301 . . . . 0.0 112.098 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.5 t -134.57 136.59 43.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.97 0.414 . . . . 0.0 110.544 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.37 83.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.63 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.14 -42.41 96.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.527 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.6 98.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.525 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.7 -43.41 98.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.03 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.23 -35.03 77.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.181 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.59 -18.73 60.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.407 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.61 -6.47 58.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.531 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 70.3 mtp 47.59 56.06 17.22 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.596 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.1 149.33 64.57 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.737 2.291 . . . . 0.0 112.12 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.24 -74.0 0.63 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.43 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.8 tp -110.22 112.91 25.17 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.268 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.4 mt -101.82 126.26 55.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.694 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 mt -109.51 133.7 52.77 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.276 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.406 HG23 HD12 ' A' ' 118' ' ' ILE . 96.8 mt -120.54 139.44 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.594 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 121' ' ' THR . 90.5 p -83.43 168.58 16.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.793 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.24 -37.43 80.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.427 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.428 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -139.74 158.99 43.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.488 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.15 177.43 33.19 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.19 -33.9 87.38 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -125.12 151.98 45.01 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.9 0.381 . . . . 0.0 110.522 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.4 t -63.14 140.99 58.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.369 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.43 10.32 11.16 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.649 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.01 -38.79 87.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.244 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.638 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.2 -35.89 23.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.449 0.643 . . . . 0.0 110.628 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.1 mt -71.05 -35.51 71.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.504 0.668 . . . . 0.0 110.673 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -42.68 -62.71 0.92 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.356 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.638 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.91 -42.73 89.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.159 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -62.08 -32.69 73.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.338 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.3 mt -73.75 -40.98 63.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.898 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.27 -48.84 79.17 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.19 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.2 m -53.2 -42.48 66.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.182 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.81 -42.94 93.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.022 0.439 . . . . 0.0 111.158 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.64 154.57 5.53 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.657 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -39.39 106.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.647 2.232 . . . . 0.0 112.496 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 95.7 m -110.5 121.35 45.09 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.093 0.473 . . . . 0.0 110.199 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.22 153.28 29.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.286 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 tt -129.29 131.55 67.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.404 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.16 128.03 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.056 0.455 . . . . 0.0 110.512 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.62 103.56 14.38 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.197 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.8 p90 -101.15 -11.21 19.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.872 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.2 p-10 -64.84 -33.41 75.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.703 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.571 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.3 p-10 -98.38 8.0 45.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.567 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.45 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.88 155.62 50.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.466 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.403 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.8 p -75.01 165.62 24.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.668 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.59 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.88 -48.62 80.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.217 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.54 -42.02 67.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.001 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.4 t -62.74 -41.06 99.01 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.37 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.6 tp -60.59 -44.41 96.29 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.406 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.37 -43.41 98.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.166 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.0 m -55.07 -44.93 75.26 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.35 -40.74 97.38 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.967 0.413 . . . . 0.0 110.507 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.446 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.94 -42.54 99.23 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.311 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.13 -40.85 95.16 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.57 -45.99 64.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.937 0.398 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.75 -43.98 96.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.837 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -93.07 -8.83 41.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.632 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.96 26.63 72.34 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.69 50.59 0.85 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.807 0.337 . . . . 0.0 110.678 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -69.44 -39.48 77.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.648 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.46 -47.2 86.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.274 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -60.13 -39.38 86.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.163 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.98 99.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.246 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.92 -28.5 70.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.591 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.29 -54.27 8.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.895 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -65.48 -42.28 92.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.366 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.9 mt -62.36 -43.84 98.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.566 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.57 -58.36 7.83 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.999 0.428 . . . . 0.0 110.356 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.13 -33.55 67.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.589 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -81.34 -36.5 29.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.774 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -55.63 -42.29 74.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.023 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.28 -42.23 99.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.74 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.27 -37.98 88.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.295 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.51 -42.12 99.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.729 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.13 -52.98 61.69 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.045 0.45 . . . . 0.0 110.667 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.22 -41.91 89.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.665 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.7 -40.02 95.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.592 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.38 -31.91 73.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.434 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.77 -22.4 18.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.67 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.75 -41.27 96.03 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.668 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.0 pt -76.24 136.27 25.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.657 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.47 107.83 10.62 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.29 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -177.16 125.8 0.29 Allowed Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.472 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.4 Cg_exo -44.04 152.38 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.864 2.376 . . . . 0.0 112.509 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.8 141.91 55.85 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.612 2.208 . . . . 0.0 112.446 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.27 147.14 2.13 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.548 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.08 154.34 70.57 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.811 2.34 . . . . 0.0 112.312 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.52 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.05 162.99 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.235 0.54 . . . . 0.0 110.403 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.665 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.0 t -143.72 170.33 16.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.927 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.665 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -148.66 137.75 21.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 110.126 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.4 pt -134.54 147.2 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.661 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.02 132.15 58.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.115 0.483 . . . . 0.0 110.488 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -152.44 155.72 38.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.444 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 88.8 m -123.25 123.48 40.85 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.945 0.402 . . . . 0.0 110.375 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.63 -25.64 66.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.626 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.69 -48.96 19.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.006 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.61 -12.06 60.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.497 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.1 m80 49.28 41.02 19.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.526 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.3 t -135.84 143.65 45.23 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.385 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -109.83 114.29 27.74 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.24 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.82 133.36 55.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.016 0.436 . . . . 0.0 110.488 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -111.87 146.62 37.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.834 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.451 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 10.0 t90 -99.97 129.65 46.06 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.186 0.517 . . . . 0.0 109.869 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.713 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -94.85 153.73 39.94 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.39 179.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.3 Cg_endo -67.77 -18.06 47.44 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.755 2.303 . . . . 0.0 111.975 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.713 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -49.27 -19.12 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.369 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.451 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.5 p -75.4 164.41 26.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.497 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.78 -27.66 65.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.526 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.61 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.0 mt-30 -63.88 -41.03 97.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.556 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.81 -44.48 97.96 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.45 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.1 mt-30 -64.49 -38.77 92.17 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 122.299 -0.53 . . . . 0.0 110.697 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.59 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.3 mmm -61.93 -41.24 97.72 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.209 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.56 -47.31 82.09 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.022 0.439 . . . . 0.0 110.437 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.91 -31.97 51.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.866 0.365 . . . . 0.0 110.268 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -70.9 -18.63 62.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.508 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 90.3 mt -87.65 -9.12 55.11 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.602 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.16 1.84 54.46 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -88.42 153.55 21.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.904 0.383 . . . . 0.0 110.468 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 7.3 p -116.4 128.87 55.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.14 0.495 . . . . 0.0 110.41 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.557 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.48 146.3 23.79 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.916 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.453 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.93 151.5 45.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.488 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.49 131.51 43.51 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.428 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.72 93.44 28.53 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.05 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.716 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.2 Cg_exo -55.38 138.78 80.84 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.545 2.163 . . . . 0.0 111.679 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.98 -26.05 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.457 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.716 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.03 -50.11 30.57 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.586 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.5 mt -54.43 -37.07 64.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.45 36.24 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.74 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.3 86.31 0.02 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.878 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.5 p -79.2 -15.08 58.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.382 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -92.6 -41.01 10.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.603 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.9 t -66.13 -17.86 64.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.645 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 56.16 43.3 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.492 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.34 -148.34 7.72 Favored Glycine 0 CA--C 1.519 0.289 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.58 142.75 49.8 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 110.347 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -152.36 149.89 29.12 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.296 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -101.28 -151.33 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.348 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 55.81 -92.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.672 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.511 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.85 175.38 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.627 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.511 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.8 mt -122.5 141.81 41.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.65 169.32 9.35 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.23 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.3 mt -147.52 150.94 35.5 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.264 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.93 -38.85 96.67 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.35 3.77 4.65 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -77.34 -58.13 3.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.924 0.392 . . . . 0.0 110.538 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -62.14 -36.34 81.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.308 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.55 -67.51 0.25 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.86 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.75 -42.37 68.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.081 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.7 17.59 0.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.669 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.86 48.47 0.27 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.394 -0.683 . . . . 0.0 111.394 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.3 mp 38.82 -109.98 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.593 0.235 . . . . 0.0 110.712 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.453 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.6 m120 -60.86 -44.93 96.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.475 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.47 7.99 83.87 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -98.91 -13.66 19.91 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.647 -0.325 . . . . 0.0 110.66 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.4 t 177.25 142.78 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.087 0.47 . . . . 0.0 110.42 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 tt -148.13 125.34 11.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.165 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -98.28 143.63 28.56 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 120.865 0.364 . . . . 0.0 110.83 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.7 mt -95.18 106.67 18.71 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.794 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.437 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.7 t80 -102.26 -12.1 18.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.158 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.44 -40.4 89.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.886 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.0 173.3 45.86 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.461 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.3 m-20 -74.07 -113.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.756 0.312 . . . . 0.0 110.704 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.72 -28.81 67.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.686 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.1 -43.86 91.9 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.225 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.32 -44.55 94.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.316 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.56 -59.98 3.8 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.189 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -51.02 -43.38 60.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.151 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.47 -43.41 75.51 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.19 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.53 -43.68 96.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.629 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.25 -37.55 69.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.098 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.48 0.79 18.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.131 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -115.21 91.7 28.81 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.148 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.35 -27.07 29.73 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.748 2.299 . . . . 0.0 111.95 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.515 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.55 -41.06 98.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.503 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.434 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.33 5.24 52.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.381 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.13 -35.08 69.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.585 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.93 4.53 16.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.51 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.553 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.64 121.25 80.33 Favored Pre-proline 0 N--CA 1.445 -0.7 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.549 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -47.14 -38.0 24.3 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.483 2.122 . . . . 0.0 112.529 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.553 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -58.8 -43.66 90.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.704 0.288 . . . . 0.0 110.37 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.0 -43.62 92.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.355 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.92 -40.78 95.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.415 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.6 t-20 -89.65 -12.41 39.7 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.588 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.2 mtmt 61.94 32.19 17.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.995 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.76 43.97 1.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.061 0.457 . . . . 0.0 110.307 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.68 135.67 41.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.503 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.78 132.69 56.63 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.447 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.15 89.16 7.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.732 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.453 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.8 mt -63.82 -41.05 97.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.021 0.438 . . . . 0.0 110.856 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.437 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.2 165.02 33.52 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.516 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 74.1 p -75.28 -25.71 58.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.94 0.4 . . . . 0.0 110.771 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.3 tp10 -68.42 -34.03 75.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.393 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.506 ' O ' ' CG2' ' A' ' 296' ' ' THR . 96.6 m -73.35 24.84 0.07 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.736 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.61 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 39.7 t80 -58.07 -50.66 72.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.433 ' CZ ' ' CE2' ' A' ' 297' ' ' PHE . 80.0 mmt-85 -111.19 154.01 24.99 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 44.8 tp -115.44 124.98 52.51 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.814 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 41.8 t0 -147.69 165.55 30.13 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.619 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -49.34 -37.88 26.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.57 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -71.12 -65.6 0.72 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.504 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -61.01 -32.91 72.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.975 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.19 -25.55 23.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.743 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.2 mtt -63.6 -40.9 98.11 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 120.829 0.347 . . . . 0.0 111.07 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.76 -43.94 24.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.195 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.34 -42.85 91.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.357 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.1 tp -60.22 -46.96 87.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.464 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -70.07 -39.47 75.62 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.054 0.454 . . . . 0.0 110.759 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.9 ttt180 -61.75 -38.29 87.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.248 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.12 4.39 42.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.607 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -112.77 -11.01 13.55 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.091 0.472 . . . . 0.0 110.347 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.41 -37.09 85.95 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.487 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.84 -48.71 80.58 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.457 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.006 179.868 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.618 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.02 -2.52 58.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.464 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.8 179.03 1.25 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.552 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.96 144.97 99.69 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.84 2.36 . . . . 0.0 112.092 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.618 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.68 -179.58 8.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.601 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.73 136.84 52.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.358 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.0 tp -124.53 147.5 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.396 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -120.35 135.97 54.85 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 110.742 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.27 -143.5 0.32 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.194 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.54 -37.11 86.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.417 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.09 -67.21 0.22 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.507 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.54 142.72 45.18 Favored Glycine 0 C--O 1.228 -0.275 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.9 p -112.29 131.57 55.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.962 0.41 . . . . 0.0 110.481 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -118.94 128.92 54.86 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.507 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.2 m -85.41 130.35 34.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.247 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.3 mt -95.59 78.54 3.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.405 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.69 -32.17 73.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.52 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.5 109.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.121 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -122.74 91.47 49.59 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.326 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.94 148.67 66.31 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.818 2.345 . . . . 0.0 111.894 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -40.71 82.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 O-C-N 123.657 0.598 . . . . 0.0 111.008 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.44 66.85 0.89 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.266 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.22 130.74 35.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.752 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.2 t -122.61 146.95 27.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.041 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 t -136.23 143.62 44.42 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.718 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.71 ' HG1' ' H ' ' A' ' 50' ' ' SER . 25.8 p -99.38 -59.25 1.76 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.526 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.71 ' H ' ' HG1' ' A' ' 49' ' ' THR . 85.8 p -79.35 155.57 28.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.646 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.5 t -74.46 -21.97 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.591 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.412 ' O ' ' OG ' ' A' ' 56' ' ' SER . 73.7 m -60.25 -52.15 66.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.575 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.35 -42.53 87.93 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.173 0.511 . . . . 0.0 110.939 177.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.4 m -42.92 -54.07 4.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.041 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.47 -37.69 69.39 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.2 m -62.36 -44.63 96.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 110.299 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.4 mt -66.3 -41.98 88.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.445 0.641 . . . . 0.0 110.756 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -62.55 -40.17 95.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.442 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.19 -35.83 76.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.133 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 pt -91.41 29.06 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.266 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.42 51.92 10.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.887 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.4 75.67 22.35 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.961 0.41 . . . . 0.0 109.906 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.73 151.45 85.65 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.837 2.358 . . . . 0.0 112.162 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -113.58 137.16 47.65 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-O 121.214 0.53 . . . . 0.0 110.255 179.743 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.7 pt -69.48 -43.38 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.305 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.9 131.08 53.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.603 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.535 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.1 p -155.54 168.66 26.42 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.422 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.68 -177.2 21.76 Favored Glycine 0 N--CA 1.463 0.496 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.8 172.66 12.48 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.954 0.407 . . . . 0.0 110.538 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 p -132.26 -113.17 0.23 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.421 . . . . 0.0 110.359 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.77 179.72 0.95 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.408 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.1 Cg_exo -61.31 57.48 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 123.069 2.513 . . . . 0.0 112.091 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 60.4 t-20 -64.3 -33.07 74.97 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.462 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.3 m-20 93.65 -35.55 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.962 0.789 . . . . 0.0 109.795 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -63.23 -39.74 95.47 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.987 0.422 . . . . 0.0 110.173 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.79 -25.19 18.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.719 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -48.96 -171.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.555 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -73.72 -153.84 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.787 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 36.4 p-10 -52.34 -7.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.726 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.52 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -86.51 114.99 23.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.003 0.43 . . . . 0.0 110.59 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.07 70.2 1.34 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.453 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.3 m-85 -143.57 147.46 34.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.825 0.345 . . . . 0.0 110.823 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.525 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -85.82 -98.58 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.136 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.551 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.82 -42.71 97.58 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.114 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.591 ' NE2' ' HZ3' ' A' ' 88' ' ' LYS . 35.4 tt0 91.61 52.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.962 0.789 . . . . 0.0 110.907 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -102.53 -9.27 20.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.33 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.453 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.56 -34.17 77.63 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.043 0.449 . . . . 0.0 110.631 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.591 ' HZ3' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.2 -24.36 1.71 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.614 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.42 -45.64 78.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.753 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.45 -48.3 81.76 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.037 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.52 -38.24 89.17 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.36 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.53 -32.98 52.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.155 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.581 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.86 1.46 56.15 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.493 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.581 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.98 -48.98 0.15 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.984 0.803 . . . . 0.0 110.208 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.651 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.5 153.83 0.34 Allowed 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 117.65 -1.167 . . . . 0.0 109.307 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.651 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.59 92.46 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 O-C-N 125.482 1.739 . . . . 0.0 110.491 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.52 143.19 42.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.138 0.494 . . . . 0.0 110.321 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.3 mt -132.24 27.1 4.5 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.122 -0.361 . . . . 0.0 110.362 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -140.31 137.83 34.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.045 0.45 . . . . 0.0 110.524 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.5 mt -136.99 165.02 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.447 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.523 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 144.97 -28.61 1.85 Allowed Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -152.61 70.79 7.39 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.153 0.501 . . . . 0.0 110.355 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.08 145.43 98.46 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.75 2.3 . . . . 0.0 112.06 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.7 t -134.56 136.77 43.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.514 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.37 82.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.635 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.11 -42.24 96.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.483 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.15 -41.62 98.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.48 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.59 -43.45 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.043 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.3 78.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.195 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.44 -18.7 60.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.413 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.52 -6.53 58.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.486 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 73.8 mtp 48.09 55.94 17.35 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.616 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.12 149.13 64.17 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.808 2.339 . . . . 0.0 112.129 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.32 -73.05 0.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.5 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.5 tp -111.35 113.48 25.98 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.313 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.4 mt -102.3 126.64 56.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.567 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 mt -110.19 133.94 52.72 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.262 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.98 139.95 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.474 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 121' ' ' THR . 87.6 p -83.5 168.67 16.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.741 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.46 80.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.442 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.424 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.1 t -139.94 159.21 42.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.423 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.31 177.29 33.4 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.28 -33.81 87.25 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.53 151.53 44.57 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.575 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.4 t -63.55 140.93 58.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.298 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.66 10.7 11.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.666 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.04 -39.05 88.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.187 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.01 -35.91 23.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.445 0.64 . . . . 0.0 110.576 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -70.8 -35.48 72.56 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.54 0.686 . . . . 0.0 110.784 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -42.91 -62.99 0.87 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.289 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.61 -42.84 91.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.132 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -61.95 -32.73 73.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.257 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.1 mt -73.82 -40.69 63.17 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.032 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.31 -48.98 78.78 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.186 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.5 m -53.0 -42.39 65.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.187 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.89 -43.04 93.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.089 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.43 153.61 5.33 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.633 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -39.15 106.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.687 2.258 . . . . 0.0 112.393 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 93.4 m -109.94 121.35 45.04 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.191 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -113.71 152.82 29.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.269 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 tt -129.13 131.17 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.326 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.16 128.17 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.073 0.463 . . . . 0.0 110.497 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.476 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.61 103.57 14.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.23 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.4 p90 -101.34 -11.35 19.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.832 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 48.9 p-10 -64.67 -33.52 76.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.639 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.566 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.2 p-10 -98.37 7.7 45.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.596 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.447 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.49 155.72 50.05 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.539 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.6 p -74.94 165.68 24.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.643 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.3 t90 -60.12 -48.76 80.38 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.256 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -53.42 -41.82 66.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.89 0.376 . . . . 0.0 110.064 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.1 t -62.82 -41.13 99.17 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.334 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.7 tp -60.7 -44.4 96.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.331 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.1 tp -61.4 -43.54 98.69 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.168 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -54.85 -45.03 74.48 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.44 -40.56 96.99 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.936 0.398 . . . . 0.0 110.492 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.96 -42.47 99.16 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.368 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.1 -40.85 95.22 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.59 -45.98 64.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.891 0.377 . . . . 0.0 110.842 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.8 mt -64.68 -43.96 96.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.893 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.3 p -92.99 -8.79 42.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.621 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.84 26.96 72.35 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -101.98 50.71 0.84 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 110.716 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.48 -39.23 77.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.635 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.66 -47.24 86.39 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.3 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -60.14 -39.47 86.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.225 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.96 99.31 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.292 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.92 -28.62 70.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.649 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.21 -54.3 8.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.048 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -65.47 -42.28 92.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.449 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.455 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.3 mt -62.52 -43.8 98.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.473 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.62 -59.08 5.43 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.067 0.46 . . . . 0.0 110.392 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -56.25 -34.2 66.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.568 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -80.87 -36.31 31.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.798 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.3 m-20 -54.98 -42.15 72.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.147 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.54 -41.92 99.2 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.639 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.08 -38.26 90.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.259 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.33 -42.19 99.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.692 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -52.81 62.52 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.135 0.493 . . . . 0.0 110.689 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.09 -41.99 89.94 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.673 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.87 -40.01 95.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.591 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.17 -32.27 73.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.379 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.3 -22.06 18.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.632 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.625 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.6 tt0 -64.75 -41.28 96.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.657 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.8 pt -77.02 136.05 25.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.668 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.2 108.05 10.55 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.27 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.59 126.05 0.32 Allowed Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.458 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.7 152.23 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.796 2.331 . . . . 0.0 112.66 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.04 141.89 54.53 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.624 2.216 . . . . 0.0 112.479 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.42 147.24 2.1 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.605 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.32 155.1 68.35 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.772 2.315 . . . . 0.0 112.356 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.526 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.78 163.26 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.207 0.527 . . . . 0.0 110.371 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.668 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.2 t -143.61 170.05 16.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.894 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.668 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.17 137.47 22.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.067 0.46 . . . . 0.0 110.03 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.0 pt -134.28 146.67 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.637 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.55 131.75 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.348 0.594 . . . . 0.0 110.488 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.437 ' HH ' ' CG1' ' A' ' 272' ' ' ILE . 52.4 p90 -152.78 156.17 38.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.425 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 199' ' ' ALA . 88.4 m -122.17 122.88 40.21 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.878 0.37 . . . . 0.0 110.307 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.523 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.8 -26.32 67.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.591 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.404 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.68 -49.5 21.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.69 -10.44 59.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.449 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.523 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.9 m80 46.28 47.05 13.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.455 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -130.97 143.76 50.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.414 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -108.57 105.32 14.9 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.169 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.6 m-20 -115.95 128.79 56.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.148 0.499 . . . . 0.0 110.321 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.7 tt -111.84 146.32 37.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.465 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.2 t90 -99.55 128.55 45.66 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.131 0.491 . . . . 0.0 109.905 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.709 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -94.41 154.22 40.31 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.293 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.71 -18.09 47.81 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.726 2.284 . . . . 0.0 111.981 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.709 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -49.65 -19.26 0.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.472 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.465 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 87.0 p -74.76 164.44 26.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.483 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.98 -27.77 65.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.518 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.583 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.67 -41.45 98.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.634 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.07 -44.29 97.43 Favored Glycine 0 C--N 1.331 0.286 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.447 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.5 mt-30 -64.52 -38.77 92.16 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 122.4 -0.471 . . . . 0.0 110.683 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.3 mmm -62.12 -41.34 98.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.16 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.6 mt -63.59 -47.36 81.77 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.534 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.24 -31.83 54.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 0.0 110.113 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.97 -18.33 62.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.493 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 92.1 mt -88.37 -8.55 54.86 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.568 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.42 2.88 55.57 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -89.02 152.56 21.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 0.0 110.445 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.3 p -115.35 128.23 55.94 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.132 0.491 . . . . 0.0 110.334 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.555 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.16 146.75 23.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.038 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.46 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.4 151.28 45.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.487 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.07 131.69 42.65 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.39 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.38 93.78 28.46 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.095 -179.667 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.721 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.2 Cg_exo -55.47 138.73 81.11 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.607 2.205 . . . . 0.0 111.568 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.53 -25.49 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.471 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.721 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.68 -49.95 27.46 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.601 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.1 mt -55.15 -37.37 66.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.851 0.358 . . . . 0.0 110.086 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -65.54 35.53 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.84 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.601 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.45 88.3 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 86.2 p -82.26 -13.83 56.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.325 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.32 -40.67 11.35 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.611 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.2 t -66.71 -16.95 64.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.593 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.99 43.69 26.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.457 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.91 -148.08 7.81 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.61 142.25 49.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.998 0.427 . . . . 0.0 110.274 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.0 149.54 29.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.342 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -102.02 -150.35 0.4 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.346 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.68 -93.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.616 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.483 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.0 tt -126.57 174.58 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.604 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.483 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 87.4 mt -121.7 140.94 44.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.902 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.28 170.33 8.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.169 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.5 mt -146.94 149.51 33.33 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.15 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.35 -39.25 97.58 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.19 3.06 4.01 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -78.33 -57.64 3.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.948 0.404 . . . . 0.0 110.583 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -61.99 -36.89 82.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.245 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.7 mp -53.13 -67.42 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.022 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.72 -42.7 68.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.145 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.38 17.85 0.13 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.685 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.79 47.59 0.23 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 7.9 mp 39.71 -110.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.595 0.236 . . . . 0.0 110.651 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.46 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -60.92 -44.52 97.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.441 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.5 8.11 83.64 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -98.7 -13.31 20.32 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.779 -0.248 . . . . 0.0 110.712 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.0 t 176.85 142.84 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 110.478 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -147.89 125.49 11.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.108 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -98.83 143.64 28.93 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 120.92 0.391 . . . . 0.0 110.758 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.9 mt -94.91 106.31 18.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.724 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.451 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.9 -11.81 18.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.219 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.91 86.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.897 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.25 172.69 45.56 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.469 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -73.81 -113.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.0 110.72 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.44 -28.86 68.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.74 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.01 -43.9 91.6 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.275 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -63.53 -44.39 94.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.386 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.57 -59.81 4.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.187 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.21 -43.44 61.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.067 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.42 74.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.267 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.437 ' CG1' ' HH ' ' A' ' 196' ' ' TYR . 91.3 mt -64.66 -43.53 96.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.58 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -56.34 -37.61 70.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.133 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.75 0.85 19.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.149 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.08 91.17 26.08 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.127 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.21 -27.09 28.8 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.724 2.283 . . . . 0.0 111.912 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.46 -41.02 98.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.557 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.3 5.48 51.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.418 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.18 -35.21 68.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.658 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.55 4.5 15.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.495 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.6 121.46 81.02 Favored Pre-proline 0 N--CA 1.444 -0.764 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.541 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -47.46 -37.93 26.61 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.51 2.14 . . . . 0.0 112.556 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.553 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.66 -43.7 89.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.738 0.304 . . . . 0.0 110.292 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.04 -43.52 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.325 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.17 -40.86 97.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.441 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.413 ' ND2' ' CG ' ' A' ' 288' ' ' GLN . 58.0 t30 -90.99 -11.22 39.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.704 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.2 mtmt 61.1 32.66 19.68 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.481 0.488 . . . . 0.0 111.001 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.413 ' CG ' ' ND2' ' A' ' 286' ' ' ASN . 97.1 mm-40 -88.11 43.9 1.16 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.361 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.5 135.83 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.534 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.88 132.15 56.77 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.373 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.6 88.65 7.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.762 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.466 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.1 mt -64.0 -41.13 97.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.003 0.43 . . . . 0.0 110.892 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.451 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.25 166.39 34.04 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 70.3 p -75.29 -25.53 58.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.835 0.35 . . . . 0.0 110.719 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.538 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.3 tp10 -68.33 -33.91 75.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.535 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.499 ' O ' ' CG2' ' A' ' 296' ' ' THR . 97.7 m -73.62 23.42 0.07 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.617 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.583 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 59.3 t80 -58.04 -51.23 70.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 66.1 mmt-85 -111.05 153.88 25.01 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 44.2 tp -116.13 125.6 52.57 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.449 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 41.7 t0 -147.43 165.43 30.27 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.561 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -49.37 -38.09 27.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.607 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -72.14 -64.86 0.86 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.52 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.32 -32.0 70.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.012 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.39 -25.36 24.13 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.614 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.8 mtt -63.37 -41.0 98.78 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 120.879 0.371 . . . . 0.0 110.782 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -78.23 -44.78 24.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 79.3 t -65.9 -43.04 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.448 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.439 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 51.2 tp -60.36 -47.16 87.25 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.606 -178.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.11 -39.61 75.4 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.736 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.7 ttt180 -61.64 -38.13 86.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.154 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.2 mt -87.63 4.74 42.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.72 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.625 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.72 -11.87 13.45 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.004 0.431 . . . . 0.0 110.334 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.12 -37.24 86.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.522 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.01 -48.73 80.46 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.383 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 . . . . . 0 C--O 1.221 -0.408 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.008 179.899 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.25 -2.61 58.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.437 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.27 179.07 1.25 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.488 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.4 Cg_exo -60.78 145.29 99.18 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.794 2.329 . . . . 0.0 112.174 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.5 -179.36 8.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.585 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.3 137.01 52.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.405 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -123.99 147.09 28.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.366 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.7 p -119.98 135.95 54.72 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.78 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.39 -143.61 0.33 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.291 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.54 -37.29 86.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.456 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.477 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.82 -67.25 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.46 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.31 142.64 44.7 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.1 p -112.4 131.4 55.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.96 0.409 . . . . 0.0 110.397 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -119.01 129.16 54.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.442 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.7 m -85.63 130.78 34.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.289 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 70.3 mt -96.79 78.83 2.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.281 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.96 -31.84 72.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.561 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.56 107.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.148 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -120.74 91.19 47.11 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.414 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.658 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.3 Cg_exo -56.94 148.57 66.86 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.765 2.31 . . . . 0.0 111.842 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.62 82.41 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.577 0.548 . . . . 0.0 111.001 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.658 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.37 66.87 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.253 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -76.62 131.06 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.745 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.76 147.25 27.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.028 0.442 . . . . 0.0 110.066 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 t -136.33 144.12 44.48 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.654 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.677 ' HG1' ' H ' ' A' ' 50' ' ' SER . 19.7 p -100.09 -59.09 1.77 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.584 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.677 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.1 p -79.25 155.02 28.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -74.07 -21.85 18.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.565 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.411 ' O ' ' OG ' ' A' ' 56' ' ' SER . 96.9 m -60.13 -52.07 66.92 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.542 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.6 mt -66.49 -42.4 87.51 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.131 0.491 . . . . 0.0 110.798 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -43.35 -53.9 5.01 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.074 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.04 -37.39 73.39 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.1 m -62.93 -44.28 96.5 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 110.38 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.8 mt -66.04 -42.05 90.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.396 0.617 . . . . 0.0 110.662 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 tp -62.88 -39.91 95.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.271 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.45 -36.1 77.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.177 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.8 pt -91.18 27.9 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.27 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.4 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 99.0 m-20 56.94 51.75 10.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.972 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.17 76.06 27.59 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.944 0.402 . . . . 0.0 110.001 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.87 149.56 90.37 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.811 2.341 . . . . 0.0 112.281 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -112.52 136.6 48.24 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-O 121.136 0.493 . . . . 0.0 110.281 179.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.3 pt -69.48 -43.4 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.32 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.51 131.39 52.82 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.946 0.403 . . . . 0.0 110.648 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.54 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.3 p -155.84 168.83 25.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.458 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.35 -177.39 21.97 Favored Glycine 0 N--CA 1.463 0.499 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.5 172.38 12.8 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.015 0.436 . . . . 0.0 110.482 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.7 p -133.33 -111.57 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 0.0 110.491 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.8 179.62 0.95 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.448 -179.221 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.4 Cg_exo -60.86 58.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.894 2.396 . . . . 0.0 112.076 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.4 t-20 -64.42 -33.98 77.12 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.5 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.6 m-20 94.29 -36.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.869 0.731 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -62.89 -39.96 96.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.937 0.398 . . . . 0.0 110.224 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -74.49 -26.0 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.675 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.59 -172.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.612 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.3 p30 -73.73 -152.75 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.771 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 36.9 p-10 -54.46 -6.6 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.726 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.59 114.19 23.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.548 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.53 71.73 1.31 Allowed Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.509 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.3 m-85 -143.19 148.21 36.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.74 0.305 . . . . 0.0 110.908 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.532 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -86.04 -98.64 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.961 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.558 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.08 -43.3 95.83 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.183 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.558 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 36.0 tt0 91.85 52.64 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.875 0.734 . . . . 0.0 110.961 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -103.47 -9.02 19.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.377 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.509 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -65.23 -33.25 75.56 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.02 0.438 . . . . 0.0 110.604 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.549 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 97.9 mttt -49.09 -24.51 1.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.619 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.6 t -69.67 -45.92 76.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.31 -48.47 81.22 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.111 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -38.38 90.17 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.364 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.8 -32.64 53.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.23 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.596 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.2 mmt-85 -89.91 1.72 55.89 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.468 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.95 -49.93 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.897 0.748 . . . . 0.0 110.294 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.668 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.1 mt -45.55 153.86 0.23 Allowed 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.456 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.668 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 121.01 92.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 125.218 1.574 . . . . 0.0 110.458 -178.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.54 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.28 142.72 43.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.201 0.524 . . . . 0.0 110.191 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.4 mt -131.71 26.75 4.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.467 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -140.11 137.52 34.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 110.51 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.522 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 93.0 mt -136.84 164.88 29.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.406 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 144.97 -28.4 1.86 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.469 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.71 70.62 7.29 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.101 0.477 . . . . 0.0 110.327 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.07 145.31 98.72 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.687 2.258 . . . . 0.0 112.215 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.7 t -133.8 136.11 44.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.527 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.74 -38.42 83.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.662 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.48 -41.99 96.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.52 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.11 -41.54 98.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.516 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -63.64 -43.29 98.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.976 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.1 77.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.284 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.76 -18.37 59.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.454 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.77 -6.39 58.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.508 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.416 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 75.2 mtp 47.93 55.79 17.17 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.614 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.6 Cg_endo -69.94 149.36 65.63 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.88 2.386 . . . . 0.0 112.114 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.76 -73.05 0.66 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.488 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.6 tp -111.43 114.21 27.18 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.267 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -103.49 126.97 57.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.525 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 mt -110.71 134.51 52.4 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.184 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.12 140.15 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.555 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 121' ' ' THR . 90.7 p -83.57 168.02 16.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.689 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.31 -37.26 80.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.472 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.427 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.7 t -139.19 158.4 44.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.486 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.3 177.0 33.54 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.71 86.99 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -125.28 151.7 45.64 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.913 0.387 . . . . 0.0 110.551 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.9 t -63.29 141.34 58.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.379 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.18 10.7 10.72 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.631 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.15 -38.97 88.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.15 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.7 -35.97 24.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.432 0.634 . . . . 0.0 110.633 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.2 mt -70.98 -35.1 71.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.486 0.66 . . . . 0.0 110.72 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -42.88 -62.94 0.88 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.285 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.61 -42.84 91.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.066 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -62.11 -32.29 72.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.242 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.4 mt -74.28 -40.64 62.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.969 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.44 -49.09 78.55 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.275 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.7 m -52.92 -42.85 65.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.157 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.18 -43.06 92.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -168.83 151.71 5.09 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.71 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -38.61 107.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.621 2.214 . . . . 0.0 112.387 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 97.2 m -109.75 121.64 45.69 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.2 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.0 153.34 29.53 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.309 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.46 131.11 69.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.371 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 142' ' ' ILE . 96.5 mt -115.18 128.19 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.571 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 54.6 t30 -100.77 104.94 16.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.227 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.411 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.4 p90 -100.71 -11.94 19.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.893 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.0 p-10 -64.95 -33.69 76.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.742 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -99.29 7.91 45.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.542 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.411 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.8 mttm -134.57 151.84 51.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.869 0.366 . . . . 0.0 110.529 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.427 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.7 p -75.82 166.26 23.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.597 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.4 t90 -59.25 -48.62 80.94 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.276 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -54.44 -44.1 72.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.03 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.4 t -62.96 -40.7 98.5 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.202 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 63.4 tp -60.92 -44.34 97.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.3 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 49.2 tp -61.49 -42.98 99.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.198 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.8 m -55.9 -45.7 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.741 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.23 -40.56 96.55 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.836 0.35 . . . . 0.0 110.394 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.452 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -62.03 -42.5 99.24 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.222 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.73 -40.06 95.56 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.42 -45.95 64.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.8 -44.0 96.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.5 p -92.77 -9.09 41.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.704 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.93 26.29 72.22 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -101.22 50.47 0.86 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.776 0.322 . . . . 0.0 110.629 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.48 -39.17 77.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.658 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.9 -47.45 85.73 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.213 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.4 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 88.0 mt-30 -59.97 -39.27 85.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.162 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.92 98.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.238 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.88 -29.13 70.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.558 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -73.86 -54.41 8.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.059 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -64.86 -42.13 95.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.455 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 174' ' ' ASP . 78.4 mt -62.43 -43.82 98.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.487 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.28 -58.71 6.72 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.009 0.433 . . . . 0.0 110.368 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -56.61 -33.57 66.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.37 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -81.1 -36.12 30.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.78 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.1 m-20 -54.84 -42.35 71.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.062 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.17 -41.77 98.64 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.696 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.0 -38.02 89.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.383 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.45 -42.48 99.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.653 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.75 -53.06 61.14 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.132 0.492 . . . . 0.0 110.752 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.48 -41.76 88.48 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.618 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.09 95.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.67 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.14 -32.63 74.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.418 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.06 -21.47 19.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.728 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.63 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.3 tt0 -64.87 -41.58 95.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.733 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.0 pt -76.5 133.9 30.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.675 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.71 106.46 9.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.4 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.59 128.37 0.34 Allowed Pre-proline 0 C--O 1.238 0.479 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.553 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.3 Cg_exo -43.65 151.42 0.4 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.839 2.359 . . . . 0.0 112.497 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.67 142.18 52.22 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.611 2.208 . . . . 0.0 112.421 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.542 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.72 147.17 2.39 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.542 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.15 153.93 70.93 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.787 2.325 . . . . 0.0 112.278 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.525 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.47 163.23 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.159 0.504 . . . . 0.0 110.45 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.587 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.1 t -143.75 169.93 16.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.832 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.587 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -147.68 137.4 22.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.3 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.2 pt -134.19 146.03 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.592 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -133.39 132.01 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.054 0.454 . . . . 0.0 110.517 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -151.82 154.45 36.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.48 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 90.0 m -121.56 122.69 40.23 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.955 0.407 . . . . 0.0 110.368 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.74 -25.59 66.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.595 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -74.96 -49.66 19.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.992 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.01 -11.53 60.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.403 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.6 m80 49.14 42.47 21.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.495 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.0 t -135.94 144.98 45.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.319 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.82 114.12 27.22 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.375 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -120.18 133.71 55.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.986 0.422 . . . . 0.0 110.399 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.18 146.53 37.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.74 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.468 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 13.3 t90 -99.38 127.96 45.46 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.101 0.477 . . . . 0.0 109.987 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.71 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -93.7 153.42 41.14 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.264 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.9 -18.29 46.81 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.648 2.232 . . . . 0.0 111.962 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.71 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -50.01 -18.75 0.59 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.368 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.468 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.1 p -75.21 167.7 21.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.476 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.11 -35.56 75.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.3 mt-30 -56.64 -41.19 76.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.763 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.37 -43.04 97.68 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.492 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.4 mt-30 -63.75 -40.08 95.84 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 122.549 -0.383 . . . . 0.0 110.542 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.597 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.2 mmm -61.56 -41.87 98.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.376 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.56 -49.88 71.67 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.473 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.11 -33.06 50.62 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -71.09 -20.21 62.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.558 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 65.9 mt -87.28 -6.42 58.55 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.74 3.52 57.16 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -88.34 149.85 23.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.93 0.395 . . . . 0.0 110.507 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.0 p -112.78 126.49 55.47 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.127 0.489 . . . . 0.0 110.355 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.568 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.79 145.84 24.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.999 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.464 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.06 150.77 46.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.438 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.86 131.21 44.43 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.502 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.634 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.69 93.25 27.51 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.118 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.721 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.6 Cg_exo -55.77 138.99 83.15 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.655 2.236 . . . . 0.0 111.561 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.75 -25.13 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.399 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.721 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.75 -49.91 27.2 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.589 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.1 mt -54.37 -37.01 64.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.54 35.92 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.801 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.58 87.92 0.01 OUTLIER 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.864 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 82.3 p -81.64 -14.28 56.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.351 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.51 -41.8 10.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.609 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.9 -16.91 64.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.587 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.91 43.69 27.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.504 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.21 -149.62 8.44 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -120.29 142.79 48.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.976 0.417 . . . . 0.0 110.36 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.24 149.76 29.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.366 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -101.21 -151.7 0.42 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.358 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 56.21 -91.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.688 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.526 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.3 tt -127.08 175.61 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.597 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.526 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.6 mt -122.23 141.68 41.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.81 169.26 9.36 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.255 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.3 mt -147.57 150.71 34.99 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.223 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.57 -39.06 97.21 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.33 3.74 4.67 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.11 -58.44 3.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.911 0.386 . . . . 0.0 110.568 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -61.95 -36.57 81.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.29 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 9.9 mp -52.3 -67.8 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.757 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.42 -42.21 66.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.148 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.87 18.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.657 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.75 47.64 0.23 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.3 mp 39.13 -110.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.521 0.201 . . . . 0.0 110.743 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.464 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.8 m120 -60.9 -44.98 96.37 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.473 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.78 8.1 83.17 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -99.14 -12.57 20.36 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.805 -0.232 . . . . 0.0 110.642 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.3 t 176.24 142.65 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.052 0.453 . . . . 0.0 110.493 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -148.1 125.47 11.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.156 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -98.37 143.03 29.27 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 120.848 0.356 . . . . 0.0 110.837 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.2 mt -94.41 106.52 18.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.674 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.469 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.87 -12.74 18.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.149 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.79 90.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.895 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.9 173.2 45.81 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.472 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 87.5 m-20 -74.07 -113.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 110.723 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.15 -28.91 68.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.765 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.08 -44.09 91.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.187 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.51 -44.45 94.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.318 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.32 -59.78 4.0 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.25 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.25 -43.47 61.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.111 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.2 -43.84 74.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.244 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.1 mt -64.39 -43.58 97.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.679 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -56.59 -37.67 70.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.163 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.28 1.17 19.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.212 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -115.04 91.47 27.13 Favored Pre-proline 0 C--O 1.231 0.114 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.17 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.14 -27.33 29.18 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.821 2.347 . . . . 0.0 111.864 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.515 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.4 -41.17 98.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.55 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.9 mp -95.24 4.75 53.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.396 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.71 -35.31 70.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.099 0.476 . . . . 0.0 110.673 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.76 4.62 15.8 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.624 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.555 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.79 121.15 80.26 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.565 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -47.64 -37.35 26.96 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.464 2.11 . . . . 0.0 112.472 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.555 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.88 -43.35 90.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.319 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.04 -43.8 92.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.303 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -64.95 -40.76 95.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.341 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.3 t-20 -89.15 -13.16 39.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.577 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.5 mtmt 62.66 32.05 16.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.93 44.51 1.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.292 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.68 135.4 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.551 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.6 132.41 56.69 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.398 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.49 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.83 88.69 6.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.786 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.469 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.4 mt -63.87 -41.72 97.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.78 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.469 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.82 165.9 34.41 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 75.5 p -75.61 -25.92 57.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.719 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.542 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -68.29 -33.97 75.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.552 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.498 ' O ' ' CG2' ' A' ' 296' ' ' THR . 98.7 m -72.62 19.85 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.668 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.542 ' H ' ' C ' ' A' ' 295' ' ' GLU . 49.1 t80 -57.28 -51.01 71.1 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.014 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 70.9 mmt-85 -107.85 149.18 28.58 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 41.1 tp -115.67 126.26 53.9 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.862 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 304' ' ' ALA . 42.6 t0 -149.74 166.67 28.71 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.611 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -49.21 -38.04 24.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.613 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.65 -65.11 0.8 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.454 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -60.71 -32.82 72.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.974 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 300' ' ' ASP . . . -54.49 -25.21 24.1 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.3 mtt -63.67 -41.02 98.23 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 120.811 0.339 . . . . 0.0 110.945 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -78.37 -44.36 25.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.988 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 79.7 t -65.97 -42.93 92.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.431 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.436 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.8 tp -60.01 -46.92 87.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.448 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -70.61 -39.48 73.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.988 0.423 . . . . 0.0 110.603 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.49 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 73.6 ttt180 -61.35 -38.0 85.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.319 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.8 mt -87.76 4.91 42.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.698 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.63 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.22 -11.71 13.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.041 0.448 . . . . 0.0 110.337 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.79 -37.1 85.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.489 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.96 -48.75 80.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.435 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.958 179.872 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.612 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -90.3 -2.39 58.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.441 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.93 179.04 1.25 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.525 -179.67 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.0 Cg_exo -60.74 144.81 99.61 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.802 2.334 . . . . 0.0 112.191 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.612 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.4 ptt-85 -156.09 -179.46 8.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.597 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.62 136.19 53.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.322 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -123.78 146.53 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.432 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.8 p -119.78 135.99 54.63 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.719 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.1 p30 -99.28 -143.5 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.328 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.8 p -63.66 -37.0 85.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.42 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.31 -66.78 0.22 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.437 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.06 142.12 44.65 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.6 p -112.09 131.23 55.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.411 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -119.2 129.17 54.83 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.498 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.1 m -85.62 130.3 34.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.301 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.4 mt -95.69 78.58 3.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.399 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.82 -32.03 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.482 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.27 108.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.204 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -121.97 91.31 48.85 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.322 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.658 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.1 Cg_exo -56.94 148.8 65.48 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.782 2.321 . . . . 0.0 111.888 179.049 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.82 82.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.487 0.492 . . . . 0.0 110.922 -179.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.658 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.09 66.79 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.277 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.45 130.93 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.748 -179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.1 t -122.82 145.57 29.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.191 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.9 t -135.13 143.59 46.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.681 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.2 p -99.54 -59.26 1.75 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.576 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.4 p -79.74 155.11 28.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.593 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -74.58 -21.9 17.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.46 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.404 ' O ' ' OG ' ' A' ' 56' ' ' SER . 97.2 m -59.9 -52.32 65.92 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.508 -178.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.0 mt -66.53 -42.35 87.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.129 0.49 . . . . 0.0 110.8 178.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.6 m -42.91 -53.73 4.55 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.169 -178.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.46 -37.34 69.42 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 178.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 52' ' ' THR . 5.6 m -62.79 -44.62 95.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.955 0.407 . . . . 0.0 110.484 -179.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.5 mt -66.37 -41.85 88.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.367 0.603 . . . . 0.0 110.683 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tp -62.5 -40.25 96.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.297 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.98 -35.75 75.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.033 -178.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.6 pt -91.57 28.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.163 -179.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.38 51.78 10.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.795 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.86 75.91 24.0 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.999 0.428 . . . . 0.0 110.05 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.19 151.27 86.03 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.739 2.293 . . . . 0.0 112.3 -178.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.51 137.48 46.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.156 0.503 . . . . 0.0 110.339 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.3 pt -69.41 -43.56 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.129 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.96 131.09 53.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.958 0.408 . . . . 0.0 110.613 -178.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.1 p -155.8 169.03 25.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.515 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.87 -177.43 21.63 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.01 172.19 12.96 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 120.979 0.418 . . . . 0.0 110.444 179.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.9 p -133.76 -110.72 0.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.364 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.95 179.53 0.96 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.421 -179.202 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.7 Cg_exo -60.89 58.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.011 2.474 . . . . 0.0 112.079 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.4 t-20 -64.29 -35.03 79.52 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.52 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 47.2 m-20 94.96 -37.66 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.926 0.766 . . . . 0.0 110.031 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.64 -40.01 95.67 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.256 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.5 p -73.94 -26.44 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.697 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.9 -172.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.504 -179.402 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -73.88 -152.51 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.72 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.3 p-10 -54.78 -6.33 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.674 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.4 113.56 23.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.634 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.4 72.66 1.28 Allowed Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.498 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.1 m-85 -143.68 148.56 35.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.919 0.39 . . . . 0.0 110.759 179.264 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.3 mp -85.76 -99.15 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.136 178.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.564 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.28 -42.74 96.27 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.322 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.564 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.3 tt0 91.5 52.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.772 0.67 . . . . 0.0 110.951 178.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.45 -9.25 19.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.412 179.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.498 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.0 p -64.74 -33.78 76.78 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.112 0.482 . . . . 0.0 110.643 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.55 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 97.9 mttt -48.66 -23.35 1.0 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.591 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.8 t -70.05 -45.87 74.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.789 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.25 -48.65 80.49 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.183 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.61 -38.15 89.08 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.382 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.64 -32.39 51.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.237 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.605 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.5 mmt-85 -89.98 1.68 56.0 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.547 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.89 -49.1 0.16 Allowed 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.816 0.697 . . . . 0.0 110.342 179.141 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.683 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.9 mt -46.3 154.05 0.3 Allowed 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.557 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.683 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 121.12 92.26 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.029 1.456 . . . . 0.0 110.543 -178.579 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.537 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.3 143.3 43.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.078 0.466 . . . . 0.0 110.287 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 mt -131.92 26.97 4.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.847 0.356 . . . . 0.0 110.479 -179.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.48 138.15 34.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.004 0.431 . . . . 0.0 110.481 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.525 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.8 mt -137.19 165.15 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.429 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.525 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.11 -28.55 1.84 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.469 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -153.21 70.64 6.93 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.039 0.447 . . . . 0.0 110.391 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.15 145.53 98.28 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.801 2.334 . . . . 0.0 112.011 -179.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.1 t -134.04 136.81 44.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.57 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.33 82.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.656 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.42 -42.28 96.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.476 -179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.71 98.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.484 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.4 t -63.66 -43.18 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.136 179.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.74 -35.23 77.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.249 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.82 -18.28 59.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.432 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.7 -6.53 58.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.523 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.413 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 66.9 mtp 48.04 55.96 17.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.623 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.9 Cg_endo -70.22 149.1 63.45 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.771 2.314 . . . . 0.0 112.134 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.36 -72.87 0.67 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.539 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.2 tp -111.42 112.4 24.12 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.377 179.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 75.6 mt -100.59 126.03 54.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.516 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.9 mt -109.38 133.0 53.6 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.287 -179.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.47 139.61 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.573 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 121' ' ' THR . 87.5 p -83.44 168.38 16.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.705 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.41 80.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.483 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.431 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.8 t -139.33 158.87 43.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.96 0.409 . . . . 0.0 110.446 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.16 177.04 33.41 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.91 87.39 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.97 151.62 45.25 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.906 0.384 . . . . 0.0 110.546 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.1 t -63.18 141.27 58.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.398 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.51 10.93 10.54 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.659 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.14 -38.83 87.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.099 -179.404 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.64 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.86 -35.79 23.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.377 0.608 . . . . 0.0 110.579 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.7 mt -71.06 -35.17 71.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.396 0.617 . . . . 0.0 110.691 179.333 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -42.94 -62.82 0.92 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.229 -178.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.64 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.87 -42.63 90.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.997 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.18 -32.28 72.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.266 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.4 mt -74.41 -40.54 61.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 178.686 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.93 -48.86 78.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.219 -179.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.5 m -52.66 -42.68 64.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.215 179.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.06 -43.05 92.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.173 179.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.36 153.21 5.22 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.622 -179.128 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -39.03 107.33 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.664 2.243 . . . . 0.0 112.435 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 93.8 m -108.72 121.01 44.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.287 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.03 152.52 30.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.343 -179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 tt -129.0 131.51 68.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.42 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.11 127.68 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.55 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.8 t30 -101.83 103.86 14.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.359 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 147' ' ' LYS . 49.1 p90 -101.29 -11.31 19.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.801 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.7 p-10 -64.77 -33.52 76.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.728 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.577 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.8 p-10 -98.33 7.68 45.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.568 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.34 155.44 50.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.508 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.3 p -74.66 165.69 24.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.615 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.571 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 90.9 t90 -60.04 -48.7 80.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.38 -179.189 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.87 -41.87 67.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.005 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.9 t -62.6 -40.77 97.98 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.484 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 48.4 tp -60.62 -43.94 96.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.417 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.1 tp -61.47 -42.96 99.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.21 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.5 m -55.75 -45.31 78.09 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.4 -40.69 97.32 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.881 0.372 . . . . 0.0 110.408 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.96 -42.38 99.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.158 179.233 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.65 -40.72 96.04 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.87 -46.04 63.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.853 0.359 . . . . 0.0 110.829 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.62 -44.03 96.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.795 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.5 p -93.01 -8.79 41.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.676 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.76 25.19 71.67 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -101.87 52.01 0.82 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.658 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.92 -39.03 76.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.685 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.28 -47.08 86.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.252 -179.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -61.4 -38.93 88.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.291 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.43 97.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.41 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.48 -27.54 69.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.507 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.92 -53.78 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.134 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.66 -43.49 96.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.441 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.0 mt -63.06 -43.85 99.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.7 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.3 -61.65 2.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.064 0.459 . . . . 0.0 110.392 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -54.61 -35.08 63.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.44 -179.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -79.75 -34.46 39.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.909 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 170' ' ' ILE . 50.2 m-20 -56.83 -40.14 75.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.805 -178.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.89 -42.45 99.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.937 0.399 . . . . 0.0 110.709 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.68 -37.96 87.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.292 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.33 -42.49 99.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.704 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.95 -53.29 57.76 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.081 0.467 . . . . 0.0 110.694 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.27 -41.66 89.56 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.633 179.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.76 94.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.68 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.22 -32.21 73.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.379 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -94.49 -21.67 18.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.615 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.631 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.94 -41.63 95.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.631 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.4 pt -77.52 136.09 25.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.745 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.24 108.95 11.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.338 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.74 126.38 0.31 Allowed Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.519 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.462 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.9 Cg_exo -43.88 152.13 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.76 2.307 . . . . 0.0 112.519 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.18 141.72 53.26 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.627 2.218 . . . . 0.0 112.354 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.37 147.22 2.11 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.497 179.402 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.21 154.46 69.88 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.764 2.31 . . . . 0.0 112.254 178.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.527 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.5 163.07 28.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.437 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.65 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.1 t -143.76 170.1 16.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.899 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.65 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -148.0 137.48 22.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.948 0.404 . . . . 0.0 110.315 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.2 146.08 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.607 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.71 131.61 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.109 0.48 . . . . 0.0 110.497 178.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -151.94 154.8 36.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.406 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 90.0 m -122.05 122.82 40.17 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.945 0.402 . . . . 0.0 110.393 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.33 -25.64 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.618 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.39 -48.86 21.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.04 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.03 -11.73 60.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.414 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.4 m80 49.19 42.19 21.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.478 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.1 t -136.5 145.58 45.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.373 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.15 114.24 27.34 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.348 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.89 133.33 55.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.036 0.446 . . . . 0.0 110.376 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.3 tt -112.03 146.38 38.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.713 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.455 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 12.2 t90 -99.37 130.01 45.61 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.121 0.486 . . . . 0.0 110.096 179.246 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.707 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.89 153.95 39.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.097 -179.854 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.71 -18.22 47.84 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.796 2.33 . . . . 0.0 111.93 178.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.707 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -49.11 -18.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.405 -179.275 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.455 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.5 p -75.97 164.98 25.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.497 179.648 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.96 -27.99 65.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.51 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.528 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.69 -41.56 98.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.763 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.91 -44.86 96.73 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.8 mt-30 -64.57 -38.81 92.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.957 0.408 . . . . 0.0 110.709 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.571 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.3 mmm -62.03 -41.44 98.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.229 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.4 mt -63.79 -47.25 81.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.912 0.387 . . . . 0.0 110.607 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.16 -32.07 54.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.154 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -70.79 -18.29 62.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.58 179.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 91.8 mt -88.7 -8.61 54.25 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.641 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.67 2.75 55.32 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -88.48 151.91 22.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.509 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 7.8 p -114.95 127.83 55.92 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.052 0.453 . . . . 0.0 110.427 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.56 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.35 146.13 23.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.962 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.456 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.56 151.07 46.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.524 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.65 131.65 43.34 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.487 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.633 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.62 93.73 29.37 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.139 -179.789 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.723 ' C ' ' H ' ' A' ' 229' ' ' GLY . 47.3 Cg_exo -55.63 138.72 81.74 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.673 2.249 . . . . 0.0 111.59 179.153 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.75 -25.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.444 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.723 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.47 -49.77 29.65 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.578 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -53.46 -36.43 61.61 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -67.16 36.57 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.725 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.578 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.63 86.67 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.831 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.3 p -78.83 -15.72 58.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.53 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.22 -40.77 10.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.626 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.9 t -66.2 -17.73 64.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.573 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.41 43.25 26.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.418 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.85 -146.6 6.98 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -123.39 143.21 50.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.96 0.409 . . . . 0.0 110.335 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.07 149.61 29.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.422 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -100.5 -152.17 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.391 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 55.9 -91.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.567 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.517 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.65 175.46 8.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.564 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.517 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.9 mt -122.16 141.76 41.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.734 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -100.0 169.12 9.41 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.328 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.5 mt -147.83 151.18 35.52 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.133 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.78 -39.01 97.01 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.19 4.1 4.63 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.23 -58.38 3.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.939 0.399 . . . . 0.0 110.573 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -61.98 -36.97 83.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.313 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.19 -67.73 0.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.813 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.46 -42.09 66.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.153 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.12 18.06 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.637 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.92 48.34 0.27 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.57 -110.0 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.667 0.27 . . . . 0.0 110.717 -178.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.456 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 12.3 m120 -60.62 -45.35 94.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.471 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.88 8.15 82.93 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.23 -12.61 20.24 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.799 -0.236 . . . . 0.0 110.631 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.6 t 176.2 142.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.063 0.459 . . . . 0.0 110.553 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -147.85 125.31 11.67 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.047 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -98.43 142.98 29.38 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 120.88 0.371 . . . . 0.0 110.781 178.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.3 mt -94.17 106.43 18.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.652 -179.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.468 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.2 t80 -101.96 -11.41 18.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.182 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.42 -40.33 85.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.788 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.39 173.75 46.11 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.499 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.5 m-20 -74.44 -113.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.756 0.312 . . . . 0.0 110.71 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.62 -28.57 67.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.685 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.01 -44.21 91.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.313 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.68 -44.4 93.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.354 179.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.38 -60.16 3.56 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.295 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.02 -43.34 60.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.227 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.39 -43.92 75.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.258 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.0 mt -64.55 -43.71 96.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.598 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -56.27 -37.72 70.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.268 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.94 1.22 18.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.316 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -115.04 91.14 25.77 Favored Pre-proline 0 CA--C 1.528 0.122 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.207 -179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.98 -27.18 27.45 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.818 2.345 . . . . 0.0 111.879 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.516 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.45 -41.08 98.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.565 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.31 5.03 52.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.459 -179.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.95 -35.01 69.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.735 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.87 4.74 15.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.541 -178.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.567 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.88 121.39 81.27 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.561 179.918 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -47.53 -37.8 26.9 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.539 2.159 . . . . 0.0 112.427 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.567 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.72 -43.72 90.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.38 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.89 -43.69 92.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.335 179.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.67 -40.6 95.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.49 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.7 t-20 -89.84 -12.19 39.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.563 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.4 mtmt 61.85 31.85 18.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.959 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.47 44.15 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.34 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.18 135.82 41.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.465 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.5 132.34 56.7 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.521 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.2 87.97 6.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.728 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.473 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.0 mt -63.94 -41.35 97.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.885 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.468 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.21 167.89 34.44 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 75.5 p -75.89 -25.82 56.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.381 . . . . 0.0 110.797 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.533 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.6 tp10 -67.9 -34.18 76.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.489 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.499 ' O ' ' CG2' ' A' ' 296' ' ' THR . 97.0 m -73.24 19.9 0.09 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.69 -179.142 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.533 ' H ' ' C ' ' A' ' 295' ' ' GLU . 53.0 t80 -57.24 -51.14 70.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.018 -179.543 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -108.22 149.41 28.62 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 41.5 tp -115.26 125.26 53.1 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.672 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 304' ' ' ALA . 42.5 t0 -149.08 166.29 29.18 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.624 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -49.08 -38.19 23.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.632 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -71.96 -64.99 0.83 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.262 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -60.81 -32.52 71.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.864 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 300' ' ' ASP . . . -54.85 -25.6 29.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.617 -179.049 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.8 mtt -63.23 -41.23 99.09 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 120.9 0.381 . . . . 0.0 110.883 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.19 -44.4 25.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.994 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.14 -42.88 92.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.397 179.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.443 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.4 tp -59.89 -47.46 85.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.451 -178.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -69.85 -39.72 76.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.047 0.451 . . . . 0.0 110.888 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.499 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 72.2 ttt180 -61.52 -38.19 86.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.29 -179.048 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.2 mt -87.48 5.04 41.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.658 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.631 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.66 -11.78 13.49 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.049 0.452 . . . . 0.0 110.259 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.84 -37.16 85.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.56 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.82 -48.88 79.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.427 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.022 179.786 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.618 ' H ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.45 -2.83 57.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.481 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.46 179.12 1.24 Allowed Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.477 -179.722 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.4 Cg_exo -60.52 144.42 99.52 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.79 2.326 . . . . 0.0 112.235 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.618 ' NH1' ' H ' ' A' ' 24' ' ' ALA . 35.5 ptt-85 -155.75 -179.9 8.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.55 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.58 136.77 52.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.042 0.448 . . . . 0.0 110.312 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.1 tp -124.41 146.2 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.39 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -119.54 135.97 54.55 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.805 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.9 p30 -98.71 -144.11 0.32 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.17 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.65 -36.49 84.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.405 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -147.58 -70.27 0.23 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.43 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.81 144.12 41.77 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.263 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.8 p -112.8 129.84 56.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.914 0.387 . . . . 0.0 110.451 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -114.68 129.66 56.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.683 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.9 m -86.95 130.68 34.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.35 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 70.4 mt -97.61 78.87 2.67 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.434 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.8 -32.58 74.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.544 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 t 177.15 109.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.118 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -124.52 91.5 49.4 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.39 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.62 149.27 59.46 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.865 2.377 . . . . 0.0 111.962 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -40.22 82.36 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.624 0.578 . . . . 0.0 110.998 -179.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.69 66.66 0.87 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.477 . . . . 0.0 110.18 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -77.28 131.23 35.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.4 t -122.65 147.86 26.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.104 0.478 . . . . 0.0 110.073 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.9 t -136.17 143.61 44.54 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.725 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.667 ' HG1' ' N ' ' A' ' 50' ' ' SER . 27.2 p -99.26 -59.96 1.62 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.618 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.667 ' N ' ' HG1' ' A' ' 49' ' ' THR . 87.1 p -79.07 156.14 28.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.64 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 68.9 t -74.59 -21.55 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.572 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.4 ' O ' ' OG ' ' A' ' 56' ' ' SER . 100.0 m -60.15 -51.99 67.24 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.513 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.0 mt -66.28 -42.44 88.41 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.817 177.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.23 -54.36 4.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.998 -178.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.11 -38.77 73.29 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.304 -0.719 . . . . 0.0 111.304 178.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.6 m -62.29 -43.67 98.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.934 0.397 . . . . 0.0 110.199 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.7 mt -65.46 -42.41 92.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.502 0.668 . . . . 0.0 110.684 179.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.6 tp -63.08 -38.74 92.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.263 -179.348 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.59 -36.65 81.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.224 -178.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -91.22 27.6 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.148 -179.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.419 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 90.6 m-20 57.11 52.46 9.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.123 179.41 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.79 76.48 28.94 Favored Pre-proline 0 C--O 1.225 -0.223 0 CA-C-O 121.039 0.447 . . . . 0.0 109.891 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.67 148.2 92.32 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.733 2.289 . . . . 0.0 112.08 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -112.67 136.27 49.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.126 0.489 . . . . 0.0 110.395 179.724 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -70.11 -43.05 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.189 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.76 131.04 53.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.979 0.419 . . . . 0.0 110.637 -178.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.542 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.3 p -155.58 168.42 27.19 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.424 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.61 -177.26 21.81 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.57 172.43 12.75 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 121.081 0.467 . . . . 0.0 110.422 179.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.2 p -132.95 -112.09 0.23 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.452 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.63 179.7 0.93 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.497 -179.245 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.5 Cg_exo -60.83 57.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.966 2.444 . . . . 0.0 112.157 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.4 t-20 -64.42 -33.51 76.03 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.417 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.2 m-20 93.91 -36.17 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.779 0.675 . . . . 0.0 109.899 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -63.21 -39.72 95.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.203 179.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.33 -25.3 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.688 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.24 -170.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.468 -179.354 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.83 -154.91 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.878 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 38.3 p-10 -51.44 -7.92 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.823 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.531 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -85.68 114.99 23.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.693 179.59 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.38 70.87 1.32 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -144.87 148.07 33.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.924 0.392 . . . . 0.0 110.752 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.51 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.9 mp -85.92 -98.46 0.07 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.178 178.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.0 -42.53 97.13 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.176 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.4 tt0 91.47 53.03 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.868 0.73 . . . . 0.0 110.877 179.037 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -102.69 -9.55 19.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.331 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.5 p -63.88 -34.42 77.92 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.05 0.452 . . . . 0.0 110.703 -179.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.557 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.13 -23.86 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.59 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.0 t -70.11 -45.21 76.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.592 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.42 -48.53 80.79 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.923 -179.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.04 -38.38 88.49 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.436 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.31 -34.36 57.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.251 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.594 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.6 mmt-85 -88.43 1.08 55.48 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.608 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.5 mttp 83.17 -47.94 0.14 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.845 0.715 . . . . 0.0 110.315 179.163 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.668 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.4 mt -46.68 153.3 0.4 Allowed 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 117.817 -1.087 . . . . 0.0 109.606 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.668 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.6 tt0 122.03 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 O-C-N 125.318 1.636 . . . . 0.0 110.452 -178.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.84 142.85 44.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.204 0.526 . . . . 0.0 110.337 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.2 mt -131.95 26.61 4.6 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.096 -0.377 . . . . 0.0 110.49 -179.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.09 137.46 34.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.576 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.521 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.0 mt -136.99 164.86 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.411 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.521 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.48 -28.83 1.78 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.35 70.5 7.54 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 121.134 0.492 . . . . 0.0 110.219 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.15 145.32 98.74 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.783 2.322 . . . . 0.0 112.098 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.9 t -134.45 137.12 43.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.584 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.56 83.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.655 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.32 -42.0 96.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.485 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.08 -41.79 98.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.466 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.7 -43.21 97.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.063 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.23 -35.27 78.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.218 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.26 -18.3 57.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.433 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -87.09 -6.06 58.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.483 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 70.3 mtp 47.71 55.99 17.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.621 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.0 Cg_endo -70.08 149.26 64.57 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.784 2.323 . . . . 0.0 112.067 179.556 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.24 -72.39 0.68 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.579 179.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.2 tp -111.91 113.22 25.4 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.399 179.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.8 mt -102.0 126.9 55.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.0 0.429 . . . . 0.0 110.587 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.3 mt -110.74 133.72 53.1 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.212 -179.297 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.4 139.92 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.559 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 121' ' ' THR . 95.7 p -83.6 167.41 17.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.683 179.695 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.59 -36.85 79.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.455 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.422 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.4 t -138.2 157.78 45.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.456 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.55 175.4 34.17 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.55 -33.61 87.03 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.38 151.42 44.42 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.97 0.414 . . . . 0.0 110.513 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.5 t -63.53 140.53 58.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.389 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.05 10.93 10.86 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.648 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -60.96 -38.92 87.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.219 -179.428 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.634 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.14 -35.58 23.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.445 0.641 . . . . 0.0 110.577 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.3 mt -71.16 -35.16 71.56 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.457 0.646 . . . . 0.0 110.654 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -43.02 -62.82 0.93 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.215 -178.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.634 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.5 p-10 -65.98 -42.93 89.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.021 -179.162 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.3 mt-30 -61.73 -32.38 72.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.343 -179.524 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.7 mt -74.38 -40.49 62.05 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.922 178.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.09 -49.09 78.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.277 -179.104 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 m -52.92 -42.56 65.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.211 179.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.83 -42.72 92.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.152 179.26 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.54 153.16 5.05 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.628 -179.335 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -39.04 106.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.679 2.253 . . . . 0.0 112.393 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 98.1 m -109.36 121.89 46.16 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.416 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.86 154.07 29.3 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.264 -179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 tt -130.38 129.23 64.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.409 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 92.9 mt -110.6 122.71 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.024 0.44 . . . . 0.0 110.614 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.544 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 54.2 t30 -101.17 106.91 18.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.256 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -100.76 0.25 38.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.847 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.4 p-10 -65.61 -34.77 78.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.959 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -101.88 10.22 39.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.728 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -133.99 148.31 51.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.909 0.385 . . . . 0.0 110.49 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.409 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 22.9 p -77.61 168.82 19.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.623 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.6 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.1 t90 -58.7 -49.87 75.99 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.064 -179.009 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -54.46 -46.17 73.26 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.944 0.402 . . . . 0.0 110.048 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 40.1 t -63.07 -40.77 98.67 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.14 0.495 . . . . 0.0 110.314 178.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.0 tp -60.72 -44.54 96.48 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.309 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.89 -43.5 98.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.113 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.9 m -54.51 -45.85 73.39 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.86 -40.1 94.2 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.853 0.358 . . . . 0.0 110.364 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -61.59 -42.2 98.52 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.115 179.234 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.84 -38.8 94.68 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.148 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.52 -45.08 66.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.962 0.41 . . . . 0.0 110.712 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.69 -44.11 96.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.789 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.8 p -93.41 -8.69 41.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.533 -178.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.5 27.08 72.17 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -102.54 50.27 0.83 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.66 -179.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -69.31 -39.03 78.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.622 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.56 -47.26 86.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.31 -179.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.419 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 86.4 mt-30 -60.5 -39.33 87.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.213 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.51 -41.02 98.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.278 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.31 -29.28 70.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.607 179.334 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.18 -54.46 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.855 179.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -64.22 -42.89 96.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.431 -179.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 174' ' ' ASP . 82.0 mt -62.59 -43.77 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.483 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.6 -61.11 2.76 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.2 0.524 . . . . 0.0 110.201 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.77 -34.51 62.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.521 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -80.33 -34.84 36.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.761 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -55.26 -41.71 72.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.059 -178.686 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.2 -41.8 98.7 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.662 179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.14 -37.87 88.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.313 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.33 -42.39 99.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.756 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.8 -52.95 62.08 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.112 0.482 . . . . 0.0 110.59 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.34 -41.43 89.57 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.601 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.28 -39.78 94.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.615 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.64 -33.08 74.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.369 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.54 -21.49 19.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.612 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.628 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -65.18 -41.43 94.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.694 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 30.9 pt -76.98 133.83 30.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.802 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -127.55 107.05 9.6 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.298 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.93 127.39 0.31 Allowed Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.483 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.78 151.99 0.38 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.865 2.377 . . . . 0.0 112.53 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.52 142.39 53.67 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.599 2.199 . . . . 0.0 112.368 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.545 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.78 146.86 2.3 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.548 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.0 153.9 71.65 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.855 2.37 . . . . 0.0 112.37 178.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.527 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.37 163.11 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 110.475 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.622 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.0 t -143.93 170.72 15.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.032 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.622 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.74 137.8 21.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.074 0.464 . . . . 0.0 110.098 179.388 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.9 pt -134.39 146.64 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.691 179.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.44 131.68 60.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.1 0.476 . . . . 0.0 110.472 178.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -152.09 154.84 36.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.431 179.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 89.5 m -122.02 122.71 39.93 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.921 0.391 . . . . 0.0 110.341 179.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.89 -25.34 66.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.662 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.12 -49.34 19.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.899 179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.16 -11.49 60.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.345 -179.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.2 m80 49.21 42.57 21.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.483 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.0 t -136.42 144.56 44.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.33 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.79 114.54 27.96 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.293 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -120.41 133.95 55.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.048 0.451 . . . . 0.0 110.405 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.3 tt -112.4 146.75 37.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.778 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.45 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 9.4 t90 -100.51 129.28 46.44 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.177 0.513 . . . . 0.0 109.962 179.335 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.703 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -93.27 153.75 41.53 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.164 179.976 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.406 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.8 Cg_endo -67.77 -18.05 47.44 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.685 2.256 . . . . 0.0 112.057 178.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.703 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -48.74 -18.92 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.468 -179.214 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.45 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 84.8 p -74.84 163.89 27.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.551 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.5 -28.24 65.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.478 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.507 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.2 mt-30 -63.55 -42.86 98.35 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.577 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.0 -43.74 97.89 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.409 ' OE1' ' C ' ' A' ' 148' ' ' SER . 74.8 mt-30 -63.68 -38.52 91.42 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 122.271 -0.546 . . . . 0.0 110.629 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.6 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 85.6 mmm -61.99 -41.66 98.28 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.26 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 82.2 mt -63.83 -49.73 71.67 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.136 0.493 . . . . 0.0 110.257 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -51.96 -33.91 39.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.845 0.355 . . . . 0.0 110.241 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -70.88 -20.74 62.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.519 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 75.1 mt -87.61 -6.32 58.34 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 -179.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.87 -7.04 57.19 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -77.06 147.6 36.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.854 0.359 . . . . 0.0 110.614 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.4 p -112.58 126.67 55.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.133 0.492 . . . . 0.0 110.284 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.41 145.49 24.43 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.995 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.468 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.23 150.59 47.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.448 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -129.98 130.81 45.51 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.379 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.633 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.96 92.79 27.08 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.192 -179.716 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.722 ' C ' ' H ' ' A' ' 229' ' ' GLY . 43.3 Cg_exo -55.61 139.11 82.55 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.581 2.188 . . . . 0.0 111.676 178.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.55 -25.42 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.485 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.722 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.14 -50.2 29.42 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.575 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -53.58 -35.89 61.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.892 0.377 . . . . 0.0 110.132 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -67.57 36.65 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.715 179.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.575 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.16 86.33 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.813 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.1 p -79.02 -16.07 57.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.4 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -91.66 -40.67 11.16 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.622 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -66.22 -17.35 64.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.594 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.56 43.22 26.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.462 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.78 -146.17 6.87 Favored Glycine 0 CA--C 1.519 0.292 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -123.39 143.37 50.17 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.961 0.41 . . . . 0.0 110.262 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -151.86 149.32 28.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -100.25 -152.35 0.42 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.43 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.86 -91.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.693 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.511 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.4 tt -126.31 175.1 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.617 -179.427 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.511 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.4 mt -121.7 141.22 43.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.698 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.58 169.35 9.35 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.256 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.7 mt -147.73 151.02 35.38 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.204 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.91 -38.76 96.56 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.96 4.14 4.73 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -77.3 -58.34 3.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.98 0.419 . . . . 0.0 110.522 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -62.04 -36.81 82.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.314 -179.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.42 -67.63 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.746 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.43 -42.2 66.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.149 -179.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.13 17.99 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.641 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.82 48.58 0.27 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.48 -109.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.516 0.198 . . . . 0.0 110.787 -178.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.468 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.3 m120 -60.58 -45.52 93.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.528 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 85.18 7.9 82.51 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -99.04 -12.66 20.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.598 0.237 . . . . 0.0 110.658 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.4 t 176.23 142.88 0.07 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.067 0.46 . . . . 0.0 110.44 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 tt -148.36 125.35 11.33 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -98.29 143.14 29.09 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 120.873 0.368 . . . . 0.0 110.861 178.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.9 mt -94.35 106.75 18.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.762 -179.174 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.454 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.9 t80 -102.1 -12.63 17.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.173 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.36 89.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.88 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.74 173.19 45.86 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.493 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -74.06 -112.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 0.0 110.74 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.81 -28.97 68.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.693 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.81 -43.95 90.69 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.261 -178.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.44 -44.52 94.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.304 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.36 -60.05 3.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.198 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.96 -43.47 60.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.211 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.26 -43.58 74.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.247 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.3 mt -64.57 -43.53 96.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.548 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.45 -37.65 70.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.2 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.14 1.02 19.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.218 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -115.03 91.41 26.83 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.078 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.05 -27.27 28.27 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.769 2.312 . . . . 0.0 111.984 179.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.515 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.51 -41.09 98.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.584 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.428 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.9 mp -95.52 5.02 52.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.4 -179.269 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.9 -34.89 69.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.647 179.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -80.12 4.85 16.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.494 -178.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.555 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -69.04 121.23 80.98 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.511 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -47.38 -37.58 25.39 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.513 2.142 . . . . 0.0 112.562 -179.53 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.555 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.6 -43.38 89.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.759 0.314 . . . . 0.0 110.372 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.09 -43.51 92.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.309 179.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -65.06 -40.72 95.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.349 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 44.4 t-20 -89.31 -12.99 39.0 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.59 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 62.19 31.64 17.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.912 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.53 44.29 1.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.157 0.503 . . . . 0.0 110.366 179.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.79 135.69 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.446 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.93 132.25 56.75 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.457 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.493 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.3 88.71 6.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.756 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.466 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.7 mt -63.87 -41.39 97.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 179.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.454 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.52 165.66 33.26 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.524 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 77.5 p -75.56 -25.83 57.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.885 0.374 . . . . 0.0 110.791 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.0 tp10 -68.43 -33.71 74.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.483 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.497 ' O ' ' CG2' ' A' ' 296' ' ' THR . 97.2 m -73.06 21.54 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.696 -179.174 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.543 ' H ' ' C ' ' A' ' 295' ' ' GLU . 51.7 t80 -57.41 -51.02 71.1 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 70.4 mmt-85 -109.35 151.15 27.0 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 39.0 tp -115.57 125.13 52.59 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.934 0.397 . . . . 0.0 110.69 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 304' ' ' ALA . 40.6 t0 -147.94 165.75 29.75 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.631 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -49.35 -37.95 26.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.499 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -70.8 -65.67 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.235 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -61.11 -33.04 72.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 300' ' ' ASP . . . -53.44 -25.6 16.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.575 -179.08 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.1 mtt -63.7 -40.85 97.82 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 120.874 0.368 . . . . 0.0 111.035 179.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -78.08 -44.69 25.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.115 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 75.1 t -66.11 -42.76 91.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.383 179.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.431 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 48.6 tp -59.62 -47.31 86.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.465 -178.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -70.32 -39.26 74.89 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.016 0.436 . . . . 0.0 110.729 179.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.493 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 72.5 ttt180 -61.66 -38.05 86.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.251 -178.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.0 mt -87.74 5.16 41.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.624 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.628 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.88 -11.59 13.42 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.016 0.436 . . . . 0.0 110.333 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.08 -37.07 85.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.486 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.78 -48.89 79.77 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.396 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 C--O 1.222 -0.365 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.002 179.836 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.612 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.05 -2.32 58.1 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.371 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.489 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.8 179.15 1.23 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.502 -179.682 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.79 144.98 99.65 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.851 2.367 . . . . 0.0 112.197 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.612 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.99 -179.32 8.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.562 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -115.94 136.77 52.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.327 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.23 146.99 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.369 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.5 p -120.02 135.97 54.73 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.734 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.39 -143.34 0.32 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.259 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.65 -37.04 85.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.536 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.42 -66.48 0.22 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.393 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.52 142.33 45.47 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.331 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.5 p -112.2 131.54 55.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.917 0.389 . . . . 0.0 110.459 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -119.38 128.98 54.57 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.546 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.8 m -85.57 130.15 34.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.191 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.3 mt -95.62 78.69 3.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.496 179.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.73 -31.74 72.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.596 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 175.97 109.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.983 0.42 . . . . 0.0 110.109 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -122.58 91.41 49.46 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-O 120.752 0.311 . . . . 0.0 110.381 -179.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.647 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.59 148.42 64.2 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.797 2.331 . . . . 0.0 112.067 178.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -40.64 82.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.634 0.584 . . . . 0.0 110.963 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.647 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.51 66.92 0.89 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.222 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.21 130.56 36.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.819 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.7 t -122.49 146.69 27.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.016 -179.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 t -135.97 143.7 44.98 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.742 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.598 ' HG1' ' H ' ' A' ' 50' ' ' SER . 26.5 p -99.35 -59.28 1.75 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.564 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.598 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.3 p -79.35 155.09 28.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.583 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.4 t -74.1 -21.84 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.548 179.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.408 ' O ' ' OG ' ' A' ' 56' ' ' SER . 98.3 m -60.28 -52.09 66.76 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.499 -178.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.4 mt -66.26 -42.76 88.06 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.8 177.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.1 m -42.87 -54.18 4.3 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.968 -178.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.23 -37.17 71.48 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 178.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.6 m -62.84 -44.79 95.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.915 0.388 . . . . 0.0 110.16 -179.237 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt -66.48 -41.91 88.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.521 0.677 . . . . 0.0 110.701 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 tp -62.75 -40.46 97.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.401 -179.264 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.93 76.08 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.158 -179.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -91.15 28.92 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.176 -179.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.54 51.74 10.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.971 179.409 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.56 76.05 21.3 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.07 151.66 84.96 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.74 2.293 . . . . 0.0 112.032 -178.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -113.44 137.48 46.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.242 0.544 . . . . 0.0 110.237 179.706 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.3 pt -69.47 -43.54 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.307 179.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.13 131.35 53.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.947 0.403 . . . . 0.0 110.526 -178.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.536 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.7 p -155.86 168.65 26.53 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.462 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.42 -177.32 21.93 Favored Glycine 0 N--CA 1.464 0.513 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.17 171.99 13.27 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.088 0.47 . . . . 0.0 110.36 179.383 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.7 p -131.94 -113.48 0.23 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.981 0.419 . . . . 0.0 110.269 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.99 179.82 0.93 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.407 -179.148 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.5 Cg_exo -60.7 57.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 123.031 2.488 . . . . 0.0 112.18 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.8 t-20 -64.42 -33.64 76.33 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 119.081 -0.485 . . . . 0.0 110.345 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.6 m-20 94.03 -36.74 0.02 OUTLIER 'General case' 0 C--N 1.346 0.448 0 O-C-N 123.832 0.707 . . . . 0.0 109.806 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -62.51 -39.7 94.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.191 179.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.499 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.25 -25.48 19.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.762 179.374 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.52 -171.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.456 -179.201 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.05 -154.08 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.815 -179.599 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 38.2 p-10 -52.49 -7.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.769 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.1 mm-40 -86.32 115.0 23.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.674 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.02 69.92 1.35 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.416 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.3 m-85 -143.45 147.72 35.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.971 0.415 . . . . 0.0 110.768 179.141 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.526 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -85.66 -98.29 0.07 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.185 178.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.25 -42.42 96.52 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.036 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.547 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.17 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.988 0.805 . . . . 0.0 110.996 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -102.86 -8.79 20.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.322 179.306 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.416 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.6 p -64.87 -33.82 76.92 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.132 0.492 . . . . 0.0 110.763 -179.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.537 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.36 -23.4 1.45 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.682 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 73.4 t -70.02 -45.86 74.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.688 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.64 80.4 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.891 -179.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.36 -38.29 88.96 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.927 0.394 . . . . 0.0 110.509 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.64 -32.34 51.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.185 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.576 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.7 mmt-85 -90.3 1.95 56.0 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.622 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.55 -49.58 0.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.942 0.776 . . . . 0.0 110.223 179.181 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.646 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.0 mt -45.81 154.65 0.21 Allowed 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 117.451 -1.262 . . . . 0.0 109.441 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.646 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 120.8 92.6 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 O-C-N 125.676 1.86 . . . . 0.0 110.471 -178.532 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.536 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.57 143.25 42.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.238 0.542 . . . . 0.0 110.294 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.7 mt -132.42 27.1 4.44 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.976 -0.453 . . . . 0.0 110.391 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.25 137.77 34.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.065 0.46 . . . . 0.0 110.516 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.522 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 93.1 mt -137.01 165.01 28.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.331 179.581 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.2 -28.57 1.82 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -152.98 71.08 7.13 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 121.203 0.525 . . . . 0.0 110.262 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.17 145.54 98.27 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.803 2.335 . . . . 0.0 112.027 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.9 t -134.56 136.85 43.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.597 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.22 81.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.651 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.14 -42.38 96.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.518 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.99 -41.65 98.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.5 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.71 -43.23 97.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.05 179.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.17 -35.09 77.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.994 0.426 . . . . 0.0 110.146 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.7 -18.8 61.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.451 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.63 -6.48 58.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.529 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 63.1 mtp 47.22 56.22 17.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.613 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.34 149.9 63.9 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.763 2.309 . . . . 0.0 112.106 179.413 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.14 -74.25 0.62 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.454 179.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.4 tp -110.2 113.33 25.93 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.372 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.4 mt -102.04 126.26 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 120.955 0.407 . . . . 0.0 110.661 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.1 mt -109.58 133.95 52.5 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.22 -179.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.85 139.63 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.496 -179.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 121' ' ' THR . 88.4 p -83.38 168.5 16.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.799 179.623 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.13 -37.52 80.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.443 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.428 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -139.79 159.16 42.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.012 0.434 . . . . 0.0 110.381 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.22 176.96 33.49 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.71 86.99 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -124.82 151.51 45.12 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.925 0.393 . . . . 0.0 110.508 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.3 t -63.26 140.81 58.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.333 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.62 10.37 11.04 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.676 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -60.83 -38.87 86.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.258 -179.367 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.67 23.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.562 0.696 . . . . 0.0 110.613 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.9 mt -71.11 -35.44 71.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.587 0.708 . . . . 0.0 110.631 179.359 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -42.81 -62.84 0.9 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.353 -178.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.85 -42.84 89.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.7 mt-30 -61.99 -32.54 73.01 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.493 0.495 . . . . 0.0 110.427 -179.594 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.7 mt -73.91 -40.95 62.79 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.803 178.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.13 -48.86 78.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.153 -178.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.5 m -53.31 -42.38 66.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.036 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.12 -42.61 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.943 0.401 . . . . 0.0 111.199 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.64 154.24 5.39 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.665 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -39.48 106.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.622 2.215 . . . . 0.0 112.589 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 95.4 m -110.08 121.4 45.18 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.115 0.483 . . . . 0.0 110.264 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -113.99 152.84 30.32 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.2 -179.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 tt -128.91 131.55 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.353 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.8 mt -115.31 128.02 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.488 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.6 t30 -101.6 103.92 14.77 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.206 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.2 p90 -101.38 -11.18 19.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.823 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.5 p-10 -64.83 -33.5 76.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.704 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -98.45 7.59 45.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.531 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.31 155.45 50.58 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.467 -179.418 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.6 p -75.05 165.68 24.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.695 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.589 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.85 -48.85 80.01 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.166 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -53.5 -42.05 66.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.929 0.395 . . . . 0.0 110.132 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.1 t -62.73 -41.05 98.98 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.36 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.9 tp -60.5 -44.54 95.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.374 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.8 tp -61.34 -43.33 99.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.235 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.6 m -55.02 -44.94 75.03 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.34 -40.67 97.14 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 120.928 0.394 . . . . 0.0 110.488 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -62.02 -42.45 99.18 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.418 178.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.24 -40.86 94.94 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.68 -45.92 64.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.894 0.378 . . . . 0.0 110.781 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.78 -43.99 96.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.798 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 156' ' ' LEU . 32.7 p -93.13 -8.7 41.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.581 -178.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.88 26.64 72.28 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -101.75 50.85 0.84 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 110.65 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -69.55 -39.75 77.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.591 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.16 -47.26 85.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.3 -179.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -60.22 -39.3 86.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.136 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.07 -40.87 98.96 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 121.064 0.459 . . . . 0.0 110.279 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.02 -28.31 70.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.685 179.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.35 -54.35 7.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.894 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -65.51 -42.17 92.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.366 -179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.3 mt -62.4 -43.83 98.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.481 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.3 -58.32 8.15 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.026 0.441 . . . . 0.0 110.216 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.28 -33.1 67.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.689 -179.03 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -81.53 -36.71 28.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.676 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.1 m-20 -55.92 -41.99 75.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.933 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.49 -42.24 99.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.911 0.386 . . . . 0.0 110.774 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.28 -37.94 88.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.279 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.37 -42.19 99.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.791 179.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.15 -52.91 61.93 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.169 0.509 . . . . 0.0 110.628 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.1 -41.81 90.11 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.75 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.99 95.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.652 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.26 -32.07 73.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.429 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.62 -22.38 18.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.679 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.79 -41.38 95.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.67 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.0 pt -76.93 136.53 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.72 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.1 108.09 10.6 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.245 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.63 126.01 0.31 Allowed Pre-proline 0 C--O 1.241 0.611 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.562 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.451 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.94 152.46 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.823 2.349 . . . . 0.0 112.596 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.35 142.15 53.85 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.541 2.161 . . . . 0.0 112.428 179.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.38 147.32 2.13 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.573 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.19 154.82 69.38 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.81 2.34 . . . . 0.0 112.392 178.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.525 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.52 163.29 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.185 0.517 . . . . 0.0 110.484 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.662 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.1 t -143.62 170.34 16.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.955 179.457 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.662 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -148.2 137.44 22.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.946 0.403 . . . . 0.0 110.105 179.434 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 38.4 pt -134.14 146.51 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.726 179.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.71 131.77 59.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.257 0.551 . . . . 0.0 110.502 178.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.447 ' HH ' ' CG1' ' A' ' 272' ' ' ILE . 52.3 p90 -153.01 156.68 39.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.476 179.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 89.3 m -121.98 122.86 40.3 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.915 0.388 . . . . 0.0 110.358 179.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.517 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -61.06 -26.17 67.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.69 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -74.56 -49.25 22.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.872 179.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -77.42 -9.95 59.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.409 -179.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.9 m80 45.91 47.58 12.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.512 -179.635 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.2 t -130.76 143.0 50.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.968 0.413 . . . . 0.0 110.32 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -108.44 105.62 15.36 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.162 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.7 m-20 -116.39 129.2 56.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.159 0.504 . . . . 0.0 110.321 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.6 tt -111.92 146.46 37.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.806 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.451 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.5 t90 -99.61 128.73 45.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.207 0.527 . . . . 0.0 109.891 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.652 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -94.52 153.94 40.24 Favored Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.379 179.805 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.67 -17.74 47.95 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.682 2.254 . . . . 0.0 112.049 178.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.652 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.3 mt-10 -49.75 -18.89 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.342 -179.091 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.451 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.4 p -75.44 164.6 26.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.495 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.92 -27.88 65.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.496 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.574 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.7 mt-30 -63.73 -41.39 98.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.609 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.32 -44.45 97.52 Favored Glycine 0 C--N 1.332 0.337 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.49 -38.84 92.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 122.119 -0.636 . . . . 0.0 110.796 179.576 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.3 mmm -61.84 -41.27 97.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.279 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.3 mt -63.53 -47.63 80.84 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.055 0.455 . . . . 0.0 110.386 179.221 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.63 -32.07 49.87 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.872 0.368 . . . . 0.0 110.405 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.96 -17.91 62.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.473 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 90.7 mt -88.4 -9.14 53.62 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.575 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.1 2.37 54.65 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -88.72 153.0 21.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 110.453 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.2 p -115.86 128.44 55.81 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.149 0.499 . . . . 0.0 110.355 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.557 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.09 146.74 23.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.915 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.459 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.42 151.17 45.46 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.413 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.9 131.73 42.98 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.432 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.625 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.52 93.33 27.05 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.002 -179.453 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.721 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.2 Cg_exo -55.0 138.66 78.88 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.604 2.203 . . . . 0.0 111.71 178.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.38 -25.51 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.508 -179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.721 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.64 -49.93 27.79 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.598 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.1 mt -55.15 -37.05 66.47 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.034 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -65.66 35.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.816 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.598 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.45 88.34 0.01 OUTLIER 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 85.1 p -81.82 -13.65 57.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.297 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.73 -40.84 11.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.6 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 29.3 t -66.64 -17.03 64.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.591 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.8 43.86 27.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.444 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.93 -148.74 8.14 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.65 142.03 48.81 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.963 0.411 . . . . 0.0 110.288 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.03 149.51 28.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.241 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -102.38 -149.86 0.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.307 179.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.41 -92.91 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.636 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.484 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.4 tt -126.68 174.43 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.56 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.484 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 88.2 mt -122.31 141.27 43.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.839 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.48 170.6 8.5 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.19 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 67.1 mt -146.71 149.61 33.77 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.12 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.26 -39.35 97.76 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.01 3.22 4.05 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -78.64 -57.46 3.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.949 0.404 . . . . 0.0 110.482 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -62.14 -36.91 83.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.163 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.7 mp -52.88 -67.46 0.25 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.985 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.8 -42.49 68.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.094 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.67 17.45 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.666 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.15 48.33 0.29 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.1 mp 38.97 -109.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.505 0.193 . . . . 0.0 110.769 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.459 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -60.79 -44.71 96.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.349 -179.572 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.46 8.07 83.77 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -98.8 -13.64 20.05 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 122.685 -0.303 . . . . 0.0 110.661 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.423 ' HG ' ' N ' ' A' ' 259' ' ' LEU . 6.0 t 177.25 142.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.072 0.463 . . . . 0.0 110.445 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.423 ' N ' ' HG ' ' A' ' 258' ' ' SER . 9.2 tt -147.98 125.45 11.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.14 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -98.55 143.84 28.53 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 120.902 0.382 . . . . 0.0 110.922 178.133 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.8 mt -95.24 106.38 18.41 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.73 -179.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.45 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.5 t80 -102.31 -11.4 18.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.114 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.61 -40.64 84.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.815 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.27 172.68 45.54 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.453 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 90.8 m-20 -73.72 -113.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.846 0.355 . . . . 0.0 110.794 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.35 -28.99 68.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.7 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.04 -43.71 91.68 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.251 -178.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -63.43 -44.48 94.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.31 179.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.6 -59.88 3.93 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.136 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.94 -43.55 60.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.233 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.32 -43.34 74.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.23 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.447 ' CG1' ' HH ' ' A' ' 196' ' ' TYR . 91.2 mt -64.68 -43.61 96.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.634 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -55.97 -37.75 69.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.135 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.5 1.03 17.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.241 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -114.93 91.11 25.16 Favored Pre-proline 0 N--CA 1.464 0.256 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.161 -179.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.96 -27.3 27.81 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.764 2.309 . . . . 0.0 112.02 179.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.69 -40.93 98.01 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.545 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.25 5.39 51.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.327 -179.187 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.36 -35.04 68.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.527 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.72 4.49 16.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.472 -178.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.551 HD22 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.62 121.1 79.76 Favored Pre-proline 0 N--CA 1.442 -0.868 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.566 -179.983 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.27 -37.74 24.87 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.503 2.135 . . . . 0.0 112.643 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.551 ' H ' HD22 ' A' ' 281' ' ' LEU . . . -58.89 -43.84 91.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.803 0.335 . . . . 0.0 110.398 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.98 -43.48 92.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.356 179.345 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.07 -40.57 94.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.382 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.443 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.9 t-20 -89.73 -12.59 38.94 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.501 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.12 32.31 17.49 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.395 0.435 . . . . 0.0 110.992 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.04 43.69 1.16 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.126 0.489 . . . . 0.0 110.334 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.23 135.82 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.488 -179.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -116.87 132.44 56.7 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.469 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.19 88.93 7.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.709 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.458 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.8 mt -63.88 -41.05 97.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.869 179.478 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.45 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.75 165.55 33.58 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 72.1 p -75.38 -25.75 57.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 110.824 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.54 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.2 tp10 -68.26 -33.94 75.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.414 -179.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.503 ' O ' ' CG2' ' A' ' 296' ' ' THR . 96.7 m -73.37 24.33 0.07 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.698 -179.026 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.574 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 43.0 t80 -58.28 -50.93 71.84 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.22 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -110.4 152.9 25.71 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.085 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 44.1 tp -115.53 125.11 52.6 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 120.893 0.377 . . . . 0.0 110.723 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 40.9 t0 -148.04 165.76 29.81 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.652 179.517 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -49.32 -37.74 25.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.642 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -71.35 -65.6 0.73 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.487 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.88 -32.99 72.41 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.041 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.25 -25.49 23.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.703 -179.104 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.4 mtt -63.57 -40.8 97.91 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 120.892 0.377 . . . . 0.0 111.097 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.63 -44.27 24.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.188 179.524 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.23 -42.82 91.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.308 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 51.0 tp -60.19 -47.11 87.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.464 -178.512 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -69.96 -39.24 76.13 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.593 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.5 ttt180 -61.89 -38.18 87.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.235 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.6 mt -87.26 4.67 41.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.625 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.9 -10.95 13.49 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.046 0.451 . . . . 0.0 110.221 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.29 86.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.432 179.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.81 -48.82 80.06 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.41 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.029 179.915 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.3 -2.46 58.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.43 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.493 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.05 1.25 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.537 -179.682 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.493 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.8 Cg_exo -60.75 144.93 99.63 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.806 2.337 . . . . 0.0 112.203 179.718 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.95 -179.53 8.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.635 -179.74 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.81 136.84 52.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.389 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.44 147.07 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.418 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 79.2 p -120.03 136.07 54.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.733 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.47 -143.34 0.33 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.266 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -63.67 -37.19 86.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.472 179.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.25 -66.53 0.22 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.416 179.637 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.43 142.22 45.36 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.0 p -112.17 131.53 55.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.949 0.404 . . . . 0.0 110.485 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -119.23 129.05 54.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.588 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.9 m -85.46 130.19 34.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.307 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.5 mt -95.51 78.75 3.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.373 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.73 -31.9 73.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.579 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.65 109.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.984 0.421 . . . . 0.0 110.119 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -122.35 91.81 49.12 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.416 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.7 Cg_exo -56.68 148.35 65.63 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.826 2.35 . . . . 0.0 111.956 178.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.4 82.66 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.526 0.516 . . . . 0.0 110.961 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.6 mtm180 -151.41 66.87 0.89 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.062 0.458 . . . . 0.0 110.263 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.38 130.69 35.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.77 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.6 147.01 26.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.151 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.8 t -136.27 143.83 44.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.025 0.441 . . . . 0.0 110.639 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.626 ' HG1' ' N ' ' A' ' 50' ' ' SER . 26.1 p -99.53 -59.65 1.68 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.62 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.626 ' N ' ' HG1' ' A' ' 49' ' ' THR . 87.3 p -78.91 155.25 29.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.675 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.8 t -74.42 -21.8 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.546 179.446 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.412 ' O ' ' OG ' ' A' ' 56' ' ' SER . 97.8 m -60.11 -52.28 66.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.506 -178.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.4 -42.59 87.62 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.723 177.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.0 m -42.91 -54.17 4.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.035 -178.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.31 -37.18 70.78 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.5 m -62.85 -44.69 95.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.906 0.384 . . . . 0.0 110.336 -179.358 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.9 mt -66.35 -41.84 88.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.426 0.632 . . . . 0.0 110.781 179.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.59 -40.44 96.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.333 -179.319 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.17 -35.76 76.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.185 -178.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -91.27 28.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.237 -179.24 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.53 51.76 10.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.009 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.17 75.53 23.32 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.996 0.427 . . . . 0.0 109.995 -179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.36 150.98 87.27 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.794 2.329 . . . . 0.0 112.121 -178.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -113.17 137.27 46.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 CA-C-O 121.13 0.49 . . . . 0.0 110.356 179.814 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.0 pt -69.52 -43.49 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.219 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.06 131.25 53.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.522 -178.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.7 p -155.67 168.72 26.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.547 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.89 -177.21 21.62 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.33 172.55 12.54 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 121.043 0.449 . . . . 0.0 110.439 179.336 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.4 p -132.76 -112.43 0.23 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.991 0.424 . . . . 0.0 110.396 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.31 179.66 0.95 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.427 -179.185 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.3 Cg_exo -60.9 58.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.977 2.452 . . . . 0.0 112.07 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.572 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.0 t-20 -64.52 -33.84 76.83 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.438 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.3 m-20 93.92 -36.74 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.736 0.648 . . . . 0.0 109.926 -179.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -62.61 -39.58 94.24 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.256 179.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.499 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.9 p -74.55 -25.44 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.606 179.467 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.41 -171.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.449 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -74.03 -153.65 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.805 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.9 p-10 -52.82 -7.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.675 -179.405 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.525 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.5 114.8 23.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.623 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.03 70.0 1.35 Allowed Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.435 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.1 m-85 -143.31 147.36 34.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.917 0.389 . . . . 0.0 110.769 179.15 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.528 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -85.33 -98.44 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.12 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.563 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.11 -42.81 96.74 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.123 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.563 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.55 53.0 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.771 0.669 . . . . 0.0 110.856 178.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -102.92 -9.63 19.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.407 179.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.435 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.4 p -64.05 -34.11 77.28 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.047 0.451 . . . . 0.0 110.683 -179.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.541 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.96 -23.38 1.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.668 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.1 t -70.12 -45.72 75.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.713 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.58 80.65 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.048 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.37 -38.26 88.86 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.431 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.66 -32.65 52.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.166 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.606 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.8 mmt-85 -89.91 1.5 56.16 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.587 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.94 -49.19 0.16 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.761 0.663 . . . . 0.0 110.213 179.122 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.682 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.6 mt -46.05 154.08 0.27 Allowed 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.69 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.682 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.6 tt0 121.26 92.57 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 125.115 1.509 . . . . 0.0 110.445 -178.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.65 143.35 42.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.0 110.337 179.345 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.8 mt -132.41 27.25 4.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.879 0.371 . . . . 0.0 110.426 -179.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.31 137.86 34.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.525 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 91.7 mt -137.16 165.13 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.369 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.525 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.16 -28.76 1.82 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -153.0 70.93 7.11 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.124 0.488 . . . . 0.0 110.333 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.96 145.41 98.4 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.792 2.328 . . . . 0.0 112.058 -179.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.0 t -134.37 136.96 43.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.573 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.28 82.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.576 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.02 -42.34 97.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.569 -179.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.88 -41.65 98.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.55 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -63.7 -43.32 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.107 179.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.91 -35.18 77.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.274 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.78 -18.68 60.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.42 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.65 -6.78 58.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.538 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 68.6 mtp 47.48 56.25 17.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.648 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.28 149.44 63.57 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.759 2.306 . . . . 0.0 112.064 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.09 -73.5 0.64 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.529 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.6 tp -111.01 113.57 26.21 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.271 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.0 mt -102.16 126.63 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.6 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.7 mt -109.84 133.91 52.63 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.278 -179.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.99 139.98 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.522 -179.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 121' ' ' THR . 91.1 p -83.68 168.62 16.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.71 179.814 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.25 -37.41 80.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.472 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.422 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -139.98 158.86 43.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.453 -179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -155.94 177.07 33.21 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.22 -33.71 86.83 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.84 151.4 45.3 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.891 0.376 . . . . 0.0 110.54 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -63.29 140.93 58.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.326 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.78 10.64 10.99 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.647 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -60.97 -38.89 87.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.168 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.2 -35.75 23.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.375 0.607 . . . . 0.0 110.538 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.3 mt -71.0 -35.21 71.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.41 0.624 . . . . 0.0 110.697 179.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -42.8 -63.03 0.85 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.319 -178.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.2 p-10 -65.67 -42.85 90.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.091 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.545 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -61.91 -32.62 73.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.314 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.5 mt -73.95 -40.79 62.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 178.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -57.99 -49.23 77.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.169 -179.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 75.2 m -52.46 -42.67 64.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.263 179.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.3 -42.87 91.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 111.022 179.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.4 153.48 5.3 Favored Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.676 -179.336 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -39.41 107.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.675 2.25 . . . . 0.0 112.435 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 97.2 m -109.61 121.68 45.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.074 0.464 . . . . 0.0 110.258 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.05 152.55 30.84 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.299 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 tt -128.87 131.24 68.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.474 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.99 128.01 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.527 -179.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.8 t30 -101.82 103.87 14.6 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.2 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.6 p90 -101.51 -10.85 19.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.888 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.77 -33.24 75.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.704 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.6 p-10 -98.8 8.05 45.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.583 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.442 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.87 155.56 50.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.534 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -75.08 165.93 24.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.69 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.596 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.3 t90 -60.01 -48.65 80.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.278 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.36 -42.41 66.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.116 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.8 t -62.84 -41.11 99.21 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.348 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.8 tp -60.5 -44.45 95.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.317 -179.621 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.9 tp -61.26 -43.74 98.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.205 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 m -54.7 -45.22 73.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.708 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.14 -40.93 97.61 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.878 0.37 . . . . 0.0 110.455 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.68 -42.4 98.87 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.206 179.117 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.16 -40.6 95.0 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.508 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.75 -46.01 63.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.874 0.369 . . . . 0.0 110.847 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.74 -43.92 96.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.735 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -93.18 -8.66 41.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.632 -179.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.01 26.58 72.37 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.66 50.72 0.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 110.708 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.64 -39.47 77.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.584 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.45 -47.3 86.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.357 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -59.82 -39.56 85.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.317 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.88 -40.99 99.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.297 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.1 -28.66 70.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.601 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.29 -54.51 7.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.873 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -65.0 -42.43 94.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.533 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.454 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.1 mt -62.33 -43.91 98.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.53 -179.508 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.19 -60.8 3.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.967 0.413 . . . . 0.0 110.415 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.9 -34.0 62.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.619 -179.183 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -81.1 -35.84 31.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.762 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.7 m-20 -55.28 -41.95 72.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.124 -178.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.47 -42.04 99.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.643 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.04 -38.27 90.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.363 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.36 -42.1 99.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.672 179.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.06 -53.27 57.84 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.068 0.461 . . . . 0.0 110.682 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.22 -41.85 89.53 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.635 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.0 95.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.615 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.42 -31.56 72.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.434 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -95.03 -22.68 17.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.611 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.635 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.7 tt0 -64.85 -41.42 95.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.582 -179.55 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.2 pt -76.22 135.99 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.719 -179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -126.1 108.1 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.292 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.6 pp -177.3 125.2 0.28 Allowed Pre-proline 0 C--O 1.239 0.502 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.497 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.5 Cg_exo -44.03 152.47 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.898 2.399 . . . . 0.0 112.429 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.8 141.73 55.2 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.622 2.215 . . . . 0.0 112.352 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.46 147.25 2.08 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.511 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.9 154.38 71.04 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.856 2.371 . . . . 0.0 112.328 178.661 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.52 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.14 162.91 30.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.134 0.492 . . . . 0.0 110.449 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.625 ' HG1' ' N ' ' A' ' 193' ' ' ALA . 2.1 t -144.03 170.72 15.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.999 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.625 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -148.61 137.73 21.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.938 0.399 . . . . 0.0 110.245 179.382 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.5 pt -134.44 147.16 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.726 179.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -132.89 131.73 59.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 110.467 178.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.404 ' HH ' ' CG1' ' A' ' 272' ' ' ILE . 54.6 p90 -152.32 155.37 37.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.379 179.316 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 90.4 m -122.82 122.93 39.87 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.972 0.415 . . . . 0.0 110.425 179.45 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.79 -25.55 66.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.571 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.23 -48.88 21.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.925 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.81 -11.77 60.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.516 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.8 m80 49.4 41.63 21.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.582 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.8 t -136.29 144.76 44.92 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.408 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.96 114.47 27.81 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.393 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.9 133.56 55.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 0.0 110.347 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.3 tt -112.27 146.91 37.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.771 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.452 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.6 t90 -100.42 131.14 46.5 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.196 0.522 . . . . 0.0 109.965 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.698 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.66 153.94 39.29 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.244 -179.959 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.406 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.9 Cg_endo -67.87 -17.99 46.93 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.736 2.29 . . . . 0.0 111.985 178.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.698 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -49.19 -18.69 0.37 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.388 -179.148 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.452 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 84.1 p -75.5 164.66 26.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.518 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.11 -27.92 66.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.473 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.589 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.5 mt-30 -64.03 -41.22 97.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.605 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.24 -45.06 96.77 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.83 -38.86 92.4 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 122.438 -0.448 . . . . 0.0 110.731 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.596 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.1 mmm -62.03 -41.71 98.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.262 179.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 45.5 mt -63.43 -46.87 84.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.019 0.438 . . . . 0.0 110.325 179.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.94 -31.56 60.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.346 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.16 -17.52 63.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.496 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.54 -9.34 52.68 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.576 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.58 1.78 50.01 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -88.46 154.42 20.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.843 0.354 . . . . 0.0 110.567 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.2 p -116.35 128.7 55.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.132 0.492 . . . . 0.0 110.387 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.557 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.5 mm? -91.76 146.14 24.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.999 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.454 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.52 151.88 44.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.405 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.36 131.53 41.98 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.571 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.632 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.45 93.45 27.24 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.238 -179.815 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.719 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.9 Cg_exo -55.22 139.14 80.74 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.604 2.203 . . . . 0.0 111.758 178.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.0 -26.32 0.05 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.427 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.719 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.24 -50.3 28.27 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.586 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -53.65 -37.19 62.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.176 -179.385 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -66.77 36.09 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.709 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.02 88.32 0.01 OUTLIER 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.932 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 79.5 p -81.21 -14.18 57.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.36 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.9 -41.29 10.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.565 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.84 -16.98 64.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.633 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 55.72 43.68 27.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.539 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.5 -148.62 7.91 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.88 142.59 49.54 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.956 0.408 . . . . 0.0 110.382 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -151.91 149.44 28.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.352 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -101.22 -151.49 0.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.316 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.75 -92.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.655 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.508 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.6 tt -126.58 175.18 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.532 -179.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.508 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -122.79 141.91 41.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.809 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.65 169.32 9.36 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.279 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.7 mt -147.96 150.97 35.0 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.176 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.91 -38.99 96.89 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.41 4.12 4.52 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -77.43 -58.25 3.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.485 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -61.85 -36.89 82.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.518 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.35 -67.86 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.635 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.36 -42.32 66.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.159 -179.515 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.04 17.56 0.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.635 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.71 49.13 0.27 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.5 mp 38.23 -109.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.565 0.222 . . . . 0.0 110.67 -178.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.454 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.9 m120 -60.37 -45.24 94.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.635 -179.742 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.55 7.87 83.89 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.338 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.95 -13.24 20.05 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.669 -0.312 . . . . 0.0 110.743 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.2 t 176.87 142.61 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.97 0.414 . . . . 0.0 110.465 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 tt -148.2 125.09 11.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.094 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -98.27 143.34 28.86 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.841 0.353 . . . . 0.0 110.758 178.276 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.7 mt -94.91 106.78 18.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.807 -179.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.441 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.1 t80 -101.98 -12.52 18.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.209 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.07 -40.95 91.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.857 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.5 173.03 45.82 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.474 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 93.5 m-20 -73.7 -112.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.678 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -68.2 -28.83 67.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.614 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.96 -43.95 91.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.278 -178.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.39 -44.66 94.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.371 179.171 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.47 -60.16 3.57 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.378 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.83 -43.68 59.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.21 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.28 -43.38 74.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.205 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.404 ' CG1' ' HH ' ' A' ' 196' ' ' TYR . 91.9 mt -64.75 -43.67 96.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.563 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -56.1 -37.51 69.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.182 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.23 0.84 17.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.238 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -115.17 91.13 26.37 Favored Pre-proline 0 N--CA 1.46 0.073 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.25 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.98 -27.07 27.11 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.847 2.365 . . . . 0.0 111.959 179.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.52 -40.94 98.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.513 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.436 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.1 mp -95.2 5.49 51.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.443 -179.143 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.19 -34.59 68.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.631 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -79.97 4.5 16.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.569 -178.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.558 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.96 121.1 80.4 Favored Pre-proline 0 N--CA 1.446 -0.645 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.462 -179.974 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -47.29 -37.65 24.83 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.463 2.108 . . . . 0.0 112.499 -179.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.558 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -59.06 -43.96 91.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.769 0.318 . . . . 0.0 110.446 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.08 -43.54 92.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.358 179.281 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.44 -40.99 96.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.428 -179.319 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -90.27 -11.54 40.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.69 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.62 32.8 18.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.965 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -89.0 43.85 1.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.096 0.474 . . . . 0.0 110.366 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.52 135.82 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.451 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -116.73 132.55 56.66 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.387 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.06 89.17 7.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.732 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.458 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.3 mt -63.9 -40.88 97.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.441 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.03 165.27 33.67 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.51 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 74.4 p -75.43 -25.72 57.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.878 0.37 . . . . 0.0 110.679 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.8 tp10 -68.53 -33.7 74.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.454 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.508 ' O ' ' CG2' ' A' ' 296' ' ' THR . 95.8 m -73.59 24.96 0.07 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.74 -179.148 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.589 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 40.2 t80 -58.32 -50.72 72.62 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.387 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.416 ' CZ ' ' CE2' ' A' ' 297' ' ' PHE . 79.3 mmt-85 -111.03 153.95 24.88 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 46.3 tp -115.77 125.17 52.4 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.757 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 41.5 t0 -147.93 165.68 29.94 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.656 179.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.26 -37.94 25.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.641 -179.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -71.36 -65.58 0.73 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.403 -179.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.84 -32.85 72.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.269 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.19 -25.58 23.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.797 -179.057 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.6 mtt -63.54 -40.91 98.24 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.05 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.0 -43.93 23.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.979 179.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 79.8 t -66.35 -42.76 91.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.403 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.436 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.3 tp -60.17 -47.06 87.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.48 -178.737 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -70.07 -39.32 75.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.958 0.408 . . . . 0.0 110.584 179.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.7 ttt180 -61.87 -38.43 88.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.232 -178.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.09 4.49 41.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.622 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.635 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.67 -11.2 13.57 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.103 0.478 . . . . 0.0 110.435 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.21 -37.28 86.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.51 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.68 -48.83 80.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.363 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.221 -0.405 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.069 179.769 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.11 -2.54 58.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.44 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.5 179.16 1.23 Allowed Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.49 -179.66 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.4 Cg_exo -60.72 145.07 99.52 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.84 2.36 . . . . 0.0 112.142 179.611 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.613 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.25 -179.44 8.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.631 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.19 136.95 52.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.362 179.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.05 147.17 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.402 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.4 p -120.18 136.05 54.76 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.062 0.458 . . . . 0.0 110.78 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.9 p30 -99.21 -143.8 0.32 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.244 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.52 -37.04 85.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.522 179.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.481 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.76 -67.69 0.23 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.422 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.12 142.71 44.21 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.2 p -112.51 131.22 55.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.895 0.378 . . . . 0.0 110.418 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -118.6 129.2 55.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.559 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.8 m -85.67 130.58 34.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.247 -179.808 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 70.0 mt -96.69 78.76 2.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 110.433 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.84 -31.68 72.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.603 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.51 107.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 110.089 -179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -121.13 91.32 47.95 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.42 -179.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.655 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.6 Cg_exo -56.73 148.54 64.95 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.801 2.334 . . . . 0.0 111.953 178.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.61 82.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.627 0.579 . . . . 0.0 110.951 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.655 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.41 66.85 0.89 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.071 0.462 . . . . 0.0 110.192 -179.465 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -76.83 130.98 35.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.803 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.9 t -122.63 147.33 26.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.028 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.7 t -136.4 144.11 44.33 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.745 179.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.644 ' HG1' ' N ' ' A' ' 50' ' ' SER . 17.5 p -100.03 -59.04 1.78 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.549 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.644 ' N ' ' HG1' ' A' ' 49' ' ' THR . 87.3 p -79.2 155.07 28.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.612 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.0 t -74.11 -21.83 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.472 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.406 ' O ' ' OG ' ' A' ' 56' ' ' SER . 95.2 m -60.31 -51.93 67.43 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.478 -178.433 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -66.4 -42.75 87.41 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.759 177.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.9 m -42.99 -54.07 4.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.911 -178.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.08 -37.46 73.0 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 178.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.5 m -62.89 -44.26 96.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.886 0.374 . . . . 0.0 110.164 -179.292 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.5 mt -66.14 -42.21 89.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.544 0.687 . . . . 0.0 110.639 179.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.97 -39.78 95.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.379 -179.122 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.49 -35.81 76.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.231 -179.078 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.6 pt -91.5 27.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.317 -179.311 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.82 51.95 10.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.053 179.554 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.34 76.19 26.41 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 121.021 0.438 . . . . 0.0 109.839 -179.653 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.24 149.63 89.88 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.8 2.333 . . . . 0.0 112.09 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -112.4 136.66 47.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 CA-C-O 121.127 0.489 . . . . 0.0 110.34 179.696 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -69.57 -43.45 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.358 179.317 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.49 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.35 131.35 53.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.032 0.444 . . . . 0.0 110.601 -179.008 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.536 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.4 p -155.94 168.68 26.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.47 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.32 -177.35 21.99 Favored Glycine 0 N--CA 1.463 0.456 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.35 172.07 13.19 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 121.04 0.448 . . . . 0.0 110.452 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 p -133.25 -111.39 0.23 Allowed 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.018 0.437 . . . . 0.0 110.453 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.94 179.62 0.94 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.44 -179.195 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.8 Cg_exo -60.89 58.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.926 2.418 . . . . 0.0 112.156 179.518 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.8 t-20 -64.42 -34.19 77.6 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.361 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 45.1 m-20 94.76 -37.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.824 0.703 . . . . 0.0 109.814 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -62.76 -40.22 96.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.218 179.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.3 p -74.08 -25.98 20.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.758 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.84 -172.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.433 -179.219 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.87 -152.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.777 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.3 p-10 -54.36 -6.66 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.759 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.516 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.48 114.14 23.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.629 179.731 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.52 72.14 1.3 Allowed Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.5 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.2 m-85 -143.54 148.27 35.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.874 0.369 . . . . 0.0 110.899 179.236 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.531 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -85.96 -98.81 0.07 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.026 178.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.555 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.94 -43.26 96.39 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.177 179.291 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.555 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.8 tt0 91.66 52.55 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.913 0.758 . . . . 0.0 111.052 179.176 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -103.49 -8.63 19.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.335 179.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.5 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.3 p -65.33 -33.38 75.84 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.063 0.459 . . . . 0.0 110.672 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.552 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.12 -24.18 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.695 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.2 t -69.86 -45.93 75.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.765 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.14 -48.77 80.06 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.043 -179.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.48 -38.32 89.4 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.454 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.72 -32.62 52.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.136 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.591 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 83.7 mmt-85 -90.1 1.8 55.98 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.538 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.94 -49.79 0.16 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.865 0.728 . . . . 0.0 110.235 179.176 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.66 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.4 mt -45.54 153.75 0.23 Allowed 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 117.673 -1.156 . . . . 0.0 109.561 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.66 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 121.05 92.27 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 O-C-N 125.444 1.715 . . . . 0.0 110.456 -178.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.536 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.02 142.77 43.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.219 0.533 . . . . 0.0 110.262 179.34 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 mt -131.81 26.59 4.65 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.04 -0.413 . . . . 0.0 110.415 -179.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -139.97 137.27 34.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.045 0.45 . . . . 0.0 110.531 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.521 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 93.1 mt -136.72 164.89 29.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.361 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.521 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.22 -28.48 1.82 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.76 70.5 7.24 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.108 0.48 . . . . 0.0 110.259 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.1 145.32 98.72 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 122.768 2.312 . . . . 0.0 112.123 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.9 t -134.08 136.68 44.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.556 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.62 -38.54 84.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.665 179.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.35 -41.98 96.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.48 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.65 98.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.473 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.53 -43.22 98.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.077 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.01 -35.12 77.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.223 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.69 -18.69 60.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.401 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.66 -6.51 58.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.5 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.8 mtp 47.61 55.99 17.18 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.594 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.28 149.82 64.17 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.767 2.312 . . . . 0.0 112.126 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.9 -72.77 0.67 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.452 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.7 tp -111.67 114.19 27.05 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.388 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.3 mt -103.36 126.91 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 120.964 0.411 . . . . 0.0 110.608 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.0 mt -110.63 134.21 52.63 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.214 -179.401 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.86 140.12 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.572 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 121' ' ' THR . 91.0 p -83.48 168.25 16.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.788 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.5 -37.13 80.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.47 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.419 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.7 t -139.49 158.35 44.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.466 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.15 176.88 33.46 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.31 -34.0 87.87 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -179.541 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.82 151.52 45.11 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.91 0.386 . . . . 0.0 110.552 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.8 t -63.23 141.07 58.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.334 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.89 10.59 10.9 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.644 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -60.92 -38.98 87.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.235 -179.372 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.87 -35.74 23.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.479 0.657 . . . . 0.0 110.587 179.84 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.2 mt -71.16 -35.18 71.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.492 0.663 . . . . 0.0 110.614 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -42.95 -62.85 0.91 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.322 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.69 -42.96 90.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.058 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -61.86 -32.34 72.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.402 -179.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.2 mt -74.23 -40.64 62.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.869 178.637 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.42 -49.09 78.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.163 -178.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.9 m -53.04 -42.67 65.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.941 0.4 . . . . 0.0 110.142 179.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.53 -42.83 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 120.948 0.404 . . . . 0.0 111.218 179.023 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -168.6 151.4 5.18 Favored Pre-proline 0 N--CA 1.452 -0.369 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.726 -179.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -38.78 107.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.716 2.277 . . . . 0.0 112.493 179.717 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 98.4 m -109.35 121.71 45.77 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.047 0.451 . . . . 0.0 110.265 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.13 153.51 29.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.32 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.77 131.62 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.402 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.36 127.82 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 121.074 0.464 . . . . 0.0 110.535 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.2 t30 -100.99 105.1 16.28 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.149 179.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.9 p90 -101.28 -11.58 19.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.898 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.0 p-10 -64.82 -33.64 76.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.805 -179.656 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.2 p-10 -99.37 7.82 45.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.601 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.9 mttm -134.79 152.35 51.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.525 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.424 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.9 p -75.42 165.97 24.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.677 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.596 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.3 t90 -59.09 -48.49 81.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.23 -179.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -54.37 -43.68 71.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.043 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.1 t -62.9 -41.09 99.31 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.255 178.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.8 tp -60.81 -44.53 96.74 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.185 -179.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.49 -42.75 99.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.153 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.8 m -55.63 -45.46 77.58 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.49 -40.13 95.7 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 120.892 0.377 . . . . 0.0 110.505 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.446 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.5 mm? -61.99 -42.51 99.22 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.324 179.058 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.16 -40.04 94.79 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.508 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.57 -45.9 64.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 110.849 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.87 -44.06 96.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.845 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.9 p -92.98 -9.1 41.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.643 -178.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.16 26.02 72.39 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -101.17 50.38 0.86 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.811 0.338 . . . . 0.0 110.649 -179.506 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -69.43 -39.56 77.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.628 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.53 -47.35 85.89 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.294 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -60.01 -39.16 84.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.099 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.04 -40.76 98.69 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.214 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.04 -28.86 70.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.56 179.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.12 -54.46 7.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.904 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -64.78 -42.23 95.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.406 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.2 mt -62.48 -43.8 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.483 -179.508 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.95 -60.15 4.06 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.024 0.44 . . . . 0.0 110.311 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.22 -34.01 63.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.552 -179.229 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -80.7 -36.11 32.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.731 179.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.8 m-20 -54.79 -42.44 71.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.005 -178.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.01 -41.75 98.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.719 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -64.97 -38.02 89.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.355 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.53 -42.29 99.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.753 179.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.91 -52.97 61.91 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.066 0.46 . . . . 0.0 110.686 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.41 -41.79 88.75 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.711 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.74 -40.24 96.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.664 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.06 -32.81 74.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.477 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.07 -21.3 19.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.704 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.632 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.3 tt0 -64.89 -41.62 95.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.743 -179.56 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.3 pt -76.47 133.93 29.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.071 0.462 . . . . 0.0 110.716 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -127.83 106.43 9.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.417 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.58 128.31 0.34 Allowed Pre-proline 0 C--O 1.24 0.553 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.521 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.49 151.37 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.869 2.38 . . . . 0.0 112.577 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.83 142.57 52.61 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.587 2.192 . . . . 0.0 112.411 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.542 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.89 147.19 2.3 Favored Pre-proline 0 N--CA 1.448 -0.555 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.574 179.395 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.99 153.8 71.85 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.879 2.386 . . . . 0.0 112.317 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.19 163.09 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.167 0.508 . . . . 0.0 110.454 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.642 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.1 t -143.5 169.76 17.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.958 179.462 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.642 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -147.84 137.48 22.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.147 179.505 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 39.8 pt -134.35 146.58 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.693 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -133.41 132.15 57.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.129 0.49 . . . . 0.0 110.43 178.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -152.05 154.85 36.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.398 179.158 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 89.8 m -121.95 122.88 40.39 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.961 0.41 . . . . 0.0 110.355 179.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.87 -25.34 66.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.656 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.19 -49.58 18.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.02 -10.9 60.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.416 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.0 m80 48.4 42.72 18.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.489 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.9 t -136.37 145.05 44.93 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.355 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.12 114.42 27.66 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.324 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -120.19 133.71 55.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.984 0.421 . . . . 0.0 110.387 179.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.24 146.68 37.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.052 0.453 . . . . 0.0 110.762 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.465 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 12.4 t90 -99.73 127.93 45.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.195 0.521 . . . . 0.0 109.862 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.707 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -93.5 153.47 41.33 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.427 179.904 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.71 -18.56 47.92 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.629 2.219 . . . . 0.0 112.005 178.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.707 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -49.86 -18.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.419 -179.121 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.465 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.3 p -75.27 167.77 21.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.491 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.64 75.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.481 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.3 mt-30 -56.52 -41.38 76.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.722 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.22 -43.07 97.45 Favored Glycine 0 C--O 1.235 0.201 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.49 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.4 mt-30 -63.81 -39.87 95.26 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 122.231 -0.57 . . . . 0.0 110.82 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.596 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.3 mmm -61.77 -41.7 98.04 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.277 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 77.3 mt -63.31 -50.2 70.98 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.197 0.522 . . . . 0.0 110.328 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.69 -33.03 45.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.862 0.363 . . . . 0.0 110.227 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.15 -19.99 62.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.562 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 66.2 mt -87.41 -6.44 58.44 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.819 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.63 3.56 57.27 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -88.47 149.96 23.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.912 0.386 . . . . 0.0 110.519 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.1 p -113.01 126.67 55.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.137 0.494 . . . . 0.0 110.332 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.568 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.63 145.91 24.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.078 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.464 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.05 150.5 46.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.44 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.52 131.25 45.0 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.466 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.632 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -114.02 92.94 27.87 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.004 -179.552 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.719 ' C ' ' H ' ' A' ' 229' ' ' GLY . 44.5 Cg_exo -55.52 139.12 82.11 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.544 2.162 . . . . 0.0 111.693 178.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.68 -25.05 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.448 -179.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.719 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.82 -49.79 27.37 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.584 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.1 mt -54.43 -36.97 64.6 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.62 36.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.804 179.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.584 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.52 87.85 0.01 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.93 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.1 p -80.88 -14.32 58.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.318 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.77 -41.41 10.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.616 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.1 t -66.99 -16.74 64.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.584 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.78 43.97 26.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.467 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.98 -148.58 8.03 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.81 143.19 48.98 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.971 0.415 . . . . 0.0 110.316 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -151.98 149.6 29.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.328 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -101.05 -152.21 0.43 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.299 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.3 -92.14 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.626 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.522 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.4 tt -126.81 175.58 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.612 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.522 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.0 mt -122.21 141.46 42.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 -179.431 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.61 169.29 9.39 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.243 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.6 mt -147.38 150.69 35.18 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.277 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.72 -38.96 96.99 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.53 3.62 4.6 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.07 -58.33 3.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.966 0.412 . . . . 0.0 110.518 -179.743 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -61.95 -36.75 82.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.203 -179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.24 -67.72 0.23 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.849 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.56 -42.32 67.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.109 -179.394 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.81 18.19 0.14 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.664 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.63 47.85 0.23 Allowed Glycine 0 N--CA 1.464 0.555 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.3 mp 39.06 -110.07 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.501 0.191 . . . . 0.0 110.74 -178.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.464 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.8 m120 -60.84 -45.18 95.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.421 -179.482 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.95 8.05 82.96 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -99.16 -12.92 20.02 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.757 -0.261 . . . . 0.0 110.597 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.9 t 176.79 142.75 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.101 0.477 . . . . 0.0 110.417 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -148.17 125.6 11.65 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.137 179.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -98.52 143.33 29.05 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 120.915 0.388 . . . . 0.0 110.838 178.236 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.3 mt -94.65 106.55 18.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.782 -179.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.466 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.8 t80 -101.95 -12.52 18.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.13 179.582 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.7 90.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.87 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.02 173.36 45.9 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -179.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.496 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -74.01 -112.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.762 0.315 . . . . 0.0 110.768 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.74 -28.78 67.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.658 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.06 -44.06 91.81 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.236 -178.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.43 -44.49 94.42 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.288 179.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.47 -59.96 3.81 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.189 -179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.95 -43.52 60.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.159 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.31 -43.64 75.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.243 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.5 mt -64.49 -43.57 96.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.577 179.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -56.48 -37.72 70.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.152 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.22 1.02 19.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.199 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -114.83 91.49 26.25 Favored Pre-proline 0 N--CA 1.462 0.135 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.176 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.09 -27.32 28.79 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.715 2.277 . . . . 0.0 111.966 179.318 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.515 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.42 -41.08 98.7 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.545 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.424 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.9 mp -95.5 5.06 52.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.354 -179.14 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.83 -35.14 69.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.601 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -80.17 4.74 16.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.507 -178.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.552 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.73 121.11 80.0 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.57 -179.996 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.43 -37.71 26.0 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.492 2.128 . . . . 0.0 112.58 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.552 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.66 -43.4 89.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.765 0.317 . . . . 0.0 110.397 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.92 -43.67 92.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.357 179.204 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -65.1 -40.64 94.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.31 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 44.5 t-20 -89.08 -13.1 39.38 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.554 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 62.29 31.19 17.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.037 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.32 44.2 1.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.176 0.513 . . . . 0.0 110.346 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.93 135.75 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.514 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -116.65 132.41 56.69 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.439 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.492 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.09 88.68 6.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.808 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.47 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.8 mt -63.93 -41.65 97.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.021 0.439 . . . . 0.0 110.781 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.466 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.79 165.87 34.28 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 71.2 p -75.47 -25.82 57.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.9 0.381 . . . . 0.0 110.756 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.542 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.1 tp10 -68.59 -33.82 74.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.478 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.496 ' O ' ' CG2' ' A' ' 296' ' ' THR . 99.0 m -72.65 19.67 0.08 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.129 0.49 . . . . 0.0 110.677 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.542 ' H ' ' C ' ' A' ' 295' ' ' GLU . 49.6 t80 -57.1 -51.23 70.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.925 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 70.8 mmt-85 -107.65 149.05 28.56 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.7 tp -115.61 126.19 53.87 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.842 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 304' ' ' ALA . 42.7 t0 -149.74 166.87 28.12 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.618 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -49.29 -38.05 26.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.649 -179.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -71.65 -65.21 0.79 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.462 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.61 -32.83 71.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.021 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 300' ' ' ASP . . . -54.57 -25.42 26.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.735 -179.125 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.8 mtt -63.49 -41.15 98.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.827 0.346 . . . . 0.0 111.053 179.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.96 -44.48 26.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.102 179.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 79.8 t -66.15 -42.73 91.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.365 179.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.3 tp -59.9 -47.09 87.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.514 -178.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -70.57 -39.23 74.01 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.73 179.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.496 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 73.3 ttt180 -61.5 -37.84 85.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.257 -178.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.3 mt -87.95 5.05 42.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.664 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.632 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.4 -11.71 13.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.03 0.443 . . . . 0.0 110.314 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.82 -37.29 86.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.394 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.92 -48.92 79.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.46 -179.653 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.992 179.886 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -90.1 -2.18 58.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.464 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.494 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.02 179.04 1.24 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.504 -179.638 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.81 145.01 99.64 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.827 2.351 . . . . 0.0 112.18 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.3 ptt-85 -156.37 -179.1 7.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.615 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.78 136.15 53.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.984 0.421 . . . . 0.0 110.371 179.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -123.41 146.64 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.409 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.8 p -119.72 135.87 54.66 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.818 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.5 p30 -99.4 -143.47 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.26 179.877 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -63.62 -37.11 86.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.526 179.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.36 -66.76 0.22 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.431 179.719 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.21 142.2 44.9 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.42 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.7 p -112.27 131.49 55.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 0.0 110.488 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -119.1 128.98 54.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.611 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -85.38 130.15 34.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.247 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.6 mt -95.67 78.51 3.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.39 179.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.73 -31.65 72.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.589 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.23 109.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.155 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -122.18 91.08 49.11 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.414 -179.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.661 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.63 148.81 62.36 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.8 2.334 . . . . 0.0 112.049 178.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.92 82.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.506 0.504 . . . . 0.0 110.999 -179.252 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.661 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.1 66.86 0.91 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.292 -179.604 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.87 130.69 35.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.822 -179.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.73 146.23 28.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.061 -179.62 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.9 t -136.1 143.76 44.77 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.778 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.544 ' HG1' ' H ' ' A' ' 50' ' ' SER . 24.8 p -99.53 -59.05 1.79 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.579 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.544 ' H ' ' HG1' ' A' ' 49' ' ' THR . 86.9 p -79.29 155.11 28.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.627 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.3 t -74.61 -21.72 17.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.514 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.405 ' O ' ' OG ' ' A' ' 56' ' ' SER . 99.8 m -60.28 -52.2 66.29 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.518 -178.537 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.34 -42.9 87.45 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.622 177.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.0 m -42.49 -54.04 4.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.985 -178.719 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.48 -37.36 69.18 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 178.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.3 m -62.67 -44.93 95.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.815 0.34 . . . . 0.0 110.107 -179.25 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.6 mt -66.41 -41.76 88.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.433 0.635 . . . . 0.0 110.714 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.56 -40.49 97.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.283 -179.284 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.77 -35.65 75.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.236 -178.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.2 pt -91.45 28.9 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.284 -179.375 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.29 51.58 11.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.019 179.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.03 75.57 23.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 0.0 109.94 -179.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.96 151.48 85.68 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.848 2.365 . . . . 0.0 112.064 -178.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -113.38 137.44 46.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-O 121.126 0.489 . . . . 0.0 110.319 179.826 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.421 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.9 pt -69.35 -43.49 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.263 179.597 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.09 131.22 53.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.044 0.45 . . . . 0.0 110.534 -179.049 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.3 p -155.91 168.8 26.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.522 -179.717 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.63 -177.18 21.8 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.03 171.92 13.34 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 121.094 0.473 . . . . 0.0 110.451 179.39 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.7 p -133.54 -110.86 0.23 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.004 0.43 . . . . 0.0 110.516 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.86 179.6 0.95 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.494 -179.312 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.0 Cg_exo -60.75 58.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.891 2.394 . . . . 0.0 112.082 179.557 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.3 t-20 -64.39 -35.19 80.11 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.445 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 47.4 m-20 94.93 -37.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.692 0.62 . . . . 0.0 109.889 -179.365 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.54 -39.86 94.95 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.199 179.109 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.6 p -73.96 -26.55 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.621 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.96 -172.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.383 -179.367 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -74.1 -152.63 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.765 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.8 p-10 -54.56 -6.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.724 -179.429 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.88 113.32 22.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.678 179.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.33 73.31 1.26 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.615 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.498 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.2 m-85 -144.24 148.33 34.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.817 0.342 . . . . 0.0 110.901 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -85.71 -99.38 0.07 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.022 178.836 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.564 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.17 -42.84 96.55 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.088 179.255 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.564 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.5 52.91 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.672 0.607 . . . . 0.0 111.042 179.025 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -103.57 -9.02 19.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.32 179.274 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.498 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.98 -33.74 76.77 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.097 0.475 . . . . 0.0 110.701 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.551 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 97.9 mttt -48.83 -23.22 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.72 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.5 t -70.18 -45.9 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.705 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.09 -48.82 79.92 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.978 -179.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.38 -38.34 89.2 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.379 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.67 -32.4 51.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.202 -179.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.608 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.91 1.61 56.02 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.49 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.99 -49.43 0.16 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.729 0.643 . . . . 0.0 110.229 179.209 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.686 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 79.5 mt -45.88 153.85 0.27 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 118.209 -0.901 . . . . 0.0 109.758 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.686 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.3 tt0 121.24 92.17 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.966 1.416 . . . . 0.0 110.472 -178.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.26 143.24 43.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.277 0.561 . . . . 0.0 110.269 179.416 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -131.97 27.03 4.59 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 122.053 -0.404 . . . . 0.0 110.443 -179.399 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.33 137.94 34.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.456 . . . . 0.0 110.514 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 93.7 mt -137.03 165.06 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.395 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.524 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 144.91 -28.44 1.87 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -152.85 70.69 7.19 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.06 0.457 . . . . 0.0 110.271 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.11 145.37 98.6 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 122.744 2.296 . . . . 0.0 112.114 -179.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.4 t -134.27 136.87 43.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.533 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.12 -38.33 82.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.547 179.725 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.25 -42.35 96.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.499 -179.45 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.67 98.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.544 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.4 t -63.68 -43.25 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.108 179.451 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.08 -35.08 77.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.137 -179.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.73 -18.49 59.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.376 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.75 -6.51 58.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.506 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.8 mtp 47.85 56.14 17.4 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.659 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.8 Cg_endo -70.28 149.29 63.35 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.8 2.334 . . . . 0.0 112.07 179.465 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -101.24 -73.38 0.65 Allowed 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.471 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.0 tp -111.02 112.39 24.18 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.269 179.632 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 75.9 mt -100.59 126.1 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.645 -179.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.9 mt -109.42 133.38 53.13 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.268 -179.428 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.56 139.61 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.585 -179.559 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 121' ' ' THR . 91.2 p -83.5 168.24 16.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.714 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.09 -37.43 79.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.488 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.425 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -139.59 159.0 43.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.442 -179.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.27 177.22 33.41 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.2 -33.73 86.87 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 -179.684 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -125.07 151.7 45.31 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 110.519 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -63.12 141.2 58.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.334 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.72 10.03 10.89 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.666 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.7 mp -60.71 -38.97 86.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.305 -179.383 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.641 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.79 23.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.355 0.598 . . . . 0.0 110.568 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.9 mt -71.03 -35.29 71.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.482 0.658 . . . . 0.0 110.625 179.403 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.3 t80 -42.73 -62.72 0.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.355 -178.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.641 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.77 -42.83 90.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.176 -179.244 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -62.0 -32.57 73.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.417 -179.718 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 129' ' ' LEU . 71.2 mt -74.17 -40.79 62.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.792 178.745 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.1 -49.02 78.39 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.169 -179.094 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.3 m -53.06 -42.08 65.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.975 0.417 . . . . 0.0 110.155 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.56 -42.57 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 120.95 0.405 . . . . 0.0 111.081 179.241 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.78 153.61 5.01 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.661 -179.338 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -39.06 106.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.658 2.239 . . . . 0.0 112.491 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 95.1 m -109.37 121.32 44.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.129 0.49 . . . . 0.0 110.278 179.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.1 153.07 30.12 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.365 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 tt -128.96 131.56 68.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.343 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.29 127.88 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.605 -179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.9 t30 -101.9 103.67 14.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.174 179.847 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.9 p90 -101.15 -11.23 19.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.875 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.84 -33.26 75.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.731 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.5 p-10 -98.6 8.19 45.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.56 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.442 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.91 155.62 50.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.521 -179.413 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.408 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -74.86 165.83 24.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.626 -179.818 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.584 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -60.02 -48.95 79.61 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.264 -179.22 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -53.56 -42.06 67.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.17 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.0 t -62.47 -40.83 97.92 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.358 178.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 48.0 tp -60.64 -43.97 96.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.275 -179.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.5 tp -61.32 -43.25 99.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.063 179.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -55.41 -45.58 76.69 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.32 -40.73 97.29 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.895 0.379 . . . . 0.0 110.509 179.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.8 -42.42 98.99 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.238 179.046 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.86 -40.88 95.72 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 179.522 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.93 -45.74 63.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 0.0 110.84 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.1 mt -64.78 -43.99 96.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.839 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -93.29 -8.55 41.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.633 -179.066 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.76 25.37 71.74 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -101.88 51.98 0.82 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.831 0.348 . . . . 0.0 110.673 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -69.74 -39.09 76.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.593 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.25 -47.2 86.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.34 -179.416 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -61.35 -39.15 89.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.232 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.23 -40.46 97.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.347 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.43 -27.17 68.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.567 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -75.32 -53.71 8.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.842 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.88 -43.26 96.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.422 -179.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.3 mt -63.06 -43.89 99.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.73 -179.705 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.37 -61.76 2.32 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.062 0.458 . . . . 0.0 110.356 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -54.55 -35.05 62.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.565 -179.153 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -79.62 -34.99 40.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.822 179.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -56.6 -40.12 74.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.009 -178.642 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.88 -42.37 99.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.692 179.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.79 -37.75 87.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.315 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.45 -42.28 99.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.713 179.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.17 -53.32 56.99 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.017 0.436 . . . . 0.0 110.613 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.3 -41.4 89.81 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.633 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.24 -39.95 95.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.601 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.19 -32.16 73.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.471 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.52 -21.75 18.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.63 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.636 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.96 -41.57 95.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.717 -179.625 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -77.58 136.08 25.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.746 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.1 108.97 11.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.333 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.9 126.13 0.3 Allowed Pre-proline 0 C--O 1.238 0.473 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.501 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.461 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.7 Cg_exo -43.73 152.16 0.36 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.891 2.394 . . . . 0.0 112.483 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.99 141.68 54.11 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.579 2.186 . . . . 0.0 112.341 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.16 147.07 2.16 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.602 179.374 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.2 154.19 70.36 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.897 2.398 . . . . 0.0 112.269 178.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.526 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.4 163.24 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.151 0.501 . . . . 0.0 110.477 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.526 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 2.1 t -144.08 170.26 16.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.157 0.503 . . . . 0.0 110.851 179.68 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.456 ' N ' ' HG1' ' A' ' 192' ' ' THR . . . -147.82 137.4 22.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.213 179.536 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.28 146.56 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.728 179.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.29 132.09 58.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.152 0.501 . . . . 0.0 110.418 178.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -152.09 154.73 36.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.377 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.6 m -122.15 123.01 40.54 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.904 0.383 . . . . 0.0 110.408 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.38 -25.43 65.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.679 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.407 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.53 -49.0 20.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.5 -9.85 59.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.499 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.6 m80 46.5 42.76 11.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.582 -179.602 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 t -135.89 145.77 46.69 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.421 179.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.33 113.92 26.73 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.393 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -120.06 133.58 55.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.438 . . . . 0.0 110.377 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.3 tt -112.33 146.72 37.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.794 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.452 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.5 t90 -99.58 129.8 45.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.22 0.533 . . . . 0.0 109.864 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.701 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.62 153.85 39.34 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.292 179.935 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.1 Cg_endo -67.61 -18.3 48.41 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.705 2.27 . . . . 0.0 111.986 178.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.701 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -49.16 -18.72 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.414 -179.23 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.452 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.1 p -75.7 165.04 25.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.496 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.01 -28.3 66.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.508 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.543 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.47 -41.45 98.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.673 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.85 -44.89 96.66 Favored Glycine 0 C--N 1.331 0.276 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.43 -38.98 92.92 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 122.231 -0.57 . . . . 0.0 110.703 179.67 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.584 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.7 mmm -61.93 -41.41 97.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.246 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.58 -47.72 80.33 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.99 0.424 . . . . 0.0 110.44 179.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.73 -32.01 50.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.882 0.373 . . . . 0.0 110.379 179.715 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -70.89 -18.13 62.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.493 179.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 91.5 mt -88.62 -8.67 54.27 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.651 -179.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.61 2.64 55.37 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -88.59 152.26 21.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.929 0.395 . . . . 0.0 110.504 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.1 p -115.11 127.99 55.94 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.118 0.485 . . . . 0.0 110.397 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.56 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.36 146.15 23.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.943 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.455 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.84 151.66 45.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.529 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.1 131.74 42.65 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.546 179.811 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.634 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.79 93.53 29.27 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.099 -179.713 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.723 ' C ' ' H ' ' A' ' 229' ' ' GLY . 44.5 Cg_exo -55.14 138.95 80.18 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.61 2.207 . . . . 0.0 111.769 178.775 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.6 -25.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.481 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.723 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.79 -49.95 26.8 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.805 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.586 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -53.94 -37.21 63.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 -179.273 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -66.62 35.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.83 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.09 88.36 0.01 OUTLIER 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.913 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.2 p -81.94 -14.33 56.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.337 -179.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.34 -41.43 10.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.618 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.2 t -66.91 -16.67 64.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.616 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.09 43.47 26.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.495 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.56 -148.44 7.84 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.37 143.23 49.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.959 0.409 . . . . 0.0 110.358 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.1 ttt-85 -151.95 149.43 28.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.312 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -100.71 -152.09 0.42 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.372 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.4 t0 56.1 -91.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.517 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.0 tt -126.54 175.43 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.631 -179.508 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.517 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.0 mt -122.14 141.7 41.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 -179.44 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.79 169.33 9.32 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.266 -179.774 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.2 mt -147.9 150.76 34.7 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.183 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.75 -38.91 96.88 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.19 4.07 4.64 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.3 -58.24 3.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 110.539 -179.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -62.1 -36.88 83.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.281 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.3 -67.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.736 -179.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.47 -42.23 67.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.19 -179.617 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.06 18.09 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.617 179.787 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.69 48.63 0.26 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.29 -109.91 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.485 0.183 . . . . 0.0 110.746 -178.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.455 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.9 m120 -60.78 -45.25 95.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.463 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.95 8.17 82.78 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 179.255 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.32 -12.75 20.05 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.725 -0.279 . . . . 0.0 110.673 -179.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.4 t 176.6 142.49 0.07 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.013 0.435 . . . . 0.0 110.446 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.0 tt -148.17 125.19 11.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -98.27 142.93 29.32 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 120.91 0.386 . . . . 0.0 110.694 178.313 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.3 mt -94.23 106.58 18.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.805 -179.323 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.463 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.3 t80 -101.91 -11.73 18.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.15 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.99 -40.2 87.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.84 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.81 173.97 46.17 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.459 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -74.39 -112.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.789 0.328 . . . . 0.0 110.798 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.83 -28.74 67.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.671 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.95 -44.18 91.4 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.24 -178.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.56 -44.4 94.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.317 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.47 -60.09 3.65 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.194 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.8 -43.74 58.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.143 179.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.91 75.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.242 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.1 mt -64.46 -43.62 96.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.587 179.56 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -56.57 -37.87 71.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.137 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.82 1.11 18.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.208 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.0 91.2 25.82 Favored Pre-proline 0 N--CA 1.461 0.104 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.164 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.86 -27.17 26.56 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.796 2.331 . . . . 0.0 112.034 179.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.516 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.58 -41.01 98.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.468 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.38 5.33 51.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.414 -179.21 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.06 -34.82 69.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.588 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -80.26 4.71 16.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.485 -178.819 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.56 HD21 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.91 121.11 80.36 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.555 179.921 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -47.15 -37.87 24.19 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.521 2.148 . . . . 0.0 112.533 -179.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.56 ' H ' HD21 ' A' ' 281' ' ' LEU . . . -58.86 -43.77 90.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.469 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.98 -43.47 92.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.387 179.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -64.86 -40.67 95.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.439 -179.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -90.02 -12.25 39.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.504 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 62.16 32.54 17.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.989 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -89.08 43.97 1.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.079 0.466 . . . . 0.0 110.278 179.52 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.13 135.87 41.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.587 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.6 132.56 56.65 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.37 179.618 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.499 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.56 87.86 7.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.762 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.47 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.3 mt -63.97 -41.31 97.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.782 179.433 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.12 168.14 34.73 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.7 p -75.97 -25.89 56.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.756 179.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.3 tp10 -67.79 -33.92 75.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.471 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.5 ' O ' ' CG2' ' A' ' 296' ' ' THR . 97.4 m -73.47 19.9 0.1 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.076 0.465 . . . . 0.0 110.78 -179.148 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.543 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 55.3 t80 -57.26 -51.38 69.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.853 -179.369 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 67.4 mmt-85 -108.0 149.51 28.3 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.5 tp -115.34 125.39 53.18 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.851 179.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 304' ' ' ALA . 42.4 t0 -149.06 166.41 28.79 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.567 179.537 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -49.29 -37.95 25.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.663 -179.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -71.89 -65.11 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.376 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.65 -32.74 71.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.983 -179.491 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 300' ' ' ASP . . . -54.7 -25.51 27.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.786 -179.102 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.5 mtt -63.32 -40.79 98.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.851 0.358 . . . . 0.0 111.027 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.89 -44.03 23.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.982 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 74.5 t -66.26 -42.79 91.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.381 179.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.441 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 51.7 tp -60.23 -47.1 87.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.495 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -70.17 -39.48 75.25 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.987 0.422 . . . . 0.0 110.672 179.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.499 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.3 ttt180 -61.67 -38.24 87.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.275 -179.043 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.4 4.75 41.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.61 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.636 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.3 tttt -112.82 -11.18 13.5 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.964 0.411 . . . . 0.0 110.264 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.15 -37.18 86.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.388 179.737 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.75 -48.91 79.66 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.465 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.157 179.66 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -89.94 -2.58 58.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.423 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.68 179.23 1.21 Allowed Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.524 -179.673 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.4 Cg_exo -60.87 145.0 99.67 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.818 2.345 . . . . 0.0 112.141 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.613 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.92 -179.56 8.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.639 -179.735 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.93 137.02 52.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.961 0.41 . . . . 0.0 110.313 179.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -124.43 147.05 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.346 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.5 p -120.03 136.11 54.68 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.779 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.46 -143.49 0.33 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.248 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.55 -37.39 87.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.453 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.476 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.93 -66.61 0.23 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.442 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.55 142.46 45.42 Favored Glycine 0 CA--C 1.518 0.277 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 -179.38 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.7 p -112.3 131.38 55.55 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.569 -0.371 . . . . 0.0 110.465 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -119.07 129.06 54.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.56 -179.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.5 m -85.6 130.43 34.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.223 -179.834 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.6 mt -95.95 78.82 3.22 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.388 179.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.71 -31.78 72.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.56 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 176.1 109.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.032 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -122.41 91.51 49.25 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.412 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.647 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.3 Cg_exo -56.89 148.55 66.58 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.79 2.327 . . . . 0.0 111.956 178.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.48 82.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.679 0.612 . . . . 0.0 110.97 -179.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.647 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.6 66.93 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.055 0.455 . . . . 0.0 110.173 -179.389 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.23 130.69 35.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.3 t -122.42 146.55 27.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.046 0.451 . . . . 0.0 109.993 -179.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.2 t -135.81 143.77 45.36 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.038 0.447 . . . . 0.0 110.729 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.709 ' HG1' ' H ' ' A' ' 50' ' ' SER . 27.2 p -99.37 -59.53 1.7 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.619 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.709 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.5 p -79.25 155.22 28.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.654 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.7 t -74.11 -21.92 18.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.486 179.355 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.41 ' O ' ' OG ' ' A' ' 56' ' ' SER . 98.1 m -60.33 -52.13 66.59 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.488 -178.406 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.9 mt -66.24 -42.72 88.2 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.759 177.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.1 m -43.24 -53.83 4.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.905 -178.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.37 -37.23 70.21 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 178.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.8 m -62.75 -44.69 95.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.853 0.359 . . . . 0.0 110.141 -179.221 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.0 mt -66.46 -41.9 88.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.497 0.665 . . . . 0.0 110.739 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -62.56 -40.49 96.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.489 -179.392 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.92 -35.86 75.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.287 -179.084 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.5 pt -91.16 28.89 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.352 -179.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.45 51.75 10.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.058 179.56 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.49 76.04 21.51 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.03 151.53 85.46 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.836 2.357 . . . . 0.0 112.076 -178.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -113.37 137.46 46.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-O 121.176 0.512 . . . . 0.0 110.293 179.671 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.1 pt -69.46 -43.62 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.321 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.12 131.44 53.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.037 0.446 . . . . 0.0 110.569 -178.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.536 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.0 p -155.77 168.59 26.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.445 -179.715 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.47 -177.22 21.9 Favored Glycine 0 N--CA 1.463 0.471 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.97 172.77 12.35 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 121.078 0.466 . . . . 0.0 110.437 179.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 p -132.42 -112.92 0.23 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.104 0.478 . . . . 0.0 110.376 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.98 179.72 0.94 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.406 -179.198 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.5 Cg_exo -60.86 57.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.968 2.446 . . . . 0.0 112.145 179.554 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.1 t-20 -64.25 -33.16 75.16 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.382 -179.731 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 42.6 m-20 93.47 -36.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.757 0.661 . . . . 0.0 109.805 -179.524 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -62.62 -39.64 94.45 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.216 179.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.34 -25.53 19.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.684 179.384 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.31 -170.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.436 -179.232 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.03 -154.35 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.856 -179.627 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.8 p-10 -52.31 -7.56 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.757 -179.567 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -85.95 114.92 23.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.676 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.97 70.4 1.34 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -143.84 147.99 34.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.844 0.354 . . . . 0.0 110.841 179.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.525 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.5 mp -85.82 -98.46 0.07 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.082 178.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.551 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.18 -42.52 96.65 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.052 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.607 ' NE2' ' HZ1' ' A' ' 88' ' ' LYS . 35.2 tt0 91.38 52.83 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.895 0.747 . . . . 0.0 111.024 179.205 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -102.88 -9.38 19.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.313 179.37 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.2 p -64.31 -33.91 76.93 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.139 0.495 . . . . 0.0 110.699 -179.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.607 ' HZ1' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.21 -23.39 1.31 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.678 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.3 t -69.84 -45.95 75.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 179.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.23 -48.62 80.65 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.924 -179.324 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.4 -38.4 89.48 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.379 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.59 -33.07 53.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.134 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.584 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.5 mmt-85 -89.66 1.74 55.64 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.554 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.68 -49.34 0.18 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.862 0.726 . . . . 0.0 110.197 179.126 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.655 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.8 mt -45.9 154.4 0.24 Allowed 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 117.538 -1.22 . . . . 0.0 109.524 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.655 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.1 tt0 121.07 92.63 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 O-C-N 125.566 1.791 . . . . 0.0 110.443 -178.595 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.536 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.57 142.94 42.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.252 0.548 . . . . 0.0 110.312 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -131.94 26.98 4.6 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.0 -0.438 . . . . 0.0 110.437 -179.344 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.24 137.9 34.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.022 0.439 . . . . 0.0 110.589 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.5 mt -137.16 165.01 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.332 179.629 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.523 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 144.9 -28.43 1.87 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.58 70.51 7.37 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-O 121.079 0.466 . . . . 0.0 110.095 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.92 145.33 98.57 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 122.668 2.245 . . . . 0.0 112.133 -179.651 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.9 t -134.35 136.73 43.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.559 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.37 81.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.63 179.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.12 -42.23 96.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.51 -179.408 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.62 98.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.491 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.6 -43.35 98.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.004 179.479 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.08 77.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.132 -179.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.69 -18.75 60.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.362 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.66 -6.55 58.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.491 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.8 mtp 47.53 56.1 17.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.644 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.8 Cg_endo -70.03 149.46 65.19 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.791 2.327 . . . . 0.0 112.098 179.516 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.03 -73.61 0.64 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.519 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.6 tp -111.02 113.44 25.99 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.293 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -102.08 126.57 56.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 120.962 0.411 . . . . 0.0 110.64 -179.8 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.3 mt -109.92 133.96 52.6 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.266 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.73 139.6 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.558 -179.567 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 121' ' ' THR . 87.9 p -83.4 168.37 16.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.716 179.673 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.47 80.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.389 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.428 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -139.91 159.13 42.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.94 0.4 . . . . 0.0 110.432 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.23 176.82 33.54 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.29 -33.59 86.57 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.56 151.46 44.71 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.928 0.394 . . . . 0.0 110.507 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.0 t -63.33 140.78 58.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.331 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.55 10.35 11.08 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.591 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.418 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -61.01 -38.94 87.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.253 -179.283 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.97 -35.89 23.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.522 0.677 . . . . 0.0 110.605 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -70.96 -35.44 72.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.546 0.688 . . . . 0.0 110.659 179.394 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.83 -62.81 0.91 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.411 -178.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.65 -42.86 90.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.195 -179.402 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -61.98 -32.71 73.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.367 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.0 mt -73.58 -41.06 63.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.864 178.642 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.18 -48.87 78.98 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.122 -178.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.8 m -52.97 -42.5 65.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.961 0.41 . . . . 0.0 110.186 179.474 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.14 -42.84 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 120.934 0.397 . . . . 0.0 111.18 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.33 153.51 5.38 Favored Pre-proline 0 N--CA 1.452 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.655 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -39.29 107.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.682 2.255 . . . . 0.0 112.516 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 97.0 m -109.73 121.4 45.14 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.116 0.484 . . . . 0.0 110.281 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -113.56 152.44 30.27 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.279 -179.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 tt -128.77 131.22 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.351 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.09 127.9 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.099 0.476 . . . . 0.0 110.52 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.8 t30 -101.43 103.81 14.74 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.161 179.822 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.0 p90 -101.35 -11.13 19.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.875 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.5 p-10 -64.89 -33.54 76.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.768 -179.718 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -98.4 7.72 45.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.503 -179.546 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.448 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.55 155.62 50.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.484 -179.358 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.2 p -75.02 165.75 24.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.675 -179.778 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.589 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.02 -48.8 80.22 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.188 -179.1 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -53.41 -42.0 66.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 110.094 -179.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.4 t -62.74 -41.04 99.0 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.366 178.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.6 tp -60.66 -44.42 96.48 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.325 -179.469 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.0 tp -61.47 -43.49 98.77 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.079 179.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.0 m -54.91 -45.04 74.69 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.18 -40.86 97.43 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.88 0.371 . . . . 0.0 110.46 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.86 -42.51 99.13 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.388 178.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.27 -40.78 94.86 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.51 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.54 -46.05 64.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.389 . . . . 0.0 110.842 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.79 -44.02 96.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.847 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 156' ' ' LEU . 32.8 p -92.86 -8.89 42.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.622 -179.026 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.88 26.61 72.27 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -101.85 50.91 0.84 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.844 0.354 . . . . 0.0 110.693 -179.572 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.56 -39.59 77.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.622 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.37 -47.12 86.63 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.288 -179.293 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -60.07 -39.49 86.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.145 -179.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.97 99.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.247 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.88 -28.26 69.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.622 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.56 -54.18 7.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.898 179.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -65.54 -42.19 92.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.402 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.2 mt -62.43 -43.77 98.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.496 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.58 -58.15 8.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.984 0.421 . . . . 0.0 110.372 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.47 -33.35 67.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.597 -179.016 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -81.35 -36.72 29.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.756 179.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.7 m-20 -55.79 -42.01 74.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.867 -178.437 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.4 -42.19 99.24 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.919 0.39 . . . . 0.0 110.801 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.26 -38.06 89.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.237 179.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.41 -42.2 99.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.718 179.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.19 -53.01 61.38 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.07 0.462 . . . . 0.0 110.67 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.02 -41.8 90.5 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.674 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.95 95.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.28 -32.09 73.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.382 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -94.62 -22.35 18.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.688 -179.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.635 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.76 -41.33 95.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.676 -179.554 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -76.45 136.37 24.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.69 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.72 107.91 10.59 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.246 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.73 125.95 0.31 Allowed Pre-proline 0 C--O 1.239 0.55 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.465 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.452 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.6 Cg_exo -44.02 152.35 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.872 2.381 . . . . 0.0 112.553 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.09 141.98 54.6 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.556 2.171 . . . . 0.0 112.385 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.35 147.33 2.14 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.52 179.301 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.28 154.62 69.37 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.813 2.342 . . . . 0.0 112.348 178.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.42 163.15 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.207 0.527 . . . . 0.0 110.42 179.799 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.648 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.2 t -143.56 170.11 16.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.008 179.453 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.648 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -147.75 137.32 22.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.949 0.404 . . . . 0.0 110.185 179.448 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 38.7 pt -134.16 146.55 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.682 179.528 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.95 132.04 59.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.261 0.553 . . . . 0.0 110.468 178.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.431 ' HH ' ' CG1' ' A' ' 272' ' ' ILE . 52.4 p90 -153.31 156.96 39.37 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.43 179.21 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.4 m -122.8 123.31 40.74 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.944 0.402 . . . . 0.0 110.418 179.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.474 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -61.09 -25.95 67.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.583 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -74.66 -50.0 19.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.972 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.24 -11.11 59.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.548 -179.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.474 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 80.6 m80 47.11 47.39 16.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.563 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.6 t -131.47 144.75 51.38 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.277 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -109.76 106.19 15.72 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.235 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -116.76 129.61 56.21 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.177 0.513 . . . . 0.0 110.301 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.7 tt -112.1 146.54 37.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.813 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.457 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 12.1 t90 -99.49 128.46 45.6 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.203 0.525 . . . . 0.0 109.851 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.703 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -94.41 153.88 40.37 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.37 179.758 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.5 Cg_endo -67.59 -18.08 48.43 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.651 2.234 . . . . 0.0 112.003 178.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.703 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.7 mt-10 -49.6 -18.55 0.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.332 -179.165 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.457 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.9 p -75.56 164.15 26.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.474 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.71 -28.1 65.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.533 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.571 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.0 mt-30 -63.65 -41.25 98.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.656 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.57 -44.44 97.78 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -179.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.448 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.1 mt-30 -64.3 -38.81 92.35 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 122.212 -0.581 . . . . 0.0 110.712 179.588 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.2 mmm -61.99 -41.31 97.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.188 179.819 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 74.1 mt -63.49 -47.71 80.61 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.031 0.443 . . . . 0.0 110.392 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.66 -32.06 50.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.909 0.385 . . . . 0.0 110.273 179.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -71.01 -17.96 62.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.48 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.77 -8.4 54.5 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.617 -179.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.44 2.58 55.55 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.811 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -88.68 152.2 21.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.953 0.406 . . . . 0.0 110.429 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.9 p -115.18 127.97 55.88 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.183 0.516 . . . . 0.0 110.356 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -91.94 146.63 23.59 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.011 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.457 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.38 151.18 45.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.477 179.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.1 131.77 42.67 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.5 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.626 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.54 93.53 28.01 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.079 -179.52 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.725 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.5 Cg_exo -55.31 138.77 80.5 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.599 2.199 . . . . 0.0 111.633 179.034 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.27 -25.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.478 -179.621 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.725 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.45 -50.11 28.07 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.819 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.594 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.4 mt -54.76 -36.67 65.08 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.122 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -65.95 36.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.783 179.431 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.594 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.51 86.25 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.953 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.2 p -79.27 -15.14 58.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.346 -179.809 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -92.4 -40.25 10.98 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.678 179.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -66.03 -18.03 65.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.598 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.16 43.44 26.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.41 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.89 -148.16 7.79 Favored Glycine 0 CA--C 1.518 0.262 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.97 142.31 49.89 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 110.316 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.48 149.92 29.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.313 179.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -102.18 -149.95 0.4 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.3 179.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 55.29 -92.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.696 -179.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.49 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.1 tt -126.94 174.65 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.635 -179.495 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.49 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.0 mt -122.31 141.29 43.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.039 0.447 . . . . 0.0 110.899 -179.562 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.58 170.62 8.47 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.196 -179.787 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.3 mt -146.75 149.6 33.71 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.259 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.19 -39.38 97.86 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.07 3.14 4.04 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -78.5 -57.59 3.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.964 0.412 . . . . 0.0 110.517 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -62.07 -36.88 82.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.203 -179.651 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.6 mp -52.98 -67.57 0.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.0 179.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.515 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.61 -42.53 67.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.112 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.74 17.74 0.15 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.656 179.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.0 48.05 0.27 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.1 mp 39.25 -109.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.534 0.207 . . . . 0.0 110.721 -178.623 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.457 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -60.83 -44.67 96.61 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.381 -179.57 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.6 7.96 83.69 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.336 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.93 -13.34 20.02 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.689 -0.301 . . . . 0.0 110.667 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.1 t 177.06 142.89 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.083 0.468 . . . . 0.0 110.427 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -148.2 125.3 11.41 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.197 179.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -98.47 143.65 28.68 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 120.892 0.377 . . . . 0.0 110.808 178.326 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.06 106.62 18.63 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.78 -179.264 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.2 t80 -102.3 -11.41 18.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.116 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.57 -40.55 84.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.875 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.28 172.71 45.57 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.599 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.472 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 94.8 m-20 -73.9 -113.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.784 0.326 . . . . 0.0 110.723 -179.745 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.67 -28.94 68.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.661 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.11 -43.62 91.91 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.104 -178.762 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.55 -44.4 94.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.299 179.299 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.63 -59.99 3.8 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.133 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -51.02 -43.58 60.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.115 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.31 -43.23 74.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.179 -179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.431 ' CG1' ' HH ' ' A' ' 196' ' ' TYR . 92.0 mt -64.67 -43.57 96.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.641 179.541 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -55.96 -37.61 69.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.149 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.76 1.0 18.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.158 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -114.96 91.41 26.49 Favored Pre-proline 0 N--CA 1.461 0.114 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.121 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.24 -27.29 29.81 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.798 2.332 . . . . 0.0 111.917 179.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.514 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.5 -40.98 98.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.484 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.432 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.37 5.22 52.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.349 -179.132 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.95 -35.12 69.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.622 179.557 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -80.06 4.69 16.34 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.521 -178.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.76 121.17 80.27 Favored Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.541 179.967 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -47.28 -37.68 24.8 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.427 2.085 . . . . 0.0 112.611 -179.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.554 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.84 -43.75 90.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.747 0.308 . . . . 0.0 110.404 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.01 -43.64 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.285 179.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.87 -40.66 95.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.376 -179.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.8 t-20 -89.78 -12.55 38.93 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.592 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 61.87 32.18 18.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.069 -179.743 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.78 43.84 1.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.136 0.493 . . . . 0.0 110.308 179.537 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.11 135.85 39.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.487 -179.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.9 132.19 56.76 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.412 179.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.02 89.12 7.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.796 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.46 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.2 mt -64.05 -41.11 97.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.45 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.444 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.52 165.76 33.44 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.514 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 74.3 p -75.46 -25.87 57.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.887 0.375 . . . . 0.0 110.785 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.538 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.9 tp10 -68.27 -33.76 74.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.439 -179.737 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.5 ' O ' ' CG2' ' A' ' 296' ' ' THR . 95.8 m -73.59 23.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.751 -179.144 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.571 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 49.4 t80 -58.0 -50.86 71.95 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.102 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 75.0 mmt-85 -110.7 152.97 25.92 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.108 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 41.9 tp -115.48 125.54 53.2 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.989 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 41.3 t0 -148.03 165.55 30.44 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.581 179.46 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -49.35 -37.71 25.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.655 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.29 -65.54 0.73 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.58 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.96 -32.85 72.37 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.058 -179.536 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.13 -25.61 23.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.8 -179.166 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.7 mtt -63.55 -40.7 97.68 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 120.854 0.359 . . . . 0.0 111.135 179.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.64 -44.1 24.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.188 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.37 -42.87 91.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.353 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.431 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.1 tp -60.24 -47.12 87.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.507 -178.488 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -69.67 -39.36 77.07 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.069 0.462 . . . . 0.0 110.796 179.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.7 ttt180 -61.89 -38.44 88.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.218 -178.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.01 4.29 42.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.594 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.635 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.3 tttt -112.84 -10.94 13.52 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.073 0.463 . . . . 0.0 110.314 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.35 86.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.427 179.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.86 -48.7 80.59 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.403 -179.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.064 179.86 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -90.22 -2.56 58.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.428 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.7 179.13 1.23 Allowed Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.588 -179.711 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.0 Cg_exo -60.86 144.79 99.63 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.81 2.34 . . . . 0.0 112.206 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.9 -179.56 8.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.562 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -115.7 136.44 53.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.355 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.28 147.63 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.386 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.3 p -120.65 136.26 54.88 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.814 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.32 -143.34 0.32 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.239 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.8 -36.95 85.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.484 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.0 -67.67 0.22 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.436 179.676 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.16 142.53 44.46 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.295 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.4 p -112.18 131.8 55.26 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.552 -0.381 . . . . 0.0 110.513 -179.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.12 128.9 54.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.591 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.3 m -85.39 130.14 34.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.223 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.8 mt -95.37 78.43 3.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.4 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.81 -32.27 73.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.532 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.61 108.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.993 0.425 . . . . 0.0 110.157 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -122.69 91.59 49.48 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-O 120.767 0.317 . . . . 0.0 110.404 -179.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.655 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.6 Cg_exo -56.67 148.68 63.46 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.742 2.295 . . . . 0.0 111.993 178.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.26 82.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.677 0.61 . . . . 0.0 110.988 -179.196 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.655 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.57 66.88 0.88 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.261 -179.377 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.56 131.06 35.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.817 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.68 148.27 26.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.056 0.455 . . . . 0.0 110.077 -179.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.7 t -136.78 143.68 43.34 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.776 179.75 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.581 ' HG1' ' H ' ' A' ' 50' ' ' SER . 25.5 p -99.3 -59.03 1.8 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.572 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.581 ' H ' ' HG1' ' A' ' 49' ' ' THR . 87.0 p -79.16 155.43 28.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.587 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 68.8 t -74.51 -21.72 17.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.484 179.357 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.408 ' O ' ' OG ' ' A' ' 56' ' ' SER . 90.1 m -60.4 -52.1 66.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.524 -178.464 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.37 -42.7 87.61 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.754 177.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.3 m -42.9 -53.89 4.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.948 -178.585 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.15 -37.41 72.29 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 178.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 52' ' ' THR . 5.8 m -62.8 -44.34 96.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.941 0.4 . . . . 0.0 110.152 -179.321 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.6 mt -66.09 -42.05 89.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.505 0.669 . . . . 0.0 110.683 179.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.88 -40.04 96.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.393 -179.266 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.88 -36.1 78.34 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.348 -178.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.3 pt -90.92 27.81 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.27 -179.199 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.89 52.03 9.91 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.391 0.432 . . . . 0.0 111.097 179.568 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.2 75.82 27.83 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.32 148.95 92.46 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.859 2.373 . . . . 0.0 112.12 -178.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -112.5 136.58 48.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-O 121.188 0.518 . . . . 0.0 110.308 179.807 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.68 -43.5 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.251 179.352 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.13 131.26 53.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.948 0.404 . . . . 0.0 110.605 -178.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.5 p -155.55 168.43 27.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.501 -179.796 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.81 -177.37 21.67 Favored Glycine 0 N--CA 1.463 0.453 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.04 173.16 11.88 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.062 0.458 . . . . 0.0 110.402 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.6 p -133.22 -111.79 0.23 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.982 0.42 . . . . 0.0 110.4 -179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.64 179.71 0.93 Allowed Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.466 -179.247 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.3 Cg_exo -60.93 58.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 123.018 2.479 . . . . 0.0 112.089 179.463 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.0 t-20 -64.45 -33.8 76.73 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.412 -179.647 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.2 m-20 93.85 -36.13 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.788 0.68 . . . . 0.0 109.769 -179.632 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -63.22 -40.09 96.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.235 179.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.3 p -74.42 -25.37 19.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.742 179.326 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.25 -171.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.463 -179.208 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.524 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.56 -153.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 38.0 p-10 -52.15 -7.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.751 -179.594 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.524 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.1 mm-40 -86.33 114.81 23.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.619 179.707 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.79 70.61 1.34 Allowed Glycine 0 CA--C 1.52 0.379 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.472 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.1 m-85 -143.55 147.85 35.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.925 0.393 . . . . 0.0 110.802 179.233 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.527 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.4 mp -85.98 -98.34 0.07 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.035 178.874 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.558 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.3 -42.49 96.35 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.132 179.354 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.561 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.3 tt0 91.55 53.29 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.851 0.719 . . . . 0.0 111.033 179.195 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -103.15 -9.43 19.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.345 179.261 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.472 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.5 p -64.06 -34.58 78.35 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.059 0.457 . . . . 0.0 110.732 -179.805 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.561 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.71 -24.31 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.624 179.704 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.95 -45.62 76.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.58 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.89 -49.03 79.11 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.976 -179.368 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.44 -38.15 88.64 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.412 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.46 -32.8 51.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.135 -179.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.593 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.97 1.55 56.13 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.555 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 83.11 -48.98 0.15 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.743 0.652 . . . . 0.0 110.245 179.146 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.664 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.1 mt -46.51 153.64 0.35 Allowed 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 117.732 -1.128 . . . . 0.0 109.546 -179.872 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.664 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.3 tt0 121.64 92.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 125.359 1.662 . . . . 0.0 110.476 -178.634 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.42 143.16 42.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.245 0.545 . . . . 0.0 110.288 179.313 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.1 mt -132.42 26.95 4.44 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 122.02 -0.425 . . . . 0.0 110.479 -179.365 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.44 138.31 34.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 0.0 110.485 -179.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.1 mt -137.28 164.84 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.359 179.51 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.524 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.14 -29.0 1.82 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.2 70.64 7.67 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.17 0.51 . . . . 0.0 110.241 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.07 145.37 98.59 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 C-N-CA 122.795 2.33 . . . . 0.0 112.046 -179.53 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.2 t -134.66 136.68 42.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.574 179.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.63 83.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.619 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.01 -42.21 97.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.493 -179.415 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.07 -41.55 98.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.563 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.61 -43.43 98.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.994 179.487 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.15 77.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.174 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.31 -18.8 60.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.459 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.59 -6.62 58.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.523 -179.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 73.5 mtp 47.91 56.04 17.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.548 179.993 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.22 149.27 63.73 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.834 2.356 . . . . 0.0 112.1 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.31 -72.8 0.67 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.506 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.2 tp -111.56 113.9 26.62 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.386 179.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.9 mt -103.05 126.89 57.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 120.993 0.425 . . . . 0.0 110.572 -179.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.6 mt -110.11 134.29 52.33 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.251 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.84 139.92 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.499 -179.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.515 ' HG ' ' CB ' ' A' ' 50' ' ' SER . 90.3 p -83.51 168.13 16.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.776 179.722 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.09 79.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.431 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.429 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.0 t -139.61 158.71 43.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.432 -179.823 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.26 175.74 33.87 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.22 -33.62 86.54 Favored Glycine 0 CA--C 1.518 0.279 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -123.97 151.13 44.0 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.904 0.383 . . . . 0.0 110.585 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.4 t -63.52 140.08 58.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.389 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.1 10.82 11.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.656 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -60.99 -38.85 87.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.251 -179.394 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.633 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.32 -35.71 23.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.407 0.622 . . . . 0.0 110.587 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.4 mt -70.98 -35.42 72.1 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.51 0.671 . . . . 0.0 110.668 179.379 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -42.76 -63.0 0.86 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.348 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.633 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.7 p-10 -65.88 -42.83 89.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.114 -179.25 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.3 mt-30 -61.76 -32.8 73.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.362 -179.603 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.4 mt -73.62 -40.78 63.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 178.651 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.23 -49.2 77.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.165 -178.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.9 m -52.7 -42.7 65.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.186 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.09 -42.78 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 120.967 0.413 . . . . 0.0 111.144 179.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.58 153.36 5.09 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.632 -179.362 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -39.12 107.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.629 2.219 . . . . 0.0 112.538 179.65 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 98.3 m -110.04 121.35 45.06 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.095 0.474 . . . . 0.0 110.289 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 mp -113.94 153.05 29.93 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.29 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 tt -130.36 129.25 64.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.398 179.714 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.5 mt -111.74 126.72 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.626 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.513 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 57.0 t30 -100.9 103.81 15.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.149 179.711 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -100.88 -6.31 24.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.956 -179.741 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.2 p-10 -65.34 -33.39 75.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.728 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.584 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -100.37 9.18 43.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.618 -179.366 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.436 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.7 mttm -135.48 153.31 51.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.461 -179.39 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.9 p -75.81 166.55 23.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.624 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.597 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.8 t90 -59.89 -48.93 79.7 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.194 -179.095 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.85 -43.41 69.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.88 0.371 . . . . 0.0 110.087 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.0 t -62.88 -41.02 99.24 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.28 178.573 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 49.9 tp -60.68 -44.49 96.44 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.298 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.0 tp -61.04 -43.59 98.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.136 179.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -54.53 -45.02 73.28 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.37 -40.15 95.5 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.96 0.41 . . . . 0.0 110.398 179.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.444 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.4 mm? -61.79 -42.46 99.03 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.189 179.164 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.75 -40.09 95.54 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.362 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.43 -45.64 65.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.352 . . . . 0.0 110.762 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.84 -43.99 96.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.1 p -93.39 -8.95 40.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.632 -178.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.13 26.01 72.35 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -101.78 50.48 0.85 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.735 0.302 . . . . 0.0 110.65 -179.509 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.48 -39.29 77.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.625 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.39 -47.2 86.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.327 -179.452 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -60.23 -39.61 87.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.226 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.11 99.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.01 0.433 . . . . 0.0 110.245 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.03 -28.58 70.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.591 179.489 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.59 -54.12 8.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.885 179.407 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -65.26 -42.5 93.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.395 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 174' ' ' ASP . 81.2 mt -62.61 -43.94 98.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.54 -179.388 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.11 -61.06 2.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.088 0.471 . . . . 0.0 110.403 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.8 -34.52 62.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.605 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -80.41 -35.9 34.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.812 179.576 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.8 m-20 -55.08 -42.07 72.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.997 -178.658 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.42 -41.94 99.07 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.746 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.0 -38.21 90.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.316 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.46 -41.92 99.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.728 179.397 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.88 -52.81 62.61 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.097 0.475 . . . . 0.0 110.68 179.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.21 -41.75 89.69 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.674 179.408 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.92 95.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.592 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.36 -32.28 73.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.05 -22.16 18.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.589 -179.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.636 ' NE2' ' HZ2' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.82 -41.06 96.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.698 -179.593 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -76.89 135.94 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.749 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -126.85 108.33 10.91 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.257 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.62 125.75 0.31 Allowed Pre-proline 0 C--O 1.239 0.551 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.495 179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.6 Cg_exo -43.94 152.4 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.848 2.365 . . . . 0.0 112.585 -179.862 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.09 141.75 53.82 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.604 2.203 . . . . 0.0 112.382 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.3 147.31 2.16 Favored Pre-proline 0 N--CA 1.448 -0.528 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.563 179.315 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.11 154.22 70.63 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.839 2.36 . . . . 0.0 112.33 178.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.37 163.08 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.27 0.557 . . . . 0.0 110.42 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.639 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.1 t -143.77 170.39 15.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.97 179.593 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.639 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -148.17 137.6 22.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 0.0 110.182 179.432 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 40.6 pt -134.37 147.02 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.73 179.596 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.484 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -133.55 132.05 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.21 0.529 . . . . 0.0 110.436 178.772 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -152.1 155.04 37.1 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.382 179.14 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.7 m -122.26 122.89 40.16 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.952 0.406 . . . . 0.0 110.405 179.469 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.88 -25.36 66.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.678 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -75.45 -49.37 19.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.876 179.635 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.26 -9.81 59.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.393 -179.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.6 m80 46.85 43.39 13.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.544 -179.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -136.39 144.65 44.65 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.31 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.9 113.92 26.86 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.336 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.95 133.41 55.57 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.096 0.474 . . . . 0.0 110.405 179.824 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.5 tt -112.06 146.48 37.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.014 0.435 . . . . 0.0 110.728 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.456 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 13.6 t90 -99.67 129.88 45.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.14 0.495 . . . . 0.0 109.919 179.434 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.697 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -95.64 154.02 39.29 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.333 179.896 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.8 Cg_endo -67.54 -18.3 48.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.752 2.302 . . . . 0.0 111.976 178.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.697 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.6 mt-10 -49.54 -18.38 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.344 -179.148 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.456 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.4 p -75.59 164.34 26.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.51 179.664 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.83 -27.95 65.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.45 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.575 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.1 mt-30 -63.98 -41.26 97.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.61 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.04 -45.05 96.62 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -179.52 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.436 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.63 -38.71 91.94 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 122.236 -0.567 . . . . 0.0 110.783 179.54 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.597 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.7 mmm -62.14 -41.78 98.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.312 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 48.5 mt -63.5 -47.14 82.96 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.143 0.497 . . . . 0.0 110.259 179.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -54.77 -31.64 58.97 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.894 0.378 . . . . 0.0 110.411 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -70.26 -17.7 63.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.451 179.573 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.82 -9.23 52.52 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.585 -179.492 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.98 2.68 51.98 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.756 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.86 153.03 21.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.5 p -115.36 128.12 55.87 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.11 0.481 . . . . 0.0 110.323 -179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.5 mm? -91.75 146.6 23.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.032 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.456 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.81 151.62 44.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.41 179.709 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -133.06 132.1 41.4 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.465 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.63 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.42 93.96 29.42 Favored Pre-proline 0 C--O 1.235 0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.066 -179.633 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.723 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.3 Cg_exo -55.12 138.86 79.91 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.582 2.188 . . . . 0.0 111.662 178.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.6 -25.27 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.504 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.723 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.17 -49.58 26.24 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.729 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.59 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.8 mt -54.58 -37.34 65.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.093 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.33 35.75 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.767 179.376 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.59 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.48 88.02 0.01 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.926 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 81.1 p -81.0 -13.81 58.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.31 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.16 -40.71 10.86 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.604 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.7 t -67.04 -16.6 64.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.559 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.69 43.94 27.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.473 -179.589 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.61 -147.05 7.37 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.06 143.45 49.5 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.96 0.41 . . . . 0.0 110.343 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.08 149.61 29.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.338 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -101.02 -152.08 0.42 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.319 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.5 t0 56.02 -92.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.672 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.503 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.1 tt -126.49 175.13 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.661 -179.591 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.503 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -121.62 141.24 42.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.827 -179.392 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.48 168.8 9.75 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.16 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.3 mt -147.47 150.91 35.5 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.281 179.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.99 -38.74 96.48 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.09 4.3 4.63 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.63 -58.1 3.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.901 0.381 . . . . 0.0 110.466 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.15 -36.45 81.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.332 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.36 -67.8 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.842 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.32 -42.06 66.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.182 -179.362 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.29 18.03 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.629 179.816 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.59 48.46 0.24 Allowed Glycine 0 N--CA 1.465 0.591 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.4 mp 38.62 -109.84 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.467 0.175 . . . . 0.0 110.745 -178.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.456 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 12.0 m120 -60.68 -45.18 95.12 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.534 -179.555 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.82 8.17 83.01 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.258 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.37 -12.71 20.04 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 122.744 -0.268 . . . . 0.0 110.7 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.5 t 176.44 142.44 0.07 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.077 0.465 . . . . 0.0 110.436 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 tt -148.1 125.34 11.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.161 179.593 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -98.38 143.19 29.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 120.899 0.38 . . . . 0.0 110.944 178.153 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.8 mt -94.52 106.66 18.65 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.718 -179.257 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.446 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.82 -12.36 18.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.101 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.58 89.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.872 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.37 173.66 46.04 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.657 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.5 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -73.98 -112.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 110.798 -179.824 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.95 -28.61 67.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.707 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.98 -44.12 91.53 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.202 -178.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.75 -44.24 94.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.308 179.3 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.51 -60.24 3.48 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.167 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -50.9 -43.56 59.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.169 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.27 -43.72 74.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.211 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.7 mt -64.57 -43.56 96.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.635 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -56.39 -37.68 70.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.168 -179.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.8 1.07 18.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.19 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -115.25 91.1 26.64 Favored Pre-proline 0 N--CA 1.462 0.134 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.129 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.99 -26.99 26.88 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.746 2.297 . . . . 0.0 111.976 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 3.9 mm? -63.54 -41.09 98.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.495 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.0 mp -95.43 5.28 52.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.401 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.17 -34.84 68.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.536 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -80.11 4.74 16.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.526 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.555 HD22 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.9 121.28 80.94 Favored Pre-proline 0 N--CA 1.445 -0.721 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.566 179.999 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -47.22 -37.79 24.51 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.446 2.097 . . . . 0.0 112.618 -179.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.555 ' H ' HD22 ' A' ' 281' ' ' LEU . . . -58.88 -43.8 90.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.705 0.288 . . . . 0.0 110.403 179.764 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.93 -43.56 92.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.345 179.306 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.84 -40.68 95.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.327 -179.217 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -90.09 -12.06 39.5 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.572 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.69 32.84 18.29 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.393 0.433 . . . . 0.0 111.035 -179.801 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -89.3 43.87 1.17 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.17 0.509 . . . . 0.0 110.348 179.476 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.54 135.96 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.533 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -116.7 132.55 56.66 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.385 179.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.502 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.57 88.09 7.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.733 179.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.455 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.5 mt -64.06 -40.82 97.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 179.322 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.446 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.64 167.54 34.82 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.515 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 73.8 p -75.55 -25.73 57.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.803 0.335 . . . . 0.0 110.689 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.542 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.4 tp10 -67.89 -34.56 76.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.491 -179.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.501 ' O ' ' CG2' ' A' ' 296' ' ' THR . 96.7 m -73.36 24.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.649 -179.106 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.575 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 56.7 t80 -58.04 -51.17 70.79 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.348 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.0 mmt-85 -111.77 154.54 24.9 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.073 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 45.0 tp -115.89 124.99 52.03 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.97 0.414 . . . . 0.0 110.824 179.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 44.4 t0 -147.22 165.37 30.27 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.59 179.552 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.4 -38.41 28.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.617 -179.463 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -71.81 -65.1 0.81 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.527 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -60.08 -32.27 70.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.926 -179.501 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.19 -25.27 21.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.684 -179.14 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.7 mtt -63.1 -41.27 99.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.975 0.417 . . . . 0.0 110.977 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.27 -44.52 25.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.207 179.427 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 78.7 t -66.12 -42.88 92.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.465 179.703 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.443 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 52.1 tp -60.36 -47.25 86.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.524 -178.522 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -70.09 -39.54 75.49 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.696 179.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.502 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 70.2 ttt180 -61.89 -37.79 85.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.36 -178.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -87.8 4.81 42.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.723 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.636 ' HZ2' ' NE2' ' A' ' 183' ' ' GLN . 87.6 tttt -113.2 -11.99 13.18 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.052 0.453 . . . . 0.0 110.357 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.3 86.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.449 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.91 -48.8 80.15 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.431 -179.644 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.059 179.8 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.608 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.86 -2.7 58.26 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.463 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.55 179.14 1.23 Allowed Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.561 -179.65 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.4 Cg_exo -60.75 145.0 99.64 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.799 2.333 . . . . 0.0 112.171 179.634 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.608 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.03 -179.52 8.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.596 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.97 136.94 52.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.013 0.435 . . . . 0.0 110.383 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.22 147.06 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.342 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.6 p -119.93 135.88 54.73 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.073 0.463 . . . . 0.0 110.699 179.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.42 -143.44 0.33 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.252 179.893 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.61 -37.11 86.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.485 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.4 -66.68 0.22 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.416 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.52 142.47 45.35 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -179.357 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 78.4 p -112.29 131.61 55.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 0.0 110.447 -179.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -119.2 129.03 54.76 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.526 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.1 m -85.56 130.18 34.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.217 -179.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.1 mt -95.7 78.5 3.3 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.463 179.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.64 -31.73 72.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.579 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.35 109.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.018 0.437 . . . . 0.0 110.089 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -122.35 91.15 49.3 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.485 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.4 Cg_exo -56.74 148.48 65.36 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.831 2.354 . . . . 0.0 112.002 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.46 82.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.566 0.542 . . . . 0.0 110.975 -179.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.55 66.84 0.88 Allowed 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 121.094 0.473 . . . . 0.0 110.221 -179.422 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.4 130.74 35.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.803 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.42 146.61 27.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.057 -179.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.7 t -135.87 143.78 45.23 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.772 179.79 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.713 ' HG1' ' H ' ' A' ' 50' ' ' SER . 26.9 p -99.57 -59.36 1.73 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.588 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.713 ' H ' ' HG1' ' A' ' 49' ' ' THR . 86.1 p -79.22 155.17 28.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.66 179.924 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.7 t -74.2 -21.89 17.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.474 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.407 ' O ' ' OG ' ' A' ' 56' ' ' SER . 99.3 m -60.28 -52.19 66.31 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.549 -178.399 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.34 -42.72 87.75 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.756 177.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.1 m -42.94 -53.83 4.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.9 -178.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.32 -37.19 70.68 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 178.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.3 m -62.78 -44.78 95.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.871 0.367 . . . . 0.0 110.141 -179.214 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.9 mt -66.45 -41.94 88.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.51 0.671 . . . . 0.0 110.711 179.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.65 -40.48 97.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.427 -179.363 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.9 -35.67 75.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.303 -179.046 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -91.34 28.65 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.314 -179.388 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.51 51.81 10.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.084 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.34 76.04 21.98 Favored Pre-proline 0 N--CA 1.463 0.199 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.77 151.21 86.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.864 2.376 . . . . 0.0 112.102 -178.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -113.18 137.47 46.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 121.155 0.502 . . . . 0.0 110.292 179.683 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.43 -43.55 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.395 179.344 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.25 131.48 53.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.033 0.444 . . . . 0.0 110.562 -179.008 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.6 p -155.7 168.51 26.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.437 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.36 -177.37 21.96 Favored Glycine 0 N--CA 1.463 0.475 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.52 172.25 12.98 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 121.165 0.507 . . . . 0.0 110.453 179.263 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 p -132.17 -113.14 0.23 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.037 0.446 . . . . 0.0 110.406 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.64 179.58 0.97 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.399 -179.185 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.9 Cg_exo -61.04 57.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.997 2.465 . . . . 0.0 112.146 179.417 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.2 t-20 -64.1 -33.18 75.19 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.286 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.5 m-20 93.8 -36.62 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.674 0.609 . . . . 0.0 109.825 -179.527 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -62.51 -39.71 94.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.009 0.433 . . . . 0.0 110.225 179.279 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.505 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.26 -25.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.703 179.353 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.15 -171.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.444 -179.227 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.77 -154.15 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.843 -179.708 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 38.1 p-10 -52.46 -7.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.742 -179.557 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.13 114.87 23.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.679 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.23 70.05 1.34 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.428 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.4 m-85 -143.59 147.45 34.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.866 0.365 . . . . 0.0 110.856 179.161 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.525 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.5 mp -85.41 -98.2 0.07 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.126 178.859 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.3 -42.38 96.39 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.076 179.543 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.553 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.23 52.5 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.875 0.734 . . . . 0.0 111.027 179.205 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -102.6 -9.12 20.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.332 179.338 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.428 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.3 p -64.56 -33.86 76.9 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.183 0.515 . . . . 0.0 110.74 -179.728 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.539 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.29 -23.29 1.33 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 179.666 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.0 t -70.08 -45.83 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.689 179.698 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.29 -48.63 80.52 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.216 0.532 . . . . 0.0 109.963 -179.384 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.52 -38.2 89.01 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.425 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.71 -32.89 53.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.041 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.585 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.9 mmt-85 -89.87 1.77 55.8 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.453 -179.811 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.585 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.76 -49.38 0.17 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.903 0.752 . . . . 0.0 110.228 179.125 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.658 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.2 mt -45.97 154.3 0.25 Allowed 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 117.621 -1.181 . . . . 0.0 109.566 -179.768 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.658 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.9 tt0 121.16 92.65 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 O-C-N 125.461 1.726 . . . . 0.0 110.51 -178.511 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.69 142.93 42.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.242 0.544 . . . . 0.0 110.291 179.296 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.3 mt -132.05 27.15 4.55 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.973 -0.454 . . . . 0.0 110.44 -179.346 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.39 137.97 34.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.042 0.448 . . . . 0.0 110.583 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 92.9 mt -137.17 165.12 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.319 179.594 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.524 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 144.94 -28.51 1.86 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -152.96 70.89 7.14 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 121.119 0.485 . . . . 0.0 110.132 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.1 145.42 98.48 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 122.743 2.295 . . . . 0.0 112.126 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.9 t -134.27 136.75 43.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.543 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.27 81.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.643 179.652 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.25 -42.3 96.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.511 -179.385 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.92 -41.7 98.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.49 -179.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.56 -43.43 98.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.991 179.485 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.02 77.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.145 -179.636 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.62 -18.82 61.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.383 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.6 -6.68 58.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.461 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.41 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.4 mtp 47.57 56.3 17.39 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.568 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.8 Cg_endo -70.33 149.5 63.38 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.751 2.301 . . . . 0.0 112.098 179.5 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.04 -73.64 0.64 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.492 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.3 tp -111.07 113.6 26.25 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 110.295 179.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.6 mt -101.97 126.75 55.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 120.966 0.413 . . . . 0.0 110.714 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.5 mt -109.84 133.5 53.09 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.211 -179.43 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.5 139.43 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.55 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 121' ' ' THR . 87.4 p -83.32 168.39 16.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.851 179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.4 -37.3 80.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.397 179.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.424 ' O ' ' OG ' ' A' ' 119' ' ' SER . 4.3 t -139.96 158.87 43.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.968 0.414 . . . . 0.0 110.415 -179.818 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.23 176.97 33.49 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.26 -33.81 87.2 Favored Glycine 0 CA--C 1.518 0.251 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -124.58 151.3 44.95 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 110.547 -179.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.0 t -63.24 140.88 58.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.333 -179.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.48 10.37 11.14 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.659 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.7 mp -60.92 -39.0 87.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.273 -179.374 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.84 23.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.469 0.652 . . . . 0.0 110.594 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.5 mt -70.99 -35.4 72.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.517 0.675 . . . . 0.0 110.613 179.398 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -42.77 -62.91 0.88 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.424 -178.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.7 p-10 -65.63 -42.92 90.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 -179.301 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -61.89 -32.6 72.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.399 -179.609 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.4 mt -73.9 -40.8 62.9 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.78 178.672 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.04 -49.0 78.39 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.114 -178.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.9 m -53.02 -42.37 65.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.955 0.407 . . . . 0.0 110.144 179.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.21 -42.7 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 120.909 0.385 . . . . 0.0 111.252 179.044 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.64 153.81 5.22 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.681 -179.401 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -39.25 107.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.702 2.268 . . . . 0.0 112.519 179.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 96.2 m -109.56 121.08 44.4 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.152 0.501 . . . . 0.0 110.272 179.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -113.59 152.24 30.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.294 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 tt -128.77 131.43 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.3 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.8 mt -115.27 127.97 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.553 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.51 103.85 14.74 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.151 179.766 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 147' ' ' LYS . 48.4 p90 -101.3 -11.11 19.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.895 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.92 -33.49 76.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.708 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.0 p-10 -98.21 7.57 46.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.589 -179.622 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.44 155.56 50.34 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.415 -179.38 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.2 p -74.9 165.82 24.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.63 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.589 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.05 -48.83 80.08 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.19 -179.073 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.46 -41.92 66.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.351 . . . . 0.0 110.082 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.6 t -62.69 -41.03 98.89 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.399 178.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.74 -44.51 96.59 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.285 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.33 -43.47 98.83 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.106 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.0 m -55.16 -44.99 75.67 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.17 -40.66 96.78 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 120.948 0.404 . . . . 0.0 110.545 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -61.94 -42.5 99.17 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.378 178.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.19 -40.8 95.03 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.548 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.76 -46.03 63.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.786 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.68 -44.05 96.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 156' ' ' LEU . 32.0 p -92.95 -8.9 41.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.661 -179.023 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.41 26.39 72.71 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -101.74 50.32 0.85 Allowed 'General case' 0 N--CA 1.463 0.214 0 O-C-N 122.638 -0.331 . . . . 0.0 110.68 -179.576 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -69.46 -39.63 77.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.694 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.32 -47.08 86.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.301 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -60.2 -39.42 86.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.129 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.96 99.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.181 179.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.11 -28.39 70.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.67 179.476 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.3 -54.38 7.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.863 179.357 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -65.35 -42.22 93.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.376 -179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.4 mt -62.31 -43.88 98.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.559 -179.418 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.48 -59.23 5.26 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.992 0.425 . . . . 0.0 110.308 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -56.28 -33.99 66.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.572 -179.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -80.73 -36.37 32.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.815 179.524 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.8 m-20 -55.45 -42.22 73.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.91 -178.419 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.17 -42.13 98.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.8 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.08 -38.15 89.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.306 179.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.8 mt -62.44 -42.25 99.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.746 179.452 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.19 -52.84 62.17 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.026 0.441 . . . . 0.0 110.622 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.24 -41.85 89.44 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.641 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.95 95.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.641 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.34 -31.95 73.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.48 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.57 -22.26 18.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.635 -179.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.632 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.84 -41.35 95.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.597 -179.497 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.6 pt -76.73 136.13 25.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.741 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.87 107.98 10.59 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.265 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.71 125.87 0.31 Allowed Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.487 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.5 Cg_exo -43.8 152.42 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.794 2.33 . . . . 0.0 112.58 -179.804 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.18 141.95 54.0 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.536 2.157 . . . . 0.0 112.397 179.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.32 147.46 2.18 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.555 179.323 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.37 154.55 69.12 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.797 2.331 . . . . 0.0 112.272 178.52 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.526 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.57 163.3 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.232 0.539 . . . . 0.0 110.408 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.672 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.2 t -143.56 170.17 16.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.025 179.454 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.672 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -147.94 137.31 22.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.997 0.427 . . . . 0.0 110.127 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 38.0 pt -134.17 146.84 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.7 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -133.01 131.97 58.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.285 0.564 . . . . 0.0 110.439 178.775 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -152.98 156.42 38.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.362 179.202 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 199' ' ' ALA . 85.0 m -122.36 123.12 40.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.906 0.384 . . . . 0.0 110.418 179.416 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.522 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.78 -26.18 67.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.608 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.423 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.89 -49.23 21.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.68 -10.37 59.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.503 -179.703 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.522 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.5 m80 45.84 46.59 12.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 t -130.8 143.51 50.79 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.012 0.434 . . . . 0.0 110.334 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -108.23 105.62 15.42 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.18 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -116.2 128.98 56.07 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.288 0.566 . . . . 0.0 110.29 179.714 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.7 tt -111.82 146.45 37.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.816 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.452 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 11.7 t90 -99.5 128.33 45.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.205 0.526 . . . . 0.0 109.795 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.716 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -94.22 153.8 40.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.434 179.772 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.62 -17.97 48.26 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.674 2.249 . . . . 0.0 112.018 178.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.716 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.4 mt-10 -49.84 -18.59 0.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.392 -179.189 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.452 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.7 p -75.49 164.7 26.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 179.577 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.96 -28.05 65.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.576 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.561 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.5 mt-30 -63.66 -41.4 98.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.59 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.36 -44.48 97.53 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.41 -38.89 92.61 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 122.167 -0.607 . . . . 0.0 110.739 179.67 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.0 mmm -61.83 -41.35 97.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.273 179.716 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.5 -47.75 80.44 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.095 0.474 . . . . 0.0 110.407 179.271 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.63 -32.07 49.83 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.913 0.387 . . . . 0.0 110.413 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -70.84 -18.22 62.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.501 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.61 -8.7 54.23 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.558 -179.469 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.85 2.78 55.13 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.78 151.86 22.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.94 0.4 . . . . 0.0 110.432 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.3 p -114.87 127.8 55.92 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.178 0.513 . . . . 0.0 110.387 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.05 146.79 23.45 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.929 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.459 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.45 151.26 45.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.456 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.96 131.66 42.81 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.519 179.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.626 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.6 93.65 28.89 Favored Pre-proline 0 C--O 1.235 0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.055 -179.529 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.725 ' C ' ' H ' ' A' ' 229' ' ' GLY . 44.8 Cg_exo -55.17 138.55 79.38 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.618 2.212 . . . . 0.0 111.703 178.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.36 -25.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.521 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.725 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.44 -50.19 27.68 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 179.802 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.597 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -55.13 -36.93 66.28 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.101 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -65.77 35.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.806 179.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.597 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.14 88.66 0.01 OUTLIER 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.949 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 87.7 p -82.41 -13.6 56.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.331 -179.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.41 -40.95 11.15 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.633 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 31.9 t -66.65 -16.82 64.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.622 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.79 43.88 27.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.482 -179.599 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.95 -148.75 8.14 Favored Glycine 0 CA--C 1.518 0.245 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.82 142.17 48.86 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.916 0.389 . . . . 0.0 110.267 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -151.93 149.47 28.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.349 179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -102.11 -150.31 0.4 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.344 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.81 -93.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.64 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.488 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.0 tt -126.4 174.72 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.64 -179.589 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.488 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 89.5 mt -122.12 141.2 43.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -99.62 170.5 8.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.189 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 70.0 mt -146.69 149.69 33.93 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.229 179.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.22 -39.41 97.86 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.17 3.22 3.98 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -78.72 -57.42 3.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.937 0.399 . . . . 0.0 110.484 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -62.03 -36.81 82.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.242 -179.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.7 mp -53.06 -67.45 0.25 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.014 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.8 -42.71 68.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.126 -179.297 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.31 17.64 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.701 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.9 47.81 0.25 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 7.9 mp 39.47 -110.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.532 0.206 . . . . 0.0 110.699 -178.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.459 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.7 m120 -60.76 -44.57 96.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.35 -179.563 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.4 7.92 84.09 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.413 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.87 -13.5 20.03 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.761 -0.258 . . . . 0.0 110.678 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.7 t 177.21 142.94 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 0.0 110.448 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 tt -148.19 125.49 11.55 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.161 179.56 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -98.71 143.66 28.83 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 120.914 0.388 . . . . 0.0 110.847 178.269 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.9 mt -95.06 106.67 18.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.736 -179.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.442 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.1 t80 -101.91 -12.63 18.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.122 179.596 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.4 -41.04 89.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.82 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.36 172.86 45.69 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.469 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -73.59 -113.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.75 0.31 . . . . 0.0 110.815 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.6 -28.84 68.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.644 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.11 -43.64 91.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.16 -178.801 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.68 -44.28 94.18 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.267 179.248 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.6 -59.98 3.8 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.111 -179.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.96 -43.52 60.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.112 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.38 -43.33 75.06 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.199 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.2 mt -64.62 -43.61 96.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.674 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -55.94 -37.84 69.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.132 -179.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.48 0.78 18.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.182 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -115.04 90.99 25.21 Favored Pre-proline 0 N--CA 1.463 0.177 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.123 -179.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.09 -27.08 27.89 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.704 2.27 . . . . 0.0 111.979 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.514 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.48 -40.92 98.37 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.518 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 10.1 mp -95.53 5.59 51.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.343 -179.214 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.39 -34.84 68.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.612 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.86 4.59 16.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.495 -178.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.547 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.75 121.13 80.09 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.607 -179.979 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -47.28 -37.6 24.7 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.431 2.087 . . . . 0.0 112.635 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.547 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.84 -43.78 90.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.756 0.313 . . . . 0.0 110.4 179.724 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.03 -43.51 92.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.346 179.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.74 -40.64 95.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.383 -179.191 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -90.22 -12.19 38.77 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.1 mtmt 61.74 32.81 18.2 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.371 0.419 . . . . 0.0 111.024 -179.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -89.04 43.67 1.16 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.13 0.491 . . . . 0.0 110.295 179.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.22 136.02 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.44 -179.661 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -117.02 132.28 56.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.391 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.78 89.14 7.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.819 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.463 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.3 mt -63.97 -41.16 97.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.993 0.425 . . . . 0.0 110.811 179.521 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.02 165.22 33.58 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.511 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 67.6 p -75.26 -25.77 58.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.968 0.413 . . . . 0.0 110.822 179.778 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.542 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -68.39 -33.83 74.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.504 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.505 ' O ' ' CG2' ' A' ' 296' ' ' THR . 95.8 m -73.39 24.72 0.07 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.797 -179.076 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.561 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 44.0 t80 -58.71 -50.85 72.35 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.256 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 77.1 mmt-85 -110.64 153.09 25.7 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 179.135 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 42.7 tp -115.4 124.88 52.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.883 0.373 . . . . 0.0 110.816 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 304' ' ' ALA . 40.6 t0 -147.73 165.53 30.22 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.592 179.572 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -49.4 -37.92 27.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.533 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.32 -65.45 0.75 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.871 0.367 . . . . 0.0 111.582 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.87 -32.76 72.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.013 -179.504 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.5 -25.66 26.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.724 -179.153 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.5 mtt -63.37 -40.83 98.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.874 0.369 . . . . 0.0 111.145 179.694 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.41 -44.24 25.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.103 179.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 78.2 t -66.34 -42.89 91.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.347 179.652 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.438 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.3 tp -60.02 -47.22 86.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.446 -178.516 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -69.82 -39.28 76.59 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.07 0.462 . . . . 0.0 110.811 179.074 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.9 ttt180 -61.87 -38.33 87.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.219 -178.936 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.27 4.61 42.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.57 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.632 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -112.85 -11.25 13.48 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.066 0.46 . . . . 0.0 110.367 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.35 86.89 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.466 179.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.82 -48.81 80.12 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.39 -179.608 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.222 -0.379 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.012 179.912 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.36 -2.55 57.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.372 -179.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.493 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.62 179.05 1.25 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.521 -179.701 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.493 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.8 Cg_exo -60.73 144.74 99.59 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.814 2.343 . . . . 0.0 112.153 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.87 -179.57 8.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.632 -179.851 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.76 136.42 53.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.046 0.45 . . . . 0.0 110.364 179.765 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.08 147.26 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.382 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.9 p -120.3 136.1 54.79 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.813 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.21 -143.52 0.32 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.248 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.7 -37.03 85.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.47 179.623 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.482 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.15 -67.04 0.22 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.418 179.783 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.21 142.5 44.61 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.436 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.7 p -112.64 131.21 55.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.991 0.424 . . . . 0.0 110.463 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -118.96 129.14 55.0 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.54 -179.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.3 m -85.63 130.83 34.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.226 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.2 mt -96.24 78.7 3.11 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.343 179.678 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -65.93 -32.11 73.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.574 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.62 108.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.106 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -121.93 91.21 48.8 Favored Pre-proline 0 C--O 1.233 0.189 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.45 -179.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.663 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.2 Cg_exo -56.75 148.29 66.7 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.798 2.332 . . . . 0.0 111.982 178.98 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.18 82.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.695 0.622 . . . . 0.0 111.002 -179.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.663 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.47 66.72 0.89 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.263 -179.4 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.95 130.98 35.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.851 -179.742 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.75 147.7 26.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.062 0.458 . . . . 0.0 110.013 -179.678 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.2 t -136.62 144.03 43.86 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.753 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.625 ' HG1' ' N ' ' A' ' 50' ' ' SER . 27.1 p -99.45 -59.53 1.7 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.628 179.86 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.625 ' N ' ' HG1' ' A' ' 49' ' ' THR . 86.8 p -79.08 155.64 28.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.623 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.1 t -74.26 -21.65 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.532 179.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.41 ' O ' ' OG ' ' A' ' 56' ' ' SER . 95.4 m -60.34 -52.01 67.08 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.547 -178.502 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.16 -42.7 88.61 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.718 177.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.8 m -43.26 -54.38 4.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.884 -178.54 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.88 -37.36 74.89 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 178.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 52' ' ' THR . 6.8 m -62.91 -44.49 95.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.872 0.368 . . . . 0.0 110.163 -179.304 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.3 mt -66.07 -41.95 90.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.505 0.669 . . . . 0.0 110.663 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.04 -39.95 96.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.344 -179.251 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.48 -35.91 77.02 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.295 -178.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.9 pt -91.14 27.64 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.374 -179.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.403 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 98.8 m-20 57.08 51.93 9.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.084 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.48 76.39 25.25 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.98 149.46 90.49 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.877 2.385 . . . . 0.0 112.146 -178.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -112.43 136.71 47.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 121.115 0.483 . . . . 0.0 110.35 179.661 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.0 pt -69.67 -43.46 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.249 179.439 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.491 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.13 131.27 53.28 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.963 0.411 . . . . 0.0 110.608 -178.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.4 p -155.92 168.63 26.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.531 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.16 -177.43 22.09 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.26 171.92 13.38 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 121.102 0.477 . . . . 0.0 110.425 179.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.3 p -133.81 -110.51 0.22 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.008 0.432 . . . . 0.0 110.583 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.498 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.11 179.62 0.94 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.566 -179.323 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.4 Cg_exo -60.72 58.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.944 2.429 . . . . 0.0 112.126 179.512 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.3 t-20 -64.31 -34.88 79.15 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.48 -179.789 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.566 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 45.9 m-20 95.04 -38.07 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.671 0.607 . . . . 0.0 109.759 -179.436 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 -62.54 -39.88 95.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.99 0.424 . . . . 0.0 110.142 179.234 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -73.6 -26.55 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.693 179.326 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -50.04 -171.77 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.463 -179.381 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -74.38 -153.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 -179.785 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.3 p-10 -54.37 -6.77 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.675 -179.432 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.516 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.9 113.93 23.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.671 179.793 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.39 72.39 1.29 Allowed Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.473 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.3 m-85 -143.8 148.1 35.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.862 0.363 . . . . 0.0 110.876 179.244 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.53 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 7.6 mp -85.99 -98.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.939 178.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.92 -43.38 96.11 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.113 179.395 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.37 52.53 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.794 0.684 . . . . 0.0 111.147 179.195 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.78 -8.63 19.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.347 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.473 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.0 p -65.45 -33.22 75.43 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.05 0.452 . . . . 0.0 110.65 -179.596 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.523 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.87 -23.24 1.02 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.717 179.639 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.4 t -70.13 -45.81 74.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.708 179.708 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.75 80.09 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.974 -179.441 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.41 -38.37 89.41 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.39 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.65 -32.78 52.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.208 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.599 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.5 mmt-85 -89.8 1.81 55.69 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.406 -179.802 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 82.68 -49.18 0.17 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.7 0.625 . . . . 0.0 110.246 179.152 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.673 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.3 mt -45.96 154.11 0.26 Allowed 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.542 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.673 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 121.2 92.05 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 125.17 1.543 . . . . 0.0 110.477 -178.683 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.543 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.92 142.56 44.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.282 0.563 . . . . 0.0 110.368 179.374 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.2 mt -131.6 26.59 4.72 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 122.016 -0.428 . . . . 0.0 110.379 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -139.8 136.96 34.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.06 0.457 . . . . 0.0 110.596 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.52 ' CG2' ' N ' ' A' ' 101' ' ' GLY . 93.7 mt -136.52 164.69 30.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.393 179.592 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.52 ' N ' ' CG2' ' A' ' 100' ' ' ILE . . . 145.19 -28.49 1.83 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.56 70.72 7.42 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 121.08 0.466 . . . . 0.0 110.182 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.08 145.41 98.5 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.705 2.27 . . . . 0.0 112.098 -179.481 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.5 t -134.59 136.91 43.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.509 179.776 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.35 82.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.57 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.2 -42.38 96.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.603 -179.439 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.91 -41.68 98.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.544 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.57 -43.35 98.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.987 179.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.17 -35.04 77.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.206 -179.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.81 -18.71 60.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.363 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.51 -6.4 58.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.457 -179.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.4 mtp 47.54 56.0 17.15 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.576 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.9 Cg_endo -70.33 149.61 63.5 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.816 2.344 . . . . 0.0 112.049 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.46 -73.72 0.64 Allowed 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.46 179.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.1 tp -110.61 113.72 26.55 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.27 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.3 mt -102.84 126.83 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.614 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.1 mt -110.57 134.18 52.63 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.275 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.68 140.05 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.57 -179.574 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 121' ' ' THR . 92.2 p -83.44 168.19 16.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.8 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.5 79.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.455 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.419 ' O ' ' OG ' ' A' ' 119' ' ' SER . 3.6 t -139.99 159.2 42.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.398 -179.85 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.18 176.82 33.49 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.31 -33.67 86.83 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.49 151.67 44.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.858 0.361 . . . . 0.0 110.565 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.8 t -63.39 140.64 58.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.336 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.39 10.35 11.19 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.622 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 10.8 mp -60.75 -39.0 87.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.253 -179.368 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.97 -35.9 23.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.358 0.599 . . . . 0.0 110.594 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.0 mt -70.89 -35.43 72.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.47 0.653 . . . . 0.0 110.607 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -42.78 -62.92 0.88 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.453 -178.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.82 -42.75 90.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.244 -179.395 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -61.83 -32.6 72.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.402 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.2 mt -73.88 -40.82 62.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.879 178.665 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -58.24 -49.18 77.99 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.231 -179.041 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.8 m -53.01 -42.49 65.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.896 0.379 . . . . 0.0 110.089 179.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.18 -42.82 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 120.927 0.394 . . . . 0.0 111.154 179.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.4 153.39 5.26 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.684 -179.395 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -39.08 107.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.666 2.244 . . . . 0.0 112.537 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 94.1 m -109.68 121.08 44.4 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.115 0.483 . . . . 0.0 110.246 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -113.76 153.08 29.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.32 -179.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 tt -128.58 131.45 68.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.383 179.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.41 128.17 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.605 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.501 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 53.6 t30 -99.59 104.02 15.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.133 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.416 ' O ' ' O ' ' A' ' 147' ' ' LYS . 50.8 p90 -98.87 -12.39 20.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.969 -179.705 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.6 p-10 -64.93 -33.89 77.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.798 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.592 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.7 p-10 -99.23 6.89 46.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.596 -179.376 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.8 mttm -133.71 149.59 51.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.559 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.423 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -76.43 167.31 22.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.618 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.603 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.2 t90 -59.07 -48.3 82.1 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.166 -179.158 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -54.4 -45.99 73.04 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 40.4 t -63.42 -40.8 98.14 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.094 0.473 . . . . 0.0 110.2 178.429 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.5 tp -61.04 -44.67 97.05 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.119 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.49 -42.71 99.21 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.207 179.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.5 m -55.78 -45.61 78.14 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.39 -40.4 96.37 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.812 0.339 . . . . 0.0 110.445 179.766 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.3 mm? -61.81 -42.54 99.14 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.312 178.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.78 -40.0 95.45 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.425 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.36 -45.61 65.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.922 0.391 . . . . 0.0 110.843 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.9 mt -65.02 -43.88 96.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.82 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.3 p -92.89 -9.11 41.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.656 -179.049 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.96 26.42 72.28 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -101.72 50.76 0.84 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.883 0.373 . . . . 0.0 110.668 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.53 -39.31 77.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.608 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.37 -47.36 85.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.36 -179.448 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.403 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 87.3 mt-30 -60.3 -39.3 86.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.112 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.05 99.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.186 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.07 -28.39 70.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.607 179.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.21 -54.42 7.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.939 179.405 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -65.5 -41.98 92.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.561 -179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 174' ' ' ASP . 78.9 mt -62.31 -43.92 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.549 -179.319 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.91 -57.85 9.39 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 120.995 0.426 . . . . 0.0 110.416 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -57.56 -33.83 68.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.619 -179.134 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -81.15 -36.43 30.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.774 179.648 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.4 m-20 -55.72 -41.64 74.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.095 -178.672 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.49 -42.1 99.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.631 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.19 -38.35 90.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.255 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.45 -42.02 99.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.76 179.498 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.18 -53.16 59.29 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.091 0.472 . . . . 0.0 110.628 179.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -65.87 -42.08 90.82 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.722 179.502 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.51 -39.45 94.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.669 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.7 -32.06 73.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.4 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -95.34 -21.96 18.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.617 -179.677 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.64 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.38 -41.77 96.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.685 -179.494 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.4 pt -74.53 135.55 27.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.016 0.436 . . . . 0.0 110.707 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.29 106.2 9.35 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.346 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -178.02 127.51 0.28 Allowed Pre-proline 0 C--O 1.239 0.53 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.513 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.447 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.7 Cg_exo -43.53 151.81 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.892 2.395 . . . . 0.0 112.53 -179.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.44 142.81 55.46 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.608 2.205 . . . . 0.0 112.343 179.672 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.545 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -171.66 147.14 1.99 Allowed Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.527 179.327 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.13 155.29 68.49 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.887 2.391 . . . . 0.0 112.34 178.676 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.59 163.14 28.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.201 0.524 . . . . 0.0 110.409 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.67 ' HG1' ' H ' ' A' ' 193' ' ' ALA . 2.2 t -143.3 169.36 17.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.031 179.455 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.67 ' H ' ' HG1' ' A' ' 192' ' ' THR . . . -147.41 137.1 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.365 . . . . 0.0 110.177 179.525 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 38.0 pt -134.08 146.12 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.759 179.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.491 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -133.32 132.11 58.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.286 0.565 . . . . 0.0 110.431 178.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -153.07 156.55 38.94 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.403 179.193 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.4 m -121.84 122.93 40.57 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.41 179.556 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.467 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.94 -26.09 67.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.606 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.404 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.77 -49.56 20.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.974 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -75.79 -13.22 60.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.471 -179.65 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.467 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 78.4 m80 49.56 46.51 23.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.621 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.5 t -131.59 146.04 52.01 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.075 0.464 . . . . 0.0 110.247 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.21 106.05 15.33 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.234 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -116.36 129.19 56.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.09 0.471 . . . . 0.0 110.276 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.7 tt -111.95 146.32 38.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.017 0.437 . . . . 0.0 110.889 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.456 ' NE1' ' OG ' ' A' ' 210' ' ' SER . 17.4 t90 -98.73 128.86 45.11 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.139 0.495 . . . . 0.0 109.912 179.442 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.699 ' HG1' ' H ' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -96.05 153.55 39.12 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.229 179.909 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.8 -18.25 47.35 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.748 2.299 . . . . 0.0 111.981 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.699 ' H ' ' HG1' ' A' ' 207' ' ' THR . 97.5 mt-10 -49.9 -19.16 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.437 -179.273 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.456 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.7 p -75.86 167.63 21.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.449 179.61 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.46 74.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.453 -179.682 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.506 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.2 mt-30 -56.55 -40.68 75.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.756 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.31 -43.71 97.09 Favored Glycine 0 C--N 1.329 0.165 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.532 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.512 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.2 mt-30 -64.32 -40.57 96.16 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 122.341 -0.505 . . . . 0.0 110.796 -179.896 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.603 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.3 mmm -62.02 -42.46 99.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.499 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 39.7 mt -62.91 -49.21 75.69 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.049 0.452 . . . . 0.0 110.432 179.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.67 -31.52 62.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 110.441 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -69.48 -17.47 63.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.541 179.792 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.0 mt -87.3 -11.5 49.32 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.616 -179.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 105.19 1.32 41.43 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.723 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -88.2 156.1 19.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.923 0.392 . . . . 0.0 110.692 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 7.1 p -116.39 128.59 55.65 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.183 0.516 . . . . 0.0 110.201 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.566 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 3.6 mm? -90.53 146.81 23.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.993 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.458 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -71.62 150.47 44.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.414 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.5 131.94 42.15 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.575 179.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.623 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.03 94.2 28.83 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.984 -179.579 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.727 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.8 Cg_exo -55.19 138.57 79.49 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.651 2.234 . . . . 0.0 111.602 178.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.28 -25.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.46 -179.59 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.727 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.07 -49.67 26.42 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.601 ' C ' ' H ' ' A' ' 232' ' ' ALA . 98.1 mt -54.89 -37.29 66.13 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.127 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -65.71 35.52 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.775 179.37 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.601 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.78 87.82 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.5 p -81.38 -13.86 57.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.382 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.73 -40.41 11.27 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.628 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 26.9 t -66.93 -16.62 64.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.573 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.83 43.82 27.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.488 -179.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.4 -146.52 7.16 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.23 142.98 49.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.947 0.404 . . . . 0.0 110.397 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -151.82 149.37 28.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.034 0.445 . . . . 0.0 110.28 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -101.22 -151.3 0.41 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.348 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 55.67 -92.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.712 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.492 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.0 tt -126.57 174.63 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.618 -179.469 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.492 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -121.69 140.96 44.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.476 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.28 170.33 8.73 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.307 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.1 mt -146.82 149.55 33.53 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.191 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.42 -39.3 97.58 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.22 3.06 4.0 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -78.29 -57.73 3.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.935 0.398 . . . . 0.0 110.463 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -62.06 -37.06 83.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.297 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.7 mp -52.71 -67.78 0.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.74 -42.46 68.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.133 -179.283 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.39 17.69 0.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.668 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.05 48.0 0.27 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 8.1 mp 39.06 -110.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.493 0.187 . . . . 0.0 110.696 -178.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.458 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 12.0 m120 -60.66 -44.58 96.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.42 -179.639 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.32 7.85 84.33 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.329 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -98.67 -13.41 20.31 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.763 -0.257 . . . . 0.0 110.69 -179.795 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.5 t 177.03 142.72 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.132 0.492 . . . . 0.0 110.382 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 tt -147.71 125.46 11.88 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.288 179.55 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -98.61 143.7 28.71 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 120.927 0.394 . . . . 0.0 110.731 178.405 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.2 mt -95.12 106.33 18.33 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.773 -179.255 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.481 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.8 t80 -102.45 -12.26 17.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.112 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.53 -40.04 88.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.883 179.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.16 173.61 46.07 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.463 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 96.5 m-20 -74.43 -113.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 0.0 110.769 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.5 -29.16 68.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.693 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.9 -43.81 91.1 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.112 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.36 -44.68 94.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.271 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.46 -59.95 3.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.197 -179.792 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -51.02 -43.64 60.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.082 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.12 -43.75 74.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.156 -179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.8 mt -64.41 -43.65 97.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.579 179.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -56.63 -37.9 71.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.144 -179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.5 1.03 17.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.179 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -115.17 91.24 26.83 Favored Pre-proline 0 N--CA 1.461 0.089 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.176 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.12 -26.93 27.6 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.748 2.299 . . . . 0.0 111.975 179.329 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.515 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 4.0 mm? -63.55 -40.82 98.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.577 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 278' ' ' LEU . 9.9 mp -95.16 5.57 51.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.381 -179.022 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.03 -35.14 69.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.618 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.63 4.27 16.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.492 -178.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.68 120.69 77.39 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.575 179.953 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -47.27 -37.66 24.7 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.446 2.097 . . . . 0.0 112.6 -179.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.553 ' H ' HD23 ' A' ' 281' ' ' LEU . . . -58.93 -43.63 91.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.43 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.83 -43.61 93.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.337 179.241 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.9 -40.58 95.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.396 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.8 -12.28 39.65 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.508 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.81 31.66 18.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.051 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.44 44.04 1.17 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.128 0.49 . . . . 0.0 110.308 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.8 136.13 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.563 -179.704 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.66 132.5 56.67 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.361 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.496 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.35 88.66 6.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.794 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.465 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.1 mt -63.82 -41.51 97.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.697 179.533 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.481 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.5 165.13 34.28 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.789 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.7 p -75.53 -26.09 57.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.551 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.4 tp10 -68.67 -33.77 74.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.394 -179.699 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.507 ' O ' ' CG2' ' A' ' 296' ' ' THR . 98.1 m -72.47 22.19 0.06 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.215 0.531 . . . . 0.0 110.761 -179.351 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.551 ' H ' ' C ' ' A' ' 295' ' ' GLU . 49.1 t80 -57.86 -51.0 71.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.851 -179.253 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.9 mmt-85 -108.02 150.03 27.66 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 44.7 tp -116.46 127.31 54.47 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.77 179.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 304' ' ' ALA . 42.6 t0 -150.99 167.82 26.45 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.675 179.631 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.4 ' CE2' ' CE ' ' A' ' 305' ' ' MET . 91.4 t80 -49.3 -38.09 26.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.622 -179.54 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.16 -65.63 0.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.588 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.64 -33.03 72.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.028 -179.479 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 300' ' ' ASP . . . -54.17 -25.31 21.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.782 -179.125 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 305' ' ' MET . . . . . 0.4 ' CE ' ' CE2' ' A' ' 301' ' ' TYR . 61.3 mtt -63.57 -41.09 98.4 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.933 0.397 . . . . 0.0 111.158 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.96 -43.88 23.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.181 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 77.9 t -66.21 -42.86 91.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.405 179.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.2 tp -60.34 -46.76 88.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.48 -178.555 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -70.47 -39.47 74.22 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.098 0.475 . . . . 0.0 110.805 179.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.496 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 73.6 ttt180 -61.56 -37.53 84.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.292 -179.029 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.6 mt -87.99 4.18 45.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.642 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.64 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 86.9 tttt -112.2 -11.26 13.77 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.003 0.43 . . . . 0.0 110.396 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.17 86.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.406 179.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.82 -48.89 79.75 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.474 -179.703 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.005 179.877 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.61 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.06 -2.34 58.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.373 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.481 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.5 179.18 1.22 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.469 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.5 Cg_exo -60.8 145.38 99.06 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.729 2.286 . . . . 0.0 112.166 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.61 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 34.9 ptt-85 -156.29 -179.47 8.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.579 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -116.18 137.44 52.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.323 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.69 146.88 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.322 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.5 p -119.93 135.81 54.76 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.807 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.16 -143.65 0.32 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.19 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.45 -37.14 86.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.445 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.481 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.31 -66.51 0.22 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.484 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.62 142.35 45.68 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 p -112.06 131.4 55.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.89 0.376 . . . . 0.0 110.391 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -118.98 128.81 54.74 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.499 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.0 m -85.62 130.28 34.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.143 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.486 HD22 ' OE1' ' A' ' 42' ' ' GLN . 70.0 mt -96.25 78.76 3.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.317 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.54 -32.15 73.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.471 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.6 109.77 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.044 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.486 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -123.3 91.37 49.85 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.199 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.636 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.2 Cg_exo -57.07 148.92 65.88 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.738 2.292 . . . . 0.0 111.773 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.28 83.11 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.631 0.582 . . . . 0.0 111.047 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.636 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.64 67.09 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.129 0.49 . . . . 0.0 110.261 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.45 130.82 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.515 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.563 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.9 t -122.84 147.01 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.085 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.9 t -136.24 143.8 44.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.644 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.3 p -99.08 -59.25 1.76 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.53 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.1 p -79.3 155.27 28.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.695 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.524 HG21 HG23 ' A' ' 70' ' ' THR . 71.4 t -74.22 -21.85 17.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.62 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.8 m -60.37 -51.98 67.21 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.486 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.8 mt -66.29 -42.52 88.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.502 0.668 . . . . 0.0 110.951 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.0 m -43.44 -53.76 5.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.076 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.13 -37.36 72.53 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.6 m -62.77 -44.63 95.68 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.367 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.412 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.0 mt -65.98 -42.17 90.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.43 0.633 . . . . 0.0 110.69 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 tp -62.59 -40.13 95.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.467 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.505 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.29 -36.16 77.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.05 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 156' ' ' LEU . 32.0 pt -90.75 28.61 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.177 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.59 51.39 11.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.825 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.72 75.14 26.12 Favored Pre-proline 0 C--N 1.333 -0.15 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.97 151.24 86.12 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.718 2.278 . . . . 0.0 112.16 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.563 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.63 137.29 47.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.306 0.574 . . . . 0.0 110.23 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.437 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.1 pt -69.06 -43.69 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.373 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.481 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.2 130.94 53.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.987 0.423 . . . . 0.0 110.597 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.525 ' O ' ' O ' ' A' ' 97' ' ' ARG . 30.8 p -155.41 168.88 25.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.346 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.77 -177.33 21.7 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.632 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.44 172.57 12.53 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.857 0.36 . . . . 0.0 110.556 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.524 HG23 HG21 ' A' ' 51' ' ' VAL . 14.7 p -132.47 -113.0 0.23 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.348 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.03 179.98 0.9 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.211 -178.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.7 Cg_exo -60.89 57.93 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 123.027 2.485 . . . . 0.0 112.187 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.4 t-20 -64.28 -34.13 77.41 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 118.606 -0.712 . . . . 0.0 110.584 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 14.0 m120 93.91 -36.21 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.617 1.198 . . . . 0.0 109.753 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.411 ' HD3' HD21 ' A' ' 73' ' ' ASN . 78.1 mtp85 -62.7 -39.9 95.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.224 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.17 -25.83 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.804 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.32 -171.18 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.649 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -73.94 -153.88 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.833 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.8 p-10 -52.74 -7.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.658 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.3 114.89 23.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.556 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.88 70.11 1.35 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -143.25 147.91 35.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.941 0.4 . . . . 0.0 110.819 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.76 -98.62 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.125 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.1 mtt-85 -63.88 -42.71 97.43 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.236 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.3 tt0 91.72 53.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.286 0.991 . . . . 0.0 110.917 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -103.4 -9.0 19.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.404 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.5 p -64.66 -34.0 77.26 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.167 0.508 . . . . 0.0 110.777 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.79 -24.57 1.47 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.56 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.25 -46.04 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.048 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.27 -48.43 81.47 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.98 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.73 -38.21 89.62 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.347 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.95 -32.08 52.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.218 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.576 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.4 mmt-85 -90.09 1.9 55.85 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.686 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.36 -49.43 0.2 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 124.412 1.07 . . . . 0.0 110.366 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.613 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 83.2 mt -46.48 154.73 0.27 Allowed 'General case' 0 CA--C 1.485 -1.549 0 CA-C-O 117.068 -1.444 . . . . 0.0 108.966 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.613 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 120.82 92.68 0.0 OUTLIER 'General case' 0 C--N 1.359 1.001 0 O-C-N 125.958 2.036 . . . . 0.0 110.527 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.525 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.6 143.47 42.31 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.227 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.8 mt -132.47 27.03 4.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.692 0.282 . . . . 0.0 110.436 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.48 138.18 34.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.027 0.441 . . . . 0.0 110.491 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.632 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.6 mt -137.15 164.91 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.385 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.611 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.25 -28.59 1.81 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -152.54 70.99 7.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.193 0.521 . . . . 0.0 110.287 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.04 145.42 98.43 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.711 2.274 . . . . 0.0 112.075 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.1 t -134.78 136.59 42.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.035 0.445 . . . . 0.0 110.507 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.29 -38.17 81.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.702 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.25 -42.09 96.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.57 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.27 -41.48 98.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.515 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 64.9 t -63.67 -43.56 98.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.947 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.25 78.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.336 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.34 -18.67 59.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.502 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.76 -6.42 58.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.52 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 75.8 mtp 47.74 55.83 17.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.599 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.9 Cg_endo -70.49 150.02 63.11 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.841 2.361 . . . . 0.0 112.044 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -101.4 -75.9 0.58 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.404 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.4 HD11 HD13 ' A' ' 140' ' ' LEU . 38.6 tp -108.38 113.7 26.98 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.218 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.0 mt -102.64 126.77 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.404 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.5 mt -109.73 133.68 52.86 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.084 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.28 139.08 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.496 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.5 p -83.17 168.33 16.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.68 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -37.46 80.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.454 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -140.06 158.89 43.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.43 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.18 177.36 33.26 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.16 -33.82 87.11 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.61 151.84 44.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.874 0.369 . . . . 0.0 110.588 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.1 t -63.03 141.06 58.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.288 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.04 9.85 11.3 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.697 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.9 mp -61.22 -39.18 89.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.056 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.629 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.76 -36.01 23.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.647 0.737 . . . . 0.0 110.704 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -70.59 -35.61 73.1 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.488 0.661 . . . . 0.0 110.828 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -42.85 -63.03 0.86 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.332 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.629 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.89 -42.62 90.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.97 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.11 -33.18 73.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.083 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.2 mt -72.86 -40.74 65.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.24 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.51 -48.61 80.24 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.139 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 m -53.29 -42.25 66.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.105 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.78 -42.93 93.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.998 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.55 156.38 5.23 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.581 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -39.63 107.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.581 2.188 . . . . 0.0 112.347 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.642 ' C ' HD12 ' A' ' 140' ' ' LEU . 89.8 m -110.11 120.81 43.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.234 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.642 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.45 152.67 31.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.125 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -129.39 131.44 67.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.38 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.9 mt -115.17 128.12 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.384 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.2 t30 -101.6 103.61 14.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.262 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.5 p90 -100.96 -11.36 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.774 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.4 p-10 -64.79 -33.81 76.86 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.705 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.6 p-10 -98.08 7.8 45.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.63 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.7 155.41 50.44 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.543 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.404 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -74.93 165.68 24.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.668 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.598 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.84 -48.75 80.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.185 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -53.7 -41.96 67.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.918 0.39 . . . . 0.0 110.012 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.6 t -62.58 -41.14 98.76 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.391 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.406 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.8 tp -60.64 -44.13 96.75 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.315 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.7 tp -61.5 -43.42 98.9 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.226 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -54.99 -44.79 74.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.659 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.42 -40.68 97.35 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.893 0.377 . . . . 0.0 110.355 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.2 -42.35 99.21 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.387 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.05 -41.02 95.36 Favored Glycine 0 C--N 1.315 -0.587 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.42 -46.13 64.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.949 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.6 -44.05 96.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.816 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.4 p -93.02 -8.74 42.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.595 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.93 26.63 72.32 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -101.99 50.96 0.83 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.814 0.34 . . . . 0.0 110.721 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -69.67 -39.46 76.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.751 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.58 -47.08 86.98 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.268 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -60.02 -39.24 85.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.332 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.13 -40.87 98.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.277 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.91 -28.69 70.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.07 0.462 . . . . 0.0 110.571 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.03 -54.24 8.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.221 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.505 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.51 -42.1 92.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.439 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.9 mt -62.35 -43.78 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.434 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.72 -57.53 10.64 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.082 0.468 . . . . 0.0 110.509 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.89 -34.05 69.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.342 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.4 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.4 t80 -80.76 -37.15 30.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.075 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.5 m-20 -55.56 -41.45 73.31 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.245 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.75 -42.23 99.58 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.727 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.3 -37.83 88.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.227 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.4 HD11 ' CD2' ' A' ' 173' ' ' PHE . 82.6 mt -62.5 -42.24 99.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.737 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.04 -52.59 63.35 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.096 0.474 . . . . 0.0 110.7 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.37 -41.75 88.99 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.592 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.92 95.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.623 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.23 -32.43 73.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.381 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.09 -22.38 18.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.762 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.426 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.6 tt0 -64.85 -41.01 96.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.64 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.6 pt -77.16 136.6 24.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.623 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -127.15 108.22 10.71 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.218 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.08 126.0 0.34 Allowed Pre-proline 0 N--CA 1.446 -0.669 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.588 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.7 Cg_exo -44.04 152.61 0.37 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.664 2.242 . . . . 0.0 112.606 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.19 141.88 53.76 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.59 2.193 . . . . 0.0 112.456 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.547 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.16 147.2 2.19 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.648 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.46 155.23 67.5 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.745 2.297 . . . . 0.0 112.299 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.576 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.63 163.12 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.362 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.576 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.58 170.16 16.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.912 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.86 137.42 22.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.208 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.565 HG22 HD12 ' A' ' 205' ' ' LEU . 37.7 pt -134.26 146.51 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.603 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.92 131.98 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.305 0.574 . . . . 0.0 110.57 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -152.85 156.43 38.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.379 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.0 m -122.08 122.92 40.36 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.934 0.397 . . . . 0.0 110.329 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.486 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.78 -26.55 67.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.534 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.597 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.12 -50.02 21.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.079 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -75.75 -13.46 60.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.506 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.486 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 78.1 m80 49.94 46.21 24.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.529 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.6 t -131.14 144.86 51.7 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.317 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.428 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -109.4 106.08 15.71 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.204 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -116.46 129.69 56.35 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.14 0.495 . . . . 0.0 110.307 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.565 HD12 HG22 ' A' ' 194' ' ' ILE . 7.7 tt -112.36 146.19 38.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.719 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.466 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.9 t90 -99.34 128.68 45.48 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.141 0.496 . . . . 0.0 109.959 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.82 154.08 39.91 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.107 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.6 Cg_endo -67.71 -17.97 47.79 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.736 2.291 . . . . 0.0 111.897 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.43 -18.92 0.45 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.402 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.441 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.1 p -75.5 164.57 26.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.488 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.9 -27.89 65.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.532 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.61 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.8 mt-30 -63.76 -41.19 98.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.64 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.44 -44.28 97.82 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.55 -38.94 92.74 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 120.989 0.423 . . . . 0.0 110.461 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.28 -41.26 98.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.062 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 71.7 mt -63.6 -47.06 82.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.635 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.34 -31.75 55.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.91 -18.25 62.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.526 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.429 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.0 mt -88.11 -8.75 54.99 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.651 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.64 2.1 55.34 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -88.46 153.29 21.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.755 0.312 . . . . 0.0 110.436 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.462 ' O ' HG12 ' A' ' 191' ' ' VAL . 10.3 p -116.05 128.63 55.85 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.078 0.466 . . . . 0.0 110.384 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.33 146.33 23.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.901 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.456 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.24 151.36 45.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.432 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.37 131.88 42.32 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.394 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.877 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.3 93.71 27.73 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.002 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.678 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.1 Cg_exo -55.63 138.78 81.9 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.574 2.182 . . . . 0.0 111.435 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.56 -25.61 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.551 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.63 -49.89 28.03 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.9 mt -55.23 -37.16 66.8 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -65.54 35.65 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.909 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.569 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.47 88.32 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.773 0.32 . . . . 0.0 110.852 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.2 p -81.44 -13.4 58.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.377 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.86 -40.76 11.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.604 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.0 t -66.64 -17.02 64.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.644 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.01 44.0 26.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.485 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.29 -148.21 8.05 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.68 142.5 48.42 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.888 0.375 . . . . 0.0 110.352 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.422 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.3 ttt-85 -152.11 149.55 28.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.334 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -102.43 -150.12 0.4 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.26 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 55.48 -92.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.575 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.425 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.3 tt -127.2 174.13 11.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.498 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.425 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 88.2 mt -121.57 140.84 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.798 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.36 170.53 8.57 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.4 mt -146.88 149.53 33.44 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.253 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.19 -39.32 97.78 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.09 2.96 4.08 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -78.48 -57.32 3.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 110.621 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.618 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.2 m-20 -62.19 -36.81 83.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.084 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.428 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.8 mp -53.31 -67.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.05 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.482 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.84 -42.55 68.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.13 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.67 17.72 0.15 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.659 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.99 47.85 0.26 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 254' ' ' LEU . 7.8 mp 39.53 -110.17 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.601 0.238 . . . . 0.0 110.637 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.456 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -61.2 -44.15 97.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.326 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.15 8.14 84.19 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.86 -13.34 20.11 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.774 -0.251 . . . . 0.0 110.69 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.9 t 176.89 142.74 0.08 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.174 0.511 . . . . 0.0 110.51 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.3 tt -147.96 125.72 11.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.1 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.6 m-30 -98.92 143.42 29.24 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 120.917 0.389 . . . . 0.0 110.785 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.4 mt -94.7 106.26 18.23 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.55 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.436 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.0 t80 -101.98 -11.82 18.65 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.122 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.5 86.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.923 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.46 172.99 45.8 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.451 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.7 m-20 -73.9 -112.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.771 0.32 . . . . 0.0 110.701 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.05 -28.72 67.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.766 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.24 -43.59 92.4 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.159 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.48 -44.26 94.91 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.406 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.78 -59.77 4.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.158 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.29 -43.32 61.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.166 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.26 -43.42 74.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.163 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 93.2 mt -64.48 -43.63 96.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.651 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -56.43 -37.43 70.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.138 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.64 0.63 19.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.266 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -114.85 91.35 25.8 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.196 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.28 -27.22 29.78 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.773 2.315 . . . . 0.0 111.729 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.4 -41.2 98.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.585 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.25 5.12 52.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.291 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.79 -35.18 69.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.722 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -79.65 4.63 15.47 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.472 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.526 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.61 121.46 81.04 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.639 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -47.65 -37.48 27.3 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.349 2.032 . . . . 0.0 112.586 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -59.1 -43.71 91.89 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 63.0 t -65.87 -43.85 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.92 0.391 . . . . 0.0 110.287 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.68 -40.53 95.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.53 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 48.0 t-20 -89.84 -12.69 38.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.515 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 61.99 32.55 17.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.88 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.14 43.94 1.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.359 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.38 135.59 41.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.42 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.68 132.14 56.77 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.492 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.507 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.68 88.01 7.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.71 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.07 -40.64 96.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.96 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.436 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.33 167.99 34.93 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 75.7 p -75.93 -25.67 56.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 110.716 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.1 tp10 -67.45 -34.86 78.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.352 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.761 HG22 ' O ' ' A' ' 296' ' ' THR . 95.4 m -73.36 25.12 0.07 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.671 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.61 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 59.4 t80 -58.34 -51.15 71.03 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.431 HH12 ' HG3' ' A' ' 212' ' ' GLN . 68.6 mmt-85 -111.79 154.84 24.47 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.429 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.1 tp -115.92 125.2 52.27 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.484 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.6 t0 -147.79 165.67 29.85 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.585 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -48.99 -38.26 22.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.597 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -71.79 -65.17 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.458 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.6 p -60.84 -32.86 72.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.126 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.75 -25.19 26.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.585 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.8 mtt -63.54 -40.99 98.44 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 120.91 0.386 . . . . 0.0 111.01 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -79.03 -44.01 23.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.977 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.568 HG21 HG23 ' A' ' 296' ' ' THR . 77.5 t -65.94 -43.24 92.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.417 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.43 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 54.5 tp -60.66 -46.94 88.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.622 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -69.51 -39.62 77.47 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.466 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.507 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.0 ttt180 -61.94 -38.36 88.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.146 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.1 mt -86.82 4.09 42.54 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.834 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -112.71 -11.45 13.52 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.174 0.512 . . . . 0.0 110.29 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.04 85.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.624 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.02 -48.64 80.88 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.331 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.868 -1.063 . . . . 0.0 109.992 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.61 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.36 -2.63 57.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.383 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.476 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.09 179.03 1.26 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.452 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.9 Cg_exo -60.85 145.46 98.97 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.558 2.172 . . . . 0.0 112.171 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.61 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.29 -179.76 8.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.624 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.14 137.0 52.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.372 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -124.23 146.67 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.314 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -119.76 135.61 54.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.759 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.15 -143.98 0.32 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.143 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.21 -37.35 86.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.533 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.89 -66.99 0.23 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.532 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.47 142.56 45.14 Favored Glycine 0 C--O 1.224 -0.48 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.0 p -112.28 131.26 55.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.922 0.392 . . . . 0.0 110.26 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -118.7 128.86 54.9 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.545 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.1 m -85.44 130.43 34.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.198 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.487 HD22 ' OE1' ' A' ' 42' ' ' GLN . 71.1 mt -96.49 78.81 3.02 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.16 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.6 -32.06 73.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.501 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.75 108.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.024 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.487 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -122.11 90.79 48.98 Favored Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.245 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.636 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.0 Cg_exo -56.96 148.6 66.93 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.708 2.272 . . . . 0.0 111.652 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.13 82.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.574 0.546 . . . . 0.0 111.056 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.636 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.76 67.16 0.87 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.302 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.05 131.14 35.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.461 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.572 ' HA ' HG23 ' A' ' 64' ' ' VAL . 58.3 t -122.78 147.38 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.154 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.3 t -136.18 143.94 44.7 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.556 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 50' ' ' SER . 17.2 p -99.45 -59.39 1.73 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.492 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.42 ' N ' ' OG1' ' A' ' 49' ' ' THR . 86.6 p -79.4 155.06 28.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.93 0.395 . . . . 0.0 110.671 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.546 HG21 HG23 ' A' ' 70' ' ' THR . 68.9 t -73.47 -21.9 18.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.598 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.6 m -60.52 -51.74 68.13 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.384 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.9 mt -66.13 -42.62 88.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.496 0.665 . . . . 0.0 110.911 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.1 m -43.86 -54.16 5.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.996 -178.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.63 -37.11 77.01 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.0 m -63.2 -44.36 95.57 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.217 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.3 mt -65.73 -42.25 91.27 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.274 0.559 . . . . 0.0 110.544 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.93 -39.68 95.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.431 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.513 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.73 -36.2 78.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.078 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.511 HD11 HD12 ' A' ' 156' ' ' LEU . 33.5 pt -90.62 27.31 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.251 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 57.12 51.27 10.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.835 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -139.23 76.08 32.79 Favored Pre-proline 0 C--O 1.227 -0.081 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.66 149.42 90.93 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.634 2.223 . . . . 0.0 112.089 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -112.41 136.3 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.302 0.572 . . . . 0.0 110.161 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.431 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -68.97 -43.75 81.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.448 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.15 130.51 52.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.114 0.483 . . . . 0.0 110.613 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.6 p -155.28 168.83 25.78 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.305 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.6 -177.38 21.8 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.645 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.37 172.51 12.6 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.776 0.322 . . . . 0.0 110.601 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.546 HG23 HG21 ' A' ' 51' ' ' VAL . 12.9 p -133.81 -110.92 0.22 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.532 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.22 179.78 0.91 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.149 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.7 Cg_exo -60.91 58.88 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.892 2.395 . . . . 0.0 112.139 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.539 ' N ' ' O ' ' A' ' 71' ' ' THR . 57.7 t-20 -64.07 -34.44 78.03 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.693 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.8 m120 94.34 -36.73 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 125.018 1.449 . . . . 0.0 109.778 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -63.06 -40.53 97.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.083 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -73.7 -26.56 21.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.933 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.68 -172.37 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.64 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.44 -152.91 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.809 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.3 p-10 -54.74 -6.54 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.684 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.486 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -87.37 114.11 23.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.956 0.408 . . . . 0.0 110.487 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.67 71.67 1.31 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -143.02 148.7 37.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.795 0.331 . . . . 0.0 110.968 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -86.5 -99.06 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.91 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.61 -43.55 96.55 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 119.027 -0.511 . . . . 0.0 110.141 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.3 tt0 91.77 52.37 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 124.487 1.117 . . . . 0.0 111.156 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -103.48 -8.58 20.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.449 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.5 p -65.29 -33.39 75.86 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.323 0.582 . . . . 0.0 110.819 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -48.86 -23.88 1.25 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.531 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.6 t -69.88 -45.78 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.299 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.49 -48.27 81.84 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.065 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.58 -38.5 90.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.303 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.84 -33.2 55.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.177 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.566 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.3 mmt-85 -88.88 1.86 54.68 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.619 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.43 -49.42 0.19 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.616 1.197 . . . . 0.0 110.347 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.598 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.8 mt -46.48 154.14 0.31 Allowed 'General case' 0 CA--C 1.485 -1.551 0 CA-C-O 117.082 -1.437 . . . . 0.0 108.67 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.598 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.1 91.89 0.0 OUTLIER 'General case' 0 C--N 1.363 1.16 0 O-C-N 125.944 2.028 . . . . 0.0 110.677 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.531 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.85 143.14 44.02 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.046 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.6 mt -132.15 26.47 4.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.492 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.03 137.6 34.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.942 0.401 . . . . 0.0 110.579 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.645 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.6 mt -136.82 164.63 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.383 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.606 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.88 -28.82 1.72 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -151.95 70.65 7.87 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.038 0.447 . . . . 0.0 110.26 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.14 145.41 98.54 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.686 2.257 . . . . 0.0 112.059 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.4 t -135.01 137.09 42.66 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.467 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.99 -38.1 82.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.701 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.44 -41.92 96.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.629 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.25 -41.38 98.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.386 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.75 -43.57 98.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.745 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.1 77.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.326 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.52 -18.85 60.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.489 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.63 -6.56 58.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.47 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.1 mtp 47.77 55.76 17.08 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.686 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.3 Cg_endo -70.0 149.56 65.51 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.927 2.418 . . . . 0.0 112.016 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.38 -72.81 0.67 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.42 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.418 HD11 HD13 ' A' ' 140' ' ' LEU . 38.2 tp -111.76 114.22 27.08 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.8 mt -103.16 126.87 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.344 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 mt -110.22 134.27 52.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.951 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.57 139.09 48.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.612 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.4 p -82.77 167.94 17.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.839 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.51 -37.27 80.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.38 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.91 158.6 43.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.457 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.45 177.12 33.6 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.15 -33.76 86.89 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.74 151.7 44.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.898 0.38 . . . . 0.0 110.58 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.4 t -63.48 141.14 58.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.284 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.51 10.44 11.13 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.654 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.7 mp -61.1 -39.48 90.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.994 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.63 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.44 -36.12 24.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.662 0.744 . . . . 0.0 110.681 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.8 mt -70.52 -35.61 73.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.83 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -43.04 -62.81 0.93 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.485 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.63 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.86 -42.63 90.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.932 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -62.09 -33.34 74.25 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.019 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.0 mt -72.57 -40.96 66.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.49 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.78 -48.27 81.83 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.131 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 65.7 m -53.61 -42.32 67.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.93 -43.12 92.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.889 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.42 153.39 5.25 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.591 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -39.05 107.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.519 2.146 . . . . 0.0 112.152 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.635 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.9 m -109.52 121.58 45.5 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.258 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 139' ' ' THR . 10.9 mp -113.85 152.58 30.51 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.182 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.34 131.03 69.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.287 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.28 128.02 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.441 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.0 t30 -100.7 104.75 16.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.221 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.419 ' O ' ' O ' ' A' ' 147' ' ' LYS . 45.7 p90 -100.77 -11.74 19.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.919 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.1 p-10 -64.79 -33.93 77.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.848 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -99.52 7.45 45.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.758 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.9 mttm -134.71 152.04 51.46 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.856 0.36 . . . . 0.0 110.637 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.424 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -75.75 166.31 23.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.658 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.594 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.5 t90 -59.32 -48.11 82.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.244 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -54.26 -43.88 71.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.897 0.38 . . . . 0.0 110.061 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.8 t -62.97 -41.06 99.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.126 0.489 . . . . 0.0 110.343 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.0 -43.92 98.17 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.008 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 53.3 tp -61.58 -42.97 99.63 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.14 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.5 m -55.29 -45.34 76.2 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.12 -40.71 96.83 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.181 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.511 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.31 -42.54 99.45 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.341 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.54 -40.73 94.3 Favored Glycine 0 C--N 1.315 -0.62 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.24 -46.16 65.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.982 0.42 . . . . 0.0 111.016 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.73 -43.98 96.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.942 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.8 p -92.89 -9.29 40.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.575 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.28 26.06 72.52 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -101.93 50.91 0.83 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.811 0.339 . . . . 0.0 110.809 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.51 -39.22 77.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.717 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.7 -46.87 87.76 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.414 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -60.03 -39.17 84.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.156 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.46 97.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.149 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.17 -29.15 70.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.149 0.499 . . . . 0.0 110.565 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -73.48 -54.44 8.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.149 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.513 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.6 ttp180 -64.86 -42.01 95.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.443 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 174' ' ' ASP . 81.0 mt -62.27 -43.84 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.527 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.34 -58.23 8.43 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.096 0.474 . . . . 0.0 110.738 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.08 -33.99 67.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.217 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -80.54 -36.3 33.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.123 0.487 . . . . 0.0 111.098 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.1 m-20 -55.34 -41.98 73.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.137 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.25 -41.98 98.92 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.785 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -64.88 -38.24 90.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.31 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.8 mt -62.49 -42.35 99.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.646 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.83 -53.23 58.74 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.729 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.3 -41.9 89.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.575 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.75 -40.0 95.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.616 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.3 -32.64 74.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.44 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.32 -21.89 18.71 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.843 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.536 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.8 tt0 -64.5 -41.68 96.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.757 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 184' ' ' ILE . 31.9 pt -76.07 134.82 28.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.22 106.91 9.56 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.4 pp -176.5 127.88 0.34 Allowed Pre-proline 0 N--CA 1.446 -0.637 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.527 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.2 Cg_exo -43.53 151.79 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.599 2.199 . . . . 0.0 112.594 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.41 142.21 53.69 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.655 2.237 . . . . 0.0 112.385 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.54 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -170.93 146.99 2.24 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.648 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.04 154.76 70.05 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.646 2.231 . . . . 0.0 112.153 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.577 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.59 162.93 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.416 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.577 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.45 169.93 16.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.919 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.88 137.37 22.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.154 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.535 HG22 HD12 ' A' ' 205' ' ' LEU . 39.5 pt -134.16 146.39 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.707 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.25 131.63 58.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.185 0.517 . . . . 0.0 110.49 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -151.65 154.62 36.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.32 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.608 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.7 m -121.75 122.64 39.97 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.014 0.435 . . . . 0.0 110.179 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.57 -25.73 66.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.463 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.608 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.11 -49.1 20.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.088 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.75 -9.05 58.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.38 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.0 m80 46.13 43.68 11.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.505 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.4 t -136.55 145.22 44.76 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.413 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.29 113.75 26.46 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.231 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.95 133.7 55.48 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.112 0.482 . . . . 0.0 110.304 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.535 HD12 HG22 ' A' ' 194' ' ' ILE . 7.6 tt -112.53 146.24 38.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.781 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.466 ' N ' HD23 ' A' ' 205' ' ' LEU . 13.6 t90 -99.3 128.19 45.39 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.38 153.36 40.47 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.174 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.51 -18.41 48.99 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.924 2.416 . . . . 0.0 111.829 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.07 -18.86 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.369 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.447 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.0 p -75.26 168.17 20.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.485 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.45 -35.77 76.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.419 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.496 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.3 mt-30 -56.62 -40.7 75.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.743 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.92 -43.3 98.2 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.4 mt-30 -63.98 -40.65 96.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.944 0.402 . . . . 0.0 110.373 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.594 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.1 mmm -61.74 -41.79 98.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.195 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 69.9 mt -63.33 -48.34 78.41 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.843 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -54.4 -32.07 56.39 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -70.63 -18.81 62.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.621 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.421 HD11 ' CD2' ' A' ' 299' ' ' LEU . 95.1 mt -87.96 -7.8 56.59 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.749 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.14 2.86 55.86 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -88.32 152.06 22.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.0 110.558 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.445 ' O ' HG12 ' A' ' 191' ' ' VAL . 6.6 p -114.73 127.81 55.95 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.099 0.476 . . . . 0.0 110.387 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.24 145.67 24.31 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.901 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.476 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.64 150.55 46.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.453 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.32 131.71 43.96 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.318 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.879 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.69 92.77 25.63 Favored Pre-proline 0 N--CA 1.464 0.275 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.049 -179.445 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.673 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.8 Cg_exo -55.58 139.4 82.67 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.534 2.156 . . . . 0.0 111.392 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.71 -25.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.588 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.11 -49.04 29.06 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.6 mt -55.16 -37.01 66.45 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -66.38 35.89 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.837 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.556 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.56 87.71 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.794 0.33 . . . . 0.0 110.778 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.4 p -81.53 -14.9 56.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.449 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -90.94 -41.33 11.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.612 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.81 -16.79 64.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.696 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 56.01 43.4 27.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.439 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.37 -147.7 7.4 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.58 142.94 50.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.969 0.414 . . . . 0.0 110.233 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.3 149.61 28.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.312 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -100.65 -152.0 0.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.255 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 56.31 -91.74 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.722 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.469 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.91 175.14 9.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.648 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.469 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.6 mt -121.44 140.79 44.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.816 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.16 168.59 9.96 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.303 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.0 mt -147.22 150.97 35.91 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.464 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.7 -39.0 97.05 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.11 4.3 4.61 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.51 -57.95 3.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.933 0.397 . . . . 0.0 110.594 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.551 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.8 m-20 -62.39 -37.18 84.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.109 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.0 -67.36 0.26 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.918 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -54.06 -41.77 68.52 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.06 18.12 0.15 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.684 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.98 47.72 0.26 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 39.07 -109.82 0.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.696 0.284 . . . . 0.0 110.664 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.9 m120 -61.21 -44.26 97.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.372 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 83.98 8.18 84.43 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -99.29 -12.58 20.22 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.739 -0.271 . . . . 0.0 110.671 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.8 t 176.48 142.31 0.07 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.097 0.475 . . . . 0.0 110.488 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.412 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.3 tt -147.79 126.16 12.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.201 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -99.25 142.95 30.08 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.035 0.445 . . . . 0.0 110.621 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.63 106.54 18.52 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.433 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.474 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 93.2 t80 -102.23 -12.55 17.92 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.007 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.4 90.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.813 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.29 173.8 46.18 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.452 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -74.59 -112.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.691 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.57 -28.45 67.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.753 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -59.81 -43.86 94.28 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.913 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -63.72 -44.1 94.6 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.318 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.69 -59.38 4.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.181 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.81 -43.1 62.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.054 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.51 -43.94 76.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.129 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.9 mt -64.05 -43.55 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.962 0.411 . . . . 0.0 110.707 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -57.1 -37.67 72.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.067 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.14 0.8 20.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.278 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -114.73 91.14 24.47 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.248 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.83 -27.35 27.02 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.824 2.35 . . . . 0.0 111.619 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -41.26 98.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.637 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.8 mp -95.18 4.8 53.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.314 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.49 -35.61 70.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.711 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.37 4.56 14.98 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.436 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.71 121.54 81.52 Favored Pre-proline 0 N--CA 1.438 -1.033 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.581 -179.537 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.56 -37.71 27.03 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.242 1.961 . . . . 0.0 112.542 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.91 -43.8 91.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.59 -43.77 93.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.351 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.67 -40.65 95.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.534 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 47.0 t-20 -89.59 -12.4 39.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.647 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 61.92 31.97 18.0 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.78 44.38 1.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.329 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.77 135.47 43.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.455 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -116.2 132.58 56.62 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.468 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.495 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.9 87.92 6.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.775 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.423 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.1 mt -63.68 -41.74 98.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.817 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.474 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.47 166.45 34.66 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.1 p -75.59 -26.07 57.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.879 0.371 . . . . 0.0 110.823 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.2 tp10 -68.04 -34.25 76.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.444 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.757 HG22 ' O ' ' A' ' 296' ' ' THR . 98.0 m -72.47 20.59 0.07 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.688 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.501 ' H ' ' C ' ' A' ' 295' ' ' GLU . 49.0 t80 -57.54 -51.12 70.77 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.951 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.1 mmt-85 -107.43 149.26 28.11 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.421 ' CD2' HD11 ' A' ' 219' ' ' LEU . 41.0 tp -115.91 126.23 53.63 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 123.411 0.444 . . . . 0.0 110.888 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.473 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.0 t0 -149.55 166.91 27.81 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.554 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.57 -37.99 29.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.435 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -71.71 -64.99 0.82 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.604 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.8 p -60.96 -32.66 72.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.973 0.416 . . . . 0.0 111.183 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.93 -25.37 28.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.6 mtt -63.61 -41.21 98.33 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 120.984 0.421 . . . . 0.0 110.999 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -77.92 -44.42 27.03 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.052 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.576 HG21 HG23 ' A' ' 296' ' ' THR . 78.8 t -65.85 -43.1 93.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.409 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.536 HD11 ' NE2' ' A' ' 183' ' ' GLN . 49.7 tp -60.36 -46.63 89.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.317 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -70.51 -39.22 74.22 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.559 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.495 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 73.4 ttt180 -61.42 -38.26 86.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.219 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.35 4.27 43.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.833 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -111.65 -11.84 13.96 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.136 0.493 . . . . 0.0 110.323 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.24 -37.25 84.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.68 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -61.15 -48.34 82.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.358 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.023 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.23 -2.71 58.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.395 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.481 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.67 178.91 1.29 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.468 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.9 Cg_exo -60.84 144.84 99.63 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.749 2.299 . . . . 0.0 112.204 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.4 ptt-85 -155.76 -179.48 8.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.57 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.74 136.5 53.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.34 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.35 147.32 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.452 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.2 p -120.5 136.01 54.9 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.7 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.1 p30 -98.97 -143.7 0.32 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.254 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.62 -37.27 86.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.509 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.53 -67.43 0.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.527 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.0 142.66 43.98 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.1 p -112.42 131.17 55.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.924 0.392 . . . . 0.0 110.397 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -118.99 129.31 55.08 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.547 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 m -86.16 131.24 34.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.982 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.48 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.3 mt -96.51 78.96 3.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.421 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.83 -32.67 74.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.491 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 t 176.78 110.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.103 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.48 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -123.79 91.11 50.04 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.228 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.3 Cg_exo -56.91 149.11 63.25 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.697 2.265 . . . . 0.0 111.765 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.22 81.99 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.602 0.564 . . . . 0.0 110.986 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.39 66.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.092 0.473 . . . . 0.0 110.236 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.2 mt -77.36 131.17 35.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.573 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.558 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.0 t -122.6 148.07 26.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.17 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 t -136.62 143.62 43.63 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.607 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.9 p -99.3 -59.31 1.75 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.557 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.3 p -79.52 156.37 27.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.63 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.558 HG21 HG23 ' A' ' 70' ' ' THR . 73.5 t -74.88 -21.51 16.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.636 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.7 m -60.2 -51.88 67.68 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.455 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.7 mt -66.46 -42.3 87.79 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.36 0.6 . . . . 0.0 110.906 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.22 -54.41 4.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.145 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.0 -38.78 74.45 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 m -62.38 -43.6 98.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.884 0.373 . . . . 0.0 110.357 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.1 mt -65.28 -42.65 92.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.403 0.621 . . . . 0.0 110.719 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 tp -63.07 -38.65 92.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.221 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.447 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -61.64 -36.52 81.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.948 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -91.58 27.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.027 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.419 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 98.6 m-20 57.22 52.45 8.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.253 0.345 . . . . 0.0 110.789 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.72 75.39 31.31 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.049 0.452 . . . . 0.0 109.989 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.96 148.49 93.42 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.735 2.29 . . . . 0.0 112.177 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -112.75 135.97 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.195 0.521 . . . . 0.0 110.275 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.85 -43.3 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.192 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.68 130.85 53.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 110.55 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.9 p -155.14 168.42 27.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.461 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.37 -177.71 21.94 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.653 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.46 172.46 12.68 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.878 0.371 . . . . 0.0 110.541 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.558 HG23 HG21 ' A' ' 51' ' ' VAL . 14.1 p -132.9 -112.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.269 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.31 179.91 0.9 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.274 -178.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.7 Cg_exo -61.16 57.87 0.1 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.015 2.476 . . . . 0.0 112.126 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.8 t-20 -64.36 -33.41 75.79 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.878 -0.582 . . . . 0.0 110.571 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.2 m120 93.71 -35.5 0.02 OUTLIER 'General case' 0 C--N 1.345 0.383 0 O-C-N 124.322 1.014 . . . . 0.0 109.948 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.5 mtp85 -63.27 -39.97 96.09 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.283 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -74.31 -25.43 19.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.7 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.16 -170.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.65 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.66 -155.24 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.828 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.8 p-10 -51.57 -7.95 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.641 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.497 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -85.42 115.23 23.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.564 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.23 70.71 1.33 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -144.64 148.55 34.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 110.69 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.8 mp -86.29 -98.63 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.266 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.8 -42.97 97.59 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.179 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.2 tt0 91.88 52.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 124.136 0.898 . . . . 0.0 110.784 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -102.41 -8.92 20.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.446 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.9 p -64.78 -34.25 77.89 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.131 0.491 . . . . 0.0 110.648 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.57 -24.62 1.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.6 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 81.9 t -69.29 -45.55 78.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.925 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.31 81.76 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.155 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.33 -38.22 88.63 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.276 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.51 -33.87 56.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.292 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.591 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.2 mmt-85 -88.76 0.99 55.97 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.67 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 57.2 mttp 83.02 -47.61 0.14 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 124.25 0.968 . . . . 0.0 110.316 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.5 mt -47.2 153.18 0.5 Allowed 'General case' 0 CA--C 1.49 -1.359 0 CA-C-O 117.604 -1.189 . . . . 0.0 109.124 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.644 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 122.31 91.72 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 O-C-N 125.54 1.775 . . . . 0.0 110.469 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -74.81 142.59 44.21 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.963 0.411 . . . . 0.0 110.299 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 mt -131.65 26.41 4.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.741 0.305 . . . . 0.0 110.464 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.06 137.29 34.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.946 0.403 . . . . 0.0 110.479 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.653 HD12 ' O ' ' A' ' 69' ' ' ALA . 90.7 mt -137.17 164.94 28.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.354 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.613 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.21 -28.73 1.82 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.03 70.6 7.79 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.25 0.548 . . . . 0.0 110.348 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.97 145.25 98.8 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.808 2.339 . . . . 0.0 112.041 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.8 t -134.85 137.11 42.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.541 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.89 -38.44 83.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.665 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.28 -42.21 96.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.501 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.6 98.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.526 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.54 -43.36 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.037 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.07 -35.17 77.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.376 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.31 -18.74 60.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.495 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.6 -6.46 58.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.561 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.5 mtp 47.87 55.74 17.11 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.627 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.14 149.35 64.34 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.791 2.327 . . . . 0.0 112.121 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.41 -72.76 0.67 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.481 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.6 tp -111.33 113.15 25.41 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.367 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.8 mt -102.19 126.56 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.451 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.6 mt -110.57 134.0 52.79 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.173 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.55 140.22 45.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.446 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 94.8 p -83.61 167.2 17.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.665 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.58 -36.66 79.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.472 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 t -138.24 157.71 45.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.471 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.36 174.63 34.16 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.29 -33.98 87.77 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -123.57 150.98 43.41 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.92 0.391 . . . . 0.0 110.562 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.6 t -63.57 140.16 58.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.291 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.94 11.44 11.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.631 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.1 -39.25 89.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.098 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.627 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.82 -35.53 24.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.564 0.697 . . . . 0.0 110.705 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -71.11 -35.04 71.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.408 0.623 . . . . 0.0 110.787 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -43.07 -63.19 0.85 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.171 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.627 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.1 p-10 -65.89 -42.81 89.79 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.535 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -61.78 -32.6 72.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.114 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 129' ' ' LEU . 67.6 mt -73.83 -40.3 63.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.187 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.29 -49.31 77.59 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.195 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.5 m -52.62 -42.66 64.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.313 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.08 -42.97 92.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.993 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.31 152.61 5.03 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.623 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -38.58 107.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.677 2.252 . . . . 0.0 112.317 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.646 ' C ' HD12 ' A' ' 140' ' ' LEU . 94.2 m -109.35 120.95 44.08 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.293 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.646 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.54 153.64 29.69 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.225 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.456 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -130.49 128.93 64.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.376 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.1 mt -110.42 122.84 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.574 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.538 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 53.8 t30 -101.11 106.35 17.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.349 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -100.17 0.45 40.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.897 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -65.52 -34.93 79.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.585 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.0 p-10 -101.29 9.5 41.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -133.85 148.08 51.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.537 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.409 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 22.5 p -77.69 169.05 18.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.579 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.598 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.6 t90 -58.71 -49.74 76.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.087 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -54.41 -46.15 73.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.011 0.434 . . . . 0.0 110.144 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.9 t -63.24 -40.79 98.43 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.345 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.452 ' O ' HD23 ' A' ' 156' ' ' LEU . 51.4 tp -60.83 -44.37 97.03 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.367 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.2 -43.49 98.79 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.202 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -54.21 -45.8 72.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.772 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.8 -39.92 93.41 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.854 0.359 . . . . 0.0 110.268 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 152' ' ' LEU . 2.2 mm? -61.9 -42.25 98.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.059 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.8 -38.87 94.81 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.21 -45.75 65.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.963 0.411 . . . . 0.0 110.798 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.72 -44.15 96.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.715 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -92.86 -9.28 40.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.53 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.0 26.51 72.35 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -102.31 50.11 0.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.831 0.348 . . . . 0.0 110.704 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.21 -39.14 78.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.691 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.67 -47.4 85.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.256 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.419 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 86.6 mt-30 -59.99 -39.66 86.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.335 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.59 -40.89 98.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.328 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.15 -29.47 70.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.995 0.426 . . . . 0.0 110.542 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.09 -54.13 8.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.121 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.447 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.8 ttp180 -64.44 -42.79 95.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.474 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.9 mt -62.62 -43.72 98.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.499 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.71 -60.8 3.12 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.255 0.55 . . . . 0.0 110.402 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.23 -34.31 63.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.271 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -80.29 -34.96 36.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.937 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.2 m-20 -55.02 -41.53 71.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.185 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.18 -41.71 98.59 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.575 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.04 -37.74 88.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.269 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.23 -42.6 99.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.796 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.69 -53.04 61.46 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.19 0.519 . . . . 0.0 110.668 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.37 -41.45 89.44 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.544 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.28 -39.9 94.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.644 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.52 -33.23 74.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.365 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -93.21 -21.55 19.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.714 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.589 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -65.21 -41.44 94.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.667 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 184' ' ' ILE . 30.7 pt -77.48 133.94 29.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.05 0.452 . . . . 0.0 110.696 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -128.09 107.03 9.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.302 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.59 127.76 0.33 Allowed Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.556 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.445 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.3 Cg_exo -43.72 151.7 0.39 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.702 2.268 . . . . 0.0 112.598 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.63 142.51 53.49 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.629 2.219 . . . . 0.0 112.416 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.542 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.61 146.89 2.39 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.659 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.27 154.62 69.4 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.753 2.302 . . . . 0.0 112.29 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.584 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.98 163.4 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.42 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 191' ' ' VAL . 1.9 t -143.4 169.97 16.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.896 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.18 137.4 22.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.964 0.412 . . . . 0.0 110.159 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.523 HG22 HD12 ' A' ' 205' ' ' LEU . 38.0 pt -133.98 145.53 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.639 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -131.97 131.5 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.143 0.497 . . . . 0.0 110.548 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -152.62 156.04 38.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.418 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 199' ' ' ALA . 88.4 m -121.57 122.51 39.83 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.947 0.404 . . . . 0.0 110.331 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.496 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.41 -26.26 66.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.599 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.1 -48.74 22.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.014 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.83 -10.09 59.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.414 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.496 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.6 m80 45.88 46.65 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.563 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.0 t -132.16 143.09 49.73 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.402 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.404 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -108.08 107.26 17.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.296 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -116.96 130.1 56.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.099 0.476 . . . . 0.0 110.352 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.523 HD12 HG22 ' A' ' 194' ' ' ILE . 7.5 tt -112.03 145.77 39.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.603 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.487 ' N ' HD23 ' A' ' 205' ' ' LEU . 9.1 t90 -98.44 127.53 44.41 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.09 0.472 . . . . 0.0 110.043 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.08 153.18 43.26 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.156 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.04 -17.59 45.94 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.822 2.348 . . . . 0.0 111.923 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.19 -19.13 0.7 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.429 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.442 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.4 p -74.52 163.71 27.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.497 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.38 -27.73 64.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.458 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.492 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.5 mt-30 -63.37 -42.74 98.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.628 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.69 -43.58 98.9 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.409 ' OE1' ' C ' ' A' ' 148' ' ' SER . 74.7 mt-30 -63.75 -38.85 92.64 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.865 0.364 . . . . 0.0 110.46 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 85.9 mmm -62.27 -41.52 98.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.251 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.1 -49.25 72.96 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.628 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -52.36 -33.36 42.68 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -71.06 -20.43 62.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.491 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 75.0 mt -87.56 -6.45 58.32 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.63 -6.73 57.45 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -77.74 148.25 34.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.754 0.311 . . . . 0.0 110.622 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.47 ' O ' HG12 ' A' ' 191' ' ' VAL . 3.7 p -113.02 126.78 55.87 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.093 0.473 . . . . 0.0 110.331 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -91.94 145.86 24.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.925 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.472 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.88 150.26 46.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.462 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.17 131.4 44.02 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.396 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.883 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.53 93.48 27.75 Favored Pre-proline 0 C--O 1.235 0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.998 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.683 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.7 Cg_exo -55.25 138.37 79.27 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.652 2.234 . . . . 0.0 111.54 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.44 -24.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.537 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.62 -50.13 21.36 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 232' ' ' ALA . 98.5 mt -54.55 -35.98 63.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.769 0.318 . . . . 0.0 110.278 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.94 36.2 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.744 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.99 87.68 0.01 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.757 0.313 . . . . 0.0 110.873 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.3 p -81.61 -13.47 57.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.423 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -91.67 -39.48 11.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.544 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.7 t -66.63 -16.84 64.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.613 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.03 43.86 26.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.437 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 178.79 -146.45 7.3 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.22 142.21 50.13 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.925 0.393 . . . . 0.0 110.303 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.419 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.4 ttt-85 -152.18 149.58 28.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.384 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -102.41 -149.36 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.31 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 54.94 -93.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.648 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.436 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 13.0 tt -126.65 173.75 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.581 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 230' ' ' LEU . 95.1 mt -121.75 140.6 45.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.767 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.77 172.29 7.35 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.336 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 67.2 mt -146.82 149.08 32.61 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.09 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -62.89 -39.49 98.09 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.94 2.07 3.93 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -78.62 -57.54 3.71 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.93 0.395 . . . . 0.0 110.694 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.594 ' ND2' HD23 ' A' ' 226' ' ' LEU . 94.4 m-20 -62.36 -36.74 83.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.236 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.404 HD21 ' HB1' ' A' ' 203' ' ' ALA . 6.1 mp -53.84 -67.07 0.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.936 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.79 -42.24 68.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.215 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.01 18.09 0.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.652 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.07 46.91 0.24 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 254' ' ' LEU . 7.6 mp 39.83 -110.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.637 0.256 . . . . 0.0 110.608 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.472 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 10.8 m120 -60.77 -44.52 96.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.427 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.46 8.03 83.83 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -98.7 -12.54 20.91 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.778 -0.248 . . . . 0.0 110.636 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.1 t 175.75 143.06 0.06 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 110.487 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.99 125.9 11.99 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.051 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.93 143.44 29.22 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 120.882 0.372 . . . . 0.0 110.867 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.7 mt -94.62 106.3 18.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.584 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.453 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.1 t80 -101.86 -13.15 17.78 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.223 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.03 -40.39 91.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.821 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.64 173.15 45.86 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.457 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.9 m-20 -74.19 -112.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 0.0 110.74 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.76 -28.78 67.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.701 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.84 -44.13 90.89 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.314 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.56 -44.36 94.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.405 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.42 -59.81 3.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.223 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.35 -43.23 61.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.187 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.86 74.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.159 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.2 mt -64.35 -43.57 97.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.64 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.72 -37.58 71.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.246 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.06 0.88 19.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.27 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -114.99 91.13 25.51 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.179 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.01 -27.28 28.08 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.785 2.323 . . . . 0.0 111.81 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -41.24 98.9 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.559 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.9 mp -95.34 5.01 52.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.306 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.03 -35.28 69.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.679 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.21 4.62 14.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.516 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.82 121.17 80.38 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.618 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -47.53 -37.45 26.34 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.432 2.088 . . . . 0.0 112.46 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.89 -43.58 90.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.826 0.346 . . . . 0.0 110.235 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.89 -43.76 92.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.291 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.86 -40.53 95.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.494 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 48.0 t-20 -89.64 -12.87 38.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.607 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.39 32.43 16.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.801 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.98 44.03 1.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.409 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.03 135.56 42.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.429 -179.681 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.97 131.81 56.86 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.459 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.495 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.71 88.73 6.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.708 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.433 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.2 mt -63.95 -41.44 97.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.851 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.453 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.62 165.86 33.86 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 77.7 p -75.73 -25.62 56.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.831 0.348 . . . . 0.0 110.731 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.4 tp10 -68.29 -33.99 75.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.457 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 97.3 m -73.04 21.53 0.07 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.597 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.504 ' H ' ' C ' ' A' ' 295' ' ' GLU . 50.4 t80 -57.66 -50.86 71.78 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.994 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.402 HH12 ' HG3' ' A' ' 212' ' ' GLN . 71.3 mmt-85 -108.97 150.89 27.06 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.5 tp -115.48 125.03 52.57 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.765 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.488 ' CB ' HD23 ' A' ' 83' ' ' LEU . 40.7 t0 -148.04 165.85 29.54 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.569 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -49.36 -38.19 27.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.524 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -70.72 -65.63 0.71 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.212 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -61.04 -32.96 72.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.021 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -53.6 -25.7 18.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.495 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.6 mtt -63.7 -40.73 97.51 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 120.835 0.35 . . . . 0.0 110.979 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -78.01 -44.66 25.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.941 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.579 HG21 HG23 ' A' ' 296' ' ' THR . 79.2 t -66.2 -42.83 91.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.407 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.589 HD11 ' NE2' ' A' ' 183' ' ' GLN . 47.8 tp -59.57 -47.56 85.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.468 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -69.92 -39.32 76.22 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.606 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.495 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.1 ttt180 -61.77 -37.9 86.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.181 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.6 mt -87.76 4.82 42.85 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -112.58 -11.74 13.54 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.018 0.437 . . . . 0.0 110.288 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.95 -36.96 85.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.614 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -61.01 -49.11 78.73 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.434 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.099 179.875 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.614 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -90.37 -2.62 57.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.394 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.476 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.51 178.87 1.3 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.485 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.5 Cg_exo -60.79 145.11 99.47 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.556 2.17 . . . . 0.0 112.191 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.614 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.5 ptt-85 -155.99 -179.77 8.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.609 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -115.6 136.35 53.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.292 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -124.07 146.28 29.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.369 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.9 p -119.84 135.6 54.8 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.714 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.6 p30 -98.43 -144.41 0.31 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.296 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.36 -36.54 84.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.473 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.489 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -147.53 -70.4 0.23 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.593 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.77 144.09 41.68 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.0 p -112.58 130.05 56.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.783 0.325 . . . . 0.0 110.369 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -114.71 129.26 56.66 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.599 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -86.61 130.63 34.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.308 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.493 HD22 ' OE1' ' A' ' 42' ' ' GLN . 70.8 mt -97.84 78.71 2.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.2 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.03 -32.53 74.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.511 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.4 t 178.05 109.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.076 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.493 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -123.87 90.76 50.37 Favored Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.218 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.1 Cg_exo -56.66 149.3 59.68 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.709 2.272 . . . . 0.0 111.646 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.3 82.51 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.491 0.494 . . . . 0.0 110.997 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.57 66.84 0.88 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.303 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.2 mt -77.38 131.2 35.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.433 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.571 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.8 t -122.46 147.64 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.231 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.5 t -136.51 144.03 44.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.576 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 50' ' ' SER . 18.9 p -100.37 -58.9 1.81 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.46 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 49' ' ' THR . 87.5 p -79.43 155.49 28.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.901 0.381 . . . . 0.0 110.642 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.548 HG21 HG23 ' A' ' 70' ' ' THR . 72.6 t -74.2 -21.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.696 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.2 m -60.27 -51.7 68.41 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.456 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.4 mt -66.32 -42.62 87.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.532 0.682 . . . . 0.0 110.859 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.3 m -43.29 -54.58 4.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.198 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.91 -38.73 75.36 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.1 m -62.52 -43.73 98.09 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.172 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 48.2 mt -65.31 -42.57 92.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.052 0.453 . . . . 0.0 110.665 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.7 tp -62.95 -38.67 91.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.254 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.455 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -61.69 -36.45 80.92 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.068 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.4 pt -91.34 27.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.081 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 56.99 52.15 9.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.744 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.04 75.34 35.18 Favored Pre-proline 0 C--N 1.334 -0.081 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.34 148.66 92.67 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.596 2.197 . . . . 0.0 112.041 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.571 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.21 135.76 50.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 121.22 0.533 . . . . 0.0 110.229 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.441 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.4 pt -69.73 -43.38 80.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.219 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.8 130.41 52.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.013 0.435 . . . . 0.0 110.599 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.9 p -155.09 168.8 25.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.354 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.48 -177.73 21.86 Favored Glycine 0 N--CA 1.465 0.572 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.665 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -132.36 171.46 13.7 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.7 0.286 . . . . 0.0 110.575 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.548 HG23 HG21 ' A' ' 51' ' ' VAL . 13.0 p -133.82 -110.71 0.22 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.498 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.35 179.78 0.91 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.244 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.1 Cg_exo -60.94 58.51 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.912 2.408 . . . . 0.0 112.089 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.544 ' N ' ' O ' ' A' ' 71' ' ' THR . 56.7 t-20 -64.0 -35.23 80.02 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.699 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.6 m120 95.31 -37.15 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.979 1.425 . . . . 0.0 109.986 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -62.69 -40.51 97.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.264 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -72.97 -26.53 23.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.815 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.86 -171.9 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.717 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -74.33 -153.13 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.805 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.6 p-10 -54.03 -6.86 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.608 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.77 114.06 23.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.962 0.41 . . . . 0.0 110.484 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.48 72.21 1.3 Allowed Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.449 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.4 m-85 -143.87 148.44 35.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 110.806 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.68 -99.24 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.065 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.67 -43.46 96.62 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.377 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.537 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.4 tt0 92.08 52.62 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.314 1.009 . . . . 0.0 111.016 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -103.01 -9.16 20.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.507 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.449 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.52 -34.06 77.36 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.136 0.493 . . . . 0.0 110.686 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.3 -24.67 1.27 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.491 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.94 -45.36 77.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.14 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.3 -48.69 80.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.224 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.49 -38.42 89.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.28 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.55 -32.95 52.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.292 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.583 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.51 1.19 56.25 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 118.868 -0.586 . . . . 0.0 110.681 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 83.16 -48.37 0.14 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.535 1.147 . . . . 0.0 110.348 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.629 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.1 mt -46.81 152.73 0.47 Allowed 'General case' 0 CA--C 1.49 -1.351 0 CA-C-O 117.632 -1.175 . . . . 0.0 108.951 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.629 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.0 tt0 122.25 91.32 0.0 OUTLIER 'General case' 0 C--N 1.358 0.967 0 O-C-N 125.515 1.76 . . . . 0.0 110.66 -178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.52 143.04 44.72 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.201 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.9 mt -132.08 26.25 4.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.427 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -139.69 136.52 34.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.577 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.665 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.5 mt -136.62 164.72 30.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.45 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.605 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.76 -28.88 1.73 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -151.46 70.72 8.25 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.053 0.454 . . . . 0.0 110.354 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.99 145.3 98.69 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.612 2.208 . . . . 0.0 112.016 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.9 t -135.69 137.65 41.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.537 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.08 -38.12 82.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.68 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.27 -42.26 96.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.576 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.07 -41.56 98.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.429 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.57 -43.47 98.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.935 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.09 -35.11 77.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.439 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.34 -19.0 61.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.554 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.54 -6.58 58.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.478 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.4 mtp 47.68 55.81 17.07 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.663 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.8 Cg_endo -70.05 149.4 64.98 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.919 2.412 . . . . 0.0 112.034 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.27 -71.68 0.7 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.43 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.408 HD11 HD13 ' A' ' 140' ' ' LEU . 38.0 tp -112.89 113.62 25.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.221 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.7 mt -102.17 126.85 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.289 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 mt -110.82 133.75 53.1 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.042 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.61 140.18 45.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.6 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.6 p -83.28 167.44 17.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.783 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.94 79.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.475 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.6 t -138.44 158.02 45.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.471 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.5 175.34 34.16 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.24 -33.91 87.5 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -124.09 150.95 44.43 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.593 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.5 t -63.71 140.68 58.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.306 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.56 11.63 10.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.674 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.7 mp -60.87 -39.58 89.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.165 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.633 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.6 -35.63 24.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.587 0.708 . . . . 0.0 110.596 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.4 mt -70.92 -35.12 72.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.867 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -43.28 -62.82 0.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.298 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.633 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.2 p-10 -65.91 -42.95 89.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.801 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -61.8 -32.85 73.18 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.06 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 129' ' ' LEU . 67.6 mt -73.4 -40.52 64.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.459 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.55 -48.45 80.85 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.278 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.1 m -53.24 -42.11 66.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.33 -42.81 91.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.612 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.11 152.27 5.06 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.673 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -39.11 106.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.572 2.182 . . . . 0.0 111.986 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.647 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.2 m -108.89 122.06 46.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.323 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.647 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.94 154.47 28.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.282 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.6 tt -130.23 129.22 65.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.474 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 93.1 mt -110.66 122.93 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.503 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.537 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 52.7 t30 -101.45 105.14 16.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.363 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.404 ' HB3' HD13 ' A' ' 152' ' ' LEU . 41.8 p90 -98.0 -0.19 45.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.004 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.2 p-10 -65.23 -35.04 79.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.028 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.594 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.1 p-10 -101.76 8.51 41.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -133.13 146.82 51.95 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.889 0.376 . . . . 0.0 110.565 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.427 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 21.1 p -78.61 170.41 16.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.545 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.597 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 88.1 t90 -58.31 -49.54 76.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.247 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -54.75 -47.39 73.91 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.22 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.8 t -63.33 -40.81 98.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.121 0.486 . . . . 0.0 110.264 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.459 ' O ' HD23 ' A' ' 156' ' ' LEU . 59.1 tp -61.01 -44.11 97.9 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.224 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.502 HD23 HD11 ' A' ' 170' ' ' ILE . 53.6 tp -61.1 -42.85 99.27 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.314 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.6 m -55.35 -46.39 76.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.666 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.44 -40.1 93.24 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.253 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 152' ' ' LEU . 2.1 mm? -61.84 -42.18 98.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.962 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.42 -38.92 95.42 Favored Glycine 0 C--N 1.317 -0.523 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.56 -45.02 66.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.402 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.64 -43.99 96.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.76 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -94.01 -8.48 39.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.563 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.83 25.83 71.97 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -102.81 51.17 0.81 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.787 0.327 . . . . 0.0 110.818 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.23 -38.73 78.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.117 0.484 . . . . 0.0 110.744 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.87 -46.99 87.55 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.392 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -61.37 -39.17 89.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.296 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.1 -40.57 98.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.309 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.73 -28.06 69.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.23 0.538 . . . . 0.0 110.458 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -75.2 -52.76 10.15 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.174 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.489 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -63.72 -42.92 97.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.45 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 174' ' ' ASP . 86.7 mt -62.83 -43.83 99.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.594 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.47 -61.09 2.78 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.15 0.5 . . . . 0.0 110.56 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.63 -35.4 63.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.228 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -79.59 -35.14 40.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.106 0.479 . . . . 0.0 111.265 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.4 m-20 -55.33 -40.67 71.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.297 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.45 -41.87 99.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.631 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.36 -38.08 88.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.31 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 177' ' ' LEU . 77.3 mt -62.27 -42.58 99.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.711 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.83 -53.25 58.44 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.053 0.454 . . . . 0.0 110.729 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.41 -41.39 89.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.587 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.72 94.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.624 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.08 -32.71 74.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.332 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -94.05 -21.88 18.87 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.764 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.551 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -64.79 -41.88 95.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.72 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 184' ' ' ILE . 31.5 pt -76.33 134.43 28.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.684 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.58 106.52 9.22 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.184 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.5 127.92 0.34 Allowed Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.586 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.445 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.9 Cg_exo -43.57 151.69 0.36 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.615 2.21 . . . . 0.0 112.508 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.68 142.33 52.68 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.806 2.337 . . . . 0.0 112.299 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.39 146.68 2.46 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.664 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.02 154.01 71.38 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.716 2.277 . . . . 0.0 112.122 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.41 162.86 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.434 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.5 169.64 17.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.805 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.74 137.38 22.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.276 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.524 HG22 HD12 ' A' ' 205' ' ' LEU . 39.5 pt -134.24 146.25 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.652 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.47 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.88 131.52 59.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.081 0.467 . . . . 0.0 110.504 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -151.63 154.69 36.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.391 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.2 m -121.97 122.85 40.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.973 0.416 . . . . 0.0 110.268 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.42 -25.76 66.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.424 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.614 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.31 -49.15 20.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.105 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.23 -10.79 60.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.5 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.1 m80 47.93 42.95 17.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.495 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.1 t -136.47 145.35 45.07 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.386 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.412 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -111.22 113.92 26.76 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.296 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.89 133.62 55.52 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.359 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.524 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.41 146.18 38.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.721 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.48 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.4 t90 -99.69 127.93 45.8 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.021 0.438 . . . . 0.0 109.952 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.12 153.69 41.69 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.947 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.401 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.2 Cg_endo -67.58 -18.33 48.6 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.895 2.397 . . . . 0.0 111.931 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.6 -18.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.504 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.442 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.0 p -75.61 167.51 21.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.485 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.46 -35.13 75.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.447 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.2 mt-30 -56.42 -41.33 76.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.676 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.35 -42.89 97.63 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.483 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.7 mt-30 -63.59 -40.45 96.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.881 0.372 . . . . 0.0 110.302 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.597 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.2 mmm -61.87 -41.58 98.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.182 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.59 -49.95 71.34 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.661 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -52.92 -32.36 45.04 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -71.94 -19.89 61.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.54 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 64.4 mt -87.46 -6.45 58.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.57 3.94 57.24 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -89.28 151.39 22.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.711 0.291 . . . . 0.0 110.553 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.45 ' O ' HG12 ' A' ' 191' ' ' VAL . 2.6 p -114.44 127.63 55.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.994 0.426 . . . . 0.0 110.402 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.97 144.71 25.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.905 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.492 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.23 150.71 47.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.416 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.79 131.36 44.62 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.298 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.882 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.82 92.49 25.34 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.123 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.675 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.8 Cg_exo -55.24 138.9 80.52 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.603 2.202 . . . . 0.0 111.47 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.65 -25.03 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.662 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.92 -49.68 27.3 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.558 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -54.66 -36.76 64.94 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.59 35.82 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.845 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.02 87.47 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.837 0.351 . . . . 0.0 110.684 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.3 p -81.25 -14.23 57.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.486 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.45 -40.85 11.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.565 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.9 t -66.76 -16.52 64.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.639 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.1 43.64 26.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.518 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.31 -145.55 6.68 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -123.27 143.05 50.31 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 110.349 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.1 ttt-85 -151.49 148.82 28.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.36 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -100.24 -152.62 0.43 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.274 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 56.46 -92.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.593 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.464 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.56 175.09 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.635 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.464 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -120.72 140.29 45.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.769 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.01 169.03 9.71 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.406 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.8 mt -147.59 150.61 34.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.317 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.85 -38.82 96.68 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.39 3.81 4.62 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -77.24 -58.02 3.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.877 0.37 . . . . 0.0 110.678 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.538 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.1 m-20 -62.36 -36.62 82.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.255 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.412 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.0 mp -52.45 -67.44 0.25 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.828 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.74 -42.11 67.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.22 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.74 18.17 0.14 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.742 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.41 47.96 0.21 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 39.19 -110.22 0.09 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.734 0.302 . . . . 0.0 110.631 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.492 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.1 m120 -60.97 -44.87 96.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.467 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.61 8.39 83.06 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -99.4 -12.26 20.41 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.607 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.6 t 176.15 142.46 0.07 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.073 0.463 . . . . 0.0 110.555 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.17 125.74 11.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.058 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -98.97 142.9 29.88 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.024 0.44 . . . . 0.0 110.567 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.5 mt -94.47 106.62 18.61 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.533 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.477 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 93.0 t80 -102.66 -11.95 18.05 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.199 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.75 -39.89 88.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.8 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.13 173.82 46.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.456 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 96.3 m-20 -74.98 -112.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.799 0.333 . . . . 0.0 110.658 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.83 -28.44 67.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.753 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.55 -43.97 93.39 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.031 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.34 -44.47 94.8 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.433 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.53 -59.51 4.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.243 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.6 -43.19 62.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.128 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.39 -44.08 75.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.2 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.4 mt -64.19 -43.61 97.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.949 0.404 . . . . 0.0 110.735 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -56.8 -37.68 71.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.121 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.31 1.03 19.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.386 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -114.64 91.29 24.71 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.423 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.79 -27.54 27.38 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.836 2.357 . . . . 0.0 111.696 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.39 -41.32 98.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.63 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.8 mp -95.32 4.83 53.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.251 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.71 -35.58 70.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.697 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.62 4.68 15.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.428 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.533 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.74 121.71 82.2 Favored Pre-proline 0 N--CA 1.441 -0.916 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.575 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.34 -38.21 26.15 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.32 2.014 . . . . 0.0 112.446 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.533 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.83 -43.77 90.76 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.821 0.343 . . . . 0.0 110.077 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.96 -43.64 92.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.373 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.85 -40.75 95.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.576 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 48.6 t-20 -89.27 -12.59 40.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.648 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.3 mtmt 62.52 31.92 16.79 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -88.67 44.7 1.23 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.391 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -106.6 134.95 46.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.515 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -116.25 132.38 56.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.468 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.495 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.52 88.22 6.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.693 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.88 -41.61 97.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.772 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.477 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.83 167.15 34.51 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.2 p -75.6 -25.66 57.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.822 0.344 . . . . 0.0 110.711 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.6 tp10 -68.09 -34.54 76.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.512 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.742 HG22 ' O ' ' A' ' 296' ' ' THR . 98.6 m -72.5 17.68 0.11 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.598 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.513 ' O ' ' NE2' ' A' ' 212' ' ' GLN . 47.8 t80 -56.89 -51.28 69.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.115 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 -106.09 147.4 28.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.062 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.3 tp -115.27 125.61 53.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 123.461 0.476 . . . . 0.0 110.796 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.47 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.5 t0 -149.62 166.75 28.36 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.52 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -49.5 -38.13 29.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.476 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -71.51 -64.92 0.83 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.24 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -61.28 -32.53 72.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.948 0.404 . . . . 0.0 110.944 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.56 -25.8 28.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.393 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.7 mtt -63.57 -41.11 98.41 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.898 0.38 . . . . 0.0 110.811 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.6 -44.59 27.87 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.848 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.566 HG21 HG23 ' A' ' 296' ' ' THR . 77.4 t -66.12 -42.87 92.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.434 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.551 HD11 ' NE2' ' A' ' 183' ' ' GLN . 48.4 tp -59.88 -46.87 87.94 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.374 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -70.72 -39.12 73.58 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.463 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.495 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.2 ttt180 -61.56 -38.06 86.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.273 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.59 4.62 43.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.914 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.412 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.0 tttt -111.95 -12.27 13.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.118 0.485 . . . . 0.0 110.423 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.55 -37.01 84.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.678 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.02 -48.73 80.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.387 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.228 179.771 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -90.1 -2.69 58.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.406 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.04 1.25 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.489 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.2 Cg_exo -60.78 145.09 99.5 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.75 2.3 . . . . 0.0 112.168 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.04 -179.65 8.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.585 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.61 136.06 53.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.311 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' A' ' 30' ' ' ILE . 9.3 tp -123.34 146.24 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.358 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.0 p -120.35 136.42 54.71 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.767 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 53.1 p30 -100.03 -142.99 0.33 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.2 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -62.87 -37.19 85.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.513 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.464 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -152.01 -59.99 0.16 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.413 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -60.52 139.82 48.11 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.7 p -111.83 129.98 55.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.916 0.388 . . . . 0.0 110.461 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.97 128.84 53.94 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.523 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.8 m -85.45 130.62 34.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.222 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.468 HD22 ' OE1' ' A' ' 42' ' ' GLN . 67.9 mt -96.27 79.04 3.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.311 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.55 -32.03 73.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.485 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.01 109.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.063 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.468 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.5 pt20 -121.73 91.31 48.59 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.226 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.8 Cg_exo -57.05 148.95 65.58 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.759 2.306 . . . . 0.0 111.787 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.72 82.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 O-C-N 123.566 0.541 . . . . 0.0 110.983 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.24 66.95 0.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.111 0.482 . . . . 0.0 110.233 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.75 130.74 35.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.589 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.552 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.5 t -122.71 146.07 28.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.106 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 t -135.85 143.47 45.12 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.624 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.5 p -99.24 -59.31 1.75 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.51 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.8 p -79.37 154.62 28.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.638 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.5 HG21 HG23 ' A' ' 70' ' ' THR . 69.4 t -73.98 -21.72 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.573 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.8 m -60.28 -52.0 67.12 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.477 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.45 -42.34 87.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.368 0.604 . . . . 0.0 110.943 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.22 -53.93 4.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.099 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.1 -37.48 72.86 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.8 m -62.76 -44.6 95.77 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-O 120.848 0.356 . . . . 0.0 110.424 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.6 mt -66.19 -41.95 89.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.477 0.656 . . . . 0.0 110.728 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.57 -40.34 96.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.431 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.462 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.93 -35.71 75.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.976 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.538 HD11 HD12 ' A' ' 156' ' ' LEU . 31.7 pt -91.51 28.44 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.138 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.72 51.42 11.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.851 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.45 75.02 27.89 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.984 0.421 . . . . 0.0 109.941 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.17 151.3 85.94 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.765 2.31 . . . . 0.0 112.263 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.552 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.59 137.3 47.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.207 0.527 . . . . 0.0 110.235 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.445 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -69.13 -43.7 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.218 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.03 130.86 53.17 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.959 0.409 . . . . 0.0 110.548 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.529 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.1 p -155.59 168.96 25.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.408 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.86 -177.38 21.64 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.06 172.21 12.95 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.976 0.417 . . . . 0.0 110.498 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.5 HG23 HG21 ' A' ' 51' ' ' VAL . 12.8 p -134.05 -110.38 0.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.402 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.18 179.74 0.92 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.323 -179.018 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.5 Cg_exo -60.99 58.93 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 123.03 2.487 . . . . 0.0 112.088 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 56.7 t-20 -64.22 -35.16 79.92 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.586 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.2 m120 94.91 -37.67 0.01 OUTLIER 'General case' 0 C--N 1.346 0.454 0 O-C-N 124.377 1.048 . . . . 0.0 109.938 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -62.7 -40.08 96.02 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.244 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -73.88 -26.77 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.724 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.76 -172.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.627 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.64 -152.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.742 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.6 p-10 -54.76 -6.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.681 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.49 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -87.06 113.68 23.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.609 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.25 73.06 1.27 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.94 148.58 35.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.825 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.84 -99.36 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.086 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.09 -42.95 96.76 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.142 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.544 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 9.9 tt0 91.6 53.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.088 0.867 . . . . 0.0 110.834 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -103.47 -9.21 19.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.453 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.2 p -64.9 -33.78 76.84 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.112 0.482 . . . . 0.0 110.664 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.62 -23.8 1.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.554 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.5 t -69.52 -46.0 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.978 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.35 81.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.117 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.72 -38.2 89.54 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.284 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.66 -32.16 50.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.226 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.591 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.5 mmt-85 -90.12 1.7 56.1 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 119.204 -0.426 . . . . 0.0 110.609 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 82.85 -49.11 0.16 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.212 0.945 . . . . 0.0 110.322 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.642 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.3 mt -46.49 153.96 0.33 Allowed 'General case' 0 CA--C 1.49 -1.34 0 CA-C-O 117.587 -1.197 . . . . 0.0 109.148 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.642 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.2 tt0 121.23 92.19 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 O-C-N 125.558 1.786 . . . . 0.0 110.529 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.529 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.21 143.46 43.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.218 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -132.12 26.95 4.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.733 0.301 . . . . 0.0 110.462 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.54 138.42 34.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.959 0.409 . . . . 0.0 110.469 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.63 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.6 mt -137.3 165.02 28.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.351 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.615 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.29 -28.59 1.81 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.95 70.95 7.15 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.188 0.518 . . . . 0.0 110.358 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.24 145.69 98.0 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 122.803 2.335 . . . . 0.0 112.032 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.2 t -134.38 136.64 43.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.568 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.14 82.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.716 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.5 -41.94 96.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.507 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.47 98.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.514 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.66 -43.35 98.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.06 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.99 -35.17 77.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.311 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -18.52 60.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.468 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.5 -6.34 58.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.526 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.0 mtp 48.0 55.74 17.17 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.651 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.15 149.12 63.94 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.777 2.318 . . . . 0.0 112.114 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -101.2 -73.37 0.65 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.46 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.418 HD11 HD13 ' A' ' 140' ' ' LEU . 38.3 tp -110.84 112.63 24.62 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.324 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -101.13 125.99 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.446 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.2 mt -109.5 133.27 53.28 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.149 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.22 139.48 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.484 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.9 p -83.42 168.41 16.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.648 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.56 80.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.44 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.51 159.18 42.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.424 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.2 177.01 33.46 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.94 87.5 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.77 151.98 44.42 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.962 0.41 . . . . 0.0 110.527 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.6 t -62.97 141.07 58.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.362 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.66 10.15 10.96 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.647 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.7 mp -60.98 -39.18 88.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.061 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.68 -35.91 24.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.54 0.686 . . . . 0.0 110.671 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.5 mt -70.83 -35.57 72.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.458 0.647 . . . . 0.0 110.774 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -42.78 -62.86 0.89 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.265 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.83 -42.61 90.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.994 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -62.33 -32.97 73.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.129 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.8 mt -73.48 -40.71 63.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.19 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.41 -48.66 79.96 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.206 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.7 m -53.28 -42.16 66.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.208 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.01 -43.04 92.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.002 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.62 154.08 5.34 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.625 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -39.13 107.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.666 2.244 . . . . 0.0 112.298 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.642 ' C ' HD12 ' A' ' 140' ' ' LEU . 94.5 m -109.75 121.4 45.14 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.252 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.642 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.28 152.82 30.75 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.252 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -128.27 131.42 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.359 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.29 127.42 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.397 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.88 103.6 14.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.364 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.9 p90 -101.12 -11.32 19.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.782 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.91 -33.47 76.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.622 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.2 p-10 -98.35 7.57 46.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.643 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.7 mttm -135.33 155.35 50.75 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.568 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.0 p -74.54 165.47 25.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.687 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.584 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -59.86 -48.7 80.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.298 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -53.86 -41.93 68.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.918 0.389 . . . . 0.0 110.081 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.4 t -62.42 -40.82 97.77 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.402 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.411 ' O ' HD23 ' A' ' 156' ' ' LEU . 47.4 tp -60.66 -43.87 97.12 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.355 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.516 HD22 HH21 ' A' ' 169' ' ' ARG . 44.0 tp -61.39 -43.07 99.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.861 0.363 . . . . 0.0 110.14 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.2 m -55.54 -45.3 77.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.716 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.49 -40.6 97.24 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 120.877 0.37 . . . . 0.0 110.395 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.538 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.02 -42.34 99.06 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.233 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.77 -41.05 95.93 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.72 -46.21 63.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.968 0.413 . . . . 0.0 110.894 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.6 mt -64.52 -44.05 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.819 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.8 p -93.23 -8.75 41.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.6 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.09 25.05 72.07 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -101.72 51.73 0.83 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.787 0.327 . . . . 0.0 110.681 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.79 -38.92 76.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.698 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.5 -46.92 87.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.187 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -61.37 -39.04 89.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.375 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.16 -40.45 97.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.362 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.3 -27.8 69.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.542 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.77 -53.71 8.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.171 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.516 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -63.75 -43.31 96.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.468 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 174' ' ' ASP . 86.7 mt -63.05 -43.9 99.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.676 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.33 -61.51 2.5 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.12 0.486 . . . . 0.0 110.484 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -54.81 -35.22 63.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.365 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -79.44 -34.72 41.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.114 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.3 m-20 -56.9 -40.01 75.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.926 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.83 -42.39 99.71 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.733 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.82 -37.74 87.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.294 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 177' ' ' LEU . 81.6 mt -62.41 -42.5 99.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.7 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.0 -53.14 59.79 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.128 0.489 . . . . 0.0 110.711 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.44 -41.41 89.16 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.548 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.26 -39.82 94.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.622 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.3 -32.33 73.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.338 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.21 -21.88 18.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.745 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.441 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.7 tt0 -65.02 -41.42 95.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.698 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 pt -77.58 136.33 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.679 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.46 108.65 11.0 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.274 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.18 126.15 0.33 Allowed Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.89 152.18 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.724 2.283 . . . . 0.0 112.586 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.13 141.71 53.5 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.676 2.25 . . . . 0.0 112.469 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -170.96 147.07 2.24 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.669 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.13 154.5 70.15 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.734 2.289 . . . . 0.0 112.265 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.581 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.44 163.18 28.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.419 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.581 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.65 170.05 16.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.857 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.79 137.45 22.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.226 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.536 HG22 HD12 ' A' ' 205' ' ' LEU . 39.3 pt -134.03 146.01 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.603 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.72 131.68 59.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.133 0.492 . . . . 0.0 110.457 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -152.01 155.11 37.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.419 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.616 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.2 m -122.25 122.93 40.27 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.916 0.389 . . . . 0.0 110.382 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.37 -25.84 66.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.569 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.616 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.24 -49.17 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.086 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.59 -12.87 61.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.472 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.7 m80 50.43 41.55 25.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.439 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.9 t -136.27 144.79 44.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.339 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.401 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -110.5 114.31 27.62 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.35 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.1 m-20 -119.86 133.4 55.6 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.067 0.46 . . . . 0.0 110.372 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.98 146.32 38.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.756 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.484 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 12.3 t90 -99.29 129.54 45.52 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.062 0.458 . . . . 0.0 110.026 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.43 153.72 39.5 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.082 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.66 -18.29 48.12 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.791 2.328 . . . . 0.0 111.888 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.11 -18.71 0.35 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.45 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.484 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.1 p -75.65 165.23 25.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.496 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.14 -28.19 66.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.545 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.1 mt-30 -63.61 -41.43 98.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.17 -44.67 97.15 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.5 -38.92 92.7 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.981 0.42 . . . . 0.0 110.567 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.584 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.1 mmm -62.28 -41.36 98.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.114 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.5 mt -63.67 -47.05 82.8 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.648 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.48 -31.95 56.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.057 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -70.74 -18.14 62.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.543 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.427 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.4 mt -88.63 -8.67 54.24 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.692 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.85 2.52 55.12 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -88.57 152.46 21.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.768 0.318 . . . . 0.0 110.565 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.448 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.2 p -115.35 128.15 55.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.101 0.477 . . . . 0.0 110.378 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.46 146.02 24.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.852 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.47 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.64 151.16 46.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.463 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.9 131.59 42.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.408 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.89 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.56 93.4 27.59 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.061 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.677 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.0 Cg_exo -55.61 139.16 82.58 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.588 2.192 . . . . 0.0 111.519 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.86 -25.47 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.507 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.66 -49.88 27.9 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.553 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -53.99 -37.07 63.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.771 0.32 . . . . 0.0 110.19 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -66.71 35.96 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.815 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.553 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.32 88.13 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.4 p -81.72 -14.36 56.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.335 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -91.37 -41.41 10.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.564 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.7 t -66.88 -16.62 64.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.682 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.1 43.54 26.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.495 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.63 -147.99 7.63 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -121.75 143.11 49.57 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.953 0.406 . . . . 0.0 110.354 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -151.97 149.43 28.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.349 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -100.83 -151.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.313 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 55.87 -91.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.609 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.462 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.4 tt -126.67 175.12 9.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.559 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.462 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.8 mt -121.73 141.42 42.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.841 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.68 169.16 9.46 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.259 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.2 mt -147.73 150.83 35.02 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.181 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.58 -39.04 97.18 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.33 3.98 4.6 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -77.33 -58.03 3.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.001 0.429 . . . . 0.0 110.649 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.566 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.2 m-20 -62.15 -36.86 83.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.221 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.401 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.0 mp -52.36 -67.76 0.22 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.747 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.45 -42.17 66.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.248 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.11 17.92 0.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.672 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.99 48.59 0.29 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.42 -109.83 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.647 0.26 . . . . 0.0 110.744 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.47 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 12.0 m120 -60.96 -44.82 96.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.454 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.41 8.09 83.82 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -99.1 -12.95 20.05 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.783 -0.245 . . . . 0.0 110.646 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.0 t 176.69 142.57 0.07 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.121 0.486 . . . . 0.0 110.514 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.94 125.94 12.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.074 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -99.08 143.1 29.73 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 120.927 0.394 . . . . 0.0 110.79 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.4 mt -94.49 106.35 18.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.632 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.455 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.4 t80 -101.96 -12.29 18.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.163 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.22 -40.14 90.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.862 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.67 174.19 46.4 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.466 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.6 m-20 -74.67 -113.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 0.0 110.662 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.65 -28.61 67.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.743 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.04 -44.11 91.72 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.245 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.53 -44.28 94.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.398 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.56 -59.81 4.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.208 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.39 -43.34 61.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.151 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.34 -43.92 75.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.23 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.41 -43.6 97.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.682 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -56.55 -37.44 70.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.207 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.76 1.09 18.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.297 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -115.04 91.21 26.07 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.174 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.21 -27.11 28.86 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.803 2.336 . . . . 0.0 111.767 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.33 -41.06 98.87 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.641 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.22 4.93 53.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.371 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.63 -35.21 70.35 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.75 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.59 4.56 15.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.512 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.75 121.39 81.03 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.592 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -47.67 -37.67 27.77 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.46 2.107 . . . . 0.0 112.453 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.532 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -59.06 -43.75 91.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.788 0.328 . . . . 0.0 110.211 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.85 -43.75 93.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.251 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.72 -40.52 95.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.449 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.76 -12.43 39.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.534 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.2 mtmt 61.99 31.56 17.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.39 44.01 1.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.384 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.04 135.91 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.497 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.47 132.87 56.56 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.428 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.15 87.75 7.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.723 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.01 -41.25 97.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.92 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.455 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.98 168.45 34.97 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.0 p -76.05 -25.81 55.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.858 0.361 . . . . 0.0 110.731 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.1 tp10 -67.61 -34.18 76.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.465 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.762 HG22 ' O ' ' A' ' 296' ' ' THR . 97.0 m -73.52 20.47 0.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.648 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.557 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 57.0 t80 -57.63 -51.13 70.77 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.942 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.409 HH12 ' HG3' ' A' ' 212' ' ' GLN . 65.2 mmt-85 -108.28 149.72 28.26 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.427 ' CD2' HD11 ' A' ' 219' ' ' LEU . 40.4 tp -115.32 125.35 53.14 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.805 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.471 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.2 t0 -149.11 166.46 28.69 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.552 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -49.24 -38.16 25.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.61 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -71.54 -65.21 0.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.371 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -60.93 -32.86 72.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.47 -25.65 26.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.566 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.6 mtt -63.33 -40.87 98.5 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 120.865 0.364 . . . . 0.0 110.944 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.77 -44.22 23.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.562 HG21 HG23 ' A' ' 296' ' ' THR . 78.8 t -66.17 -43.03 92.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.403 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.441 HD11 ' NE2' ' A' ' 183' ' ' GLN . 50.3 tp -60.23 -47.06 87.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.466 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -69.83 -39.9 76.19 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.035 0.445 . . . . 0.0 110.744 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.498 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.2 ttt180 -61.61 -38.19 86.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.198 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.11 4.45 42.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.767 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.4 tttt -112.47 -11.51 13.62 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.045 0.45 . . . . 0.0 110.259 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.97 85.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.644 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.1 -48.87 79.67 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.339 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.042 179.947 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.44 -2.76 57.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.444 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.49 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.41 178.98 1.27 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.536 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.3 Cg_exo -60.75 144.82 99.61 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.652 2.235 . . . . 0.0 112.212 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.69 -179.75 8.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.608 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.58 136.69 52.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.392 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.1 tp -124.55 146.28 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.361 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.8 p -119.81 136.09 54.6 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.779 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.9 p30 -98.74 -144.17 0.32 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.273 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.56 -36.63 84.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.47 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.486 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.9 ttt85 -147.32 -70.59 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.565 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.81 144.07 41.81 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.2 p -112.68 130.08 56.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 0.0 110.397 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -114.8 129.65 56.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.686 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.9 m -86.83 130.6 34.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.342 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.493 HD22 ' OE1' ' A' ' 42' ' ' GLN . 71.1 mt -97.41 79.06 2.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.437 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -65.94 -32.55 74.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.53 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 t 177.09 109.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.155 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.493 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -123.36 91.59 49.64 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.324 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.3 Cg_exo -56.81 149.0 62.9 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.71 2.273 . . . . 0.0 111.82 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.69 83.05 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.933 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.48 67.27 0.89 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.316 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.59 130.69 35.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.637 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.552 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.4 t -123.04 146.31 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.108 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 t -136.16 143.84 44.68 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.626 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.7 p -99.35 -59.35 1.74 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.523 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.2 p -79.36 155.03 28.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.585 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.497 HG21 HG23 ' A' ' 70' ' ' THR . 72.5 t -74.36 -21.67 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.582 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.7 m -60.23 -52.09 66.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.537 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -66.62 -42.45 86.8 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.243 0.544 . . . . 0.0 110.759 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.8 m -42.88 -54.07 4.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.234 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.34 -37.24 70.51 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -62.85 -44.62 95.64 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 120.848 0.356 . . . . 0.0 110.428 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.422 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.9 mt -66.51 -41.93 88.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.306 0.574 . . . . 0.0 110.732 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.3 tp -62.5 -40.44 96.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.25 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.502 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.81 -36.05 75.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.928 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.527 HD11 HD12 ' A' ' 156' ' ' LEU . 30.7 pt -91.06 29.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.103 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 56.43 51.51 11.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.899 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.41 75.79 22.13 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.909 0.385 . . . . 0.0 109.98 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.15 152.11 83.35 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.783 2.322 . . . . 0.0 112.28 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.552 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.86 137.54 46.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.104 0.478 . . . . 0.0 110.33 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.5 pt -69.14 -43.65 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.241 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.1 131.21 53.33 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.948 0.404 . . . . 0.0 110.595 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.5 p -155.57 168.94 25.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.409 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.98 -177.28 21.56 Favored Glycine 0 N--CA 1.464 0.505 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.635 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.14 172.31 12.83 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.919 0.39 . . . . 0.0 110.507 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.497 HG23 HG21 ' A' ' 51' ' ' VAL . 15.0 p -132.35 -112.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.947 0.403 . . . . 0.0 110.462 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.18 179.76 0.93 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.344 -179.185 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.6 Cg_exo -60.8 57.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.962 2.441 . . . . 0.0 112.132 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.7 t-20 -64.41 -33.54 76.09 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.522 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.567 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.3 m120 93.76 -36.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.08 0.862 . . . . 0.0 109.94 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.6 mtp85 -62.43 -39.48 93.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.265 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -74.69 -25.68 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.623 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.19 -171.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.86 -153.75 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.758 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.1 p-10 -52.78 -7.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.687 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.508 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.49 115.17 23.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.653 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.94 69.85 1.35 Allowed Glycine 0 CA--C 1.521 0.42 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -143.16 147.51 35.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.815 0.341 . . . . 0.0 110.832 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.61 -98.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.185 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.1 -42.64 96.84 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.122 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 9.9 tt0 91.51 53.14 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.866 0.729 . . . . 0.0 110.878 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -103.13 -9.05 19.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.447 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -64.79 -33.74 76.69 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.058 0.456 . . . . 0.0 110.65 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -49.18 -23.85 1.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.613 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.53 -46.0 76.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.936 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.41 -48.19 82.34 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.237 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.65 -38.26 89.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.292 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.78 -32.31 52.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.238 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.608 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.3 mmt-85 -90.19 1.65 56.21 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.57 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 56.9 mttp 82.64 -49.55 0.18 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.954 0.784 . . . . 0.0 110.29 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.671 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.7 mt -45.87 154.52 0.23 Allowed 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 118.16 -0.924 . . . . 0.0 109.453 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.671 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 120.77 92.68 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 O-C-N 125.066 1.479 . . . . 0.0 110.462 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.76 143.45 42.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.992 0.425 . . . . 0.0 110.249 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.5 mt -132.38 27.21 4.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 110.517 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.35 138.04 34.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.557 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.7 mt -137.25 164.96 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.386 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.02 -28.53 1.85 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.69 70.82 7.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.078 0.466 . . . . 0.0 110.36 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.89 145.19 98.9 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.754 2.303 . . . . 0.0 112.066 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.2 t -133.99 136.13 43.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.549 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.95 -38.17 82.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.673 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.25 -41.95 96.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.514 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.37 -41.41 98.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.527 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.0 t -63.84 -43.4 97.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.068 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.13 -35.05 77.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.323 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.75 -18.41 59.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.485 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.75 -6.39 58.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.498 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 68.0 mtp 47.57 56.06 17.21 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.584 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.13 149.43 64.51 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.786 2.324 . . . . 0.0 112.034 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.11 -73.88 0.63 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.433 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.502 HD11 HD13 ' A' ' 140' ' ' LEU . 37.9 tp -110.56 112.35 24.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.262 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.9 mt -100.72 126.33 54.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.022 0.439 . . . . 0.0 110.437 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.8 mt -109.16 132.83 53.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.272 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.0 139.3 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.511 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -83.55 168.38 16.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.579 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.1 -37.52 80.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.424 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -140.14 159.32 42.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.511 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.46 178.38 32.96 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.21 -33.74 86.92 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -125.6 152.67 44.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.899 0.381 . . . . 0.0 110.556 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 33.3 t -63.4 141.27 58.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.408 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.68 10.46 11.01 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.578 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -60.93 -38.97 87.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.113 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.88 -36.12 23.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.431 0.634 . . . . 0.0 110.629 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.1 mt -70.93 -35.57 72.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.373 0.606 . . . . 0.0 110.79 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -42.69 -62.8 0.9 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.201 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -66.17 -42.69 88.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.043 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.24 -32.58 73.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.267 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 129' ' ' LEU . 74.1 mt -73.9 -41.06 62.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.078 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -58.24 -48.98 78.69 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.301 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.0 m -52.95 -42.37 65.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.353 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.96 -42.65 92.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.985 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.44 153.97 5.47 Favored Pre-proline 0 N--CA 1.453 -0.281 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.581 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -39.74 106.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.669 2.246 . . . . 0.0 112.179 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.66 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.6 m -110.07 122.76 48.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.382 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.66 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -115.05 153.68 30.25 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.304 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -129.44 131.81 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.395 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.16 127.79 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.513 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.21 104.37 15.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.298 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.2 p90 -101.57 -11.17 19.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.805 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.576 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.73 -33.66 76.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.722 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.576 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.7 p-10 -98.41 8.03 45.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.573 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.61 155.18 50.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.582 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.409 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.45 165.94 24.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.64 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.595 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.8 t90 -59.72 -49.12 78.99 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.23 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -53.51 -42.39 67.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 110.109 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.8 t -62.85 -40.99 99.15 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.328 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.401 ' O ' HD23 ' A' ' 156' ' ' LEU . 48.9 tp -60.64 -44.19 96.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.366 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.37 -43.6 98.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.206 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.5 m -54.71 -44.64 73.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.875 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.79 -40.74 98.26 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.905 0.383 . . . . 0.0 110.379 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.527 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.03 -42.38 99.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.165 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.94 -41.21 95.5 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.66 -45.81 64.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.908 0.385 . . . . 0.0 110.831 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.55 -44.0 96.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.811 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -93.34 -8.34 42.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.583 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.5 26.67 71.95 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -101.76 51.41 0.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.818 0.342 . . . . 0.0 110.679 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.8 -39.38 76.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.707 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.61 -47.41 85.67 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.297 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -59.92 -39.47 85.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.35 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.9 -40.97 99.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.368 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.52 70.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.566 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.17 -54.37 7.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.1 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.502 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.5 ttp180 -65.57 -42.19 92.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.477 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.6 mt -62.36 -43.77 98.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.566 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.66 -57.16 12.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.931 0.396 . . . . 0.0 110.551 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -58.48 -32.76 69.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.345 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.423 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.9 t80 -82.1 -36.56 27.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.772 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.6 m-20 -56.13 -41.41 75.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.155 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.99 -42.25 99.79 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.595 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.45 -37.78 87.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.281 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.423 HD11 ' CD2' ' A' ' 173' ' ' PHE . 81.9 mt -62.5 -42.23 99.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.654 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.06 -52.91 62.03 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.013 0.435 . . . . 0.0 110.668 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.4 -41.77 88.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.565 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.98 95.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.563 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.31 -31.94 73.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.424 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.54 -22.51 18.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.766 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.447 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.8 tt0 -64.65 -41.25 96.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.616 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 184' ' ' ILE . 33.0 pt -76.72 136.52 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.626 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.89 108.1 10.68 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.282 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.83 125.43 0.3 Allowed Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.505 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.451 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.7 Cg_exo -43.77 152.35 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.741 2.294 . . . . 0.0 112.484 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.89 141.81 55.06 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.634 2.223 . . . . 0.0 112.396 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.19 147.25 2.18 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.578 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.0 154.32 70.94 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.779 2.319 . . . . 0.0 112.324 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.585 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.27 163.15 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.42 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.585 ' N ' HG22 ' A' ' 191' ' ' VAL . 1.9 t -144.07 170.68 15.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.799 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.63 137.7 21.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.312 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.535 HG22 HD12 ' A' ' 205' ' ' LEU . 40.0 pt -134.31 146.96 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.675 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.28 131.83 58.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.102 0.477 . . . . 0.0 110.482 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -152.09 155.12 37.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.473 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.621 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.4 m -122.79 122.93 39.88 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.412 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.47 -25.67 66.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.579 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.621 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.33 -48.86 21.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.007 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.34 -9.41 58.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.467 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.2 m80 46.51 42.11 10.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.444 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -135.93 145.75 46.58 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.399 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.94 114.3 27.12 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.321 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.79 133.37 55.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 110.442 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.535 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.81 146.22 38.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.712 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.491 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.3 t90 -99.42 129.38 45.6 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.074 0.464 . . . . 0.0 110.056 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.02 153.42 39.84 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.073 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.85 -17.87 46.99 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.762 2.308 . . . . 0.0 111.962 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.14 -18.9 0.37 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.486 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.491 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.71 164.71 26.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.531 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.93 -27.95 65.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.504 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.6 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.9 mt-30 -63.65 -41.19 98.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.643 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.66 -44.37 97.95 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.45 -38.8 92.29 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.983 0.42 . . . . 0.0 110.464 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.595 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.0 mmm -62.14 -41.31 98.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.177 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.7 mt -63.63 -47.17 82.42 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.672 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.13 -31.95 53.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.114 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.85 -18.3 62.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.557 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.437 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.9 mt -87.87 -9.13 54.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.559 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.19 1.6 54.34 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -88.16 153.77 20.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.835 0.35 . . . . 0.0 110.519 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.455 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.0 p -116.31 128.74 55.82 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.071 0.463 . . . . 0.0 110.384 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.62 146.3 23.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.866 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.486 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.95 151.72 45.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.463 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.88 131.47 42.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.443 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.896 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.73 93.07 26.93 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.132 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.675 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.9 Cg_exo -55.43 139.21 81.77 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.597 2.198 . . . . 0.0 111.59 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.01 -26.07 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.486 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.36 -50.25 27.88 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.4 mt -53.71 -37.15 63.0 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -66.76 36.14 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.731 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.556 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 38.98 88.72 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.847 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.5 p -81.28 -13.87 58.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.377 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.98 -41.84 10.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.626 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.7 t -66.74 -16.94 64.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.636 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 55.74 44.01 26.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.453 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.67 -149.24 8.32 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.95 142.84 48.38 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.912 0.387 . . . . 0.0 110.369 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.01 149.56 29.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.391 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -101.31 -151.59 0.42 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.343 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 55.96 -92.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.631 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.466 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.4 tt -126.84 175.52 8.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.613 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.466 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.4 mt -122.72 142.04 40.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.759 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.86 169.65 9.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.329 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 58.7 mt -148.01 150.8 34.63 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.49 -39.05 97.26 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.1 4.03 4.69 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -77.55 -58.04 3.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.896 0.379 . . . . 0.0 110.596 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.56 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.4 m-20 -62.11 -36.61 82.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.264 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.36 -67.76 0.23 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.661 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.54 -42.48 67.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.264 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.63 17.42 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.56 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.02 48.83 0.3 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.53 -110.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.587 0.232 . . . . 0.0 110.704 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.486 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.9 m120 -60.8 -44.8 96.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.572 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.28 8.01 84.16 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.95 -13.58 19.89 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.628 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.1 t 177.25 142.55 0.08 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.007 0.432 . . . . 0.0 110.492 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.22 124.81 11.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.052 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.09 143.63 28.43 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 120.854 0.359 . . . . 0.0 110.699 178.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.5 mt -95.13 106.49 18.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.659 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.442 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.8 t80 -101.75 -12.27 18.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.279 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.37 -40.73 89.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.83 173.06 45.72 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.453 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -73.71 -113.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.814 0.34 . . . . 0.0 110.739 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.66 -28.62 67.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.715 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.9 -44.03 91.13 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.179 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.63 -44.22 94.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.336 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.71 -60.21 3.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.227 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.93 -43.54 60.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.165 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.27 -43.58 74.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.268 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.64 -43.63 96.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.648 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -56.28 -37.5 69.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.189 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.54 0.9 18.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.328 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -114.99 91.4 26.6 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.227 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.21 -27.28 29.54 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.809 2.34 . . . . 0.0 111.778 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -40.96 98.78 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.621 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.33 5.31 52.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.328 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.07 -35.37 69.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.009 0.433 . . . . 0.0 110.707 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.36 4.36 15.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.601 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.76 121.15 80.17 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.531 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -47.2 -37.89 24.53 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.479 2.119 . . . . 0.0 112.397 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.98 -43.74 91.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.846 0.355 . . . . 0.0 110.311 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.5 t -66.18 -43.68 91.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.337 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.89 -40.6 95.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.537 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 47.5 t-20 -89.64 -12.89 38.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.502 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 62.47 32.28 16.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.79 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.01 43.84 1.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.376 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.22 135.63 41.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.544 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.84 132.38 56.71 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.465 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.07 89.15 7.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.735 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.88 -40.98 97.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.784 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.79 165.34 33.26 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 71.7 p -75.47 -25.75 57.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 110.673 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.8 tp10 -68.36 -33.85 75.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.384 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 296' ' ' THR . 95.7 m -73.68 25.17 0.07 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.711 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.6 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 37.7 t80 -58.57 -50.75 72.68 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.413 HH12 ' HG3' ' A' ' 212' ' ' GLN . 79.4 mmt-85 -110.82 153.84 24.81 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.437 ' CD2' HD11 ' A' ' 219' ' ' LEU . 45.0 tp -115.67 125.1 52.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.721 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.487 ' CB ' HD23 ' A' ' 83' ' ' LEU . 44.7 t0 -147.98 165.66 30.05 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.531 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.16 -38.13 24.55 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.544 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.03 -65.83 0.69 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.29 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.91 -32.75 72.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.35 -25.25 23.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.627 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.5 mtt -63.72 -40.73 97.47 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 120.889 0.376 . . . . 0.0 111.01 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -79.1 -44.13 22.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.58 HG21 HG23 ' A' ' 296' ' ' THR . 79.0 t -66.15 -42.88 92.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.469 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.447 HD11 ' NE2' ' A' ' 183' ' ' GLN . 50.9 tp -60.1 -47.13 87.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.455 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.04 -39.31 75.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.58 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.2 ttt180 -61.85 -38.66 89.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.252 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -86.67 4.57 39.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.772 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.1 tttt -112.92 -11.16 13.46 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.048 0.451 . . . . 0.0 110.31 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.1 85.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.578 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.84 -48.88 79.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.422 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.178 179.701 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.612 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.68 -3.15 57.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.425 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.489 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -143.88 179.2 1.23 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.53 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 37.6 Cg_exo -60.55 144.57 99.54 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.779 2.32 . . . . 0.0 112.161 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.612 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.3 ptt-85 -155.85 179.96 8.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.571 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -116.03 137.22 52.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.346 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.83 146.17 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.46 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.8 p -119.9 136.27 54.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.744 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.7 p30 -98.33 -144.51 0.31 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.267 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.58 -36.39 83.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.481 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -147.04 -70.68 0.23 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.508 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.59 144.15 41.11 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.7 p -112.61 129.82 56.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 110.385 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -114.86 129.9 56.79 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.643 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 m -87.74 131.53 34.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.159 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.497 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.8 mt -99.02 79.64 2.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.655 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.16 -32.01 73.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.475 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 t 176.98 109.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.182 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.497 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -124.32 91.66 49.23 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.306 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.4 Cg_exo -56.64 149.04 61.05 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.792 2.328 . . . . 0.0 111.917 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.44 82.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.599 0.562 . . . . 0.0 110.923 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.0 mtm180 -151.62 67.23 0.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.24 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.84 130.99 35.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.667 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.567 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.6 t -123.16 147.74 27.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.149 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 t -136.22 143.96 44.63 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.703 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 50' ' ' SER . 16.9 p -99.65 -59.33 1.74 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.524 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.42 ' N ' ' OG1' ' A' ' 49' ' ' THR . 86.6 p -79.41 154.94 28.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.596 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.529 HG21 HG23 ' A' ' 70' ' ' THR . 70.5 t -73.72 -21.76 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.517 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.8 m -60.17 -52.03 67.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.535 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 mt -66.41 -42.32 87.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.208 0.527 . . . . 0.0 110.862 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.7 m -43.52 -54.27 4.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.091 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.63 -36.65 76.35 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 m -63.32 -44.38 95.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 0.0 110.423 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.7 mt -66.02 -42.13 90.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.484 0.659 . . . . 0.0 110.593 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tp -62.83 -40.17 96.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.367 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.534 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.52 -36.16 77.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.065 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.46 HD11 HD12 ' A' ' 156' ' ' LEU . 32.6 pt -90.99 27.66 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.168 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 57.02 51.51 10.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.944 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.81 75.92 29.86 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.036 0.446 . . . . 0.0 109.932 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -63.53 149.38 91.16 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.752 2.302 . . . . 0.0 112.214 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.567 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -112.71 137.11 46.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.198 0.523 . . . . 0.0 110.281 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.441 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.5 pt -69.51 -43.7 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.145 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.22 131.21 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.929 0.395 . . . . 0.0 110.59 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.2 p -155.78 168.67 26.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.467 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.7 -177.41 21.74 Favored Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.629 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.07 172.3 12.83 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.483 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.529 HG23 HG21 ' A' ' 51' ' ' VAL . 11.4 p -134.13 -110.27 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.396 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.545 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.43 179.6 0.94 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.348 -179.045 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.2 Cg_exo -60.79 58.87 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.996 2.464 . . . . 0.0 112.129 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 56.3 t-20 -64.37 -34.91 79.25 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.498 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.2 m120 95.04 -38.14 0.01 OUTLIER 'General case' 0 C--N 1.346 0.448 0 O-C-N 124.016 0.822 . . . . 0.0 109.875 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.45 -39.84 94.67 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.018 0.437 . . . . 0.0 110.228 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.2 p -73.79 -26.5 21.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.693 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.97 -172.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.568 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.7 p30 -74.22 -152.88 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.757 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.7 p-10 -54.49 -6.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.701 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.493 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.94 113.66 22.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.589 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.48 72.74 1.28 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.99 148.62 35.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.885 0.374 . . . . 0.0 110.817 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.75 -99.16 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.139 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.04 -42.94 96.89 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.201 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.1 tt0 91.65 52.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.953 0.783 . . . . 0.0 110.925 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -103.43 -8.99 19.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.365 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -64.92 -33.58 76.35 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.108 0.48 . . . . 0.0 110.669 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -48.85 -23.55 1.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.671 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.7 t -70.02 -46.14 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.815 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.16 -48.63 80.7 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.107 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.63 -38.18 89.23 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.41 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.76 -32.31 51.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.261 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.6 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.9 mmt-85 -89.79 1.81 55.68 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.617 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.6 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 82.64 -49.5 0.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.015 0.822 . . . . 0.0 110.319 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.655 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.6 mt -46.06 154.48 0.25 Allowed 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 117.702 -1.142 . . . . 0.0 109.407 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.655 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 120.72 92.36 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 O-C-N 125.439 1.712 . . . . 0.0 110.479 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.533 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.11 143.02 43.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.084 0.468 . . . . 0.0 110.259 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -132.07 26.71 4.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.856 0.36 . . . . 0.0 110.533 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.33 138.14 34.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.013 0.435 . . . . 0.0 110.549 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.3 mt -137.16 164.79 29.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.398 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.613 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.63 -28.91 1.75 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -151.94 70.75 7.88 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.177 0.513 . . . . 0.0 110.258 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.87 145.29 98.64 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.777 2.318 . . . . 0.0 112.057 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.8 t -134.98 136.49 42.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.549 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.97 -38.17 82.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.657 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.51 -42.07 96.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.506 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.08 -41.59 98.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.516 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.77 -43.29 97.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.064 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.17 -35.09 77.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.263 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -18.29 59.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.506 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.72 -6.1 58.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.505 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.417 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 70.4 mtp 47.83 55.73 17.09 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.608 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.0 Cg_endo -70.25 149.16 63.4 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.744 2.296 . . . . 0.0 112.116 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.48 -72.99 0.66 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.429 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.448 HD11 HD13 ' A' ' 140' ' ' LEU . 37.6 tp -111.25 113.54 26.11 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.342 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.4 mt -102.67 126.95 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.576 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.5 mt -110.06 133.85 52.76 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.225 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.33 139.65 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.468 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.6 p -83.48 167.84 17.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.688 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -37.25 79.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.47 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.61 158.6 43.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.472 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.11 176.97 33.4 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.75 86.91 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.95 152.27 44.38 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.926 0.394 . . . . 0.0 110.505 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.0 t -63.47 140.93 58.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.355 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.62 10.5 11.07 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.611 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.04 -38.89 87.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.14 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.97 -35.86 23.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.542 0.687 . . . . 0.0 110.668 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.9 mt -70.98 -35.34 72.09 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.444 0.64 . . . . 0.0 110.733 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -42.81 -63.0 0.86 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.239 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.87 -42.71 90.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.049 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.07 -32.63 73.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.3 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.9 mt -73.9 -40.7 62.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.987 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.28 -49.22 77.92 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.21 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.3 m -52.89 -42.48 65.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.246 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.59 -42.87 93.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.131 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.73 153.94 5.19 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.65 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -39.38 106.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.661 2.241 . . . . 0.0 112.354 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.649 ' C ' HD12 ' A' ' 140' ' ' LEU . 97.1 m -109.97 122.22 47.06 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.332 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.649 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.5 153.44 29.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.225 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -129.04 131.5 68.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.393 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -114.88 127.6 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.475 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.496 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 55.3 t30 -100.65 104.45 15.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.311 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 147' ' ' LYS . 50.0 p90 -100.92 -11.18 19.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.809 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.0 p-10 -64.74 -33.53 76.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.728 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.1 p-10 -98.87 8.13 45.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.591 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.441 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.27 153.04 52.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.487 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.405 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.8 p -75.37 166.05 24.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.649 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.598 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.7 t90 -59.46 -48.91 79.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.127 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -54.28 -43.07 70.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.91 0.386 . . . . 0.0 110.114 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.1 t -62.78 -40.9 98.75 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.366 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.429 ' O ' HD23 ' A' ' 156' ' ' LEU . 55.5 tp -60.69 -44.37 96.62 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.241 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.35 -42.88 99.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.853 0.359 . . . . 0.0 110.192 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.0 m -55.86 -44.9 78.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.773 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.81 -40.3 96.93 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 120.908 0.385 . . . . 0.0 110.439 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.46 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.9 -42.27 98.88 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.287 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.81 -40.45 95.6 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.52 -45.54 65.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.908 0.385 . . . . 0.0 110.792 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.71 -44.03 96.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.742 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -93.44 -8.4 41.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.596 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.67 26.5 72.04 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -101.35 50.76 0.85 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.813 0.339 . . . . 0.0 110.589 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -69.65 -39.68 76.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.667 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.58 -47.59 84.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.208 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -59.62 -39.78 85.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.268 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.15 99.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.296 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.56 -28.59 69.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.604 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.47 -54.22 7.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.016 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.534 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.7 ttp180 -65.61 -42.36 91.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.458 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.8 mt -62.38 -43.9 98.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.522 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.67 -57.67 10.19 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.079 0.466 . . . . 0.0 110.377 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.91 -33.75 69.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.482 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -81.39 -36.35 29.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.755 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.4 m-20 -55.33 -41.87 73.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.982 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.54 -42.03 99.26 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.664 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.22 -38.23 89.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.348 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 177' ' ' LEU . 82.5 mt -62.5 -42.25 99.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.733 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.11 -53.06 60.72 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.12 0.486 . . . . 0.0 110.657 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.09 -42.0 89.91 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.642 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.71 -40.06 95.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.666 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.28 -31.9 73.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.37 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.92 -22.16 18.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.662 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.439 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.6 tt0 -64.63 -41.33 96.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.599 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.5 pt -75.2 136.2 25.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.6 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -125.99 106.95 9.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.312 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -177.2 125.56 0.29 Allowed Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.57 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.8 Cg_exo -43.9 152.39 0.36 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.772 2.315 . . . . 0.0 112.56 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.87 141.93 55.54 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.658 2.239 . . . . 0.0 112.468 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.25 147.46 2.2 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.585 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.03 154.45 70.59 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.764 2.309 . . . . 0.0 112.362 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.47 163.12 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.194 0.521 . . . . 0.0 110.386 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.65 170.3 16.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.932 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.47 137.56 21.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.995 0.426 . . . . 0.0 110.111 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.536 HG22 HD12 ' A' ' 205' ' ' LEU . 39.6 pt -134.4 147.14 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.657 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.56 132.04 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.157 0.503 . . . . 0.0 110.492 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -151.95 154.84 36.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.423 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.7 m -121.82 122.62 39.87 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.947 0.403 . . . . 0.0 110.344 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.93 -25.48 66.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.646 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.86 -49.65 19.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.91 -9.53 58.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.409 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.8 m80 46.97 43.74 14.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.436 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.7 t -135.78 145.11 46.2 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.347 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.47 113.49 25.96 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.26 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.1 m-20 -119.86 133.26 55.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.384 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 194' ' ' ILE . 7.5 tt -112.02 146.35 38.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.757 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.482 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.1 t90 -99.35 128.85 45.51 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.104 0.478 . . . . 0.0 110.067 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.65 154.04 40.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.174 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.68 -17.98 47.91 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.662 2.241 . . . . 0.0 111.94 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.35 -18.79 0.42 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.405 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.482 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 84.6 p -75.42 164.73 26.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.507 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.89 -28.14 65.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.461 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.556 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.4 mt-30 -63.67 -41.74 98.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.669 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.65 -44.67 96.67 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.441 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.1 mt-30 -64.45 -38.9 92.63 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 122.448 -0.442 . . . . 0.0 110.672 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.06 -41.19 97.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.276 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.61 -47.42 81.47 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.997 0.427 . . . . 0.0 110.502 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -53.82 -32.15 51.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.193 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -70.92 -19.0 62.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.555 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' A' ' 299' ' ' LEU . 92.6 mt -87.48 -8.89 55.9 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.63 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.83 2.72 55.15 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.9 152.67 21.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.339 . . . . 0.0 110.532 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.438 ' O ' HG12 ' A' ' 191' ' ' VAL . 7.8 p -115.57 128.19 55.78 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.063 0.459 . . . . 0.0 110.305 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.41 146.52 23.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.959 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.478 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -70.07 151.1 45.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.447 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.64 131.56 43.28 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.475 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.891 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.57 93.42 27.67 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.073 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.679 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.3 Cg_exo -55.52 138.99 82.02 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.629 2.219 . . . . 0.0 111.617 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.82 -25.51 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.482 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.57 -49.82 28.78 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.553 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.1 mt -54.05 -36.97 63.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.71 36.09 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.72 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.553 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.14 86.73 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.9 p -79.61 -15.04 58.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.34 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -92.37 -41.4 10.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.59 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -65.98 -17.72 64.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.621 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 56.18 43.32 26.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.466 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.23 -148.31 7.67 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.87 142.81 49.88 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.958 0.408 . . . . 0.0 110.336 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.06 149.57 28.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.328 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -100.79 -151.86 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.308 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.5 t0 55.9 -92.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.673 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.463 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.48 175.41 8.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.601 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.463 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.7 mt -122.32 141.72 41.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.766 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.7 169.17 9.45 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.226 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.8 mt -147.66 150.86 35.17 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.191 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.64 -38.82 96.83 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.82 4.2 4.78 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -77.45 -58.22 3.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.945 0.402 . . . . 0.0 110.558 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.528 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.1 m-20 -62.17 -36.64 82.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.416 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.17 -67.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.777 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.72 -42.27 67.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.102 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.72 17.38 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.645 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.34 49.13 0.34 Allowed Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.411 -0.675 . . . . 0.0 111.411 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 37.85 -109.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.635 0.255 . . . . 0.0 110.825 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.478 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.7 m120 -60.65 -45.2 95.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.493 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.82 7.85 83.48 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.04 -13.04 20.04 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.745 -0.268 . . . . 0.0 110.696 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.4 t 176.86 142.89 0.08 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.063 0.458 . . . . 0.0 110.458 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.35 125.43 11.4 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.087 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.76 143.43 29.12 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 120.916 0.389 . . . . 0.0 110.837 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.6 mt -94.88 106.47 18.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.674 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.9 t80 -101.88 -12.02 18.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.261 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.24 89.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.834 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.54 173.86 46.16 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.443 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.5 m-20 -74.44 -113.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.759 0.314 . . . . 0.0 110.734 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.74 -28.4 67.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.66 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.96 -44.14 91.44 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.27 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.68 -44.14 94.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.341 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.48 -60.38 3.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.273 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.92 -43.53 60.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.174 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.47 -43.81 75.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.252 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.1 mt -64.54 -43.6 96.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.629 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -56.52 -37.66 70.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.2 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.66 1.19 17.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.272 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -115.0 91.28 26.16 Favored Pre-proline 0 CA--C 1.528 0.134 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.118 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.97 -27.17 27.38 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.768 2.312 . . . . 0.0 111.875 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.41 -41.26 98.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.526 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.15 5.12 52.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.407 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.96 -35.38 69.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.595 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.58 4.35 16.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.516 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.66 121.51 81.33 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.615 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -47.31 -38.13 25.82 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.487 2.125 . . . . 0.0 112.533 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.535 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.86 -43.95 90.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.812 0.339 . . . . 0.0 110.391 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.73 -43.63 93.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.293 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.83 -40.64 95.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.454 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 44.8 t-20 -89.73 -12.14 40.27 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.549 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.4 mtmt 61.73 31.3 18.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.965 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -88.17 43.78 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.435 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.43 136.09 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.453 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.59 132.8 56.59 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.452 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.1 88.49 7.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.752 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.0 -41.41 97.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.891 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.46 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.42 167.26 33.76 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.4 p -75.71 -25.97 57.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.852 0.358 . . . . 0.0 110.747 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -67.77 -33.91 75.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.533 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 296' ' ' THR . 97.1 m -73.72 20.41 0.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.674 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.556 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 55.0 t80 -57.26 -51.19 70.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.939 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 68.4 mmt-85 -108.38 150.12 27.79 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.417 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.1 tp -115.54 125.78 53.43 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.811 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.468 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.7 t0 -149.56 166.72 28.36 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.598 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -49.16 -37.97 24.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.631 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.83 -65.21 0.79 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.388 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -60.92 -32.76 72.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.7 -25.22 25.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.688 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.3 mtt -63.66 -40.98 98.2 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.871 0.367 . . . . 0.0 111.057 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.85 -43.94 24.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.03 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.572 HG21 HG23 ' A' ' 296' ' ' THR . 78.9 t -66.34 -42.85 91.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.328 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.439 HD11 ' NE2' ' A' ' 183' ' ' GLN . 49.6 tp -60.06 -47.13 87.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.505 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.99 -39.4 75.95 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.578 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.9 ttt180 -61.96 -38.24 87.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.208 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -87.14 4.31 42.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.68 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.4 tttt -113.07 -11.06 13.39 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.025 0.441 . . . . 0.0 110.283 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.3 86.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.559 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.66 -48.66 80.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.361 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 117.885 -1.055 . . . . 0.0 110.038 179.907 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.14 -2.36 58.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.442 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.488 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.06 1.24 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.533 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.93 145.26 99.32 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.774 2.316 . . . . 0.0 112.165 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.15 -179.1 7.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.6 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.0 137.0 52.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.323 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -124.57 146.73 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.443 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.4 p -119.97 135.99 54.7 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.704 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.28 -143.53 0.32 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.309 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.49 -37.15 86.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.487 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.476 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.1 ttt85 -149.31 -66.26 0.22 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.533 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.5 142.16 45.57 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 p -112.07 131.3 55.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 0.0 110.409 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -119.06 129.09 54.91 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.547 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -85.62 130.26 34.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.273 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.486 HD22 ' OE1' ' A' ' 42' ' ' GLN . 67.1 mt -95.97 78.86 3.21 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.353 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.51 -32.07 73.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.479 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 175.97 109.78 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.143 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.486 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -122.72 91.53 49.54 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.277 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.654 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.5 Cg_exo -56.97 148.92 65.0 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.818 2.345 . . . . 0.0 111.816 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.52 82.78 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.654 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.38 67.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.097 0.475 . . . . 0.0 110.279 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.19 130.73 35.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.582 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.564 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.7 t -122.78 146.91 27.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.202 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.2 t -136.26 143.48 44.28 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.62 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.6 p -99.18 -59.5 1.71 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.618 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.0 p -79.18 155.13 28.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.611 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.497 HG21 HG23 ' A' ' 70' ' ' THR . 74.0 t -74.23 -21.83 17.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.571 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.9 m -60.13 -52.25 66.13 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.553 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.8 mt -66.63 -42.33 86.93 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.249 0.547 . . . . 0.0 110.877 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.6 m -42.88 -54.06 4.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.265 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.47 -37.48 69.32 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.2 m -62.48 -44.68 95.81 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.82 0.343 . . . . 0.0 110.443 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.8 mt -66.2 -41.99 89.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.385 0.612 . . . . 0.0 110.703 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.2 tp -62.68 -40.34 96.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.284 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.17 -35.82 76.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.899 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 156' ' ' LEU . 30.6 pt -91.36 28.85 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.021 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 56.57 51.61 10.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.798 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.2 75.58 23.14 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.984 0.421 . . . . 0.0 110.054 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.53 151.41 85.67 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.723 2.282 . . . . 0.0 112.256 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.56 137.32 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.121 0.486 . . . . 0.0 110.335 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.9 pt -69.42 -43.45 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.178 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.1 131.17 53.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 110.522 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.0 p -155.77 168.98 25.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.481 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.24 -177.12 21.43 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.54 172.91 12.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 110.56 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.497 HG23 HG21 ' A' ' 51' ' ' VAL . 13.1 p -132.9 -112.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.29 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.26 179.76 0.93 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.328 -179.095 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.5 Cg_exo -60.93 57.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 123.032 2.488 . . . . 0.0 112.151 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.7 t-20 -64.43 -33.69 76.47 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.606 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 11.4 m120 93.6 -36.27 0.02 OUTLIER 'General case' 0 C--N 1.344 0.332 0 O-C-N 124.014 0.822 . . . . 0.0 109.993 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.406 ' HD3' HD21 ' A' ' 73' ' ' ASN . 78.1 mtp85 -62.64 -39.38 93.67 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.299 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.88 -25.29 18.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.73 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.38 -171.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.597 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.46 -153.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.752 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.1 p-10 -52.36 -7.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.706 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.36 114.86 23.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.531 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.85 69.98 1.35 Allowed Glycine 0 CA--C 1.522 0.469 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -143.23 147.39 34.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.968 0.414 . . . . 0.0 110.673 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.49 -98.3 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.205 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.36 -42.57 96.15 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.205 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.0 tt0 91.64 53.65 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.894 0.746 . . . . 0.0 110.791 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -103.9 -8.77 19.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.429 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -65.18 -33.79 76.85 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.175 0.512 . . . . 0.0 110.649 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.84 -24.24 1.37 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.568 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.9 t -69.5 -45.68 77.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.876 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.23 -48.57 80.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.117 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.73 -38.09 89.13 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.379 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.82 -32.42 52.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.281 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.607 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.5 mmt-85 -89.87 1.77 55.8 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.588 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.54 -49.51 0.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 124.036 0.835 . . . . 0.0 110.412 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.669 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.17 154.92 0.23 Allowed 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.443 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.669 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 120.66 92.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 125.133 1.521 . . . . 0.0 110.501 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.531 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.61 143.56 42.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.291 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.8 mt -132.58 27.15 4.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.494 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.55 138.39 34.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.541 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.63 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.6 mt -137.5 165.14 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.427 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.618 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.22 -28.71 1.82 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -152.59 70.87 7.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.121 0.486 . . . . 0.0 110.396 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.97 145.38 98.49 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.789 2.326 . . . . 0.0 112.048 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.8 t -134.47 136.37 43.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.036 0.446 . . . . 0.0 110.522 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.26 -38.17 81.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.673 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.45 -42.29 96.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.511 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.94 -41.73 98.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.481 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.51 -43.19 98.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.146 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.04 -35.07 77.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.345 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.5 -18.4 58.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.476 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.96 -6.33 58.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.486 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.418 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 75.9 mtp 47.76 55.77 17.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.66 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.14 149.4 64.4 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.807 2.338 . . . . 0.0 112.093 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.16 -74.01 0.63 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.503 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.434 HD11 HD13 ' A' ' 140' ' ' LEU . 37.8 tp -110.45 113.09 25.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.368 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -101.68 126.39 55.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.5 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.2 mt -109.7 133.53 53.02 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.248 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.56 140.02 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.587 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.8 p -83.62 168.68 16.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.641 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.08 -37.61 80.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.432 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.96 159.38 42.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.476 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.2 177.49 33.2 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.14 -33.77 86.93 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -124.87 151.93 44.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.822 0.344 . . . . 0.0 110.603 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.5 t -63.14 141.01 58.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.307 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.46 10.46 11.17 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.559 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.07 -39.03 88.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.072 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.04 -35.99 23.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.361 0.6 . . . . 0.0 110.696 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.8 mt -70.83 -35.45 72.47 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.428 0.632 . . . . 0.0 110.72 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.76 -63.28 0.81 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.158 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.6 p-10 -65.89 -42.72 89.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.4 mt-30 -62.01 -32.66 73.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.164 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.3 mt -74.01 -40.35 62.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.051 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.23 -49.12 78.2 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.208 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.1 m -52.59 -42.56 64.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.216 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.77 -42.98 93.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.08 154.81 5.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.632 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.29 106.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.709 2.273 . . . . 0.0 112.339 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.644 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.0 m -110.07 121.19 44.67 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.31 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.644 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.0 153.03 30.06 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.296 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -129.09 131.22 68.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.413 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -114.92 127.85 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.443 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.477 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.8 t30 -101.38 103.62 14.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.34 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.3 p90 -101.14 -11.37 19.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.769 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.2 p-10 -64.77 -33.63 76.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.66 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.8 p-10 -98.12 7.79 45.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.603 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.449 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.64 155.6 50.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.564 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.3 p -74.96 165.71 24.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.664 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.592 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.4 t90 -59.85 -48.88 79.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.286 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.51 -41.95 66.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.088 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.2 t -62.73 -41.01 98.96 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.406 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.409 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.6 tp -60.59 -44.28 96.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.376 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.36 -43.56 98.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.211 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.0 m -54.87 -44.93 74.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.837 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.39 -40.94 98.12 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.837 0.351 . . . . 0.0 110.331 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -61.89 -42.48 99.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.157 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.9 -40.89 95.64 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.41 -46.16 64.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.899 0.381 . . . . 0.0 110.816 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.74 -44.02 96.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.735 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -92.97 -8.69 42.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.553 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.8 26.62 72.2 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -101.8 51.07 0.84 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 110.667 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -69.91 -39.38 76.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.644 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.57 -47.26 86.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.248 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -59.88 -39.36 85.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.341 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.14 99.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.322 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.71 -28.52 70.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.974 0.416 . . . . 0.0 110.576 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.39 -54.25 7.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.058 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.506 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.4 ttp180 -65.55 -42.17 92.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.518 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.466 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.3 mt -62.35 -43.86 98.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.488 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.75 -57.73 9.93 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.021 0.439 . . . . 0.0 110.453 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.78 -33.86 68.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.35 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -81.46 -36.28 29.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.811 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.2 m-20 -55.6 -41.59 73.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.238 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.64 -42.42 99.59 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.688 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.29 -38.01 88.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.366 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 177' ' ' LEU . 81.6 mt -62.25 -42.23 99.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.68 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.8 62.53 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.044 0.45 . . . . 0.0 110.66 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.19 -41.92 89.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.559 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.86 95.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.56 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.42 -31.99 73.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.379 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.63 -22.21 18.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.729 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.454 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.6 tt0 -64.83 -41.16 95.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.651 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.8 pt -77.01 136.73 23.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.574 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.01 108.29 10.81 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.291 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.76 125.5 0.3 Allowed Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.512 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.6 Cg_exo -43.81 152.18 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.775 2.316 . . . . 0.0 112.499 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.79 141.82 55.61 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.61 2.206 . . . . 0.0 112.461 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.33 147.08 2.1 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.592 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.02 154.58 70.43 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.741 2.294 . . . . 0.0 112.292 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.35 163.13 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.4 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 1.9 t -143.97 170.76 15.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.817 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.12 137.99 21.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.237 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.533 HG22 HD12 ' A' ' 205' ' ' LEU . 39.4 pt -134.45 146.9 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.639 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 204' ' ' ASN . 3.0 p -133.08 131.76 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.145 0.498 . . . . 0.0 110.505 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -151.99 155.13 37.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.466 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.5 m -121.95 122.65 39.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.938 0.399 . . . . 0.0 110.392 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.25 -25.96 66.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.6 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.37 -48.69 21.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.066 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.7 -12.2 60.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.387 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.0 m80 49.74 41.69 22.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.491 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.3 t -136.45 144.97 44.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.407 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.403 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -110.88 114.38 27.67 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.295 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.73 133.24 55.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.064 0.459 . . . . 0.0 110.352 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.533 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.74 146.16 38.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.686 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.503 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 10.0 t90 -99.62 129.56 45.78 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.082 0.468 . . . . 0.0 110.089 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.01 153.76 39.78 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.144 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.407 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.4 Cg_endo -67.82 -18.11 47.22 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.741 2.294 . . . . 0.0 111.972 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.01 -18.83 0.33 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.507 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.503 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.61 165.05 25.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.521 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.15 -27.95 66.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.472 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.454 ' OE1' ' CD1' ' A' ' 297' ' ' PHE . 34.6 mt-30 -63.78 -41.28 97.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.642 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.55 -44.64 97.53 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.449 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.25 -38.9 92.69 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.004 0.43 . . . . 0.0 110.633 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.592 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.0 mmm -61.99 -41.21 97.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.159 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 74.8 mt -63.6 -47.22 82.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.949 0.404 . . . . 0.0 110.645 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.94 -32.09 52.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.049 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.94 -18.62 62.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.518 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.433 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.9 mt -88.01 -8.49 55.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.659 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.42 2.3 55.58 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -88.57 153.18 21.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.513 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.463 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.1 p -116.13 128.62 55.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.049 0.452 . . . . 0.0 110.421 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.74 146.14 23.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.831 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.476 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.65 151.65 45.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.526 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.68 131.4 43.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.347 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.896 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.57 93.3 27.15 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.121 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.678 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.6 Cg_exo -55.55 139.05 82.21 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.629 2.219 . . . . 0.0 111.635 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.05 -25.73 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.474 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.55 -50.11 27.46 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.554 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.8 mt -53.82 -37.31 63.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 0.0 110.252 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -66.73 36.06 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.769 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.554 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.1 88.46 0.01 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.829 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 86.7 p -81.02 -13.62 58.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.393 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -92.39 -41.49 10.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.548 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.92 -16.91 64.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.669 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.75 43.95 27.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.504 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.78 -148.67 8.03 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.63 142.98 48.92 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.996 0.426 . . . . 0.0 110.331 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.19 149.64 28.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.35 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -101.46 -151.69 0.42 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.305 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 56.19 -92.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.635 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.464 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.83 175.23 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.629 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.464 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.2 mt -122.4 141.79 41.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.676 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.98 169.55 9.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.285 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.7 mt -148.01 151.11 35.2 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.106 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.52 -39.05 97.23 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.97 4.21 4.7 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -77.57 -58.07 3.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.903 0.382 . . . . 0.0 110.577 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.552 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.9 m-20 -62.1 -36.71 82.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.301 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.403 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.0 mp -52.26 -67.75 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.748 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.31 -42.49 66.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.231 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.02 17.66 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.678 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.1 49.03 0.31 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.28 -109.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.609 0.242 . . . . 0.0 110.715 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.68 -45.06 95.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.47 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.4 7.96 84.02 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.85 -13.6 20.0 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.821 -0.223 . . . . 0.0 110.617 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.0 t 177.2 142.57 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.996 0.427 . . . . 0.0 110.5 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.05 125.34 11.54 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.998 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.432 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -98.66 143.31 29.18 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.8 178.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.6 mt -94.5 106.38 18.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.626 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.439 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.2 t80 -101.4 -12.5 18.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.254 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.66 90.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.749 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.32 173.63 46.03 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.46 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -73.91 -112.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.797 0.332 . . . . 0.0 110.72 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -68.02 -28.52 67.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.666 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -58.76 -44.12 90.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.386 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.64 -44.29 94.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.333 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.54 -60.31 3.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.267 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -50.95 -43.36 60.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.229 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.56 75.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.267 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.5 mt -64.56 -43.67 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.607 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -56.27 -37.34 69.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.241 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.54 0.79 18.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.28 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -115.22 91.24 27.05 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.242 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.26 -26.87 28.42 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.814 2.343 . . . . 0.0 111.84 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.5 -40.95 98.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.564 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.35 5.21 52.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.435 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.1 -35.07 69.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.717 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.6 4.65 15.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.538 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.99 120.99 80.03 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.559 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -47.24 -37.53 24.26 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.501 2.134 . . . . 0.0 112.451 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -59.1 -43.74 91.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.818 0.342 . . . . 0.0 110.323 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.91 -43.7 92.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.377 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.85 -40.54 95.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.483 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 44.3 t-20 -89.54 -12.72 39.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.601 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 62.03 31.37 17.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.809 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.37 43.72 1.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.417 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -103.95 136.02 38.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.489 -179.733 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -116.77 132.36 56.71 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.466 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.41 88.24 7.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.668 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.83 -40.85 97.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.821 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.439 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.6 167.24 34.14 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 76.3 p -75.68 -25.76 57.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.854 0.359 . . . . 0.0 110.746 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.0 tp10 -67.8 -34.62 77.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.427 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 94.6 m -73.53 25.44 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.714 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.499 ' H ' ' C ' ' A' ' 295' ' ' GLU . 60.8 t80 -58.18 -51.2 70.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.342 -0.39 . . . . 0.0 109.986 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.417 HH12 ' HG3' ' A' ' 212' ' ' GLN . 66.4 mmt-85 -112.02 155.24 24.11 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.433 ' CD2' HD11 ' A' ' 219' ' ' LEU . 45.5 tp -116.01 125.14 52.08 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.748 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.491 ' CB ' HD23 ' A' ' 83' ' ' LEU . 45.2 t0 -147.58 165.52 30.14 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.551 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -49.07 -38.1 23.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.512 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.71 -65.28 0.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.232 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -61.01 -32.79 72.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.51 -25.48 25.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.601 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.5 mtt -63.38 -41.09 98.77 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 120.924 0.392 . . . . 0.0 110.918 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.17 -43.91 22.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.978 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.569 HG21 HG23 ' A' ' 296' ' ' THR . 76.0 t -66.29 -42.88 91.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.417 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.454 HD11 ' NE2' ' A' ' 183' ' ' GLN . 52.1 tp -60.31 -47.23 86.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.546 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -69.74 -39.6 76.66 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.516 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.6 ttt180 -62.06 -38.24 88.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.217 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.6 mt -87.12 4.5 42.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.741 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -112.86 -11.23 13.48 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.038 0.447 . . . . 0.0 110.355 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.03 85.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.638 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.94 -48.82 80.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.366 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.134 179.804 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -89.63 -2.49 58.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.391 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.2 179.01 1.25 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.521 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.6 Cg_exo -60.66 145.13 99.39 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.718 2.279 . . . . 0.0 112.171 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.82 -179.4 8.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.655 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.91 137.4 52.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.39 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -125.05 147.11 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.437 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 79.1 p -120.24 136.26 54.71 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.788 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.18 -143.83 0.32 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.199 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -63.53 -37.23 86.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.441 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.57 -67.19 0.23 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.475 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.44 142.59 45.05 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.2 p -112.16 131.45 55.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 110.377 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -119.13 129.51 55.07 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.517 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 m -86.64 131.33 34.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.871 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.478 HD22 ' OE1' ' A' ' 42' ' ' GLN . 66.3 mt -96.96 79.37 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.496 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.75 -31.79 72.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.521 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.77 109.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.117 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.478 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.06 92.18 48.87 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.386 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 37.3 Cg_exo -57.08 148.72 67.28 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.724 2.283 . . . . 0.0 111.782 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.85 83.0 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 O-C-N 123.491 0.495 . . . . 0.0 110.927 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.49 67.11 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.293 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.09 130.75 35.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.604 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.559 ' HA ' HG23 ' A' ' 64' ' ' VAL . 56.1 t -122.62 146.47 27.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.067 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 t -135.88 143.47 45.05 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.679 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.6 p -99.06 -59.77 1.66 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.599 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.3 p -79.25 155.33 28.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.659 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.496 HG21 HG23 ' A' ' 70' ' ' THR . 70.8 t -74.06 -22.07 18.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.488 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.2 m -60.27 -52.05 66.92 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.484 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.6 mt -66.43 -42.18 88.09 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.312 0.577 . . . . 0.0 110.881 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.0 m -43.7 -53.78 5.56 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.19 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.22 -37.28 71.63 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.5 m -62.77 -44.61 95.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.826 0.346 . . . . 0.0 110.517 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.412 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.0 mt -66.22 -42.05 89.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.397 0.617 . . . . 0.0 110.652 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.57 -40.44 96.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.354 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.09 -35.77 75.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.066 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 156' ' ' LEU . 32.4 pt -91.36 28.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.256 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.53 51.68 10.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.875 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.4 75.83 22.13 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.924 0.393 . . . . 0.0 109.962 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.67 151.46 85.55 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.733 2.289 . . . . 0.0 112.382 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.48 136.87 48.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.185 0.517 . . . . 0.0 110.267 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.441 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -69.06 -43.58 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.299 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.03 131.18 53.42 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.025 0.44 . . . . 0.0 110.598 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.8 p -155.7 168.82 25.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.433 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.98 -177.07 21.57 Favored Glycine 0 N--CA 1.464 0.524 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.631 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.53 172.68 12.4 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 110.527 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.496 HG23 HG21 ' A' ' 51' ' ' VAL . 15.3 p -132.8 -112.52 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.96 0.41 . . . . 0.0 110.36 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.28 179.69 0.94 Allowed Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.368 -179.103 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.8 Cg_exo -60.91 58.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.978 2.452 . . . . 0.0 112.094 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.3 t-20 -64.57 -33.66 76.43 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.526 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.2 m120 93.8 -36.76 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.064 0.852 . . . . 0.0 109.923 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -62.57 -39.48 93.81 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.24 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.1 p -74.35 -25.66 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.715 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.16 -171.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.617 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.86 -154.2 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.76 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.0 p-10 -52.53 -7.54 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.669 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.16 115.17 23.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.545 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.99 69.54 1.36 Allowed Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -143.12 147.37 34.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.937 0.399 . . . . 0.0 110.752 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.15 -98.47 0.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.204 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.0 -42.73 97.08 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.16 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.553 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.0 tt0 91.62 53.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.97 0.794 . . . . 0.0 110.907 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -103.27 -8.7 20.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.369 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.8 p -65.06 -33.85 77.03 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.1 0.476 . . . . 0.0 110.589 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -48.88 -24.05 1.32 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.644 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.45 -46.0 77.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.921 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.4 -48.42 81.31 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.071 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.57 -38.24 89.33 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.272 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.83 -32.52 53.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.272 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.605 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.7 mmt-85 -89.98 1.57 56.13 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.566 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.8 -49.24 0.17 Allowed 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.999 0.812 . . . . 0.0 110.3 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.659 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.28 154.21 0.29 Allowed 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.259 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.659 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 121.01 92.39 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 125.287 1.617 . . . . 0.0 110.476 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.7 mtp180 -75.47 143.43 42.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.057 0.456 . . . . 0.0 110.354 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.2 mt -132.44 27.07 4.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.461 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.36 138.23 34.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.548 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.7 mt -137.43 165.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.358 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.618 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.5 -28.81 1.77 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.55 70.96 7.46 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.15 0.5 . . . . 0.0 110.373 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.89 145.27 98.71 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.714 2.276 . . . . 0.0 112.075 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.9 t -134.4 136.37 43.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.485 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.81 -38.22 83.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.669 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.37 -42.28 96.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.496 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.49 98.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.494 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.3 t -63.65 -43.4 98.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.029 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.07 77.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.32 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.66 -18.69 60.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.464 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.36 -6.42 58.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.566 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 77.9 mtp 47.74 55.82 17.11 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.56 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.12 149.18 64.26 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.768 2.312 . . . . 0.0 112.109 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.28 -74.05 0.63 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.406 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.422 HD11 HD13 ' A' ' 140' ' ' LEU . 38.5 tp -110.3 113.13 25.55 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.264 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.3 mt -101.93 126.19 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.481 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.7 mt -109.19 133.28 53.22 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.202 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.16 139.31 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.533 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.9 p -83.57 168.54 16.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.677 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.21 -37.42 80.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.437 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -139.85 158.89 43.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.477 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.16 177.67 33.08 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.89 87.36 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -125.15 152.03 45.0 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.954 0.407 . . . . 0.0 110.555 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.3 t -63.34 141.24 58.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.36 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.84 10.54 10.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.684 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.9 mp -61.27 -39.02 88.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.973 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.74 -36.09 23.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.467 0.651 . . . . 0.0 110.612 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.2 mt -70.93 -35.34 72.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.447 0.641 . . . . 0.0 110.756 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -42.81 -62.68 0.94 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.27 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.7 p-10 -65.98 -42.59 89.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.067 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.4 -32.81 73.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.14 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.7 mt -73.44 -40.91 63.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.136 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.43 -48.78 79.58 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.167 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.0 m -53.01 -42.7 65.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.241 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.7 -43.2 93.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.106 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.47 154.27 5.56 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.599 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -39.24 106.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.624 2.216 . . . . 0.0 112.377 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 94.3 m -110.22 121.4 45.18 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.983 0.421 . . . . 0.0 110.218 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.37 152.89 30.78 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.233 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -129.09 131.38 68.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.428 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -115.01 127.9 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.553 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.2 t30 -101.74 103.65 14.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.278 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.2 p90 -101.19 -11.22 19.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.797 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.7 -33.74 76.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.631 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.571 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.6 p-10 -98.09 7.96 45.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.661 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.94 155.6 50.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.503 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.401 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.0 165.7 24.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.689 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.59 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.91 -48.52 81.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.244 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.79 -42.02 67.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.1 t -62.6 -41.17 98.81 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.356 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.406 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.4 tp -60.58 -44.35 96.32 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.441 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.45 -43.42 98.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.164 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -54.99 -44.87 74.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.797 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.67 -40.63 97.66 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.837 0.351 . . . . 0.0 110.289 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -62.03 -42.53 99.27 Favored 'General case' 0 CA--C 1.51 -0.558 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.245 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.01 -41.1 95.4 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.3 -46.17 64.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.953 0.406 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.66 -44.06 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.826 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.7 p -93.01 -8.86 41.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.567 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.93 26.9 72.4 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -102.06 50.65 0.84 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.849 0.357 . . . . 0.0 110.694 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -69.57 -39.44 77.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.677 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.78 -47.23 86.54 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.292 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -59.78 -39.57 85.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.275 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.94 -40.91 99.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.259 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.68 -28.89 70.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.522 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.04 -54.24 8.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.197 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.506 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.5 ttp180 -65.49 -42.16 92.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.494 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.4 mt -62.43 -43.77 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.524 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.62 -57.61 10.44 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.971 0.415 . . . . 0.0 110.515 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.66 -33.34 68.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.366 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.409 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.2 t80 -81.58 -36.52 28.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.856 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 170' ' ' ILE . 58.0 m-20 -55.46 -41.95 73.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.411 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.72 -42.17 99.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.646 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.34 -37.89 88.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.222 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.409 HD11 ' CD2' ' A' ' 173' ' ' PHE . 81.5 mt -62.43 -42.31 99.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.715 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.93 62.0 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.078 0.466 . . . . 0.0 110.677 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.36 -41.72 89.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.519 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.05 95.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.55 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.26 -32.15 73.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.409 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.65 -22.38 18.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.681 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.451 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -64.56 -41.23 96.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.651 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 184' ' ' ILE . 32.6 pt -76.95 136.46 24.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.659 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -126.83 108.27 10.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.291 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -177.04 125.81 0.3 Allowed Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.492 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.1 Cg_exo -44.02 152.44 0.38 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.806 2.337 . . . . 0.0 112.468 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.85 141.83 55.31 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.68 2.253 . . . . 0.0 112.48 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.55 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.16 146.98 2.14 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.602 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.06 154.57 70.3 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.817 2.345 . . . . 0.0 112.272 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.38 163.22 29.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.472 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -144.03 170.75 15.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.829 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.61 137.71 21.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.225 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.537 HG22 HD12 ' A' ' 205' ' ' LEU . 39.0 pt -134.45 147.14 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.617 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.43 132.05 57.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.148 0.499 . . . . 0.0 110.482 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -151.95 154.87 36.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.398 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.0 m -122.31 122.94 40.24 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.64 -25.83 66.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.623 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.22 -48.99 20.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.035 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.99 -11.03 60.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.373 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 76.8 m80 48.59 41.74 17.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.467 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.6 t -136.31 144.97 44.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.391 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.19 114.36 27.54 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.278 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.6 m-20 -119.79 133.41 55.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 110.376 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.537 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.81 146.24 37.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.79 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.498 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.6 t90 -99.26 129.94 45.52 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.083 0.468 . . . . 0.0 109.997 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.55 153.72 39.42 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.126 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.4 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.9 Cg_endo -67.95 -17.97 46.47 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.811 2.341 . . . . 0.0 111.852 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.24 -19.16 0.44 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.397 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.498 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.1 p -75.44 164.72 26.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.502 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.95 -27.72 65.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.504 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.585 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.0 mt-30 -63.85 -41.22 97.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.582 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.69 -44.52 97.81 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.41 -38.86 92.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.995 0.426 . . . . 0.0 110.578 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.59 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.1 mmm -62.24 -41.18 98.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.063 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.1 mt -63.78 -46.65 84.25 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.646 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.7 -31.84 58.58 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.7 -18.77 62.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.537 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.443 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.4 mt -87.39 -9.4 54.86 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.664 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.51 1.71 53.36 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -88.34 153.84 20.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.884 0.373 . . . . 0.0 110.469 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.444 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.0 p -116.41 128.84 55.86 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.071 0.462 . . . . 0.0 110.471 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.65 146.33 23.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.864 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.479 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.82 151.41 45.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.516 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.56 131.41 43.32 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.43 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.892 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.61 93.53 28.35 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.095 -179.738 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.675 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.0 Cg_exo -55.85 139.07 83.62 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.556 2.171 . . . . 0.0 111.521 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.1 -26.05 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.503 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.18 -50.03 30.11 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.553 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.7 mt -53.99 -37.05 63.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -66.73 36.09 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.794 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.553 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.0 88.38 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.949 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 81.5 p -80.98 -14.08 58.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.398 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.85 -41.82 10.41 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.597 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.2 t -66.64 -16.96 64.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.621 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.76 44.01 26.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.507 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.75 -149.21 8.32 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.09 142.75 48.61 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.013 0.435 . . . . 0.0 110.339 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -151.95 149.61 29.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.368 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -101.32 -151.67 0.42 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.319 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.03 -92.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.689 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.468 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.85 175.38 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.596 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.468 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.2 mt -122.69 141.85 41.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.815 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.87 169.61 9.1 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.31 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.4 mt -147.82 150.9 35.04 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.21 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.65 -38.98 97.06 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.1 3.97 4.71 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -77.49 -57.98 3.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.897 0.38 . . . . 0.0 110.651 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.55 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.4 m-20 -62.09 -36.73 82.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.196 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 9.9 mp -52.38 -67.59 0.24 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.725 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.66 -42.24 67.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.154 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.92 17.42 0.17 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.649 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.37 48.76 0.33 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.31 -109.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.621 0.248 . . . . 0.0 110.753 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.479 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.7 m120 -60.94 -44.58 97.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.521 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.15 7.89 84.56 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.92 -13.54 19.94 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.748 -0.266 . . . . 0.0 110.732 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.5 t 177.08 142.52 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.131 0.491 . . . . 0.0 110.504 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.95 125.47 11.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.106 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 191' ' ' VAL . 14.0 m-30 -98.42 143.72 28.56 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 120.937 0.399 . . . . 0.0 110.711 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.2 mt -95.22 106.28 18.29 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.727 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.442 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.0 t80 -101.79 -11.81 18.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.221 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.96 -40.75 87.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.831 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.9 173.2 45.81 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.472 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -74.06 -113.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 110.709 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.28 -28.76 68.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.725 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.01 -43.89 91.61 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.27 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -63.62 -44.33 94.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.31 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.65 -60.02 3.75 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.266 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.09 -43.38 61.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.102 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.43 -43.57 75.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.161 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.56 -43.66 96.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.615 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -56.22 -37.59 69.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.156 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.5 0.93 18.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.259 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -115.12 91.51 27.63 Favored Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.167 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.4 -27.09 30.13 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.846 2.364 . . . . 0.0 111.717 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.41 -41.2 98.72 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.558 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.594 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.9 mp -95.1 4.9 53.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.432 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.08 70.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.703 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -79.97 4.53 16.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.615 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.64 121.29 80.49 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.536 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -47.49 -37.65 26.38 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.408 2.072 . . . . 0.0 112.424 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.527 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -59.03 -43.63 91.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.792 0.329 . . . . 0.0 110.289 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.05 -43.86 92.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.279 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.82 -40.65 95.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.519 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 47.9 t-20 -89.54 -12.92 38.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.541 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.35 32.7 16.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.49 43.87 1.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.341 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.48 135.67 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.539 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.72 132.62 56.64 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.469 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.32 89.01 7.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.7 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.411 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.1 mt -63.9 -41.11 97.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.783 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.95 165.57 34.09 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 76.5 p -75.44 -25.74 57.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.865 0.364 . . . . 0.0 110.665 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -68.35 -34.49 76.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.345 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 296' ' ' THR . 95.3 m -72.98 25.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.722 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.585 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 39.6 t80 -58.53 -50.36 74.05 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.408 HH12 ' HG3' ' A' ' 212' ' ' GLN . 79.1 mmt-85 -111.05 153.48 25.56 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.443 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.9 tp -115.53 125.03 52.51 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.691 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.482 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.4 t0 -147.88 165.71 29.81 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.614 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -49.3 -38.16 26.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.509 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -71.23 -65.47 0.74 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.421 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -60.96 -32.73 72.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.962 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.4 -25.61 25.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.634 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.6 mtt -63.5 -41.02 98.55 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 120.905 0.383 . . . . 0.0 111.003 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -78.7 -44.03 24.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.067 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.58 HG21 HG23 ' A' ' 296' ' ' THR . 76.6 t -66.18 -42.99 92.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.352 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.451 HD11 ' NE2' ' A' ' 183' ' ' GLN . 50.9 tp -60.14 -47.27 86.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.481 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -69.7 -39.66 76.79 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.634 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.4 ttt180 -61.63 -38.67 88.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.19 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -86.84 4.42 41.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.759 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.2 tttt -112.59 -11.19 13.61 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.018 0.437 . . . . 0.0 110.28 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.83 -37.12 85.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.632 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.19 -48.63 80.65 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.326 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.975 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.618 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.75 -2.4 58.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.38 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.484 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.12 179.06 1.24 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.047 0.451 . . . . 0.0 110.514 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.6 Cg_exo -60.98 145.1 99.57 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.773 2.316 . . . . 0.0 112.169 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.618 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.77 -179.31 8.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.553 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.7 136.88 52.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.355 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.0 tp -124.64 147.44 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.372 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.4 p -120.39 136.1 54.83 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.767 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.5 -143.47 0.33 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.25 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.41 -37.3 86.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.477 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.1 -66.85 0.22 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.467 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.64 142.48 45.61 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.2 p -112.2 131.71 55.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.951 0.405 . . . . 0.0 110.401 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.15 128.89 54.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.53 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.2 m -85.49 130.36 34.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.237 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.472 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.8 mt -95.71 78.75 3.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.306 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.6 -32.19 73.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.493 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 176.03 109.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.099 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.472 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -122.55 91.59 49.35 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.28 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.2 Cg_exo -56.95 148.54 67.19 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.794 2.329 . . . . 0.0 111.869 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.15 82.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.595 0.56 . . . . 0.0 111.022 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.43 66.82 0.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.227 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.85 130.83 35.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.697 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.572 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.7 t -122.57 147.43 26.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.079 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 t -136.62 143.74 43.69 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.65 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.7 p -99.22 -59.48 1.72 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.572 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.0 p -79.01 155.46 28.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.688 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.538 HG21 HG23 ' A' ' 70' ' ' THR . 70.3 t -74.43 -21.9 17.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.557 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.2 m -60.22 -51.87 67.72 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.503 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.4 mt -66.56 -42.4 87.15 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.319 0.58 . . . . 0.0 110.905 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.5 m -43.37 -53.83 5.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.065 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.27 -37.84 71.35 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.7 m -62.5 -44.45 96.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.846 0.355 . . . . 0.0 110.34 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.408 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.5 mt -65.99 -42.14 90.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.464 0.65 . . . . 0.0 110.714 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tp -62.57 -40.13 95.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.453 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.517 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.48 -36.11 77.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.134 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 156' ' ' LEU . 33.3 pt -90.9 28.29 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.208 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.81 51.82 10.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.939 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.83 75.75 24.45 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.974 0.416 . . . . 0.0 109.889 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.18 150.63 87.93 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.781 2.32 . . . . 0.0 112.213 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.36 136.88 48.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.198 0.523 . . . . 0.0 110.282 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.25 -43.55 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.307 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.11 131.19 53.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.006 0.431 . . . . 0.0 110.553 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.6 p -155.46 168.61 26.54 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.399 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.69 -177.42 21.75 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.637 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.77 172.86 12.2 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 120.881 0.372 . . . . 0.0 110.518 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.538 HG23 HG21 ' A' ' 51' ' ' VAL . 14.7 p -132.41 -113.16 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.374 . . . . 0.0 110.312 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.87 179.85 0.92 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.353 -179.02 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.8 Cg_exo -61.23 57.74 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.988 2.458 . . . . 0.0 112.137 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.545 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 60.4 t-20 -64.37 -33.38 75.71 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.468 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 11.4 m120 93.76 -35.68 0.02 OUTLIER 'General case' 0 C--N 1.345 0.403 0 O-C-N 124.182 0.926 . . . . 0.0 109.804 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.6 mtp85 -63.05 -39.86 95.98 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.989 0.423 . . . . 0.0 110.267 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -74.73 -25.33 18.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.738 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.03 -171.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.599 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -73.3 -154.16 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.787 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.2 p-10 -52.11 -7.71 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.684 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -86.34 115.1 23.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.594 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.18 70.06 1.34 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -143.57 147.46 34.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.931 0.396 . . . . 0.0 110.784 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.57 -98.48 0.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.137 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.87 -42.74 97.44 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.129 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.2 tt0 91.68 53.13 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.066 0.854 . . . . 0.0 110.892 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -102.95 -9.31 19.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.419 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -64.54 -34.26 77.82 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.173 0.511 . . . . 0.0 110.664 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -48.91 -24.79 1.61 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.597 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.2 -45.66 79.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.792 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.25 -48.47 81.28 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.038 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.48 -38.35 89.52 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.364 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.67 -33.0 53.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.176 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.592 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.1 mmt-85 -89.72 1.47 56.03 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.598 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.92 -49.13 0.16 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 124.159 0.912 . . . . 0.0 110.288 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.64 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.1 mt -46.52 153.79 0.34 Allowed 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 117.403 -1.284 . . . . 0.0 109.264 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.64 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 121.62 92.62 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 O-C-N 125.625 1.828 . . . . 0.0 110.431 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.533 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.7 143.29 42.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.122 0.487 . . . . 0.0 110.276 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.3 mt -132.42 27.06 4.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.453 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.37 138.07 34.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.036 0.446 . . . . 0.0 110.512 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.9 mt -137.17 164.98 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.401 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.614 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.13 -28.63 1.83 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -153.01 70.93 7.1 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.167 0.508 . . . . 0.0 110.232 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.12 145.48 98.37 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.715 2.277 . . . . 0.0 112.089 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.5 t -134.2 136.61 43.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.563 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.35 82.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.649 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.31 -42.18 96.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.512 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.57 98.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.478 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.66 -43.31 98.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.961 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.2 77.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.26 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.48 -18.7 60.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.438 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.39 -6.44 58.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.523 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 72.4 mtp 47.94 55.85 17.23 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.617 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.16 148.99 63.72 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.798 2.332 . . . . 0.0 112.098 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.15 -73.04 0.66 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.501 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 140' ' ' LEU . 37.9 tp -111.32 113.64 26.26 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.313 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.4 mt -102.6 126.37 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.537 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.3 mt -109.77 134.06 52.44 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.143 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.77 139.87 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.496 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.4 p -83.4 168.45 16.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.707 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.16 -37.4 80.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.41 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -139.99 159.21 42.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.433 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.27 177.28 33.37 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.24 -33.87 87.36 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.57 151.74 44.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.904 0.383 . . . . 0.0 110.543 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -63.39 140.85 58.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.32 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.54 10.66 11.16 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.657 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.18 -39.04 88.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.092 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.633 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.86 23.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.586 0.708 . . . . 0.0 110.611 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.0 mt -70.76 -35.65 72.72 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.531 0.681 . . . . 0.0 110.764 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.88 -62.96 0.88 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.273 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.633 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.89 -42.64 90.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.046 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -62.17 -32.77 73.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.177 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.5 mt -73.48 -40.9 63.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.24 -48.85 79.11 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.16 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.3 m -52.9 -42.58 65.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.199 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.74 -43.05 93.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.107 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.75 153.89 5.15 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.62 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -39.12 106.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.664 2.243 . . . . 0.0 112.406 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.64 ' C ' HD12 ' A' ' 140' ' ' LEU . 96.8 m -110.33 121.52 45.47 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.244 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.64 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.02 152.96 30.19 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.26 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.9 131.0 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.309 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -114.79 127.78 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.432 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.3 103.75 14.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.278 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 147' ' ' LYS . 45.5 p90 -101.45 -11.2 19.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.783 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.69 -33.61 76.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.666 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -98.21 7.79 45.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.525 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.76 155.46 50.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.527 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.7 p -74.89 165.71 24.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.709 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -60.05 -48.65 80.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.197 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.79 -42.02 67.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.923 0.392 . . . . 0.0 110.027 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.8 t -62.63 -41.11 98.83 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.358 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.409 ' CD1' HG21 ' A' ' 142' ' ' ILE . 47.4 tp -60.7 -44.17 96.89 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.353 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.4 tp -61.5 -43.22 99.26 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.101 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -55.31 -44.88 76.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.52 -40.65 97.44 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.894 0.378 . . . . 0.0 110.327 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -61.95 -42.46 99.14 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.31 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.88 -40.62 95.54 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.58 -45.86 64.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.926 0.393 . . . . 0.0 110.855 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.67 -44.04 96.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.85 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.3 p -93.19 -8.61 41.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.588 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.78 26.34 72.08 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -101.47 50.75 0.85 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.768 0.318 . . . . 0.0 110.67 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.58 -39.36 77.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.659 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.5 -47.17 86.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.234 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -60.19 -39.45 86.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.308 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.1 99.37 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.307 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.94 -28.69 70.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.994 0.426 . . . . 0.0 110.602 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.19 -54.24 8.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.15 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.517 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.4 ttp180 -65.55 -42.25 92.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.477 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.454 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.3 mt -62.45 -43.94 98.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.492 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.48 -58.96 5.71 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.14 0.495 . . . . 0.0 110.48 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -56.51 -34.16 66.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.448 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -80.79 -36.21 32.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.886 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.7 m-20 -55.1 -42.26 72.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.095 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.42 -41.82 98.98 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.686 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.05 -38.19 90.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.285 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.7 mt -62.38 -42.11 99.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.771 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.47 63.87 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.084 0.469 . . . . 0.0 110.677 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.35 -41.79 89.02 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.601 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.06 -39.94 95.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.566 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.12 -32.43 73.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.361 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.24 -21.97 18.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.668 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.491 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -64.67 -41.35 96.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.64 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 pt -76.59 135.92 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.677 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.93 107.79 10.39 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.273 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.67 125.97 0.31 Allowed Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.541 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 73.9 Cg_exo -43.72 152.24 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.781 2.32 . . . . 0.0 112.601 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.87 141.98 55.75 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.573 2.182 . . . . 0.0 112.484 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.547 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.22 147.32 2.19 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.628 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.34 154.85 68.79 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.735 2.29 . . . . 0.0 112.284 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.56 163.27 28.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.419 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.84 170.8 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.959 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.92 137.92 21.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.93 0.395 . . . . 0.0 110.195 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.542 HG22 HD12 ' A' ' 205' ' ' LEU . 40.1 pt -134.47 147.37 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.692 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -133.2 131.95 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.098 0.475 . . . . 0.0 110.501 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -151.99 155.08 37.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.442 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.615 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.6 m -122.33 122.84 40.0 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.96 0.41 . . . . 0.0 110.366 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.2 -25.78 65.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.613 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.615 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.49 -48.46 22.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.069 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.07 -11.21 60.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.386 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.6 m80 48.25 41.55 16.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.485 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.3 t -135.89 145.22 46.08 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.42 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.406 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -110.94 114.02 27.03 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.233 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.63 133.13 55.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 110.351 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.542 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.77 146.24 37.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.772 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.468 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 10.3 t90 -99.36 129.77 45.59 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.096 0.475 . . . . 0.0 109.973 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.59 153.81 39.37 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.306 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.414 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.8 Cg_endo -67.76 -18.39 47.56 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.716 2.277 . . . . 0.0 111.954 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.1 -18.44 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.4 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.468 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.3 p -76.42 164.69 25.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.508 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.78 -27.64 65.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.514 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.454 ' OE1' ' CD1' ' A' ' 297' ' ' PHE . 34.9 mt-30 -63.75 -41.1 98.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.77 -44.48 97.93 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.63 -38.63 91.68 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.961 0.41 . . . . 0.0 110.575 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.3 mmm -62.16 -41.35 98.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.082 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.71 -46.91 83.28 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.534 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.5 -31.91 56.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.073 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.79 -18.68 62.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.449 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.414 HD11 ' CD2' ' A' ' 299' ' ' LEU . 92.1 mt -87.61 -9.31 54.64 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.61 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.29 1.9 54.04 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -88.34 153.77 20.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 110.516 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.458 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.3 p -116.56 129.02 55.94 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.119 0.485 . . . . 0.0 110.331 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -93.02 146.21 23.79 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.927 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.477 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.41 151.48 46.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.49 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.39 131.41 43.63 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.397 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.891 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.54 93.3 27.01 Favored Pre-proline 0 C--O 1.234 0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.077 -179.548 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.677 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.6 Cg_exo -55.75 138.96 82.94 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.569 2.179 . . . . 0.0 111.527 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.84 -25.59 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.46 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.26 -49.96 29.96 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.552 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.0 mt -54.0 -36.8 63.34 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.85 36.42 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.814 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.75 86.94 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.905 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.1 p -79.4 -15.39 57.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.405 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -92.19 -41.29 10.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.627 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -66.03 -17.94 65.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.605 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.17 43.37 26.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.468 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.49 -147.76 7.46 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.97 142.66 50.08 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.026 0.441 . . . . 0.0 110.294 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.43 149.82 28.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.353 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -101.3 -151.55 0.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.347 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.4 t0 56.16 -91.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.652 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.471 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.85 175.35 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.559 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.471 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 93.4 mt -122.29 141.76 41.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.833 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.81 169.02 9.53 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.221 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.5 mt -147.68 151.07 35.53 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.266 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.69 -39.0 97.06 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.06 4.0 4.72 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.27 -58.06 3.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.996 0.426 . . . . 0.0 110.578 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.541 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.8 m-20 -62.22 -36.93 83.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.212 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.406 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.1 mp -52.21 -67.61 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.778 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.71 -42.13 67.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.132 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.0 17.71 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.607 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.25 48.46 0.31 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.47 -109.79 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.605 0.24 . . . . 0.0 110.7 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.9 -44.59 96.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.42 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.21 7.95 84.38 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -98.91 -13.33 20.05 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.713 -0.286 . . . . 0.0 110.693 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.6 t 177.03 142.71 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.089 0.471 . . . . 0.0 110.498 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.06 125.49 11.64 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.176 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.6 m-30 -98.65 143.26 29.23 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 120.923 0.392 . . . . 0.0 110.809 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.9 mt -94.42 106.32 18.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.678 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.451 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.9 t80 -101.58 -11.55 19.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.108 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.43 87.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.874 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.74 174.12 46.32 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.475 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.4 m-20 -74.35 -113.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.741 0.305 . . . . 0.0 110.772 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.78 -28.69 67.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.708 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.03 -43.93 91.68 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.271 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.72 -44.26 94.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.377 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.52 -60.14 3.59 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.247 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.11 -43.26 61.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.17 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.53 -43.68 75.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.2 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.2 mt -64.47 -43.65 96.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.664 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -56.31 -37.39 69.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.162 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.77 0.95 18.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.197 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -115.05 91.31 26.5 Favored Pre-proline 0 CA--C 1.529 0.147 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.148 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.29 -27.2 29.76 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.796 2.33 . . . . 0.0 111.832 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.36 -41.02 98.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.569 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.45 5.22 52.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.349 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.97 -35.21 69.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.695 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.58 4.56 15.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.527 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.58 121.33 80.51 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.566 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -47.6 -37.69 27.25 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.397 2.065 . . . . 0.0 112.558 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.53 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.94 -43.57 91.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.856 0.36 . . . . 0.0 110.305 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.88 -43.89 92.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.285 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.91 -40.59 95.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.444 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.7 t-20 -89.32 -12.93 39.13 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.529 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.5 mtmt 62.32 31.94 17.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.893 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -89.01 43.87 1.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.046 0.45 . . . . 0.0 110.313 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.51 135.87 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.444 -179.718 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -116.61 132.55 56.65 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.485 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.1 87.84 7.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.769 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.86 -41.23 97.83 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.866 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.451 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.46 167.65 34.58 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 71.2 p -75.53 -25.69 57.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.845 0.355 . . . . 0.0 110.763 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.4 tp10 -67.84 -34.86 77.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.452 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 95.7 m -73.27 24.59 0.06 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.65 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.502 ' H ' ' C ' ' A' ' 295' ' ' GLU . 65.5 t80 -58.23 -51.18 70.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.421 HH12 ' HG3' ' A' ' 212' ' ' GLN . 58.9 mmt-85 -112.17 155.1 24.5 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.414 ' CD2' HD11 ' A' ' 219' ' ' LEU . 46.1 tp -116.3 125.64 52.43 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.49 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.0 t0 -147.29 165.3 30.52 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.573 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -49.41 -38.2 28.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.548 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -72.23 -64.8 0.87 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.509 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.3 -32.11 70.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.984 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.66 -25.3 26.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.571 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.6 mtt -63.08 -41.18 99.35 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 120.965 0.412 . . . . 0.0 110.953 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -78.33 -44.79 24.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.095 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.554 HG21 HG23 ' A' ' 296' ' ' THR . 73.6 t -66.0 -43.06 92.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.435 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.491 HD11 ' NE2' ' A' ' 183' ' ' GLN . 52.7 tp -60.26 -47.37 86.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.548 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.94 -39.39 76.11 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.635 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.1 ttt180 -61.96 -38.07 87.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.233 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.8 mt -87.38 4.61 42.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.794 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -112.87 -11.7 13.4 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.045 0.45 . . . . 0.0 110.284 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.04 -37.31 86.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.539 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.95 -48.69 80.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.379 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.022 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.56 -2.53 57.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.43 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.488 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.61 179.03 1.25 Allowed Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.457 -179.658 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.7 Cg_exo -60.81 144.7 99.6 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.796 2.331 . . . . 0.0 112.183 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.98 -179.65 8.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.596 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.61 136.27 53.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.317 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -123.91 146.65 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.333 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.3 p -119.91 136.0 54.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.77 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.1 p30 -99.42 -143.62 0.33 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.225 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -63.4 -37.19 86.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.593 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.9 ttt85 -149.3 -66.62 0.22 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.501 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.29 142.1 45.16 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.8 p -112.15 131.03 55.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.934 0.397 . . . . 0.0 110.437 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -118.92 129.08 54.99 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.542 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.6 m -85.67 130.64 34.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.214 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.1 mt -96.0 78.77 3.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.343 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.81 -32.0 73.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.473 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.12 108.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.164 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.489 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.5 pt20 -121.65 91.4 48.52 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.304 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.652 ' O ' ' N ' ' A' ' 45' ' ' ARG . 37.1 Cg_exo -57.0 148.59 67.44 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.738 2.292 . . . . 0.0 111.824 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.69 82.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.556 0.535 . . . . 0.0 111.018 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.14 66.85 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.046 0.45 . . . . 0.0 110.251 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.44 131.0 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.614 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.544 ' HA ' HG23 ' A' ' 64' ' ' VAL . 56.7 t -122.89 145.54 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.146 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -135.52 143.32 45.7 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.623 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.0 p -99.26 -59.19 1.77 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.552 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.9 p -79.52 154.97 28.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.647 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 70' ' ' THR . 70.8 t -74.58 -21.79 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.57 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.5 m -60.12 -52.18 66.45 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.434 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.6 -42.4 86.94 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.245 0.545 . . . . 0.0 110.873 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -42.82 -53.64 4.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.153 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.45 -37.75 69.56 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.9 m -62.56 -44.62 95.88 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.884 0.373 . . . . 0.0 110.459 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.418 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.8 mt -66.19 -41.94 89.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.38 0.61 . . . . 0.0 110.739 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.65 -40.15 96.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.324 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.466 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.03 -35.91 76.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.94 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 156' ' ' LEU . 31.4 pt -91.31 28.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.118 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.54 51.64 10.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.819 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.02 75.93 23.12 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.95 0.405 . . . . 0.0 110.003 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.4 151.77 84.06 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.746 2.298 . . . . 0.0 112.265 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.544 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.85 137.42 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.149 0.499 . . . . 0.0 110.316 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.447 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.5 pt -69.26 -43.61 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.219 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.78 130.96 53.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.926 0.393 . . . . 0.0 110.547 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.5 p -155.75 168.99 25.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.44 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.75 -177.44 21.71 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -132.67 171.86 13.3 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 120.943 0.402 . . . . 0.0 110.531 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.493 HG23 HG21 ' A' ' 51' ' ' VAL . 12.4 p -133.45 -111.02 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.426 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.91 179.61 0.95 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.303 -179.171 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.6 Cg_exo -60.88 58.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.953 2.436 . . . . 0.0 112.129 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.1 t-20 -64.24 -35.21 80.09 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.483 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.7 m120 95.26 -37.65 0.01 OUTLIER 'General case' 0 C--N 1.345 0.401 0 O-C-N 124.113 0.883 . . . . 0.0 110.008 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -62.61 -39.87 95.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.2 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.9 p -73.81 -26.41 21.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.689 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -50.06 -172.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.547 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.05 -152.79 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.711 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.7 p-10 -54.37 -6.66 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.685 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.493 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -86.92 113.82 23.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.559 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.15 72.73 1.28 Allowed Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.84 148.05 34.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 0.0 110.809 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.25 -99.47 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.109 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.554 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.86 -43.11 97.09 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.252 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.0 tt0 91.74 52.8 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.916 0.76 . . . . 0.0 110.861 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -103.32 -9.21 19.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.457 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.3 p -64.79 -33.86 76.98 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.049 0.452 . . . . 0.0 110.679 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.66 -23.67 1.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.516 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.3 t -69.7 -45.88 76.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.889 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.23 -48.6 80.74 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.165 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.67 -38.12 89.11 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.337 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.63 -32.51 51.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.218 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.605 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.3 mmt-85 -89.76 1.62 55.88 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.575 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.84 -49.08 0.16 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 124.045 0.841 . . . . 0.0 110.331 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.662 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.7 mt -46.49 154.3 0.3 Allowed 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 117.89 -1.053 . . . . 0.0 109.349 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.662 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 121.17 92.36 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 125.313 1.633 . . . . 0.0 110.502 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.39 143.26 42.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.251 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.9 mt -131.77 26.83 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.758 0.313 . . . . 0.0 110.481 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.42 138.08 34.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.969 0.414 . . . . 0.0 110.506 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.63 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.0 mt -137.17 165.19 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.432 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.615 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.04 -28.51 1.85 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -153.01 70.65 7.07 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.178 0.513 . . . . 0.0 110.362 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.12 145.52 98.28 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.772 2.315 . . . . 0.0 112.053 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.5 t -134.1 137.0 44.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.59 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.2 -38.17 81.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.666 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.41 -42.23 96.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.529 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.7 98.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.503 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 64.2 t -63.72 -43.33 97.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.066 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.65 -35.32 77.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.332 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.8 -18.36 59.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.484 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.52 -6.44 58.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.508 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.413 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.9 mtp 48.15 55.78 17.26 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.588 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.05 148.98 64.39 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.844 2.363 . . . . 0.0 112.133 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.28 -73.1 0.66 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.424 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 140' ' ' LEU . 38.7 tp -111.33 112.42 24.18 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.305 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.4 mt -100.55 126.07 54.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.476 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.4 mt -109.36 133.16 53.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.203 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.55 139.55 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.526 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.9 p -83.43 168.25 16.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.673 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.23 -37.48 80.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.494 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -139.03 158.96 43.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.502 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.44 176.8 33.71 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.83 87.16 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.93 151.55 45.28 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.876 0.369 . . . . 0.0 110.604 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.2 t -62.93 141.17 58.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.291 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.05 10.51 10.77 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.664 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.07 -39.07 88.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.031 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.83 -35.7 24.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.452 0.644 . . . . 0.0 110.654 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.3 mt -71.11 -35.31 71.73 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.437 0.637 . . . . 0.0 110.772 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -42.87 -62.93 0.89 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.185 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.76 -42.82 90.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -62.12 -32.65 73.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.204 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.8 mt -74.03 -40.46 62.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.054 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.16 -48.81 79.13 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.209 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.3 m -52.88 -42.44 65.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.194 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.15 -43.05 92.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.103 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.35 153.37 5.3 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.632 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -39.18 107.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.643 2.229 . . . . 0.0 112.326 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.3 m -109.09 121.38 45.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.285 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.36 152.89 30.76 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.26 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.95 131.45 68.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.365 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.07 127.72 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.493 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.4 t30 -101.86 103.67 14.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.324 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 49.6 p90 -101.23 -11.27 19.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.751 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.9 p-10 -64.78 -33.44 76.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.652 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.577 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.1 p-10 -98.31 7.41 46.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.584 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.14 155.35 50.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.572 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.408 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.2 p -74.65 165.7 24.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.664 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.588 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -59.99 -48.86 79.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.281 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -53.84 -41.99 68.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.104 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.2 t -62.49 -40.82 97.92 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.451 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 156' ' ' LEU . 48.7 tp -60.61 -43.75 97.1 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.297 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.507 HD22 HH21 ' A' ' 169' ' ' ARG . 44.6 tp -61.4 -43.2 99.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.826 0.346 . . . . 0.0 110.213 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.7 m -55.63 -45.37 77.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.833 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.35 -40.76 97.43 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-O 120.847 0.356 . . . . 0.0 110.377 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -61.88 -42.38 98.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.184 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.63 -40.76 96.1 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.77 -46.15 63.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.941 0.401 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.52 -43.98 96.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.766 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.2 p -93.21 -8.49 42.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.585 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.69 25.32 71.63 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -101.8 52.09 0.83 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.779 0.323 . . . . 0.0 110.623 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.84 -39.07 76.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.629 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.3 -47.17 86.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.262 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -61.33 -38.97 88.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.413 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.4 97.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.324 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.41 -27.69 69.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.491 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.77 -53.75 8.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.207 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.507 HH21 HD22 ' A' ' 153' ' ' LEU . 61.8 ttp180 -63.78 -43.51 96.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.458 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.1 mt -63.08 -43.88 99.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.654 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.35 -61.62 2.41 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.118 0.485 . . . . 0.0 110.377 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.66 -35.08 63.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.457 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -79.6 -34.77 40.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.004 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.6 m-20 -56.49 -40.12 74.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.112 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.95 -42.41 99.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.686 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.79 -37.72 87.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.309 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 177' ' ' LEU . 82.0 mt -62.44 -42.45 99.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.737 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.09 -53.17 59.18 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.059 0.457 . . . . 0.0 110.679 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.12 -41.77 90.08 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.562 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.93 95.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.647 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.17 -32.26 73.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.419 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.3 -21.97 18.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.719 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.472 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.6 tt0 -64.94 -41.4 95.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.68 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 pt -77.48 136.14 24.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.666 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.26 108.69 11.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.351 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.5 126.14 0.32 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.559 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.457 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.4 Cg_exo -43.68 152.02 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.742 2.295 . . . . 0.0 112.598 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.03 141.66 53.81 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.605 2.203 . . . . 0.0 112.465 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.12 147.34 2.23 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.62 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.28 154.62 69.37 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.74 2.293 . . . . 0.0 112.26 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.52 163.2 28.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.446 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.82 170.1 16.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.853 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.51 137.75 21.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.238 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.546 HG22 HD12 ' A' ' 205' ' ' LEU . 39.7 pt -134.29 146.71 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.288 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.654 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.76 131.77 59.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.099 0.476 . . . . 0.0 110.53 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -152.05 155.11 37.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.369 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.624 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.5 m -122.62 122.92 39.98 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.924 0.393 . . . . 0.0 110.401 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.11 -25.71 65.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.601 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.624 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.42 -48.97 20.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.091 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.62 -13.25 61.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.442 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.3 m80 50.72 41.36 26.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.503 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 43.3 t -136.32 144.68 44.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.344 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.14 114.18 27.47 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.315 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.1 m-20 -119.74 133.35 55.65 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.972 0.415 . . . . 0.0 110.372 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.546 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.07 146.32 38.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.735 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.478 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.2 t90 -99.5 129.8 45.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.108 0.48 . . . . 0.0 110.059 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.48 154.14 39.37 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.086 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.7 Cg_endo -67.8 -17.93 47.26 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.742 2.295 . . . . 0.0 111.933 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.56 -18.43 0.43 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.457 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.478 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.83 165.26 25.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.523 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.26 -28.17 66.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.491 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.526 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.51 -41.63 98.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.705 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.84 -44.95 96.59 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.44 -39.01 93.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.949 0.404 . . . . 0.0 110.612 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.588 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.4 mmm -62.08 -41.31 98.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.226 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.71 -47.14 82.33 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.64 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.33 -32.05 55.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.095 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.71 -18.3 62.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.496 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.43 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.1 mt -88.53 -8.6 54.53 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.691 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.74 2.43 55.25 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -88.55 152.63 21.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.0 110.499 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.448 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.2 p -115.5 128.32 55.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.077 0.465 . . . . 0.0 110.42 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.563 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.52 146.1 23.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.899 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.469 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.37 151.05 46.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.49 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.76 131.47 43.0 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.463 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.893 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.62 93.41 27.93 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.142 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.679 ' C ' ' H ' ' A' ' 229' ' ' GLY . 47.5 Cg_exo -55.65 139.16 82.79 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.62 2.213 . . . . 0.0 111.558 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.99 -25.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.445 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.71 -49.81 27.97 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.0 mt -53.97 -37.14 63.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.56 35.99 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.782 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.2 88.18 0.01 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.844 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.9 p -81.33 -14.31 57.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.356 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.64 -41.19 10.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.567 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.8 t -66.84 -16.72 64.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.607 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.06 43.53 26.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.469 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.91 -147.1 7.25 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -122.49 143.16 49.88 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.994 0.426 . . . . 0.0 110.389 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -151.97 149.47 28.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.453 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -100.72 -151.94 0.42 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.392 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 55.92 -92.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.648 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.464 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.54 175.08 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.565 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.464 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.5 mt -121.83 141.43 42.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.726 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.75 169.22 9.4 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.281 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.4 mt -147.83 150.85 34.95 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.182 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.65 -38.95 97.01 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.15 4.13 4.64 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.37 -58.15 3.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.922 0.392 . . . . 0.0 110.579 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.552 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.1 m-20 -62.13 -36.86 83.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.271 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.28 -67.81 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.722 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.33 -42.11 66.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.185 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.14 18.12 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.64 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.79 48.61 0.27 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.41 -109.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.6 0.238 . . . . 0.0 110.726 -178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.469 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 12.0 m120 -60.89 -44.72 96.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.425 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.41 8.13 83.76 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -99.13 -12.74 20.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.58 0.229 . . . . 0.0 110.715 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.8 t 176.37 142.42 0.07 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.062 0.458 . . . . 0.0 110.533 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.88 125.39 11.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.03 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 191' ' ' VAL . 14.0 m-30 -98.6 143.03 29.44 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 120.85 0.357 . . . . 0.0 110.817 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.1 mt -94.33 106.5 18.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.675 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.463 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.3 t80 -102.28 -11.65 18.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.25 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.08 -40.15 86.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.804 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.11 173.68 46.14 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.5 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.0 m-20 -74.45 -112.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.347 . . . . 0.0 110.618 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.13 -28.72 67.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.728 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.85 -44.17 90.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.296 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -63.35 -44.54 94.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.353 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.34 -59.92 3.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.29 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.16 -43.32 61.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.221 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.38 -43.92 75.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.216 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.4 mt -64.42 -43.63 97.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.589 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -56.71 -37.43 70.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.172 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.96 1.03 18.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.251 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.0 91.35 26.43 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.195 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.01 -27.19 27.75 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.743 2.296 . . . . 0.0 111.87 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.34 -41.19 98.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.634 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.9 mp -95.21 5.11 52.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.41 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.72 -35.09 70.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.683 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.8 4.7 15.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.528 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.95 121.08 80.32 Favored Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.556 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -47.27 -37.8 24.94 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.507 2.138 . . . . 0.0 112.487 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.9 -43.82 91.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.294 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.82 -43.72 93.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.303 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.6 -40.52 95.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.539 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -90.32 -11.94 39.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.53 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.86 32.38 18.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.884 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.77 44.0 1.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.385 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.34 135.74 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.566 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.44 133.03 56.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.435 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.497 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.69 87.95 7.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.686 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.91 -41.47 97.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.834 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.16 167.93 34.42 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.8 p -75.9 -25.82 56.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.84 0.352 . . . . 0.0 110.691 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.4 tp10 -67.84 -34.32 76.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.39 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.763 HG22 ' O ' ' A' ' 296' ' ' THR . 97.1 m -73.14 19.7 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.631 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.526 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 53.1 t80 -57.25 -51.08 70.8 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.058 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.401 HH12 ' HG3' ' A' ' 212' ' ' GLN . 68.5 mmt-85 -108.05 149.36 28.53 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.43 ' CD2' HD11 ' A' ' 219' ' ' LEU . 42.3 tp -115.46 125.57 53.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.756 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.47 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.6 t0 -149.37 166.61 28.52 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.632 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -49.15 -38.14 24.47 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.588 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.82 -65.15 0.8 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.231 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.86 -32.79 72.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.44 -26.01 28.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.659 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.6 mtt -63.36 -41.04 98.8 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 120.851 0.357 . . . . 0.0 110.908 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.26 -44.41 25.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.914 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.565 HG21 HG23 ' A' ' 296' ' ' THR . 74.9 t -66.17 -42.89 92.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.425 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.472 HD11 ' NE2' ' A' ' 183' ' ' GLN . 49.3 tp -59.86 -47.49 85.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.505 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -69.64 -39.56 77.05 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.027 0.441 . . . . 0.0 110.723 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.5 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 72.2 ttt180 -61.7 -38.43 87.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.203 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -87.14 4.9 40.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.785 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.401 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.2 tttt -112.65 -11.77 13.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.04 0.448 . . . . 0.0 110.266 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.74 -37.08 85.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.642 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.99 -48.78 80.24 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.386 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.057 179.855 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.85 -2.46 58.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.413 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.9 179.08 1.24 Allowed Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.556 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.1 Cg_exo -60.9 145.11 99.52 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.781 2.321 . . . . 0.0 112.165 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.03 -179.21 7.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.589 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.81 136.67 52.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.342 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.39 147.29 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.362 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.9 p -120.39 136.12 54.82 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.27 -143.57 0.32 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.191 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -63.46 -37.18 86.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.526 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.05 -66.96 0.22 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.412 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.32 142.4 44.96 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.7 p -112.24 131.44 55.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.907 0.384 . . . . 0.0 110.435 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -119.22 129.06 54.76 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.518 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.0 m -85.68 130.36 34.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.225 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.48 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.8 mt -95.94 78.88 3.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.32 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.9 -31.91 73.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.491 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 176.06 108.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.05 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.48 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -121.89 91.56 48.77 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.312 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.646 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.3 Cg_exo -56.94 148.77 65.7 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.787 2.325 . . . . 0.0 111.862 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.64 82.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.607 0.567 . . . . 0.0 111.044 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.646 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.16 66.71 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.229 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.7 130.65 36.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.63 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.553 ' HA ' HG23 ' A' ' 64' ' ' VAL . 57.9 t -122.91 146.34 28.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.027 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -135.96 144.3 45.32 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 50' ' ' SER . 20.8 p -100.13 -59.28 1.74 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.619 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.406 ' N ' ' OG1' ' A' ' 49' ' ' THR . 86.5 p -79.21 154.78 28.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.653 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.516 HG21 HG23 ' A' ' 70' ' ' THR . 72.2 t -74.0 -22.01 18.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.578 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.4 m -60.24 -51.89 67.62 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.559 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -66.45 -42.42 87.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.196 0.522 . . . . 0.0 110.855 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.1 m -43.38 -53.74 5.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.048 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.41 -37.64 69.88 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.5 m -62.51 -44.66 95.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.896 0.379 . . . . 0.0 110.324 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.0 mt -66.16 -42.01 89.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.535 0.683 . . . . 0.0 110.704 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.63 -40.21 96.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.398 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.508 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.05 -35.79 75.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.07 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 156' ' ' LEU . 31.8 pt -91.36 28.91 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.229 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.5 51.66 10.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.881 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.35 75.55 22.71 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.91 151.88 84.22 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.742 2.295 . . . . 0.0 112.136 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.553 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.82 137.48 46.86 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 CA-C-O 121.172 0.51 . . . . 0.0 110.236 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.22 -43.63 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.317 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.483 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.97 131.12 53.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.051 0.453 . . . . 0.0 110.552 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.53 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.0 p -155.62 168.84 25.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.493 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.82 -177.25 21.67 Favored Glycine 0 N--CA 1.464 0.544 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.64 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.72 172.76 12.32 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.0 0.428 . . . . 0.0 110.486 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.516 HG23 HG21 ' A' ' 51' ' ' VAL . 14.6 p -132.59 -112.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.339 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.17 179.9 0.91 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.359 -179.131 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.8 Cg_exo -60.89 57.59 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.973 2.449 . . . . 0.0 112.154 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.6 t-20 -63.87 -33.36 75.52 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.407 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 14.6 m120 93.42 -36.64 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.014 0.821 . . . . 0.0 109.855 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.7 mtp85 -62.65 -39.51 94.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.019 0.438 . . . . 0.0 110.145 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 77' ' ' ALA . 15.0 p -74.29 -25.65 19.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.758 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.36 -171.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.545 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -74.12 -154.13 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.845 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.2 p-10 -52.52 -7.4 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.665 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.19 115.02 23.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.977 0.418 . . . . 0.0 110.631 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.82 70.16 1.35 Allowed Glycine 0 CA--C 1.52 0.39 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.3 m-85 -143.47 148.18 35.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 110.793 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -86.08 -98.42 0.07 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.135 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.89 -42.84 97.37 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.183 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.547 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.0 tt0 91.53 52.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.991 0.807 . . . . 0.0 110.858 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -102.86 -9.48 19.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.429 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.419 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.3 p -64.24 -33.85 76.75 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.149 0.5 . . . . 0.0 110.691 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -49.12 -23.96 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.66 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.39 -45.99 77.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.27 -48.33 81.9 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.043 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.65 -38.11 89.0 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.374 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.82 -32.72 53.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.161 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.594 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.94 1.71 55.93 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.523 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.65 -49.38 0.18 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.115 0.884 . . . . 0.0 110.265 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.5 mt -46.16 154.65 0.25 Allowed 'General case' 0 CA--C 1.49 -1.336 0 CA-C-O 117.475 -1.25 . . . . 0.0 109.343 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.644 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 120.95 92.57 0.0 OUTLIER 'General case' 0 C--N 1.353 0.735 0 O-C-N 125.563 1.79 . . . . 0.0 110.46 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.53 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.7 mtp180 -75.7 143.36 42.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.14 0.495 . . . . 0.0 110.265 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.5 mt -132.43 27.12 4.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 0.0 110.461 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.21 137.7 34.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.003 0.43 . . . . 0.0 110.49 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.8 mt -137.29 165.09 28.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.391 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.08 -28.46 1.84 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.35 70.84 7.59 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.191 0.52 . . . . 0.0 110.208 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -60.0 145.3 98.71 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 C-N-CA 122.751 2.3 . . . . 0.0 112.066 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.7 t -134.73 136.81 42.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.553 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.12 81.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.711 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.26 -42.33 96.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.52 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.86 -41.61 98.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.546 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.4 t -63.5 -43.42 98.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.99 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.06 77.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.23 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.76 -18.9 61.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.478 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.38 -6.57 58.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 81.9 mtp 47.8 55.97 17.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.59 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.3 Cg_endo -70.37 149.36 62.87 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.807 2.338 . . . . 0.0 112.101 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.22 -72.94 0.66 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.454 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.456 HD11 HD13 ' A' ' 140' ' ' LEU . 38.2 tp -111.56 113.01 25.14 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.324 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.1 mt -101.27 126.46 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.584 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.7 mt -109.52 133.47 53.05 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.225 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.68 139.65 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.493 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.4 p -83.45 168.56 16.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.671 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.42 80.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.381 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.8 t -139.53 158.94 43.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.943 0.402 . . . . 0.0 110.453 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.29 176.92 33.56 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.21 -33.71 86.82 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.77 151.52 45.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.925 0.393 . . . . 0.0 110.507 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.1 t -63.06 140.98 58.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.339 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.69 10.42 11.0 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.642 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.09 -39.16 88.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.081 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.79 -35.98 23.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.588 0.709 . . . . 0.0 110.705 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.4 mt -70.83 -35.54 72.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.528 0.68 . . . . 0.0 110.732 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -42.81 -62.83 0.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.317 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.81 -42.78 90.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.06 -179.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -62.03 -32.73 73.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.24 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.3 mt -73.77 -40.64 63.31 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.102 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.29 -48.76 79.47 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.153 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.1 m -53.05 -42.5 65.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.097 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.88 -43.09 93.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.937 0.399 . . . . 0.0 111.099 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.32 153.47 5.36 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.674 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -39.25 107.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.65 2.233 . . . . 0.0 112.445 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.641 ' C ' HD12 ' A' ' 140' ' ' LEU . 97.8 m -109.65 121.64 45.67 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.24 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.96 152.6 30.64 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.256 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.98 131.4 68.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.321 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.403 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -115.14 127.89 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.491 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.472 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 57.0 t30 -101.56 103.8 14.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.265 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.6 p90 -101.38 -11.21 19.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.816 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.75 -33.65 76.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.682 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.9 p-10 -98.3 7.66 45.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.612 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.448 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.46 155.39 50.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.51 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.403 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.8 p -74.86 165.64 24.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.641 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.86 -48.77 80.35 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.247 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.66 -41.95 67.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.028 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.3 t -62.65 -41.08 98.86 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.385 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.403 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.5 tp -60.61 -44.38 96.36 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.393 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.3 tp -61.41 -43.43 98.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.145 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -55.07 -44.88 75.2 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.43 -40.78 97.68 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.943 0.402 . . . . 0.0 110.469 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -62.03 -42.47 99.2 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.305 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.21 -40.91 95.02 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.5 -45.96 64.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.832 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.75 -44.04 96.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.794 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.4 p -93.03 -8.81 41.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.622 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.01 26.58 72.38 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -101.54 50.63 0.85 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.807 0.337 . . . . 0.0 110.703 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.45 -39.61 77.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.617 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.4 -47.26 86.13 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.252 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -59.94 -39.55 85.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.314 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.77 98.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.278 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.0 -28.61 70.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.614 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.18 -54.26 8.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.067 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.508 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.4 ttp180 -65.49 -42.27 92.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.456 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.459 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.6 mt -62.35 -43.98 98.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.502 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.66 -58.35 7.8 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.037 0.446 . . . . 0.0 110.344 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.05 -34.05 67.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.471 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.4 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.2 t80 -81.01 -36.35 30.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.875 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -55.61 -41.84 74.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.03 -178.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.7 -42.1 99.47 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.684 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.29 -38.05 89.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.288 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 177' ' ' LEU . 82.3 mt -62.47 -42.23 99.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.674 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.08 -52.79 62.48 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.091 0.472 . . . . 0.0 110.664 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.32 -41.75 89.23 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.588 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.89 95.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.611 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.34 -32.13 73.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.426 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.62 -22.26 18.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.693 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.429 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -64.77 -41.26 96.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.652 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.3 pt -76.56 136.45 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.698 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.72 107.91 10.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.224 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.82 125.69 0.3 Allowed Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.45 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.452 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.2 Cg_exo -43.96 152.38 0.37 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.757 2.305 . . . . 0.0 112.623 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.75 141.85 55.88 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.589 2.193 . . . . 0.0 112.466 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.01 147.44 2.29 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.622 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.31 154.32 69.71 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.782 2.321 . . . . 0.0 112.303 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.581 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.39 163.15 29.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.438 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.581 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.91 170.73 15.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.915 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.36 137.75 22.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.238 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.551 HG22 HD12 ' A' ' 205' ' ' LEU . 40.1 pt -134.24 146.89 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.672 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.03 131.87 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.168 0.508 . . . . 0.0 110.488 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -152.12 155.25 37.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.388 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.621 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.6 m -122.69 123.16 40.49 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.917 0.389 . . . . 0.0 110.341 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.5 -25.66 66.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.649 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.621 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.59 -48.94 20.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.038 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.18 -13.62 61.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.435 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 76.5 m80 51.05 40.92 26.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.518 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.9 t -136.48 143.96 44.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.422 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -109.56 114.54 28.25 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.287 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.3 m-20 -119.8 133.32 55.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.128 0.49 . . . . 0.0 110.346 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.551 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.97 146.41 37.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.787 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.478 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.6 t90 -99.47 129.61 45.66 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.142 0.496 . . . . 0.0 109.996 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.14 153.89 39.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.225 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.7 Cg_endo -67.8 -18.04 47.3 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.647 2.231 . . . . 0.0 111.958 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.29 -18.7 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.441 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.478 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.63 164.65 26.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.486 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.91 -27.94 65.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.503 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.579 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.9 mt-30 -63.82 -41.33 97.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.586 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.37 -44.61 97.4 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.448 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.2 mt-30 -64.51 -38.75 92.11 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 122.524 -0.398 . . . . 0.0 110.575 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.2 mmm -62.16 -41.08 97.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.167 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.3 mt -63.59 -47.02 83.18 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.464 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.31 -31.91 55.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.155 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -70.84 -18.24 62.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.558 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.437 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.6 mt -88.17 -9.11 54.16 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.617 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.18 1.97 54.41 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -88.43 153.22 21.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 110.467 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.447 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.0 p -116.12 128.73 55.91 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.129 0.49 . . . . 0.0 110.348 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.562 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.66 146.24 23.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.897 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.476 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.75 151.26 46.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.402 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.43 131.44 43.57 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.425 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.893 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.62 93.37 27.72 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.032 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.677 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.7 Cg_exo -55.65 139.0 82.62 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.575 2.183 . . . . 0.0 111.518 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.84 -25.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.483 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -69.94 -50.1 31.18 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.552 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.5 mt -53.94 -36.92 63.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.814 0.34 . . . . 0.0 110.123 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -66.7 36.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.829 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.88 86.81 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.948 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.3 p -79.09 -15.24 58.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.325 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.58 -41.04 10.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.616 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.1 t -66.21 -18.0 65.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.546 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.14 43.48 26.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.435 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.52 -148.22 7.71 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.68 142.79 49.81 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.002 0.429 . . . . 0.0 110.294 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.41 149.93 29.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.317 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -101.21 -151.55 0.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.369 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 56.0 -91.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.646 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.471 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.84 175.42 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.648 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.471 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.1 mt -122.54 141.78 41.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.83 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.76 169.29 9.35 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.327 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.5 mt -147.65 151.01 35.46 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.289 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.63 -38.95 97.02 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.95 4.13 4.74 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -77.37 -58.1 3.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.986 0.422 . . . . 0.0 110.595 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.549 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.1 m-20 -62.11 -36.69 82.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.232 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.44 -67.53 0.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.55 -42.21 67.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.1 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.29 17.67 0.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.62 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.17 48.62 0.31 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.5 mp 38.65 -109.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.6 0.238 . . . . 0.0 110.736 -178.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.9 m120 -60.95 -44.75 96.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.427 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.42 7.97 83.98 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.88 -13.51 20.0 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.743 -0.269 . . . . 0.0 110.65 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.7 t 176.97 142.7 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.122 0.487 . . . . 0.0 110.479 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.13 125.21 11.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.14 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.6 m-30 -98.31 143.52 28.7 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 120.898 0.38 . . . . 0.0 110.763 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.87 106.55 18.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.688 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.4 t80 -101.79 -12.21 18.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.157 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.47 -40.86 89.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.853 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.79 173.22 45.87 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.009 -0.837 . . . . 0.0 111.009 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.461 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.4 m-20 -73.85 -113.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 110.758 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.89 -28.69 67.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.711 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.9 -43.9 91.11 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.237 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.57 -44.17 94.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.408 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.73 -60.09 3.68 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.217 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.08 -43.34 61.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.142 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.48 -43.62 75.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.144 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.6 mt -64.59 -43.66 96.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.6 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -56.07 -37.49 69.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.16 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.72 0.94 18.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.185 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -114.98 91.14 25.49 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.147 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.19 -27.09 28.69 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.756 2.304 . . . . 0.0 111.848 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.45 -40.97 98.55 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.592 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.35 5.11 52.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.352 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.87 -35.19 69.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.687 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.65 4.5 15.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.53 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.67 121.17 80.07 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -47.32 -37.66 25.12 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.469 2.113 . . . . 0.0 112.512 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.532 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -59.05 -43.82 91.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.804 0.335 . . . . 0.0 110.273 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.5 t -65.86 -43.77 93.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.299 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -65.03 -40.66 95.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.428 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.9 t-20 -89.49 -12.73 39.22 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.575 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.7 mtmt 62.16 32.07 17.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -88.9 43.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.101 0.477 . . . . 0.0 110.332 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.13 135.81 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.419 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.8 132.3 56.73 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.403 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.13 89.05 7.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.765 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.9 -41.23 97.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.877 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.444 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.79 165.64 33.84 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 69.0 p -75.47 -25.83 57.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.888 0.375 . . . . 0.0 110.813 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.0 tp10 -68.23 -33.84 75.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.439 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 96.7 m -73.53 24.45 0.07 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.67 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.579 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 43.7 t80 -58.28 -50.7 72.66 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.409 HH12 ' HG3' ' A' ' 212' ' ' GLN . 76.9 mmt-85 -110.8 153.17 25.75 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.437 ' CD2' HD11 ' A' ' 219' ' ' LEU . 43.6 tp -115.49 125.34 52.94 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.819 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.488 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.1 t0 -148.16 165.77 29.89 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.605 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -49.38 -38.05 27.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.567 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -70.92 -65.76 0.7 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.449 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -60.97 -32.72 72.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.056 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.22 -25.58 23.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.678 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.7 mtt -63.51 -40.83 98.08 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 120.872 0.368 . . . . 0.0 111.081 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.75 -44.24 23.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.108 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.581 HG21 HG23 ' A' ' 296' ' ' THR . 78.6 t -66.14 -42.91 92.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.409 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.3 tp -60.29 -47.01 87.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.48 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -70.0 -39.33 75.93 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.598 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.498 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.7 ttt180 -61.79 -38.29 87.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.166 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.5 mt -87.07 4.45 42.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.71 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.404 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.1 tttt -112.78 -11.3 13.5 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 110.264 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.12 85.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.552 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.85 -48.61 81.01 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.296 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.964 179.971 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.614 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.34 -2.46 57.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.412 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.89 179.04 1.25 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.0 Cg_exo -60.73 144.61 99.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.71 2.273 . . . . 0.0 112.194 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.614 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.58 -179.87 8.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.621 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.63 136.52 52.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.318 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.12 147.07 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.368 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.6 p -120.25 136.08 54.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 110.745 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.6 -143.43 0.33 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.269 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.41 -37.27 86.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.504 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.474 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.17 -66.84 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.486 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.62 142.38 45.65 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.0 p -112.26 131.41 55.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.908 0.385 . . . . 0.0 110.45 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -118.8 128.96 54.96 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.561 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.5 m -85.35 130.33 34.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.237 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.473 HD22 ' OE1' ' A' ' 42' ' ' GLN . 67.7 mt -95.68 78.9 3.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.324 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.53 -31.94 73.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.493 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.79 109.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.073 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.473 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.5 pt20 -122.05 91.66 48.9 Favored Pre-proline 0 C--O 1.233 0.203 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.296 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.646 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.2 Cg_exo -56.94 148.76 65.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.766 2.311 . . . . 0.0 111.874 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.61 82.75 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 O-C-N 123.587 0.554 . . . . 0.0 110.991 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.646 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.45 67.03 0.89 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.244 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.14 130.66 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.665 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.56 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.2 t -122.66 146.68 27.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.047 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.9 t -136.28 143.87 44.45 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.697 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.2 p -99.26 -59.2 1.77 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.584 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.2 p -79.46 155.39 28.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.632 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.525 HG21 HG23 ' A' ' 70' ' ' THR . 70.6 t -74.3 -21.86 17.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.567 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.4 m -60.28 -52.01 67.11 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.456 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.29 -42.54 88.23 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.375 0.607 . . . . 0.0 110.879 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.0 m -43.38 -53.93 5.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.086 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.31 -37.75 70.89 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.7 m -62.51 -44.67 95.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.805 0.336 . . . . 0.0 110.277 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.2 mt -66.14 -41.98 89.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.464 0.649 . . . . 0.0 110.761 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.53 -40.19 95.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.476 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.467 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.14 -36.0 76.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.135 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.535 HD11 HD12 ' A' ' 156' ' ' LEU . 32.9 pt -91.07 28.7 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.239 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.72 51.48 10.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.861 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.94 75.66 23.97 Favored Pre-proline 0 C--N 1.332 -0.167 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.68 151.44 85.64 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.743 2.295 . . . . 0.0 112.17 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.56 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.61 137.18 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.191 0.519 . . . . 0.0 110.25 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.444 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.7 pt -69.09 -43.69 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.339 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.95 130.97 53.43 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.933 0.396 . . . . 0.0 110.581 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.53 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.8 p -155.51 168.79 25.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.429 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.78 -177.45 21.69 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.631 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.54 172.88 12.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.944 0.402 . . . . 0.0 110.523 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.525 HG23 HG21 ' A' ' 51' ' ' VAL . 13.6 p -133.03 -112.11 0.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.404 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.36 179.79 0.92 Allowed Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.346 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.3 Cg_exo -61.2 57.86 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.943 2.428 . . . . 0.0 112.117 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.8 t-20 -63.97 -33.98 76.95 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.51 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.3 m120 94.01 -36.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.176 0.923 . . . . 0.0 109.808 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.2 mtp85 -62.99 -40.1 96.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.258 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 77' ' ' ALA . 15.0 p -74.43 -25.92 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.744 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.21 -171.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.608 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -73.69 -153.87 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.819 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.1 p-10 -52.79 -7.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.751 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.504 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.22 114.59 23.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.619 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.81 71.04 1.33 Allowed Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -143.75 148.23 35.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.861 0.362 . . . . 0.0 110.812 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -86.07 -98.66 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.031 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.99 -42.83 97.06 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.227 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.2 tt0 91.7 53.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.994 0.809 . . . . 0.0 110.887 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -103.12 -9.22 19.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.36 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -64.49 -34.19 77.64 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.079 0.466 . . . . 0.0 110.625 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -48.91 -23.76 1.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.562 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.9 t -69.53 -45.93 77.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.41 -48.38 81.46 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.055 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.63 -38.21 89.35 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.276 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.71 -32.25 51.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.173 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.595 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 83.2 mmt-85 -90.16 1.67 56.17 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.575 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.76 -49.18 0.17 Allowed 'General case' 0 N--CA 1.465 0.305 0 O-C-N 124.169 0.918 . . . . 0.0 110.288 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.1 mt -46.54 154.21 0.31 Allowed 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 117.503 -1.237 . . . . 0.0 109.274 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.644 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.32 92.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 O-C-N 125.569 1.793 . . . . 0.0 110.431 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.53 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.59 143.51 42.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.123 0.487 . . . . 0.0 110.228 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 mt -132.37 27.18 4.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.769 0.319 . . . . 0.0 110.471 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.48 138.25 34.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.015 0.436 . . . . 0.0 110.495 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.1 mt -137.3 165.04 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.367 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.0 -28.57 1.85 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -153.16 70.93 7.01 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.13 0.49 . . . . 0.0 110.292 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.08 145.48 98.34 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.724 2.282 . . . . 0.0 112.075 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.7 t -134.05 136.37 43.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.05 -38.29 82.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.63 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.28 -42.03 96.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.53 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.4 98.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.523 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -63.74 -43.54 98.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.946 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.13 77.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.237 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.68 -18.6 60.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.427 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.6 -6.61 58.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.509 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.5 mtp 47.93 56.02 17.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.609 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.4 Cg_endo -70.23 149.09 63.35 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.834 2.356 . . . . 0.0 112.112 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -100.75 -74.11 0.62 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.564 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.436 HD11 HD13 ' A' ' 140' ' ' LEU . 38.1 tp -110.45 113.32 25.87 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.296 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.9 mt -101.78 126.38 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.508 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.1 mt -109.79 133.55 53.02 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.183 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.26 139.62 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.563 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.2 p -83.45 168.41 16.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.701 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.42 80.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.459 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.2 t -139.58 158.97 43.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.436 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.01 176.65 33.41 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.33 -33.82 87.34 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.48 151.57 44.43 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.881 0.372 . . . . 0.0 110.537 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.5 t -63.1 140.57 58.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.316 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.39 10.5 11.23 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.677 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.52 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.06 -38.97 88.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.049 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.99 -35.92 23.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.554 0.692 . . . . 0.0 110.645 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.9 mt -70.69 -35.65 72.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.495 0.664 . . . . 0.0 110.726 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -42.8 -62.93 0.88 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.375 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.74 -42.65 90.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.102 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -62.14 -32.97 73.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.209 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.5 mt -73.29 -40.95 64.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.038 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.42 -48.85 79.32 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.145 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.4 m -52.94 -42.32 65.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.247 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.11 -42.93 92.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.928 0.394 . . . . 0.0 111.043 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.53 154.37 5.55 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.621 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -39.63 107.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.621 2.214 . . . . 0.0 112.335 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.637 ' C ' HD12 ' A' ' 140' ' ' LEU . 93.8 m -110.09 121.13 44.54 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.255 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.637 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.88 152.74 30.31 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.223 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.6 tt -128.8 131.39 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.391 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.404 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.5 mt -115.13 127.75 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.469 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.9 t30 -101.52 103.23 14.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.243 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 147' ' ' LYS . 44.5 p90 -100.96 -11.09 20.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.812 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.5 p-10 -64.8 -33.56 76.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.703 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.7 p-10 -98.47 8.12 45.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.601 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.443 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.8 155.51 50.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.51 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.404 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.8 p -74.99 165.85 24.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.705 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.4 t90 -60.01 -48.8 80.22 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.246 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.5 -42.19 67.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.921 0.391 . . . . 0.0 110.103 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.7 t -62.54 -40.81 97.99 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.406 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.408 ' O ' HD23 ' A' ' 156' ' ' LEU . 46.3 tp -60.62 -43.91 96.93 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.282 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.505 HD22 HH21 ' A' ' 169' ' ' ARG . 44.8 tp -61.45 -43.25 99.2 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.111 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.5 m -55.01 -45.27 75.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.53 -40.67 97.52 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.855 0.359 . . . . 0.0 110.338 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.535 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.02 -42.37 99.09 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.302 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.07 -41.18 95.25 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.61 -46.03 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.952 0.406 . . . . 0.0 110.975 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.53 -44.05 96.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.887 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.8 p -93.31 -8.54 41.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.597 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.89 25.46 71.92 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -102.12 51.83 0.82 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.8 0.333 . . . . 0.0 110.699 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.76 -39.23 76.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.664 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.28 -46.94 87.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.173 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -61.36 -39.02 89.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.315 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.4 -40.46 97.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.311 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.62 69.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.018 0.437 . . . . 0.0 110.545 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.77 -53.61 8.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.158 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.505 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -64.11 -43.25 95.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.406 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.2 mt -62.98 -43.89 99.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.717 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.46 -61.38 2.57 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.128 0.489 . . . . 0.0 110.461 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.71 -35.11 63.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.451 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -79.6 -35.24 39.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.957 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.4 m-20 -56.29 -40.66 74.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.255 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.01 -42.37 99.81 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.684 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.64 -37.83 87.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.287 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 177' ' ' LEU . 81.7 mt -62.42 -42.16 99.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.736 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.05 -52.78 62.56 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.128 0.489 . . . . 0.0 110.694 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.46 -41.47 89.02 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.609 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.8 94.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.633 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.01 -32.53 73.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.43 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.03 -21.93 18.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.696 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.413 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.6 tt0 -65.11 -41.03 95.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.734 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -77.45 136.32 24.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.74 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.28 108.56 10.97 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.258 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.44 125.96 0.32 Allowed Pre-proline 0 C--O 1.24 0.555 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.529 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.1 Cg_exo -43.92 152.21 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.824 2.349 . . . . 0.0 112.533 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.26 142.12 54.16 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.678 2.252 . . . . 0.0 112.472 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.44 147.26 2.09 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.607 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.85 154.29 71.3 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.726 2.284 . . . . 0.0 112.293 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.12 162.99 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.452 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.578 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.83 170.57 15.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.948 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.77 137.84 21.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.0 110.166 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.549 HG22 HD12 ' A' ' 205' ' ' LEU . 40.0 pt -134.33 146.99 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.695 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.94 131.86 59.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.161 0.505 . . . . 0.0 110.468 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -152.22 155.45 37.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.363 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.616 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.6 m -123.05 123.23 40.39 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.939 0.4 . . . . 0.0 110.331 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.78 66.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.635 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.616 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.23 -49.28 19.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.1 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.89 -11.65 60.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.403 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.5 m80 48.84 41.98 19.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.485 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.9 t -136.16 143.48 44.49 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.363 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -109.86 114.18 27.53 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.29 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.94 133.63 55.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.05 0.452 . . . . 0.0 110.445 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.549 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.05 146.45 37.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.787 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.481 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.4 t90 -99.8 129.78 45.94 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.127 0.489 . . . . 0.0 109.939 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.54 153.82 39.41 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.281 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.417 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.0 Cg_endo -67.62 -18.37 48.39 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.72 2.28 . . . . 0.0 111.912 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -48.92 -18.28 0.27 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.401 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.481 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.4 p -76.2 165.35 25.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.499 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.35 -28.34 66.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.484 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.464 ' OE1' ' CD1' ' A' ' 297' ' ' PHE . 34.6 mt-30 -63.57 -41.13 98.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.617 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.31 -44.52 97.43 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.443 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.8 mt-30 -64.57 -39.05 93.05 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.886 0.374 . . . . 0.0 110.496 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.19 -41.31 98.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.107 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 70.5 mt -63.59 -47.05 83.03 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.588 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -54.63 -31.77 57.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.112 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.7 -18.38 62.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.539 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.0 mt -87.94 -9.1 54.62 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.609 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.27 2.34 54.14 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -88.59 153.43 21.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.359 . . . . 0.0 110.549 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.442 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.0 p -115.98 128.52 55.8 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.154 0.502 . . . . 0.0 110.307 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.4 145.88 24.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.944 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.474 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.66 151.59 45.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.503 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.17 131.72 42.5 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.385 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.887 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.73 93.36 28.19 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.063 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.677 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.5 Cg_exo -55.38 138.91 81.15 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.571 2.181 . . . . 0.0 111.539 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.78 -25.78 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.505 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.18 -50.16 29.42 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.562 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.7 mt -54.48 -37.11 64.86 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.18 35.89 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.898 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.562 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.3 88.24 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.909 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.3 p -81.68 -13.91 57.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.323 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.64 -41.45 10.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.577 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.4 t -67.02 -16.66 64.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.649 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.95 43.81 26.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.461 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 180.0 -148.5 8.0 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.55 143.02 48.82 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.001 0.429 . . . . 0.0 110.313 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -151.95 149.48 28.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.273 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -101.14 -151.86 0.42 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.33 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.06 -91.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.664 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.459 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.8 tt -127.08 175.29 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.545 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.459 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.1 mt -122.17 141.63 41.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.84 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.55 169.13 9.51 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.207 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.3 mt -147.69 150.72 34.87 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.241 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.67 -39.01 97.08 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.21 4.07 4.63 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.49 -57.98 3.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.949 0.404 . . . . 0.0 110.566 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.546 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.1 m-20 -62.25 -36.27 81.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.326 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.52 -67.72 0.23 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.735 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.4 -42.29 66.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.241 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.06 17.85 0.16 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.681 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.76 48.59 0.26 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.62 -109.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.59 0.233 . . . . 0.0 110.728 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.474 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -61.08 -44.57 97.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.406 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.25 8.15 84.01 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -99.2 -13.05 19.9 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.75 -0.265 . . . . 0.0 110.69 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.3 t 176.79 142.34 0.08 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.112 0.482 . . . . 0.0 110.454 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.423 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.9 125.4 11.69 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.165 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.434 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.67 143.02 29.51 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 120.894 0.378 . . . . 0.0 110.775 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.9 mt -94.15 106.29 18.27 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.664 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.441 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.3 t80 -101.48 -11.88 18.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.129 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.3 87.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.84 174.14 46.32 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.451 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -74.41 -113.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.799 0.333 . . . . 0.0 110.786 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.45 -28.61 68.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.702 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.1 -44.1 91.91 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.172 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.89 -44.02 94.28 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.383 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.81 -60.27 3.47 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.233 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.15 -43.39 61.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.13 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.57 75.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.139 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.7 mt -64.45 -43.67 96.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.657 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -56.46 -37.5 70.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.139 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.82 0.91 18.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.223 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -114.9 91.35 26.04 Favored Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.164 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.2 -27.19 29.11 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.802 2.335 . . . . 0.0 111.786 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.36 -41.25 98.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.545 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.15 4.99 53.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.343 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.75 -35.16 70.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.719 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.83 4.73 15.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.558 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.89 121.32 81.04 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.6 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -47.58 -37.44 26.68 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.411 2.074 . . . . 0.0 112.523 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -59.12 -43.73 91.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.777 0.323 . . . . 0.0 110.244 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.89 -43.79 92.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.33 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -64.81 -40.65 95.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.424 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.8 t-20 -89.54 -12.78 38.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.588 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.8 mtmt 62.11 32.27 17.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.96 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -89.07 43.87 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.072 0.463 . . . . 0.0 110.352 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.44 135.85 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.453 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -116.53 132.45 56.68 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.44 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.503 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.79 87.22 7.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.751 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.04 -40.77 97.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.441 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.58 169.35 35.54 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 72.4 p -76.35 -25.78 55.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.819 0.343 . . . . 0.0 110.699 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.7 tp10 -67.24 -34.82 78.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.398 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.763 HG22 ' O ' ' A' ' 296' ' ' THR . 93.2 m -73.59 25.01 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.758 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.495 ' H ' ' C ' ' A' ' 295' ' ' GLU . 64.2 t80 -58.27 -51.25 70.55 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.418 HH12 ' HG3' ' A' ' 212' ' ' GLN . 61.2 mmt-85 -112.16 154.96 24.72 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.417 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.3 tp -115.54 124.4 50.95 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.494 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.9 t0 -147.42 165.58 29.81 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.583 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -49.0 -38.51 23.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.624 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -71.5 -65.37 0.76 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.523 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.73 -32.87 72.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.082 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.64 -25.29 25.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.697 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.7 mtt -63.35 -41.0 98.83 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 120.894 0.378 . . . . 0.0 111.018 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.34 -43.99 22.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.987 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.564 HG21 HG23 ' A' ' 296' ' ' THR . 75.1 t -65.81 -43.22 93.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.398 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 56.5 tp -60.65 -47.28 86.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.494 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -69.39 -39.64 77.87 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.725 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.503 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.2 ttt180 -62.13 -38.39 88.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.207 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.2 mt -86.86 3.88 43.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.84 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.4 tttt -112.57 -11.29 13.6 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.064 0.459 . . . . 0.0 110.315 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.07 -37.0 85.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.515 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.01 -48.74 80.4 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.414 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.09 179.829 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.618 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.15 -2.05 58.02 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.369 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.484 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.08 179.04 1.24 Allowed Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.499 -179.625 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.0 Cg_exo -61.04 145.2 99.33 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.769 2.313 . . . . 0.0 112.226 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.618 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.4 ptt-85 -156.41 -178.95 7.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.601 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.91 136.68 52.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.281 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -123.97 146.68 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.378 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.8 p -119.8 135.94 54.66 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.736 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.41 -143.53 0.33 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.295 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -63.28 -37.06 85.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.598 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.88 -65.56 0.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.518 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.84 141.95 46.47 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 p -112.02 131.19 55.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.922 0.392 . . . . 0.0 110.36 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -119.08 128.87 54.73 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.51 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.1 m -85.45 130.13 34.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.201 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.0 mt -96.03 78.67 3.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.432 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.52 -31.69 72.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.466 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.28 109.98 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.172 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -122.99 91.35 49.91 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.196 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.645 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.9 Cg_exo -57.01 148.99 64.96 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.756 2.304 . . . . 0.0 111.784 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.79 82.89 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 O-C-N 123.603 0.564 . . . . 0.0 110.928 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.645 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.28 67.09 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.289 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.1 130.69 35.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.549 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.554 ' HA ' HG23 ' A' ' 64' ' ' VAL . 56.5 t -122.79 146.51 27.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.124 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.4 t -136.04 144.16 45.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.63 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 p -100.48 -58.87 1.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.564 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.2 p -79.43 154.78 28.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.598 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.547 HG21 HG23 ' A' ' 70' ' ' THR . 72.8 t -74.07 -21.81 18.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.629 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 94.7 m -60.31 -52.1 66.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.474 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.3 mt -66.5 -42.2 87.74 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.347 0.594 . . . . 0.0 111.003 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.2 m -43.32 -54.06 4.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.143 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.26 -37.84 71.42 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.7 m -62.28 -44.5 96.37 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.956 0.407 . . . . 0.0 110.645 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.9 mt -66.2 -42.18 89.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.459 0.647 . . . . 0.0 110.737 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.63 -40.25 96.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.371 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.464 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.21 -36.03 76.76 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.914 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.535 HD11 HD12 ' A' ' 156' ' ' LEU . 31.6 pt -91.2 28.89 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.042 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.6 51.63 10.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.777 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.0 75.34 24.23 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.949 0.404 . . . . 0.0 109.998 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.44 151.57 85.0 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.743 2.295 . . . . 0.0 112.246 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.554 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.77 137.37 47.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.181 0.515 . . . . 0.0 110.245 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.4 pt -69.34 -43.61 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.163 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.482 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.9 130.87 53.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.915 0.388 . . . . 0.0 110.544 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.53 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.0 p -155.64 168.98 25.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.456 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.98 -177.04 21.58 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.627 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.58 172.65 12.46 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 120.934 0.397 . . . . 0.0 110.513 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.547 HG23 HG21 ' A' ' 51' ' ' VAL . 13.6 p -132.68 -112.49 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.276 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.41 179.84 0.91 Allowed Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.326 -179.115 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.3 Cg_exo -60.93 57.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 123.054 2.503 . . . . 0.0 112.214 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.1 t-20 -64.41 -33.82 76.75 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.487 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.5 m120 93.85 -36.09 0.02 OUTLIER 'General case' 0 C--N 1.346 0.435 0 O-C-N 124.08 0.862 . . . . 0.0 109.966 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.405 ' HD3' HD21 ' A' ' 73' ' ' ASN . 77.9 mtp85 -63.1 -39.39 94.55 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.218 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 77' ' ' ALA . 15.0 p -74.71 -25.29 18.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.692 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.35 -171.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.588 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.7 p30 -74.08 -153.66 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.765 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.0 p-10 -52.77 -7.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.639 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.508 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.37 115.06 23.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.582 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.85 69.69 1.36 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -142.96 147.53 35.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.958 0.409 . . . . 0.0 110.704 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.29 -98.4 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.313 178.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.548 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.4 -42.5 96.06 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.108 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.548 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.2 tt0 91.69 53.05 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.075 0.859 . . . . 0.0 110.79 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.24 -9.09 19.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.466 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.0 p -64.64 -34.04 77.35 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.118 0.485 . . . . 0.0 110.653 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.66 -23.9 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.553 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.53 -46.02 76.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.881 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.24 -48.49 81.24 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.073 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.68 -38.09 89.0 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.357 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.68 -32.58 52.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.248 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.594 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.1 mmt-85 -89.69 1.67 55.75 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.695 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 56.9 mttp 82.69 -49.05 0.17 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 124.115 0.885 . . . . 0.0 110.31 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.649 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.71 154.79 0.29 Allowed 'General case' 0 CA--C 1.49 -1.327 0 CA-C-O 117.592 -1.194 . . . . 0.0 109.253 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.649 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 120.85 92.47 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 O-C-N 125.462 1.726 . . . . 0.0 110.542 -178.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.53 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.39 143.44 42.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.108 0.48 . . . . 0.0 110.244 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.4 mt -132.4 26.95 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.0 110.47 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.52 138.15 34.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.441 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.4 mt -137.31 165.01 28.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.391 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.15 -28.8 1.82 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.408 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -152.18 70.13 7.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.201 0.524 . . . . 0.0 110.348 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.03 145.44 98.39 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 122.663 2.242 . . . . 0.0 112.126 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.0 t -134.81 137.35 43.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.521 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.22 -38.07 81.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.716 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.27 -42.29 96.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.547 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.52 98.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.558 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.2 t -63.58 -43.41 98.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.057 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.13 77.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.294 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.52 -18.62 59.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.463 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.58 -6.62 58.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.576 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 64.3 mtp 48.17 55.87 17.34 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.609 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.37 149.23 62.66 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.716 2.277 . . . . 0.0 112.111 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.13 -73.21 0.65 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.468 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.426 HD11 HD13 ' A' ' 140' ' ' LEU . 38.0 tp -111.02 112.65 24.62 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.44 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.8 mt -101.11 126.06 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.469 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.6 mt -109.59 133.64 52.87 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.294 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -121.01 140.17 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.472 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.6 p -83.5 168.68 16.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.64 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.43 80.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.433 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.1 t -140.15 159.09 42.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.963 0.411 . . . . 0.0 110.416 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.3 177.66 33.2 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.26 -33.79 87.15 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -124.84 151.72 44.9 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.904 0.383 . . . . 0.0 110.567 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.2 t -63.36 141.2 58.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.355 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.74 10.67 11.02 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.577 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.31 -39.07 89.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.071 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.634 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.9 -35.72 23.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.516 0.675 . . . . 0.0 110.709 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.5 mt -71.0 -35.42 72.06 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.473 0.654 . . . . 0.0 110.727 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -42.74 -63.19 0.82 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.132 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.634 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.83 -42.64 90.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -61.99 -32.91 73.42 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.424 0.453 . . . . 0.0 110.17 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.9 mt -73.8 -40.24 63.53 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.22 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.17 -49.13 78.08 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.15 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 78.9 m -52.36 -42.74 64.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.314 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.37 -43.26 94.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.141 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.99 154.85 5.3 Favored Pre-proline 0 N--CA 1.453 -0.285 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.646 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -39.19 106.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.696 2.264 . . . . 0.0 112.356 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.643 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.4 m -110.09 121.5 45.41 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.169 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.26 152.93 30.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.257 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -129.01 129.11 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.382 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.4 mt -112.54 127.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.498 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.11 103.34 14.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.3 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 147' ' ' LYS . 44.0 p90 -101.04 -11.17 19.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.703 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.2 p-10 -64.72 -33.77 76.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.619 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.7 p-10 -98.27 8.1 45.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.597 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.83 155.62 50.05 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.499 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.1 165.91 24.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.594 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.09 -48.62 80.94 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.22 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.76 -42.03 67.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.992 0.425 . . . . 0.0 110.084 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.0 t -62.63 -40.63 97.58 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.435 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.406 ' CD1' HG21 ' A' ' 142' ' ' ILE . 45.9 tp -60.62 -43.88 96.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.417 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.514 HD22 HH21 ' A' ' 169' ' ' ARG . 43.9 tp -61.45 -43.19 99.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.188 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.2 m -54.94 -45.17 74.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.806 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.5 -40.72 97.62 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-O 120.889 0.376 . . . . 0.0 110.381 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.535 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.95 -42.33 98.99 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.249 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.05 -41.03 95.36 Favored Glycine 0 C--N 1.316 -0.533 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.85 -46.0 63.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.94 0.4 . . . . 0.0 110.807 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.61 -44.03 96.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.741 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.6 p -93.27 -8.64 41.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.546 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.8 25.16 71.71 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -102.15 52.49 0.81 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.72 0.295 . . . . 0.0 110.593 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -70.04 -39.11 75.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.696 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.16 -47.01 86.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.165 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -61.38 -38.91 88.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.434 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.38 97.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.413 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.45 -27.67 69.15 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.537 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.82 -53.77 8.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.17 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.514 HH21 HD22 ' A' ' 153' ' ' LEU . 61.8 ttp180 -63.55 -43.56 96.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.448 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 174' ' ' ASP . 85.7 mt -63.01 -43.78 99.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.658 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.08 -61.65 2.42 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.112 0.482 . . . . 0.0 110.383 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.54 -35.09 62.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.425 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.411 ' CD2' HD11 ' A' ' 177' ' ' LEU . 23.3 t80 -79.6 -35.05 40.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.891 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.3 m-20 -56.68 -40.43 75.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.96 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.94 -42.61 99.86 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.769 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.85 -37.52 86.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.303 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.411 HD11 ' CD2' ' A' ' 173' ' ' PHE . 80.9 mt -62.26 -42.36 99.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.702 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -53.0 61.77 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.168 0.509 . . . . 0.0 110.645 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.25 -41.69 89.6 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.597 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.31 -39.68 94.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.5 -32.36 73.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.302 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.93 -22.12 18.79 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.647 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.41 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -65.22 -40.91 94.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.632 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.1 pt -78.45 136.45 23.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.568 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.53 109.45 11.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.277 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.48 125.8 0.32 Allowed Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.518 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.4 Cg_exo -43.92 152.29 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.713 2.276 . . . . 0.0 112.598 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.16 142.0 54.28 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.612 2.208 . . . . 0.0 112.461 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.37 147.4 2.14 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.602 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.15 154.74 69.67 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.805 2.337 . . . . 0.0 112.296 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.27 163.23 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.405 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -144.1 170.41 16.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.793 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.83 137.89 21.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.017 0.437 . . . . 0.0 110.226 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.543 HG22 HD12 ' A' ' 205' ' ' LEU . 38.9 pt -134.44 146.72 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.574 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.98 131.73 58.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.128 0.49 . . . . 0.0 110.474 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -151.92 154.89 36.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.357 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.2 m -122.08 122.62 39.68 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.961 0.41 . . . . 0.0 110.371 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.32 -25.98 66.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.613 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.72 -49.02 22.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.007 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.38 -11.04 60.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.285 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.8 m80 48.6 42.47 19.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.452 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.6 t -136.43 145.7 45.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.386 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.41 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -111.44 114.18 27.12 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.311 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.72 133.32 55.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.08 0.467 . . . . 0.0 110.343 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.543 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.13 146.43 38.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.671 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.519 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 10.9 t90 -99.77 130.23 45.96 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.104 0.478 . . . . 0.0 110.148 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.65 153.88 39.31 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.133 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.412 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.2 Cg_endo -67.76 -18.05 47.51 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.663 2.242 . . . . 0.0 111.95 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -48.99 -18.57 0.3 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.405 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.519 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.96 165.11 25.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.543 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.22 -28.04 66.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.516 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.464 ' OE1' ' CD1' ' A' ' 297' ' ' PHE . 34.9 mt-30 -63.76 -41.21 98.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.669 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.12 -44.75 97.02 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.8 mt-30 -64.6 -38.71 91.94 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 120.99 0.424 . . . . 0.0 110.649 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.14 -41.15 98.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.11 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.81 -46.74 83.76 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.644 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.59 -31.73 57.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.089 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.88 -18.12 62.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.57 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.418 HD11 ' CD2' ' A' ' 299' ' ' LEU . 89.0 mt -88.25 -8.49 55.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.612 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.39 2.05 55.61 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -88.41 153.36 21.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.512 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.46 ' O ' HG12 ' A' ' 191' ' ' VAL . 7.9 p -116.09 128.72 55.91 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.055 0.455 . . . . 0.0 110.308 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.571 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.62 145.97 24.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.802 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.469 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.68 151.5 45.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.534 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.72 131.53 43.12 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.526 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.893 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.55 93.22 26.67 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.049 -179.689 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.679 ' C ' ' H ' ' A' ' 229' ' ' GLY . 47.6 Cg_exo -55.59 139.25 82.59 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.56 2.173 . . . . 0.0 111.612 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.04 -25.64 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.459 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.54 -49.78 29.2 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.8 mt -53.87 -37.01 63.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 0.0 110.197 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.92 36.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.777 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.85 86.85 0.01 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.861 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.3 p -79.42 -15.17 58.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.411 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.38 -41.12 10.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.616 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.8 t -66.06 -17.78 64.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.65 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.25 43.22 26.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.508 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.48 -147.27 7.21 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.96 143.01 50.19 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.955 0.407 . . . . 0.0 110.323 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -152.51 149.85 28.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.391 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -100.95 -151.75 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.398 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 66.9 t0 55.99 -91.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.555 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.459 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.96 175.25 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.54 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.459 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 93.0 mt -122.3 141.73 41.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.693 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.77 168.97 9.57 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.244 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.3 mt -147.73 150.9 35.16 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.154 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.53 -39.21 97.4 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.32 4.01 4.6 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.28 -58.06 3.49 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.011 0.434 . . . . 0.0 110.636 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.551 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.2 m-20 -62.2 -37.04 83.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.271 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.41 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.1 mp -52.14 -67.69 0.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.784 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.43 -42.07 66.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.145 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.16 17.96 0.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.724 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.92 48.13 0.26 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.83 -109.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.663 0.268 . . . . 0.0 110.675 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.469 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.71 -44.87 96.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.502 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.26 8.13 84.03 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -99.02 -13.19 19.98 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.672 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.6 t 176.8 142.45 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.079 0.466 . . . . 0.0 110.423 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.93 125.42 11.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.983 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.433 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -98.57 142.94 29.53 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 120.877 0.37 . . . . 0.0 110.88 177.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.9 mt -93.88 106.26 18.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.655 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.429 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.2 t80 -101.48 -12.27 18.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.215 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.4 -40.62 89.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.833 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.43 173.73 46.09 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.448 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -74.09 -112.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.811 0.339 . . . . 0.0 110.683 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.88 -28.74 67.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.689 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -58.85 -43.95 90.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.371 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.8 -44.32 93.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.357 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.48 -60.17 3.56 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.247 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.31 -43.55 61.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.084 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.16 -43.6 74.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.229 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.4 mt -64.62 -43.63 96.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.597 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -56.23 -37.48 69.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.211 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.87 1.25 18.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.277 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -114.94 91.33 26.13 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.213 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.31 -27.25 30.1 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.753 2.302 . . . . 0.0 111.841 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.38 -41.17 98.77 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.591 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.592 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.9 mp -95.07 5.12 52.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.362 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.87 -35.13 69.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.713 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.53 4.52 15.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.52 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.91 120.91 79.38 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.61 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -47.41 -37.43 25.4 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.478 2.119 . . . . 0.0 112.493 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -59.01 -43.84 91.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.758 0.313 . . . . 0.0 110.356 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.96 -43.7 92.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.344 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.81 -40.7 95.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.445 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.9 t-20 -89.42 -12.86 39.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.625 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.7 mtmt 62.18 32.36 17.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -89.15 43.87 1.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.074 0.464 . . . . 0.0 110.353 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.51 135.89 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.448 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.78 132.37 56.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.491 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.504 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.67 87.49 7.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.674 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.02 -40.69 96.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.971 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.429 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.72 168.85 35.0 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 77.8 p -76.13 -25.89 55.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 0.0 110.698 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.1 tp10 -67.27 -34.6 77.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.524 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.766 HG22 ' O ' ' A' ' 296' ' ' THR . 95.7 m -73.66 25.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.601 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.497 ' H ' ' C ' ' A' ' 295' ' ' GLU . 61.8 t80 -58.13 -51.13 70.99 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.402 HH12 ' HG3' ' A' ' 212' ' ' GLN . 64.4 mmt-85 -112.3 155.13 24.6 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.418 ' CD2' HD11 ' A' ' 219' ' ' LEU . 45.2 tp -115.88 124.77 51.48 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.766 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.49 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.7 t0 -147.79 165.79 29.5 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -49.13 -38.55 25.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.579 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -71.53 -65.31 0.77 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.267 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -60.79 -32.75 72.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.913 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.88 -25.19 27.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.549 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.1 mtt -63.08 -41.42 99.43 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.88 0.371 . . . . 0.0 110.857 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.18 -43.85 23.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.997 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.56 HG21 HG23 ' A' ' 296' ' ' THR . 76.6 t -66.04 -43.18 92.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.414 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 56.0 tp -60.55 -47.04 87.92 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.549 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -69.84 -39.85 76.18 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.546 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.504 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.3 ttt180 -62.06 -37.97 87.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.133 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.3 mt -87.19 4.32 42.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.795 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -112.59 -11.51 13.56 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.042 0.448 . . . . 0.0 110.263 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.9 84.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.66 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.02 -48.78 80.2 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.332 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.898 -1.048 . . . . 0.0 110.097 179.941 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.47 -2.1 57.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.298 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.94 179.09 1.23 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.991 0.424 . . . . 0.0 110.481 -179.65 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.6 Cg_exo -60.95 144.91 99.68 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.814 2.343 . . . . 0.0 112.149 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.96 -179.3 8.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.597 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.68 136.66 52.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.388 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.36 147.11 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.297 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.8 p -120.18 135.99 54.78 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.41 -143.38 0.32 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.233 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -63.52 -37.13 86.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.549 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.477 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.54 -66.12 0.22 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.546 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.48 141.99 45.68 Favored Glycine 0 CA--C 1.519 0.309 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.4 p -112.19 131.23 55.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.939 0.4 . . . . 0.0 110.4 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.21 128.9 54.65 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.532 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -85.49 130.3 34.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.227 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.453 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.0 mt -95.74 78.86 3.3 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.287 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.28 -32.31 73.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.55 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 175.88 110.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.075 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.453 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.5 pt20 -123.05 91.7 49.66 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.322 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.645 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.1 Cg_exo -56.95 148.82 65.44 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.769 2.313 . . . . 0.0 111.864 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.42 82.78 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 O-C-N 123.59 0.557 . . . . 0.0 111.017 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.645 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.45 67.07 0.89 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.133 0.492 . . . . 0.0 110.183 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.17 130.78 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.709 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.557 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.1 t -122.85 146.59 27.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.034 0.445 . . . . 0.0 110.015 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -136.38 143.91 44.28 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.693 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.1 p -99.31 -59.5 1.71 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.647 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.0 p -78.95 155.61 28.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.706 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 70' ' ' THR . 71.4 t -74.65 -21.84 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.55 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 94.7 m -60.36 -51.88 67.63 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.459 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.5 mt -66.3 -42.62 88.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.207 0.527 . . . . 0.0 110.85 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.15 -53.9 4.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.005 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.39 -38.12 70.24 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.7 m -62.21 -44.55 96.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 110.203 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.418 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.3 mt -66.27 -42.03 89.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.443 0.64 . . . . 0.0 110.756 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.59 -40.12 95.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.495 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.471 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.97 -35.91 76.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.183 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.537 HD11 HD12 ' A' ' 156' ' ' LEU . 32.7 pt -91.2 28.69 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.295 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.58 51.52 11.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.98 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.74 75.52 25.38 Favored Pre-proline 0 C--N 1.331 -0.208 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.34 151.15 86.64 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.793 2.328 . . . . 0.0 112.199 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.59 137.26 47.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.223 0.535 . . . . 0.0 110.208 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.447 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.0 pt -69.21 -43.65 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.326 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.483 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.02 131.07 53.46 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.964 0.411 . . . . 0.0 110.564 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.526 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.4 p -155.68 168.72 26.25 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.501 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.96 -176.97 21.59 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.627 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.37 172.54 12.56 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 121.01 0.433 . . . . 0.0 110.44 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.493 HG23 HG21 ' A' ' 51' ' ' VAL . 12.9 p -133.13 -111.84 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 110.349 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.49 179.68 0.94 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.348 -179.143 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.7 Cg_exo -61.34 57.89 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.975 2.45 . . . . 0.0 112.094 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.5 t-20 -64.19 -34.13 77.37 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 118.894 -0.574 . . . . 0.0 110.398 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.9 m120 94.06 -36.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.103 0.877 . . . . 0.0 109.838 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -62.9 -39.84 95.73 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.179 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.49 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -74.27 -25.71 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.758 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.68 -171.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.575 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.26 -153.68 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.864 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.0 p-10 -52.72 -7.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.677 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.25 114.6 23.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.618 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.61 70.36 1.34 Allowed Glycine 0 C--O 1.225 -0.428 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -143.18 147.93 35.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.824 0.345 . . . . 0.0 110.961 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -85.94 -98.4 0.07 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.995 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.1 mtt-85 -64.28 -42.69 96.3 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.08 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.1 tt0 91.49 53.43 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.057 0.848 . . . . 0.0 110.954 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.38 -9.1 19.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.391 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.2 p -64.71 -33.99 77.27 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.165 0.507 . . . . 0.0 110.681 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.85 -24.27 1.39 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.59 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.4 t -69.13 -46.11 78.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.936 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.21 -48.49 81.26 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.964 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.69 -38.17 89.35 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.302 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.82 -32.28 52.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.095 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.593 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.7 mmt-85 -90.04 1.82 55.89 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.585 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.6 -49.34 0.18 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 124.102 0.876 . . . . 0.0 110.192 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.638 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.5 mt -46.42 154.88 0.25 Allowed 'General case' 0 CA--C 1.49 -1.345 0 CA-C-O 117.365 -1.302 . . . . 0.0 109.275 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.638 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 120.76 92.48 0.0 OUTLIER 'General case' 0 C--N 1.354 0.764 0 O-C-N 125.699 1.875 . . . . 0.0 110.464 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.526 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.34 143.54 42.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.098 0.475 . . . . 0.0 110.311 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.5 mt -132.52 27.2 4.4 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.147 -0.346 . . . . 0.0 110.428 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -140.6 138.46 34.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.015 0.436 . . . . 0.0 110.542 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.5 mt -137.37 164.99 28.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.418 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.34 -28.71 1.8 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -153.23 70.87 6.95 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.166 0.508 . . . . 0.0 110.288 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.22 145.58 98.22 Favored 'Trans proline' 0 C--N 1.301 -1.936 0 C-N-CA 122.719 2.279 . . . . 0.0 112.108 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.4 t -133.99 136.55 44.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.481 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.38 83.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.683 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.38 -42.17 96.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.52 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.53 98.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.581 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.6 t -63.68 -43.45 98.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.925 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.81 -35.12 77.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.233 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.55 -18.61 59.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.38 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -86.67 -6.85 58.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.562 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.409 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.6 mtp 48.1 56.09 17.47 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.627 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.0 Cg_endo -70.12 149.23 64.28 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.766 2.31 . . . . 0.0 112.122 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.04 -73.47 0.64 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.43 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 140' ' ' LEU . 38.4 tp -111.03 112.84 24.94 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.26 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.1 mt -101.13 126.19 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.556 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.5 mt -109.58 133.42 53.12 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.198 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.46 139.7 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.506 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 94.4 p -83.42 168.42 16.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.692 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.12 -37.41 79.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.402 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.2 t -139.38 159.07 43.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.932 0.396 . . . . 0.0 110.475 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.07 176.33 33.55 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.13 -33.84 87.14 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.7 151.53 44.88 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 110.523 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.9 t -63.06 140.82 58.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.359 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.7 10.44 11.0 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.607 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.08 -39.13 88.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.099 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.68 -35.86 24.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.59 0.709 . . . . 0.0 110.721 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.2 mt -70.8 -35.62 72.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.642 0.734 . . . . 0.0 110.738 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -42.84 -62.71 0.94 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.408 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.64 -42.66 91.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -62.1 -33.02 73.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.301 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.1 mt -73.3 -40.77 64.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.145 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.8 t -58.53 -48.58 80.36 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.013 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.8 m -52.9 -42.35 65.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.302 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.15 -43.03 92.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.082 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.4 154.15 5.58 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.659 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -39.37 107.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.639 2.226 . . . . 0.0 112.422 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.635 ' C ' HD12 ' A' ' 140' ' ' LEU . 93.8 m -110.13 120.88 43.85 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.037 0.446 . . . . 0.0 110.238 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.62 152.78 29.89 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.292 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.421 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.7 tt -128.75 131.04 68.82 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.268 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.81 127.79 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.504 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.9 t30 -101.79 103.53 14.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.302 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 147' ' ' LYS . 45.3 p90 -101.05 -11.29 19.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.862 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.74 -33.73 76.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.671 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -98.29 7.86 45.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.548 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.6 155.54 50.29 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.538 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.404 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.07 165.8 24.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.715 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.05 -48.69 80.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.152 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -53.7 -42.2 67.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.002 0.429 . . . . 0.0 110.063 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.2 t -62.49 -40.89 98.15 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.362 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.41 ' O ' HD23 ' A' ' 156' ' ' LEU . 47.4 tp -60.59 -43.95 96.79 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.261 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.501 HD22 HH21 ' A' ' 169' ' ' ARG . 45.0 tp -61.27 -43.43 98.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.139 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 m -55.03 -45.37 75.17 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.59 -40.58 97.36 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.891 0.377 . . . . 0.0 110.446 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.537 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.97 -42.29 98.96 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.343 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.19 -40.89 95.05 Favored Glycine 0 C--N 1.315 -0.587 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.72 -45.91 64.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.0 mt -64.61 -44.0 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.794 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.6 p -93.35 -8.56 41.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.587 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.85 25.37 71.85 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -102.06 52.26 0.82 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.769 0.319 . . . . 0.0 110.663 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.87 -39.23 76.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.575 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.15 -46.95 87.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.243 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -61.41 -39.12 89.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.35 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.27 -40.32 97.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.257 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.49 -27.51 69.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.545 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.95 -53.81 8.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.059 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.501 HH21 HD22 ' A' ' 153' ' ' LEU . 61.8 ttp180 -63.88 -43.24 96.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.47 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.9 mt -63.07 -43.86 99.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.726 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.18 -61.52 2.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.146 0.498 . . . . 0.0 110.403 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.65 -35.32 63.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.466 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.422 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.4 t80 -79.21 -35.19 42.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.963 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.1 m-20 -56.98 -40.1 75.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.146 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.08 -42.64 99.68 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.828 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.74 -37.76 87.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.285 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.422 HD11 ' CD2' ' A' ' 173' ' ' PHE . 80.4 mt -62.29 -42.33 99.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.715 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.07 -52.76 62.61 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.073 0.463 . . . . 0.0 110.639 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.41 -41.56 89.1 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.624 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.33 -39.65 94.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.671 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.29 -32.49 73.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.306 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.95 -21.99 18.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.657 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.411 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.7 tt0 -65.02 -40.9 95.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.726 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.8 pt -78.1 136.47 24.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.727 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.37 109.31 11.65 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.214 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.8 125.66 0.3 Allowed Pre-proline 0 C--O 1.242 0.666 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.495 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.4 Cg_exo -43.88 152.36 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.786 2.324 . . . . 0.0 112.618 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.13 142.29 55.41 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.554 2.17 . . . . 0.0 112.504 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.3 147.07 2.11 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.626 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.91 154.6 70.64 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.75 2.3 . . . . 0.0 112.307 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.29 163.2 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.487 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -144.02 170.35 16.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.889 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.01 137.65 22.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.253 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.54 HG22 HD12 ' A' ' 205' ' ' LEU . 38.9 pt -134.37 146.75 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.65 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.46 132.26 57.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.168 0.509 . . . . 0.0 110.497 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -152.12 155.15 37.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.439 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.8 m -122.34 123.06 40.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.957 0.408 . . . . 0.0 110.364 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.51 -25.76 66.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.631 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.614 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.12 -49.18 20.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.084 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.12 -12.18 60.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.413 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.4 m80 49.47 41.95 21.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.496 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.1 t -135.97 144.76 45.57 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.328 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.5 113.97 27.02 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.258 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.474 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.8 133.33 55.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.039 0.447 . . . . 0.0 110.362 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.54 HD12 HG22 ' A' ' 194' ' ' ILE . 7.5 tt -111.92 146.32 37.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.483 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 12.5 t90 -99.11 129.74 45.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.175 0.512 . . . . 0.0 109.932 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.74 153.87 39.25 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.294 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.2 Cg_endo -67.59 -18.15 48.47 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.671 2.247 . . . . 0.0 111.957 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.37 -18.83 0.43 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.36 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.483 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.9 p -75.39 164.59 26.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.536 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.99 -27.84 65.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.559 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.471 ' OE1' ' CD1' ' A' ' 297' ' ' PHE . 34.9 mt-30 -63.99 -41.0 97.63 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.589 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.26 -44.54 97.36 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.6 mt-30 -64.59 -38.71 91.96 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.022 0.439 . . . . 0.0 110.557 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.2 mmm -62.18 -41.21 98.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.103 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.3 mt -63.7 -47.09 82.58 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.525 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.27 -31.84 54.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.355 . . . . 0.0 110.193 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.02 -18.32 62.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.472 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.422 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.5 mt -87.94 -8.67 55.38 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.626 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.57 2.13 55.42 Favored Glycine 0 N--CA 1.464 0.503 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -88.4 153.29 21.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.939 0.4 . . . . 0.0 110.464 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.448 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.3 p -115.93 128.7 55.97 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.143 0.497 . . . . 0.0 110.334 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.567 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.71 145.89 24.07 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.948 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.474 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.46 151.49 46.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.423 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.65 131.59 43.3 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.461 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.89 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.7 93.29 27.74 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.062 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.678 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.5 Cg_exo -55.52 139.13 82.15 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.556 2.171 . . . . 0.0 111.58 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.76 -25.69 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.477 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.13 -50.07 30.2 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.552 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.7 mt -54.17 -36.93 63.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.68 35.99 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.819 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.08 88.31 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.003 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 79.5 p -81.23 -14.15 57.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.31 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.8 -41.57 10.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.685 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.1 t -66.7 -16.92 64.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.647 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 55.94 43.76 26.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.439 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.74 -148.45 7.9 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.91 142.94 49.24 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.0 0.428 . . . . 0.0 110.327 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.14 149.56 28.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.278 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -101.19 -151.85 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.297 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.12 -92.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.624 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.463 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.67 175.24 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.596 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.463 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.5 mt -122.37 141.62 42.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.56 169.05 9.56 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.264 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.0 mt -147.63 150.86 35.21 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.224 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.69 -38.98 97.03 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.18 3.87 4.7 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -77.18 -58.04 3.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.958 0.409 . . . . 0.0 110.631 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.547 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.1 m-20 -62.25 -36.85 83.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.249 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.24 -67.74 0.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.67 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.68 -42.08 67.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.135 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.97 17.8 0.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.644 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.88 48.5 0.27 Allowed Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.45 -109.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.596 0.236 . . . . 0.0 110.754 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.474 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 12.0 m120 -61.12 -44.65 97.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.469 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.31 8.05 84.06 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -98.93 -13.25 20.07 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.668 -0.313 . . . . 0.0 110.697 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.8 t 176.96 142.53 0.08 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.087 0.47 . . . . 0.0 110.434 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -147.84 125.62 11.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.191 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.433 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -98.68 143.15 29.37 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 120.899 0.381 . . . . 0.0 110.778 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.1 mt -94.44 106.3 18.28 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.672 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.435 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.58 -11.69 19.05 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.171 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.14 -40.66 86.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.27 173.69 46.1 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.442 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.5 m-20 -74.02 -112.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.352 . . . . 0.0 110.856 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.76 -28.75 67.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.731 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.11 -44.01 91.95 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.147 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.68 -44.2 94.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.308 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.72 -59.93 3.88 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.201 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.32 -43.58 61.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.982 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.32 -43.63 75.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.181 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.7 mt -64.57 -43.62 96.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.581 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.4 -37.51 70.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.113 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.92 1.24 18.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.179 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -114.73 91.46 25.72 Favored Pre-proline 0 CA--C 1.528 0.11 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.179 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.33 -27.32 30.54 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.801 2.334 . . . . 0.0 111.811 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.42 -41.14 98.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.575 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.593 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.9 mp -95.14 5.04 52.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.346 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.58 -35.08 70.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.645 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.99 4.43 17.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.512 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.73 120.9 78.88 Favored Pre-proline 0 N--CA 1.441 -0.884 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.512 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.37 -37.47 25.19 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.41 2.074 . . . . 0.0 112.635 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.529 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -59.02 -43.65 91.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.75 0.31 . . . . 0.0 110.352 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.99 -43.75 92.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.301 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.89 -40.64 95.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.422 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.8 t-20 -89.51 -12.86 38.79 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.516 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.23 32.08 17.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.88 44.01 1.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.115 0.484 . . . . 0.0 110.367 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.78 135.63 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.529 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -116.64 132.51 56.67 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.386 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.506 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.5 87.31 7.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.834 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.97 -40.77 97.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.919 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.435 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.94 168.84 35.59 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 77.0 p -76.07 -25.88 55.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.901 0.382 . . . . 0.0 110.781 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.8 tp10 -67.37 -34.7 77.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.357 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.764 HG22 ' O ' ' A' ' 296' ' ' THR . 94.7 m -73.49 25.1 0.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.748 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.496 ' H ' ' C ' ' A' ' 295' ' ' GLU . 63.2 t80 -58.26 -51.07 71.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.413 HH12 ' HG3' ' A' ' 212' ' ' GLN . 63.5 mmt-85 -112.42 155.0 24.93 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.422 ' CD2' HD11 ' A' ' 219' ' ' LEU . 43.9 tp -115.72 124.92 52.04 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.491 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.2 t0 -148.04 165.89 29.42 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.533 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -49.08 -38.64 25.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.659 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -71.05 -65.61 0.72 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.54 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -60.61 -32.93 72.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.079 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.62 -24.97 23.75 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.811 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.9 mtt -63.23 -41.18 99.07 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 120.948 0.404 . . . . 0.0 111.105 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.54 -43.89 22.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.064 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.56 HG21 HG23 ' A' ' 296' ' ' THR . 77.3 t -65.81 -43.24 93.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.417 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 55.4 tp -60.82 -46.96 88.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.518 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -69.83 -39.65 76.33 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.663 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.506 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.5 ttt180 -62.09 -38.15 87.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.136 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.03 3.97 43.85 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.753 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -112.78 -11.06 13.54 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.114 0.483 . . . . 0.0 110.189 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.23 -36.95 85.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.549 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.95 -48.7 80.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.395 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.003 179.9 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.06 -2.63 58.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.415 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.72 179.16 1.22 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.498 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.3 Cg_exo -60.87 144.94 99.66 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.76 2.307 . . . . 0.0 112.203 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.613 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.78 -179.7 8.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.581 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.51 136.14 53.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.333 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -123.94 146.82 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.395 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.6 p -120.02 135.98 54.73 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.812 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.25 -143.61 0.32 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.259 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.65 -36.98 85.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.437 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.22 -66.96 0.22 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.523 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.27 142.3 44.93 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.3 p -112.18 131.24 55.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.934 0.397 . . . . 0.0 110.324 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.08 128.94 54.79 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.541 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.9 m -85.55 130.64 34.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.178 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.0 mt -95.83 78.63 3.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.271 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.04 -32.18 73.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.493 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.43 108.87 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.086 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -122.25 91.56 49.09 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.194 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.644 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.1 Cg_exo -56.97 148.67 66.6 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.802 2.334 . . . . 0.0 111.827 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.79 82.67 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 O-C-N 123.57 0.544 . . . . 0.0 111.028 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.644 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.28 67.07 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.226 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.0 130.85 35.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.609 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.554 ' HA ' HG23 ' A' ' 64' ' ' VAL . 57.5 t -122.61 145.86 28.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.08 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -135.66 143.45 45.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.63 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.0 p -99.34 -59.54 1.7 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.594 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.7 p -79.07 155.12 28.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.668 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.492 HG21 HG23 ' A' ' 70' ' ' THR . 69.9 t -74.41 -21.72 17.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.569 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.5 m -60.36 -52.04 66.94 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.518 -178.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.5 mt -66.51 -42.37 87.43 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.363 0.601 . . . . 0.0 110.956 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -43.21 -53.63 4.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.083 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.3 -37.69 71.01 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -62.58 -44.48 96.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.893 0.378 . . . . 0.0 110.393 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.2 mt -66.25 -42.14 88.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.547 0.689 . . . . 0.0 110.769 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tp -62.62 -40.09 95.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.439 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.463 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.07 -35.75 75.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.006 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 156' ' ' LEU . 31.4 pt -91.6 28.92 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.16 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.35 51.65 11.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.816 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.86 75.71 24.32 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.98 151.5 85.61 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.775 2.317 . . . . 0.0 112.289 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.554 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.45 137.15 47.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.219 0.533 . . . . 0.0 110.251 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.442 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.1 pt -69.2 -43.63 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.243 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.08 130.92 53.24 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.97 0.414 . . . . 0.0 110.505 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.4 p -155.39 168.84 25.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.464 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.55 -177.53 21.83 Favored Glycine 0 N--CA 1.464 0.564 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.637 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -132.99 172.07 13.12 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.009 0.433 . . . . 0.0 110.458 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.492 HG23 HG21 ' A' ' 51' ' ' VAL . 14.2 p -133.49 -111.34 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.321 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.542 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.56 179.65 0.95 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.348 -179.044 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.2 Cg_exo -60.97 58.71 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.059 2.506 . . . . 0.0 112.108 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.543 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.2 t-20 -64.35 -34.94 79.31 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 118.669 -0.681 . . . . 0.0 110.521 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.1 m120 95.07 -37.58 0.01 OUTLIER 'General case' 0 C--N 1.349 0.557 0 O-C-N 124.332 1.02 . . . . 0.0 109.857 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -62.54 -39.89 95.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.025 0.44 . . . . 0.0 110.261 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -73.93 -26.45 21.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.678 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.83 -172.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.518 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.2 p30 -73.77 -152.79 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.787 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.0 p-10 -54.61 -6.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.683 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.491 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.93 113.74 22.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.585 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.23 72.92 1.27 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.87 148.67 35.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.897 0.38 . . . . 0.0 110.825 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -86.0 -99.14 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.172 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.541 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.04 -43.28 96.02 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.143 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.541 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.2 tt0 91.8 52.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.117 0.886 . . . . 0.0 110.919 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -103.12 -8.9 20.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.347 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.2 p -65.05 -33.97 77.31 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.164 0.507 . . . . 0.0 110.727 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.49 -24.17 1.2 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.624 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.5 t -69.55 -45.84 77.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.1 -48.74 80.29 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.071 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.77 -38.2 89.66 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.348 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -53.7 -32.45 51.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.207 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.59 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.9 mmt-85 -90.02 1.71 56.0 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 119.19 -0.433 . . . . 0.0 110.579 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.85 -49.41 0.16 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.232 0.957 . . . . 0.0 110.351 179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.636 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.9 mt -46.32 154.01 0.31 Allowed 'General case' 0 CA--C 1.489 -1.39 0 CA-C-O 117.331 -1.319 . . . . 0.0 109.139 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.636 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.6 tt0 121.37 92.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 O-C-N 125.754 1.909 . . . . 0.0 110.538 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.48 143.09 42.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.115 0.483 . . . . 0.0 110.279 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 mt -131.91 26.81 4.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.8 0.333 . . . . 0.0 110.443 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.16 137.56 34.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.974 0.416 . . . . 0.0 110.525 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.9 mt -136.99 165.19 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.42 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.13 -28.44 1.84 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -153.32 70.85 6.89 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.192 0.52 . . . . 0.0 110.281 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.94 145.55 98.04 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.759 2.306 . . . . 0.0 112.135 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.3 t -134.06 136.72 44.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.981 0.42 . . . . 0.0 110.541 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.96 -38.3 82.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.642 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.27 -42.29 96.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.518 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.12 -41.44 98.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.561 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.67 -43.34 98.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.05 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.13 77.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.295 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -18.62 60.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.489 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.51 -6.6 58.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.524 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 78.7 mtp 47.91 55.98 17.3 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.596 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.31 149.27 63.1 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.755 2.303 . . . . 0.0 112.083 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.38 -72.56 0.68 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.498 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.427 HD11 HD13 ' A' ' 140' ' ' LEU . 38.7 tp -111.7 112.7 24.58 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.321 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.3 mt -101.09 126.37 54.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.567 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.2 mt -110.07 133.7 52.93 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.156 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -121.17 139.97 46.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.517 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.7 p -83.34 168.43 16.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.705 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -37.48 80.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.418 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -139.47 159.0 43.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.434 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.15 176.94 33.44 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.02 -34.0 87.49 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.88 151.56 45.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.927 0.394 . . . . 0.0 110.531 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.3 t -63.16 141.06 58.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.291 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.09 10.94 10.84 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.625 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.29 -38.93 88.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.007 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.632 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.81 -35.7 24.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.594 0.711 . . . . 0.0 110.605 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.0 mt -71.14 -35.42 71.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.52 0.676 . . . . 0.0 110.8 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.9 t80 -42.89 -62.95 0.88 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.19 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.632 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.3 p-10 -65.67 -42.64 91.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.988 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -62.24 -32.58 73.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.124 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.5 mt -73.94 -40.54 62.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.15 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.23 -48.87 79.03 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.221 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.6 m -52.69 -42.78 65.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.212 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.96 -43.07 92.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.221 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.04 152.63 5.27 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.66 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -39.02 107.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.627 2.218 . . . . 0.0 112.421 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.634 ' C ' HD12 ' A' ' 140' ' ' LEU . 94.2 m -109.43 121.02 44.27 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.239 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.634 HD12 ' C ' ' A' ' 139' ' ' THR . 10.9 mp -113.6 152.68 30.01 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.12 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.53 131.05 69.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.36 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.99 127.79 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.463 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.99 103.76 14.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.324 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.3 p90 -101.36 -11.42 19.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.772 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.4 p-10 -64.82 -33.48 76.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.673 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.1 p-10 -98.17 7.59 46.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.585 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.44 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.56 155.48 50.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.507 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -74.43 165.39 25.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.67 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.549 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 90.8 t90 -60.0 -48.52 81.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.255 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -53.95 -41.73 68.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.99 0.424 . . . . 0.0 110.061 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.9 t -62.55 -40.84 98.1 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.401 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.412 ' O ' HD23 ' A' ' 156' ' ' LEU . 47.4 tp -60.61 -43.93 96.87 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.338 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.541 HD22 HH21 ' A' ' 169' ' ' ARG . 45.0 tp -61.37 -42.97 99.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 0.0 110.261 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -55.79 -45.25 78.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.679 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.44 -40.6 97.13 Favored 'General case' 0 C--O 1.228 -0.044 0 CA-C-O 120.938 0.399 . . . . 0.0 110.388 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.93 -42.34 98.99 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.321 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.77 -40.72 95.8 Favored Glycine 0 C--N 1.316 -0.575 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.89 -45.85 63.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.937 0.399 . . . . 0.0 110.899 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.0 mt -64.49 -44.13 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.742 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.5 p -93.47 -8.15 42.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.538 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.65 25.0 71.47 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -101.35 52.24 0.84 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.817 0.341 . . . . 0.0 110.653 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.7 -39.02 77.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.668 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.47 -47.12 86.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.201 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -61.41 -39.02 89.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.357 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.4 97.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.068 0.461 . . . . 0.0 110.355 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.19 -27.71 69.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.541 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.71 -53.57 9.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.192 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.541 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -63.98 -43.26 96.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.461 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 174' ' ' ASP . 86.9 mt -63.08 -43.86 99.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.687 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.45 -61.72 2.33 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.173 0.511 . . . . 0.0 110.369 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.45 -34.99 62.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.448 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.4 ' CD2' HD11 ' A' ' 177' ' ' LEU . 23.2 t80 -79.66 -35.37 39.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.056 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.0 m-20 -56.0 -41.15 74.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.128 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.92 -42.25 99.73 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.756 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.3 -37.93 88.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.29 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 177' ' ' LEU . 82.0 mt -62.41 -42.26 99.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.752 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.8 -52.97 62.01 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.132 0.491 . . . . 0.0 110.704 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.45 -41.78 88.61 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.649 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.03 -40.0 95.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.7 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.32 -32.4 73.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.349 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.16 -21.69 18.93 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.684 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.494 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.7 tt0 -64.86 -41.36 95.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.642 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.0 pt -77.23 135.58 26.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.656 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.02 108.62 11.09 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.27 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.86 126.83 0.31 Allowed Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.548 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.9 Cg_exo -43.75 152.09 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.749 2.3 . . . . 0.0 112.609 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.2 142.09 54.42 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.598 2.198 . . . . 0.0 112.487 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.547 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.12 147.32 2.23 Favored Pre-proline 0 N--CA 1.446 -0.631 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.62 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.2 154.46 69.92 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.71 2.274 . . . . 0.0 112.293 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.58 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.42 163.14 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.417 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.58 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.75 170.46 15.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.905 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.64 137.65 21.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.961 0.41 . . . . 0.0 110.141 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.536 HG22 HD12 ' A' ' 205' ' ' LEU . 39.3 pt -134.08 146.46 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.623 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.9 131.74 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.182 0.515 . . . . 0.0 110.485 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -151.73 154.59 36.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.404 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 199' ' ' ALA . 84.8 m -121.86 122.54 39.66 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.996 0.427 . . . . 0.0 110.382 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.76 -25.5 66.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.551 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.611 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.45 -50.0 20.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.071 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.53 -10.74 60.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.398 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.3 m80 48.61 43.26 20.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.475 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.1 t -136.07 145.24 45.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.323 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.402 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -111.19 113.77 26.52 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.297 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.9 133.65 55.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.07 0.462 . . . . 0.0 110.301 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.23 146.43 38.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.72 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.495 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.8 t90 -99.36 129.86 45.6 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.152 0.501 . . . . 0.0 110.024 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.67 154.37 39.18 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.211 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.9 Cg_endo -67.64 -18.22 48.24 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.702 2.268 . . . . 0.0 111.925 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.2 -18.72 0.37 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.431 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.495 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.73 164.99 25.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.559 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.07 -27.94 66.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.529 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.52 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.8 mt-30 -63.56 -41.59 98.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.675 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.05 -44.87 96.85 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.38 -38.97 92.9 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.952 0.406 . . . . 0.0 110.642 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.549 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.4 mmm -62.23 -41.39 98.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.148 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 70.9 mt -63.78 -47.15 82.08 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.641 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.51 -31.97 57.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.075 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -70.7 -18.28 62.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.493 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.426 HD11 ' CD2' ' A' ' 299' ' ' LEU . 93.5 mt -88.61 -8.3 54.92 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.656 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.47 2.64 55.52 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -88.54 152.33 21.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.346 . . . . 0.0 110.543 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.446 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.2 p -115.15 128.12 55.99 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.117 0.484 . . . . 0.0 110.337 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.52 145.7 24.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.468 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.38 151.41 46.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.43 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.31 131.81 42.34 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.409 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.885 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.52 93.54 28.01 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.078 -179.57 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.68 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.4 Cg_exo -55.62 138.99 82.45 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.553 2.169 . . . . 0.0 111.493 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.77 -25.42 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.463 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.68 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.83 -49.55 28.42 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.56 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.8 mt -54.61 -37.18 65.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 0.0 110.098 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.29 35.8 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.837 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.56 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.38 88.35 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 82.6 p -81.83 -14.12 56.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.307 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.53 -40.89 11.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.582 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 24.7 t -66.86 -16.87 64.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.643 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.99 43.6 26.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.45 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.94 -147.44 7.43 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.02 142.95 49.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.035 0.445 . . . . 0.0 110.291 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.23 149.69 28.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.361 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -101.3 -151.35 0.41 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.294 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 55.76 -92.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.611 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.455 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.3 tt -126.56 174.8 9.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.604 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.455 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.7 mt -121.4 141.09 43.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.781 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.42 168.85 9.73 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.224 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.8 mt -147.57 150.85 35.26 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.191 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.75 -38.76 96.66 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.05 4.27 4.65 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.47 -58.03 3.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.94 0.4 . . . . 0.0 110.571 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.545 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.1 m-20 -62.42 -36.6 82.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.282 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.402 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.2 mp -52.29 -67.64 0.23 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.808 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.67 -42.11 67.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.072 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.84 17.97 0.15 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.698 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.77 48.32 0.26 Allowed Glycine 0 N--CA 1.464 0.564 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.36 -109.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.595 0.236 . . . . 0.0 110.741 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.74 -44.95 96.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.484 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.54 8.23 83.41 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -99.53 -12.24 20.31 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.751 -0.264 . . . . 0.0 110.732 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.7 t 176.2 142.47 0.07 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.096 0.474 . . . . 0.0 110.482 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.06 126.04 12.04 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.077 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 14.0 m-30 -99.06 142.89 29.97 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 120.893 0.378 . . . . 0.0 110.907 178.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.45 106.61 18.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.596 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.47 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.8 t80 -102.3 -12.1 18.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.203 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.66 -40.32 88.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.833 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.22 173.45 45.92 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.495 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.4 m-20 -74.49 -113.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.772 0.32 . . . . 0.0 110.77 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.27 -28.69 68.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.635 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.06 -44.19 91.81 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.306 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.64 -44.29 94.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.379 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.54 -60.09 3.66 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.174 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.21 -43.41 61.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.219 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.45 -43.87 75.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.159 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.6 mt -64.31 -43.62 97.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.651 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -56.84 -37.49 71.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.21 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.03 0.93 19.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.249 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -114.83 91.53 26.45 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.086 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.14 -27.26 28.91 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.743 2.295 . . . . 0.0 111.823 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.27 -41.37 99.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.63 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.8 mp -95.01 4.87 53.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.324 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.7 -35.24 70.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.667 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.72 4.59 15.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.51 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.82 121.51 81.6 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.563 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -47.72 -37.76 28.31 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.415 2.076 . . . . 0.0 112.553 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.535 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.94 -43.7 91.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.803 0.335 . . . . 0.0 110.266 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.7 -43.78 93.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.286 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.91 -40.6 95.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.43 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.4 -12.48 40.19 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.569 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.25 31.69 17.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.891 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -88.64 44.22 1.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.419 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.91 135.58 43.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.436 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.23 132.87 56.54 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.452 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.42 87.6 6.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.72 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.95 -41.33 97.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.983 0.421 . . . . 0.0 110.906 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.47 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.91 168.6 35.04 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 77.2 p -75.89 -25.79 56.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.834 0.35 . . . . 0.0 110.705 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -67.71 -34.55 77.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.484 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.759 HG22 ' O ' ' A' ' 296' ' ' THR . 98.5 m -72.96 19.38 0.09 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.596 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.52 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 52.0 t80 -57.36 -50.88 71.56 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.049 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 69.8 mmt-85 -108.15 148.98 29.11 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.426 ' CD2' HD11 ' A' ' 219' ' ' LEU . 40.1 tp -115.54 125.87 53.54 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.696 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.476 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.6 t0 -149.32 166.7 28.18 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.651 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -49.45 -38.22 28.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.597 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -72.6 -64.61 0.92 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.925 0.393 . . . . 0.0 111.381 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.26 -31.49 70.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.889 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -55.54 -25.05 35.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.523 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.7 mtt -63.08 -41.52 99.43 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 120.923 0.392 . . . . 0.0 110.809 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.16 -44.28 26.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.018 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.534 HG21 HG23 ' A' ' 296' ' ' THR . 78.6 t -66.16 -43.08 92.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.415 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.494 HD11 ' NE2' ' A' ' 183' ' ' GLN . 50.5 tp -60.37 -47.3 86.66 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.529 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -69.8 -39.69 76.4 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.675 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.498 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 70.6 ttt180 -61.76 -37.92 86.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.218 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.72 4.79 42.78 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.769 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.402 ' HZ2' ' CD ' ' A' ' 183' ' ' GLN . 87.4 tttt -112.58 -12.09 13.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.045 0.45 . . . . 0.0 110.246 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.22 85.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.574 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.87 -48.63 80.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.328 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.025 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -90.16 -2.81 58.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.369 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.09 179.22 1.22 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.513 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.6 Cg_exo -60.92 145.16 99.46 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.815 2.343 . . . . 0.0 112.179 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.35 -179.38 8.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.571 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -116.33 137.15 52.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.98 0.419 . . . . 0.0 110.329 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -123.99 146.61 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.349 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -120.28 136.4 54.68 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.771 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 53.1 p30 -99.81 -143.16 0.33 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.133 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -62.87 -36.87 84.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.399 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.468 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -152.23 -59.76 0.15 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.446 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -60.75 140.27 48.06 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.1 p -111.78 130.21 55.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.925 0.393 . . . . 0.0 110.404 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -120.05 128.62 53.68 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.509 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.2 m -85.5 130.14 34.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.205 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.497 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.7 mt -96.29 78.61 3.08 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.343 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.46 -31.83 73.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.556 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.75 109.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.976 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.497 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -122.75 91.2 49.74 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.287 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.643 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -57.15 148.63 68.44 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.82 2.347 . . . . 0.0 111.876 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.28 82.77 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.653 0.595 . . . . 0.0 110.999 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.643 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.67 67.0 0.88 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.142 0.496 . . . . 0.0 110.229 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -77.07 130.93 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.752 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.575 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.6 t -122.58 147.72 26.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.047 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.0 t -136.55 143.97 43.97 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.666 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.408 ' OG1' ' N ' ' A' ' 50' ' ' SER . 18.2 p -99.71 -58.8 1.84 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.557 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.408 ' N ' ' OG1' ' A' ' 49' ' ' THR . 88.4 p -79.43 155.25 28.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.637 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.527 HG21 HG23 ' A' ' 70' ' ' THR . 69.0 t -74.05 -21.94 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.569 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.6 m -60.26 -51.92 67.48 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.516 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 mt -66.21 -42.68 88.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.172 0.511 . . . . 0.0 110.897 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.3 m -43.16 -53.96 4.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.959 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.0 -37.55 73.86 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 m -62.86 -44.22 96.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.87 0.366 . . . . 0.0 110.244 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 17.5 mt -65.86 -42.33 90.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.602 0.715 . . . . 0.0 110.679 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tp -62.93 -39.69 95.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.519 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.495 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.6 -36.0 77.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.235 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.51 HD11 HD12 ' A' ' 156' ' ' LEU . 34.2 pt -91.36 28.09 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.257 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.79 51.83 10.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.011 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.16 76.07 27.62 Favored Pre-proline 0 C--O 1.225 -0.189 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.02 149.6 90.14 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.742 2.294 . . . . 0.0 112.108 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.575 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.57 136.61 48.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-O 121.233 0.539 . . . . 0.0 110.256 179.678 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.434 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.3 pt -69.3 -43.73 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.369 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.16 131.15 53.27 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.989 0.423 . . . . 0.0 110.628 -178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.5 p -155.65 168.6 26.64 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.38 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.34 -177.24 21.98 Favored Glycine 0 N--CA 1.465 0.593 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.635 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.42 172.04 13.25 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 121.067 0.46 . . . . 0.0 110.434 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.527 HG23 HG21 ' A' ' 51' ' ' VAL . 12.8 p -133.38 -111.37 0.23 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.001 0.429 . . . . 0.0 110.346 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.94 179.73 0.93 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.356 -179.019 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.0 Cg_exo -61.02 58.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 123.032 2.488 . . . . 0.0 112.14 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.535 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.7 t-20 -64.38 -34.23 77.68 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 118.716 -0.659 . . . . 0.0 110.423 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.6 m120 94.6 -37.27 0.01 OUTLIER 'General case' 0 C--N 1.348 0.543 0 O-C-N 124.156 0.91 . . . . 0.0 109.684 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -62.73 -40.07 96.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.029 0.442 . . . . 0.0 110.203 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -73.99 -26.16 20.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.714 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.75 -172.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.539 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.54 -153.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.79 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.3 p-10 -54.21 -6.85 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.707 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.01 114.19 23.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.647 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.42 72.06 1.3 Allowed Glycine 0 C--O 1.225 -0.446 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -143.58 148.13 35.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.913 0.387 . . . . 0.0 110.839 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -85.89 -98.77 0.07 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.076 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.86 -43.39 96.23 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.14 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.537 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.2 tt0 91.65 52.69 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 124.143 0.902 . . . . 0.0 110.919 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -103.33 -8.53 20.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.387 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -65.52 -33.31 75.63 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.198 0.523 . . . . 0.0 110.687 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -49.24 -24.26 1.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.629 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.8 t -69.57 -46.02 76.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.842 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.24 -48.51 81.12 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.984 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.61 -38.23 89.38 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.367 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.71 -32.86 53.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.144 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.588 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.79 1.71 55.8 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.554 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 83.03 -49.38 0.15 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.141 0.901 . . . . 0.0 110.275 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.628 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.1 mt -46.23 153.72 0.31 Allowed 'General case' 0 CA--C 1.486 -1.483 0 CA-C-O 117.127 -1.416 . . . . 0.0 109.257 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.628 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.35 92.06 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 O-C-N 125.896 1.998 . . . . 0.0 110.525 -178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.01 142.83 43.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.174 0.512 . . . . 0.0 110.212 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.8 mt -131.96 26.52 4.6 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.041 -0.412 . . . . 0.0 110.443 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -140.03 137.5 34.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.032 0.444 . . . . 0.0 110.516 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.7 mt -136.82 164.7 29.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.352 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.612 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.76 -28.76 1.74 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.08 70.67 7.77 Favored Pre-proline 0 N--CA 1.464 0.256 0 CA-C-O 121.195 0.521 . . . . 0.0 110.206 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.98 145.29 98.7 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.743 2.295 . . . . 0.0 112.087 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.1 t -135.03 137.11 42.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.507 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.0 -38.35 82.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.697 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.19 -42.23 96.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.512 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.91 -41.61 98.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.545 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.46 -43.35 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.96 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.04 -35.17 77.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.022 0.439 . . . . 0.0 110.216 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.58 -18.96 61.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.459 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.32 -6.55 58.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.537 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.413 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 68.9 mtp 47.65 55.87 17.11 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.661 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.5 Cg_endo -70.34 149.64 63.48 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.755 2.303 . . . . 0.0 112.132 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.48 -72.78 0.67 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.451 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.421 HD11 HD13 ' A' ' 140' ' ' LEU . 38.5 tp -111.61 113.93 26.65 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.348 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.0 mt -102.96 126.79 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 120.935 0.398 . . . . 0.0 110.566 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.2 mt -110.33 134.16 52.56 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.111 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.65 139.72 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.501 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.1 p -83.22 167.78 17.37 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.708 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.34 -37.25 80.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.43 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.6 t -139.57 158.6 43.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.439 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.59 176.64 33.87 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.68 86.88 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.34 151.38 44.41 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.919 0.39 . . . . 0.0 110.547 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.4 t -63.56 140.89 58.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.268 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.55 10.65 11.15 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.618 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.2 -39.07 88.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.171 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.628 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.75 -35.9 24.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.614 0.721 . . . . 0.0 110.667 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.8 mt -70.98 -35.26 72.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.525 0.678 . . . . 0.0 110.74 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.9 -62.98 0.87 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.339 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.628 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.72 -42.73 90.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -61.97 -32.64 73.1 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.509 0.506 . . . . 0.0 110.222 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.4 mt -73.75 -40.56 63.41 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.49 -49.03 78.82 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.137 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.8 m -52.98 -42.52 65.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.237 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.91 -43.08 93.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.991 0.424 . . . . 0.0 111.208 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.06 152.89 5.36 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.677 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -38.92 107.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.673 2.249 . . . . 0.0 112.488 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.637 ' C ' HD12 ' A' ' 140' ' ' LEU . 96.8 m -109.61 121.44 45.22 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.041 0.448 . . . . 0.0 110.181 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.637 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.83 152.68 30.33 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.254 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.2 tt -128.06 131.16 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.38 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.34 127.75 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.49 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 54.4 t30 -100.15 104.57 16.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.176 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -100.28 -12.02 19.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.014 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.8 p-10 -65.16 -34.08 77.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.81 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.581 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.8 p-10 -99.34 7.92 45.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.585 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -134.05 151.44 51.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.56 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.42 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.8 p -75.87 166.31 23.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.635 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.595 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.0 t90 -59.26 -48.76 80.43 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.101 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -54.24 -44.12 71.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.989 0.423 . . . . 0.0 110.04 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.3 t -63.05 -40.8 98.78 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.344 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.416 ' O ' HD23 ' A' ' 156' ' ' LEU . 62.7 tp -60.62 -44.52 96.23 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.287 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.6 tp -61.56 -42.51 98.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.192 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.9 m -55.55 -46.14 77.17 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.83 -40.6 95.87 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.962 0.41 . . . . 0.0 110.337 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.51 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -62.12 -42.51 99.3 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.41 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.27 -40.11 94.62 Favored Glycine 0 C--O 1.222 -0.608 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.34 -45.9 65.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.931 0.396 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.83 -44.1 96.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.2 p -92.95 -9.3 40.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.61 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.18 26.37 72.49 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -101.97 50.73 0.84 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.822 0.344 . . . . 0.0 110.694 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.63 -39.27 77.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.667 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.5 -47.21 86.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.223 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -59.84 -39.54 85.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.209 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.16 -40.82 98.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.059 0.457 . . . . 0.0 110.259 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.83 -29.03 70.42 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.966 0.412 . . . . 0.0 110.616 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -73.94 -54.39 8.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.076 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.495 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.6 ttp180 -64.67 -42.02 95.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.419 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.4 mt -62.3 -43.93 98.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.531 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.99 -59.67 4.76 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.136 0.493 . . . . 0.0 110.253 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -55.91 -34.15 65.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.48 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -80.17 -36.18 35.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.798 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.2 m-20 -54.66 -42.02 70.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.926 -178.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.98 -41.39 97.97 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.62 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -64.93 -38.21 90.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.322 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.1 mt -62.33 -42.45 99.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.804 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.84 -53.38 56.67 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.149 0.5 . . . . 0.0 110.685 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.22 -41.82 89.55 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.694 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.7 -40.31 96.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.697 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.03 -32.54 73.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.39 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.2 -21.53 19.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.736 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.594 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.7 tt0 -64.7 -41.93 95.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.763 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.1 pt -75.98 133.76 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.043 0.449 . . . . 0.0 110.723 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -127.51 106.11 8.95 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.317 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.3 128.27 0.35 Allowed Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.576 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.447 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.5 Cg_exo -43.44 151.3 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.812 2.342 . . . . 0.0 112.667 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.66 142.43 53.06 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.577 2.185 . . . . 0.0 112.517 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.544 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -170.97 147.29 2.28 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.672 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.9 153.96 71.77 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.761 2.308 . . . . 0.0 112.299 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.21 163.05 29.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.228 0.537 . . . . 0.0 110.415 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.578 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.52 169.82 16.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.949 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.03 137.59 22.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.987 0.422 . . . . 0.0 110.11 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.532 HG22 HD12 ' A' ' 205' ' ' LEU . 39.5 pt -134.22 146.34 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.76 131.9 59.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.198 0.523 . . . . 0.0 110.471 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -151.86 154.77 36.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.409 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.0 m -121.64 122.78 40.39 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 110.358 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.6 -25.61 66.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.638 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.611 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.95 -49.43 20.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.966 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.75 -12.03 60.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.34 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.7 m80 49.59 42.35 22.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.435 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.8 t -136.39 145.29 45.17 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.354 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.84 114.39 27.7 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.268 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.93 133.37 55.59 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.108 0.48 . . . . 0.0 110.289 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.532 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.07 146.4 38.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.793 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.476 ' N ' HD23 ' A' ' 205' ' ' LEU . 12.9 t90 -99.69 127.99 45.8 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.187 0.518 . . . . 0.0 109.86 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.46 153.67 41.35 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.401 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.74 -18.57 47.72 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.655 2.237 . . . . 0.0 111.977 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.13 -18.35 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.343 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.448 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.6 p -75.36 167.8 21.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.484 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.24 -35.62 75.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.429 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.5 mt-30 -56.74 -41.12 76.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.698 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.42 -42.99 97.77 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.503 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 73.1 mt-30 -63.91 -39.95 95.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 122.279 -0.541 . . . . 0.0 110.745 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.595 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.4 mmm -61.83 -41.54 97.91 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.196 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 77.5 mt -63.46 -49.79 72.26 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 121.16 0.505 . . . . 0.0 110.404 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.38 -32.66 50.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 0.0 110.076 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.18 -20.07 62.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.578 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 219' ' ' LEU . 67.1 mt -87.39 -6.53 58.42 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.58 3.89 57.24 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -88.63 149.81 23.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 0.0 110.527 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.447 ' O ' HG12 ' A' ' 191' ' ' VAL . 3.5 p -112.96 126.83 55.91 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.211 0.529 . . . . 0.0 110.191 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.87 145.61 24.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.061 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.48 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.9 150.51 46.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.398 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.61 131.29 44.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.385 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.888 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.67 92.97 26.18 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.996 -179.535 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.681 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.1 Cg_exo -55.6 139.13 82.53 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.542 2.161 . . . . 0.0 111.582 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.51 -24.62 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.483 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.681 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.07 -49.59 26.77 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.555 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -54.57 -36.91 64.88 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.63 36.06 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.82 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.555 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.68 87.4 0.01 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.879 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.5 p -80.81 -14.73 57.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.334 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.42 -41.11 11.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.668 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.2 t -66.85 -16.65 64.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.585 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.01 43.74 26.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.431 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.77 -146.87 7.22 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.57 143.42 49.75 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.026 0.441 . . . . 0.0 110.296 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -151.75 149.26 28.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.279 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -100.36 -152.83 0.43 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.317 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.6 t0 56.44 -91.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.671 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.471 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.67 175.39 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.594 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.471 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.8 mt -121.41 141.04 43.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.842 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.41 168.98 9.65 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.14 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.0 mt -147.3 150.69 35.27 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.278 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.69 -39.04 97.09 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.56 3.75 4.55 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.0 -58.31 3.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.959 0.409 . . . . 0.0 110.562 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.556 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.1 m-20 -62.06 -36.92 83.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.209 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.18 -67.66 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.79 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.6 -42.02 67.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.091 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.15 18.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.689 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.44 47.53 0.2 Allowed Glycine 0 N--CA 1.466 0.642 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 39.23 -109.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.569 0.223 . . . . 0.0 110.684 -178.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.48 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.5 m120 -60.98 -44.99 96.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.367 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.78 8.04 83.26 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -99.22 -12.47 20.38 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.709 -0.289 . . . . 0.0 110.687 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.4 t 176.38 142.65 0.07 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.085 0.469 . . . . 0.0 110.449 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.16 125.77 11.77 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.207 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.63 143.04 29.45 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 120.885 0.374 . . . . 0.0 110.958 178.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.0 mt -94.39 106.77 18.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.659 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.472 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 93.0 t80 -102.23 -12.95 17.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.117 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -65.87 -40.45 91.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.892 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.18 173.48 45.95 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.492 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -74.27 -112.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.76 0.314 . . . . 0.0 110.749 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.93 -28.77 67.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.673 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.2 -44.05 92.23 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.259 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.5 -44.49 94.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.327 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.45 -59.67 4.15 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.12 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.35 -43.41 61.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.069 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.74 74.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.194 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.3 -43.61 97.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.592 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -56.57 -37.77 71.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.074 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.32 0.99 20.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.168 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -115.07 91.28 26.48 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.094 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.05 -27.22 28.16 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.786 2.324 . . . . 0.0 111.897 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -41.27 98.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.536 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.9 mp -95.44 4.91 52.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.347 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.76 -35.31 70.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.644 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.82 4.77 15.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.489 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.525 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.68 121.2 80.22 Favored Pre-proline 0 N--CA 1.44 -0.937 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.587 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -47.55 -37.48 26.53 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.41 2.073 . . . . 0.0 112.628 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.72 -43.48 90.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.747 0.308 . . . . 0.0 110.245 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.85 -43.74 93.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.246 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.86 -40.62 95.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.335 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.46 -12.6 39.68 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.603 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 62.01 31.64 17.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.003 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.42 44.33 1.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.136 0.493 . . . . 0.0 110.327 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.4 135.82 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.439 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.65 132.42 56.69 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.4 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.49 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.83 88.39 6.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.77 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.431 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.9 mt -63.83 -41.74 97.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.983 0.42 . . . . 0.0 110.832 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.472 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.85 165.94 34.56 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 76.8 p -75.62 -25.99 57.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.846 0.355 . . . . 0.0 110.703 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.3 tp10 -68.4 -34.03 75.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.442 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.758 HG22 ' O ' ' A' ' 296' ' ' THR . 99.4 m -72.26 18.82 0.08 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.558 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.508 ' O ' ' NE2' ' A' ' 212' ' ' GLN . 48.1 t80 -56.93 -51.03 70.76 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.873 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -107.09 148.15 29.13 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 41.0 tp -115.52 126.11 53.86 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.842 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.477 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.0 t0 -149.55 166.83 28.04 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.672 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -49.28 -38.03 25.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.631 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -71.75 -64.91 0.84 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.47 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.9 -32.94 72.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.979 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.47 -25.52 25.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.66 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.2 mtt -63.56 -41.07 98.43 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 120.906 0.384 . . . . 0.0 111.06 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -77.65 -44.61 27.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.084 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.579 HG21 HG23 ' A' ' 296' ' ' THR . 79.6 t -66.12 -42.88 92.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.346 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.594 HD11 ' NE2' ' A' ' 183' ' ' GLN . 48.3 tp -59.92 -47.05 87.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.449 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -70.19 -39.55 75.15 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.134 0.492 . . . . 0.0 110.897 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.492 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 73.9 ttt180 -61.28 -37.79 84.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.197 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -88.06 5.06 42.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.689 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -112.23 -11.84 13.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.075 0.464 . . . . 0.0 110.303 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.26 85.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.53 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.97 -48.73 80.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.339 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.941 -179.964 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -89.89 -2.68 58.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.417 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.493 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.15 1.23 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.501 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.493 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.8 Cg_exo -60.81 144.89 99.64 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.86 2.373 . . . . 0.0 112.123 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.83 -179.48 8.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.592 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.77 137.0 52.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.371 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.71 146.99 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.383 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -120.03 136.14 54.67 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.791 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.36 -143.48 0.32 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.225 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.66 -37.08 86.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.458 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.21 -66.62 0.22 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.435 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.6 142.39 45.59 Favored Glycine 0 CA--C 1.519 0.294 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.6 p -112.17 131.36 55.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 110.443 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -119.1 129.1 54.88 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.485 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.9 m -85.76 130.37 34.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.225 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.486 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.3 mt -95.91 79.07 3.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.439 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.61 -31.96 73.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.71 109.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.986 0.422 . . . . 0.0 110.121 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.486 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.49 91.92 49.19 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.435 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.9 Cg_exo -56.7 148.67 63.9 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.804 2.336 . . . . 0.0 111.953 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.58 82.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.591 0.557 . . . . 0.0 110.979 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.5 66.84 0.89 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.271 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.06 130.58 36.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.812 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.561 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.7 t -122.61 146.71 27.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.061 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.0 t -135.96 143.96 45.16 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.77 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.5 p -99.5 -59.4 1.73 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.624 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.2 p -79.28 155.07 28.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.651 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.503 HG21 HG23 ' A' ' 70' ' ' THR . 73.3 t -74.05 -21.91 18.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.529 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.4 m -60.23 -52.07 66.85 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.536 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.38 -42.6 87.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.102 0.477 . . . . 0.0 110.787 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.9 m -43.14 -54.07 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.029 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.33 -37.05 70.53 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m -62.88 -44.71 95.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.867 0.365 . . . . 0.0 110.252 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.0 mt -66.37 -41.9 88.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.487 0.661 . . . . 0.0 110.75 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -62.61 -40.33 96.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.431 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.501 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.04 -35.61 75.48 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.202 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.529 HD11 HD12 ' A' ' 156' ' ' LEU . 32.6 pt -91.54 28.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.253 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.45 51.67 11.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.32 75.7 22.57 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.0 0.429 . . . . 0.0 109.919 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.61 151.35 85.96 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.825 2.35 . . . . 0.0 112.16 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.561 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.42 137.31 46.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.182 0.515 . . . . 0.0 110.274 179.772 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.445 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.4 pt -69.42 -43.4 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.359 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.03 131.17 53.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.96 0.41 . . . . 0.0 110.594 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.8 p -155.64 168.49 26.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.489 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.66 -177.16 21.78 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.649 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.92 172.85 12.24 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 110.449 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.503 HG23 HG21 ' A' ' 51' ' ' VAL . 14.9 p -133.16 -111.93 0.23 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.001 0.429 . . . . 0.0 110.428 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.43 179.68 0.94 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.509 -179.278 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.7 Cg_exo -60.97 58.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.965 2.443 . . . . 0.0 112.099 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.1 t-20 -64.43 -33.73 76.54 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.485 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 11.1 m120 94.07 -36.96 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.875 0.734 . . . . 0.0 109.808 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -62.75 -39.73 95.06 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.188 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.35 -25.54 19.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.669 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.31 -171.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.428 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.14 -153.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.87 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.5 p-10 -52.72 -7.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.749 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.509 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.52 114.88 23.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.648 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.95 69.69 1.36 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -143.05 147.15 34.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 110.813 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -84.92 -98.58 0.06 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.11 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.556 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.06 -42.48 97.0 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.13 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.556 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 9.8 tt0 91.29 52.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.841 0.713 . . . . 0.0 111.076 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -102.8 -9.25 20.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.374 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.3 p -64.36 -34.11 77.39 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.138 0.494 . . . . 0.0 110.695 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -49.05 -23.61 1.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.677 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.92 -45.97 75.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.746 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.26 -48.55 80.9 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.009 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.37 -38.34 89.2 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.446 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.57 -32.74 52.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.175 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.611 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.4 mmt-85 -90.1 1.75 56.03 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.535 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.611 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 56.9 mttp 82.84 -49.38 0.17 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.838 0.711 . . . . 0.0 110.318 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.664 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.3 mt -45.86 154.01 0.25 Allowed 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 117.733 -1.127 . . . . 0.0 109.598 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.664 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.22 92.62 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 125.387 1.679 . . . . 0.0 110.521 -178.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.543 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.65 143.17 42.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.249 0.547 . . . . 0.0 110.244 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.9 mt -132.23 27.04 4.5 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 122.013 -0.429 . . . . 0.0 110.454 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.32 137.94 34.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.03 0.443 . . . . 0.0 110.559 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.2 mt -137.33 165.1 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.356 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.58 -28.48 1.91 Allowed Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.22 70.45 7.63 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.13 0.49 . . . . 0.0 110.172 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.93 145.23 98.83 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.751 2.301 . . . . 0.0 112.098 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.5 t -134.57 136.59 43.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.97 0.414 . . . . 0.0 110.544 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.37 83.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.63 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.14 -42.41 96.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.527 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.6 98.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.525 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.7 -43.41 98.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.03 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.23 -35.03 77.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.181 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.59 -18.73 60.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.407 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.61 -6.47 58.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.531 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 70.3 mtp 47.59 56.06 17.22 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.596 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.1 149.33 64.57 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.737 2.291 . . . . 0.0 112.12 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.24 -74.0 0.63 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.43 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.8 tp -110.22 112.91 25.17 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.268 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.4 mt -101.82 126.26 55.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.694 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 mt -109.51 133.7 52.77 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.276 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.54 139.44 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.594 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.5 p -83.43 168.58 16.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.793 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.24 -37.43 80.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.427 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.74 158.99 43.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.488 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.15 177.43 33.19 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.19 -33.9 87.38 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -125.12 151.98 45.01 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.9 0.381 . . . . 0.0 110.522 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.4 t -63.14 140.99 58.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.369 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.43 10.32 11.16 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.649 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.01 -38.79 87.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.244 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.638 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.2 -35.89 23.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.449 0.643 . . . . 0.0 110.628 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.1 mt -71.05 -35.51 71.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.504 0.668 . . . . 0.0 110.673 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -42.68 -62.71 0.92 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.356 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.638 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.91 -42.73 89.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.159 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -62.08 -32.69 73.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.338 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.3 mt -73.75 -40.98 63.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.898 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.27 -48.84 79.17 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.19 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.2 m -53.2 -42.48 66.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.182 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.81 -42.94 93.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.022 0.439 . . . . 0.0 111.158 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.64 154.57 5.53 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.657 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -39.39 106.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.647 2.232 . . . . 0.0 112.496 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.7 m -110.5 121.35 45.09 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.093 0.473 . . . . 0.0 110.199 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.22 153.28 29.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.286 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -129.29 131.55 67.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.404 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -115.16 128.03 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.056 0.455 . . . . 0.0 110.512 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.62 103.56 14.38 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.197 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.8 p90 -101.15 -11.21 19.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.872 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.2 p-10 -64.84 -33.41 75.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.703 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.571 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.3 p-10 -98.38 8.0 45.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.567 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.45 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.88 155.62 50.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.466 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.403 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.8 p -75.01 165.62 24.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.668 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.59 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.88 -48.62 80.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.217 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.54 -42.02 67.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.001 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.4 t -62.74 -41.06 99.01 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.37 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.409 ' CD1' HG21 ' A' ' 142' ' ' ILE . 45.6 tp -60.59 -44.41 96.29 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.406 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.37 -43.41 98.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.166 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.0 m -55.07 -44.93 75.26 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.35 -40.74 97.38 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.967 0.413 . . . . 0.0 110.507 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.529 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.94 -42.54 99.23 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.311 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.13 -40.85 95.16 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.57 -45.99 64.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.937 0.398 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.75 -43.98 96.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.837 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -93.07 -8.83 41.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.632 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.96 26.63 72.34 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.69 50.59 0.85 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.807 0.337 . . . . 0.0 110.678 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -69.44 -39.48 77.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.648 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.46 -47.2 86.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.274 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -60.13 -39.38 86.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.163 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.98 99.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.246 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.92 -28.5 70.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.591 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.29 -54.27 8.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.895 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.501 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.48 -42.28 92.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.366 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.9 mt -62.36 -43.84 98.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.566 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.57 -58.36 7.83 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.999 0.428 . . . . 0.0 110.356 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.13 -33.55 67.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.589 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.402 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.5 t80 -81.34 -36.5 29.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.774 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -55.63 -42.29 74.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.023 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.28 -42.23 99.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.74 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.27 -37.98 88.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.295 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.7 mt -62.51 -42.12 99.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.729 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.13 -52.98 61.69 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.045 0.45 . . . . 0.0 110.667 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.22 -41.91 89.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.665 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.7 -40.02 95.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.592 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.38 -31.91 73.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.434 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.77 -22.4 18.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.67 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.459 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -64.75 -41.27 96.03 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.668 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.0 pt -76.24 136.27 25.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.657 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.47 107.83 10.62 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.29 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -177.16 125.8 0.29 Allowed Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.472 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.4 Cg_exo -44.04 152.38 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.864 2.376 . . . . 0.0 112.509 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.8 141.91 55.85 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.612 2.208 . . . . 0.0 112.446 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.27 147.14 2.13 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.548 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.08 154.34 70.57 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.811 2.34 . . . . 0.0 112.312 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.05 162.99 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.235 0.54 . . . . 0.0 110.403 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.72 170.33 16.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.927 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.66 137.75 21.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 110.126 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.557 HG22 HD12 ' A' ' 205' ' ' LEU . 39.4 pt -134.54 147.2 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.661 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.02 132.15 58.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.115 0.483 . . . . 0.0 110.488 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -152.44 155.72 38.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.444 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.626 HG22 ' H ' ' A' ' 199' ' ' ALA . 88.8 m -123.25 123.48 40.85 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.945 0.402 . . . . 0.0 110.375 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.63 -25.64 66.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.626 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.626 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.69 -48.96 19.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.006 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.61 -12.06 60.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.497 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.1 m80 49.28 41.02 19.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.526 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.3 t -135.84 143.65 45.23 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.385 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.424 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -109.83 114.29 27.74 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.24 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.82 133.36 55.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.016 0.436 . . . . 0.0 110.488 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.557 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.87 146.62 37.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.834 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.497 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 10.0 t90 -99.97 129.65 46.06 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.186 0.517 . . . . 0.0 109.869 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.85 153.73 39.94 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.39 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.3 Cg_endo -67.77 -18.06 47.44 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.755 2.303 . . . . 0.0 111.975 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.27 -19.12 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.369 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.497 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.5 p -75.4 164.41 26.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.497 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.78 -27.66 65.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.526 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.61 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.0 mt-30 -63.88 -41.03 97.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.556 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.81 -44.48 97.96 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.45 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.1 mt-30 -64.49 -38.77 92.17 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 122.299 -0.53 . . . . 0.0 110.697 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.59 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.3 mmm -61.93 -41.24 97.72 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.209 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.56 -47.31 82.09 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.022 0.439 . . . . 0.0 110.437 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.91 -31.97 51.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.866 0.365 . . . . 0.0 110.268 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -70.9 -18.63 62.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.508 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.436 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.3 mt -87.65 -9.12 55.11 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.602 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.16 1.84 54.46 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -88.42 153.55 21.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.904 0.383 . . . . 0.0 110.468 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.434 ' O ' HG12 ' A' ' 191' ' ' VAL . 7.3 p -116.4 128.87 55.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.14 0.495 . . . . 0.0 110.41 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.48 146.3 23.79 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.916 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.486 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.93 151.5 45.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.488 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.49 131.51 43.51 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.428 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.888 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.72 93.44 28.53 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.05 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.676 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.2 Cg_exo -55.38 138.78 80.84 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.545 2.163 . . . . 0.0 111.679 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.98 -26.05 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.457 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.676 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.03 -50.11 30.57 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.56 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.5 mt -54.43 -37.07 64.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.45 36.24 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.74 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.56 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.3 86.31 0.02 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.878 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.5 p -79.2 -15.08 58.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.382 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -92.6 -41.01 10.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.603 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.9 t -66.13 -17.86 64.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.645 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 56.16 43.3 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.492 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.34 -148.34 7.72 Favored Glycine 0 CA--C 1.519 0.289 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.58 142.75 49.8 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 110.347 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -152.36 149.89 29.12 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.296 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -101.28 -151.33 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.348 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 55.81 -92.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.672 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.462 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.85 175.38 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.627 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.462 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.8 mt -122.5 141.81 41.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.65 169.32 9.35 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.23 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.3 mt -147.52 150.94 35.5 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.264 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.93 -38.85 96.67 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.35 3.77 4.65 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -77.34 -58.13 3.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.924 0.392 . . . . 0.0 110.538 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.546 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.0 m-20 -62.14 -36.34 81.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.308 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.424 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.1 mp -52.55 -67.51 0.25 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.86 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.75 -42.37 68.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.081 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.7 17.59 0.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.669 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.86 48.47 0.27 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.394 -0.683 . . . . 0.0 111.394 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 38.82 -109.98 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.593 0.235 . . . . 0.0 110.712 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.486 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.6 m120 -60.86 -44.93 96.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.475 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.47 7.99 83.87 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -98.91 -13.66 19.91 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.647 -0.325 . . . . 0.0 110.66 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.4 t 177.25 142.78 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.087 0.47 . . . . 0.0 110.42 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.13 125.34 11.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.165 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 14.0 m-30 -98.28 143.63 28.56 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 120.865 0.364 . . . . 0.0 110.83 178.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.7 mt -95.18 106.67 18.71 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.794 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.437 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.7 t80 -102.26 -12.1 18.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.158 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.44 -40.4 89.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.886 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.0 173.3 45.86 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.461 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.3 m-20 -74.07 -113.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.756 0.312 . . . . 0.0 110.704 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.72 -28.81 67.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.686 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.1 -43.86 91.9 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.225 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.32 -44.55 94.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.316 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.56 -59.98 3.8 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.189 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -51.02 -43.38 60.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.151 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.47 -43.41 75.51 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.19 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.53 -43.68 96.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.629 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.25 -37.55 69.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.098 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.48 0.79 18.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.131 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -115.21 91.7 28.81 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.148 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.35 -27.07 29.73 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.748 2.299 . . . . 0.0 111.95 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.55 -41.06 98.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.503 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.597 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.33 5.24 52.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.381 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.13 -35.08 69.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.585 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.93 4.53 16.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.51 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.64 121.25 80.33 Favored Pre-proline 0 N--CA 1.445 -0.7 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.549 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -47.14 -38.0 24.3 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.483 2.122 . . . . 0.0 112.529 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.529 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.8 -43.66 90.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.704 0.288 . . . . 0.0 110.37 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.0 -43.62 92.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.355 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.92 -40.78 95.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.415 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 47.6 t-20 -89.65 -12.41 39.7 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.588 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.2 mtmt 61.94 32.19 17.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.995 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.76 43.97 1.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.061 0.457 . . . . 0.0 110.307 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.68 135.67 41.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.503 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.78 132.69 56.63 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.447 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.15 89.16 7.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.732 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.403 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.8 mt -63.82 -41.05 97.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.021 0.438 . . . . 0.0 110.856 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.437 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.2 165.02 33.52 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.1 p -75.28 -25.71 58.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.94 0.4 . . . . 0.0 110.771 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.503 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.3 tp10 -68.42 -34.03 75.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.393 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 96.6 m -73.35 24.84 0.07 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.736 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.61 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 39.7 t80 -58.07 -50.66 72.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.433 ' CZ ' ' CE2' ' A' ' 297' ' ' PHE . 80.0 mmt-85 -111.19 154.01 24.99 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.436 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.8 tp -115.44 124.98 52.51 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.814 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.481 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.8 t0 -147.69 165.55 30.13 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.619 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -49.34 -37.88 26.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.57 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -71.12 -65.6 0.72 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.504 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -61.01 -32.91 72.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.975 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.19 -25.55 23.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.743 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.2 mtt -63.6 -40.9 98.11 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 120.829 0.347 . . . . 0.0 111.07 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.76 -43.94 24.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.195 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.578 HG21 HG23 ' A' ' 296' ' ' THR . 76.6 t -66.34 -42.85 91.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.357 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.459 HD11 ' NE2' ' A' ' 183' ' ' GLN . 49.1 tp -60.22 -46.96 87.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.464 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -70.07 -39.47 75.62 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.054 0.454 . . . . 0.0 110.759 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.9 ttt180 -61.75 -38.29 87.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.248 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.12 4.39 42.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.607 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.404 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.4 tttt -112.77 -11.01 13.55 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.091 0.472 . . . . 0.0 110.347 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.41 -37.09 85.95 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.487 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.84 -48.71 80.58 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.457 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.006 179.868 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.618 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.02 -2.52 58.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.464 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.8 179.03 1.25 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.552 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.96 144.97 99.69 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.84 2.36 . . . . 0.0 112.092 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.618 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.68 -179.58 8.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.601 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.73 136.84 52.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.358 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.0 tp -124.53 147.5 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.396 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -120.35 135.97 54.85 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 110.742 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.27 -143.5 0.32 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.194 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.54 -37.11 86.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.417 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.09 -67.21 0.22 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.507 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.54 142.72 45.18 Favored Glycine 0 C--O 1.228 -0.275 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.9 p -112.29 131.57 55.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.962 0.41 . . . . 0.0 110.481 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -118.94 128.92 54.86 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.507 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.2 m -85.41 130.35 34.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.247 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.481 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.3 mt -95.59 78.54 3.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.405 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.69 -32.17 73.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.52 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.5 109.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.121 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.481 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.74 91.47 49.59 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.326 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.94 148.67 66.31 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.818 2.345 . . . . 0.0 111.894 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -40.71 82.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 O-C-N 123.657 0.598 . . . . 0.0 111.008 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.44 66.85 0.89 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.266 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.22 130.74 35.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.752 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.567 ' HA ' HG23 ' A' ' 64' ' ' VAL . 56.2 t -122.61 146.95 27.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.041 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 t -136.23 143.62 44.42 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.718 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.8 p -99.38 -59.25 1.76 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.526 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.8 p -79.35 155.57 28.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.646 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.548 HG21 HG23 ' A' ' 70' ' ' THR . 69.5 t -74.46 -21.97 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.591 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.7 m -60.25 -52.15 66.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.575 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.35 -42.53 87.93 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.173 0.511 . . . . 0.0 110.939 177.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.4 m -42.92 -54.07 4.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.041 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.47 -37.69 69.39 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.2 m -62.36 -44.63 96.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 110.299 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.4 mt -66.3 -41.98 88.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.445 0.641 . . . . 0.0 110.756 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -62.55 -40.17 95.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.442 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.495 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.19 -35.83 76.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.133 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.538 HD11 HD12 ' A' ' 156' ' ' LEU . 32.0 pt -91.41 29.06 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.266 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.42 51.92 10.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.887 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.4 75.67 22.35 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.961 0.41 . . . . 0.0 109.906 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.73 151.45 85.65 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.837 2.358 . . . . 0.0 112.162 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.567 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.58 137.16 47.65 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-O 121.214 0.53 . . . . 0.0 110.255 179.743 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.442 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.7 pt -69.48 -43.38 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.305 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.9 131.08 53.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.603 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.535 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.1 p -155.54 168.66 26.42 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.422 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.68 -177.2 21.76 Favored Glycine 0 N--CA 1.463 0.496 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.637 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.8 172.66 12.48 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.954 0.407 . . . . 0.0 110.538 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.548 HG23 HG21 ' A' ' 51' ' ' VAL . 15.3 p -132.26 -113.17 0.23 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.421 . . . . 0.0 110.359 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.77 179.72 0.95 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.408 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.1 Cg_exo -61.31 57.48 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 123.069 2.513 . . . . 0.0 112.091 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 60.4 t-20 -64.3 -33.07 74.97 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.462 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.5 m120 93.65 -35.55 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.962 0.789 . . . . 0.0 109.795 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HD3' HD21 ' A' ' 73' ' ' ASN . 77.4 mtp85 -63.23 -39.74 95.47 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.987 0.422 . . . . 0.0 110.173 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.79 -25.19 18.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.719 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -48.96 -171.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.555 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -73.72 -153.84 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.787 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 36.4 p-10 -52.34 -7.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.726 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -86.51 114.99 23.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.003 0.43 . . . . 0.0 110.59 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.07 70.2 1.34 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -143.57 147.46 34.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.825 0.345 . . . . 0.0 110.823 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.82 -98.58 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.136 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.551 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.82 -42.71 97.58 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.114 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.1 tt0 91.61 52.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.962 0.789 . . . . 0.0 110.907 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -102.53 -9.27 20.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.33 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -64.56 -34.17 77.63 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.043 0.449 . . . . 0.0 110.631 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -49.2 -24.36 1.71 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.614 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.42 -45.64 78.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.753 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.45 -48.3 81.76 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.037 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.52 -38.24 89.17 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.36 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.53 -32.98 52.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.155 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.601 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.86 1.46 56.15 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.493 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.98 -48.98 0.15 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.984 0.803 . . . . 0.0 110.208 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.651 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.5 153.83 0.34 Allowed 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 117.65 -1.167 . . . . 0.0 109.307 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.651 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.59 92.46 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 O-C-N 125.482 1.739 . . . . 0.0 110.491 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.52 143.19 42.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.138 0.494 . . . . 0.0 110.321 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.3 mt -132.24 27.1 4.5 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.122 -0.361 . . . . 0.0 110.362 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -140.31 137.83 34.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.045 0.45 . . . . 0.0 110.524 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.5 mt -136.99 165.02 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.447 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.97 -28.61 1.85 Allowed Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -152.61 70.79 7.39 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.153 0.501 . . . . 0.0 110.355 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.08 145.43 98.46 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.75 2.3 . . . . 0.0 112.06 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.7 t -134.56 136.77 43.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.514 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.37 82.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.635 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.11 -42.24 96.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.483 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.15 -41.62 98.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.48 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.59 -43.45 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.043 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.3 78.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.195 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.44 -18.7 60.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.413 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.52 -6.53 58.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.486 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 73.8 mtp 48.09 55.94 17.35 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.616 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.12 149.13 64.17 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.808 2.339 . . . . 0.0 112.129 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.32 -73.05 0.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.5 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.43 HD11 HD13 ' A' ' 140' ' ' LEU . 38.5 tp -111.35 113.48 25.98 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.313 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.4 mt -102.3 126.64 56.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.567 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 mt -110.19 133.94 52.72 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.262 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.98 139.95 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.474 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.6 p -83.5 168.67 16.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.741 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.46 80.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.442 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.1 t -139.94 159.21 42.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.423 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.31 177.29 33.4 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.28 -33.81 87.25 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.53 151.53 44.57 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.575 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.4 t -63.55 140.93 58.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.298 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.66 10.7 11.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.666 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.04 -39.05 88.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.187 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.01 -35.91 23.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.445 0.64 . . . . 0.0 110.576 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -70.8 -35.48 72.56 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.54 0.686 . . . . 0.0 110.784 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -42.91 -62.99 0.87 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.289 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.61 -42.84 91.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.132 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -61.95 -32.73 73.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.257 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.1 mt -73.82 -40.69 63.17 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.032 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.31 -48.98 78.78 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.186 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.5 m -53.0 -42.39 65.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.187 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.89 -43.04 93.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.089 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.43 153.61 5.33 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.633 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -39.15 106.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.687 2.258 . . . . 0.0 112.393 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.635 ' C ' HD12 ' A' ' 140' ' ' LEU . 93.4 m -109.94 121.35 45.04 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.191 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.71 152.82 29.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.269 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -129.13 131.17 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.326 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.411 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -115.16 128.17 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.073 0.463 . . . . 0.0 110.497 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.476 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.61 103.57 14.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.23 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.4 p90 -101.34 -11.35 19.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.832 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 48.9 p-10 -64.67 -33.52 76.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.639 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.566 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.2 p-10 -98.37 7.7 45.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.596 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.447 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.49 155.72 50.05 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.539 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.6 p -74.94 165.68 24.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.643 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.3 t90 -60.12 -48.76 80.38 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.256 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -53.42 -41.82 66.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.89 0.376 . . . . 0.0 110.064 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.1 t -62.82 -41.13 99.17 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.334 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.411 ' CD1' HG21 ' A' ' 142' ' ' ILE . 45.7 tp -60.7 -44.4 96.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.331 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.1 tp -61.4 -43.54 98.69 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.168 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -54.85 -45.03 74.48 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.44 -40.56 96.99 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.936 0.398 . . . . 0.0 110.492 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.538 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.96 -42.47 99.16 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.368 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.1 -40.85 95.22 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.59 -45.98 64.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.891 0.377 . . . . 0.0 110.842 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.8 mt -64.68 -43.96 96.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.893 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.3 p -92.99 -8.79 42.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.621 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.84 26.96 72.35 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -101.98 50.71 0.84 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 110.716 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.48 -39.23 77.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.635 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.66 -47.24 86.39 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.3 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -60.14 -39.47 86.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.225 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.96 99.31 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.292 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.92 -28.62 70.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.649 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.21 -54.3 8.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.048 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.495 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.4 ttp180 -65.47 -42.28 92.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.449 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.455 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.3 mt -62.52 -43.8 98.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.473 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.62 -59.08 5.43 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.067 0.46 . . . . 0.0 110.392 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -56.25 -34.2 66.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.568 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -80.87 -36.31 31.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.798 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.3 m-20 -54.98 -42.15 72.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.147 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.54 -41.92 99.2 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.639 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.08 -38.26 90.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.259 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 177' ' ' LEU . 81.4 mt -62.33 -42.19 99.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.692 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -52.81 62.52 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.135 0.493 . . . . 0.0 110.689 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.09 -41.99 89.94 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.673 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.87 -40.01 95.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.591 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.17 -32.27 73.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.379 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.3 -22.06 18.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.632 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.492 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.2 tt0 -64.75 -41.28 96.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.657 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 184' ' ' ILE . 32.8 pt -77.02 136.05 25.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.668 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.2 108.05 10.55 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.27 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.59 126.05 0.32 Allowed Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.458 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.7 152.23 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.796 2.331 . . . . 0.0 112.66 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.04 141.89 54.53 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.624 2.216 . . . . 0.0 112.479 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.42 147.24 2.1 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.605 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.32 155.1 68.35 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.772 2.315 . . . . 0.0 112.356 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.78 163.26 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.207 0.527 . . . . 0.0 110.371 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.61 170.05 16.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.894 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.17 137.47 22.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.067 0.46 . . . . 0.0 110.03 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.56 HG22 HD12 ' A' ' 205' ' ' LEU . 39.0 pt -134.28 146.67 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.637 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.55 131.75 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.348 0.594 . . . . 0.0 110.488 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -152.78 156.17 38.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.425 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 199' ' ' ALA . 88.4 m -122.17 122.88 40.21 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.878 0.37 . . . . 0.0 110.307 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.523 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.8 -26.32 67.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.591 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.599 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.68 -49.5 21.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.69 -10.44 59.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.449 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.523 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.9 m80 46.28 47.05 13.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.455 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -130.97 143.76 50.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.414 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.452 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -108.57 105.32 14.9 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.169 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.6 m-20 -115.95 128.79 56.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.148 0.499 . . . . 0.0 110.321 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.56 HD12 HG22 ' A' ' 194' ' ' ILE . 7.7 tt -111.84 146.32 37.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.47 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.2 t90 -99.55 128.55 45.66 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.131 0.491 . . . . 0.0 109.905 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.41 154.22 40.31 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.293 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.71 -18.09 47.81 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.726 2.284 . . . . 0.0 111.981 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.65 -19.26 0.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.472 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.434 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 87.0 p -74.76 164.44 26.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.483 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.98 -27.77 65.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.518 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.583 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.67 -41.45 98.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.634 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.07 -44.29 97.43 Favored Glycine 0 C--N 1.331 0.286 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.447 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.5 mt-30 -64.52 -38.77 92.16 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 122.4 -0.471 . . . . 0.0 110.683 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.3 mmm -62.12 -41.34 98.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.16 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.6 mt -63.59 -47.36 81.77 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.534 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.24 -31.83 54.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 0.0 110.113 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.97 -18.33 62.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.493 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.418 HD11 ' CD2' ' A' ' 299' ' ' LEU . 92.1 mt -88.37 -8.55 54.86 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.568 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.42 2.88 55.57 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -89.02 152.56 21.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 0.0 110.445 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.456 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.3 p -115.35 128.23 55.94 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.132 0.491 . . . . 0.0 110.334 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.16 146.75 23.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.038 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.46 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.4 151.28 45.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.487 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.07 131.69 42.65 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.39 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.884 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.38 93.78 28.46 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.095 -179.667 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.683 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.2 Cg_exo -55.47 138.73 81.11 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.607 2.205 . . . . 0.0 111.568 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.53 -25.49 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.471 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.68 -49.95 27.46 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.1 mt -55.15 -37.37 66.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.851 0.358 . . . . 0.0 110.086 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -65.54 35.53 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.84 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.573 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.45 88.3 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 86.2 p -82.26 -13.83 56.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.325 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.32 -40.67 11.35 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.611 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.2 t -66.71 -16.95 64.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.593 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.99 43.69 26.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.457 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.91 -148.08 7.81 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.61 142.25 49.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.998 0.427 . . . . 0.0 110.274 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.403 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.4 ttt-85 -152.0 149.54 29.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.342 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -102.02 -150.35 0.4 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.346 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.68 -93.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.616 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.0 tt -126.57 174.58 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.604 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.435 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 87.4 mt -121.7 140.94 44.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.902 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.28 170.33 8.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.169 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.5 mt -146.94 149.51 33.33 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.15 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.35 -39.25 97.58 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.19 3.06 4.01 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -78.33 -57.64 3.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.948 0.404 . . . . 0.0 110.583 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.617 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.8 m-20 -61.99 -36.89 82.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.245 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.452 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.7 mp -53.13 -67.42 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.022 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.488 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.72 -42.7 68.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.145 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.38 17.85 0.13 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.685 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.79 47.59 0.23 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 7.9 mp 39.71 -110.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.595 0.236 . . . . 0.0 110.651 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.46 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -60.92 -44.52 97.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.441 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.5 8.11 83.64 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -98.7 -13.31 20.32 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.779 -0.248 . . . . 0.0 110.712 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.0 t 176.85 142.84 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 110.478 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.89 125.49 11.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.108 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.83 143.64 28.93 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 120.92 0.391 . . . . 0.0 110.758 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.9 mt -94.91 106.31 18.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.724 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.451 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.9 -11.81 18.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.219 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.91 86.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.897 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.25 172.69 45.56 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.469 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -73.81 -113.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.0 110.72 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.44 -28.86 68.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.74 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.01 -43.9 91.6 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.275 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -63.53 -44.39 94.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.386 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.57 -59.81 4.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.187 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.21 -43.44 61.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.067 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.42 74.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.267 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.3 mt -64.66 -43.53 96.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.58 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -56.34 -37.61 70.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.133 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.75 0.85 19.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.149 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.08 91.17 26.08 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.127 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.21 -27.09 28.8 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.724 2.283 . . . . 0.0 111.912 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.46 -41.02 98.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.557 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.592 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.3 5.48 51.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.418 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.18 -35.21 68.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.658 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.55 4.5 15.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.495 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.6 121.46 81.02 Favored Pre-proline 0 N--CA 1.444 -0.764 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.541 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -47.46 -37.93 26.61 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.51 2.14 . . . . 0.0 112.556 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.66 -43.7 89.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.738 0.304 . . . . 0.0 110.292 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.04 -43.52 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.325 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.17 -40.86 97.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.441 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.413 ' ND2' ' CG ' ' A' ' 288' ' ' GLN . 58.0 t30 -90.99 -11.22 39.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.704 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.2 mtmt 61.1 32.66 19.68 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.481 0.488 . . . . 0.0 111.001 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' GLN . . . . . 0.413 ' CG ' ' ND2' ' A' ' 286' ' ' ASN . 97.1 mm-40 -88.11 43.9 1.16 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.361 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.5 135.83 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.534 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.88 132.15 56.77 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.373 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.6 88.65 7.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.762 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.441 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.1 mt -64.0 -41.13 97.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.003 0.43 . . . . 0.0 110.892 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.451 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.25 166.39 34.04 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 70.3 p -75.29 -25.53 58.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.835 0.35 . . . . 0.0 110.719 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.3 tp10 -68.33 -33.91 75.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.535 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 296' ' ' THR . 97.7 m -73.62 23.42 0.07 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.617 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.583 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 59.3 t80 -58.04 -51.23 70.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.428 HH12 ' HG3' ' A' ' 212' ' ' GLN . 66.1 mmt-85 -111.05 153.88 25.01 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.418 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.2 tp -116.13 125.6 52.57 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.494 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.7 t0 -147.43 165.43 30.27 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.561 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -49.37 -38.09 27.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.607 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -72.14 -64.86 0.86 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.52 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.32 -32.0 70.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.012 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.39 -25.36 24.13 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.614 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.8 mtt -63.37 -41.0 98.78 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 120.879 0.371 . . . . 0.0 110.782 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -78.23 -44.78 24.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.55 HG21 HG23 ' A' ' 296' ' ' THR . 79.3 t -65.9 -43.04 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.448 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.492 HD11 ' NE2' ' A' ' 183' ' ' GLN . 51.2 tp -60.36 -47.16 87.25 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.606 -178.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.11 -39.61 75.4 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.736 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.7 ttt180 -61.64 -38.13 86.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.154 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.2 mt -87.63 4.74 42.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.72 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.411 ' HZ2' ' CD ' ' A' ' 183' ' ' GLN . 87.2 tttt -112.72 -11.87 13.45 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.004 0.431 . . . . 0.0 110.334 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.12 -37.24 86.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.522 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.01 -48.73 80.46 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.383 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 . . . . . 0 C--O 1.221 -0.408 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.008 179.899 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.25 -2.61 58.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.437 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.27 179.07 1.25 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.488 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.4 Cg_exo -60.78 145.29 99.18 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.794 2.329 . . . . 0.0 112.174 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.5 -179.36 8.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.585 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.3 137.01 52.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.405 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -123.99 147.09 28.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.366 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.7 p -119.98 135.95 54.72 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.78 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.39 -143.61 0.33 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.291 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.54 -37.29 86.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.456 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.477 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.82 -67.25 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.46 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.31 142.64 44.7 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.1 p -112.4 131.4 55.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.96 0.409 . . . . 0.0 110.397 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -119.01 129.16 54.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.442 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.7 m -85.63 130.78 34.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.289 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.484 HD22 ' OE1' ' A' ' 42' ' ' GLN . 70.3 mt -96.79 78.83 2.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.281 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.96 -31.84 72.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.561 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.56 107.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.148 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.484 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -120.74 91.19 47.11 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.414 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.658 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.3 Cg_exo -56.94 148.57 66.86 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.765 2.31 . . . . 0.0 111.842 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.62 82.41 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.577 0.548 . . . . 0.0 111.001 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.658 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.37 66.87 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.253 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -76.62 131.06 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.745 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.568 ' HA ' HG23 ' A' ' 64' ' ' VAL . 61.6 t -122.76 147.25 27.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.028 0.442 . . . . 0.0 110.066 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 t -136.33 144.12 44.48 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.654 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.404 ' OG1' ' N ' ' A' ' 50' ' ' SER . 19.7 p -100.09 -59.09 1.77 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.584 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.404 ' N ' ' OG1' ' A' ' 49' ' ' THR . 87.1 p -79.25 155.02 28.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.508 HG21 HG23 ' A' ' 70' ' ' THR . 71.4 t -74.07 -21.85 18.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.565 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.9 m -60.13 -52.07 66.92 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.542 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.6 mt -66.49 -42.4 87.51 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.131 0.491 . . . . 0.0 110.798 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -43.35 -53.9 5.01 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.074 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.04 -37.39 73.39 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 m -62.93 -44.28 96.5 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 110.38 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 17.8 mt -66.04 -42.05 90.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.396 0.617 . . . . 0.0 110.662 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 tp -62.88 -39.91 95.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.271 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.527 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.45 -36.1 77.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.177 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.45 HD11 HD12 ' A' ' 156' ' ' LEU . 32.8 pt -91.18 27.9 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.27 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.4 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 99.0 m-20 56.94 51.75 10.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.972 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.17 76.06 27.59 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.944 0.402 . . . . 0.0 110.001 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.87 149.56 90.37 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.811 2.341 . . . . 0.0 112.281 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.52 136.6 48.24 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-O 121.136 0.493 . . . . 0.0 110.281 179.787 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.3 pt -69.48 -43.4 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.32 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.51 131.39 52.82 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.946 0.403 . . . . 0.0 110.648 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.54 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.3 p -155.84 168.83 25.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.458 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.35 -177.39 21.97 Favored Glycine 0 N--CA 1.463 0.499 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.632 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.5 172.38 12.8 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.015 0.436 . . . . 0.0 110.482 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.508 HG23 HG21 ' A' ' 51' ' ' VAL . 13.7 p -133.33 -111.57 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 0.0 110.491 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.55 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.8 179.62 0.95 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.448 -179.221 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.4 Cg_exo -60.86 58.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.894 2.396 . . . . 0.0 112.076 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.4 t-20 -64.42 -33.98 77.12 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.5 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.6 m120 94.29 -36.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.869 0.731 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.401 ' HD3' HD21 ' A' ' 73' ' ' ASN . 77.1 mtp85 -62.89 -39.96 96.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.937 0.398 . . . . 0.0 110.224 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -74.49 -26.0 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.675 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.59 -172.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.612 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.3 p30 -73.73 -152.75 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.771 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 36.9 p-10 -54.46 -6.6 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.726 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.495 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.59 114.19 23.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.548 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.53 71.73 1.31 Allowed Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.475 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.3 m-85 -143.19 148.21 36.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.74 0.305 . . . . 0.0 110.908 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -86.04 -98.64 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.961 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.558 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.08 -43.3 95.83 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.183 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.558 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.4 tt0 91.85 52.64 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.875 0.734 . . . . 0.0 110.961 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -103.47 -9.02 19.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.377 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.475 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -65.23 -33.25 75.56 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.02 0.438 . . . . 0.0 110.604 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -49.09 -24.51 1.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.619 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.6 t -69.67 -45.92 76.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.31 -48.47 81.22 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.111 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -38.38 90.17 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.364 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.8 -32.64 53.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.23 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.615 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.2 mmt-85 -89.91 1.72 55.89 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.468 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.615 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.95 -49.93 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.897 0.748 . . . . 0.0 110.294 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.668 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.1 mt -45.55 153.86 0.23 Allowed 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.456 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.668 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 121.01 92.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 125.218 1.574 . . . . 0.0 110.458 -178.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.54 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.28 142.72 43.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.201 0.524 . . . . 0.0 110.191 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.4 mt -131.71 26.75 4.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.467 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -140.11 137.52 34.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 110.51 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.632 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.0 mt -136.84 164.88 29.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.406 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.97 -28.4 1.86 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.469 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.71 70.62 7.29 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.101 0.477 . . . . 0.0 110.327 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.07 145.31 98.72 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.687 2.258 . . . . 0.0 112.215 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.7 t -133.8 136.11 44.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.527 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.74 -38.42 83.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.662 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.48 -41.99 96.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.52 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.11 -41.54 98.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.516 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -63.64 -43.29 98.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.976 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.1 77.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.284 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.76 -18.37 59.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.454 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.77 -6.39 58.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.508 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.416 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 75.2 mtp 47.93 55.79 17.17 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.614 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.6 Cg_endo -69.94 149.36 65.63 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.88 2.386 . . . . 0.0 112.114 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.76 -73.05 0.66 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.488 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.6 tp -111.43 114.21 27.18 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.267 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -103.49 126.97 57.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.525 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 mt -110.71 134.51 52.4 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.184 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.12 140.15 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.555 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.7 p -83.57 168.02 16.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.689 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.31 -37.26 80.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.472 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 t -139.19 158.4 44.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.486 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.3 177.0 33.54 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.71 86.99 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -125.28 151.7 45.64 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.913 0.387 . . . . 0.0 110.551 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.9 t -63.29 141.34 58.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.379 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.18 10.7 10.72 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.631 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.15 -38.97 88.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.15 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.7 -35.97 24.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.432 0.634 . . . . 0.0 110.633 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.2 mt -70.98 -35.1 71.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.486 0.66 . . . . 0.0 110.72 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -42.88 -62.94 0.88 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.285 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.61 -42.84 91.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.066 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -62.11 -32.29 72.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.242 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.4 mt -74.28 -40.64 62.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.969 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.44 -49.09 78.55 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.275 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.7 m -52.92 -42.85 65.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.157 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.18 -43.06 92.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -168.83 151.71 5.09 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.71 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -38.61 107.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.621 2.214 . . . . 0.0 112.387 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.643 ' C ' HD12 ' A' ' 140' ' ' LEU . 97.2 m -109.75 121.64 45.69 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.2 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.0 153.34 29.53 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.309 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -128.46 131.11 69.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.371 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.18 128.19 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.571 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 54.6 t30 -100.77 104.94 16.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.227 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.411 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.4 p90 -100.71 -11.94 19.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.893 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.0 p-10 -64.95 -33.69 76.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.742 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -99.29 7.91 45.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.542 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.411 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.8 mttm -134.57 151.84 51.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.869 0.366 . . . . 0.0 110.529 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.427 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.7 p -75.82 166.26 23.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.597 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.4 t90 -59.25 -48.62 80.94 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.276 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -54.44 -44.1 72.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.03 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.4 t -62.96 -40.7 98.5 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.202 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.436 ' O ' HD23 ' A' ' 156' ' ' LEU . 63.4 tp -60.92 -44.34 97.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.3 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 49.2 tp -61.49 -42.98 99.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.198 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.8 m -55.9 -45.7 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.741 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.23 -40.56 96.55 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.836 0.35 . . . . 0.0 110.394 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.45 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.03 -42.5 99.24 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.222 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.73 -40.06 95.56 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.42 -45.95 64.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.8 -44.0 96.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.5 p -92.77 -9.09 41.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.704 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.93 26.29 72.22 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -101.22 50.47 0.86 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.776 0.322 . . . . 0.0 110.629 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.48 -39.17 77.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.658 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.9 -47.45 85.73 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.213 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.4 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 88.0 mt-30 -59.97 -39.27 85.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.162 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.92 98.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.238 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.88 -29.13 70.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.558 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -73.86 -54.41 8.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.059 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.527 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.6 ttp180 -64.86 -42.13 95.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.455 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 174' ' ' ASP . 78.4 mt -62.43 -43.82 98.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.487 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.28 -58.71 6.72 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.009 0.433 . . . . 0.0 110.368 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -56.61 -33.57 66.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.37 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -81.1 -36.12 30.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.78 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.1 m-20 -54.84 -42.35 71.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.062 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.17 -41.77 98.64 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.696 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.0 -38.02 89.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.383 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.45 -42.48 99.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.653 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.75 -53.06 61.14 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.132 0.492 . . . . 0.0 110.752 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.48 -41.76 88.48 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.618 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.09 95.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.67 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.14 -32.63 74.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.418 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.06 -21.47 19.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.728 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.588 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.6 tt0 -64.87 -41.58 95.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.733 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.0 pt -76.5 133.9 30.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.675 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.71 106.46 9.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.4 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.59 128.37 0.34 Allowed Pre-proline 0 C--O 1.238 0.479 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.553 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.3 Cg_exo -43.65 151.42 0.4 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.839 2.359 . . . . 0.0 112.497 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.67 142.18 52.22 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.611 2.208 . . . . 0.0 112.421 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.542 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.72 147.17 2.39 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.542 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.15 153.93 70.93 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.787 2.325 . . . . 0.0 112.278 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.47 163.23 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.159 0.504 . . . . 0.0 110.45 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.75 169.93 16.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.832 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.68 137.4 22.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.3 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.53 HG22 HD12 ' A' ' 205' ' ' LEU . 39.2 pt -134.19 146.03 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.592 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -133.39 132.01 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.054 0.454 . . . . 0.0 110.517 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -151.82 154.45 36.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.48 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.0 m -121.56 122.69 40.23 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.955 0.407 . . . . 0.0 110.368 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.74 -25.59 66.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.595 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.96 -49.66 19.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.992 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.01 -11.53 60.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.403 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.6 m80 49.14 42.47 21.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.495 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.0 t -135.94 144.98 45.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.319 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.82 114.12 27.22 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.375 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -120.18 133.71 55.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.986 0.422 . . . . 0.0 110.399 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.18 146.53 37.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.74 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.48 ' N ' HD23 ' A' ' 205' ' ' LEU . 13.3 t90 -99.38 127.96 45.46 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.101 0.477 . . . . 0.0 109.987 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.7 153.42 41.14 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.264 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.9 -18.29 46.81 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.648 2.232 . . . . 0.0 111.962 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -18.75 0.59 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.368 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.443 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.1 p -75.21 167.7 21.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.476 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.11 -35.56 75.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.3 mt-30 -56.64 -41.19 76.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.763 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.37 -43.04 97.68 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.492 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.4 mt-30 -63.75 -40.08 95.84 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 122.549 -0.383 . . . . 0.0 110.542 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.597 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.2 mmm -61.56 -41.87 98.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.376 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.56 -49.88 71.67 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.473 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.11 -33.06 50.62 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -71.09 -20.21 62.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.558 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 219' ' ' LEU . 65.9 mt -87.28 -6.42 58.55 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.74 3.52 57.16 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -88.34 149.85 23.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.93 0.395 . . . . 0.0 110.507 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.441 ' O ' HG12 ' A' ' 191' ' ' VAL . 3.0 p -112.78 126.49 55.47 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.127 0.489 . . . . 0.0 110.355 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.79 145.84 24.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.999 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.489 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -70.06 150.77 46.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.438 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.86 131.21 44.43 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.502 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.896 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.69 93.25 27.51 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.118 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.679 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.6 Cg_exo -55.77 138.99 83.15 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.655 2.236 . . . . 0.0 111.561 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.75 -25.13 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.399 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.75 -49.91 27.2 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.56 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.1 mt -54.37 -37.01 64.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.54 35.92 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.801 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.56 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.58 87.92 0.01 OUTLIER 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.864 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 82.3 p -81.64 -14.28 56.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.351 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.51 -41.8 10.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.609 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.9 -16.91 64.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.587 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.91 43.69 27.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.504 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.21 -149.62 8.44 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -120.29 142.79 48.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.976 0.417 . . . . 0.0 110.36 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.24 149.76 29.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.366 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -101.21 -151.7 0.42 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.358 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 56.21 -91.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.688 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.479 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.3 tt -127.08 175.61 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.597 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.479 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.6 mt -122.23 141.68 41.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.81 169.26 9.36 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.255 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.3 mt -147.57 150.71 34.99 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.223 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.57 -39.06 97.21 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.33 3.74 4.67 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.11 -58.44 3.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.911 0.386 . . . . 0.0 110.568 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.55 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.9 m-20 -61.95 -36.57 81.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.29 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 9.9 mp -52.3 -67.8 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.757 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.42 -42.21 66.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.148 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.87 18.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.657 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.75 47.64 0.23 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 39.13 -110.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.521 0.201 . . . . 0.0 110.743 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.489 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.9 -44.98 96.37 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.473 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.78 8.1 83.17 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -99.14 -12.57 20.36 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.805 -0.232 . . . . 0.0 110.642 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.3 t 176.24 142.65 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.052 0.453 . . . . 0.0 110.493 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.432 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.1 125.47 11.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.156 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -98.37 143.03 29.27 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 120.848 0.356 . . . . 0.0 110.837 178.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.2 mt -94.41 106.52 18.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.674 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.469 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.87 -12.74 18.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.149 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.79 90.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.895 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.9 173.2 45.81 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.472 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 87.5 m-20 -74.07 -113.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 110.723 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.15 -28.91 68.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.765 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.08 -44.09 91.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.187 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.51 -44.45 94.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.318 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.32 -59.78 4.0 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.25 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.25 -43.47 61.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.111 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.2 -43.84 74.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.244 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.1 mt -64.39 -43.58 97.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.679 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -56.59 -37.67 70.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.163 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.28 1.17 19.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.212 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -115.04 91.47 27.13 Favored Pre-proline 0 C--O 1.231 0.114 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.17 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.14 -27.33 29.18 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.821 2.347 . . . . 0.0 111.864 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.4 -41.17 98.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.55 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.9 mp -95.24 4.75 53.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.396 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.71 -35.31 70.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.099 0.476 . . . . 0.0 110.673 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.76 4.62 15.8 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.624 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.79 121.15 80.26 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.565 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -47.64 -37.35 26.96 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.464 2.11 . . . . 0.0 112.472 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.528 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.88 -43.35 90.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.319 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.04 -43.8 92.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.303 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -64.95 -40.76 95.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.341 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 47.3 t-20 -89.15 -13.16 39.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.577 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.5 mtmt 62.66 32.05 16.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.93 44.51 1.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.292 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.68 135.4 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.551 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.6 132.41 56.69 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.398 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.49 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.83 88.69 6.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.786 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.425 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.4 mt -63.87 -41.72 97.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.78 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.469 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.82 165.9 34.41 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 75.5 p -75.61 -25.92 57.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.719 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -68.29 -33.97 75.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.552 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 296' ' ' THR . 98.7 m -72.62 19.85 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.668 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.508 ' O ' ' NE2' ' A' ' 212' ' ' GLN . 49.1 t80 -57.28 -51.01 71.1 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.014 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 70.9 mmt-85 -107.85 149.18 28.58 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 41.1 tp -115.67 126.26 53.9 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.862 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.475 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.6 t0 -149.74 166.67 28.71 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.611 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -49.21 -38.04 24.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.613 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.65 -65.11 0.8 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.454 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -60.71 -32.82 72.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.974 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.49 -25.21 24.1 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.3 mtt -63.67 -41.02 98.23 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 120.811 0.339 . . . . 0.0 110.945 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -78.37 -44.36 25.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.988 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.573 HG21 HG23 ' A' ' 296' ' ' THR . 79.7 t -65.97 -42.93 92.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.431 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.588 HD11 ' NE2' ' A' ' 183' ' ' GLN . 49.8 tp -60.01 -46.92 87.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.448 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -70.61 -39.48 73.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.988 0.423 . . . . 0.0 110.603 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.49 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 73.6 ttt180 -61.35 -38.0 85.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.319 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.8 mt -87.76 4.91 42.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.698 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -112.22 -11.71 13.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.041 0.448 . . . . 0.0 110.337 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.79 -37.1 85.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.489 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.96 -48.75 80.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.435 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.958 179.872 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.612 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -90.3 -2.39 58.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.441 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.93 179.04 1.25 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.525 -179.67 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.0 Cg_exo -60.74 144.81 99.61 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.802 2.334 . . . . 0.0 112.191 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.612 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.4 ptt-85 -156.09 -179.46 8.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.597 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.62 136.19 53.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.322 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.411 ' HA ' HD12 ' A' ' 30' ' ' ILE . 9.5 tp -123.78 146.53 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.432 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.8 p -119.78 135.99 54.63 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.719 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.1 p30 -99.28 -143.5 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.328 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.8 p -63.66 -37.0 85.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.42 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.31 -66.78 0.22 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.437 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.06 142.12 44.65 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.6 p -112.09 131.23 55.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.411 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -119.2 129.17 54.83 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.498 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.1 m -85.62 130.3 34.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.301 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' OE1' ' A' ' 42' ' ' GLN . 67.4 mt -95.69 78.58 3.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.399 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.82 -32.03 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.482 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.27 108.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.204 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.489 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -121.97 91.31 48.85 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.322 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.658 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.1 Cg_exo -56.94 148.8 65.48 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.782 2.321 . . . . 0.0 111.888 179.049 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.82 82.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.487 0.492 . . . . 0.0 110.922 -179.19 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.658 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.09 66.79 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.277 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.45 130.93 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.748 -179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.548 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.1 t -122.82 145.57 29.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.191 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.9 t -135.13 143.59 46.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.681 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.2 p -99.54 -59.26 1.75 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.576 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.4 p -79.74 155.11 28.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.593 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.482 HG21 HG23 ' A' ' 70' ' ' THR . 71.4 t -74.58 -21.9 17.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.46 179.472 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.2 m -59.9 -52.32 65.92 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.508 -178.606 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.0 mt -66.53 -42.35 87.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.129 0.49 . . . . 0.0 110.8 178.111 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.6 m -42.91 -53.73 4.55 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.169 -178.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.46 -37.34 69.42 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 178.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 m -62.79 -44.62 95.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.955 0.407 . . . . 0.0 110.484 -179.463 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.5 mt -66.37 -41.85 88.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.367 0.603 . . . . 0.0 110.683 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tp -62.5 -40.25 96.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.297 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.468 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.98 -35.75 75.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.033 -178.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.539 HD11 HD12 ' A' ' 156' ' ' LEU . 31.6 pt -91.57 28.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.163 -179.163 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.38 51.78 10.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.795 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.86 75.91 24.0 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.999 0.428 . . . . 0.0 110.05 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.19 151.27 86.03 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.739 2.293 . . . . 0.0 112.3 -178.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.548 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.51 137.48 46.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.156 0.503 . . . . 0.0 110.339 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.3 pt -69.41 -43.56 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.129 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.96 131.09 53.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.958 0.408 . . . . 0.0 110.613 -178.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.1 p -155.8 169.03 25.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.515 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.87 -177.43 21.63 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.628 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.01 172.19 12.96 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 120.979 0.418 . . . . 0.0 110.444 179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.482 HG23 HG21 ' A' ' 51' ' ' VAL . 11.9 p -133.76 -110.72 0.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.364 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.549 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.95 179.53 0.96 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.421 -179.202 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.7 Cg_exo -60.89 58.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.011 2.474 . . . . 0.0 112.079 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.4 t-20 -64.29 -35.03 79.52 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.52 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.3 m120 94.96 -37.66 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.926 0.766 . . . . 0.0 110.031 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.64 -40.01 95.67 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.256 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.5 p -73.94 -26.44 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.697 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.9 -172.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.504 -179.402 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -73.88 -152.51 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.72 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.3 p-10 -54.78 -6.33 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.674 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.4 113.56 23.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.634 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.4 72.66 1.28 Allowed Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -143.68 148.56 35.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.919 0.39 . . . . 0.0 110.759 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.76 -99.15 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.136 178.85 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.564 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.28 -42.74 96.27 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.322 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.564 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.0 tt0 91.5 52.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.772 0.67 . . . . 0.0 110.951 178.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.45 -9.25 19.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.412 179.114 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.0 p -64.74 -33.78 76.78 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.112 0.482 . . . . 0.0 110.643 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -48.66 -23.35 1.0 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.591 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.8 t -70.05 -45.87 74.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.789 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.25 -48.65 80.49 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.183 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.61 -38.15 89.08 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.382 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.64 -32.39 51.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.237 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.617 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.5 mmt-85 -89.98 1.68 56.0 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.547 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.617 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.89 -49.1 0.16 Allowed 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.816 0.697 . . . . 0.0 110.342 179.141 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.683 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.9 mt -46.3 154.05 0.3 Allowed 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.557 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.683 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 121.12 92.26 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.029 1.456 . . . . 0.0 110.543 -178.579 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.537 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.3 143.3 43.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.078 0.466 . . . . 0.0 110.287 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 mt -131.92 26.97 4.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.847 0.356 . . . . 0.0 110.479 -179.322 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.48 138.15 34.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.004 0.431 . . . . 0.0 110.481 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.8 mt -137.19 165.15 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.429 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.62 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.11 -28.55 1.84 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.469 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -153.21 70.64 6.93 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.039 0.447 . . . . 0.0 110.391 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.15 145.53 98.28 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.801 2.334 . . . . 0.0 112.011 -179.527 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.1 t -134.04 136.81 44.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.57 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.33 82.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.656 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.42 -42.28 96.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.476 -179.402 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.71 98.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.484 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.4 t -63.66 -43.18 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.136 179.398 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.74 -35.23 77.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.249 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.82 -18.28 59.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.432 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.7 -6.53 58.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.523 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.413 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 66.9 mtp 48.04 55.96 17.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.623 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.9 Cg_endo -70.22 149.1 63.45 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.771 2.314 . . . . 0.0 112.134 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.36 -72.87 0.67 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.539 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.427 HD11 HD13 ' A' ' 140' ' ' LEU . 39.2 tp -111.42 112.4 24.12 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.377 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 75.6 mt -100.59 126.03 54.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.516 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.9 mt -109.38 133.0 53.6 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.287 -179.443 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.47 139.61 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.573 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.5 p -83.44 168.38 16.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.705 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.41 80.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.483 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.8 t -139.33 158.87 43.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.96 0.409 . . . . 0.0 110.446 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.16 177.04 33.41 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.91 87.39 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.97 151.62 45.25 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.906 0.384 . . . . 0.0 110.546 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.1 t -63.18 141.27 58.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.398 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.51 10.93 10.54 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.659 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.14 -38.83 87.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.099 -179.404 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.64 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.86 -35.79 23.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.377 0.608 . . . . 0.0 110.579 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.7 mt -71.06 -35.17 71.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.396 0.617 . . . . 0.0 110.691 179.333 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -42.94 -62.82 0.92 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.229 -178.755 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.64 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.87 -42.63 90.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.997 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.18 -32.28 72.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.266 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.4 mt -74.41 -40.54 61.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 178.686 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.93 -48.86 78.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.219 -179.08 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.5 m -52.66 -42.68 64.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.215 179.396 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.06 -43.05 92.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.173 179.147 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.36 153.21 5.22 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.622 -179.128 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -39.03 107.33 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.664 2.243 . . . . 0.0 112.435 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 93.8 m -108.72 121.01 44.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.287 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.03 152.52 30.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.343 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -129.0 131.51 68.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.42 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.11 127.68 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.55 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.8 t30 -101.83 103.86 14.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.359 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 147' ' ' LYS . 49.1 p90 -101.29 -11.31 19.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.801 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.7 p-10 -64.77 -33.52 76.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.728 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.577 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.8 p-10 -98.33 7.68 45.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.568 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.34 155.44 50.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.508 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.3 p -74.66 165.69 24.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.615 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.571 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 90.9 t90 -60.04 -48.7 80.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.38 -179.189 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.87 -41.87 67.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.005 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.9 t -62.6 -40.77 97.98 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.484 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 156' ' ' LEU . 48.4 tp -60.62 -43.94 96.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.417 -179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.5 HD23 HD11 ' A' ' 170' ' ' ILE . 46.1 tp -61.47 -42.96 99.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.21 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.5 m -55.75 -45.31 78.09 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.4 -40.69 97.32 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.881 0.372 . . . . 0.0 110.408 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.539 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.96 -42.38 99.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.158 179.233 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.65 -40.72 96.04 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.87 -46.04 63.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.853 0.359 . . . . 0.0 110.829 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.62 -44.03 96.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.795 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.5 p -93.01 -8.79 41.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.676 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.76 25.19 71.67 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -101.87 52.01 0.82 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.658 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.92 -39.03 76.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.685 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.28 -47.08 86.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.252 -179.403 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -61.4 -38.93 88.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.291 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.43 97.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.41 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.48 -27.54 69.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.507 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.92 -53.78 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.134 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.494 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -63.66 -43.49 96.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.441 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.0 mt -63.06 -43.85 99.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.7 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.3 -61.65 2.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.064 0.459 . . . . 0.0 110.392 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -54.61 -35.08 63.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.44 -179.178 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -79.75 -34.46 39.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.909 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 170' ' ' ILE . 50.2 m-20 -56.83 -40.14 75.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.805 -178.616 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.89 -42.45 99.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.937 0.399 . . . . 0.0 110.709 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.68 -37.96 87.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.292 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 177' ' ' LEU . 83.0 mt -62.33 -42.49 99.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.704 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.95 -53.29 57.76 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.081 0.467 . . . . 0.0 110.694 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.27 -41.66 89.56 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.633 179.398 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.76 94.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.68 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.22 -32.21 73.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.379 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -94.49 -21.67 18.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.615 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.469 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -64.94 -41.63 95.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.631 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.4 pt -77.52 136.09 25.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.745 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.24 108.95 11.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.338 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.74 126.38 0.31 Allowed Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.519 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.462 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.9 Cg_exo -43.88 152.13 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.76 2.307 . . . . 0.0 112.519 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.18 141.72 53.26 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.627 2.218 . . . . 0.0 112.354 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.37 147.22 2.11 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.497 179.402 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.21 154.46 69.88 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.764 2.31 . . . . 0.0 112.254 178.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.5 163.07 28.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.437 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.76 170.1 16.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.899 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.0 137.48 22.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.948 0.404 . . . . 0.0 110.315 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.535 HG22 HD12 ' A' ' 205' ' ' LEU . 38.9 pt -134.2 146.08 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.607 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.71 131.61 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.109 0.48 . . . . 0.0 110.497 178.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -151.94 154.8 36.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.406 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.62 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.0 m -122.05 122.82 40.17 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.945 0.402 . . . . 0.0 110.393 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.33 -25.64 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.618 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.62 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.39 -48.86 21.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.04 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.03 -11.73 60.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.414 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.4 m80 49.19 42.19 21.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.478 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.1 t -136.5 145.58 45.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.373 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.15 114.24 27.34 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.348 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.89 133.33 55.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.036 0.446 . . . . 0.0 110.376 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.535 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.03 146.38 38.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.713 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.488 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 12.2 t90 -99.37 130.01 45.61 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.121 0.486 . . . . 0.0 110.096 179.246 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.89 153.95 39.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.097 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.71 -18.22 47.84 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.796 2.33 . . . . 0.0 111.93 178.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.11 -18.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.405 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.488 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.5 p -75.97 164.98 25.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.497 179.648 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.96 -27.99 65.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.51 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.528 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.69 -41.56 98.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.763 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.91 -44.86 96.73 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.8 mt-30 -64.57 -38.81 92.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.957 0.408 . . . . 0.0 110.709 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.571 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.3 mmm -62.03 -41.44 98.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.229 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.4 mt -63.79 -47.25 81.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.912 0.387 . . . . 0.0 110.607 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.16 -32.07 54.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.154 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -70.79 -18.29 62.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.58 179.547 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.426 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.8 mt -88.7 -8.61 54.25 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.641 -179.558 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.67 2.75 55.32 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -88.48 151.91 22.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.509 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.448 ' O ' HG12 ' A' ' 191' ' ' VAL . 7.8 p -114.95 127.83 55.92 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.052 0.453 . . . . 0.0 110.427 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.566 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.35 146.13 23.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.962 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.472 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.56 151.07 46.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.524 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.65 131.65 43.34 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.487 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.894 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.62 93.73 29.37 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.139 -179.789 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.683 ' C ' ' H ' ' A' ' 229' ' ' GLY . 47.3 Cg_exo -55.63 138.72 81.74 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.673 2.249 . . . . 0.0 111.59 179.153 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.75 -25.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.444 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.47 -49.77 29.65 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.55 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -53.46 -36.43 61.61 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -67.16 36.57 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.725 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.55 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.63 86.67 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.831 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.3 p -78.83 -15.72 58.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.53 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.22 -40.77 10.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.626 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.9 t -66.2 -17.73 64.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.573 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.41 43.25 26.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.418 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.85 -146.6 6.98 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -123.39 143.21 50.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.96 0.409 . . . . 0.0 110.335 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.07 149.61 29.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.422 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -100.5 -152.17 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.391 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 55.9 -91.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.567 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.471 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.65 175.46 8.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.564 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.471 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.9 mt -122.16 141.76 41.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.734 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -100.0 169.12 9.41 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.328 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.5 mt -147.83 151.18 35.52 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.133 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.78 -39.01 97.01 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.19 4.1 4.63 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.23 -58.38 3.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.939 0.399 . . . . 0.0 110.573 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.546 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.0 m-20 -61.98 -36.97 83.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.313 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.19 -67.73 0.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.813 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.46 -42.09 66.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.153 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.12 18.06 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.637 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.92 48.34 0.27 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.57 -110.0 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.667 0.27 . . . . 0.0 110.717 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.472 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 12.3 m120 -60.62 -45.35 94.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.471 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.88 8.15 82.93 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.23 -12.61 20.24 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.799 -0.236 . . . . 0.0 110.631 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.6 t 176.2 142.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.063 0.459 . . . . 0.0 110.553 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.433 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.85 125.31 11.67 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.047 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.432 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -98.43 142.98 29.38 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 120.88 0.371 . . . . 0.0 110.781 178.167 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.3 mt -94.17 106.43 18.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.652 -179.169 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.468 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.2 t80 -101.96 -11.41 18.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.182 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.42 -40.33 85.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.788 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.39 173.75 46.11 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.499 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.5 m-20 -74.44 -113.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.756 0.312 . . . . 0.0 110.71 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.62 -28.57 67.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.685 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.01 -44.21 91.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.313 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.68 -44.4 93.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.354 179.239 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.38 -60.16 3.56 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.295 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.02 -43.34 60.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.227 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.39 -43.92 75.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.258 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.0 mt -64.55 -43.71 96.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.598 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -56.27 -37.72 70.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.268 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.94 1.22 18.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.316 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -115.04 91.14 25.77 Favored Pre-proline 0 CA--C 1.528 0.122 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.207 -179.759 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.98 -27.18 27.45 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.818 2.345 . . . . 0.0 111.879 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.45 -41.08 98.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.565 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.31 5.03 52.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.459 -179.223 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.95 -35.01 69.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.735 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.87 4.74 15.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.541 -178.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.533 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.88 121.39 81.27 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.561 179.918 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -47.53 -37.8 26.9 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.539 2.159 . . . . 0.0 112.427 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.533 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.72 -43.72 90.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.38 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.89 -43.69 92.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.335 179.334 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.67 -40.6 95.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.49 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.7 t-20 -89.84 -12.19 39.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.563 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.4 mtmt 61.85 31.85 18.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.959 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.47 44.15 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.34 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.18 135.82 41.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.465 -179.661 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.5 132.34 56.7 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.521 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.2 87.97 6.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.728 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.94 -41.35 97.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.885 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.468 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.21 167.89 34.44 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.728 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 75.5 p -75.89 -25.82 56.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.381 . . . . 0.0 110.797 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.6 tp10 -67.9 -34.18 76.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.489 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.768 HG22 ' O ' ' A' ' 296' ' ' THR . 97.0 m -73.24 19.9 0.09 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.69 -179.142 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.528 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 53.0 t80 -57.24 -51.14 70.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.018 -179.543 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -108.22 149.41 28.62 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.765 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.426 ' CD2' HD11 ' A' ' 219' ' ' LEU . 41.5 tp -115.26 125.26 53.1 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.672 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.468 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.5 t0 -149.08 166.29 29.18 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.624 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -49.08 -38.19 23.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.632 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -71.96 -64.99 0.83 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.262 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -60.81 -32.52 71.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.864 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.85 -25.6 29.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.617 -179.049 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.8 mtt -63.23 -41.23 99.09 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 120.9 0.381 . . . . 0.0 110.883 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.19 -44.4 25.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.994 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.568 HG21 HG23 ' A' ' 296' ' ' THR . 76.5 t -66.14 -42.88 92.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.397 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.469 HD11 ' NE2' ' A' ' 183' ' ' GLN . 49.4 tp -59.89 -47.46 85.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.451 -178.608 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -69.85 -39.72 76.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.047 0.451 . . . . 0.0 110.888 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.499 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 72.2 ttt180 -61.52 -38.19 86.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.29 -179.048 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.2 mt -87.48 5.04 41.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.658 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -112.66 -11.78 13.49 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.049 0.452 . . . . 0.0 110.259 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.84 -37.16 85.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.56 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.82 -48.88 79.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.427 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.022 179.786 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.45 -2.83 57.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.481 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.46 179.12 1.24 Allowed Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.477 -179.722 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.4 Cg_exo -60.52 144.42 99.52 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.79 2.326 . . . . 0.0 112.235 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.5 ptt-85 -155.75 -179.9 8.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.55 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.58 136.77 52.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.042 0.448 . . . . 0.0 110.312 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' HA ' HD12 ' A' ' 30' ' ' ILE . 9.1 tp -124.41 146.2 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.39 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -119.54 135.97 54.55 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.805 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.9 p30 -98.71 -144.11 0.32 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.17 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.65 -36.49 84.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.405 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -147.58 -70.27 0.23 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.43 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.81 144.12 41.77 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.263 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.8 p -112.8 129.84 56.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.914 0.387 . . . . 0.0 110.451 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -114.68 129.66 56.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.683 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.9 m -86.95 130.68 34.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.35 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.496 HD22 ' OE1' ' A' ' 42' ' ' GLN . 70.4 mt -97.61 78.87 2.67 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.434 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.8 -32.58 74.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.544 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 t 177.15 109.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.118 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.496 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.2 pt20 -124.52 91.5 49.4 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.39 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.62 149.27 59.46 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.865 2.377 . . . . 0.0 111.962 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -40.22 82.36 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.624 0.578 . . . . 0.0 110.998 -179.182 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.69 66.66 0.87 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.477 . . . . 0.0 110.18 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -77.28 131.23 35.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.555 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.4 t -122.65 147.86 26.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.104 0.478 . . . . 0.0 110.073 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.9 t -136.17 143.61 44.54 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.725 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 50' ' ' SER . 27.2 p -99.26 -59.96 1.62 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.618 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.401 ' N ' ' OG1' ' A' ' 49' ' ' THR . 87.1 p -79.07 156.14 28.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.64 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.575 HG21 HG23 ' A' ' 70' ' ' THR . 68.9 t -74.59 -21.55 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.572 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 100.0 m -60.15 -51.99 67.24 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.513 -178.496 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.0 mt -66.28 -42.44 88.41 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.817 177.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.23 -54.36 4.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.998 -178.624 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.11 -38.77 73.29 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.304 -0.719 . . . . 0.0 111.304 178.643 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.6 m -62.29 -43.67 98.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.934 0.397 . . . . 0.0 110.199 -179.361 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.7 mt -65.46 -42.41 92.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.502 0.668 . . . . 0.0 110.684 179.414 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.6 tp -63.08 -38.74 92.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.263 -179.348 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -61.59 -36.65 81.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.224 -178.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -91.22 27.6 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.148 -179.188 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.419 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 90.6 m-20 57.11 52.46 9.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.123 179.41 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.79 76.48 28.94 Favored Pre-proline 0 C--O 1.225 -0.223 0 CA-C-O 121.039 0.447 . . . . 0.0 109.891 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.67 148.2 92.32 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.733 2.289 . . . . 0.0 112.08 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -112.67 136.27 49.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.126 0.489 . . . . 0.0 110.395 179.724 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -70.11 -43.05 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.189 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.76 131.04 53.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.979 0.419 . . . . 0.0 110.637 -178.844 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.542 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.3 p -155.58 168.42 27.19 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.424 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.61 -177.26 21.81 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.646 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.57 172.43 12.75 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 121.081 0.467 . . . . 0.0 110.422 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.575 HG23 HG21 ' A' ' 51' ' ' VAL . 14.2 p -132.95 -112.09 0.23 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.452 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.63 179.7 0.93 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.497 -179.245 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.5 Cg_exo -60.83 57.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.966 2.444 . . . . 0.0 112.157 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.4 t-20 -64.42 -33.51 76.03 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.417 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.5 m120 93.91 -36.17 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.779 0.675 . . . . 0.0 109.899 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.401 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.6 mtp85 -63.21 -39.72 95.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.203 179.273 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.33 -25.3 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.688 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.24 -170.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.468 -179.354 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.83 -154.91 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.878 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.3 p-10 -51.44 -7.92 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.823 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.516 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -85.68 114.99 23.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.693 179.59 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.38 70.87 1.32 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -144.87 148.07 33.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.924 0.392 . . . . 0.0 110.752 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.9 mp -85.92 -98.46 0.07 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.178 178.745 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.0 -42.53 97.13 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.176 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.1 tt0 91.47 53.03 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.868 0.73 . . . . 0.0 110.877 179.037 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -102.69 -9.55 19.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.331 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.5 p -63.88 -34.42 77.92 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.05 0.452 . . . . 0.0 110.703 -179.754 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -49.13 -23.86 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.59 179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.0 t -70.11 -45.21 76.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.592 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.42 -48.53 80.79 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.923 -179.489 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.04 -38.38 88.49 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.436 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.31 -34.36 57.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.251 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.61 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.6 mmt-85 -88.43 1.08 55.48 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.608 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.5 mttp 83.17 -47.94 0.14 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.845 0.715 . . . . 0.0 110.315 179.163 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.668 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.4 mt -46.68 153.3 0.4 Allowed 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 117.817 -1.087 . . . . 0.0 109.606 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.668 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.6 tt0 122.03 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 O-C-N 125.318 1.636 . . . . 0.0 110.452 -178.573 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.84 142.85 44.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.204 0.526 . . . . 0.0 110.337 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.2 mt -131.95 26.61 4.6 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.096 -0.377 . . . . 0.0 110.49 -179.396 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.09 137.46 34.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.576 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.646 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.0 mt -136.99 164.86 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.411 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.48 -28.83 1.78 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.35 70.5 7.54 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 121.134 0.492 . . . . 0.0 110.219 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.15 145.32 98.74 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.783 2.322 . . . . 0.0 112.098 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.9 t -134.45 137.12 43.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.584 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.56 83.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.655 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.32 -42.0 96.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.485 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.08 -41.79 98.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.466 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.7 -43.21 97.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.063 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.23 -35.27 78.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.218 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.26 -18.3 57.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.433 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -87.09 -6.06 58.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.483 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 70.3 mtp 47.71 55.99 17.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.621 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.0 Cg_endo -70.08 149.26 64.57 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.784 2.323 . . . . 0.0 112.067 179.556 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.24 -72.39 0.68 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.579 179.741 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.403 HD11 HD13 ' A' ' 140' ' ' LEU . 38.2 tp -111.91 113.22 25.4 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.399 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.8 mt -102.0 126.9 55.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.0 0.429 . . . . 0.0 110.587 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.3 mt -110.74 133.72 53.1 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.212 -179.297 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.4 139.92 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.559 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.7 p -83.6 167.41 17.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.683 179.695 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.59 -36.85 79.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.455 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.4 t -138.2 157.78 45.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.456 -179.764 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.55 175.4 34.17 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.55 -33.61 87.03 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.38 151.42 44.42 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.97 0.414 . . . . 0.0 110.513 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.5 t -63.53 140.53 58.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.389 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.05 10.93 10.86 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.648 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -60.96 -38.92 87.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.219 -179.428 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.634 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.14 -35.58 23.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.445 0.641 . . . . 0.0 110.577 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.3 mt -71.16 -35.16 71.56 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.457 0.646 . . . . 0.0 110.654 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -43.02 -62.82 0.93 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.215 -178.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.634 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.5 p-10 -65.98 -42.93 89.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.021 -179.162 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.3 mt-30 -61.73 -32.38 72.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.343 -179.524 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.7 mt -74.38 -40.49 62.05 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.922 178.655 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.09 -49.09 78.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.277 -179.104 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 m -52.92 -42.56 65.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.211 179.392 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.83 -42.72 92.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.152 179.26 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.54 153.16 5.05 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.628 -179.335 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -39.04 106.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.679 2.253 . . . . 0.0 112.393 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.654 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.1 m -109.36 121.89 46.16 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.416 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.654 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.86 154.07 29.3 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.264 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.2 tt -130.38 129.23 64.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.409 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 92.9 mt -110.6 122.71 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.024 0.44 . . . . 0.0 110.614 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.544 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 54.2 t30 -101.17 106.91 18.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.256 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -100.76 0.25 38.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.847 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.4 p-10 -65.61 -34.77 78.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.959 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -101.88 10.22 39.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.728 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -133.99 148.31 51.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.909 0.385 . . . . 0.0 110.49 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.409 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 22.9 p -77.61 168.82 19.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.623 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.6 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.1 t90 -58.7 -49.87 75.99 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.064 -179.009 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -54.46 -46.17 73.26 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.944 0.402 . . . . 0.0 110.048 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 40.1 t -63.07 -40.77 98.67 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.14 0.495 . . . . 0.0 110.314 178.424 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.46 ' O ' HD23 ' A' ' 156' ' ' LEU . 52.0 tp -60.72 -44.54 96.48 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.309 -179.585 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.89 -43.5 98.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.113 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.9 m -54.51 -45.85 73.39 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.86 -40.1 94.2 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.853 0.358 . . . . 0.0 110.364 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 152' ' ' LEU . 2.3 mm? -61.59 -42.2 98.52 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.115 179.234 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.84 -38.8 94.68 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.148 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.52 -45.08 66.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.962 0.41 . . . . 0.0 110.712 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.69 -44.11 96.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.789 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.8 p -93.41 -8.69 41.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.533 -178.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.5 27.08 72.17 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -102.54 50.27 0.83 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.66 -179.552 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -69.31 -39.03 78.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.622 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.56 -47.26 86.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.31 -179.515 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.419 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 86.4 mt-30 -60.5 -39.33 87.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.213 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.51 -41.02 98.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.278 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.31 -29.28 70.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.607 179.334 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.18 -54.46 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.855 179.509 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.419 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.8 ttp180 -64.22 -42.89 96.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.431 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 174' ' ' ASP . 82.0 mt -62.59 -43.77 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.483 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.6 -61.11 2.76 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.2 0.524 . . . . 0.0 110.201 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.77 -34.51 62.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.521 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -80.33 -34.84 36.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.761 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -55.26 -41.71 72.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.059 -178.686 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.2 -41.8 98.7 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.662 179.773 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.14 -37.87 88.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.313 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.33 -42.39 99.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.756 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.8 -52.95 62.08 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.112 0.482 . . . . 0.0 110.59 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.34 -41.43 89.57 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.601 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.28 -39.78 94.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.615 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.64 -33.08 74.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.369 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.54 -21.49 19.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.612 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.574 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -65.18 -41.43 94.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.694 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 184' ' ' ILE . 30.9 pt -76.98 133.83 30.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.802 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -127.55 107.05 9.6 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.298 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.93 127.39 0.31 Allowed Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.483 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.78 151.99 0.38 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.865 2.377 . . . . 0.0 112.53 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.52 142.39 53.67 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.599 2.199 . . . . 0.0 112.368 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.545 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.78 146.86 2.3 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.548 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.0 153.9 71.65 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.855 2.37 . . . . 0.0 112.37 178.661 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.58 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.37 163.11 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 110.475 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.58 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.93 170.72 15.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.032 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.74 137.8 21.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.074 0.464 . . . . 0.0 110.098 179.388 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.55 HG22 HD12 ' A' ' 205' ' ' LEU . 39.9 pt -134.39 146.64 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.691 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.44 131.68 60.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.1 0.476 . . . . 0.0 110.472 178.821 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -152.09 154.84 36.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.431 179.218 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.5 m -122.02 122.71 39.93 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.921 0.391 . . . . 0.0 110.341 179.469 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.89 -25.34 66.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.662 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.613 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.12 -49.34 19.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.899 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.16 -11.49 60.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.345 -179.535 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.2 m80 49.21 42.57 21.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.483 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.0 t -136.42 144.56 44.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.33 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.79 114.54 27.96 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.293 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -120.41 133.95 55.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.048 0.451 . . . . 0.0 110.405 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.55 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.4 146.75 37.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.778 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.563 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 9.4 t90 -100.51 129.28 46.44 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.177 0.513 . . . . 0.0 109.962 179.335 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.27 153.75 41.53 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.164 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.406 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.8 Cg_endo -67.77 -18.05 47.44 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.685 2.256 . . . . 0.0 112.057 178.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -48.74 -18.92 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.468 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.563 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 84.8 p -74.84 163.89 27.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.551 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.5 -28.24 65.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.478 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.507 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.2 mt-30 -63.55 -42.86 98.35 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.577 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.0 -43.74 97.89 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.609 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.409 ' OE1' ' C ' ' A' ' 148' ' ' SER . 74.8 mt-30 -63.68 -38.52 91.42 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 122.271 -0.546 . . . . 0.0 110.629 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.6 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 85.6 mmm -61.99 -41.66 98.28 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.26 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 82.2 mt -63.83 -49.73 71.67 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.136 0.493 . . . . 0.0 110.257 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -51.96 -33.91 39.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.845 0.355 . . . . 0.0 110.241 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -70.88 -20.74 62.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.519 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 75.1 mt -87.61 -6.32 58.34 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 -179.569 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.87 -7.04 57.19 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -77.06 147.6 36.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.854 0.359 . . . . 0.0 110.614 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.423 ' O ' HG12 ' A' ' 191' ' ' VAL . 2.4 p -112.58 126.67 55.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.133 0.492 . . . . 0.0 110.284 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.558 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.41 145.49 24.43 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.995 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.501 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.23 150.59 47.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.448 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -129.98 130.81 45.51 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.379 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.895 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.96 92.79 27.08 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.192 -179.716 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.684 ' C ' ' H ' ' A' ' 229' ' ' GLY . 43.3 Cg_exo -55.61 139.11 82.55 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.581 2.188 . . . . 0.0 111.676 178.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.55 -25.42 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.485 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.684 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.14 -50.2 29.42 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.547 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -53.58 -35.89 61.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.892 0.377 . . . . 0.0 110.132 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -67.57 36.65 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.715 179.558 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.547 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.16 86.33 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.813 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.1 p -79.02 -16.07 57.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.4 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -91.66 -40.67 11.16 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.622 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -66.22 -17.35 64.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.594 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.56 43.22 26.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.462 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.78 -146.17 6.87 Favored Glycine 0 CA--C 1.519 0.292 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -123.39 143.37 50.17 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.961 0.41 . . . . 0.0 110.262 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -151.86 149.32 28.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -100.25 -152.35 0.42 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.43 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.86 -91.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.693 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.466 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.4 tt -126.31 175.1 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.617 -179.427 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.466 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.4 mt -121.7 141.22 43.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.698 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.58 169.35 9.35 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.256 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.7 mt -147.73 151.02 35.38 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.204 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.91 -38.76 96.56 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.96 4.14 4.73 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -77.3 -58.34 3.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.98 0.419 . . . . 0.0 110.522 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.537 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.3 m-20 -62.04 -36.81 82.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.314 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.42 -67.63 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.746 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.43 -42.2 66.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.149 -179.55 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.13 17.99 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.641 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.82 48.58 0.27 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.48 -109.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.516 0.198 . . . . 0.0 110.787 -178.577 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.501 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.3 m120 -60.58 -45.52 93.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.528 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 85.18 7.9 82.51 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -99.04 -12.66 20.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.598 0.237 . . . . 0.0 110.658 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.4 t 176.23 142.88 0.07 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.067 0.46 . . . . 0.0 110.44 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.36 125.35 11.33 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -98.29 143.14 29.09 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 120.873 0.368 . . . . 0.0 110.861 178.193 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.9 mt -94.35 106.75 18.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.762 -179.174 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.454 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.9 t80 -102.1 -12.63 17.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.173 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.36 89.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.88 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.74 173.19 45.86 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.493 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -74.06 -112.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 0.0 110.74 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.81 -28.97 68.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.693 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.81 -43.95 90.69 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.261 -178.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.44 -44.52 94.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.304 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.36 -60.05 3.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.198 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.96 -43.47 60.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.211 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.26 -43.58 74.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.247 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.3 mt -64.57 -43.53 96.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.548 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.45 -37.65 70.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.2 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.14 1.02 19.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.218 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -115.03 91.41 26.83 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.078 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.05 -27.27 28.27 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.769 2.312 . . . . 0.0 111.984 179.322 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.51 -41.09 98.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.584 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.597 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.9 mp -95.52 5.02 52.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.4 -179.269 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.9 -34.89 69.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.647 179.474 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -80.12 4.85 16.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.494 -178.82 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.526 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -69.04 121.23 80.98 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.511 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -47.38 -37.58 25.39 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.513 2.142 . . . . 0.0 112.562 -179.53 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.6 -43.38 89.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.759 0.314 . . . . 0.0 110.372 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.09 -43.51 92.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.309 179.269 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -65.06 -40.72 95.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.349 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 44.4 t-20 -89.31 -12.99 39.0 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.59 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 62.19 31.64 17.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.912 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.53 44.29 1.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.157 0.503 . . . . 0.0 110.366 179.419 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.79 135.69 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.446 -179.701 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.93 132.25 56.75 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.457 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.493 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.3 88.71 6.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.756 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.7 mt -63.87 -41.39 97.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.454 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.52 165.66 33.26 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 77.5 p -75.56 -25.83 57.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.885 0.374 . . . . 0.0 110.791 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.0 tp10 -68.43 -33.71 74.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.483 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.77 HG22 ' O ' ' A' ' 296' ' ' THR . 97.2 m -73.06 21.54 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.696 -179.174 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.507 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 51.7 t80 -57.41 -51.02 71.1 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.413 HH12 ' HG3' ' A' ' 212' ' ' GLN . 70.4 mmt-85 -109.35 151.15 27.0 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.802 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 39.0 tp -115.57 125.13 52.59 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.934 0.397 . . . . 0.0 110.69 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.481 ' CB ' HD23 ' A' ' 83' ' ' LEU . 40.6 t0 -147.94 165.75 29.75 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.631 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -49.35 -37.95 26.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.499 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -70.8 -65.67 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.235 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -61.11 -33.04 72.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.3 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -53.44 -25.6 16.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.575 -179.08 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.1 mtt -63.7 -40.85 97.82 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 120.874 0.368 . . . . 0.0 111.035 179.714 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -78.08 -44.69 25.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.115 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.576 HG21 HG23 ' A' ' 296' ' ' THR . 75.1 t -66.11 -42.76 91.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.383 179.556 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.574 HD11 ' NE2' ' A' ' 183' ' ' GLN . 48.6 tp -59.62 -47.31 86.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.465 -178.505 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -70.32 -39.26 74.89 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.016 0.436 . . . . 0.0 110.729 179.102 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.493 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 72.5 ttt180 -61.66 -38.05 86.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.251 -178.859 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.0 mt -87.74 5.16 41.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.624 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -112.88 -11.59 13.42 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.016 0.436 . . . . 0.0 110.333 179.891 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.08 -37.07 85.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.486 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.78 -48.89 79.77 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.396 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 C--O 1.222 -0.365 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.002 179.836 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.612 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.05 -2.32 58.1 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.371 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.489 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.8 179.15 1.23 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.502 -179.682 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.79 144.98 99.65 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.851 2.367 . . . . 0.0 112.197 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.612 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.99 -179.32 8.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.562 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -115.94 136.77 52.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.327 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.23 146.99 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.369 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.5 p -120.02 135.97 54.73 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.734 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.39 -143.34 0.32 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.259 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.65 -37.04 85.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.536 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.42 -66.48 0.22 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.393 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.52 142.33 45.47 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.331 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.5 p -112.2 131.54 55.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.917 0.389 . . . . 0.0 110.459 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -119.38 128.98 54.57 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.546 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.8 m -85.57 130.15 34.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.191 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.494 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.3 mt -95.62 78.69 3.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.496 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.73 -31.74 72.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.596 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 175.97 109.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.983 0.42 . . . . 0.0 110.109 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.494 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.58 91.41 49.46 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-O 120.752 0.311 . . . . 0.0 110.381 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.647 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.59 148.42 64.2 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.797 2.331 . . . . 0.0 112.067 178.821 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -40.64 82.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.634 0.584 . . . . 0.0 110.963 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.647 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.51 66.92 0.89 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.222 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.21 130.56 36.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.819 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.565 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.7 t -122.49 146.69 27.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.016 -179.66 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 t -135.97 143.7 44.98 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.742 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.5 p -99.35 -59.28 1.75 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.564 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.3 p -79.35 155.09 28.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.583 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.53 HG21 HG23 ' A' ' 70' ' ' THR . 72.4 t -74.1 -21.84 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.548 179.322 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.3 m -60.28 -52.09 66.76 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.499 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.4 mt -66.26 -42.76 88.06 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.8 177.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.1 m -42.87 -54.18 4.3 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.968 -178.521 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.23 -37.17 71.48 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 178.567 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.6 m -62.84 -44.79 95.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.915 0.388 . . . . 0.0 110.16 -179.237 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.2 mt -66.48 -41.91 88.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.521 0.677 . . . . 0.0 110.701 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 tp -62.75 -40.46 97.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.401 -179.264 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.99 -35.93 76.08 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.158 -179.043 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.524 HD11 HD12 ' A' ' 156' ' ' LEU . 32.6 pt -91.15 28.92 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.176 -179.289 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.54 51.74 10.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.971 179.409 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.56 76.05 21.3 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.614 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.07 151.66 84.96 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.74 2.293 . . . . 0.0 112.032 -178.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.565 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.44 137.48 46.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.242 0.544 . . . . 0.0 110.237 179.706 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.442 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.3 pt -69.47 -43.54 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.307 179.35 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.13 131.35 53.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.947 0.403 . . . . 0.0 110.526 -178.86 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.536 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.7 p -155.86 168.65 26.53 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.462 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.42 -177.32 21.93 Favored Glycine 0 N--CA 1.464 0.513 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.631 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.17 171.99 13.27 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.088 0.47 . . . . 0.0 110.36 179.383 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.53 HG23 HG21 ' A' ' 51' ' ' VAL . 14.7 p -131.94 -113.48 0.23 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.981 0.419 . . . . 0.0 110.269 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.99 179.82 0.93 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.407 -179.148 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.5 Cg_exo -60.7 57.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 123.031 2.488 . . . . 0.0 112.18 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.8 t-20 -64.42 -33.64 76.33 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 119.081 -0.485 . . . . 0.0 110.345 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.2 m120 94.03 -36.74 0.02 OUTLIER 'General case' 0 C--N 1.346 0.448 0 O-C-N 123.832 0.707 . . . . 0.0 109.806 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.406 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.5 mtp85 -62.51 -39.7 94.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.191 179.315 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.499 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.25 -25.48 19.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.762 179.374 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.52 -171.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.456 -179.201 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.05 -154.08 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.815 -179.599 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.405 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.2 p-10 -52.49 -7.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.769 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.1 mm-40 -86.32 115.0 23.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.674 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.02 69.92 1.35 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.578 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -143.45 147.72 35.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.971 0.415 . . . . 0.0 110.768 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.66 -98.29 0.07 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.185 178.786 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.25 -42.42 96.52 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.036 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.547 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.0 tt0 91.17 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.988 0.805 . . . . 0.0 110.996 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -102.86 -8.79 20.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.322 179.306 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.6 p -64.87 -33.82 76.92 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.132 0.492 . . . . 0.0 110.763 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -49.36 -23.4 1.45 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.682 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 73.4 t -70.02 -45.86 74.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.688 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.64 80.4 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.891 -179.324 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.36 -38.29 88.96 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.927 0.394 . . . . 0.0 110.509 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.64 -32.34 51.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.185 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.596 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.7 mmt-85 -90.3 1.95 56.0 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.622 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.55 -49.58 0.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.942 0.776 . . . . 0.0 110.223 179.181 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.646 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.0 mt -45.81 154.65 0.21 Allowed 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 117.451 -1.262 . . . . 0.0 109.441 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.646 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 120.8 92.6 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 O-C-N 125.676 1.86 . . . . 0.0 110.471 -178.532 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.536 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.57 143.25 42.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.238 0.542 . . . . 0.0 110.294 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.7 mt -132.42 27.1 4.44 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.976 -0.453 . . . . 0.0 110.391 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.25 137.77 34.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.065 0.46 . . . . 0.0 110.516 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.1 mt -137.01 165.01 28.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.331 179.581 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.2 -28.57 1.82 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -152.98 71.08 7.13 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 121.203 0.525 . . . . 0.0 110.262 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.17 145.54 98.27 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.803 2.335 . . . . 0.0 112.027 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.9 t -134.56 136.85 43.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.597 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.22 81.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.651 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.14 -42.38 96.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.518 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.99 -41.65 98.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.5 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.71 -43.23 97.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.05 179.486 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.17 -35.09 77.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.994 0.426 . . . . 0.0 110.146 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.7 -18.8 61.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.451 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.63 -6.48 58.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.529 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 63.1 mtp 47.22 56.22 17.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.613 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.34 149.9 63.9 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.763 2.309 . . . . 0.0 112.106 179.413 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.14 -74.25 0.62 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.454 179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.448 HD11 HD13 ' A' ' 140' ' ' LEU . 38.4 tp -110.2 113.33 25.93 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.372 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.4 mt -102.04 126.26 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 120.955 0.407 . . . . 0.0 110.661 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.1 mt -109.58 133.95 52.5 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.22 -179.349 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.85 139.63 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.496 -179.586 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.4 p -83.38 168.5 16.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.799 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.13 -37.52 80.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.443 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.79 159.16 42.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.012 0.434 . . . . 0.0 110.381 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.22 176.96 33.49 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.705 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.71 86.99 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -124.82 151.51 45.12 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.925 0.393 . . . . 0.0 110.508 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.3 t -63.26 140.81 58.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.333 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.62 10.37 11.04 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.676 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.52 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -60.83 -38.87 86.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.258 -179.367 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.67 23.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.562 0.696 . . . . 0.0 110.613 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.9 mt -71.11 -35.44 71.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.587 0.708 . . . . 0.0 110.631 179.359 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -42.81 -62.84 0.9 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.353 -178.821 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.85 -42.84 89.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.7 mt-30 -61.99 -32.54 73.01 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.493 0.495 . . . . 0.0 110.427 -179.594 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.7 mt -73.91 -40.95 62.79 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.803 178.727 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.13 -48.86 78.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.153 -178.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.5 m -53.31 -42.38 66.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.036 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.12 -42.61 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.943 0.401 . . . . 0.0 111.199 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.64 154.24 5.39 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.665 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -39.48 106.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.622 2.215 . . . . 0.0 112.589 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.641 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.4 m -110.08 121.4 45.18 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.115 0.483 . . . . 0.0 110.264 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.99 152.84 30.32 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.2 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.91 131.55 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.353 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.402 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.8 mt -115.31 128.02 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.488 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.6 t30 -101.6 103.92 14.77 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.206 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.2 p90 -101.38 -11.18 19.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.823 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.5 p-10 -64.83 -33.5 76.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.704 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -98.45 7.59 45.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.531 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.31 155.45 50.58 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.467 -179.418 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.6 p -75.05 165.68 24.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.695 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.589 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.85 -48.85 80.01 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.166 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -53.5 -42.05 66.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.929 0.395 . . . . 0.0 110.132 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.1 t -62.73 -41.05 98.98 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.36 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.402 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.9 tp -60.5 -44.54 95.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.374 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.8 tp -61.34 -43.33 99.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.235 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.6 m -55.02 -44.94 75.03 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.34 -40.67 97.14 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 120.928 0.394 . . . . 0.0 110.488 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.524 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -62.02 -42.45 99.18 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.418 178.966 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.24 -40.86 94.94 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.68 -45.92 64.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.894 0.378 . . . . 0.0 110.781 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.78 -43.99 96.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.798 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.7 p -93.13 -8.7 41.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.581 -178.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.88 26.64 72.28 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -101.75 50.85 0.84 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 110.65 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -69.55 -39.75 77.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.591 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.16 -47.26 85.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.3 -179.374 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -60.22 -39.3 86.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.136 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.07 -40.87 98.96 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 121.064 0.459 . . . . 0.0 110.279 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.02 -28.31 70.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.685 179.403 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.35 -54.35 7.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.894 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.506 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.51 -42.17 92.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.366 -179.8 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.3 mt -62.4 -43.83 98.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.481 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.3 -58.32 8.15 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.026 0.441 . . . . 0.0 110.216 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.28 -33.1 67.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.689 -179.03 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.415 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.7 t80 -81.53 -36.71 28.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.676 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.1 m-20 -55.92 -41.99 75.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.933 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.49 -42.24 99.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.911 0.386 . . . . 0.0 110.774 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.28 -37.94 88.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.279 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.415 HD11 ' CD2' ' A' ' 173' ' ' PHE . 82.0 mt -62.37 -42.19 99.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.791 179.476 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.15 -52.91 61.93 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.169 0.509 . . . . 0.0 110.628 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.1 -41.81 90.11 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.75 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.99 95.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.652 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.26 -32.07 73.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.429 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.62 -22.38 18.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.679 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.451 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.4 tt0 -64.79 -41.38 95.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.67 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 184' ' ' ILE . 33.0 pt -76.93 136.53 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.72 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.1 108.09 10.6 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.245 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.63 126.01 0.31 Allowed Pre-proline 0 C--O 1.241 0.611 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.562 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.451 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.94 152.46 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.823 2.349 . . . . 0.0 112.596 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.35 142.15 53.85 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.541 2.161 . . . . 0.0 112.428 179.734 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.38 147.32 2.13 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.573 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.19 154.82 69.38 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.81 2.34 . . . . 0.0 112.392 178.481 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.52 163.29 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.185 0.517 . . . . 0.0 110.484 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.62 170.34 16.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.955 179.457 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.2 137.44 22.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.946 0.403 . . . . 0.0 110.105 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.569 HG22 HD12 ' A' ' 205' ' ' LEU . 38.4 pt -134.14 146.51 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.726 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.71 131.77 59.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.257 0.551 . . . . 0.0 110.502 178.675 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -153.01 156.68 39.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.476 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.594 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.3 m -121.98 122.86 40.3 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.915 0.388 . . . . 0.0 110.358 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.517 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -61.06 -26.17 67.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.69 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.594 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.56 -49.25 22.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.872 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -77.42 -9.95 59.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.409 -179.705 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.9 m80 45.91 47.58 12.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.512 -179.635 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.2 t -130.76 143.0 50.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.968 0.413 . . . . 0.0 110.32 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.448 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -108.44 105.62 15.36 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.162 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.7 m-20 -116.39 129.2 56.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.159 0.504 . . . . 0.0 110.321 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.569 HD12 HG22 ' A' ' 194' ' ' ILE . 7.6 tt -111.92 146.46 37.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.806 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.472 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.5 t90 -99.61 128.73 45.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.207 0.527 . . . . 0.0 109.891 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.52 153.94 40.24 Favored Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.379 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.67 -17.74 47.95 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.682 2.254 . . . . 0.0 112.049 178.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -49.75 -18.89 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.342 -179.091 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.45 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.4 p -75.44 164.6 26.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.495 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.92 -27.88 65.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.496 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.574 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.7 mt-30 -63.73 -41.39 98.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.609 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.32 -44.45 97.52 Favored Glycine 0 C--N 1.332 0.337 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.525 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.49 -38.84 92.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 122.119 -0.636 . . . . 0.0 110.796 179.576 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.3 mmm -61.84 -41.27 97.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.279 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.3 mt -63.53 -47.63 80.84 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.055 0.455 . . . . 0.0 110.386 179.221 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.63 -32.07 49.87 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.872 0.368 . . . . 0.0 110.405 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.96 -17.91 62.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.473 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.431 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.7 mt -88.4 -9.14 53.62 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.575 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.1 2.37 54.65 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -88.72 153.0 21.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 110.453 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.457 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.2 p -115.86 128.44 55.81 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.149 0.499 . . . . 0.0 110.355 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.09 146.74 23.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.915 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.459 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.42 151.17 45.46 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.413 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.9 131.73 42.98 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.432 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.881 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.52 93.33 27.05 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.002 -179.453 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.684 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.2 Cg_exo -55.0 138.66 78.88 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.604 2.203 . . . . 0.0 111.71 178.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.38 -25.51 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.508 -179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.684 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.64 -49.93 27.79 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.1 mt -55.15 -37.05 66.47 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.034 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -65.66 35.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.816 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.573 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.45 88.34 0.01 OUTLIER 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 85.1 p -81.82 -13.65 57.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.297 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.73 -40.84 11.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.6 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 29.3 t -66.64 -17.03 64.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.591 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.8 43.86 27.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.444 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.93 -148.74 8.14 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.65 142.03 48.81 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.963 0.411 . . . . 0.0 110.288 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.416 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.3 ttt-85 -152.03 149.51 28.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.241 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -102.38 -149.86 0.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.307 179.823 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.41 -92.91 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.636 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.4 tt -126.68 174.43 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.56 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.435 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 88.2 mt -122.31 141.27 43.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.839 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.48 170.6 8.5 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.19 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 67.1 mt -146.71 149.61 33.77 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.12 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.26 -39.35 97.76 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.01 3.22 4.05 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -78.64 -57.46 3.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.949 0.404 . . . . 0.0 110.482 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.608 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.8 m-20 -62.14 -36.91 83.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.163 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.448 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.7 mp -52.88 -67.46 0.25 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.985 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.8 -42.49 68.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.094 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.67 17.45 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.666 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.15 48.33 0.29 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.1 mp 38.97 -109.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.505 0.193 . . . . 0.0 110.769 -178.501 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.459 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -60.79 -44.71 96.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.349 -179.572 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.46 8.07 83.77 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -98.8 -13.64 20.05 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 122.685 -0.303 . . . . 0.0 110.661 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.0 t 177.25 142.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.072 0.463 . . . . 0.0 110.445 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.98 125.45 11.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.14 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.55 143.84 28.53 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 120.902 0.382 . . . . 0.0 110.922 178.133 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.8 mt -95.24 106.38 18.41 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.73 -179.183 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.45 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.5 t80 -102.31 -11.4 18.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.114 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.61 -40.64 84.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.815 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.27 172.68 45.54 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.453 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 90.8 m-20 -73.72 -113.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.846 0.355 . . . . 0.0 110.794 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.35 -28.99 68.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.7 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.04 -43.71 91.68 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.251 -178.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -63.43 -44.48 94.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.31 179.216 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.6 -59.88 3.93 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.136 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.94 -43.55 60.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.233 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.32 -43.34 74.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.23 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.2 mt -64.68 -43.61 96.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.634 179.519 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -55.97 -37.75 69.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.135 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.5 1.03 17.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.241 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -114.93 91.11 25.16 Favored Pre-proline 0 N--CA 1.464 0.256 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.161 -179.543 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.96 -27.3 27.81 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.764 2.309 . . . . 0.0 112.02 179.208 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.69 -40.93 98.01 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.545 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.594 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.25 5.39 51.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.327 -179.187 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.36 -35.04 68.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.527 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.72 4.49 16.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.472 -178.799 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.62 121.1 79.76 Favored Pre-proline 0 N--CA 1.442 -0.868 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.566 -179.983 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.27 -37.74 24.87 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.503 2.135 . . . . 0.0 112.643 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.89 -43.84 91.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.803 0.335 . . . . 0.0 110.398 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.98 -43.48 92.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.356 179.345 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.07 -40.57 94.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.382 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 47.9 t-20 -89.73 -12.59 38.94 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.501 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.12 32.31 17.49 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.395 0.435 . . . . 0.0 110.992 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.04 43.69 1.16 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.126 0.489 . . . . 0.0 110.334 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.23 135.82 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.488 -179.764 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -116.87 132.44 56.7 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.469 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.19 88.93 7.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.709 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.88 -41.05 97.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.869 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.45 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.75 165.55 33.58 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 72.1 p -75.38 -25.75 57.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 110.824 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.2 tp10 -68.26 -33.94 75.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.414 -179.75 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 296' ' ' THR . 96.7 m -73.37 24.33 0.07 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.698 -179.026 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.574 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 43.0 t80 -58.28 -50.93 71.84 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.22 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.416 HH12 ' HG3' ' A' ' 212' ' ' GLN . 77.4 mmt-85 -110.4 152.9 25.71 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.085 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.431 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.1 tp -115.53 125.11 52.6 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 120.893 0.377 . . . . 0.0 110.723 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.49 ' CB ' HD23 ' A' ' 83' ' ' LEU . 40.9 t0 -148.04 165.76 29.81 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.652 179.517 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -49.32 -37.74 25.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.642 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -71.35 -65.6 0.73 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.487 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.88 -32.99 72.41 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.041 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.25 -25.49 23.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.703 -179.104 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.4 mtt -63.57 -40.8 97.91 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 120.892 0.377 . . . . 0.0 111.097 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.63 -44.27 24.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.188 179.524 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.581 HG21 HG23 ' A' ' 296' ' ' THR . 79.2 t -66.23 -42.82 91.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.308 179.645 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.451 HD11 ' NE2' ' A' ' 183' ' ' GLN . 51.0 tp -60.19 -47.11 87.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.464 -178.512 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -69.96 -39.24 76.13 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.593 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.5 ttt180 -61.89 -38.18 87.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.235 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.6 mt -87.26 4.67 41.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.625 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.405 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.2 tttt -112.9 -10.95 13.49 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.046 0.451 . . . . 0.0 110.221 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.29 86.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.432 179.672 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.81 -48.82 80.06 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.41 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.029 179.915 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.3 -2.46 58.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.43 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.493 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.05 1.25 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.537 -179.682 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.493 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.8 Cg_exo -60.75 144.93 99.63 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.806 2.337 . . . . 0.0 112.203 179.718 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.95 -179.53 8.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.635 -179.74 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.81 136.84 52.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.389 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.44 147.07 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.418 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 79.2 p -120.03 136.07 54.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.733 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.47 -143.34 0.33 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.266 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -63.67 -37.19 86.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.472 179.683 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.25 -66.53 0.22 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.416 179.637 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.43 142.22 45.36 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.0 p -112.17 131.53 55.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.949 0.404 . . . . 0.0 110.485 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -119.23 129.05 54.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.588 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.9 m -85.46 130.19 34.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.307 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.471 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.5 mt -95.51 78.75 3.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.373 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.73 -31.9 73.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.579 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.65 109.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.984 0.421 . . . . 0.0 110.119 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.471 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.35 91.81 49.12 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.416 -179.685 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.7 Cg_exo -56.68 148.35 65.63 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.826 2.35 . . . . 0.0 111.956 178.909 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.4 82.66 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.526 0.516 . . . . 0.0 110.961 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.6 mtm180 -151.41 66.87 0.89 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.062 0.458 . . . . 0.0 110.263 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.38 130.69 35.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.77 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.568 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.5 t -122.6 147.01 26.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.151 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.8 t -136.27 143.83 44.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.025 0.441 . . . . 0.0 110.639 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.4 ' OG1' ' N ' ' A' ' 50' ' ' SER . 26.1 p -99.53 -59.65 1.68 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.62 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.4 ' N ' ' OG1' ' A' ' 49' ' ' THR . 87.3 p -78.91 155.25 29.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.675 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.515 HG21 HG23 ' A' ' 70' ' ' THR . 73.8 t -74.42 -21.8 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.546 179.446 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.8 m -60.11 -52.28 66.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.506 -178.595 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.4 -42.59 87.62 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.723 177.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.0 m -42.91 -54.17 4.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.035 -178.716 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.31 -37.18 70.78 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.767 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.5 m -62.85 -44.69 95.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.906 0.384 . . . . 0.0 110.336 -179.358 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.407 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.9 mt -66.35 -41.84 88.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.426 0.632 . . . . 0.0 110.781 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.59 -40.44 96.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.333 -179.319 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.512 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.17 -35.76 76.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.185 -178.784 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.524 HD11 HD12 ' A' ' 156' ' ' LEU . 32.6 pt -91.27 28.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.237 -179.24 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.53 51.76 10.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.009 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.17 75.53 23.32 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.996 0.427 . . . . 0.0 109.995 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.36 150.98 87.27 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.794 2.329 . . . . 0.0 112.121 -178.735 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.17 137.27 46.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 CA-C-O 121.13 0.49 . . . . 0.0 110.356 179.814 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.445 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.0 pt -69.52 -43.49 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.219 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.06 131.25 53.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.522 -178.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.7 p -155.67 168.72 26.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.547 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.89 -177.21 21.62 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.636 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.33 172.55 12.54 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 121.043 0.449 . . . . 0.0 110.439 179.336 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.515 HG23 HG21 ' A' ' 51' ' ' VAL . 13.4 p -132.76 -112.43 0.23 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.991 0.424 . . . . 0.0 110.396 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.31 179.66 0.95 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.427 -179.185 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.3 Cg_exo -60.9 58.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.977 2.452 . . . . 0.0 112.07 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.572 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.0 t-20 -64.52 -33.84 76.83 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.438 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.2 m120 93.92 -36.74 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.736 0.648 . . . . 0.0 109.926 -179.545 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.401 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.9 mtp85 -62.61 -39.58 94.24 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.256 179.116 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.499 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.9 p -74.55 -25.44 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.606 179.467 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.41 -171.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.449 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -74.03 -153.65 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.805 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.9 p-10 -52.82 -7.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.675 -179.405 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.5 114.8 23.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.623 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.03 70.0 1.35 Allowed Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -143.31 147.36 34.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.917 0.389 . . . . 0.0 110.769 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.33 -98.44 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.12 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.563 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.11 -42.81 96.74 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.123 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.563 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.0 tt0 91.55 53.0 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.771 0.669 . . . . 0.0 110.856 178.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -102.92 -9.63 19.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.407 179.239 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.4 p -64.05 -34.11 77.28 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.047 0.451 . . . . 0.0 110.683 -179.662 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.96 -23.38 1.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.668 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.1 t -70.12 -45.72 75.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.713 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.58 80.65 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.048 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.37 -38.26 88.86 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.431 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.66 -32.65 52.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.166 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.62 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.8 mmt-85 -89.91 1.5 56.16 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.587 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.94 -49.19 0.16 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.761 0.663 . . . . 0.0 110.213 179.122 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.682 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.6 mt -46.05 154.08 0.27 Allowed 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.69 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.682 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.6 tt0 121.26 92.57 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 125.115 1.509 . . . . 0.0 110.445 -178.703 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.65 143.35 42.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.0 110.337 179.345 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.8 mt -132.41 27.25 4.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.879 0.371 . . . . 0.0 110.426 -179.37 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.31 137.86 34.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.636 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.7 mt -137.16 165.13 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.369 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.62 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.16 -28.76 1.82 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -153.0 70.93 7.11 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.124 0.488 . . . . 0.0 110.333 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.96 145.41 98.4 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.792 2.328 . . . . 0.0 112.058 -179.494 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.0 t -134.37 136.96 43.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.573 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.28 82.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.576 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.02 -42.34 97.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.569 -179.466 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.88 -41.65 98.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.55 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -63.7 -43.32 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.107 179.418 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.91 -35.18 77.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.274 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.78 -18.68 60.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.42 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.65 -6.78 58.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.538 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 68.6 mtp 47.48 56.25 17.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.648 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.28 149.44 63.57 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.759 2.306 . . . . 0.0 112.064 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.09 -73.5 0.64 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.529 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.417 HD11 HD13 ' A' ' 140' ' ' LEU . 38.6 tp -111.01 113.57 26.21 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.271 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.0 mt -102.16 126.63 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.6 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.7 mt -109.84 133.91 52.63 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.278 -179.467 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.99 139.98 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.522 -179.499 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.1 p -83.68 168.62 16.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.71 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.25 -37.41 80.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.472 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.98 158.86 43.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.453 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -155.94 177.07 33.21 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.22 -33.71 86.83 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.84 151.4 45.3 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.891 0.376 . . . . 0.0 110.54 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -63.29 140.93 58.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.326 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.78 10.64 10.99 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.647 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -60.97 -38.89 87.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.168 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.2 -35.75 23.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.375 0.607 . . . . 0.0 110.538 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.3 mt -71.0 -35.21 71.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.41 0.624 . . . . 0.0 110.697 179.294 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -42.8 -63.03 0.85 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.319 -178.852 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.2 p-10 -65.67 -42.85 90.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.091 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.545 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -61.91 -32.62 73.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.314 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.5 mt -73.95 -40.79 62.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 178.704 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -57.99 -49.23 77.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.169 -179.072 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 75.2 m -52.46 -42.67 64.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.263 179.314 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.3 -42.87 91.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 111.022 179.283 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.4 153.48 5.3 Favored Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.676 -179.336 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -39.41 107.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.675 2.25 . . . . 0.0 112.435 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.646 ' C ' HD12 ' A' ' 140' ' ' LEU . 97.2 m -109.61 121.68 45.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.074 0.464 . . . . 0.0 110.258 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.646 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.05 152.55 30.84 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.299 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -128.87 131.24 68.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.474 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.408 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.8 mt -114.99 128.01 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.527 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.8 t30 -101.82 103.87 14.6 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.2 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.6 p90 -101.51 -10.85 19.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.888 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.77 -33.24 75.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.704 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.6 p-10 -98.8 8.05 45.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.583 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.442 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.87 155.56 50.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.534 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -75.08 165.93 24.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.69 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.596 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.3 t90 -60.01 -48.65 80.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.278 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.36 -42.41 66.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.116 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.8 t -62.84 -41.11 99.21 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.348 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.408 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.8 tp -60.5 -44.45 95.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.317 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.9 tp -61.26 -43.74 98.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.205 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 m -54.7 -45.22 73.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.708 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.14 -40.93 97.61 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.878 0.37 . . . . 0.0 110.455 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.524 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.68 -42.4 98.87 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.206 179.117 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.16 -40.6 95.0 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.508 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.75 -46.01 63.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.874 0.369 . . . . 0.0 110.847 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.74 -43.92 96.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.735 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -93.18 -8.66 41.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.632 -179.032 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.01 26.58 72.37 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.66 50.72 0.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 110.708 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.64 -39.47 77.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.584 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.45 -47.3 86.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.357 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -59.82 -39.56 85.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.317 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.88 -40.99 99.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.297 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.1 -28.66 70.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.601 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.29 -54.51 7.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.873 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.512 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.0 -42.43 94.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.533 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.454 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.1 mt -62.33 -43.91 98.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.53 -179.508 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.19 -60.8 3.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.967 0.413 . . . . 0.0 110.415 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.9 -34.0 62.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.619 -179.183 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -81.1 -35.84 31.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.762 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.7 m-20 -55.28 -41.95 72.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.124 -178.874 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.47 -42.04 99.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.643 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.04 -38.27 90.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.363 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.8 mt -62.36 -42.1 99.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.672 179.404 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.06 -53.27 57.84 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.068 0.461 . . . . 0.0 110.682 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.22 -41.85 89.53 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.635 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.0 95.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.615 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.42 -31.56 72.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.434 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -95.03 -22.68 17.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.611 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.436 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.4 tt0 -64.85 -41.42 95.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.582 -179.55 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.2 pt -76.22 135.99 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.719 -179.802 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -126.1 108.1 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.292 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.6 pp -177.3 125.2 0.28 Allowed Pre-proline 0 C--O 1.239 0.502 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.497 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.5 Cg_exo -44.03 152.47 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.898 2.399 . . . . 0.0 112.429 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.8 141.73 55.2 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.622 2.215 . . . . 0.0 112.352 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.46 147.25 2.08 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.511 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.9 154.38 71.04 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.856 2.371 . . . . 0.0 112.328 178.661 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.581 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.14 162.91 30.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.134 0.492 . . . . 0.0 110.449 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.581 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -144.03 170.72 15.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.999 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.61 137.73 21.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.938 0.399 . . . . 0.0 110.245 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.565 HG22 HD12 ' A' ' 205' ' ' LEU . 39.5 pt -134.44 147.16 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.726 179.69 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -132.89 131.73 59.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 110.467 178.799 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -152.32 155.37 37.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.379 179.316 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.619 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.4 m -122.82 122.93 39.87 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.972 0.415 . . . . 0.0 110.425 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.79 -25.55 66.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.571 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.619 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.23 -48.88 21.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.925 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.81 -11.77 60.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.516 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.8 m80 49.4 41.63 21.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.582 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.8 t -136.29 144.76 44.92 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.408 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.431 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -110.96 114.47 27.81 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.393 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.9 133.56 55.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 0.0 110.347 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.565 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.27 146.91 37.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.771 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.544 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.6 t90 -100.42 131.14 46.5 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.196 0.522 . . . . 0.0 109.965 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.66 153.94 39.29 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.244 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.406 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.9 Cg_endo -67.87 -17.99 46.93 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.736 2.29 . . . . 0.0 111.985 178.982 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.19 -18.69 0.37 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.388 -179.148 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.544 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 84.1 p -75.5 164.66 26.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.518 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.11 -27.92 66.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.473 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.589 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.5 mt-30 -64.03 -41.22 97.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.605 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.24 -45.06 96.77 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.83 -38.86 92.4 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 122.438 -0.448 . . . . 0.0 110.731 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.596 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.1 mmm -62.03 -41.71 98.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.262 179.781 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.432 HD23 HD12 ' A' ' 219' ' ' LEU . 45.5 mt -63.43 -46.87 84.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.019 0.438 . . . . 0.0 110.325 179.488 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.94 -31.56 60.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.346 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.16 -17.52 63.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.496 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.453 HD11 ' CD2' ' A' ' 299' ' ' LEU . 88.4 mt -88.54 -9.34 52.68 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.576 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.58 1.78 50.01 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.774 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -88.46 154.42 20.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.843 0.354 . . . . 0.0 110.567 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.44 ' O ' HG12 ' A' ' 191' ' ' VAL . 6.2 p -116.35 128.7 55.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.132 0.492 . . . . 0.0 110.387 179.948 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.588 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.5 mm? -91.76 146.14 24.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.999 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.478 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -70.52 151.88 44.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.405 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.36 131.53 41.98 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.571 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.892 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.45 93.45 27.24 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.238 -179.815 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.678 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.9 Cg_exo -55.22 139.14 80.74 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.604 2.203 . . . . 0.0 111.758 178.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.0 -26.32 0.05 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.427 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.24 -50.3 28.27 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -53.65 -37.19 62.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.176 -179.385 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -66.77 36.09 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.709 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.02 88.32 0.01 OUTLIER 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.932 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 79.5 p -81.21 -14.18 57.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.36 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.9 -41.29 10.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.565 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.84 -16.98 64.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.633 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 55.72 43.68 27.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.539 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.5 -148.62 7.91 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.88 142.59 49.54 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.956 0.408 . . . . 0.0 110.382 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.416 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.0 ttt-85 -151.91 149.44 28.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.352 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -101.22 -151.49 0.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.316 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.75 -92.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.655 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.463 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.6 tt -126.58 175.18 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.532 -179.395 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.463 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -122.79 141.91 41.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.809 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.65 169.32 9.36 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.279 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.7 mt -147.96 150.97 35.0 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.176 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.91 -38.99 96.89 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.41 4.12 4.52 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -77.43 -58.25 3.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.485 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.551 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.0 m-20 -61.85 -36.89 82.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.518 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.431 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.1 mp -52.35 -67.86 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.635 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.36 -42.32 66.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.159 -179.515 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.04 17.56 0.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.635 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.71 49.13 0.27 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.5 mp 38.23 -109.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.565 0.222 . . . . 0.0 110.67 -178.773 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.478 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.9 m120 -60.37 -45.24 94.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.635 -179.742 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.55 7.87 83.89 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.338 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.95 -13.24 20.05 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.669 -0.312 . . . . 0.0 110.743 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.2 t 176.87 142.61 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.97 0.414 . . . . 0.0 110.465 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.2 125.09 11.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.094 179.729 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -98.27 143.34 28.86 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.841 0.353 . . . . 0.0 110.758 178.276 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.7 mt -94.91 106.78 18.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.807 -179.32 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.441 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.1 t80 -101.98 -12.52 18.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.209 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.07 -40.95 91.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.857 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.5 173.03 45.82 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.653 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.474 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 93.5 m-20 -73.7 -112.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.678 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -68.2 -28.83 67.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.614 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.96 -43.95 91.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.278 -178.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.39 -44.66 94.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.371 179.171 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.47 -60.16 3.57 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.378 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.83 -43.68 59.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.21 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.28 -43.38 74.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.205 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.75 -43.67 96.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.563 179.587 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -56.1 -37.51 69.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.182 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.23 0.84 17.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.238 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -115.17 91.13 26.37 Favored Pre-proline 0 N--CA 1.46 0.073 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.25 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.98 -27.07 27.11 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.847 2.365 . . . . 0.0 111.959 179.267 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.52 -40.94 98.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.513 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.597 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.1 mp -95.2 5.49 51.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.443 -179.143 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.19 -34.59 68.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.631 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -79.97 4.5 16.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.569 -178.841 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.96 121.1 80.4 Favored Pre-proline 0 N--CA 1.446 -0.645 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.462 -179.974 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -47.29 -37.65 24.83 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.463 2.108 . . . . 0.0 112.499 -179.467 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.53 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -59.06 -43.96 91.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.769 0.318 . . . . 0.0 110.446 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.08 -43.54 92.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.358 179.281 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.44 -40.99 96.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.428 -179.319 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -90.27 -11.54 40.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.69 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.62 32.8 18.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.965 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -89.0 43.85 1.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.096 0.474 . . . . 0.0 110.366 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.52 135.82 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.451 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -116.73 132.55 56.66 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.387 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.06 89.17 7.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.732 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.409 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.3 mt -63.9 -40.88 97.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.441 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.03 165.27 33.67 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.4 p -75.43 -25.72 57.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.878 0.37 . . . . 0.0 110.679 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.5 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.8 tp10 -68.53 -33.7 74.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.454 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 296' ' ' THR . 95.8 m -73.59 24.96 0.07 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.74 -179.148 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.589 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 40.2 t80 -58.32 -50.72 72.62 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.387 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.416 ' CZ ' ' CE2' ' A' ' 297' ' ' PHE . 79.3 mmt-85 -111.03 153.95 24.88 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.791 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.453 ' CD2' HD11 ' A' ' 219' ' ' LEU . 46.3 tp -115.77 125.17 52.4 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.757 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.486 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.5 t0 -147.93 165.68 29.94 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.656 179.627 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.26 -37.94 25.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.641 -179.506 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -71.36 -65.58 0.73 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.403 -179.796 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.84 -32.85 72.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.269 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.19 -25.58 23.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.797 -179.057 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.6 mtt -63.54 -40.91 98.24 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.05 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.0 -43.93 23.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.979 179.755 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.576 HG21 HG23 ' A' ' 296' ' ' THR . 79.8 t -66.35 -42.76 91.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.403 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.436 HD11 ' NE2' ' A' ' 183' ' ' GLN . 50.3 tp -60.17 -47.06 87.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.48 -178.737 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -70.07 -39.32 75.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.958 0.408 . . . . 0.0 110.584 179.252 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.7 ttt180 -61.87 -38.43 88.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.232 -178.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.09 4.49 41.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.622 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.405 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.2 tttt -112.67 -11.2 13.57 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.103 0.478 . . . . 0.0 110.435 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.21 -37.28 86.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.51 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.68 -48.83 80.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.363 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.221 -0.405 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.069 179.769 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.11 -2.54 58.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.44 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.5 179.16 1.23 Allowed Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.49 -179.66 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.4 Cg_exo -60.72 145.07 99.52 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.84 2.36 . . . . 0.0 112.142 179.611 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.613 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.25 -179.44 8.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.631 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.19 136.95 52.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.362 179.702 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.05 147.17 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.402 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.4 p -120.18 136.05 54.76 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.062 0.458 . . . . 0.0 110.78 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.9 p30 -99.21 -143.8 0.32 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.244 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.52 -37.04 85.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.522 179.635 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.481 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.76 -67.69 0.23 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.422 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.12 142.71 44.21 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.288 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.2 p -112.51 131.22 55.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.895 0.378 . . . . 0.0 110.418 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -118.6 129.2 55.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.559 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.8 m -85.67 130.58 34.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.247 -179.808 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.475 HD22 ' OE1' ' A' ' 42' ' ' GLN . 70.0 mt -96.69 78.76 2.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 110.433 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.84 -31.68 72.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.603 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.51 107.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 110.089 -179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.475 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -121.13 91.32 47.95 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.42 -179.719 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.655 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.6 Cg_exo -56.73 148.54 64.95 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.801 2.334 . . . . 0.0 111.953 178.974 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.61 82.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.627 0.579 . . . . 0.0 110.951 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.655 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.41 66.85 0.89 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.071 0.462 . . . . 0.0 110.192 -179.465 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -76.83 130.98 35.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.803 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.571 ' HA ' HG23 ' A' ' 64' ' ' VAL . 58.9 t -122.63 147.33 26.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.028 -179.702 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.7 t -136.4 144.11 44.33 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.745 179.813 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 50' ' ' SER . 17.5 p -100.03 -59.04 1.78 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.549 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.415 ' N ' ' OG1' ' A' ' 49' ' ' THR . 87.3 p -79.2 155.07 28.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.612 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.523 HG21 HG23 ' A' ' 70' ' ' THR . 72.0 t -74.11 -21.83 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.472 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.2 m -60.31 -51.93 67.43 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.478 -178.433 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -66.4 -42.75 87.41 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.759 177.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.9 m -42.99 -54.07 4.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.911 -178.547 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.08 -37.46 73.0 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 178.602 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.5 m -62.89 -44.26 96.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.886 0.374 . . . . 0.0 110.164 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 17.5 mt -66.14 -42.21 89.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.544 0.687 . . . . 0.0 110.639 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.97 -39.78 95.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.379 -179.122 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.528 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.49 -35.81 76.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.231 -179.078 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.492 HD11 HD12 ' A' ' 156' ' ' LEU . 33.6 pt -91.5 27.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.317 -179.311 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.82 51.95 10.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.053 179.554 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.34 76.19 26.41 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 121.021 0.438 . . . . 0.0 109.839 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.24 149.63 89.88 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.8 2.333 . . . . 0.0 112.09 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.571 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.4 136.66 47.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 CA-C-O 121.127 0.489 . . . . 0.0 110.34 179.696 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -69.57 -43.45 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.358 179.317 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.49 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.35 131.35 53.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.032 0.444 . . . . 0.0 110.601 -179.008 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.536 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.4 p -155.94 168.68 26.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.47 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.32 -177.35 21.99 Favored Glycine 0 N--CA 1.463 0.456 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.639 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.35 172.07 13.19 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 121.04 0.448 . . . . 0.0 110.452 179.355 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.523 HG23 HG21 ' A' ' 51' ' ' VAL . 14.0 p -133.25 -111.39 0.23 Allowed 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.018 0.437 . . . . 0.0 110.453 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.94 179.62 0.94 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.44 -179.195 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.8 Cg_exo -60.89 58.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.926 2.418 . . . . 0.0 112.156 179.518 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.8 t-20 -64.42 -34.19 77.6 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.361 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.8 m120 94.76 -37.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.824 0.703 . . . . 0.0 109.814 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HD3' HD21 ' A' ' 73' ' ' ASN . 77.3 mtp85 -62.76 -40.22 96.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.218 179.217 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.3 p -74.08 -25.98 20.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.758 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.84 -172.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.433 -179.219 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.87 -152.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.777 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.3 p-10 -54.36 -6.66 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.759 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.48 114.14 23.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.629 179.731 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.52 72.14 1.3 Allowed Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.567 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.2 m-85 -143.54 148.27 35.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.874 0.369 . . . . 0.0 110.899 179.236 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.96 -98.81 0.07 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.026 178.844 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.555 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.94 -43.26 96.39 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.177 179.291 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.555 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.2 tt0 91.66 52.55 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.913 0.758 . . . . 0.0 111.052 179.176 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -103.49 -8.63 19.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.335 179.267 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.465 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.3 p -65.33 -33.38 75.84 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.063 0.459 . . . . 0.0 110.672 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -49.12 -24.18 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.695 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.2 t -69.86 -45.93 75.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.765 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.14 -48.77 80.06 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.043 -179.384 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.48 -38.32 89.4 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.454 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.72 -32.62 52.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.136 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.607 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 83.7 mmt-85 -90.1 1.8 55.98 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.538 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.94 -49.79 0.16 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.865 0.728 . . . . 0.0 110.235 179.176 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.66 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.4 mt -45.54 153.75 0.23 Allowed 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 117.673 -1.156 . . . . 0.0 109.561 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.66 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 121.05 92.27 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 O-C-N 125.444 1.715 . . . . 0.0 110.456 -178.581 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.536 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.02 142.77 43.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.219 0.533 . . . . 0.0 110.262 179.34 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 mt -131.81 26.59 4.65 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.04 -0.413 . . . . 0.0 110.415 -179.341 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -139.97 137.27 34.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.045 0.45 . . . . 0.0 110.531 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.639 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.1 mt -136.72 164.89 29.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.361 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.614 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.22 -28.48 1.82 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.76 70.5 7.24 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.108 0.48 . . . . 0.0 110.259 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.1 145.32 98.72 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 122.768 2.312 . . . . 0.0 112.123 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.9 t -134.08 136.68 44.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.556 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.62 -38.54 84.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.665 179.652 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.35 -41.98 96.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.48 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.65 98.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.473 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.53 -43.22 98.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.077 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.01 -35.12 77.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.223 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.69 -18.69 60.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.401 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.66 -6.51 58.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.5 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.8 mtp 47.61 55.99 17.18 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.594 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.28 149.82 64.17 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.767 2.312 . . . . 0.0 112.126 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.9 -72.77 0.67 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.452 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.7 tp -111.67 114.19 27.05 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.388 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.3 mt -103.36 126.91 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 120.964 0.411 . . . . 0.0 110.608 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.0 mt -110.63 134.21 52.63 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.214 -179.401 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.86 140.12 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.572 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.0 p -83.48 168.25 16.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.788 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.5 -37.13 80.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.47 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 t -139.49 158.35 44.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.466 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.15 176.88 33.46 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.66 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.31 -34.0 87.87 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -179.541 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.82 151.52 45.11 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.91 0.386 . . . . 0.0 110.552 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.8 t -63.23 141.07 58.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.334 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.89 10.59 10.9 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.644 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -60.92 -38.98 87.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.235 -179.372 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.87 -35.74 23.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.479 0.657 . . . . 0.0 110.587 179.84 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.2 mt -71.16 -35.18 71.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.492 0.663 . . . . 0.0 110.614 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -42.95 -62.85 0.91 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.322 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.69 -42.96 90.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.058 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -61.86 -32.34 72.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.402 -179.607 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.2 mt -74.23 -40.64 62.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.869 178.637 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.42 -49.09 78.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.163 -178.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.9 m -53.04 -42.67 65.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.941 0.4 . . . . 0.0 110.142 179.6 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.53 -42.83 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 120.948 0.404 . . . . 0.0 111.218 179.023 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -168.6 151.4 5.18 Favored Pre-proline 0 N--CA 1.452 -0.369 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.726 -179.265 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -38.78 107.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.716 2.277 . . . . 0.0 112.493 179.717 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.4 m -109.35 121.71 45.77 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.047 0.451 . . . . 0.0 110.265 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.13 153.51 29.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.32 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -128.77 131.62 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.402 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.36 127.82 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 121.074 0.464 . . . . 0.0 110.535 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.2 t30 -100.99 105.1 16.28 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.149 179.868 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.9 p90 -101.28 -11.58 19.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.898 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.0 p-10 -64.82 -33.64 76.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.805 -179.656 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.2 p-10 -99.37 7.82 45.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.601 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.9 mttm -134.79 152.35 51.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.525 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.424 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.9 p -75.42 165.97 24.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.677 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.596 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.3 t90 -59.09 -48.49 81.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.23 -179.081 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -54.37 -43.68 71.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.043 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.1 t -62.9 -41.09 99.31 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.255 178.595 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.434 ' O ' HD23 ' A' ' 156' ' ' LEU . 54.8 tp -60.81 -44.53 96.74 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.185 -179.454 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.49 -42.75 99.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.153 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.8 m -55.63 -45.46 77.58 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.49 -40.13 95.7 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 120.892 0.377 . . . . 0.0 110.505 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.492 HD12 HD11 ' A' ' 60' ' ' ILE . 2.5 mm? -61.99 -42.51 99.22 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.324 179.058 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.16 -40.04 94.79 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.508 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.57 -45.9 64.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 110.849 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.87 -44.06 96.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.845 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.9 p -92.98 -9.1 41.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.643 -178.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.16 26.02 72.39 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -101.17 50.38 0.86 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.811 0.338 . . . . 0.0 110.649 -179.506 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -69.43 -39.56 77.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.628 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.53 -47.35 85.89 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.294 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -60.01 -39.16 84.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.099 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.04 -40.76 98.69 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.214 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.04 -28.86 70.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.56 179.437 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.12 -54.46 7.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.904 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.528 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.6 ttp180 -64.78 -42.23 95.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.406 -179.795 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.2 mt -62.48 -43.8 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.483 -179.508 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.95 -60.15 4.06 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.024 0.44 . . . . 0.0 110.311 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.22 -34.01 63.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.552 -179.229 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -80.7 -36.11 32.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.731 179.555 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.8 m-20 -54.79 -42.44 71.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.005 -178.548 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.01 -41.75 98.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.719 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -64.97 -38.02 89.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.355 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 177' ' ' LEU . 79.8 mt -62.53 -42.29 99.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.753 179.45 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.91 -52.97 61.91 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.066 0.46 . . . . 0.0 110.686 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.41 -41.79 88.75 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.711 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.74 -40.24 96.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.664 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.06 -32.81 74.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.477 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.07 -21.3 19.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.704 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.597 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.6 tt0 -64.89 -41.62 95.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.743 -179.56 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 184' ' ' ILE . 31.3 pt -76.47 133.93 29.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.071 0.462 . . . . 0.0 110.716 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -127.83 106.43 9.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.417 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.58 128.31 0.34 Allowed Pre-proline 0 C--O 1.24 0.553 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.521 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.49 151.37 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.869 2.38 . . . . 0.0 112.577 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.83 142.57 52.61 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.587 2.192 . . . . 0.0 112.411 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.542 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.89 147.19 2.3 Favored Pre-proline 0 N--CA 1.448 -0.555 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.574 179.395 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.99 153.8 71.85 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.879 2.386 . . . . 0.0 112.317 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.19 163.09 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.167 0.508 . . . . 0.0 110.454 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.578 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.5 169.76 17.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.958 179.462 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.84 137.48 22.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.147 179.505 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.538 HG22 HD12 ' A' ' 205' ' ' LEU . 39.8 pt -134.35 146.58 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.693 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -133.41 132.15 57.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.129 0.49 . . . . 0.0 110.43 178.843 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -152.05 154.85 36.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.398 179.158 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.615 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.8 m -121.95 122.88 40.39 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.961 0.41 . . . . 0.0 110.355 179.398 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.87 -25.34 66.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.656 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.615 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.19 -49.58 18.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.02 -10.9 60.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.416 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.0 m80 48.4 42.72 18.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.489 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.9 t -136.37 145.05 44.93 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.355 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.12 114.42 27.66 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.324 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -120.19 133.71 55.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.984 0.421 . . . . 0.0 110.387 179.843 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.538 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.24 146.68 37.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.052 0.453 . . . . 0.0 110.762 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.488 ' N ' HD23 ' A' ' 205' ' ' LEU . 12.4 t90 -99.73 127.93 45.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.195 0.521 . . . . 0.0 109.862 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.5 153.47 41.33 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.427 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.71 -18.56 47.92 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.629 2.219 . . . . 0.0 112.005 178.894 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.86 -18.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.419 -179.121 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.442 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.3 p -75.27 167.77 21.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.491 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.64 75.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.481 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.3 mt-30 -56.52 -41.38 76.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.722 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.22 -43.07 97.45 Favored Glycine 0 C--O 1.235 0.201 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.49 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.4 mt-30 -63.81 -39.87 95.26 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 122.231 -0.57 . . . . 0.0 110.82 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.596 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.3 mmm -61.77 -41.7 98.04 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.277 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 77.3 mt -63.31 -50.2 70.98 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.197 0.522 . . . . 0.0 110.328 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.69 -33.03 45.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.862 0.363 . . . . 0.0 110.227 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.15 -19.99 62.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.562 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 219' ' ' LEU . 66.2 mt -87.41 -6.44 58.44 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.819 -179.632 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.63 3.56 57.27 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -88.47 149.96 23.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.912 0.386 . . . . 0.0 110.519 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.438 ' O ' HG12 ' A' ' 191' ' ' VAL . 3.1 p -113.01 126.67 55.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.137 0.494 . . . . 0.0 110.332 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.63 145.91 24.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.078 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.489 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -70.05 150.5 46.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.44 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.52 131.25 45.0 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.466 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.895 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -114.02 92.94 27.87 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.004 -179.552 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.68 ' C ' ' H ' ' A' ' 229' ' ' GLY . 44.5 Cg_exo -55.52 139.12 82.11 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.544 2.162 . . . . 0.0 111.693 178.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.68 -25.05 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.448 -179.59 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.68 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.82 -49.79 27.37 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.721 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.558 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.1 mt -54.43 -36.97 64.6 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.62 36.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.804 179.414 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.52 87.85 0.01 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.93 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.1 p -80.88 -14.32 58.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.318 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.77 -41.41 10.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.616 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.1 t -66.99 -16.74 64.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.584 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.78 43.97 26.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.467 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.98 -148.58 8.03 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.81 143.19 48.98 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.971 0.415 . . . . 0.0 110.316 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -151.98 149.6 29.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.328 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -101.05 -152.21 0.43 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.299 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.3 -92.14 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.626 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.475 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.4 tt -126.81 175.58 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.612 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.475 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.0 mt -122.21 141.46 42.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 -179.431 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.61 169.29 9.39 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.243 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.6 mt -147.38 150.69 35.18 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.277 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.72 -38.96 96.99 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.53 3.62 4.6 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.07 -58.33 3.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.966 0.412 . . . . 0.0 110.518 -179.743 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.559 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.9 m-20 -61.95 -36.75 82.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.203 -179.663 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.24 -67.72 0.23 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.849 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.56 -42.32 67.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.109 -179.394 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.81 18.19 0.14 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.664 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.63 47.85 0.23 Allowed Glycine 0 N--CA 1.464 0.555 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 39.06 -110.07 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.501 0.191 . . . . 0.0 110.74 -178.589 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.489 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.84 -45.18 95.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.421 -179.482 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.95 8.05 82.96 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -99.16 -12.92 20.02 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.757 -0.261 . . . . 0.0 110.597 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.9 t 176.79 142.75 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.101 0.477 . . . . 0.0 110.417 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.17 125.6 11.65 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.137 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -98.52 143.33 29.05 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 120.915 0.388 . . . . 0.0 110.838 178.236 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.3 mt -94.65 106.55 18.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.782 -179.214 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.466 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.8 t80 -101.95 -12.52 18.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.13 179.582 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.7 90.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.87 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.02 173.36 45.9 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -179.621 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.496 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -74.01 -112.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.762 0.315 . . . . 0.0 110.768 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.74 -28.78 67.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.658 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.06 -44.06 91.81 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.236 -178.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.43 -44.49 94.42 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.288 179.214 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.47 -59.96 3.81 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.189 -179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.95 -43.52 60.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.159 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.31 -43.64 75.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.243 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.5 mt -64.49 -43.57 96.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.577 179.571 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -56.48 -37.72 70.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.152 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.22 1.02 19.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.199 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -114.83 91.49 26.25 Favored Pre-proline 0 N--CA 1.462 0.135 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.176 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.09 -27.32 28.79 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.715 2.277 . . . . 0.0 111.966 179.318 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.42 -41.08 98.7 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.545 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.9 mp -95.5 5.06 52.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.354 -179.14 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.83 -35.14 69.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.601 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -80.17 4.74 16.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.507 -178.846 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.73 121.11 80.0 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.57 -179.996 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.43 -37.71 26.0 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.492 2.128 . . . . 0.0 112.58 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.66 -43.4 89.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.765 0.317 . . . . 0.0 110.397 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.92 -43.67 92.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.357 179.204 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -65.1 -40.64 94.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.31 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 44.5 t-20 -89.08 -13.1 39.38 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.554 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 62.29 31.19 17.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.037 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.32 44.2 1.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.176 0.513 . . . . 0.0 110.346 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.93 135.75 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.514 -179.72 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -116.65 132.41 56.69 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.439 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.492 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.09 88.68 6.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.808 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.427 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.8 mt -63.93 -41.65 97.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.021 0.439 . . . . 0.0 110.781 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.466 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.79 165.87 34.28 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 71.2 p -75.47 -25.82 57.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.9 0.381 . . . . 0.0 110.756 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.503 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.1 tp10 -68.59 -33.82 74.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.478 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 99.0 m -72.65 19.67 0.08 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.129 0.49 . . . . 0.0 110.677 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.511 ' O ' ' NE2' ' A' ' 212' ' ' GLN . 49.6 t80 -57.1 -51.23 70.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.925 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 70.8 mmt-85 -107.65 149.05 28.56 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.7 tp -115.61 126.19 53.87 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.842 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.478 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.7 t0 -149.74 166.87 28.12 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.618 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -49.29 -38.05 26.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.649 -179.547 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -71.65 -65.21 0.79 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.462 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.61 -32.83 71.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.021 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.57 -25.42 26.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.735 -179.125 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.8 mtt -63.49 -41.15 98.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.827 0.346 . . . . 0.0 111.053 179.768 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.96 -44.48 26.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.102 179.563 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.575 HG21 HG23 ' A' ' 296' ' ' THR . 79.8 t -66.15 -42.73 91.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.365 179.643 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.597 HD11 ' NE2' ' A' ' 183' ' ' GLN . 49.3 tp -59.9 -47.09 87.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.514 -178.487 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -70.57 -39.23 74.01 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.73 179.151 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.496 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 73.3 ttt180 -61.5 -37.84 85.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.257 -178.88 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.3 mt -87.95 5.05 42.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.664 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -112.4 -11.71 13.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.03 0.443 . . . . 0.0 110.314 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.82 -37.29 86.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.394 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.92 -48.92 79.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.46 -179.653 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.992 179.886 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -90.1 -2.18 58.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.464 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.494 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.02 179.04 1.24 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.504 -179.638 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.81 145.01 99.64 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.827 2.351 . . . . 0.0 112.18 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.3 ptt-85 -156.37 -179.1 7.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.615 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.78 136.15 53.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.984 0.421 . . . . 0.0 110.371 179.734 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -123.41 146.64 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.409 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.8 p -119.72 135.87 54.66 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.818 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.5 p30 -99.4 -143.47 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.26 179.877 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -63.62 -37.11 86.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.526 179.58 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.36 -66.76 0.22 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.431 179.719 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.21 142.2 44.9 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.42 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.7 p -112.27 131.49 55.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 0.0 110.488 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -119.1 128.98 54.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.611 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -85.38 130.15 34.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.247 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.471 HD22 ' OE1' ' A' ' 42' ' ' GLN . 67.6 mt -95.67 78.51 3.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.39 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.73 -31.65 72.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.589 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.23 109.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.155 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.471 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.5 pt20 -122.18 91.08 49.11 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.414 -179.66 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.661 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.63 148.81 62.36 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.8 2.334 . . . . 0.0 112.049 178.904 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.92 82.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.506 0.504 . . . . 0.0 110.999 -179.252 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.661 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.1 66.86 0.91 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.292 -179.604 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.87 130.69 35.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.822 -179.729 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.556 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.7 t -122.73 146.23 28.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.061 -179.62 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.9 t -136.1 143.76 44.77 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.778 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.8 p -99.53 -59.05 1.79 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.579 179.944 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.9 p -79.29 155.11 28.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.627 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.501 HG21 HG23 ' A' ' 70' ' ' THR . 71.3 t -74.61 -21.72 17.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.514 179.377 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.8 m -60.28 -52.2 66.29 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.518 -178.537 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.34 -42.9 87.45 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.622 177.951 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.0 m -42.49 -54.04 4.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.985 -178.719 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.48 -37.36 69.18 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 178.79 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 m -62.67 -44.93 95.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.815 0.34 . . . . 0.0 110.107 -179.25 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.6 mt -66.41 -41.76 88.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.433 0.635 . . . . 0.0 110.714 179.697 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.56 -40.49 97.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.283 -179.284 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.468 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.77 -35.65 75.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.236 -178.909 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.533 HD11 HD12 ' A' ' 156' ' ' LEU . 32.2 pt -91.45 28.9 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.284 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.29 51.58 11.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.019 179.506 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.03 75.57 23.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 0.0 109.94 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.96 151.48 85.68 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.848 2.365 . . . . 0.0 112.064 -178.755 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.556 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.38 137.44 46.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-O 121.126 0.489 . . . . 0.0 110.319 179.826 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.448 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.9 pt -69.35 -43.49 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.263 179.597 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.09 131.22 53.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.044 0.45 . . . . 0.0 110.534 -179.049 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.3 p -155.91 168.8 26.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.522 -179.717 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.63 -177.18 21.8 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.635 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.03 171.92 13.34 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 121.094 0.473 . . . . 0.0 110.451 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.501 HG23 HG21 ' A' ' 51' ' ' VAL . 12.7 p -133.54 -110.86 0.23 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.004 0.43 . . . . 0.0 110.516 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.549 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.86 179.6 0.95 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.494 -179.312 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.0 Cg_exo -60.75 58.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.891 2.394 . . . . 0.0 112.082 179.557 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.3 t-20 -64.39 -35.19 80.11 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.445 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.4 m120 94.93 -37.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.692 0.62 . . . . 0.0 109.889 -179.365 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.54 -39.86 94.95 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.199 179.109 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.6 p -73.96 -26.55 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.621 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.96 -172.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.383 -179.367 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -74.1 -152.63 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.765 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.8 p-10 -54.56 -6.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.724 -179.429 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.493 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.88 113.32 22.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.678 179.738 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.33 73.31 1.26 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.615 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.401 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.2 m-85 -144.24 148.33 34.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.817 0.342 . . . . 0.0 110.901 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.71 -99.38 0.07 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.022 178.836 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.564 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.17 -42.84 96.55 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.088 179.255 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.564 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 9.9 tt0 91.5 52.91 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.672 0.607 . . . . 0.0 111.042 179.025 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -103.57 -9.02 19.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.32 179.274 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.401 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.98 -33.74 76.77 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.097 0.475 . . . . 0.0 110.701 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -48.83 -23.22 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.72 179.635 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.5 t -70.18 -45.9 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.705 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.09 -48.82 79.92 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.978 -179.472 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.38 -38.34 89.2 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.379 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.67 -32.4 51.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.202 -179.751 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.621 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.91 1.61 56.02 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.49 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.621 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.99 -49.43 0.16 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.729 0.643 . . . . 0.0 110.229 179.209 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.686 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 79.5 mt -45.88 153.85 0.27 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 118.209 -0.901 . . . . 0.0 109.758 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.686 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.3 tt0 121.24 92.17 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.966 1.416 . . . . 0.0 110.472 -178.713 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.26 143.24 43.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.277 0.561 . . . . 0.0 110.269 179.416 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -131.97 27.03 4.59 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 122.053 -0.404 . . . . 0.0 110.443 -179.399 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.33 137.94 34.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.456 . . . . 0.0 110.514 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.7 mt -137.03 165.06 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.395 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.91 -28.44 1.87 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -152.85 70.69 7.19 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.06 0.457 . . . . 0.0 110.271 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.11 145.37 98.6 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 122.744 2.296 . . . . 0.0 112.114 -179.536 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.4 t -134.27 136.87 43.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.533 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.12 -38.33 82.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.547 179.725 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.25 -42.35 96.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.499 -179.45 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.67 98.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.544 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.4 t -63.68 -43.25 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.108 179.451 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.08 -35.08 77.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.137 -179.744 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.73 -18.49 59.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.376 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.75 -6.51 58.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.506 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.8 mtp 47.85 56.14 17.4 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.659 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.8 Cg_endo -70.28 149.29 63.35 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.8 2.334 . . . . 0.0 112.07 179.465 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -101.24 -73.38 0.65 Allowed 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.471 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.432 HD11 HD13 ' A' ' 140' ' ' LEU . 39.0 tp -111.02 112.39 24.18 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.269 179.632 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 75.9 mt -100.59 126.1 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.645 -179.767 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.9 mt -109.42 133.38 53.13 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.268 -179.428 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.56 139.61 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.585 -179.559 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.2 p -83.5 168.24 16.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.714 179.778 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.09 -37.43 79.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.488 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.59 159.0 43.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.442 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.27 177.22 33.41 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.2 -33.73 86.87 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 -179.684 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -125.07 151.7 45.31 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 110.519 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -63.12 141.2 58.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.334 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.72 10.03 10.89 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.666 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.7 mp -60.71 -38.97 86.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.305 -179.383 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.641 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.79 23.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.355 0.598 . . . . 0.0 110.568 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.9 mt -71.03 -35.29 71.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.482 0.658 . . . . 0.0 110.625 179.403 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.3 t80 -42.73 -62.72 0.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.355 -178.759 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.641 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.77 -42.83 90.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.176 -179.244 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -62.0 -32.57 73.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.417 -179.718 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 129' ' ' LEU . 71.2 mt -74.17 -40.79 62.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.792 178.745 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.1 -49.02 78.39 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.169 -179.094 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.3 m -53.06 -42.08 65.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.975 0.417 . . . . 0.0 110.155 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.56 -42.57 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 120.95 0.405 . . . . 0.0 111.081 179.241 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.78 153.61 5.01 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.661 -179.338 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -39.06 106.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.658 2.239 . . . . 0.0 112.491 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.1 m -109.37 121.32 44.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.129 0.49 . . . . 0.0 110.278 179.802 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.1 153.07 30.12 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.365 -179.757 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.6 tt -128.96 131.56 68.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.343 179.911 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.29 127.88 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.605 -179.899 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.9 t30 -101.9 103.67 14.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.174 179.847 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.9 p90 -101.15 -11.23 19.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.875 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.84 -33.26 75.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.731 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.5 p-10 -98.6 8.19 45.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.56 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.442 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.91 155.62 50.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.521 -179.413 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.408 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -74.86 165.83 24.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.626 -179.818 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.584 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -60.02 -48.95 79.61 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.264 -179.22 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -53.56 -42.06 67.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.17 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.0 t -62.47 -40.83 97.92 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.358 178.773 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.424 ' O ' HD23 ' A' ' 156' ' ' LEU . 48.0 tp -60.64 -43.97 96.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.275 -179.564 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.495 HD22 HH21 ' A' ' 169' ' ' ARG . 45.5 tp -61.32 -43.25 99.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.063 179.663 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -55.41 -45.58 76.69 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.924 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.32 -40.73 97.29 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.895 0.379 . . . . 0.0 110.509 179.893 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.533 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.8 -42.42 98.99 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.238 179.046 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.86 -40.88 95.72 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 179.522 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.93 -45.74 63.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 0.0 110.84 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.1 mt -64.78 -43.99 96.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.839 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -93.29 -8.55 41.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.633 -179.066 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.76 25.37 71.74 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -101.88 51.98 0.82 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.831 0.348 . . . . 0.0 110.673 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -69.74 -39.09 76.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.593 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.25 -47.2 86.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.34 -179.416 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -61.35 -39.15 89.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.232 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.23 -40.46 97.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.347 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.43 -27.17 68.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.567 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -75.32 -53.71 8.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.842 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.495 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -63.88 -43.26 96.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.422 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.3 mt -63.06 -43.89 99.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.73 -179.705 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.37 -61.76 2.32 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.062 0.458 . . . . 0.0 110.356 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -54.55 -35.05 62.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.565 -179.153 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -79.62 -34.99 40.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.822 179.694 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -56.6 -40.12 74.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.009 -178.642 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.88 -42.37 99.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.692 179.803 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.79 -37.75 87.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.315 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 177' ' ' LEU . 82.3 mt -62.45 -42.28 99.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.713 179.612 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.17 -53.32 56.99 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.017 0.436 . . . . 0.0 110.613 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.3 -41.4 89.81 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.633 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.24 -39.95 95.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.601 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.19 -32.16 73.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.471 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.52 -21.75 18.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.63 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.458 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.6 tt0 -64.96 -41.57 95.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.717 -179.625 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -77.58 136.08 25.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.746 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.1 108.97 11.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.333 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.9 126.13 0.3 Allowed Pre-proline 0 C--O 1.238 0.473 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.501 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.461 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.7 Cg_exo -43.73 152.16 0.36 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.891 2.394 . . . . 0.0 112.483 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.99 141.68 54.11 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.579 2.186 . . . . 0.0 112.341 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.16 147.07 2.16 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.602 179.374 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.2 154.19 70.36 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.897 2.398 . . . . 0.0 112.269 178.713 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.584 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.4 163.24 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.151 0.501 . . . . 0.0 110.477 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -144.08 170.26 16.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.157 0.503 . . . . 0.0 110.851 179.68 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.82 137.4 22.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.213 179.536 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.547 HG22 HD12 ' A' ' 205' ' ' LEU . 38.9 pt -134.28 146.56 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.728 179.607 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.29 132.09 58.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.152 0.501 . . . . 0.0 110.418 178.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -152.09 154.73 36.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.377 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.628 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.6 m -122.15 123.01 40.54 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.904 0.383 . . . . 0.0 110.408 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.38 -25.43 65.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.679 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.628 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.53 -49.0 20.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.5 -9.85 59.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.499 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.6 m80 46.5 42.76 11.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.582 -179.602 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 t -135.89 145.77 46.69 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.421 179.802 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.406 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -111.33 113.92 26.73 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.393 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -120.06 133.58 55.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.438 . . . . 0.0 110.377 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.547 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.33 146.72 37.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.794 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.488 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.5 t90 -99.58 129.8 45.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.22 0.533 . . . . 0.0 109.864 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.62 153.85 39.34 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.292 179.935 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.1 Cg_endo -67.61 -18.3 48.41 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.705 2.27 . . . . 0.0 111.986 178.981 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.16 -18.72 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.414 -179.23 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.488 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.1 p -75.7 165.04 25.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.496 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.01 -28.3 66.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.508 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.543 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.47 -41.45 98.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.673 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.85 -44.89 96.66 Favored Glycine 0 C--N 1.331 0.276 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.43 -38.98 92.92 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 122.231 -0.57 . . . . 0.0 110.703 179.67 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.584 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.7 mmm -61.93 -41.41 97.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.246 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.58 -47.72 80.33 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.99 0.424 . . . . 0.0 110.44 179.266 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.73 -32.01 50.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.882 0.373 . . . . 0.0 110.379 179.715 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -70.89 -18.13 62.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.493 179.568 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.429 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.5 mt -88.62 -8.67 54.27 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.651 -179.494 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.61 2.64 55.37 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -88.59 152.26 21.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.929 0.395 . . . . 0.0 110.504 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.442 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.1 p -115.11 127.99 55.94 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.118 0.485 . . . . 0.0 110.397 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.566 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.36 146.15 23.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.943 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.474 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.84 151.66 45.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.529 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.1 131.74 42.65 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.546 179.811 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.896 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.79 93.53 29.27 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.099 -179.713 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.682 ' C ' ' H ' ' A' ' 229' ' ' GLY . 44.5 Cg_exo -55.14 138.95 80.18 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.61 2.207 . . . . 0.0 111.769 178.775 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.6 -25.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.481 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.682 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.79 -49.95 26.8 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.805 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -53.94 -37.21 63.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 -179.273 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -66.62 35.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.83 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.09 88.36 0.01 OUTLIER 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.913 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.2 p -81.94 -14.33 56.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.337 -179.672 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.34 -41.43 10.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.618 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.2 t -66.91 -16.67 64.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.616 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.09 43.47 26.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.495 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.56 -148.44 7.84 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.88 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.37 143.23 49.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.959 0.409 . . . . 0.0 110.358 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.1 ttt-85 -151.95 149.43 28.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.312 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -100.71 -152.09 0.42 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.372 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.4 t0 56.1 -91.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.469 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.0 tt -126.54 175.43 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.631 -179.508 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.469 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.0 mt -122.14 141.7 41.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 -179.44 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.79 169.33 9.32 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.266 -179.774 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.2 mt -147.9 150.76 34.7 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.183 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.75 -38.91 96.88 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.19 4.07 4.64 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.3 -58.24 3.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 110.539 -179.857 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.56 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.6 m-20 -62.1 -36.88 83.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.281 -179.757 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.406 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.0 mp -52.3 -67.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.736 -179.69 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.47 -42.23 67.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.19 -179.617 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.06 18.09 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.617 179.787 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.69 48.63 0.26 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.29 -109.91 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.485 0.183 . . . . 0.0 110.746 -178.664 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.474 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.9 m120 -60.78 -45.25 95.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.463 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.95 8.17 82.78 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 179.255 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.32 -12.75 20.05 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.725 -0.279 . . . . 0.0 110.673 -179.744 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.4 t 176.6 142.49 0.07 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.013 0.435 . . . . 0.0 110.446 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.0 tt -148.17 125.19 11.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.657 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.428 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -98.27 142.93 29.32 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 120.91 0.386 . . . . 0.0 110.694 178.313 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.3 mt -94.23 106.58 18.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.805 -179.323 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.463 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.3 t80 -101.91 -11.73 18.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.15 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.99 -40.2 87.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.84 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.81 173.97 46.17 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.459 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -74.39 -112.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.789 0.328 . . . . 0.0 110.798 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.83 -28.74 67.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.671 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.95 -44.18 91.4 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.24 -178.894 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.56 -44.4 94.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.317 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.47 -60.09 3.65 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.194 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.8 -43.74 58.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.143 179.763 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.91 75.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.242 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.1 mt -64.46 -43.62 96.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.587 179.56 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -56.57 -37.87 71.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.137 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.82 1.11 18.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.208 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.0 91.2 25.82 Favored Pre-proline 0 N--CA 1.461 0.104 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.164 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.86 -27.17 26.56 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.796 2.331 . . . . 0.0 112.034 179.37 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.537 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.58 -41.01 98.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.468 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.592 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.38 5.33 51.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.414 -179.21 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.06 -34.82 69.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.588 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -80.26 4.71 16.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.485 -178.819 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.91 121.11 80.36 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.555 179.921 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -47.15 -37.87 24.19 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.521 2.148 . . . . 0.0 112.533 -179.499 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.86 -43.77 90.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.469 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.98 -43.47 92.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.387 179.261 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -64.86 -40.67 95.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.439 -179.343 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -90.02 -12.25 39.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.504 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 62.16 32.54 17.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.989 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -89.08 43.97 1.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.079 0.466 . . . . 0.0 110.278 179.52 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.13 135.87 41.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.587 -179.752 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.6 132.56 56.65 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.37 179.618 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.499 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.56 87.86 7.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.762 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.97 -41.31 97.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.782 179.433 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.12 168.14 34.73 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.7 p -75.97 -25.89 56.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.756 179.79 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.491 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.3 tp10 -67.79 -33.92 75.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.471 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 296' ' ' THR . 97.4 m -73.47 19.9 0.1 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.076 0.465 . . . . 0.0 110.78 -179.148 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.543 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 55.3 t80 -57.26 -51.38 69.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.853 -179.369 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 67.4 mmt-85 -108.0 149.51 28.3 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.767 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.429 ' CD2' HD11 ' A' ' 219' ' ' LEU . 40.5 tp -115.34 125.39 53.18 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.851 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.474 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.4 t0 -149.06 166.41 28.79 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.567 179.537 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -49.29 -37.95 25.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.663 -179.511 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -71.89 -65.11 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.376 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.65 -32.74 71.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.983 -179.491 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.7 -25.51 27.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.786 -179.102 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.5 mtt -63.32 -40.79 98.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.851 0.358 . . . . 0.0 111.027 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.89 -44.03 23.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.982 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.563 HG21 HG23 ' A' ' 296' ' ' THR . 74.5 t -66.26 -42.79 91.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.381 179.605 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.458 HD11 ' NE2' ' A' ' 183' ' ' GLN . 51.7 tp -60.23 -47.1 87.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.495 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -70.17 -39.48 75.25 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.987 0.422 . . . . 0.0 110.672 179.28 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.499 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.3 ttt180 -61.67 -38.24 87.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.275 -179.043 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.4 4.75 41.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.61 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.405 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.3 tttt -112.82 -11.18 13.5 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.964 0.411 . . . . 0.0 110.264 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.15 -37.18 86.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.388 179.737 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.75 -48.91 79.66 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.465 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.157 179.66 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -89.94 -2.58 58.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.423 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.68 179.23 1.21 Allowed Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.524 -179.673 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.4 Cg_exo -60.87 145.0 99.67 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.818 2.345 . . . . 0.0 112.141 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.613 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.92 -179.56 8.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.639 -179.735 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.93 137.02 52.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.961 0.41 . . . . 0.0 110.313 179.774 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -124.43 147.05 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.346 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.5 p -120.03 136.11 54.68 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.779 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.46 -143.49 0.33 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.248 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.55 -37.39 87.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.453 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.476 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.93 -66.61 0.23 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.442 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.55 142.46 45.42 Favored Glycine 0 CA--C 1.518 0.277 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 -179.38 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.7 p -112.3 131.38 55.55 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.569 -0.371 . . . . 0.0 110.465 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -119.07 129.06 54.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.56 -179.832 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.5 m -85.6 130.43 34.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.223 -179.834 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.481 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.6 mt -95.95 78.82 3.22 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.388 179.679 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.71 -31.78 72.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.56 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 176.1 109.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.032 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.481 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.41 91.51 49.25 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.412 -179.753 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.647 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.3 Cg_exo -56.89 148.55 66.58 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.79 2.327 . . . . 0.0 111.956 178.965 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.48 82.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.679 0.612 . . . . 0.0 110.97 -179.24 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.647 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.6 66.93 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.055 0.455 . . . . 0.0 110.173 -179.389 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.23 130.69 35.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.561 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.3 t -122.42 146.55 27.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.046 0.451 . . . . 0.0 109.993 -179.664 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.2 t -135.81 143.77 45.36 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.038 0.447 . . . . 0.0 110.729 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.2 p -99.37 -59.53 1.7 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.619 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.5 p -79.25 155.22 28.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.654 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.524 HG21 HG23 ' A' ' 70' ' ' THR . 73.7 t -74.11 -21.92 18.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.486 179.355 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.1 m -60.33 -52.13 66.59 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.488 -178.406 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.9 mt -66.24 -42.72 88.2 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.759 177.823 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.1 m -43.24 -53.83 4.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.905 -178.314 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.37 -37.23 70.21 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 178.598 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m -62.75 -44.69 95.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.853 0.359 . . . . 0.0 110.141 -179.221 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.0 mt -66.46 -41.9 88.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.497 0.665 . . . . 0.0 110.739 179.688 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -62.56 -40.49 96.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.489 -179.392 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.92 -35.86 75.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.287 -179.084 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.529 HD11 HD12 ' A' ' 156' ' ' LEU . 32.5 pt -91.16 28.89 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.352 -179.465 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.45 51.75 10.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.058 179.56 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.49 76.04 21.51 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.584 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.03 151.53 85.46 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.836 2.357 . . . . 0.0 112.076 -178.904 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.561 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.37 137.46 46.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-O 121.176 0.512 . . . . 0.0 110.293 179.671 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.1 pt -69.46 -43.62 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.321 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.12 131.44 53.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.037 0.446 . . . . 0.0 110.569 -178.984 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.536 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.0 p -155.77 168.59 26.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.445 -179.715 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.47 -177.22 21.9 Favored Glycine 0 N--CA 1.463 0.471 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.638 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.97 172.77 12.35 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 121.078 0.466 . . . . 0.0 110.437 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.524 HG23 HG21 ' A' ' 51' ' ' VAL . 14.9 p -132.42 -112.92 0.23 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.104 0.478 . . . . 0.0 110.376 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.98 179.72 0.94 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.406 -179.198 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.5 Cg_exo -60.86 57.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.968 2.446 . . . . 0.0 112.145 179.554 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.1 t-20 -64.25 -33.16 75.16 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.382 -179.731 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 14.5 m120 93.47 -36.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.757 0.661 . . . . 0.0 109.805 -179.524 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HD3' HD21 ' A' ' 73' ' ' ASN . 77.0 mtp85 -62.62 -39.64 94.45 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.216 179.271 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.34 -25.53 19.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.684 179.384 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.31 -170.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.436 -179.232 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.03 -154.35 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.856 -179.627 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.8 p-10 -52.31 -7.56 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.757 -179.567 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -85.95 114.92 23.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.676 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.97 70.4 1.34 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.625 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -143.84 147.99 34.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.844 0.354 . . . . 0.0 110.841 179.232 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -85.82 -98.46 0.07 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.082 178.863 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.551 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.18 -42.52 96.65 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.052 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 9.9 tt0 91.38 52.83 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.895 0.747 . . . . 0.0 111.024 179.205 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -102.88 -9.38 19.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.313 179.37 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.2 p -64.31 -33.91 76.93 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.139 0.495 . . . . 0.0 110.699 -179.628 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -49.21 -23.39 1.31 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.678 179.651 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.3 t -69.84 -45.95 75.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 179.602 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.23 -48.62 80.65 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.924 -179.324 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.4 -38.4 89.48 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.379 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.59 -33.07 53.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.134 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.606 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.5 mmt-85 -89.66 1.74 55.64 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.554 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.68 -49.34 0.18 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.862 0.726 . . . . 0.0 110.197 179.126 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.655 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.8 mt -45.9 154.4 0.24 Allowed 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 117.538 -1.22 . . . . 0.0 109.524 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.655 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.1 tt0 121.07 92.63 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 O-C-N 125.566 1.791 . . . . 0.0 110.443 -178.595 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.536 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.57 142.94 42.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.252 0.548 . . . . 0.0 110.312 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -131.94 26.98 4.6 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.0 -0.438 . . . . 0.0 110.437 -179.344 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.24 137.9 34.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.022 0.439 . . . . 0.0 110.589 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.638 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.5 mt -137.16 165.01 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.332 179.629 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.9 -28.43 1.87 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.58 70.51 7.37 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-O 121.079 0.466 . . . . 0.0 110.095 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.92 145.33 98.57 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 122.668 2.245 . . . . 0.0 112.133 -179.651 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.9 t -134.35 136.73 43.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.559 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.37 81.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.63 179.66 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.12 -42.23 96.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.51 -179.408 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.62 98.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.491 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.6 -43.35 98.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.004 179.479 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.08 77.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.132 -179.598 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.69 -18.75 60.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.362 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.66 -6.55 58.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.491 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.8 mtp 47.53 56.1 17.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.644 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.8 Cg_endo -70.03 149.46 65.19 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.791 2.327 . . . . 0.0 112.098 179.516 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.03 -73.61 0.64 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.519 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.435 HD11 HD13 ' A' ' 140' ' ' LEU . 38.6 tp -111.02 113.44 25.99 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.293 179.633 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -102.08 126.57 56.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 120.962 0.411 . . . . 0.0 110.64 -179.8 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.3 mt -109.92 133.96 52.6 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.266 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.73 139.6 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.558 -179.567 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.9 p -83.4 168.37 16.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.716 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.47 80.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.389 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.91 159.13 42.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.94 0.4 . . . . 0.0 110.432 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.23 176.82 33.54 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.29 -33.59 86.57 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.57 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.56 151.46 44.71 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.928 0.394 . . . . 0.0 110.507 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.0 t -63.33 140.78 58.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.331 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.55 10.35 11.08 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.591 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.01 -38.94 87.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.253 -179.283 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.97 -35.89 23.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.522 0.677 . . . . 0.0 110.605 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -70.96 -35.44 72.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.546 0.688 . . . . 0.0 110.659 179.394 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.83 -62.81 0.91 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.411 -178.756 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.65 -42.86 90.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.195 -179.402 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -61.98 -32.71 73.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.367 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.0 mt -73.58 -41.06 63.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.864 178.642 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.18 -48.87 78.98 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.122 -178.852 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.8 m -52.97 -42.5 65.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.961 0.41 . . . . 0.0 110.186 179.474 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.14 -42.84 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 120.934 0.397 . . . . 0.0 111.18 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.33 153.51 5.38 Favored Pre-proline 0 N--CA 1.452 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.655 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -39.29 107.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.682 2.255 . . . . 0.0 112.516 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.636 ' C ' HD12 ' A' ' 140' ' ' LEU . 97.0 m -109.73 121.4 45.14 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.116 0.484 . . . . 0.0 110.281 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.636 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.56 152.44 30.27 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.279 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -128.77 131.22 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.351 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -115.09 127.9 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.099 0.476 . . . . 0.0 110.52 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.8 t30 -101.43 103.81 14.74 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.161 179.822 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.0 p90 -101.35 -11.13 19.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.875 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.5 p-10 -64.89 -33.54 76.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.768 -179.718 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -98.4 7.72 45.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.503 -179.546 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.448 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.55 155.62 50.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.484 -179.358 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.2 p -75.02 165.75 24.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.675 -179.778 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.589 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.02 -48.8 80.22 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.188 -179.1 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -53.41 -42.0 66.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 110.094 -179.747 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.4 t -62.74 -41.04 99.0 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.366 178.684 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.409 ' CD1' HG21 ' A' ' 142' ' ' ILE . 45.6 tp -60.66 -44.42 96.48 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.325 -179.469 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.0 tp -61.47 -43.49 98.77 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.079 179.768 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.0 m -54.91 -45.04 74.69 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.18 -40.86 97.43 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.88 0.371 . . . . 0.0 110.46 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.529 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.86 -42.51 99.13 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.388 178.968 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.27 -40.78 94.86 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.51 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.54 -46.05 64.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.389 . . . . 0.0 110.842 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.79 -44.02 96.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.847 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.8 p -92.86 -8.89 42.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.622 -179.026 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.88 26.61 72.27 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -101.85 50.91 0.84 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.844 0.354 . . . . 0.0 110.693 -179.572 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.56 -39.59 77.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.622 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.37 -47.12 86.63 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.288 -179.293 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -60.07 -39.49 86.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.145 -179.734 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.97 99.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.247 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.88 -28.26 69.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.622 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.56 -54.18 7.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.898 179.404 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.506 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.54 -42.19 92.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.402 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.2 mt -62.43 -43.77 98.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.496 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.58 -58.15 8.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.984 0.421 . . . . 0.0 110.372 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.47 -33.35 67.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.597 -179.016 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.409 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.8 t80 -81.35 -36.72 29.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.756 179.558 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.7 m-20 -55.79 -42.01 74.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.867 -178.437 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.4 -42.19 99.24 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.919 0.39 . . . . 0.0 110.801 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.26 -38.06 89.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.237 179.802 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.409 HD11 ' CD2' ' A' ' 173' ' ' PHE . 82.4 mt -62.41 -42.2 99.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.718 179.569 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.19 -53.01 61.38 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.07 0.462 . . . . 0.0 110.67 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.02 -41.8 90.5 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.674 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.95 95.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.28 -32.09 73.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.382 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -94.62 -22.35 18.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.688 -179.764 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.443 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.6 tt0 -64.76 -41.33 95.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.676 -179.554 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -76.45 136.37 24.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.69 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.72 107.91 10.59 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.246 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.73 125.95 0.31 Allowed Pre-proline 0 C--O 1.239 0.55 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.465 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.452 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.6 Cg_exo -44.02 152.35 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.872 2.381 . . . . 0.0 112.553 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.09 141.98 54.6 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.556 2.171 . . . . 0.0 112.385 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.35 147.33 2.14 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.52 179.301 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.28 154.62 69.37 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.813 2.342 . . . . 0.0 112.348 178.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.42 163.15 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.207 0.527 . . . . 0.0 110.42 179.799 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.56 170.11 16.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.008 179.453 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.75 137.32 22.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.949 0.404 . . . . 0.0 110.185 179.448 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.567 HG22 HD12 ' A' ' 205' ' ' LEU . 38.7 pt -134.16 146.55 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.682 179.528 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.95 132.04 59.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.261 0.553 . . . . 0.0 110.468 178.858 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -153.31 156.96 39.37 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.43 179.21 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.4 m -122.8 123.31 40.74 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.944 0.402 . . . . 0.0 110.418 179.383 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.474 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -61.09 -25.95 67.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.583 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.614 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.66 -50.0 19.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.972 179.708 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.24 -11.11 59.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.548 -179.714 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.474 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 80.6 m80 47.11 47.39 16.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.563 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.6 t -131.47 144.75 51.38 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.277 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.431 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -109.76 106.19 15.72 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.235 -179.846 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -116.76 129.61 56.21 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.177 0.513 . . . . 0.0 110.301 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.567 HD12 HG22 ' A' ' 194' ' ' ILE . 7.7 tt -112.1 146.54 37.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.813 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.472 ' N ' HD23 ' A' ' 205' ' ' LEU . 12.1 t90 -99.49 128.46 45.6 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.203 0.525 . . . . 0.0 109.851 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.41 153.88 40.37 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.37 179.758 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.5 Cg_endo -67.59 -18.08 48.43 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.651 2.234 . . . . 0.0 112.003 178.978 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -49.6 -18.55 0.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.332 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.421 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.9 p -75.56 164.15 26.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.474 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.71 -28.1 65.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.533 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.571 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.0 mt-30 -63.65 -41.25 98.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.656 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.57 -44.44 97.78 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -179.514 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.448 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.1 mt-30 -64.3 -38.81 92.35 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 122.212 -0.581 . . . . 0.0 110.712 179.588 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.2 mmm -61.99 -41.31 97.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.188 179.819 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 74.1 mt -63.49 -47.71 80.61 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.031 0.443 . . . . 0.0 110.392 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.66 -32.06 50.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.909 0.385 . . . . 0.0 110.273 179.828 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -71.01 -17.96 62.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.48 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.419 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.7 mt -88.77 -8.4 54.5 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.617 -179.477 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.44 2.58 55.55 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.811 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -88.68 152.2 21.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.953 0.406 . . . . 0.0 110.429 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.451 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.9 p -115.18 127.97 55.88 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.183 0.516 . . . . 0.0 110.356 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -91.94 146.63 23.59 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.011 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.457 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.38 151.18 45.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.477 179.727 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.1 131.77 42.67 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.5 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.881 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.54 93.53 28.01 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.079 -179.52 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.686 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.5 Cg_exo -55.31 138.77 80.5 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.599 2.199 . . . . 0.0 111.633 179.034 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.27 -25.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.478 -179.621 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.686 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.45 -50.11 28.07 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.819 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.4 mt -54.76 -36.67 65.08 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.122 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -65.95 36.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.783 179.431 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.569 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.51 86.25 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.953 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.2 p -79.27 -15.14 58.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.346 -179.809 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -92.4 -40.25 10.98 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.678 179.918 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -66.03 -18.03 65.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.598 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.16 43.44 26.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.41 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.89 -148.16 7.79 Favored Glycine 0 CA--C 1.518 0.262 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.97 142.31 49.89 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 110.316 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.406 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.4 ttt-85 -152.48 149.92 29.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.313 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -102.18 -149.95 0.4 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.3 179.815 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 55.29 -92.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.696 -179.782 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.441 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.1 tt -126.94 174.65 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.635 -179.495 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.441 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.0 mt -122.31 141.29 43.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.039 0.447 . . . . 0.0 110.899 -179.562 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.58 170.62 8.47 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.196 -179.787 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.3 mt -146.75 149.6 33.71 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.259 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.19 -39.38 97.86 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.07 3.14 4.04 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -78.5 -57.59 3.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.964 0.412 . . . . 0.0 110.517 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.613 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.6 m-20 -62.07 -36.88 82.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.203 -179.651 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.431 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.6 mp -52.98 -67.57 0.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.0 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.61 -42.53 67.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.112 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.74 17.74 0.15 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.656 179.828 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.0 48.05 0.27 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.1 mp 39.25 -109.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.534 0.207 . . . . 0.0 110.721 -178.623 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.457 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -60.83 -44.67 96.61 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.381 -179.57 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.6 7.96 83.69 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.336 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.93 -13.34 20.02 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.689 -0.301 . . . . 0.0 110.667 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.1 t 177.06 142.89 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.083 0.468 . . . . 0.0 110.427 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.431 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.2 125.3 11.41 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.197 179.521 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.47 143.65 28.68 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 120.892 0.377 . . . . 0.0 110.808 178.326 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.06 106.62 18.63 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.78 -179.264 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.2 t80 -102.3 -11.41 18.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.116 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.57 -40.55 84.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.875 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.28 172.71 45.57 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.599 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.472 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 94.8 m-20 -73.9 -113.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.784 0.326 . . . . 0.0 110.723 -179.745 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.67 -28.94 68.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.661 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.11 -43.62 91.91 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.104 -178.762 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.55 -44.4 94.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.299 179.299 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.63 -59.99 3.8 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.133 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -51.02 -43.58 60.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.115 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.31 -43.23 74.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.179 -179.905 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.67 -43.57 96.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.641 179.541 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -55.96 -37.61 69.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.149 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.76 1.0 18.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.158 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -114.96 91.41 26.49 Favored Pre-proline 0 N--CA 1.461 0.114 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.121 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.24 -27.29 29.81 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.798 2.332 . . . . 0.0 111.917 179.24 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.5 -40.98 98.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.484 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.37 5.22 52.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.349 -179.132 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.95 -35.12 69.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.622 179.557 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -80.06 4.69 16.34 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.521 -178.742 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.76 121.17 80.27 Favored Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.541 179.967 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -47.28 -37.68 24.8 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.427 2.085 . . . . 0.0 112.611 -179.582 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.53 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.84 -43.75 90.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.747 0.308 . . . . 0.0 110.404 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.01 -43.64 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.285 179.376 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.87 -40.66 95.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.376 -179.232 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.8 t-20 -89.78 -12.55 38.93 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.592 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 61.87 32.18 18.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.069 -179.743 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.78 43.84 1.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.136 0.493 . . . . 0.0 110.308 179.537 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.11 135.85 39.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.487 -179.711 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.9 132.19 56.76 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.412 179.669 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.02 89.12 7.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.796 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.05 -41.11 97.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.45 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.444 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.52 165.76 33.44 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.3 p -75.46 -25.87 57.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.887 0.375 . . . . 0.0 110.785 179.787 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.9 tp10 -68.27 -33.76 74.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.439 -179.737 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 296' ' ' THR . 95.8 m -73.59 23.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.751 -179.144 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.571 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 49.4 t80 -58.0 -50.86 71.95 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.102 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 75.0 mmt-85 -110.7 152.97 25.92 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.108 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.419 ' CD2' HD11 ' A' ' 219' ' ' LEU . 41.9 tp -115.48 125.54 53.2 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.989 179.767 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.492 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.3 t0 -148.03 165.55 30.44 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.581 179.46 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -49.35 -37.71 25.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.655 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.29 -65.54 0.73 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.58 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.96 -32.85 72.37 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.058 -179.536 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.13 -25.61 23.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.8 -179.166 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.7 mtt -63.55 -40.7 97.68 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 120.854 0.359 . . . . 0.0 111.135 179.664 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.64 -44.1 24.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.188 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.584 HG21 HG23 ' A' ' 296' ' ' THR . 77.2 t -66.37 -42.87 91.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.353 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.443 HD11 ' NE2' ' A' ' 183' ' ' GLN . 50.1 tp -60.24 -47.12 87.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.507 -178.488 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -69.67 -39.36 77.07 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.069 0.462 . . . . 0.0 110.796 179.033 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.7 ttt180 -61.89 -38.44 88.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.218 -178.884 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.01 4.29 42.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.594 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.405 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.3 tttt -112.84 -10.94 13.52 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.073 0.463 . . . . 0.0 110.314 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.35 86.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.427 179.669 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.86 -48.7 80.59 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.403 -179.568 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.064 179.86 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -90.22 -2.56 58.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.428 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.7 179.13 1.23 Allowed Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.588 -179.711 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.0 Cg_exo -60.86 144.79 99.63 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.81 2.34 . . . . 0.0 112.206 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.9 -179.56 8.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.562 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -115.7 136.44 53.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.355 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.28 147.63 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.386 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.3 p -120.65 136.26 54.88 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.814 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.32 -143.34 0.32 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.239 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.8 -36.95 85.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.484 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.0 -67.67 0.22 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.436 179.676 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.16 142.53 44.46 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.295 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.4 p -112.18 131.8 55.26 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.552 -0.381 . . . . 0.0 110.513 -179.752 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.12 128.9 54.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.591 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.3 m -85.39 130.14 34.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.223 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.8 mt -95.37 78.43 3.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.4 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.81 -32.27 73.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.532 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.61 108.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.993 0.425 . . . . 0.0 110.157 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.489 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.69 91.59 49.48 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-O 120.767 0.317 . . . . 0.0 110.404 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.655 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.6 Cg_exo -56.67 148.68 63.46 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.742 2.295 . . . . 0.0 111.993 178.96 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.26 82.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.677 0.61 . . . . 0.0 110.988 -179.196 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.655 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.57 66.88 0.88 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.261 -179.377 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.56 131.06 35.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.817 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.576 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.5 t -122.68 148.27 26.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.056 0.455 . . . . 0.0 110.077 -179.787 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.7 t -136.78 143.68 43.34 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.776 179.75 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.5 p -99.3 -59.03 1.8 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.572 179.864 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.0 p -79.16 155.43 28.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.587 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.548 HG21 HG23 ' A' ' 70' ' ' THR . 68.8 t -74.51 -21.72 17.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.484 179.357 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.1 m -60.4 -52.1 66.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.524 -178.464 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.37 -42.7 87.61 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.754 177.87 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.3 m -42.9 -53.89 4.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.948 -178.585 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.15 -37.41 72.29 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 178.575 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.8 m -62.8 -44.34 96.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.941 0.4 . . . . 0.0 110.152 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.6 mt -66.09 -42.05 89.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.505 0.669 . . . . 0.0 110.683 179.702 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.88 -40.04 96.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.393 -179.266 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.525 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.88 -36.1 78.34 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.348 -178.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.472 HD11 HD12 ' A' ' 156' ' ' LEU . 34.3 pt -90.92 27.81 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.27 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.89 52.03 9.91 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.391 0.432 . . . . 0.0 111.097 179.568 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.2 75.82 27.83 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.733 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.32 148.95 92.46 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.859 2.373 . . . . 0.0 112.12 -178.822 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.576 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.5 136.58 48.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-O 121.188 0.518 . . . . 0.0 110.308 179.807 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.442 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.68 -43.5 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.251 179.352 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.13 131.26 53.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.948 0.404 . . . . 0.0 110.605 -178.971 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.5 p -155.55 168.43 27.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.501 -179.796 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.81 -177.37 21.67 Favored Glycine 0 N--CA 1.463 0.453 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.638 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -134.04 173.16 11.88 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.062 0.458 . . . . 0.0 110.402 179.367 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.548 HG23 HG21 ' A' ' 51' ' ' VAL . 13.6 p -133.22 -111.79 0.23 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.982 0.42 . . . . 0.0 110.4 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.64 179.71 0.93 Allowed Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.466 -179.247 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.3 Cg_exo -60.93 58.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 123.018 2.479 . . . . 0.0 112.089 179.463 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.0 t-20 -64.45 -33.8 76.73 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.412 -179.647 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.2 m120 93.85 -36.13 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.788 0.68 . . . . 0.0 109.769 -179.632 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.407 ' HD3' HD21 ' A' ' 73' ' ' ASN . 78.1 mtp85 -63.22 -40.09 96.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.235 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.3 p -74.42 -25.37 19.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.742 179.326 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.25 -171.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.463 -179.208 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.56 -153.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.0 p-10 -52.15 -7.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.751 -179.594 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.1 mm-40 -86.33 114.81 23.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.619 179.707 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.79 70.61 1.34 Allowed Glycine 0 CA--C 1.52 0.379 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.617 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -143.55 147.85 35.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.925 0.393 . . . . 0.0 110.802 179.233 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.98 -98.34 0.07 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.035 178.874 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.558 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.3 -42.49 96.35 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.132 179.354 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.558 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.0 tt0 91.55 53.29 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.851 0.719 . . . . 0.0 111.033 179.195 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -103.15 -9.43 19.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.345 179.261 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.5 p -64.06 -34.58 78.35 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.059 0.457 . . . . 0.0 110.732 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.71 -24.31 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.624 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.95 -45.62 76.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.58 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.89 -49.03 79.11 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.976 -179.368 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.44 -38.15 88.64 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.412 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.46 -32.8 51.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.135 -179.751 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.61 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.97 1.55 56.13 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.555 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 83.11 -48.98 0.15 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.743 0.652 . . . . 0.0 110.245 179.146 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.664 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.1 mt -46.51 153.64 0.35 Allowed 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 117.732 -1.128 . . . . 0.0 109.546 -179.872 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.664 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.3 tt0 121.64 92.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 125.359 1.662 . . . . 0.0 110.476 -178.634 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.42 143.16 42.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.245 0.545 . . . . 0.0 110.288 179.313 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.1 mt -132.42 26.95 4.44 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 122.02 -0.425 . . . . 0.0 110.479 -179.365 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.44 138.31 34.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 0.0 110.485 -179.883 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.638 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.1 mt -137.28 164.84 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.359 179.51 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.14 -29.0 1.82 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.2 70.64 7.67 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.17 0.51 . . . . 0.0 110.241 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.07 145.37 98.59 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 C-N-CA 122.795 2.33 . . . . 0.0 112.046 -179.53 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.2 t -134.66 136.68 42.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.574 179.637 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.63 83.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.619 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.01 -42.21 97.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.493 -179.415 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.07 -41.55 98.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.563 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.61 -43.43 98.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.994 179.487 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.15 77.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.174 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.31 -18.8 60.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.459 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.59 -6.62 58.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.523 -179.773 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 73.5 mtp 47.91 56.04 17.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.548 179.993 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.22 149.27 63.73 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.834 2.356 . . . . 0.0 112.1 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.31 -72.8 0.67 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.506 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.403 HD11 HD13 ' A' ' 140' ' ' LEU . 38.2 tp -111.56 113.9 26.62 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.386 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.9 mt -103.05 126.89 57.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 120.993 0.425 . . . . 0.0 110.572 -179.765 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.6 mt -110.11 134.29 52.33 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.251 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.84 139.92 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.499 -179.651 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.3 p -83.51 168.13 16.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.776 179.722 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.09 79.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.431 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.61 158.71 43.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.432 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.26 175.74 33.87 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.22 -33.62 86.54 Favored Glycine 0 CA--C 1.518 0.279 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.571 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -123.97 151.13 44.0 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.904 0.383 . . . . 0.0 110.585 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.4 t -63.52 140.08 58.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.389 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.1 10.82 11.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.656 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -60.99 -38.85 87.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.251 -179.394 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.633 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.32 -35.71 23.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.407 0.622 . . . . 0.0 110.587 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.4 mt -70.98 -35.42 72.1 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.51 0.671 . . . . 0.0 110.668 179.379 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -42.76 -63.0 0.86 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.348 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.633 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.7 p-10 -65.88 -42.83 89.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.114 -179.25 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.3 mt-30 -61.76 -32.8 73.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.362 -179.603 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.4 mt -73.62 -40.78 63.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 178.651 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.23 -49.2 77.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.165 -178.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.9 m -52.7 -42.7 65.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.186 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.09 -42.78 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 120.967 0.413 . . . . 0.0 111.144 179.165 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.58 153.36 5.09 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.632 -179.362 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -39.12 107.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.629 2.219 . . . . 0.0 112.538 179.65 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.639 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.3 m -110.04 121.35 45.06 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.095 0.474 . . . . 0.0 110.289 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.639 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -113.94 153.05 29.93 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.29 -179.729 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.456 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -130.36 129.25 64.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.398 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.5 mt -111.74 126.72 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.626 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.513 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 57.0 t30 -100.9 103.81 15.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.149 179.711 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -100.88 -6.31 24.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.956 -179.741 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.2 p-10 -65.34 -33.39 75.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.728 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.584 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -100.37 9.18 43.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.618 -179.366 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.436 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.7 mttm -135.48 153.31 51.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.461 -179.39 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.9 p -75.81 166.55 23.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.624 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.597 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.8 t90 -59.89 -48.93 79.7 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.194 -179.095 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.85 -43.41 69.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.88 0.371 . . . . 0.0 110.087 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.0 t -62.88 -41.02 99.24 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.28 178.573 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.421 ' O ' HD23 ' A' ' 156' ' ' LEU . 49.9 tp -60.68 -44.49 96.44 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.298 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.0 tp -61.04 -43.59 98.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.136 179.882 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -54.53 -45.02 73.28 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.892 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.37 -40.15 95.5 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.96 0.41 . . . . 0.0 110.398 179.718 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.472 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.79 -42.46 99.03 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.189 179.164 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.75 -40.09 95.54 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.362 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.43 -45.64 65.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.352 . . . . 0.0 110.762 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.84 -43.99 96.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.1 p -93.39 -8.95 40.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.632 -178.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.13 26.01 72.35 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -101.78 50.48 0.85 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.735 0.302 . . . . 0.0 110.65 -179.509 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.48 -39.29 77.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.625 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.39 -47.2 86.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.327 -179.452 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -60.23 -39.61 87.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.226 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.11 99.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.01 0.433 . . . . 0.0 110.245 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.03 -28.58 70.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.591 179.489 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.59 -54.12 8.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.885 179.407 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.525 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.5 ttp180 -65.26 -42.5 93.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.395 -179.764 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 174' ' ' ASP . 81.2 mt -62.61 -43.94 98.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.54 -179.388 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.11 -61.06 2.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.088 0.471 . . . . 0.0 110.403 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.8 -34.52 62.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.605 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -80.41 -35.9 34.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.812 179.576 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.8 m-20 -55.08 -42.07 72.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.997 -178.658 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.42 -41.94 99.07 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.746 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.0 -38.21 90.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.316 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.9 mt -62.46 -41.92 99.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.728 179.397 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.88 -52.81 62.61 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.097 0.475 . . . . 0.0 110.68 179.805 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.21 -41.75 89.69 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.674 179.408 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.92 95.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.592 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.36 -32.28 73.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.05 -22.16 18.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.589 -179.807 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.491 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -64.82 -41.06 96.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.698 -179.593 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -76.89 135.94 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.749 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -126.85 108.33 10.91 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.257 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.62 125.75 0.31 Allowed Pre-proline 0 C--O 1.239 0.551 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.495 179.954 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.6 Cg_exo -43.94 152.4 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.848 2.365 . . . . 0.0 112.585 -179.862 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.09 141.75 53.82 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.604 2.203 . . . . 0.0 112.382 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.3 147.31 2.16 Favored Pre-proline 0 N--CA 1.448 -0.528 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.563 179.315 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.11 154.22 70.63 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.839 2.36 . . . . 0.0 112.33 178.621 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.58 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.37 163.08 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.27 0.557 . . . . 0.0 110.42 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.58 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.77 170.39 15.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.97 179.593 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.17 137.6 22.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 0.0 110.182 179.432 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.542 HG22 HD12 ' A' ' 205' ' ' LEU . 40.6 pt -134.37 147.02 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.73 179.596 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.484 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -133.55 132.05 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.21 0.529 . . . . 0.0 110.436 178.772 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -152.1 155.04 37.1 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.382 179.14 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.7 m -122.26 122.89 40.16 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.952 0.406 . . . . 0.0 110.405 179.469 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.88 -25.36 66.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.678 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.614 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.45 -49.37 19.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.876 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.26 -9.81 59.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.393 -179.526 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.6 m80 46.85 43.39 13.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.544 -179.653 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -136.39 144.65 44.65 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.31 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.9 113.92 26.86 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.336 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.95 133.41 55.57 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.096 0.474 . . . . 0.0 110.405 179.824 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.542 HD12 HG22 ' A' ' 194' ' ' ILE . 7.5 tt -112.06 146.48 37.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.014 0.435 . . . . 0.0 110.728 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.459 ' N ' HD23 ' A' ' 205' ' ' LEU . 13.6 t90 -99.67 129.88 45.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.14 0.495 . . . . 0.0 109.919 179.434 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.64 154.02 39.29 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.333 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.8 Cg_endo -67.54 -18.3 48.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.752 2.302 . . . . 0.0 111.976 178.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -49.54 -18.38 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.344 -179.148 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.406 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.4 p -75.59 164.34 26.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.51 179.664 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.83 -27.95 65.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.45 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.575 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.1 mt-30 -63.98 -41.26 97.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.61 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.04 -45.05 96.62 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -179.52 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.436 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.63 -38.71 91.94 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 122.236 -0.567 . . . . 0.0 110.783 179.54 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.597 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.7 mmm -62.14 -41.78 98.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.312 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.405 HD23 HD12 ' A' ' 219' ' ' LEU . 48.5 mt -63.5 -47.14 82.96 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.143 0.497 . . . . 0.0 110.259 179.545 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -54.77 -31.64 58.97 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.894 0.378 . . . . 0.0 110.411 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -70.26 -17.7 63.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.451 179.573 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.423 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.5 mt -88.82 -9.23 52.52 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.585 -179.492 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.98 2.68 51.98 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.756 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.86 153.03 21.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.456 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.5 p -115.36 128.12 55.87 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.11 0.481 . . . . 0.0 110.323 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.5 mm? -91.75 146.6 23.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.032 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.456 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.81 151.62 44.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.41 179.709 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -133.06 132.1 41.4 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.465 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.887 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.42 93.96 29.42 Favored Pre-proline 0 C--O 1.235 0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.066 -179.633 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.684 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.3 Cg_exo -55.12 138.86 79.91 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.582 2.188 . . . . 0.0 111.662 178.937 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.6 -25.27 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.504 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.684 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.17 -49.58 26.24 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.729 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.563 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.8 mt -54.58 -37.34 65.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.093 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.33 35.75 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.767 179.376 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.563 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.48 88.02 0.01 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.926 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 81.1 p -81.0 -13.81 58.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.31 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.16 -40.71 10.86 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.604 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.7 t -67.04 -16.6 64.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.559 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.69 43.94 27.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.473 -179.589 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.61 -147.05 7.37 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.06 143.45 49.5 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.96 0.41 . . . . 0.0 110.343 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.08 149.61 29.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.338 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -101.02 -152.08 0.42 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.319 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.5 t0 56.02 -92.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.672 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.457 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.1 tt -126.49 175.13 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.661 -179.591 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.457 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -121.62 141.24 42.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.827 -179.392 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.48 168.8 9.75 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.16 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.3 mt -147.47 150.91 35.5 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.281 179.813 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.99 -38.74 96.48 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.09 4.3 4.63 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.63 -58.1 3.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.901 0.381 . . . . 0.0 110.466 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.567 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.1 m-20 -62.15 -36.45 81.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.332 -179.724 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.36 -67.8 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.842 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.32 -42.06 66.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.182 -179.362 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.29 18.03 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.629 179.816 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.59 48.46 0.24 Allowed Glycine 0 N--CA 1.465 0.591 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.62 -109.84 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.467 0.175 . . . . 0.0 110.745 -178.536 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.456 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 12.0 m120 -60.68 -45.18 95.12 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.534 -179.555 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.82 8.17 83.01 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.258 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.37 -12.71 20.04 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 122.744 -0.268 . . . . 0.0 110.7 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.5 t 176.44 142.44 0.07 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.077 0.465 . . . . 0.0 110.436 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.1 125.34 11.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.161 179.593 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.432 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.38 143.19 29.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 120.899 0.38 . . . . 0.0 110.944 178.153 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.8 mt -94.52 106.66 18.65 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.718 -179.257 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.446 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.82 -12.36 18.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.101 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.58 89.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.872 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.37 173.66 46.04 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.657 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.5 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -73.98 -112.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 110.798 -179.824 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.95 -28.61 67.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.707 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.98 -44.12 91.53 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.202 -178.811 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.75 -44.24 94.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.308 179.3 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.51 -60.24 3.48 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.167 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -50.9 -43.56 59.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.169 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.27 -43.72 74.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.211 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.7 mt -64.57 -43.56 96.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.635 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -56.39 -37.68 70.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.168 -179.858 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.8 1.07 18.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.19 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -115.25 91.1 26.64 Favored Pre-proline 0 N--CA 1.462 0.134 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.129 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.99 -26.99 26.88 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.746 2.297 . . . . 0.0 111.976 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.54 -41.09 98.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.495 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.598 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.43 5.28 52.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.401 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.17 -34.84 68.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.536 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -80.11 4.74 16.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.526 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.9 121.28 80.94 Favored Pre-proline 0 N--CA 1.445 -0.721 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.566 179.999 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -47.22 -37.79 24.51 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.446 2.097 . . . . 0.0 112.618 -179.569 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.88 -43.8 90.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.705 0.288 . . . . 0.0 110.403 179.764 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.93 -43.56 92.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.345 179.306 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.84 -40.68 95.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.327 -179.217 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -90.09 -12.06 39.5 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.572 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.69 32.84 18.29 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.393 0.433 . . . . 0.0 111.035 -179.801 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -89.3 43.87 1.17 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.17 0.509 . . . . 0.0 110.348 179.476 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.54 135.96 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.533 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -116.7 132.55 56.66 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.385 179.653 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.502 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.57 88.09 7.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.733 179.917 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.06 -40.82 97.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.446 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.64 167.54 34.82 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.8 p -75.55 -25.73 57.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.803 0.335 . . . . 0.0 110.689 179.832 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.503 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.4 tp10 -67.89 -34.56 76.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.491 -179.763 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.773 HG22 ' O ' ' A' ' 296' ' ' THR . 96.7 m -73.36 24.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.649 -179.106 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.575 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 56.7 t80 -58.04 -51.17 70.79 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.348 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.408 HH12 ' HG3' ' A' ' 212' ' ' GLN . 71.0 mmt-85 -111.77 154.54 24.9 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.073 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.423 ' CD2' HD11 ' A' ' 219' ' ' LEU . 45.0 tp -115.89 124.99 52.03 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.97 0.414 . . . . 0.0 110.824 179.688 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.488 ' CB ' HD23 ' A' ' 83' ' ' LEU . 44.4 t0 -147.22 165.37 30.27 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.59 179.552 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.4 -38.41 28.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.617 -179.463 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -71.81 -65.1 0.81 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.527 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -60.08 -32.27 70.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.926 -179.501 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.19 -25.27 21.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.684 -179.14 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.7 mtt -63.1 -41.27 99.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.975 0.417 . . . . 0.0 110.977 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.27 -44.52 25.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.207 179.427 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.546 HG21 HG23 ' A' ' 296' ' ' THR . 78.7 t -66.12 -42.88 92.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.465 179.703 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.491 HD11 ' NE2' ' A' ' 183' ' ' GLN . 52.1 tp -60.36 -47.25 86.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.524 -178.522 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -70.09 -39.54 75.49 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.696 179.336 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.502 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 70.2 ttt180 -61.89 -37.79 85.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.36 -178.907 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -87.8 4.81 42.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.723 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -113.2 -11.99 13.18 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.052 0.453 . . . . 0.0 110.357 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.3 86.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.449 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.91 -48.8 80.15 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.431 -179.644 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.059 179.8 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.608 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.86 -2.7 58.26 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.463 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.55 179.14 1.23 Allowed Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.561 -179.65 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.4 Cg_exo -60.75 145.0 99.64 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.799 2.333 . . . . 0.0 112.171 179.634 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.608 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.03 -179.52 8.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.596 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.97 136.94 52.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.013 0.435 . . . . 0.0 110.383 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.22 147.06 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.342 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.6 p -119.93 135.88 54.73 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.073 0.463 . . . . 0.0 110.699 179.84 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.42 -143.44 0.33 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.252 179.893 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.61 -37.11 86.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.485 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.4 -66.68 0.22 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.416 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.52 142.47 45.35 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -179.357 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 78.4 p -112.29 131.61 55.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 0.0 110.447 -179.811 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -119.2 129.03 54.76 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.526 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.1 m -85.56 130.18 34.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.217 -179.841 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.1 mt -95.7 78.5 3.3 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.463 179.646 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.64 -31.73 72.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.579 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.35 109.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.018 0.437 . . . . 0.0 110.089 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -122.35 91.15 49.3 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.485 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.4 Cg_exo -56.74 148.48 65.36 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.831 2.354 . . . . 0.0 112.002 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.46 82.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.566 0.542 . . . . 0.0 110.975 -179.214 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.55 66.84 0.88 Allowed 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 121.094 0.473 . . . . 0.0 110.221 -179.422 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.4 130.74 35.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.803 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.565 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.4 t -122.42 146.61 27.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.057 -179.699 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.7 t -135.87 143.78 45.23 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.772 179.79 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.9 p -99.57 -59.36 1.73 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.588 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.1 p -79.22 155.17 28.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.66 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.524 HG21 HG23 ' A' ' 70' ' ' THR . 69.7 t -74.2 -21.89 17.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.474 179.355 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.3 m -60.28 -52.19 66.31 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.549 -178.399 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.34 -42.72 87.75 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.756 177.864 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.1 m -42.94 -53.83 4.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.9 -178.383 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.32 -37.19 70.68 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 178.564 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 m -62.78 -44.78 95.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.871 0.367 . . . . 0.0 110.141 -179.214 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.9 mt -66.45 -41.94 88.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.51 0.671 . . . . 0.0 110.711 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.65 -40.48 97.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.427 -179.363 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.9 -35.67 75.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.303 -179.046 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 156' ' ' LEU . 32.6 pt -91.34 28.65 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.314 -179.388 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.51 51.81 10.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.084 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.34 76.04 21.98 Favored Pre-proline 0 N--CA 1.463 0.199 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.624 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.77 151.21 86.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.864 2.376 . . . . 0.0 112.102 -178.864 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.565 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.18 137.47 46.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 121.155 0.502 . . . . 0.0 110.292 179.683 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.43 -43.55 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.395 179.344 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.25 131.48 53.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.033 0.444 . . . . 0.0 110.562 -179.008 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.6 p -155.7 168.51 26.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.437 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.36 -177.37 21.96 Favored Glycine 0 N--CA 1.463 0.475 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.634 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.52 172.25 12.98 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 121.165 0.507 . . . . 0.0 110.453 179.263 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.524 HG23 HG21 ' A' ' 51' ' ' VAL . 15.0 p -132.17 -113.14 0.23 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.037 0.446 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.64 179.58 0.97 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.399 -179.185 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.9 Cg_exo -61.04 57.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.997 2.465 . . . . 0.0 112.146 179.417 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.2 t-20 -64.1 -33.18 75.19 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.286 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.2 m120 93.8 -36.62 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.674 0.609 . . . . 0.0 109.825 -179.527 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -62.51 -39.71 94.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.009 0.433 . . . . 0.0 110.225 179.279 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.505 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.26 -25.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.703 179.353 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.15 -171.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.444 -179.227 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.77 -154.15 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.843 -179.708 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.405 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.1 p-10 -52.46 -7.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.742 -179.557 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.13 114.87 23.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.679 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.23 70.05 1.34 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -143.59 147.45 34.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.866 0.365 . . . . 0.0 110.856 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -85.41 -98.2 0.07 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.126 178.859 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.3 -42.38 96.39 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.076 179.543 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.553 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.0 tt0 91.23 52.5 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.875 0.734 . . . . 0.0 111.027 179.205 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -102.6 -9.12 20.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.332 179.338 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.3 p -64.56 -33.86 76.9 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.183 0.515 . . . . 0.0 110.74 -179.728 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -49.29 -23.29 1.33 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 179.666 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.0 t -70.08 -45.83 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.689 179.698 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.29 -48.63 80.52 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.216 0.532 . . . . 0.0 109.963 -179.384 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.52 -38.2 89.01 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.425 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.71 -32.89 53.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.041 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.605 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.9 mmt-85 -89.87 1.77 55.8 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.453 -179.811 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.76 -49.38 0.17 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.903 0.752 . . . . 0.0 110.228 179.125 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.658 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.2 mt -45.97 154.3 0.25 Allowed 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 117.621 -1.181 . . . . 0.0 109.566 -179.768 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.658 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.9 tt0 121.16 92.65 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 O-C-N 125.461 1.726 . . . . 0.0 110.51 -178.511 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.69 142.93 42.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.242 0.544 . . . . 0.0 110.291 179.296 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.3 mt -132.05 27.15 4.55 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.973 -0.454 . . . . 0.0 110.44 -179.346 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.39 137.97 34.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.042 0.448 . . . . 0.0 110.583 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.9 mt -137.17 165.12 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.319 179.594 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.94 -28.51 1.86 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -152.96 70.89 7.14 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 121.119 0.485 . . . . 0.0 110.132 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.1 145.42 98.48 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 122.743 2.295 . . . . 0.0 112.126 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.9 t -134.27 136.75 43.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.543 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.27 81.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.643 179.652 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.25 -42.3 96.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.511 -179.385 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.92 -41.7 98.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.49 -179.892 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.56 -43.43 98.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.991 179.485 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.02 77.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.145 -179.636 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.62 -18.82 61.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.383 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.6 -6.68 58.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.461 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.41 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.4 mtp 47.57 56.3 17.39 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.568 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.8 Cg_endo -70.33 149.5 63.38 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.751 2.301 . . . . 0.0 112.098 179.5 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.04 -73.64 0.64 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.492 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.429 HD11 HD13 ' A' ' 140' ' ' LEU . 39.3 tp -111.07 113.6 26.25 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 110.295 179.648 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.6 mt -101.97 126.75 55.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 120.966 0.413 . . . . 0.0 110.714 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.5 mt -109.84 133.5 53.09 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.211 -179.43 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.5 139.43 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.55 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.4 p -83.32 168.39 16.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.851 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.4 -37.3 80.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.397 179.929 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.3 t -139.96 158.87 43.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.968 0.414 . . . . 0.0 110.415 -179.818 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.23 176.97 33.49 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.26 -33.81 87.2 Favored Glycine 0 CA--C 1.518 0.251 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.588 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -124.58 151.3 44.95 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 110.547 -179.925 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.0 t -63.24 140.88 58.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.333 -179.846 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.48 10.37 11.14 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.659 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.7 mp -60.92 -39.0 87.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.273 -179.374 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.84 23.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.469 0.652 . . . . 0.0 110.594 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.5 mt -70.99 -35.4 72.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.517 0.675 . . . . 0.0 110.613 179.398 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -42.77 -62.91 0.88 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.424 -178.82 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.7 p-10 -65.63 -42.92 90.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 -179.301 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -61.89 -32.6 72.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.399 -179.609 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.4 mt -73.9 -40.8 62.9 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.78 178.672 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.04 -49.0 78.39 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.114 -178.969 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.9 m -53.02 -42.37 65.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.955 0.407 . . . . 0.0 110.144 179.582 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.21 -42.7 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 120.909 0.385 . . . . 0.0 111.252 179.044 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.64 153.81 5.22 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.681 -179.401 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -39.25 107.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.702 2.268 . . . . 0.0 112.519 179.544 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.64 ' C ' HD12 ' A' ' 140' ' ' LEU . 96.2 m -109.56 121.08 44.4 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.152 0.501 . . . . 0.0 110.272 179.883 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.64 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.59 152.24 30.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.294 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.77 131.43 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.3 179.815 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.404 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.8 mt -115.27 127.97 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.553 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.51 103.85 14.74 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.151 179.766 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 147' ' ' LYS . 48.4 p90 -101.3 -11.11 19.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.895 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.92 -33.49 76.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.708 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.0 p-10 -98.21 7.57 46.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.589 -179.622 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.44 155.56 50.34 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.415 -179.38 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.2 p -74.9 165.82 24.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.63 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.589 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.05 -48.83 80.08 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.19 -179.073 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.46 -41.92 66.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.351 . . . . 0.0 110.082 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.6 t -62.69 -41.03 98.89 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.399 178.687 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.404 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.3 tp -60.74 -44.51 96.59 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.285 -179.472 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.33 -43.47 98.83 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.106 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.0 m -55.16 -44.99 75.67 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.741 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.17 -40.66 96.78 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 120.948 0.404 . . . . 0.0 110.545 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.521 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -61.94 -42.5 99.17 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.378 178.959 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.19 -40.8 95.03 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.548 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.76 -46.03 63.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.786 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.68 -44.05 96.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -92.95 -8.9 41.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.661 -179.023 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.41 26.39 72.71 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -101.74 50.32 0.85 Allowed 'General case' 0 N--CA 1.463 0.214 0 O-C-N 122.638 -0.331 . . . . 0.0 110.68 -179.576 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -69.46 -39.63 77.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.694 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.32 -47.08 86.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.301 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -60.2 -39.42 86.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.129 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.96 99.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.181 179.724 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.11 -28.39 70.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.67 179.476 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.3 -54.38 7.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.863 179.357 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.509 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.35 -42.22 93.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.376 -179.758 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.4 mt -62.31 -43.88 98.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.559 -179.418 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.48 -59.23 5.26 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.992 0.425 . . . . 0.0 110.308 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -56.28 -33.99 66.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.572 -179.085 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -80.73 -36.37 32.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.815 179.524 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.8 m-20 -55.45 -42.22 73.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.91 -178.419 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.17 -42.13 98.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.8 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.08 -38.15 89.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.306 179.789 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 177' ' ' LEU . 81.8 mt -62.44 -42.25 99.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.746 179.452 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.19 -52.84 62.17 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.026 0.441 . . . . 0.0 110.622 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.24 -41.85 89.44 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.641 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.95 95.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.641 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.34 -31.95 73.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.48 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.57 -22.26 18.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.635 -179.828 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.465 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -64.84 -41.35 95.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.597 -179.497 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.6 pt -76.73 136.13 25.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.741 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.87 107.98 10.59 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.265 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.71 125.87 0.31 Allowed Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.487 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.5 Cg_exo -43.8 152.42 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.794 2.33 . . . . 0.0 112.58 -179.804 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.18 141.95 54.0 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.536 2.157 . . . . 0.0 112.397 179.687 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.32 147.46 2.18 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.555 179.323 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.37 154.55 69.12 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.797 2.331 . . . . 0.0 112.272 178.52 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.57 163.3 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.232 0.539 . . . . 0.0 110.408 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.56 170.17 16.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.025 179.454 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.94 137.31 22.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.997 0.427 . . . . 0.0 110.127 179.484 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.554 HG22 HD12 ' A' ' 205' ' ' LEU . 38.0 pt -134.17 146.84 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.7 179.622 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -133.01 131.97 58.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.285 0.564 . . . . 0.0 110.439 178.775 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -152.98 156.42 38.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.362 179.202 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.607 HG22 ' H ' ' A' ' 199' ' ' ALA . 85.0 m -122.36 123.12 40.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.906 0.384 . . . . 0.0 110.418 179.416 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.522 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.78 -26.18 67.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.608 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.607 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.89 -49.23 21.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.68 -10.37 59.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.503 -179.703 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.522 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.5 m80 45.84 46.59 12.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 t -130.8 143.51 50.79 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.012 0.434 . . . . 0.0 110.334 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.456 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -108.23 105.62 15.42 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.18 -179.773 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -116.2 128.98 56.07 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.288 0.566 . . . . 0.0 110.29 179.714 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.554 HD12 HG22 ' A' ' 194' ' ' ILE . 7.7 tt -111.82 146.45 37.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.816 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.476 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.7 t90 -99.5 128.33 45.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.205 0.526 . . . . 0.0 109.795 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.22 153.8 40.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.434 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.62 -17.97 48.26 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.674 2.249 . . . . 0.0 112.018 178.836 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.84 -18.59 0.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.392 -179.189 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.422 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.7 p -75.49 164.7 26.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 179.577 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.96 -28.05 65.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.576 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.561 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.5 mt-30 -63.66 -41.4 98.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.59 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.36 -44.48 97.53 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.41 -38.89 92.61 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 122.167 -0.607 . . . . 0.0 110.739 179.67 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.0 mmm -61.83 -41.35 97.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.273 179.716 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.5 -47.75 80.44 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.095 0.474 . . . . 0.0 110.407 179.271 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.63 -32.07 49.83 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.913 0.387 . . . . 0.0 110.413 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -70.84 -18.22 62.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.501 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.414 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.7 mt -88.61 -8.7 54.23 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.558 -179.469 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.85 2.78 55.13 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.78 151.86 22.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.94 0.4 . . . . 0.0 110.432 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.449 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.3 p -114.87 127.8 55.92 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.178 0.513 . . . . 0.0 110.387 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.05 146.79 23.45 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.929 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.461 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -70.45 151.26 45.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.456 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.96 131.66 42.81 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.519 179.71 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.883 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.6 93.65 28.89 Favored Pre-proline 0 C--O 1.235 0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.055 -179.529 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.685 ' C ' ' H ' ' A' ' 229' ' ' GLY . 44.8 Cg_exo -55.17 138.55 79.38 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.618 2.212 . . . . 0.0 111.703 178.975 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.36 -25.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.521 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.685 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.44 -50.19 27.68 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 179.802 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.571 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -55.13 -36.93 66.28 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.101 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -65.77 35.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.806 179.353 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.571 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.14 88.66 0.01 OUTLIER 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.949 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 87.7 p -82.41 -13.6 56.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.331 -179.704 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.41 -40.95 11.15 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.633 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 31.9 t -66.65 -16.82 64.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.622 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.79 43.88 27.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.482 -179.599 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.95 -148.75 8.14 Favored Glycine 0 CA--C 1.518 0.245 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.766 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.82 142.17 48.86 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.916 0.389 . . . . 0.0 110.267 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.402 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.5 ttt-85 -151.93 149.47 28.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.349 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -102.11 -150.31 0.4 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.344 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.81 -93.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.64 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.439 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.0 tt -126.4 174.72 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.64 -179.589 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.439 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 89.5 mt -122.12 141.2 43.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -99.62 170.5 8.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.189 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 70.0 mt -146.69 149.69 33.93 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.229 179.743 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.22 -39.41 97.86 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.17 3.22 3.98 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -78.72 -57.42 3.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.937 0.399 . . . . 0.0 110.484 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.616 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.8 m-20 -62.03 -36.81 82.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.242 -179.67 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.456 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.7 mp -53.06 -67.45 0.25 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.014 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.8 -42.71 68.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.126 -179.297 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.31 17.64 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.701 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.9 47.81 0.25 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 7.9 mp 39.47 -110.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.532 0.206 . . . . 0.0 110.699 -178.677 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.461 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.7 m120 -60.76 -44.57 96.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.35 -179.563 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.4 7.92 84.09 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.413 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.87 -13.5 20.03 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.761 -0.258 . . . . 0.0 110.678 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.7 t 177.21 142.94 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 0.0 110.448 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.19 125.49 11.55 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.161 179.56 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.71 143.66 28.83 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 120.914 0.388 . . . . 0.0 110.847 178.269 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.9 mt -95.06 106.67 18.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.736 -179.214 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.442 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.1 t80 -101.91 -12.63 18.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.122 179.596 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.4 -41.04 89.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.82 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.36 172.86 45.69 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.699 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.469 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -73.59 -113.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.75 0.31 . . . . 0.0 110.815 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.6 -28.84 68.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.644 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.11 -43.64 91.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.16 -178.801 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.68 -44.28 94.18 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.267 179.248 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.6 -59.98 3.8 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.111 -179.727 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.96 -43.52 60.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.112 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.38 -43.33 75.06 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.199 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.2 mt -64.62 -43.61 96.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.674 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -55.94 -37.84 69.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.132 -179.846 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.48 0.78 18.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.182 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -115.04 90.99 25.21 Favored Pre-proline 0 N--CA 1.463 0.177 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.123 -179.564 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.09 -27.08 27.89 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.704 2.27 . . . . 0.0 111.979 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.48 -40.92 98.37 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.518 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.1 mp -95.53 5.59 51.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.343 -179.214 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.39 -34.84 68.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.612 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.86 4.59 16.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.495 -178.843 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.75 121.13 80.09 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.607 -179.979 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -47.28 -37.6 24.7 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.431 2.087 . . . . 0.0 112.635 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.84 -43.78 90.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.756 0.313 . . . . 0.0 110.4 179.724 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.03 -43.51 92.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.346 179.348 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.74 -40.64 95.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.383 -179.191 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -90.22 -12.19 38.77 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.1 mtmt 61.74 32.81 18.2 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.371 0.419 . . . . 0.0 111.024 -179.77 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -89.04 43.67 1.16 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.13 0.491 . . . . 0.0 110.295 179.549 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.22 136.02 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.44 -179.661 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -117.02 132.28 56.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.391 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.78 89.14 7.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.819 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.415 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.3 mt -63.97 -41.16 97.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.993 0.425 . . . . 0.0 110.811 179.521 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.02 165.22 33.58 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 67.6 p -75.26 -25.77 58.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.968 0.413 . . . . 0.0 110.822 179.778 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -68.39 -33.83 74.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.504 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.768 HG22 ' O ' ' A' ' 296' ' ' THR . 95.8 m -73.39 24.72 0.07 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.797 -179.076 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.561 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 44.0 t80 -58.71 -50.85 72.35 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.256 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.419 HH12 ' HG3' ' A' ' 212' ' ' GLN . 77.1 mmt-85 -110.64 153.09 25.7 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 179.135 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.414 ' CD2' HD11 ' A' ' 219' ' ' LEU . 42.7 tp -115.4 124.88 52.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.883 0.373 . . . . 0.0 110.816 179.759 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.489 ' CB ' HD23 ' A' ' 83' ' ' LEU . 40.6 t0 -147.73 165.53 30.22 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.592 179.572 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -49.4 -37.92 27.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.533 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.32 -65.45 0.75 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.871 0.367 . . . . 0.0 111.582 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.87 -32.76 72.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.013 -179.504 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.5 -25.66 26.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.724 -179.153 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.5 mtt -63.37 -40.83 98.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.874 0.369 . . . . 0.0 111.145 179.694 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.41 -44.24 25.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.103 179.492 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.585 HG21 HG23 ' A' ' 296' ' ' THR . 78.2 t -66.34 -42.89 91.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.347 179.652 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.465 HD11 ' NE2' ' A' ' 183' ' ' GLN . 49.3 tp -60.02 -47.22 86.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.446 -178.516 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -69.82 -39.28 76.59 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.07 0.462 . . . . 0.0 110.811 179.074 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.9 ttt180 -61.87 -38.33 87.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.219 -178.936 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.27 4.61 42.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.57 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -112.85 -11.25 13.48 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.066 0.46 . . . . 0.0 110.367 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.35 86.89 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.466 179.645 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.82 -48.81 80.12 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.39 -179.608 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.222 -0.379 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.012 179.912 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.36 -2.55 57.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.372 -179.81 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.493 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.62 179.05 1.25 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.521 -179.701 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.493 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.8 Cg_exo -60.73 144.74 99.59 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.814 2.343 . . . . 0.0 112.153 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.87 -179.57 8.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.632 -179.851 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.76 136.42 53.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.046 0.45 . . . . 0.0 110.364 179.765 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.08 147.26 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.382 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.9 p -120.3 136.1 54.79 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.813 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.21 -143.52 0.32 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.248 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.7 -37.03 85.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.47 179.623 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.482 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.15 -67.04 0.22 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.418 179.783 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.21 142.5 44.61 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.436 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.7 p -112.64 131.21 55.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.991 0.424 . . . . 0.0 110.463 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -118.96 129.14 55.0 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.54 -179.905 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.3 m -85.63 130.83 34.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.226 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.2 mt -96.24 78.7 3.11 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.343 179.678 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -65.93 -32.11 73.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.574 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.62 108.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.106 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.489 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -121.93 91.21 48.8 Favored Pre-proline 0 C--O 1.233 0.189 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.45 -179.729 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.663 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.2 Cg_exo -56.75 148.29 66.7 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.798 2.332 . . . . 0.0 111.982 178.98 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.18 82.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.695 0.622 . . . . 0.0 111.002 -179.262 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.663 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.47 66.72 0.89 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.263 -179.4 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.95 130.98 35.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.851 -179.742 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.569 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.1 t -122.75 147.7 26.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.062 0.458 . . . . 0.0 110.013 -179.678 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.2 t -136.62 144.03 43.86 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.753 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.1 p -99.45 -59.53 1.7 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.628 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.8 p -79.08 155.64 28.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.623 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.529 HG21 HG23 ' A' ' 70' ' ' THR . 70.1 t -74.26 -21.65 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.532 179.414 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -60.34 -52.01 67.08 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.547 -178.502 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.16 -42.7 88.61 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.718 177.886 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.8 m -43.26 -54.38 4.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.884 -178.54 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.88 -37.36 74.89 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 178.7 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m -62.91 -44.49 95.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.872 0.368 . . . . 0.0 110.163 -179.304 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 18.3 mt -66.07 -41.95 90.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.505 0.669 . . . . 0.0 110.663 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.04 -39.95 96.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.344 -179.251 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.541 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.48 -35.91 77.02 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.295 -178.981 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.445 HD11 HD12 ' A' ' 156' ' ' LEU . 33.9 pt -91.14 27.64 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.374 -179.381 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.403 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 98.8 m-20 57.08 51.93 9.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.084 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.48 76.39 25.25 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.66 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.98 149.46 90.49 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.877 2.385 . . . . 0.0 112.146 -178.884 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.43 136.71 47.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 121.115 0.483 . . . . 0.0 110.35 179.661 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.444 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.0 pt -69.67 -43.46 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.249 179.439 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.491 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.13 131.27 53.28 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.963 0.411 . . . . 0.0 110.608 -178.983 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.4 p -155.92 168.63 26.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.531 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.16 -177.43 22.09 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.644 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.26 171.92 13.38 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 121.102 0.477 . . . . 0.0 110.425 179.297 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.529 HG23 HG21 ' A' ' 51' ' ' VAL . 12.3 p -133.81 -110.51 0.22 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.008 0.432 . . . . 0.0 110.583 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.11 179.62 0.94 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.566 -179.323 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.4 Cg_exo -60.72 58.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.944 2.429 . . . . 0.0 112.126 179.512 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.3 t-20 -64.31 -34.88 79.15 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.48 -179.789 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.566 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.0 m120 95.04 -38.07 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.671 0.607 . . . . 0.0 109.759 -179.436 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 -62.54 -39.88 95.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.99 0.424 . . . . 0.0 110.142 179.234 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -73.6 -26.55 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.693 179.326 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -50.04 -171.77 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.463 -179.381 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -74.38 -153.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 -179.785 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.3 p-10 -54.37 -6.77 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.675 -179.432 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.9 113.93 23.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.671 179.793 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.39 72.39 1.29 Allowed Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.603 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -143.8 148.1 35.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.862 0.363 . . . . 0.0 110.876 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.6 mp -85.99 -98.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.939 178.891 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.92 -43.38 96.11 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.113 179.395 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.1 tt0 91.37 52.53 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.794 0.684 . . . . 0.0 111.147 179.195 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.78 -8.63 19.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.347 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.0 p -65.45 -33.22 75.43 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.05 0.452 . . . . 0.0 110.65 -179.596 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.87 -23.24 1.02 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.717 179.639 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.4 t -70.13 -45.81 74.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.708 179.708 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.75 80.09 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.974 -179.441 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.41 -38.37 89.41 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.39 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.65 -32.78 52.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.208 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.618 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.5 mmt-85 -89.8 1.81 55.69 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.406 -179.802 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.618 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 82.68 -49.18 0.17 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.7 0.625 . . . . 0.0 110.246 179.152 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.673 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.3 mt -45.96 154.11 0.26 Allowed 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.542 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.673 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 121.2 92.05 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 125.17 1.543 . . . . 0.0 110.477 -178.683 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.543 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.92 142.56 44.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.282 0.563 . . . . 0.0 110.368 179.374 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.2 mt -131.6 26.59 4.72 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 122.016 -0.428 . . . . 0.0 110.379 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -139.8 136.96 34.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.06 0.457 . . . . 0.0 110.596 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.644 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.7 mt -136.52 164.69 30.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.393 179.592 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.613 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.19 -28.49 1.83 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.56 70.72 7.42 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 121.08 0.466 . . . . 0.0 110.182 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.08 145.41 98.5 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.705 2.27 . . . . 0.0 112.098 -179.481 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.5 t -134.59 136.91 43.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.509 179.776 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.35 82.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.57 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.2 -42.38 96.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.603 -179.439 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.91 -41.68 98.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.544 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.57 -43.35 98.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.987 179.487 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.17 -35.04 77.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.206 -179.722 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.81 -18.71 60.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.363 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.51 -6.4 58.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.457 -179.794 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.4 mtp 47.54 56.0 17.15 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.576 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.9 Cg_endo -70.33 149.61 63.5 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.816 2.344 . . . . 0.0 112.049 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.46 -73.72 0.64 Allowed 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.46 179.768 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.1 tp -110.61 113.72 26.55 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.27 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.3 mt -102.84 126.83 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.614 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.1 mt -110.57 134.18 52.63 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.275 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.68 140.05 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.57 -179.574 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.2 p -83.44 168.19 16.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.8 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.5 79.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.455 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.6 t -139.99 159.2 42.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.398 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.18 176.82 33.49 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.721 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.31 -33.67 86.83 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.49 151.67 44.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.858 0.361 . . . . 0.0 110.565 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.8 t -63.39 140.64 58.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.336 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.39 10.35 11.19 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.622 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -60.75 -39.0 87.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.253 -179.368 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.97 -35.9 23.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.358 0.599 . . . . 0.0 110.594 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.0 mt -70.89 -35.43 72.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.47 0.653 . . . . 0.0 110.607 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -42.78 -62.92 0.88 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.453 -178.781 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.82 -42.75 90.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.244 -179.395 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -61.83 -32.6 72.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.402 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.2 mt -73.88 -40.82 62.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.879 178.665 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -58.24 -49.18 77.99 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.231 -179.041 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.8 m -53.01 -42.49 65.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.896 0.379 . . . . 0.0 110.089 179.535 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.18 -42.82 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 120.927 0.394 . . . . 0.0 111.154 179.216 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.4 153.39 5.26 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.684 -179.395 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -39.08 107.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.666 2.244 . . . . 0.0 112.537 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.641 ' C ' HD12 ' A' ' 140' ' ' LEU . 94.1 m -109.68 121.08 44.4 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.115 0.483 . . . . 0.0 110.246 179.905 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.76 153.08 29.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.32 -179.841 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.6 tt -128.58 131.45 68.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.383 179.856 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.41 128.17 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.605 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.501 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 53.6 t30 -99.59 104.02 15.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.133 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.416 ' O ' ' O ' ' A' ' 147' ' ' LYS . 50.8 p90 -98.87 -12.39 20.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.969 -179.705 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.6 p-10 -64.93 -33.89 77.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.798 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.592 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.7 p-10 -99.23 6.89 46.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.596 -179.376 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.8 mttm -133.71 149.59 51.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.559 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.423 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -76.43 167.31 22.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.618 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.603 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.2 t90 -59.07 -48.3 82.1 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.166 -179.158 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -54.4 -45.99 73.04 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 40.4 t -63.42 -40.8 98.14 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.094 0.473 . . . . 0.0 110.2 178.429 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.434 ' O ' HD23 ' A' ' 156' ' ' LEU . 66.5 tp -61.04 -44.67 97.05 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.119 -179.353 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.49 -42.71 99.21 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.207 179.728 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.5 m -55.78 -45.61 78.14 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.73 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.39 -40.4 96.37 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.812 0.339 . . . . 0.0 110.445 179.766 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.445 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -61.81 -42.54 99.14 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.312 178.996 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.78 -40.0 95.45 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.425 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.36 -45.61 65.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.922 0.391 . . . . 0.0 110.843 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.9 mt -65.02 -43.88 96.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.82 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.3 p -92.89 -9.11 41.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.656 -179.049 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.96 26.42 72.28 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -101.72 50.76 0.84 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.883 0.373 . . . . 0.0 110.668 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.53 -39.31 77.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.608 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.37 -47.36 85.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.36 -179.448 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.403 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 87.3 mt-30 -60.3 -39.3 86.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.112 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.05 99.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.186 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.07 -28.39 70.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.607 179.579 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.21 -54.42 7.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.939 179.405 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.541 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.5 ttp180 -65.5 -41.98 92.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.561 -179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 174' ' ' ASP . 78.9 mt -62.31 -43.92 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.549 -179.319 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.91 -57.85 9.39 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 120.995 0.426 . . . . 0.0 110.416 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -57.56 -33.83 68.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.619 -179.134 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -81.15 -36.43 30.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.774 179.648 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.4 m-20 -55.72 -41.64 74.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.095 -178.672 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.49 -42.1 99.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.631 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.19 -38.35 90.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.255 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 177' ' ' LEU . 83.0 mt -62.45 -42.02 99.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.76 179.498 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.18 -53.16 59.29 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.091 0.472 . . . . 0.0 110.628 179.869 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -65.87 -42.08 90.82 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.722 179.502 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.51 -39.45 94.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.669 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.7 -32.06 73.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.4 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -95.34 -21.96 18.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.617 -179.677 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.473 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.3 tt0 -64.38 -41.77 96.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.685 -179.494 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.4 pt -74.53 135.55 27.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.016 0.436 . . . . 0.0 110.707 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.29 106.2 9.35 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.346 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -178.02 127.51 0.28 Allowed Pre-proline 0 C--O 1.239 0.53 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.513 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.447 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.7 Cg_exo -43.53 151.81 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.892 2.395 . . . . 0.0 112.53 -179.829 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.44 142.81 55.46 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.608 2.205 . . . . 0.0 112.343 179.672 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.545 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -171.66 147.14 1.99 Allowed Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.527 179.327 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.13 155.29 68.49 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.887 2.391 . . . . 0.0 112.34 178.676 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.59 163.14 28.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.201 0.524 . . . . 0.0 110.409 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.3 169.36 17.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.031 179.455 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.41 137.1 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.365 . . . . 0.0 110.177 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.57 HG22 HD12 ' A' ' 205' ' ' LEU . 38.0 pt -134.08 146.12 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.759 179.511 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.491 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -133.32 132.11 58.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.286 0.565 . . . . 0.0 110.431 178.979 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -153.07 156.55 38.94 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.403 179.193 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.605 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.4 m -121.84 122.93 40.57 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.41 179.556 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.467 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.94 -26.09 67.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.606 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.605 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.77 -49.56 20.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.974 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -75.79 -13.22 60.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.471 -179.65 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.467 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 78.4 m80 49.56 46.51 23.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.621 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.5 t -131.59 146.04 52.01 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.075 0.464 . . . . 0.0 110.247 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.426 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -110.21 106.05 15.33 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.234 -179.741 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -116.36 129.19 56.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.09 0.471 . . . . 0.0 110.276 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.57 HD12 HG22 ' A' ' 194' ' ' ILE . 7.7 tt -111.95 146.32 38.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.017 0.437 . . . . 0.0 110.889 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.464 ' N ' HD23 ' A' ' 205' ' ' LEU . 17.4 t90 -98.73 128.86 45.11 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.139 0.495 . . . . 0.0 109.912 179.442 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.05 153.55 39.12 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.229 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.8 -18.25 47.35 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.748 2.299 . . . . 0.0 111.981 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.9 -19.16 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.437 -179.273 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 86.7 p -75.86 167.63 21.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.449 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.46 74.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.453 -179.682 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.506 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.2 mt-30 -56.55 -40.68 75.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.756 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.31 -43.71 97.09 Favored Glycine 0 C--N 1.329 0.165 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.532 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.512 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.2 mt-30 -64.32 -40.57 96.16 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 122.341 -0.505 . . . . 0.0 110.796 -179.896 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.603 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.3 mmm -62.02 -42.46 99.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.499 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 39.7 mt -62.91 -49.21 75.69 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.049 0.452 . . . . 0.0 110.432 179.833 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.67 -31.52 62.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 110.441 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -69.48 -17.47 63.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.541 179.792 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.401 HD11 ' CD2' ' A' ' 299' ' ' LEU . 95.0 mt -87.3 -11.5 49.32 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.616 -179.569 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 105.19 1.32 41.43 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.723 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -88.2 156.1 19.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.923 0.392 . . . . 0.0 110.692 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.458 ' O ' HG12 ' A' ' 191' ' ' VAL . 7.1 p -116.39 128.59 55.65 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.183 0.516 . . . . 0.0 110.201 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.63 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.6 mm? -90.53 146.81 23.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.993 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.458 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -71.62 150.47 44.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.414 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.5 131.94 42.15 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.575 179.688 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.877 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.03 94.2 28.83 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.984 -179.579 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.687 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.8 Cg_exo -55.19 138.57 79.49 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.651 2.234 . . . . 0.0 111.602 178.962 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.28 -25.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.46 -179.59 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.687 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.07 -49.67 26.42 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.575 ' C ' ' H ' ' A' ' 232' ' ' ALA . 98.1 mt -54.89 -37.29 66.13 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.127 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -65.71 35.52 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.775 179.37 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.575 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.78 87.82 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.5 p -81.38 -13.86 57.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.382 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.73 -40.41 11.27 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.628 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 26.9 t -66.93 -16.62 64.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.573 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.83 43.82 27.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.488 -179.662 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.4 -146.52 7.16 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.23 142.98 49.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.947 0.404 . . . . 0.0 110.397 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.401 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.3 ttt-85 -151.82 149.37 28.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.034 0.445 . . . . 0.0 110.28 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -101.22 -151.3 0.41 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.348 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 55.67 -92.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.712 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.444 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.0 tt -126.57 174.63 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.618 -179.469 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.444 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -121.69 140.96 44.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.476 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.28 170.33 8.73 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.307 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.1 mt -146.82 149.55 33.53 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.191 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.42 -39.3 97.58 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.22 3.06 4.0 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -78.29 -57.73 3.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.935 0.398 . . . . 0.0 110.463 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.63 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.4 m-20 -62.06 -37.06 83.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.297 -179.649 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.426 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.7 mp -52.71 -67.78 0.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.74 -42.46 68.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.133 -179.283 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.39 17.69 0.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.668 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.05 48.0 0.27 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.1 mp 39.06 -110.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.493 0.187 . . . . 0.0 110.696 -178.775 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.458 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 12.0 m120 -60.66 -44.58 96.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.42 -179.639 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.32 7.85 84.33 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.329 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -98.67 -13.41 20.31 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.763 -0.257 . . . . 0.0 110.69 -179.795 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.5 t 177.03 142.72 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.132 0.492 . . . . 0.0 110.382 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.432 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -147.71 125.46 11.88 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.288 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 191' ' ' VAL . 14.0 m-30 -98.61 143.7 28.71 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 120.927 0.394 . . . . 0.0 110.731 178.405 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.2 mt -95.12 106.33 18.33 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.773 -179.255 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.481 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.8 t80 -102.45 -12.26 17.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.112 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.53 -40.04 88.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.883 179.777 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.16 173.61 46.07 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.61 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.463 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 96.5 m-20 -74.43 -113.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 0.0 110.769 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.5 -29.16 68.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.693 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.9 -43.81 91.1 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.112 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.36 -44.68 94.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.271 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.46 -59.95 3.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.197 -179.792 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -51.02 -43.64 60.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.082 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.12 -43.75 74.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.156 -179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.8 mt -64.41 -43.65 97.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.579 179.568 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -56.63 -37.9 71.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.144 -179.919 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.5 1.03 17.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.179 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -115.17 91.24 26.83 Favored Pre-proline 0 N--CA 1.461 0.089 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.176 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.12 -26.93 27.6 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.748 2.299 . . . . 0.0 111.975 179.329 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.55 -40.82 98.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.577 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.9 mp -95.16 5.57 51.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.381 -179.022 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.03 -35.14 69.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.618 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.63 4.27 16.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.492 -178.873 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.68 120.69 77.39 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.575 179.953 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -47.27 -37.66 24.7 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.446 2.097 . . . . 0.0 112.6 -179.515 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.535 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.93 -43.63 91.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.43 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.83 -43.61 93.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.337 179.241 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.9 -40.58 95.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.396 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.8 -12.28 39.65 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.508 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.81 31.66 18.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.051 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.44 44.04 1.17 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.128 0.49 . . . . 0.0 110.308 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.8 136.13 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.563 -179.704 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.66 132.5 56.67 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.361 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.496 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.35 88.66 6.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.794 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.82 -41.51 97.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.697 179.533 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.481 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.5 165.13 34.28 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.789 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.7 p -75.53 -26.09 57.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.4 tp10 -68.67 -33.77 74.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.394 -179.699 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.777 HG22 ' O ' ' A' ' 296' ' ' THR . 98.1 m -72.47 22.19 0.06 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.215 0.531 . . . . 0.0 110.761 -179.351 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.513 ' H ' ' C ' ' A' ' 295' ' ' GLU . 49.1 t80 -57.86 -51.0 71.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.851 -179.253 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.9 mmt-85 -108.02 150.03 27.66 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.879 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.401 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.7 tp -116.46 127.31 54.47 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.77 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.464 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.6 t0 -150.99 167.82 26.45 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.675 179.631 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.4 ' CE2' ' CE ' ' A' ' 305' ' ' MET . 91.4 t80 -49.3 -38.09 26.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.622 -179.54 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.16 -65.63 0.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.588 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.64 -33.03 72.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.028 -179.479 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.17 -25.31 21.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.782 -179.125 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 305' ' ' MET . . . . . 0.4 ' CE ' ' CE2' ' A' ' 301' ' ' TYR . 61.3 mtt -63.57 -41.09 98.4 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.933 0.397 . . . . 0.0 111.158 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.96 -43.88 23.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.181 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.567 HG21 HG23 ' A' ' 296' ' ' THR . 77.9 t -66.21 -42.86 91.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.405 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.473 HD11 ' NE2' ' A' ' 183' ' ' GLN . 50.2 tp -60.34 -46.76 88.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.48 -178.555 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -70.47 -39.47 74.22 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.098 0.475 . . . . 0.0 110.805 179.162 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.496 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 73.6 ttt180 -61.56 -37.53 84.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.292 -179.029 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.6 mt -87.99 4.18 45.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.642 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -112.2 -11.26 13.77 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.003 0.43 . . . . 0.0 110.396 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.17 86.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.406 179.761 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.82 -48.89 79.75 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.474 -179.703 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.005 179.877 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.61 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.06 -2.34 58.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.373 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.481 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.5 179.18 1.22 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.469 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.5 Cg_exo -60.8 145.38 99.06 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.729 2.286 . . . . 0.0 112.166 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.61 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 34.9 ptt-85 -156.29 -179.47 8.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.579 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -116.18 137.44 52.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.323 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.69 146.88 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.322 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.5 p -119.93 135.81 54.76 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.807 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.16 -143.65 0.32 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.19 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.45 -37.14 86.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.445 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.481 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.31 -66.51 0.22 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.484 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.62 142.35 45.68 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 p -112.06 131.4 55.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.89 0.376 . . . . 0.0 110.391 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -118.98 128.81 54.74 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.499 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.0 m -85.62 130.28 34.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.143 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.486 HD22 ' OE1' ' A' ' 42' ' ' GLN . 70.0 mt -96.25 78.76 3.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.317 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.54 -32.15 73.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.471 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.6 109.77 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.044 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.486 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -123.3 91.37 49.85 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.199 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.636 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.2 Cg_exo -57.07 148.92 65.88 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.738 2.292 . . . . 0.0 111.773 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.28 83.11 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.631 0.582 . . . . 0.0 111.047 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.636 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.64 67.09 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.129 0.49 . . . . 0.0 110.261 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.45 130.82 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.515 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.563 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.9 t -122.84 147.01 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.085 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.9 t -136.24 143.8 44.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.644 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.3 p -99.08 -59.25 1.76 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.53 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.1 p -79.3 155.27 28.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.695 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.524 HG21 HG23 ' A' ' 70' ' ' THR . 71.4 t -74.22 -21.85 17.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.62 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.8 m -60.37 -51.98 67.21 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.486 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.8 mt -66.29 -42.52 88.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.502 0.668 . . . . 0.0 110.951 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.0 m -43.44 -53.76 5.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.076 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.13 -37.36 72.53 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.6 m -62.77 -44.63 95.68 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.367 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.412 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.0 mt -65.98 -42.17 90.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.43 0.633 . . . . 0.0 110.69 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 tp -62.59 -40.13 95.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.467 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.505 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.29 -36.16 77.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.05 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 156' ' ' LEU . 32.0 pt -90.75 28.61 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.177 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.59 51.39 11.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.825 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.72 75.14 26.12 Favored Pre-proline 0 C--N 1.333 -0.15 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.97 151.24 86.12 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.718 2.278 . . . . 0.0 112.16 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.563 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.63 137.29 47.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.306 0.574 . . . . 0.0 110.23 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.437 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.1 pt -69.06 -43.69 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.373 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.481 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.2 130.94 53.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.987 0.423 . . . . 0.0 110.597 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.525 ' O ' ' O ' ' A' ' 97' ' ' ARG . 30.8 p -155.41 168.88 25.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.346 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.77 -177.33 21.7 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.632 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.44 172.57 12.53 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.857 0.36 . . . . 0.0 110.556 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.524 HG23 HG21 ' A' ' 51' ' ' VAL . 14.7 p -132.47 -113.0 0.23 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.348 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.03 179.98 0.9 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.211 -178.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.7 Cg_exo -60.89 57.93 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 123.027 2.485 . . . . 0.0 112.187 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.4 t-20 -64.28 -34.13 77.41 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 118.606 -0.712 . . . . 0.0 110.584 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 14.0 m120 93.91 -36.21 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.617 1.198 . . . . 0.0 109.753 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.411 ' HD3' HD21 ' A' ' 73' ' ' ASN . 78.1 mtp85 -62.7 -39.9 95.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.224 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.17 -25.83 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.804 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.32 -171.18 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.649 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -73.94 -153.88 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.833 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.8 p-10 -52.74 -7.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.658 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.3 114.89 23.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.556 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.88 70.11 1.35 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -143.25 147.91 35.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.941 0.4 . . . . 0.0 110.819 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.76 -98.62 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.125 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.1 mtt-85 -63.88 -42.71 97.43 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.236 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.3 tt0 91.72 53.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.286 0.991 . . . . 0.0 110.917 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -103.4 -9.0 19.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.404 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.5 p -64.66 -34.0 77.26 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.167 0.508 . . . . 0.0 110.777 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.79 -24.57 1.47 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.56 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.25 -46.04 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.048 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.27 -48.43 81.47 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.98 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.73 -38.21 89.62 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.347 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.95 -32.08 52.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.218 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.576 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.4 mmt-85 -90.09 1.9 55.85 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.686 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.36 -49.43 0.2 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 124.412 1.07 . . . . 0.0 110.366 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.613 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 83.2 mt -46.48 154.73 0.27 Allowed 'General case' 0 CA--C 1.485 -1.549 0 CA-C-O 117.068 -1.444 . . . . 0.0 108.966 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.613 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 120.82 92.68 0.0 OUTLIER 'General case' 0 C--N 1.359 1.001 0 O-C-N 125.958 2.036 . . . . 0.0 110.527 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.525 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.6 143.47 42.31 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.227 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.8 mt -132.47 27.03 4.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.692 0.282 . . . . 0.0 110.436 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.48 138.18 34.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.027 0.441 . . . . 0.0 110.491 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.632 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.6 mt -137.15 164.91 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.385 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.611 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.25 -28.59 1.81 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -152.54 70.99 7.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.193 0.521 . . . . 0.0 110.287 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.04 145.42 98.43 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.711 2.274 . . . . 0.0 112.075 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.1 t -134.78 136.59 42.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.035 0.445 . . . . 0.0 110.507 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.29 -38.17 81.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.702 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.25 -42.09 96.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.57 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.27 -41.48 98.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.515 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 64.9 t -63.67 -43.56 98.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.947 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.25 78.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.336 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.34 -18.67 59.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.502 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.76 -6.42 58.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.52 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 75.8 mtp 47.74 55.83 17.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.599 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.9 Cg_endo -70.49 150.02 63.11 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.841 2.361 . . . . 0.0 112.044 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -101.4 -75.9 0.58 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.404 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.4 HD11 HD13 ' A' ' 140' ' ' LEU . 38.6 tp -108.38 113.7 26.98 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.218 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.0 mt -102.64 126.77 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.404 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.5 mt -109.73 133.68 52.86 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.084 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.28 139.08 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.496 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.5 p -83.17 168.33 16.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.68 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -37.46 80.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.454 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -140.06 158.89 43.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.43 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.18 177.36 33.26 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.16 -33.82 87.11 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.61 151.84 44.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.874 0.369 . . . . 0.0 110.588 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.1 t -63.03 141.06 58.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.288 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.04 9.85 11.3 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.697 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.9 mp -61.22 -39.18 89.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.056 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.629 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.76 -36.01 23.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.647 0.737 . . . . 0.0 110.704 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -70.59 -35.61 73.1 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.488 0.661 . . . . 0.0 110.828 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -42.85 -63.03 0.86 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.332 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.629 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.89 -42.62 90.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.97 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.11 -33.18 73.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.083 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.2 mt -72.86 -40.74 65.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.24 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.51 -48.61 80.24 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.139 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 m -53.29 -42.25 66.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.105 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.78 -42.93 93.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.998 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.55 156.38 5.23 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.581 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -39.63 107.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.581 2.188 . . . . 0.0 112.347 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.642 ' C ' HD12 ' A' ' 140' ' ' LEU . 89.8 m -110.11 120.81 43.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.234 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.642 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.45 152.67 31.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.125 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -129.39 131.44 67.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.38 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.9 mt -115.17 128.12 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.384 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.2 t30 -101.6 103.61 14.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.262 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.5 p90 -100.96 -11.36 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.774 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.4 p-10 -64.79 -33.81 76.86 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.705 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.6 p-10 -98.08 7.8 45.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.63 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.7 155.41 50.44 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.543 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.404 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -74.93 165.68 24.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.668 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.598 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.84 -48.75 80.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.185 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -53.7 -41.96 67.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.918 0.39 . . . . 0.0 110.012 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.6 t -62.58 -41.14 98.76 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.391 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.406 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.8 tp -60.64 -44.13 96.75 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.315 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.7 tp -61.5 -43.42 98.9 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.226 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -54.99 -44.79 74.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.659 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.42 -40.68 97.35 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.893 0.377 . . . . 0.0 110.355 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.2 -42.35 99.21 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.387 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.05 -41.02 95.36 Favored Glycine 0 C--N 1.315 -0.587 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.42 -46.13 64.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.949 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.6 -44.05 96.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.816 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.4 p -93.02 -8.74 42.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.595 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.93 26.63 72.32 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -101.99 50.96 0.83 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.814 0.34 . . . . 0.0 110.721 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -69.67 -39.46 76.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.751 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.58 -47.08 86.98 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.268 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -60.02 -39.24 85.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.332 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.13 -40.87 98.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.277 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.91 -28.69 70.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.07 0.462 . . . . 0.0 110.571 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.03 -54.24 8.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.221 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.505 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.51 -42.1 92.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.439 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.9 mt -62.35 -43.78 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.434 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.72 -57.53 10.64 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.082 0.468 . . . . 0.0 110.509 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.89 -34.05 69.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.342 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.4 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.4 t80 -80.76 -37.15 30.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.075 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.5 m-20 -55.56 -41.45 73.31 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.245 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.75 -42.23 99.58 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.727 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.3 -37.83 88.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.227 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.4 HD11 ' CD2' ' A' ' 173' ' ' PHE . 82.6 mt -62.5 -42.24 99.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.737 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.04 -52.59 63.35 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.096 0.474 . . . . 0.0 110.7 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.37 -41.75 88.99 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.592 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.92 95.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.623 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.23 -32.43 73.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.381 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.09 -22.38 18.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.762 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.426 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.6 tt0 -64.85 -41.01 96.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.64 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.6 pt -77.16 136.6 24.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.623 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -127.15 108.22 10.71 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.218 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.08 126.0 0.34 Allowed Pre-proline 0 N--CA 1.446 -0.669 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.588 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.7 Cg_exo -44.04 152.61 0.37 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.664 2.242 . . . . 0.0 112.606 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.19 141.88 53.76 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.59 2.193 . . . . 0.0 112.456 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.547 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.16 147.2 2.19 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.648 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.46 155.23 67.5 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.745 2.297 . . . . 0.0 112.299 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.576 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.63 163.12 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.362 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.576 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.58 170.16 16.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.912 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.86 137.42 22.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.208 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.565 HG22 HD12 ' A' ' 205' ' ' LEU . 37.7 pt -134.26 146.51 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.603 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.92 131.98 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.305 0.574 . . . . 0.0 110.57 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -152.85 156.43 38.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.379 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.0 m -122.08 122.92 40.36 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.934 0.397 . . . . 0.0 110.329 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.486 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.78 -26.55 67.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.534 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.597 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.12 -50.02 21.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.079 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -75.75 -13.46 60.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.506 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.486 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 78.1 m80 49.94 46.21 24.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.529 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.6 t -131.14 144.86 51.7 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.317 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.428 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -109.4 106.08 15.71 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.204 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -116.46 129.69 56.35 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.14 0.495 . . . . 0.0 110.307 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.565 HD12 HG22 ' A' ' 194' ' ' ILE . 7.7 tt -112.36 146.19 38.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.719 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.466 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.9 t90 -99.34 128.68 45.48 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.141 0.496 . . . . 0.0 109.959 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.82 154.08 39.91 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.107 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.6 Cg_endo -67.71 -17.97 47.79 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.736 2.291 . . . . 0.0 111.897 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.43 -18.92 0.45 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.402 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.441 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.1 p -75.5 164.57 26.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.488 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.9 -27.89 65.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.532 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.61 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.8 mt-30 -63.76 -41.19 98.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.64 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.44 -44.28 97.82 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.55 -38.94 92.74 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 120.989 0.423 . . . . 0.0 110.461 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.28 -41.26 98.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.062 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 71.7 mt -63.6 -47.06 82.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.635 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.34 -31.75 55.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.91 -18.25 62.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.526 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.429 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.0 mt -88.11 -8.75 54.99 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.651 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.64 2.1 55.34 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -88.46 153.29 21.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.755 0.312 . . . . 0.0 110.436 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.462 ' O ' HG12 ' A' ' 191' ' ' VAL . 10.3 p -116.05 128.63 55.85 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.078 0.466 . . . . 0.0 110.384 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.33 146.33 23.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.901 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.456 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.24 151.36 45.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.432 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.37 131.88 42.32 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.394 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.877 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.3 93.71 27.73 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.002 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.678 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.1 Cg_exo -55.63 138.78 81.9 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.574 2.182 . . . . 0.0 111.435 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.56 -25.61 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.551 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.63 -49.89 28.03 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.9 mt -55.23 -37.16 66.8 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -65.54 35.65 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.909 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.569 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.47 88.32 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.773 0.32 . . . . 0.0 110.852 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.2 p -81.44 -13.4 58.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.377 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.86 -40.76 11.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.604 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.0 t -66.64 -17.02 64.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.644 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.01 44.0 26.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.485 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.29 -148.21 8.05 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.68 142.5 48.42 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.888 0.375 . . . . 0.0 110.352 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.422 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.3 ttt-85 -152.11 149.55 28.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.334 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -102.43 -150.12 0.4 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.26 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 55.48 -92.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.575 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.425 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.3 tt -127.2 174.13 11.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.498 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.425 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 88.2 mt -121.57 140.84 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.798 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.36 170.53 8.57 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.4 mt -146.88 149.53 33.44 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.253 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.19 -39.32 97.78 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.09 2.96 4.08 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -78.48 -57.32 3.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 110.621 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.618 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.2 m-20 -62.19 -36.81 83.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.084 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.428 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.8 mp -53.31 -67.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.05 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.482 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.84 -42.55 68.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.13 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.67 17.72 0.15 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.659 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.99 47.85 0.26 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 254' ' ' LEU . 7.8 mp 39.53 -110.17 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.601 0.238 . . . . 0.0 110.637 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.456 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -61.2 -44.15 97.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.326 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.15 8.14 84.19 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.86 -13.34 20.11 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.774 -0.251 . . . . 0.0 110.69 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.9 t 176.89 142.74 0.08 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.174 0.511 . . . . 0.0 110.51 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.3 tt -147.96 125.72 11.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.1 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.6 m-30 -98.92 143.42 29.24 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 120.917 0.389 . . . . 0.0 110.785 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.4 mt -94.7 106.26 18.23 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.55 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.436 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.0 t80 -101.98 -11.82 18.65 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.122 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.5 86.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.923 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.46 172.99 45.8 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.451 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.7 m-20 -73.9 -112.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.771 0.32 . . . . 0.0 110.701 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.05 -28.72 67.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.766 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.24 -43.59 92.4 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.159 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.48 -44.26 94.91 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.406 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.78 -59.77 4.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.158 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.29 -43.32 61.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.166 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.26 -43.42 74.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.163 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 93.2 mt -64.48 -43.63 96.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.651 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -56.43 -37.43 70.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.138 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.64 0.63 19.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.266 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -114.85 91.35 25.8 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.196 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.28 -27.22 29.78 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.773 2.315 . . . . 0.0 111.729 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.4 -41.2 98.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.585 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.25 5.12 52.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.291 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.79 -35.18 69.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.722 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -79.65 4.63 15.47 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.472 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.526 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.61 121.46 81.04 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.639 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -47.65 -37.48 27.3 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.349 2.032 . . . . 0.0 112.586 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -59.1 -43.71 91.89 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 63.0 t -65.87 -43.85 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.92 0.391 . . . . 0.0 110.287 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.68 -40.53 95.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.53 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 48.0 t-20 -89.84 -12.69 38.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.515 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 61.99 32.55 17.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.88 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.14 43.94 1.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.359 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.38 135.59 41.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.42 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.68 132.14 56.77 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.492 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.507 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.68 88.01 7.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.71 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.07 -40.64 96.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.96 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.436 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.33 167.99 34.93 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 75.7 p -75.93 -25.67 56.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 110.716 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.1 tp10 -67.45 -34.86 78.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.352 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.761 HG22 ' O ' ' A' ' 296' ' ' THR . 95.4 m -73.36 25.12 0.07 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.671 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.61 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 59.4 t80 -58.34 -51.15 71.03 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.431 HH12 ' HG3' ' A' ' 212' ' ' GLN . 68.6 mmt-85 -111.79 154.84 24.47 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.429 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.1 tp -115.92 125.2 52.27 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.484 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.6 t0 -147.79 165.67 29.85 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.585 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -48.99 -38.26 22.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.597 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -71.79 -65.17 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.458 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.6 p -60.84 -32.86 72.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.126 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.75 -25.19 26.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.585 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.8 mtt -63.54 -40.99 98.44 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 120.91 0.386 . . . . 0.0 111.01 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -79.03 -44.01 23.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.977 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.568 HG21 HG23 ' A' ' 296' ' ' THR . 77.5 t -65.94 -43.24 92.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.417 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.43 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 54.5 tp -60.66 -46.94 88.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.622 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -69.51 -39.62 77.47 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.466 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.507 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.0 ttt180 -61.94 -38.36 88.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.146 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.1 mt -86.82 4.09 42.54 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.834 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -112.71 -11.45 13.52 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.174 0.512 . . . . 0.0 110.29 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.04 85.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.624 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.02 -48.64 80.88 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.331 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.868 -1.063 . . . . 0.0 109.992 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.61 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.36 -2.63 57.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.383 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.476 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.09 179.03 1.26 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.452 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.9 Cg_exo -60.85 145.46 98.97 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.558 2.172 . . . . 0.0 112.171 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.61 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.29 -179.76 8.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.624 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.14 137.0 52.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.372 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -124.23 146.67 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.314 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -119.76 135.61 54.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.759 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.15 -143.98 0.32 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.143 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.21 -37.35 86.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.533 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.89 -66.99 0.23 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.532 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.47 142.56 45.14 Favored Glycine 0 C--O 1.224 -0.48 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.0 p -112.28 131.26 55.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.922 0.392 . . . . 0.0 110.26 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -118.7 128.86 54.9 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.545 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.1 m -85.44 130.43 34.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.198 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.487 HD22 ' OE1' ' A' ' 42' ' ' GLN . 71.1 mt -96.49 78.81 3.02 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.16 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.6 -32.06 73.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.501 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.75 108.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.024 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.487 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -122.11 90.79 48.98 Favored Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.245 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.636 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.0 Cg_exo -56.96 148.6 66.93 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.708 2.272 . . . . 0.0 111.652 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.13 82.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.574 0.546 . . . . 0.0 111.056 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.636 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.76 67.16 0.87 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.302 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.05 131.14 35.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.461 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.572 ' HA ' HG23 ' A' ' 64' ' ' VAL . 58.3 t -122.78 147.38 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.154 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.3 t -136.18 143.94 44.7 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.556 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 50' ' ' SER . 17.2 p -99.45 -59.39 1.73 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.492 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.42 ' N ' ' OG1' ' A' ' 49' ' ' THR . 86.6 p -79.4 155.06 28.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.93 0.395 . . . . 0.0 110.671 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.546 HG21 HG23 ' A' ' 70' ' ' THR . 68.9 t -73.47 -21.9 18.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.598 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.6 m -60.52 -51.74 68.13 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.384 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.9 mt -66.13 -42.62 88.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.496 0.665 . . . . 0.0 110.911 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.1 m -43.86 -54.16 5.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.996 -178.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.63 -37.11 77.01 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.0 m -63.2 -44.36 95.57 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.217 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.3 mt -65.73 -42.25 91.27 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.274 0.559 . . . . 0.0 110.544 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.93 -39.68 95.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.431 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.513 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.73 -36.2 78.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.078 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.511 HD11 HD12 ' A' ' 156' ' ' LEU . 33.5 pt -90.62 27.31 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.251 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 57.12 51.27 10.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.835 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -139.23 76.08 32.79 Favored Pre-proline 0 C--O 1.227 -0.081 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.66 149.42 90.93 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.634 2.223 . . . . 0.0 112.089 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -112.41 136.3 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.302 0.572 . . . . 0.0 110.161 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.431 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -68.97 -43.75 81.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.448 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.15 130.51 52.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.114 0.483 . . . . 0.0 110.613 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.6 p -155.28 168.83 25.78 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.305 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.6 -177.38 21.8 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.645 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.37 172.51 12.6 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.776 0.322 . . . . 0.0 110.601 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.546 HG23 HG21 ' A' ' 51' ' ' VAL . 12.9 p -133.81 -110.92 0.22 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.532 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.22 179.78 0.91 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.149 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.7 Cg_exo -60.91 58.88 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.892 2.395 . . . . 0.0 112.139 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.539 ' N ' ' O ' ' A' ' 71' ' ' THR . 57.7 t-20 -64.07 -34.44 78.03 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.693 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.8 m120 94.34 -36.73 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 125.018 1.449 . . . . 0.0 109.778 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -63.06 -40.53 97.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.083 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -73.7 -26.56 21.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.933 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.68 -172.37 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.64 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.44 -152.91 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.809 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.3 p-10 -54.74 -6.54 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.684 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.486 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -87.37 114.11 23.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.956 0.408 . . . . 0.0 110.487 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.67 71.67 1.31 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -143.02 148.7 37.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.795 0.331 . . . . 0.0 110.968 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -86.5 -99.06 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.91 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.61 -43.55 96.55 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 119.027 -0.511 . . . . 0.0 110.141 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.3 tt0 91.77 52.37 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 124.487 1.117 . . . . 0.0 111.156 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -103.48 -8.58 20.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.449 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.5 p -65.29 -33.39 75.86 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.323 0.582 . . . . 0.0 110.819 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -48.86 -23.88 1.25 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.531 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.6 t -69.88 -45.78 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.299 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.49 -48.27 81.84 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.065 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.58 -38.5 90.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.303 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.84 -33.2 55.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.177 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.566 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.3 mmt-85 -88.88 1.86 54.68 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.619 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.43 -49.42 0.19 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.616 1.197 . . . . 0.0 110.347 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.598 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.8 mt -46.48 154.14 0.31 Allowed 'General case' 0 CA--C 1.485 -1.551 0 CA-C-O 117.082 -1.437 . . . . 0.0 108.67 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.598 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.1 91.89 0.0 OUTLIER 'General case' 0 C--N 1.363 1.16 0 O-C-N 125.944 2.028 . . . . 0.0 110.677 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.531 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.85 143.14 44.02 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.046 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.6 mt -132.15 26.47 4.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.492 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.03 137.6 34.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.942 0.401 . . . . 0.0 110.579 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.645 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.6 mt -136.82 164.63 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.383 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.606 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.88 -28.82 1.72 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -151.95 70.65 7.87 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.038 0.447 . . . . 0.0 110.26 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.14 145.41 98.54 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.686 2.257 . . . . 0.0 112.059 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.4 t -135.01 137.09 42.66 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.467 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.99 -38.1 82.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.701 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.44 -41.92 96.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.629 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.25 -41.38 98.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.386 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.75 -43.57 98.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.745 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.1 77.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.326 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.52 -18.85 60.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.489 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.63 -6.56 58.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.47 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.1 mtp 47.77 55.76 17.08 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.686 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.3 Cg_endo -70.0 149.56 65.51 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.927 2.418 . . . . 0.0 112.016 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.38 -72.81 0.67 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.42 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.418 HD11 HD13 ' A' ' 140' ' ' LEU . 38.2 tp -111.76 114.22 27.08 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.8 mt -103.16 126.87 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.344 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 mt -110.22 134.27 52.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.951 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.57 139.09 48.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.612 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.4 p -82.77 167.94 17.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.839 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.51 -37.27 80.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.38 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.91 158.6 43.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.457 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.45 177.12 33.6 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.15 -33.76 86.89 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.74 151.7 44.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.898 0.38 . . . . 0.0 110.58 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.4 t -63.48 141.14 58.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.284 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.51 10.44 11.13 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.654 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.7 mp -61.1 -39.48 90.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.994 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.63 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.44 -36.12 24.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.662 0.744 . . . . 0.0 110.681 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.8 mt -70.52 -35.61 73.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.83 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -43.04 -62.81 0.93 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.485 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.63 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.86 -42.63 90.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.932 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -62.09 -33.34 74.25 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.019 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.0 mt -72.57 -40.96 66.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.49 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.78 -48.27 81.83 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.131 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 65.7 m -53.61 -42.32 67.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.93 -43.12 92.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.889 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.42 153.39 5.25 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.591 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -39.05 107.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.519 2.146 . . . . 0.0 112.152 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.635 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.9 m -109.52 121.58 45.5 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.258 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 139' ' ' THR . 10.9 mp -113.85 152.58 30.51 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.182 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.34 131.03 69.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.287 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.28 128.02 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.441 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.0 t30 -100.7 104.75 16.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.221 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.419 ' O ' ' O ' ' A' ' 147' ' ' LYS . 45.7 p90 -100.77 -11.74 19.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.919 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.1 p-10 -64.79 -33.93 77.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.848 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -99.52 7.45 45.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.758 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.9 mttm -134.71 152.04 51.46 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.856 0.36 . . . . 0.0 110.637 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.424 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -75.75 166.31 23.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.658 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.594 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.5 t90 -59.32 -48.11 82.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.244 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -54.26 -43.88 71.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.897 0.38 . . . . 0.0 110.061 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.8 t -62.97 -41.06 99.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.126 0.489 . . . . 0.0 110.343 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.0 -43.92 98.17 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.008 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 53.3 tp -61.58 -42.97 99.63 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.14 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.5 m -55.29 -45.34 76.2 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.12 -40.71 96.83 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.181 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.511 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.31 -42.54 99.45 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.341 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.54 -40.73 94.3 Favored Glycine 0 C--N 1.315 -0.62 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.24 -46.16 65.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.982 0.42 . . . . 0.0 111.016 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.73 -43.98 96.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.942 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.8 p -92.89 -9.29 40.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.575 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.28 26.06 72.52 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -101.93 50.91 0.83 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.811 0.339 . . . . 0.0 110.809 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.51 -39.22 77.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.717 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.7 -46.87 87.76 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.414 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -60.03 -39.17 84.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.156 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.46 97.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.149 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.17 -29.15 70.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.149 0.499 . . . . 0.0 110.565 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -73.48 -54.44 8.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.149 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.513 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.6 ttp180 -64.86 -42.01 95.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.443 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 174' ' ' ASP . 81.0 mt -62.27 -43.84 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.527 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.34 -58.23 8.43 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.096 0.474 . . . . 0.0 110.738 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.08 -33.99 67.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.217 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -80.54 -36.3 33.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.123 0.487 . . . . 0.0 111.098 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.1 m-20 -55.34 -41.98 73.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.137 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.25 -41.98 98.92 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.785 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -64.88 -38.24 90.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.31 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.8 mt -62.49 -42.35 99.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.646 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.83 -53.23 58.74 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.729 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.3 -41.9 89.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.575 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.75 -40.0 95.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.616 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.3 -32.64 74.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.44 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.32 -21.89 18.71 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.843 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.536 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.8 tt0 -64.5 -41.68 96.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.757 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 184' ' ' ILE . 31.9 pt -76.07 134.82 28.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.22 106.91 9.56 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.4 pp -176.5 127.88 0.34 Allowed Pre-proline 0 N--CA 1.446 -0.637 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.527 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.2 Cg_exo -43.53 151.79 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.599 2.199 . . . . 0.0 112.594 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.41 142.21 53.69 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.655 2.237 . . . . 0.0 112.385 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.54 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -170.93 146.99 2.24 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.648 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.04 154.76 70.05 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.646 2.231 . . . . 0.0 112.153 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.577 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.59 162.93 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.416 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.577 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.45 169.93 16.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.919 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.88 137.37 22.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.154 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.535 HG22 HD12 ' A' ' 205' ' ' LEU . 39.5 pt -134.16 146.39 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.707 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.25 131.63 58.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.185 0.517 . . . . 0.0 110.49 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -151.65 154.62 36.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.32 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.608 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.7 m -121.75 122.64 39.97 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.014 0.435 . . . . 0.0 110.179 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.57 -25.73 66.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.463 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.608 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.11 -49.1 20.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.088 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.75 -9.05 58.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.38 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.0 m80 46.13 43.68 11.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.505 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.4 t -136.55 145.22 44.76 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.413 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.29 113.75 26.46 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.231 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.95 133.7 55.48 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.112 0.482 . . . . 0.0 110.304 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.535 HD12 HG22 ' A' ' 194' ' ' ILE . 7.6 tt -112.53 146.24 38.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.781 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.466 ' N ' HD23 ' A' ' 205' ' ' LEU . 13.6 t90 -99.3 128.19 45.39 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.38 153.36 40.47 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.174 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.51 -18.41 48.99 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.924 2.416 . . . . 0.0 111.829 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.07 -18.86 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.369 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.447 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.0 p -75.26 168.17 20.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.485 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.45 -35.77 76.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.419 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.496 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.3 mt-30 -56.62 -40.7 75.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.743 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.92 -43.3 98.2 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.4 mt-30 -63.98 -40.65 96.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.944 0.402 . . . . 0.0 110.373 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.594 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.1 mmm -61.74 -41.79 98.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.195 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 69.9 mt -63.33 -48.34 78.41 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.843 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -54.4 -32.07 56.39 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -70.63 -18.81 62.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.621 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.421 HD11 ' CD2' ' A' ' 299' ' ' LEU . 95.1 mt -87.96 -7.8 56.59 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.749 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.14 2.86 55.86 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -88.32 152.06 22.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.0 110.558 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.445 ' O ' HG12 ' A' ' 191' ' ' VAL . 6.6 p -114.73 127.81 55.95 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.099 0.476 . . . . 0.0 110.387 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.24 145.67 24.31 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.901 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.476 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.64 150.55 46.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.453 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.32 131.71 43.96 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.318 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.879 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.69 92.77 25.63 Favored Pre-proline 0 N--CA 1.464 0.275 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.049 -179.445 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.673 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.8 Cg_exo -55.58 139.4 82.67 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.534 2.156 . . . . 0.0 111.392 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.71 -25.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.588 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.11 -49.04 29.06 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.6 mt -55.16 -37.01 66.45 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -66.38 35.89 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.837 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.556 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.56 87.71 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.794 0.33 . . . . 0.0 110.778 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.4 p -81.53 -14.9 56.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.449 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -90.94 -41.33 11.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.612 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.81 -16.79 64.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.696 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 56.01 43.4 27.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.439 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.37 -147.7 7.4 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.58 142.94 50.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.969 0.414 . . . . 0.0 110.233 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.3 149.61 28.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.312 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -100.65 -152.0 0.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.255 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 56.31 -91.74 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.722 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.469 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.91 175.14 9.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.648 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.469 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.6 mt -121.44 140.79 44.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.816 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.16 168.59 9.96 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.303 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.0 mt -147.22 150.97 35.91 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.464 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.7 -39.0 97.05 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.11 4.3 4.61 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.51 -57.95 3.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.933 0.397 . . . . 0.0 110.594 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.551 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.8 m-20 -62.39 -37.18 84.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.109 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.0 -67.36 0.26 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.918 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -54.06 -41.77 68.52 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.06 18.12 0.15 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.684 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.98 47.72 0.26 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 39.07 -109.82 0.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.696 0.284 . . . . 0.0 110.664 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.9 m120 -61.21 -44.26 97.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.372 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 83.98 8.18 84.43 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -99.29 -12.58 20.22 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.739 -0.271 . . . . 0.0 110.671 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.8 t 176.48 142.31 0.07 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.097 0.475 . . . . 0.0 110.488 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.412 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.3 tt -147.79 126.16 12.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.201 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -99.25 142.95 30.08 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.035 0.445 . . . . 0.0 110.621 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.63 106.54 18.52 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.433 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.474 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 93.2 t80 -102.23 -12.55 17.92 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.007 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.4 90.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.813 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.29 173.8 46.18 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.452 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -74.59 -112.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.691 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.57 -28.45 67.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.753 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -59.81 -43.86 94.28 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.913 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -63.72 -44.1 94.6 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.318 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.69 -59.38 4.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.181 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.81 -43.1 62.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.054 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.51 -43.94 76.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.129 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.9 mt -64.05 -43.55 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.962 0.411 . . . . 0.0 110.707 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -57.1 -37.67 72.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.067 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.14 0.8 20.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.278 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -114.73 91.14 24.47 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.248 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.83 -27.35 27.02 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.824 2.35 . . . . 0.0 111.619 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -41.26 98.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.637 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.8 mp -95.18 4.8 53.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.314 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.49 -35.61 70.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.711 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.37 4.56 14.98 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.436 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.71 121.54 81.52 Favored Pre-proline 0 N--CA 1.438 -1.033 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.581 -179.537 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.56 -37.71 27.03 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.242 1.961 . . . . 0.0 112.542 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.91 -43.8 91.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.59 -43.77 93.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.351 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.67 -40.65 95.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.534 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 47.0 t-20 -89.59 -12.4 39.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.647 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 61.92 31.97 18.0 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.78 44.38 1.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.329 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.77 135.47 43.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.455 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -116.2 132.58 56.62 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.468 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.495 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.9 87.92 6.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.775 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.423 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.1 mt -63.68 -41.74 98.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.817 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.474 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.47 166.45 34.66 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.1 p -75.59 -26.07 57.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.879 0.371 . . . . 0.0 110.823 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.2 tp10 -68.04 -34.25 76.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.444 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.757 HG22 ' O ' ' A' ' 296' ' ' THR . 98.0 m -72.47 20.59 0.07 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.688 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.501 ' H ' ' C ' ' A' ' 295' ' ' GLU . 49.0 t80 -57.54 -51.12 70.77 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.951 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.1 mmt-85 -107.43 149.26 28.11 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.421 ' CD2' HD11 ' A' ' 219' ' ' LEU . 41.0 tp -115.91 126.23 53.63 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 123.411 0.444 . . . . 0.0 110.888 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.473 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.0 t0 -149.55 166.91 27.81 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.554 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.57 -37.99 29.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.435 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -71.71 -64.99 0.82 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.604 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.8 p -60.96 -32.66 72.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.973 0.416 . . . . 0.0 111.183 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.93 -25.37 28.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.6 mtt -63.61 -41.21 98.33 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 120.984 0.421 . . . . 0.0 110.999 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -77.92 -44.42 27.03 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.052 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.576 HG21 HG23 ' A' ' 296' ' ' THR . 78.8 t -65.85 -43.1 93.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.409 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.536 HD11 ' NE2' ' A' ' 183' ' ' GLN . 49.7 tp -60.36 -46.63 89.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.317 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -70.51 -39.22 74.22 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.559 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.495 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 73.4 ttt180 -61.42 -38.26 86.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.219 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.35 4.27 43.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.833 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -111.65 -11.84 13.96 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.136 0.493 . . . . 0.0 110.323 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.24 -37.25 84.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.68 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -61.15 -48.34 82.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.358 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.023 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.23 -2.71 58.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.395 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.481 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.67 178.91 1.29 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.468 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.9 Cg_exo -60.84 144.84 99.63 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.749 2.299 . . . . 0.0 112.204 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.4 ptt-85 -155.76 -179.48 8.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.57 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.74 136.5 53.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.34 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.35 147.32 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.452 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.2 p -120.5 136.01 54.9 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.7 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.1 p30 -98.97 -143.7 0.32 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.254 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.62 -37.27 86.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.509 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.53 -67.43 0.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.527 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.0 142.66 43.98 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.1 p -112.42 131.17 55.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.924 0.392 . . . . 0.0 110.397 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -118.99 129.31 55.08 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.547 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 m -86.16 131.24 34.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.982 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.48 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.3 mt -96.51 78.96 3.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.421 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.83 -32.67 74.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.491 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 t 176.78 110.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.103 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.48 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -123.79 91.11 50.04 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.228 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.3 Cg_exo -56.91 149.11 63.25 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.697 2.265 . . . . 0.0 111.765 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.22 81.99 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.602 0.564 . . . . 0.0 110.986 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.39 66.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.092 0.473 . . . . 0.0 110.236 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.2 mt -77.36 131.17 35.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.573 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.558 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.0 t -122.6 148.07 26.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.17 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 t -136.62 143.62 43.63 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.607 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.9 p -99.3 -59.31 1.75 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.557 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.3 p -79.52 156.37 27.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.63 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.558 HG21 HG23 ' A' ' 70' ' ' THR . 73.5 t -74.88 -21.51 16.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.636 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.7 m -60.2 -51.88 67.68 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.455 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.7 mt -66.46 -42.3 87.79 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.36 0.6 . . . . 0.0 110.906 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.22 -54.41 4.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.145 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.0 -38.78 74.45 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 m -62.38 -43.6 98.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.884 0.373 . . . . 0.0 110.357 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.1 mt -65.28 -42.65 92.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.403 0.621 . . . . 0.0 110.719 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 tp -63.07 -38.65 92.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.221 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.447 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -61.64 -36.52 81.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.948 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -91.58 27.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.027 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.419 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 98.6 m-20 57.22 52.45 8.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.253 0.345 . . . . 0.0 110.789 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.72 75.39 31.31 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.049 0.452 . . . . 0.0 109.989 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.96 148.49 93.42 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.735 2.29 . . . . 0.0 112.177 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -112.75 135.97 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.195 0.521 . . . . 0.0 110.275 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.85 -43.3 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.192 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.68 130.85 53.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 110.55 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.9 p -155.14 168.42 27.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.461 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.37 -177.71 21.94 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.653 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.46 172.46 12.68 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.878 0.371 . . . . 0.0 110.541 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.558 HG23 HG21 ' A' ' 51' ' ' VAL . 14.1 p -132.9 -112.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.269 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.31 179.91 0.9 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.274 -178.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.7 Cg_exo -61.16 57.87 0.1 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.015 2.476 . . . . 0.0 112.126 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.8 t-20 -64.36 -33.41 75.79 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.878 -0.582 . . . . 0.0 110.571 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.2 m120 93.71 -35.5 0.02 OUTLIER 'General case' 0 C--N 1.345 0.383 0 O-C-N 124.322 1.014 . . . . 0.0 109.948 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.5 mtp85 -63.27 -39.97 96.09 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.283 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -74.31 -25.43 19.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.7 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.16 -170.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.65 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.66 -155.24 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.828 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.8 p-10 -51.57 -7.95 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.641 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.497 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -85.42 115.23 23.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.564 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.23 70.71 1.33 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -144.64 148.55 34.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 110.69 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.8 mp -86.29 -98.63 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.266 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.8 -42.97 97.59 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.179 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.2 tt0 91.88 52.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 124.136 0.898 . . . . 0.0 110.784 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -102.41 -8.92 20.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.446 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.9 p -64.78 -34.25 77.89 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.131 0.491 . . . . 0.0 110.648 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.57 -24.62 1.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.6 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 81.9 t -69.29 -45.55 78.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.925 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.31 81.76 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.155 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.33 -38.22 88.63 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.276 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.51 -33.87 56.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.292 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.591 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.2 mmt-85 -88.76 0.99 55.97 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.67 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 57.2 mttp 83.02 -47.61 0.14 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 124.25 0.968 . . . . 0.0 110.316 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.5 mt -47.2 153.18 0.5 Allowed 'General case' 0 CA--C 1.49 -1.359 0 CA-C-O 117.604 -1.189 . . . . 0.0 109.124 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.644 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 122.31 91.72 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 O-C-N 125.54 1.775 . . . . 0.0 110.469 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -74.81 142.59 44.21 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.963 0.411 . . . . 0.0 110.299 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 mt -131.65 26.41 4.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.741 0.305 . . . . 0.0 110.464 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.06 137.29 34.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.946 0.403 . . . . 0.0 110.479 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.653 HD12 ' O ' ' A' ' 69' ' ' ALA . 90.7 mt -137.17 164.94 28.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.354 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.613 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.21 -28.73 1.82 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.03 70.6 7.79 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.25 0.548 . . . . 0.0 110.348 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.97 145.25 98.8 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.808 2.339 . . . . 0.0 112.041 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.8 t -134.85 137.11 42.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.541 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.89 -38.44 83.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.665 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.28 -42.21 96.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.501 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.6 98.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.526 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.54 -43.36 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.037 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.07 -35.17 77.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.376 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.31 -18.74 60.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.495 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.6 -6.46 58.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.561 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.5 mtp 47.87 55.74 17.11 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.627 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.14 149.35 64.34 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.791 2.327 . . . . 0.0 112.121 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.41 -72.76 0.67 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.481 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.6 tp -111.33 113.15 25.41 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.367 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.8 mt -102.19 126.56 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.451 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.6 mt -110.57 134.0 52.79 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.173 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.55 140.22 45.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.446 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 94.8 p -83.61 167.2 17.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.665 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.58 -36.66 79.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.472 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 t -138.24 157.71 45.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.471 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.36 174.63 34.16 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.29 -33.98 87.77 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -123.57 150.98 43.41 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.92 0.391 . . . . 0.0 110.562 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.6 t -63.57 140.16 58.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.291 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.94 11.44 11.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.631 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.1 -39.25 89.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.098 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.627 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.82 -35.53 24.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.564 0.697 . . . . 0.0 110.705 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -71.11 -35.04 71.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.408 0.623 . . . . 0.0 110.787 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -43.07 -63.19 0.85 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.171 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.627 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.1 p-10 -65.89 -42.81 89.79 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.535 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -61.78 -32.6 72.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.114 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 129' ' ' LEU . 67.6 mt -73.83 -40.3 63.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.187 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.29 -49.31 77.59 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.195 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.5 m -52.62 -42.66 64.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.313 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.08 -42.97 92.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.993 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.31 152.61 5.03 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.623 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -38.58 107.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.677 2.252 . . . . 0.0 112.317 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.646 ' C ' HD12 ' A' ' 140' ' ' LEU . 94.2 m -109.35 120.95 44.08 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.293 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.646 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.54 153.64 29.69 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.225 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.456 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -130.49 128.93 64.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.376 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.1 mt -110.42 122.84 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.574 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.538 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 53.8 t30 -101.11 106.35 17.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.349 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -100.17 0.45 40.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.897 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -65.52 -34.93 79.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.585 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.0 p-10 -101.29 9.5 41.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -133.85 148.08 51.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.537 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.409 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 22.5 p -77.69 169.05 18.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.579 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.598 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.6 t90 -58.71 -49.74 76.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.087 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -54.41 -46.15 73.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.011 0.434 . . . . 0.0 110.144 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.9 t -63.24 -40.79 98.43 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.345 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.452 ' O ' HD23 ' A' ' 156' ' ' LEU . 51.4 tp -60.83 -44.37 97.03 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.367 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.2 -43.49 98.79 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.202 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -54.21 -45.8 72.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.772 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.8 -39.92 93.41 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.854 0.359 . . . . 0.0 110.268 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 152' ' ' LEU . 2.2 mm? -61.9 -42.25 98.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.059 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.8 -38.87 94.81 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.21 -45.75 65.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.963 0.411 . . . . 0.0 110.798 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.72 -44.15 96.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.715 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -92.86 -9.28 40.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.53 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.0 26.51 72.35 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -102.31 50.11 0.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.831 0.348 . . . . 0.0 110.704 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.21 -39.14 78.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.691 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.67 -47.4 85.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.256 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.419 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 86.6 mt-30 -59.99 -39.66 86.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.335 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.59 -40.89 98.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.328 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.15 -29.47 70.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.995 0.426 . . . . 0.0 110.542 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.09 -54.13 8.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.121 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.447 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.8 ttp180 -64.44 -42.79 95.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.474 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.9 mt -62.62 -43.72 98.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.499 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.71 -60.8 3.12 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.255 0.55 . . . . 0.0 110.402 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.23 -34.31 63.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.271 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -80.29 -34.96 36.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.937 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.2 m-20 -55.02 -41.53 71.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.185 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.18 -41.71 98.59 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.575 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.04 -37.74 88.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.269 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.23 -42.6 99.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.796 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.69 -53.04 61.46 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.19 0.519 . . . . 0.0 110.668 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.37 -41.45 89.44 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.544 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.28 -39.9 94.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.644 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.52 -33.23 74.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.365 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -93.21 -21.55 19.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.714 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.589 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -65.21 -41.44 94.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.667 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 184' ' ' ILE . 30.7 pt -77.48 133.94 29.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.05 0.452 . . . . 0.0 110.696 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -128.09 107.03 9.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.302 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.59 127.76 0.33 Allowed Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.556 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.445 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.3 Cg_exo -43.72 151.7 0.39 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.702 2.268 . . . . 0.0 112.598 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.63 142.51 53.49 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.629 2.219 . . . . 0.0 112.416 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.542 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.61 146.89 2.39 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.659 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.27 154.62 69.4 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.753 2.302 . . . . 0.0 112.29 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.584 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.98 163.4 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.42 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 191' ' ' VAL . 1.9 t -143.4 169.97 16.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.896 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.18 137.4 22.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.964 0.412 . . . . 0.0 110.159 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.523 HG22 HD12 ' A' ' 205' ' ' LEU . 38.0 pt -133.98 145.53 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.639 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -131.97 131.5 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.143 0.497 . . . . 0.0 110.548 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -152.62 156.04 38.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.418 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 199' ' ' ALA . 88.4 m -121.57 122.51 39.83 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.947 0.404 . . . . 0.0 110.331 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.496 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.41 -26.26 66.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.599 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.1 -48.74 22.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.014 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.83 -10.09 59.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.414 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.496 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.6 m80 45.88 46.65 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.563 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.0 t -132.16 143.09 49.73 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.402 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.404 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -108.08 107.26 17.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.296 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -116.96 130.1 56.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.099 0.476 . . . . 0.0 110.352 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.523 HD12 HG22 ' A' ' 194' ' ' ILE . 7.5 tt -112.03 145.77 39.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.603 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.487 ' N ' HD23 ' A' ' 205' ' ' LEU . 9.1 t90 -98.44 127.53 44.41 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.09 0.472 . . . . 0.0 110.043 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.08 153.18 43.26 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.156 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.04 -17.59 45.94 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.822 2.348 . . . . 0.0 111.923 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.19 -19.13 0.7 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.429 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.442 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.4 p -74.52 163.71 27.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.497 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.38 -27.73 64.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.458 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.492 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.5 mt-30 -63.37 -42.74 98.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.628 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.69 -43.58 98.9 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.409 ' OE1' ' C ' ' A' ' 148' ' ' SER . 74.7 mt-30 -63.75 -38.85 92.64 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.865 0.364 . . . . 0.0 110.46 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 85.9 mmm -62.27 -41.52 98.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.251 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.1 -49.25 72.96 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.628 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -52.36 -33.36 42.68 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -71.06 -20.43 62.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.491 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 75.0 mt -87.56 -6.45 58.32 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.63 -6.73 57.45 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -77.74 148.25 34.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.754 0.311 . . . . 0.0 110.622 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.47 ' O ' HG12 ' A' ' 191' ' ' VAL . 3.7 p -113.02 126.78 55.87 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.093 0.473 . . . . 0.0 110.331 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -91.94 145.86 24.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.925 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.472 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.88 150.26 46.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.462 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.17 131.4 44.02 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.396 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.883 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.53 93.48 27.75 Favored Pre-proline 0 C--O 1.235 0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.998 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.683 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.7 Cg_exo -55.25 138.37 79.27 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.652 2.234 . . . . 0.0 111.54 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.44 -24.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.537 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.62 -50.13 21.36 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 232' ' ' ALA . 98.5 mt -54.55 -35.98 63.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.769 0.318 . . . . 0.0 110.278 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.94 36.2 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.744 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.99 87.68 0.01 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.757 0.313 . . . . 0.0 110.873 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.3 p -81.61 -13.47 57.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.423 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -91.67 -39.48 11.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.544 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.7 t -66.63 -16.84 64.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.613 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.03 43.86 26.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.437 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 178.79 -146.45 7.3 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.22 142.21 50.13 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.925 0.393 . . . . 0.0 110.303 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.419 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.4 ttt-85 -152.18 149.58 28.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.384 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -102.41 -149.36 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.31 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 54.94 -93.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.648 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.436 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 13.0 tt -126.65 173.75 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.581 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 230' ' ' LEU . 95.1 mt -121.75 140.6 45.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.767 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.77 172.29 7.35 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.336 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 67.2 mt -146.82 149.08 32.61 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.09 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -62.89 -39.49 98.09 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.94 2.07 3.93 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -78.62 -57.54 3.71 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.93 0.395 . . . . 0.0 110.694 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.594 ' ND2' HD23 ' A' ' 226' ' ' LEU . 94.4 m-20 -62.36 -36.74 83.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.236 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.404 HD21 ' HB1' ' A' ' 203' ' ' ALA . 6.1 mp -53.84 -67.07 0.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.936 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.79 -42.24 68.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.215 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.01 18.09 0.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.652 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.07 46.91 0.24 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 254' ' ' LEU . 7.6 mp 39.83 -110.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.637 0.256 . . . . 0.0 110.608 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.472 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 10.8 m120 -60.77 -44.52 96.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.427 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.46 8.03 83.83 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -98.7 -12.54 20.91 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.778 -0.248 . . . . 0.0 110.636 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.1 t 175.75 143.06 0.06 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 110.487 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.99 125.9 11.99 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.051 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.93 143.44 29.22 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 120.882 0.372 . . . . 0.0 110.867 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.7 mt -94.62 106.3 18.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.584 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.453 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.1 t80 -101.86 -13.15 17.78 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.223 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.03 -40.39 91.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.821 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.64 173.15 45.86 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.457 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.9 m-20 -74.19 -112.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 0.0 110.74 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.76 -28.78 67.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.701 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.84 -44.13 90.89 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.314 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.56 -44.36 94.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.405 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.42 -59.81 3.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.223 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.35 -43.23 61.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.187 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.86 74.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.159 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.2 mt -64.35 -43.57 97.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.64 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.72 -37.58 71.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.246 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.06 0.88 19.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.27 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -114.99 91.13 25.51 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.179 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.01 -27.28 28.08 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.785 2.323 . . . . 0.0 111.81 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -41.24 98.9 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.559 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.9 mp -95.34 5.01 52.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.306 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.03 -35.28 69.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.679 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.21 4.62 14.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.516 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.82 121.17 80.38 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.618 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -47.53 -37.45 26.34 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.432 2.088 . . . . 0.0 112.46 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.89 -43.58 90.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.826 0.346 . . . . 0.0 110.235 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.89 -43.76 92.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.291 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.86 -40.53 95.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.494 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 48.0 t-20 -89.64 -12.87 38.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.607 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.39 32.43 16.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.801 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.98 44.03 1.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.409 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.03 135.56 42.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.429 -179.681 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.97 131.81 56.86 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.459 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.495 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.71 88.73 6.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.708 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.433 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.2 mt -63.95 -41.44 97.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.851 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.453 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.62 165.86 33.86 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 77.7 p -75.73 -25.62 56.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.831 0.348 . . . . 0.0 110.731 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.4 tp10 -68.29 -33.99 75.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.457 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 97.3 m -73.04 21.53 0.07 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.597 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.504 ' H ' ' C ' ' A' ' 295' ' ' GLU . 50.4 t80 -57.66 -50.86 71.78 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.994 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.402 HH12 ' HG3' ' A' ' 212' ' ' GLN . 71.3 mmt-85 -108.97 150.89 27.06 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.5 tp -115.48 125.03 52.57 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.765 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.488 ' CB ' HD23 ' A' ' 83' ' ' LEU . 40.7 t0 -148.04 165.85 29.54 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.569 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -49.36 -38.19 27.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.524 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -70.72 -65.63 0.71 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.212 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -61.04 -32.96 72.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.021 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -53.6 -25.7 18.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.495 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.6 mtt -63.7 -40.73 97.51 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 120.835 0.35 . . . . 0.0 110.979 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -78.01 -44.66 25.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.941 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.579 HG21 HG23 ' A' ' 296' ' ' THR . 79.2 t -66.2 -42.83 91.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.407 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.589 HD11 ' NE2' ' A' ' 183' ' ' GLN . 47.8 tp -59.57 -47.56 85.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.468 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -69.92 -39.32 76.22 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.606 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.495 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.1 ttt180 -61.77 -37.9 86.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.181 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.6 mt -87.76 4.82 42.85 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -112.58 -11.74 13.54 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.018 0.437 . . . . 0.0 110.288 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.95 -36.96 85.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.614 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -61.01 -49.11 78.73 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.434 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.099 179.875 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.614 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -90.37 -2.62 57.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.394 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.476 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.51 178.87 1.3 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.485 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.5 Cg_exo -60.79 145.11 99.47 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.556 2.17 . . . . 0.0 112.191 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.614 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.5 ptt-85 -155.99 -179.77 8.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.609 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -115.6 136.35 53.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.292 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -124.07 146.28 29.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.369 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.9 p -119.84 135.6 54.8 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.714 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.6 p30 -98.43 -144.41 0.31 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.296 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.36 -36.54 84.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.473 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.489 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -147.53 -70.4 0.23 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.593 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.77 144.09 41.68 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.0 p -112.58 130.05 56.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.783 0.325 . . . . 0.0 110.369 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -114.71 129.26 56.66 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.599 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -86.61 130.63 34.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.308 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.493 HD22 ' OE1' ' A' ' 42' ' ' GLN . 70.8 mt -97.84 78.71 2.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.2 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.03 -32.53 74.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.511 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.4 t 178.05 109.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.076 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.493 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -123.87 90.76 50.37 Favored Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.218 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.1 Cg_exo -56.66 149.3 59.68 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.709 2.272 . . . . 0.0 111.646 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.3 82.51 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.491 0.494 . . . . 0.0 110.997 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.57 66.84 0.88 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.303 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.2 mt -77.38 131.2 35.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.433 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.571 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.8 t -122.46 147.64 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.231 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.5 t -136.51 144.03 44.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.576 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 50' ' ' SER . 18.9 p -100.37 -58.9 1.81 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.46 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 49' ' ' THR . 87.5 p -79.43 155.49 28.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.901 0.381 . . . . 0.0 110.642 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.548 HG21 HG23 ' A' ' 70' ' ' THR . 72.6 t -74.2 -21.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.696 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.2 m -60.27 -51.7 68.41 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.456 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.4 mt -66.32 -42.62 87.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.532 0.682 . . . . 0.0 110.859 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.3 m -43.29 -54.58 4.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.198 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.91 -38.73 75.36 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.1 m -62.52 -43.73 98.09 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.172 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 48.2 mt -65.31 -42.57 92.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.052 0.453 . . . . 0.0 110.665 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.7 tp -62.95 -38.67 91.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.254 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.455 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -61.69 -36.45 80.92 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.068 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.4 pt -91.34 27.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.081 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 56.99 52.15 9.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.744 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.04 75.34 35.18 Favored Pre-proline 0 C--N 1.334 -0.081 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.34 148.66 92.67 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.596 2.197 . . . . 0.0 112.041 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.571 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.21 135.76 50.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 121.22 0.533 . . . . 0.0 110.229 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.441 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.4 pt -69.73 -43.38 80.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.219 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.8 130.41 52.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.013 0.435 . . . . 0.0 110.599 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.9 p -155.09 168.8 25.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.354 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.48 -177.73 21.86 Favored Glycine 0 N--CA 1.465 0.572 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.665 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -132.36 171.46 13.7 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.7 0.286 . . . . 0.0 110.575 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.548 HG23 HG21 ' A' ' 51' ' ' VAL . 13.0 p -133.82 -110.71 0.22 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.498 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.35 179.78 0.91 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.244 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.1 Cg_exo -60.94 58.51 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.912 2.408 . . . . 0.0 112.089 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.544 ' N ' ' O ' ' A' ' 71' ' ' THR . 56.7 t-20 -64.0 -35.23 80.02 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.699 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.6 m120 95.31 -37.15 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.979 1.425 . . . . 0.0 109.986 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -62.69 -40.51 97.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.264 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -72.97 -26.53 23.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.815 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.86 -171.9 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.717 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -74.33 -153.13 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.805 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.6 p-10 -54.03 -6.86 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.608 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.77 114.06 23.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.962 0.41 . . . . 0.0 110.484 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.48 72.21 1.3 Allowed Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.449 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.4 m-85 -143.87 148.44 35.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 110.806 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.68 -99.24 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.065 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.67 -43.46 96.62 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.377 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.537 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.4 tt0 92.08 52.62 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.314 1.009 . . . . 0.0 111.016 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -103.01 -9.16 20.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.507 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.449 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.52 -34.06 77.36 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.136 0.493 . . . . 0.0 110.686 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.3 -24.67 1.27 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.491 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.94 -45.36 77.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.14 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.3 -48.69 80.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.224 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.49 -38.42 89.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.28 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.55 -32.95 52.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.292 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.583 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.51 1.19 56.25 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 118.868 -0.586 . . . . 0.0 110.681 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 83.16 -48.37 0.14 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.535 1.147 . . . . 0.0 110.348 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.629 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.1 mt -46.81 152.73 0.47 Allowed 'General case' 0 CA--C 1.49 -1.351 0 CA-C-O 117.632 -1.175 . . . . 0.0 108.951 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.629 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.0 tt0 122.25 91.32 0.0 OUTLIER 'General case' 0 C--N 1.358 0.967 0 O-C-N 125.515 1.76 . . . . 0.0 110.66 -178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.52 143.04 44.72 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.201 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.9 mt -132.08 26.25 4.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.427 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -139.69 136.52 34.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.577 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.665 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.5 mt -136.62 164.72 30.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.45 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.605 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.76 -28.88 1.73 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -151.46 70.72 8.25 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.053 0.454 . . . . 0.0 110.354 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.99 145.3 98.69 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.612 2.208 . . . . 0.0 112.016 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.9 t -135.69 137.65 41.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.537 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.08 -38.12 82.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.68 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.27 -42.26 96.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.576 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.07 -41.56 98.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.429 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.57 -43.47 98.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.935 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.09 -35.11 77.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.439 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.34 -19.0 61.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.554 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.54 -6.58 58.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.478 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.4 mtp 47.68 55.81 17.07 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.663 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.8 Cg_endo -70.05 149.4 64.98 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.919 2.412 . . . . 0.0 112.034 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.27 -71.68 0.7 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.43 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.408 HD11 HD13 ' A' ' 140' ' ' LEU . 38.0 tp -112.89 113.62 25.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.221 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.7 mt -102.17 126.85 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.289 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 mt -110.82 133.75 53.1 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.042 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.61 140.18 45.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.6 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.6 p -83.28 167.44 17.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.783 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.94 79.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.475 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.6 t -138.44 158.02 45.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.471 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.5 175.34 34.16 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.24 -33.91 87.5 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -124.09 150.95 44.43 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.593 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.5 t -63.71 140.68 58.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.306 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.56 11.63 10.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.674 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.7 mp -60.87 -39.58 89.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.165 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.633 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.6 -35.63 24.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.587 0.708 . . . . 0.0 110.596 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.4 mt -70.92 -35.12 72.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.867 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -43.28 -62.82 0.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.298 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.633 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.2 p-10 -65.91 -42.95 89.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.801 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -61.8 -32.85 73.18 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.06 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 129' ' ' LEU . 67.6 mt -73.4 -40.52 64.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.459 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.55 -48.45 80.85 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.278 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.1 m -53.24 -42.11 66.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.33 -42.81 91.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.612 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.11 152.27 5.06 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.673 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -39.11 106.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.572 2.182 . . . . 0.0 111.986 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.647 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.2 m -108.89 122.06 46.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.323 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.647 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.94 154.47 28.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.282 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.6 tt -130.23 129.22 65.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.474 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 93.1 mt -110.66 122.93 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.503 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.537 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 52.7 t30 -101.45 105.14 16.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.363 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.404 ' HB3' HD13 ' A' ' 152' ' ' LEU . 41.8 p90 -98.0 -0.19 45.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.004 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.2 p-10 -65.23 -35.04 79.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.028 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.594 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.1 p-10 -101.76 8.51 41.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -133.13 146.82 51.95 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.889 0.376 . . . . 0.0 110.565 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.427 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 21.1 p -78.61 170.41 16.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.545 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.597 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 88.1 t90 -58.31 -49.54 76.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.247 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -54.75 -47.39 73.91 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.22 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.8 t -63.33 -40.81 98.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.121 0.486 . . . . 0.0 110.264 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.459 ' O ' HD23 ' A' ' 156' ' ' LEU . 59.1 tp -61.01 -44.11 97.9 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.224 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.502 HD23 HD11 ' A' ' 170' ' ' ILE . 53.6 tp -61.1 -42.85 99.27 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.314 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.6 m -55.35 -46.39 76.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.666 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.44 -40.1 93.24 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.253 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 152' ' ' LEU . 2.1 mm? -61.84 -42.18 98.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.962 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.42 -38.92 95.42 Favored Glycine 0 C--N 1.317 -0.523 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.56 -45.02 66.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.402 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.64 -43.99 96.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.76 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -94.01 -8.48 39.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.563 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.83 25.83 71.97 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -102.81 51.17 0.81 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.787 0.327 . . . . 0.0 110.818 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.23 -38.73 78.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.117 0.484 . . . . 0.0 110.744 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.87 -46.99 87.55 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.392 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -61.37 -39.17 89.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.296 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.1 -40.57 98.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.309 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.73 -28.06 69.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.23 0.538 . . . . 0.0 110.458 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -75.2 -52.76 10.15 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.174 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.489 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -63.72 -42.92 97.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.45 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 174' ' ' ASP . 86.7 mt -62.83 -43.83 99.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.594 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.47 -61.09 2.78 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.15 0.5 . . . . 0.0 110.56 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.63 -35.4 63.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.228 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -79.59 -35.14 40.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.106 0.479 . . . . 0.0 111.265 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.4 m-20 -55.33 -40.67 71.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.297 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.45 -41.87 99.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.631 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.36 -38.08 88.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.31 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 177' ' ' LEU . 77.3 mt -62.27 -42.58 99.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.711 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.83 -53.25 58.44 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.053 0.454 . . . . 0.0 110.729 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.41 -41.39 89.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.587 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.72 94.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.624 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.08 -32.71 74.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.332 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -94.05 -21.88 18.87 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.764 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.551 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -64.79 -41.88 95.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.72 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 184' ' ' ILE . 31.5 pt -76.33 134.43 28.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.684 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.58 106.52 9.22 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.184 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.5 127.92 0.34 Allowed Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.586 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.445 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.9 Cg_exo -43.57 151.69 0.36 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.615 2.21 . . . . 0.0 112.508 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.68 142.33 52.68 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.806 2.337 . . . . 0.0 112.299 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.39 146.68 2.46 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.664 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.02 154.01 71.38 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.716 2.277 . . . . 0.0 112.122 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.41 162.86 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.434 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.5 169.64 17.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.805 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.74 137.38 22.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.276 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.524 HG22 HD12 ' A' ' 205' ' ' LEU . 39.5 pt -134.24 146.25 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.652 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.47 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.88 131.52 59.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.081 0.467 . . . . 0.0 110.504 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -151.63 154.69 36.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.391 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.2 m -121.97 122.85 40.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.973 0.416 . . . . 0.0 110.268 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.42 -25.76 66.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.424 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.614 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.31 -49.15 20.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.105 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.23 -10.79 60.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.5 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.1 m80 47.93 42.95 17.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.495 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.1 t -136.47 145.35 45.07 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.386 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.412 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -111.22 113.92 26.76 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.296 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.89 133.62 55.52 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.359 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.524 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.41 146.18 38.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.721 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.48 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.4 t90 -99.69 127.93 45.8 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.021 0.438 . . . . 0.0 109.952 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.12 153.69 41.69 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.947 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.401 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.2 Cg_endo -67.58 -18.33 48.6 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.895 2.397 . . . . 0.0 111.931 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.6 -18.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.504 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.442 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.0 p -75.61 167.51 21.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.485 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.46 -35.13 75.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.447 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.2 mt-30 -56.42 -41.33 76.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.676 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.35 -42.89 97.63 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.483 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.7 mt-30 -63.59 -40.45 96.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.881 0.372 . . . . 0.0 110.302 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.597 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.2 mmm -61.87 -41.58 98.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.182 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.59 -49.95 71.34 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.661 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -52.92 -32.36 45.04 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -71.94 -19.89 61.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.54 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 64.4 mt -87.46 -6.45 58.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.57 3.94 57.24 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -89.28 151.39 22.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.711 0.291 . . . . 0.0 110.553 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.45 ' O ' HG12 ' A' ' 191' ' ' VAL . 2.6 p -114.44 127.63 55.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.994 0.426 . . . . 0.0 110.402 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.97 144.71 25.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.905 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.492 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.23 150.71 47.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.416 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.79 131.36 44.62 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.298 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.882 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.82 92.49 25.34 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.123 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.675 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.8 Cg_exo -55.24 138.9 80.52 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.603 2.202 . . . . 0.0 111.47 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.65 -25.03 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.662 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.92 -49.68 27.3 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.558 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -54.66 -36.76 64.94 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.59 35.82 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.845 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.02 87.47 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.837 0.351 . . . . 0.0 110.684 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.3 p -81.25 -14.23 57.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.486 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.45 -40.85 11.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.565 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.9 t -66.76 -16.52 64.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.639 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.1 43.64 26.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.518 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.31 -145.55 6.68 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -123.27 143.05 50.31 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 110.349 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.1 ttt-85 -151.49 148.82 28.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.36 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -100.24 -152.62 0.43 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.274 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 56.46 -92.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.593 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.464 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.56 175.09 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.635 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.464 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -120.72 140.29 45.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.769 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.01 169.03 9.71 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.406 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.8 mt -147.59 150.61 34.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.317 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.85 -38.82 96.68 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.39 3.81 4.62 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -77.24 -58.02 3.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.877 0.37 . . . . 0.0 110.678 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.538 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.1 m-20 -62.36 -36.62 82.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.255 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.412 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.0 mp -52.45 -67.44 0.25 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.828 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.74 -42.11 67.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.22 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.74 18.17 0.14 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.742 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.41 47.96 0.21 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 39.19 -110.22 0.09 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.734 0.302 . . . . 0.0 110.631 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.492 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.1 m120 -60.97 -44.87 96.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.467 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.61 8.39 83.06 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -99.4 -12.26 20.41 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.607 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.6 t 176.15 142.46 0.07 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.073 0.463 . . . . 0.0 110.555 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.17 125.74 11.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.058 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -98.97 142.9 29.88 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.024 0.44 . . . . 0.0 110.567 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.5 mt -94.47 106.62 18.61 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.533 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.477 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 93.0 t80 -102.66 -11.95 18.05 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.199 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.75 -39.89 88.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.8 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.13 173.82 46.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.456 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 96.3 m-20 -74.98 -112.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.799 0.333 . . . . 0.0 110.658 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.83 -28.44 67.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.753 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.55 -43.97 93.39 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.031 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.34 -44.47 94.8 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.433 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.53 -59.51 4.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.243 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.6 -43.19 62.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.128 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.39 -44.08 75.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.2 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.4 mt -64.19 -43.61 97.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.949 0.404 . . . . 0.0 110.735 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -56.8 -37.68 71.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.121 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.31 1.03 19.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.386 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -114.64 91.29 24.71 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.423 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.79 -27.54 27.38 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.836 2.357 . . . . 0.0 111.696 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.39 -41.32 98.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.63 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.8 mp -95.32 4.83 53.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.251 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.71 -35.58 70.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.697 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.62 4.68 15.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.428 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.533 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.74 121.71 82.2 Favored Pre-proline 0 N--CA 1.441 -0.916 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.575 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.34 -38.21 26.15 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.32 2.014 . . . . 0.0 112.446 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.533 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.83 -43.77 90.76 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.821 0.343 . . . . 0.0 110.077 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.96 -43.64 92.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.373 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.85 -40.75 95.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.576 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 48.6 t-20 -89.27 -12.59 40.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.648 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.3 mtmt 62.52 31.92 16.79 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -88.67 44.7 1.23 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.391 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -106.6 134.95 46.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.515 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -116.25 132.38 56.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.468 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.495 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.52 88.22 6.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.693 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.88 -41.61 97.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.772 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.477 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.83 167.15 34.51 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.2 p -75.6 -25.66 57.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.822 0.344 . . . . 0.0 110.711 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.6 tp10 -68.09 -34.54 76.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.512 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.742 HG22 ' O ' ' A' ' 296' ' ' THR . 98.6 m -72.5 17.68 0.11 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.598 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.513 ' O ' ' NE2' ' A' ' 212' ' ' GLN . 47.8 t80 -56.89 -51.28 69.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.115 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 -106.09 147.4 28.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.062 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.3 tp -115.27 125.61 53.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 123.461 0.476 . . . . 0.0 110.796 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.47 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.5 t0 -149.62 166.75 28.36 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.52 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -49.5 -38.13 29.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.476 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -71.51 -64.92 0.83 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.24 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -61.28 -32.53 72.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.948 0.404 . . . . 0.0 110.944 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.56 -25.8 28.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.393 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.7 mtt -63.57 -41.11 98.41 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.898 0.38 . . . . 0.0 110.811 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.6 -44.59 27.87 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.848 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.566 HG21 HG23 ' A' ' 296' ' ' THR . 77.4 t -66.12 -42.87 92.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.434 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.551 HD11 ' NE2' ' A' ' 183' ' ' GLN . 48.4 tp -59.88 -46.87 87.94 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.374 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -70.72 -39.12 73.58 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.463 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.495 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.2 ttt180 -61.56 -38.06 86.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.273 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.59 4.62 43.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.914 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.412 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.0 tttt -111.95 -12.27 13.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.118 0.485 . . . . 0.0 110.423 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.55 -37.01 84.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.678 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.02 -48.73 80.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.387 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.228 179.771 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -90.1 -2.69 58.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.406 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.04 1.25 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.489 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.2 Cg_exo -60.78 145.09 99.5 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.75 2.3 . . . . 0.0 112.168 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.04 -179.65 8.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.585 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.61 136.06 53.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.311 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' A' ' 30' ' ' ILE . 9.3 tp -123.34 146.24 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.358 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.0 p -120.35 136.42 54.71 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.767 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 53.1 p30 -100.03 -142.99 0.33 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.2 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -62.87 -37.19 85.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.513 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.464 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -152.01 -59.99 0.16 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.413 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -60.52 139.82 48.11 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.7 p -111.83 129.98 55.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.916 0.388 . . . . 0.0 110.461 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.97 128.84 53.94 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.523 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.8 m -85.45 130.62 34.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.222 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.468 HD22 ' OE1' ' A' ' 42' ' ' GLN . 67.9 mt -96.27 79.04 3.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.311 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.55 -32.03 73.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.485 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.01 109.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.063 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.468 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.5 pt20 -121.73 91.31 48.59 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.226 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.8 Cg_exo -57.05 148.95 65.58 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.759 2.306 . . . . 0.0 111.787 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.72 82.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 O-C-N 123.566 0.541 . . . . 0.0 110.983 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.24 66.95 0.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.111 0.482 . . . . 0.0 110.233 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.75 130.74 35.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.589 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.552 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.5 t -122.71 146.07 28.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.106 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 t -135.85 143.47 45.12 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.624 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.5 p -99.24 -59.31 1.75 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.51 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.8 p -79.37 154.62 28.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.638 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.5 HG21 HG23 ' A' ' 70' ' ' THR . 69.4 t -73.98 -21.72 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.573 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.8 m -60.28 -52.0 67.12 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.477 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.45 -42.34 87.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.368 0.604 . . . . 0.0 110.943 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.22 -53.93 4.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.099 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.1 -37.48 72.86 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.8 m -62.76 -44.6 95.77 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-O 120.848 0.356 . . . . 0.0 110.424 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.6 mt -66.19 -41.95 89.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.477 0.656 . . . . 0.0 110.728 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.57 -40.34 96.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.431 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.462 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.93 -35.71 75.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.976 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.538 HD11 HD12 ' A' ' 156' ' ' LEU . 31.7 pt -91.51 28.44 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.138 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.72 51.42 11.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.851 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.45 75.02 27.89 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.984 0.421 . . . . 0.0 109.941 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.17 151.3 85.94 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.765 2.31 . . . . 0.0 112.263 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.552 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.59 137.3 47.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.207 0.527 . . . . 0.0 110.235 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.445 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -69.13 -43.7 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.218 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.03 130.86 53.17 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.959 0.409 . . . . 0.0 110.548 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.529 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.1 p -155.59 168.96 25.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.408 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.86 -177.38 21.64 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.06 172.21 12.95 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.976 0.417 . . . . 0.0 110.498 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.5 HG23 HG21 ' A' ' 51' ' ' VAL . 12.8 p -134.05 -110.38 0.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.402 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.18 179.74 0.92 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.323 -179.018 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.5 Cg_exo -60.99 58.93 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 123.03 2.487 . . . . 0.0 112.088 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 56.7 t-20 -64.22 -35.16 79.92 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.586 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.2 m120 94.91 -37.67 0.01 OUTLIER 'General case' 0 C--N 1.346 0.454 0 O-C-N 124.377 1.048 . . . . 0.0 109.938 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -62.7 -40.08 96.02 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.244 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -73.88 -26.77 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.724 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.76 -172.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.627 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.64 -152.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.742 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.6 p-10 -54.76 -6.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.681 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.49 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -87.06 113.68 23.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.609 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.25 73.06 1.27 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.94 148.58 35.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.825 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.84 -99.36 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.086 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.09 -42.95 96.76 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.142 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.544 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 9.9 tt0 91.6 53.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.088 0.867 . . . . 0.0 110.834 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -103.47 -9.21 19.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.453 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.2 p -64.9 -33.78 76.84 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.112 0.482 . . . . 0.0 110.664 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.62 -23.8 1.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.554 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.5 t -69.52 -46.0 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.978 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.35 81.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.117 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.72 -38.2 89.54 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.284 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.66 -32.16 50.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.226 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.591 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.5 mmt-85 -90.12 1.7 56.1 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 119.204 -0.426 . . . . 0.0 110.609 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 82.85 -49.11 0.16 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.212 0.945 . . . . 0.0 110.322 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.642 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.3 mt -46.49 153.96 0.33 Allowed 'General case' 0 CA--C 1.49 -1.34 0 CA-C-O 117.587 -1.197 . . . . 0.0 109.148 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.642 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.2 tt0 121.23 92.19 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 O-C-N 125.558 1.786 . . . . 0.0 110.529 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.529 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.21 143.46 43.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.218 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -132.12 26.95 4.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.733 0.301 . . . . 0.0 110.462 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.54 138.42 34.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.959 0.409 . . . . 0.0 110.469 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.63 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.6 mt -137.3 165.02 28.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.351 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.615 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.29 -28.59 1.81 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.95 70.95 7.15 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.188 0.518 . . . . 0.0 110.358 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.24 145.69 98.0 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 122.803 2.335 . . . . 0.0 112.032 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.2 t -134.38 136.64 43.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.568 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.14 82.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.716 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.5 -41.94 96.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.507 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.47 98.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.514 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.66 -43.35 98.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.06 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.99 -35.17 77.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.311 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -18.52 60.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.468 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.5 -6.34 58.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.526 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.0 mtp 48.0 55.74 17.17 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.651 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.15 149.12 63.94 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.777 2.318 . . . . 0.0 112.114 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -101.2 -73.37 0.65 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.46 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.418 HD11 HD13 ' A' ' 140' ' ' LEU . 38.3 tp -110.84 112.63 24.62 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.324 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -101.13 125.99 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.446 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.2 mt -109.5 133.27 53.28 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.149 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.22 139.48 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.484 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.9 p -83.42 168.41 16.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.648 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.56 80.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.44 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.51 159.18 42.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.424 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.2 177.01 33.46 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.94 87.5 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.77 151.98 44.42 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.962 0.41 . . . . 0.0 110.527 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.6 t -62.97 141.07 58.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.362 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.66 10.15 10.96 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.647 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.7 mp -60.98 -39.18 88.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.061 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.68 -35.91 24.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.54 0.686 . . . . 0.0 110.671 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.5 mt -70.83 -35.57 72.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.458 0.647 . . . . 0.0 110.774 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -42.78 -62.86 0.89 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.265 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.83 -42.61 90.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.994 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -62.33 -32.97 73.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.129 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.8 mt -73.48 -40.71 63.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.19 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.41 -48.66 79.96 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.206 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.7 m -53.28 -42.16 66.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.208 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.01 -43.04 92.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.002 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.62 154.08 5.34 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.625 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -39.13 107.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.666 2.244 . . . . 0.0 112.298 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.642 ' C ' HD12 ' A' ' 140' ' ' LEU . 94.5 m -109.75 121.4 45.14 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.252 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.642 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.28 152.82 30.75 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.252 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -128.27 131.42 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.359 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.29 127.42 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.397 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.88 103.6 14.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.364 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.9 p90 -101.12 -11.32 19.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.782 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.91 -33.47 76.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.622 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.2 p-10 -98.35 7.57 46.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.643 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.7 mttm -135.33 155.35 50.75 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.568 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.0 p -74.54 165.47 25.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.687 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.584 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -59.86 -48.7 80.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.298 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -53.86 -41.93 68.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.918 0.389 . . . . 0.0 110.081 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.4 t -62.42 -40.82 97.77 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.402 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.411 ' O ' HD23 ' A' ' 156' ' ' LEU . 47.4 tp -60.66 -43.87 97.12 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.355 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.516 HD22 HH21 ' A' ' 169' ' ' ARG . 44.0 tp -61.39 -43.07 99.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.861 0.363 . . . . 0.0 110.14 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.2 m -55.54 -45.3 77.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.716 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.49 -40.6 97.24 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 120.877 0.37 . . . . 0.0 110.395 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.538 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.02 -42.34 99.06 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.233 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.77 -41.05 95.93 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.72 -46.21 63.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.968 0.413 . . . . 0.0 110.894 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.6 mt -64.52 -44.05 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.819 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.8 p -93.23 -8.75 41.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.6 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.09 25.05 72.07 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -101.72 51.73 0.83 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.787 0.327 . . . . 0.0 110.681 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.79 -38.92 76.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.698 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.5 -46.92 87.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.187 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -61.37 -39.04 89.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.375 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.16 -40.45 97.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.362 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.3 -27.8 69.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.542 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.77 -53.71 8.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.171 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.516 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -63.75 -43.31 96.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.468 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 174' ' ' ASP . 86.7 mt -63.05 -43.9 99.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.676 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.33 -61.51 2.5 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.12 0.486 . . . . 0.0 110.484 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -54.81 -35.22 63.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.365 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -79.44 -34.72 41.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.114 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.3 m-20 -56.9 -40.01 75.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.926 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.83 -42.39 99.71 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.733 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.82 -37.74 87.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.294 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 177' ' ' LEU . 81.6 mt -62.41 -42.5 99.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.7 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.0 -53.14 59.79 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.128 0.489 . . . . 0.0 110.711 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.44 -41.41 89.16 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.548 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.26 -39.82 94.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.622 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.3 -32.33 73.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.338 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.21 -21.88 18.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.745 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.441 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.7 tt0 -65.02 -41.42 95.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.698 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 pt -77.58 136.33 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.679 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.46 108.65 11.0 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.274 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.18 126.15 0.33 Allowed Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.89 152.18 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.724 2.283 . . . . 0.0 112.586 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.13 141.71 53.5 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.676 2.25 . . . . 0.0 112.469 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -170.96 147.07 2.24 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.669 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.13 154.5 70.15 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.734 2.289 . . . . 0.0 112.265 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.581 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.44 163.18 28.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.419 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.581 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.65 170.05 16.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.857 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.79 137.45 22.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.226 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.536 HG22 HD12 ' A' ' 205' ' ' LEU . 39.3 pt -134.03 146.01 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.603 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.72 131.68 59.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.133 0.492 . . . . 0.0 110.457 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -152.01 155.11 37.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.419 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.616 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.2 m -122.25 122.93 40.27 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.916 0.389 . . . . 0.0 110.382 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.37 -25.84 66.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.569 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.616 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.24 -49.17 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.086 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.59 -12.87 61.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.472 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.7 m80 50.43 41.55 25.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.439 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.9 t -136.27 144.79 44.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.339 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.401 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -110.5 114.31 27.62 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.35 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.1 m-20 -119.86 133.4 55.6 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.067 0.46 . . . . 0.0 110.372 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.98 146.32 38.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.756 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.484 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 12.3 t90 -99.29 129.54 45.52 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.062 0.458 . . . . 0.0 110.026 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.43 153.72 39.5 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.082 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.66 -18.29 48.12 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.791 2.328 . . . . 0.0 111.888 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.11 -18.71 0.35 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.45 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.484 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.1 p -75.65 165.23 25.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.496 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.14 -28.19 66.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.545 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.1 mt-30 -63.61 -41.43 98.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.17 -44.67 97.15 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.5 -38.92 92.7 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.981 0.42 . . . . 0.0 110.567 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.584 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.1 mmm -62.28 -41.36 98.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.114 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.5 mt -63.67 -47.05 82.8 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.648 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.48 -31.95 56.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.057 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -70.74 -18.14 62.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.543 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.427 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.4 mt -88.63 -8.67 54.24 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.692 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.85 2.52 55.12 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -88.57 152.46 21.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.768 0.318 . . . . 0.0 110.565 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.448 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.2 p -115.35 128.15 55.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.101 0.477 . . . . 0.0 110.378 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.46 146.02 24.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.852 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.47 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.64 151.16 46.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.463 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.9 131.59 42.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.408 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.89 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.56 93.4 27.59 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.061 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.677 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.0 Cg_exo -55.61 139.16 82.58 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.588 2.192 . . . . 0.0 111.519 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.86 -25.47 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.507 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.66 -49.88 27.9 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.553 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -53.99 -37.07 63.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.771 0.32 . . . . 0.0 110.19 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -66.71 35.96 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.815 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.553 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.32 88.13 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.4 p -81.72 -14.36 56.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.335 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -91.37 -41.41 10.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.564 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.7 t -66.88 -16.62 64.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.682 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.1 43.54 26.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.495 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.63 -147.99 7.63 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -121.75 143.11 49.57 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.953 0.406 . . . . 0.0 110.354 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -151.97 149.43 28.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.349 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -100.83 -151.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.313 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 55.87 -91.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.609 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.462 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.4 tt -126.67 175.12 9.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.559 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.462 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.8 mt -121.73 141.42 42.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.841 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.68 169.16 9.46 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.259 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.2 mt -147.73 150.83 35.02 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.181 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.58 -39.04 97.18 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.33 3.98 4.6 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -77.33 -58.03 3.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.001 0.429 . . . . 0.0 110.649 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.566 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.2 m-20 -62.15 -36.86 83.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.221 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.401 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.0 mp -52.36 -67.76 0.22 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.747 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.45 -42.17 66.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.248 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.11 17.92 0.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.672 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.99 48.59 0.29 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.42 -109.83 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.647 0.26 . . . . 0.0 110.744 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.47 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 12.0 m120 -60.96 -44.82 96.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.454 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.41 8.09 83.82 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -99.1 -12.95 20.05 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.783 -0.245 . . . . 0.0 110.646 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.0 t 176.69 142.57 0.07 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.121 0.486 . . . . 0.0 110.514 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.94 125.94 12.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.074 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -99.08 143.1 29.73 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 120.927 0.394 . . . . 0.0 110.79 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.4 mt -94.49 106.35 18.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.632 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.455 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.4 t80 -101.96 -12.29 18.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.163 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.22 -40.14 90.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.862 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.67 174.19 46.4 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.466 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.6 m-20 -74.67 -113.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 0.0 110.662 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.65 -28.61 67.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.743 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.04 -44.11 91.72 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.245 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.53 -44.28 94.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.398 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.56 -59.81 4.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.208 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.39 -43.34 61.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.151 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.34 -43.92 75.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.23 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.41 -43.6 97.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.682 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -56.55 -37.44 70.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.207 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.76 1.09 18.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.297 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -115.04 91.21 26.07 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.174 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.21 -27.11 28.86 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.803 2.336 . . . . 0.0 111.767 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.33 -41.06 98.87 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.641 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.22 4.93 53.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.371 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.63 -35.21 70.35 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.75 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.59 4.56 15.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.512 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.75 121.39 81.03 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.592 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -47.67 -37.67 27.77 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.46 2.107 . . . . 0.0 112.453 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.532 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -59.06 -43.75 91.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.788 0.328 . . . . 0.0 110.211 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.85 -43.75 93.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.251 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.72 -40.52 95.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.449 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.76 -12.43 39.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.534 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.2 mtmt 61.99 31.56 17.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.39 44.01 1.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.384 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.04 135.91 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.497 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.47 132.87 56.56 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.428 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.15 87.75 7.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.723 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.01 -41.25 97.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.92 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.455 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.98 168.45 34.97 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.0 p -76.05 -25.81 55.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.858 0.361 . . . . 0.0 110.731 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.1 tp10 -67.61 -34.18 76.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.465 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.762 HG22 ' O ' ' A' ' 296' ' ' THR . 97.0 m -73.52 20.47 0.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.648 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.557 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 57.0 t80 -57.63 -51.13 70.77 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.942 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.409 HH12 ' HG3' ' A' ' 212' ' ' GLN . 65.2 mmt-85 -108.28 149.72 28.26 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.427 ' CD2' HD11 ' A' ' 219' ' ' LEU . 40.4 tp -115.32 125.35 53.14 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.805 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.471 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.2 t0 -149.11 166.46 28.69 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.552 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -49.24 -38.16 25.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.61 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -71.54 -65.21 0.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.371 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -60.93 -32.86 72.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.47 -25.65 26.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.566 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.6 mtt -63.33 -40.87 98.5 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 120.865 0.364 . . . . 0.0 110.944 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.77 -44.22 23.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.562 HG21 HG23 ' A' ' 296' ' ' THR . 78.8 t -66.17 -43.03 92.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.403 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.441 HD11 ' NE2' ' A' ' 183' ' ' GLN . 50.3 tp -60.23 -47.06 87.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.466 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -69.83 -39.9 76.19 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.035 0.445 . . . . 0.0 110.744 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.498 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.2 ttt180 -61.61 -38.19 86.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.198 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.11 4.45 42.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.767 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.4 tttt -112.47 -11.51 13.62 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.045 0.45 . . . . 0.0 110.259 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.97 85.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.644 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.1 -48.87 79.67 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.339 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.042 179.947 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.44 -2.76 57.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.444 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.49 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.41 178.98 1.27 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.536 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.3 Cg_exo -60.75 144.82 99.61 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.652 2.235 . . . . 0.0 112.212 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.69 -179.75 8.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.608 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.58 136.69 52.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.392 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.1 tp -124.55 146.28 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.361 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.8 p -119.81 136.09 54.6 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.779 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.9 p30 -98.74 -144.17 0.32 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.273 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.56 -36.63 84.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.47 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.486 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.9 ttt85 -147.32 -70.59 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.565 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.81 144.07 41.81 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.2 p -112.68 130.08 56.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 0.0 110.397 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -114.8 129.65 56.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.686 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.9 m -86.83 130.6 34.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.342 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.493 HD22 ' OE1' ' A' ' 42' ' ' GLN . 71.1 mt -97.41 79.06 2.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.437 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -65.94 -32.55 74.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.53 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 t 177.09 109.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.155 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.493 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -123.36 91.59 49.64 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.324 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.3 Cg_exo -56.81 149.0 62.9 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.71 2.273 . . . . 0.0 111.82 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.69 83.05 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.933 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.48 67.27 0.89 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.316 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.59 130.69 35.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.637 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.552 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.4 t -123.04 146.31 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.108 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 t -136.16 143.84 44.68 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.626 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.7 p -99.35 -59.35 1.74 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.523 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.2 p -79.36 155.03 28.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.585 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.497 HG21 HG23 ' A' ' 70' ' ' THR . 72.5 t -74.36 -21.67 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.582 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.7 m -60.23 -52.09 66.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.537 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -66.62 -42.45 86.8 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.243 0.544 . . . . 0.0 110.759 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.8 m -42.88 -54.07 4.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.234 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.34 -37.24 70.51 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -62.85 -44.62 95.64 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 120.848 0.356 . . . . 0.0 110.428 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.422 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.9 mt -66.51 -41.93 88.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.306 0.574 . . . . 0.0 110.732 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.3 tp -62.5 -40.44 96.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.25 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.502 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.81 -36.05 75.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.928 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.527 HD11 HD12 ' A' ' 156' ' ' LEU . 30.7 pt -91.06 29.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.103 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 56.43 51.51 11.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.899 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.41 75.79 22.13 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.909 0.385 . . . . 0.0 109.98 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.15 152.11 83.35 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.783 2.322 . . . . 0.0 112.28 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.552 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.86 137.54 46.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.104 0.478 . . . . 0.0 110.33 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.5 pt -69.14 -43.65 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.241 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.1 131.21 53.33 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.948 0.404 . . . . 0.0 110.595 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.5 p -155.57 168.94 25.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.409 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.98 -177.28 21.56 Favored Glycine 0 N--CA 1.464 0.505 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.635 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.14 172.31 12.83 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.919 0.39 . . . . 0.0 110.507 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.497 HG23 HG21 ' A' ' 51' ' ' VAL . 15.0 p -132.35 -112.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.947 0.403 . . . . 0.0 110.462 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.18 179.76 0.93 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.344 -179.185 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.6 Cg_exo -60.8 57.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.962 2.441 . . . . 0.0 112.132 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.7 t-20 -64.41 -33.54 76.09 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.522 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.567 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.3 m120 93.76 -36.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.08 0.862 . . . . 0.0 109.94 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.6 mtp85 -62.43 -39.48 93.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.265 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -74.69 -25.68 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.623 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.19 -171.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.86 -153.75 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.758 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.1 p-10 -52.78 -7.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.687 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.508 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.49 115.17 23.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.653 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.94 69.85 1.35 Allowed Glycine 0 CA--C 1.521 0.42 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -143.16 147.51 35.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.815 0.341 . . . . 0.0 110.832 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.61 -98.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.185 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.1 -42.64 96.84 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.122 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 9.9 tt0 91.51 53.14 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.866 0.729 . . . . 0.0 110.878 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -103.13 -9.05 19.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.447 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -64.79 -33.74 76.69 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.058 0.456 . . . . 0.0 110.65 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -49.18 -23.85 1.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.613 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.53 -46.0 76.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.936 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.41 -48.19 82.34 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.237 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.65 -38.26 89.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.292 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.78 -32.31 52.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.238 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.608 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.3 mmt-85 -90.19 1.65 56.21 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.57 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 56.9 mttp 82.64 -49.55 0.18 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.954 0.784 . . . . 0.0 110.29 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.671 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.7 mt -45.87 154.52 0.23 Allowed 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 118.16 -0.924 . . . . 0.0 109.453 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.671 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 120.77 92.68 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 O-C-N 125.066 1.479 . . . . 0.0 110.462 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.76 143.45 42.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.992 0.425 . . . . 0.0 110.249 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.5 mt -132.38 27.21 4.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 110.517 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.35 138.04 34.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.557 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.7 mt -137.25 164.96 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.386 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.02 -28.53 1.85 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.69 70.82 7.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.078 0.466 . . . . 0.0 110.36 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.89 145.19 98.9 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.754 2.303 . . . . 0.0 112.066 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.2 t -133.99 136.13 43.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.549 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.95 -38.17 82.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.673 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.25 -41.95 96.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.514 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.37 -41.41 98.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.527 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.0 t -63.84 -43.4 97.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.068 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.13 -35.05 77.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.323 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.75 -18.41 59.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.485 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.75 -6.39 58.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.498 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 68.0 mtp 47.57 56.06 17.21 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.584 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.13 149.43 64.51 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.786 2.324 . . . . 0.0 112.034 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.11 -73.88 0.63 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.433 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.502 HD11 HD13 ' A' ' 140' ' ' LEU . 37.9 tp -110.56 112.35 24.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.262 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.9 mt -100.72 126.33 54.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.022 0.439 . . . . 0.0 110.437 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.8 mt -109.16 132.83 53.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.272 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.0 139.3 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.511 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -83.55 168.38 16.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.579 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.1 -37.52 80.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.424 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -140.14 159.32 42.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.511 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.46 178.38 32.96 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.21 -33.74 86.92 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -125.6 152.67 44.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.899 0.381 . . . . 0.0 110.556 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 33.3 t -63.4 141.27 58.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.408 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.68 10.46 11.01 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.578 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -60.93 -38.97 87.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.113 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.88 -36.12 23.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.431 0.634 . . . . 0.0 110.629 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.1 mt -70.93 -35.57 72.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.373 0.606 . . . . 0.0 110.79 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -42.69 -62.8 0.9 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.201 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -66.17 -42.69 88.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.043 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.24 -32.58 73.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.267 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 129' ' ' LEU . 74.1 mt -73.9 -41.06 62.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.078 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -58.24 -48.98 78.69 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.301 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.0 m -52.95 -42.37 65.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.353 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.96 -42.65 92.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.985 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.44 153.97 5.47 Favored Pre-proline 0 N--CA 1.453 -0.281 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.581 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -39.74 106.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.669 2.246 . . . . 0.0 112.179 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.66 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.6 m -110.07 122.76 48.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.382 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.66 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -115.05 153.68 30.25 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.304 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -129.44 131.81 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.395 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.16 127.79 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.513 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.21 104.37 15.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.298 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.2 p90 -101.57 -11.17 19.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.805 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.576 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.73 -33.66 76.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.722 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.576 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.7 p-10 -98.41 8.03 45.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.573 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.61 155.18 50.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.582 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.409 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.45 165.94 24.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.64 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.595 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.8 t90 -59.72 -49.12 78.99 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.23 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -53.51 -42.39 67.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 110.109 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.8 t -62.85 -40.99 99.15 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.328 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.401 ' O ' HD23 ' A' ' 156' ' ' LEU . 48.9 tp -60.64 -44.19 96.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.366 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.37 -43.6 98.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.206 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.5 m -54.71 -44.64 73.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.875 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.79 -40.74 98.26 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.905 0.383 . . . . 0.0 110.379 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.527 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.03 -42.38 99.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.165 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.94 -41.21 95.5 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.66 -45.81 64.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.908 0.385 . . . . 0.0 110.831 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.55 -44.0 96.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.811 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -93.34 -8.34 42.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.583 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.5 26.67 71.95 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -101.76 51.41 0.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.818 0.342 . . . . 0.0 110.679 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.8 -39.38 76.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.707 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.61 -47.41 85.67 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.297 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -59.92 -39.47 85.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.35 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.9 -40.97 99.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.368 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.52 70.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.566 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.17 -54.37 7.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.1 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.502 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.5 ttp180 -65.57 -42.19 92.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.477 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.6 mt -62.36 -43.77 98.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.566 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.66 -57.16 12.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.931 0.396 . . . . 0.0 110.551 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -58.48 -32.76 69.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.345 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.423 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.9 t80 -82.1 -36.56 27.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.772 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.6 m-20 -56.13 -41.41 75.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.155 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.99 -42.25 99.79 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.595 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.45 -37.78 87.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.281 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.423 HD11 ' CD2' ' A' ' 173' ' ' PHE . 81.9 mt -62.5 -42.23 99.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.654 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.06 -52.91 62.03 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.013 0.435 . . . . 0.0 110.668 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.4 -41.77 88.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.565 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.98 95.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.563 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.31 -31.94 73.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.424 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.54 -22.51 18.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.766 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.447 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.8 tt0 -64.65 -41.25 96.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.616 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 184' ' ' ILE . 33.0 pt -76.72 136.52 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.626 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.89 108.1 10.68 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.282 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.83 125.43 0.3 Allowed Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.505 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.451 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.7 Cg_exo -43.77 152.35 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.741 2.294 . . . . 0.0 112.484 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.89 141.81 55.06 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.634 2.223 . . . . 0.0 112.396 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.19 147.25 2.18 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.578 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.0 154.32 70.94 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.779 2.319 . . . . 0.0 112.324 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.585 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.27 163.15 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.42 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.585 ' N ' HG22 ' A' ' 191' ' ' VAL . 1.9 t -144.07 170.68 15.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.799 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.63 137.7 21.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.312 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.535 HG22 HD12 ' A' ' 205' ' ' LEU . 40.0 pt -134.31 146.96 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.675 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.28 131.83 58.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.102 0.477 . . . . 0.0 110.482 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -152.09 155.12 37.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.473 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.621 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.4 m -122.79 122.93 39.88 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.412 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.47 -25.67 66.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.579 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.621 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.33 -48.86 21.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.007 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.34 -9.41 58.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.467 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.2 m80 46.51 42.11 10.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.444 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -135.93 145.75 46.58 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.399 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.94 114.3 27.12 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.321 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.79 133.37 55.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 110.442 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.535 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.81 146.22 38.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.712 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.491 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.3 t90 -99.42 129.38 45.6 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.074 0.464 . . . . 0.0 110.056 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.02 153.42 39.84 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.073 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.85 -17.87 46.99 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.762 2.308 . . . . 0.0 111.962 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.14 -18.9 0.37 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.486 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.491 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.71 164.71 26.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.531 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.93 -27.95 65.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.504 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.6 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.9 mt-30 -63.65 -41.19 98.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.643 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.66 -44.37 97.95 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.45 -38.8 92.29 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.983 0.42 . . . . 0.0 110.464 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.595 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.0 mmm -62.14 -41.31 98.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.177 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.7 mt -63.63 -47.17 82.42 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.672 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.13 -31.95 53.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.114 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.85 -18.3 62.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.557 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.437 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.9 mt -87.87 -9.13 54.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.559 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.19 1.6 54.34 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -88.16 153.77 20.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.835 0.35 . . . . 0.0 110.519 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.455 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.0 p -116.31 128.74 55.82 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.071 0.463 . . . . 0.0 110.384 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.62 146.3 23.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.866 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.486 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.95 151.72 45.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.463 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.88 131.47 42.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.443 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.896 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.73 93.07 26.93 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.132 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.675 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.9 Cg_exo -55.43 139.21 81.77 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.597 2.198 . . . . 0.0 111.59 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.01 -26.07 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.486 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.36 -50.25 27.88 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.4 mt -53.71 -37.15 63.0 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -66.76 36.14 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.731 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.556 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 38.98 88.72 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.847 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.5 p -81.28 -13.87 58.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.377 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.98 -41.84 10.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.626 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.7 t -66.74 -16.94 64.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.636 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 55.74 44.01 26.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.453 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.67 -149.24 8.32 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.95 142.84 48.38 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.912 0.387 . . . . 0.0 110.369 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.01 149.56 29.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.391 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -101.31 -151.59 0.42 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.343 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 55.96 -92.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.631 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.466 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.4 tt -126.84 175.52 8.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.613 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.466 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.4 mt -122.72 142.04 40.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.759 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.86 169.65 9.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.329 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 58.7 mt -148.01 150.8 34.63 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.49 -39.05 97.26 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.1 4.03 4.69 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -77.55 -58.04 3.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.896 0.379 . . . . 0.0 110.596 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.56 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.4 m-20 -62.11 -36.61 82.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.264 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.36 -67.76 0.23 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.661 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.54 -42.48 67.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.264 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.63 17.42 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.56 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.02 48.83 0.3 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.53 -110.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.587 0.232 . . . . 0.0 110.704 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.486 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.9 m120 -60.8 -44.8 96.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.572 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.28 8.01 84.16 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.95 -13.58 19.89 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.628 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.1 t 177.25 142.55 0.08 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.007 0.432 . . . . 0.0 110.492 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.22 124.81 11.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.052 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.09 143.63 28.43 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 120.854 0.359 . . . . 0.0 110.699 178.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.5 mt -95.13 106.49 18.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.659 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.442 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.8 t80 -101.75 -12.27 18.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.279 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.37 -40.73 89.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.83 173.06 45.72 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.453 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -73.71 -113.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.814 0.34 . . . . 0.0 110.739 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.66 -28.62 67.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.715 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.9 -44.03 91.13 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.179 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.63 -44.22 94.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.336 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.71 -60.21 3.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.227 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.93 -43.54 60.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.165 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.27 -43.58 74.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.268 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.64 -43.63 96.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.648 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -56.28 -37.5 69.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.189 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.54 0.9 18.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.328 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -114.99 91.4 26.6 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.227 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.21 -27.28 29.54 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.809 2.34 . . . . 0.0 111.778 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -40.96 98.78 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.621 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.33 5.31 52.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.328 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.07 -35.37 69.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.009 0.433 . . . . 0.0 110.707 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.36 4.36 15.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.601 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.76 121.15 80.17 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.531 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -47.2 -37.89 24.53 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.479 2.119 . . . . 0.0 112.397 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.98 -43.74 91.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.846 0.355 . . . . 0.0 110.311 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.5 t -66.18 -43.68 91.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.337 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.89 -40.6 95.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.537 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 47.5 t-20 -89.64 -12.89 38.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.502 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 62.47 32.28 16.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.79 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.01 43.84 1.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.376 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.22 135.63 41.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.544 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.84 132.38 56.71 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.465 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.07 89.15 7.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.735 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.88 -40.98 97.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.784 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.79 165.34 33.26 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 71.7 p -75.47 -25.75 57.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 110.673 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.8 tp10 -68.36 -33.85 75.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.384 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 296' ' ' THR . 95.7 m -73.68 25.17 0.07 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.711 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.6 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 37.7 t80 -58.57 -50.75 72.68 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.413 HH12 ' HG3' ' A' ' 212' ' ' GLN . 79.4 mmt-85 -110.82 153.84 24.81 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.437 ' CD2' HD11 ' A' ' 219' ' ' LEU . 45.0 tp -115.67 125.1 52.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.721 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.487 ' CB ' HD23 ' A' ' 83' ' ' LEU . 44.7 t0 -147.98 165.66 30.05 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.531 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.16 -38.13 24.55 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.544 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.03 -65.83 0.69 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.29 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.91 -32.75 72.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.35 -25.25 23.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.627 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.5 mtt -63.72 -40.73 97.47 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 120.889 0.376 . . . . 0.0 111.01 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -79.1 -44.13 22.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.58 HG21 HG23 ' A' ' 296' ' ' THR . 79.0 t -66.15 -42.88 92.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.469 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.447 HD11 ' NE2' ' A' ' 183' ' ' GLN . 50.9 tp -60.1 -47.13 87.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.455 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.04 -39.31 75.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.58 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.2 ttt180 -61.85 -38.66 89.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.252 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -86.67 4.57 39.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.772 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.1 tttt -112.92 -11.16 13.46 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.048 0.451 . . . . 0.0 110.31 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.1 85.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.578 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.84 -48.88 79.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.422 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.178 179.701 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.612 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.68 -3.15 57.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.425 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.489 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -143.88 179.2 1.23 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.53 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 37.6 Cg_exo -60.55 144.57 99.54 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.779 2.32 . . . . 0.0 112.161 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.612 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.3 ptt-85 -155.85 179.96 8.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.571 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -116.03 137.22 52.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.346 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.83 146.17 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.46 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.8 p -119.9 136.27 54.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.744 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.7 p30 -98.33 -144.51 0.31 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.267 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.58 -36.39 83.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.481 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -147.04 -70.68 0.23 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.508 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.59 144.15 41.11 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.7 p -112.61 129.82 56.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 110.385 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -114.86 129.9 56.79 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.643 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 m -87.74 131.53 34.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.159 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.497 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.8 mt -99.02 79.64 2.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.655 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.16 -32.01 73.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.475 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 t 176.98 109.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.182 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.497 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -124.32 91.66 49.23 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.306 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.4 Cg_exo -56.64 149.04 61.05 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.792 2.328 . . . . 0.0 111.917 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.44 82.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.599 0.562 . . . . 0.0 110.923 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.0 mtm180 -151.62 67.23 0.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.24 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.84 130.99 35.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.667 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.567 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.6 t -123.16 147.74 27.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.149 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 t -136.22 143.96 44.63 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.703 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 50' ' ' SER . 16.9 p -99.65 -59.33 1.74 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.524 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.42 ' N ' ' OG1' ' A' ' 49' ' ' THR . 86.6 p -79.41 154.94 28.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.596 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.529 HG21 HG23 ' A' ' 70' ' ' THR . 70.5 t -73.72 -21.76 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.517 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.8 m -60.17 -52.03 67.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.535 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 mt -66.41 -42.32 87.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.208 0.527 . . . . 0.0 110.862 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.7 m -43.52 -54.27 4.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.091 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.63 -36.65 76.35 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 m -63.32 -44.38 95.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 0.0 110.423 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.7 mt -66.02 -42.13 90.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.484 0.659 . . . . 0.0 110.593 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tp -62.83 -40.17 96.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.367 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.534 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.52 -36.16 77.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.065 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.46 HD11 HD12 ' A' ' 156' ' ' LEU . 32.6 pt -90.99 27.66 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.168 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 57.02 51.51 10.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.944 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.81 75.92 29.86 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.036 0.446 . . . . 0.0 109.932 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -63.53 149.38 91.16 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.752 2.302 . . . . 0.0 112.214 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.567 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -112.71 137.11 46.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.198 0.523 . . . . 0.0 110.281 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.441 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.5 pt -69.51 -43.7 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.145 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.22 131.21 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.929 0.395 . . . . 0.0 110.59 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.2 p -155.78 168.67 26.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.467 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.7 -177.41 21.74 Favored Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.629 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.07 172.3 12.83 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.483 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.529 HG23 HG21 ' A' ' 51' ' ' VAL . 11.4 p -134.13 -110.27 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.396 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.545 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.43 179.6 0.94 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.348 -179.045 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.2 Cg_exo -60.79 58.87 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.996 2.464 . . . . 0.0 112.129 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 56.3 t-20 -64.37 -34.91 79.25 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.498 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.2 m120 95.04 -38.14 0.01 OUTLIER 'General case' 0 C--N 1.346 0.448 0 O-C-N 124.016 0.822 . . . . 0.0 109.875 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.45 -39.84 94.67 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.018 0.437 . . . . 0.0 110.228 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.2 p -73.79 -26.5 21.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.693 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.97 -172.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.568 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.7 p30 -74.22 -152.88 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.757 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.7 p-10 -54.49 -6.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.701 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.493 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.94 113.66 22.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.589 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.48 72.74 1.28 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.99 148.62 35.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.885 0.374 . . . . 0.0 110.817 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.75 -99.16 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.139 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.04 -42.94 96.89 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.201 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.1 tt0 91.65 52.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.953 0.783 . . . . 0.0 110.925 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -103.43 -8.99 19.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.365 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -64.92 -33.58 76.35 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.108 0.48 . . . . 0.0 110.669 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -48.85 -23.55 1.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.671 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.7 t -70.02 -46.14 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.815 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.16 -48.63 80.7 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.107 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.63 -38.18 89.23 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.41 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.76 -32.31 51.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.261 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.6 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.9 mmt-85 -89.79 1.81 55.68 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.617 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.6 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 82.64 -49.5 0.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.015 0.822 . . . . 0.0 110.319 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.655 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.6 mt -46.06 154.48 0.25 Allowed 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 117.702 -1.142 . . . . 0.0 109.407 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.655 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 120.72 92.36 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 O-C-N 125.439 1.712 . . . . 0.0 110.479 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.533 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.11 143.02 43.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.084 0.468 . . . . 0.0 110.259 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -132.07 26.71 4.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.856 0.36 . . . . 0.0 110.533 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.33 138.14 34.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.013 0.435 . . . . 0.0 110.549 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.3 mt -137.16 164.79 29.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.398 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.613 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.63 -28.91 1.75 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -151.94 70.75 7.88 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.177 0.513 . . . . 0.0 110.258 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.87 145.29 98.64 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.777 2.318 . . . . 0.0 112.057 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.8 t -134.98 136.49 42.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.549 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.97 -38.17 82.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.657 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.51 -42.07 96.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.506 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.08 -41.59 98.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.516 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.77 -43.29 97.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.064 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.17 -35.09 77.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.263 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -18.29 59.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.506 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.72 -6.1 58.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.505 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.417 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 70.4 mtp 47.83 55.73 17.09 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.608 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.0 Cg_endo -70.25 149.16 63.4 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.744 2.296 . . . . 0.0 112.116 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.48 -72.99 0.66 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.429 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.448 HD11 HD13 ' A' ' 140' ' ' LEU . 37.6 tp -111.25 113.54 26.11 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.342 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.4 mt -102.67 126.95 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.576 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.5 mt -110.06 133.85 52.76 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.225 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.33 139.65 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.468 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.6 p -83.48 167.84 17.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.688 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -37.25 79.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.47 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.61 158.6 43.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.472 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.11 176.97 33.4 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.75 86.91 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.95 152.27 44.38 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.926 0.394 . . . . 0.0 110.505 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.0 t -63.47 140.93 58.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.355 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.62 10.5 11.07 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.611 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.04 -38.89 87.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.14 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.97 -35.86 23.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.542 0.687 . . . . 0.0 110.668 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.9 mt -70.98 -35.34 72.09 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.444 0.64 . . . . 0.0 110.733 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -42.81 -63.0 0.86 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.239 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.87 -42.71 90.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.049 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.07 -32.63 73.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.3 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.9 mt -73.9 -40.7 62.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.987 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.28 -49.22 77.92 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.21 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.3 m -52.89 -42.48 65.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.246 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.59 -42.87 93.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.131 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.73 153.94 5.19 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.65 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -39.38 106.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.661 2.241 . . . . 0.0 112.354 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.649 ' C ' HD12 ' A' ' 140' ' ' LEU . 97.1 m -109.97 122.22 47.06 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.332 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.649 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.5 153.44 29.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.225 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -129.04 131.5 68.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.393 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -114.88 127.6 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.475 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.496 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 55.3 t30 -100.65 104.45 15.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.311 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 147' ' ' LYS . 50.0 p90 -100.92 -11.18 19.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.809 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.0 p-10 -64.74 -33.53 76.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.728 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.1 p-10 -98.87 8.13 45.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.591 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.441 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.27 153.04 52.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.487 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.405 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.8 p -75.37 166.05 24.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.649 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.598 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.7 t90 -59.46 -48.91 79.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.127 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -54.28 -43.07 70.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.91 0.386 . . . . 0.0 110.114 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.1 t -62.78 -40.9 98.75 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.366 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.429 ' O ' HD23 ' A' ' 156' ' ' LEU . 55.5 tp -60.69 -44.37 96.62 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.241 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.35 -42.88 99.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.853 0.359 . . . . 0.0 110.192 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.0 m -55.86 -44.9 78.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.773 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.81 -40.3 96.93 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 120.908 0.385 . . . . 0.0 110.439 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.46 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.9 -42.27 98.88 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.287 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.81 -40.45 95.6 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.52 -45.54 65.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.908 0.385 . . . . 0.0 110.792 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.71 -44.03 96.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.742 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -93.44 -8.4 41.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.596 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.67 26.5 72.04 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -101.35 50.76 0.85 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.813 0.339 . . . . 0.0 110.589 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -69.65 -39.68 76.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.667 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.58 -47.59 84.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.208 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -59.62 -39.78 85.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.268 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.15 99.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.296 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.56 -28.59 69.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.604 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.47 -54.22 7.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.016 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.534 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.7 ttp180 -65.61 -42.36 91.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.458 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.8 mt -62.38 -43.9 98.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.522 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.67 -57.67 10.19 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.079 0.466 . . . . 0.0 110.377 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.91 -33.75 69.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.482 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -81.39 -36.35 29.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.755 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.4 m-20 -55.33 -41.87 73.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.982 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.54 -42.03 99.26 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.664 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.22 -38.23 89.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.348 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 177' ' ' LEU . 82.5 mt -62.5 -42.25 99.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.733 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.11 -53.06 60.72 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.12 0.486 . . . . 0.0 110.657 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.09 -42.0 89.91 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.642 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.71 -40.06 95.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.666 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.28 -31.9 73.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.37 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.92 -22.16 18.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.662 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.439 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.6 tt0 -64.63 -41.33 96.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.599 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.5 pt -75.2 136.2 25.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.6 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -125.99 106.95 9.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.312 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -177.2 125.56 0.29 Allowed Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.57 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.8 Cg_exo -43.9 152.39 0.36 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.772 2.315 . . . . 0.0 112.56 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.87 141.93 55.54 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.658 2.239 . . . . 0.0 112.468 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.25 147.46 2.2 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.585 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.03 154.45 70.59 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.764 2.309 . . . . 0.0 112.362 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.47 163.12 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.194 0.521 . . . . 0.0 110.386 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.65 170.3 16.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.932 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.47 137.56 21.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.995 0.426 . . . . 0.0 110.111 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.536 HG22 HD12 ' A' ' 205' ' ' LEU . 39.6 pt -134.4 147.14 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.657 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.56 132.04 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.157 0.503 . . . . 0.0 110.492 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -151.95 154.84 36.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.423 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.7 m -121.82 122.62 39.87 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.947 0.403 . . . . 0.0 110.344 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.93 -25.48 66.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.646 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.86 -49.65 19.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.91 -9.53 58.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.409 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.8 m80 46.97 43.74 14.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.436 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.7 t -135.78 145.11 46.2 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.347 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.47 113.49 25.96 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.26 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.1 m-20 -119.86 133.26 55.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.384 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 194' ' ' ILE . 7.5 tt -112.02 146.35 38.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.757 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.482 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.1 t90 -99.35 128.85 45.51 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.104 0.478 . . . . 0.0 110.067 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.65 154.04 40.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.174 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.68 -17.98 47.91 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.662 2.241 . . . . 0.0 111.94 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.35 -18.79 0.42 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.405 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.482 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 84.6 p -75.42 164.73 26.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.507 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.89 -28.14 65.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.461 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.556 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.4 mt-30 -63.67 -41.74 98.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.669 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.65 -44.67 96.67 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.441 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.1 mt-30 -64.45 -38.9 92.63 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 122.448 -0.442 . . . . 0.0 110.672 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.06 -41.19 97.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.276 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.61 -47.42 81.47 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.997 0.427 . . . . 0.0 110.502 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -53.82 -32.15 51.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.193 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -70.92 -19.0 62.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.555 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' A' ' 299' ' ' LEU . 92.6 mt -87.48 -8.89 55.9 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.63 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.83 2.72 55.15 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.9 152.67 21.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.339 . . . . 0.0 110.532 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.438 ' O ' HG12 ' A' ' 191' ' ' VAL . 7.8 p -115.57 128.19 55.78 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.063 0.459 . . . . 0.0 110.305 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.41 146.52 23.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.959 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.478 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -70.07 151.1 45.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.447 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.64 131.56 43.28 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.475 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.891 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.57 93.42 27.67 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.073 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.679 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.3 Cg_exo -55.52 138.99 82.02 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.629 2.219 . . . . 0.0 111.617 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.82 -25.51 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.482 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.57 -49.82 28.78 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.553 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.1 mt -54.05 -36.97 63.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.71 36.09 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.72 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.553 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.14 86.73 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.9 p -79.61 -15.04 58.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.34 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -92.37 -41.4 10.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.59 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -65.98 -17.72 64.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.621 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 56.18 43.32 26.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.466 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.23 -148.31 7.67 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.87 142.81 49.88 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.958 0.408 . . . . 0.0 110.336 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.06 149.57 28.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.328 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -100.79 -151.86 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.308 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.5 t0 55.9 -92.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.673 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.463 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.48 175.41 8.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.601 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.463 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.7 mt -122.32 141.72 41.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.766 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.7 169.17 9.45 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.226 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.8 mt -147.66 150.86 35.17 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.191 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.64 -38.82 96.83 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.82 4.2 4.78 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -77.45 -58.22 3.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.945 0.402 . . . . 0.0 110.558 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.528 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.1 m-20 -62.17 -36.64 82.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.416 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.17 -67.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.777 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.72 -42.27 67.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.102 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.72 17.38 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.645 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.34 49.13 0.34 Allowed Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.411 -0.675 . . . . 0.0 111.411 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 37.85 -109.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.635 0.255 . . . . 0.0 110.825 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.478 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.7 m120 -60.65 -45.2 95.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.493 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.82 7.85 83.48 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.04 -13.04 20.04 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.745 -0.268 . . . . 0.0 110.696 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.4 t 176.86 142.89 0.08 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.063 0.458 . . . . 0.0 110.458 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.35 125.43 11.4 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.087 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.76 143.43 29.12 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 120.916 0.389 . . . . 0.0 110.837 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.6 mt -94.88 106.47 18.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.674 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.9 t80 -101.88 -12.02 18.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.261 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.24 89.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.834 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.54 173.86 46.16 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.443 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.5 m-20 -74.44 -113.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.759 0.314 . . . . 0.0 110.734 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.74 -28.4 67.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.66 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.96 -44.14 91.44 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.27 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.68 -44.14 94.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.341 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.48 -60.38 3.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.273 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.92 -43.53 60.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.174 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.47 -43.81 75.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.252 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.1 mt -64.54 -43.6 96.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.629 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -56.52 -37.66 70.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.2 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.66 1.19 17.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.272 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -115.0 91.28 26.16 Favored Pre-proline 0 CA--C 1.528 0.134 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.118 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.97 -27.17 27.38 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.768 2.312 . . . . 0.0 111.875 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.41 -41.26 98.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.526 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.15 5.12 52.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.407 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.96 -35.38 69.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.595 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.58 4.35 16.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.516 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.66 121.51 81.33 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.615 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -47.31 -38.13 25.82 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.487 2.125 . . . . 0.0 112.533 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.535 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.86 -43.95 90.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.812 0.339 . . . . 0.0 110.391 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.73 -43.63 93.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.293 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.83 -40.64 95.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.454 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 44.8 t-20 -89.73 -12.14 40.27 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.549 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.4 mtmt 61.73 31.3 18.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.965 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -88.17 43.78 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.435 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.43 136.09 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.453 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.59 132.8 56.59 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.452 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.1 88.49 7.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.752 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.0 -41.41 97.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.891 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.46 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.42 167.26 33.76 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.4 p -75.71 -25.97 57.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.852 0.358 . . . . 0.0 110.747 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -67.77 -33.91 75.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.533 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 296' ' ' THR . 97.1 m -73.72 20.41 0.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.674 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.556 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 55.0 t80 -57.26 -51.19 70.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.939 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 68.4 mmt-85 -108.38 150.12 27.79 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.417 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.1 tp -115.54 125.78 53.43 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.811 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.468 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.7 t0 -149.56 166.72 28.36 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.598 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -49.16 -37.97 24.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.631 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.83 -65.21 0.79 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.388 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -60.92 -32.76 72.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.7 -25.22 25.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.688 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.3 mtt -63.66 -40.98 98.2 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.871 0.367 . . . . 0.0 111.057 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.85 -43.94 24.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.03 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.572 HG21 HG23 ' A' ' 296' ' ' THR . 78.9 t -66.34 -42.85 91.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.328 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.439 HD11 ' NE2' ' A' ' 183' ' ' GLN . 49.6 tp -60.06 -47.13 87.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.505 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.99 -39.4 75.95 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.578 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.9 ttt180 -61.96 -38.24 87.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.208 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -87.14 4.31 42.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.68 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.4 tttt -113.07 -11.06 13.39 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.025 0.441 . . . . 0.0 110.283 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.3 86.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.559 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.66 -48.66 80.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.361 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 117.885 -1.055 . . . . 0.0 110.038 179.907 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.14 -2.36 58.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.442 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.488 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.06 1.24 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.533 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.93 145.26 99.32 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.774 2.316 . . . . 0.0 112.165 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.15 -179.1 7.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.6 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.0 137.0 52.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.323 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -124.57 146.73 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.443 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.4 p -119.97 135.99 54.7 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.704 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.28 -143.53 0.32 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.309 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.49 -37.15 86.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.487 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.476 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.1 ttt85 -149.31 -66.26 0.22 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.533 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.5 142.16 45.57 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 p -112.07 131.3 55.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 0.0 110.409 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -119.06 129.09 54.91 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.547 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -85.62 130.26 34.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.273 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.486 HD22 ' OE1' ' A' ' 42' ' ' GLN . 67.1 mt -95.97 78.86 3.21 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.353 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.51 -32.07 73.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.479 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 175.97 109.78 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.143 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.486 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -122.72 91.53 49.54 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.277 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.654 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.5 Cg_exo -56.97 148.92 65.0 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.818 2.345 . . . . 0.0 111.816 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.52 82.78 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.654 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.38 67.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.097 0.475 . . . . 0.0 110.279 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.19 130.73 35.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.582 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.564 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.7 t -122.78 146.91 27.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.202 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.2 t -136.26 143.48 44.28 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.62 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.6 p -99.18 -59.5 1.71 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.618 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.0 p -79.18 155.13 28.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.611 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.497 HG21 HG23 ' A' ' 70' ' ' THR . 74.0 t -74.23 -21.83 17.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.571 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.9 m -60.13 -52.25 66.13 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.553 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.8 mt -66.63 -42.33 86.93 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.249 0.547 . . . . 0.0 110.877 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.6 m -42.88 -54.06 4.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.265 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.47 -37.48 69.32 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.2 m -62.48 -44.68 95.81 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.82 0.343 . . . . 0.0 110.443 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.8 mt -66.2 -41.99 89.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.385 0.612 . . . . 0.0 110.703 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.2 tp -62.68 -40.34 96.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.284 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.17 -35.82 76.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.899 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 156' ' ' LEU . 30.6 pt -91.36 28.85 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.021 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 56.57 51.61 10.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.798 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.2 75.58 23.14 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.984 0.421 . . . . 0.0 110.054 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.53 151.41 85.67 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.723 2.282 . . . . 0.0 112.256 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.56 137.32 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.121 0.486 . . . . 0.0 110.335 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.9 pt -69.42 -43.45 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.178 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.1 131.17 53.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 110.522 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.0 p -155.77 168.98 25.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.481 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.24 -177.12 21.43 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.54 172.91 12.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 110.56 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.497 HG23 HG21 ' A' ' 51' ' ' VAL . 13.1 p -132.9 -112.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.29 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.26 179.76 0.93 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.328 -179.095 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.5 Cg_exo -60.93 57.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 123.032 2.488 . . . . 0.0 112.151 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.7 t-20 -64.43 -33.69 76.47 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.606 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 11.4 m120 93.6 -36.27 0.02 OUTLIER 'General case' 0 C--N 1.344 0.332 0 O-C-N 124.014 0.822 . . . . 0.0 109.993 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.406 ' HD3' HD21 ' A' ' 73' ' ' ASN . 78.1 mtp85 -62.64 -39.38 93.67 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.299 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.88 -25.29 18.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.73 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.38 -171.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.597 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.46 -153.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.752 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.1 p-10 -52.36 -7.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.706 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.36 114.86 23.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.531 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.85 69.98 1.35 Allowed Glycine 0 CA--C 1.522 0.469 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -143.23 147.39 34.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.968 0.414 . . . . 0.0 110.673 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.49 -98.3 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.205 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.36 -42.57 96.15 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.205 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.0 tt0 91.64 53.65 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.894 0.746 . . . . 0.0 110.791 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -103.9 -8.77 19.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.429 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -65.18 -33.79 76.85 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.175 0.512 . . . . 0.0 110.649 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.84 -24.24 1.37 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.568 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.9 t -69.5 -45.68 77.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.876 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.23 -48.57 80.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.117 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.73 -38.09 89.13 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.379 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.82 -32.42 52.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.281 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.607 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.5 mmt-85 -89.87 1.77 55.8 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.588 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.54 -49.51 0.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 124.036 0.835 . . . . 0.0 110.412 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.669 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.17 154.92 0.23 Allowed 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.443 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.669 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 120.66 92.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 125.133 1.521 . . . . 0.0 110.501 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.531 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.61 143.56 42.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.291 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.8 mt -132.58 27.15 4.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.494 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.55 138.39 34.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.541 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.63 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.6 mt -137.5 165.14 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.427 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.618 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.22 -28.71 1.82 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -152.59 70.87 7.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.121 0.486 . . . . 0.0 110.396 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.97 145.38 98.49 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.789 2.326 . . . . 0.0 112.048 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.8 t -134.47 136.37 43.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.036 0.446 . . . . 0.0 110.522 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.26 -38.17 81.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.673 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.45 -42.29 96.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.511 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.94 -41.73 98.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.481 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.51 -43.19 98.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.146 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.04 -35.07 77.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.345 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.5 -18.4 58.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.476 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.96 -6.33 58.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.486 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.418 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 75.9 mtp 47.76 55.77 17.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.66 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.14 149.4 64.4 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.807 2.338 . . . . 0.0 112.093 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.16 -74.01 0.63 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.503 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.434 HD11 HD13 ' A' ' 140' ' ' LEU . 37.8 tp -110.45 113.09 25.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.368 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -101.68 126.39 55.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.5 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.2 mt -109.7 133.53 53.02 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.248 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.56 140.02 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.587 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.8 p -83.62 168.68 16.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.641 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.08 -37.61 80.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.432 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.96 159.38 42.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.476 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.2 177.49 33.2 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.14 -33.77 86.93 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -124.87 151.93 44.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.822 0.344 . . . . 0.0 110.603 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.5 t -63.14 141.01 58.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.307 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.46 10.46 11.17 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.559 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.07 -39.03 88.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.072 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.04 -35.99 23.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.361 0.6 . . . . 0.0 110.696 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.8 mt -70.83 -35.45 72.47 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.428 0.632 . . . . 0.0 110.72 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.76 -63.28 0.81 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.158 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.6 p-10 -65.89 -42.72 89.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.4 mt-30 -62.01 -32.66 73.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.164 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.3 mt -74.01 -40.35 62.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.051 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.23 -49.12 78.2 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.208 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.1 m -52.59 -42.56 64.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.216 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.77 -42.98 93.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.08 154.81 5.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.632 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.29 106.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.709 2.273 . . . . 0.0 112.339 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.644 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.0 m -110.07 121.19 44.67 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.31 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.644 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.0 153.03 30.06 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.296 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -129.09 131.22 68.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.413 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -114.92 127.85 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.443 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.477 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.8 t30 -101.38 103.62 14.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.34 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.3 p90 -101.14 -11.37 19.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.769 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.2 p-10 -64.77 -33.63 76.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.66 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.8 p-10 -98.12 7.79 45.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.603 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.449 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.64 155.6 50.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.564 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.3 p -74.96 165.71 24.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.664 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.592 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.4 t90 -59.85 -48.88 79.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.286 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.51 -41.95 66.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.088 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.2 t -62.73 -41.01 98.96 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.406 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.409 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.6 tp -60.59 -44.28 96.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.376 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.36 -43.56 98.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.211 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.0 m -54.87 -44.93 74.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.837 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.39 -40.94 98.12 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.837 0.351 . . . . 0.0 110.331 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -61.89 -42.48 99.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.157 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.9 -40.89 95.64 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.41 -46.16 64.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.899 0.381 . . . . 0.0 110.816 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.74 -44.02 96.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.735 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -92.97 -8.69 42.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.553 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.8 26.62 72.2 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -101.8 51.07 0.84 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 110.667 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -69.91 -39.38 76.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.644 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.57 -47.26 86.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.248 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -59.88 -39.36 85.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.341 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.14 99.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.322 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.71 -28.52 70.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.974 0.416 . . . . 0.0 110.576 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.39 -54.25 7.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.058 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.506 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.4 ttp180 -65.55 -42.17 92.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.518 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.466 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.3 mt -62.35 -43.86 98.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.488 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.75 -57.73 9.93 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.021 0.439 . . . . 0.0 110.453 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.78 -33.86 68.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.35 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -81.46 -36.28 29.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.811 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.2 m-20 -55.6 -41.59 73.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.238 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.64 -42.42 99.59 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.688 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.29 -38.01 88.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.366 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 177' ' ' LEU . 81.6 mt -62.25 -42.23 99.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.68 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.8 62.53 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.044 0.45 . . . . 0.0 110.66 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.19 -41.92 89.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.559 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.86 95.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.56 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.42 -31.99 73.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.379 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.63 -22.21 18.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.729 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.454 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.6 tt0 -64.83 -41.16 95.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.651 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.8 pt -77.01 136.73 23.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.574 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.01 108.29 10.81 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.291 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.76 125.5 0.3 Allowed Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.512 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.6 Cg_exo -43.81 152.18 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.775 2.316 . . . . 0.0 112.499 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.79 141.82 55.61 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.61 2.206 . . . . 0.0 112.461 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.33 147.08 2.1 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.592 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.02 154.58 70.43 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.741 2.294 . . . . 0.0 112.292 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.35 163.13 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.4 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 1.9 t -143.97 170.76 15.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.817 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.12 137.99 21.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.237 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.533 HG22 HD12 ' A' ' 205' ' ' LEU . 39.4 pt -134.45 146.9 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.639 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 204' ' ' ASN . 3.0 p -133.08 131.76 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.145 0.498 . . . . 0.0 110.505 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -151.99 155.13 37.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.466 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.5 m -121.95 122.65 39.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.938 0.399 . . . . 0.0 110.392 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.25 -25.96 66.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.6 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.37 -48.69 21.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.066 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.7 -12.2 60.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.387 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.0 m80 49.74 41.69 22.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.491 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.3 t -136.45 144.97 44.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.407 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.403 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -110.88 114.38 27.67 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.295 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.73 133.24 55.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.064 0.459 . . . . 0.0 110.352 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.533 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.74 146.16 38.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.686 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.503 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 10.0 t90 -99.62 129.56 45.78 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.082 0.468 . . . . 0.0 110.089 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.01 153.76 39.78 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.144 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.407 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.4 Cg_endo -67.82 -18.11 47.22 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.741 2.294 . . . . 0.0 111.972 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.01 -18.83 0.33 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.507 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.503 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.61 165.05 25.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.521 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.15 -27.95 66.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.472 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.454 ' OE1' ' CD1' ' A' ' 297' ' ' PHE . 34.6 mt-30 -63.78 -41.28 97.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.642 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.55 -44.64 97.53 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.449 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.25 -38.9 92.69 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.004 0.43 . . . . 0.0 110.633 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.592 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.0 mmm -61.99 -41.21 97.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.159 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 74.8 mt -63.6 -47.22 82.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.949 0.404 . . . . 0.0 110.645 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.94 -32.09 52.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.049 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.94 -18.62 62.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.518 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.433 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.9 mt -88.01 -8.49 55.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.659 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.42 2.3 55.58 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -88.57 153.18 21.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.513 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.463 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.1 p -116.13 128.62 55.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.049 0.452 . . . . 0.0 110.421 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.74 146.14 23.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.831 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.476 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.65 151.65 45.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.526 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.68 131.4 43.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.347 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.896 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.57 93.3 27.15 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.121 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.678 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.6 Cg_exo -55.55 139.05 82.21 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.629 2.219 . . . . 0.0 111.635 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.05 -25.73 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.474 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.55 -50.11 27.46 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.554 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.8 mt -53.82 -37.31 63.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 0.0 110.252 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -66.73 36.06 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.769 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.554 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.1 88.46 0.01 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.829 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 86.7 p -81.02 -13.62 58.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.393 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -92.39 -41.49 10.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.548 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.92 -16.91 64.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.669 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.75 43.95 27.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.504 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.78 -148.67 8.03 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.63 142.98 48.92 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.996 0.426 . . . . 0.0 110.331 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.19 149.64 28.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.35 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -101.46 -151.69 0.42 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.305 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 56.19 -92.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.635 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.464 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.83 175.23 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.629 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.464 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.2 mt -122.4 141.79 41.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.676 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.98 169.55 9.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.285 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.7 mt -148.01 151.11 35.2 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.106 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.52 -39.05 97.23 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.97 4.21 4.7 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -77.57 -58.07 3.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.903 0.382 . . . . 0.0 110.577 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.552 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.9 m-20 -62.1 -36.71 82.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.301 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.403 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.0 mp -52.26 -67.75 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.748 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.31 -42.49 66.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.231 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.02 17.66 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.678 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.1 49.03 0.31 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.28 -109.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.609 0.242 . . . . 0.0 110.715 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.68 -45.06 95.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.47 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.4 7.96 84.02 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.85 -13.6 20.0 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.821 -0.223 . . . . 0.0 110.617 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.0 t 177.2 142.57 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.996 0.427 . . . . 0.0 110.5 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.05 125.34 11.54 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.998 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.432 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -98.66 143.31 29.18 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.8 178.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.6 mt -94.5 106.38 18.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.626 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.439 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.2 t80 -101.4 -12.5 18.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.254 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.66 90.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.749 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.32 173.63 46.03 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.46 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -73.91 -112.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.797 0.332 . . . . 0.0 110.72 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -68.02 -28.52 67.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.666 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -58.76 -44.12 90.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.386 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.64 -44.29 94.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.333 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.54 -60.31 3.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.267 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -50.95 -43.36 60.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.229 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.56 75.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.267 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.5 mt -64.56 -43.67 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.607 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -56.27 -37.34 69.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.241 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.54 0.79 18.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.28 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -115.22 91.24 27.05 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.242 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.26 -26.87 28.42 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.814 2.343 . . . . 0.0 111.84 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.5 -40.95 98.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.564 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.35 5.21 52.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.435 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.1 -35.07 69.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.717 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.6 4.65 15.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.538 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.99 120.99 80.03 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.559 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -47.24 -37.53 24.26 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.501 2.134 . . . . 0.0 112.451 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -59.1 -43.74 91.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.818 0.342 . . . . 0.0 110.323 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.91 -43.7 92.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.377 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.85 -40.54 95.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.483 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 44.3 t-20 -89.54 -12.72 39.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.601 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 62.03 31.37 17.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.809 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.37 43.72 1.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.417 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -103.95 136.02 38.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.489 -179.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -116.77 132.36 56.71 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.466 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.41 88.24 7.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.668 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.83 -40.85 97.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.821 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.439 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.6 167.24 34.14 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 76.3 p -75.68 -25.76 57.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.854 0.359 . . . . 0.0 110.746 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.0 tp10 -67.8 -34.62 77.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.427 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 94.6 m -73.53 25.44 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.714 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.499 ' H ' ' C ' ' A' ' 295' ' ' GLU . 60.8 t80 -58.18 -51.2 70.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.342 -0.39 . . . . 0.0 109.986 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.417 HH12 ' HG3' ' A' ' 212' ' ' GLN . 66.4 mmt-85 -112.02 155.24 24.11 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.433 ' CD2' HD11 ' A' ' 219' ' ' LEU . 45.5 tp -116.01 125.14 52.08 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.748 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.491 ' CB ' HD23 ' A' ' 83' ' ' LEU . 45.2 t0 -147.58 165.52 30.14 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.551 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -49.07 -38.1 23.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.512 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.71 -65.28 0.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.232 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -61.01 -32.79 72.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.51 -25.48 25.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.601 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.5 mtt -63.38 -41.09 98.77 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 120.924 0.392 . . . . 0.0 110.918 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.17 -43.91 22.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.978 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.569 HG21 HG23 ' A' ' 296' ' ' THR . 76.0 t -66.29 -42.88 91.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.417 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.454 HD11 ' NE2' ' A' ' 183' ' ' GLN . 52.1 tp -60.31 -47.23 86.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.546 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -69.74 -39.6 76.66 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.516 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.6 ttt180 -62.06 -38.24 88.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.217 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.6 mt -87.12 4.5 42.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.741 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -112.86 -11.23 13.48 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.038 0.447 . . . . 0.0 110.355 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.03 85.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.638 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.94 -48.82 80.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.366 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.134 179.804 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -89.63 -2.49 58.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.391 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.2 179.01 1.25 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.521 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.6 Cg_exo -60.66 145.13 99.39 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.718 2.279 . . . . 0.0 112.171 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.82 -179.4 8.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.655 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.91 137.4 52.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.39 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -125.05 147.11 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.437 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 79.1 p -120.24 136.26 54.71 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.788 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.18 -143.83 0.32 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.199 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -63.53 -37.23 86.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.441 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.57 -67.19 0.23 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.475 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.44 142.59 45.05 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.2 p -112.16 131.45 55.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 110.377 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -119.13 129.51 55.07 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.517 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 m -86.64 131.33 34.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.871 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.478 HD22 ' OE1' ' A' ' 42' ' ' GLN . 66.3 mt -96.96 79.37 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.496 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.75 -31.79 72.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.521 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.77 109.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.117 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.478 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.06 92.18 48.87 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.386 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 37.3 Cg_exo -57.08 148.72 67.28 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.724 2.283 . . . . 0.0 111.782 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.85 83.0 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 O-C-N 123.491 0.495 . . . . 0.0 110.927 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.49 67.11 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.293 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.09 130.75 35.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.604 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.559 ' HA ' HG23 ' A' ' 64' ' ' VAL . 56.1 t -122.62 146.47 27.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.067 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 t -135.88 143.47 45.05 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.679 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.6 p -99.06 -59.77 1.66 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.599 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.3 p -79.25 155.33 28.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.659 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.496 HG21 HG23 ' A' ' 70' ' ' THR . 70.8 t -74.06 -22.07 18.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.488 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.2 m -60.27 -52.05 66.92 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.484 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.6 mt -66.43 -42.18 88.09 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.312 0.577 . . . . 0.0 110.881 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.0 m -43.7 -53.78 5.56 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.19 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.22 -37.28 71.63 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.5 m -62.77 -44.61 95.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.826 0.346 . . . . 0.0 110.517 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.412 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.0 mt -66.22 -42.05 89.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.397 0.617 . . . . 0.0 110.652 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.57 -40.44 96.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.354 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.09 -35.77 75.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.066 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 156' ' ' LEU . 32.4 pt -91.36 28.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.256 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.53 51.68 10.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.875 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.4 75.83 22.13 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.924 0.393 . . . . 0.0 109.962 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.67 151.46 85.55 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.733 2.289 . . . . 0.0 112.382 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.48 136.87 48.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.185 0.517 . . . . 0.0 110.267 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.441 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -69.06 -43.58 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.299 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.03 131.18 53.42 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.025 0.44 . . . . 0.0 110.598 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.8 p -155.7 168.82 25.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.433 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.98 -177.07 21.57 Favored Glycine 0 N--CA 1.464 0.524 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.631 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.53 172.68 12.4 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 110.527 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.496 HG23 HG21 ' A' ' 51' ' ' VAL . 15.3 p -132.8 -112.52 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.96 0.41 . . . . 0.0 110.36 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.28 179.69 0.94 Allowed Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.368 -179.103 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.8 Cg_exo -60.91 58.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.978 2.452 . . . . 0.0 112.094 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.3 t-20 -64.57 -33.66 76.43 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.526 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.2 m120 93.8 -36.76 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.064 0.852 . . . . 0.0 109.923 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -62.57 -39.48 93.81 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.24 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.1 p -74.35 -25.66 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.715 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.16 -171.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.617 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.86 -154.2 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.76 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.0 p-10 -52.53 -7.54 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.669 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.16 115.17 23.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.545 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.99 69.54 1.36 Allowed Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -143.12 147.37 34.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.937 0.399 . . . . 0.0 110.752 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.15 -98.47 0.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.204 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.0 -42.73 97.08 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.16 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.553 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.0 tt0 91.62 53.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.97 0.794 . . . . 0.0 110.907 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -103.27 -8.7 20.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.369 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.8 p -65.06 -33.85 77.03 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.1 0.476 . . . . 0.0 110.589 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -48.88 -24.05 1.32 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.644 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.45 -46.0 77.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.921 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.4 -48.42 81.31 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.071 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.57 -38.24 89.33 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.272 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.83 -32.52 53.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.272 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.605 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.7 mmt-85 -89.98 1.57 56.13 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.566 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.8 -49.24 0.17 Allowed 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.999 0.812 . . . . 0.0 110.3 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.659 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.28 154.21 0.29 Allowed 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.259 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.659 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 121.01 92.39 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 125.287 1.617 . . . . 0.0 110.476 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.7 mtp180 -75.47 143.43 42.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.057 0.456 . . . . 0.0 110.354 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.2 mt -132.44 27.07 4.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.461 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.36 138.23 34.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.548 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.7 mt -137.43 165.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.358 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.618 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.5 -28.81 1.77 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.55 70.96 7.46 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.15 0.5 . . . . 0.0 110.373 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.89 145.27 98.71 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.714 2.276 . . . . 0.0 112.075 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.9 t -134.4 136.37 43.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.485 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.81 -38.22 83.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.669 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.37 -42.28 96.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.496 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.49 98.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.494 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.3 t -63.65 -43.4 98.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.029 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.07 77.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.32 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.66 -18.69 60.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.464 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.36 -6.42 58.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.566 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 77.9 mtp 47.74 55.82 17.11 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.56 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.12 149.18 64.26 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.768 2.312 . . . . 0.0 112.109 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.28 -74.05 0.63 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.406 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.422 HD11 HD13 ' A' ' 140' ' ' LEU . 38.5 tp -110.3 113.13 25.55 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.264 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.3 mt -101.93 126.19 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.481 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.7 mt -109.19 133.28 53.22 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.202 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.16 139.31 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.533 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.9 p -83.57 168.54 16.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.677 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.21 -37.42 80.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.437 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -139.85 158.89 43.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.477 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.16 177.67 33.08 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.89 87.36 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -125.15 152.03 45.0 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.954 0.407 . . . . 0.0 110.555 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.3 t -63.34 141.24 58.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.36 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.84 10.54 10.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.684 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.9 mp -61.27 -39.02 88.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.973 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.74 -36.09 23.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.467 0.651 . . . . 0.0 110.612 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.2 mt -70.93 -35.34 72.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.447 0.641 . . . . 0.0 110.756 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -42.81 -62.68 0.94 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.27 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.7 p-10 -65.98 -42.59 89.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.067 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.4 -32.81 73.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.14 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.7 mt -73.44 -40.91 63.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.136 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.43 -48.78 79.58 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.167 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.0 m -53.01 -42.7 65.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.241 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.7 -43.2 93.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.106 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.47 154.27 5.56 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.599 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -39.24 106.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.624 2.216 . . . . 0.0 112.377 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 94.3 m -110.22 121.4 45.18 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.983 0.421 . . . . 0.0 110.218 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.37 152.89 30.78 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.233 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -129.09 131.38 68.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.428 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -115.01 127.9 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.553 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.2 t30 -101.74 103.65 14.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.278 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.2 p90 -101.19 -11.22 19.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.797 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.7 -33.74 76.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.631 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.571 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.6 p-10 -98.09 7.96 45.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.661 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.94 155.6 50.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.503 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.401 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.0 165.7 24.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.689 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.59 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.91 -48.52 81.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.244 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.79 -42.02 67.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.1 t -62.6 -41.17 98.81 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.356 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.406 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.4 tp -60.58 -44.35 96.32 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.441 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.45 -43.42 98.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.164 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -54.99 -44.87 74.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.797 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.67 -40.63 97.66 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.837 0.351 . . . . 0.0 110.289 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -62.03 -42.53 99.27 Favored 'General case' 0 CA--C 1.51 -0.558 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.245 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.01 -41.1 95.4 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.3 -46.17 64.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.953 0.406 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.66 -44.06 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.826 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.7 p -93.01 -8.86 41.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.567 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.93 26.9 72.4 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -102.06 50.65 0.84 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.849 0.357 . . . . 0.0 110.694 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -69.57 -39.44 77.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.677 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.78 -47.23 86.54 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.292 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -59.78 -39.57 85.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.275 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.94 -40.91 99.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.259 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.68 -28.89 70.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.522 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.04 -54.24 8.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.197 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.506 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.5 ttp180 -65.49 -42.16 92.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.494 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.4 mt -62.43 -43.77 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.524 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.62 -57.61 10.44 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.971 0.415 . . . . 0.0 110.515 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.66 -33.34 68.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.366 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.409 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.2 t80 -81.58 -36.52 28.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.856 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 170' ' ' ILE . 58.0 m-20 -55.46 -41.95 73.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.411 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.72 -42.17 99.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.646 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.34 -37.89 88.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.222 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.409 HD11 ' CD2' ' A' ' 173' ' ' PHE . 81.5 mt -62.43 -42.31 99.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.715 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.93 62.0 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.078 0.466 . . . . 0.0 110.677 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.36 -41.72 89.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.519 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.05 95.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.55 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.26 -32.15 73.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.409 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.65 -22.38 18.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.681 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.451 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -64.56 -41.23 96.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.651 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 184' ' ' ILE . 32.6 pt -76.95 136.46 24.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.659 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -126.83 108.27 10.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.291 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -177.04 125.81 0.3 Allowed Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.492 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.1 Cg_exo -44.02 152.44 0.38 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.806 2.337 . . . . 0.0 112.468 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.85 141.83 55.31 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.68 2.253 . . . . 0.0 112.48 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.55 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.16 146.98 2.14 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.602 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.06 154.57 70.3 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.817 2.345 . . . . 0.0 112.272 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.38 163.22 29.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.472 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -144.03 170.75 15.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.829 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.61 137.71 21.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.225 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.537 HG22 HD12 ' A' ' 205' ' ' LEU . 39.0 pt -134.45 147.14 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.617 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.43 132.05 57.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.148 0.499 . . . . 0.0 110.482 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -151.95 154.87 36.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.398 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.0 m -122.31 122.94 40.24 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.64 -25.83 66.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.623 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.22 -48.99 20.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.035 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.99 -11.03 60.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.373 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 76.8 m80 48.59 41.74 17.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.467 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.6 t -136.31 144.97 44.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.391 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.19 114.36 27.54 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.278 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.6 m-20 -119.79 133.41 55.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 110.376 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.537 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.81 146.24 37.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.79 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.498 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.6 t90 -99.26 129.94 45.52 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.083 0.468 . . . . 0.0 109.997 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.55 153.72 39.42 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.126 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.4 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.9 Cg_endo -67.95 -17.97 46.47 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.811 2.341 . . . . 0.0 111.852 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.24 -19.16 0.44 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.397 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.498 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.1 p -75.44 164.72 26.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.502 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.95 -27.72 65.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.504 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.585 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.0 mt-30 -63.85 -41.22 97.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.582 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.69 -44.52 97.81 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.41 -38.86 92.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.995 0.426 . . . . 0.0 110.578 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.59 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.1 mmm -62.24 -41.18 98.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.063 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.1 mt -63.78 -46.65 84.25 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.646 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.7 -31.84 58.58 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.7 -18.77 62.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.537 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.443 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.4 mt -87.39 -9.4 54.86 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.664 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.51 1.71 53.36 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -88.34 153.84 20.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.884 0.373 . . . . 0.0 110.469 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.444 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.0 p -116.41 128.84 55.86 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.071 0.462 . . . . 0.0 110.471 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.65 146.33 23.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.864 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.479 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.82 151.41 45.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.516 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.56 131.41 43.32 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.43 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.892 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.61 93.53 28.35 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.095 -179.738 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.675 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.0 Cg_exo -55.85 139.07 83.62 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.556 2.171 . . . . 0.0 111.521 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.1 -26.05 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.503 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.18 -50.03 30.11 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.553 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.7 mt -53.99 -37.05 63.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -66.73 36.09 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.794 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.553 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.0 88.38 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.949 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 81.5 p -80.98 -14.08 58.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.398 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.85 -41.82 10.41 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.597 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.2 t -66.64 -16.96 64.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.621 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.76 44.01 26.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.507 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.75 -149.21 8.32 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.09 142.75 48.61 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.013 0.435 . . . . 0.0 110.339 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -151.95 149.61 29.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.368 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -101.32 -151.67 0.42 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.319 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.03 -92.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.689 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.468 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.85 175.38 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.596 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.468 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.2 mt -122.69 141.85 41.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.815 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.87 169.61 9.1 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.31 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.4 mt -147.82 150.9 35.04 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.21 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.65 -38.98 97.06 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.1 3.97 4.71 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -77.49 -57.98 3.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.897 0.38 . . . . 0.0 110.651 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.55 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.4 m-20 -62.09 -36.73 82.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.196 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 9.9 mp -52.38 -67.59 0.24 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.725 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.66 -42.24 67.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.154 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.92 17.42 0.17 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.649 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.37 48.76 0.33 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.31 -109.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.621 0.248 . . . . 0.0 110.753 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.479 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.7 m120 -60.94 -44.58 97.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.521 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.15 7.89 84.56 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.92 -13.54 19.94 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.748 -0.266 . . . . 0.0 110.732 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.5 t 177.08 142.52 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.131 0.491 . . . . 0.0 110.504 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.95 125.47 11.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.106 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 191' ' ' VAL . 14.0 m-30 -98.42 143.72 28.56 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 120.937 0.399 . . . . 0.0 110.711 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.2 mt -95.22 106.28 18.29 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.727 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.442 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.0 t80 -101.79 -11.81 18.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.221 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.96 -40.75 87.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.831 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.9 173.2 45.81 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.472 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -74.06 -113.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 110.709 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.28 -28.76 68.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.725 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.01 -43.89 91.61 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.27 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -63.62 -44.33 94.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.31 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.65 -60.02 3.75 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.266 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.09 -43.38 61.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.102 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.43 -43.57 75.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.161 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.56 -43.66 96.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.615 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -56.22 -37.59 69.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.156 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.5 0.93 18.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.259 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -115.12 91.51 27.63 Favored Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.167 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.4 -27.09 30.13 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.846 2.364 . . . . 0.0 111.717 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.41 -41.2 98.72 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.558 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.594 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.9 mp -95.1 4.9 53.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.432 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.08 70.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.703 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -79.97 4.53 16.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.615 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.64 121.29 80.49 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.536 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -47.49 -37.65 26.38 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.408 2.072 . . . . 0.0 112.424 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.527 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -59.03 -43.63 91.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.792 0.329 . . . . 0.0 110.289 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.05 -43.86 92.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.279 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.82 -40.65 95.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.519 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 47.9 t-20 -89.54 -12.92 38.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.541 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.35 32.7 16.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.49 43.87 1.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.341 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.48 135.67 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.539 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.72 132.62 56.64 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.469 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.32 89.01 7.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.7 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.411 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.1 mt -63.9 -41.11 97.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.783 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.95 165.57 34.09 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 76.5 p -75.44 -25.74 57.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.865 0.364 . . . . 0.0 110.665 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -68.35 -34.49 76.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.345 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 296' ' ' THR . 95.3 m -72.98 25.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.722 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.585 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 39.6 t80 -58.53 -50.36 74.05 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.408 HH12 ' HG3' ' A' ' 212' ' ' GLN . 79.1 mmt-85 -111.05 153.48 25.56 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.443 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.9 tp -115.53 125.03 52.51 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.691 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.482 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.4 t0 -147.88 165.71 29.81 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.614 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -49.3 -38.16 26.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.509 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -71.23 -65.47 0.74 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.421 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -60.96 -32.73 72.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.962 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.4 -25.61 25.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.634 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.6 mtt -63.5 -41.02 98.55 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 120.905 0.383 . . . . 0.0 111.003 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -78.7 -44.03 24.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.067 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.58 HG21 HG23 ' A' ' 296' ' ' THR . 76.6 t -66.18 -42.99 92.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.352 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.451 HD11 ' NE2' ' A' ' 183' ' ' GLN . 50.9 tp -60.14 -47.27 86.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.481 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -69.7 -39.66 76.79 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.634 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.4 ttt180 -61.63 -38.67 88.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.19 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -86.84 4.42 41.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.759 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.2 tttt -112.59 -11.19 13.61 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.018 0.437 . . . . 0.0 110.28 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.83 -37.12 85.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.632 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.19 -48.63 80.65 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.326 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.975 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.618 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.75 -2.4 58.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.38 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.484 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.12 179.06 1.24 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.047 0.451 . . . . 0.0 110.514 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.6 Cg_exo -60.98 145.1 99.57 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.773 2.316 . . . . 0.0 112.169 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.618 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.77 -179.31 8.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.553 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.7 136.88 52.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.355 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.0 tp -124.64 147.44 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.372 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.4 p -120.39 136.1 54.83 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.767 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.5 -143.47 0.33 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.25 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.41 -37.3 86.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.477 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.1 -66.85 0.22 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.467 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.64 142.48 45.61 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.2 p -112.2 131.71 55.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.951 0.405 . . . . 0.0 110.401 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.15 128.89 54.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.53 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.2 m -85.49 130.36 34.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.237 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.472 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.8 mt -95.71 78.75 3.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.306 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.6 -32.19 73.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.493 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 176.03 109.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.099 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.472 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -122.55 91.59 49.35 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.28 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.2 Cg_exo -56.95 148.54 67.19 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.794 2.329 . . . . 0.0 111.869 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.15 82.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.595 0.56 . . . . 0.0 111.022 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.43 66.82 0.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.227 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.85 130.83 35.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.697 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.572 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.7 t -122.57 147.43 26.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.079 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 t -136.62 143.74 43.69 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.65 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.7 p -99.22 -59.48 1.72 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.572 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.0 p -79.01 155.46 28.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.688 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.538 HG21 HG23 ' A' ' 70' ' ' THR . 70.3 t -74.43 -21.9 17.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.557 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.2 m -60.22 -51.87 67.72 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.503 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.4 mt -66.56 -42.4 87.15 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.319 0.58 . . . . 0.0 110.905 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.5 m -43.37 -53.83 5.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.065 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.27 -37.84 71.35 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.7 m -62.5 -44.45 96.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.846 0.355 . . . . 0.0 110.34 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.408 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.5 mt -65.99 -42.14 90.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.464 0.65 . . . . 0.0 110.714 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tp -62.57 -40.13 95.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.453 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.517 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.48 -36.11 77.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.134 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 156' ' ' LEU . 33.3 pt -90.9 28.29 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.208 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.81 51.82 10.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.939 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.83 75.75 24.45 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.974 0.416 . . . . 0.0 109.889 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.18 150.63 87.93 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.781 2.32 . . . . 0.0 112.213 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.36 136.88 48.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.198 0.523 . . . . 0.0 110.282 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.25 -43.55 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.307 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.11 131.19 53.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.006 0.431 . . . . 0.0 110.553 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.6 p -155.46 168.61 26.54 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.399 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.69 -177.42 21.75 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.637 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.77 172.86 12.2 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 120.881 0.372 . . . . 0.0 110.518 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.538 HG23 HG21 ' A' ' 51' ' ' VAL . 14.7 p -132.41 -113.16 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.374 . . . . 0.0 110.312 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.87 179.85 0.92 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.353 -179.02 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.8 Cg_exo -61.23 57.74 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.988 2.458 . . . . 0.0 112.137 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.545 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 60.4 t-20 -64.37 -33.38 75.71 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.468 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 11.4 m120 93.76 -35.68 0.02 OUTLIER 'General case' 0 C--N 1.345 0.403 0 O-C-N 124.182 0.926 . . . . 0.0 109.804 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.6 mtp85 -63.05 -39.86 95.98 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.989 0.423 . . . . 0.0 110.267 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -74.73 -25.33 18.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.738 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.03 -171.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.599 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -73.3 -154.16 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.787 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.2 p-10 -52.11 -7.71 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.684 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -86.34 115.1 23.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.594 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.18 70.06 1.34 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -143.57 147.46 34.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.931 0.396 . . . . 0.0 110.784 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.57 -98.48 0.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.137 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.87 -42.74 97.44 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.129 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.2 tt0 91.68 53.13 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.066 0.854 . . . . 0.0 110.892 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -102.95 -9.31 19.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.419 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -64.54 -34.26 77.82 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.173 0.511 . . . . 0.0 110.664 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -48.91 -24.79 1.61 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.597 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.2 -45.66 79.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.792 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.25 -48.47 81.28 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.038 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.48 -38.35 89.52 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.364 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.67 -33.0 53.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.176 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.592 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.1 mmt-85 -89.72 1.47 56.03 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.598 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.92 -49.13 0.16 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 124.159 0.912 . . . . 0.0 110.288 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.64 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.1 mt -46.52 153.79 0.34 Allowed 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 117.403 -1.284 . . . . 0.0 109.264 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.64 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 121.62 92.62 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 O-C-N 125.625 1.828 . . . . 0.0 110.431 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.533 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.7 143.29 42.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.122 0.487 . . . . 0.0 110.276 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.3 mt -132.42 27.06 4.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.453 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.37 138.07 34.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.036 0.446 . . . . 0.0 110.512 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.9 mt -137.17 164.98 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.401 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.614 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.13 -28.63 1.83 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -153.01 70.93 7.1 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.167 0.508 . . . . 0.0 110.232 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.12 145.48 98.37 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.715 2.277 . . . . 0.0 112.089 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.5 t -134.2 136.61 43.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.563 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.35 82.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.649 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.31 -42.18 96.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.512 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.57 98.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.478 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.66 -43.31 98.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.961 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.2 77.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.26 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.48 -18.7 60.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.438 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.39 -6.44 58.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.523 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 72.4 mtp 47.94 55.85 17.23 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.617 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.16 148.99 63.72 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.798 2.332 . . . . 0.0 112.098 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.15 -73.04 0.66 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.501 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 140' ' ' LEU . 37.9 tp -111.32 113.64 26.26 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.313 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.4 mt -102.6 126.37 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.537 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.3 mt -109.77 134.06 52.44 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.143 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.77 139.87 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.496 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.4 p -83.4 168.45 16.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.707 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.16 -37.4 80.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.41 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -139.99 159.21 42.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.433 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.27 177.28 33.37 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.24 -33.87 87.36 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.57 151.74 44.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.904 0.383 . . . . 0.0 110.543 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -63.39 140.85 58.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.32 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.54 10.66 11.16 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.657 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.18 -39.04 88.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.092 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.633 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.86 23.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.586 0.708 . . . . 0.0 110.611 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.0 mt -70.76 -35.65 72.72 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.531 0.681 . . . . 0.0 110.764 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.88 -62.96 0.88 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.273 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.633 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.89 -42.64 90.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.046 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -62.17 -32.77 73.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.177 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.5 mt -73.48 -40.9 63.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.24 -48.85 79.11 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.16 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.3 m -52.9 -42.58 65.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.199 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.74 -43.05 93.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.107 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.75 153.89 5.15 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.62 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -39.12 106.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.664 2.243 . . . . 0.0 112.406 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.64 ' C ' HD12 ' A' ' 140' ' ' LEU . 96.8 m -110.33 121.52 45.47 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.244 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.64 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.02 152.96 30.19 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.26 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.9 131.0 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.309 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -114.79 127.78 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.432 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.3 103.75 14.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.278 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 147' ' ' LYS . 45.5 p90 -101.45 -11.2 19.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.783 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.69 -33.61 76.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.666 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -98.21 7.79 45.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.525 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.76 155.46 50.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.527 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.7 p -74.89 165.71 24.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.709 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -60.05 -48.65 80.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.197 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.79 -42.02 67.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.923 0.392 . . . . 0.0 110.027 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.8 t -62.63 -41.11 98.83 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.358 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.409 ' CD1' HG21 ' A' ' 142' ' ' ILE . 47.4 tp -60.7 -44.17 96.89 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.353 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.4 tp -61.5 -43.22 99.26 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.101 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -55.31 -44.88 76.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.52 -40.65 97.44 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.894 0.378 . . . . 0.0 110.327 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -61.95 -42.46 99.14 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.31 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.88 -40.62 95.54 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.58 -45.86 64.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.926 0.393 . . . . 0.0 110.855 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.67 -44.04 96.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.85 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.3 p -93.19 -8.61 41.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.588 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.78 26.34 72.08 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -101.47 50.75 0.85 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.768 0.318 . . . . 0.0 110.67 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.58 -39.36 77.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.659 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.5 -47.17 86.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.234 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -60.19 -39.45 86.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.308 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.1 99.37 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.307 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.94 -28.69 70.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.994 0.426 . . . . 0.0 110.602 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.19 -54.24 8.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.15 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.517 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.4 ttp180 -65.55 -42.25 92.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.477 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.454 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.3 mt -62.45 -43.94 98.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.492 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.48 -58.96 5.71 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.14 0.495 . . . . 0.0 110.48 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -56.51 -34.16 66.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.448 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -80.79 -36.21 32.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.886 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.7 m-20 -55.1 -42.26 72.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.095 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.42 -41.82 98.98 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.686 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.05 -38.19 90.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.285 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.7 mt -62.38 -42.11 99.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.771 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.47 63.87 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.084 0.469 . . . . 0.0 110.677 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.35 -41.79 89.02 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.601 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.06 -39.94 95.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.566 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.12 -32.43 73.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.361 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.24 -21.97 18.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.668 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.491 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -64.67 -41.35 96.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.64 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 pt -76.59 135.92 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.677 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.93 107.79 10.39 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.273 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.67 125.97 0.31 Allowed Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.541 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 73.9 Cg_exo -43.72 152.24 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.781 2.32 . . . . 0.0 112.601 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.87 141.98 55.75 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.573 2.182 . . . . 0.0 112.484 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.547 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.22 147.32 2.19 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.628 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.34 154.85 68.79 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.735 2.29 . . . . 0.0 112.284 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.56 163.27 28.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.419 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.84 170.8 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.959 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.92 137.92 21.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.93 0.395 . . . . 0.0 110.195 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.542 HG22 HD12 ' A' ' 205' ' ' LEU . 40.1 pt -134.47 147.37 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.692 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -133.2 131.95 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.098 0.475 . . . . 0.0 110.501 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -151.99 155.08 37.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.442 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.615 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.6 m -122.33 122.84 40.0 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.96 0.41 . . . . 0.0 110.366 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.2 -25.78 65.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.613 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.615 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.49 -48.46 22.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.069 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.07 -11.21 60.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.386 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.6 m80 48.25 41.55 16.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.485 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.3 t -135.89 145.22 46.08 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.42 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.406 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -110.94 114.02 27.03 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.233 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.63 133.13 55.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 110.351 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.542 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.77 146.24 37.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.772 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.468 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 10.3 t90 -99.36 129.77 45.59 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.096 0.475 . . . . 0.0 109.973 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.59 153.81 39.37 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.306 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.414 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.8 Cg_endo -67.76 -18.39 47.56 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.716 2.277 . . . . 0.0 111.954 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.1 -18.44 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.4 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.468 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.3 p -76.42 164.69 25.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.508 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.78 -27.64 65.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.514 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.454 ' OE1' ' CD1' ' A' ' 297' ' ' PHE . 34.9 mt-30 -63.75 -41.1 98.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.77 -44.48 97.93 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.63 -38.63 91.68 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.961 0.41 . . . . 0.0 110.575 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.3 mmm -62.16 -41.35 98.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.082 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.71 -46.91 83.28 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.534 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.5 -31.91 56.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.073 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.79 -18.68 62.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.449 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.414 HD11 ' CD2' ' A' ' 299' ' ' LEU . 92.1 mt -87.61 -9.31 54.64 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.61 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.29 1.9 54.04 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -88.34 153.77 20.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 110.516 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.458 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.3 p -116.56 129.02 55.94 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.119 0.485 . . . . 0.0 110.331 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -93.02 146.21 23.79 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.927 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.477 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.41 151.48 46.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.49 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.39 131.41 43.63 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.397 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.891 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.54 93.3 27.01 Favored Pre-proline 0 C--O 1.234 0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.077 -179.548 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.677 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.6 Cg_exo -55.75 138.96 82.94 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.569 2.179 . . . . 0.0 111.527 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.84 -25.59 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.46 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.26 -49.96 29.96 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.552 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.0 mt -54.0 -36.8 63.34 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.85 36.42 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.814 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.75 86.94 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.905 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.1 p -79.4 -15.39 57.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.405 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -92.19 -41.29 10.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.627 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -66.03 -17.94 65.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.605 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.17 43.37 26.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.468 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.49 -147.76 7.46 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.97 142.66 50.08 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.026 0.441 . . . . 0.0 110.294 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.43 149.82 28.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.353 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -101.3 -151.55 0.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.347 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.4 t0 56.16 -91.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.652 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.471 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.85 175.35 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.559 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.471 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 93.4 mt -122.29 141.76 41.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.833 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.81 169.02 9.53 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.221 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.5 mt -147.68 151.07 35.53 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.266 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.69 -39.0 97.06 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.06 4.0 4.72 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.27 -58.06 3.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.996 0.426 . . . . 0.0 110.578 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.541 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.8 m-20 -62.22 -36.93 83.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.212 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.406 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.1 mp -52.21 -67.61 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.778 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.71 -42.13 67.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.132 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.0 17.71 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.607 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.25 48.46 0.31 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.47 -109.79 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.605 0.24 . . . . 0.0 110.7 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.9 -44.59 96.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.42 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.21 7.95 84.38 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -98.91 -13.33 20.05 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.713 -0.286 . . . . 0.0 110.693 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.6 t 177.03 142.71 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.089 0.471 . . . . 0.0 110.498 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.06 125.49 11.64 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.176 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.6 m-30 -98.65 143.26 29.23 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 120.923 0.392 . . . . 0.0 110.809 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.9 mt -94.42 106.32 18.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.678 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.451 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.9 t80 -101.58 -11.55 19.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.108 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.43 87.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.874 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.74 174.12 46.32 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.475 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.4 m-20 -74.35 -113.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.741 0.305 . . . . 0.0 110.772 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.78 -28.69 67.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.708 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.03 -43.93 91.68 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.271 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.72 -44.26 94.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.377 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.52 -60.14 3.59 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.247 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.11 -43.26 61.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.17 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.53 -43.68 75.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.2 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.2 mt -64.47 -43.65 96.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.664 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -56.31 -37.39 69.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.162 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.77 0.95 18.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.197 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -115.05 91.31 26.5 Favored Pre-proline 0 CA--C 1.529 0.147 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.148 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.29 -27.2 29.76 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.796 2.33 . . . . 0.0 111.832 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.36 -41.02 98.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.569 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.45 5.22 52.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.349 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.97 -35.21 69.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.695 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.58 4.56 15.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.527 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.58 121.33 80.51 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.566 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -47.6 -37.69 27.25 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.397 2.065 . . . . 0.0 112.558 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.53 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.94 -43.57 91.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.856 0.36 . . . . 0.0 110.305 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.88 -43.89 92.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.285 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.91 -40.59 95.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.444 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.7 t-20 -89.32 -12.93 39.13 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.529 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.5 mtmt 62.32 31.94 17.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.893 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -89.01 43.87 1.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.046 0.45 . . . . 0.0 110.313 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.51 135.87 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.444 -179.718 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -116.61 132.55 56.65 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.485 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.1 87.84 7.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.769 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.86 -41.23 97.83 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.866 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.451 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.46 167.65 34.58 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 71.2 p -75.53 -25.69 57.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.845 0.355 . . . . 0.0 110.763 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.4 tp10 -67.84 -34.86 77.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.452 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 95.7 m -73.27 24.59 0.06 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.65 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.502 ' H ' ' C ' ' A' ' 295' ' ' GLU . 65.5 t80 -58.23 -51.18 70.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.421 HH12 ' HG3' ' A' ' 212' ' ' GLN . 58.9 mmt-85 -112.17 155.1 24.5 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.414 ' CD2' HD11 ' A' ' 219' ' ' LEU . 46.1 tp -116.3 125.64 52.43 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.49 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.0 t0 -147.29 165.3 30.52 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.573 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -49.41 -38.2 28.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.548 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -72.23 -64.8 0.87 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.509 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.3 -32.11 70.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.984 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.66 -25.3 26.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.571 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.6 mtt -63.08 -41.18 99.35 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 120.965 0.412 . . . . 0.0 110.953 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -78.33 -44.79 24.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.095 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.554 HG21 HG23 ' A' ' 296' ' ' THR . 73.6 t -66.0 -43.06 92.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.435 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.491 HD11 ' NE2' ' A' ' 183' ' ' GLN . 52.7 tp -60.26 -47.37 86.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.548 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.94 -39.39 76.11 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.635 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.1 ttt180 -61.96 -38.07 87.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.233 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.8 mt -87.38 4.61 42.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.794 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -112.87 -11.7 13.4 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.045 0.45 . . . . 0.0 110.284 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.04 -37.31 86.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.539 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.95 -48.69 80.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.379 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.022 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.56 -2.53 57.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.43 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.488 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.61 179.03 1.25 Allowed Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.457 -179.658 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.7 Cg_exo -60.81 144.7 99.6 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.796 2.331 . . . . 0.0 112.183 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.98 -179.65 8.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.596 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.61 136.27 53.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.317 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -123.91 146.65 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.333 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.3 p -119.91 136.0 54.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.77 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.1 p30 -99.42 -143.62 0.33 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.225 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -63.4 -37.19 86.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.593 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.9 ttt85 -149.3 -66.62 0.22 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.501 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.29 142.1 45.16 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.8 p -112.15 131.03 55.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.934 0.397 . . . . 0.0 110.437 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -118.92 129.08 54.99 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.542 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.6 m -85.67 130.64 34.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.214 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.1 mt -96.0 78.77 3.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.343 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.81 -32.0 73.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.473 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.12 108.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.164 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.489 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.5 pt20 -121.65 91.4 48.52 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.304 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.652 ' O ' ' N ' ' A' ' 45' ' ' ARG . 37.1 Cg_exo -57.0 148.59 67.44 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.738 2.292 . . . . 0.0 111.824 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.69 82.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.556 0.535 . . . . 0.0 111.018 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.14 66.85 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.046 0.45 . . . . 0.0 110.251 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.44 131.0 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.614 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.544 ' HA ' HG23 ' A' ' 64' ' ' VAL . 56.7 t -122.89 145.54 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.146 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -135.52 143.32 45.7 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.623 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.0 p -99.26 -59.19 1.77 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.552 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.9 p -79.52 154.97 28.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.647 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 70' ' ' THR . 70.8 t -74.58 -21.79 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.57 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.5 m -60.12 -52.18 66.45 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.434 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.6 -42.4 86.94 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.245 0.545 . . . . 0.0 110.873 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -42.82 -53.64 4.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.153 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.45 -37.75 69.56 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.9 m -62.56 -44.62 95.88 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.884 0.373 . . . . 0.0 110.459 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.418 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.8 mt -66.19 -41.94 89.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.38 0.61 . . . . 0.0 110.739 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.65 -40.15 96.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.324 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.466 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.03 -35.91 76.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.94 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 156' ' ' LEU . 31.4 pt -91.31 28.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.118 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.54 51.64 10.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.819 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.02 75.93 23.12 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.95 0.405 . . . . 0.0 110.003 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.4 151.77 84.06 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.746 2.298 . . . . 0.0 112.265 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.544 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.85 137.42 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.149 0.499 . . . . 0.0 110.316 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.447 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.5 pt -69.26 -43.61 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.219 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.78 130.96 53.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.926 0.393 . . . . 0.0 110.547 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.5 p -155.75 168.99 25.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.44 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.75 -177.44 21.71 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -132.67 171.86 13.3 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 120.943 0.402 . . . . 0.0 110.531 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.493 HG23 HG21 ' A' ' 51' ' ' VAL . 12.4 p -133.45 -111.02 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.426 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.91 179.61 0.95 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.303 -179.171 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.6 Cg_exo -60.88 58.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.953 2.436 . . . . 0.0 112.129 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.1 t-20 -64.24 -35.21 80.09 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.483 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.7 m120 95.26 -37.65 0.01 OUTLIER 'General case' 0 C--N 1.345 0.401 0 O-C-N 124.113 0.883 . . . . 0.0 110.008 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -62.61 -39.87 95.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.2 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.9 p -73.81 -26.41 21.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.689 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -50.06 -172.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.547 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.05 -152.79 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.711 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.7 p-10 -54.37 -6.66 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.685 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.493 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -86.92 113.82 23.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.559 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.15 72.73 1.28 Allowed Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.84 148.05 34.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 0.0 110.809 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.25 -99.47 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.109 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.554 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.86 -43.11 97.09 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.252 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.0 tt0 91.74 52.8 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.916 0.76 . . . . 0.0 110.861 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -103.32 -9.21 19.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.457 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.3 p -64.79 -33.86 76.98 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.049 0.452 . . . . 0.0 110.679 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.66 -23.67 1.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.516 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.3 t -69.7 -45.88 76.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.889 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.23 -48.6 80.74 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.165 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.67 -38.12 89.11 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.337 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.63 -32.51 51.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.218 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.605 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.3 mmt-85 -89.76 1.62 55.88 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.575 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.84 -49.08 0.16 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 124.045 0.841 . . . . 0.0 110.331 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.662 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.7 mt -46.49 154.3 0.3 Allowed 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 117.89 -1.053 . . . . 0.0 109.349 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.662 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 121.17 92.36 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 125.313 1.633 . . . . 0.0 110.502 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.39 143.26 42.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.251 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.9 mt -131.77 26.83 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.758 0.313 . . . . 0.0 110.481 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.42 138.08 34.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.969 0.414 . . . . 0.0 110.506 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.63 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.0 mt -137.17 165.19 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.432 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.615 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.04 -28.51 1.85 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -153.01 70.65 7.07 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.178 0.513 . . . . 0.0 110.362 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.12 145.52 98.28 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.772 2.315 . . . . 0.0 112.053 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.5 t -134.1 137.0 44.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.59 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.2 -38.17 81.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.666 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.41 -42.23 96.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.529 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.7 98.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.503 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 64.2 t -63.72 -43.33 97.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.066 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.65 -35.32 77.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.332 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.8 -18.36 59.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.484 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.52 -6.44 58.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.508 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.413 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.9 mtp 48.15 55.78 17.26 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.588 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.05 148.98 64.39 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.844 2.363 . . . . 0.0 112.133 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.28 -73.1 0.66 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.424 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 140' ' ' LEU . 38.7 tp -111.33 112.42 24.18 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.305 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.4 mt -100.55 126.07 54.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.476 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.4 mt -109.36 133.16 53.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.203 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.55 139.55 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.526 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.9 p -83.43 168.25 16.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.673 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.23 -37.48 80.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.494 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -139.03 158.96 43.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.502 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.44 176.8 33.71 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.83 87.16 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.93 151.55 45.28 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.876 0.369 . . . . 0.0 110.604 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.2 t -62.93 141.17 58.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.291 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.05 10.51 10.77 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.664 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.07 -39.07 88.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.031 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.83 -35.7 24.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.452 0.644 . . . . 0.0 110.654 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.3 mt -71.11 -35.31 71.73 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.437 0.637 . . . . 0.0 110.772 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -42.87 -62.93 0.89 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.185 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.76 -42.82 90.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -62.12 -32.65 73.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.204 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.8 mt -74.03 -40.46 62.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.054 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.16 -48.81 79.13 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.209 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.3 m -52.88 -42.44 65.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.194 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.15 -43.05 92.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.103 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.35 153.37 5.3 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.632 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -39.18 107.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.643 2.229 . . . . 0.0 112.326 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.3 m -109.09 121.38 45.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.285 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.36 152.89 30.76 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.26 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.95 131.45 68.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.365 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.07 127.72 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.493 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.4 t30 -101.86 103.67 14.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.324 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 49.6 p90 -101.23 -11.27 19.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.751 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.9 p-10 -64.78 -33.44 76.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.652 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.577 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.1 p-10 -98.31 7.41 46.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.584 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.14 155.35 50.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.572 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.408 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.2 p -74.65 165.7 24.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.664 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.588 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -59.99 -48.86 79.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.281 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -53.84 -41.99 68.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.104 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.2 t -62.49 -40.82 97.92 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.451 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 156' ' ' LEU . 48.7 tp -60.61 -43.75 97.1 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.297 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.507 HD22 HH21 ' A' ' 169' ' ' ARG . 44.6 tp -61.4 -43.2 99.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.826 0.346 . . . . 0.0 110.213 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.7 m -55.63 -45.37 77.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.833 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.35 -40.76 97.43 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-O 120.847 0.356 . . . . 0.0 110.377 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -61.88 -42.38 98.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.184 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.63 -40.76 96.1 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.77 -46.15 63.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.941 0.401 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.52 -43.98 96.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.766 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.2 p -93.21 -8.49 42.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.585 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.69 25.32 71.63 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -101.8 52.09 0.83 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.779 0.323 . . . . 0.0 110.623 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.84 -39.07 76.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.629 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.3 -47.17 86.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.262 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -61.33 -38.97 88.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.413 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.4 97.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.324 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.41 -27.69 69.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.491 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.77 -53.75 8.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.207 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.507 HH21 HD22 ' A' ' 153' ' ' LEU . 61.8 ttp180 -63.78 -43.51 96.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.458 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.1 mt -63.08 -43.88 99.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.654 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.35 -61.62 2.41 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.118 0.485 . . . . 0.0 110.377 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.66 -35.08 63.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.457 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -79.6 -34.77 40.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.004 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.6 m-20 -56.49 -40.12 74.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.112 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.95 -42.41 99.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.686 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.79 -37.72 87.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.309 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 177' ' ' LEU . 82.0 mt -62.44 -42.45 99.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.737 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.09 -53.17 59.18 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.059 0.457 . . . . 0.0 110.679 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.12 -41.77 90.08 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.562 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.93 95.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.647 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.17 -32.26 73.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.419 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.3 -21.97 18.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.719 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.472 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.6 tt0 -64.94 -41.4 95.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.68 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 pt -77.48 136.14 24.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.666 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.26 108.69 11.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.351 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.5 126.14 0.32 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.559 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.457 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.4 Cg_exo -43.68 152.02 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.742 2.295 . . . . 0.0 112.598 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.03 141.66 53.81 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.605 2.203 . . . . 0.0 112.465 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.12 147.34 2.23 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.62 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.28 154.62 69.37 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.74 2.293 . . . . 0.0 112.26 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.52 163.2 28.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.446 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.82 170.1 16.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.853 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.51 137.75 21.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.238 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.546 HG22 HD12 ' A' ' 205' ' ' LEU . 39.7 pt -134.29 146.71 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.288 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.654 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.76 131.77 59.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.099 0.476 . . . . 0.0 110.53 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -152.05 155.11 37.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.369 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.624 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.5 m -122.62 122.92 39.98 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.924 0.393 . . . . 0.0 110.401 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.11 -25.71 65.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.601 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.624 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.42 -48.97 20.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.091 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.62 -13.25 61.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.442 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.3 m80 50.72 41.36 26.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.503 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 43.3 t -136.32 144.68 44.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.344 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.14 114.18 27.47 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.315 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.1 m-20 -119.74 133.35 55.65 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.972 0.415 . . . . 0.0 110.372 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.546 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.07 146.32 38.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.735 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.478 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.2 t90 -99.5 129.8 45.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.108 0.48 . . . . 0.0 110.059 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.48 154.14 39.37 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.086 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.7 Cg_endo -67.8 -17.93 47.26 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.742 2.295 . . . . 0.0 111.933 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.56 -18.43 0.43 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.457 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.478 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.83 165.26 25.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.523 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.26 -28.17 66.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.491 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.526 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.51 -41.63 98.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.705 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.84 -44.95 96.59 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.44 -39.01 93.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.949 0.404 . . . . 0.0 110.612 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.588 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.4 mmm -62.08 -41.31 98.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.226 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.71 -47.14 82.33 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.64 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.33 -32.05 55.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.095 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.71 -18.3 62.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.496 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.43 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.1 mt -88.53 -8.6 54.53 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.691 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.74 2.43 55.25 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -88.55 152.63 21.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.0 110.499 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.448 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.2 p -115.5 128.32 55.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.077 0.465 . . . . 0.0 110.42 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.563 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.52 146.1 23.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.899 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.469 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.37 151.05 46.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.49 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.76 131.47 43.0 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.463 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.893 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.62 93.41 27.93 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.142 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.679 ' C ' ' H ' ' A' ' 229' ' ' GLY . 47.5 Cg_exo -55.65 139.16 82.79 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.62 2.213 . . . . 0.0 111.558 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.99 -25.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.445 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.71 -49.81 27.97 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.0 mt -53.97 -37.14 63.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.56 35.99 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.782 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.2 88.18 0.01 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.844 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.9 p -81.33 -14.31 57.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.356 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.64 -41.19 10.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.567 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.8 t -66.84 -16.72 64.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.607 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.06 43.53 26.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.469 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.91 -147.1 7.25 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -122.49 143.16 49.88 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.994 0.426 . . . . 0.0 110.389 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -151.97 149.47 28.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.453 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -100.72 -151.94 0.42 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.392 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 55.92 -92.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.648 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.464 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.54 175.08 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.565 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.464 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.5 mt -121.83 141.43 42.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.726 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.75 169.22 9.4 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.281 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.4 mt -147.83 150.85 34.95 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.182 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.65 -38.95 97.01 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.15 4.13 4.64 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.37 -58.15 3.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.922 0.392 . . . . 0.0 110.579 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.552 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.1 m-20 -62.13 -36.86 83.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.271 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.28 -67.81 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.722 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.33 -42.11 66.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.185 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.14 18.12 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.64 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.79 48.61 0.27 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.41 -109.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.6 0.238 . . . . 0.0 110.726 -178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.469 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 12.0 m120 -60.89 -44.72 96.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.425 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.41 8.13 83.76 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -99.13 -12.74 20.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.58 0.229 . . . . 0.0 110.715 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.8 t 176.37 142.42 0.07 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.062 0.458 . . . . 0.0 110.533 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.88 125.39 11.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.03 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 191' ' ' VAL . 14.0 m-30 -98.6 143.03 29.44 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 120.85 0.357 . . . . 0.0 110.817 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.1 mt -94.33 106.5 18.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.675 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.463 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.3 t80 -102.28 -11.65 18.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.25 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.08 -40.15 86.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.804 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.11 173.68 46.14 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.5 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.0 m-20 -74.45 -112.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.347 . . . . 0.0 110.618 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.13 -28.72 67.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.728 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.85 -44.17 90.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.296 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -63.35 -44.54 94.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.353 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.34 -59.92 3.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.29 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.16 -43.32 61.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.221 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.38 -43.92 75.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.216 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.4 mt -64.42 -43.63 97.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.589 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -56.71 -37.43 70.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.172 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.96 1.03 18.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.251 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.0 91.35 26.43 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.195 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.01 -27.19 27.75 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.743 2.296 . . . . 0.0 111.87 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.34 -41.19 98.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.634 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.9 mp -95.21 5.11 52.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.41 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.72 -35.09 70.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.683 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.8 4.7 15.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.528 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.95 121.08 80.32 Favored Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.556 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -47.27 -37.8 24.94 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.507 2.138 . . . . 0.0 112.487 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.9 -43.82 91.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.294 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.82 -43.72 93.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.303 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.6 -40.52 95.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.539 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -90.32 -11.94 39.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.53 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.86 32.38 18.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.884 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.77 44.0 1.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.385 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.34 135.74 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.566 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.44 133.03 56.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.435 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.497 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.69 87.95 7.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.686 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.91 -41.47 97.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.834 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.16 167.93 34.42 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.8 p -75.9 -25.82 56.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.84 0.352 . . . . 0.0 110.691 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.4 tp10 -67.84 -34.32 76.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.39 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.763 HG22 ' O ' ' A' ' 296' ' ' THR . 97.1 m -73.14 19.7 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.631 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.526 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 53.1 t80 -57.25 -51.08 70.8 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.058 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.401 HH12 ' HG3' ' A' ' 212' ' ' GLN . 68.5 mmt-85 -108.05 149.36 28.53 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.43 ' CD2' HD11 ' A' ' 219' ' ' LEU . 42.3 tp -115.46 125.57 53.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.756 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.47 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.6 t0 -149.37 166.61 28.52 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.632 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -49.15 -38.14 24.47 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.588 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.82 -65.15 0.8 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.231 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.86 -32.79 72.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.44 -26.01 28.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.659 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.6 mtt -63.36 -41.04 98.8 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 120.851 0.357 . . . . 0.0 110.908 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.26 -44.41 25.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.914 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.565 HG21 HG23 ' A' ' 296' ' ' THR . 74.9 t -66.17 -42.89 92.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.425 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.472 HD11 ' NE2' ' A' ' 183' ' ' GLN . 49.3 tp -59.86 -47.49 85.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.505 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -69.64 -39.56 77.05 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.027 0.441 . . . . 0.0 110.723 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.5 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 72.2 ttt180 -61.7 -38.43 87.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.203 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -87.14 4.9 40.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.785 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.401 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.2 tttt -112.65 -11.77 13.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.04 0.448 . . . . 0.0 110.266 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.74 -37.08 85.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.642 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.99 -48.78 80.24 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.386 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.057 179.855 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.85 -2.46 58.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.413 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.9 179.08 1.24 Allowed Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.556 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.1 Cg_exo -60.9 145.11 99.52 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.781 2.321 . . . . 0.0 112.165 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.03 -179.21 7.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.589 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.81 136.67 52.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.342 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.39 147.29 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.362 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.9 p -120.39 136.12 54.82 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.27 -143.57 0.32 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.191 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -63.46 -37.18 86.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.526 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.05 -66.96 0.22 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.412 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.32 142.4 44.96 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.7 p -112.24 131.44 55.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.907 0.384 . . . . 0.0 110.435 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -119.22 129.06 54.76 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.518 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.0 m -85.68 130.36 34.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.225 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.48 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.8 mt -95.94 78.88 3.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.32 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.9 -31.91 73.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.491 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 176.06 108.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.05 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.48 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -121.89 91.56 48.77 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.312 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.646 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.3 Cg_exo -56.94 148.77 65.7 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.787 2.325 . . . . 0.0 111.862 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.64 82.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.607 0.567 . . . . 0.0 111.044 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.646 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.16 66.71 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.229 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.7 130.65 36.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.63 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.553 ' HA ' HG23 ' A' ' 64' ' ' VAL . 57.9 t -122.91 146.34 28.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.027 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -135.96 144.3 45.32 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 50' ' ' SER . 20.8 p -100.13 -59.28 1.74 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.619 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.406 ' N ' ' OG1' ' A' ' 49' ' ' THR . 86.5 p -79.21 154.78 28.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.653 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.516 HG21 HG23 ' A' ' 70' ' ' THR . 72.2 t -74.0 -22.01 18.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.578 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.4 m -60.24 -51.89 67.62 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.559 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -66.45 -42.42 87.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.196 0.522 . . . . 0.0 110.855 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.1 m -43.38 -53.74 5.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.048 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.41 -37.64 69.88 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.5 m -62.51 -44.66 95.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.896 0.379 . . . . 0.0 110.324 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.0 mt -66.16 -42.01 89.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.535 0.683 . . . . 0.0 110.704 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.63 -40.21 96.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.398 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.508 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.05 -35.79 75.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.07 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 156' ' ' LEU . 31.8 pt -91.36 28.91 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.229 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.5 51.66 10.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.881 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.35 75.55 22.71 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.91 151.88 84.22 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.742 2.295 . . . . 0.0 112.136 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.553 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.82 137.48 46.86 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 CA-C-O 121.172 0.51 . . . . 0.0 110.236 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.22 -43.63 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.317 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.483 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.97 131.12 53.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.051 0.453 . . . . 0.0 110.552 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.53 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.0 p -155.62 168.84 25.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.493 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.82 -177.25 21.67 Favored Glycine 0 N--CA 1.464 0.544 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.64 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.72 172.76 12.32 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.0 0.428 . . . . 0.0 110.486 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.516 HG23 HG21 ' A' ' 51' ' ' VAL . 14.6 p -132.59 -112.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.339 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.17 179.9 0.91 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.359 -179.131 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.8 Cg_exo -60.89 57.59 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.973 2.449 . . . . 0.0 112.154 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.6 t-20 -63.87 -33.36 75.52 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.407 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 14.6 m120 93.42 -36.64 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.014 0.821 . . . . 0.0 109.855 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.7 mtp85 -62.65 -39.51 94.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.019 0.438 . . . . 0.0 110.145 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 77' ' ' ALA . 15.0 p -74.29 -25.65 19.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.758 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.36 -171.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.545 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -74.12 -154.13 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.845 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.2 p-10 -52.52 -7.4 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.665 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.19 115.02 23.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.977 0.418 . . . . 0.0 110.631 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.82 70.16 1.35 Allowed Glycine 0 CA--C 1.52 0.39 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.3 m-85 -143.47 148.18 35.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 110.793 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -86.08 -98.42 0.07 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.135 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.89 -42.84 97.37 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.183 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.547 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.0 tt0 91.53 52.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.991 0.807 . . . . 0.0 110.858 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -102.86 -9.48 19.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.429 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.419 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.3 p -64.24 -33.85 76.75 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.149 0.5 . . . . 0.0 110.691 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -49.12 -23.96 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.66 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.39 -45.99 77.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.27 -48.33 81.9 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.043 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.65 -38.11 89.0 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.374 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.82 -32.72 53.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.161 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.594 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.94 1.71 55.93 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.523 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.65 -49.38 0.18 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.115 0.884 . . . . 0.0 110.265 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.5 mt -46.16 154.65 0.25 Allowed 'General case' 0 CA--C 1.49 -1.336 0 CA-C-O 117.475 -1.25 . . . . 0.0 109.343 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.644 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 120.95 92.57 0.0 OUTLIER 'General case' 0 C--N 1.353 0.735 0 O-C-N 125.563 1.79 . . . . 0.0 110.46 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.53 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.7 mtp180 -75.7 143.36 42.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.14 0.495 . . . . 0.0 110.265 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.5 mt -132.43 27.12 4.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 0.0 110.461 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.21 137.7 34.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.003 0.43 . . . . 0.0 110.49 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.8 mt -137.29 165.09 28.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.391 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.08 -28.46 1.84 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.35 70.84 7.59 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.191 0.52 . . . . 0.0 110.208 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -60.0 145.3 98.71 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 C-N-CA 122.751 2.3 . . . . 0.0 112.066 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.7 t -134.73 136.81 42.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.553 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.12 81.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.711 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.26 -42.33 96.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.52 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.86 -41.61 98.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.546 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.4 t -63.5 -43.42 98.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.99 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.06 77.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.23 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.76 -18.9 61.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.478 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.38 -6.57 58.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 81.9 mtp 47.8 55.97 17.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.59 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.3 Cg_endo -70.37 149.36 62.87 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.807 2.338 . . . . 0.0 112.101 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.22 -72.94 0.66 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.454 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.456 HD11 HD13 ' A' ' 140' ' ' LEU . 38.2 tp -111.56 113.01 25.14 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.324 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.1 mt -101.27 126.46 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.584 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.7 mt -109.52 133.47 53.05 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.225 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.68 139.65 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.493 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.4 p -83.45 168.56 16.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.671 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.42 80.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.381 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.8 t -139.53 158.94 43.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.943 0.402 . . . . 0.0 110.453 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.29 176.92 33.56 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.21 -33.71 86.82 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.77 151.52 45.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.925 0.393 . . . . 0.0 110.507 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.1 t -63.06 140.98 58.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.339 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.69 10.42 11.0 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.642 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.09 -39.16 88.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.081 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.79 -35.98 23.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.588 0.709 . . . . 0.0 110.705 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.4 mt -70.83 -35.54 72.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.528 0.68 . . . . 0.0 110.732 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -42.81 -62.83 0.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.317 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.81 -42.78 90.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.06 -179.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -62.03 -32.73 73.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.24 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.3 mt -73.77 -40.64 63.31 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.102 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.29 -48.76 79.47 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.153 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.1 m -53.05 -42.5 65.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.097 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.88 -43.09 93.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.937 0.399 . . . . 0.0 111.099 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.32 153.47 5.36 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.674 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -39.25 107.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.65 2.233 . . . . 0.0 112.445 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.641 ' C ' HD12 ' A' ' 140' ' ' LEU . 97.8 m -109.65 121.64 45.67 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.24 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.96 152.6 30.64 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.256 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.98 131.4 68.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.321 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.403 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -115.14 127.89 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.491 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.472 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 57.0 t30 -101.56 103.8 14.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.265 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.6 p90 -101.38 -11.21 19.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.816 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.75 -33.65 76.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.682 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.9 p-10 -98.3 7.66 45.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.612 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.448 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.46 155.39 50.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.51 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.403 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.8 p -74.86 165.64 24.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.641 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.86 -48.77 80.35 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.247 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.66 -41.95 67.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.028 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.3 t -62.65 -41.08 98.86 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.385 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.403 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.5 tp -60.61 -44.38 96.36 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.393 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.3 tp -61.41 -43.43 98.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.145 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -55.07 -44.88 75.2 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.43 -40.78 97.68 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.943 0.402 . . . . 0.0 110.469 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -62.03 -42.47 99.2 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.305 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.21 -40.91 95.02 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.5 -45.96 64.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.832 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.75 -44.04 96.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.794 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.4 p -93.03 -8.81 41.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.622 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.01 26.58 72.38 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -101.54 50.63 0.85 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.807 0.337 . . . . 0.0 110.703 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.45 -39.61 77.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.617 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.4 -47.26 86.13 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.252 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -59.94 -39.55 85.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.314 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.77 98.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.278 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.0 -28.61 70.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.614 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.18 -54.26 8.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.067 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.508 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.4 ttp180 -65.49 -42.27 92.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.456 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.459 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.6 mt -62.35 -43.98 98.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.502 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.66 -58.35 7.8 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.037 0.446 . . . . 0.0 110.344 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.05 -34.05 67.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.471 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.4 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.2 t80 -81.01 -36.35 30.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.875 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -55.61 -41.84 74.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.03 -178.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.7 -42.1 99.47 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.684 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.29 -38.05 89.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.288 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 177' ' ' LEU . 82.3 mt -62.47 -42.23 99.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.674 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.08 -52.79 62.48 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.091 0.472 . . . . 0.0 110.664 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.32 -41.75 89.23 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.588 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.89 95.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.611 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.34 -32.13 73.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.426 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.62 -22.26 18.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.693 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.429 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -64.77 -41.26 96.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.652 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.3 pt -76.56 136.45 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.698 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.72 107.91 10.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.224 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.82 125.69 0.3 Allowed Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.45 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.452 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.2 Cg_exo -43.96 152.38 0.37 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.757 2.305 . . . . 0.0 112.623 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.75 141.85 55.88 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.589 2.193 . . . . 0.0 112.466 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.01 147.44 2.29 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.622 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.31 154.32 69.71 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.782 2.321 . . . . 0.0 112.303 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.581 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.39 163.15 29.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.438 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.581 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.91 170.73 15.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.915 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.36 137.75 22.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.238 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.551 HG22 HD12 ' A' ' 205' ' ' LEU . 40.1 pt -134.24 146.89 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.672 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.03 131.87 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.168 0.508 . . . . 0.0 110.488 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -152.12 155.25 37.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.388 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.621 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.6 m -122.69 123.16 40.49 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.917 0.389 . . . . 0.0 110.341 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.5 -25.66 66.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.649 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.621 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.59 -48.94 20.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.038 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.18 -13.62 61.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.435 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 76.5 m80 51.05 40.92 26.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.518 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.9 t -136.48 143.96 44.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.422 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -109.56 114.54 28.25 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.287 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.3 m-20 -119.8 133.32 55.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.128 0.49 . . . . 0.0 110.346 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.551 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.97 146.41 37.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.787 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.478 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.6 t90 -99.47 129.61 45.66 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.142 0.496 . . . . 0.0 109.996 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.14 153.89 39.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.225 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.7 Cg_endo -67.8 -18.04 47.3 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.647 2.231 . . . . 0.0 111.958 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.29 -18.7 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.441 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.478 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.63 164.65 26.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.486 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.91 -27.94 65.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.503 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.579 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.9 mt-30 -63.82 -41.33 97.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.586 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.37 -44.61 97.4 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.448 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.2 mt-30 -64.51 -38.75 92.11 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 122.524 -0.398 . . . . 0.0 110.575 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.2 mmm -62.16 -41.08 97.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.167 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.3 mt -63.59 -47.02 83.18 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.464 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.31 -31.91 55.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.155 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -70.84 -18.24 62.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.558 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.437 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.6 mt -88.17 -9.11 54.16 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.617 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.18 1.97 54.41 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -88.43 153.22 21.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 110.467 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.447 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.0 p -116.12 128.73 55.91 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.129 0.49 . . . . 0.0 110.348 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.562 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.66 146.24 23.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.897 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.476 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.75 151.26 46.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.402 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.43 131.44 43.57 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.425 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.893 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.62 93.37 27.72 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.032 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.677 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.7 Cg_exo -55.65 139.0 82.62 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.575 2.183 . . . . 0.0 111.518 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.84 -25.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.483 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -69.94 -50.1 31.18 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.552 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.5 mt -53.94 -36.92 63.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.814 0.34 . . . . 0.0 110.123 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -66.7 36.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.829 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.88 86.81 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.948 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.3 p -79.09 -15.24 58.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.325 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.58 -41.04 10.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.616 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.1 t -66.21 -18.0 65.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.546 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.14 43.48 26.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.435 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.52 -148.22 7.71 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.68 142.79 49.81 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.002 0.429 . . . . 0.0 110.294 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.41 149.93 29.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.317 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -101.21 -151.55 0.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.369 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 56.0 -91.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.646 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.471 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.84 175.42 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.648 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.471 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.1 mt -122.54 141.78 41.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.83 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.76 169.29 9.35 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.327 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.5 mt -147.65 151.01 35.46 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.289 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.63 -38.95 97.02 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.95 4.13 4.74 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -77.37 -58.1 3.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.986 0.422 . . . . 0.0 110.595 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.549 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.1 m-20 -62.11 -36.69 82.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.232 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.44 -67.53 0.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.55 -42.21 67.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.1 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.29 17.67 0.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.62 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.17 48.62 0.31 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.5 mp 38.65 -109.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.6 0.238 . . . . 0.0 110.736 -178.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.9 m120 -60.95 -44.75 96.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.427 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.42 7.97 83.98 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.88 -13.51 20.0 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.743 -0.269 . . . . 0.0 110.65 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.7 t 176.97 142.7 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.122 0.487 . . . . 0.0 110.479 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.13 125.21 11.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.14 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.6 m-30 -98.31 143.52 28.7 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 120.898 0.38 . . . . 0.0 110.763 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.87 106.55 18.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.688 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.4 t80 -101.79 -12.21 18.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.157 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.47 -40.86 89.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.853 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.79 173.22 45.87 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.009 -0.837 . . . . 0.0 111.009 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.461 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.4 m-20 -73.85 -113.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 110.758 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.89 -28.69 67.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.711 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.9 -43.9 91.11 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.237 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.57 -44.17 94.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.408 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.73 -60.09 3.68 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.217 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.08 -43.34 61.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.142 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.48 -43.62 75.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.144 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.6 mt -64.59 -43.66 96.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.6 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -56.07 -37.49 69.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.16 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.72 0.94 18.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.185 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -114.98 91.14 25.49 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.147 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.19 -27.09 28.69 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.756 2.304 . . . . 0.0 111.848 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.45 -40.97 98.55 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.592 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.35 5.11 52.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.352 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.87 -35.19 69.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.687 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.65 4.5 15.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.53 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.67 121.17 80.07 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -47.32 -37.66 25.12 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.469 2.113 . . . . 0.0 112.512 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.532 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -59.05 -43.82 91.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.804 0.335 . . . . 0.0 110.273 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.5 t -65.86 -43.77 93.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.299 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -65.03 -40.66 95.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.428 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.9 t-20 -89.49 -12.73 39.22 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.575 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.7 mtmt 62.16 32.07 17.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -88.9 43.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.101 0.477 . . . . 0.0 110.332 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.13 135.81 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.419 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.8 132.3 56.73 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.403 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.13 89.05 7.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.765 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.9 -41.23 97.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.877 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.444 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.79 165.64 33.84 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 69.0 p -75.47 -25.83 57.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.888 0.375 . . . . 0.0 110.813 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.0 tp10 -68.23 -33.84 75.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.439 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 96.7 m -73.53 24.45 0.07 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.67 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.579 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 43.7 t80 -58.28 -50.7 72.66 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.409 HH12 ' HG3' ' A' ' 212' ' ' GLN . 76.9 mmt-85 -110.8 153.17 25.75 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.437 ' CD2' HD11 ' A' ' 219' ' ' LEU . 43.6 tp -115.49 125.34 52.94 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.819 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.488 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.1 t0 -148.16 165.77 29.89 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.605 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -49.38 -38.05 27.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.567 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -70.92 -65.76 0.7 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.449 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -60.97 -32.72 72.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.056 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.22 -25.58 23.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.678 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.7 mtt -63.51 -40.83 98.08 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 120.872 0.368 . . . . 0.0 111.081 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.75 -44.24 23.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.108 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.581 HG21 HG23 ' A' ' 296' ' ' THR . 78.6 t -66.14 -42.91 92.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.409 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.3 tp -60.29 -47.01 87.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.48 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -70.0 -39.33 75.93 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.598 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.498 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.7 ttt180 -61.79 -38.29 87.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.166 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.5 mt -87.07 4.45 42.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.71 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.404 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.1 tttt -112.78 -11.3 13.5 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 110.264 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.12 85.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.552 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.85 -48.61 81.01 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.296 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.964 179.971 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.614 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.34 -2.46 57.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.412 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.89 179.04 1.25 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.0 Cg_exo -60.73 144.61 99.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.71 2.273 . . . . 0.0 112.194 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.614 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.58 -179.87 8.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.621 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.63 136.52 52.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.318 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.12 147.07 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.368 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.6 p -120.25 136.08 54.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 110.745 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.6 -143.43 0.33 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.269 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.41 -37.27 86.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.504 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.474 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.17 -66.84 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.486 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.62 142.38 45.65 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.0 p -112.26 131.41 55.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.908 0.385 . . . . 0.0 110.45 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -118.8 128.96 54.96 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.561 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.5 m -85.35 130.33 34.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.237 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.473 HD22 ' OE1' ' A' ' 42' ' ' GLN . 67.7 mt -95.68 78.9 3.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.324 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.53 -31.94 73.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.493 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.79 109.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.073 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.473 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.5 pt20 -122.05 91.66 48.9 Favored Pre-proline 0 C--O 1.233 0.203 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.296 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.646 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.2 Cg_exo -56.94 148.76 65.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.766 2.311 . . . . 0.0 111.874 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.61 82.75 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 O-C-N 123.587 0.554 . . . . 0.0 110.991 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.646 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.45 67.03 0.89 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.244 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.14 130.66 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.665 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.56 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.2 t -122.66 146.68 27.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.047 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.9 t -136.28 143.87 44.45 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.697 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.2 p -99.26 -59.2 1.77 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.584 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.2 p -79.46 155.39 28.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.632 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.525 HG21 HG23 ' A' ' 70' ' ' THR . 70.6 t -74.3 -21.86 17.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.567 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.4 m -60.28 -52.01 67.11 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.456 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.29 -42.54 88.23 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.375 0.607 . . . . 0.0 110.879 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.0 m -43.38 -53.93 5.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.086 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.31 -37.75 70.89 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.7 m -62.51 -44.67 95.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.805 0.336 . . . . 0.0 110.277 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.2 mt -66.14 -41.98 89.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.464 0.649 . . . . 0.0 110.761 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.53 -40.19 95.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.476 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.467 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.14 -36.0 76.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.135 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.535 HD11 HD12 ' A' ' 156' ' ' LEU . 32.9 pt -91.07 28.7 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.239 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.72 51.48 10.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.861 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.94 75.66 23.97 Favored Pre-proline 0 C--N 1.332 -0.167 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.68 151.44 85.64 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.743 2.295 . . . . 0.0 112.17 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.56 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.61 137.18 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.191 0.519 . . . . 0.0 110.25 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.444 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.7 pt -69.09 -43.69 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.339 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.95 130.97 53.43 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.933 0.396 . . . . 0.0 110.581 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.53 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.8 p -155.51 168.79 25.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.429 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.78 -177.45 21.69 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.631 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.54 172.88 12.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.944 0.402 . . . . 0.0 110.523 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.525 HG23 HG21 ' A' ' 51' ' ' VAL . 13.6 p -133.03 -112.11 0.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.404 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.36 179.79 0.92 Allowed Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.346 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.3 Cg_exo -61.2 57.86 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.943 2.428 . . . . 0.0 112.117 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.8 t-20 -63.97 -33.98 76.95 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.51 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.3 m120 94.01 -36.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.176 0.923 . . . . 0.0 109.808 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.2 mtp85 -62.99 -40.1 96.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.258 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 77' ' ' ALA . 15.0 p -74.43 -25.92 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.744 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.21 -171.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.608 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -73.69 -153.87 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.819 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.1 p-10 -52.79 -7.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.751 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.504 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.22 114.59 23.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.619 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.81 71.04 1.33 Allowed Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -143.75 148.23 35.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.861 0.362 . . . . 0.0 110.812 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -86.07 -98.66 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.031 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.99 -42.83 97.06 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.227 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.2 tt0 91.7 53.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.994 0.809 . . . . 0.0 110.887 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -103.12 -9.22 19.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.36 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -64.49 -34.19 77.64 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.079 0.466 . . . . 0.0 110.625 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -48.91 -23.76 1.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.562 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.9 t -69.53 -45.93 77.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.41 -48.38 81.46 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.055 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.63 -38.21 89.35 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.276 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.71 -32.25 51.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.173 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.595 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 83.2 mmt-85 -90.16 1.67 56.17 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.575 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.76 -49.18 0.17 Allowed 'General case' 0 N--CA 1.465 0.305 0 O-C-N 124.169 0.918 . . . . 0.0 110.288 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.1 mt -46.54 154.21 0.31 Allowed 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 117.503 -1.237 . . . . 0.0 109.274 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.644 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.32 92.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 O-C-N 125.569 1.793 . . . . 0.0 110.431 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.53 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.59 143.51 42.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.123 0.487 . . . . 0.0 110.228 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 mt -132.37 27.18 4.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.769 0.319 . . . . 0.0 110.471 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.48 138.25 34.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.015 0.436 . . . . 0.0 110.495 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.1 mt -137.3 165.04 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.367 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.0 -28.57 1.85 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -153.16 70.93 7.01 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.13 0.49 . . . . 0.0 110.292 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.08 145.48 98.34 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.724 2.282 . . . . 0.0 112.075 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.7 t -134.05 136.37 43.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.05 -38.29 82.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.63 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.28 -42.03 96.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.53 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.4 98.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.523 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -63.74 -43.54 98.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.946 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.13 77.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.237 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.68 -18.6 60.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.427 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.6 -6.61 58.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.509 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.5 mtp 47.93 56.02 17.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.609 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.4 Cg_endo -70.23 149.09 63.35 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.834 2.356 . . . . 0.0 112.112 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -100.75 -74.11 0.62 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.564 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.436 HD11 HD13 ' A' ' 140' ' ' LEU . 38.1 tp -110.45 113.32 25.87 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.296 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.9 mt -101.78 126.38 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.508 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.1 mt -109.79 133.55 53.02 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.183 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.26 139.62 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.563 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.2 p -83.45 168.41 16.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.701 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.42 80.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.459 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.2 t -139.58 158.97 43.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.436 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.01 176.65 33.41 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.33 -33.82 87.34 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.48 151.57 44.43 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.881 0.372 . . . . 0.0 110.537 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.5 t -63.1 140.57 58.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.316 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.39 10.5 11.23 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.677 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.52 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.06 -38.97 88.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.049 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.99 -35.92 23.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.554 0.692 . . . . 0.0 110.645 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.9 mt -70.69 -35.65 72.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.495 0.664 . . . . 0.0 110.726 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -42.8 -62.93 0.88 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.375 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.74 -42.65 90.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.102 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -62.14 -32.97 73.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.209 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.5 mt -73.29 -40.95 64.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.038 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.42 -48.85 79.32 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.145 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.4 m -52.94 -42.32 65.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.247 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.11 -42.93 92.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.928 0.394 . . . . 0.0 111.043 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.53 154.37 5.55 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.621 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -39.63 107.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.621 2.214 . . . . 0.0 112.335 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.637 ' C ' HD12 ' A' ' 140' ' ' LEU . 93.8 m -110.09 121.13 44.54 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.255 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.637 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.88 152.74 30.31 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.223 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.6 tt -128.8 131.39 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.391 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.404 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.5 mt -115.13 127.75 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.469 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.9 t30 -101.52 103.23 14.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.243 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 147' ' ' LYS . 44.5 p90 -100.96 -11.09 20.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.812 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.5 p-10 -64.8 -33.56 76.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.703 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.7 p-10 -98.47 8.12 45.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.601 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.443 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.8 155.51 50.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.51 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.404 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.8 p -74.99 165.85 24.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.705 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.4 t90 -60.01 -48.8 80.22 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.246 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.5 -42.19 67.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.921 0.391 . . . . 0.0 110.103 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.7 t -62.54 -40.81 97.99 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.406 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.408 ' O ' HD23 ' A' ' 156' ' ' LEU . 46.3 tp -60.62 -43.91 96.93 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.282 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.505 HD22 HH21 ' A' ' 169' ' ' ARG . 44.8 tp -61.45 -43.25 99.2 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.111 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.5 m -55.01 -45.27 75.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.53 -40.67 97.52 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.855 0.359 . . . . 0.0 110.338 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.535 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.02 -42.37 99.09 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.302 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.07 -41.18 95.25 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.61 -46.03 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.952 0.406 . . . . 0.0 110.975 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.53 -44.05 96.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.887 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.8 p -93.31 -8.54 41.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.597 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.89 25.46 71.92 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -102.12 51.83 0.82 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.8 0.333 . . . . 0.0 110.699 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.76 -39.23 76.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.664 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.28 -46.94 87.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.173 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -61.36 -39.02 89.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.315 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.4 -40.46 97.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.311 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.62 69.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.018 0.437 . . . . 0.0 110.545 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.77 -53.61 8.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.158 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.505 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -64.11 -43.25 95.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.406 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.2 mt -62.98 -43.89 99.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.717 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.46 -61.38 2.57 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.128 0.489 . . . . 0.0 110.461 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.71 -35.11 63.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.451 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -79.6 -35.24 39.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.957 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.4 m-20 -56.29 -40.66 74.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.255 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.01 -42.37 99.81 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.684 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.64 -37.83 87.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.287 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 177' ' ' LEU . 81.7 mt -62.42 -42.16 99.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.736 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.05 -52.78 62.56 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.128 0.489 . . . . 0.0 110.694 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.46 -41.47 89.02 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.609 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.8 94.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.633 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.01 -32.53 73.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.43 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.03 -21.93 18.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.696 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.413 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.6 tt0 -65.11 -41.03 95.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.734 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -77.45 136.32 24.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.74 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.28 108.56 10.97 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.258 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.44 125.96 0.32 Allowed Pre-proline 0 C--O 1.24 0.555 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.529 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.1 Cg_exo -43.92 152.21 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.824 2.349 . . . . 0.0 112.533 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.26 142.12 54.16 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.678 2.252 . . . . 0.0 112.472 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.44 147.26 2.09 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.607 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.85 154.29 71.3 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.726 2.284 . . . . 0.0 112.293 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.12 162.99 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.452 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.578 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.83 170.57 15.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.948 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.77 137.84 21.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.0 110.166 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.549 HG22 HD12 ' A' ' 205' ' ' LEU . 40.0 pt -134.33 146.99 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.695 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.94 131.86 59.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.161 0.505 . . . . 0.0 110.468 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -152.22 155.45 37.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.363 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.616 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.6 m -123.05 123.23 40.39 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.939 0.4 . . . . 0.0 110.331 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.78 66.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.635 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.616 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.23 -49.28 19.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.1 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.89 -11.65 60.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.403 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.5 m80 48.84 41.98 19.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.485 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.9 t -136.16 143.48 44.49 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.363 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -109.86 114.18 27.53 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.29 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.94 133.63 55.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.05 0.452 . . . . 0.0 110.445 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.549 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.05 146.45 37.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.787 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.481 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.4 t90 -99.8 129.78 45.94 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.127 0.489 . . . . 0.0 109.939 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.54 153.82 39.41 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.281 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.417 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.0 Cg_endo -67.62 -18.37 48.39 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.72 2.28 . . . . 0.0 111.912 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -48.92 -18.28 0.27 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.401 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.481 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.4 p -76.2 165.35 25.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.499 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.35 -28.34 66.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.484 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.464 ' OE1' ' CD1' ' A' ' 297' ' ' PHE . 34.6 mt-30 -63.57 -41.13 98.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.617 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.31 -44.52 97.43 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.443 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.8 mt-30 -64.57 -39.05 93.05 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.886 0.374 . . . . 0.0 110.496 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.19 -41.31 98.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.107 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 70.5 mt -63.59 -47.05 83.03 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.588 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -54.63 -31.77 57.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.112 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.7 -18.38 62.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.539 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.0 mt -87.94 -9.1 54.62 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.609 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.27 2.34 54.14 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -88.59 153.43 21.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.359 . . . . 0.0 110.549 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.442 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.0 p -115.98 128.52 55.8 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.154 0.502 . . . . 0.0 110.307 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.4 145.88 24.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.944 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.474 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.66 151.59 45.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.503 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.17 131.72 42.5 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.385 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.887 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.73 93.36 28.19 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.063 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.677 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.5 Cg_exo -55.38 138.91 81.15 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.571 2.181 . . . . 0.0 111.539 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.78 -25.78 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.505 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.18 -50.16 29.42 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.562 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.7 mt -54.48 -37.11 64.86 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.18 35.89 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.898 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.562 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.3 88.24 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.909 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.3 p -81.68 -13.91 57.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.323 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.64 -41.45 10.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.577 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.4 t -67.02 -16.66 64.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.649 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.95 43.81 26.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.461 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 180.0 -148.5 8.0 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.55 143.02 48.82 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.001 0.429 . . . . 0.0 110.313 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -151.95 149.48 28.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.273 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -101.14 -151.86 0.42 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.33 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.06 -91.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.664 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.459 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.8 tt -127.08 175.29 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.545 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.459 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.1 mt -122.17 141.63 41.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.84 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.55 169.13 9.51 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.207 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.3 mt -147.69 150.72 34.87 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.241 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.67 -39.01 97.08 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.21 4.07 4.63 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.49 -57.98 3.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.949 0.404 . . . . 0.0 110.566 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.546 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.1 m-20 -62.25 -36.27 81.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.326 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.52 -67.72 0.23 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.735 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.4 -42.29 66.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.241 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.06 17.85 0.16 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.681 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.76 48.59 0.26 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.62 -109.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.59 0.233 . . . . 0.0 110.728 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.474 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -61.08 -44.57 97.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.406 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.25 8.15 84.01 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -99.2 -13.05 19.9 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.75 -0.265 . . . . 0.0 110.69 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.3 t 176.79 142.34 0.08 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.112 0.482 . . . . 0.0 110.454 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.423 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.9 125.4 11.69 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.165 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.434 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.67 143.02 29.51 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 120.894 0.378 . . . . 0.0 110.775 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.9 mt -94.15 106.29 18.27 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.664 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.441 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.3 t80 -101.48 -11.88 18.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.129 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.3 87.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.84 174.14 46.32 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.451 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -74.41 -113.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.799 0.333 . . . . 0.0 110.786 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.45 -28.61 68.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.702 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.1 -44.1 91.91 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.172 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.89 -44.02 94.28 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.383 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.81 -60.27 3.47 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.233 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.15 -43.39 61.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.13 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.57 75.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.139 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.7 mt -64.45 -43.67 96.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.657 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -56.46 -37.5 70.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.139 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.82 0.91 18.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.223 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -114.9 91.35 26.04 Favored Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.164 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.2 -27.19 29.11 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.802 2.335 . . . . 0.0 111.786 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.36 -41.25 98.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.545 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.15 4.99 53.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.343 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.75 -35.16 70.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.719 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.83 4.73 15.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.558 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.89 121.32 81.04 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.6 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -47.58 -37.44 26.68 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.411 2.074 . . . . 0.0 112.523 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -59.12 -43.73 91.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.777 0.323 . . . . 0.0 110.244 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.89 -43.79 92.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.33 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -64.81 -40.65 95.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.424 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.8 t-20 -89.54 -12.78 38.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.588 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.8 mtmt 62.11 32.27 17.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.96 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -89.07 43.87 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.072 0.463 . . . . 0.0 110.352 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.44 135.85 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.453 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -116.53 132.45 56.68 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.44 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.503 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.79 87.22 7.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.751 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.04 -40.77 97.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.441 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.58 169.35 35.54 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 72.4 p -76.35 -25.78 55.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.819 0.343 . . . . 0.0 110.699 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.7 tp10 -67.24 -34.82 78.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.398 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.763 HG22 ' O ' ' A' ' 296' ' ' THR . 93.2 m -73.59 25.01 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.758 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.495 ' H ' ' C ' ' A' ' 295' ' ' GLU . 64.2 t80 -58.27 -51.25 70.55 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.418 HH12 ' HG3' ' A' ' 212' ' ' GLN . 61.2 mmt-85 -112.16 154.96 24.72 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.417 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.3 tp -115.54 124.4 50.95 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.494 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.9 t0 -147.42 165.58 29.81 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.583 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -49.0 -38.51 23.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.624 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -71.5 -65.37 0.76 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.523 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.73 -32.87 72.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.082 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.64 -25.29 25.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.697 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.7 mtt -63.35 -41.0 98.83 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 120.894 0.378 . . . . 0.0 111.018 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.34 -43.99 22.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.987 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.564 HG21 HG23 ' A' ' 296' ' ' THR . 75.1 t -65.81 -43.22 93.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.398 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 56.5 tp -60.65 -47.28 86.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.494 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -69.39 -39.64 77.87 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.725 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.503 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.2 ttt180 -62.13 -38.39 88.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.207 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.2 mt -86.86 3.88 43.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.84 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.4 tttt -112.57 -11.29 13.6 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.064 0.459 . . . . 0.0 110.315 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.07 -37.0 85.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.515 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.01 -48.74 80.4 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.414 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.09 179.829 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.618 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.15 -2.05 58.02 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.369 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.484 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.08 179.04 1.24 Allowed Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.499 -179.625 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.0 Cg_exo -61.04 145.2 99.33 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.769 2.313 . . . . 0.0 112.226 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.618 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.4 ptt-85 -156.41 -178.95 7.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.601 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.91 136.68 52.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.281 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -123.97 146.68 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.378 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.8 p -119.8 135.94 54.66 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.736 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.41 -143.53 0.33 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.295 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -63.28 -37.06 85.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.598 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.88 -65.56 0.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.518 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.84 141.95 46.47 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 p -112.02 131.19 55.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.922 0.392 . . . . 0.0 110.36 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -119.08 128.87 54.73 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.51 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.1 m -85.45 130.13 34.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.201 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.0 mt -96.03 78.67 3.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.432 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.52 -31.69 72.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.466 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.28 109.98 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.172 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -122.99 91.35 49.91 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.196 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.645 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.9 Cg_exo -57.01 148.99 64.96 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.756 2.304 . . . . 0.0 111.784 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.79 82.89 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 O-C-N 123.603 0.564 . . . . 0.0 110.928 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.645 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.28 67.09 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.289 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.1 130.69 35.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.549 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.554 ' HA ' HG23 ' A' ' 64' ' ' VAL . 56.5 t -122.79 146.51 27.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.124 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.4 t -136.04 144.16 45.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.63 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 p -100.48 -58.87 1.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.564 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.2 p -79.43 154.78 28.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.598 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.547 HG21 HG23 ' A' ' 70' ' ' THR . 72.8 t -74.07 -21.81 18.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.629 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 94.7 m -60.31 -52.1 66.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.474 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.3 mt -66.5 -42.2 87.74 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.347 0.594 . . . . 0.0 111.003 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.2 m -43.32 -54.06 4.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.143 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.26 -37.84 71.42 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.7 m -62.28 -44.5 96.37 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.956 0.407 . . . . 0.0 110.645 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.9 mt -66.2 -42.18 89.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.459 0.647 . . . . 0.0 110.737 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.63 -40.25 96.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.371 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.464 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.21 -36.03 76.76 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.914 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.535 HD11 HD12 ' A' ' 156' ' ' LEU . 31.6 pt -91.2 28.89 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.042 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.6 51.63 10.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.777 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.0 75.34 24.23 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.949 0.404 . . . . 0.0 109.998 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.44 151.57 85.0 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.743 2.295 . . . . 0.0 112.246 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.554 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.77 137.37 47.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.181 0.515 . . . . 0.0 110.245 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.4 pt -69.34 -43.61 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.163 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.482 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.9 130.87 53.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.915 0.388 . . . . 0.0 110.544 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.53 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.0 p -155.64 168.98 25.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.456 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.98 -177.04 21.58 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.627 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.58 172.65 12.46 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 120.934 0.397 . . . . 0.0 110.513 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.547 HG23 HG21 ' A' ' 51' ' ' VAL . 13.6 p -132.68 -112.49 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.276 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.41 179.84 0.91 Allowed Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.326 -179.115 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.3 Cg_exo -60.93 57.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 123.054 2.503 . . . . 0.0 112.214 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.1 t-20 -64.41 -33.82 76.75 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.487 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.5 m120 93.85 -36.09 0.02 OUTLIER 'General case' 0 C--N 1.346 0.435 0 O-C-N 124.08 0.862 . . . . 0.0 109.966 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.405 ' HD3' HD21 ' A' ' 73' ' ' ASN . 77.9 mtp85 -63.1 -39.39 94.55 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.218 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 77' ' ' ALA . 15.0 p -74.71 -25.29 18.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.692 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.35 -171.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.588 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.7 p30 -74.08 -153.66 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.765 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.0 p-10 -52.77 -7.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.639 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.508 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.37 115.06 23.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.582 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.85 69.69 1.36 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -142.96 147.53 35.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.958 0.409 . . . . 0.0 110.704 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.29 -98.4 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.313 178.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.548 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.4 -42.5 96.06 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.108 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.548 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.2 tt0 91.69 53.05 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.075 0.859 . . . . 0.0 110.79 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.24 -9.09 19.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.466 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.0 p -64.64 -34.04 77.35 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.118 0.485 . . . . 0.0 110.653 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.66 -23.9 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.553 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.53 -46.02 76.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.881 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.24 -48.49 81.24 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.073 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.68 -38.09 89.0 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.357 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.68 -32.58 52.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.248 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.594 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.1 mmt-85 -89.69 1.67 55.75 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.695 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 56.9 mttp 82.69 -49.05 0.17 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 124.115 0.885 . . . . 0.0 110.31 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.649 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.71 154.79 0.29 Allowed 'General case' 0 CA--C 1.49 -1.327 0 CA-C-O 117.592 -1.194 . . . . 0.0 109.253 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.649 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 120.85 92.47 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 O-C-N 125.462 1.726 . . . . 0.0 110.542 -178.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.53 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.39 143.44 42.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.108 0.48 . . . . 0.0 110.244 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.4 mt -132.4 26.95 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.0 110.47 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.52 138.15 34.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.441 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.4 mt -137.31 165.01 28.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.391 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.15 -28.8 1.82 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.408 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -152.18 70.13 7.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.201 0.524 . . . . 0.0 110.348 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.03 145.44 98.39 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 122.663 2.242 . . . . 0.0 112.126 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.0 t -134.81 137.35 43.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.521 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.22 -38.07 81.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.716 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.27 -42.29 96.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.547 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.52 98.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.558 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.2 t -63.58 -43.41 98.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.057 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.13 77.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.294 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.52 -18.62 59.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.463 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.58 -6.62 58.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.576 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 64.3 mtp 48.17 55.87 17.34 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.609 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.37 149.23 62.66 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.716 2.277 . . . . 0.0 112.111 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.13 -73.21 0.65 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.468 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.426 HD11 HD13 ' A' ' 140' ' ' LEU . 38.0 tp -111.02 112.65 24.62 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.44 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.8 mt -101.11 126.06 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.469 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.6 mt -109.59 133.64 52.87 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.294 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -121.01 140.17 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.472 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.6 p -83.5 168.68 16.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.64 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.43 80.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.433 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.1 t -140.15 159.09 42.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.963 0.411 . . . . 0.0 110.416 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.3 177.66 33.2 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.26 -33.79 87.15 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -124.84 151.72 44.9 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.904 0.383 . . . . 0.0 110.567 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.2 t -63.36 141.2 58.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.355 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.74 10.67 11.02 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.577 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.31 -39.07 89.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.071 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.634 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.9 -35.72 23.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.516 0.675 . . . . 0.0 110.709 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.5 mt -71.0 -35.42 72.06 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.473 0.654 . . . . 0.0 110.727 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -42.74 -63.19 0.82 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.132 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.634 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.83 -42.64 90.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -61.99 -32.91 73.42 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.424 0.453 . . . . 0.0 110.17 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.9 mt -73.8 -40.24 63.53 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.22 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.17 -49.13 78.08 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.15 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 78.9 m -52.36 -42.74 64.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.314 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.37 -43.26 94.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.141 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.99 154.85 5.3 Favored Pre-proline 0 N--CA 1.453 -0.285 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.646 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -39.19 106.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.696 2.264 . . . . 0.0 112.356 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.643 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.4 m -110.09 121.5 45.41 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.169 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.26 152.93 30.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.257 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -129.01 129.11 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.382 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.4 mt -112.54 127.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.498 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.11 103.34 14.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.3 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 147' ' ' LYS . 44.0 p90 -101.04 -11.17 19.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.703 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.2 p-10 -64.72 -33.77 76.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.619 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.7 p-10 -98.27 8.1 45.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.597 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.83 155.62 50.05 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.499 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.1 165.91 24.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.594 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.09 -48.62 80.94 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.22 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.76 -42.03 67.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.992 0.425 . . . . 0.0 110.084 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.0 t -62.63 -40.63 97.58 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.435 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.406 ' CD1' HG21 ' A' ' 142' ' ' ILE . 45.9 tp -60.62 -43.88 96.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.417 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.514 HD22 HH21 ' A' ' 169' ' ' ARG . 43.9 tp -61.45 -43.19 99.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.188 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.2 m -54.94 -45.17 74.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.806 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.5 -40.72 97.62 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-O 120.889 0.376 . . . . 0.0 110.381 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.535 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.95 -42.33 98.99 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.249 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.05 -41.03 95.36 Favored Glycine 0 C--N 1.316 -0.533 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.85 -46.0 63.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.94 0.4 . . . . 0.0 110.807 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.61 -44.03 96.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.741 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.6 p -93.27 -8.64 41.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.546 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.8 25.16 71.71 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -102.15 52.49 0.81 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.72 0.295 . . . . 0.0 110.593 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -70.04 -39.11 75.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.696 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.16 -47.01 86.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.165 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -61.38 -38.91 88.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.434 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.38 97.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.413 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.45 -27.67 69.15 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.537 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.82 -53.77 8.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.17 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.514 HH21 HD22 ' A' ' 153' ' ' LEU . 61.8 ttp180 -63.55 -43.56 96.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.448 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 174' ' ' ASP . 85.7 mt -63.01 -43.78 99.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.658 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.08 -61.65 2.42 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.112 0.482 . . . . 0.0 110.383 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.54 -35.09 62.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.425 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.411 ' CD2' HD11 ' A' ' 177' ' ' LEU . 23.3 t80 -79.6 -35.05 40.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.891 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.3 m-20 -56.68 -40.43 75.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.96 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.94 -42.61 99.86 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.769 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.85 -37.52 86.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.303 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.411 HD11 ' CD2' ' A' ' 173' ' ' PHE . 80.9 mt -62.26 -42.36 99.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.702 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -53.0 61.77 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.168 0.509 . . . . 0.0 110.645 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.25 -41.69 89.6 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.597 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.31 -39.68 94.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.5 -32.36 73.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.302 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.93 -22.12 18.79 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.647 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.41 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -65.22 -40.91 94.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.632 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.1 pt -78.45 136.45 23.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.568 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.53 109.45 11.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.277 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.48 125.8 0.32 Allowed Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.518 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.4 Cg_exo -43.92 152.29 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.713 2.276 . . . . 0.0 112.598 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.16 142.0 54.28 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.612 2.208 . . . . 0.0 112.461 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.37 147.4 2.14 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.602 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.15 154.74 69.67 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.805 2.337 . . . . 0.0 112.296 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.27 163.23 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.405 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -144.1 170.41 16.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.793 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.83 137.89 21.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.017 0.437 . . . . 0.0 110.226 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.543 HG22 HD12 ' A' ' 205' ' ' LEU . 38.9 pt -134.44 146.72 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.574 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.98 131.73 58.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.128 0.49 . . . . 0.0 110.474 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -151.92 154.89 36.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.357 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.2 m -122.08 122.62 39.68 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.961 0.41 . . . . 0.0 110.371 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.32 -25.98 66.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.613 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.72 -49.02 22.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.007 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.38 -11.04 60.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.285 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.8 m80 48.6 42.47 19.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.452 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.6 t -136.43 145.7 45.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.386 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.41 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -111.44 114.18 27.12 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.311 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.72 133.32 55.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.08 0.467 . . . . 0.0 110.343 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.543 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.13 146.43 38.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.671 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.519 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 10.9 t90 -99.77 130.23 45.96 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.104 0.478 . . . . 0.0 110.148 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.65 153.88 39.31 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.133 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.412 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.2 Cg_endo -67.76 -18.05 47.51 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.663 2.242 . . . . 0.0 111.95 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -48.99 -18.57 0.3 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.405 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.519 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.96 165.11 25.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.543 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.22 -28.04 66.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.516 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.464 ' OE1' ' CD1' ' A' ' 297' ' ' PHE . 34.9 mt-30 -63.76 -41.21 98.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.669 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.12 -44.75 97.02 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.8 mt-30 -64.6 -38.71 91.94 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 120.99 0.424 . . . . 0.0 110.649 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.14 -41.15 98.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.11 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.81 -46.74 83.76 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.644 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.59 -31.73 57.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.089 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.88 -18.12 62.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.57 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.418 HD11 ' CD2' ' A' ' 299' ' ' LEU . 89.0 mt -88.25 -8.49 55.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.612 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.39 2.05 55.61 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -88.41 153.36 21.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.512 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.46 ' O ' HG12 ' A' ' 191' ' ' VAL . 7.9 p -116.09 128.72 55.91 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.055 0.455 . . . . 0.0 110.308 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.571 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.62 145.97 24.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.802 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.469 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.68 151.5 45.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.534 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.72 131.53 43.12 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.526 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.893 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.55 93.22 26.67 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.049 -179.689 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.679 ' C ' ' H ' ' A' ' 229' ' ' GLY . 47.6 Cg_exo -55.59 139.25 82.59 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.56 2.173 . . . . 0.0 111.612 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.04 -25.64 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.459 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.54 -49.78 29.2 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.8 mt -53.87 -37.01 63.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 0.0 110.197 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.92 36.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.777 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.85 86.85 0.01 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.861 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.3 p -79.42 -15.17 58.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.411 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.38 -41.12 10.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.616 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.8 t -66.06 -17.78 64.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.65 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.25 43.22 26.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.508 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.48 -147.27 7.21 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.96 143.01 50.19 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.955 0.407 . . . . 0.0 110.323 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -152.51 149.85 28.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.391 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -100.95 -151.75 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.398 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 66.9 t0 55.99 -91.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.555 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.459 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.96 175.25 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.54 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.459 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 93.0 mt -122.3 141.73 41.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.693 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.77 168.97 9.57 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.244 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.3 mt -147.73 150.9 35.16 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.154 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.53 -39.21 97.4 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.32 4.01 4.6 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.28 -58.06 3.49 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.011 0.434 . . . . 0.0 110.636 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.551 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.2 m-20 -62.2 -37.04 83.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.271 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.41 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.1 mp -52.14 -67.69 0.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.784 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.43 -42.07 66.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.145 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.16 17.96 0.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.724 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.92 48.13 0.26 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.83 -109.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.663 0.268 . . . . 0.0 110.675 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.469 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.71 -44.87 96.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.502 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.26 8.13 84.03 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -99.02 -13.19 19.98 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.672 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.6 t 176.8 142.45 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.079 0.466 . . . . 0.0 110.423 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.93 125.42 11.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.983 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.433 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -98.57 142.94 29.53 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 120.877 0.37 . . . . 0.0 110.88 177.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.9 mt -93.88 106.26 18.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.655 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.429 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.2 t80 -101.48 -12.27 18.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.215 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.4 -40.62 89.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.833 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.43 173.73 46.09 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.448 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -74.09 -112.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.811 0.339 . . . . 0.0 110.683 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.88 -28.74 67.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.689 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -58.85 -43.95 90.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.371 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.8 -44.32 93.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.357 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.48 -60.17 3.56 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.247 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.31 -43.55 61.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.084 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.16 -43.6 74.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.229 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.4 mt -64.62 -43.63 96.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.597 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -56.23 -37.48 69.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.211 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.87 1.25 18.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.277 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -114.94 91.33 26.13 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.213 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.31 -27.25 30.1 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.753 2.302 . . . . 0.0 111.841 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.38 -41.17 98.77 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.591 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.592 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.9 mp -95.07 5.12 52.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.362 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.87 -35.13 69.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.713 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.53 4.52 15.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.52 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.91 120.91 79.38 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.61 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -47.41 -37.43 25.4 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.478 2.119 . . . . 0.0 112.493 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -59.01 -43.84 91.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.758 0.313 . . . . 0.0 110.356 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.96 -43.7 92.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.344 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.81 -40.7 95.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.445 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.9 t-20 -89.42 -12.86 39.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.625 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.7 mtmt 62.18 32.36 17.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -89.15 43.87 1.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.074 0.464 . . . . 0.0 110.353 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.51 135.89 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.448 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.78 132.37 56.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.491 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.504 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.67 87.49 7.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.674 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.02 -40.69 96.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.971 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.429 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.72 168.85 35.0 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 77.8 p -76.13 -25.89 55.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 0.0 110.698 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.1 tp10 -67.27 -34.6 77.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.524 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.766 HG22 ' O ' ' A' ' 296' ' ' THR . 95.7 m -73.66 25.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.601 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.497 ' H ' ' C ' ' A' ' 295' ' ' GLU . 61.8 t80 -58.13 -51.13 70.99 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.402 HH12 ' HG3' ' A' ' 212' ' ' GLN . 64.4 mmt-85 -112.3 155.13 24.6 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.418 ' CD2' HD11 ' A' ' 219' ' ' LEU . 45.2 tp -115.88 124.77 51.48 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.766 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.49 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.7 t0 -147.79 165.79 29.5 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -49.13 -38.55 25.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.579 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -71.53 -65.31 0.77 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.267 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -60.79 -32.75 72.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.913 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.88 -25.19 27.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.549 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.1 mtt -63.08 -41.42 99.43 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.88 0.371 . . . . 0.0 110.857 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.18 -43.85 23.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.997 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.56 HG21 HG23 ' A' ' 296' ' ' THR . 76.6 t -66.04 -43.18 92.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.414 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 56.0 tp -60.55 -47.04 87.92 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.549 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -69.84 -39.85 76.18 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.546 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.504 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.3 ttt180 -62.06 -37.97 87.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.133 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.3 mt -87.19 4.32 42.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.795 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -112.59 -11.51 13.56 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.042 0.448 . . . . 0.0 110.263 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.9 84.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.66 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.02 -48.78 80.2 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.332 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.898 -1.048 . . . . 0.0 110.097 179.941 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.47 -2.1 57.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.298 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.94 179.09 1.23 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.991 0.424 . . . . 0.0 110.481 -179.65 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.6 Cg_exo -60.95 144.91 99.68 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.814 2.343 . . . . 0.0 112.149 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.96 -179.3 8.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.597 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.68 136.66 52.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.388 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.36 147.11 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.297 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.8 p -120.18 135.99 54.78 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.41 -143.38 0.32 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.233 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -63.52 -37.13 86.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.549 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.477 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.54 -66.12 0.22 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.546 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.48 141.99 45.68 Favored Glycine 0 CA--C 1.519 0.309 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.4 p -112.19 131.23 55.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.939 0.4 . . . . 0.0 110.4 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.21 128.9 54.65 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.532 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -85.49 130.3 34.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.227 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.453 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.0 mt -95.74 78.86 3.3 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.287 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.28 -32.31 73.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.55 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 175.88 110.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.075 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.453 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.5 pt20 -123.05 91.7 49.66 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.322 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.645 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.1 Cg_exo -56.95 148.82 65.44 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.769 2.313 . . . . 0.0 111.864 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.42 82.78 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 O-C-N 123.59 0.557 . . . . 0.0 111.017 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.645 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.45 67.07 0.89 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.133 0.492 . . . . 0.0 110.183 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.17 130.78 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.709 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.557 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.1 t -122.85 146.59 27.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.034 0.445 . . . . 0.0 110.015 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -136.38 143.91 44.28 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.693 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.1 p -99.31 -59.5 1.71 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.647 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.0 p -78.95 155.61 28.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.706 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 70' ' ' THR . 71.4 t -74.65 -21.84 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.55 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 94.7 m -60.36 -51.88 67.63 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.459 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.5 mt -66.3 -42.62 88.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.207 0.527 . . . . 0.0 110.85 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.15 -53.9 4.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.005 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.39 -38.12 70.24 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.7 m -62.21 -44.55 96.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 110.203 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.418 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.3 mt -66.27 -42.03 89.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.443 0.64 . . . . 0.0 110.756 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.59 -40.12 95.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.495 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.471 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.97 -35.91 76.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.183 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.537 HD11 HD12 ' A' ' 156' ' ' LEU . 32.7 pt -91.2 28.69 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.295 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.58 51.52 11.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.98 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.74 75.52 25.38 Favored Pre-proline 0 C--N 1.331 -0.208 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.34 151.15 86.64 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.793 2.328 . . . . 0.0 112.199 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.59 137.26 47.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.223 0.535 . . . . 0.0 110.208 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.447 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.0 pt -69.21 -43.65 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.326 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.483 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.02 131.07 53.46 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.964 0.411 . . . . 0.0 110.564 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.526 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.4 p -155.68 168.72 26.25 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.501 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.96 -176.97 21.59 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.627 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.37 172.54 12.56 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 121.01 0.433 . . . . 0.0 110.44 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.493 HG23 HG21 ' A' ' 51' ' ' VAL . 12.9 p -133.13 -111.84 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 110.349 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.49 179.68 0.94 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.348 -179.143 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.7 Cg_exo -61.34 57.89 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.975 2.45 . . . . 0.0 112.094 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.5 t-20 -64.19 -34.13 77.37 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 118.894 -0.574 . . . . 0.0 110.398 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.9 m120 94.06 -36.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.103 0.877 . . . . 0.0 109.838 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -62.9 -39.84 95.73 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.179 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.49 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -74.27 -25.71 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.758 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.68 -171.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.575 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.26 -153.68 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.864 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.0 p-10 -52.72 -7.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.677 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.25 114.6 23.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.618 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.61 70.36 1.34 Allowed Glycine 0 C--O 1.225 -0.428 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -143.18 147.93 35.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.824 0.345 . . . . 0.0 110.961 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -85.94 -98.4 0.07 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.995 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.1 mtt-85 -64.28 -42.69 96.3 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.08 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.1 tt0 91.49 53.43 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.057 0.848 . . . . 0.0 110.954 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.38 -9.1 19.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.391 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.2 p -64.71 -33.99 77.27 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.165 0.507 . . . . 0.0 110.681 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.85 -24.27 1.39 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.59 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.4 t -69.13 -46.11 78.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.936 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.21 -48.49 81.26 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.964 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.69 -38.17 89.35 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.302 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.82 -32.28 52.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.095 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.593 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.7 mmt-85 -90.04 1.82 55.89 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.585 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.6 -49.34 0.18 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 124.102 0.876 . . . . 0.0 110.192 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.638 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.5 mt -46.42 154.88 0.25 Allowed 'General case' 0 CA--C 1.49 -1.345 0 CA-C-O 117.365 -1.302 . . . . 0.0 109.275 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.638 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 120.76 92.48 0.0 OUTLIER 'General case' 0 C--N 1.354 0.764 0 O-C-N 125.699 1.875 . . . . 0.0 110.464 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.526 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.34 143.54 42.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.098 0.475 . . . . 0.0 110.311 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.5 mt -132.52 27.2 4.4 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.147 -0.346 . . . . 0.0 110.428 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -140.6 138.46 34.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.015 0.436 . . . . 0.0 110.542 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.5 mt -137.37 164.99 28.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.418 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.34 -28.71 1.8 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -153.23 70.87 6.95 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.166 0.508 . . . . 0.0 110.288 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.22 145.58 98.22 Favored 'Trans proline' 0 C--N 1.301 -1.936 0 C-N-CA 122.719 2.279 . . . . 0.0 112.108 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.4 t -133.99 136.55 44.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.481 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.38 83.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.683 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.38 -42.17 96.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.52 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.53 98.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.581 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.6 t -63.68 -43.45 98.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.925 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.81 -35.12 77.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.233 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.55 -18.61 59.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.38 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -86.67 -6.85 58.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.562 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.409 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.6 mtp 48.1 56.09 17.47 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.627 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.0 Cg_endo -70.12 149.23 64.28 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.766 2.31 . . . . 0.0 112.122 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.04 -73.47 0.64 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.43 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 140' ' ' LEU . 38.4 tp -111.03 112.84 24.94 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.26 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.1 mt -101.13 126.19 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.556 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.5 mt -109.58 133.42 53.12 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.198 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.46 139.7 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.506 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 94.4 p -83.42 168.42 16.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.692 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.12 -37.41 79.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.402 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.2 t -139.38 159.07 43.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.932 0.396 . . . . 0.0 110.475 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.07 176.33 33.55 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.13 -33.84 87.14 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.7 151.53 44.88 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 110.523 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.9 t -63.06 140.82 58.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.359 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.7 10.44 11.0 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.607 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.08 -39.13 88.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.099 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.68 -35.86 24.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.59 0.709 . . . . 0.0 110.721 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.2 mt -70.8 -35.62 72.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.642 0.734 . . . . 0.0 110.738 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -42.84 -62.71 0.94 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.408 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.64 -42.66 91.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -62.1 -33.02 73.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.301 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.1 mt -73.3 -40.77 64.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.145 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.8 t -58.53 -48.58 80.36 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.013 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.8 m -52.9 -42.35 65.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.302 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.15 -43.03 92.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.082 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.4 154.15 5.58 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.659 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -39.37 107.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.639 2.226 . . . . 0.0 112.422 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.635 ' C ' HD12 ' A' ' 140' ' ' LEU . 93.8 m -110.13 120.88 43.85 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.037 0.446 . . . . 0.0 110.238 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.62 152.78 29.89 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.292 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.421 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.7 tt -128.75 131.04 68.82 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.268 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.81 127.79 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.504 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.9 t30 -101.79 103.53 14.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.302 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 147' ' ' LYS . 45.3 p90 -101.05 -11.29 19.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.862 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.74 -33.73 76.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.671 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -98.29 7.86 45.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.548 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.6 155.54 50.29 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.538 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.404 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.07 165.8 24.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.715 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.05 -48.69 80.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.152 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -53.7 -42.2 67.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.002 0.429 . . . . 0.0 110.063 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.2 t -62.49 -40.89 98.15 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.362 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.41 ' O ' HD23 ' A' ' 156' ' ' LEU . 47.4 tp -60.59 -43.95 96.79 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.261 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.501 HD22 HH21 ' A' ' 169' ' ' ARG . 45.0 tp -61.27 -43.43 98.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.139 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 m -55.03 -45.37 75.17 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.59 -40.58 97.36 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.891 0.377 . . . . 0.0 110.446 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.537 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.97 -42.29 98.96 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.343 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.19 -40.89 95.05 Favored Glycine 0 C--N 1.315 -0.587 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.72 -45.91 64.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.0 mt -64.61 -44.0 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.794 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.6 p -93.35 -8.56 41.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.587 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.85 25.37 71.85 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -102.06 52.26 0.82 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.769 0.319 . . . . 0.0 110.663 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.87 -39.23 76.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.575 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.15 -46.95 87.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.243 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -61.41 -39.12 89.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.35 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.27 -40.32 97.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.257 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.49 -27.51 69.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.545 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.95 -53.81 8.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.059 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.501 HH21 HD22 ' A' ' 153' ' ' LEU . 61.8 ttp180 -63.88 -43.24 96.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.47 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.9 mt -63.07 -43.86 99.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.726 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.18 -61.52 2.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.146 0.498 . . . . 0.0 110.403 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.65 -35.32 63.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.466 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.422 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.4 t80 -79.21 -35.19 42.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.963 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.1 m-20 -56.98 -40.1 75.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.146 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.08 -42.64 99.68 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.828 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.74 -37.76 87.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.285 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.422 HD11 ' CD2' ' A' ' 173' ' ' PHE . 80.4 mt -62.29 -42.33 99.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.715 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.07 -52.76 62.61 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.073 0.463 . . . . 0.0 110.639 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.41 -41.56 89.1 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.624 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.33 -39.65 94.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.671 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.29 -32.49 73.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.306 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.95 -21.99 18.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.657 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.411 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.7 tt0 -65.02 -40.9 95.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.726 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.8 pt -78.1 136.47 24.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.727 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.37 109.31 11.65 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.214 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.8 125.66 0.3 Allowed Pre-proline 0 C--O 1.242 0.666 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.495 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.4 Cg_exo -43.88 152.36 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.786 2.324 . . . . 0.0 112.618 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.13 142.29 55.41 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.554 2.17 . . . . 0.0 112.504 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.3 147.07 2.11 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.626 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.91 154.6 70.64 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.75 2.3 . . . . 0.0 112.307 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.29 163.2 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.487 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -144.02 170.35 16.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.889 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.01 137.65 22.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.253 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.54 HG22 HD12 ' A' ' 205' ' ' LEU . 38.9 pt -134.37 146.75 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.65 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.46 132.26 57.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.168 0.509 . . . . 0.0 110.497 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -152.12 155.15 37.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.439 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.8 m -122.34 123.06 40.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.957 0.408 . . . . 0.0 110.364 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.51 -25.76 66.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.631 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.614 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.12 -49.18 20.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.084 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.12 -12.18 60.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.413 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.4 m80 49.47 41.95 21.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.496 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.1 t -135.97 144.76 45.57 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.328 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.5 113.97 27.02 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.258 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.474 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.8 133.33 55.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.039 0.447 . . . . 0.0 110.362 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.54 HD12 HG22 ' A' ' 194' ' ' ILE . 7.5 tt -111.92 146.32 37.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.483 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 12.5 t90 -99.11 129.74 45.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.175 0.512 . . . . 0.0 109.932 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.74 153.87 39.25 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.294 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.2 Cg_endo -67.59 -18.15 48.47 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.671 2.247 . . . . 0.0 111.957 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.37 -18.83 0.43 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.36 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.483 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.9 p -75.39 164.59 26.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.536 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.99 -27.84 65.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.559 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.471 ' OE1' ' CD1' ' A' ' 297' ' ' PHE . 34.9 mt-30 -63.99 -41.0 97.63 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.589 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.26 -44.54 97.36 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.6 mt-30 -64.59 -38.71 91.96 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.022 0.439 . . . . 0.0 110.557 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.2 mmm -62.18 -41.21 98.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.103 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.3 mt -63.7 -47.09 82.58 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.525 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.27 -31.84 54.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.355 . . . . 0.0 110.193 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.02 -18.32 62.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.472 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.422 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.5 mt -87.94 -8.67 55.38 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.626 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.57 2.13 55.42 Favored Glycine 0 N--CA 1.464 0.503 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -88.4 153.29 21.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.939 0.4 . . . . 0.0 110.464 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.448 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.3 p -115.93 128.7 55.97 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.143 0.497 . . . . 0.0 110.334 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.567 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.71 145.89 24.07 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.948 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.474 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.46 151.49 46.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.423 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.65 131.59 43.3 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.461 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.89 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.7 93.29 27.74 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.062 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.678 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.5 Cg_exo -55.52 139.13 82.15 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.556 2.171 . . . . 0.0 111.58 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.76 -25.69 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.477 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.13 -50.07 30.2 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.552 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.7 mt -54.17 -36.93 63.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.68 35.99 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.819 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.08 88.31 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.003 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 79.5 p -81.23 -14.15 57.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.31 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.8 -41.57 10.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.685 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.1 t -66.7 -16.92 64.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.647 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 55.94 43.76 26.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.439 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.74 -148.45 7.9 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.91 142.94 49.24 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.0 0.428 . . . . 0.0 110.327 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.14 149.56 28.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.278 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -101.19 -151.85 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.297 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.12 -92.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.624 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.463 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.67 175.24 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.596 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.463 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.5 mt -122.37 141.62 42.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.56 169.05 9.56 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.264 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.0 mt -147.63 150.86 35.21 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.224 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.69 -38.98 97.03 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.18 3.87 4.7 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -77.18 -58.04 3.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.958 0.409 . . . . 0.0 110.631 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.547 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.1 m-20 -62.25 -36.85 83.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.249 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.24 -67.74 0.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.67 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.68 -42.08 67.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.135 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.97 17.8 0.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.644 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.88 48.5 0.27 Allowed Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.45 -109.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.596 0.236 . . . . 0.0 110.754 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.474 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 12.0 m120 -61.12 -44.65 97.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.469 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.31 8.05 84.06 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -98.93 -13.25 20.07 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.668 -0.313 . . . . 0.0 110.697 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.8 t 176.96 142.53 0.08 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.087 0.47 . . . . 0.0 110.434 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -147.84 125.62 11.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.191 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.433 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -98.68 143.15 29.37 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 120.899 0.381 . . . . 0.0 110.778 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.1 mt -94.44 106.3 18.28 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.672 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.435 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.58 -11.69 19.05 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.171 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.14 -40.66 86.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.27 173.69 46.1 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.442 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.5 m-20 -74.02 -112.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.352 . . . . 0.0 110.856 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.76 -28.75 67.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.731 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.11 -44.01 91.95 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.147 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.68 -44.2 94.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.308 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.72 -59.93 3.88 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.201 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.32 -43.58 61.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.982 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.32 -43.63 75.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.181 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.7 mt -64.57 -43.62 96.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.581 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.4 -37.51 70.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.113 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.92 1.24 18.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.179 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -114.73 91.46 25.72 Favored Pre-proline 0 CA--C 1.528 0.11 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.179 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.33 -27.32 30.54 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.801 2.334 . . . . 0.0 111.811 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.42 -41.14 98.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.575 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.593 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.9 mp -95.14 5.04 52.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.346 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.58 -35.08 70.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.645 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.99 4.43 17.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.512 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.73 120.9 78.88 Favored Pre-proline 0 N--CA 1.441 -0.884 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.512 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.37 -37.47 25.19 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.41 2.074 . . . . 0.0 112.635 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.529 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -59.02 -43.65 91.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.75 0.31 . . . . 0.0 110.352 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.99 -43.75 92.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.301 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.89 -40.64 95.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.422 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.8 t-20 -89.51 -12.86 38.79 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.516 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.23 32.08 17.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.88 44.01 1.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.115 0.484 . . . . 0.0 110.367 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.78 135.63 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.529 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -116.64 132.51 56.67 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.386 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.506 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.5 87.31 7.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.834 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.97 -40.77 97.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.919 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.435 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.94 168.84 35.59 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 77.0 p -76.07 -25.88 55.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.901 0.382 . . . . 0.0 110.781 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.8 tp10 -67.37 -34.7 77.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.357 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.764 HG22 ' O ' ' A' ' 296' ' ' THR . 94.7 m -73.49 25.1 0.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.748 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.496 ' H ' ' C ' ' A' ' 295' ' ' GLU . 63.2 t80 -58.26 -51.07 71.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.413 HH12 ' HG3' ' A' ' 212' ' ' GLN . 63.5 mmt-85 -112.42 155.0 24.93 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.422 ' CD2' HD11 ' A' ' 219' ' ' LEU . 43.9 tp -115.72 124.92 52.04 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.491 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.2 t0 -148.04 165.89 29.42 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.533 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -49.08 -38.64 25.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.659 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -71.05 -65.61 0.72 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.54 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -60.61 -32.93 72.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.079 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.62 -24.97 23.75 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.811 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.9 mtt -63.23 -41.18 99.07 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 120.948 0.404 . . . . 0.0 111.105 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.54 -43.89 22.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.064 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.56 HG21 HG23 ' A' ' 296' ' ' THR . 77.3 t -65.81 -43.24 93.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.417 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 55.4 tp -60.82 -46.96 88.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.518 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -69.83 -39.65 76.33 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.663 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.506 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.5 ttt180 -62.09 -38.15 87.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.136 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.03 3.97 43.85 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.753 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -112.78 -11.06 13.54 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.114 0.483 . . . . 0.0 110.189 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.23 -36.95 85.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.549 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.95 -48.7 80.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.395 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.003 179.9 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.06 -2.63 58.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.415 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.72 179.16 1.22 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.498 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.3 Cg_exo -60.87 144.94 99.66 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.76 2.307 . . . . 0.0 112.203 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.613 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.78 -179.7 8.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.581 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.51 136.14 53.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.333 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -123.94 146.82 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.395 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.6 p -120.02 135.98 54.73 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.812 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.25 -143.61 0.32 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.259 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.65 -36.98 85.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.437 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.22 -66.96 0.22 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.523 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.27 142.3 44.93 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.3 p -112.18 131.24 55.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.934 0.397 . . . . 0.0 110.324 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.08 128.94 54.79 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.541 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.9 m -85.55 130.64 34.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.178 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.0 mt -95.83 78.63 3.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.271 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.04 -32.18 73.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.493 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.43 108.87 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.086 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -122.25 91.56 49.09 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.194 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.644 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.1 Cg_exo -56.97 148.67 66.6 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.802 2.334 . . . . 0.0 111.827 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.79 82.67 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 O-C-N 123.57 0.544 . . . . 0.0 111.028 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.644 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.28 67.07 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.226 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.0 130.85 35.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.609 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.554 ' HA ' HG23 ' A' ' 64' ' ' VAL . 57.5 t -122.61 145.86 28.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.08 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -135.66 143.45 45.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.63 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.0 p -99.34 -59.54 1.7 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.594 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.7 p -79.07 155.12 28.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.668 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.492 HG21 HG23 ' A' ' 70' ' ' THR . 69.9 t -74.41 -21.72 17.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.569 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.5 m -60.36 -52.04 66.94 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.518 -178.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.5 mt -66.51 -42.37 87.43 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.363 0.601 . . . . 0.0 110.956 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -43.21 -53.63 4.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.083 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.3 -37.69 71.01 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -62.58 -44.48 96.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.893 0.378 . . . . 0.0 110.393 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.2 mt -66.25 -42.14 88.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.547 0.689 . . . . 0.0 110.769 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tp -62.62 -40.09 95.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.439 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.463 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.07 -35.75 75.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.006 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 156' ' ' LEU . 31.4 pt -91.6 28.92 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.16 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.35 51.65 11.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.816 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.86 75.71 24.32 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.98 151.5 85.61 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.775 2.317 . . . . 0.0 112.289 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.554 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.45 137.15 47.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.219 0.533 . . . . 0.0 110.251 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.442 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.1 pt -69.2 -43.63 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.243 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.08 130.92 53.24 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.97 0.414 . . . . 0.0 110.505 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.4 p -155.39 168.84 25.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.464 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.55 -177.53 21.83 Favored Glycine 0 N--CA 1.464 0.564 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.637 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -132.99 172.07 13.12 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.009 0.433 . . . . 0.0 110.458 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.492 HG23 HG21 ' A' ' 51' ' ' VAL . 14.2 p -133.49 -111.34 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.321 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.542 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.56 179.65 0.95 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.348 -179.044 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.2 Cg_exo -60.97 58.71 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.059 2.506 . . . . 0.0 112.108 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.543 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.2 t-20 -64.35 -34.94 79.31 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 118.669 -0.681 . . . . 0.0 110.521 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.1 m120 95.07 -37.58 0.01 OUTLIER 'General case' 0 C--N 1.349 0.557 0 O-C-N 124.332 1.02 . . . . 0.0 109.857 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -62.54 -39.89 95.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.025 0.44 . . . . 0.0 110.261 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -73.93 -26.45 21.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.678 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.83 -172.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.518 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.2 p30 -73.77 -152.79 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.787 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.0 p-10 -54.61 -6.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.683 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.491 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.93 113.74 22.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.585 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.23 72.92 1.27 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.87 148.67 35.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.897 0.38 . . . . 0.0 110.825 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -86.0 -99.14 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.172 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.541 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.04 -43.28 96.02 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.143 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.541 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.2 tt0 91.8 52.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.117 0.886 . . . . 0.0 110.919 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -103.12 -8.9 20.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.347 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.2 p -65.05 -33.97 77.31 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.164 0.507 . . . . 0.0 110.727 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.49 -24.17 1.2 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.624 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.5 t -69.55 -45.84 77.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.1 -48.74 80.29 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.071 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.77 -38.2 89.66 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.348 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -53.7 -32.45 51.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.207 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.59 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.9 mmt-85 -90.02 1.71 56.0 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 119.19 -0.433 . . . . 0.0 110.579 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.85 -49.41 0.16 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.232 0.957 . . . . 0.0 110.351 179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.636 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.9 mt -46.32 154.01 0.31 Allowed 'General case' 0 CA--C 1.489 -1.39 0 CA-C-O 117.331 -1.319 . . . . 0.0 109.139 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.636 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.6 tt0 121.37 92.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 O-C-N 125.754 1.909 . . . . 0.0 110.538 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.48 143.09 42.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.115 0.483 . . . . 0.0 110.279 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 mt -131.91 26.81 4.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.8 0.333 . . . . 0.0 110.443 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.16 137.56 34.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.974 0.416 . . . . 0.0 110.525 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.9 mt -136.99 165.19 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.42 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.13 -28.44 1.84 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -153.32 70.85 6.89 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.192 0.52 . . . . 0.0 110.281 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.94 145.55 98.04 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.759 2.306 . . . . 0.0 112.135 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.3 t -134.06 136.72 44.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.981 0.42 . . . . 0.0 110.541 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.96 -38.3 82.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.642 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.27 -42.29 96.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.518 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.12 -41.44 98.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.561 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.67 -43.34 98.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.05 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.13 77.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.295 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -18.62 60.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.489 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.51 -6.6 58.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.524 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 78.7 mtp 47.91 55.98 17.3 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.596 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.31 149.27 63.1 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.755 2.303 . . . . 0.0 112.083 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.38 -72.56 0.68 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.498 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.427 HD11 HD13 ' A' ' 140' ' ' LEU . 38.7 tp -111.7 112.7 24.58 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.321 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.3 mt -101.09 126.37 54.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.567 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.2 mt -110.07 133.7 52.93 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.156 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -121.17 139.97 46.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.517 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.7 p -83.34 168.43 16.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.705 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -37.48 80.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.418 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -139.47 159.0 43.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.434 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.15 176.94 33.44 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.02 -34.0 87.49 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.88 151.56 45.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.927 0.394 . . . . 0.0 110.531 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.3 t -63.16 141.06 58.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.291 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.09 10.94 10.84 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.625 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.29 -38.93 88.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.007 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.632 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.81 -35.7 24.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.594 0.711 . . . . 0.0 110.605 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.0 mt -71.14 -35.42 71.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.52 0.676 . . . . 0.0 110.8 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.9 t80 -42.89 -62.95 0.88 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.19 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.632 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.3 p-10 -65.67 -42.64 91.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.988 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -62.24 -32.58 73.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.124 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.5 mt -73.94 -40.54 62.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.15 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.23 -48.87 79.03 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.221 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.6 m -52.69 -42.78 65.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.212 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.96 -43.07 92.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.221 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.04 152.63 5.27 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.66 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -39.02 107.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.627 2.218 . . . . 0.0 112.421 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.634 ' C ' HD12 ' A' ' 140' ' ' LEU . 94.2 m -109.43 121.02 44.27 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.239 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.634 HD12 ' C ' ' A' ' 139' ' ' THR . 10.9 mp -113.6 152.68 30.01 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.12 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.53 131.05 69.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.36 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.99 127.79 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.463 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.99 103.76 14.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.324 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.3 p90 -101.36 -11.42 19.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.772 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.4 p-10 -64.82 -33.48 76.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.673 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.1 p-10 -98.17 7.59 46.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.585 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.44 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.56 155.48 50.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.507 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -74.43 165.39 25.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.67 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.549 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 90.8 t90 -60.0 -48.52 81.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.255 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -53.95 -41.73 68.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.99 0.424 . . . . 0.0 110.061 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.9 t -62.55 -40.84 98.1 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.401 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.412 ' O ' HD23 ' A' ' 156' ' ' LEU . 47.4 tp -60.61 -43.93 96.87 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.338 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.541 HD22 HH21 ' A' ' 169' ' ' ARG . 45.0 tp -61.37 -42.97 99.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 0.0 110.261 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -55.79 -45.25 78.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.679 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.44 -40.6 97.13 Favored 'General case' 0 C--O 1.228 -0.044 0 CA-C-O 120.938 0.399 . . . . 0.0 110.388 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.93 -42.34 98.99 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.321 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.77 -40.72 95.8 Favored Glycine 0 C--N 1.316 -0.575 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.89 -45.85 63.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.937 0.399 . . . . 0.0 110.899 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.0 mt -64.49 -44.13 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.742 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.5 p -93.47 -8.15 42.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.538 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.65 25.0 71.47 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -101.35 52.24 0.84 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.817 0.341 . . . . 0.0 110.653 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.7 -39.02 77.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.668 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.47 -47.12 86.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.201 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -61.41 -39.02 89.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.357 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.4 97.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.068 0.461 . . . . 0.0 110.355 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.19 -27.71 69.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.541 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.71 -53.57 9.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.192 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.541 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -63.98 -43.26 96.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.461 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 174' ' ' ASP . 86.9 mt -63.08 -43.86 99.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.687 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.45 -61.72 2.33 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.173 0.511 . . . . 0.0 110.369 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.45 -34.99 62.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.448 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.4 ' CD2' HD11 ' A' ' 177' ' ' LEU . 23.2 t80 -79.66 -35.37 39.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.056 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.0 m-20 -56.0 -41.15 74.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.128 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.92 -42.25 99.73 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.756 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.3 -37.93 88.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.29 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 177' ' ' LEU . 82.0 mt -62.41 -42.26 99.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.752 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.8 -52.97 62.01 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.132 0.491 . . . . 0.0 110.704 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.45 -41.78 88.61 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.649 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.03 -40.0 95.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.7 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.32 -32.4 73.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.349 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.16 -21.69 18.93 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.684 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.494 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.7 tt0 -64.86 -41.36 95.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.642 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.0 pt -77.23 135.58 26.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.656 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.02 108.62 11.09 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.27 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.86 126.83 0.31 Allowed Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.548 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.9 Cg_exo -43.75 152.09 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.749 2.3 . . . . 0.0 112.609 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.2 142.09 54.42 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.598 2.198 . . . . 0.0 112.487 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.547 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.12 147.32 2.23 Favored Pre-proline 0 N--CA 1.446 -0.631 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.62 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.2 154.46 69.92 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.71 2.274 . . . . 0.0 112.293 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.58 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.42 163.14 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.417 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.58 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.75 170.46 15.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.905 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.64 137.65 21.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.961 0.41 . . . . 0.0 110.141 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.536 HG22 HD12 ' A' ' 205' ' ' LEU . 39.3 pt -134.08 146.46 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.623 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.9 131.74 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.182 0.515 . . . . 0.0 110.485 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -151.73 154.59 36.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.404 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 199' ' ' ALA . 84.8 m -121.86 122.54 39.66 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.996 0.427 . . . . 0.0 110.382 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.76 -25.5 66.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.551 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.611 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.45 -50.0 20.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.071 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.53 -10.74 60.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.398 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.3 m80 48.61 43.26 20.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.475 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.1 t -136.07 145.24 45.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.323 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.402 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -111.19 113.77 26.52 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.297 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.9 133.65 55.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.07 0.462 . . . . 0.0 110.301 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.23 146.43 38.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.72 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.495 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.8 t90 -99.36 129.86 45.6 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.152 0.501 . . . . 0.0 110.024 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.67 154.37 39.18 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.211 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.9 Cg_endo -67.64 -18.22 48.24 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.702 2.268 . . . . 0.0 111.925 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.2 -18.72 0.37 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.431 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.495 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.73 164.99 25.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.559 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.07 -27.94 66.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.529 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.52 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.8 mt-30 -63.56 -41.59 98.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.675 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.05 -44.87 96.85 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.38 -38.97 92.9 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.952 0.406 . . . . 0.0 110.642 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.549 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.4 mmm -62.23 -41.39 98.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.148 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 70.9 mt -63.78 -47.15 82.08 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.641 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.51 -31.97 57.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.075 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -70.7 -18.28 62.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.493 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.426 HD11 ' CD2' ' A' ' 299' ' ' LEU . 93.5 mt -88.61 -8.3 54.92 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.656 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.47 2.64 55.52 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -88.54 152.33 21.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.346 . . . . 0.0 110.543 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.446 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.2 p -115.15 128.12 55.99 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.117 0.484 . . . . 0.0 110.337 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.52 145.7 24.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.468 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.38 151.41 46.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.43 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.31 131.81 42.34 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.409 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.885 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.52 93.54 28.01 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.078 -179.57 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.68 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.4 Cg_exo -55.62 138.99 82.45 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.553 2.169 . . . . 0.0 111.493 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.77 -25.42 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.463 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.68 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.83 -49.55 28.42 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.56 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.8 mt -54.61 -37.18 65.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 0.0 110.098 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.29 35.8 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.837 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.56 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.38 88.35 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 82.6 p -81.83 -14.12 56.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.307 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.53 -40.89 11.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.582 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 24.7 t -66.86 -16.87 64.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.643 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.99 43.6 26.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.45 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.94 -147.44 7.43 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.02 142.95 49.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.035 0.445 . . . . 0.0 110.291 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.23 149.69 28.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.361 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -101.3 -151.35 0.41 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.294 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 55.76 -92.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.611 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.455 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.3 tt -126.56 174.8 9.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.604 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.455 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.7 mt -121.4 141.09 43.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.781 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.42 168.85 9.73 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.224 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.8 mt -147.57 150.85 35.26 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.191 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.75 -38.76 96.66 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.05 4.27 4.65 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.47 -58.03 3.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.94 0.4 . . . . 0.0 110.571 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.545 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.1 m-20 -62.42 -36.6 82.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.282 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.402 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.2 mp -52.29 -67.64 0.23 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.808 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.67 -42.11 67.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.072 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.84 17.97 0.15 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.698 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.77 48.32 0.26 Allowed Glycine 0 N--CA 1.464 0.564 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.36 -109.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.595 0.236 . . . . 0.0 110.741 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.74 -44.95 96.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.484 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.54 8.23 83.41 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -99.53 -12.24 20.31 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.751 -0.264 . . . . 0.0 110.732 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.7 t 176.2 142.47 0.07 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.096 0.474 . . . . 0.0 110.482 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.06 126.04 12.04 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.077 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 14.0 m-30 -99.06 142.89 29.97 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 120.893 0.378 . . . . 0.0 110.907 178.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.45 106.61 18.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.596 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.47 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.8 t80 -102.3 -12.1 18.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.203 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.66 -40.32 88.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.833 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.22 173.45 45.92 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.495 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.4 m-20 -74.49 -113.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.772 0.32 . . . . 0.0 110.77 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.27 -28.69 68.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.635 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.06 -44.19 91.81 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.306 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.64 -44.29 94.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.379 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.54 -60.09 3.66 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.174 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.21 -43.41 61.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.219 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.45 -43.87 75.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.159 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.6 mt -64.31 -43.62 97.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.651 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -56.84 -37.49 71.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.21 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.03 0.93 19.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.249 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -114.83 91.53 26.45 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.086 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.14 -27.26 28.91 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.743 2.295 . . . . 0.0 111.823 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.27 -41.37 99.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.63 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.8 mp -95.01 4.87 53.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.324 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.7 -35.24 70.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.667 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.72 4.59 15.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.51 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.82 121.51 81.6 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.563 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -47.72 -37.76 28.31 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.415 2.076 . . . . 0.0 112.553 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.535 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.94 -43.7 91.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.803 0.335 . . . . 0.0 110.266 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.7 -43.78 93.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.286 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.91 -40.6 95.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.43 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.4 -12.48 40.19 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.569 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.25 31.69 17.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.891 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -88.64 44.22 1.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.419 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.91 135.58 43.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.436 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.23 132.87 56.54 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.452 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.42 87.6 6.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.72 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.95 -41.33 97.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.983 0.421 . . . . 0.0 110.906 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.47 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.91 168.6 35.04 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 77.2 p -75.89 -25.79 56.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.834 0.35 . . . . 0.0 110.705 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -67.71 -34.55 77.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.484 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.759 HG22 ' O ' ' A' ' 296' ' ' THR . 98.5 m -72.96 19.38 0.09 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.596 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.52 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 52.0 t80 -57.36 -50.88 71.56 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.049 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 69.8 mmt-85 -108.15 148.98 29.11 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.426 ' CD2' HD11 ' A' ' 219' ' ' LEU . 40.1 tp -115.54 125.87 53.54 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.696 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.476 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.6 t0 -149.32 166.7 28.18 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.651 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -49.45 -38.22 28.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.597 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -72.6 -64.61 0.92 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.925 0.393 . . . . 0.0 111.381 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.26 -31.49 70.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.889 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -55.54 -25.05 35.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.523 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.7 mtt -63.08 -41.52 99.43 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 120.923 0.392 . . . . 0.0 110.809 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.16 -44.28 26.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.018 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.534 HG21 HG23 ' A' ' 296' ' ' THR . 78.6 t -66.16 -43.08 92.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.415 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.494 HD11 ' NE2' ' A' ' 183' ' ' GLN . 50.5 tp -60.37 -47.3 86.66 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.529 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -69.8 -39.69 76.4 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.675 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.498 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 70.6 ttt180 -61.76 -37.92 86.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.218 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.72 4.79 42.78 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.769 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.402 ' HZ2' ' CD ' ' A' ' 183' ' ' GLN . 87.4 tttt -112.58 -12.09 13.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.045 0.45 . . . . 0.0 110.246 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.22 85.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.574 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.87 -48.63 80.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.328 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.025 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -90.16 -2.81 58.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.369 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.09 179.22 1.22 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.513 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.6 Cg_exo -60.92 145.16 99.46 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.815 2.343 . . . . 0.0 112.179 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.35 -179.38 8.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.571 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -116.33 137.15 52.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.98 0.419 . . . . 0.0 110.329 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -123.99 146.61 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.349 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -120.28 136.4 54.68 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.771 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 53.1 p30 -99.81 -143.16 0.33 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.133 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -62.87 -36.87 84.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.399 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.468 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -152.23 -59.76 0.15 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.446 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -60.75 140.27 48.06 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.1 p -111.78 130.21 55.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.925 0.393 . . . . 0.0 110.404 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -120.05 128.62 53.68 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.509 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.2 m -85.5 130.14 34.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.205 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.497 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.7 mt -96.29 78.61 3.08 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.343 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.46 -31.83 73.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.556 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.75 109.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.976 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.497 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -122.75 91.2 49.74 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.287 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.643 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -57.15 148.63 68.44 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.82 2.347 . . . . 0.0 111.876 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.28 82.77 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.653 0.595 . . . . 0.0 110.999 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.643 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.67 67.0 0.88 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.142 0.496 . . . . 0.0 110.229 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -77.07 130.93 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.752 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.575 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.6 t -122.58 147.72 26.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.047 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.0 t -136.55 143.97 43.97 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.666 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.408 ' OG1' ' N ' ' A' ' 50' ' ' SER . 18.2 p -99.71 -58.8 1.84 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.557 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.408 ' N ' ' OG1' ' A' ' 49' ' ' THR . 88.4 p -79.43 155.25 28.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.637 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.527 HG21 HG23 ' A' ' 70' ' ' THR . 69.0 t -74.05 -21.94 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.569 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.6 m -60.26 -51.92 67.48 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.516 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 mt -66.21 -42.68 88.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.172 0.511 . . . . 0.0 110.897 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.3 m -43.16 -53.96 4.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.959 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.0 -37.55 73.86 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 m -62.86 -44.22 96.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.87 0.366 . . . . 0.0 110.244 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 17.5 mt -65.86 -42.33 90.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.602 0.715 . . . . 0.0 110.679 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tp -62.93 -39.69 95.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.519 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.495 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.6 -36.0 77.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.235 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.51 HD11 HD12 ' A' ' 156' ' ' LEU . 34.2 pt -91.36 28.09 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.257 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.79 51.83 10.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.011 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.16 76.07 27.62 Favored Pre-proline 0 C--O 1.225 -0.189 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.02 149.6 90.14 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.742 2.294 . . . . 0.0 112.108 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.575 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.57 136.61 48.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-O 121.233 0.539 . . . . 0.0 110.256 179.678 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.434 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.3 pt -69.3 -43.73 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.369 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.16 131.15 53.27 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.989 0.423 . . . . 0.0 110.628 -178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.5 p -155.65 168.6 26.64 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.38 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.34 -177.24 21.98 Favored Glycine 0 N--CA 1.465 0.593 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.635 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.42 172.04 13.25 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 121.067 0.46 . . . . 0.0 110.434 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.527 HG23 HG21 ' A' ' 51' ' ' VAL . 12.8 p -133.38 -111.37 0.23 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.001 0.429 . . . . 0.0 110.346 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.94 179.73 0.93 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.356 -179.019 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.0 Cg_exo -61.02 58.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 123.032 2.488 . . . . 0.0 112.14 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.535 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.7 t-20 -64.38 -34.23 77.68 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 118.716 -0.659 . . . . 0.0 110.423 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.6 m120 94.6 -37.27 0.01 OUTLIER 'General case' 0 C--N 1.348 0.543 0 O-C-N 124.156 0.91 . . . . 0.0 109.684 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -62.73 -40.07 96.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.029 0.442 . . . . 0.0 110.203 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -73.99 -26.16 20.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.714 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.75 -172.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.539 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.54 -153.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.79 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.3 p-10 -54.21 -6.85 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.707 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.01 114.19 23.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.647 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.42 72.06 1.3 Allowed Glycine 0 C--O 1.225 -0.446 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -143.58 148.13 35.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.913 0.387 . . . . 0.0 110.839 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -85.89 -98.77 0.07 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.076 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.86 -43.39 96.23 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.14 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.537 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.2 tt0 91.65 52.69 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 124.143 0.902 . . . . 0.0 110.919 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -103.33 -8.53 20.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.387 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -65.52 -33.31 75.63 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.198 0.523 . . . . 0.0 110.687 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -49.24 -24.26 1.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.629 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.8 t -69.57 -46.02 76.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.842 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.24 -48.51 81.12 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.984 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.61 -38.23 89.38 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.367 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.71 -32.86 53.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.144 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.588 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.79 1.71 55.8 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.554 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 83.03 -49.38 0.15 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.141 0.901 . . . . 0.0 110.275 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.628 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.1 mt -46.23 153.72 0.31 Allowed 'General case' 0 CA--C 1.486 -1.483 0 CA-C-O 117.127 -1.416 . . . . 0.0 109.257 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.628 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.35 92.06 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 O-C-N 125.896 1.998 . . . . 0.0 110.525 -178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.01 142.83 43.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.174 0.512 . . . . 0.0 110.212 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.8 mt -131.96 26.52 4.6 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.041 -0.412 . . . . 0.0 110.443 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -140.03 137.5 34.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.032 0.444 . . . . 0.0 110.516 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.7 mt -136.82 164.7 29.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.352 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.612 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.76 -28.76 1.74 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.08 70.67 7.77 Favored Pre-proline 0 N--CA 1.464 0.256 0 CA-C-O 121.195 0.521 . . . . 0.0 110.206 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.98 145.29 98.7 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.743 2.295 . . . . 0.0 112.087 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.1 t -135.03 137.11 42.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.507 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.0 -38.35 82.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.697 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.19 -42.23 96.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.512 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.91 -41.61 98.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.545 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.46 -43.35 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.96 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.04 -35.17 77.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.022 0.439 . . . . 0.0 110.216 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.58 -18.96 61.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.459 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.32 -6.55 58.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.537 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.413 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 68.9 mtp 47.65 55.87 17.11 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.661 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.5 Cg_endo -70.34 149.64 63.48 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.755 2.303 . . . . 0.0 112.132 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.48 -72.78 0.67 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.451 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.421 HD11 HD13 ' A' ' 140' ' ' LEU . 38.5 tp -111.61 113.93 26.65 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.348 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.0 mt -102.96 126.79 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 120.935 0.398 . . . . 0.0 110.566 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.2 mt -110.33 134.16 52.56 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.111 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.65 139.72 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.501 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.1 p -83.22 167.78 17.37 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.708 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.34 -37.25 80.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.43 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.6 t -139.57 158.6 43.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.439 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.59 176.64 33.87 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.68 86.88 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.34 151.38 44.41 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.919 0.39 . . . . 0.0 110.547 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.4 t -63.56 140.89 58.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.268 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.55 10.65 11.15 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.618 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.2 -39.07 88.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.171 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.628 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.75 -35.9 24.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.614 0.721 . . . . 0.0 110.667 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.8 mt -70.98 -35.26 72.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.525 0.678 . . . . 0.0 110.74 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.9 -62.98 0.87 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.339 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.628 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.72 -42.73 90.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -61.97 -32.64 73.1 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.509 0.506 . . . . 0.0 110.222 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.4 mt -73.75 -40.56 63.41 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.49 -49.03 78.82 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.137 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.8 m -52.98 -42.52 65.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.237 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.91 -43.08 93.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.991 0.424 . . . . 0.0 111.208 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.06 152.89 5.36 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.677 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -38.92 107.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.673 2.249 . . . . 0.0 112.488 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.637 ' C ' HD12 ' A' ' 140' ' ' LEU . 96.8 m -109.61 121.44 45.22 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.041 0.448 . . . . 0.0 110.181 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.637 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.83 152.68 30.33 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.254 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.2 tt -128.06 131.16 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.38 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.34 127.75 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.49 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 54.4 t30 -100.15 104.57 16.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.176 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -100.28 -12.02 19.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.014 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.8 p-10 -65.16 -34.08 77.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.81 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.581 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.8 p-10 -99.34 7.92 45.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.585 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -134.05 151.44 51.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.56 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.42 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.8 p -75.87 166.31 23.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.635 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.595 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.0 t90 -59.26 -48.76 80.43 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.101 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -54.24 -44.12 71.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.989 0.423 . . . . 0.0 110.04 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.3 t -63.05 -40.8 98.78 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.344 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.416 ' O ' HD23 ' A' ' 156' ' ' LEU . 62.7 tp -60.62 -44.52 96.23 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.287 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.6 tp -61.56 -42.51 98.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.192 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.9 m -55.55 -46.14 77.17 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.83 -40.6 95.87 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.962 0.41 . . . . 0.0 110.337 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.51 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -62.12 -42.51 99.3 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.41 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.27 -40.11 94.62 Favored Glycine 0 C--O 1.222 -0.608 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.34 -45.9 65.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.931 0.396 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.83 -44.1 96.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.2 p -92.95 -9.3 40.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.61 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.18 26.37 72.49 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -101.97 50.73 0.84 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.822 0.344 . . . . 0.0 110.694 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.63 -39.27 77.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.667 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.5 -47.21 86.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.223 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -59.84 -39.54 85.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.209 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.16 -40.82 98.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.059 0.457 . . . . 0.0 110.259 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.83 -29.03 70.42 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.966 0.412 . . . . 0.0 110.616 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -73.94 -54.39 8.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.076 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.495 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.6 ttp180 -64.67 -42.02 95.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.419 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.4 mt -62.3 -43.93 98.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.531 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.99 -59.67 4.76 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.136 0.493 . . . . 0.0 110.253 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -55.91 -34.15 65.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.48 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -80.17 -36.18 35.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.798 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.2 m-20 -54.66 -42.02 70.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.926 -178.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.98 -41.39 97.97 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.62 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -64.93 -38.21 90.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.322 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.1 mt -62.33 -42.45 99.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.804 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.84 -53.38 56.67 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.149 0.5 . . . . 0.0 110.685 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.22 -41.82 89.55 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.694 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.7 -40.31 96.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.697 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.03 -32.54 73.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.39 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.2 -21.53 19.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.736 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.594 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.7 tt0 -64.7 -41.93 95.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.763 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.1 pt -75.98 133.76 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.043 0.449 . . . . 0.0 110.723 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -127.51 106.11 8.95 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.317 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.3 128.27 0.35 Allowed Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.576 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.447 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.5 Cg_exo -43.44 151.3 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.812 2.342 . . . . 0.0 112.667 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.66 142.43 53.06 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.577 2.185 . . . . 0.0 112.517 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.544 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -170.97 147.29 2.28 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.672 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.9 153.96 71.77 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.761 2.308 . . . . 0.0 112.299 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.21 163.05 29.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.228 0.537 . . . . 0.0 110.415 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.578 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.52 169.82 16.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.949 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.03 137.59 22.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.987 0.422 . . . . 0.0 110.11 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.532 HG22 HD12 ' A' ' 205' ' ' LEU . 39.5 pt -134.22 146.34 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.76 131.9 59.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.198 0.523 . . . . 0.0 110.471 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -151.86 154.77 36.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.409 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.0 m -121.64 122.78 40.39 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 110.358 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.6 -25.61 66.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.638 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.611 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.95 -49.43 20.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.966 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.75 -12.03 60.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.34 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.7 m80 49.59 42.35 22.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.435 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.8 t -136.39 145.29 45.17 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.354 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.84 114.39 27.7 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.268 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.93 133.37 55.59 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.108 0.48 . . . . 0.0 110.289 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.532 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.07 146.4 38.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.793 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.476 ' N ' HD23 ' A' ' 205' ' ' LEU . 12.9 t90 -99.69 127.99 45.8 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.187 0.518 . . . . 0.0 109.86 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.46 153.67 41.35 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.401 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.74 -18.57 47.72 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.655 2.237 . . . . 0.0 111.977 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.13 -18.35 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.343 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.448 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.6 p -75.36 167.8 21.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.484 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.24 -35.62 75.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.429 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.5 mt-30 -56.74 -41.12 76.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.698 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.42 -42.99 97.77 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.503 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 73.1 mt-30 -63.91 -39.95 95.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 122.279 -0.541 . . . . 0.0 110.745 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.595 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.4 mmm -61.83 -41.54 97.91 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.196 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 77.5 mt -63.46 -49.79 72.26 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 121.16 0.505 . . . . 0.0 110.404 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.38 -32.66 50.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 0.0 110.076 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.18 -20.07 62.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.578 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 219' ' ' LEU . 67.1 mt -87.39 -6.53 58.42 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.58 3.89 57.24 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -88.63 149.81 23.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 0.0 110.527 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.447 ' O ' HG12 ' A' ' 191' ' ' VAL . 3.5 p -112.96 126.83 55.91 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.211 0.529 . . . . 0.0 110.191 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.87 145.61 24.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.061 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.48 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.9 150.51 46.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.398 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.61 131.29 44.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.385 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.888 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.67 92.97 26.18 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.996 -179.535 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.681 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.1 Cg_exo -55.6 139.13 82.53 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.542 2.161 . . . . 0.0 111.582 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.51 -24.62 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.483 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.681 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.07 -49.59 26.77 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.555 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -54.57 -36.91 64.88 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.63 36.06 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.82 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.555 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.68 87.4 0.01 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.879 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.5 p -80.81 -14.73 57.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.334 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.42 -41.11 11.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.668 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.2 t -66.85 -16.65 64.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.585 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.01 43.74 26.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.431 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.77 -146.87 7.22 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.57 143.42 49.75 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.026 0.441 . . . . 0.0 110.296 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -151.75 149.26 28.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.279 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -100.36 -152.83 0.43 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.317 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.6 t0 56.44 -91.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.671 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.471 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.67 175.39 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.594 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.471 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.8 mt -121.41 141.04 43.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.842 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.41 168.98 9.65 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.14 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.0 mt -147.3 150.69 35.27 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.278 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.69 -39.04 97.09 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.56 3.75 4.55 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.0 -58.31 3.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.959 0.409 . . . . 0.0 110.562 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.556 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.1 m-20 -62.06 -36.92 83.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.209 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.18 -67.66 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.79 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.6 -42.02 67.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.091 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.15 18.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.689 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.44 47.53 0.2 Allowed Glycine 0 N--CA 1.466 0.642 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 39.23 -109.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.569 0.223 . . . . 0.0 110.684 -178.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.48 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.5 m120 -60.98 -44.99 96.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.367 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.78 8.04 83.26 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -99.22 -12.47 20.38 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.709 -0.289 . . . . 0.0 110.687 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.4 t 176.38 142.65 0.07 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.085 0.469 . . . . 0.0 110.449 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.16 125.77 11.77 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.207 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.63 143.04 29.45 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 120.885 0.374 . . . . 0.0 110.958 178.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.0 mt -94.39 106.77 18.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.659 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.472 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 93.0 t80 -102.23 -12.95 17.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.117 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -65.87 -40.45 91.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.892 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.18 173.48 45.95 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.492 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -74.27 -112.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.76 0.314 . . . . 0.0 110.749 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.93 -28.77 67.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.673 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.2 -44.05 92.23 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.259 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.5 -44.49 94.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.327 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.45 -59.67 4.15 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.12 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.35 -43.41 61.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.069 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.74 74.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.194 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.3 -43.61 97.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.592 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -56.57 -37.77 71.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.074 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.32 0.99 20.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.168 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -115.07 91.28 26.48 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.094 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.05 -27.22 28.16 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.786 2.324 . . . . 0.0 111.897 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -41.27 98.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.536 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.9 mp -95.44 4.91 52.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.347 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.76 -35.31 70.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.644 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.82 4.77 15.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.489 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.525 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.68 121.2 80.22 Favored Pre-proline 0 N--CA 1.44 -0.937 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.587 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -47.55 -37.48 26.53 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.41 2.073 . . . . 0.0 112.628 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.72 -43.48 90.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.747 0.308 . . . . 0.0 110.245 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.85 -43.74 93.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.246 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.86 -40.62 95.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.335 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.46 -12.6 39.68 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.603 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 62.01 31.64 17.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.003 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.42 44.33 1.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.136 0.493 . . . . 0.0 110.327 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.4 135.82 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.439 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.65 132.42 56.69 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.4 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.49 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.83 88.39 6.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.77 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.431 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.9 mt -63.83 -41.74 97.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.983 0.42 . . . . 0.0 110.832 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.472 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.85 165.94 34.56 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 76.8 p -75.62 -25.99 57.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.846 0.355 . . . . 0.0 110.703 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.3 tp10 -68.4 -34.03 75.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.442 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.758 HG22 ' O ' ' A' ' 296' ' ' THR . 99.4 m -72.26 18.82 0.08 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.558 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.508 ' O ' ' NE2' ' A' ' 212' ' ' GLN . 48.1 t80 -56.93 -51.03 70.76 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.873 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -107.09 148.15 29.13 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 41.0 tp -115.52 126.11 53.86 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.842 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.477 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.0 t0 -149.55 166.83 28.04 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.672 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -49.28 -38.03 25.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.631 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -71.75 -64.91 0.84 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.47 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.9 -32.94 72.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.979 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.47 -25.52 25.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.66 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.2 mtt -63.56 -41.07 98.43 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 120.906 0.384 . . . . 0.0 111.06 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -77.65 -44.61 27.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.084 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.579 HG21 HG23 ' A' ' 296' ' ' THR . 79.6 t -66.12 -42.88 92.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.346 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.594 HD11 ' NE2' ' A' ' 183' ' ' GLN . 48.3 tp -59.92 -47.05 87.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.449 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -70.19 -39.55 75.15 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.134 0.492 . . . . 0.0 110.897 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.492 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 73.9 ttt180 -61.28 -37.79 84.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.197 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -88.06 5.06 42.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.689 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -112.23 -11.84 13.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.075 0.464 . . . . 0.0 110.303 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.26 85.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.53 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.97 -48.73 80.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.339 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.941 -179.964 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -89.89 -2.68 58.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.417 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.493 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.15 1.23 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.501 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.493 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.8 Cg_exo -60.81 144.89 99.64 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.86 2.373 . . . . 0.0 112.123 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.83 -179.48 8.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.592 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.77 137.0 52.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.371 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.71 146.99 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.383 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -120.03 136.14 54.67 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.791 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.36 -143.48 0.32 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.225 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.66 -37.08 86.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.458 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.21 -66.62 0.22 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.435 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.6 142.39 45.59 Favored Glycine 0 CA--C 1.519 0.294 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.6 p -112.17 131.36 55.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 110.443 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -119.1 129.1 54.88 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.485 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.9 m -85.76 130.37 34.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.225 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.486 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.3 mt -95.91 79.07 3.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.439 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.61 -31.96 73.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.71 109.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.986 0.422 . . . . 0.0 110.121 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.486 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.49 91.92 49.19 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.435 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.9 Cg_exo -56.7 148.67 63.9 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.804 2.336 . . . . 0.0 111.953 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.58 82.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.591 0.557 . . . . 0.0 110.979 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.5 66.84 0.89 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.271 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.06 130.58 36.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.812 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.561 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.7 t -122.61 146.71 27.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.061 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.0 t -135.96 143.96 45.16 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.77 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.5 p -99.5 -59.4 1.73 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.624 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.2 p -79.28 155.07 28.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.651 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.503 HG21 HG23 ' A' ' 70' ' ' THR . 73.3 t -74.05 -21.91 18.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.529 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.4 m -60.23 -52.07 66.85 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.536 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.38 -42.6 87.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.102 0.477 . . . . 0.0 110.787 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.9 m -43.14 -54.07 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.029 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.33 -37.05 70.53 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m -62.88 -44.71 95.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.867 0.365 . . . . 0.0 110.252 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.0 mt -66.37 -41.9 88.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.487 0.661 . . . . 0.0 110.75 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -62.61 -40.33 96.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.431 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.501 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.04 -35.61 75.48 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.202 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.529 HD11 HD12 ' A' ' 156' ' ' LEU . 32.6 pt -91.54 28.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.253 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.45 51.67 11.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.32 75.7 22.57 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.0 0.429 . . . . 0.0 109.919 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.61 151.35 85.96 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.825 2.35 . . . . 0.0 112.16 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.561 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.42 137.31 46.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.182 0.515 . . . . 0.0 110.274 179.772 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.445 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.4 pt -69.42 -43.4 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.359 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.03 131.17 53.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.96 0.41 . . . . 0.0 110.594 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.8 p -155.64 168.49 26.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.489 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.66 -177.16 21.78 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.649 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.92 172.85 12.24 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 110.449 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.503 HG23 HG21 ' A' ' 51' ' ' VAL . 14.9 p -133.16 -111.93 0.23 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.001 0.429 . . . . 0.0 110.428 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.43 179.68 0.94 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.509 -179.278 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.7 Cg_exo -60.97 58.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.965 2.443 . . . . 0.0 112.099 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.1 t-20 -64.43 -33.73 76.54 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.485 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 11.1 m120 94.07 -36.96 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.875 0.734 . . . . 0.0 109.808 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -62.75 -39.73 95.06 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.188 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.35 -25.54 19.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.669 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.31 -171.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.428 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.14 -153.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.87 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.5 p-10 -52.72 -7.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.749 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.509 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.52 114.88 23.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.648 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.95 69.69 1.36 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -143.05 147.15 34.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 110.813 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -84.92 -98.58 0.06 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.11 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.556 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.06 -42.48 97.0 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.13 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.556 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 9.8 tt0 91.29 52.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.841 0.713 . . . . 0.0 111.076 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -102.8 -9.25 20.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.374 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.3 p -64.36 -34.11 77.39 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.138 0.494 . . . . 0.0 110.695 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -49.05 -23.61 1.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.677 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.92 -45.97 75.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.746 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.26 -48.55 80.9 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.009 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.37 -38.34 89.2 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.446 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.57 -32.74 52.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.175 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.611 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.4 mmt-85 -90.1 1.75 56.03 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.535 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.611 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 56.9 mttp 82.84 -49.38 0.17 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.838 0.711 . . . . 0.0 110.318 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.664 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.3 mt -45.86 154.01 0.25 Allowed 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 117.733 -1.127 . . . . 0.0 109.598 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.664 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.22 92.62 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 125.387 1.679 . . . . 0.0 110.521 -178.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.543 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.65 143.17 42.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.249 0.547 . . . . 0.0 110.244 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.9 mt -132.23 27.04 4.5 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 122.013 -0.429 . . . . 0.0 110.454 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.32 137.94 34.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.03 0.443 . . . . 0.0 110.559 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.2 mt -137.33 165.1 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.356 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.58 -28.48 1.91 Allowed Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.22 70.45 7.63 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.13 0.49 . . . . 0.0 110.172 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.93 145.23 98.83 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.751 2.301 . . . . 0.0 112.098 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.5 t -134.57 136.59 43.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.97 0.414 . . . . 0.0 110.544 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.37 83.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.63 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.14 -42.41 96.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.527 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.6 98.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.525 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.7 -43.41 98.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.03 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.23 -35.03 77.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.181 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.59 -18.73 60.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.407 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.61 -6.47 58.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.531 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 70.3 mtp 47.59 56.06 17.22 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.596 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.1 149.33 64.57 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.737 2.291 . . . . 0.0 112.12 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.24 -74.0 0.63 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.43 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.8 tp -110.22 112.91 25.17 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.268 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.4 mt -101.82 126.26 55.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.694 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 mt -109.51 133.7 52.77 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.276 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.54 139.44 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.594 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.5 p -83.43 168.58 16.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.793 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.24 -37.43 80.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.427 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.74 158.99 43.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.488 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.15 177.43 33.19 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.19 -33.9 87.38 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -125.12 151.98 45.01 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.9 0.381 . . . . 0.0 110.522 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.4 t -63.14 140.99 58.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.369 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.43 10.32 11.16 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.649 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.01 -38.79 87.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.244 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.638 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.2 -35.89 23.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.449 0.643 . . . . 0.0 110.628 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.1 mt -71.05 -35.51 71.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.504 0.668 . . . . 0.0 110.673 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -42.68 -62.71 0.92 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.356 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.638 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.91 -42.73 89.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.159 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -62.08 -32.69 73.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.338 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.3 mt -73.75 -40.98 63.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.898 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.27 -48.84 79.17 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.19 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.2 m -53.2 -42.48 66.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.182 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.81 -42.94 93.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.022 0.439 . . . . 0.0 111.158 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.64 154.57 5.53 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.657 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -39.39 106.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.647 2.232 . . . . 0.0 112.496 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.7 m -110.5 121.35 45.09 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.093 0.473 . . . . 0.0 110.199 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.22 153.28 29.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.286 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -129.29 131.55 67.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.404 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -115.16 128.03 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.056 0.455 . . . . 0.0 110.512 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.62 103.56 14.38 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.197 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.8 p90 -101.15 -11.21 19.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.872 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.2 p-10 -64.84 -33.41 75.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.703 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.571 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.3 p-10 -98.38 8.0 45.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.567 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.45 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.88 155.62 50.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.466 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.403 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.8 p -75.01 165.62 24.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.668 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.59 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.88 -48.62 80.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.217 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.54 -42.02 67.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.001 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.4 t -62.74 -41.06 99.01 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.37 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.409 ' CD1' HG21 ' A' ' 142' ' ' ILE . 45.6 tp -60.59 -44.41 96.29 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.406 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.37 -43.41 98.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.166 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.0 m -55.07 -44.93 75.26 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.35 -40.74 97.38 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.967 0.413 . . . . 0.0 110.507 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.529 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.94 -42.54 99.23 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.311 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.13 -40.85 95.16 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.57 -45.99 64.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.937 0.398 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.75 -43.98 96.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.837 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -93.07 -8.83 41.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.632 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.96 26.63 72.34 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.69 50.59 0.85 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.807 0.337 . . . . 0.0 110.678 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -69.44 -39.48 77.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.648 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.46 -47.2 86.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.274 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -60.13 -39.38 86.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.163 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.98 99.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.246 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.92 -28.5 70.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.591 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.29 -54.27 8.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.895 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.501 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.48 -42.28 92.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.366 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.9 mt -62.36 -43.84 98.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.566 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.57 -58.36 7.83 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.999 0.428 . . . . 0.0 110.356 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.13 -33.55 67.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.589 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.402 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.5 t80 -81.34 -36.5 29.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.774 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -55.63 -42.29 74.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.023 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.28 -42.23 99.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.74 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.27 -37.98 88.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.295 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.7 mt -62.51 -42.12 99.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.729 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.13 -52.98 61.69 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.045 0.45 . . . . 0.0 110.667 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.22 -41.91 89.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.665 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.7 -40.02 95.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.592 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.38 -31.91 73.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.434 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.77 -22.4 18.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.67 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.459 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -64.75 -41.27 96.03 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.668 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.0 pt -76.24 136.27 25.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.657 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.47 107.83 10.62 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.29 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -177.16 125.8 0.29 Allowed Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.472 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.4 Cg_exo -44.04 152.38 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.864 2.376 . . . . 0.0 112.509 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.8 141.91 55.85 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.612 2.208 . . . . 0.0 112.446 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.27 147.14 2.13 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.548 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.08 154.34 70.57 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.811 2.34 . . . . 0.0 112.312 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.05 162.99 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.235 0.54 . . . . 0.0 110.403 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.72 170.33 16.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.927 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.66 137.75 21.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 110.126 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.557 HG22 HD12 ' A' ' 205' ' ' LEU . 39.4 pt -134.54 147.2 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.661 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.02 132.15 58.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.115 0.483 . . . . 0.0 110.488 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -152.44 155.72 38.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.444 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.626 HG22 ' H ' ' A' ' 199' ' ' ALA . 88.8 m -123.25 123.48 40.85 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.945 0.402 . . . . 0.0 110.375 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.63 -25.64 66.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.626 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.626 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.69 -48.96 19.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.006 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.61 -12.06 60.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.497 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.1 m80 49.28 41.02 19.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.526 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.3 t -135.84 143.65 45.23 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.385 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.424 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -109.83 114.29 27.74 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.24 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.82 133.36 55.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.016 0.436 . . . . 0.0 110.488 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.557 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.87 146.62 37.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.834 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.497 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 10.0 t90 -99.97 129.65 46.06 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.186 0.517 . . . . 0.0 109.869 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.85 153.73 39.94 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.39 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.3 Cg_endo -67.77 -18.06 47.44 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.755 2.303 . . . . 0.0 111.975 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.27 -19.12 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.369 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.497 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.5 p -75.4 164.41 26.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.497 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.78 -27.66 65.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.526 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.61 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.0 mt-30 -63.88 -41.03 97.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.556 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.81 -44.48 97.96 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.45 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.1 mt-30 -64.49 -38.77 92.17 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 122.299 -0.53 . . . . 0.0 110.697 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.59 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.3 mmm -61.93 -41.24 97.72 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.209 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.56 -47.31 82.09 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.022 0.439 . . . . 0.0 110.437 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.91 -31.97 51.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.866 0.365 . . . . 0.0 110.268 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -70.9 -18.63 62.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.508 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.436 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.3 mt -87.65 -9.12 55.11 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.602 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.16 1.84 54.46 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -88.42 153.55 21.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.904 0.383 . . . . 0.0 110.468 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.434 ' O ' HG12 ' A' ' 191' ' ' VAL . 7.3 p -116.4 128.87 55.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.14 0.495 . . . . 0.0 110.41 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.48 146.3 23.79 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.916 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.486 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.93 151.5 45.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.488 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.49 131.51 43.51 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.428 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.888 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.72 93.44 28.53 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.05 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.676 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.2 Cg_exo -55.38 138.78 80.84 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.545 2.163 . . . . 0.0 111.679 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.98 -26.05 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.457 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.676 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.03 -50.11 30.57 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.56 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.5 mt -54.43 -37.07 64.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.45 36.24 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.74 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.56 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.3 86.31 0.02 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.878 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.5 p -79.2 -15.08 58.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.382 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -92.6 -41.01 10.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.603 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.9 t -66.13 -17.86 64.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.645 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 56.16 43.3 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.492 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.34 -148.34 7.72 Favored Glycine 0 CA--C 1.519 0.289 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.58 142.75 49.8 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 110.347 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -152.36 149.89 29.12 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.296 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -101.28 -151.33 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.348 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 55.81 -92.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.672 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.462 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.85 175.38 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.627 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.462 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.8 mt -122.5 141.81 41.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.65 169.32 9.35 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.23 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.3 mt -147.52 150.94 35.5 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.264 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.93 -38.85 96.67 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.35 3.77 4.65 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -77.34 -58.13 3.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.924 0.392 . . . . 0.0 110.538 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.546 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.0 m-20 -62.14 -36.34 81.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.308 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.424 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.1 mp -52.55 -67.51 0.25 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.86 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.75 -42.37 68.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.081 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.7 17.59 0.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.669 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.86 48.47 0.27 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.394 -0.683 . . . . 0.0 111.394 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 38.82 -109.98 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.593 0.235 . . . . 0.0 110.712 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.486 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.6 m120 -60.86 -44.93 96.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.475 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.47 7.99 83.87 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -98.91 -13.66 19.91 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.647 -0.325 . . . . 0.0 110.66 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.4 t 177.25 142.78 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.087 0.47 . . . . 0.0 110.42 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.13 125.34 11.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.165 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 14.0 m-30 -98.28 143.63 28.56 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 120.865 0.364 . . . . 0.0 110.83 178.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.7 mt -95.18 106.67 18.71 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.794 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.437 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.7 t80 -102.26 -12.1 18.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.158 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.44 -40.4 89.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.886 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.0 173.3 45.86 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.461 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.3 m-20 -74.07 -113.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.756 0.312 . . . . 0.0 110.704 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.72 -28.81 67.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.686 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.1 -43.86 91.9 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.225 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.32 -44.55 94.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.316 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.56 -59.98 3.8 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.189 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -51.02 -43.38 60.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.151 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.47 -43.41 75.51 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.19 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.53 -43.68 96.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.629 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.25 -37.55 69.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.098 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.48 0.79 18.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.131 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -115.21 91.7 28.81 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.148 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.35 -27.07 29.73 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.748 2.299 . . . . 0.0 111.95 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.55 -41.06 98.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.503 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.597 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.33 5.24 52.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.381 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.13 -35.08 69.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.585 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.93 4.53 16.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.51 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.64 121.25 80.33 Favored Pre-proline 0 N--CA 1.445 -0.7 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.549 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -47.14 -38.0 24.3 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.483 2.122 . . . . 0.0 112.529 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.529 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.8 -43.66 90.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.704 0.288 . . . . 0.0 110.37 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.0 -43.62 92.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.355 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.92 -40.78 95.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.415 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 47.6 t-20 -89.65 -12.41 39.7 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.588 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.2 mtmt 61.94 32.19 17.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.995 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.76 43.97 1.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.061 0.457 . . . . 0.0 110.307 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.68 135.67 41.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.503 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.78 132.69 56.63 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.447 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.15 89.16 7.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.732 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.403 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.8 mt -63.82 -41.05 97.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.021 0.438 . . . . 0.0 110.856 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.437 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.2 165.02 33.52 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.1 p -75.28 -25.71 58.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.94 0.4 . . . . 0.0 110.771 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.503 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.3 tp10 -68.42 -34.03 75.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.393 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 96.6 m -73.35 24.84 0.07 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.736 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.61 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 39.7 t80 -58.07 -50.66 72.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.433 ' CZ ' ' CE2' ' A' ' 297' ' ' PHE . 80.0 mmt-85 -111.19 154.01 24.99 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.436 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.8 tp -115.44 124.98 52.51 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.814 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.481 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.8 t0 -147.69 165.55 30.13 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.619 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -49.34 -37.88 26.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.57 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -71.12 -65.6 0.72 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.504 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -61.01 -32.91 72.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.975 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.19 -25.55 23.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.743 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.2 mtt -63.6 -40.9 98.11 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 120.829 0.347 . . . . 0.0 111.07 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.76 -43.94 24.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.195 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.578 HG21 HG23 ' A' ' 296' ' ' THR . 76.6 t -66.34 -42.85 91.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.357 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.459 HD11 ' NE2' ' A' ' 183' ' ' GLN . 49.1 tp -60.22 -46.96 87.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.464 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -70.07 -39.47 75.62 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.054 0.454 . . . . 0.0 110.759 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.9 ttt180 -61.75 -38.29 87.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.248 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.12 4.39 42.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.607 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.404 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.4 tttt -112.77 -11.01 13.55 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.091 0.472 . . . . 0.0 110.347 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.41 -37.09 85.95 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.487 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.84 -48.71 80.58 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.457 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.006 179.868 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.618 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.02 -2.52 58.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.464 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.8 179.03 1.25 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.552 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.96 144.97 99.69 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.84 2.36 . . . . 0.0 112.092 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.618 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.68 -179.58 8.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.601 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.73 136.84 52.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.358 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.0 tp -124.53 147.5 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.396 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -120.35 135.97 54.85 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 110.742 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.27 -143.5 0.32 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.194 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.54 -37.11 86.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.417 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.09 -67.21 0.22 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.507 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.54 142.72 45.18 Favored Glycine 0 C--O 1.228 -0.275 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.9 p -112.29 131.57 55.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.962 0.41 . . . . 0.0 110.481 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -118.94 128.92 54.86 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.507 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.2 m -85.41 130.35 34.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.247 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.481 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.3 mt -95.59 78.54 3.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.405 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.69 -32.17 73.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.52 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.5 109.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.121 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.481 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.74 91.47 49.59 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.326 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.94 148.67 66.31 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.818 2.345 . . . . 0.0 111.894 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -40.71 82.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 O-C-N 123.657 0.598 . . . . 0.0 111.008 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.44 66.85 0.89 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.266 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.22 130.74 35.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.752 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.567 ' HA ' HG23 ' A' ' 64' ' ' VAL . 56.2 t -122.61 146.95 27.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.041 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 t -136.23 143.62 44.42 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.718 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.8 p -99.38 -59.25 1.76 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.526 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.8 p -79.35 155.57 28.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.646 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.548 HG21 HG23 ' A' ' 70' ' ' THR . 69.5 t -74.46 -21.97 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.591 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.7 m -60.25 -52.15 66.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.575 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.35 -42.53 87.93 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.173 0.511 . . . . 0.0 110.939 177.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.4 m -42.92 -54.07 4.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.041 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.47 -37.69 69.39 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.2 m -62.36 -44.63 96.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 110.299 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.4 mt -66.3 -41.98 88.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.445 0.641 . . . . 0.0 110.756 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -62.55 -40.17 95.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.442 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.495 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.19 -35.83 76.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.133 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.538 HD11 HD12 ' A' ' 156' ' ' LEU . 32.0 pt -91.41 29.06 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.266 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.42 51.92 10.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.887 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.4 75.67 22.35 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.961 0.41 . . . . 0.0 109.906 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.73 151.45 85.65 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.837 2.358 . . . . 0.0 112.162 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.567 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.58 137.16 47.65 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-O 121.214 0.53 . . . . 0.0 110.255 179.743 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.442 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.7 pt -69.48 -43.38 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.305 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.9 131.08 53.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.603 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.535 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.1 p -155.54 168.66 26.42 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.422 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.68 -177.2 21.76 Favored Glycine 0 N--CA 1.463 0.496 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.637 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.8 172.66 12.48 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.954 0.407 . . . . 0.0 110.538 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.548 HG23 HG21 ' A' ' 51' ' ' VAL . 15.3 p -132.26 -113.17 0.23 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.421 . . . . 0.0 110.359 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.77 179.72 0.95 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.408 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.1 Cg_exo -61.31 57.48 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 123.069 2.513 . . . . 0.0 112.091 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 60.4 t-20 -64.3 -33.07 74.97 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.462 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.5 m120 93.65 -35.55 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.962 0.789 . . . . 0.0 109.795 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HD3' HD21 ' A' ' 73' ' ' ASN . 77.4 mtp85 -63.23 -39.74 95.47 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.987 0.422 . . . . 0.0 110.173 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.79 -25.19 18.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.719 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -48.96 -171.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.555 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -73.72 -153.84 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.787 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 36.4 p-10 -52.34 -7.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.726 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -86.51 114.99 23.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.003 0.43 . . . . 0.0 110.59 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.07 70.2 1.34 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -143.57 147.46 34.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.825 0.345 . . . . 0.0 110.823 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.82 -98.58 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.136 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.551 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.82 -42.71 97.58 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.114 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.1 tt0 91.61 52.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.962 0.789 . . . . 0.0 110.907 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -102.53 -9.27 20.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.33 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -64.56 -34.17 77.63 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.043 0.449 . . . . 0.0 110.631 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -49.2 -24.36 1.71 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.614 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.42 -45.64 78.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.753 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.45 -48.3 81.76 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.037 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.52 -38.24 89.17 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.36 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.53 -32.98 52.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.155 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.601 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.86 1.46 56.15 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.493 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.98 -48.98 0.15 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.984 0.803 . . . . 0.0 110.208 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.651 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.5 153.83 0.34 Allowed 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 117.65 -1.167 . . . . 0.0 109.307 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.651 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.59 92.46 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 O-C-N 125.482 1.739 . . . . 0.0 110.491 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.52 143.19 42.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.138 0.494 . . . . 0.0 110.321 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.3 mt -132.24 27.1 4.5 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.122 -0.361 . . . . 0.0 110.362 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -140.31 137.83 34.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.045 0.45 . . . . 0.0 110.524 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.5 mt -136.99 165.02 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.447 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.97 -28.61 1.85 Allowed Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -152.61 70.79 7.39 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.153 0.501 . . . . 0.0 110.355 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.08 145.43 98.46 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.75 2.3 . . . . 0.0 112.06 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.7 t -134.56 136.77 43.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.514 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.37 82.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.635 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.11 -42.24 96.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.483 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.15 -41.62 98.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.48 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.59 -43.45 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.043 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.3 78.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.195 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.44 -18.7 60.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.413 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.52 -6.53 58.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.486 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 73.8 mtp 48.09 55.94 17.35 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.616 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.12 149.13 64.17 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.808 2.339 . . . . 0.0 112.129 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.32 -73.05 0.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.5 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.43 HD11 HD13 ' A' ' 140' ' ' LEU . 38.5 tp -111.35 113.48 25.98 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.313 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.4 mt -102.3 126.64 56.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.567 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 mt -110.19 133.94 52.72 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.262 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.98 139.95 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.474 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.6 p -83.5 168.67 16.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.741 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.46 80.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.442 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.1 t -139.94 159.21 42.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.423 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.31 177.29 33.4 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.28 -33.81 87.25 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.53 151.53 44.57 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.575 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.4 t -63.55 140.93 58.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.298 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.66 10.7 11.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.666 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.04 -39.05 88.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.187 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.01 -35.91 23.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.445 0.64 . . . . 0.0 110.576 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -70.8 -35.48 72.56 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.54 0.686 . . . . 0.0 110.784 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -42.91 -62.99 0.87 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.289 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.61 -42.84 91.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.132 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -61.95 -32.73 73.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.257 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.1 mt -73.82 -40.69 63.17 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.032 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.31 -48.98 78.78 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.186 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.5 m -53.0 -42.39 65.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.187 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.89 -43.04 93.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.089 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.43 153.61 5.33 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.633 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -39.15 106.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.687 2.258 . . . . 0.0 112.393 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.635 ' C ' HD12 ' A' ' 140' ' ' LEU . 93.4 m -109.94 121.35 45.04 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.191 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.71 152.82 29.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.269 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -129.13 131.17 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.326 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.411 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -115.16 128.17 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.073 0.463 . . . . 0.0 110.497 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.476 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.61 103.57 14.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.23 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.4 p90 -101.34 -11.35 19.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.832 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 48.9 p-10 -64.67 -33.52 76.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.639 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.566 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.2 p-10 -98.37 7.7 45.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.596 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.447 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.49 155.72 50.05 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.539 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.6 p -74.94 165.68 24.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.643 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.3 t90 -60.12 -48.76 80.38 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.256 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -53.42 -41.82 66.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.89 0.376 . . . . 0.0 110.064 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.1 t -62.82 -41.13 99.17 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.334 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.411 ' CD1' HG21 ' A' ' 142' ' ' ILE . 45.7 tp -60.7 -44.4 96.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.331 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.1 tp -61.4 -43.54 98.69 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.168 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -54.85 -45.03 74.48 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.44 -40.56 96.99 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.936 0.398 . . . . 0.0 110.492 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.538 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.96 -42.47 99.16 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.368 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.1 -40.85 95.22 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.59 -45.98 64.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.891 0.377 . . . . 0.0 110.842 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.8 mt -64.68 -43.96 96.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.893 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.3 p -92.99 -8.79 42.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.621 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.84 26.96 72.35 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -101.98 50.71 0.84 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 110.716 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.48 -39.23 77.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.635 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.66 -47.24 86.39 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.3 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -60.14 -39.47 86.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.225 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.96 99.31 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.292 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.92 -28.62 70.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.649 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.21 -54.3 8.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.048 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.495 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.4 ttp180 -65.47 -42.28 92.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.449 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.455 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.3 mt -62.52 -43.8 98.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.473 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.62 -59.08 5.43 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.067 0.46 . . . . 0.0 110.392 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -56.25 -34.2 66.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.568 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -80.87 -36.31 31.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.798 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.3 m-20 -54.98 -42.15 72.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.147 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.54 -41.92 99.2 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.639 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.08 -38.26 90.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.259 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 177' ' ' LEU . 81.4 mt -62.33 -42.19 99.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.692 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -52.81 62.52 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.135 0.493 . . . . 0.0 110.689 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.09 -41.99 89.94 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.673 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.87 -40.01 95.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.591 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.17 -32.27 73.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.379 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.3 -22.06 18.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.632 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.492 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.2 tt0 -64.75 -41.28 96.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.657 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 184' ' ' ILE . 32.8 pt -77.02 136.05 25.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.668 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.2 108.05 10.55 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.27 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.59 126.05 0.32 Allowed Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.458 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.7 152.23 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.796 2.331 . . . . 0.0 112.66 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.04 141.89 54.53 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.624 2.216 . . . . 0.0 112.479 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.42 147.24 2.1 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.605 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.32 155.1 68.35 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.772 2.315 . . . . 0.0 112.356 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.78 163.26 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.207 0.527 . . . . 0.0 110.371 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.61 170.05 16.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.894 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.17 137.47 22.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.067 0.46 . . . . 0.0 110.03 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.56 HG22 HD12 ' A' ' 205' ' ' LEU . 39.0 pt -134.28 146.67 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.637 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.55 131.75 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.348 0.594 . . . . 0.0 110.488 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -152.78 156.17 38.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.425 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 199' ' ' ALA . 88.4 m -122.17 122.88 40.21 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.878 0.37 . . . . 0.0 110.307 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.523 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.8 -26.32 67.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.591 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.599 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.68 -49.5 21.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.69 -10.44 59.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.449 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.523 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.9 m80 46.28 47.05 13.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.455 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -130.97 143.76 50.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.414 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.452 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -108.57 105.32 14.9 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.169 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.6 m-20 -115.95 128.79 56.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.148 0.499 . . . . 0.0 110.321 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.56 HD12 HG22 ' A' ' 194' ' ' ILE . 7.7 tt -111.84 146.32 37.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.47 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.2 t90 -99.55 128.55 45.66 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.131 0.491 . . . . 0.0 109.905 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.41 154.22 40.31 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.293 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.71 -18.09 47.81 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.726 2.284 . . . . 0.0 111.981 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.65 -19.26 0.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.472 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.434 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 87.0 p -74.76 164.44 26.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.483 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.98 -27.77 65.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.518 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.583 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.67 -41.45 98.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.634 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.07 -44.29 97.43 Favored Glycine 0 C--N 1.331 0.286 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.447 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.5 mt-30 -64.52 -38.77 92.16 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 122.4 -0.471 . . . . 0.0 110.683 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.3 mmm -62.12 -41.34 98.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.16 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.6 mt -63.59 -47.36 81.77 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.534 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.24 -31.83 54.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 0.0 110.113 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.97 -18.33 62.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.493 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.418 HD11 ' CD2' ' A' ' 299' ' ' LEU . 92.1 mt -88.37 -8.55 54.86 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.568 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.42 2.88 55.57 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -89.02 152.56 21.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 0.0 110.445 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.456 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.3 p -115.35 128.23 55.94 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.132 0.491 . . . . 0.0 110.334 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.16 146.75 23.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.038 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.46 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.4 151.28 45.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.487 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.07 131.69 42.65 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.39 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.884 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.38 93.78 28.46 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.095 -179.667 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.683 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.2 Cg_exo -55.47 138.73 81.11 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.607 2.205 . . . . 0.0 111.568 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.53 -25.49 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.471 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.68 -49.95 27.46 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.1 mt -55.15 -37.37 66.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.851 0.358 . . . . 0.0 110.086 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -65.54 35.53 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.84 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.573 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.45 88.3 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 86.2 p -82.26 -13.83 56.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.325 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.32 -40.67 11.35 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.611 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.2 t -66.71 -16.95 64.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.593 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.99 43.69 26.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.457 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.91 -148.08 7.81 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.61 142.25 49.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.998 0.427 . . . . 0.0 110.274 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.403 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.4 ttt-85 -152.0 149.54 29.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.342 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -102.02 -150.35 0.4 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.346 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.68 -93.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.616 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.0 tt -126.57 174.58 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.604 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.435 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 87.4 mt -121.7 140.94 44.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.902 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.28 170.33 8.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.169 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.5 mt -146.94 149.51 33.33 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.15 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.35 -39.25 97.58 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.19 3.06 4.01 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -78.33 -57.64 3.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.948 0.404 . . . . 0.0 110.583 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.617 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.8 m-20 -61.99 -36.89 82.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.245 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.452 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.7 mp -53.13 -67.42 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.022 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.488 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.72 -42.7 68.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.145 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.38 17.85 0.13 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.685 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.79 47.59 0.23 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 7.9 mp 39.71 -110.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.595 0.236 . . . . 0.0 110.651 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.46 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -60.92 -44.52 97.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.441 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.5 8.11 83.64 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -98.7 -13.31 20.32 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.779 -0.248 . . . . 0.0 110.712 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.0 t 176.85 142.84 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 110.478 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.89 125.49 11.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.108 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.83 143.64 28.93 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 120.92 0.391 . . . . 0.0 110.758 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.9 mt -94.91 106.31 18.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.724 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.451 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.9 -11.81 18.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.219 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.91 86.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.897 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.25 172.69 45.56 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.469 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -73.81 -113.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.0 110.72 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.44 -28.86 68.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.74 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.01 -43.9 91.6 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.275 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -63.53 -44.39 94.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.386 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.57 -59.81 4.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.187 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.21 -43.44 61.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.067 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.42 74.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.267 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.3 mt -64.66 -43.53 96.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.58 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -56.34 -37.61 70.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.133 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.75 0.85 19.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.149 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.08 91.17 26.08 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.127 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.21 -27.09 28.8 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.724 2.283 . . . . 0.0 111.912 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.46 -41.02 98.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.557 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.592 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.3 5.48 51.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.418 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.18 -35.21 68.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.658 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.55 4.5 15.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.495 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.6 121.46 81.02 Favored Pre-proline 0 N--CA 1.444 -0.764 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.541 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -47.46 -37.93 26.61 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.51 2.14 . . . . 0.0 112.556 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.66 -43.7 89.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.738 0.304 . . . . 0.0 110.292 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.04 -43.52 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.325 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.17 -40.86 97.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.441 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.413 ' ND2' ' CG ' ' A' ' 288' ' ' GLN . 58.0 t30 -90.99 -11.22 39.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.704 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.2 mtmt 61.1 32.66 19.68 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.481 0.488 . . . . 0.0 111.001 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.413 ' CG ' ' ND2' ' A' ' 286' ' ' ASN . 97.1 mm-40 -88.11 43.9 1.16 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.361 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.5 135.83 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.534 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.88 132.15 56.77 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.373 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.6 88.65 7.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.762 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.441 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.1 mt -64.0 -41.13 97.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.003 0.43 . . . . 0.0 110.892 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.451 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.25 166.39 34.04 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 70.3 p -75.29 -25.53 58.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.835 0.35 . . . . 0.0 110.719 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.3 tp10 -68.33 -33.91 75.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.535 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 296' ' ' THR . 97.7 m -73.62 23.42 0.07 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.617 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.583 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 59.3 t80 -58.04 -51.23 70.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.428 HH12 ' HG3' ' A' ' 212' ' ' GLN . 66.1 mmt-85 -111.05 153.88 25.01 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.418 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.2 tp -116.13 125.6 52.57 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.494 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.7 t0 -147.43 165.43 30.27 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.561 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -49.37 -38.09 27.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.607 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -72.14 -64.86 0.86 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.52 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.32 -32.0 70.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.012 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.39 -25.36 24.13 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.614 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.8 mtt -63.37 -41.0 98.78 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 120.879 0.371 . . . . 0.0 110.782 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -78.23 -44.78 24.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.55 HG21 HG23 ' A' ' 296' ' ' THR . 79.3 t -65.9 -43.04 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.448 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.492 HD11 ' NE2' ' A' ' 183' ' ' GLN . 51.2 tp -60.36 -47.16 87.25 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.606 -178.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.11 -39.61 75.4 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.736 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.7 ttt180 -61.64 -38.13 86.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.154 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.2 mt -87.63 4.74 42.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.72 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.411 ' HZ2' ' CD ' ' A' ' 183' ' ' GLN . 87.2 tttt -112.72 -11.87 13.45 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.004 0.431 . . . . 0.0 110.334 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.12 -37.24 86.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.522 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.01 -48.73 80.46 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.383 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 . . . . . 0 C--O 1.221 -0.408 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.008 179.899 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.25 -2.61 58.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.437 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.27 179.07 1.25 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.488 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.4 Cg_exo -60.78 145.29 99.18 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.794 2.329 . . . . 0.0 112.174 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.5 -179.36 8.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.585 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.3 137.01 52.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.405 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -123.99 147.09 28.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.366 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.7 p -119.98 135.95 54.72 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.78 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.39 -143.61 0.33 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.291 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.54 -37.29 86.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.456 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.477 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.82 -67.25 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.46 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.31 142.64 44.7 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.1 p -112.4 131.4 55.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.96 0.409 . . . . 0.0 110.397 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -119.01 129.16 54.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.442 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.7 m -85.63 130.78 34.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.289 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.484 HD22 ' OE1' ' A' ' 42' ' ' GLN . 70.3 mt -96.79 78.83 2.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.281 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.96 -31.84 72.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.561 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.56 107.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.148 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.484 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -120.74 91.19 47.11 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.414 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.658 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.3 Cg_exo -56.94 148.57 66.86 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.765 2.31 . . . . 0.0 111.842 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.62 82.41 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.577 0.548 . . . . 0.0 111.001 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.658 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.37 66.87 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.253 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -76.62 131.06 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.745 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.568 ' HA ' HG23 ' A' ' 64' ' ' VAL . 61.6 t -122.76 147.25 27.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.028 0.442 . . . . 0.0 110.066 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 t -136.33 144.12 44.48 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.654 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.404 ' OG1' ' N ' ' A' ' 50' ' ' SER . 19.7 p -100.09 -59.09 1.77 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.584 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.404 ' N ' ' OG1' ' A' ' 49' ' ' THR . 87.1 p -79.25 155.02 28.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.508 HG21 HG23 ' A' ' 70' ' ' THR . 71.4 t -74.07 -21.85 18.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.565 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.9 m -60.13 -52.07 66.92 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.542 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.6 mt -66.49 -42.4 87.51 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.131 0.491 . . . . 0.0 110.798 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -43.35 -53.9 5.01 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.074 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.04 -37.39 73.39 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 m -62.93 -44.28 96.5 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 110.38 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 17.8 mt -66.04 -42.05 90.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.396 0.617 . . . . 0.0 110.662 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 tp -62.88 -39.91 95.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.271 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.527 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.45 -36.1 77.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.177 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.45 HD11 HD12 ' A' ' 156' ' ' LEU . 32.8 pt -91.18 27.9 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.27 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.4 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 99.0 m-20 56.94 51.75 10.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.972 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.17 76.06 27.59 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.944 0.402 . . . . 0.0 110.001 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.87 149.56 90.37 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.811 2.341 . . . . 0.0 112.281 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.52 136.6 48.24 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-O 121.136 0.493 . . . . 0.0 110.281 179.787 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.3 pt -69.48 -43.4 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.32 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.51 131.39 52.82 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.946 0.403 . . . . 0.0 110.648 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.54 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.3 p -155.84 168.83 25.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.458 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.35 -177.39 21.97 Favored Glycine 0 N--CA 1.463 0.499 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.632 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.5 172.38 12.8 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.015 0.436 . . . . 0.0 110.482 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.508 HG23 HG21 ' A' ' 51' ' ' VAL . 13.7 p -133.33 -111.57 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 0.0 110.491 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.55 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.8 179.62 0.95 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.448 -179.221 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.4 Cg_exo -60.86 58.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.894 2.396 . . . . 0.0 112.076 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.4 t-20 -64.42 -33.98 77.12 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.5 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.6 m120 94.29 -36.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.869 0.731 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.401 ' HD3' HD21 ' A' ' 73' ' ' ASN . 77.1 mtp85 -62.89 -39.96 96.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.937 0.398 . . . . 0.0 110.224 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -74.49 -26.0 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.675 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.59 -172.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.612 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.3 p30 -73.73 -152.75 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.771 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 36.9 p-10 -54.46 -6.6 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.726 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.495 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.59 114.19 23.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.548 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.53 71.73 1.31 Allowed Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.475 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.3 m-85 -143.19 148.21 36.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.74 0.305 . . . . 0.0 110.908 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -86.04 -98.64 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.961 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.558 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.08 -43.3 95.83 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.183 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.558 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.4 tt0 91.85 52.64 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.875 0.734 . . . . 0.0 110.961 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -103.47 -9.02 19.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.377 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.475 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -65.23 -33.25 75.56 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.02 0.438 . . . . 0.0 110.604 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -49.09 -24.51 1.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.619 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.6 t -69.67 -45.92 76.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.31 -48.47 81.22 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.111 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -38.38 90.17 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.364 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.8 -32.64 53.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.23 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.615 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.2 mmt-85 -89.91 1.72 55.89 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.468 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.615 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.95 -49.93 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.897 0.748 . . . . 0.0 110.294 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.668 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.1 mt -45.55 153.86 0.23 Allowed 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.456 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.668 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 121.01 92.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 125.218 1.574 . . . . 0.0 110.458 -178.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.54 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.28 142.72 43.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.201 0.524 . . . . 0.0 110.191 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.4 mt -131.71 26.75 4.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.467 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -140.11 137.52 34.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 110.51 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.632 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.0 mt -136.84 164.88 29.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.406 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.97 -28.4 1.86 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.469 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.71 70.62 7.29 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.101 0.477 . . . . 0.0 110.327 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.07 145.31 98.72 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.687 2.258 . . . . 0.0 112.215 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.7 t -133.8 136.11 44.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.527 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.74 -38.42 83.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.662 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.48 -41.99 96.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.52 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.11 -41.54 98.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.516 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -63.64 -43.29 98.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.976 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.1 77.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.284 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.76 -18.37 59.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.454 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.77 -6.39 58.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.508 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.416 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 75.2 mtp 47.93 55.79 17.17 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.614 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.6 Cg_endo -69.94 149.36 65.63 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.88 2.386 . . . . 0.0 112.114 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.76 -73.05 0.66 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.488 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.6 tp -111.43 114.21 27.18 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.267 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -103.49 126.97 57.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.525 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 mt -110.71 134.51 52.4 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.184 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.12 140.15 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.555 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.7 p -83.57 168.02 16.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.689 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.31 -37.26 80.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.472 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 t -139.19 158.4 44.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.486 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.3 177.0 33.54 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.71 86.99 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -125.28 151.7 45.64 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.913 0.387 . . . . 0.0 110.551 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.9 t -63.29 141.34 58.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.379 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.18 10.7 10.72 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.631 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.15 -38.97 88.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.15 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.7 -35.97 24.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.432 0.634 . . . . 0.0 110.633 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.2 mt -70.98 -35.1 71.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.486 0.66 . . . . 0.0 110.72 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -42.88 -62.94 0.88 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.285 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.61 -42.84 91.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.066 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -62.11 -32.29 72.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.242 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.4 mt -74.28 -40.64 62.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.969 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.44 -49.09 78.55 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.275 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.7 m -52.92 -42.85 65.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.157 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.18 -43.06 92.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -168.83 151.71 5.09 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.71 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -38.61 107.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.621 2.214 . . . . 0.0 112.387 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.643 ' C ' HD12 ' A' ' 140' ' ' LEU . 97.2 m -109.75 121.64 45.69 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.2 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.0 153.34 29.53 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.309 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -128.46 131.11 69.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.371 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.18 128.19 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.571 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 54.6 t30 -100.77 104.94 16.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.227 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.411 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.4 p90 -100.71 -11.94 19.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.893 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.0 p-10 -64.95 -33.69 76.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.742 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -99.29 7.91 45.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.542 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.411 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.8 mttm -134.57 151.84 51.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.869 0.366 . . . . 0.0 110.529 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.427 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.7 p -75.82 166.26 23.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.597 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.4 t90 -59.25 -48.62 80.94 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.276 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -54.44 -44.1 72.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.03 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.4 t -62.96 -40.7 98.5 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.202 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.436 ' O ' HD23 ' A' ' 156' ' ' LEU . 63.4 tp -60.92 -44.34 97.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.3 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 49.2 tp -61.49 -42.98 99.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.198 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.8 m -55.9 -45.7 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.741 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.23 -40.56 96.55 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.836 0.35 . . . . 0.0 110.394 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.45 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.03 -42.5 99.24 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.222 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.73 -40.06 95.56 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.42 -45.95 64.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.8 -44.0 96.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.5 p -92.77 -9.09 41.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.704 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.93 26.29 72.22 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -101.22 50.47 0.86 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.776 0.322 . . . . 0.0 110.629 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.48 -39.17 77.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.658 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.9 -47.45 85.73 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.213 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.4 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 88.0 mt-30 -59.97 -39.27 85.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.162 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.92 98.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.238 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.88 -29.13 70.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.558 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -73.86 -54.41 8.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.059 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.527 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.6 ttp180 -64.86 -42.13 95.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.455 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 174' ' ' ASP . 78.4 mt -62.43 -43.82 98.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.487 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.28 -58.71 6.72 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.009 0.433 . . . . 0.0 110.368 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -56.61 -33.57 66.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.37 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -81.1 -36.12 30.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.78 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.1 m-20 -54.84 -42.35 71.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.062 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.17 -41.77 98.64 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.696 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.0 -38.02 89.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.383 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.45 -42.48 99.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.653 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.75 -53.06 61.14 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.132 0.492 . . . . 0.0 110.752 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.48 -41.76 88.48 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.618 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.09 95.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.67 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.14 -32.63 74.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.418 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.06 -21.47 19.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.728 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.588 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.6 tt0 -64.87 -41.58 95.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.733 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.0 pt -76.5 133.9 30.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.675 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.71 106.46 9.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.4 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.59 128.37 0.34 Allowed Pre-proline 0 C--O 1.238 0.479 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.553 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.3 Cg_exo -43.65 151.42 0.4 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.839 2.359 . . . . 0.0 112.497 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.67 142.18 52.22 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.611 2.208 . . . . 0.0 112.421 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.542 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.72 147.17 2.39 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.542 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.15 153.93 70.93 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.787 2.325 . . . . 0.0 112.278 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.47 163.23 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.159 0.504 . . . . 0.0 110.45 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.75 169.93 16.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.832 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.68 137.4 22.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.3 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.53 HG22 HD12 ' A' ' 205' ' ' LEU . 39.2 pt -134.19 146.03 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.592 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -133.39 132.01 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.054 0.454 . . . . 0.0 110.517 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -151.82 154.45 36.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.48 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.0 m -121.56 122.69 40.23 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.955 0.407 . . . . 0.0 110.368 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.74 -25.59 66.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.595 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.96 -49.66 19.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.992 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.01 -11.53 60.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.403 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.6 m80 49.14 42.47 21.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.495 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.0 t -135.94 144.98 45.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.319 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.82 114.12 27.22 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.375 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -120.18 133.71 55.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.986 0.422 . . . . 0.0 110.399 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.18 146.53 37.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.74 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.48 ' N ' HD23 ' A' ' 205' ' ' LEU . 13.3 t90 -99.38 127.96 45.46 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.101 0.477 . . . . 0.0 109.987 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.7 153.42 41.14 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.264 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.9 -18.29 46.81 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.648 2.232 . . . . 0.0 111.962 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -18.75 0.59 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.368 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.443 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.1 p -75.21 167.7 21.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.476 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.11 -35.56 75.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.3 mt-30 -56.64 -41.19 76.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.763 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.37 -43.04 97.68 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.492 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.4 mt-30 -63.75 -40.08 95.84 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 122.549 -0.383 . . . . 0.0 110.542 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.597 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.2 mmm -61.56 -41.87 98.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.376 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.56 -49.88 71.67 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.473 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.11 -33.06 50.62 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -71.09 -20.21 62.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.558 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 219' ' ' LEU . 65.9 mt -87.28 -6.42 58.55 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.74 3.52 57.16 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -88.34 149.85 23.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.93 0.395 . . . . 0.0 110.507 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.441 ' O ' HG12 ' A' ' 191' ' ' VAL . 3.0 p -112.78 126.49 55.47 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.127 0.489 . . . . 0.0 110.355 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.79 145.84 24.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.999 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.489 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -70.06 150.77 46.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.438 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.86 131.21 44.43 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.502 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.896 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.69 93.25 27.51 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.118 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.679 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.6 Cg_exo -55.77 138.99 83.15 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.655 2.236 . . . . 0.0 111.561 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.75 -25.13 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.399 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.75 -49.91 27.2 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.56 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.1 mt -54.37 -37.01 64.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.54 35.92 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.801 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.56 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.58 87.92 0.01 OUTLIER 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.864 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 82.3 p -81.64 -14.28 56.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.351 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.51 -41.8 10.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.609 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.9 -16.91 64.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.587 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.91 43.69 27.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.504 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.21 -149.62 8.44 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -120.29 142.79 48.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.976 0.417 . . . . 0.0 110.36 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.24 149.76 29.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.366 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -101.21 -151.7 0.42 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.358 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 56.21 -91.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.688 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.479 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.3 tt -127.08 175.61 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.597 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.479 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.6 mt -122.23 141.68 41.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.81 169.26 9.36 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.255 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.3 mt -147.57 150.71 34.99 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.223 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.57 -39.06 97.21 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.33 3.74 4.67 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.11 -58.44 3.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.911 0.386 . . . . 0.0 110.568 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.55 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.9 m-20 -61.95 -36.57 81.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.29 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 9.9 mp -52.3 -67.8 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.757 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.42 -42.21 66.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.148 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.87 18.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.657 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.75 47.64 0.23 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 39.13 -110.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.521 0.201 . . . . 0.0 110.743 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.489 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.9 -44.98 96.37 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.473 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.78 8.1 83.17 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -99.14 -12.57 20.36 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.805 -0.232 . . . . 0.0 110.642 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.3 t 176.24 142.65 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.052 0.453 . . . . 0.0 110.493 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.432 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.1 125.47 11.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.156 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -98.37 143.03 29.27 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 120.848 0.356 . . . . 0.0 110.837 178.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.2 mt -94.41 106.52 18.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.674 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.469 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.87 -12.74 18.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.149 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.79 90.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.895 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.9 173.2 45.81 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.472 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 87.5 m-20 -74.07 -113.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 110.723 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.15 -28.91 68.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.765 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.08 -44.09 91.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.187 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.51 -44.45 94.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.318 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.32 -59.78 4.0 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.25 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.25 -43.47 61.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.111 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.2 -43.84 74.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.244 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.1 mt -64.39 -43.58 97.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.679 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -56.59 -37.67 70.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.163 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.28 1.17 19.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.212 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -115.04 91.47 27.13 Favored Pre-proline 0 C--O 1.231 0.114 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.17 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.14 -27.33 29.18 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.821 2.347 . . . . 0.0 111.864 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.4 -41.17 98.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.55 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.9 mp -95.24 4.75 53.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.396 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.71 -35.31 70.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.099 0.476 . . . . 0.0 110.673 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.76 4.62 15.8 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.624 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.79 121.15 80.26 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.565 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -47.64 -37.35 26.96 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.464 2.11 . . . . 0.0 112.472 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.528 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.88 -43.35 90.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.319 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.04 -43.8 92.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.303 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -64.95 -40.76 95.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.341 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 47.3 t-20 -89.15 -13.16 39.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.577 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.5 mtmt 62.66 32.05 16.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.93 44.51 1.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.292 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.68 135.4 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.551 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.6 132.41 56.69 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.398 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.49 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.83 88.69 6.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.786 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.425 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.4 mt -63.87 -41.72 97.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.78 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.469 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.82 165.9 34.41 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 75.5 p -75.61 -25.92 57.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.719 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -68.29 -33.97 75.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.552 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 296' ' ' THR . 98.7 m -72.62 19.85 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.668 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.508 ' O ' ' NE2' ' A' ' 212' ' ' GLN . 49.1 t80 -57.28 -51.01 71.1 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.014 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 70.9 mmt-85 -107.85 149.18 28.58 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 41.1 tp -115.67 126.26 53.9 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.862 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.475 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.6 t0 -149.74 166.67 28.71 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.611 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -49.21 -38.04 24.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.613 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.65 -65.11 0.8 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.454 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -60.71 -32.82 72.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.974 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.49 -25.21 24.1 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.3 mtt -63.67 -41.02 98.23 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 120.811 0.339 . . . . 0.0 110.945 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -78.37 -44.36 25.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.988 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.573 HG21 HG23 ' A' ' 296' ' ' THR . 79.7 t -65.97 -42.93 92.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.431 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.588 HD11 ' NE2' ' A' ' 183' ' ' GLN . 49.8 tp -60.01 -46.92 87.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.448 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -70.61 -39.48 73.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.988 0.423 . . . . 0.0 110.603 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.49 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 73.6 ttt180 -61.35 -38.0 85.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.319 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.8 mt -87.76 4.91 42.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.698 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -112.22 -11.71 13.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.041 0.448 . . . . 0.0 110.337 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.79 -37.1 85.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.489 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.96 -48.75 80.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.435 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.958 179.872 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.612 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -90.3 -2.39 58.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.441 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.93 179.04 1.25 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.525 -179.67 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.0 Cg_exo -60.74 144.81 99.61 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.802 2.334 . . . . 0.0 112.191 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.612 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.4 ptt-85 -156.09 -179.46 8.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.597 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.62 136.19 53.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.322 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.411 ' HA ' HD12 ' A' ' 30' ' ' ILE . 9.5 tp -123.78 146.53 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.432 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.8 p -119.78 135.99 54.63 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.719 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.1 p30 -99.28 -143.5 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.328 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.8 p -63.66 -37.0 85.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.42 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.31 -66.78 0.22 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.437 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.06 142.12 44.65 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.6 p -112.09 131.23 55.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.411 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -119.2 129.17 54.83 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.498 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.1 m -85.62 130.3 34.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.301 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' OE1' ' A' ' 42' ' ' GLN . 67.4 mt -95.69 78.58 3.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.399 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.82 -32.03 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.482 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.27 108.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.204 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.489 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -121.97 91.31 48.85 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.322 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.658 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.1 Cg_exo -56.94 148.8 65.48 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.782 2.321 . . . . 0.0 111.888 179.049 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.82 82.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.487 0.492 . . . . 0.0 110.922 -179.19 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.658 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.09 66.79 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.277 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.45 130.93 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.748 -179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.548 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.1 t -122.82 145.57 29.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.191 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.9 t -135.13 143.59 46.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.681 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.2 p -99.54 -59.26 1.75 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.576 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.4 p -79.74 155.11 28.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.593 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.482 HG21 HG23 ' A' ' 70' ' ' THR . 71.4 t -74.58 -21.9 17.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.46 179.472 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.2 m -59.9 -52.32 65.92 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.508 -178.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.0 mt -66.53 -42.35 87.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.129 0.49 . . . . 0.0 110.8 178.111 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.6 m -42.91 -53.73 4.55 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.169 -178.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.46 -37.34 69.42 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 178.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 m -62.79 -44.62 95.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.955 0.407 . . . . 0.0 110.484 -179.463 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.5 mt -66.37 -41.85 88.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.367 0.603 . . . . 0.0 110.683 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tp -62.5 -40.25 96.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.297 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.468 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.98 -35.75 75.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.033 -178.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.539 HD11 HD12 ' A' ' 156' ' ' LEU . 31.6 pt -91.57 28.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.163 -179.163 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.38 51.78 10.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.795 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.86 75.91 24.0 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.999 0.428 . . . . 0.0 110.05 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.19 151.27 86.03 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.739 2.293 . . . . 0.0 112.3 -178.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.548 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.51 137.48 46.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.156 0.503 . . . . 0.0 110.339 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.3 pt -69.41 -43.56 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.129 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.96 131.09 53.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.958 0.408 . . . . 0.0 110.613 -178.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.1 p -155.8 169.03 25.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.515 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.87 -177.43 21.63 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.628 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.01 172.19 12.96 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 120.979 0.418 . . . . 0.0 110.444 179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.482 HG23 HG21 ' A' ' 51' ' ' VAL . 11.9 p -133.76 -110.72 0.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.364 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.549 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.95 179.53 0.96 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.421 -179.202 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.7 Cg_exo -60.89 58.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.011 2.474 . . . . 0.0 112.079 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.4 t-20 -64.29 -35.03 79.52 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.52 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.3 m120 94.96 -37.66 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.926 0.766 . . . . 0.0 110.031 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.64 -40.01 95.67 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.256 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.5 p -73.94 -26.44 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.697 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.9 -172.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.504 -179.402 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -73.88 -152.51 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.72 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.3 p-10 -54.78 -6.33 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.674 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.4 113.56 23.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.634 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.4 72.66 1.28 Allowed Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -143.68 148.56 35.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.919 0.39 . . . . 0.0 110.759 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.76 -99.15 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.136 178.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.564 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.28 -42.74 96.27 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.322 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.564 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.0 tt0 91.5 52.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.772 0.67 . . . . 0.0 110.951 178.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.45 -9.25 19.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.412 179.114 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.0 p -64.74 -33.78 76.78 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.112 0.482 . . . . 0.0 110.643 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -48.66 -23.35 1.0 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.591 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.8 t -70.05 -45.87 74.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.789 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.25 -48.65 80.49 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.183 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.61 -38.15 89.08 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.382 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.64 -32.39 51.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.237 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.617 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.5 mmt-85 -89.98 1.68 56.0 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.547 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.617 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.89 -49.1 0.16 Allowed 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.816 0.697 . . . . 0.0 110.342 179.141 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.683 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.9 mt -46.3 154.05 0.3 Allowed 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.557 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.683 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 121.12 92.26 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.029 1.456 . . . . 0.0 110.543 -178.579 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.537 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.3 143.3 43.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.078 0.466 . . . . 0.0 110.287 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 mt -131.92 26.97 4.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.847 0.356 . . . . 0.0 110.479 -179.322 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.48 138.15 34.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.004 0.431 . . . . 0.0 110.481 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.8 mt -137.19 165.15 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.429 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.62 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.11 -28.55 1.84 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.469 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -153.21 70.64 6.93 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.039 0.447 . . . . 0.0 110.391 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.15 145.53 98.28 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.801 2.334 . . . . 0.0 112.011 -179.527 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.1 t -134.04 136.81 44.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.57 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.33 82.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.656 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.42 -42.28 96.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.476 -179.402 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.71 98.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.484 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.4 t -63.66 -43.18 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.136 179.398 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.74 -35.23 77.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.249 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.82 -18.28 59.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.432 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.7 -6.53 58.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.523 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.413 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 66.9 mtp 48.04 55.96 17.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.623 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.9 Cg_endo -70.22 149.1 63.45 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.771 2.314 . . . . 0.0 112.134 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.36 -72.87 0.67 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.539 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.427 HD11 HD13 ' A' ' 140' ' ' LEU . 39.2 tp -111.42 112.4 24.12 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.377 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 75.6 mt -100.59 126.03 54.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.516 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.9 mt -109.38 133.0 53.6 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.287 -179.443 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.47 139.61 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.573 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.5 p -83.44 168.38 16.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.705 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.41 80.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.483 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.8 t -139.33 158.87 43.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.96 0.409 . . . . 0.0 110.446 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.16 177.04 33.41 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.91 87.39 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.97 151.62 45.25 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.906 0.384 . . . . 0.0 110.546 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.1 t -63.18 141.27 58.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.398 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.51 10.93 10.54 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.659 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.14 -38.83 87.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.099 -179.404 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.64 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.86 -35.79 23.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.377 0.608 . . . . 0.0 110.579 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.7 mt -71.06 -35.17 71.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.396 0.617 . . . . 0.0 110.691 179.333 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -42.94 -62.82 0.92 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.229 -178.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.64 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.87 -42.63 90.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.997 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.18 -32.28 72.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.266 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.4 mt -74.41 -40.54 61.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 178.686 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.93 -48.86 78.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.219 -179.08 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.5 m -52.66 -42.68 64.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.215 179.396 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.06 -43.05 92.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.173 179.147 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.36 153.21 5.22 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.622 -179.128 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -39.03 107.33 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.664 2.243 . . . . 0.0 112.435 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 93.8 m -108.72 121.01 44.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.287 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.03 152.52 30.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.343 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -129.0 131.51 68.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.42 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.11 127.68 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.55 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.8 t30 -101.83 103.86 14.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.359 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 147' ' ' LYS . 49.1 p90 -101.29 -11.31 19.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.801 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.7 p-10 -64.77 -33.52 76.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.728 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.577 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.8 p-10 -98.33 7.68 45.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.568 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.34 155.44 50.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.508 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.3 p -74.66 165.69 24.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.615 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.571 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 90.9 t90 -60.04 -48.7 80.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.38 -179.189 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.87 -41.87 67.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.005 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.9 t -62.6 -40.77 97.98 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.484 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 156' ' ' LEU . 48.4 tp -60.62 -43.94 96.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.417 -179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.5 HD23 HD11 ' A' ' 170' ' ' ILE . 46.1 tp -61.47 -42.96 99.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.21 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.5 m -55.75 -45.31 78.09 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.4 -40.69 97.32 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.881 0.372 . . . . 0.0 110.408 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.539 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.96 -42.38 99.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.158 179.233 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.65 -40.72 96.04 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.87 -46.04 63.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.853 0.359 . . . . 0.0 110.829 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.62 -44.03 96.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.795 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.5 p -93.01 -8.79 41.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.676 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.76 25.19 71.67 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -101.87 52.01 0.82 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.658 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.92 -39.03 76.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.685 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.28 -47.08 86.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.252 -179.403 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -61.4 -38.93 88.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.291 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.43 97.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.41 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.48 -27.54 69.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.507 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.92 -53.78 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.134 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.494 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -63.66 -43.49 96.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.441 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.0 mt -63.06 -43.85 99.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.7 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.3 -61.65 2.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.064 0.459 . . . . 0.0 110.392 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -54.61 -35.08 63.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.44 -179.178 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -79.75 -34.46 39.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.909 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 170' ' ' ILE . 50.2 m-20 -56.83 -40.14 75.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.805 -178.616 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.89 -42.45 99.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.937 0.399 . . . . 0.0 110.709 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.68 -37.96 87.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.292 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 177' ' ' LEU . 83.0 mt -62.33 -42.49 99.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.704 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.95 -53.29 57.76 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.081 0.467 . . . . 0.0 110.694 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.27 -41.66 89.56 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.633 179.398 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.76 94.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.68 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.22 -32.21 73.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.379 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -94.49 -21.67 18.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.615 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.469 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -64.94 -41.63 95.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.631 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.4 pt -77.52 136.09 25.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.745 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.24 108.95 11.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.338 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.74 126.38 0.31 Allowed Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.519 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.462 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.9 Cg_exo -43.88 152.13 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.76 2.307 . . . . 0.0 112.519 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.18 141.72 53.26 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.627 2.218 . . . . 0.0 112.354 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.37 147.22 2.11 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.497 179.402 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.21 154.46 69.88 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.764 2.31 . . . . 0.0 112.254 178.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.5 163.07 28.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.437 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.76 170.1 16.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.899 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.0 137.48 22.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.948 0.404 . . . . 0.0 110.315 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.535 HG22 HD12 ' A' ' 205' ' ' LEU . 38.9 pt -134.2 146.08 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.607 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.71 131.61 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.109 0.48 . . . . 0.0 110.497 178.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -151.94 154.8 36.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.406 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.62 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.0 m -122.05 122.82 40.17 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.945 0.402 . . . . 0.0 110.393 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.33 -25.64 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.618 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.62 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.39 -48.86 21.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.04 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.03 -11.73 60.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.414 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.4 m80 49.19 42.19 21.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.478 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.1 t -136.5 145.58 45.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.373 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.15 114.24 27.34 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.348 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.89 133.33 55.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.036 0.446 . . . . 0.0 110.376 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.535 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.03 146.38 38.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.713 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.488 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 12.2 t90 -99.37 130.01 45.61 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.121 0.486 . . . . 0.0 110.096 179.246 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.89 153.95 39.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.097 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.71 -18.22 47.84 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.796 2.33 . . . . 0.0 111.93 178.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.11 -18.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.405 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.488 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.5 p -75.97 164.98 25.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.497 179.648 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.96 -27.99 65.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.51 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.528 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.69 -41.56 98.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.763 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.91 -44.86 96.73 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.8 mt-30 -64.57 -38.81 92.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.957 0.408 . . . . 0.0 110.709 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.571 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.3 mmm -62.03 -41.44 98.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.229 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.4 mt -63.79 -47.25 81.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.912 0.387 . . . . 0.0 110.607 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.16 -32.07 54.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.154 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -70.79 -18.29 62.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.58 179.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.426 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.8 mt -88.7 -8.61 54.25 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.641 -179.558 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.67 2.75 55.32 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -88.48 151.91 22.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.509 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.448 ' O ' HG12 ' A' ' 191' ' ' VAL . 7.8 p -114.95 127.83 55.92 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.052 0.453 . . . . 0.0 110.427 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.566 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.35 146.13 23.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.962 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.472 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.56 151.07 46.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.524 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.65 131.65 43.34 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.487 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.894 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.62 93.73 29.37 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.139 -179.789 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.683 ' C ' ' H ' ' A' ' 229' ' ' GLY . 47.3 Cg_exo -55.63 138.72 81.74 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.673 2.249 . . . . 0.0 111.59 179.153 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.75 -25.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.444 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.47 -49.77 29.65 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.55 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -53.46 -36.43 61.61 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -67.16 36.57 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.725 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.55 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.63 86.67 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.831 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.3 p -78.83 -15.72 58.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.53 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.22 -40.77 10.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.626 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.9 t -66.2 -17.73 64.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.573 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.41 43.25 26.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.418 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.85 -146.6 6.98 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -123.39 143.21 50.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.96 0.409 . . . . 0.0 110.335 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.07 149.61 29.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.422 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -100.5 -152.17 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.391 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 55.9 -91.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.567 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.471 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.65 175.46 8.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.564 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.471 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.9 mt -122.16 141.76 41.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.734 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -100.0 169.12 9.41 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.328 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.5 mt -147.83 151.18 35.52 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.133 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.78 -39.01 97.01 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.19 4.1 4.63 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.23 -58.38 3.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.939 0.399 . . . . 0.0 110.573 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.546 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.0 m-20 -61.98 -36.97 83.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.313 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.19 -67.73 0.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.813 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.46 -42.09 66.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.153 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.12 18.06 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.637 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.92 48.34 0.27 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.57 -110.0 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.667 0.27 . . . . 0.0 110.717 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.472 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 12.3 m120 -60.62 -45.35 94.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.471 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.88 8.15 82.93 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.23 -12.61 20.24 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.799 -0.236 . . . . 0.0 110.631 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.6 t 176.2 142.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.063 0.459 . . . . 0.0 110.553 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.433 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.85 125.31 11.67 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.047 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.432 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -98.43 142.98 29.38 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 120.88 0.371 . . . . 0.0 110.781 178.167 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.3 mt -94.17 106.43 18.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.652 -179.169 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.468 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.2 t80 -101.96 -11.41 18.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.182 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.42 -40.33 85.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.788 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.39 173.75 46.11 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.499 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.5 m-20 -74.44 -113.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.756 0.312 . . . . 0.0 110.71 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.62 -28.57 67.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.685 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.01 -44.21 91.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.313 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.68 -44.4 93.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.354 179.239 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.38 -60.16 3.56 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.295 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.02 -43.34 60.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.227 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.39 -43.92 75.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.258 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.0 mt -64.55 -43.71 96.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.598 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -56.27 -37.72 70.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.268 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.94 1.22 18.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.316 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -115.04 91.14 25.77 Favored Pre-proline 0 CA--C 1.528 0.122 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.207 -179.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.98 -27.18 27.45 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.818 2.345 . . . . 0.0 111.879 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.45 -41.08 98.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.565 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.31 5.03 52.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.459 -179.223 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.95 -35.01 69.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.735 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.87 4.74 15.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.541 -178.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.533 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.88 121.39 81.27 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.561 179.918 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -47.53 -37.8 26.9 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.539 2.159 . . . . 0.0 112.427 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.533 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.72 -43.72 90.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.38 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.89 -43.69 92.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.335 179.334 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.67 -40.6 95.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.49 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.7 t-20 -89.84 -12.19 39.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.563 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.4 mtmt 61.85 31.85 18.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.959 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.47 44.15 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.34 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.18 135.82 41.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.465 -179.661 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.5 132.34 56.7 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.521 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.2 87.97 6.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.728 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.94 -41.35 97.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.885 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.468 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.21 167.89 34.44 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.728 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 75.5 p -75.89 -25.82 56.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.381 . . . . 0.0 110.797 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.6 tp10 -67.9 -34.18 76.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.489 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.768 HG22 ' O ' ' A' ' 296' ' ' THR . 97.0 m -73.24 19.9 0.09 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.69 -179.142 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.528 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 53.0 t80 -57.24 -51.14 70.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.018 -179.543 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -108.22 149.41 28.62 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.426 ' CD2' HD11 ' A' ' 219' ' ' LEU . 41.5 tp -115.26 125.26 53.1 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.672 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.468 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.5 t0 -149.08 166.29 29.18 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.624 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -49.08 -38.19 23.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.632 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -71.96 -64.99 0.83 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.262 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -60.81 -32.52 71.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.864 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.85 -25.6 29.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.617 -179.049 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.8 mtt -63.23 -41.23 99.09 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 120.9 0.381 . . . . 0.0 110.883 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.19 -44.4 25.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.994 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.568 HG21 HG23 ' A' ' 296' ' ' THR . 76.5 t -66.14 -42.88 92.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.397 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.469 HD11 ' NE2' ' A' ' 183' ' ' GLN . 49.4 tp -59.89 -47.46 85.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.451 -178.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -69.85 -39.72 76.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.047 0.451 . . . . 0.0 110.888 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.499 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 72.2 ttt180 -61.52 -38.19 86.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.29 -179.048 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.2 mt -87.48 5.04 41.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.658 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -112.66 -11.78 13.49 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.049 0.452 . . . . 0.0 110.259 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.84 -37.16 85.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.56 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.82 -48.88 79.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.427 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.022 179.786 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.45 -2.83 57.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.481 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.46 179.12 1.24 Allowed Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.477 -179.722 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.4 Cg_exo -60.52 144.42 99.52 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.79 2.326 . . . . 0.0 112.235 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.5 ptt-85 -155.75 -179.9 8.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.55 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.58 136.77 52.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.042 0.448 . . . . 0.0 110.312 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' HA ' HD12 ' A' ' 30' ' ' ILE . 9.1 tp -124.41 146.2 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.39 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -119.54 135.97 54.55 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.805 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.9 p30 -98.71 -144.11 0.32 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.17 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.65 -36.49 84.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.405 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -147.58 -70.27 0.23 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.43 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.81 144.12 41.77 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.263 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.8 p -112.8 129.84 56.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.914 0.387 . . . . 0.0 110.451 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -114.68 129.66 56.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.683 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.9 m -86.95 130.68 34.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.35 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.496 HD22 ' OE1' ' A' ' 42' ' ' GLN . 70.4 mt -97.61 78.87 2.67 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.434 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.8 -32.58 74.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.544 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 t 177.15 109.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.118 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.496 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.2 pt20 -124.52 91.5 49.4 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.39 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.62 149.27 59.46 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.865 2.377 . . . . 0.0 111.962 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -40.22 82.36 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.624 0.578 . . . . 0.0 110.998 -179.182 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.69 66.66 0.87 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.477 . . . . 0.0 110.18 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -77.28 131.23 35.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.555 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.4 t -122.65 147.86 26.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.104 0.478 . . . . 0.0 110.073 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.9 t -136.17 143.61 44.54 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.725 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 50' ' ' SER . 27.2 p -99.26 -59.96 1.62 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.618 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.401 ' N ' ' OG1' ' A' ' 49' ' ' THR . 87.1 p -79.07 156.14 28.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.64 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.575 HG21 HG23 ' A' ' 70' ' ' THR . 68.9 t -74.59 -21.55 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.572 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 100.0 m -60.15 -51.99 67.24 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.513 -178.496 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.0 mt -66.28 -42.44 88.41 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.817 177.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.23 -54.36 4.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.998 -178.624 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.11 -38.77 73.29 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.304 -0.719 . . . . 0.0 111.304 178.643 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.6 m -62.29 -43.67 98.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.934 0.397 . . . . 0.0 110.199 -179.361 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.7 mt -65.46 -42.41 92.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.502 0.668 . . . . 0.0 110.684 179.414 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.6 tp -63.08 -38.74 92.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.263 -179.348 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -61.59 -36.65 81.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.224 -178.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -91.22 27.6 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.148 -179.188 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.419 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 90.6 m-20 57.11 52.46 9.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.123 179.41 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.79 76.48 28.94 Favored Pre-proline 0 C--O 1.225 -0.223 0 CA-C-O 121.039 0.447 . . . . 0.0 109.891 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.67 148.2 92.32 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.733 2.289 . . . . 0.0 112.08 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -112.67 136.27 49.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.126 0.489 . . . . 0.0 110.395 179.724 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -70.11 -43.05 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.189 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.76 131.04 53.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.979 0.419 . . . . 0.0 110.637 -178.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.542 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.3 p -155.58 168.42 27.19 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.424 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.61 -177.26 21.81 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.646 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.57 172.43 12.75 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 121.081 0.467 . . . . 0.0 110.422 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.575 HG23 HG21 ' A' ' 51' ' ' VAL . 14.2 p -132.95 -112.09 0.23 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.452 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.63 179.7 0.93 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.497 -179.245 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.5 Cg_exo -60.83 57.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.966 2.444 . . . . 0.0 112.157 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.4 t-20 -64.42 -33.51 76.03 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.417 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.5 m120 93.91 -36.17 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.779 0.675 . . . . 0.0 109.899 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.401 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.6 mtp85 -63.21 -39.72 95.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.203 179.273 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.33 -25.3 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.688 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.24 -170.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.468 -179.354 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.83 -154.91 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.878 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.3 p-10 -51.44 -7.92 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.823 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.516 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -85.68 114.99 23.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.693 179.59 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.38 70.87 1.32 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -144.87 148.07 33.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.924 0.392 . . . . 0.0 110.752 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.9 mp -85.92 -98.46 0.07 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.178 178.745 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.0 -42.53 97.13 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.176 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.1 tt0 91.47 53.03 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.868 0.73 . . . . 0.0 110.877 179.037 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -102.69 -9.55 19.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.331 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.5 p -63.88 -34.42 77.92 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.05 0.452 . . . . 0.0 110.703 -179.754 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -49.13 -23.86 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.59 179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.0 t -70.11 -45.21 76.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.592 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.42 -48.53 80.79 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.923 -179.489 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.04 -38.38 88.49 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.436 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.31 -34.36 57.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.251 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.61 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.6 mmt-85 -88.43 1.08 55.48 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.608 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.5 mttp 83.17 -47.94 0.14 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.845 0.715 . . . . 0.0 110.315 179.163 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.668 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.4 mt -46.68 153.3 0.4 Allowed 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 117.817 -1.087 . . . . 0.0 109.606 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.668 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.6 tt0 122.03 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 O-C-N 125.318 1.636 . . . . 0.0 110.452 -178.573 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.84 142.85 44.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.204 0.526 . . . . 0.0 110.337 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.2 mt -131.95 26.61 4.6 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.096 -0.377 . . . . 0.0 110.49 -179.396 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.09 137.46 34.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.576 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.646 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.0 mt -136.99 164.86 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.411 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.48 -28.83 1.78 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.35 70.5 7.54 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 121.134 0.492 . . . . 0.0 110.219 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.15 145.32 98.74 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.783 2.322 . . . . 0.0 112.098 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.9 t -134.45 137.12 43.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.584 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.56 83.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.655 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.32 -42.0 96.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.485 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.08 -41.79 98.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.466 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.7 -43.21 97.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.063 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.23 -35.27 78.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.218 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.26 -18.3 57.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.433 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -87.09 -6.06 58.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.483 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 70.3 mtp 47.71 55.99 17.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.621 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.0 Cg_endo -70.08 149.26 64.57 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.784 2.323 . . . . 0.0 112.067 179.556 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.24 -72.39 0.68 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.579 179.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.403 HD11 HD13 ' A' ' 140' ' ' LEU . 38.2 tp -111.91 113.22 25.4 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.399 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.8 mt -102.0 126.9 55.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.0 0.429 . . . . 0.0 110.587 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.3 mt -110.74 133.72 53.1 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.212 -179.297 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.4 139.92 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.559 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.7 p -83.6 167.41 17.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.683 179.695 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.59 -36.85 79.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.455 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.4 t -138.2 157.78 45.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.456 -179.764 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.55 175.4 34.17 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.55 -33.61 87.03 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.38 151.42 44.42 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.97 0.414 . . . . 0.0 110.513 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.5 t -63.53 140.53 58.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.389 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.05 10.93 10.86 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.648 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -60.96 -38.92 87.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.219 -179.428 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.634 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.14 -35.58 23.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.445 0.641 . . . . 0.0 110.577 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.3 mt -71.16 -35.16 71.56 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.457 0.646 . . . . 0.0 110.654 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -43.02 -62.82 0.93 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.215 -178.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.634 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.5 p-10 -65.98 -42.93 89.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.021 -179.162 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.3 mt-30 -61.73 -32.38 72.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.343 -179.524 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.7 mt -74.38 -40.49 62.05 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.922 178.655 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.09 -49.09 78.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.277 -179.104 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 m -52.92 -42.56 65.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.211 179.392 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.83 -42.72 92.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.152 179.26 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.54 153.16 5.05 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.628 -179.335 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -39.04 106.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.679 2.253 . . . . 0.0 112.393 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.654 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.1 m -109.36 121.89 46.16 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.416 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.654 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.86 154.07 29.3 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.264 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.2 tt -130.38 129.23 64.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.409 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 92.9 mt -110.6 122.71 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.024 0.44 . . . . 0.0 110.614 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.544 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 54.2 t30 -101.17 106.91 18.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.256 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -100.76 0.25 38.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.847 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.4 p-10 -65.61 -34.77 78.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.959 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -101.88 10.22 39.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.728 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -133.99 148.31 51.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.909 0.385 . . . . 0.0 110.49 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.409 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 22.9 p -77.61 168.82 19.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.623 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.6 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.1 t90 -58.7 -49.87 75.99 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.064 -179.009 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -54.46 -46.17 73.26 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.944 0.402 . . . . 0.0 110.048 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 40.1 t -63.07 -40.77 98.67 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.14 0.495 . . . . 0.0 110.314 178.424 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.46 ' O ' HD23 ' A' ' 156' ' ' LEU . 52.0 tp -60.72 -44.54 96.48 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.309 -179.585 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.89 -43.5 98.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.113 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.9 m -54.51 -45.85 73.39 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.86 -40.1 94.2 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.853 0.358 . . . . 0.0 110.364 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 152' ' ' LEU . 2.3 mm? -61.59 -42.2 98.52 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.115 179.234 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.84 -38.8 94.68 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.148 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.52 -45.08 66.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.962 0.41 . . . . 0.0 110.712 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.69 -44.11 96.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.789 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.8 p -93.41 -8.69 41.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.533 -178.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.5 27.08 72.17 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -102.54 50.27 0.83 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.66 -179.552 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -69.31 -39.03 78.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.622 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.56 -47.26 86.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.31 -179.515 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.419 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 86.4 mt-30 -60.5 -39.33 87.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.213 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.51 -41.02 98.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.278 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.31 -29.28 70.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.607 179.334 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.18 -54.46 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.855 179.509 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.419 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.8 ttp180 -64.22 -42.89 96.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.431 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 174' ' ' ASP . 82.0 mt -62.59 -43.77 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.483 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.6 -61.11 2.76 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.2 0.524 . . . . 0.0 110.201 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.77 -34.51 62.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.521 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -80.33 -34.84 36.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.761 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -55.26 -41.71 72.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.059 -178.686 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.2 -41.8 98.7 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.662 179.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.14 -37.87 88.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.313 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.33 -42.39 99.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.756 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.8 -52.95 62.08 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.112 0.482 . . . . 0.0 110.59 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.34 -41.43 89.57 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.601 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.28 -39.78 94.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.615 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.64 -33.08 74.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.369 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.54 -21.49 19.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.612 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.574 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -65.18 -41.43 94.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.694 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 184' ' ' ILE . 30.9 pt -76.98 133.83 30.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.802 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -127.55 107.05 9.6 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.298 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.93 127.39 0.31 Allowed Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.483 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.78 151.99 0.38 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.865 2.377 . . . . 0.0 112.53 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.52 142.39 53.67 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.599 2.199 . . . . 0.0 112.368 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.545 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.78 146.86 2.3 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.548 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.0 153.9 71.65 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.855 2.37 . . . . 0.0 112.37 178.661 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.58 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.37 163.11 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 110.475 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.58 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.93 170.72 15.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.032 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.74 137.8 21.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.074 0.464 . . . . 0.0 110.098 179.388 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.55 HG22 HD12 ' A' ' 205' ' ' LEU . 39.9 pt -134.39 146.64 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.691 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.44 131.68 60.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.1 0.476 . . . . 0.0 110.472 178.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -152.09 154.84 36.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.431 179.218 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.5 m -122.02 122.71 39.93 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.921 0.391 . . . . 0.0 110.341 179.469 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.89 -25.34 66.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.662 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.613 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.12 -49.34 19.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.899 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.16 -11.49 60.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.345 -179.535 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.2 m80 49.21 42.57 21.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.483 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.0 t -136.42 144.56 44.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.33 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.79 114.54 27.96 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.293 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -120.41 133.95 55.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.048 0.451 . . . . 0.0 110.405 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.55 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.4 146.75 37.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.778 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.563 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 9.4 t90 -100.51 129.28 46.44 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.177 0.513 . . . . 0.0 109.962 179.335 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.27 153.75 41.53 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.164 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.406 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.8 Cg_endo -67.77 -18.05 47.44 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.685 2.256 . . . . 0.0 112.057 178.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -48.74 -18.92 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.468 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.563 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 84.8 p -74.84 163.89 27.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.551 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.5 -28.24 65.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.478 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.507 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.2 mt-30 -63.55 -42.86 98.35 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.577 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.0 -43.74 97.89 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.609 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.409 ' OE1' ' C ' ' A' ' 148' ' ' SER . 74.8 mt-30 -63.68 -38.52 91.42 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 122.271 -0.546 . . . . 0.0 110.629 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.6 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 85.6 mmm -61.99 -41.66 98.28 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.26 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 82.2 mt -63.83 -49.73 71.67 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.136 0.493 . . . . 0.0 110.257 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -51.96 -33.91 39.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.845 0.355 . . . . 0.0 110.241 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -70.88 -20.74 62.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.519 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 75.1 mt -87.61 -6.32 58.34 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 -179.569 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.87 -7.04 57.19 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -77.06 147.6 36.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.854 0.359 . . . . 0.0 110.614 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.423 ' O ' HG12 ' A' ' 191' ' ' VAL . 2.4 p -112.58 126.67 55.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.133 0.492 . . . . 0.0 110.284 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.558 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.41 145.49 24.43 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.995 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.501 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.23 150.59 47.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.448 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -129.98 130.81 45.51 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.379 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.895 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.96 92.79 27.08 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.192 -179.716 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.684 ' C ' ' H ' ' A' ' 229' ' ' GLY . 43.3 Cg_exo -55.61 139.11 82.55 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.581 2.188 . . . . 0.0 111.676 178.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.55 -25.42 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.485 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.684 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.14 -50.2 29.42 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.547 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -53.58 -35.89 61.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.892 0.377 . . . . 0.0 110.132 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -67.57 36.65 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.715 179.558 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.547 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.16 86.33 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.813 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.1 p -79.02 -16.07 57.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.4 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -91.66 -40.67 11.16 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.622 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -66.22 -17.35 64.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.594 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.56 43.22 26.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.462 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.78 -146.17 6.87 Favored Glycine 0 CA--C 1.519 0.292 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -123.39 143.37 50.17 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.961 0.41 . . . . 0.0 110.262 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -151.86 149.32 28.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -100.25 -152.35 0.42 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.43 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.86 -91.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.693 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.466 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.4 tt -126.31 175.1 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.617 -179.427 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.466 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.4 mt -121.7 141.22 43.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.698 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.58 169.35 9.35 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.256 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.7 mt -147.73 151.02 35.38 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.204 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.91 -38.76 96.56 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.96 4.14 4.73 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -77.3 -58.34 3.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.98 0.419 . . . . 0.0 110.522 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.537 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.3 m-20 -62.04 -36.81 82.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.314 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.42 -67.63 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.746 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.43 -42.2 66.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.149 -179.55 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.13 17.99 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.641 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.82 48.58 0.27 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.48 -109.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.516 0.198 . . . . 0.0 110.787 -178.577 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.501 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.3 m120 -60.58 -45.52 93.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.528 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 85.18 7.9 82.51 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -99.04 -12.66 20.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.598 0.237 . . . . 0.0 110.658 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.4 t 176.23 142.88 0.07 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.067 0.46 . . . . 0.0 110.44 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.36 125.35 11.33 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -98.29 143.14 29.09 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 120.873 0.368 . . . . 0.0 110.861 178.193 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.9 mt -94.35 106.75 18.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.762 -179.174 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.454 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.9 t80 -102.1 -12.63 17.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.173 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.36 89.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.88 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.74 173.19 45.86 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.493 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -74.06 -112.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 0.0 110.74 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.81 -28.97 68.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.693 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.81 -43.95 90.69 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.261 -178.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.44 -44.52 94.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.304 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.36 -60.05 3.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.198 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.96 -43.47 60.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.211 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.26 -43.58 74.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.247 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.3 mt -64.57 -43.53 96.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.548 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.45 -37.65 70.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.2 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.14 1.02 19.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.218 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -115.03 91.41 26.83 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.078 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.05 -27.27 28.27 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.769 2.312 . . . . 0.0 111.984 179.322 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.51 -41.09 98.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.584 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.597 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.9 mp -95.52 5.02 52.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.4 -179.269 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.9 -34.89 69.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.647 179.474 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -80.12 4.85 16.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.494 -178.82 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.526 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -69.04 121.23 80.98 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.511 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -47.38 -37.58 25.39 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.513 2.142 . . . . 0.0 112.562 -179.53 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.6 -43.38 89.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.759 0.314 . . . . 0.0 110.372 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.09 -43.51 92.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.309 179.269 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -65.06 -40.72 95.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.349 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 44.4 t-20 -89.31 -12.99 39.0 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.59 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 62.19 31.64 17.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.912 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.53 44.29 1.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.157 0.503 . . . . 0.0 110.366 179.419 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.79 135.69 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.446 -179.701 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.93 132.25 56.75 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.457 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.493 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.3 88.71 6.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.756 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.7 mt -63.87 -41.39 97.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.454 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.52 165.66 33.26 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 77.5 p -75.56 -25.83 57.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.885 0.374 . . . . 0.0 110.791 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.0 tp10 -68.43 -33.71 74.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.483 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.77 HG22 ' O ' ' A' ' 296' ' ' THR . 97.2 m -73.06 21.54 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.696 -179.174 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.507 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 51.7 t80 -57.41 -51.02 71.1 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.413 HH12 ' HG3' ' A' ' 212' ' ' GLN . 70.4 mmt-85 -109.35 151.15 27.0 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.802 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 39.0 tp -115.57 125.13 52.59 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.934 0.397 . . . . 0.0 110.69 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.481 ' CB ' HD23 ' A' ' 83' ' ' LEU . 40.6 t0 -147.94 165.75 29.75 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.631 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -49.35 -37.95 26.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.499 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -70.8 -65.67 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.235 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -61.11 -33.04 72.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.3 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -53.44 -25.6 16.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.575 -179.08 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.1 mtt -63.7 -40.85 97.82 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 120.874 0.368 . . . . 0.0 111.035 179.714 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -78.08 -44.69 25.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.115 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.576 HG21 HG23 ' A' ' 296' ' ' THR . 75.1 t -66.11 -42.76 91.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.383 179.556 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.574 HD11 ' NE2' ' A' ' 183' ' ' GLN . 48.6 tp -59.62 -47.31 86.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.465 -178.505 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -70.32 -39.26 74.89 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.016 0.436 . . . . 0.0 110.729 179.102 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.493 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 72.5 ttt180 -61.66 -38.05 86.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.251 -178.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.0 mt -87.74 5.16 41.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.624 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -112.88 -11.59 13.42 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.016 0.436 . . . . 0.0 110.333 179.891 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.08 -37.07 85.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.486 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.78 -48.89 79.77 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.396 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 C--O 1.222 -0.365 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.002 179.836 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.612 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.05 -2.32 58.1 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.371 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.489 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.8 179.15 1.23 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.502 -179.682 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.79 144.98 99.65 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.851 2.367 . . . . 0.0 112.197 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.612 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.99 -179.32 8.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.562 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -115.94 136.77 52.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.327 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.23 146.99 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.369 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.5 p -120.02 135.97 54.73 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.734 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.39 -143.34 0.32 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.259 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.65 -37.04 85.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.536 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.42 -66.48 0.22 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.393 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.52 142.33 45.47 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.331 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.5 p -112.2 131.54 55.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.917 0.389 . . . . 0.0 110.459 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -119.38 128.98 54.57 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.546 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.8 m -85.57 130.15 34.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.191 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.494 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.3 mt -95.62 78.69 3.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.496 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.73 -31.74 72.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.596 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 175.97 109.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.983 0.42 . . . . 0.0 110.109 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.494 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.58 91.41 49.46 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-O 120.752 0.311 . . . . 0.0 110.381 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.647 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.59 148.42 64.2 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.797 2.331 . . . . 0.0 112.067 178.821 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -40.64 82.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.634 0.584 . . . . 0.0 110.963 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.647 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.51 66.92 0.89 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.222 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.21 130.56 36.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.819 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.565 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.7 t -122.49 146.69 27.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.016 -179.66 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 t -135.97 143.7 44.98 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.742 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.5 p -99.35 -59.28 1.75 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.564 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.3 p -79.35 155.09 28.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.583 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.53 HG21 HG23 ' A' ' 70' ' ' THR . 72.4 t -74.1 -21.84 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.548 179.322 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.3 m -60.28 -52.09 66.76 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.499 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.4 mt -66.26 -42.76 88.06 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.8 177.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.1 m -42.87 -54.18 4.3 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.968 -178.521 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.23 -37.17 71.48 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 178.567 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.6 m -62.84 -44.79 95.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.915 0.388 . . . . 0.0 110.16 -179.237 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.2 mt -66.48 -41.91 88.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.521 0.677 . . . . 0.0 110.701 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 tp -62.75 -40.46 97.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.401 -179.264 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.99 -35.93 76.08 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.158 -179.043 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.524 HD11 HD12 ' A' ' 156' ' ' LEU . 32.6 pt -91.15 28.92 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.176 -179.289 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.54 51.74 10.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.971 179.409 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.56 76.05 21.3 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.614 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.07 151.66 84.96 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.74 2.293 . . . . 0.0 112.032 -178.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.565 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.44 137.48 46.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.242 0.544 . . . . 0.0 110.237 179.706 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.442 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.3 pt -69.47 -43.54 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.307 179.35 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.13 131.35 53.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.947 0.403 . . . . 0.0 110.526 -178.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.536 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.7 p -155.86 168.65 26.53 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.462 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.42 -177.32 21.93 Favored Glycine 0 N--CA 1.464 0.513 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.631 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.17 171.99 13.27 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.088 0.47 . . . . 0.0 110.36 179.383 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.53 HG23 HG21 ' A' ' 51' ' ' VAL . 14.7 p -131.94 -113.48 0.23 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.981 0.419 . . . . 0.0 110.269 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.99 179.82 0.93 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.407 -179.148 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.5 Cg_exo -60.7 57.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 123.031 2.488 . . . . 0.0 112.18 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.8 t-20 -64.42 -33.64 76.33 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 119.081 -0.485 . . . . 0.0 110.345 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.2 m120 94.03 -36.74 0.02 OUTLIER 'General case' 0 C--N 1.346 0.448 0 O-C-N 123.832 0.707 . . . . 0.0 109.806 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.406 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.5 mtp85 -62.51 -39.7 94.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.191 179.315 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.499 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.25 -25.48 19.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.762 179.374 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.52 -171.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.456 -179.201 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.05 -154.08 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.815 -179.599 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.405 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.2 p-10 -52.49 -7.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.769 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.1 mm-40 -86.32 115.0 23.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.674 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.02 69.92 1.35 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.578 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -143.45 147.72 35.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.971 0.415 . . . . 0.0 110.768 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.66 -98.29 0.07 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.185 178.786 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.25 -42.42 96.52 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.036 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.547 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.0 tt0 91.17 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.988 0.805 . . . . 0.0 110.996 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -102.86 -8.79 20.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.322 179.306 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.6 p -64.87 -33.82 76.92 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.132 0.492 . . . . 0.0 110.763 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -49.36 -23.4 1.45 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.682 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 73.4 t -70.02 -45.86 74.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.688 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.64 80.4 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.891 -179.324 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.36 -38.29 88.96 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.927 0.394 . . . . 0.0 110.509 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.64 -32.34 51.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.185 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.596 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.7 mmt-85 -90.3 1.95 56.0 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.622 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.55 -49.58 0.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.942 0.776 . . . . 0.0 110.223 179.181 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.646 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.0 mt -45.81 154.65 0.21 Allowed 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 117.451 -1.262 . . . . 0.0 109.441 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.646 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 120.8 92.6 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 O-C-N 125.676 1.86 . . . . 0.0 110.471 -178.532 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.536 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.57 143.25 42.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.238 0.542 . . . . 0.0 110.294 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.7 mt -132.42 27.1 4.44 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.976 -0.453 . . . . 0.0 110.391 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.25 137.77 34.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.065 0.46 . . . . 0.0 110.516 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.1 mt -137.01 165.01 28.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.331 179.581 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.2 -28.57 1.82 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -152.98 71.08 7.13 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 121.203 0.525 . . . . 0.0 110.262 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.17 145.54 98.27 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.803 2.335 . . . . 0.0 112.027 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.9 t -134.56 136.85 43.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.597 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.22 81.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.651 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.14 -42.38 96.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.518 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.99 -41.65 98.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.5 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.71 -43.23 97.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.05 179.486 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.17 -35.09 77.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.994 0.426 . . . . 0.0 110.146 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.7 -18.8 61.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.451 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.63 -6.48 58.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.529 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 63.1 mtp 47.22 56.22 17.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.613 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.34 149.9 63.9 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.763 2.309 . . . . 0.0 112.106 179.413 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.14 -74.25 0.62 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.454 179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.448 HD11 HD13 ' A' ' 140' ' ' LEU . 38.4 tp -110.2 113.33 25.93 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.372 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.4 mt -102.04 126.26 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 120.955 0.407 . . . . 0.0 110.661 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.1 mt -109.58 133.95 52.5 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.22 -179.349 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.85 139.63 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.496 -179.586 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.4 p -83.38 168.5 16.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.799 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.13 -37.52 80.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.443 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.79 159.16 42.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.012 0.434 . . . . 0.0 110.381 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.22 176.96 33.49 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.705 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.71 86.99 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -124.82 151.51 45.12 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.925 0.393 . . . . 0.0 110.508 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.3 t -63.26 140.81 58.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.333 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.62 10.37 11.04 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.676 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.52 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -60.83 -38.87 86.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.258 -179.367 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.67 23.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.562 0.696 . . . . 0.0 110.613 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.9 mt -71.11 -35.44 71.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.587 0.708 . . . . 0.0 110.631 179.359 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -42.81 -62.84 0.9 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.353 -178.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.85 -42.84 89.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.7 mt-30 -61.99 -32.54 73.01 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.493 0.495 . . . . 0.0 110.427 -179.594 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.7 mt -73.91 -40.95 62.79 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.803 178.727 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.13 -48.86 78.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.153 -178.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.5 m -53.31 -42.38 66.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.036 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.12 -42.61 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.943 0.401 . . . . 0.0 111.199 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.64 154.24 5.39 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.665 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -39.48 106.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.622 2.215 . . . . 0.0 112.589 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.641 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.4 m -110.08 121.4 45.18 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.115 0.483 . . . . 0.0 110.264 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.99 152.84 30.32 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.2 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.91 131.55 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.353 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.402 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.8 mt -115.31 128.02 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.488 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.6 t30 -101.6 103.92 14.77 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.206 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.2 p90 -101.38 -11.18 19.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.823 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.5 p-10 -64.83 -33.5 76.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.704 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -98.45 7.59 45.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.531 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.31 155.45 50.58 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.467 -179.418 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.6 p -75.05 165.68 24.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.695 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.589 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.85 -48.85 80.01 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.166 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -53.5 -42.05 66.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.929 0.395 . . . . 0.0 110.132 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.1 t -62.73 -41.05 98.98 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.36 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.402 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.9 tp -60.5 -44.54 95.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.374 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.8 tp -61.34 -43.33 99.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.235 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.6 m -55.02 -44.94 75.03 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.34 -40.67 97.14 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 120.928 0.394 . . . . 0.0 110.488 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.524 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -62.02 -42.45 99.18 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.418 178.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.24 -40.86 94.94 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.68 -45.92 64.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.894 0.378 . . . . 0.0 110.781 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.78 -43.99 96.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.798 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.7 p -93.13 -8.7 41.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.581 -178.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.88 26.64 72.28 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -101.75 50.85 0.84 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 110.65 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -69.55 -39.75 77.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.591 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.16 -47.26 85.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.3 -179.374 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -60.22 -39.3 86.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.136 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.07 -40.87 98.96 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 121.064 0.459 . . . . 0.0 110.279 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.02 -28.31 70.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.685 179.403 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.35 -54.35 7.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.894 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.506 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.51 -42.17 92.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.366 -179.8 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.3 mt -62.4 -43.83 98.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.481 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.3 -58.32 8.15 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.026 0.441 . . . . 0.0 110.216 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.28 -33.1 67.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.689 -179.03 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.415 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.7 t80 -81.53 -36.71 28.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.676 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.1 m-20 -55.92 -41.99 75.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.933 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.49 -42.24 99.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.911 0.386 . . . . 0.0 110.774 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.28 -37.94 88.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.279 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.415 HD11 ' CD2' ' A' ' 173' ' ' PHE . 82.0 mt -62.37 -42.19 99.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.791 179.476 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.15 -52.91 61.93 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.169 0.509 . . . . 0.0 110.628 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.1 -41.81 90.11 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.75 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.99 95.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.652 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.26 -32.07 73.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.429 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.62 -22.38 18.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.679 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.451 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.4 tt0 -64.79 -41.38 95.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.67 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 184' ' ' ILE . 33.0 pt -76.93 136.53 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.72 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.1 108.09 10.6 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.245 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.63 126.01 0.31 Allowed Pre-proline 0 C--O 1.241 0.611 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.562 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.451 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.94 152.46 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.823 2.349 . . . . 0.0 112.596 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.35 142.15 53.85 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.541 2.161 . . . . 0.0 112.428 179.734 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.38 147.32 2.13 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.573 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.19 154.82 69.38 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.81 2.34 . . . . 0.0 112.392 178.481 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.52 163.29 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.185 0.517 . . . . 0.0 110.484 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.62 170.34 16.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.955 179.457 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.2 137.44 22.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.946 0.403 . . . . 0.0 110.105 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.569 HG22 HD12 ' A' ' 205' ' ' LEU . 38.4 pt -134.14 146.51 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.726 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.71 131.77 59.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.257 0.551 . . . . 0.0 110.502 178.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -153.01 156.68 39.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.476 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.594 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.3 m -121.98 122.86 40.3 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.915 0.388 . . . . 0.0 110.358 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.517 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -61.06 -26.17 67.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.69 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.594 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.56 -49.25 22.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.872 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -77.42 -9.95 59.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.409 -179.705 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.9 m80 45.91 47.58 12.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.512 -179.635 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.2 t -130.76 143.0 50.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.968 0.413 . . . . 0.0 110.32 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.448 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -108.44 105.62 15.36 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.162 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.7 m-20 -116.39 129.2 56.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.159 0.504 . . . . 0.0 110.321 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.569 HD12 HG22 ' A' ' 194' ' ' ILE . 7.6 tt -111.92 146.46 37.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.806 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.472 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.5 t90 -99.61 128.73 45.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.207 0.527 . . . . 0.0 109.891 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.52 153.94 40.24 Favored Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.379 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.67 -17.74 47.95 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.682 2.254 . . . . 0.0 112.049 178.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -49.75 -18.89 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.342 -179.091 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.45 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.4 p -75.44 164.6 26.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.495 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.92 -27.88 65.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.496 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.574 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.7 mt-30 -63.73 -41.39 98.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.609 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.32 -44.45 97.52 Favored Glycine 0 C--N 1.332 0.337 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.525 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.49 -38.84 92.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 122.119 -0.636 . . . . 0.0 110.796 179.576 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.3 mmm -61.84 -41.27 97.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.279 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.3 mt -63.53 -47.63 80.84 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.055 0.455 . . . . 0.0 110.386 179.221 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.63 -32.07 49.87 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.872 0.368 . . . . 0.0 110.405 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.96 -17.91 62.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.473 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.431 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.7 mt -88.4 -9.14 53.62 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.575 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.1 2.37 54.65 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -88.72 153.0 21.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 110.453 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.457 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.2 p -115.86 128.44 55.81 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.149 0.499 . . . . 0.0 110.355 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.09 146.74 23.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.915 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.459 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.42 151.17 45.46 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.413 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.9 131.73 42.98 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.432 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.881 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.52 93.33 27.05 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.002 -179.453 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.684 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.2 Cg_exo -55.0 138.66 78.88 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.604 2.203 . . . . 0.0 111.71 178.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.38 -25.51 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.508 -179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.684 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.64 -49.93 27.79 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.1 mt -55.15 -37.05 66.47 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.034 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -65.66 35.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.816 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.573 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.45 88.34 0.01 OUTLIER 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 85.1 p -81.82 -13.65 57.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.297 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.73 -40.84 11.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.6 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 29.3 t -66.64 -17.03 64.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.591 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.8 43.86 27.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.444 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.93 -148.74 8.14 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.65 142.03 48.81 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.963 0.411 . . . . 0.0 110.288 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.416 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.3 ttt-85 -152.03 149.51 28.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.241 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -102.38 -149.86 0.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.307 179.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.41 -92.91 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.636 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.4 tt -126.68 174.43 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.56 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.435 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 88.2 mt -122.31 141.27 43.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.839 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.48 170.6 8.5 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.19 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 67.1 mt -146.71 149.61 33.77 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.12 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.26 -39.35 97.76 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.01 3.22 4.05 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -78.64 -57.46 3.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.949 0.404 . . . . 0.0 110.482 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.608 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.8 m-20 -62.14 -36.91 83.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.163 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.448 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.7 mp -52.88 -67.46 0.25 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.985 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.8 -42.49 68.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.094 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.67 17.45 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.666 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.15 48.33 0.29 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.1 mp 38.97 -109.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.505 0.193 . . . . 0.0 110.769 -178.501 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.459 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -60.79 -44.71 96.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.349 -179.572 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.46 8.07 83.77 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -98.8 -13.64 20.05 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 122.685 -0.303 . . . . 0.0 110.661 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.0 t 177.25 142.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.072 0.463 . . . . 0.0 110.445 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.98 125.45 11.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.14 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.55 143.84 28.53 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 120.902 0.382 . . . . 0.0 110.922 178.133 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.8 mt -95.24 106.38 18.41 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.73 -179.183 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.45 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.5 t80 -102.31 -11.4 18.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.114 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.61 -40.64 84.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.815 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.27 172.68 45.54 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.453 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 90.8 m-20 -73.72 -113.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.846 0.355 . . . . 0.0 110.794 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.35 -28.99 68.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.7 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.04 -43.71 91.68 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.251 -178.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -63.43 -44.48 94.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.31 179.216 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.6 -59.88 3.93 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.136 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.94 -43.55 60.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.233 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.32 -43.34 74.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.23 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.2 mt -64.68 -43.61 96.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.634 179.519 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -55.97 -37.75 69.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.135 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.5 1.03 17.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.241 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -114.93 91.11 25.16 Favored Pre-proline 0 N--CA 1.464 0.256 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.161 -179.543 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.96 -27.3 27.81 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.764 2.309 . . . . 0.0 112.02 179.208 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.69 -40.93 98.01 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.545 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.594 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.25 5.39 51.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.327 -179.187 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.36 -35.04 68.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.527 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.72 4.49 16.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.472 -178.799 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.62 121.1 79.76 Favored Pre-proline 0 N--CA 1.442 -0.868 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.566 -179.983 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.27 -37.74 24.87 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.503 2.135 . . . . 0.0 112.643 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.89 -43.84 91.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.803 0.335 . . . . 0.0 110.398 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.98 -43.48 92.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.356 179.345 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.07 -40.57 94.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.382 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 47.9 t-20 -89.73 -12.59 38.94 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.501 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.12 32.31 17.49 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.395 0.435 . . . . 0.0 110.992 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.04 43.69 1.16 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.126 0.489 . . . . 0.0 110.334 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.23 135.82 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.488 -179.764 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -116.87 132.44 56.7 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.469 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.19 88.93 7.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.709 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.88 -41.05 97.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.869 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.45 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.75 165.55 33.58 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 72.1 p -75.38 -25.75 57.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 110.824 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.2 tp10 -68.26 -33.94 75.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.414 -179.75 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 296' ' ' THR . 96.7 m -73.37 24.33 0.07 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.698 -179.026 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.574 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 43.0 t80 -58.28 -50.93 71.84 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.22 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.416 HH12 ' HG3' ' A' ' 212' ' ' GLN . 77.4 mmt-85 -110.4 152.9 25.71 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.085 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.431 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.1 tp -115.53 125.11 52.6 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 120.893 0.377 . . . . 0.0 110.723 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.49 ' CB ' HD23 ' A' ' 83' ' ' LEU . 40.9 t0 -148.04 165.76 29.81 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.652 179.517 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -49.32 -37.74 25.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.642 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -71.35 -65.6 0.73 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.487 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.88 -32.99 72.41 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.041 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.25 -25.49 23.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.703 -179.104 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.4 mtt -63.57 -40.8 97.91 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 120.892 0.377 . . . . 0.0 111.097 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.63 -44.27 24.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.188 179.524 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.581 HG21 HG23 ' A' ' 296' ' ' THR . 79.2 t -66.23 -42.82 91.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.308 179.645 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.451 HD11 ' NE2' ' A' ' 183' ' ' GLN . 51.0 tp -60.19 -47.11 87.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.464 -178.512 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -69.96 -39.24 76.13 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.593 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.5 ttt180 -61.89 -38.18 87.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.235 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.6 mt -87.26 4.67 41.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.625 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.405 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.2 tttt -112.9 -10.95 13.49 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.046 0.451 . . . . 0.0 110.221 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.29 86.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.432 179.672 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.81 -48.82 80.06 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.41 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.029 179.915 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.3 -2.46 58.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.43 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.493 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.05 1.25 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.537 -179.682 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.493 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.8 Cg_exo -60.75 144.93 99.63 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.806 2.337 . . . . 0.0 112.203 179.718 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.95 -179.53 8.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.635 -179.74 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.81 136.84 52.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.389 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.44 147.07 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.418 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 79.2 p -120.03 136.07 54.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.733 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.47 -143.34 0.33 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.266 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -63.67 -37.19 86.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.472 179.683 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.25 -66.53 0.22 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.416 179.637 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.43 142.22 45.36 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.0 p -112.17 131.53 55.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.949 0.404 . . . . 0.0 110.485 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -119.23 129.05 54.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.588 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.9 m -85.46 130.19 34.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.307 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.471 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.5 mt -95.51 78.75 3.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.373 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.73 -31.9 73.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.579 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.65 109.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.984 0.421 . . . . 0.0 110.119 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.471 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.35 91.81 49.12 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.416 -179.685 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.7 Cg_exo -56.68 148.35 65.63 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.826 2.35 . . . . 0.0 111.956 178.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.4 82.66 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.526 0.516 . . . . 0.0 110.961 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.6 mtm180 -151.41 66.87 0.89 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.062 0.458 . . . . 0.0 110.263 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.38 130.69 35.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.77 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.568 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.5 t -122.6 147.01 26.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.151 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.8 t -136.27 143.83 44.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.025 0.441 . . . . 0.0 110.639 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.4 ' OG1' ' N ' ' A' ' 50' ' ' SER . 26.1 p -99.53 -59.65 1.68 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.62 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.4 ' N ' ' OG1' ' A' ' 49' ' ' THR . 87.3 p -78.91 155.25 29.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.675 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.515 HG21 HG23 ' A' ' 70' ' ' THR . 73.8 t -74.42 -21.8 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.546 179.446 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.8 m -60.11 -52.28 66.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.506 -178.595 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.4 -42.59 87.62 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.723 177.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.0 m -42.91 -54.17 4.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.035 -178.716 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.31 -37.18 70.78 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.767 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.5 m -62.85 -44.69 95.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.906 0.384 . . . . 0.0 110.336 -179.358 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.407 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.9 mt -66.35 -41.84 88.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.426 0.632 . . . . 0.0 110.781 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.59 -40.44 96.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.333 -179.319 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.512 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.17 -35.76 76.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.185 -178.784 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.524 HD11 HD12 ' A' ' 156' ' ' LEU . 32.6 pt -91.27 28.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.237 -179.24 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.53 51.76 10.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.009 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.17 75.53 23.32 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.996 0.427 . . . . 0.0 109.995 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.36 150.98 87.27 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.794 2.329 . . . . 0.0 112.121 -178.735 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.17 137.27 46.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 CA-C-O 121.13 0.49 . . . . 0.0 110.356 179.814 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.445 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.0 pt -69.52 -43.49 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.219 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.06 131.25 53.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.522 -178.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.7 p -155.67 168.72 26.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.547 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.89 -177.21 21.62 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.636 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.33 172.55 12.54 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 121.043 0.449 . . . . 0.0 110.439 179.336 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.515 HG23 HG21 ' A' ' 51' ' ' VAL . 13.4 p -132.76 -112.43 0.23 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.991 0.424 . . . . 0.0 110.396 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.31 179.66 0.95 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.427 -179.185 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.3 Cg_exo -60.9 58.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.977 2.452 . . . . 0.0 112.07 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.572 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.0 t-20 -64.52 -33.84 76.83 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.438 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.2 m120 93.92 -36.74 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.736 0.648 . . . . 0.0 109.926 -179.545 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.401 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.9 mtp85 -62.61 -39.58 94.24 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.256 179.116 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.499 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.9 p -74.55 -25.44 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.606 179.467 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.41 -171.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.449 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -74.03 -153.65 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.805 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.9 p-10 -52.82 -7.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.675 -179.405 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.5 114.8 23.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.623 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.03 70.0 1.35 Allowed Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -143.31 147.36 34.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.917 0.389 . . . . 0.0 110.769 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.33 -98.44 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.12 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.563 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.11 -42.81 96.74 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.123 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.563 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.0 tt0 91.55 53.0 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.771 0.669 . . . . 0.0 110.856 178.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -102.92 -9.63 19.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.407 179.239 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.4 p -64.05 -34.11 77.28 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.047 0.451 . . . . 0.0 110.683 -179.662 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.96 -23.38 1.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.668 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.1 t -70.12 -45.72 75.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.713 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.58 80.65 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.048 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.37 -38.26 88.86 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.431 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.66 -32.65 52.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.166 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.62 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.8 mmt-85 -89.91 1.5 56.16 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.587 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.94 -49.19 0.16 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.761 0.663 . . . . 0.0 110.213 179.122 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.682 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.6 mt -46.05 154.08 0.27 Allowed 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.69 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.682 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.6 tt0 121.26 92.57 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 125.115 1.509 . . . . 0.0 110.445 -178.703 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.65 143.35 42.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.0 110.337 179.345 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.8 mt -132.41 27.25 4.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.879 0.371 . . . . 0.0 110.426 -179.37 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.31 137.86 34.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.636 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.7 mt -137.16 165.13 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.369 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.62 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.16 -28.76 1.82 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -153.0 70.93 7.11 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.124 0.488 . . . . 0.0 110.333 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.96 145.41 98.4 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.792 2.328 . . . . 0.0 112.058 -179.494 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.0 t -134.37 136.96 43.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.573 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.28 82.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.576 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.02 -42.34 97.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.569 -179.466 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.88 -41.65 98.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.55 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -63.7 -43.32 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.107 179.418 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.91 -35.18 77.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.274 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.78 -18.68 60.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.42 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.65 -6.78 58.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.538 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 68.6 mtp 47.48 56.25 17.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.648 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.28 149.44 63.57 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.759 2.306 . . . . 0.0 112.064 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.09 -73.5 0.64 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.529 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.417 HD11 HD13 ' A' ' 140' ' ' LEU . 38.6 tp -111.01 113.57 26.21 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.271 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.0 mt -102.16 126.63 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.6 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.7 mt -109.84 133.91 52.63 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.278 -179.467 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.99 139.98 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.522 -179.499 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.1 p -83.68 168.62 16.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.71 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.25 -37.41 80.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.472 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.98 158.86 43.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.453 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -155.94 177.07 33.21 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.22 -33.71 86.83 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.84 151.4 45.3 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.891 0.376 . . . . 0.0 110.54 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -63.29 140.93 58.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.326 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.78 10.64 10.99 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.647 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -60.97 -38.89 87.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.168 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.2 -35.75 23.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.375 0.607 . . . . 0.0 110.538 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.3 mt -71.0 -35.21 71.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.41 0.624 . . . . 0.0 110.697 179.294 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -42.8 -63.03 0.85 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.319 -178.852 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.2 p-10 -65.67 -42.85 90.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.091 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.545 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -61.91 -32.62 73.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.314 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.5 mt -73.95 -40.79 62.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 178.704 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -57.99 -49.23 77.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.169 -179.072 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 75.2 m -52.46 -42.67 64.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.263 179.314 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.3 -42.87 91.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 111.022 179.283 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.4 153.48 5.3 Favored Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.676 -179.336 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -39.41 107.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.675 2.25 . . . . 0.0 112.435 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.646 ' C ' HD12 ' A' ' 140' ' ' LEU . 97.2 m -109.61 121.68 45.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.074 0.464 . . . . 0.0 110.258 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.646 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.05 152.55 30.84 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.299 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -128.87 131.24 68.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.474 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.408 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.8 mt -114.99 128.01 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.527 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.8 t30 -101.82 103.87 14.6 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.2 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.6 p90 -101.51 -10.85 19.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.888 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.77 -33.24 75.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.704 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.6 p-10 -98.8 8.05 45.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.583 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.442 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.87 155.56 50.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.534 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -75.08 165.93 24.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.69 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.596 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.3 t90 -60.01 -48.65 80.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.278 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.36 -42.41 66.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.116 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.8 t -62.84 -41.11 99.21 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.348 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.408 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.8 tp -60.5 -44.45 95.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.317 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.9 tp -61.26 -43.74 98.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.205 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 m -54.7 -45.22 73.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.708 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.14 -40.93 97.61 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.878 0.37 . . . . 0.0 110.455 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.524 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.68 -42.4 98.87 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.206 179.117 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.16 -40.6 95.0 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.508 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.75 -46.01 63.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.874 0.369 . . . . 0.0 110.847 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.74 -43.92 96.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.735 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -93.18 -8.66 41.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.632 -179.032 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.01 26.58 72.37 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.66 50.72 0.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 110.708 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.64 -39.47 77.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.584 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.45 -47.3 86.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.357 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -59.82 -39.56 85.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.317 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.88 -40.99 99.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.297 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.1 -28.66 70.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.601 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.29 -54.51 7.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.873 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.512 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.0 -42.43 94.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.533 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.454 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.1 mt -62.33 -43.91 98.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.53 -179.508 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.19 -60.8 3.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.967 0.413 . . . . 0.0 110.415 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.9 -34.0 62.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.619 -179.183 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -81.1 -35.84 31.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.762 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.7 m-20 -55.28 -41.95 72.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.124 -178.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.47 -42.04 99.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.643 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.04 -38.27 90.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.363 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.8 mt -62.36 -42.1 99.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.672 179.404 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.06 -53.27 57.84 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.068 0.461 . . . . 0.0 110.682 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.22 -41.85 89.53 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.635 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.0 95.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.615 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.42 -31.56 72.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.434 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -95.03 -22.68 17.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.611 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.436 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.4 tt0 -64.85 -41.42 95.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.582 -179.55 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.2 pt -76.22 135.99 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.719 -179.802 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -126.1 108.1 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.292 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.6 pp -177.3 125.2 0.28 Allowed Pre-proline 0 C--O 1.239 0.502 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.497 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.5 Cg_exo -44.03 152.47 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.898 2.399 . . . . 0.0 112.429 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.8 141.73 55.2 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.622 2.215 . . . . 0.0 112.352 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.46 147.25 2.08 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.511 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.9 154.38 71.04 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.856 2.371 . . . . 0.0 112.328 178.661 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.581 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.14 162.91 30.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.134 0.492 . . . . 0.0 110.449 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.581 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -144.03 170.72 15.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.999 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.61 137.73 21.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.938 0.399 . . . . 0.0 110.245 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.565 HG22 HD12 ' A' ' 205' ' ' LEU . 39.5 pt -134.44 147.16 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.726 179.69 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -132.89 131.73 59.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 110.467 178.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -152.32 155.37 37.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.379 179.316 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.619 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.4 m -122.82 122.93 39.87 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.972 0.415 . . . . 0.0 110.425 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.79 -25.55 66.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.571 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.619 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.23 -48.88 21.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.925 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.81 -11.77 60.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.516 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.8 m80 49.4 41.63 21.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.582 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.8 t -136.29 144.76 44.92 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.408 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.431 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -110.96 114.47 27.81 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.393 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.9 133.56 55.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 0.0 110.347 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.565 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.27 146.91 37.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.771 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.544 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.6 t90 -100.42 131.14 46.5 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.196 0.522 . . . . 0.0 109.965 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.66 153.94 39.29 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.244 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.406 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.9 Cg_endo -67.87 -17.99 46.93 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.736 2.29 . . . . 0.0 111.985 178.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.19 -18.69 0.37 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.388 -179.148 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.544 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 84.1 p -75.5 164.66 26.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.518 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.11 -27.92 66.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.473 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.589 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.5 mt-30 -64.03 -41.22 97.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.605 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.24 -45.06 96.77 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.83 -38.86 92.4 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 122.438 -0.448 . . . . 0.0 110.731 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.596 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.1 mmm -62.03 -41.71 98.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.262 179.781 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.432 HD23 HD12 ' A' ' 219' ' ' LEU . 45.5 mt -63.43 -46.87 84.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.019 0.438 . . . . 0.0 110.325 179.488 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.94 -31.56 60.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.346 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.16 -17.52 63.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.496 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.453 HD11 ' CD2' ' A' ' 299' ' ' LEU . 88.4 mt -88.54 -9.34 52.68 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.576 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.58 1.78 50.01 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.774 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -88.46 154.42 20.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.843 0.354 . . . . 0.0 110.567 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.44 ' O ' HG12 ' A' ' 191' ' ' VAL . 6.2 p -116.35 128.7 55.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.132 0.492 . . . . 0.0 110.387 179.948 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.588 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.5 mm? -91.76 146.14 24.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.999 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.478 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -70.52 151.88 44.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.405 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.36 131.53 41.98 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.571 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.892 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.45 93.45 27.24 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.238 -179.815 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.678 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.9 Cg_exo -55.22 139.14 80.74 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.604 2.203 . . . . 0.0 111.758 178.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.0 -26.32 0.05 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.427 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.24 -50.3 28.27 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -53.65 -37.19 62.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.176 -179.385 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -66.77 36.09 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.709 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.02 88.32 0.01 OUTLIER 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.932 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 79.5 p -81.21 -14.18 57.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.36 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.9 -41.29 10.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.565 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.84 -16.98 64.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.633 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 55.72 43.68 27.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.539 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.5 -148.62 7.91 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.88 142.59 49.54 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.956 0.408 . . . . 0.0 110.382 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.416 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.0 ttt-85 -151.91 149.44 28.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.352 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -101.22 -151.49 0.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.316 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.75 -92.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.655 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.463 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.6 tt -126.58 175.18 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.532 -179.395 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.463 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -122.79 141.91 41.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.809 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.65 169.32 9.36 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.279 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.7 mt -147.96 150.97 35.0 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.176 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.91 -38.99 96.89 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.41 4.12 4.52 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -77.43 -58.25 3.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.485 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.551 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.0 m-20 -61.85 -36.89 82.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.518 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.431 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.1 mp -52.35 -67.86 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.635 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.36 -42.32 66.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.159 -179.515 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.04 17.56 0.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.635 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.71 49.13 0.27 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.5 mp 38.23 -109.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.565 0.222 . . . . 0.0 110.67 -178.773 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.478 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.9 m120 -60.37 -45.24 94.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.635 -179.742 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.55 7.87 83.89 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.338 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.95 -13.24 20.05 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.669 -0.312 . . . . 0.0 110.743 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.2 t 176.87 142.61 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.97 0.414 . . . . 0.0 110.465 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.2 125.09 11.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.094 179.729 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -98.27 143.34 28.86 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.841 0.353 . . . . 0.0 110.758 178.276 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.7 mt -94.91 106.78 18.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.807 -179.32 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.441 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.1 t80 -101.98 -12.52 18.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.209 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.07 -40.95 91.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.857 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.5 173.03 45.82 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.653 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.474 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 93.5 m-20 -73.7 -112.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.678 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -68.2 -28.83 67.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.614 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.96 -43.95 91.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.278 -178.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.39 -44.66 94.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.371 179.171 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.47 -60.16 3.57 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.378 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.83 -43.68 59.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.21 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.28 -43.38 74.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.205 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.75 -43.67 96.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.563 179.587 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -56.1 -37.51 69.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.182 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.23 0.84 17.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.238 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -115.17 91.13 26.37 Favored Pre-proline 0 N--CA 1.46 0.073 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.25 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.98 -27.07 27.11 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.847 2.365 . . . . 0.0 111.959 179.267 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.52 -40.94 98.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.513 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.597 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.1 mp -95.2 5.49 51.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.443 -179.143 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.19 -34.59 68.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.631 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -79.97 4.5 16.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.569 -178.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.96 121.1 80.4 Favored Pre-proline 0 N--CA 1.446 -0.645 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.462 -179.974 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -47.29 -37.65 24.83 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.463 2.108 . . . . 0.0 112.499 -179.467 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.53 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -59.06 -43.96 91.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.769 0.318 . . . . 0.0 110.446 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.08 -43.54 92.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.358 179.281 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.44 -40.99 96.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.428 -179.319 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -90.27 -11.54 40.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.69 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.62 32.8 18.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.965 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -89.0 43.85 1.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.096 0.474 . . . . 0.0 110.366 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.52 135.82 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.451 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -116.73 132.55 56.66 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.387 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.06 89.17 7.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.732 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.409 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.3 mt -63.9 -40.88 97.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.441 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.03 165.27 33.67 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.4 p -75.43 -25.72 57.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.878 0.37 . . . . 0.0 110.679 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.5 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.8 tp10 -68.53 -33.7 74.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.454 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 296' ' ' THR . 95.8 m -73.59 24.96 0.07 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.74 -179.148 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.589 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 40.2 t80 -58.32 -50.72 72.62 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.387 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.416 ' CZ ' ' CE2' ' A' ' 297' ' ' PHE . 79.3 mmt-85 -111.03 153.95 24.88 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.791 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.453 ' CD2' HD11 ' A' ' 219' ' ' LEU . 46.3 tp -115.77 125.17 52.4 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.757 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.486 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.5 t0 -147.93 165.68 29.94 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.656 179.627 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.26 -37.94 25.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.641 -179.506 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -71.36 -65.58 0.73 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.403 -179.796 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.84 -32.85 72.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.269 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.19 -25.58 23.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.797 -179.057 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.6 mtt -63.54 -40.91 98.24 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.05 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.0 -43.93 23.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.979 179.755 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.576 HG21 HG23 ' A' ' 296' ' ' THR . 79.8 t -66.35 -42.76 91.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.403 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.436 HD11 ' NE2' ' A' ' 183' ' ' GLN . 50.3 tp -60.17 -47.06 87.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.48 -178.737 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -70.07 -39.32 75.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.958 0.408 . . . . 0.0 110.584 179.252 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.7 ttt180 -61.87 -38.43 88.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.232 -178.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.09 4.49 41.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.622 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.405 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.2 tttt -112.67 -11.2 13.57 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.103 0.478 . . . . 0.0 110.435 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.21 -37.28 86.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.51 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.68 -48.83 80.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.363 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.221 -0.405 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.069 179.769 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.11 -2.54 58.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.44 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.5 179.16 1.23 Allowed Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.49 -179.66 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.4 Cg_exo -60.72 145.07 99.52 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.84 2.36 . . . . 0.0 112.142 179.611 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.613 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.25 -179.44 8.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.631 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.19 136.95 52.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.362 179.702 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.05 147.17 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.402 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.4 p -120.18 136.05 54.76 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.062 0.458 . . . . 0.0 110.78 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.9 p30 -99.21 -143.8 0.32 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.244 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.52 -37.04 85.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.522 179.635 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.481 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.76 -67.69 0.23 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.422 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.12 142.71 44.21 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.288 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.2 p -112.51 131.22 55.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.895 0.378 . . . . 0.0 110.418 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -118.6 129.2 55.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.559 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.8 m -85.67 130.58 34.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.247 -179.808 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.475 HD22 ' OE1' ' A' ' 42' ' ' GLN . 70.0 mt -96.69 78.76 2.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 110.433 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.84 -31.68 72.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.603 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.51 107.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 110.089 -179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.475 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -121.13 91.32 47.95 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.42 -179.719 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.655 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.6 Cg_exo -56.73 148.54 64.95 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.801 2.334 . . . . 0.0 111.953 178.974 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.61 82.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.627 0.579 . . . . 0.0 110.951 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.655 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.41 66.85 0.89 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.071 0.462 . . . . 0.0 110.192 -179.465 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -76.83 130.98 35.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.803 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.571 ' HA ' HG23 ' A' ' 64' ' ' VAL . 58.9 t -122.63 147.33 26.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.028 -179.702 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.7 t -136.4 144.11 44.33 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.745 179.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 50' ' ' SER . 17.5 p -100.03 -59.04 1.78 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.549 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.415 ' N ' ' OG1' ' A' ' 49' ' ' THR . 87.3 p -79.2 155.07 28.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.612 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.523 HG21 HG23 ' A' ' 70' ' ' THR . 72.0 t -74.11 -21.83 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.472 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.2 m -60.31 -51.93 67.43 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.478 -178.433 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -66.4 -42.75 87.41 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.759 177.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.9 m -42.99 -54.07 4.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.911 -178.547 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.08 -37.46 73.0 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 178.602 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.5 m -62.89 -44.26 96.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.886 0.374 . . . . 0.0 110.164 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 17.5 mt -66.14 -42.21 89.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.544 0.687 . . . . 0.0 110.639 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.97 -39.78 95.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.379 -179.122 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.528 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.49 -35.81 76.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.231 -179.078 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.492 HD11 HD12 ' A' ' 156' ' ' LEU . 33.6 pt -91.5 27.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.317 -179.311 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.82 51.95 10.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.053 179.554 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.34 76.19 26.41 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 121.021 0.438 . . . . 0.0 109.839 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.24 149.63 89.88 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.8 2.333 . . . . 0.0 112.09 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.571 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.4 136.66 47.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 CA-C-O 121.127 0.489 . . . . 0.0 110.34 179.696 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -69.57 -43.45 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.358 179.317 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.49 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.35 131.35 53.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.032 0.444 . . . . 0.0 110.601 -179.008 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.536 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.4 p -155.94 168.68 26.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.47 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.32 -177.35 21.99 Favored Glycine 0 N--CA 1.463 0.456 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.639 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.35 172.07 13.19 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 121.04 0.448 . . . . 0.0 110.452 179.355 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.523 HG23 HG21 ' A' ' 51' ' ' VAL . 14.0 p -133.25 -111.39 0.23 Allowed 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.018 0.437 . . . . 0.0 110.453 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.94 179.62 0.94 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.44 -179.195 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.8 Cg_exo -60.89 58.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.926 2.418 . . . . 0.0 112.156 179.518 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.8 t-20 -64.42 -34.19 77.6 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.361 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.8 m120 94.76 -37.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.824 0.703 . . . . 0.0 109.814 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HD3' HD21 ' A' ' 73' ' ' ASN . 77.3 mtp85 -62.76 -40.22 96.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.218 179.217 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.3 p -74.08 -25.98 20.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.758 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.84 -172.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.433 -179.219 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.87 -152.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.777 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.3 p-10 -54.36 -6.66 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.759 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.48 114.14 23.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.629 179.731 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.52 72.14 1.3 Allowed Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.567 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.2 m-85 -143.54 148.27 35.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.874 0.369 . . . . 0.0 110.899 179.236 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.96 -98.81 0.07 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.026 178.844 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.555 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.94 -43.26 96.39 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.177 179.291 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.555 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.2 tt0 91.66 52.55 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.913 0.758 . . . . 0.0 111.052 179.176 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -103.49 -8.63 19.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.335 179.267 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.465 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.3 p -65.33 -33.38 75.84 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.063 0.459 . . . . 0.0 110.672 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -49.12 -24.18 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.695 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.2 t -69.86 -45.93 75.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.765 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.14 -48.77 80.06 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.043 -179.384 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.48 -38.32 89.4 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.454 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.72 -32.62 52.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.136 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.607 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 83.7 mmt-85 -90.1 1.8 55.98 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.538 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.94 -49.79 0.16 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.865 0.728 . . . . 0.0 110.235 179.176 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.66 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.4 mt -45.54 153.75 0.23 Allowed 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 117.673 -1.156 . . . . 0.0 109.561 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.66 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 121.05 92.27 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 O-C-N 125.444 1.715 . . . . 0.0 110.456 -178.581 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.536 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.02 142.77 43.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.219 0.533 . . . . 0.0 110.262 179.34 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 mt -131.81 26.59 4.65 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.04 -0.413 . . . . 0.0 110.415 -179.341 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -139.97 137.27 34.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.045 0.45 . . . . 0.0 110.531 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.639 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.1 mt -136.72 164.89 29.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.361 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.614 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.22 -28.48 1.82 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.76 70.5 7.24 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.108 0.48 . . . . 0.0 110.259 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.1 145.32 98.72 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 122.768 2.312 . . . . 0.0 112.123 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.9 t -134.08 136.68 44.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.556 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.62 -38.54 84.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.665 179.652 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.35 -41.98 96.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.48 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.65 98.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.473 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.53 -43.22 98.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.077 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.01 -35.12 77.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.223 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.69 -18.69 60.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.401 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.66 -6.51 58.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.5 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.8 mtp 47.61 55.99 17.18 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.594 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.28 149.82 64.17 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.767 2.312 . . . . 0.0 112.126 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.9 -72.77 0.67 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.452 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.7 tp -111.67 114.19 27.05 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.388 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.3 mt -103.36 126.91 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 120.964 0.411 . . . . 0.0 110.608 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.0 mt -110.63 134.21 52.63 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.214 -179.401 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.86 140.12 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.572 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.0 p -83.48 168.25 16.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.788 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.5 -37.13 80.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.47 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 t -139.49 158.35 44.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.466 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.15 176.88 33.46 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.66 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.31 -34.0 87.87 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -179.541 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.82 151.52 45.11 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.91 0.386 . . . . 0.0 110.552 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.8 t -63.23 141.07 58.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.334 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.89 10.59 10.9 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.644 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -60.92 -38.98 87.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.235 -179.372 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.87 -35.74 23.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.479 0.657 . . . . 0.0 110.587 179.84 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.2 mt -71.16 -35.18 71.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.492 0.663 . . . . 0.0 110.614 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -42.95 -62.85 0.91 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.322 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.69 -42.96 90.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.058 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -61.86 -32.34 72.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.402 -179.607 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.2 mt -74.23 -40.64 62.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.869 178.637 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.42 -49.09 78.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.163 -178.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.9 m -53.04 -42.67 65.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.941 0.4 . . . . 0.0 110.142 179.6 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.53 -42.83 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 120.948 0.404 . . . . 0.0 111.218 179.023 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -168.6 151.4 5.18 Favored Pre-proline 0 N--CA 1.452 -0.369 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.726 -179.265 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -38.78 107.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.716 2.277 . . . . 0.0 112.493 179.717 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.4 m -109.35 121.71 45.77 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.047 0.451 . . . . 0.0 110.265 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.13 153.51 29.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.32 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -128.77 131.62 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.402 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.36 127.82 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 121.074 0.464 . . . . 0.0 110.535 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.2 t30 -100.99 105.1 16.28 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.149 179.868 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.9 p90 -101.28 -11.58 19.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.898 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.0 p-10 -64.82 -33.64 76.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.805 -179.656 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.2 p-10 -99.37 7.82 45.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.601 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.9 mttm -134.79 152.35 51.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.525 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.424 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.9 p -75.42 165.97 24.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.677 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.596 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.3 t90 -59.09 -48.49 81.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.23 -179.081 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -54.37 -43.68 71.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.043 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.1 t -62.9 -41.09 99.31 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.255 178.595 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.434 ' O ' HD23 ' A' ' 156' ' ' LEU . 54.8 tp -60.81 -44.53 96.74 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.185 -179.454 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.49 -42.75 99.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.153 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.8 m -55.63 -45.46 77.58 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.49 -40.13 95.7 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 120.892 0.377 . . . . 0.0 110.505 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.492 HD12 HD11 ' A' ' 60' ' ' ILE . 2.5 mm? -61.99 -42.51 99.22 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.324 179.058 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.16 -40.04 94.79 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.508 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.57 -45.9 64.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 110.849 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.87 -44.06 96.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.845 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.9 p -92.98 -9.1 41.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.643 -178.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.16 26.02 72.39 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -101.17 50.38 0.86 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.811 0.338 . . . . 0.0 110.649 -179.506 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -69.43 -39.56 77.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.628 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.53 -47.35 85.89 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.294 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -60.01 -39.16 84.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.099 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.04 -40.76 98.69 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.214 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.04 -28.86 70.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.56 179.437 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.12 -54.46 7.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.904 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.528 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.6 ttp180 -64.78 -42.23 95.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.406 -179.795 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.2 mt -62.48 -43.8 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.483 -179.508 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.95 -60.15 4.06 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.024 0.44 . . . . 0.0 110.311 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.22 -34.01 63.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.552 -179.229 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -80.7 -36.11 32.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.731 179.555 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.8 m-20 -54.79 -42.44 71.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.005 -178.548 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.01 -41.75 98.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.719 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -64.97 -38.02 89.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.355 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 177' ' ' LEU . 79.8 mt -62.53 -42.29 99.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.753 179.45 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.91 -52.97 61.91 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.066 0.46 . . . . 0.0 110.686 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.41 -41.79 88.75 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.711 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.74 -40.24 96.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.664 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.06 -32.81 74.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.477 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.07 -21.3 19.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.704 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.597 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.6 tt0 -64.89 -41.62 95.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.743 -179.56 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 184' ' ' ILE . 31.3 pt -76.47 133.93 29.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.071 0.462 . . . . 0.0 110.716 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -127.83 106.43 9.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.417 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.58 128.31 0.34 Allowed Pre-proline 0 C--O 1.24 0.553 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.521 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.49 151.37 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.869 2.38 . . . . 0.0 112.577 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.83 142.57 52.61 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.587 2.192 . . . . 0.0 112.411 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.542 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.89 147.19 2.3 Favored Pre-proline 0 N--CA 1.448 -0.555 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.574 179.395 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.99 153.8 71.85 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.879 2.386 . . . . 0.0 112.317 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.19 163.09 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.167 0.508 . . . . 0.0 110.454 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.578 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.5 169.76 17.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.958 179.462 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.84 137.48 22.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.147 179.505 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.538 HG22 HD12 ' A' ' 205' ' ' LEU . 39.8 pt -134.35 146.58 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.693 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -133.41 132.15 57.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.129 0.49 . . . . 0.0 110.43 178.843 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -152.05 154.85 36.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.398 179.158 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.615 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.8 m -121.95 122.88 40.39 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.961 0.41 . . . . 0.0 110.355 179.398 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.87 -25.34 66.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.656 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.615 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.19 -49.58 18.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.02 -10.9 60.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.416 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.0 m80 48.4 42.72 18.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.489 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.9 t -136.37 145.05 44.93 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.355 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.12 114.42 27.66 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.324 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -120.19 133.71 55.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.984 0.421 . . . . 0.0 110.387 179.843 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.538 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.24 146.68 37.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.052 0.453 . . . . 0.0 110.762 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.488 ' N ' HD23 ' A' ' 205' ' ' LEU . 12.4 t90 -99.73 127.93 45.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.195 0.521 . . . . 0.0 109.862 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.5 153.47 41.33 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.427 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.71 -18.56 47.92 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.629 2.219 . . . . 0.0 112.005 178.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.86 -18.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.419 -179.121 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.442 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.3 p -75.27 167.77 21.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.491 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.64 75.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.481 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.3 mt-30 -56.52 -41.38 76.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.722 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.22 -43.07 97.45 Favored Glycine 0 C--O 1.235 0.201 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.49 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.4 mt-30 -63.81 -39.87 95.26 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 122.231 -0.57 . . . . 0.0 110.82 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.596 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.3 mmm -61.77 -41.7 98.04 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.277 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 77.3 mt -63.31 -50.2 70.98 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.197 0.522 . . . . 0.0 110.328 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.69 -33.03 45.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.862 0.363 . . . . 0.0 110.227 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.15 -19.99 62.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.562 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 219' ' ' LEU . 66.2 mt -87.41 -6.44 58.44 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.819 -179.632 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.63 3.56 57.27 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -88.47 149.96 23.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.912 0.386 . . . . 0.0 110.519 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.438 ' O ' HG12 ' A' ' 191' ' ' VAL . 3.1 p -113.01 126.67 55.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.137 0.494 . . . . 0.0 110.332 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.63 145.91 24.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.078 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.489 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -70.05 150.5 46.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.44 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.52 131.25 45.0 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.466 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.895 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -114.02 92.94 27.87 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.004 -179.552 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.68 ' C ' ' H ' ' A' ' 229' ' ' GLY . 44.5 Cg_exo -55.52 139.12 82.11 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.544 2.162 . . . . 0.0 111.693 178.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.68 -25.05 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.448 -179.59 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.68 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.82 -49.79 27.37 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.721 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.558 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.1 mt -54.43 -36.97 64.6 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.62 36.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.804 179.414 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.52 87.85 0.01 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.93 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.1 p -80.88 -14.32 58.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.318 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.77 -41.41 10.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.616 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.1 t -66.99 -16.74 64.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.584 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.78 43.97 26.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.467 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.98 -148.58 8.03 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.81 143.19 48.98 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.971 0.415 . . . . 0.0 110.316 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -151.98 149.6 29.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.328 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -101.05 -152.21 0.43 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.299 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.3 -92.14 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.626 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.475 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.4 tt -126.81 175.58 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.612 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.475 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.0 mt -122.21 141.46 42.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 -179.431 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.61 169.29 9.39 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.243 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.6 mt -147.38 150.69 35.18 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.277 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.72 -38.96 96.99 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.53 3.62 4.6 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.07 -58.33 3.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.966 0.412 . . . . 0.0 110.518 -179.743 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.559 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.9 m-20 -61.95 -36.75 82.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.203 -179.663 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.24 -67.72 0.23 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.849 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.56 -42.32 67.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.109 -179.394 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.81 18.19 0.14 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.664 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.63 47.85 0.23 Allowed Glycine 0 N--CA 1.464 0.555 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 39.06 -110.07 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.501 0.191 . . . . 0.0 110.74 -178.589 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.489 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.84 -45.18 95.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.421 -179.482 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.95 8.05 82.96 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -99.16 -12.92 20.02 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.757 -0.261 . . . . 0.0 110.597 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.9 t 176.79 142.75 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.101 0.477 . . . . 0.0 110.417 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.17 125.6 11.65 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.137 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -98.52 143.33 29.05 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 120.915 0.388 . . . . 0.0 110.838 178.236 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.3 mt -94.65 106.55 18.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.782 -179.214 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.466 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.8 t80 -101.95 -12.52 18.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.13 179.582 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.7 90.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.87 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.02 173.36 45.9 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -179.621 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.496 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -74.01 -112.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.762 0.315 . . . . 0.0 110.768 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.74 -28.78 67.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.658 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.06 -44.06 91.81 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.236 -178.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.43 -44.49 94.42 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.288 179.214 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.47 -59.96 3.81 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.189 -179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.95 -43.52 60.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.159 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.31 -43.64 75.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.243 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.5 mt -64.49 -43.57 96.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.577 179.571 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -56.48 -37.72 70.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.152 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.22 1.02 19.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.199 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -114.83 91.49 26.25 Favored Pre-proline 0 N--CA 1.462 0.135 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.176 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.09 -27.32 28.79 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.715 2.277 . . . . 0.0 111.966 179.318 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.42 -41.08 98.7 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.545 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.9 mp -95.5 5.06 52.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.354 -179.14 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.83 -35.14 69.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.601 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -80.17 4.74 16.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.507 -178.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.73 121.11 80.0 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.57 -179.996 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.43 -37.71 26.0 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.492 2.128 . . . . 0.0 112.58 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.66 -43.4 89.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.765 0.317 . . . . 0.0 110.397 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.92 -43.67 92.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.357 179.204 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -65.1 -40.64 94.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.31 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 44.5 t-20 -89.08 -13.1 39.38 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.554 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 62.29 31.19 17.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.037 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.32 44.2 1.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.176 0.513 . . . . 0.0 110.346 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.93 135.75 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.514 -179.72 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -116.65 132.41 56.69 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.439 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.492 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.09 88.68 6.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.808 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.427 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.8 mt -63.93 -41.65 97.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.021 0.439 . . . . 0.0 110.781 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.466 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.79 165.87 34.28 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 71.2 p -75.47 -25.82 57.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.9 0.381 . . . . 0.0 110.756 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.503 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.1 tp10 -68.59 -33.82 74.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.478 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 99.0 m -72.65 19.67 0.08 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.129 0.49 . . . . 0.0 110.677 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.511 ' O ' ' NE2' ' A' ' 212' ' ' GLN . 49.6 t80 -57.1 -51.23 70.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.925 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 70.8 mmt-85 -107.65 149.05 28.56 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.7 tp -115.61 126.19 53.87 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.842 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.478 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.7 t0 -149.74 166.87 28.12 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.618 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -49.29 -38.05 26.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.649 -179.547 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -71.65 -65.21 0.79 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.462 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.61 -32.83 71.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.021 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.57 -25.42 26.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.735 -179.125 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.8 mtt -63.49 -41.15 98.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.827 0.346 . . . . 0.0 111.053 179.768 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.96 -44.48 26.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.102 179.563 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.575 HG21 HG23 ' A' ' 296' ' ' THR . 79.8 t -66.15 -42.73 91.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.365 179.643 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.597 HD11 ' NE2' ' A' ' 183' ' ' GLN . 49.3 tp -59.9 -47.09 87.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.514 -178.487 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -70.57 -39.23 74.01 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.73 179.151 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.496 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 73.3 ttt180 -61.5 -37.84 85.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.257 -178.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.3 mt -87.95 5.05 42.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.664 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -112.4 -11.71 13.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.03 0.443 . . . . 0.0 110.314 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.82 -37.29 86.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.394 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.92 -48.92 79.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.46 -179.653 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.992 179.886 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -90.1 -2.18 58.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.464 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.494 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.02 179.04 1.24 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.504 -179.638 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.81 145.01 99.64 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.827 2.351 . . . . 0.0 112.18 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.3 ptt-85 -156.37 -179.1 7.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.615 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.78 136.15 53.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.984 0.421 . . . . 0.0 110.371 179.734 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -123.41 146.64 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.409 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.8 p -119.72 135.87 54.66 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.818 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.5 p30 -99.4 -143.47 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.26 179.877 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -63.62 -37.11 86.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.526 179.58 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.36 -66.76 0.22 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.431 179.719 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.21 142.2 44.9 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.42 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.7 p -112.27 131.49 55.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 0.0 110.488 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -119.1 128.98 54.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.611 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -85.38 130.15 34.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.247 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.471 HD22 ' OE1' ' A' ' 42' ' ' GLN . 67.6 mt -95.67 78.51 3.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.39 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.73 -31.65 72.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.589 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.23 109.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.155 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.471 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.5 pt20 -122.18 91.08 49.11 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.414 -179.66 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.661 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.63 148.81 62.36 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.8 2.334 . . . . 0.0 112.049 178.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.92 82.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.506 0.504 . . . . 0.0 110.999 -179.252 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.661 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.1 66.86 0.91 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.292 -179.604 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.87 130.69 35.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.822 -179.729 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.556 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.7 t -122.73 146.23 28.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.061 -179.62 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.9 t -136.1 143.76 44.77 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.778 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.8 p -99.53 -59.05 1.79 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.579 179.944 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.9 p -79.29 155.11 28.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.627 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.501 HG21 HG23 ' A' ' 70' ' ' THR . 71.3 t -74.61 -21.72 17.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.514 179.377 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.8 m -60.28 -52.2 66.29 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.518 -178.537 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.34 -42.9 87.45 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.622 177.951 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.0 m -42.49 -54.04 4.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.985 -178.719 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.48 -37.36 69.18 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 178.79 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 m -62.67 -44.93 95.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.815 0.34 . . . . 0.0 110.107 -179.25 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.6 mt -66.41 -41.76 88.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.433 0.635 . . . . 0.0 110.714 179.697 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.56 -40.49 97.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.283 -179.284 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.468 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.77 -35.65 75.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.236 -178.909 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.533 HD11 HD12 ' A' ' 156' ' ' LEU . 32.2 pt -91.45 28.9 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.284 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.29 51.58 11.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.019 179.506 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.03 75.57 23.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 0.0 109.94 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.96 151.48 85.68 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.848 2.365 . . . . 0.0 112.064 -178.755 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.556 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.38 137.44 46.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-O 121.126 0.489 . . . . 0.0 110.319 179.826 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.448 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.9 pt -69.35 -43.49 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.263 179.597 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.09 131.22 53.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.044 0.45 . . . . 0.0 110.534 -179.049 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.3 p -155.91 168.8 26.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.522 -179.717 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.63 -177.18 21.8 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.635 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.03 171.92 13.34 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 121.094 0.473 . . . . 0.0 110.451 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.501 HG23 HG21 ' A' ' 51' ' ' VAL . 12.7 p -133.54 -110.86 0.23 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.004 0.43 . . . . 0.0 110.516 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.549 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.86 179.6 0.95 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.494 -179.312 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.0 Cg_exo -60.75 58.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.891 2.394 . . . . 0.0 112.082 179.557 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.3 t-20 -64.39 -35.19 80.11 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.445 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.4 m120 94.93 -37.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.692 0.62 . . . . 0.0 109.889 -179.365 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.54 -39.86 94.95 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.199 179.109 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.6 p -73.96 -26.55 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.621 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.96 -172.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.383 -179.367 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -74.1 -152.63 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.765 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.8 p-10 -54.56 -6.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.724 -179.429 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.493 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.88 113.32 22.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.678 179.738 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.33 73.31 1.26 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.615 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.401 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.2 m-85 -144.24 148.33 34.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.817 0.342 . . . . 0.0 110.901 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.71 -99.38 0.07 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.022 178.836 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.564 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.17 -42.84 96.55 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.088 179.255 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.564 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 9.9 tt0 91.5 52.91 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.672 0.607 . . . . 0.0 111.042 179.025 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -103.57 -9.02 19.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.32 179.274 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.401 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.98 -33.74 76.77 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.097 0.475 . . . . 0.0 110.701 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -48.83 -23.22 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.72 179.635 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.5 t -70.18 -45.9 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.705 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.09 -48.82 79.92 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.978 -179.472 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.38 -38.34 89.2 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.379 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.67 -32.4 51.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.202 -179.751 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.621 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.91 1.61 56.02 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.49 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.621 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.99 -49.43 0.16 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.729 0.643 . . . . 0.0 110.229 179.209 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.686 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 79.5 mt -45.88 153.85 0.27 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 118.209 -0.901 . . . . 0.0 109.758 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.686 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.3 tt0 121.24 92.17 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.966 1.416 . . . . 0.0 110.472 -178.713 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.26 143.24 43.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.277 0.561 . . . . 0.0 110.269 179.416 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -131.97 27.03 4.59 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 122.053 -0.404 . . . . 0.0 110.443 -179.399 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.33 137.94 34.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.456 . . . . 0.0 110.514 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.7 mt -137.03 165.06 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.395 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.91 -28.44 1.87 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -152.85 70.69 7.19 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.06 0.457 . . . . 0.0 110.271 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.11 145.37 98.6 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 122.744 2.296 . . . . 0.0 112.114 -179.536 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.4 t -134.27 136.87 43.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.533 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.12 -38.33 82.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.547 179.725 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.25 -42.35 96.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.499 -179.45 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.67 98.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.544 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.4 t -63.68 -43.25 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.108 179.451 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.08 -35.08 77.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.137 -179.744 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.73 -18.49 59.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.376 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.75 -6.51 58.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.506 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.8 mtp 47.85 56.14 17.4 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.659 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.8 Cg_endo -70.28 149.29 63.35 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.8 2.334 . . . . 0.0 112.07 179.465 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -101.24 -73.38 0.65 Allowed 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.471 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.432 HD11 HD13 ' A' ' 140' ' ' LEU . 39.0 tp -111.02 112.39 24.18 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.269 179.632 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 75.9 mt -100.59 126.1 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.645 -179.767 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.9 mt -109.42 133.38 53.13 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.268 -179.428 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.56 139.61 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.585 -179.559 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.2 p -83.5 168.24 16.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.714 179.778 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.09 -37.43 79.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.488 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.59 159.0 43.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.442 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.27 177.22 33.41 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.2 -33.73 86.87 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 -179.684 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -125.07 151.7 45.31 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 110.519 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -63.12 141.2 58.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.334 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.72 10.03 10.89 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.666 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.7 mp -60.71 -38.97 86.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.305 -179.383 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.641 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.79 23.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.355 0.598 . . . . 0.0 110.568 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.9 mt -71.03 -35.29 71.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.482 0.658 . . . . 0.0 110.625 179.403 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.3 t80 -42.73 -62.72 0.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.355 -178.759 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.641 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.77 -42.83 90.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.176 -179.244 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -62.0 -32.57 73.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.417 -179.718 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 129' ' ' LEU . 71.2 mt -74.17 -40.79 62.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.792 178.745 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.1 -49.02 78.39 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.169 -179.094 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.3 m -53.06 -42.08 65.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.975 0.417 . . . . 0.0 110.155 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.56 -42.57 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 120.95 0.405 . . . . 0.0 111.081 179.241 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.78 153.61 5.01 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.661 -179.338 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -39.06 106.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.658 2.239 . . . . 0.0 112.491 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.1 m -109.37 121.32 44.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.129 0.49 . . . . 0.0 110.278 179.802 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.1 153.07 30.12 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.365 -179.757 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.6 tt -128.96 131.56 68.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.343 179.911 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.29 127.88 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.605 -179.899 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.9 t30 -101.9 103.67 14.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.174 179.847 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.9 p90 -101.15 -11.23 19.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.875 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.84 -33.26 75.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.731 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.5 p-10 -98.6 8.19 45.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.56 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.442 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.91 155.62 50.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.521 -179.413 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.408 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -74.86 165.83 24.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.626 -179.818 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.584 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -60.02 -48.95 79.61 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.264 -179.22 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -53.56 -42.06 67.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.17 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.0 t -62.47 -40.83 97.92 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.358 178.773 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.424 ' O ' HD23 ' A' ' 156' ' ' LEU . 48.0 tp -60.64 -43.97 96.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.275 -179.564 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.495 HD22 HH21 ' A' ' 169' ' ' ARG . 45.5 tp -61.32 -43.25 99.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.063 179.663 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -55.41 -45.58 76.69 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.924 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.32 -40.73 97.29 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.895 0.379 . . . . 0.0 110.509 179.893 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.533 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.8 -42.42 98.99 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.238 179.046 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.86 -40.88 95.72 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 179.522 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.93 -45.74 63.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 0.0 110.84 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.1 mt -64.78 -43.99 96.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.839 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -93.29 -8.55 41.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.633 -179.066 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.76 25.37 71.74 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -101.88 51.98 0.82 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.831 0.348 . . . . 0.0 110.673 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -69.74 -39.09 76.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.593 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.25 -47.2 86.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.34 -179.416 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -61.35 -39.15 89.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.232 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.23 -40.46 97.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.347 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.43 -27.17 68.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.567 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -75.32 -53.71 8.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.842 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.495 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -63.88 -43.26 96.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.422 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.3 mt -63.06 -43.89 99.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.73 -179.705 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.37 -61.76 2.32 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.062 0.458 . . . . 0.0 110.356 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -54.55 -35.05 62.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.565 -179.153 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -79.62 -34.99 40.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.822 179.694 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -56.6 -40.12 74.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.009 -178.642 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.88 -42.37 99.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.692 179.803 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.79 -37.75 87.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.315 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 177' ' ' LEU . 82.3 mt -62.45 -42.28 99.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.713 179.612 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.17 -53.32 56.99 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.017 0.436 . . . . 0.0 110.613 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.3 -41.4 89.81 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.633 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.24 -39.95 95.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.601 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.19 -32.16 73.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.471 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.52 -21.75 18.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.63 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.458 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.6 tt0 -64.96 -41.57 95.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.717 -179.625 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -77.58 136.08 25.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.746 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.1 108.97 11.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.333 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.9 126.13 0.3 Allowed Pre-proline 0 C--O 1.238 0.473 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.501 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.461 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.7 Cg_exo -43.73 152.16 0.36 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.891 2.394 . . . . 0.0 112.483 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.99 141.68 54.11 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.579 2.186 . . . . 0.0 112.341 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.16 147.07 2.16 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.602 179.374 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.2 154.19 70.36 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.897 2.398 . . . . 0.0 112.269 178.713 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.584 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.4 163.24 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.151 0.501 . . . . 0.0 110.477 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -144.08 170.26 16.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.157 0.503 . . . . 0.0 110.851 179.68 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.82 137.4 22.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.213 179.536 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.547 HG22 HD12 ' A' ' 205' ' ' LEU . 38.9 pt -134.28 146.56 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.728 179.607 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.29 132.09 58.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.152 0.501 . . . . 0.0 110.418 178.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -152.09 154.73 36.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.377 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.628 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.6 m -122.15 123.01 40.54 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.904 0.383 . . . . 0.0 110.408 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.38 -25.43 65.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.679 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.628 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.53 -49.0 20.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.5 -9.85 59.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.499 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.6 m80 46.5 42.76 11.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.582 -179.602 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 t -135.89 145.77 46.69 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.421 179.802 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.406 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -111.33 113.92 26.73 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.393 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -120.06 133.58 55.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.438 . . . . 0.0 110.377 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.547 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.33 146.72 37.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.794 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.488 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.5 t90 -99.58 129.8 45.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.22 0.533 . . . . 0.0 109.864 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.62 153.85 39.34 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.292 179.935 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.1 Cg_endo -67.61 -18.3 48.41 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.705 2.27 . . . . 0.0 111.986 178.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.16 -18.72 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.414 -179.23 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.488 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.1 p -75.7 165.04 25.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.496 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.01 -28.3 66.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.508 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.543 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.47 -41.45 98.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.673 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.85 -44.89 96.66 Favored Glycine 0 C--N 1.331 0.276 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.43 -38.98 92.92 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 122.231 -0.57 . . . . 0.0 110.703 179.67 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.584 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.7 mmm -61.93 -41.41 97.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.246 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.58 -47.72 80.33 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.99 0.424 . . . . 0.0 110.44 179.266 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.73 -32.01 50.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.882 0.373 . . . . 0.0 110.379 179.715 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -70.89 -18.13 62.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.493 179.568 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.429 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.5 mt -88.62 -8.67 54.27 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.651 -179.494 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.61 2.64 55.37 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -88.59 152.26 21.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.929 0.395 . . . . 0.0 110.504 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.442 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.1 p -115.11 127.99 55.94 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.118 0.485 . . . . 0.0 110.397 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.566 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.36 146.15 23.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.943 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.474 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.84 151.66 45.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.529 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.1 131.74 42.65 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.546 179.811 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.896 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.79 93.53 29.27 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.099 -179.713 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.682 ' C ' ' H ' ' A' ' 229' ' ' GLY . 44.5 Cg_exo -55.14 138.95 80.18 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.61 2.207 . . . . 0.0 111.769 178.775 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.6 -25.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.481 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.682 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.79 -49.95 26.8 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.805 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -53.94 -37.21 63.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 -179.273 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -66.62 35.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.83 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.09 88.36 0.01 OUTLIER 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.913 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.2 p -81.94 -14.33 56.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.337 -179.672 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.34 -41.43 10.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.618 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.2 t -66.91 -16.67 64.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.616 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.09 43.47 26.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.495 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.56 -148.44 7.84 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.88 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.37 143.23 49.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.959 0.409 . . . . 0.0 110.358 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.1 ttt-85 -151.95 149.43 28.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.312 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -100.71 -152.09 0.42 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.372 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.4 t0 56.1 -91.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.469 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.0 tt -126.54 175.43 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.631 -179.508 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.469 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.0 mt -122.14 141.7 41.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 -179.44 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.79 169.33 9.32 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.266 -179.774 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.2 mt -147.9 150.76 34.7 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.183 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.75 -38.91 96.88 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.19 4.07 4.64 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.3 -58.24 3.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 110.539 -179.857 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.56 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.6 m-20 -62.1 -36.88 83.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.281 -179.757 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.406 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.0 mp -52.3 -67.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.736 -179.69 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.47 -42.23 67.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.19 -179.617 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.06 18.09 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.617 179.787 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.69 48.63 0.26 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.29 -109.91 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.485 0.183 . . . . 0.0 110.746 -178.664 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.474 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.9 m120 -60.78 -45.25 95.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.463 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.95 8.17 82.78 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 179.255 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.32 -12.75 20.05 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.725 -0.279 . . . . 0.0 110.673 -179.744 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.4 t 176.6 142.49 0.07 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.013 0.435 . . . . 0.0 110.446 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.0 tt -148.17 125.19 11.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.657 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.428 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -98.27 142.93 29.32 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 120.91 0.386 . . . . 0.0 110.694 178.313 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.3 mt -94.23 106.58 18.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.805 -179.323 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.463 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.3 t80 -101.91 -11.73 18.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.15 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.99 -40.2 87.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.84 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.81 173.97 46.17 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.459 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -74.39 -112.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.789 0.328 . . . . 0.0 110.798 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.83 -28.74 67.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.671 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.95 -44.18 91.4 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.24 -178.894 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.56 -44.4 94.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.317 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.47 -60.09 3.65 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.194 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.8 -43.74 58.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.143 179.763 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.91 75.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.242 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.1 mt -64.46 -43.62 96.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.587 179.56 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -56.57 -37.87 71.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.137 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.82 1.11 18.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.208 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.0 91.2 25.82 Favored Pre-proline 0 N--CA 1.461 0.104 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.164 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.86 -27.17 26.56 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.796 2.331 . . . . 0.0 112.034 179.37 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.537 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.58 -41.01 98.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.468 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.592 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.38 5.33 51.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.414 -179.21 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.06 -34.82 69.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.588 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -80.26 4.71 16.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.485 -178.819 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.91 121.11 80.36 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.555 179.921 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -47.15 -37.87 24.19 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.521 2.148 . . . . 0.0 112.533 -179.499 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.86 -43.77 90.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.469 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.98 -43.47 92.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.387 179.261 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -64.86 -40.67 95.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.439 -179.343 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -90.02 -12.25 39.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.504 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 62.16 32.54 17.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.989 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -89.08 43.97 1.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.079 0.466 . . . . 0.0 110.278 179.52 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.13 135.87 41.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.587 -179.752 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.6 132.56 56.65 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.37 179.618 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.499 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.56 87.86 7.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.762 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.97 -41.31 97.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.782 179.433 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.12 168.14 34.73 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.7 p -75.97 -25.89 56.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.756 179.79 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.491 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.3 tp10 -67.79 -33.92 75.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.471 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 296' ' ' THR . 97.4 m -73.47 19.9 0.1 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.076 0.465 . . . . 0.0 110.78 -179.148 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.543 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 55.3 t80 -57.26 -51.38 69.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.853 -179.369 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 67.4 mmt-85 -108.0 149.51 28.3 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.767 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.429 ' CD2' HD11 ' A' ' 219' ' ' LEU . 40.5 tp -115.34 125.39 53.18 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.851 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.474 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.4 t0 -149.06 166.41 28.79 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.567 179.537 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -49.29 -37.95 25.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.663 -179.511 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -71.89 -65.11 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.376 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.65 -32.74 71.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.983 -179.491 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.7 -25.51 27.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.786 -179.102 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.5 mtt -63.32 -40.79 98.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.851 0.358 . . . . 0.0 111.027 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.89 -44.03 23.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.982 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.563 HG21 HG23 ' A' ' 296' ' ' THR . 74.5 t -66.26 -42.79 91.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.381 179.605 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.458 HD11 ' NE2' ' A' ' 183' ' ' GLN . 51.7 tp -60.23 -47.1 87.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.495 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -70.17 -39.48 75.25 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.987 0.422 . . . . 0.0 110.672 179.28 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.499 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.3 ttt180 -61.67 -38.24 87.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.275 -179.043 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.4 4.75 41.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.61 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.405 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.3 tttt -112.82 -11.18 13.5 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.964 0.411 . . . . 0.0 110.264 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.15 -37.18 86.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.388 179.737 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.75 -48.91 79.66 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.465 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.157 179.66 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -89.94 -2.58 58.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.423 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.68 179.23 1.21 Allowed Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.524 -179.673 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.4 Cg_exo -60.87 145.0 99.67 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.818 2.345 . . . . 0.0 112.141 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.613 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.92 -179.56 8.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.639 -179.735 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.93 137.02 52.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.961 0.41 . . . . 0.0 110.313 179.774 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -124.43 147.05 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.346 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.5 p -120.03 136.11 54.68 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.779 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.46 -143.49 0.33 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.248 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.55 -37.39 87.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.453 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.476 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.93 -66.61 0.23 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.442 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.55 142.46 45.42 Favored Glycine 0 CA--C 1.518 0.277 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 -179.38 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.7 p -112.3 131.38 55.55 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.569 -0.371 . . . . 0.0 110.465 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -119.07 129.06 54.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.56 -179.832 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.5 m -85.6 130.43 34.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.223 -179.834 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.481 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.6 mt -95.95 78.82 3.22 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.388 179.679 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.71 -31.78 72.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.56 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 176.1 109.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.032 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.481 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.41 91.51 49.25 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.412 -179.753 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.647 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.3 Cg_exo -56.89 148.55 66.58 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.79 2.327 . . . . 0.0 111.956 178.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.48 82.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.679 0.612 . . . . 0.0 110.97 -179.24 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.647 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.6 66.93 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.055 0.455 . . . . 0.0 110.173 -179.389 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.23 130.69 35.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.561 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.3 t -122.42 146.55 27.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.046 0.451 . . . . 0.0 109.993 -179.664 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.2 t -135.81 143.77 45.36 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.038 0.447 . . . . 0.0 110.729 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.2 p -99.37 -59.53 1.7 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.619 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.5 p -79.25 155.22 28.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.654 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.524 HG21 HG23 ' A' ' 70' ' ' THR . 73.7 t -74.11 -21.92 18.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.486 179.355 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.1 m -60.33 -52.13 66.59 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.488 -178.406 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.9 mt -66.24 -42.72 88.2 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.759 177.823 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.1 m -43.24 -53.83 4.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.905 -178.314 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.37 -37.23 70.21 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 178.598 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m -62.75 -44.69 95.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.853 0.359 . . . . 0.0 110.141 -179.221 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.0 mt -66.46 -41.9 88.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.497 0.665 . . . . 0.0 110.739 179.688 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -62.56 -40.49 96.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.489 -179.392 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.92 -35.86 75.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.287 -179.084 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.529 HD11 HD12 ' A' ' 156' ' ' LEU . 32.5 pt -91.16 28.89 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.352 -179.465 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.45 51.75 10.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.058 179.56 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.49 76.04 21.51 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.584 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.03 151.53 85.46 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.836 2.357 . . . . 0.0 112.076 -178.904 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.561 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.37 137.46 46.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-O 121.176 0.512 . . . . 0.0 110.293 179.671 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.1 pt -69.46 -43.62 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.321 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.12 131.44 53.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.037 0.446 . . . . 0.0 110.569 -178.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.536 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.0 p -155.77 168.59 26.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.445 -179.715 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.47 -177.22 21.9 Favored Glycine 0 N--CA 1.463 0.471 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.638 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.97 172.77 12.35 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 121.078 0.466 . . . . 0.0 110.437 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.524 HG23 HG21 ' A' ' 51' ' ' VAL . 14.9 p -132.42 -112.92 0.23 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.104 0.478 . . . . 0.0 110.376 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.98 179.72 0.94 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.406 -179.198 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.5 Cg_exo -60.86 57.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.968 2.446 . . . . 0.0 112.145 179.554 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.1 t-20 -64.25 -33.16 75.16 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.382 -179.731 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 14.5 m120 93.47 -36.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.757 0.661 . . . . 0.0 109.805 -179.524 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HD3' HD21 ' A' ' 73' ' ' ASN . 77.0 mtp85 -62.62 -39.64 94.45 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.216 179.271 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.34 -25.53 19.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.684 179.384 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.31 -170.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.436 -179.232 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.03 -154.35 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.856 -179.627 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.8 p-10 -52.31 -7.56 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.757 -179.567 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -85.95 114.92 23.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.676 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.97 70.4 1.34 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.625 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -143.84 147.99 34.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.844 0.354 . . . . 0.0 110.841 179.232 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -85.82 -98.46 0.07 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.082 178.863 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.551 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.18 -42.52 96.65 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.052 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 9.9 tt0 91.38 52.83 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.895 0.747 . . . . 0.0 111.024 179.205 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -102.88 -9.38 19.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.313 179.37 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.2 p -64.31 -33.91 76.93 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.139 0.495 . . . . 0.0 110.699 -179.628 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -49.21 -23.39 1.31 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.678 179.651 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.3 t -69.84 -45.95 75.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 179.602 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.23 -48.62 80.65 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.924 -179.324 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.4 -38.4 89.48 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.379 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.59 -33.07 53.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.134 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.606 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.5 mmt-85 -89.66 1.74 55.64 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.554 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.68 -49.34 0.18 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.862 0.726 . . . . 0.0 110.197 179.126 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.655 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.8 mt -45.9 154.4 0.24 Allowed 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 117.538 -1.22 . . . . 0.0 109.524 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.655 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.1 tt0 121.07 92.63 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 O-C-N 125.566 1.791 . . . . 0.0 110.443 -178.595 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.536 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.57 142.94 42.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.252 0.548 . . . . 0.0 110.312 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -131.94 26.98 4.6 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.0 -0.438 . . . . 0.0 110.437 -179.344 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.24 137.9 34.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.022 0.439 . . . . 0.0 110.589 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.638 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.5 mt -137.16 165.01 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.332 179.629 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.9 -28.43 1.87 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.58 70.51 7.37 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-O 121.079 0.466 . . . . 0.0 110.095 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.92 145.33 98.57 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 122.668 2.245 . . . . 0.0 112.133 -179.651 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.9 t -134.35 136.73 43.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.559 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.37 81.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.63 179.66 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.12 -42.23 96.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.51 -179.408 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.62 98.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.491 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.6 -43.35 98.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.004 179.479 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.08 77.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.132 -179.598 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.69 -18.75 60.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.362 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.66 -6.55 58.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.491 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.8 mtp 47.53 56.1 17.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.644 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.8 Cg_endo -70.03 149.46 65.19 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.791 2.327 . . . . 0.0 112.098 179.516 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.03 -73.61 0.64 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.519 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.435 HD11 HD13 ' A' ' 140' ' ' LEU . 38.6 tp -111.02 113.44 25.99 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.293 179.633 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -102.08 126.57 56.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 120.962 0.411 . . . . 0.0 110.64 -179.8 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.3 mt -109.92 133.96 52.6 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.266 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.73 139.6 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.558 -179.567 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.9 p -83.4 168.37 16.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.716 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.47 80.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.389 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.91 159.13 42.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.94 0.4 . . . . 0.0 110.432 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.23 176.82 33.54 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.29 -33.59 86.57 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.57 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.56 151.46 44.71 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.928 0.394 . . . . 0.0 110.507 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.0 t -63.33 140.78 58.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.331 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.55 10.35 11.08 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.591 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -61.01 -38.94 87.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.253 -179.283 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.97 -35.89 23.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.522 0.677 . . . . 0.0 110.605 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -70.96 -35.44 72.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.546 0.688 . . . . 0.0 110.659 179.394 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.83 -62.81 0.91 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.411 -178.756 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.65 -42.86 90.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.195 -179.402 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -61.98 -32.71 73.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.367 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.0 mt -73.58 -41.06 63.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.864 178.642 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.18 -48.87 78.98 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.122 -178.852 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.8 m -52.97 -42.5 65.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.961 0.41 . . . . 0.0 110.186 179.474 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.14 -42.84 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 120.934 0.397 . . . . 0.0 111.18 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.33 153.51 5.38 Favored Pre-proline 0 N--CA 1.452 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.655 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -39.29 107.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.682 2.255 . . . . 0.0 112.516 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.636 ' C ' HD12 ' A' ' 140' ' ' LEU . 97.0 m -109.73 121.4 45.14 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.116 0.484 . . . . 0.0 110.281 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.636 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.56 152.44 30.27 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.279 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -128.77 131.22 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.351 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -115.09 127.9 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.099 0.476 . . . . 0.0 110.52 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.8 t30 -101.43 103.81 14.74 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.161 179.822 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.0 p90 -101.35 -11.13 19.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.875 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.5 p-10 -64.89 -33.54 76.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.768 -179.718 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -98.4 7.72 45.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.503 -179.546 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.448 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.55 155.62 50.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.484 -179.358 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.2 p -75.02 165.75 24.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.675 -179.778 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.589 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.02 -48.8 80.22 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.188 -179.1 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -53.41 -42.0 66.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 110.094 -179.747 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.4 t -62.74 -41.04 99.0 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.366 178.684 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.409 ' CD1' HG21 ' A' ' 142' ' ' ILE . 45.6 tp -60.66 -44.42 96.48 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.325 -179.469 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.0 tp -61.47 -43.49 98.77 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.079 179.768 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.0 m -54.91 -45.04 74.69 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.18 -40.86 97.43 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.88 0.371 . . . . 0.0 110.46 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.529 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.86 -42.51 99.13 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.388 178.968 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.27 -40.78 94.86 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.51 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.54 -46.05 64.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.389 . . . . 0.0 110.842 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.79 -44.02 96.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.847 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.8 p -92.86 -8.89 42.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.622 -179.026 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.88 26.61 72.27 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -101.85 50.91 0.84 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.844 0.354 . . . . 0.0 110.693 -179.572 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.56 -39.59 77.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.622 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.37 -47.12 86.63 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.288 -179.293 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -60.07 -39.49 86.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.145 -179.734 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.97 99.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.247 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.88 -28.26 69.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.622 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.56 -54.18 7.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.898 179.404 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.506 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.54 -42.19 92.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.402 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.2 mt -62.43 -43.77 98.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.496 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.58 -58.15 8.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.984 0.421 . . . . 0.0 110.372 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.47 -33.35 67.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.597 -179.016 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.409 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.8 t80 -81.35 -36.72 29.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.756 179.558 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.7 m-20 -55.79 -42.01 74.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.867 -178.437 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.4 -42.19 99.24 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.919 0.39 . . . . 0.0 110.801 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.26 -38.06 89.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.237 179.802 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.409 HD11 ' CD2' ' A' ' 173' ' ' PHE . 82.4 mt -62.41 -42.2 99.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.718 179.569 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.19 -53.01 61.38 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.07 0.462 . . . . 0.0 110.67 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.02 -41.8 90.5 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.674 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.95 95.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.28 -32.09 73.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.382 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -94.62 -22.35 18.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.688 -179.764 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.443 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.6 tt0 -64.76 -41.33 95.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.676 -179.554 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -76.45 136.37 24.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.69 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.72 107.91 10.59 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.246 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.73 125.95 0.31 Allowed Pre-proline 0 C--O 1.239 0.55 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.465 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.452 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.6 Cg_exo -44.02 152.35 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.872 2.381 . . . . 0.0 112.553 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.09 141.98 54.6 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.556 2.171 . . . . 0.0 112.385 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.35 147.33 2.14 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.52 179.301 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.28 154.62 69.37 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.813 2.342 . . . . 0.0 112.348 178.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.42 163.15 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.207 0.527 . . . . 0.0 110.42 179.799 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.56 170.11 16.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.008 179.453 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.75 137.32 22.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.949 0.404 . . . . 0.0 110.185 179.448 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.567 HG22 HD12 ' A' ' 205' ' ' LEU . 38.7 pt -134.16 146.55 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.682 179.528 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.95 132.04 59.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.261 0.553 . . . . 0.0 110.468 178.858 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -153.31 156.96 39.37 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.43 179.21 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.4 m -122.8 123.31 40.74 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.944 0.402 . . . . 0.0 110.418 179.383 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.474 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -61.09 -25.95 67.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.583 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.614 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.66 -50.0 19.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.972 179.708 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.24 -11.11 59.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.548 -179.714 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.474 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 80.6 m80 47.11 47.39 16.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.563 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.6 t -131.47 144.75 51.38 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.277 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.431 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -109.76 106.19 15.72 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.235 -179.846 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -116.76 129.61 56.21 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.177 0.513 . . . . 0.0 110.301 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.567 HD12 HG22 ' A' ' 194' ' ' ILE . 7.7 tt -112.1 146.54 37.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.813 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.472 ' N ' HD23 ' A' ' 205' ' ' LEU . 12.1 t90 -99.49 128.46 45.6 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.203 0.525 . . . . 0.0 109.851 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.41 153.88 40.37 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.37 179.758 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.5 Cg_endo -67.59 -18.08 48.43 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.651 2.234 . . . . 0.0 112.003 178.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -49.6 -18.55 0.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.332 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.421 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.9 p -75.56 164.15 26.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.474 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.71 -28.1 65.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.533 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.571 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.0 mt-30 -63.65 -41.25 98.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.656 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.57 -44.44 97.78 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -179.514 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.448 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.1 mt-30 -64.3 -38.81 92.35 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 122.212 -0.581 . . . . 0.0 110.712 179.588 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.2 mmm -61.99 -41.31 97.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.188 179.819 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 74.1 mt -63.49 -47.71 80.61 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.031 0.443 . . . . 0.0 110.392 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.66 -32.06 50.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.909 0.385 . . . . 0.0 110.273 179.828 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -71.01 -17.96 62.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.48 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.419 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.7 mt -88.77 -8.4 54.5 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.617 -179.477 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.44 2.58 55.55 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.811 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -88.68 152.2 21.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.953 0.406 . . . . 0.0 110.429 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.451 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.9 p -115.18 127.97 55.88 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.183 0.516 . . . . 0.0 110.356 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -91.94 146.63 23.59 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.011 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.457 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.38 151.18 45.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.477 179.727 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.1 131.77 42.67 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.5 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.881 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.54 93.53 28.01 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.079 -179.52 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.686 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.5 Cg_exo -55.31 138.77 80.5 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.599 2.199 . . . . 0.0 111.633 179.034 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.27 -25.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.478 -179.621 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.686 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.45 -50.11 28.07 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.819 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.4 mt -54.76 -36.67 65.08 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.122 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -65.95 36.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.783 179.431 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.569 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.51 86.25 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.953 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.2 p -79.27 -15.14 58.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.346 -179.809 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -92.4 -40.25 10.98 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.678 179.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -66.03 -18.03 65.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.598 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.16 43.44 26.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.41 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.89 -148.16 7.79 Favored Glycine 0 CA--C 1.518 0.262 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.97 142.31 49.89 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 110.316 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.406 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.4 ttt-85 -152.48 149.92 29.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.313 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -102.18 -149.95 0.4 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.3 179.815 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 55.29 -92.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.696 -179.782 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.441 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.1 tt -126.94 174.65 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.635 -179.495 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.441 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.0 mt -122.31 141.29 43.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.039 0.447 . . . . 0.0 110.899 -179.562 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.58 170.62 8.47 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.196 -179.787 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.3 mt -146.75 149.6 33.71 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.259 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.19 -39.38 97.86 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.07 3.14 4.04 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -78.5 -57.59 3.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.964 0.412 . . . . 0.0 110.517 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.613 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.6 m-20 -62.07 -36.88 82.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.203 -179.651 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.431 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.6 mp -52.98 -67.57 0.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.0 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.61 -42.53 67.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.112 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.74 17.74 0.15 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.656 179.828 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.0 48.05 0.27 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.1 mp 39.25 -109.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.534 0.207 . . . . 0.0 110.721 -178.623 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.457 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -60.83 -44.67 96.61 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.381 -179.57 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.6 7.96 83.69 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.336 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.93 -13.34 20.02 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.689 -0.301 . . . . 0.0 110.667 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.1 t 177.06 142.89 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.083 0.468 . . . . 0.0 110.427 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.431 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.2 125.3 11.41 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.197 179.521 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.47 143.65 28.68 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 120.892 0.377 . . . . 0.0 110.808 178.326 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.06 106.62 18.63 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.78 -179.264 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.2 t80 -102.3 -11.41 18.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.116 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.57 -40.55 84.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.875 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.28 172.71 45.57 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.599 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.472 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 94.8 m-20 -73.9 -113.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.784 0.326 . . . . 0.0 110.723 -179.745 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.67 -28.94 68.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.661 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.11 -43.62 91.91 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.104 -178.762 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.55 -44.4 94.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.299 179.299 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.63 -59.99 3.8 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.133 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -51.02 -43.58 60.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.115 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.31 -43.23 74.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.179 -179.905 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.67 -43.57 96.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.641 179.541 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -55.96 -37.61 69.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.149 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.76 1.0 18.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.158 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -114.96 91.41 26.49 Favored Pre-proline 0 N--CA 1.461 0.114 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.121 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.24 -27.29 29.81 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.798 2.332 . . . . 0.0 111.917 179.24 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.5 -40.98 98.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.484 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.37 5.22 52.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.349 -179.132 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.95 -35.12 69.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.622 179.557 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -80.06 4.69 16.34 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.521 -178.742 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.76 121.17 80.27 Favored Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.541 179.967 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -47.28 -37.68 24.8 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.427 2.085 . . . . 0.0 112.611 -179.582 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.53 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.84 -43.75 90.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.747 0.308 . . . . 0.0 110.404 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.01 -43.64 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.285 179.376 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.87 -40.66 95.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.376 -179.232 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.8 t-20 -89.78 -12.55 38.93 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.592 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 61.87 32.18 18.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.069 -179.743 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.78 43.84 1.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.136 0.493 . . . . 0.0 110.308 179.537 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.11 135.85 39.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.487 -179.711 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.9 132.19 56.76 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.412 179.669 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.02 89.12 7.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.796 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.05 -41.11 97.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.45 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.444 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.52 165.76 33.44 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.3 p -75.46 -25.87 57.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.887 0.375 . . . . 0.0 110.785 179.787 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.9 tp10 -68.27 -33.76 74.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.439 -179.737 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 296' ' ' THR . 95.8 m -73.59 23.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.751 -179.144 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.571 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 49.4 t80 -58.0 -50.86 71.95 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.102 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 75.0 mmt-85 -110.7 152.97 25.92 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.108 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.419 ' CD2' HD11 ' A' ' 219' ' ' LEU . 41.9 tp -115.48 125.54 53.2 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.989 179.767 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.492 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.3 t0 -148.03 165.55 30.44 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.581 179.46 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -49.35 -37.71 25.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.655 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.29 -65.54 0.73 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.58 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.96 -32.85 72.37 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.058 -179.536 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.13 -25.61 23.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.8 -179.166 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.7 mtt -63.55 -40.7 97.68 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 120.854 0.359 . . . . 0.0 111.135 179.664 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.64 -44.1 24.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.188 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.584 HG21 HG23 ' A' ' 296' ' ' THR . 77.2 t -66.37 -42.87 91.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.353 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.443 HD11 ' NE2' ' A' ' 183' ' ' GLN . 50.1 tp -60.24 -47.12 87.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.507 -178.488 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -69.67 -39.36 77.07 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.069 0.462 . . . . 0.0 110.796 179.033 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.7 ttt180 -61.89 -38.44 88.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.218 -178.884 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.01 4.29 42.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.594 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.405 ' NZ ' ' OE1' ' A' ' 183' ' ' GLN . 87.3 tttt -112.84 -10.94 13.52 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.073 0.463 . . . . 0.0 110.314 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.35 86.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.427 179.669 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.86 -48.7 80.59 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.403 -179.568 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.064 179.86 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -90.22 -2.56 58.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.428 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.7 179.13 1.23 Allowed Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.588 -179.711 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.0 Cg_exo -60.86 144.79 99.63 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.81 2.34 . . . . 0.0 112.206 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.9 -179.56 8.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.562 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -115.7 136.44 53.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.355 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.28 147.63 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.386 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.3 p -120.65 136.26 54.88 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.814 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.32 -143.34 0.32 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.239 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.8 -36.95 85.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.484 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.0 -67.67 0.22 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.436 179.676 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.16 142.53 44.46 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.295 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.4 p -112.18 131.8 55.26 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.552 -0.381 . . . . 0.0 110.513 -179.752 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.12 128.9 54.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.591 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.3 m -85.39 130.14 34.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.223 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.8 mt -95.37 78.43 3.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.4 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.81 -32.27 73.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.532 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.61 108.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.993 0.425 . . . . 0.0 110.157 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.489 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.69 91.59 49.48 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-O 120.767 0.317 . . . . 0.0 110.404 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.655 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.6 Cg_exo -56.67 148.68 63.46 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.742 2.295 . . . . 0.0 111.993 178.96 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.26 82.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.677 0.61 . . . . 0.0 110.988 -179.196 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.655 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.57 66.88 0.88 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.261 -179.377 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.56 131.06 35.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.817 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.576 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.5 t -122.68 148.27 26.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.056 0.455 . . . . 0.0 110.077 -179.787 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.7 t -136.78 143.68 43.34 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.776 179.75 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.5 p -99.3 -59.03 1.8 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.572 179.864 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.0 p -79.16 155.43 28.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.587 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.548 HG21 HG23 ' A' ' 70' ' ' THR . 68.8 t -74.51 -21.72 17.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.484 179.357 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.1 m -60.4 -52.1 66.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.524 -178.464 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.37 -42.7 87.61 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.754 177.87 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.3 m -42.9 -53.89 4.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.948 -178.585 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.15 -37.41 72.29 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 178.575 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.8 m -62.8 -44.34 96.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.941 0.4 . . . . 0.0 110.152 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.6 mt -66.09 -42.05 89.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.505 0.669 . . . . 0.0 110.683 179.702 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.88 -40.04 96.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.393 -179.266 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.525 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.88 -36.1 78.34 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.348 -178.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.472 HD11 HD12 ' A' ' 156' ' ' LEU . 34.3 pt -90.92 27.81 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.27 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.89 52.03 9.91 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.391 0.432 . . . . 0.0 111.097 179.568 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.2 75.82 27.83 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.733 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.32 148.95 92.46 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.859 2.373 . . . . 0.0 112.12 -178.822 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.576 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.5 136.58 48.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-O 121.188 0.518 . . . . 0.0 110.308 179.807 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.442 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.68 -43.5 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.251 179.352 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.13 131.26 53.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.948 0.404 . . . . 0.0 110.605 -178.971 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.5 p -155.55 168.43 27.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.501 -179.796 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.81 -177.37 21.67 Favored Glycine 0 N--CA 1.463 0.453 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.638 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -134.04 173.16 11.88 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.062 0.458 . . . . 0.0 110.402 179.367 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.548 HG23 HG21 ' A' ' 51' ' ' VAL . 13.6 p -133.22 -111.79 0.23 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.982 0.42 . . . . 0.0 110.4 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.64 179.71 0.93 Allowed Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.466 -179.247 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.3 Cg_exo -60.93 58.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 123.018 2.479 . . . . 0.0 112.089 179.463 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.0 t-20 -64.45 -33.8 76.73 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.412 -179.647 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 12.2 m120 93.85 -36.13 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.788 0.68 . . . . 0.0 109.769 -179.632 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.407 ' HD3' HD21 ' A' ' 73' ' ' ASN . 78.1 mtp85 -63.22 -40.09 96.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.235 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.3 p -74.42 -25.37 19.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.742 179.326 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.25 -171.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.463 -179.208 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.56 -153.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.0 p-10 -52.15 -7.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.751 -179.594 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.1 mm-40 -86.33 114.81 23.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.619 179.707 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.79 70.61 1.34 Allowed Glycine 0 CA--C 1.52 0.379 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.617 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -143.55 147.85 35.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.925 0.393 . . . . 0.0 110.802 179.233 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.98 -98.34 0.07 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.035 178.874 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.558 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.3 -42.49 96.35 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.132 179.354 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.558 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.0 tt0 91.55 53.29 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.851 0.719 . . . . 0.0 111.033 179.195 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -103.15 -9.43 19.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.345 179.261 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.5 p -64.06 -34.58 78.35 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.059 0.457 . . . . 0.0 110.732 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.71 -24.31 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.624 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.95 -45.62 76.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.58 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.89 -49.03 79.11 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.976 -179.368 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.44 -38.15 88.64 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.412 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.46 -32.8 51.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.135 -179.751 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.61 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.97 1.55 56.13 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.555 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 83.11 -48.98 0.15 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.743 0.652 . . . . 0.0 110.245 179.146 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.664 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.1 mt -46.51 153.64 0.35 Allowed 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 117.732 -1.128 . . . . 0.0 109.546 -179.872 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.664 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.3 tt0 121.64 92.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 125.359 1.662 . . . . 0.0 110.476 -178.634 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.42 143.16 42.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.245 0.545 . . . . 0.0 110.288 179.313 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.1 mt -132.42 26.95 4.44 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 122.02 -0.425 . . . . 0.0 110.479 -179.365 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.44 138.31 34.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 0.0 110.485 -179.883 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.638 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.1 mt -137.28 164.84 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.359 179.51 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.14 -29.0 1.82 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.2 70.64 7.67 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.17 0.51 . . . . 0.0 110.241 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.07 145.37 98.59 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 C-N-CA 122.795 2.33 . . . . 0.0 112.046 -179.53 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.2 t -134.66 136.68 42.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.574 179.637 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.63 83.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.619 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.01 -42.21 97.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.493 -179.415 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.07 -41.55 98.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.563 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.61 -43.43 98.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.994 179.487 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.15 77.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.174 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.31 -18.8 60.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.459 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.59 -6.62 58.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.523 -179.773 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 73.5 mtp 47.91 56.04 17.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.548 179.993 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.22 149.27 63.73 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.834 2.356 . . . . 0.0 112.1 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.31 -72.8 0.67 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.506 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.403 HD11 HD13 ' A' ' 140' ' ' LEU . 38.2 tp -111.56 113.9 26.62 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.386 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.9 mt -103.05 126.89 57.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 120.993 0.425 . . . . 0.0 110.572 -179.765 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.6 mt -110.11 134.29 52.33 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.251 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.84 139.92 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.499 -179.651 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.3 p -83.51 168.13 16.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.776 179.722 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.09 79.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.431 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.61 158.71 43.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.432 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.26 175.74 33.87 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.22 -33.62 86.54 Favored Glycine 0 CA--C 1.518 0.279 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.571 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -123.97 151.13 44.0 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.904 0.383 . . . . 0.0 110.585 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.4 t -63.52 140.08 58.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.389 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.1 10.82 11.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.656 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -60.99 -38.85 87.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.251 -179.394 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.633 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.32 -35.71 23.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.407 0.622 . . . . 0.0 110.587 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.4 mt -70.98 -35.42 72.1 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.51 0.671 . . . . 0.0 110.668 179.379 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -42.76 -63.0 0.86 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.348 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.633 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.7 p-10 -65.88 -42.83 89.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.114 -179.25 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.3 mt-30 -61.76 -32.8 73.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.362 -179.603 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.4 mt -73.62 -40.78 63.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 178.651 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.23 -49.2 77.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.165 -178.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.9 m -52.7 -42.7 65.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.186 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.09 -42.78 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 120.967 0.413 . . . . 0.0 111.144 179.165 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.58 153.36 5.09 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.632 -179.362 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -39.12 107.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.629 2.219 . . . . 0.0 112.538 179.65 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.639 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.3 m -110.04 121.35 45.06 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.095 0.474 . . . . 0.0 110.289 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.639 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -113.94 153.05 29.93 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.29 -179.729 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.456 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -130.36 129.25 64.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.398 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.5 mt -111.74 126.72 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.626 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.513 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 57.0 t30 -100.9 103.81 15.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.149 179.711 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -100.88 -6.31 24.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.956 -179.741 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.2 p-10 -65.34 -33.39 75.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.728 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.584 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -100.37 9.18 43.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.618 -179.366 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.436 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.7 mttm -135.48 153.31 51.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.461 -179.39 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.9 p -75.81 166.55 23.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.624 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.597 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.8 t90 -59.89 -48.93 79.7 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.194 -179.095 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.85 -43.41 69.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.88 0.371 . . . . 0.0 110.087 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.0 t -62.88 -41.02 99.24 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.28 178.573 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.421 ' O ' HD23 ' A' ' 156' ' ' LEU . 49.9 tp -60.68 -44.49 96.44 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.298 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.0 tp -61.04 -43.59 98.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.136 179.882 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -54.53 -45.02 73.28 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.892 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.37 -40.15 95.5 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.96 0.41 . . . . 0.0 110.398 179.718 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.472 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.79 -42.46 99.03 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.189 179.164 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.75 -40.09 95.54 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.362 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.43 -45.64 65.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.352 . . . . 0.0 110.762 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.84 -43.99 96.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.1 p -93.39 -8.95 40.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.632 -178.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.13 26.01 72.35 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -101.78 50.48 0.85 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.735 0.302 . . . . 0.0 110.65 -179.509 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.48 -39.29 77.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.625 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.39 -47.2 86.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.327 -179.452 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -60.23 -39.61 87.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.226 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.11 99.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.01 0.433 . . . . 0.0 110.245 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.03 -28.58 70.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.591 179.489 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.59 -54.12 8.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.885 179.407 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.525 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.5 ttp180 -65.26 -42.5 93.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.395 -179.764 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 174' ' ' ASP . 81.2 mt -62.61 -43.94 98.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.54 -179.388 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.11 -61.06 2.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.088 0.471 . . . . 0.0 110.403 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.8 -34.52 62.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.605 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -80.41 -35.9 34.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.812 179.576 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.8 m-20 -55.08 -42.07 72.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.997 -178.658 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.42 -41.94 99.07 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.746 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.0 -38.21 90.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.316 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.9 mt -62.46 -41.92 99.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.728 179.397 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.88 -52.81 62.61 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.097 0.475 . . . . 0.0 110.68 179.805 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.21 -41.75 89.69 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.674 179.408 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.92 95.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.592 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.36 -32.28 73.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.05 -22.16 18.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.589 -179.807 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.491 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -64.82 -41.06 96.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.698 -179.593 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -76.89 135.94 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.749 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -126.85 108.33 10.91 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.257 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.62 125.75 0.31 Allowed Pre-proline 0 C--O 1.239 0.551 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.495 179.954 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.6 Cg_exo -43.94 152.4 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.848 2.365 . . . . 0.0 112.585 -179.862 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.09 141.75 53.82 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.604 2.203 . . . . 0.0 112.382 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.3 147.31 2.16 Favored Pre-proline 0 N--CA 1.448 -0.528 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.563 179.315 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.11 154.22 70.63 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.839 2.36 . . . . 0.0 112.33 178.621 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.58 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.37 163.08 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.27 0.557 . . . . 0.0 110.42 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.58 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.77 170.39 15.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.97 179.593 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.17 137.6 22.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 0.0 110.182 179.432 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.542 HG22 HD12 ' A' ' 205' ' ' LEU . 40.6 pt -134.37 147.02 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.73 179.596 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.484 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -133.55 132.05 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.21 0.529 . . . . 0.0 110.436 178.772 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -152.1 155.04 37.1 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.382 179.14 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.7 m -122.26 122.89 40.16 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.952 0.406 . . . . 0.0 110.405 179.469 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.88 -25.36 66.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.678 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.614 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.45 -49.37 19.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.876 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.26 -9.81 59.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.393 -179.526 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.6 m80 46.85 43.39 13.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.544 -179.653 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -136.39 144.65 44.65 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.31 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.9 113.92 26.86 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.336 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.95 133.41 55.57 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.096 0.474 . . . . 0.0 110.405 179.824 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.542 HD12 HG22 ' A' ' 194' ' ' ILE . 7.5 tt -112.06 146.48 37.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.014 0.435 . . . . 0.0 110.728 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.459 ' N ' HD23 ' A' ' 205' ' ' LEU . 13.6 t90 -99.67 129.88 45.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.14 0.495 . . . . 0.0 109.919 179.434 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.64 154.02 39.29 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.333 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.8 Cg_endo -67.54 -18.3 48.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.752 2.302 . . . . 0.0 111.976 178.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -49.54 -18.38 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.344 -179.148 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.406 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.4 p -75.59 164.34 26.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.51 179.664 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.83 -27.95 65.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.45 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.575 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.1 mt-30 -63.98 -41.26 97.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.61 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.04 -45.05 96.62 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -179.52 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.436 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.63 -38.71 91.94 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 122.236 -0.567 . . . . 0.0 110.783 179.54 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.597 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.7 mmm -62.14 -41.78 98.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.312 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.405 HD23 HD12 ' A' ' 219' ' ' LEU . 48.5 mt -63.5 -47.14 82.96 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.143 0.497 . . . . 0.0 110.259 179.545 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -54.77 -31.64 58.97 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.894 0.378 . . . . 0.0 110.411 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -70.26 -17.7 63.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.451 179.573 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.423 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.5 mt -88.82 -9.23 52.52 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.585 -179.492 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.98 2.68 51.98 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.756 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.86 153.03 21.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.456 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.5 p -115.36 128.12 55.87 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.11 0.481 . . . . 0.0 110.323 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.5 mm? -91.75 146.6 23.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.032 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.456 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.81 151.62 44.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.41 179.709 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -133.06 132.1 41.4 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.465 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.887 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.42 93.96 29.42 Favored Pre-proline 0 C--O 1.235 0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.066 -179.633 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.684 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.3 Cg_exo -55.12 138.86 79.91 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.582 2.188 . . . . 0.0 111.662 178.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.6 -25.27 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.504 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.684 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.17 -49.58 26.24 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.729 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.563 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.8 mt -54.58 -37.34 65.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.093 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.33 35.75 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.767 179.376 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.563 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.48 88.02 0.01 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.926 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 81.1 p -81.0 -13.81 58.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.31 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.16 -40.71 10.86 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.604 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.7 t -67.04 -16.6 64.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.559 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.69 43.94 27.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.473 -179.589 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.61 -147.05 7.37 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.06 143.45 49.5 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.96 0.41 . . . . 0.0 110.343 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.08 149.61 29.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.338 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -101.02 -152.08 0.42 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.319 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.5 t0 56.02 -92.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.672 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.457 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.1 tt -126.49 175.13 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.661 -179.591 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.457 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -121.62 141.24 42.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.827 -179.392 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.48 168.8 9.75 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.16 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.3 mt -147.47 150.91 35.5 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.281 179.813 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.99 -38.74 96.48 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.09 4.3 4.63 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.63 -58.1 3.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.901 0.381 . . . . 0.0 110.466 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.567 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.1 m-20 -62.15 -36.45 81.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.332 -179.724 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.36 -67.8 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.842 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.32 -42.06 66.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.182 -179.362 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.29 18.03 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.629 179.816 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.59 48.46 0.24 Allowed Glycine 0 N--CA 1.465 0.591 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.62 -109.84 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.467 0.175 . . . . 0.0 110.745 -178.536 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.456 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 12.0 m120 -60.68 -45.18 95.12 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.534 -179.555 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.82 8.17 83.01 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.258 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.37 -12.71 20.04 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 122.744 -0.268 . . . . 0.0 110.7 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.5 t 176.44 142.44 0.07 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.077 0.465 . . . . 0.0 110.436 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.1 125.34 11.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.161 179.593 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.432 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.38 143.19 29.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 120.899 0.38 . . . . 0.0 110.944 178.153 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.8 mt -94.52 106.66 18.65 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.718 -179.257 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.446 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.82 -12.36 18.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.101 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.58 89.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.872 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.37 173.66 46.04 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.657 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.5 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -73.98 -112.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 110.798 -179.824 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.95 -28.61 67.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.707 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.98 -44.12 91.53 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.202 -178.811 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.75 -44.24 94.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.308 179.3 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.51 -60.24 3.48 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.167 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -50.9 -43.56 59.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.169 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.27 -43.72 74.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.211 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.7 mt -64.57 -43.56 96.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.635 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -56.39 -37.68 70.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.168 -179.858 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.8 1.07 18.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.19 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -115.25 91.1 26.64 Favored Pre-proline 0 N--CA 1.462 0.134 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.129 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.99 -26.99 26.88 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.746 2.297 . . . . 0.0 111.976 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 277' ' ' LEU . 3.9 mm? -63.54 -41.09 98.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.495 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.598 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.0 mp -95.43 5.28 52.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.401 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.17 -34.84 68.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.536 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -80.11 4.74 16.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.526 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.9 121.28 80.94 Favored Pre-proline 0 N--CA 1.445 -0.721 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.566 179.999 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -47.22 -37.79 24.51 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.446 2.097 . . . . 0.0 112.618 -179.569 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.88 -43.8 90.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.705 0.288 . . . . 0.0 110.403 179.764 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.93 -43.56 92.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.345 179.306 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.84 -40.68 95.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.327 -179.217 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -90.09 -12.06 39.5 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.572 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.69 32.84 18.29 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.393 0.433 . . . . 0.0 111.035 -179.801 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -89.3 43.87 1.17 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.17 0.509 . . . . 0.0 110.348 179.476 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.54 135.96 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.533 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -116.7 132.55 56.66 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.385 179.653 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.502 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.57 88.09 7.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.733 179.917 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.06 -40.82 97.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.446 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.64 167.54 34.82 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.8 p -75.55 -25.73 57.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.803 0.335 . . . . 0.0 110.689 179.832 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.503 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.4 tp10 -67.89 -34.56 76.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.491 -179.763 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.773 HG22 ' O ' ' A' ' 296' ' ' THR . 96.7 m -73.36 24.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.649 -179.106 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.575 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 56.7 t80 -58.04 -51.17 70.79 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.348 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.408 HH12 ' HG3' ' A' ' 212' ' ' GLN . 71.0 mmt-85 -111.77 154.54 24.9 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.073 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.423 ' CD2' HD11 ' A' ' 219' ' ' LEU . 45.0 tp -115.89 124.99 52.03 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.97 0.414 . . . . 0.0 110.824 179.688 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.488 ' CB ' HD23 ' A' ' 83' ' ' LEU . 44.4 t0 -147.22 165.37 30.27 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.59 179.552 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.4 -38.41 28.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.617 -179.463 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -71.81 -65.1 0.81 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.527 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -60.08 -32.27 70.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.926 -179.501 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.19 -25.27 21.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.684 -179.14 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.7 mtt -63.1 -41.27 99.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.975 0.417 . . . . 0.0 110.977 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.27 -44.52 25.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.207 179.427 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.546 HG21 HG23 ' A' ' 296' ' ' THR . 78.7 t -66.12 -42.88 92.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.465 179.703 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.491 HD11 ' NE2' ' A' ' 183' ' ' GLN . 52.1 tp -60.36 -47.25 86.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.524 -178.522 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -70.09 -39.54 75.49 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.696 179.336 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.502 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 70.2 ttt180 -61.89 -37.79 85.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.36 -178.907 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -87.8 4.81 42.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.723 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -113.2 -11.99 13.18 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.052 0.453 . . . . 0.0 110.357 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.3 86.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.449 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.91 -48.8 80.15 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.431 -179.644 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.059 179.8 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.608 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.86 -2.7 58.26 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.463 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.55 179.14 1.23 Allowed Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.561 -179.65 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.4 Cg_exo -60.75 145.0 99.64 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.799 2.333 . . . . 0.0 112.171 179.634 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.608 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.03 -179.52 8.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.596 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.97 136.94 52.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.013 0.435 . . . . 0.0 110.383 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.22 147.06 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.342 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.6 p -119.93 135.88 54.73 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.073 0.463 . . . . 0.0 110.699 179.84 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.42 -143.44 0.33 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.252 179.893 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.61 -37.11 86.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.485 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.4 -66.68 0.22 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.416 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.52 142.47 45.35 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -179.357 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 78.4 p -112.29 131.61 55.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 0.0 110.447 -179.811 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -119.2 129.03 54.76 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.526 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.1 m -85.56 130.18 34.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.217 -179.841 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.1 mt -95.7 78.5 3.3 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.463 179.646 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.64 -31.73 72.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.579 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.35 109.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.018 0.437 . . . . 0.0 110.089 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -122.35 91.15 49.3 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.485 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.4 Cg_exo -56.74 148.48 65.36 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.831 2.354 . . . . 0.0 112.002 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.46 82.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.566 0.542 . . . . 0.0 110.975 -179.214 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.55 66.84 0.88 Allowed 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 121.094 0.473 . . . . 0.0 110.221 -179.422 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.4 130.74 35.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.803 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.565 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.4 t -122.42 146.61 27.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.057 -179.699 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.7 t -135.87 143.78 45.23 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.772 179.79 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.9 p -99.57 -59.36 1.73 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.588 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.1 p -79.22 155.17 28.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.66 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.524 HG21 HG23 ' A' ' 70' ' ' THR . 69.7 t -74.2 -21.89 17.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.474 179.355 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.3 m -60.28 -52.19 66.31 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.549 -178.399 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.34 -42.72 87.75 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.756 177.864 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.1 m -42.94 -53.83 4.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.9 -178.383 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.32 -37.19 70.68 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 178.564 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 m -62.78 -44.78 95.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.871 0.367 . . . . 0.0 110.141 -179.214 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.9 mt -66.45 -41.94 88.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.51 0.671 . . . . 0.0 110.711 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.65 -40.48 97.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.427 -179.363 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.9 -35.67 75.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.303 -179.046 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 156' ' ' LEU . 32.6 pt -91.34 28.65 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.314 -179.388 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.51 51.81 10.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.084 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.34 76.04 21.98 Favored Pre-proline 0 N--CA 1.463 0.199 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.624 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.77 151.21 86.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.864 2.376 . . . . 0.0 112.102 -178.864 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.565 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.18 137.47 46.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 121.155 0.502 . . . . 0.0 110.292 179.683 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.43 -43.55 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.395 179.344 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.25 131.48 53.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.033 0.444 . . . . 0.0 110.562 -179.008 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.6 p -155.7 168.51 26.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.437 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.36 -177.37 21.96 Favored Glycine 0 N--CA 1.463 0.475 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.634 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.52 172.25 12.98 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 121.165 0.507 . . . . 0.0 110.453 179.263 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.524 HG23 HG21 ' A' ' 51' ' ' VAL . 15.0 p -132.17 -113.14 0.23 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.037 0.446 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.64 179.58 0.97 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.399 -179.185 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.9 Cg_exo -61.04 57.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.997 2.465 . . . . 0.0 112.146 179.417 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.2 t-20 -64.1 -33.18 75.19 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.286 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.2 m120 93.8 -36.62 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.674 0.609 . . . . 0.0 109.825 -179.527 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -62.51 -39.71 94.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.009 0.433 . . . . 0.0 110.225 179.279 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.505 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.26 -25.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.703 179.353 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.15 -171.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.444 -179.227 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.77 -154.15 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.843 -179.708 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.405 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.1 p-10 -52.46 -7.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.742 -179.557 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.13 114.87 23.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.679 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.23 70.05 1.34 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -143.59 147.45 34.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.866 0.365 . . . . 0.0 110.856 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -85.41 -98.2 0.07 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.126 178.859 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.3 -42.38 96.39 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.076 179.543 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.553 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.0 tt0 91.23 52.5 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.875 0.734 . . . . 0.0 111.027 179.205 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -102.6 -9.12 20.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.332 179.338 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.3 p -64.56 -33.86 76.9 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.183 0.515 . . . . 0.0 110.74 -179.728 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -49.29 -23.29 1.33 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 179.666 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.0 t -70.08 -45.83 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.689 179.698 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.29 -48.63 80.52 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.216 0.532 . . . . 0.0 109.963 -179.384 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.52 -38.2 89.01 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.425 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.71 -32.89 53.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.041 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.605 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.9 mmt-85 -89.87 1.77 55.8 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.453 -179.811 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.76 -49.38 0.17 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.903 0.752 . . . . 0.0 110.228 179.125 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.658 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.2 mt -45.97 154.3 0.25 Allowed 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 117.621 -1.181 . . . . 0.0 109.566 -179.768 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.658 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.9 tt0 121.16 92.65 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 O-C-N 125.461 1.726 . . . . 0.0 110.51 -178.511 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.69 142.93 42.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.242 0.544 . . . . 0.0 110.291 179.296 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.3 mt -132.05 27.15 4.55 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.973 -0.454 . . . . 0.0 110.44 -179.346 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.39 137.97 34.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.042 0.448 . . . . 0.0 110.583 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.9 mt -137.17 165.12 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.319 179.594 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.94 -28.51 1.86 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -152.96 70.89 7.14 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 121.119 0.485 . . . . 0.0 110.132 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.1 145.42 98.48 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 122.743 2.295 . . . . 0.0 112.126 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.9 t -134.27 136.75 43.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.543 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.27 81.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.643 179.652 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.25 -42.3 96.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.511 -179.385 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.92 -41.7 98.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.49 -179.892 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.56 -43.43 98.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.991 179.485 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.02 77.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.145 -179.636 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.62 -18.82 61.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.383 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.6 -6.68 58.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.461 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.41 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.4 mtp 47.57 56.3 17.39 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.568 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.8 Cg_endo -70.33 149.5 63.38 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.751 2.301 . . . . 0.0 112.098 179.5 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.04 -73.64 0.64 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.492 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.429 HD11 HD13 ' A' ' 140' ' ' LEU . 39.3 tp -111.07 113.6 26.25 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 110.295 179.648 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.6 mt -101.97 126.75 55.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 120.966 0.413 . . . . 0.0 110.714 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.5 mt -109.84 133.5 53.09 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.211 -179.43 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.5 139.43 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.55 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.4 p -83.32 168.39 16.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.851 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.4 -37.3 80.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.397 179.929 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.3 t -139.96 158.87 43.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.968 0.414 . . . . 0.0 110.415 -179.818 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.23 176.97 33.49 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.26 -33.81 87.2 Favored Glycine 0 CA--C 1.518 0.251 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.588 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -124.58 151.3 44.95 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 110.547 -179.925 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.0 t -63.24 140.88 58.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.333 -179.846 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.48 10.37 11.14 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.659 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.7 mp -60.92 -39.0 87.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.273 -179.374 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.84 23.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.469 0.652 . . . . 0.0 110.594 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.5 mt -70.99 -35.4 72.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.517 0.675 . . . . 0.0 110.613 179.398 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -42.77 -62.91 0.88 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.424 -178.82 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.7 p-10 -65.63 -42.92 90.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 -179.301 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -61.89 -32.6 72.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.399 -179.609 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.4 mt -73.9 -40.8 62.9 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.78 178.672 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.04 -49.0 78.39 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.114 -178.969 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.9 m -53.02 -42.37 65.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.955 0.407 . . . . 0.0 110.144 179.582 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.21 -42.7 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 120.909 0.385 . . . . 0.0 111.252 179.044 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.64 153.81 5.22 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.681 -179.401 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -39.25 107.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.702 2.268 . . . . 0.0 112.519 179.544 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.64 ' C ' HD12 ' A' ' 140' ' ' LEU . 96.2 m -109.56 121.08 44.4 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.152 0.501 . . . . 0.0 110.272 179.883 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.64 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.59 152.24 30.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.294 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.77 131.43 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.3 179.815 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.404 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.8 mt -115.27 127.97 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.553 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.51 103.85 14.74 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.151 179.766 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 147' ' ' LYS . 48.4 p90 -101.3 -11.11 19.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.895 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.92 -33.49 76.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.708 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.0 p-10 -98.21 7.57 46.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.589 -179.622 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.44 155.56 50.34 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.415 -179.38 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.2 p -74.9 165.82 24.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.63 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.589 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.05 -48.83 80.08 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.19 -179.073 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.46 -41.92 66.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.351 . . . . 0.0 110.082 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.6 t -62.69 -41.03 98.89 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.399 178.687 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.404 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.3 tp -60.74 -44.51 96.59 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.285 -179.472 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.33 -43.47 98.83 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.106 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.0 m -55.16 -44.99 75.67 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.741 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.17 -40.66 96.78 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 120.948 0.404 . . . . 0.0 110.545 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.521 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -61.94 -42.5 99.17 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.378 178.959 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.19 -40.8 95.03 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.548 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.76 -46.03 63.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.786 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.68 -44.05 96.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -92.95 -8.9 41.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.661 -179.023 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.41 26.39 72.71 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -101.74 50.32 0.85 Allowed 'General case' 0 N--CA 1.463 0.214 0 O-C-N 122.638 -0.331 . . . . 0.0 110.68 -179.576 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -69.46 -39.63 77.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.694 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.32 -47.08 86.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.301 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -60.2 -39.42 86.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.129 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.96 99.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.181 179.724 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.11 -28.39 70.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.67 179.476 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.3 -54.38 7.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.863 179.357 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.509 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.35 -42.22 93.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.376 -179.758 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.4 mt -62.31 -43.88 98.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.559 -179.418 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.48 -59.23 5.26 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.992 0.425 . . . . 0.0 110.308 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -56.28 -33.99 66.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.572 -179.085 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -80.73 -36.37 32.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.815 179.524 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.8 m-20 -55.45 -42.22 73.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.91 -178.419 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.17 -42.13 98.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.8 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.08 -38.15 89.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.306 179.789 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 177' ' ' LEU . 81.8 mt -62.44 -42.25 99.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.746 179.452 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.19 -52.84 62.17 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.026 0.441 . . . . 0.0 110.622 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.24 -41.85 89.44 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.641 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.95 95.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.641 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.34 -31.95 73.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.48 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.57 -22.26 18.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.635 -179.828 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.465 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.5 tt0 -64.84 -41.35 95.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.597 -179.497 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.6 pt -76.73 136.13 25.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.741 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.87 107.98 10.59 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.265 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.71 125.87 0.31 Allowed Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.487 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.5 Cg_exo -43.8 152.42 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.794 2.33 . . . . 0.0 112.58 -179.804 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.18 141.95 54.0 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.536 2.157 . . . . 0.0 112.397 179.687 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.32 147.46 2.18 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.555 179.323 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.37 154.55 69.12 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.797 2.331 . . . . 0.0 112.272 178.52 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.57 163.3 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.232 0.539 . . . . 0.0 110.408 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.56 170.17 16.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.025 179.454 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.94 137.31 22.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.997 0.427 . . . . 0.0 110.127 179.484 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.554 HG22 HD12 ' A' ' 205' ' ' LEU . 38.0 pt -134.17 146.84 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.7 179.622 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -133.01 131.97 58.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.285 0.564 . . . . 0.0 110.439 178.775 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -152.98 156.42 38.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.362 179.202 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.607 HG22 ' H ' ' A' ' 199' ' ' ALA . 85.0 m -122.36 123.12 40.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.906 0.384 . . . . 0.0 110.418 179.416 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.522 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.78 -26.18 67.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.608 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.607 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.89 -49.23 21.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.68 -10.37 59.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.503 -179.703 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.522 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.5 m80 45.84 46.59 12.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 t -130.8 143.51 50.79 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.012 0.434 . . . . 0.0 110.334 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.456 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -108.23 105.62 15.42 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.18 -179.773 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -116.2 128.98 56.07 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.288 0.566 . . . . 0.0 110.29 179.714 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.554 HD12 HG22 ' A' ' 194' ' ' ILE . 7.7 tt -111.82 146.45 37.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.816 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.476 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.7 t90 -99.5 128.33 45.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.205 0.526 . . . . 0.0 109.795 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.22 153.8 40.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.434 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.62 -17.97 48.26 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.674 2.249 . . . . 0.0 112.018 178.836 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.84 -18.59 0.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.392 -179.189 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.422 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.7 p -75.49 164.7 26.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 179.577 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.96 -28.05 65.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.576 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.561 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.5 mt-30 -63.66 -41.4 98.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.59 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.36 -44.48 97.53 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.41 -38.89 92.61 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 122.167 -0.607 . . . . 0.0 110.739 179.67 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.0 mmm -61.83 -41.35 97.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.273 179.716 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.5 -47.75 80.44 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.095 0.474 . . . . 0.0 110.407 179.271 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.63 -32.07 49.83 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.913 0.387 . . . . 0.0 110.413 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -70.84 -18.22 62.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.501 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.414 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.7 mt -88.61 -8.7 54.23 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.558 -179.469 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.85 2.78 55.13 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.78 151.86 22.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.94 0.4 . . . . 0.0 110.432 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.449 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.3 p -114.87 127.8 55.92 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.178 0.513 . . . . 0.0 110.387 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.05 146.79 23.45 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.929 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.461 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -70.45 151.26 45.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.456 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.96 131.66 42.81 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.519 179.71 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.883 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.6 93.65 28.89 Favored Pre-proline 0 C--O 1.235 0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.055 -179.529 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.685 ' C ' ' H ' ' A' ' 229' ' ' GLY . 44.8 Cg_exo -55.17 138.55 79.38 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.618 2.212 . . . . 0.0 111.703 178.975 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.36 -25.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.521 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.685 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.44 -50.19 27.68 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 179.802 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.571 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -55.13 -36.93 66.28 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.101 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -65.77 35.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.806 179.353 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.571 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.14 88.66 0.01 OUTLIER 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.949 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 87.7 p -82.41 -13.6 56.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.331 -179.704 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.41 -40.95 11.15 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.633 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 31.9 t -66.65 -16.82 64.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.622 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.79 43.88 27.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.482 -179.599 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.95 -148.75 8.14 Favored Glycine 0 CA--C 1.518 0.245 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.766 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.82 142.17 48.86 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.916 0.389 . . . . 0.0 110.267 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.402 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.5 ttt-85 -151.93 149.47 28.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.349 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -102.11 -150.31 0.4 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.344 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.81 -93.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.64 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.439 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.0 tt -126.4 174.72 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.64 -179.589 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.439 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 89.5 mt -122.12 141.2 43.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -99.62 170.5 8.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.189 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 70.0 mt -146.69 149.69 33.93 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.229 179.743 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.22 -39.41 97.86 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.17 3.22 3.98 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -78.72 -57.42 3.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.937 0.399 . . . . 0.0 110.484 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.616 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.8 m-20 -62.03 -36.81 82.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.242 -179.67 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.456 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.7 mp -53.06 -67.45 0.25 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.014 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.8 -42.71 68.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.126 -179.297 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.31 17.64 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.701 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.9 47.81 0.25 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 7.9 mp 39.47 -110.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.532 0.206 . . . . 0.0 110.699 -178.677 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.461 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.7 m120 -60.76 -44.57 96.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.35 -179.563 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.4 7.92 84.09 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.413 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.87 -13.5 20.03 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.761 -0.258 . . . . 0.0 110.678 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.7 t 177.21 142.94 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 0.0 110.448 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.19 125.49 11.55 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.161 179.56 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.71 143.66 28.83 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 120.914 0.388 . . . . 0.0 110.847 178.269 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.9 mt -95.06 106.67 18.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.736 -179.214 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.442 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.1 t80 -101.91 -12.63 18.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.122 179.596 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.4 -41.04 89.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.82 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.36 172.86 45.69 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.699 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.469 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -73.59 -113.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.75 0.31 . . . . 0.0 110.815 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.6 -28.84 68.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.644 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.11 -43.64 91.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.16 -178.801 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.68 -44.28 94.18 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.267 179.248 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.6 -59.98 3.8 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.111 -179.727 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.96 -43.52 60.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.112 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.38 -43.33 75.06 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.199 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.2 mt -64.62 -43.61 96.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.674 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -55.94 -37.84 69.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.132 -179.846 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.48 0.78 18.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.182 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -115.04 90.99 25.21 Favored Pre-proline 0 N--CA 1.463 0.177 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.123 -179.564 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.09 -27.08 27.89 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.704 2.27 . . . . 0.0 111.979 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.48 -40.92 98.37 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.518 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 278' ' ' LEU . 10.1 mp -95.53 5.59 51.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.343 -179.214 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.39 -34.84 68.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.612 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.86 4.59 16.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.495 -178.843 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.75 121.13 80.09 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.607 -179.979 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -47.28 -37.6 24.7 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.431 2.087 . . . . 0.0 112.635 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.84 -43.78 90.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.756 0.313 . . . . 0.0 110.4 179.724 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.03 -43.51 92.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.346 179.348 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.74 -40.64 95.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.383 -179.191 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -90.22 -12.19 38.77 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.1 mtmt 61.74 32.81 18.2 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.371 0.419 . . . . 0.0 111.024 -179.77 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -89.04 43.67 1.16 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.13 0.491 . . . . 0.0 110.295 179.549 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.22 136.02 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.44 -179.661 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -117.02 132.28 56.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.391 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.78 89.14 7.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.819 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.415 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.3 mt -63.97 -41.16 97.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.993 0.425 . . . . 0.0 110.811 179.521 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.02 165.22 33.58 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 67.6 p -75.26 -25.77 58.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.968 0.413 . . . . 0.0 110.822 179.778 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -68.39 -33.83 74.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.504 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.768 HG22 ' O ' ' A' ' 296' ' ' THR . 95.8 m -73.39 24.72 0.07 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.797 -179.076 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.561 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 44.0 t80 -58.71 -50.85 72.35 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.256 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.419 HH12 ' HG3' ' A' ' 212' ' ' GLN . 77.1 mmt-85 -110.64 153.09 25.7 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 179.135 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.414 ' CD2' HD11 ' A' ' 219' ' ' LEU . 42.7 tp -115.4 124.88 52.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.883 0.373 . . . . 0.0 110.816 179.759 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.489 ' CB ' HD23 ' A' ' 83' ' ' LEU . 40.6 t0 -147.73 165.53 30.22 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.592 179.572 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -49.4 -37.92 27.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.533 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.32 -65.45 0.75 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.871 0.367 . . . . 0.0 111.582 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.87 -32.76 72.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.013 -179.504 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.5 -25.66 26.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.724 -179.153 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.5 mtt -63.37 -40.83 98.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.874 0.369 . . . . 0.0 111.145 179.694 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.41 -44.24 25.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.103 179.492 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.585 HG21 HG23 ' A' ' 296' ' ' THR . 78.2 t -66.34 -42.89 91.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.347 179.652 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.465 HD11 ' NE2' ' A' ' 183' ' ' GLN . 49.3 tp -60.02 -47.22 86.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.446 -178.516 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -69.82 -39.28 76.59 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.07 0.462 . . . . 0.0 110.811 179.074 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.9 ttt180 -61.87 -38.33 87.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.219 -178.936 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.27 4.61 42.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.57 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -112.85 -11.25 13.48 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.066 0.46 . . . . 0.0 110.367 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.35 86.89 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.466 179.645 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.82 -48.81 80.12 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.39 -179.608 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.222 -0.379 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.012 179.912 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.36 -2.55 57.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.372 -179.81 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.493 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.62 179.05 1.25 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.521 -179.701 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.493 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.8 Cg_exo -60.73 144.74 99.59 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.814 2.343 . . . . 0.0 112.153 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.87 -179.57 8.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.632 -179.851 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.76 136.42 53.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.046 0.45 . . . . 0.0 110.364 179.765 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.08 147.26 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.382 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.9 p -120.3 136.1 54.79 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.813 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.21 -143.52 0.32 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.248 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.7 -37.03 85.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.47 179.623 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.482 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.15 -67.04 0.22 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.418 179.783 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.21 142.5 44.61 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.436 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.7 p -112.64 131.21 55.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.991 0.424 . . . . 0.0 110.463 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -118.96 129.14 55.0 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.54 -179.905 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.3 m -85.63 130.83 34.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.226 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.2 mt -96.24 78.7 3.11 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.343 179.678 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -65.93 -32.11 73.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.574 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.62 108.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.106 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.489 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -121.93 91.21 48.8 Favored Pre-proline 0 C--O 1.233 0.189 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.45 -179.729 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.663 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.2 Cg_exo -56.75 148.29 66.7 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.798 2.332 . . . . 0.0 111.982 178.98 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.18 82.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.695 0.622 . . . . 0.0 111.002 -179.262 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.663 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.47 66.72 0.89 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.263 -179.4 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.95 130.98 35.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.851 -179.742 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.569 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.1 t -122.75 147.7 26.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.062 0.458 . . . . 0.0 110.013 -179.678 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.2 t -136.62 144.03 43.86 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.753 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.1 p -99.45 -59.53 1.7 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.628 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.8 p -79.08 155.64 28.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.623 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.529 HG21 HG23 ' A' ' 70' ' ' THR . 70.1 t -74.26 -21.65 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.532 179.414 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -60.34 -52.01 67.08 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.547 -178.502 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.16 -42.7 88.61 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.718 177.886 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.8 m -43.26 -54.38 4.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.884 -178.54 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.88 -37.36 74.89 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 178.7 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m -62.91 -44.49 95.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.872 0.368 . . . . 0.0 110.163 -179.304 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 18.3 mt -66.07 -41.95 90.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.505 0.669 . . . . 0.0 110.663 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.04 -39.95 96.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.344 -179.251 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.541 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.48 -35.91 77.02 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.295 -178.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.445 HD11 HD12 ' A' ' 156' ' ' LEU . 33.9 pt -91.14 27.64 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.374 -179.381 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.403 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 98.8 m-20 57.08 51.93 9.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.084 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.48 76.39 25.25 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.66 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.98 149.46 90.49 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.877 2.385 . . . . 0.0 112.146 -178.884 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.43 136.71 47.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 121.115 0.483 . . . . 0.0 110.35 179.661 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.444 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.0 pt -69.67 -43.46 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.249 179.439 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.491 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.13 131.27 53.28 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.963 0.411 . . . . 0.0 110.608 -178.983 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.4 p -155.92 168.63 26.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.531 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.16 -177.43 22.09 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.644 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.26 171.92 13.38 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 121.102 0.477 . . . . 0.0 110.425 179.297 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.529 HG23 HG21 ' A' ' 51' ' ' VAL . 12.3 p -133.81 -110.51 0.22 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.008 0.432 . . . . 0.0 110.583 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.11 179.62 0.94 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.566 -179.323 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.4 Cg_exo -60.72 58.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.944 2.429 . . . . 0.0 112.126 179.512 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.3 t-20 -64.31 -34.88 79.15 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.48 -179.789 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.566 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 13.0 m120 95.04 -38.07 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.671 0.607 . . . . 0.0 109.759 -179.436 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 -62.54 -39.88 95.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.99 0.424 . . . . 0.0 110.142 179.234 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -73.6 -26.55 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.693 179.326 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -50.04 -171.77 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.463 -179.381 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -74.38 -153.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 -179.785 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.3 p-10 -54.37 -6.77 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.675 -179.432 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.9 113.93 23.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.671 179.793 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.39 72.39 1.29 Allowed Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.603 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -143.8 148.1 35.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.862 0.363 . . . . 0.0 110.876 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.6 mp -85.99 -98.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.939 178.891 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.92 -43.38 96.11 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.113 179.395 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 10.1 tt0 91.37 52.53 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.794 0.684 . . . . 0.0 111.147 179.195 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.78 -8.63 19.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.347 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.0 p -65.45 -33.22 75.43 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.05 0.452 . . . . 0.0 110.65 -179.596 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -48.87 -23.24 1.02 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.717 179.639 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.4 t -70.13 -45.81 74.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.708 179.708 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.75 80.09 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.974 -179.441 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.41 -38.37 89.41 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.39 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.65 -32.78 52.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.208 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.618 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.5 mmt-85 -89.8 1.81 55.69 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.406 -179.802 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.618 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 82.68 -49.18 0.17 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.7 0.625 . . . . 0.0 110.246 179.152 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.673 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.3 mt -45.96 154.11 0.26 Allowed 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.542 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.673 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 121.2 92.05 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 125.17 1.543 . . . . 0.0 110.477 -178.683 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.543 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.92 142.56 44.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.282 0.563 . . . . 0.0 110.368 179.374 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.2 mt -131.6 26.59 4.72 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 122.016 -0.428 . . . . 0.0 110.379 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -139.8 136.96 34.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.06 0.457 . . . . 0.0 110.596 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.644 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.7 mt -136.52 164.69 30.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.393 179.592 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.613 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.19 -28.49 1.83 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.56 70.72 7.42 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 121.08 0.466 . . . . 0.0 110.182 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.08 145.41 98.5 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.705 2.27 . . . . 0.0 112.098 -179.481 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.5 t -134.59 136.91 43.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.509 179.776 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.35 82.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.57 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.2 -42.38 96.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.603 -179.439 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.91 -41.68 98.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.544 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.57 -43.35 98.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.987 179.487 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.17 -35.04 77.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.206 -179.722 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.81 -18.71 60.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.363 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.51 -6.4 58.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.457 -179.794 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.4 mtp 47.54 56.0 17.15 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.576 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.9 Cg_endo -70.33 149.61 63.5 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.816 2.344 . . . . 0.0 112.049 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.46 -73.72 0.64 Allowed 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.46 179.768 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.1 tp -110.61 113.72 26.55 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.27 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.3 mt -102.84 126.83 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.614 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.1 mt -110.57 134.18 52.63 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.275 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.68 140.05 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.57 -179.574 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.2 p -83.44 168.19 16.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.8 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.5 79.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.455 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.6 t -139.99 159.2 42.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.398 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.18 176.82 33.49 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.721 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.31 -33.67 86.83 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.49 151.67 44.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.858 0.361 . . . . 0.0 110.565 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.8 t -63.39 140.64 58.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.336 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.39 10.35 11.19 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.622 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.8 mp -60.75 -39.0 87.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.253 -179.368 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.97 -35.9 23.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.358 0.599 . . . . 0.0 110.594 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.0 mt -70.89 -35.43 72.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.47 0.653 . . . . 0.0 110.607 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -42.78 -62.92 0.88 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.453 -178.781 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.82 -42.75 90.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.244 -179.395 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -61.83 -32.6 72.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.402 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.2 mt -73.88 -40.82 62.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.879 178.665 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -58.24 -49.18 77.99 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.231 -179.041 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.8 m -53.01 -42.49 65.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.896 0.379 . . . . 0.0 110.089 179.535 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.18 -42.82 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 120.927 0.394 . . . . 0.0 111.154 179.216 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.4 153.39 5.26 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.684 -179.395 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -39.08 107.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.666 2.244 . . . . 0.0 112.537 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.641 ' C ' HD12 ' A' ' 140' ' ' LEU . 94.1 m -109.68 121.08 44.4 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.115 0.483 . . . . 0.0 110.246 179.905 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.76 153.08 29.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.32 -179.841 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.6 tt -128.58 131.45 68.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.383 179.856 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.41 128.17 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.605 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.501 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 53.6 t30 -99.59 104.02 15.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.133 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.416 ' O ' ' O ' ' A' ' 147' ' ' LYS . 50.8 p90 -98.87 -12.39 20.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.969 -179.705 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.6 p-10 -64.93 -33.89 77.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.798 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.592 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.7 p-10 -99.23 6.89 46.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.596 -179.376 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.8 mttm -133.71 149.59 51.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.559 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.423 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -76.43 167.31 22.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.618 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.603 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.2 t90 -59.07 -48.3 82.1 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.166 -179.158 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -54.4 -45.99 73.04 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 40.4 t -63.42 -40.8 98.14 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.094 0.473 . . . . 0.0 110.2 178.429 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.434 ' O ' HD23 ' A' ' 156' ' ' LEU . 66.5 tp -61.04 -44.67 97.05 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.119 -179.353 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.49 -42.71 99.21 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.207 179.728 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.5 m -55.78 -45.61 78.14 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.73 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.39 -40.4 96.37 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.812 0.339 . . . . 0.0 110.445 179.766 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.445 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -61.81 -42.54 99.14 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.312 178.996 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.78 -40.0 95.45 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.425 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.36 -45.61 65.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.922 0.391 . . . . 0.0 110.843 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.9 mt -65.02 -43.88 96.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.82 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.3 p -92.89 -9.11 41.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.656 -179.049 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.96 26.42 72.28 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -101.72 50.76 0.84 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.883 0.373 . . . . 0.0 110.668 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.53 -39.31 77.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.608 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.37 -47.36 85.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.36 -179.448 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.403 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 87.3 mt-30 -60.3 -39.3 86.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.112 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.05 99.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.186 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.07 -28.39 70.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.607 179.579 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.21 -54.42 7.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.939 179.405 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.541 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.5 ttp180 -65.5 -41.98 92.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.561 -179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 174' ' ' ASP . 78.9 mt -62.31 -43.92 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.549 -179.319 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.91 -57.85 9.39 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 120.995 0.426 . . . . 0.0 110.416 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -57.56 -33.83 68.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.619 -179.134 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -81.15 -36.43 30.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.774 179.648 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.4 m-20 -55.72 -41.64 74.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.095 -178.672 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.49 -42.1 99.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.631 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.19 -38.35 90.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.255 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 177' ' ' LEU . 83.0 mt -62.45 -42.02 99.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.76 179.498 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.18 -53.16 59.29 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.091 0.472 . . . . 0.0 110.628 179.869 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -65.87 -42.08 90.82 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.722 179.502 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.51 -39.45 94.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.669 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.7 -32.06 73.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.4 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -95.34 -21.96 18.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.617 -179.677 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.473 ' NE2' HD11 ' A' ' 308' ' ' LEU . 19.3 tt0 -64.38 -41.77 96.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.685 -179.494 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.4 pt -74.53 135.55 27.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.016 0.436 . . . . 0.0 110.707 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.29 106.2 9.35 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.346 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -178.02 127.51 0.28 Allowed Pre-proline 0 C--O 1.239 0.53 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.513 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.447 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.7 Cg_exo -43.53 151.81 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.892 2.395 . . . . 0.0 112.53 -179.829 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.44 142.81 55.46 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.608 2.205 . . . . 0.0 112.343 179.672 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.545 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -171.66 147.14 1.99 Allowed Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.527 179.327 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.13 155.29 68.49 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.887 2.391 . . . . 0.0 112.34 178.676 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.59 163.14 28.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.201 0.524 . . . . 0.0 110.409 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.3 169.36 17.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.031 179.455 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.41 137.1 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.365 . . . . 0.0 110.177 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.57 HG22 HD12 ' A' ' 205' ' ' LEU . 38.0 pt -134.08 146.12 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.759 179.511 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.491 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -133.32 132.11 58.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.286 0.565 . . . . 0.0 110.431 178.979 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -153.07 156.55 38.94 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.403 179.193 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.605 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.4 m -121.84 122.93 40.57 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.41 179.556 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.467 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.94 -26.09 67.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.606 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.605 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.77 -49.56 20.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.974 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -75.79 -13.22 60.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.471 -179.65 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.467 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 78.4 m80 49.56 46.51 23.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.621 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.5 t -131.59 146.04 52.01 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.075 0.464 . . . . 0.0 110.247 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.426 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -110.21 106.05 15.33 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.234 -179.741 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -116.36 129.19 56.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.09 0.471 . . . . 0.0 110.276 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.57 HD12 HG22 ' A' ' 194' ' ' ILE . 7.7 tt -111.95 146.32 38.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.017 0.437 . . . . 0.0 110.889 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.464 ' N ' HD23 ' A' ' 205' ' ' LEU . 17.4 t90 -98.73 128.86 45.11 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.139 0.495 . . . . 0.0 109.912 179.442 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.05 153.55 39.12 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.229 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.8 -18.25 47.35 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.748 2.299 . . . . 0.0 111.981 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.9 -19.16 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.437 -179.273 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 86.7 p -75.86 167.63 21.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.449 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.46 74.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.453 -179.682 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.506 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.2 mt-30 -56.55 -40.68 75.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.756 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.31 -43.71 97.09 Favored Glycine 0 C--N 1.329 0.165 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.532 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.512 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.2 mt-30 -64.32 -40.57 96.16 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 122.341 -0.505 . . . . 0.0 110.796 -179.896 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.603 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.3 mmm -62.02 -42.46 99.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.499 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 39.7 mt -62.91 -49.21 75.69 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.049 0.452 . . . . 0.0 110.432 179.833 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.67 -31.52 62.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 110.441 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -69.48 -17.47 63.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.541 179.792 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.401 HD11 ' CD2' ' A' ' 299' ' ' LEU . 95.0 mt -87.3 -11.5 49.32 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.616 -179.569 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 105.19 1.32 41.43 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.723 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -88.2 156.1 19.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.923 0.392 . . . . 0.0 110.692 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.458 ' O ' HG12 ' A' ' 191' ' ' VAL . 7.1 p -116.39 128.59 55.65 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.183 0.516 . . . . 0.0 110.201 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.63 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.6 mm? -90.53 146.81 23.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.993 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.458 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -71.62 150.47 44.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.414 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.5 131.94 42.15 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.575 179.688 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.877 HD12 ' N ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.03 94.2 28.83 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.984 -179.579 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.687 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.8 Cg_exo -55.19 138.57 79.49 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.651 2.234 . . . . 0.0 111.602 178.962 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.28 -25.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.46 -179.59 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.687 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.07 -49.67 26.42 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.575 ' C ' ' H ' ' A' ' 232' ' ' ALA . 98.1 mt -54.89 -37.29 66.13 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.127 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -65.71 35.52 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.775 179.37 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.575 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.78 87.82 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.5 p -81.38 -13.86 57.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.382 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.73 -40.41 11.27 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.628 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 26.9 t -66.93 -16.62 64.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.573 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.83 43.82 27.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.488 -179.662 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.4 -146.52 7.16 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.23 142.98 49.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.947 0.404 . . . . 0.0 110.397 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.401 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.3 ttt-85 -151.82 149.37 28.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.034 0.445 . . . . 0.0 110.28 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -101.22 -151.3 0.41 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.348 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 55.67 -92.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.712 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.444 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.0 tt -126.57 174.63 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.618 -179.469 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.444 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -121.69 140.96 44.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.476 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.28 170.33 8.73 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.307 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.1 mt -146.82 149.55 33.53 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.191 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.42 -39.3 97.58 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.22 3.06 4.0 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -78.29 -57.73 3.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.935 0.398 . . . . 0.0 110.463 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.63 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.4 m-20 -62.06 -37.06 83.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.297 -179.649 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.426 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.7 mp -52.71 -67.78 0.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.74 -42.46 68.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.133 -179.283 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.39 17.69 0.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.668 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.05 48.0 0.27 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.1 mp 39.06 -110.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.493 0.187 . . . . 0.0 110.696 -178.775 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.458 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 12.0 m120 -60.66 -44.58 96.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.42 -179.639 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.32 7.85 84.33 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.329 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -98.67 -13.41 20.31 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.763 -0.257 . . . . 0.0 110.69 -179.795 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.5 t 177.03 142.72 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.132 0.492 . . . . 0.0 110.382 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.432 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -147.71 125.46 11.88 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.288 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 191' ' ' VAL . 14.0 m-30 -98.61 143.7 28.71 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 120.927 0.394 . . . . 0.0 110.731 178.405 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.2 mt -95.12 106.33 18.33 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.773 -179.255 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.481 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.8 t80 -102.45 -12.26 17.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.112 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.53 -40.04 88.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.883 179.777 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.16 173.61 46.07 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.61 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.463 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 96.5 m-20 -74.43 -113.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 0.0 110.769 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.5 -29.16 68.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.693 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.9 -43.81 91.1 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.112 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.36 -44.68 94.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.271 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.46 -59.95 3.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.197 -179.792 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -51.02 -43.64 60.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.082 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.12 -43.75 74.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.156 -179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.8 mt -64.41 -43.65 97.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.579 179.568 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -56.63 -37.9 71.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.144 -179.919 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.5 1.03 17.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.179 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -115.17 91.24 26.83 Favored Pre-proline 0 N--CA 1.461 0.089 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.176 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.12 -26.93 27.6 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.748 2.299 . . . . 0.0 111.975 179.329 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 277' ' ' LEU . 4.0 mm? -63.55 -40.82 98.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.577 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 278' ' ' LEU . 9.9 mp -95.16 5.57 51.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.381 -179.022 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.03 -35.14 69.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.618 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.63 4.27 16.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.492 -178.873 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.68 120.69 77.39 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.575 179.953 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -47.27 -37.66 24.7 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.446 2.097 . . . . 0.0 112.6 -179.515 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.535 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.93 -43.63 91.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.43 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.83 -43.61 93.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.337 179.241 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.9 -40.58 95.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.396 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.8 -12.28 39.65 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.508 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.81 31.66 18.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.051 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.44 44.04 1.17 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.128 0.49 . . . . 0.0 110.308 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.8 136.13 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.563 -179.704 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.66 132.5 56.67 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.361 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.496 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.35 88.66 6.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.794 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.82 -41.51 97.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.697 179.533 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.481 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.5 165.13 34.28 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.789 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.7 p -75.53 -26.09 57.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.4 tp10 -68.67 -33.77 74.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.394 -179.699 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.777 HG22 ' O ' ' A' ' 296' ' ' THR . 98.1 m -72.47 22.19 0.06 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.215 0.531 . . . . 0.0 110.761 -179.351 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.513 ' H ' ' C ' ' A' ' 295' ' ' GLU . 49.1 t80 -57.86 -51.0 71.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.851 -179.253 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.9 mmt-85 -108.02 150.03 27.66 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.879 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.401 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.7 tp -116.46 127.31 54.47 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.77 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.464 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.6 t0 -150.99 167.82 26.45 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.675 179.631 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.4 ' CE2' ' CE ' ' A' ' 305' ' ' MET . 91.4 t80 -49.3 -38.09 26.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.622 -179.54 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.16 -65.63 0.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.588 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.64 -33.03 72.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.028 -179.479 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.17 -25.31 21.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.782 -179.125 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 305' ' ' MET . . . . . 0.4 ' CE ' ' CE2' ' A' ' 301' ' ' TYR . 61.3 mtt -63.57 -41.09 98.4 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.933 0.397 . . . . 0.0 111.158 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.96 -43.88 23.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.181 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.567 HG21 HG23 ' A' ' 296' ' ' THR . 77.9 t -66.21 -42.86 91.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.405 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.473 HD11 ' NE2' ' A' ' 183' ' ' GLN . 50.2 tp -60.34 -46.76 88.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.48 -178.555 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -70.47 -39.47 74.22 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.098 0.475 . . . . 0.0 110.805 179.162 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.496 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 73.6 ttt180 -61.56 -37.53 84.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.292 -179.029 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.6 mt -87.99 4.18 45.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.642 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -112.2 -11.26 13.77 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.003 0.43 . . . . 0.0 110.396 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.17 86.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.406 179.761 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.82 -48.89 79.75 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.474 -179.703 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.005 179.877 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.61 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.06 -2.34 58.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.373 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.481 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.5 179.18 1.22 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.469 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.5 Cg_exo -60.8 145.38 99.06 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.729 2.286 . . . . 0.0 112.166 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.61 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 34.9 ptt-85 -156.29 -179.47 8.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.579 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -116.18 137.44 52.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.323 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.69 146.88 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.322 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.5 p -119.93 135.81 54.76 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.807 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.16 -143.65 0.32 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.19 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.45 -37.14 86.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.445 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.481 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.31 -66.51 0.22 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.484 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.62 142.35 45.68 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 p -112.06 131.4 55.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.89 0.376 . . . . 0.0 110.391 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -118.98 128.81 54.74 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.499 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.0 m -85.62 130.28 34.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.143 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.486 HD22 ' OE1' ' A' ' 42' ' ' GLN . 70.0 mt -96.25 78.76 3.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.317 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.54 -32.15 73.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.471 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.6 109.77 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.044 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.486 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -123.3 91.37 49.85 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.199 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.636 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.2 Cg_exo -57.07 148.92 65.88 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.738 2.292 . . . . 0.0 111.773 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.28 83.11 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.631 0.582 . . . . 0.0 111.047 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.636 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.64 67.09 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.129 0.49 . . . . 0.0 110.261 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.45 130.82 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.515 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.563 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.9 t -122.84 147.01 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.085 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.9 t -136.24 143.8 44.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.644 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.3 p -99.08 -59.25 1.76 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.53 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.1 p -79.3 155.27 28.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.695 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.524 HG21 HG23 ' A' ' 70' ' ' THR . 71.4 t -74.22 -21.85 17.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.62 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.8 m -60.37 -51.98 67.21 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.486 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.8 mt -66.29 -42.52 88.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.502 0.668 . . . . 0.0 110.951 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.0 m -43.44 -53.76 5.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.076 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.13 -37.36 72.53 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.6 m -62.77 -44.63 95.68 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.367 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.412 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.0 mt -65.98 -42.17 90.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.43 0.633 . . . . 0.0 110.69 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 tp -62.59 -40.13 95.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.467 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.505 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.29 -36.16 77.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.05 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 156' ' ' LEU . 32.0 pt -90.75 28.61 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.177 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.59 51.39 11.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.825 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.72 75.14 26.12 Favored Pre-proline 0 C--N 1.333 -0.15 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.97 151.24 86.12 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.718 2.278 . . . . 0.0 112.16 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.563 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.63 137.29 47.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.306 0.574 . . . . 0.0 110.23 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.437 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.1 pt -69.06 -43.69 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.373 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.481 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.2 130.94 53.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.987 0.423 . . . . 0.0 110.597 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.525 ' O ' ' O ' ' A' ' 97' ' ' ARG . 30.8 p -155.41 168.88 25.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.346 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.77 -177.33 21.7 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.632 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.44 172.57 12.53 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.857 0.36 . . . . 0.0 110.556 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.524 HG23 HG21 ' A' ' 51' ' ' VAL . 14.7 p -132.47 -113.0 0.23 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.348 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.03 179.98 0.9 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.211 -178.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.7 Cg_exo -60.89 57.93 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 123.027 2.485 . . . . 0.0 112.187 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.4 t-20 -64.28 -34.13 77.41 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 118.606 -0.712 . . . . 0.0 110.584 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 45.1 m-20 93.91 -36.21 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.617 1.198 . . . . 0.0 109.753 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.411 ' HD3' HD21 ' A' ' 73' ' ' ASN . 78.1 mtp85 -62.7 -39.9 95.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.224 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.17 -25.83 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.804 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.32 -171.18 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.649 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -73.94 -153.88 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.833 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.8 p-10 -52.74 -7.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.658 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.3 114.89 23.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.556 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.88 70.11 1.35 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -143.25 147.91 35.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.941 0.4 . . . . 0.0 110.819 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.76 -98.62 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.125 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.1 mtt-85 -63.88 -42.71 97.43 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.236 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.5 tt0 91.72 53.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.286 0.991 . . . . 0.0 110.917 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -103.4 -9.0 19.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.404 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.5 p -64.66 -34.0 77.26 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.167 0.508 . . . . 0.0 110.777 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.531 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.79 -24.57 1.47 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.56 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.25 -46.04 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.048 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.27 -48.43 81.47 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.98 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.73 -38.21 89.62 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.347 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.95 -32.08 52.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.218 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.576 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.4 mmt-85 -90.09 1.9 55.85 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.686 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.36 -49.43 0.2 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 124.412 1.07 . . . . 0.0 110.366 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.613 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 83.2 mt -46.48 154.73 0.27 Allowed 'General case' 0 CA--C 1.485 -1.549 0 CA-C-O 117.068 -1.444 . . . . 0.0 108.966 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.613 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 120.82 92.68 0.0 OUTLIER 'General case' 0 C--N 1.359 1.001 0 O-C-N 125.958 2.036 . . . . 0.0 110.527 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.525 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.6 143.47 42.31 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.227 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.8 mt -132.47 27.03 4.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.692 0.282 . . . . 0.0 110.436 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.48 138.18 34.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.027 0.441 . . . . 0.0 110.491 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.632 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.6 mt -137.15 164.91 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.385 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.611 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.25 -28.59 1.81 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -152.54 70.99 7.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.193 0.521 . . . . 0.0 110.287 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.04 145.42 98.43 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.711 2.274 . . . . 0.0 112.075 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.1 t -134.78 136.59 42.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.035 0.445 . . . . 0.0 110.507 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.29 -38.17 81.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.702 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.25 -42.09 96.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.57 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.27 -41.48 98.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.515 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 64.9 t -63.67 -43.56 98.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.947 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.25 78.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.336 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.34 -18.67 59.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.502 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.76 -6.42 58.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.52 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 75.8 mtp 47.74 55.83 17.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.599 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.9 Cg_endo -70.49 150.02 63.11 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.841 2.361 . . . . 0.0 112.044 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -101.4 -75.9 0.58 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.404 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.4 HD11 HD13 ' A' ' 140' ' ' LEU . 38.6 tp -108.38 113.7 26.98 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.218 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.0 mt -102.64 126.77 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.404 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.5 mt -109.73 133.68 52.86 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.084 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.28 139.08 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.496 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.5 p -83.17 168.33 16.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.68 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -37.46 80.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.454 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -140.06 158.89 43.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.43 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.18 177.36 33.26 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.16 -33.82 87.11 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.61 151.84 44.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.874 0.369 . . . . 0.0 110.588 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.1 t -63.03 141.06 58.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.288 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.04 9.85 11.3 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.697 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.9 mp -61.22 -39.18 89.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.056 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.629 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.76 -36.01 23.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.647 0.737 . . . . 0.0 110.704 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -70.59 -35.61 73.1 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.488 0.661 . . . . 0.0 110.828 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -42.85 -63.03 0.86 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.332 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.629 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.89 -42.62 90.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.97 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.11 -33.18 73.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.083 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.2 mt -72.86 -40.74 65.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.24 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.51 -48.61 80.24 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.139 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 m -53.29 -42.25 66.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.105 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.78 -42.93 93.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.998 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.55 156.38 5.23 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.581 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -39.63 107.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.581 2.188 . . . . 0.0 112.347 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.642 ' C ' HD12 ' A' ' 140' ' ' LEU . 89.8 m -110.11 120.81 43.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.234 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.642 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.45 152.67 31.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.125 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -129.39 131.44 67.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.38 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.9 mt -115.17 128.12 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.384 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.2 t30 -101.6 103.61 14.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.262 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.5 p90 -100.96 -11.36 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.774 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.4 p-10 -64.79 -33.81 76.86 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.705 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.6 p-10 -98.08 7.8 45.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.63 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.7 155.41 50.44 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.543 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.404 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -74.93 165.68 24.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.668 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.598 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.84 -48.75 80.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.185 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -53.7 -41.96 67.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.918 0.39 . . . . 0.0 110.012 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.6 t -62.58 -41.14 98.76 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.391 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.406 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.8 tp -60.64 -44.13 96.75 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.315 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.7 tp -61.5 -43.42 98.9 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.226 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -54.99 -44.79 74.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.659 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.42 -40.68 97.35 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.893 0.377 . . . . 0.0 110.355 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.2 -42.35 99.21 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.387 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.05 -41.02 95.36 Favored Glycine 0 C--N 1.315 -0.587 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.42 -46.13 64.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.949 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.6 -44.05 96.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.816 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.4 p -93.02 -8.74 42.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.595 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.93 26.63 72.32 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -101.99 50.96 0.83 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.814 0.34 . . . . 0.0 110.721 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -69.67 -39.46 76.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.751 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.58 -47.08 86.98 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.268 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -60.02 -39.24 85.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.332 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.13 -40.87 98.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.277 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.91 -28.69 70.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.07 0.462 . . . . 0.0 110.571 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.03 -54.24 8.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.221 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.505 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.51 -42.1 92.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.439 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.9 mt -62.35 -43.78 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.434 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.72 -57.53 10.64 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.082 0.468 . . . . 0.0 110.509 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.89 -34.05 69.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.342 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.4 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.4 t80 -80.76 -37.15 30.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.075 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.5 m-20 -55.56 -41.45 73.31 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.245 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.75 -42.23 99.58 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.727 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.3 -37.83 88.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.227 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.4 HD11 ' CD2' ' A' ' 173' ' ' PHE . 82.6 mt -62.5 -42.24 99.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.737 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.04 -52.59 63.35 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.096 0.474 . . . . 0.0 110.7 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.37 -41.75 88.99 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.592 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.92 95.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.623 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.23 -32.43 73.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.381 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.09 -22.38 18.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.762 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.629 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.0 tt0 -64.85 -41.01 96.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.64 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.6 pt -77.16 136.6 24.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.623 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -127.15 108.22 10.71 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.218 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.08 126.0 0.34 Allowed Pre-proline 0 N--CA 1.446 -0.669 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.588 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.7 Cg_exo -44.04 152.61 0.37 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.664 2.242 . . . . 0.0 112.606 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.19 141.88 53.76 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.59 2.193 . . . . 0.0 112.456 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.547 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.16 147.2 2.19 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.648 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.46 155.23 67.5 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.745 2.297 . . . . 0.0 112.299 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.576 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.63 163.12 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.362 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.576 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.58 170.16 16.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.912 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.86 137.42 22.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.208 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.565 HG22 HD12 ' A' ' 205' ' ' LEU . 37.7 pt -134.26 146.51 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.603 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.92 131.98 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.305 0.574 . . . . 0.0 110.57 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -152.85 156.43 38.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.379 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.0 m -122.08 122.92 40.36 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.934 0.397 . . . . 0.0 110.329 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.486 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.78 -26.55 67.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.534 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.597 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.12 -50.02 21.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.079 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -75.75 -13.46 60.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.506 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.486 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 78.1 m80 49.94 46.21 24.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.529 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.6 t -131.14 144.86 51.7 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.317 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.428 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -109.4 106.08 15.71 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.204 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -116.46 129.69 56.35 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.14 0.495 . . . . 0.0 110.307 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.565 HD12 HG22 ' A' ' 194' ' ' ILE . 7.7 tt -112.36 146.19 38.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.719 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.466 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.9 t90 -99.34 128.68 45.48 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.141 0.496 . . . . 0.0 109.959 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.82 154.08 39.91 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.107 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.6 Cg_endo -67.71 -17.97 47.79 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.736 2.291 . . . . 0.0 111.897 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.43 -18.92 0.45 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.402 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.441 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.1 p -75.5 164.57 26.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.488 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.9 -27.89 65.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.532 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.61 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.8 mt-30 -63.76 -41.19 98.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.64 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.44 -44.28 97.82 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.55 -38.94 92.74 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 120.989 0.423 . . . . 0.0 110.461 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.28 -41.26 98.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.062 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 71.7 mt -63.6 -47.06 82.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.635 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.34 -31.75 55.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.91 -18.25 62.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.526 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.429 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.0 mt -88.11 -8.75 54.99 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.651 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.64 2.1 55.34 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -88.46 153.29 21.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.755 0.312 . . . . 0.0 110.436 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.462 ' O ' HG12 ' A' ' 191' ' ' VAL . 10.3 p -116.05 128.63 55.85 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.078 0.466 . . . . 0.0 110.384 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.33 146.33 23.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.901 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.456 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.24 151.36 45.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.432 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.37 131.88 42.32 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.394 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.877 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.3 93.71 27.73 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.002 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.678 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.1 Cg_exo -55.63 138.78 81.9 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.574 2.182 . . . . 0.0 111.435 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.56 -25.61 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.551 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.63 -49.89 28.03 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.9 mt -55.23 -37.16 66.8 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -65.54 35.65 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.909 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.569 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.47 88.32 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.773 0.32 . . . . 0.0 110.852 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.2 p -81.44 -13.4 58.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.377 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.86 -40.76 11.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.604 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.0 t -66.64 -17.02 64.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.644 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.01 44.0 26.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.485 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.29 -148.21 8.05 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.68 142.5 48.42 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.888 0.375 . . . . 0.0 110.352 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.422 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.3 ttt-85 -152.11 149.55 28.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.334 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -102.43 -150.12 0.4 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.26 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 55.48 -92.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.575 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.425 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.3 tt -127.2 174.13 11.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.498 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.425 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 88.2 mt -121.57 140.84 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.798 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.36 170.53 8.57 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.4 mt -146.88 149.53 33.44 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.253 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.19 -39.32 97.78 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.09 2.96 4.08 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -78.48 -57.32 3.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 110.621 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.618 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.2 m-20 -62.19 -36.81 83.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.084 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.428 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.8 mp -53.31 -67.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.05 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.482 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.84 -42.55 68.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.13 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.67 17.72 0.15 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.659 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.99 47.85 0.26 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 254' ' ' LEU . 7.8 mp 39.53 -110.17 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.601 0.238 . . . . 0.0 110.637 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.456 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -61.2 -44.15 97.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.326 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.15 8.14 84.19 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.86 -13.34 20.11 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.774 -0.251 . . . . 0.0 110.69 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.9 t 176.89 142.74 0.08 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.174 0.511 . . . . 0.0 110.51 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.3 tt -147.96 125.72 11.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.1 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.6 m-30 -98.92 143.42 29.24 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 120.917 0.389 . . . . 0.0 110.785 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.4 mt -94.7 106.26 18.23 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.55 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.436 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.0 t80 -101.98 -11.82 18.65 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.122 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.5 86.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.923 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.46 172.99 45.8 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.451 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.7 m-20 -73.9 -112.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.771 0.32 . . . . 0.0 110.701 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.05 -28.72 67.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.766 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.24 -43.59 92.4 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.159 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.48 -44.26 94.91 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.406 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.78 -59.77 4.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.158 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.29 -43.32 61.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.166 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.26 -43.42 74.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.163 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 93.2 mt -64.48 -43.63 96.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.651 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -56.43 -37.43 70.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.138 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.64 0.63 19.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.266 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -114.85 91.35 25.8 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.196 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.28 -27.22 29.78 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.773 2.315 . . . . 0.0 111.729 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.536 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.4 -41.2 98.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.585 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.25 5.12 52.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.291 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.79 -35.18 69.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.722 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -79.65 4.63 15.47 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.472 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.526 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.61 121.46 81.04 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.639 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -47.65 -37.48 27.3 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.349 2.032 . . . . 0.0 112.586 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -59.1 -43.71 91.89 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 63.0 t -65.87 -43.85 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.92 0.391 . . . . 0.0 110.287 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.68 -40.53 95.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.53 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.445 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 48.0 t-20 -89.84 -12.69 38.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.515 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 61.99 32.55 17.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.88 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.14 43.94 1.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.359 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.38 135.59 41.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.42 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.68 132.14 56.77 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.492 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.507 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.68 88.01 7.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.71 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.07 -40.64 96.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.96 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.436 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.33 167.99 34.93 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.51 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 75.7 p -75.93 -25.67 56.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 110.716 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.1 tp10 -67.45 -34.86 78.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.352 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.761 HG22 ' O ' ' A' ' 296' ' ' THR . 95.4 m -73.36 25.12 0.07 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.671 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.61 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 59.4 t80 -58.34 -51.15 71.03 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.431 HH12 ' HG3' ' A' ' 212' ' ' GLN . 68.6 mmt-85 -111.79 154.84 24.47 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.429 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.1 tp -115.92 125.2 52.27 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.484 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.6 t0 -147.79 165.67 29.85 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.585 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -48.99 -38.26 22.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.597 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -71.79 -65.17 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.458 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.6 p -60.84 -32.86 72.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.126 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.75 -25.19 26.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.585 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.8 mtt -63.54 -40.99 98.44 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 120.91 0.386 . . . . 0.0 111.01 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -79.03 -44.01 23.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.977 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.568 HG21 HG23 ' A' ' 296' ' ' THR . 77.5 t -65.94 -43.24 92.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.417 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.43 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 54.5 tp -60.66 -46.94 88.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.622 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -69.51 -39.62 77.47 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.466 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.507 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.0 ttt180 -61.94 -38.36 88.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.146 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.1 mt -86.82 4.09 42.54 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.834 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.629 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.3 tttt -112.71 -11.45 13.52 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.174 0.512 . . . . 0.0 110.29 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.04 85.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.624 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.02 -48.64 80.88 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.331 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.868 -1.063 . . . . 0.0 109.992 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.61 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.36 -2.63 57.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.383 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.476 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.09 179.03 1.26 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.452 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.9 Cg_exo -60.85 145.46 98.97 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.558 2.172 . . . . 0.0 112.171 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.61 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.29 -179.76 8.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.624 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.14 137.0 52.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.372 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -124.23 146.67 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.314 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -119.76 135.61 54.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.759 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.15 -143.98 0.32 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.143 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.21 -37.35 86.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.533 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.89 -66.99 0.23 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.532 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.47 142.56 45.14 Favored Glycine 0 C--O 1.224 -0.48 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.0 p -112.28 131.26 55.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.922 0.392 . . . . 0.0 110.26 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -118.7 128.86 54.9 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.545 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.1 m -85.44 130.43 34.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.198 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.487 HD22 ' OE1' ' A' ' 42' ' ' GLN . 71.1 mt -96.49 78.81 3.02 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.16 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.6 -32.06 73.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.501 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.75 108.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.024 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.487 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -122.11 90.79 48.98 Favored Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.245 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.636 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.0 Cg_exo -56.96 148.6 66.93 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.708 2.272 . . . . 0.0 111.652 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.13 82.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.574 0.546 . . . . 0.0 111.056 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.636 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.76 67.16 0.87 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.302 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.05 131.14 35.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.461 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.572 ' HA ' HG23 ' A' ' 64' ' ' VAL . 58.3 t -122.78 147.38 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.154 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.3 t -136.18 143.94 44.7 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.556 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 50' ' ' SER . 17.2 p -99.45 -59.39 1.73 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.492 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.42 ' N ' ' OG1' ' A' ' 49' ' ' THR . 86.6 p -79.4 155.06 28.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.93 0.395 . . . . 0.0 110.671 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.546 HG21 HG23 ' A' ' 70' ' ' THR . 68.9 t -73.47 -21.9 18.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.598 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.6 m -60.52 -51.74 68.13 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.384 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.9 mt -66.13 -42.62 88.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.496 0.665 . . . . 0.0 110.911 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.1 m -43.86 -54.16 5.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.996 -178.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.63 -37.11 77.01 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.0 m -63.2 -44.36 95.57 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.217 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.3 mt -65.73 -42.25 91.27 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.274 0.559 . . . . 0.0 110.544 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.93 -39.68 95.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.431 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.513 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.73 -36.2 78.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.078 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.511 HD11 HD12 ' A' ' 156' ' ' LEU . 33.5 pt -90.62 27.31 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.251 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 57.12 51.27 10.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.835 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -139.23 76.08 32.79 Favored Pre-proline 0 C--O 1.227 -0.081 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.66 149.42 90.93 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.634 2.223 . . . . 0.0 112.089 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -112.41 136.3 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.302 0.572 . . . . 0.0 110.161 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.431 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -68.97 -43.75 81.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.448 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.15 130.51 52.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.114 0.483 . . . . 0.0 110.613 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.6 p -155.28 168.83 25.78 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.305 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.6 -177.38 21.8 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.645 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.37 172.51 12.6 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.776 0.322 . . . . 0.0 110.601 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.546 HG23 HG21 ' A' ' 51' ' ' VAL . 12.9 p -133.81 -110.92 0.22 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.532 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.22 179.78 0.91 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.149 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.7 Cg_exo -60.91 58.88 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.892 2.395 . . . . 0.0 112.139 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.539 ' N ' ' O ' ' A' ' 71' ' ' THR . 57.7 t-20 -64.07 -34.44 78.03 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.693 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.5 m-20 94.34 -36.73 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 125.018 1.449 . . . . 0.0 109.778 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -63.06 -40.53 97.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.083 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -73.7 -26.56 21.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.933 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.68 -172.37 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.64 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.44 -152.91 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.809 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.3 p-10 -54.74 -6.54 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.684 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.486 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -87.37 114.11 23.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.956 0.408 . . . . 0.0 110.487 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.67 71.67 1.31 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -143.02 148.7 37.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.795 0.331 . . . . 0.0 110.968 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -86.5 -99.06 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.91 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.61 -43.55 96.55 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 119.027 -0.511 . . . . 0.0 110.141 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.529 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.8 tt0 91.77 52.37 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 124.487 1.117 . . . . 0.0 111.156 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -103.48 -8.58 20.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.449 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.5 p -65.29 -33.39 75.86 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.323 0.582 . . . . 0.0 110.819 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.529 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.1 mttt -48.86 -23.88 1.25 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.531 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.6 t -69.88 -45.78 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.299 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.49 -48.27 81.84 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.065 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.58 -38.5 90.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.303 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.84 -33.2 55.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.177 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.566 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.3 mmt-85 -88.88 1.86 54.68 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.619 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.43 -49.42 0.19 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.616 1.197 . . . . 0.0 110.347 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.598 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.8 mt -46.48 154.14 0.31 Allowed 'General case' 0 CA--C 1.485 -1.551 0 CA-C-O 117.082 -1.437 . . . . 0.0 108.67 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.598 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.1 91.89 0.0 OUTLIER 'General case' 0 C--N 1.363 1.16 0 O-C-N 125.944 2.028 . . . . 0.0 110.677 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.531 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.85 143.14 44.02 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.046 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.6 mt -132.15 26.47 4.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.492 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.03 137.6 34.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.942 0.401 . . . . 0.0 110.579 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.645 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.6 mt -136.82 164.63 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.383 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.606 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.88 -28.82 1.72 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -151.95 70.65 7.87 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.038 0.447 . . . . 0.0 110.26 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.14 145.41 98.54 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.686 2.257 . . . . 0.0 112.059 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.4 t -135.01 137.09 42.66 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.467 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.99 -38.1 82.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.701 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.44 -41.92 96.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.629 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.25 -41.38 98.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.386 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.75 -43.57 98.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.745 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.1 77.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.326 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.52 -18.85 60.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.489 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.63 -6.56 58.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.47 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.1 mtp 47.77 55.76 17.08 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.686 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.3 Cg_endo -70.0 149.56 65.51 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.927 2.418 . . . . 0.0 112.016 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.38 -72.81 0.67 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.42 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.418 HD11 HD13 ' A' ' 140' ' ' LEU . 38.2 tp -111.76 114.22 27.08 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.8 mt -103.16 126.87 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.344 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 mt -110.22 134.27 52.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.951 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.57 139.09 48.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.612 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.4 p -82.77 167.94 17.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.839 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.51 -37.27 80.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.38 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.91 158.6 43.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.457 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.45 177.12 33.6 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.15 -33.76 86.89 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.74 151.7 44.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.898 0.38 . . . . 0.0 110.58 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.4 t -63.48 141.14 58.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.284 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.51 10.44 11.13 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.654 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.513 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.7 mp -61.1 -39.48 90.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.994 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.63 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.44 -36.12 24.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.662 0.744 . . . . 0.0 110.681 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.8 mt -70.52 -35.61 73.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.83 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -43.04 -62.81 0.93 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.485 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.63 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.86 -42.63 90.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.932 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -62.09 -33.34 74.25 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.019 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.0 mt -72.57 -40.96 66.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.49 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.78 -48.27 81.83 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.131 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 65.7 m -53.61 -42.32 67.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.93 -43.12 92.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.889 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.42 153.39 5.25 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.591 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -39.05 107.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.519 2.146 . . . . 0.0 112.152 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.635 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.9 m -109.52 121.58 45.5 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.258 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 139' ' ' THR . 10.9 mp -113.85 152.58 30.51 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.182 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.34 131.03 69.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.287 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.28 128.02 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.441 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.0 t30 -100.7 104.75 16.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.221 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.419 ' O ' ' O ' ' A' ' 147' ' ' LYS . 45.7 p90 -100.77 -11.74 19.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.919 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.1 p-10 -64.79 -33.93 77.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.848 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -99.52 7.45 45.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.758 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.9 mttm -134.71 152.04 51.46 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.856 0.36 . . . . 0.0 110.637 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.424 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -75.75 166.31 23.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.658 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.594 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.5 t90 -59.32 -48.11 82.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.244 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -54.26 -43.88 71.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.897 0.38 . . . . 0.0 110.061 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.8 t -62.97 -41.06 99.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.126 0.489 . . . . 0.0 110.343 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.0 -43.92 98.17 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.008 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 53.3 tp -61.58 -42.97 99.63 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.14 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.5 m -55.29 -45.34 76.2 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.12 -40.71 96.83 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.181 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.511 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.31 -42.54 99.45 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.341 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.54 -40.73 94.3 Favored Glycine 0 C--N 1.315 -0.62 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.24 -46.16 65.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.982 0.42 . . . . 0.0 111.016 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.73 -43.98 96.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.942 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.8 p -92.89 -9.29 40.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.575 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.28 26.06 72.52 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -101.93 50.91 0.83 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.811 0.339 . . . . 0.0 110.809 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.51 -39.22 77.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.717 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.7 -46.87 87.76 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.414 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -60.03 -39.17 84.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.156 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.46 97.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.149 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.17 -29.15 70.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.149 0.499 . . . . 0.0 110.565 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -73.48 -54.44 8.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.149 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.513 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.6 ttp180 -64.86 -42.01 95.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.443 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 174' ' ' ASP . 81.0 mt -62.27 -43.84 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.527 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.34 -58.23 8.43 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.096 0.474 . . . . 0.0 110.738 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.08 -33.99 67.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.217 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -80.54 -36.3 33.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.123 0.487 . . . . 0.0 111.098 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.1 m-20 -55.34 -41.98 73.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.137 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.25 -41.98 98.92 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.785 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -64.88 -38.24 90.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.31 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.8 mt -62.49 -42.35 99.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.646 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.83 -53.23 58.74 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.729 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.3 -41.9 89.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.575 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.75 -40.0 95.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.616 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.3 -32.64 74.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.44 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.32 -21.89 18.71 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.843 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.636 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.2 tt0 -64.5 -41.68 96.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.757 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 184' ' ' ILE . 31.9 pt -76.07 134.82 28.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.22 106.91 9.56 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.4 pp -176.5 127.88 0.34 Allowed Pre-proline 0 N--CA 1.446 -0.637 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.527 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.2 Cg_exo -43.53 151.79 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.599 2.199 . . . . 0.0 112.594 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.41 142.21 53.69 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.655 2.237 . . . . 0.0 112.385 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.54 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -170.93 146.99 2.24 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.648 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.04 154.76 70.05 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.646 2.231 . . . . 0.0 112.153 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.577 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.59 162.93 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.416 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.577 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.45 169.93 16.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.919 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.88 137.37 22.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.154 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.535 HG22 HD12 ' A' ' 205' ' ' LEU . 39.5 pt -134.16 146.39 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.707 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.25 131.63 58.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.185 0.517 . . . . 0.0 110.49 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -151.65 154.62 36.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.32 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.608 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.7 m -121.75 122.64 39.97 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.014 0.435 . . . . 0.0 110.179 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.57 -25.73 66.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.463 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.608 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.11 -49.1 20.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.088 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.75 -9.05 58.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.38 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.0 m80 46.13 43.68 11.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.505 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.4 t -136.55 145.22 44.76 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.413 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.29 113.75 26.46 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.231 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.95 133.7 55.48 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.112 0.482 . . . . 0.0 110.304 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.535 HD12 HG22 ' A' ' 194' ' ' ILE . 7.6 tt -112.53 146.24 38.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.781 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.466 ' N ' HD23 ' A' ' 205' ' ' LEU . 13.6 t90 -99.3 128.19 45.39 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.38 153.36 40.47 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.174 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.51 -18.41 48.99 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.924 2.416 . . . . 0.0 111.829 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.07 -18.86 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.369 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.447 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.0 p -75.26 168.17 20.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.485 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.45 -35.77 76.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.419 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.496 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.3 mt-30 -56.62 -40.7 75.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.743 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.92 -43.3 98.2 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.4 mt-30 -63.98 -40.65 96.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.944 0.402 . . . . 0.0 110.373 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.594 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.1 mmm -61.74 -41.79 98.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.195 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 69.9 mt -63.33 -48.34 78.41 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.843 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -54.4 -32.07 56.39 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -70.63 -18.81 62.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.621 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.421 HD11 ' CD2' ' A' ' 299' ' ' LEU . 95.1 mt -87.96 -7.8 56.59 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.749 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.14 2.86 55.86 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -88.32 152.06 22.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.0 110.558 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.445 ' O ' HG12 ' A' ' 191' ' ' VAL . 6.6 p -114.73 127.81 55.95 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.099 0.476 . . . . 0.0 110.387 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.24 145.67 24.31 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.901 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.476 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.64 150.55 46.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.453 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.32 131.71 43.96 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.318 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.879 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.69 92.77 25.63 Favored Pre-proline 0 N--CA 1.464 0.275 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.049 -179.445 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.673 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.8 Cg_exo -55.58 139.4 82.67 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.534 2.156 . . . . 0.0 111.392 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.71 -25.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.588 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.11 -49.04 29.06 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.6 mt -55.16 -37.01 66.45 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -66.38 35.89 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.837 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.556 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.56 87.71 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.794 0.33 . . . . 0.0 110.778 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.4 p -81.53 -14.9 56.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.449 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -90.94 -41.33 11.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.612 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.81 -16.79 64.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.696 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 56.01 43.4 27.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.439 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.37 -147.7 7.4 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.58 142.94 50.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.969 0.414 . . . . 0.0 110.233 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.3 149.61 28.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.312 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -100.65 -152.0 0.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.255 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 56.31 -91.74 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.722 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.469 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.91 175.14 9.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.648 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.469 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.6 mt -121.44 140.79 44.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.816 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.16 168.59 9.96 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.303 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.0 mt -147.22 150.97 35.91 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.464 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.7 -39.0 97.05 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.11 4.3 4.61 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.51 -57.95 3.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.933 0.397 . . . . 0.0 110.594 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.551 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.8 m-20 -62.39 -37.18 84.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.109 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.0 -67.36 0.26 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.918 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -54.06 -41.77 68.52 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.06 18.12 0.15 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.684 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.98 47.72 0.26 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 39.07 -109.82 0.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.696 0.284 . . . . 0.0 110.664 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.9 m120 -61.21 -44.26 97.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.372 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 83.98 8.18 84.43 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -99.29 -12.58 20.22 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.739 -0.271 . . . . 0.0 110.671 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.8 t 176.48 142.31 0.07 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.097 0.475 . . . . 0.0 110.488 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.412 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.3 tt -147.79 126.16 12.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.201 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -99.25 142.95 30.08 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.035 0.445 . . . . 0.0 110.621 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.63 106.54 18.52 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.433 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.474 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 93.2 t80 -102.23 -12.55 17.92 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.007 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.4 90.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.813 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.29 173.8 46.18 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.452 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -74.59 -112.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.691 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.57 -28.45 67.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.753 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -59.81 -43.86 94.28 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.913 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -63.72 -44.1 94.6 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.318 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.69 -59.38 4.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.181 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.81 -43.1 62.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.054 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.51 -43.94 76.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.129 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.9 mt -64.05 -43.55 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.962 0.411 . . . . 0.0 110.707 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -57.1 -37.67 72.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.067 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.14 0.8 20.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.278 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -114.73 91.14 24.47 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.248 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.83 -27.35 27.02 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.824 2.35 . . . . 0.0 111.619 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -41.26 98.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.637 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.8 mp -95.18 4.8 53.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.314 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.49 -35.61 70.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.711 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.37 4.56 14.98 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.436 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.71 121.54 81.52 Favored Pre-proline 0 N--CA 1.438 -1.033 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.581 -179.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.56 -37.71 27.03 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.242 1.961 . . . . 0.0 112.542 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.91 -43.8 91.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.59 -43.77 93.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.351 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.67 -40.65 95.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.534 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.0 t-20 -89.59 -12.4 39.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.647 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 61.92 31.97 18.0 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.78 44.38 1.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.329 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.77 135.47 43.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.455 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -116.2 132.58 56.62 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.468 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.495 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.9 87.92 6.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.775 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.423 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.1 mt -63.68 -41.74 98.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.817 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.474 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.47 166.45 34.66 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.1 p -75.59 -26.07 57.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.879 0.371 . . . . 0.0 110.823 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.2 tp10 -68.04 -34.25 76.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.444 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.757 HG22 ' O ' ' A' ' 296' ' ' THR . 98.0 m -72.47 20.59 0.07 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.688 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.501 ' H ' ' C ' ' A' ' 295' ' ' GLU . 49.0 t80 -57.54 -51.12 70.77 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.951 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.1 mmt-85 -107.43 149.26 28.11 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.421 ' CD2' HD11 ' A' ' 219' ' ' LEU . 41.0 tp -115.91 126.23 53.63 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 123.411 0.444 . . . . 0.0 110.888 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.473 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.0 t0 -149.55 166.91 27.81 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.554 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.57 -37.99 29.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.435 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -71.71 -64.99 0.82 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.604 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.8 p -60.96 -32.66 72.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.973 0.416 . . . . 0.0 111.183 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.93 -25.37 28.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.6 mtt -63.61 -41.21 98.33 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 120.984 0.421 . . . . 0.0 110.999 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -77.92 -44.42 27.03 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.052 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.576 HG21 HG23 ' A' ' 296' ' ' THR . 78.8 t -65.85 -43.1 93.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.409 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.429 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.7 tp -60.36 -46.63 89.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.317 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -70.51 -39.22 74.22 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.559 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.495 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 73.4 ttt180 -61.42 -38.26 86.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.219 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.35 4.27 43.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.833 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.636 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.0 tttt -111.65 -11.84 13.96 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.136 0.493 . . . . 0.0 110.323 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.24 -37.25 84.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.68 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -61.15 -48.34 82.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.358 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.023 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.23 -2.71 58.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.395 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.481 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.67 178.91 1.29 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.468 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.9 Cg_exo -60.84 144.84 99.63 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.749 2.299 . . . . 0.0 112.204 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.4 ptt-85 -155.76 -179.48 8.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.57 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.74 136.5 53.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.34 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.35 147.32 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.452 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.2 p -120.5 136.01 54.9 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.7 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.1 p30 -98.97 -143.7 0.32 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.254 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.62 -37.27 86.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.509 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.53 -67.43 0.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.527 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.0 142.66 43.98 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.1 p -112.42 131.17 55.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.924 0.392 . . . . 0.0 110.397 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -118.99 129.31 55.08 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.547 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 m -86.16 131.24 34.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.982 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.48 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.3 mt -96.51 78.96 3.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.421 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.83 -32.67 74.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.491 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 t 176.78 110.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.103 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.48 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -123.79 91.11 50.04 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.228 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.3 Cg_exo -56.91 149.11 63.25 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.697 2.265 . . . . 0.0 111.765 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.22 81.99 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.602 0.564 . . . . 0.0 110.986 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.39 66.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.092 0.473 . . . . 0.0 110.236 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.2 mt -77.36 131.17 35.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.573 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.558 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.0 t -122.6 148.07 26.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.17 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 t -136.62 143.62 43.63 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.607 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.9 p -99.3 -59.31 1.75 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.557 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.3 p -79.52 156.37 27.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.63 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.558 HG21 HG23 ' A' ' 70' ' ' THR . 73.5 t -74.88 -21.51 16.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.636 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.7 m -60.2 -51.88 67.68 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.455 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.7 mt -66.46 -42.3 87.79 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.36 0.6 . . . . 0.0 110.906 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.22 -54.41 4.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.145 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.0 -38.78 74.45 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 m -62.38 -43.6 98.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.884 0.373 . . . . 0.0 110.357 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.1 mt -65.28 -42.65 92.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.403 0.621 . . . . 0.0 110.719 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 tp -63.07 -38.65 92.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.221 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.447 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -61.64 -36.52 81.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.948 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -91.58 27.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.027 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.419 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 98.6 m-20 57.22 52.45 8.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.253 0.345 . . . . 0.0 110.789 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.72 75.39 31.31 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.049 0.452 . . . . 0.0 109.989 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.96 148.49 93.42 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.735 2.29 . . . . 0.0 112.177 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -112.75 135.97 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.195 0.521 . . . . 0.0 110.275 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.85 -43.3 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.192 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.68 130.85 53.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 110.55 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.9 p -155.14 168.42 27.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.461 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.37 -177.71 21.94 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.653 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.46 172.46 12.68 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.878 0.371 . . . . 0.0 110.541 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.558 HG23 HG21 ' A' ' 51' ' ' VAL . 14.1 p -132.9 -112.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.269 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.31 179.91 0.9 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.274 -178.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.7 Cg_exo -61.16 57.87 0.1 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.015 2.476 . . . . 0.0 112.126 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.8 t-20 -64.36 -33.41 75.79 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.878 -0.582 . . . . 0.0 110.571 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 43.9 m-20 93.71 -35.5 0.02 OUTLIER 'General case' 0 C--N 1.345 0.383 0 O-C-N 124.322 1.014 . . . . 0.0 109.948 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.5 mtp85 -63.27 -39.97 96.09 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.283 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -74.31 -25.43 19.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.7 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.16 -170.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.65 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.66 -155.24 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.828 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.8 p-10 -51.57 -7.95 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.641 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.497 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -85.42 115.23 23.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.564 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.23 70.71 1.33 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -144.64 148.55 34.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 110.69 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.8 mp -86.29 -98.63 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.266 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.8 -42.97 97.59 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.179 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.555 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.7 tt0 91.88 52.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 124.136 0.898 . . . . 0.0 110.784 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -102.41 -8.92 20.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.446 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.9 p -64.78 -34.25 77.89 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.131 0.491 . . . . 0.0 110.648 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.555 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.57 -24.62 1.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.6 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 81.9 t -69.29 -45.55 78.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.925 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.31 81.76 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.155 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.33 -38.22 88.63 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.276 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.51 -33.87 56.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.292 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.591 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.2 mmt-85 -88.76 0.99 55.97 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.67 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 57.2 mttp 83.02 -47.61 0.14 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 124.25 0.968 . . . . 0.0 110.316 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.5 mt -47.2 153.18 0.5 Allowed 'General case' 0 CA--C 1.49 -1.359 0 CA-C-O 117.604 -1.189 . . . . 0.0 109.124 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.644 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 122.31 91.72 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 O-C-N 125.54 1.775 . . . . 0.0 110.469 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -74.81 142.59 44.21 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.963 0.411 . . . . 0.0 110.299 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 mt -131.65 26.41 4.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.741 0.305 . . . . 0.0 110.464 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.06 137.29 34.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.946 0.403 . . . . 0.0 110.479 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.653 HD12 ' O ' ' A' ' 69' ' ' ALA . 90.7 mt -137.17 164.94 28.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.354 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.613 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.21 -28.73 1.82 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.03 70.6 7.79 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.25 0.548 . . . . 0.0 110.348 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.97 145.25 98.8 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.808 2.339 . . . . 0.0 112.041 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.8 t -134.85 137.11 42.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.541 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.89 -38.44 83.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.665 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.28 -42.21 96.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.501 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.6 98.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.526 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.54 -43.36 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.037 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.07 -35.17 77.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.376 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.31 -18.74 60.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.495 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.6 -6.46 58.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.561 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.5 mtp 47.87 55.74 17.11 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.627 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.14 149.35 64.34 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.791 2.327 . . . . 0.0 112.121 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.41 -72.76 0.67 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.481 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.6 tp -111.33 113.15 25.41 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.367 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.8 mt -102.19 126.56 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.451 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.6 mt -110.57 134.0 52.79 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.173 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.55 140.22 45.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.446 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 94.8 p -83.61 167.2 17.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.665 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.58 -36.66 79.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.472 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 t -138.24 157.71 45.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.471 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.36 174.63 34.16 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.29 -33.98 87.77 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -123.57 150.98 43.41 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.92 0.391 . . . . 0.0 110.562 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.6 t -63.57 140.16 58.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.291 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.94 11.44 11.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.631 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.1 -39.25 89.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.098 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.627 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.82 -35.53 24.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.564 0.697 . . . . 0.0 110.705 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -71.11 -35.04 71.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.408 0.623 . . . . 0.0 110.787 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -43.07 -63.19 0.85 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.171 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.627 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.1 p-10 -65.89 -42.81 89.79 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.535 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -61.78 -32.6 72.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.114 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 129' ' ' LEU . 67.6 mt -73.83 -40.3 63.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.187 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.29 -49.31 77.59 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.195 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.5 m -52.62 -42.66 64.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.313 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.08 -42.97 92.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.993 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.31 152.61 5.03 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.623 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -38.58 107.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.677 2.252 . . . . 0.0 112.317 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.646 ' C ' HD12 ' A' ' 140' ' ' LEU . 94.2 m -109.35 120.95 44.08 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.293 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.646 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.54 153.64 29.69 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.225 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.456 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -130.49 128.93 64.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.376 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.1 mt -110.42 122.84 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.574 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.538 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 53.8 t30 -101.11 106.35 17.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.349 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -100.17 0.45 40.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.897 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -65.52 -34.93 79.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.585 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.0 p-10 -101.29 9.5 41.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -133.85 148.08 51.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.537 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.409 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 22.5 p -77.69 169.05 18.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.579 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.598 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.6 t90 -58.71 -49.74 76.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.087 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -54.41 -46.15 73.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.011 0.434 . . . . 0.0 110.144 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.9 t -63.24 -40.79 98.43 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.345 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.452 ' O ' HD23 ' A' ' 156' ' ' LEU . 51.4 tp -60.83 -44.37 97.03 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.367 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.2 -43.49 98.79 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.202 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -54.21 -45.8 72.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.772 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.8 -39.92 93.41 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.854 0.359 . . . . 0.0 110.268 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 152' ' ' LEU . 2.2 mm? -61.9 -42.25 98.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.059 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.8 -38.87 94.81 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.21 -45.75 65.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.963 0.411 . . . . 0.0 110.798 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.72 -44.15 96.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.715 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -92.86 -9.28 40.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.53 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.0 26.51 72.35 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -102.31 50.11 0.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.831 0.348 . . . . 0.0 110.704 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.21 -39.14 78.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.691 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.67 -47.4 85.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.256 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.419 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 86.6 mt-30 -59.99 -39.66 86.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.335 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.59 -40.89 98.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.328 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.15 -29.47 70.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.995 0.426 . . . . 0.0 110.542 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.09 -54.13 8.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.121 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.447 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.8 ttp180 -64.44 -42.79 95.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.474 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.9 mt -62.62 -43.72 98.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.499 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.71 -60.8 3.12 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.255 0.55 . . . . 0.0 110.402 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.23 -34.31 63.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.271 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -80.29 -34.96 36.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.937 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.2 m-20 -55.02 -41.53 71.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.185 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.18 -41.71 98.59 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.575 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.04 -37.74 88.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.269 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.23 -42.6 99.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.796 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.69 -53.04 61.46 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.19 0.519 . . . . 0.0 110.668 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.37 -41.45 89.44 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.544 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.28 -39.9 94.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.644 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.52 -33.23 74.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.365 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -93.21 -21.55 19.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.714 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.626 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -65.21 -41.44 94.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.667 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 184' ' ' ILE . 30.7 pt -77.48 133.94 29.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.05 0.452 . . . . 0.0 110.696 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -128.09 107.03 9.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.302 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.59 127.76 0.33 Allowed Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.556 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.445 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.3 Cg_exo -43.72 151.7 0.39 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.702 2.268 . . . . 0.0 112.598 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.63 142.51 53.49 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.629 2.219 . . . . 0.0 112.416 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.542 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.61 146.89 2.39 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.659 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.27 154.62 69.4 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.753 2.302 . . . . 0.0 112.29 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.584 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.98 163.4 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.42 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 191' ' ' VAL . 1.9 t -143.4 169.97 16.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.896 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.18 137.4 22.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.964 0.412 . . . . 0.0 110.159 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.523 HG22 HD12 ' A' ' 205' ' ' LEU . 38.0 pt -133.98 145.53 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.639 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -131.97 131.5 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.143 0.497 . . . . 0.0 110.548 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -152.62 156.04 38.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.418 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 199' ' ' ALA . 88.4 m -121.57 122.51 39.83 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.947 0.404 . . . . 0.0 110.331 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.496 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.41 -26.26 66.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.599 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.1 -48.74 22.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.014 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.83 -10.09 59.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.414 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.496 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.6 m80 45.88 46.65 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.563 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.0 t -132.16 143.09 49.73 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.402 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.404 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -108.08 107.26 17.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.296 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -116.96 130.1 56.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.099 0.476 . . . . 0.0 110.352 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.523 HD12 HG22 ' A' ' 194' ' ' ILE . 7.5 tt -112.03 145.77 39.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.603 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.487 ' N ' HD23 ' A' ' 205' ' ' LEU . 9.1 t90 -98.44 127.53 44.41 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.09 0.472 . . . . 0.0 110.043 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.08 153.18 43.26 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.156 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.04 -17.59 45.94 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.822 2.348 . . . . 0.0 111.923 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.19 -19.13 0.7 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.429 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.442 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.4 p -74.52 163.71 27.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.497 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.38 -27.73 64.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.458 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.492 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.5 mt-30 -63.37 -42.74 98.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.628 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.69 -43.58 98.9 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.409 ' OE1' ' C ' ' A' ' 148' ' ' SER . 74.7 mt-30 -63.75 -38.85 92.64 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.865 0.364 . . . . 0.0 110.46 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 85.9 mmm -62.27 -41.52 98.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.251 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.1 -49.25 72.96 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.628 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -52.36 -33.36 42.68 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -71.06 -20.43 62.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.491 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 75.0 mt -87.56 -6.45 58.32 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.63 -6.73 57.45 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -77.74 148.25 34.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.754 0.311 . . . . 0.0 110.622 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.47 ' O ' HG12 ' A' ' 191' ' ' VAL . 3.7 p -113.02 126.78 55.87 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.093 0.473 . . . . 0.0 110.331 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -91.94 145.86 24.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.925 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.472 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.88 150.26 46.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.462 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.17 131.4 44.02 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.396 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.883 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.53 93.48 27.75 Favored Pre-proline 0 C--O 1.235 0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.998 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.683 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.7 Cg_exo -55.25 138.37 79.27 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.652 2.234 . . . . 0.0 111.54 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.44 -24.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.537 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.62 -50.13 21.36 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 232' ' ' ALA . 98.5 mt -54.55 -35.98 63.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.769 0.318 . . . . 0.0 110.278 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.94 36.2 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.744 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.99 87.68 0.01 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.757 0.313 . . . . 0.0 110.873 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.3 p -81.61 -13.47 57.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.423 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -91.67 -39.48 11.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.544 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.7 t -66.63 -16.84 64.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.613 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.03 43.86 26.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.437 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 178.79 -146.45 7.3 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.22 142.21 50.13 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.925 0.393 . . . . 0.0 110.303 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.419 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.4 ttt-85 -152.18 149.58 28.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.384 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -102.41 -149.36 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.31 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 54.94 -93.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.648 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.436 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 13.0 tt -126.65 173.75 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.581 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 230' ' ' LEU . 95.1 mt -121.75 140.6 45.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.767 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.77 172.29 7.35 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.336 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 67.2 mt -146.82 149.08 32.61 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.09 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -62.89 -39.49 98.09 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.94 2.07 3.93 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -78.62 -57.54 3.71 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.93 0.395 . . . . 0.0 110.694 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.594 ' ND2' HD23 ' A' ' 226' ' ' LEU . 94.4 m-20 -62.36 -36.74 83.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.236 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.404 HD21 ' HB1' ' A' ' 203' ' ' ALA . 6.1 mp -53.84 -67.07 0.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.936 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.79 -42.24 68.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.215 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.01 18.09 0.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.652 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.07 46.91 0.24 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 254' ' ' LEU . 7.6 mp 39.83 -110.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.637 0.256 . . . . 0.0 110.608 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.472 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 10.8 m120 -60.77 -44.52 96.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.427 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.46 8.03 83.83 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -98.7 -12.54 20.91 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.778 -0.248 . . . . 0.0 110.636 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.1 t 175.75 143.06 0.06 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 110.487 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.99 125.9 11.99 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.051 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.93 143.44 29.22 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 120.882 0.372 . . . . 0.0 110.867 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.7 mt -94.62 106.3 18.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.584 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.453 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.1 t80 -101.86 -13.15 17.78 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.223 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.03 -40.39 91.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.821 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.64 173.15 45.86 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.457 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.9 m-20 -74.19 -112.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 0.0 110.74 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.76 -28.78 67.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.701 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.84 -44.13 90.89 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.314 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.56 -44.36 94.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.405 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.42 -59.81 3.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.223 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.35 -43.23 61.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.187 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.86 74.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.159 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.2 mt -64.35 -43.57 97.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.64 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.72 -37.58 71.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.246 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.06 0.88 19.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.27 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -114.99 91.13 25.51 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.179 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.01 -27.28 28.08 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.785 2.323 . . . . 0.0 111.81 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.533 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -41.24 98.9 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.559 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.9 mp -95.34 5.01 52.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.306 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.03 -35.28 69.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.679 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.21 4.62 14.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.516 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.82 121.17 80.38 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.618 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -47.53 -37.45 26.34 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.432 2.088 . . . . 0.0 112.46 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.89 -43.58 90.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.826 0.346 . . . . 0.0 110.235 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.89 -43.76 92.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.291 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.86 -40.53 95.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.494 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 48.0 t-20 -89.64 -12.87 38.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.607 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.39 32.43 16.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.801 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.98 44.03 1.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.409 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.03 135.56 42.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.429 -179.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.97 131.81 56.86 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.459 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.495 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.71 88.73 6.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.708 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.433 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.2 mt -63.95 -41.44 97.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.851 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.453 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.62 165.86 33.86 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.521 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 77.7 p -75.73 -25.62 56.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.831 0.348 . . . . 0.0 110.731 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.4 tp10 -68.29 -33.99 75.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.457 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 97.3 m -73.04 21.53 0.07 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.597 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.504 ' H ' ' C ' ' A' ' 295' ' ' GLU . 50.4 t80 -57.66 -50.86 71.78 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.994 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.402 HH12 ' HG3' ' A' ' 212' ' ' GLN . 71.3 mmt-85 -108.97 150.89 27.06 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.5 tp -115.48 125.03 52.57 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.765 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.488 ' CB ' HD23 ' A' ' 83' ' ' LEU . 40.7 t0 -148.04 165.85 29.54 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.569 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -49.36 -38.19 27.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.524 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -70.72 -65.63 0.71 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.212 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -61.04 -32.96 72.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.021 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -53.6 -25.7 18.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.495 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.6 mtt -63.7 -40.73 97.51 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 120.835 0.35 . . . . 0.0 110.979 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -78.01 -44.66 25.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.941 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.579 HG21 HG23 ' A' ' 296' ' ' THR . 79.2 t -66.2 -42.83 91.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.407 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.439 HD11 ' OE1' ' A' ' 183' ' ' GLN . 47.8 tp -59.57 -47.56 85.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.468 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -69.92 -39.32 76.22 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.606 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.495 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.1 ttt180 -61.77 -37.9 86.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.181 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.6 mt -87.76 4.82 42.85 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.626 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.58 -11.74 13.54 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.018 0.437 . . . . 0.0 110.288 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.95 -36.96 85.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.614 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -61.01 -49.11 78.73 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.434 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.099 179.875 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.614 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -90.37 -2.62 57.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.394 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.476 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.51 178.87 1.3 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.485 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.5 Cg_exo -60.79 145.11 99.47 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.556 2.17 . . . . 0.0 112.191 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.614 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.5 ptt-85 -155.99 -179.77 8.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.609 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -115.6 136.35 53.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.292 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -124.07 146.28 29.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.369 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.9 p -119.84 135.6 54.8 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.714 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.6 p30 -98.43 -144.41 0.31 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.296 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.36 -36.54 84.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.473 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.489 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -147.53 -70.4 0.23 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.593 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.77 144.09 41.68 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.0 p -112.58 130.05 56.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.783 0.325 . . . . 0.0 110.369 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -114.71 129.26 56.66 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.599 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -86.61 130.63 34.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.308 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.493 HD22 ' OE1' ' A' ' 42' ' ' GLN . 70.8 mt -97.84 78.71 2.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.2 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.03 -32.53 74.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.511 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.4 t 178.05 109.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.076 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.493 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -123.87 90.76 50.37 Favored Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.218 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.1 Cg_exo -56.66 149.3 59.68 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.709 2.272 . . . . 0.0 111.646 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.3 82.51 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.491 0.494 . . . . 0.0 110.997 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.57 66.84 0.88 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.303 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.2 mt -77.38 131.2 35.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.433 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.571 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.8 t -122.46 147.64 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.231 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.5 t -136.51 144.03 44.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.576 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 50' ' ' SER . 18.9 p -100.37 -58.9 1.81 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.46 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 49' ' ' THR . 87.5 p -79.43 155.49 28.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.901 0.381 . . . . 0.0 110.642 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.548 HG21 HG23 ' A' ' 70' ' ' THR . 72.6 t -74.2 -21.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.696 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.2 m -60.27 -51.7 68.41 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.456 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.4 mt -66.32 -42.62 87.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.532 0.682 . . . . 0.0 110.859 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.3 m -43.29 -54.58 4.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.198 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.91 -38.73 75.36 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.1 m -62.52 -43.73 98.09 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.172 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 48.2 mt -65.31 -42.57 92.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.052 0.453 . . . . 0.0 110.665 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.7 tp -62.95 -38.67 91.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.254 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.455 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -61.69 -36.45 80.92 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.068 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.4 pt -91.34 27.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.081 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 56.99 52.15 9.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.744 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.04 75.34 35.18 Favored Pre-proline 0 C--N 1.334 -0.081 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.34 148.66 92.67 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.596 2.197 . . . . 0.0 112.041 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.571 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.21 135.76 50.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 121.22 0.533 . . . . 0.0 110.229 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.441 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.4 pt -69.73 -43.38 80.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.219 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.8 130.41 52.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.013 0.435 . . . . 0.0 110.599 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.9 p -155.09 168.8 25.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.354 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.48 -177.73 21.86 Favored Glycine 0 N--CA 1.465 0.572 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.665 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -132.36 171.46 13.7 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.7 0.286 . . . . 0.0 110.575 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.548 HG23 HG21 ' A' ' 51' ' ' VAL . 13.0 p -133.82 -110.71 0.22 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.498 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.35 179.78 0.91 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.244 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.1 Cg_exo -60.94 58.51 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.912 2.408 . . . . 0.0 112.089 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.544 ' N ' ' O ' ' A' ' 71' ' ' THR . 56.7 t-20 -64.0 -35.23 80.02 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.699 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 48.0 m-20 95.31 -37.15 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.979 1.425 . . . . 0.0 109.986 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -62.69 -40.51 97.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.264 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -72.97 -26.53 23.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.815 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.86 -171.9 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.717 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -74.33 -153.13 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.805 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.6 p-10 -54.03 -6.86 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.608 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.77 114.06 23.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.962 0.41 . . . . 0.0 110.484 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.48 72.21 1.3 Allowed Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.449 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.4 m-85 -143.87 148.44 35.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 110.806 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.68 -99.24 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.065 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.67 -43.46 96.62 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.377 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.542 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 36.0 tt0 92.08 52.62 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.314 1.009 . . . . 0.0 111.016 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -103.01 -9.16 20.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.507 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.449 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.52 -34.06 77.36 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.136 0.493 . . . . 0.0 110.686 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.542 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.3 -24.67 1.27 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.491 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.94 -45.36 77.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.14 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.3 -48.69 80.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.224 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.49 -38.42 89.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.28 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.55 -32.95 52.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.292 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.583 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.51 1.19 56.25 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 118.868 -0.586 . . . . 0.0 110.681 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 83.16 -48.37 0.14 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.535 1.147 . . . . 0.0 110.348 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.629 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.1 mt -46.81 152.73 0.47 Allowed 'General case' 0 CA--C 1.49 -1.351 0 CA-C-O 117.632 -1.175 . . . . 0.0 108.951 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.629 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.0 tt0 122.25 91.32 0.0 OUTLIER 'General case' 0 C--N 1.358 0.967 0 O-C-N 125.515 1.76 . . . . 0.0 110.66 -178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.52 143.04 44.72 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.201 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.9 mt -132.08 26.25 4.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.427 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -139.69 136.52 34.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.577 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.665 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.5 mt -136.62 164.72 30.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.45 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.605 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.76 -28.88 1.73 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -151.46 70.72 8.25 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.053 0.454 . . . . 0.0 110.354 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.99 145.3 98.69 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.612 2.208 . . . . 0.0 112.016 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.9 t -135.69 137.65 41.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.537 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.08 -38.12 82.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.68 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.27 -42.26 96.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.576 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.07 -41.56 98.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.429 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.57 -43.47 98.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.935 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.09 -35.11 77.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.439 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.34 -19.0 61.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.554 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.54 -6.58 58.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.478 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.4 mtp 47.68 55.81 17.07 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.663 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.8 Cg_endo -70.05 149.4 64.98 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.919 2.412 . . . . 0.0 112.034 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.27 -71.68 0.7 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.43 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.408 HD11 HD13 ' A' ' 140' ' ' LEU . 38.0 tp -112.89 113.62 25.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.221 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.7 mt -102.17 126.85 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.289 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 mt -110.82 133.75 53.1 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.042 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.61 140.18 45.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.6 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.6 p -83.28 167.44 17.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.783 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.94 79.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.475 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.6 t -138.44 158.02 45.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.471 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.5 175.34 34.16 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.24 -33.91 87.5 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -124.09 150.95 44.43 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.593 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.5 t -63.71 140.68 58.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.306 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.56 11.63 10.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.674 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.7 mp -60.87 -39.58 89.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.165 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.633 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.6 -35.63 24.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.587 0.708 . . . . 0.0 110.596 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.4 mt -70.92 -35.12 72.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.867 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -43.28 -62.82 0.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.298 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.633 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.2 p-10 -65.91 -42.95 89.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.801 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -61.8 -32.85 73.18 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.06 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 129' ' ' LEU . 67.6 mt -73.4 -40.52 64.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.459 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.55 -48.45 80.85 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.278 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.1 m -53.24 -42.11 66.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.33 -42.81 91.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.612 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.11 152.27 5.06 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.673 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -39.11 106.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.572 2.182 . . . . 0.0 111.986 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.647 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.2 m -108.89 122.06 46.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.323 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.647 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.94 154.47 28.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.282 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.6 tt -130.23 129.22 65.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.474 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 93.1 mt -110.66 122.93 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.503 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.537 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 52.7 t30 -101.45 105.14 16.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.363 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.404 ' HB3' HD13 ' A' ' 152' ' ' LEU . 41.8 p90 -98.0 -0.19 45.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.004 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.2 p-10 -65.23 -35.04 79.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.028 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.594 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.1 p-10 -101.76 8.51 41.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -133.13 146.82 51.95 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.889 0.376 . . . . 0.0 110.565 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.427 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 21.1 p -78.61 170.41 16.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.545 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.597 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 88.1 t90 -58.31 -49.54 76.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.247 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -54.75 -47.39 73.91 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.22 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.8 t -63.33 -40.81 98.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.121 0.486 . . . . 0.0 110.264 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.459 ' O ' HD23 ' A' ' 156' ' ' LEU . 59.1 tp -61.01 -44.11 97.9 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.224 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.502 HD23 HD11 ' A' ' 170' ' ' ILE . 53.6 tp -61.1 -42.85 99.27 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.314 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.6 m -55.35 -46.39 76.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.666 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.44 -40.1 93.24 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.253 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 152' ' ' LEU . 2.1 mm? -61.84 -42.18 98.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.962 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.42 -38.92 95.42 Favored Glycine 0 C--N 1.317 -0.523 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.56 -45.02 66.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.402 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.64 -43.99 96.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.76 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -94.01 -8.48 39.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.563 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.83 25.83 71.97 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -102.81 51.17 0.81 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.787 0.327 . . . . 0.0 110.818 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.23 -38.73 78.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.117 0.484 . . . . 0.0 110.744 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.87 -46.99 87.55 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.392 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -61.37 -39.17 89.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.296 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.1 -40.57 98.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.309 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.73 -28.06 69.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.23 0.538 . . . . 0.0 110.458 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -75.2 -52.76 10.15 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.174 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.489 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -63.72 -42.92 97.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.45 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 174' ' ' ASP . 86.7 mt -62.83 -43.83 99.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.594 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.47 -61.09 2.78 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.15 0.5 . . . . 0.0 110.56 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.63 -35.4 63.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.228 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -79.59 -35.14 40.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.106 0.479 . . . . 0.0 111.265 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.4 m-20 -55.33 -40.67 71.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.297 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.45 -41.87 99.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.631 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.36 -38.08 88.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.31 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 177' ' ' LEU . 77.3 mt -62.27 -42.58 99.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.711 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.83 -53.25 58.44 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.053 0.454 . . . . 0.0 110.729 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.41 -41.39 89.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.587 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.72 94.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.624 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.08 -32.71 74.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.332 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -94.05 -21.88 18.87 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.764 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.63 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.1 tt0 -64.79 -41.88 95.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.72 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 184' ' ' ILE . 31.5 pt -76.33 134.43 28.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.684 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.58 106.52 9.22 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.184 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.5 127.92 0.34 Allowed Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.586 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.445 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.9 Cg_exo -43.57 151.69 0.36 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.615 2.21 . . . . 0.0 112.508 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.68 142.33 52.68 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.806 2.337 . . . . 0.0 112.299 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.39 146.68 2.46 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.664 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.02 154.01 71.38 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.716 2.277 . . . . 0.0 112.122 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.41 162.86 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.434 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.5 169.64 17.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.805 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.74 137.38 22.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.276 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.524 HG22 HD12 ' A' ' 205' ' ' LEU . 39.5 pt -134.24 146.25 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.652 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.47 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.88 131.52 59.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.081 0.467 . . . . 0.0 110.504 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -151.63 154.69 36.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.391 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.2 m -121.97 122.85 40.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.973 0.416 . . . . 0.0 110.268 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.42 -25.76 66.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.424 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.614 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.31 -49.15 20.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.105 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.23 -10.79 60.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.5 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.1 m80 47.93 42.95 17.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.495 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.1 t -136.47 145.35 45.07 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.386 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.412 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -111.22 113.92 26.76 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.296 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.89 133.62 55.52 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.359 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.524 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.41 146.18 38.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.721 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.48 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.4 t90 -99.69 127.93 45.8 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.021 0.438 . . . . 0.0 109.952 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.12 153.69 41.69 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.947 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.401 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.2 Cg_endo -67.58 -18.33 48.6 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.895 2.397 . . . . 0.0 111.931 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.6 -18.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.504 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.442 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.0 p -75.61 167.51 21.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.485 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.46 -35.13 75.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.447 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.2 mt-30 -56.42 -41.33 76.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.676 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.35 -42.89 97.63 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.483 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.7 mt-30 -63.59 -40.45 96.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.881 0.372 . . . . 0.0 110.302 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.597 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.2 mmm -61.87 -41.58 98.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.182 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.59 -49.95 71.34 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.661 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -52.92 -32.36 45.04 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -71.94 -19.89 61.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.54 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 64.4 mt -87.46 -6.45 58.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.57 3.94 57.24 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -89.28 151.39 22.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.711 0.291 . . . . 0.0 110.553 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.45 ' O ' HG12 ' A' ' 191' ' ' VAL . 2.6 p -114.44 127.63 55.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.994 0.426 . . . . 0.0 110.402 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.97 144.71 25.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.905 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.492 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.23 150.71 47.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.416 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.79 131.36 44.62 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.298 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.882 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.82 92.49 25.34 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.123 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.675 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.8 Cg_exo -55.24 138.9 80.52 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.603 2.202 . . . . 0.0 111.47 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.65 -25.03 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.662 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.92 -49.68 27.3 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.558 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -54.66 -36.76 64.94 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.59 35.82 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.845 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.02 87.47 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.837 0.351 . . . . 0.0 110.684 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.3 p -81.25 -14.23 57.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.486 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.45 -40.85 11.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.565 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.9 t -66.76 -16.52 64.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.639 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.1 43.64 26.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.518 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.31 -145.55 6.68 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -123.27 143.05 50.31 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 110.349 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.1 ttt-85 -151.49 148.82 28.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.36 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -100.24 -152.62 0.43 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.274 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 56.46 -92.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.593 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.464 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.56 175.09 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.635 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.464 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -120.72 140.29 45.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.769 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.01 169.03 9.71 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.406 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.8 mt -147.59 150.61 34.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.317 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.85 -38.82 96.68 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.39 3.81 4.62 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -77.24 -58.02 3.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.877 0.37 . . . . 0.0 110.678 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.538 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.1 m-20 -62.36 -36.62 82.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.255 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.412 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.0 mp -52.45 -67.44 0.25 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.828 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.74 -42.11 67.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.22 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.74 18.17 0.14 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.742 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.41 47.96 0.21 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 39.19 -110.22 0.09 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.734 0.302 . . . . 0.0 110.631 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.492 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.1 m120 -60.97 -44.87 96.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.467 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.61 8.39 83.06 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -99.4 -12.26 20.41 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.607 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.6 t 176.15 142.46 0.07 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.073 0.463 . . . . 0.0 110.555 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.17 125.74 11.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.058 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -98.97 142.9 29.88 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.024 0.44 . . . . 0.0 110.567 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.5 mt -94.47 106.62 18.61 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.533 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.477 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 93.0 t80 -102.66 -11.95 18.05 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.199 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.75 -39.89 88.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.8 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.13 173.82 46.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.456 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 96.3 m-20 -74.98 -112.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.799 0.333 . . . . 0.0 110.658 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.83 -28.44 67.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.753 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.55 -43.97 93.39 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.031 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.34 -44.47 94.8 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.433 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.53 -59.51 4.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.243 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.6 -43.19 62.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.128 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.39 -44.08 75.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.2 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.4 mt -64.19 -43.61 97.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.949 0.404 . . . . 0.0 110.735 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -56.8 -37.68 71.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.121 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.31 1.03 19.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.386 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -114.64 91.29 24.71 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.423 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.79 -27.54 27.38 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.836 2.357 . . . . 0.0 111.696 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.39 -41.32 98.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.63 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.8 mp -95.32 4.83 53.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.251 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.71 -35.58 70.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.697 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.62 4.68 15.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.428 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.533 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.74 121.71 82.2 Favored Pre-proline 0 N--CA 1.441 -0.916 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.575 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.34 -38.21 26.15 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.32 2.014 . . . . 0.0 112.446 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.533 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.83 -43.77 90.76 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.821 0.343 . . . . 0.0 110.077 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.96 -43.64 92.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.373 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.85 -40.75 95.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.576 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.446 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 48.6 t-20 -89.27 -12.59 40.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.648 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.3 mtmt 62.52 31.92 16.79 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -88.67 44.7 1.23 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.391 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -106.6 134.95 46.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.515 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -116.25 132.38 56.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.468 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.495 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.52 88.22 6.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.693 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.88 -41.61 97.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.772 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.477 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.83 167.15 34.51 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.2 p -75.6 -25.66 57.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.822 0.344 . . . . 0.0 110.711 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.6 tp10 -68.09 -34.54 76.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.512 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.742 HG22 ' O ' ' A' ' 296' ' ' THR . 98.6 m -72.5 17.68 0.11 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.598 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.513 ' O ' ' NE2' ' A' ' 212' ' ' GLN . 47.8 t80 -56.89 -51.28 69.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.115 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 -106.09 147.4 28.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.062 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.3 tp -115.27 125.61 53.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 123.461 0.476 . . . . 0.0 110.796 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.47 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.5 t0 -149.62 166.75 28.36 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.52 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -49.5 -38.13 29.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.476 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -71.51 -64.92 0.83 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.24 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -61.28 -32.53 72.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.948 0.404 . . . . 0.0 110.944 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.56 -25.8 28.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.393 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.7 mtt -63.57 -41.11 98.41 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.898 0.38 . . . . 0.0 110.811 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.6 -44.59 27.87 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.848 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.566 HG21 HG23 ' A' ' 296' ' ' THR . 77.4 t -66.12 -42.87 92.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.434 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 48.4 tp -59.88 -46.87 87.94 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.374 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -70.72 -39.12 73.58 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.463 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.495 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.2 ttt180 -61.56 -38.06 86.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.273 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.59 4.62 43.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.914 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.63 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.0 tttt -111.95 -12.27 13.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.118 0.485 . . . . 0.0 110.423 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.55 -37.01 84.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.678 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.02 -48.73 80.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.387 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.228 179.771 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -90.1 -2.69 58.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.406 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.04 1.25 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.489 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.2 Cg_exo -60.78 145.09 99.5 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.75 2.3 . . . . 0.0 112.168 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.04 -179.65 8.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.585 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.61 136.06 53.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.311 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' A' ' 30' ' ' ILE . 9.3 tp -123.34 146.24 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.358 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.0 p -120.35 136.42 54.71 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.767 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 53.1 p30 -100.03 -142.99 0.33 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.2 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -62.87 -37.19 85.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.513 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.464 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -152.01 -59.99 0.16 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.413 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -60.52 139.82 48.11 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.7 p -111.83 129.98 55.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.916 0.388 . . . . 0.0 110.461 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.97 128.84 53.94 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.523 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.8 m -85.45 130.62 34.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.222 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.468 HD22 ' OE1' ' A' ' 42' ' ' GLN . 67.9 mt -96.27 79.04 3.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.311 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.55 -32.03 73.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.485 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.01 109.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.063 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.468 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.5 pt20 -121.73 91.31 48.59 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.226 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.8 Cg_exo -57.05 148.95 65.58 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.759 2.306 . . . . 0.0 111.787 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.72 82.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 O-C-N 123.566 0.541 . . . . 0.0 110.983 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.24 66.95 0.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.111 0.482 . . . . 0.0 110.233 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.75 130.74 35.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.589 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.552 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.5 t -122.71 146.07 28.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.106 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 t -135.85 143.47 45.12 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.624 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.5 p -99.24 -59.31 1.75 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.51 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.8 p -79.37 154.62 28.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.638 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.5 HG21 HG23 ' A' ' 70' ' ' THR . 69.4 t -73.98 -21.72 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.573 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.8 m -60.28 -52.0 67.12 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.477 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.45 -42.34 87.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.368 0.604 . . . . 0.0 110.943 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.22 -53.93 4.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.099 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.1 -37.48 72.86 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.8 m -62.76 -44.6 95.77 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-O 120.848 0.356 . . . . 0.0 110.424 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.6 mt -66.19 -41.95 89.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.477 0.656 . . . . 0.0 110.728 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.57 -40.34 96.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.431 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.462 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.93 -35.71 75.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.976 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.538 HD11 HD12 ' A' ' 156' ' ' LEU . 31.7 pt -91.51 28.44 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.138 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.72 51.42 11.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.851 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.45 75.02 27.89 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.984 0.421 . . . . 0.0 109.941 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.17 151.3 85.94 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.765 2.31 . . . . 0.0 112.263 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.552 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.59 137.3 47.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.207 0.527 . . . . 0.0 110.235 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.445 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -69.13 -43.7 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.218 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.03 130.86 53.17 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.959 0.409 . . . . 0.0 110.548 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.529 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.1 p -155.59 168.96 25.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.408 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.86 -177.38 21.64 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.06 172.21 12.95 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.976 0.417 . . . . 0.0 110.498 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.5 HG23 HG21 ' A' ' 51' ' ' VAL . 12.8 p -134.05 -110.38 0.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.402 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.18 179.74 0.92 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.323 -179.018 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.5 Cg_exo -60.99 58.93 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 123.03 2.487 . . . . 0.0 112.088 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 56.7 t-20 -64.22 -35.16 79.92 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.586 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 46.2 m-20 94.91 -37.67 0.01 OUTLIER 'General case' 0 C--N 1.346 0.454 0 O-C-N 124.377 1.048 . . . . 0.0 109.938 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -62.7 -40.08 96.02 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.244 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -73.88 -26.77 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.724 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.76 -172.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.627 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.64 -152.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.742 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.6 p-10 -54.76 -6.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.681 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.49 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -87.06 113.68 23.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.609 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.25 73.06 1.27 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.94 148.58 35.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.825 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.84 -99.36 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.086 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.09 -42.95 96.76 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.142 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.548 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.2 tt0 91.6 53.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.088 0.867 . . . . 0.0 110.834 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -103.47 -9.21 19.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.453 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.2 p -64.9 -33.78 76.84 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.112 0.482 . . . . 0.0 110.664 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.548 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.62 -23.8 1.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.554 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.5 t -69.52 -46.0 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.978 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.35 81.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.117 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.72 -38.2 89.54 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.284 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.66 -32.16 50.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.226 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.591 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.5 mmt-85 -90.12 1.7 56.1 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 119.204 -0.426 . . . . 0.0 110.609 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 82.85 -49.11 0.16 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.212 0.945 . . . . 0.0 110.322 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.642 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.3 mt -46.49 153.96 0.33 Allowed 'General case' 0 CA--C 1.49 -1.34 0 CA-C-O 117.587 -1.197 . . . . 0.0 109.148 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.642 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.2 tt0 121.23 92.19 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 O-C-N 125.558 1.786 . . . . 0.0 110.529 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.529 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.21 143.46 43.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.218 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -132.12 26.95 4.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.733 0.301 . . . . 0.0 110.462 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.54 138.42 34.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.959 0.409 . . . . 0.0 110.469 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.63 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.6 mt -137.3 165.02 28.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.351 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.615 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.29 -28.59 1.81 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.95 70.95 7.15 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.188 0.518 . . . . 0.0 110.358 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.24 145.69 98.0 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 122.803 2.335 . . . . 0.0 112.032 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.2 t -134.38 136.64 43.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.568 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.14 82.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.716 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.5 -41.94 96.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.507 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.47 98.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.514 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.66 -43.35 98.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.06 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.99 -35.17 77.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.311 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -18.52 60.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.468 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.5 -6.34 58.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.526 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.0 mtp 48.0 55.74 17.17 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.651 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.15 149.12 63.94 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.777 2.318 . . . . 0.0 112.114 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -101.2 -73.37 0.65 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.46 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.418 HD11 HD13 ' A' ' 140' ' ' LEU . 38.3 tp -110.84 112.63 24.62 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.324 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -101.13 125.99 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.446 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.2 mt -109.5 133.27 53.28 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.149 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.22 139.48 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.484 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.9 p -83.42 168.41 16.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.648 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.56 80.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.44 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.51 159.18 42.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.424 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.2 177.01 33.46 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.94 87.5 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.77 151.98 44.42 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.962 0.41 . . . . 0.0 110.527 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.6 t -62.97 141.07 58.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.362 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.66 10.15 10.96 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.647 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.7 mp -60.98 -39.18 88.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.061 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.68 -35.91 24.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.54 0.686 . . . . 0.0 110.671 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.5 mt -70.83 -35.57 72.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.458 0.647 . . . . 0.0 110.774 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -42.78 -62.86 0.89 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.265 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.83 -42.61 90.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.994 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -62.33 -32.97 73.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.129 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.8 mt -73.48 -40.71 63.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.19 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.41 -48.66 79.96 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.206 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.7 m -53.28 -42.16 66.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.208 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.01 -43.04 92.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.002 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.62 154.08 5.34 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.625 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -39.13 107.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.666 2.244 . . . . 0.0 112.298 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.642 ' C ' HD12 ' A' ' 140' ' ' LEU . 94.5 m -109.75 121.4 45.14 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.252 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.642 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.28 152.82 30.75 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.252 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -128.27 131.42 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.359 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.29 127.42 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.397 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.88 103.6 14.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.364 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.9 p90 -101.12 -11.32 19.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.782 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.91 -33.47 76.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.622 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.2 p-10 -98.35 7.57 46.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.643 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.7 mttm -135.33 155.35 50.75 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.568 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.0 p -74.54 165.47 25.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.687 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.584 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -59.86 -48.7 80.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.298 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -53.86 -41.93 68.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.918 0.389 . . . . 0.0 110.081 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.4 t -62.42 -40.82 97.77 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.402 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.411 ' O ' HD23 ' A' ' 156' ' ' LEU . 47.4 tp -60.66 -43.87 97.12 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.355 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.516 HD22 HH21 ' A' ' 169' ' ' ARG . 44.0 tp -61.39 -43.07 99.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.861 0.363 . . . . 0.0 110.14 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.2 m -55.54 -45.3 77.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.716 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.49 -40.6 97.24 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 120.877 0.37 . . . . 0.0 110.395 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.538 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.02 -42.34 99.06 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.233 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.77 -41.05 95.93 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.72 -46.21 63.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.968 0.413 . . . . 0.0 110.894 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.6 mt -64.52 -44.05 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.819 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.8 p -93.23 -8.75 41.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.6 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.09 25.05 72.07 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -101.72 51.73 0.83 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.787 0.327 . . . . 0.0 110.681 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.79 -38.92 76.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.698 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.5 -46.92 87.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.187 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -61.37 -39.04 89.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.375 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.16 -40.45 97.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.362 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.3 -27.8 69.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.542 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.77 -53.71 8.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.171 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.516 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -63.75 -43.31 96.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.468 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 174' ' ' ASP . 86.7 mt -63.05 -43.9 99.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.676 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.33 -61.51 2.5 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.12 0.486 . . . . 0.0 110.484 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -54.81 -35.22 63.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.365 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -79.44 -34.72 41.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.114 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.3 m-20 -56.9 -40.01 75.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.926 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.83 -42.39 99.71 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.733 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.82 -37.74 87.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.294 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 177' ' ' LEU . 81.6 mt -62.41 -42.5 99.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.7 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.0 -53.14 59.79 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.128 0.489 . . . . 0.0 110.711 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.44 -41.41 89.16 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.548 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.26 -39.82 94.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.622 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.3 -32.33 73.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.338 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.21 -21.88 18.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.745 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.638 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -65.02 -41.42 95.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.698 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 pt -77.58 136.33 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.679 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.46 108.65 11.0 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.274 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.18 126.15 0.33 Allowed Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.89 152.18 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.724 2.283 . . . . 0.0 112.586 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.13 141.71 53.5 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.676 2.25 . . . . 0.0 112.469 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -170.96 147.07 2.24 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.669 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.13 154.5 70.15 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.734 2.289 . . . . 0.0 112.265 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.581 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.44 163.18 28.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.419 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.581 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.65 170.05 16.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.857 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.79 137.45 22.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.226 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.536 HG22 HD12 ' A' ' 205' ' ' LEU . 39.3 pt -134.03 146.01 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.603 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.72 131.68 59.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.133 0.492 . . . . 0.0 110.457 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -152.01 155.11 37.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.419 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.616 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.2 m -122.25 122.93 40.27 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.916 0.389 . . . . 0.0 110.382 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.37 -25.84 66.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.569 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.616 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.24 -49.17 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.086 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.59 -12.87 61.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.472 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.7 m80 50.43 41.55 25.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.439 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.9 t -136.27 144.79 44.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.339 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.401 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -110.5 114.31 27.62 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.35 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.1 m-20 -119.86 133.4 55.6 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.067 0.46 . . . . 0.0 110.372 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.98 146.32 38.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.756 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.484 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 12.3 t90 -99.29 129.54 45.52 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.062 0.458 . . . . 0.0 110.026 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.43 153.72 39.5 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.082 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.66 -18.29 48.12 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.791 2.328 . . . . 0.0 111.888 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.11 -18.71 0.35 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.45 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.484 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.1 p -75.65 165.23 25.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.496 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.14 -28.19 66.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.545 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.1 mt-30 -63.61 -41.43 98.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.17 -44.67 97.15 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.5 -38.92 92.7 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.981 0.42 . . . . 0.0 110.567 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.584 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.1 mmm -62.28 -41.36 98.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.114 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.5 mt -63.67 -47.05 82.8 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.648 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.48 -31.95 56.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.057 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -70.74 -18.14 62.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.543 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.427 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.4 mt -88.63 -8.67 54.24 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.692 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.85 2.52 55.12 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -88.57 152.46 21.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.768 0.318 . . . . 0.0 110.565 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.448 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.2 p -115.35 128.15 55.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.101 0.477 . . . . 0.0 110.378 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.46 146.02 24.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.852 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.47 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.64 151.16 46.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.463 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.9 131.59 42.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.408 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.89 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.56 93.4 27.59 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.061 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.677 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.0 Cg_exo -55.61 139.16 82.58 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.588 2.192 . . . . 0.0 111.519 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.86 -25.47 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.507 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.66 -49.88 27.9 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.553 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -53.99 -37.07 63.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.771 0.32 . . . . 0.0 110.19 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -66.71 35.96 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.815 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.553 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.32 88.13 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.4 p -81.72 -14.36 56.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.335 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -91.37 -41.41 10.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.564 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.7 t -66.88 -16.62 64.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.682 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.1 43.54 26.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.495 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.63 -147.99 7.63 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -121.75 143.11 49.57 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.953 0.406 . . . . 0.0 110.354 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -151.97 149.43 28.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.349 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -100.83 -151.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.313 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 55.87 -91.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.609 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.462 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.4 tt -126.67 175.12 9.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.559 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.462 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.8 mt -121.73 141.42 42.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.841 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.68 169.16 9.46 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.259 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.2 mt -147.73 150.83 35.02 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.181 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.58 -39.04 97.18 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.33 3.98 4.6 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -77.33 -58.03 3.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.001 0.429 . . . . 0.0 110.649 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.566 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.2 m-20 -62.15 -36.86 83.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.221 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.401 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.0 mp -52.36 -67.76 0.22 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.747 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.45 -42.17 66.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.248 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.11 17.92 0.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.672 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.99 48.59 0.29 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.42 -109.83 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.647 0.26 . . . . 0.0 110.744 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.47 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 12.0 m120 -60.96 -44.82 96.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.454 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.41 8.09 83.82 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -99.1 -12.95 20.05 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.783 -0.245 . . . . 0.0 110.646 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.0 t 176.69 142.57 0.07 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.121 0.486 . . . . 0.0 110.514 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.94 125.94 12.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.074 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -99.08 143.1 29.73 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 120.927 0.394 . . . . 0.0 110.79 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.4 mt -94.49 106.35 18.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.632 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.455 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.4 t80 -101.96 -12.29 18.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.163 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.22 -40.14 90.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.862 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.67 174.19 46.4 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.466 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.6 m-20 -74.67 -113.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 0.0 110.662 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.65 -28.61 67.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.743 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.04 -44.11 91.72 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.245 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.53 -44.28 94.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.398 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.56 -59.81 4.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.208 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.39 -43.34 61.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.151 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.34 -43.92 75.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.23 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.41 -43.6 97.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.682 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -56.55 -37.44 70.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.207 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.76 1.09 18.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.297 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -115.04 91.21 26.07 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.174 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.21 -27.11 28.86 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.803 2.336 . . . . 0.0 111.767 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.33 -41.06 98.87 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.641 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.22 4.93 53.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.371 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.63 -35.21 70.35 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.75 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.59 4.56 15.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.512 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.75 121.39 81.03 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.592 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -47.67 -37.67 27.77 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.46 2.107 . . . . 0.0 112.453 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.532 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -59.06 -43.75 91.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.788 0.328 . . . . 0.0 110.211 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.85 -43.75 93.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.251 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.72 -40.52 95.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.449 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.76 -12.43 39.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.534 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.2 mtmt 61.99 31.56 17.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.39 44.01 1.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.384 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.04 135.91 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.497 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.47 132.87 56.56 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.428 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.15 87.75 7.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.723 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.01 -41.25 97.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.92 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.455 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.98 168.45 34.97 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.0 p -76.05 -25.81 55.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.858 0.361 . . . . 0.0 110.731 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.1 tp10 -67.61 -34.18 76.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.465 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.762 HG22 ' O ' ' A' ' 296' ' ' THR . 97.0 m -73.52 20.47 0.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.648 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.557 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 57.0 t80 -57.63 -51.13 70.77 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.942 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.409 HH12 ' HG3' ' A' ' 212' ' ' GLN . 65.2 mmt-85 -108.28 149.72 28.26 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.427 ' CD2' HD11 ' A' ' 219' ' ' LEU . 40.4 tp -115.32 125.35 53.14 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.805 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.471 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.2 t0 -149.11 166.46 28.69 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.552 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -49.24 -38.16 25.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.61 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -71.54 -65.21 0.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.371 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -60.93 -32.86 72.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.47 -25.65 26.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.566 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.6 mtt -63.33 -40.87 98.5 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 120.865 0.364 . . . . 0.0 110.944 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.77 -44.22 23.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.562 HG21 HG23 ' A' ' 296' ' ' THR . 78.8 t -66.17 -43.03 92.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.403 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.3 tp -60.23 -47.06 87.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.466 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -69.83 -39.9 76.19 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.035 0.445 . . . . 0.0 110.744 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.498 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.2 ttt180 -61.61 -38.19 86.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.198 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.11 4.45 42.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.767 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.638 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -112.47 -11.51 13.62 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.045 0.45 . . . . 0.0 110.259 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.97 85.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.644 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.1 -48.87 79.67 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.339 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.042 179.947 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.44 -2.76 57.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.444 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.49 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.41 178.98 1.27 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.536 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.3 Cg_exo -60.75 144.82 99.61 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.652 2.235 . . . . 0.0 112.212 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.69 -179.75 8.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.608 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.58 136.69 52.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.392 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.1 tp -124.55 146.28 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.361 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.8 p -119.81 136.09 54.6 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.779 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.9 p30 -98.74 -144.17 0.32 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.273 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.56 -36.63 84.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.47 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.486 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.9 ttt85 -147.32 -70.59 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.565 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.81 144.07 41.81 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.2 p -112.68 130.08 56.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 0.0 110.397 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -114.8 129.65 56.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.686 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.9 m -86.83 130.6 34.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.342 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.493 HD22 ' OE1' ' A' ' 42' ' ' GLN . 71.1 mt -97.41 79.06 2.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.437 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -65.94 -32.55 74.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.53 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 t 177.09 109.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.155 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.493 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -123.36 91.59 49.64 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.324 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.3 Cg_exo -56.81 149.0 62.9 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.71 2.273 . . . . 0.0 111.82 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.69 83.05 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.933 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.48 67.27 0.89 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.316 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.59 130.69 35.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.637 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.552 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.4 t -123.04 146.31 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.108 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 t -136.16 143.84 44.68 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.626 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.7 p -99.35 -59.35 1.74 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.523 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.2 p -79.36 155.03 28.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.585 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.497 HG21 HG23 ' A' ' 70' ' ' THR . 72.5 t -74.36 -21.67 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.582 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.7 m -60.23 -52.09 66.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.537 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -66.62 -42.45 86.8 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.243 0.544 . . . . 0.0 110.759 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.8 m -42.88 -54.07 4.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.234 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.34 -37.24 70.51 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -62.85 -44.62 95.64 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 120.848 0.356 . . . . 0.0 110.428 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.422 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.9 mt -66.51 -41.93 88.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.306 0.574 . . . . 0.0 110.732 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.3 tp -62.5 -40.44 96.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.25 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.502 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.81 -36.05 75.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.928 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.527 HD11 HD12 ' A' ' 156' ' ' LEU . 30.7 pt -91.06 29.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.103 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 56.43 51.51 11.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.899 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.41 75.79 22.13 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.909 0.385 . . . . 0.0 109.98 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.15 152.11 83.35 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.783 2.322 . . . . 0.0 112.28 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.552 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.86 137.54 46.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.104 0.478 . . . . 0.0 110.33 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.5 pt -69.14 -43.65 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.241 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.1 131.21 53.33 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.948 0.404 . . . . 0.0 110.595 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.5 p -155.57 168.94 25.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.409 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.98 -177.28 21.56 Favored Glycine 0 N--CA 1.464 0.505 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.635 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.14 172.31 12.83 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.919 0.39 . . . . 0.0 110.507 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.497 HG23 HG21 ' A' ' 51' ' ' VAL . 15.0 p -132.35 -112.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.947 0.403 . . . . 0.0 110.462 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.18 179.76 0.93 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.344 -179.185 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.6 Cg_exo -60.8 57.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.962 2.441 . . . . 0.0 112.132 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.7 t-20 -64.41 -33.54 76.09 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.522 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.567 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.6 m-20 93.76 -36.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.08 0.862 . . . . 0.0 109.94 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.6 mtp85 -62.43 -39.48 93.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.265 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -74.69 -25.68 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.623 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.19 -171.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.86 -153.75 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.758 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.1 p-10 -52.78 -7.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.687 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.508 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.49 115.17 23.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.653 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.94 69.85 1.35 Allowed Glycine 0 CA--C 1.521 0.42 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -143.16 147.51 35.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.815 0.341 . . . . 0.0 110.832 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.61 -98.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.185 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.1 -42.64 96.84 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.122 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.0 tt0 91.51 53.14 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.866 0.729 . . . . 0.0 110.878 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -103.13 -9.05 19.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.447 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -64.79 -33.74 76.69 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.058 0.456 . . . . 0.0 110.65 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.55 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.18 -23.85 1.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.613 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.53 -46.0 76.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.936 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.41 -48.19 82.34 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.237 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.65 -38.26 89.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.292 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.78 -32.31 52.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.238 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.608 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.3 mmt-85 -90.19 1.65 56.21 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.57 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 56.9 mttp 82.64 -49.55 0.18 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.954 0.784 . . . . 0.0 110.29 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.671 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.7 mt -45.87 154.52 0.23 Allowed 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 118.16 -0.924 . . . . 0.0 109.453 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.671 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 120.77 92.68 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 O-C-N 125.066 1.479 . . . . 0.0 110.462 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.76 143.45 42.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.992 0.425 . . . . 0.0 110.249 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.5 mt -132.38 27.21 4.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 110.517 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.35 138.04 34.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.557 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.7 mt -137.25 164.96 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.386 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.02 -28.53 1.85 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.69 70.82 7.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.078 0.466 . . . . 0.0 110.36 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.89 145.19 98.9 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.754 2.303 . . . . 0.0 112.066 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.2 t -133.99 136.13 43.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.549 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.95 -38.17 82.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.673 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.25 -41.95 96.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.514 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.37 -41.41 98.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.527 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.0 t -63.84 -43.4 97.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.068 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.13 -35.05 77.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.323 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.75 -18.41 59.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.485 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.75 -6.39 58.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.498 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 68.0 mtp 47.57 56.06 17.21 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.584 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.13 149.43 64.51 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.786 2.324 . . . . 0.0 112.034 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.11 -73.88 0.63 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.433 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.502 HD11 HD13 ' A' ' 140' ' ' LEU . 37.9 tp -110.56 112.35 24.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.262 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.9 mt -100.72 126.33 54.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.022 0.439 . . . . 0.0 110.437 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.8 mt -109.16 132.83 53.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.272 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.0 139.3 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.511 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -83.55 168.38 16.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.579 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.1 -37.52 80.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.424 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -140.14 159.32 42.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.511 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.46 178.38 32.96 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.21 -33.74 86.92 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -125.6 152.67 44.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.899 0.381 . . . . 0.0 110.556 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 33.3 t -63.4 141.27 58.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.408 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.68 10.46 11.01 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.578 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -60.93 -38.97 87.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.113 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.88 -36.12 23.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.431 0.634 . . . . 0.0 110.629 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.1 mt -70.93 -35.57 72.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.373 0.606 . . . . 0.0 110.79 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -42.69 -62.8 0.9 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.201 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -66.17 -42.69 88.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.043 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.24 -32.58 73.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.267 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 129' ' ' LEU . 74.1 mt -73.9 -41.06 62.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.078 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -58.24 -48.98 78.69 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.301 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.0 m -52.95 -42.37 65.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.353 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.96 -42.65 92.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.985 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.44 153.97 5.47 Favored Pre-proline 0 N--CA 1.453 -0.281 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.581 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -39.74 106.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.669 2.246 . . . . 0.0 112.179 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.66 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.6 m -110.07 122.76 48.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.382 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.66 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -115.05 153.68 30.25 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.304 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -129.44 131.81 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.395 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.16 127.79 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.513 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.21 104.37 15.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.298 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.2 p90 -101.57 -11.17 19.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.805 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.576 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.73 -33.66 76.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.722 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.576 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.7 p-10 -98.41 8.03 45.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.573 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.61 155.18 50.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.582 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.409 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.45 165.94 24.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.64 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.595 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.8 t90 -59.72 -49.12 78.99 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.23 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -53.51 -42.39 67.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 110.109 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.8 t -62.85 -40.99 99.15 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.328 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.401 ' O ' HD23 ' A' ' 156' ' ' LEU . 48.9 tp -60.64 -44.19 96.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.366 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.37 -43.6 98.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.206 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.5 m -54.71 -44.64 73.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.875 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.79 -40.74 98.26 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.905 0.383 . . . . 0.0 110.379 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.527 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.03 -42.38 99.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.165 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.94 -41.21 95.5 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.66 -45.81 64.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.908 0.385 . . . . 0.0 110.831 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.55 -44.0 96.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.811 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -93.34 -8.34 42.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.583 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.5 26.67 71.95 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -101.76 51.41 0.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.818 0.342 . . . . 0.0 110.679 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.8 -39.38 76.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.707 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.61 -47.41 85.67 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.297 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -59.92 -39.47 85.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.35 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.9 -40.97 99.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.368 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.52 70.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.566 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.17 -54.37 7.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.1 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.502 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.5 ttp180 -65.57 -42.19 92.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.477 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.6 mt -62.36 -43.77 98.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.566 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.66 -57.16 12.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.931 0.396 . . . . 0.0 110.551 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -58.48 -32.76 69.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.345 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.423 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.9 t80 -82.1 -36.56 27.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.772 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.6 m-20 -56.13 -41.41 75.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.155 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.99 -42.25 99.79 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.595 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.45 -37.78 87.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.281 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.423 HD11 ' CD2' ' A' ' 173' ' ' PHE . 81.9 mt -62.5 -42.23 99.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.654 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.06 -52.91 62.03 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.013 0.435 . . . . 0.0 110.668 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.4 -41.77 88.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.565 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.98 95.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.563 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.31 -31.94 73.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.424 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.54 -22.51 18.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.766 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.65 -41.25 96.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.616 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 184' ' ' ILE . 33.0 pt -76.72 136.52 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.626 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.89 108.1 10.68 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.282 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.83 125.43 0.3 Allowed Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.505 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.451 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.7 Cg_exo -43.77 152.35 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.741 2.294 . . . . 0.0 112.484 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.89 141.81 55.06 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.634 2.223 . . . . 0.0 112.396 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.19 147.25 2.18 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.578 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.0 154.32 70.94 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.779 2.319 . . . . 0.0 112.324 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.585 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.27 163.15 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.42 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.585 ' N ' HG22 ' A' ' 191' ' ' VAL . 1.9 t -144.07 170.68 15.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.799 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.63 137.7 21.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.312 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.535 HG22 HD12 ' A' ' 205' ' ' LEU . 40.0 pt -134.31 146.96 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.675 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.28 131.83 58.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.102 0.477 . . . . 0.0 110.482 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -152.09 155.12 37.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.473 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.621 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.4 m -122.79 122.93 39.88 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.412 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.47 -25.67 66.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.579 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.621 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.33 -48.86 21.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.007 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.34 -9.41 58.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.467 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.2 m80 46.51 42.11 10.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.444 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -135.93 145.75 46.58 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.399 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.94 114.3 27.12 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.321 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.79 133.37 55.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 110.442 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.535 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.81 146.22 38.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.712 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.491 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.3 t90 -99.42 129.38 45.6 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.074 0.464 . . . . 0.0 110.056 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.02 153.42 39.84 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.073 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.85 -17.87 46.99 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.762 2.308 . . . . 0.0 111.962 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.14 -18.9 0.37 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.486 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.491 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.71 164.71 26.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.531 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.93 -27.95 65.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.504 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.6 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.9 mt-30 -63.65 -41.19 98.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.643 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.66 -44.37 97.95 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.45 -38.8 92.29 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.983 0.42 . . . . 0.0 110.464 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.595 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.0 mmm -62.14 -41.31 98.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.177 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.7 mt -63.63 -47.17 82.42 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.672 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.13 -31.95 53.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.114 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.85 -18.3 62.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.557 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.437 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.9 mt -87.87 -9.13 54.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.559 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.19 1.6 54.34 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -88.16 153.77 20.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.835 0.35 . . . . 0.0 110.519 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.455 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.0 p -116.31 128.74 55.82 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.071 0.463 . . . . 0.0 110.384 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.62 146.3 23.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.866 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.486 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.95 151.72 45.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.463 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.88 131.47 42.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.443 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.896 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.73 93.07 26.93 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.132 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.675 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.9 Cg_exo -55.43 139.21 81.77 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.597 2.198 . . . . 0.0 111.59 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.01 -26.07 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.486 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.36 -50.25 27.88 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.4 mt -53.71 -37.15 63.0 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -66.76 36.14 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.731 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.556 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 38.98 88.72 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.847 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.5 p -81.28 -13.87 58.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.377 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.98 -41.84 10.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.626 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.7 t -66.74 -16.94 64.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.636 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 55.74 44.01 26.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.453 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.67 -149.24 8.32 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.95 142.84 48.38 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.912 0.387 . . . . 0.0 110.369 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.01 149.56 29.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.391 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -101.31 -151.59 0.42 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.343 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 55.96 -92.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.631 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.466 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.4 tt -126.84 175.52 8.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.613 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.466 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.4 mt -122.72 142.04 40.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.759 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.86 169.65 9.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.329 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 58.7 mt -148.01 150.8 34.63 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.49 -39.05 97.26 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.1 4.03 4.69 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -77.55 -58.04 3.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.896 0.379 . . . . 0.0 110.596 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.56 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.4 m-20 -62.11 -36.61 82.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.264 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.36 -67.76 0.23 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.661 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.54 -42.48 67.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.264 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.63 17.42 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.56 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.02 48.83 0.3 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.53 -110.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.587 0.232 . . . . 0.0 110.704 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.486 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.9 m120 -60.8 -44.8 96.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.572 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.28 8.01 84.16 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.95 -13.58 19.89 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.628 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.1 t 177.25 142.55 0.08 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.007 0.432 . . . . 0.0 110.492 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.22 124.81 11.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.052 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.09 143.63 28.43 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 120.854 0.359 . . . . 0.0 110.699 178.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.5 mt -95.13 106.49 18.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.659 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.442 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.8 t80 -101.75 -12.27 18.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.279 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.37 -40.73 89.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.83 173.06 45.72 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.453 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -73.71 -113.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.814 0.34 . . . . 0.0 110.739 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.66 -28.62 67.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.715 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.9 -44.03 91.13 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.179 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.63 -44.22 94.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.336 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.71 -60.21 3.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.227 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.93 -43.54 60.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.165 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.27 -43.58 74.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.268 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.64 -43.63 96.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.648 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -56.28 -37.5 69.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.189 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.54 0.9 18.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.328 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -114.99 91.4 26.6 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.227 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.21 -27.28 29.54 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.809 2.34 . . . . 0.0 111.778 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.54 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -40.96 98.78 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.621 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.33 5.31 52.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.328 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.07 -35.37 69.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.009 0.433 . . . . 0.0 110.707 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.36 4.36 15.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.601 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.76 121.15 80.17 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.531 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -47.2 -37.89 24.53 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.479 2.119 . . . . 0.0 112.397 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.98 -43.74 91.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.846 0.355 . . . . 0.0 110.311 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.5 t -66.18 -43.68 91.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.337 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.89 -40.6 95.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.537 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.5 t-20 -89.64 -12.89 38.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.502 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 62.47 32.28 16.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.79 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.01 43.84 1.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.376 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.22 135.63 41.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.544 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.84 132.38 56.71 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.465 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.07 89.15 7.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.735 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.88 -40.98 97.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.784 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.79 165.34 33.26 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 71.7 p -75.47 -25.75 57.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 110.673 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.8 tp10 -68.36 -33.85 75.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.384 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 296' ' ' THR . 95.7 m -73.68 25.17 0.07 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.711 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.6 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 37.7 t80 -58.57 -50.75 72.68 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.413 HH12 ' HG3' ' A' ' 212' ' ' GLN . 79.4 mmt-85 -110.82 153.84 24.81 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.437 ' CD2' HD11 ' A' ' 219' ' ' LEU . 45.0 tp -115.67 125.1 52.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.721 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.487 ' CB ' HD23 ' A' ' 83' ' ' LEU . 44.7 t0 -147.98 165.66 30.05 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.531 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.16 -38.13 24.55 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.544 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.03 -65.83 0.69 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.29 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.91 -32.75 72.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.35 -25.25 23.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.627 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.5 mtt -63.72 -40.73 97.47 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 120.889 0.376 . . . . 0.0 111.01 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -79.1 -44.13 22.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.58 HG21 HG23 ' A' ' 296' ' ' THR . 79.0 t -66.15 -42.88 92.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.469 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.9 tp -60.1 -47.13 87.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.455 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.04 -39.31 75.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.58 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.2 ttt180 -61.85 -38.66 89.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.252 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -86.67 4.57 39.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.772 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.92 -11.16 13.46 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.048 0.451 . . . . 0.0 110.31 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.1 85.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.578 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.84 -48.88 79.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.422 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.178 179.701 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.612 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.68 -3.15 57.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.425 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.489 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -143.88 179.2 1.23 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.53 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 37.6 Cg_exo -60.55 144.57 99.54 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.779 2.32 . . . . 0.0 112.161 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.612 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.3 ptt-85 -155.85 179.96 8.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.571 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -116.03 137.22 52.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.346 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.83 146.17 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.46 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.8 p -119.9 136.27 54.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.744 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.7 p30 -98.33 -144.51 0.31 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.267 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.58 -36.39 83.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.481 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -147.04 -70.68 0.23 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.508 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.59 144.15 41.11 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.7 p -112.61 129.82 56.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 110.385 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -114.86 129.9 56.79 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.643 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 m -87.74 131.53 34.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.159 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.497 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.8 mt -99.02 79.64 2.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.655 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.16 -32.01 73.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.475 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 t 176.98 109.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.182 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.497 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -124.32 91.66 49.23 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.306 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.4 Cg_exo -56.64 149.04 61.05 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.792 2.328 . . . . 0.0 111.917 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.44 82.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.599 0.562 . . . . 0.0 110.923 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.0 mtm180 -151.62 67.23 0.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.24 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.84 130.99 35.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.667 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.567 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.6 t -123.16 147.74 27.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.149 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 t -136.22 143.96 44.63 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.703 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 50' ' ' SER . 16.9 p -99.65 -59.33 1.74 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.524 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.42 ' N ' ' OG1' ' A' ' 49' ' ' THR . 86.6 p -79.41 154.94 28.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.596 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.529 HG21 HG23 ' A' ' 70' ' ' THR . 70.5 t -73.72 -21.76 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.517 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.8 m -60.17 -52.03 67.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.535 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 mt -66.41 -42.32 87.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.208 0.527 . . . . 0.0 110.862 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.7 m -43.52 -54.27 4.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.091 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.63 -36.65 76.35 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 m -63.32 -44.38 95.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 0.0 110.423 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.7 mt -66.02 -42.13 90.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.484 0.659 . . . . 0.0 110.593 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tp -62.83 -40.17 96.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.367 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.534 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.52 -36.16 77.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.065 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.46 HD11 HD12 ' A' ' 156' ' ' LEU . 32.6 pt -90.99 27.66 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.168 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 57.02 51.51 10.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.944 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.81 75.92 29.86 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.036 0.446 . . . . 0.0 109.932 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -63.53 149.38 91.16 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.752 2.302 . . . . 0.0 112.214 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.567 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -112.71 137.11 46.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.198 0.523 . . . . 0.0 110.281 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.441 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.5 pt -69.51 -43.7 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.145 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.22 131.21 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.929 0.395 . . . . 0.0 110.59 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.2 p -155.78 168.67 26.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.467 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.7 -177.41 21.74 Favored Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.629 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.07 172.3 12.83 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.483 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.529 HG23 HG21 ' A' ' 51' ' ' VAL . 11.4 p -134.13 -110.27 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.396 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.545 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.43 179.6 0.94 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.348 -179.045 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.2 Cg_exo -60.79 58.87 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.996 2.464 . . . . 0.0 112.129 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 56.3 t-20 -64.37 -34.91 79.25 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.498 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 46.7 m-20 95.04 -38.14 0.01 OUTLIER 'General case' 0 C--N 1.346 0.448 0 O-C-N 124.016 0.822 . . . . 0.0 109.875 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.45 -39.84 94.67 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.018 0.437 . . . . 0.0 110.228 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.2 p -73.79 -26.5 21.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.693 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.97 -172.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.568 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.7 p30 -74.22 -152.88 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.757 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.7 p-10 -54.49 -6.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.701 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.493 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.94 113.66 22.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.589 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.48 72.74 1.28 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.99 148.62 35.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.885 0.374 . . . . 0.0 110.817 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.75 -99.16 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.139 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.04 -42.94 96.89 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.201 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.5 tt0 91.65 52.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.953 0.783 . . . . 0.0 110.925 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -103.43 -8.99 19.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.365 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -64.92 -33.58 76.35 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.108 0.48 . . . . 0.0 110.669 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.531 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 97.9 mttt -48.85 -23.55 1.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.671 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.7 t -70.02 -46.14 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.815 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.16 -48.63 80.7 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.107 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.63 -38.18 89.23 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.41 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.76 -32.31 51.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.261 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.6 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.9 mmt-85 -89.79 1.81 55.68 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.617 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.6 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 82.64 -49.5 0.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.015 0.822 . . . . 0.0 110.319 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.655 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.6 mt -46.06 154.48 0.25 Allowed 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 117.702 -1.142 . . . . 0.0 109.407 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.655 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 120.72 92.36 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 O-C-N 125.439 1.712 . . . . 0.0 110.479 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.533 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.11 143.02 43.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.084 0.468 . . . . 0.0 110.259 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -132.07 26.71 4.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.856 0.36 . . . . 0.0 110.533 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.33 138.14 34.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.013 0.435 . . . . 0.0 110.549 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.3 mt -137.16 164.79 29.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.398 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.613 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.63 -28.91 1.75 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -151.94 70.75 7.88 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.177 0.513 . . . . 0.0 110.258 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.87 145.29 98.64 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.777 2.318 . . . . 0.0 112.057 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.8 t -134.98 136.49 42.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.549 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.97 -38.17 82.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.657 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.51 -42.07 96.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.506 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.08 -41.59 98.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.516 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.77 -43.29 97.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.064 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.17 -35.09 77.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.263 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -18.29 59.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.506 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.72 -6.1 58.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.505 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.417 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 70.4 mtp 47.83 55.73 17.09 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.608 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.0 Cg_endo -70.25 149.16 63.4 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.744 2.296 . . . . 0.0 112.116 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.48 -72.99 0.66 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.429 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.448 HD11 HD13 ' A' ' 140' ' ' LEU . 37.6 tp -111.25 113.54 26.11 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.342 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.4 mt -102.67 126.95 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.576 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.5 mt -110.06 133.85 52.76 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.225 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.33 139.65 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.468 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.6 p -83.48 167.84 17.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.688 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -37.25 79.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.47 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.61 158.6 43.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.472 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.11 176.97 33.4 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.75 86.91 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.95 152.27 44.38 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.926 0.394 . . . . 0.0 110.505 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.0 t -63.47 140.93 58.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.355 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.62 10.5 11.07 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.611 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.513 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.04 -38.89 87.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.14 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.97 -35.86 23.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.542 0.687 . . . . 0.0 110.668 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.9 mt -70.98 -35.34 72.09 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.444 0.64 . . . . 0.0 110.733 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -42.81 -63.0 0.86 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.239 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.87 -42.71 90.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.049 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.07 -32.63 73.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.3 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.9 mt -73.9 -40.7 62.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.987 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.28 -49.22 77.92 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.21 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.3 m -52.89 -42.48 65.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.246 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.59 -42.87 93.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.131 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.73 153.94 5.19 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.65 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -39.38 106.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.661 2.241 . . . . 0.0 112.354 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.649 ' C ' HD12 ' A' ' 140' ' ' LEU . 97.1 m -109.97 122.22 47.06 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.332 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.649 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.5 153.44 29.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.225 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -129.04 131.5 68.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.393 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -114.88 127.6 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.475 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.496 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 55.3 t30 -100.65 104.45 15.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.311 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 147' ' ' LYS . 50.0 p90 -100.92 -11.18 19.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.809 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.0 p-10 -64.74 -33.53 76.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.728 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.1 p-10 -98.87 8.13 45.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.591 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.441 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.27 153.04 52.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.487 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.405 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.8 p -75.37 166.05 24.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.649 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.598 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.7 t90 -59.46 -48.91 79.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.127 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -54.28 -43.07 70.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.91 0.386 . . . . 0.0 110.114 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.1 t -62.78 -40.9 98.75 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.366 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.429 ' O ' HD23 ' A' ' 156' ' ' LEU . 55.5 tp -60.69 -44.37 96.62 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.241 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.35 -42.88 99.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.853 0.359 . . . . 0.0 110.192 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.0 m -55.86 -44.9 78.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.773 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.81 -40.3 96.93 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 120.908 0.385 . . . . 0.0 110.439 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.46 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.9 -42.27 98.88 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.287 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.81 -40.45 95.6 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.52 -45.54 65.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.908 0.385 . . . . 0.0 110.792 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.71 -44.03 96.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.742 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -93.44 -8.4 41.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.596 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.67 26.5 72.04 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -101.35 50.76 0.85 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.813 0.339 . . . . 0.0 110.589 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -69.65 -39.68 76.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.667 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.58 -47.59 84.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.208 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -59.62 -39.78 85.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.268 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.15 99.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.296 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.56 -28.59 69.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.604 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.47 -54.22 7.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.016 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.534 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.7 ttp180 -65.61 -42.36 91.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.458 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.8 mt -62.38 -43.9 98.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.522 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.67 -57.67 10.19 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.079 0.466 . . . . 0.0 110.377 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.91 -33.75 69.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.482 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -81.39 -36.35 29.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.755 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.4 m-20 -55.33 -41.87 73.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.982 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.54 -42.03 99.26 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.664 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.22 -38.23 89.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.348 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 177' ' ' LEU . 82.5 mt -62.5 -42.25 99.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.733 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.11 -53.06 60.72 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.12 0.486 . . . . 0.0 110.657 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.09 -42.0 89.91 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.642 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.71 -40.06 95.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.666 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.28 -31.9 73.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.37 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.92 -22.16 18.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.662 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.656 ' NE2' ' HZ2' ' A' ' 312' ' ' LYS . 51.7 tt0 -64.63 -41.33 96.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.599 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.5 pt -75.2 136.2 25.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.6 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -125.99 106.95 9.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.312 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -177.2 125.56 0.29 Allowed Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.57 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.8 Cg_exo -43.9 152.39 0.36 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.772 2.315 . . . . 0.0 112.56 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.87 141.93 55.54 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.658 2.239 . . . . 0.0 112.468 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.25 147.46 2.2 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.585 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.03 154.45 70.59 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.764 2.309 . . . . 0.0 112.362 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.47 163.12 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.194 0.521 . . . . 0.0 110.386 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.65 170.3 16.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.932 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.47 137.56 21.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.995 0.426 . . . . 0.0 110.111 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.536 HG22 HD12 ' A' ' 205' ' ' LEU . 39.6 pt -134.4 147.14 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.657 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.56 132.04 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.157 0.503 . . . . 0.0 110.492 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -151.95 154.84 36.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.423 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.7 m -121.82 122.62 39.87 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.947 0.403 . . . . 0.0 110.344 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.93 -25.48 66.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.646 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.86 -49.65 19.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.91 -9.53 58.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.409 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.8 m80 46.97 43.74 14.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.436 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.7 t -135.78 145.11 46.2 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.347 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.47 113.49 25.96 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.26 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.1 m-20 -119.86 133.26 55.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.384 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 194' ' ' ILE . 7.5 tt -112.02 146.35 38.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.757 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.482 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.1 t90 -99.35 128.85 45.51 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.104 0.478 . . . . 0.0 110.067 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.65 154.04 40.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.174 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.68 -17.98 47.91 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.662 2.241 . . . . 0.0 111.94 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.35 -18.79 0.42 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.405 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.482 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 84.6 p -75.42 164.73 26.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.507 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.89 -28.14 65.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.461 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.556 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.4 mt-30 -63.67 -41.74 98.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.669 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.65 -44.67 96.67 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.441 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.1 mt-30 -64.45 -38.9 92.63 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 122.448 -0.442 . . . . 0.0 110.672 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.06 -41.19 97.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.276 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.61 -47.42 81.47 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.997 0.427 . . . . 0.0 110.502 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -53.82 -32.15 51.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.193 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -70.92 -19.0 62.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.555 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' A' ' 299' ' ' LEU . 92.6 mt -87.48 -8.89 55.9 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.63 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.83 2.72 55.15 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.9 152.67 21.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.339 . . . . 0.0 110.532 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.438 ' O ' HG12 ' A' ' 191' ' ' VAL . 7.8 p -115.57 128.19 55.78 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.063 0.459 . . . . 0.0 110.305 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.41 146.52 23.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.959 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.478 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -70.07 151.1 45.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.447 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.64 131.56 43.28 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.475 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.891 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.57 93.42 27.67 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.073 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.679 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.3 Cg_exo -55.52 138.99 82.02 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.629 2.219 . . . . 0.0 111.617 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.82 -25.51 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.482 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.57 -49.82 28.78 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.553 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.1 mt -54.05 -36.97 63.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.71 36.09 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.72 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.553 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.14 86.73 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.9 p -79.61 -15.04 58.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.34 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -92.37 -41.4 10.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.59 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -65.98 -17.72 64.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.621 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 56.18 43.32 26.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.466 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.23 -148.31 7.67 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.87 142.81 49.88 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.958 0.408 . . . . 0.0 110.336 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.06 149.57 28.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.328 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -100.79 -151.86 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.308 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.5 t0 55.9 -92.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.673 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.463 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.48 175.41 8.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.601 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.463 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.7 mt -122.32 141.72 41.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.766 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.7 169.17 9.45 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.226 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.8 mt -147.66 150.86 35.17 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.191 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.64 -38.82 96.83 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.82 4.2 4.78 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -77.45 -58.22 3.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.945 0.402 . . . . 0.0 110.558 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.528 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.1 m-20 -62.17 -36.64 82.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.416 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.17 -67.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.777 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.72 -42.27 67.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.102 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.72 17.38 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.645 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.34 49.13 0.34 Allowed Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.411 -0.675 . . . . 0.0 111.411 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 37.85 -109.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.635 0.255 . . . . 0.0 110.825 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.478 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.7 m120 -60.65 -45.2 95.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.493 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.82 7.85 83.48 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.04 -13.04 20.04 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.745 -0.268 . . . . 0.0 110.696 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.4 t 176.86 142.89 0.08 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.063 0.458 . . . . 0.0 110.458 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.35 125.43 11.4 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.087 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.76 143.43 29.12 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 120.916 0.389 . . . . 0.0 110.837 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.6 mt -94.88 106.47 18.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.674 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.9 t80 -101.88 -12.02 18.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.261 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.24 89.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.834 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.54 173.86 46.16 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.443 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.5 m-20 -74.44 -113.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.759 0.314 . . . . 0.0 110.734 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.74 -28.4 67.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.66 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.96 -44.14 91.44 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.27 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.68 -44.14 94.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.341 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.48 -60.38 3.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.273 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.92 -43.53 60.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.174 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.47 -43.81 75.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.252 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.1 mt -64.54 -43.6 96.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.629 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -56.52 -37.66 70.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.2 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.66 1.19 17.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.272 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -115.0 91.28 26.16 Favored Pre-proline 0 CA--C 1.528 0.134 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.118 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.97 -27.17 27.38 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.768 2.312 . . . . 0.0 111.875 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.533 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.41 -41.26 98.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.526 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.15 5.12 52.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.407 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.96 -35.38 69.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.595 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.58 4.35 16.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.516 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.66 121.51 81.33 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.615 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -47.31 -38.13 25.82 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.487 2.125 . . . . 0.0 112.533 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.535 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.86 -43.95 90.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.812 0.339 . . . . 0.0 110.391 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.73 -43.63 93.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.293 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.83 -40.64 95.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.454 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 44.8 t-20 -89.73 -12.14 40.27 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.549 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.4 mtmt 61.73 31.3 18.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.965 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -88.17 43.78 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.435 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.43 136.09 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.453 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.59 132.8 56.59 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.452 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.1 88.49 7.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.752 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.0 -41.41 97.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.891 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.46 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.42 167.26 33.76 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.4 p -75.71 -25.97 57.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.852 0.358 . . . . 0.0 110.747 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -67.77 -33.91 75.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.533 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 296' ' ' THR . 97.1 m -73.72 20.41 0.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.674 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.556 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 55.0 t80 -57.26 -51.19 70.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.939 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 68.4 mmt-85 -108.38 150.12 27.79 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.417 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.1 tp -115.54 125.78 53.43 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.811 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.468 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.7 t0 -149.56 166.72 28.36 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.598 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -49.16 -37.97 24.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.631 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.83 -65.21 0.79 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.388 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -60.92 -32.76 72.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.7 -25.22 25.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.688 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.3 mtt -63.66 -40.98 98.2 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.871 0.367 . . . . 0.0 111.057 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.85 -43.94 24.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.03 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.572 HG21 HG23 ' A' ' 296' ' ' THR . 78.9 t -66.34 -42.85 91.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.328 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.6 tp -60.06 -47.13 87.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.505 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.99 -39.4 75.95 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.578 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.9 ttt180 -61.96 -38.24 87.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.208 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -87.14 4.31 42.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.68 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.656 ' HZ2' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -113.07 -11.06 13.39 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.025 0.441 . . . . 0.0 110.283 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.3 86.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.559 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.66 -48.66 80.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.361 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 117.885 -1.055 . . . . 0.0 110.038 179.907 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.14 -2.36 58.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.442 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.488 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.06 1.24 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.533 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.93 145.26 99.32 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.774 2.316 . . . . 0.0 112.165 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.15 -179.1 7.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.6 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.0 137.0 52.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.323 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -124.57 146.73 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.443 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.4 p -119.97 135.99 54.7 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.704 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.28 -143.53 0.32 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.309 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.49 -37.15 86.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.487 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.476 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.1 ttt85 -149.31 -66.26 0.22 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.533 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.5 142.16 45.57 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 p -112.07 131.3 55.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 0.0 110.409 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -119.06 129.09 54.91 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.547 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -85.62 130.26 34.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.273 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.486 HD22 ' OE1' ' A' ' 42' ' ' GLN . 67.1 mt -95.97 78.86 3.21 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.353 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.51 -32.07 73.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.479 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 175.97 109.78 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.143 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.486 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -122.72 91.53 49.54 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.277 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.654 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.5 Cg_exo -56.97 148.92 65.0 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.818 2.345 . . . . 0.0 111.816 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.52 82.78 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.654 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.38 67.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.097 0.475 . . . . 0.0 110.279 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.19 130.73 35.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.582 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.564 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.7 t -122.78 146.91 27.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.202 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.2 t -136.26 143.48 44.28 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.62 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.6 p -99.18 -59.5 1.71 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.618 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.0 p -79.18 155.13 28.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.611 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.497 HG21 HG23 ' A' ' 70' ' ' THR . 74.0 t -74.23 -21.83 17.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.571 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.9 m -60.13 -52.25 66.13 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.553 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.8 mt -66.63 -42.33 86.93 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.249 0.547 . . . . 0.0 110.877 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.6 m -42.88 -54.06 4.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.265 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.47 -37.48 69.32 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.2 m -62.48 -44.68 95.81 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.82 0.343 . . . . 0.0 110.443 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.8 mt -66.2 -41.99 89.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.385 0.612 . . . . 0.0 110.703 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.2 tp -62.68 -40.34 96.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.284 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.17 -35.82 76.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.899 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 156' ' ' LEU . 30.6 pt -91.36 28.85 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.021 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 56.57 51.61 10.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.798 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.2 75.58 23.14 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.984 0.421 . . . . 0.0 110.054 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.53 151.41 85.67 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.723 2.282 . . . . 0.0 112.256 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.56 137.32 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.121 0.486 . . . . 0.0 110.335 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.9 pt -69.42 -43.45 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.178 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.1 131.17 53.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 110.522 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.0 p -155.77 168.98 25.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.481 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.24 -177.12 21.43 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.54 172.91 12.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 110.56 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.497 HG23 HG21 ' A' ' 51' ' ' VAL . 13.1 p -132.9 -112.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.29 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.26 179.76 0.93 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.328 -179.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.5 Cg_exo -60.93 57.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 123.032 2.488 . . . . 0.0 112.151 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.7 t-20 -64.43 -33.69 76.47 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.606 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 43.4 m-20 93.6 -36.27 0.02 OUTLIER 'General case' 0 C--N 1.344 0.332 0 O-C-N 124.014 0.822 . . . . 0.0 109.993 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.406 ' HD3' HD21 ' A' ' 73' ' ' ASN . 78.1 mtp85 -62.64 -39.38 93.67 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.299 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.88 -25.29 18.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.73 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.38 -171.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.597 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.46 -153.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.752 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.1 p-10 -52.36 -7.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.706 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.36 114.86 23.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.531 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.85 69.98 1.35 Allowed Glycine 0 CA--C 1.522 0.469 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -143.23 147.39 34.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.968 0.414 . . . . 0.0 110.673 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.49 -98.3 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.205 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.36 -42.57 96.15 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.205 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.64 53.65 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.894 0.746 . . . . 0.0 110.791 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -103.9 -8.77 19.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.429 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -65.18 -33.79 76.85 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.175 0.512 . . . . 0.0 110.649 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.548 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.84 -24.24 1.37 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.568 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.9 t -69.5 -45.68 77.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.876 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.23 -48.57 80.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.117 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.73 -38.09 89.13 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.379 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.82 -32.42 52.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.281 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.607 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.5 mmt-85 -89.87 1.77 55.8 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.588 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.54 -49.51 0.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 124.036 0.835 . . . . 0.0 110.412 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.669 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.17 154.92 0.23 Allowed 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.443 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.669 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 120.66 92.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 125.133 1.521 . . . . 0.0 110.501 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.531 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.61 143.56 42.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.291 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.8 mt -132.58 27.15 4.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.494 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.55 138.39 34.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.541 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.63 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.6 mt -137.5 165.14 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.427 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.618 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.22 -28.71 1.82 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -152.59 70.87 7.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.121 0.486 . . . . 0.0 110.396 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.97 145.38 98.49 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.789 2.326 . . . . 0.0 112.048 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.8 t -134.47 136.37 43.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.036 0.446 . . . . 0.0 110.522 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.26 -38.17 81.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.673 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.45 -42.29 96.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.511 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.94 -41.73 98.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.481 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.51 -43.19 98.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.146 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.04 -35.07 77.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.345 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.5 -18.4 58.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.476 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.96 -6.33 58.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.486 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.418 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 75.9 mtp 47.76 55.77 17.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.66 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.14 149.4 64.4 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.807 2.338 . . . . 0.0 112.093 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.16 -74.01 0.63 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.503 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.434 HD11 HD13 ' A' ' 140' ' ' LEU . 37.8 tp -110.45 113.09 25.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.368 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -101.68 126.39 55.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.5 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.2 mt -109.7 133.53 53.02 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.248 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.56 140.02 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.587 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.8 p -83.62 168.68 16.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.641 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.08 -37.61 80.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.432 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.96 159.38 42.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.476 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.2 177.49 33.2 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.14 -33.77 86.93 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -124.87 151.93 44.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.822 0.344 . . . . 0.0 110.603 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.5 t -63.14 141.01 58.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.307 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.46 10.46 11.17 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.559 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.07 -39.03 88.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.072 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.04 -35.99 23.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.361 0.6 . . . . 0.0 110.696 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.8 mt -70.83 -35.45 72.47 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.428 0.632 . . . . 0.0 110.72 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.76 -63.28 0.81 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.158 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.6 p-10 -65.89 -42.72 89.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.4 mt-30 -62.01 -32.66 73.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.164 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.3 mt -74.01 -40.35 62.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.051 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.23 -49.12 78.2 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.208 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.1 m -52.59 -42.56 64.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.216 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.77 -42.98 93.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.08 154.81 5.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.632 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.29 106.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.709 2.273 . . . . 0.0 112.339 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.644 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.0 m -110.07 121.19 44.67 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.31 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.644 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.0 153.03 30.06 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.296 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -129.09 131.22 68.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.413 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -114.92 127.85 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.443 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.477 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.8 t30 -101.38 103.62 14.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.34 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.3 p90 -101.14 -11.37 19.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.769 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.2 p-10 -64.77 -33.63 76.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.66 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.8 p-10 -98.12 7.79 45.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.603 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.449 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.64 155.6 50.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.564 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.3 p -74.96 165.71 24.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.664 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.592 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.4 t90 -59.85 -48.88 79.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.286 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.51 -41.95 66.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.088 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.2 t -62.73 -41.01 98.96 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.406 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.409 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.6 tp -60.59 -44.28 96.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.376 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.36 -43.56 98.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.211 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.0 m -54.87 -44.93 74.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.837 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.39 -40.94 98.12 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.837 0.351 . . . . 0.0 110.331 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -61.89 -42.48 99.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.157 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.9 -40.89 95.64 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.41 -46.16 64.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.899 0.381 . . . . 0.0 110.816 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.74 -44.02 96.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.735 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -92.97 -8.69 42.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.553 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.8 26.62 72.2 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -101.8 51.07 0.84 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 110.667 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -69.91 -39.38 76.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.644 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.57 -47.26 86.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.248 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -59.88 -39.36 85.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.341 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.14 99.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.322 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.71 -28.52 70.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.974 0.416 . . . . 0.0 110.576 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.39 -54.25 7.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.058 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.506 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.4 ttp180 -65.55 -42.17 92.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.518 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.466 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.3 mt -62.35 -43.86 98.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.488 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.75 -57.73 9.93 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.021 0.439 . . . . 0.0 110.453 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.78 -33.86 68.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.35 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -81.46 -36.28 29.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.811 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.2 m-20 -55.6 -41.59 73.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.238 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.64 -42.42 99.59 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.688 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.29 -38.01 88.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.366 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 177' ' ' LEU . 81.6 mt -62.25 -42.23 99.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.68 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.8 62.53 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.044 0.45 . . . . 0.0 110.66 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.19 -41.92 89.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.559 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.86 95.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.56 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.42 -31.99 73.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.379 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.63 -22.21 18.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.729 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.633 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.83 -41.16 95.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.651 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.8 pt -77.01 136.73 23.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.574 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.01 108.29 10.81 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.291 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.76 125.5 0.3 Allowed Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.512 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.6 Cg_exo -43.81 152.18 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.775 2.316 . . . . 0.0 112.499 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.79 141.82 55.61 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.61 2.206 . . . . 0.0 112.461 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.33 147.08 2.1 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.592 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.02 154.58 70.43 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.741 2.294 . . . . 0.0 112.292 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.35 163.13 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.4 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 1.9 t -143.97 170.76 15.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.817 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.12 137.99 21.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.237 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.533 HG22 HD12 ' A' ' 205' ' ' LEU . 39.4 pt -134.45 146.9 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.639 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 204' ' ' ASN . 3.0 p -133.08 131.76 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.145 0.498 . . . . 0.0 110.505 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -151.99 155.13 37.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.466 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.5 m -121.95 122.65 39.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.938 0.399 . . . . 0.0 110.392 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.25 -25.96 66.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.6 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.37 -48.69 21.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.066 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.7 -12.2 60.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.387 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.0 m80 49.74 41.69 22.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.491 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.3 t -136.45 144.97 44.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.407 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.403 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -110.88 114.38 27.67 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.295 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.73 133.24 55.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.064 0.459 . . . . 0.0 110.352 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.533 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.74 146.16 38.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.686 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.503 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 10.0 t90 -99.62 129.56 45.78 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.082 0.468 . . . . 0.0 110.089 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.01 153.76 39.78 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.144 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.407 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.4 Cg_endo -67.82 -18.11 47.22 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.741 2.294 . . . . 0.0 111.972 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.01 -18.83 0.33 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.507 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.503 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.61 165.05 25.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.521 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.15 -27.95 66.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.472 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.605 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.3 mt-30 -63.78 -41.28 97.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.642 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.55 -44.64 97.53 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.449 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.25 -38.9 92.69 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.004 0.43 . . . . 0.0 110.633 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.592 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.0 mmm -61.99 -41.21 97.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.159 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 74.8 mt -63.6 -47.22 82.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.949 0.404 . . . . 0.0 110.645 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.94 -32.09 52.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.049 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.94 -18.62 62.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.518 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.433 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.9 mt -88.01 -8.49 55.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.659 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.42 2.3 55.58 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -88.57 153.18 21.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.513 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.463 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.1 p -116.13 128.62 55.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.049 0.452 . . . . 0.0 110.421 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.74 146.14 23.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.831 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.476 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.65 151.65 45.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.526 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.68 131.4 43.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.347 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.896 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.57 93.3 27.15 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.121 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.678 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.6 Cg_exo -55.55 139.05 82.21 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.629 2.219 . . . . 0.0 111.635 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.05 -25.73 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.474 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.55 -50.11 27.46 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.554 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.8 mt -53.82 -37.31 63.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 0.0 110.252 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -66.73 36.06 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.769 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.554 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.1 88.46 0.01 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.829 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 86.7 p -81.02 -13.62 58.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.393 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -92.39 -41.49 10.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.548 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.92 -16.91 64.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.669 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.75 43.95 27.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.504 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.78 -148.67 8.03 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.63 142.98 48.92 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.996 0.426 . . . . 0.0 110.331 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.19 149.64 28.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.35 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -101.46 -151.69 0.42 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.305 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 56.19 -92.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.635 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.464 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.83 175.23 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.629 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.464 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.2 mt -122.4 141.79 41.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.676 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.98 169.55 9.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.285 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.7 mt -148.01 151.11 35.2 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.106 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.52 -39.05 97.23 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.97 4.21 4.7 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -77.57 -58.07 3.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.903 0.382 . . . . 0.0 110.577 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.552 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.9 m-20 -62.1 -36.71 82.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.301 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.403 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.0 mp -52.26 -67.75 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.748 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.31 -42.49 66.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.231 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.02 17.66 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.678 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.1 49.03 0.31 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.28 -109.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.609 0.242 . . . . 0.0 110.715 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.68 -45.06 95.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.47 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.4 7.96 84.02 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.85 -13.6 20.0 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.821 -0.223 . . . . 0.0 110.617 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.0 t 177.2 142.57 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.996 0.427 . . . . 0.0 110.5 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.05 125.34 11.54 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.998 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.432 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -98.66 143.31 29.18 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.8 178.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.6 mt -94.5 106.38 18.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.626 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.439 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.2 t80 -101.4 -12.5 18.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.254 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.66 90.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.749 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.32 173.63 46.03 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.46 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -73.91 -112.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.797 0.332 . . . . 0.0 110.72 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -68.02 -28.52 67.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.666 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -58.76 -44.12 90.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.386 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.64 -44.29 94.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.333 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.54 -60.31 3.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.267 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -50.95 -43.36 60.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.229 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.56 75.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.267 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.5 mt -64.56 -43.67 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.607 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -56.27 -37.34 69.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.241 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.54 0.79 18.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.28 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -115.22 91.24 27.05 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.242 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.26 -26.87 28.42 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.814 2.343 . . . . 0.0 111.84 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.5 -40.95 98.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.564 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.591 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.35 5.21 52.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.435 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.1 -35.07 69.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.717 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.6 4.65 15.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.538 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.99 120.99 80.03 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.559 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -47.24 -37.53 24.26 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.501 2.134 . . . . 0.0 112.451 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -59.1 -43.74 91.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.818 0.342 . . . . 0.0 110.323 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.91 -43.7 92.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.377 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.85 -40.54 95.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.483 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.437 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 44.3 t-20 -89.54 -12.72 39.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.601 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 62.03 31.37 17.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.809 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.37 43.72 1.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.417 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -103.95 136.02 38.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.489 -179.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -116.77 132.36 56.71 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.466 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.41 88.24 7.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.668 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.83 -40.85 97.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.821 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.439 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.6 167.24 34.14 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.51 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 76.3 p -75.68 -25.76 57.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.854 0.359 . . . . 0.0 110.746 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.0 tp10 -67.8 -34.62 77.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.427 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 94.6 m -73.53 25.44 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.714 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.605 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 60.8 t80 -58.18 -51.2 70.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.342 -0.39 . . . . 0.0 109.986 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.417 HH12 ' HG3' ' A' ' 212' ' ' GLN . 66.4 mmt-85 -112.02 155.24 24.11 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.433 ' CD2' HD11 ' A' ' 219' ' ' LEU . 45.5 tp -116.01 125.14 52.08 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.748 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.491 ' CB ' HD23 ' A' ' 83' ' ' LEU . 45.2 t0 -147.58 165.52 30.14 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.551 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -49.07 -38.1 23.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.512 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.71 -65.28 0.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.232 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -61.01 -32.79 72.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.51 -25.48 25.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.601 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.5 mtt -63.38 -41.09 98.77 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 120.924 0.392 . . . . 0.0 110.918 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.17 -43.91 22.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.978 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.569 HG21 HG23 ' A' ' 296' ' ' THR . 76.0 t -66.29 -42.88 91.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.417 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 52.1 tp -60.31 -47.23 86.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.546 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -69.74 -39.6 76.66 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.516 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.6 ttt180 -62.06 -38.24 88.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.217 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.6 mt -87.12 4.5 42.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.741 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.633 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.3 tttt -112.86 -11.23 13.48 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.038 0.447 . . . . 0.0 110.355 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.03 85.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.638 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.94 -48.82 80.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.366 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.134 179.804 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -89.63 -2.49 58.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.391 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.2 179.01 1.25 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.521 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.6 Cg_exo -60.66 145.13 99.39 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.718 2.279 . . . . 0.0 112.171 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.82 -179.4 8.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.655 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.91 137.4 52.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.39 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -125.05 147.11 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.437 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 79.1 p -120.24 136.26 54.71 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.788 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.18 -143.83 0.32 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.199 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -63.53 -37.23 86.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.441 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.57 -67.19 0.23 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.475 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.44 142.59 45.05 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.2 p -112.16 131.45 55.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 110.377 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -119.13 129.51 55.07 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.517 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 m -86.64 131.33 34.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.871 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.478 HD22 ' OE1' ' A' ' 42' ' ' GLN . 66.3 mt -96.96 79.37 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.496 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.75 -31.79 72.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.521 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.77 109.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.117 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.478 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.06 92.18 48.87 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.386 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 37.3 Cg_exo -57.08 148.72 67.28 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.724 2.283 . . . . 0.0 111.782 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.85 83.0 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 O-C-N 123.491 0.495 . . . . 0.0 110.927 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.49 67.11 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.293 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.09 130.75 35.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.604 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.559 ' HA ' HG23 ' A' ' 64' ' ' VAL . 56.1 t -122.62 146.47 27.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.067 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 t -135.88 143.47 45.05 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.679 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.6 p -99.06 -59.77 1.66 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.599 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.3 p -79.25 155.33 28.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.659 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.496 HG21 HG23 ' A' ' 70' ' ' THR . 70.8 t -74.06 -22.07 18.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.488 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.2 m -60.27 -52.05 66.92 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.484 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.6 mt -66.43 -42.18 88.09 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.312 0.577 . . . . 0.0 110.881 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.0 m -43.7 -53.78 5.56 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.19 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.22 -37.28 71.63 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.5 m -62.77 -44.61 95.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.826 0.346 . . . . 0.0 110.517 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.412 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.0 mt -66.22 -42.05 89.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.397 0.617 . . . . 0.0 110.652 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.57 -40.44 96.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.354 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.09 -35.77 75.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.066 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 156' ' ' LEU . 32.4 pt -91.36 28.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.256 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.53 51.68 10.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.875 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.4 75.83 22.13 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.924 0.393 . . . . 0.0 109.962 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.67 151.46 85.55 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.733 2.289 . . . . 0.0 112.382 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.48 136.87 48.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.185 0.517 . . . . 0.0 110.267 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.441 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -69.06 -43.58 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.299 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.03 131.18 53.42 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.025 0.44 . . . . 0.0 110.598 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.8 p -155.7 168.82 25.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.433 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.98 -177.07 21.57 Favored Glycine 0 N--CA 1.464 0.524 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.631 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.53 172.68 12.4 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 110.527 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.496 HG23 HG21 ' A' ' 51' ' ' VAL . 15.3 p -132.8 -112.52 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.96 0.41 . . . . 0.0 110.36 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.28 179.69 0.94 Allowed Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.368 -179.103 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.8 Cg_exo -60.91 58.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.978 2.452 . . . . 0.0 112.094 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.3 t-20 -64.57 -33.66 76.43 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.526 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.2 m-20 93.8 -36.76 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.064 0.852 . . . . 0.0 109.923 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -62.57 -39.48 93.81 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.24 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.1 p -74.35 -25.66 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.715 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.16 -171.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.617 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.86 -154.2 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.76 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 38.0 p-10 -52.53 -7.54 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.669 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.16 115.17 23.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.545 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.99 69.54 1.36 Allowed Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -143.12 147.37 34.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.937 0.399 . . . . 0.0 110.752 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.15 -98.47 0.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.204 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.0 -42.73 97.08 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.16 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.553 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.0 tt0 91.62 53.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.97 0.794 . . . . 0.0 110.907 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -103.27 -8.7 20.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.369 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.8 p -65.06 -33.85 77.03 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.1 0.476 . . . . 0.0 110.589 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.542 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.1 mttt -48.88 -24.05 1.32 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.644 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.45 -46.0 77.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.921 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.4 -48.42 81.31 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.071 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.57 -38.24 89.33 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.272 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.83 -32.52 53.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.272 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.605 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.7 mmt-85 -89.98 1.57 56.13 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.566 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.8 -49.24 0.17 Allowed 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.999 0.812 . . . . 0.0 110.3 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.659 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.28 154.21 0.29 Allowed 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.259 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.659 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 121.01 92.39 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 125.287 1.617 . . . . 0.0 110.476 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.7 mtp180 -75.47 143.43 42.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.057 0.456 . . . . 0.0 110.354 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.2 mt -132.44 27.07 4.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.461 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.36 138.23 34.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.548 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.7 mt -137.43 165.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.358 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.618 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.5 -28.81 1.77 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.55 70.96 7.46 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.15 0.5 . . . . 0.0 110.373 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.89 145.27 98.71 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.714 2.276 . . . . 0.0 112.075 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.9 t -134.4 136.37 43.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.485 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.81 -38.22 83.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.669 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.37 -42.28 96.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.496 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.49 98.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.494 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.3 t -63.65 -43.4 98.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.029 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.07 77.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.32 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.66 -18.69 60.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.464 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.36 -6.42 58.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.566 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 77.9 mtp 47.74 55.82 17.11 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.56 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.12 149.18 64.26 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.768 2.312 . . . . 0.0 112.109 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.28 -74.05 0.63 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.406 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.422 HD11 HD13 ' A' ' 140' ' ' LEU . 38.5 tp -110.3 113.13 25.55 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.264 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.3 mt -101.93 126.19 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.481 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.7 mt -109.19 133.28 53.22 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.202 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.16 139.31 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.533 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.9 p -83.57 168.54 16.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.677 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.21 -37.42 80.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.437 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -139.85 158.89 43.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.477 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.16 177.67 33.08 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.89 87.36 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -125.15 152.03 45.0 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.954 0.407 . . . . 0.0 110.555 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.3 t -63.34 141.24 58.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.36 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.84 10.54 10.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.684 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.9 mp -61.27 -39.02 88.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.973 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.74 -36.09 23.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.467 0.651 . . . . 0.0 110.612 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.2 mt -70.93 -35.34 72.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.447 0.641 . . . . 0.0 110.756 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -42.81 -62.68 0.94 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.27 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.7 p-10 -65.98 -42.59 89.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.067 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.4 -32.81 73.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.14 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.7 mt -73.44 -40.91 63.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.136 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.43 -48.78 79.58 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.167 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.0 m -53.01 -42.7 65.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.241 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.7 -43.2 93.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.106 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.47 154.27 5.56 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.599 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -39.24 106.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.624 2.216 . . . . 0.0 112.377 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 94.3 m -110.22 121.4 45.18 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.983 0.421 . . . . 0.0 110.218 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.37 152.89 30.78 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.233 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -129.09 131.38 68.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.428 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -115.01 127.9 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.553 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.2 t30 -101.74 103.65 14.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.278 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.2 p90 -101.19 -11.22 19.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.797 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.7 -33.74 76.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.631 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.571 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.6 p-10 -98.09 7.96 45.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.661 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.94 155.6 50.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.503 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.401 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.0 165.7 24.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.689 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.59 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.91 -48.52 81.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.244 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.79 -42.02 67.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.1 t -62.6 -41.17 98.81 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.356 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.406 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.4 tp -60.58 -44.35 96.32 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.441 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.45 -43.42 98.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.164 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -54.99 -44.87 74.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.797 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.67 -40.63 97.66 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.837 0.351 . . . . 0.0 110.289 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -62.03 -42.53 99.27 Favored 'General case' 0 CA--C 1.51 -0.558 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.245 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.01 -41.1 95.4 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.3 -46.17 64.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.953 0.406 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.66 -44.06 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.826 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.7 p -93.01 -8.86 41.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.567 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.93 26.9 72.4 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -102.06 50.65 0.84 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.849 0.357 . . . . 0.0 110.694 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -69.57 -39.44 77.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.677 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.78 -47.23 86.54 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.292 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -59.78 -39.57 85.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.275 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.94 -40.91 99.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.259 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.68 -28.89 70.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.522 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.04 -54.24 8.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.197 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.506 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.5 ttp180 -65.49 -42.16 92.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.494 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.4 mt -62.43 -43.77 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.524 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.62 -57.61 10.44 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.971 0.415 . . . . 0.0 110.515 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.66 -33.34 68.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.366 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.409 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.2 t80 -81.58 -36.52 28.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.856 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 170' ' ' ILE . 58.0 m-20 -55.46 -41.95 73.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.411 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.72 -42.17 99.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.646 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.34 -37.89 88.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.222 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.409 HD11 ' CD2' ' A' ' 173' ' ' PHE . 81.5 mt -62.43 -42.31 99.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.715 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.93 62.0 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.078 0.466 . . . . 0.0 110.677 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.36 -41.72 89.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.519 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.05 95.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.55 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.26 -32.15 73.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.409 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.65 -22.38 18.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.681 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.56 -41.23 96.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.651 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 184' ' ' ILE . 32.6 pt -76.95 136.46 24.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.659 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -126.83 108.27 10.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.291 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -177.04 125.81 0.3 Allowed Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.492 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.1 Cg_exo -44.02 152.44 0.38 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.806 2.337 . . . . 0.0 112.468 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.85 141.83 55.31 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.68 2.253 . . . . 0.0 112.48 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.55 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.16 146.98 2.14 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.602 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.06 154.57 70.3 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.817 2.345 . . . . 0.0 112.272 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.38 163.22 29.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.472 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -144.03 170.75 15.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.829 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.61 137.71 21.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.225 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.537 HG22 HD12 ' A' ' 205' ' ' LEU . 39.0 pt -134.45 147.14 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.617 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.43 132.05 57.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.148 0.499 . . . . 0.0 110.482 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -151.95 154.87 36.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.398 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.0 m -122.31 122.94 40.24 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.64 -25.83 66.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.623 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.22 -48.99 20.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.035 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.99 -11.03 60.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.373 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 76.8 m80 48.59 41.74 17.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.467 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.6 t -136.31 144.97 44.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.391 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.19 114.36 27.54 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.278 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.6 m-20 -119.79 133.41 55.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 110.376 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.537 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.81 146.24 37.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.79 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.498 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.6 t90 -99.26 129.94 45.52 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.083 0.468 . . . . 0.0 109.997 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.55 153.72 39.42 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.126 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.4 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.9 Cg_endo -67.95 -17.97 46.47 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.811 2.341 . . . . 0.0 111.852 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.24 -19.16 0.44 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.397 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.498 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.1 p -75.44 164.72 26.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.502 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.95 -27.72 65.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.504 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.585 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.0 mt-30 -63.85 -41.22 97.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.582 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.69 -44.52 97.81 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.41 -38.86 92.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.995 0.426 . . . . 0.0 110.578 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.59 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.1 mmm -62.24 -41.18 98.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.063 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.1 mt -63.78 -46.65 84.25 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.646 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.7 -31.84 58.58 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.7 -18.77 62.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.537 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.443 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.4 mt -87.39 -9.4 54.86 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.664 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.51 1.71 53.36 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -88.34 153.84 20.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.884 0.373 . . . . 0.0 110.469 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.444 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.0 p -116.41 128.84 55.86 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.071 0.462 . . . . 0.0 110.471 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.65 146.33 23.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.864 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.479 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.82 151.41 45.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.516 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.56 131.41 43.32 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.43 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.892 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.61 93.53 28.35 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.095 -179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.675 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.0 Cg_exo -55.85 139.07 83.62 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.556 2.171 . . . . 0.0 111.521 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.1 -26.05 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.503 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.18 -50.03 30.11 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.553 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.7 mt -53.99 -37.05 63.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -66.73 36.09 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.794 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.553 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.0 88.38 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.949 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 81.5 p -80.98 -14.08 58.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.398 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.85 -41.82 10.41 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.597 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.2 t -66.64 -16.96 64.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.621 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.76 44.01 26.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.507 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.75 -149.21 8.32 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.09 142.75 48.61 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.013 0.435 . . . . 0.0 110.339 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -151.95 149.61 29.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.368 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -101.32 -151.67 0.42 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.319 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.03 -92.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.689 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.468 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.85 175.38 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.596 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.468 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.2 mt -122.69 141.85 41.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.815 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.87 169.61 9.1 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.31 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.4 mt -147.82 150.9 35.04 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.21 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.65 -38.98 97.06 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.1 3.97 4.71 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -77.49 -57.98 3.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.897 0.38 . . . . 0.0 110.651 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.55 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.4 m-20 -62.09 -36.73 82.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.196 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 9.9 mp -52.38 -67.59 0.24 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.725 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.66 -42.24 67.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.154 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.92 17.42 0.17 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.649 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.37 48.76 0.33 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.31 -109.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.621 0.248 . . . . 0.0 110.753 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.479 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.7 m120 -60.94 -44.58 97.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.521 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.15 7.89 84.56 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.92 -13.54 19.94 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.748 -0.266 . . . . 0.0 110.732 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.5 t 177.08 142.52 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.131 0.491 . . . . 0.0 110.504 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.95 125.47 11.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.106 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 191' ' ' VAL . 14.0 m-30 -98.42 143.72 28.56 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 120.937 0.399 . . . . 0.0 110.711 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.2 mt -95.22 106.28 18.29 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.727 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.442 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.0 t80 -101.79 -11.81 18.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.221 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.96 -40.75 87.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.831 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.9 173.2 45.81 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.472 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -74.06 -113.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 110.709 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.28 -28.76 68.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.725 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.01 -43.89 91.61 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.27 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -63.62 -44.33 94.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.31 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.65 -60.02 3.75 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.266 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.09 -43.38 61.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.102 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.43 -43.57 75.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.161 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.56 -43.66 96.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.615 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -56.22 -37.59 69.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.156 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.5 0.93 18.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.259 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -115.12 91.51 27.63 Favored Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.167 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.4 -27.09 30.13 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.846 2.364 . . . . 0.0 111.717 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.536 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.41 -41.2 98.72 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.558 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.9 mp -95.1 4.9 53.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.432 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.08 70.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.703 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -79.97 4.53 16.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.615 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.64 121.29 80.49 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.536 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -47.49 -37.65 26.38 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.408 2.072 . . . . 0.0 112.424 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.527 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -59.03 -43.63 91.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.792 0.329 . . . . 0.0 110.289 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.05 -43.86 92.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.279 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.82 -40.65 95.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.519 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.9 t-20 -89.54 -12.92 38.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.541 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.35 32.7 16.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.49 43.87 1.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.341 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.48 135.67 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.539 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.72 132.62 56.64 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.469 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.32 89.01 7.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.7 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.411 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.1 mt -63.9 -41.11 97.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.783 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.95 165.57 34.09 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.52 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 76.5 p -75.44 -25.74 57.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.865 0.364 . . . . 0.0 110.665 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -68.35 -34.49 76.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.345 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 296' ' ' THR . 95.3 m -72.98 25.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.722 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.585 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 39.6 t80 -58.53 -50.36 74.05 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.408 HH12 ' HG3' ' A' ' 212' ' ' GLN . 79.1 mmt-85 -111.05 153.48 25.56 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.443 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.9 tp -115.53 125.03 52.51 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.691 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.482 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.4 t0 -147.88 165.71 29.81 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.614 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -49.3 -38.16 26.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.509 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -71.23 -65.47 0.74 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.421 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -60.96 -32.73 72.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.962 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.4 -25.61 25.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.634 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.6 mtt -63.5 -41.02 98.55 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 120.905 0.383 . . . . 0.0 111.003 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -78.7 -44.03 24.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.067 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.58 HG21 HG23 ' A' ' 296' ' ' THR . 76.6 t -66.18 -42.99 92.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.352 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.9 tp -60.14 -47.27 86.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.481 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -69.7 -39.66 76.79 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.634 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.4 ttt180 -61.63 -38.67 88.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.19 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -86.84 4.42 41.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.759 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.59 -11.19 13.61 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.018 0.437 . . . . 0.0 110.28 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.83 -37.12 85.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.632 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.19 -48.63 80.65 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.326 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.975 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.618 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.75 -2.4 58.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.38 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.484 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.12 179.06 1.24 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.047 0.451 . . . . 0.0 110.514 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.6 Cg_exo -60.98 145.1 99.57 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.773 2.316 . . . . 0.0 112.169 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.618 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.77 -179.31 8.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.553 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.7 136.88 52.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.355 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.0 tp -124.64 147.44 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.372 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.4 p -120.39 136.1 54.83 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.767 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.5 -143.47 0.33 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.25 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.41 -37.3 86.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.477 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.1 -66.85 0.22 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.467 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.64 142.48 45.61 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.2 p -112.2 131.71 55.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.951 0.405 . . . . 0.0 110.401 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.15 128.89 54.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.53 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.2 m -85.49 130.36 34.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.237 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.472 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.8 mt -95.71 78.75 3.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.306 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.6 -32.19 73.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.493 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 176.03 109.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.099 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.472 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -122.55 91.59 49.35 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.28 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.2 Cg_exo -56.95 148.54 67.19 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.794 2.329 . . . . 0.0 111.869 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.15 82.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.595 0.56 . . . . 0.0 111.022 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.43 66.82 0.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.227 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.85 130.83 35.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.697 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.572 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.7 t -122.57 147.43 26.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.079 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 t -136.62 143.74 43.69 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.65 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.7 p -99.22 -59.48 1.72 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.572 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.0 p -79.01 155.46 28.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.688 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.538 HG21 HG23 ' A' ' 70' ' ' THR . 70.3 t -74.43 -21.9 17.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.557 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.2 m -60.22 -51.87 67.72 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.503 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.4 mt -66.56 -42.4 87.15 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.319 0.58 . . . . 0.0 110.905 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.5 m -43.37 -53.83 5.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.065 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.27 -37.84 71.35 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.7 m -62.5 -44.45 96.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.846 0.355 . . . . 0.0 110.34 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.408 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.5 mt -65.99 -42.14 90.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.464 0.65 . . . . 0.0 110.714 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tp -62.57 -40.13 95.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.453 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.517 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.48 -36.11 77.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.134 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 156' ' ' LEU . 33.3 pt -90.9 28.29 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.208 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.81 51.82 10.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.939 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.83 75.75 24.45 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.974 0.416 . . . . 0.0 109.889 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.18 150.63 87.93 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.781 2.32 . . . . 0.0 112.213 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.36 136.88 48.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.198 0.523 . . . . 0.0 110.282 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.25 -43.55 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.307 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.11 131.19 53.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.006 0.431 . . . . 0.0 110.553 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.6 p -155.46 168.61 26.54 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.399 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.69 -177.42 21.75 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.637 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.77 172.86 12.2 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 120.881 0.372 . . . . 0.0 110.518 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.538 HG23 HG21 ' A' ' 51' ' ' VAL . 14.7 p -132.41 -113.16 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.374 . . . . 0.0 110.312 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.87 179.85 0.92 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.353 -179.02 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.8 Cg_exo -61.23 57.74 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.988 2.458 . . . . 0.0 112.137 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.545 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 60.4 t-20 -64.37 -33.38 75.71 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.468 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 42.7 m-20 93.76 -35.68 0.02 OUTLIER 'General case' 0 C--N 1.345 0.403 0 O-C-N 124.182 0.926 . . . . 0.0 109.804 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.6 mtp85 -63.05 -39.86 95.98 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.989 0.423 . . . . 0.0 110.267 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -74.73 -25.33 18.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.738 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.03 -171.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.599 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -73.3 -154.16 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.787 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.2 p-10 -52.11 -7.71 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.684 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -86.34 115.1 23.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.594 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.18 70.06 1.34 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -143.57 147.46 34.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.931 0.396 . . . . 0.0 110.784 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.57 -98.48 0.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.137 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.87 -42.74 97.44 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.129 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.569 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.6 tt0 91.68 53.13 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.066 0.854 . . . . 0.0 110.892 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -102.95 -9.31 19.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.419 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -64.54 -34.26 77.82 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.173 0.511 . . . . 0.0 110.664 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.569 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.1 mttt -48.91 -24.79 1.61 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.597 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.2 -45.66 79.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.792 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.25 -48.47 81.28 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.038 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.48 -38.35 89.52 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.364 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.67 -33.0 53.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.176 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.592 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.1 mmt-85 -89.72 1.47 56.03 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.598 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.92 -49.13 0.16 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 124.159 0.912 . . . . 0.0 110.288 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.64 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.1 mt -46.52 153.79 0.34 Allowed 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 117.403 -1.284 . . . . 0.0 109.264 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.64 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 121.62 92.62 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 O-C-N 125.625 1.828 . . . . 0.0 110.431 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.533 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.7 143.29 42.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.122 0.487 . . . . 0.0 110.276 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.3 mt -132.42 27.06 4.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.453 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.37 138.07 34.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.036 0.446 . . . . 0.0 110.512 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.9 mt -137.17 164.98 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.401 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.614 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.13 -28.63 1.83 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -153.01 70.93 7.1 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.167 0.508 . . . . 0.0 110.232 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.12 145.48 98.37 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.715 2.277 . . . . 0.0 112.089 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.5 t -134.2 136.61 43.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.563 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.35 82.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.649 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.31 -42.18 96.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.512 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.57 98.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.478 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.66 -43.31 98.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.961 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.2 77.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.26 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.48 -18.7 60.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.438 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.39 -6.44 58.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.523 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 72.4 mtp 47.94 55.85 17.23 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.617 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.16 148.99 63.72 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.798 2.332 . . . . 0.0 112.098 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.15 -73.04 0.66 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.501 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 140' ' ' LEU . 37.9 tp -111.32 113.64 26.26 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.313 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.4 mt -102.6 126.37 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.537 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.3 mt -109.77 134.06 52.44 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.143 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.77 139.87 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.496 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.4 p -83.4 168.45 16.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.707 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.16 -37.4 80.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.41 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -139.99 159.21 42.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.433 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.27 177.28 33.37 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.24 -33.87 87.36 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.57 151.74 44.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.904 0.383 . . . . 0.0 110.543 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -63.39 140.85 58.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.32 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.54 10.66 11.16 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.657 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.18 -39.04 88.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.092 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.633 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.86 23.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.586 0.708 . . . . 0.0 110.611 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.0 mt -70.76 -35.65 72.72 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.531 0.681 . . . . 0.0 110.764 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.88 -62.96 0.88 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.273 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.633 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.89 -42.64 90.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.046 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -62.17 -32.77 73.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.177 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.5 mt -73.48 -40.9 63.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.24 -48.85 79.11 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.16 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.3 m -52.9 -42.58 65.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.199 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.74 -43.05 93.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.107 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.75 153.89 5.15 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.62 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -39.12 106.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.664 2.243 . . . . 0.0 112.406 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.64 ' C ' HD12 ' A' ' 140' ' ' LEU . 96.8 m -110.33 121.52 45.47 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.244 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.64 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.02 152.96 30.19 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.26 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.9 131.0 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.309 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -114.79 127.78 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.432 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.3 103.75 14.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.278 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 147' ' ' LYS . 45.5 p90 -101.45 -11.2 19.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.783 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.69 -33.61 76.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.666 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -98.21 7.79 45.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.525 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.76 155.46 50.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.527 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.7 p -74.89 165.71 24.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.709 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -60.05 -48.65 80.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.197 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.79 -42.02 67.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.923 0.392 . . . . 0.0 110.027 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.8 t -62.63 -41.11 98.83 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.358 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.409 ' CD1' HG21 ' A' ' 142' ' ' ILE . 47.4 tp -60.7 -44.17 96.89 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.353 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.4 tp -61.5 -43.22 99.26 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.101 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -55.31 -44.88 76.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.52 -40.65 97.44 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.894 0.378 . . . . 0.0 110.327 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -61.95 -42.46 99.14 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.31 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.88 -40.62 95.54 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.58 -45.86 64.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.926 0.393 . . . . 0.0 110.855 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.67 -44.04 96.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.85 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.3 p -93.19 -8.61 41.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.588 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.78 26.34 72.08 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -101.47 50.75 0.85 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.768 0.318 . . . . 0.0 110.67 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.58 -39.36 77.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.659 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.5 -47.17 86.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.234 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -60.19 -39.45 86.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.308 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.1 99.37 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.307 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.94 -28.69 70.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.994 0.426 . . . . 0.0 110.602 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.19 -54.24 8.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.15 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.517 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.4 ttp180 -65.55 -42.25 92.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.477 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.454 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.3 mt -62.45 -43.94 98.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.492 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.48 -58.96 5.71 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.14 0.495 . . . . 0.0 110.48 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -56.51 -34.16 66.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.448 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -80.79 -36.21 32.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.886 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.7 m-20 -55.1 -42.26 72.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.095 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.42 -41.82 98.98 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.686 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.05 -38.19 90.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.285 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.7 mt -62.38 -42.11 99.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.771 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.47 63.87 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.084 0.469 . . . . 0.0 110.677 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.35 -41.79 89.02 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.601 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.06 -39.94 95.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.566 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.12 -32.43 73.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.361 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.24 -21.97 18.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.668 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.625 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.67 -41.35 96.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.64 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 pt -76.59 135.92 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.677 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.93 107.79 10.39 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.273 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.67 125.97 0.31 Allowed Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.541 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 73.9 Cg_exo -43.72 152.24 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.781 2.32 . . . . 0.0 112.601 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.87 141.98 55.75 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.573 2.182 . . . . 0.0 112.484 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.547 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.22 147.32 2.19 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.628 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.34 154.85 68.79 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.735 2.29 . . . . 0.0 112.284 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.56 163.27 28.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.419 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.84 170.8 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.959 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.92 137.92 21.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.93 0.395 . . . . 0.0 110.195 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.542 HG22 HD12 ' A' ' 205' ' ' LEU . 40.1 pt -134.47 147.37 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.692 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -133.2 131.95 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.098 0.475 . . . . 0.0 110.501 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -151.99 155.08 37.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.442 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.615 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.6 m -122.33 122.84 40.0 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.96 0.41 . . . . 0.0 110.366 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.2 -25.78 65.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.613 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.615 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.49 -48.46 22.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.069 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.07 -11.21 60.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.386 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.6 m80 48.25 41.55 16.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.485 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.3 t -135.89 145.22 46.08 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.42 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.406 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -110.94 114.02 27.03 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.233 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.63 133.13 55.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 110.351 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.542 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.77 146.24 37.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.772 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.468 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 10.3 t90 -99.36 129.77 45.59 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.096 0.475 . . . . 0.0 109.973 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.59 153.81 39.37 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.306 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.414 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.8 Cg_endo -67.76 -18.39 47.56 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.716 2.277 . . . . 0.0 111.954 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.1 -18.44 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.4 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.468 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.3 p -76.42 164.69 25.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.508 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.78 -27.64 65.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.514 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.603 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.1 mt-30 -63.75 -41.1 98.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.77 -44.48 97.93 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.63 -38.63 91.68 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.961 0.41 . . . . 0.0 110.575 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.3 mmm -62.16 -41.35 98.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.082 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.71 -46.91 83.28 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.534 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.5 -31.91 56.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.073 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.79 -18.68 62.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.449 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.414 HD11 ' CD2' ' A' ' 299' ' ' LEU . 92.1 mt -87.61 -9.31 54.64 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.61 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.29 1.9 54.04 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -88.34 153.77 20.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 110.516 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.458 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.3 p -116.56 129.02 55.94 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.119 0.485 . . . . 0.0 110.331 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -93.02 146.21 23.79 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.927 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.477 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.41 151.48 46.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.49 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.39 131.41 43.63 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.397 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.891 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.54 93.3 27.01 Favored Pre-proline 0 C--O 1.234 0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.077 -179.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.677 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.6 Cg_exo -55.75 138.96 82.94 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.569 2.179 . . . . 0.0 111.527 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.84 -25.59 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.46 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.26 -49.96 29.96 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.552 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.0 mt -54.0 -36.8 63.34 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.85 36.42 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.814 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.75 86.94 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.905 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.1 p -79.4 -15.39 57.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.405 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -92.19 -41.29 10.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.627 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -66.03 -17.94 65.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.605 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.17 43.37 26.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.468 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.49 -147.76 7.46 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.97 142.66 50.08 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.026 0.441 . . . . 0.0 110.294 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.43 149.82 28.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.353 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -101.3 -151.55 0.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.347 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.4 t0 56.16 -91.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.652 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.471 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.85 175.35 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.559 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.471 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 93.4 mt -122.29 141.76 41.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.833 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.81 169.02 9.53 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.221 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.5 mt -147.68 151.07 35.53 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.266 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.69 -39.0 97.06 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.06 4.0 4.72 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.27 -58.06 3.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.996 0.426 . . . . 0.0 110.578 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.541 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.8 m-20 -62.22 -36.93 83.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.212 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.406 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.1 mp -52.21 -67.61 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.778 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.71 -42.13 67.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.132 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.0 17.71 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.607 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.25 48.46 0.31 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.47 -109.79 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.605 0.24 . . . . 0.0 110.7 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.9 -44.59 96.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.42 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.21 7.95 84.38 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -98.91 -13.33 20.05 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.713 -0.286 . . . . 0.0 110.693 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.6 t 177.03 142.71 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.089 0.471 . . . . 0.0 110.498 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.06 125.49 11.64 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.176 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.6 m-30 -98.65 143.26 29.23 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 120.923 0.392 . . . . 0.0 110.809 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.9 mt -94.42 106.32 18.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.678 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.451 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.9 t80 -101.58 -11.55 19.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.108 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.43 87.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.874 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.74 174.12 46.32 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.475 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.4 m-20 -74.35 -113.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.741 0.305 . . . . 0.0 110.772 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.78 -28.69 67.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.708 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.03 -43.93 91.68 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.271 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.72 -44.26 94.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.377 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.52 -60.14 3.59 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.247 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.11 -43.26 61.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.17 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.53 -43.68 75.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.2 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.2 mt -64.47 -43.65 96.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.664 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -56.31 -37.39 69.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.162 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.77 0.95 18.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.197 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -115.05 91.31 26.5 Favored Pre-proline 0 CA--C 1.529 0.147 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.148 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.29 -27.2 29.76 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.796 2.33 . . . . 0.0 111.832 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.36 -41.02 98.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.569 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.45 5.22 52.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.349 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.97 -35.21 69.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.695 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.58 4.56 15.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.527 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.58 121.33 80.51 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.566 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -47.6 -37.69 27.25 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.397 2.065 . . . . 0.0 112.558 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.53 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.94 -43.57 91.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.856 0.36 . . . . 0.0 110.305 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.88 -43.89 92.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.285 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.91 -40.59 95.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.444 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.437 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.7 t-20 -89.32 -12.93 39.13 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.529 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.5 mtmt 62.32 31.94 17.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.893 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -89.01 43.87 1.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.046 0.45 . . . . 0.0 110.313 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.51 135.87 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.444 -179.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -116.61 132.55 56.65 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.485 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.1 87.84 7.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.769 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.86 -41.23 97.83 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.866 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.451 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.46 167.65 34.58 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.516 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 71.2 p -75.53 -25.69 57.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.845 0.355 . . . . 0.0 110.763 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.4 tp10 -67.84 -34.86 77.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.452 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 95.7 m -73.27 24.59 0.06 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.65 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.603 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 65.5 t80 -58.23 -51.18 70.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.421 HH12 ' HG3' ' A' ' 212' ' ' GLN . 58.9 mmt-85 -112.17 155.1 24.5 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.414 ' CD2' HD11 ' A' ' 219' ' ' LEU . 46.1 tp -116.3 125.64 52.43 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.49 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.0 t0 -147.29 165.3 30.52 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.573 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -49.41 -38.2 28.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.548 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -72.23 -64.8 0.87 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.509 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.3 -32.11 70.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.984 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.66 -25.3 26.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.571 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.6 mtt -63.08 -41.18 99.35 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 120.965 0.412 . . . . 0.0 110.953 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -78.33 -44.79 24.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.095 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.554 HG21 HG23 ' A' ' 296' ' ' THR . 73.6 t -66.0 -43.06 92.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.435 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.441 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 52.7 tp -60.26 -47.37 86.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.548 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.94 -39.39 76.11 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.635 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.1 ttt180 -61.96 -38.07 87.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.233 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.8 mt -87.38 4.61 42.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.794 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.625 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.3 tttt -112.87 -11.7 13.4 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.045 0.45 . . . . 0.0 110.284 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.04 -37.31 86.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.539 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.95 -48.69 80.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.379 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.022 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.56 -2.53 57.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.43 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.488 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.61 179.03 1.25 Allowed Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.457 -179.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.7 Cg_exo -60.81 144.7 99.6 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.796 2.331 . . . . 0.0 112.183 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.98 -179.65 8.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.596 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.61 136.27 53.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.317 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -123.91 146.65 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.333 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.3 p -119.91 136.0 54.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.77 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.1 p30 -99.42 -143.62 0.33 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.225 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -63.4 -37.19 86.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.593 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.9 ttt85 -149.3 -66.62 0.22 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.501 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.29 142.1 45.16 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.8 p -112.15 131.03 55.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.934 0.397 . . . . 0.0 110.437 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -118.92 129.08 54.99 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.542 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.6 m -85.67 130.64 34.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.214 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.1 mt -96.0 78.77 3.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.343 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.81 -32.0 73.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.473 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.12 108.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.164 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.489 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.5 pt20 -121.65 91.4 48.52 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.304 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.652 ' O ' ' N ' ' A' ' 45' ' ' ARG . 37.1 Cg_exo -57.0 148.59 67.44 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.738 2.292 . . . . 0.0 111.824 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.69 82.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.556 0.535 . . . . 0.0 111.018 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.14 66.85 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.046 0.45 . . . . 0.0 110.251 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.44 131.0 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.614 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.544 ' HA ' HG23 ' A' ' 64' ' ' VAL . 56.7 t -122.89 145.54 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.146 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -135.52 143.32 45.7 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.623 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.0 p -99.26 -59.19 1.77 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.552 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.9 p -79.52 154.97 28.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.647 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 70' ' ' THR . 70.8 t -74.58 -21.79 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.57 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.5 m -60.12 -52.18 66.45 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.434 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.6 -42.4 86.94 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.245 0.545 . . . . 0.0 110.873 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -42.82 -53.64 4.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.153 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.45 -37.75 69.56 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.9 m -62.56 -44.62 95.88 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.884 0.373 . . . . 0.0 110.459 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.418 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.8 mt -66.19 -41.94 89.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.38 0.61 . . . . 0.0 110.739 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.65 -40.15 96.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.324 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.466 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.03 -35.91 76.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.94 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 156' ' ' LEU . 31.4 pt -91.31 28.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.118 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.54 51.64 10.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.819 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.02 75.93 23.12 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.95 0.405 . . . . 0.0 110.003 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.4 151.77 84.06 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.746 2.298 . . . . 0.0 112.265 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.544 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.85 137.42 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.149 0.499 . . . . 0.0 110.316 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.447 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.5 pt -69.26 -43.61 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.219 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.78 130.96 53.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.926 0.393 . . . . 0.0 110.547 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.5 p -155.75 168.99 25.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.44 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.75 -177.44 21.71 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -132.67 171.86 13.3 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 120.943 0.402 . . . . 0.0 110.531 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.493 HG23 HG21 ' A' ' 51' ' ' VAL . 12.4 p -133.45 -111.02 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.426 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.91 179.61 0.95 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.303 -179.171 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.6 Cg_exo -60.88 58.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.953 2.436 . . . . 0.0 112.129 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.1 t-20 -64.24 -35.21 80.09 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.483 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 48.3 m-20 95.26 -37.65 0.01 OUTLIER 'General case' 0 C--N 1.345 0.401 0 O-C-N 124.113 0.883 . . . . 0.0 110.008 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -62.61 -39.87 95.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.2 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.9 p -73.81 -26.41 21.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.689 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -50.06 -172.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.547 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.05 -152.79 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.711 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.7 p-10 -54.37 -6.66 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.685 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.493 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -86.92 113.82 23.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.559 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.15 72.73 1.28 Allowed Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.84 148.05 34.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 0.0 110.809 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.25 -99.47 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.109 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.554 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.86 -43.11 97.09 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.252 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.4 tt0 91.74 52.8 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.916 0.76 . . . . 0.0 110.861 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -103.32 -9.21 19.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.457 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.3 p -64.79 -33.86 76.98 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.049 0.452 . . . . 0.0 110.679 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.554 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.66 -23.67 1.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.516 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.3 t -69.7 -45.88 76.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.889 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.23 -48.6 80.74 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.165 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.67 -38.12 89.11 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.337 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.63 -32.51 51.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.218 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.605 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.3 mmt-85 -89.76 1.62 55.88 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.575 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.84 -49.08 0.16 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 124.045 0.841 . . . . 0.0 110.331 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.662 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.7 mt -46.49 154.3 0.3 Allowed 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 117.89 -1.053 . . . . 0.0 109.349 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.662 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 121.17 92.36 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 125.313 1.633 . . . . 0.0 110.502 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.39 143.26 42.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.251 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.9 mt -131.77 26.83 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.758 0.313 . . . . 0.0 110.481 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.42 138.08 34.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.969 0.414 . . . . 0.0 110.506 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.63 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.0 mt -137.17 165.19 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.432 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.615 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.04 -28.51 1.85 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -153.01 70.65 7.07 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.178 0.513 . . . . 0.0 110.362 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.12 145.52 98.28 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.772 2.315 . . . . 0.0 112.053 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.5 t -134.1 137.0 44.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.59 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.2 -38.17 81.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.666 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.41 -42.23 96.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.529 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.7 98.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.503 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 64.2 t -63.72 -43.33 97.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.066 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.65 -35.32 77.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.332 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.8 -18.36 59.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.484 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.52 -6.44 58.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.508 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.413 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.9 mtp 48.15 55.78 17.26 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.588 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.05 148.98 64.39 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.844 2.363 . . . . 0.0 112.133 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.28 -73.1 0.66 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.424 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 140' ' ' LEU . 38.7 tp -111.33 112.42 24.18 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.305 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.4 mt -100.55 126.07 54.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.476 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.4 mt -109.36 133.16 53.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.203 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.55 139.55 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.526 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.9 p -83.43 168.25 16.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.673 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.23 -37.48 80.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.494 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -139.03 158.96 43.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.502 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.44 176.8 33.71 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.83 87.16 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.93 151.55 45.28 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.876 0.369 . . . . 0.0 110.604 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.2 t -62.93 141.17 58.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.291 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.05 10.51 10.77 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.664 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.07 -39.07 88.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.031 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.83 -35.7 24.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.452 0.644 . . . . 0.0 110.654 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.3 mt -71.11 -35.31 71.73 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.437 0.637 . . . . 0.0 110.772 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -42.87 -62.93 0.89 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.185 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.76 -42.82 90.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -62.12 -32.65 73.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.204 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.8 mt -74.03 -40.46 62.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.054 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.16 -48.81 79.13 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.209 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.3 m -52.88 -42.44 65.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.194 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.15 -43.05 92.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.103 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.35 153.37 5.3 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.632 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -39.18 107.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.643 2.229 . . . . 0.0 112.326 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.3 m -109.09 121.38 45.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.285 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.36 152.89 30.76 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.26 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.95 131.45 68.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.365 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.07 127.72 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.493 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.4 t30 -101.86 103.67 14.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.324 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 49.6 p90 -101.23 -11.27 19.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.751 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.9 p-10 -64.78 -33.44 76.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.652 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.577 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.1 p-10 -98.31 7.41 46.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.584 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.14 155.35 50.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.572 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.408 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.2 p -74.65 165.7 24.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.664 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.588 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -59.99 -48.86 79.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.281 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -53.84 -41.99 68.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.104 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.2 t -62.49 -40.82 97.92 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.451 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 156' ' ' LEU . 48.7 tp -60.61 -43.75 97.1 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.297 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.507 HD22 HH21 ' A' ' 169' ' ' ARG . 44.6 tp -61.4 -43.2 99.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.826 0.346 . . . . 0.0 110.213 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.7 m -55.63 -45.37 77.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.833 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.35 -40.76 97.43 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-O 120.847 0.356 . . . . 0.0 110.377 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -61.88 -42.38 98.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.184 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.63 -40.76 96.1 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.77 -46.15 63.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.941 0.401 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.52 -43.98 96.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.766 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.2 p -93.21 -8.49 42.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.585 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.69 25.32 71.63 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -101.8 52.09 0.83 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.779 0.323 . . . . 0.0 110.623 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.84 -39.07 76.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.629 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.3 -47.17 86.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.262 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -61.33 -38.97 88.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.413 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.4 97.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.324 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.41 -27.69 69.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.491 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.77 -53.75 8.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.207 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.507 HH21 HD22 ' A' ' 153' ' ' LEU . 61.8 ttp180 -63.78 -43.51 96.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.458 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.1 mt -63.08 -43.88 99.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.654 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.35 -61.62 2.41 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.118 0.485 . . . . 0.0 110.377 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.66 -35.08 63.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.457 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -79.6 -34.77 40.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.004 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.6 m-20 -56.49 -40.12 74.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.112 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.95 -42.41 99.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.686 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.79 -37.72 87.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.309 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 177' ' ' LEU . 82.0 mt -62.44 -42.45 99.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.737 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.09 -53.17 59.18 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.059 0.457 . . . . 0.0 110.679 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.12 -41.77 90.08 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.562 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.93 95.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.647 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.17 -32.26 73.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.419 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.3 -21.97 18.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.719 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.637 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.94 -41.4 95.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.68 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 pt -77.48 136.14 24.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.666 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.26 108.69 11.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.351 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.5 126.14 0.32 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.559 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.457 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.4 Cg_exo -43.68 152.02 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.742 2.295 . . . . 0.0 112.598 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.03 141.66 53.81 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.605 2.203 . . . . 0.0 112.465 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.12 147.34 2.23 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.62 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.28 154.62 69.37 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.74 2.293 . . . . 0.0 112.26 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.52 163.2 28.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.446 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.82 170.1 16.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.853 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.51 137.75 21.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.238 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.546 HG22 HD12 ' A' ' 205' ' ' LEU . 39.7 pt -134.29 146.71 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.288 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.654 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.76 131.77 59.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.099 0.476 . . . . 0.0 110.53 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -152.05 155.11 37.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.369 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.624 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.5 m -122.62 122.92 39.98 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.924 0.393 . . . . 0.0 110.401 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.11 -25.71 65.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.601 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.624 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.42 -48.97 20.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.091 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.62 -13.25 61.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.442 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.3 m80 50.72 41.36 26.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.503 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 43.3 t -136.32 144.68 44.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.344 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.14 114.18 27.47 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.315 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.1 m-20 -119.74 133.35 55.65 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.972 0.415 . . . . 0.0 110.372 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.546 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.07 146.32 38.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.735 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.478 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.2 t90 -99.5 129.8 45.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.108 0.48 . . . . 0.0 110.059 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.48 154.14 39.37 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.086 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.7 Cg_endo -67.8 -17.93 47.26 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.742 2.295 . . . . 0.0 111.933 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.56 -18.43 0.43 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.457 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.478 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.83 165.26 25.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.523 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.26 -28.17 66.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.491 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.526 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.51 -41.63 98.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.705 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.84 -44.95 96.59 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.44 -39.01 93.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.949 0.404 . . . . 0.0 110.612 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.588 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.4 mmm -62.08 -41.31 98.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.226 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.71 -47.14 82.33 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.64 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.33 -32.05 55.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.095 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.71 -18.3 62.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.496 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.43 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.1 mt -88.53 -8.6 54.53 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.691 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.74 2.43 55.25 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -88.55 152.63 21.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.0 110.499 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.448 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.2 p -115.5 128.32 55.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.077 0.465 . . . . 0.0 110.42 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.563 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.52 146.1 23.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.899 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.469 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.37 151.05 46.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.49 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.76 131.47 43.0 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.463 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.893 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.62 93.41 27.93 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.142 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.679 ' C ' ' H ' ' A' ' 229' ' ' GLY . 47.5 Cg_exo -55.65 139.16 82.79 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.62 2.213 . . . . 0.0 111.558 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.99 -25.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.445 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.71 -49.81 27.97 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.0 mt -53.97 -37.14 63.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.56 35.99 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.782 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.2 88.18 0.01 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.844 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.9 p -81.33 -14.31 57.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.356 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.64 -41.19 10.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.567 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.8 t -66.84 -16.72 64.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.607 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.06 43.53 26.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.469 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.91 -147.1 7.25 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -122.49 143.16 49.88 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.994 0.426 . . . . 0.0 110.389 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -151.97 149.47 28.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.453 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -100.72 -151.94 0.42 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.392 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 55.92 -92.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.648 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.464 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.54 175.08 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.565 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.464 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.5 mt -121.83 141.43 42.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.726 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.75 169.22 9.4 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.281 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.4 mt -147.83 150.85 34.95 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.182 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.65 -38.95 97.01 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.15 4.13 4.64 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.37 -58.15 3.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.922 0.392 . . . . 0.0 110.579 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.552 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.1 m-20 -62.13 -36.86 83.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.271 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.28 -67.81 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.722 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.33 -42.11 66.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.185 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.14 18.12 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.64 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.79 48.61 0.27 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.41 -109.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.6 0.238 . . . . 0.0 110.726 -178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.469 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 12.0 m120 -60.89 -44.72 96.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.425 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.41 8.13 83.76 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -99.13 -12.74 20.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.58 0.229 . . . . 0.0 110.715 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.8 t 176.37 142.42 0.07 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.062 0.458 . . . . 0.0 110.533 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.88 125.39 11.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.03 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 191' ' ' VAL . 14.0 m-30 -98.6 143.03 29.44 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 120.85 0.357 . . . . 0.0 110.817 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.1 mt -94.33 106.5 18.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.675 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.463 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.3 t80 -102.28 -11.65 18.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.25 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.08 -40.15 86.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.804 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.11 173.68 46.14 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.5 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.0 m-20 -74.45 -112.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.347 . . . . 0.0 110.618 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.13 -28.72 67.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.728 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.85 -44.17 90.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.296 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -63.35 -44.54 94.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.353 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.34 -59.92 3.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.29 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.16 -43.32 61.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.221 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.38 -43.92 75.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.216 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.4 mt -64.42 -43.63 97.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.589 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -56.71 -37.43 70.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.172 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.96 1.03 18.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.251 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.0 91.35 26.43 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.195 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.01 -27.19 27.75 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.743 2.296 . . . . 0.0 111.87 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.34 -41.19 98.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.634 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.9 mp -95.21 5.11 52.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.41 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.72 -35.09 70.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.683 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.8 4.7 15.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.528 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.95 121.08 80.32 Favored Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.556 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -47.27 -37.8 24.94 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.507 2.138 . . . . 0.0 112.487 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.9 -43.82 91.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.294 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.82 -43.72 93.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.303 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.6 -40.52 95.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.539 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -90.32 -11.94 39.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.53 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.86 32.38 18.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.884 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.77 44.0 1.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.385 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.34 135.74 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.566 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.44 133.03 56.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.435 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.497 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.69 87.95 7.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.686 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.91 -41.47 97.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.834 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.16 167.93 34.42 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.8 p -75.9 -25.82 56.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.84 0.352 . . . . 0.0 110.691 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.4 tp10 -67.84 -34.32 76.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.39 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.763 HG22 ' O ' ' A' ' 296' ' ' THR . 97.1 m -73.14 19.7 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.631 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.526 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 53.1 t80 -57.25 -51.08 70.8 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.058 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.401 HH12 ' HG3' ' A' ' 212' ' ' GLN . 68.5 mmt-85 -108.05 149.36 28.53 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.43 ' CD2' HD11 ' A' ' 219' ' ' LEU . 42.3 tp -115.46 125.57 53.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.756 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.47 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.6 t0 -149.37 166.61 28.52 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.632 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -49.15 -38.14 24.47 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.588 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.82 -65.15 0.8 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.231 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.86 -32.79 72.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.44 -26.01 28.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.659 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.6 mtt -63.36 -41.04 98.8 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 120.851 0.357 . . . . 0.0 110.908 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.26 -44.41 25.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.914 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.565 HG21 HG23 ' A' ' 296' ' ' THR . 74.9 t -66.17 -42.89 92.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.425 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.436 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.3 tp -59.86 -47.49 85.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.505 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -69.64 -39.56 77.05 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.027 0.441 . . . . 0.0 110.723 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.5 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 72.2 ttt180 -61.7 -38.43 87.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.203 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -87.14 4.9 40.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.785 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.637 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.65 -11.77 13.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.04 0.448 . . . . 0.0 110.266 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.74 -37.08 85.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.642 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.99 -48.78 80.24 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.386 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.057 179.855 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.85 -2.46 58.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.413 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.9 179.08 1.24 Allowed Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.556 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.1 Cg_exo -60.9 145.11 99.52 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.781 2.321 . . . . 0.0 112.165 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.03 -179.21 7.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.589 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.81 136.67 52.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.342 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.39 147.29 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.362 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.9 p -120.39 136.12 54.82 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.27 -143.57 0.32 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.191 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -63.46 -37.18 86.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.526 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.05 -66.96 0.22 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.412 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.32 142.4 44.96 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.7 p -112.24 131.44 55.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.907 0.384 . . . . 0.0 110.435 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -119.22 129.06 54.76 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.518 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.0 m -85.68 130.36 34.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.225 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.48 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.8 mt -95.94 78.88 3.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.32 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.9 -31.91 73.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.491 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 176.06 108.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.05 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.48 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -121.89 91.56 48.77 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.312 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.646 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.3 Cg_exo -56.94 148.77 65.7 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.787 2.325 . . . . 0.0 111.862 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.64 82.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.607 0.567 . . . . 0.0 111.044 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.646 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.16 66.71 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.229 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.7 130.65 36.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.63 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.553 ' HA ' HG23 ' A' ' 64' ' ' VAL . 57.9 t -122.91 146.34 28.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.027 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -135.96 144.3 45.32 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 50' ' ' SER . 20.8 p -100.13 -59.28 1.74 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.619 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.406 ' N ' ' OG1' ' A' ' 49' ' ' THR . 86.5 p -79.21 154.78 28.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.653 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.516 HG21 HG23 ' A' ' 70' ' ' THR . 72.2 t -74.0 -22.01 18.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.578 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.4 m -60.24 -51.89 67.62 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.559 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -66.45 -42.42 87.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.196 0.522 . . . . 0.0 110.855 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.1 m -43.38 -53.74 5.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.048 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.41 -37.64 69.88 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.5 m -62.51 -44.66 95.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.896 0.379 . . . . 0.0 110.324 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.0 mt -66.16 -42.01 89.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.535 0.683 . . . . 0.0 110.704 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.63 -40.21 96.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.398 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.508 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.05 -35.79 75.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.07 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 156' ' ' LEU . 31.8 pt -91.36 28.91 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.229 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.5 51.66 10.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.881 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.35 75.55 22.71 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.91 151.88 84.22 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.742 2.295 . . . . 0.0 112.136 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.553 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.82 137.48 46.86 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 CA-C-O 121.172 0.51 . . . . 0.0 110.236 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.22 -43.63 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.317 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.483 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.97 131.12 53.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.051 0.453 . . . . 0.0 110.552 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.53 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.0 p -155.62 168.84 25.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.493 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.82 -177.25 21.67 Favored Glycine 0 N--CA 1.464 0.544 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.64 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.72 172.76 12.32 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.0 0.428 . . . . 0.0 110.486 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.516 HG23 HG21 ' A' ' 51' ' ' VAL . 14.6 p -132.59 -112.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.339 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.17 179.9 0.91 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.359 -179.131 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.8 Cg_exo -60.89 57.59 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.973 2.449 . . . . 0.0 112.154 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.6 t-20 -63.87 -33.36 75.52 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.407 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 43.6 m-20 93.42 -36.64 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.014 0.821 . . . . 0.0 109.855 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.7 mtp85 -62.65 -39.51 94.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.019 0.438 . . . . 0.0 110.145 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 77' ' ' ALA . 15.0 p -74.29 -25.65 19.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.758 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.36 -171.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.545 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -74.12 -154.13 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.845 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.2 p-10 -52.52 -7.4 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.665 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.19 115.02 23.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.977 0.418 . . . . 0.0 110.631 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.82 70.16 1.35 Allowed Glycine 0 CA--C 1.52 0.39 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.3 m-85 -143.47 148.18 35.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 110.793 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -86.08 -98.42 0.07 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.135 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.89 -42.84 97.37 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.183 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.547 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.3 tt0 91.53 52.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.991 0.807 . . . . 0.0 110.858 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -102.86 -9.48 19.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.429 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.419 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.3 p -64.24 -33.85 76.75 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.149 0.5 . . . . 0.0 110.691 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.546 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.12 -23.96 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.66 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.39 -45.99 77.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.27 -48.33 81.9 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.043 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.65 -38.11 89.0 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.374 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.82 -32.72 53.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.161 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.594 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.94 1.71 55.93 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.523 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.65 -49.38 0.18 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.115 0.884 . . . . 0.0 110.265 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.5 mt -46.16 154.65 0.25 Allowed 'General case' 0 CA--C 1.49 -1.336 0 CA-C-O 117.475 -1.25 . . . . 0.0 109.343 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.644 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 120.95 92.57 0.0 OUTLIER 'General case' 0 C--N 1.353 0.735 0 O-C-N 125.563 1.79 . . . . 0.0 110.46 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.53 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.7 mtp180 -75.7 143.36 42.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.14 0.495 . . . . 0.0 110.265 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.5 mt -132.43 27.12 4.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 0.0 110.461 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.21 137.7 34.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.003 0.43 . . . . 0.0 110.49 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.8 mt -137.29 165.09 28.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.391 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.08 -28.46 1.84 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.35 70.84 7.59 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.191 0.52 . . . . 0.0 110.208 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -60.0 145.3 98.71 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 C-N-CA 122.751 2.3 . . . . 0.0 112.066 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.7 t -134.73 136.81 42.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.553 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.12 81.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.711 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.26 -42.33 96.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.52 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.86 -41.61 98.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.546 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.4 t -63.5 -43.42 98.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.99 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.06 77.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.23 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.76 -18.9 61.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.478 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.38 -6.57 58.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 81.9 mtp 47.8 55.97 17.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.59 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.3 Cg_endo -70.37 149.36 62.87 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.807 2.338 . . . . 0.0 112.101 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.22 -72.94 0.66 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.454 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.456 HD11 HD13 ' A' ' 140' ' ' LEU . 38.2 tp -111.56 113.01 25.14 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.324 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.1 mt -101.27 126.46 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.584 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.7 mt -109.52 133.47 53.05 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.225 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.68 139.65 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.493 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.4 p -83.45 168.56 16.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.671 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.42 80.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.381 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.8 t -139.53 158.94 43.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.943 0.402 . . . . 0.0 110.453 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.29 176.92 33.56 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.21 -33.71 86.82 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.77 151.52 45.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.925 0.393 . . . . 0.0 110.507 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.1 t -63.06 140.98 58.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.339 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.69 10.42 11.0 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.642 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.09 -39.16 88.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.081 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.79 -35.98 23.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.588 0.709 . . . . 0.0 110.705 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.4 mt -70.83 -35.54 72.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.528 0.68 . . . . 0.0 110.732 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -42.81 -62.83 0.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.317 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.81 -42.78 90.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.06 -179.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -62.03 -32.73 73.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.24 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.3 mt -73.77 -40.64 63.31 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.102 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.29 -48.76 79.47 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.153 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.1 m -53.05 -42.5 65.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.097 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.88 -43.09 93.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.937 0.399 . . . . 0.0 111.099 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.32 153.47 5.36 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.674 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -39.25 107.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.65 2.233 . . . . 0.0 112.445 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.641 ' C ' HD12 ' A' ' 140' ' ' LEU . 97.8 m -109.65 121.64 45.67 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.24 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.96 152.6 30.64 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.256 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.98 131.4 68.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.321 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.403 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -115.14 127.89 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.491 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.472 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 57.0 t30 -101.56 103.8 14.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.265 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.6 p90 -101.38 -11.21 19.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.816 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.75 -33.65 76.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.682 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.9 p-10 -98.3 7.66 45.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.612 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.448 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.46 155.39 50.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.51 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.403 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.8 p -74.86 165.64 24.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.641 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.86 -48.77 80.35 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.247 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.66 -41.95 67.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.028 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.3 t -62.65 -41.08 98.86 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.385 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.403 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.5 tp -60.61 -44.38 96.36 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.393 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.3 tp -61.41 -43.43 98.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.145 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -55.07 -44.88 75.2 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.43 -40.78 97.68 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.943 0.402 . . . . 0.0 110.469 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -62.03 -42.47 99.2 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.305 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.21 -40.91 95.02 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.5 -45.96 64.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.832 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.75 -44.04 96.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.794 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.4 p -93.03 -8.81 41.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.622 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.01 26.58 72.38 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -101.54 50.63 0.85 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.807 0.337 . . . . 0.0 110.703 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.45 -39.61 77.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.617 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.4 -47.26 86.13 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.252 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -59.94 -39.55 85.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.314 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.77 98.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.278 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.0 -28.61 70.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.614 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.18 -54.26 8.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.067 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.508 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.4 ttp180 -65.49 -42.27 92.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.456 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.459 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.6 mt -62.35 -43.98 98.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.502 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.66 -58.35 7.8 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.037 0.446 . . . . 0.0 110.344 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.05 -34.05 67.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.471 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.4 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.2 t80 -81.01 -36.35 30.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.875 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -55.61 -41.84 74.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.03 -178.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.7 -42.1 99.47 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.684 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.29 -38.05 89.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.288 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 177' ' ' LEU . 82.3 mt -62.47 -42.23 99.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.674 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.08 -52.79 62.48 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.091 0.472 . . . . 0.0 110.664 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.32 -41.75 89.23 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.588 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.89 95.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.611 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.34 -32.13 73.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.426 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.62 -22.26 18.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.693 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.636 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.77 -41.26 96.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.652 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.3 pt -76.56 136.45 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.698 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.72 107.91 10.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.224 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.82 125.69 0.3 Allowed Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.45 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.452 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.2 Cg_exo -43.96 152.38 0.37 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.757 2.305 . . . . 0.0 112.623 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.75 141.85 55.88 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.589 2.193 . . . . 0.0 112.466 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.01 147.44 2.29 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.622 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.31 154.32 69.71 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.782 2.321 . . . . 0.0 112.303 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.581 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.39 163.15 29.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.438 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.581 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.91 170.73 15.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.915 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.36 137.75 22.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.238 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.551 HG22 HD12 ' A' ' 205' ' ' LEU . 40.1 pt -134.24 146.89 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.672 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.03 131.87 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.168 0.508 . . . . 0.0 110.488 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -152.12 155.25 37.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.388 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.621 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.6 m -122.69 123.16 40.49 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.917 0.389 . . . . 0.0 110.341 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.5 -25.66 66.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.649 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.621 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.59 -48.94 20.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.038 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.18 -13.62 61.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.435 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 76.5 m80 51.05 40.92 26.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.518 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.9 t -136.48 143.96 44.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.422 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -109.56 114.54 28.25 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.287 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.3 m-20 -119.8 133.32 55.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.128 0.49 . . . . 0.0 110.346 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.551 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.97 146.41 37.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.787 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.478 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.6 t90 -99.47 129.61 45.66 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.142 0.496 . . . . 0.0 109.996 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.14 153.89 39.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.225 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.7 Cg_endo -67.8 -18.04 47.3 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.647 2.231 . . . . 0.0 111.958 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.29 -18.7 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.441 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.478 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.63 164.65 26.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.486 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.91 -27.94 65.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.503 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.579 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.9 mt-30 -63.82 -41.33 97.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.586 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.37 -44.61 97.4 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.448 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.2 mt-30 -64.51 -38.75 92.11 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 122.524 -0.398 . . . . 0.0 110.575 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.2 mmm -62.16 -41.08 97.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.167 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.3 mt -63.59 -47.02 83.18 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.464 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.31 -31.91 55.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.155 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -70.84 -18.24 62.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.558 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.437 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.6 mt -88.17 -9.11 54.16 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.617 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.18 1.97 54.41 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -88.43 153.22 21.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 110.467 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.447 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.0 p -116.12 128.73 55.91 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.129 0.49 . . . . 0.0 110.348 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.562 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.66 146.24 23.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.897 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.476 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.75 151.26 46.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.402 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.43 131.44 43.57 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.425 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.893 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.62 93.37 27.72 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.032 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.677 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.7 Cg_exo -55.65 139.0 82.62 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.575 2.183 . . . . 0.0 111.518 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.84 -25.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.483 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -69.94 -50.1 31.18 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.552 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.5 mt -53.94 -36.92 63.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.814 0.34 . . . . 0.0 110.123 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -66.7 36.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.829 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.88 86.81 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.948 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.3 p -79.09 -15.24 58.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.325 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.58 -41.04 10.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.616 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.1 t -66.21 -18.0 65.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.546 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.14 43.48 26.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.435 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.52 -148.22 7.71 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.68 142.79 49.81 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.002 0.429 . . . . 0.0 110.294 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.41 149.93 29.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.317 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -101.21 -151.55 0.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.369 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 56.0 -91.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.646 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.471 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.84 175.42 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.648 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.471 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.1 mt -122.54 141.78 41.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.83 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.76 169.29 9.35 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.327 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.5 mt -147.65 151.01 35.46 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.289 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.63 -38.95 97.02 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.95 4.13 4.74 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -77.37 -58.1 3.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.986 0.422 . . . . 0.0 110.595 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.549 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.1 m-20 -62.11 -36.69 82.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.232 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.44 -67.53 0.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.55 -42.21 67.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.1 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.29 17.67 0.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.62 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.17 48.62 0.31 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.5 mp 38.65 -109.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.6 0.238 . . . . 0.0 110.736 -178.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.9 m120 -60.95 -44.75 96.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.427 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.42 7.97 83.98 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.88 -13.51 20.0 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.743 -0.269 . . . . 0.0 110.65 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.7 t 176.97 142.7 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.122 0.487 . . . . 0.0 110.479 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.13 125.21 11.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.14 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.6 m-30 -98.31 143.52 28.7 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 120.898 0.38 . . . . 0.0 110.763 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.87 106.55 18.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.688 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.4 t80 -101.79 -12.21 18.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.157 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.47 -40.86 89.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.853 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.79 173.22 45.87 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.009 -0.837 . . . . 0.0 111.009 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.461 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.4 m-20 -73.85 -113.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 110.758 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.89 -28.69 67.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.711 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.9 -43.9 91.11 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.237 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.57 -44.17 94.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.408 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.73 -60.09 3.68 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.217 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.08 -43.34 61.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.142 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.48 -43.62 75.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.144 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.6 mt -64.59 -43.66 96.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.6 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -56.07 -37.49 69.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.16 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.72 0.94 18.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.185 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -114.98 91.14 25.49 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.147 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.19 -27.09 28.69 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.756 2.304 . . . . 0.0 111.848 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.536 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.45 -40.97 98.55 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.592 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.35 5.11 52.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.352 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.87 -35.19 69.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.687 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.65 4.5 15.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.53 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.67 121.17 80.07 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -47.32 -37.66 25.12 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.469 2.113 . . . . 0.0 112.512 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.532 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -59.05 -43.82 91.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.804 0.335 . . . . 0.0 110.273 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.5 t -65.86 -43.77 93.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.299 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -65.03 -40.66 95.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.428 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.9 t-20 -89.49 -12.73 39.22 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.575 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.7 mtmt 62.16 32.07 17.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -88.9 43.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.101 0.477 . . . . 0.0 110.332 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.13 135.81 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.419 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.8 132.3 56.73 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.403 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.13 89.05 7.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.765 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.9 -41.23 97.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.877 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.444 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.79 165.64 33.84 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 69.0 p -75.47 -25.83 57.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.888 0.375 . . . . 0.0 110.813 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.0 tp10 -68.23 -33.84 75.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.439 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 96.7 m -73.53 24.45 0.07 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.67 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.579 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 43.7 t80 -58.28 -50.7 72.66 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.409 HH12 ' HG3' ' A' ' 212' ' ' GLN . 76.9 mmt-85 -110.8 153.17 25.75 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.437 ' CD2' HD11 ' A' ' 219' ' ' LEU . 43.6 tp -115.49 125.34 52.94 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.819 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.488 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.1 t0 -148.16 165.77 29.89 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.605 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -49.38 -38.05 27.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.567 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -70.92 -65.76 0.7 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.449 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -60.97 -32.72 72.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.056 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.22 -25.58 23.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.678 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.7 mtt -63.51 -40.83 98.08 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 120.872 0.368 . . . . 0.0 111.081 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.75 -44.24 23.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.108 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.581 HG21 HG23 ' A' ' 296' ' ' THR . 78.6 t -66.14 -42.91 92.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.409 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.3 tp -60.29 -47.01 87.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.48 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -70.0 -39.33 75.93 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.598 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.498 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.7 ttt180 -61.79 -38.29 87.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.166 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.5 mt -87.07 4.45 42.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.71 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.636 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.78 -11.3 13.5 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 110.264 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.12 85.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.552 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.85 -48.61 81.01 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.296 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.964 179.971 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.614 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.34 -2.46 57.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.412 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.89 179.04 1.25 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.0 Cg_exo -60.73 144.61 99.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.71 2.273 . . . . 0.0 112.194 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.614 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.58 -179.87 8.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.621 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.63 136.52 52.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.318 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.12 147.07 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.368 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.6 p -120.25 136.08 54.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 110.745 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.6 -143.43 0.33 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.269 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.41 -37.27 86.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.504 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.474 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.17 -66.84 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.486 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.62 142.38 45.65 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.0 p -112.26 131.41 55.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.908 0.385 . . . . 0.0 110.45 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -118.8 128.96 54.96 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.561 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.5 m -85.35 130.33 34.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.237 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.473 HD22 ' OE1' ' A' ' 42' ' ' GLN . 67.7 mt -95.68 78.9 3.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.324 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.53 -31.94 73.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.493 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.79 109.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.073 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.473 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.5 pt20 -122.05 91.66 48.9 Favored Pre-proline 0 C--O 1.233 0.203 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.296 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.646 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.2 Cg_exo -56.94 148.76 65.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.766 2.311 . . . . 0.0 111.874 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.61 82.75 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 O-C-N 123.587 0.554 . . . . 0.0 110.991 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.646 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.45 67.03 0.89 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.244 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.14 130.66 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.665 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.56 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.2 t -122.66 146.68 27.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.047 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.9 t -136.28 143.87 44.45 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.697 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.2 p -99.26 -59.2 1.77 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.584 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.2 p -79.46 155.39 28.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.632 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.525 HG21 HG23 ' A' ' 70' ' ' THR . 70.6 t -74.3 -21.86 17.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.567 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.4 m -60.28 -52.01 67.11 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.456 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.29 -42.54 88.23 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.375 0.607 . . . . 0.0 110.879 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.0 m -43.38 -53.93 5.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.086 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.31 -37.75 70.89 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.7 m -62.51 -44.67 95.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.805 0.336 . . . . 0.0 110.277 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.2 mt -66.14 -41.98 89.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.464 0.649 . . . . 0.0 110.761 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.53 -40.19 95.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.476 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.467 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.14 -36.0 76.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.135 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.535 HD11 HD12 ' A' ' 156' ' ' LEU . 32.9 pt -91.07 28.7 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.239 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.72 51.48 10.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.861 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.94 75.66 23.97 Favored Pre-proline 0 C--N 1.332 -0.167 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.68 151.44 85.64 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.743 2.295 . . . . 0.0 112.17 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.56 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.61 137.18 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.191 0.519 . . . . 0.0 110.25 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.444 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.7 pt -69.09 -43.69 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.339 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.95 130.97 53.43 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.933 0.396 . . . . 0.0 110.581 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.53 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.8 p -155.51 168.79 25.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.429 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.78 -177.45 21.69 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.631 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.54 172.88 12.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.944 0.402 . . . . 0.0 110.523 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.525 HG23 HG21 ' A' ' 51' ' ' VAL . 13.6 p -133.03 -112.11 0.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.404 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.36 179.79 0.92 Allowed Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.346 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.3 Cg_exo -61.2 57.86 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.943 2.428 . . . . 0.0 112.117 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.8 t-20 -63.97 -33.98 76.95 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.51 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.3 m-20 94.01 -36.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.176 0.923 . . . . 0.0 109.808 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.2 mtp85 -62.99 -40.1 96.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.258 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 77' ' ' ALA . 15.0 p -74.43 -25.92 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.744 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.21 -171.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.608 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -73.69 -153.87 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.819 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.1 p-10 -52.79 -7.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.751 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.504 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.22 114.59 23.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.619 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.81 71.04 1.33 Allowed Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -143.75 148.23 35.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.861 0.362 . . . . 0.0 110.812 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -86.07 -98.66 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.031 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.99 -42.83 97.06 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.227 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.561 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.7 tt0 91.7 53.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.994 0.809 . . . . 0.0 110.887 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -103.12 -9.22 19.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.36 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -64.49 -34.19 77.64 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.079 0.466 . . . . 0.0 110.625 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.561 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.1 mttt -48.91 -23.76 1.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.562 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.9 t -69.53 -45.93 77.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.41 -48.38 81.46 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.055 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.63 -38.21 89.35 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.276 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.71 -32.25 51.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.173 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.595 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 83.2 mmt-85 -90.16 1.67 56.17 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.575 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.76 -49.18 0.17 Allowed 'General case' 0 N--CA 1.465 0.305 0 O-C-N 124.169 0.918 . . . . 0.0 110.288 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.1 mt -46.54 154.21 0.31 Allowed 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 117.503 -1.237 . . . . 0.0 109.274 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.644 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.32 92.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 O-C-N 125.569 1.793 . . . . 0.0 110.431 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.53 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.59 143.51 42.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.123 0.487 . . . . 0.0 110.228 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 mt -132.37 27.18 4.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.769 0.319 . . . . 0.0 110.471 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.48 138.25 34.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.015 0.436 . . . . 0.0 110.495 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.1 mt -137.3 165.04 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.367 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.0 -28.57 1.85 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -153.16 70.93 7.01 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.13 0.49 . . . . 0.0 110.292 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.08 145.48 98.34 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.724 2.282 . . . . 0.0 112.075 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.7 t -134.05 136.37 43.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.05 -38.29 82.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.63 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.28 -42.03 96.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.53 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.4 98.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.523 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -63.74 -43.54 98.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.946 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.13 77.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.237 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.68 -18.6 60.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.427 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.6 -6.61 58.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.509 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.5 mtp 47.93 56.02 17.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.609 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.4 Cg_endo -70.23 149.09 63.35 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.834 2.356 . . . . 0.0 112.112 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -100.75 -74.11 0.62 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.564 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.436 HD11 HD13 ' A' ' 140' ' ' LEU . 38.1 tp -110.45 113.32 25.87 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.296 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.9 mt -101.78 126.38 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.508 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.1 mt -109.79 133.55 53.02 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.183 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.26 139.62 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.563 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.2 p -83.45 168.41 16.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.701 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.42 80.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.459 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.2 t -139.58 158.97 43.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.436 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.01 176.65 33.41 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.33 -33.82 87.34 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.48 151.57 44.43 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.881 0.372 . . . . 0.0 110.537 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.5 t -63.1 140.57 58.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.316 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.39 10.5 11.23 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.677 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.52 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.06 -38.97 88.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.049 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.99 -35.92 23.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.554 0.692 . . . . 0.0 110.645 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.9 mt -70.69 -35.65 72.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.495 0.664 . . . . 0.0 110.726 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -42.8 -62.93 0.88 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.375 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.74 -42.65 90.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.102 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -62.14 -32.97 73.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.209 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.5 mt -73.29 -40.95 64.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.038 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.42 -48.85 79.32 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.145 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.4 m -52.94 -42.32 65.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.247 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.11 -42.93 92.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.928 0.394 . . . . 0.0 111.043 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.53 154.37 5.55 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.621 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -39.63 107.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.621 2.214 . . . . 0.0 112.335 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.637 ' C ' HD12 ' A' ' 140' ' ' LEU . 93.8 m -110.09 121.13 44.54 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.255 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.637 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.88 152.74 30.31 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.223 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.6 tt -128.8 131.39 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.391 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.404 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.5 mt -115.13 127.75 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.469 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.9 t30 -101.52 103.23 14.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.243 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 147' ' ' LYS . 44.5 p90 -100.96 -11.09 20.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.812 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.5 p-10 -64.8 -33.56 76.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.703 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.7 p-10 -98.47 8.12 45.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.601 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.443 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.8 155.51 50.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.51 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.404 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.8 p -74.99 165.85 24.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.705 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.4 t90 -60.01 -48.8 80.22 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.246 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.5 -42.19 67.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.921 0.391 . . . . 0.0 110.103 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.7 t -62.54 -40.81 97.99 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.406 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.408 ' O ' HD23 ' A' ' 156' ' ' LEU . 46.3 tp -60.62 -43.91 96.93 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.282 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.505 HD22 HH21 ' A' ' 169' ' ' ARG . 44.8 tp -61.45 -43.25 99.2 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.111 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.5 m -55.01 -45.27 75.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.53 -40.67 97.52 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.855 0.359 . . . . 0.0 110.338 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.535 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.02 -42.37 99.09 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.302 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.07 -41.18 95.25 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.61 -46.03 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.952 0.406 . . . . 0.0 110.975 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.53 -44.05 96.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.887 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.8 p -93.31 -8.54 41.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.597 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.89 25.46 71.92 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -102.12 51.83 0.82 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.8 0.333 . . . . 0.0 110.699 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.76 -39.23 76.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.664 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.28 -46.94 87.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.173 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -61.36 -39.02 89.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.315 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.4 -40.46 97.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.311 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.62 69.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.018 0.437 . . . . 0.0 110.545 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.77 -53.61 8.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.158 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.505 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -64.11 -43.25 95.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.406 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.2 mt -62.98 -43.89 99.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.717 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.46 -61.38 2.57 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.128 0.489 . . . . 0.0 110.461 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.71 -35.11 63.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.451 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -79.6 -35.24 39.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.957 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.4 m-20 -56.29 -40.66 74.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.255 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.01 -42.37 99.81 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.684 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.64 -37.83 87.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.287 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 177' ' ' LEU . 81.7 mt -62.42 -42.16 99.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.736 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.05 -52.78 62.56 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.128 0.489 . . . . 0.0 110.694 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.46 -41.47 89.02 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.609 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.8 94.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.633 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.01 -32.53 73.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.43 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.03 -21.93 18.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.696 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -65.11 -41.03 95.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.734 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -77.45 136.32 24.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.74 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.28 108.56 10.97 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.258 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.44 125.96 0.32 Allowed Pre-proline 0 C--O 1.24 0.555 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.529 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.1 Cg_exo -43.92 152.21 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.824 2.349 . . . . 0.0 112.533 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.26 142.12 54.16 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.678 2.252 . . . . 0.0 112.472 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.44 147.26 2.09 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.607 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.85 154.29 71.3 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.726 2.284 . . . . 0.0 112.293 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.12 162.99 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.452 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.578 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.83 170.57 15.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.948 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.77 137.84 21.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.0 110.166 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.549 HG22 HD12 ' A' ' 205' ' ' LEU . 40.0 pt -134.33 146.99 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.695 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.94 131.86 59.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.161 0.505 . . . . 0.0 110.468 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -152.22 155.45 37.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.363 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.616 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.6 m -123.05 123.23 40.39 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.939 0.4 . . . . 0.0 110.331 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.78 66.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.635 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.616 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.23 -49.28 19.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.1 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.89 -11.65 60.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.403 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.5 m80 48.84 41.98 19.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.485 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.9 t -136.16 143.48 44.49 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.363 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -109.86 114.18 27.53 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.29 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.94 133.63 55.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.05 0.452 . . . . 0.0 110.445 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.549 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.05 146.45 37.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.787 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.481 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.4 t90 -99.8 129.78 45.94 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.127 0.489 . . . . 0.0 109.939 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.54 153.82 39.41 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.281 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.417 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.0 Cg_endo -67.62 -18.37 48.39 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.72 2.28 . . . . 0.0 111.912 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -48.92 -18.28 0.27 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.401 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.481 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.4 p -76.2 165.35 25.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.499 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.35 -28.34 66.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.484 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.613 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.0 mt-30 -63.57 -41.13 98.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.617 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.31 -44.52 97.43 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.443 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.8 mt-30 -64.57 -39.05 93.05 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.886 0.374 . . . . 0.0 110.496 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.19 -41.31 98.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.107 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 70.5 mt -63.59 -47.05 83.03 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.588 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -54.63 -31.77 57.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.112 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.7 -18.38 62.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.539 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.0 mt -87.94 -9.1 54.62 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.609 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.27 2.34 54.14 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -88.59 153.43 21.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.359 . . . . 0.0 110.549 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.442 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.0 p -115.98 128.52 55.8 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.154 0.502 . . . . 0.0 110.307 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.4 145.88 24.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.944 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.474 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.66 151.59 45.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.503 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.17 131.72 42.5 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.385 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.887 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.73 93.36 28.19 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.063 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.677 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.5 Cg_exo -55.38 138.91 81.15 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.571 2.181 . . . . 0.0 111.539 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.78 -25.78 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.505 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.18 -50.16 29.42 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.562 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.7 mt -54.48 -37.11 64.86 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.18 35.89 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.898 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.562 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.3 88.24 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.909 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.3 p -81.68 -13.91 57.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.323 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.64 -41.45 10.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.577 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.4 t -67.02 -16.66 64.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.649 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.95 43.81 26.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.461 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 180.0 -148.5 8.0 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.55 143.02 48.82 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.001 0.429 . . . . 0.0 110.313 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -151.95 149.48 28.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.273 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -101.14 -151.86 0.42 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.33 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.06 -91.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.664 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.459 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.8 tt -127.08 175.29 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.545 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.459 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.1 mt -122.17 141.63 41.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.84 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.55 169.13 9.51 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.207 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.3 mt -147.69 150.72 34.87 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.241 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.67 -39.01 97.08 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.21 4.07 4.63 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.49 -57.98 3.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.949 0.404 . . . . 0.0 110.566 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.546 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.1 m-20 -62.25 -36.27 81.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.326 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.52 -67.72 0.23 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.735 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.4 -42.29 66.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.241 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.06 17.85 0.16 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.681 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.76 48.59 0.26 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.62 -109.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.59 0.233 . . . . 0.0 110.728 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.474 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -61.08 -44.57 97.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.406 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.25 8.15 84.01 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -99.2 -13.05 19.9 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.75 -0.265 . . . . 0.0 110.69 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.3 t 176.79 142.34 0.08 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.112 0.482 . . . . 0.0 110.454 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.423 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.9 125.4 11.69 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.165 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.434 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.67 143.02 29.51 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 120.894 0.378 . . . . 0.0 110.775 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.9 mt -94.15 106.29 18.27 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.664 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.441 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.3 t80 -101.48 -11.88 18.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.129 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.3 87.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.84 174.14 46.32 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.451 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -74.41 -113.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.799 0.333 . . . . 0.0 110.786 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.45 -28.61 68.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.702 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.1 -44.1 91.91 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.172 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.89 -44.02 94.28 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.383 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.81 -60.27 3.47 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.233 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.15 -43.39 61.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.13 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.57 75.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.139 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.7 mt -64.45 -43.67 96.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.657 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -56.46 -37.5 70.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.139 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.82 0.91 18.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.223 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -114.9 91.35 26.04 Favored Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.164 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.2 -27.19 29.11 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.802 2.335 . . . . 0.0 111.786 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.536 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.36 -41.25 98.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.545 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.15 4.99 53.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.343 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.75 -35.16 70.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.719 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.83 4.73 15.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.558 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.89 121.32 81.04 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.6 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -47.58 -37.44 26.68 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.411 2.074 . . . . 0.0 112.523 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -59.12 -43.73 91.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.777 0.323 . . . . 0.0 110.244 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.89 -43.79 92.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.33 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -64.81 -40.65 95.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.424 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.8 t-20 -89.54 -12.78 38.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.588 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.8 mtmt 62.11 32.27 17.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.96 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -89.07 43.87 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.072 0.463 . . . . 0.0 110.352 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.44 135.85 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.453 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -116.53 132.45 56.68 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.44 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.503 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.79 87.22 7.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.751 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.04 -40.77 97.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.441 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.58 169.35 35.54 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.508 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 72.4 p -76.35 -25.78 55.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.819 0.343 . . . . 0.0 110.699 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.7 tp10 -67.24 -34.82 78.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.398 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.763 HG22 ' O ' ' A' ' 296' ' ' THR . 93.2 m -73.59 25.01 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.758 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.613 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 64.2 t80 -58.27 -51.25 70.55 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.418 HH12 ' HG3' ' A' ' 212' ' ' GLN . 61.2 mmt-85 -112.16 154.96 24.72 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.417 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.3 tp -115.54 124.4 50.95 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.494 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.9 t0 -147.42 165.58 29.81 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.583 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -49.0 -38.51 23.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.624 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -71.5 -65.37 0.76 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.523 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.73 -32.87 72.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.082 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.64 -25.29 25.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.697 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.7 mtt -63.35 -41.0 98.83 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 120.894 0.378 . . . . 0.0 111.018 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.34 -43.99 22.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.987 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.564 HG21 HG23 ' A' ' 296' ' ' THR . 75.1 t -65.81 -43.22 93.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.398 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 56.5 tp -60.65 -47.28 86.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.494 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -69.39 -39.64 77.87 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.725 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.503 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.2 ttt180 -62.13 -38.39 88.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.207 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.2 mt -86.86 3.88 43.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.84 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -112.57 -11.29 13.6 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.064 0.459 . . . . 0.0 110.315 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.07 -37.0 85.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.515 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.01 -48.74 80.4 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.414 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.09 179.829 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.618 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.15 -2.05 58.02 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.369 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.484 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.08 179.04 1.24 Allowed Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.499 -179.625 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.0 Cg_exo -61.04 145.2 99.33 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.769 2.313 . . . . 0.0 112.226 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.618 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.4 ptt-85 -156.41 -178.95 7.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.601 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.91 136.68 52.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.281 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -123.97 146.68 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.378 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.8 p -119.8 135.94 54.66 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.736 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.41 -143.53 0.33 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.295 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -63.28 -37.06 85.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.598 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.88 -65.56 0.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.518 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.84 141.95 46.47 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 p -112.02 131.19 55.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.922 0.392 . . . . 0.0 110.36 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -119.08 128.87 54.73 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.51 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.1 m -85.45 130.13 34.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.201 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.471 HD22 ' NE2' ' A' ' 42' ' ' GLN . 69.0 mt -96.03 78.67 3.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.432 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.52 -31.69 72.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.466 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.28 109.98 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.172 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.471 ' NE2' HD22 ' A' ' 39' ' ' LEU . 1.4 pt20 -122.99 91.35 49.91 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.196 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.645 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.9 Cg_exo -57.01 148.99 64.96 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.756 2.304 . . . . 0.0 111.784 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.79 82.89 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 O-C-N 123.603 0.564 . . . . 0.0 110.928 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.645 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.28 67.09 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.289 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.1 130.69 35.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.549 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.554 ' HA ' HG23 ' A' ' 64' ' ' VAL . 56.5 t -122.79 146.51 27.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.124 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.4 t -136.04 144.16 45.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.63 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 p -100.48 -58.87 1.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.564 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.2 p -79.43 154.78 28.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.598 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.547 HG21 HG23 ' A' ' 70' ' ' THR . 72.8 t -74.07 -21.81 18.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.629 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 94.7 m -60.31 -52.1 66.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.474 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.3 mt -66.5 -42.2 87.74 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.347 0.594 . . . . 0.0 111.003 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.2 m -43.32 -54.06 4.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.143 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.26 -37.84 71.42 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.7 m -62.28 -44.5 96.37 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.956 0.407 . . . . 0.0 110.645 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.9 mt -66.2 -42.18 89.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.459 0.647 . . . . 0.0 110.737 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.63 -40.25 96.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.371 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.464 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.21 -36.03 76.76 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.914 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.535 HD11 HD12 ' A' ' 156' ' ' LEU . 31.6 pt -91.2 28.89 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.042 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.6 51.63 10.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.777 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.0 75.34 24.23 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.949 0.404 . . . . 0.0 109.998 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.44 151.57 85.0 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.743 2.295 . . . . 0.0 112.246 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.554 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.77 137.37 47.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.181 0.515 . . . . 0.0 110.245 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.4 pt -69.34 -43.61 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.163 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.482 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.9 130.87 53.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.915 0.388 . . . . 0.0 110.544 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.53 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.0 p -155.64 168.98 25.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.456 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.98 -177.04 21.58 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.627 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.58 172.65 12.46 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 120.934 0.397 . . . . 0.0 110.513 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.547 HG23 HG21 ' A' ' 51' ' ' VAL . 13.6 p -132.68 -112.49 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.276 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.41 179.84 0.91 Allowed Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.326 -179.115 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.3 Cg_exo -60.93 57.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 123.054 2.503 . . . . 0.0 112.214 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.1 t-20 -64.41 -33.82 76.75 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.487 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.8 m-20 93.85 -36.09 0.02 OUTLIER 'General case' 0 C--N 1.346 0.435 0 O-C-N 124.08 0.862 . . . . 0.0 109.966 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.405 ' HD3' HD21 ' A' ' 73' ' ' ASN . 77.9 mtp85 -63.1 -39.39 94.55 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.218 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 77' ' ' ALA . 15.0 p -74.71 -25.29 18.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.692 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.35 -171.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.588 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.7 p30 -74.08 -153.66 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.765 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.0 p-10 -52.77 -7.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.639 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.508 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.37 115.06 23.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.582 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.85 69.69 1.36 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -142.96 147.53 35.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.958 0.409 . . . . 0.0 110.704 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.29 -98.4 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.313 178.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.548 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.4 -42.5 96.06 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.108 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.548 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.5 tt0 91.69 53.05 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.075 0.859 . . . . 0.0 110.79 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.24 -9.09 19.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.466 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.0 p -64.64 -34.04 77.35 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.118 0.485 . . . . 0.0 110.653 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.532 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.66 -23.9 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.553 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.53 -46.02 76.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.881 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.24 -48.49 81.24 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.073 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.68 -38.09 89.0 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.357 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.68 -32.58 52.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.248 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.594 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.1 mmt-85 -89.69 1.67 55.75 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.695 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 56.9 mttp 82.69 -49.05 0.17 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 124.115 0.885 . . . . 0.0 110.31 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.649 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.71 154.79 0.29 Allowed 'General case' 0 CA--C 1.49 -1.327 0 CA-C-O 117.592 -1.194 . . . . 0.0 109.253 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.649 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 120.85 92.47 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 O-C-N 125.462 1.726 . . . . 0.0 110.542 -178.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.53 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.39 143.44 42.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.108 0.48 . . . . 0.0 110.244 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.4 mt -132.4 26.95 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.0 110.47 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.52 138.15 34.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.441 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.4 mt -137.31 165.01 28.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.391 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.15 -28.8 1.82 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.408 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -152.18 70.13 7.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.201 0.524 . . . . 0.0 110.348 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.03 145.44 98.39 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 122.663 2.242 . . . . 0.0 112.126 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.0 t -134.81 137.35 43.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.521 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.22 -38.07 81.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.716 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.27 -42.29 96.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.547 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.52 98.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.558 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.2 t -63.58 -43.41 98.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.057 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.13 77.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.294 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.52 -18.62 59.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.463 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.58 -6.62 58.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.576 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 64.3 mtp 48.17 55.87 17.34 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.609 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.37 149.23 62.66 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.716 2.277 . . . . 0.0 112.111 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.13 -73.21 0.65 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.468 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.469 HD22 HE22 ' A' ' 42' ' ' GLN . 38.0 tp -111.02 112.65 24.62 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.44 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.8 mt -101.11 126.06 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.469 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.6 mt -109.59 133.64 52.87 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.294 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -121.01 140.17 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.472 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.6 p -83.5 168.68 16.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.64 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.43 80.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.433 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.1 t -140.15 159.09 42.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.963 0.411 . . . . 0.0 110.416 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.3 177.66 33.2 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.26 -33.79 87.15 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -124.84 151.72 44.9 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.904 0.383 . . . . 0.0 110.567 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.2 t -63.36 141.2 58.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.355 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.74 10.67 11.02 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.577 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.31 -39.07 89.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.071 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.634 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.9 -35.72 23.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.516 0.675 . . . . 0.0 110.709 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.5 mt -71.0 -35.42 72.06 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.473 0.654 . . . . 0.0 110.727 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -42.74 -63.19 0.82 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.132 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.634 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.83 -42.64 90.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -61.99 -32.91 73.42 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.424 0.453 . . . . 0.0 110.17 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.9 mt -73.8 -40.24 63.53 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.22 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.17 -49.13 78.08 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.15 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 78.9 m -52.36 -42.74 64.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.314 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.37 -43.26 94.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.141 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.99 154.85 5.3 Favored Pre-proline 0 N--CA 1.453 -0.285 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.646 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -39.19 106.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.696 2.264 . . . . 0.0 112.356 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.643 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.4 m -110.09 121.5 45.41 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.169 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.26 152.93 30.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.257 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -129.01 129.11 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.382 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.4 mt -112.54 127.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.498 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.11 103.34 14.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.3 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 147' ' ' LYS . 44.0 p90 -101.04 -11.17 19.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.703 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.2 p-10 -64.72 -33.77 76.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.619 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.7 p-10 -98.27 8.1 45.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.597 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.83 155.62 50.05 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.499 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.1 165.91 24.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.594 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.09 -48.62 80.94 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.22 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.76 -42.03 67.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.992 0.425 . . . . 0.0 110.084 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.0 t -62.63 -40.63 97.58 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.435 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.406 ' CD1' HG21 ' A' ' 142' ' ' ILE . 45.9 tp -60.62 -43.88 96.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.417 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.514 HD22 HH21 ' A' ' 169' ' ' ARG . 43.9 tp -61.45 -43.19 99.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.188 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.2 m -54.94 -45.17 74.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.806 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.5 -40.72 97.62 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-O 120.889 0.376 . . . . 0.0 110.381 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.535 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.95 -42.33 98.99 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.249 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.05 -41.03 95.36 Favored Glycine 0 C--N 1.316 -0.533 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.85 -46.0 63.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.94 0.4 . . . . 0.0 110.807 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.61 -44.03 96.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.741 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.6 p -93.27 -8.64 41.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.546 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.8 25.16 71.71 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -102.15 52.49 0.81 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.72 0.295 . . . . 0.0 110.593 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -70.04 -39.11 75.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.696 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.16 -47.01 86.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.165 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -61.38 -38.91 88.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.434 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.38 97.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.413 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.45 -27.67 69.15 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.537 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.82 -53.77 8.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.17 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.514 HH21 HD22 ' A' ' 153' ' ' LEU . 61.8 ttp180 -63.55 -43.56 96.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.448 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 174' ' ' ASP . 85.7 mt -63.01 -43.78 99.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.658 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.08 -61.65 2.42 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.112 0.482 . . . . 0.0 110.383 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.54 -35.09 62.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.425 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.411 ' CD2' HD11 ' A' ' 177' ' ' LEU . 23.3 t80 -79.6 -35.05 40.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.891 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.3 m-20 -56.68 -40.43 75.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.96 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.94 -42.61 99.86 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.769 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.85 -37.52 86.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.303 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.411 HD11 ' CD2' ' A' ' 173' ' ' PHE . 80.9 mt -62.26 -42.36 99.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.702 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -53.0 61.77 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.168 0.509 . . . . 0.0 110.645 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.25 -41.69 89.6 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.597 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.31 -39.68 94.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.5 -32.36 73.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.302 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.93 -22.12 18.79 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.647 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.631 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -65.22 -40.91 94.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.632 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.1 pt -78.45 136.45 23.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.568 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.53 109.45 11.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.277 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.48 125.8 0.32 Allowed Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.518 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.4 Cg_exo -43.92 152.29 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.713 2.276 . . . . 0.0 112.598 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.16 142.0 54.28 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.612 2.208 . . . . 0.0 112.461 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.37 147.4 2.14 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.602 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.15 154.74 69.67 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.805 2.337 . . . . 0.0 112.296 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.27 163.23 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.405 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -144.1 170.41 16.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.793 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.83 137.89 21.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.017 0.437 . . . . 0.0 110.226 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.543 HG22 HD12 ' A' ' 205' ' ' LEU . 38.9 pt -134.44 146.72 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.574 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.98 131.73 58.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.128 0.49 . . . . 0.0 110.474 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -151.92 154.89 36.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.357 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.2 m -122.08 122.62 39.68 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.961 0.41 . . . . 0.0 110.371 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.32 -25.98 66.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.613 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.72 -49.02 22.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.007 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.38 -11.04 60.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.285 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.8 m80 48.6 42.47 19.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.452 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.6 t -136.43 145.7 45.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.386 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.41 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -111.44 114.18 27.12 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.311 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.72 133.32 55.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.08 0.467 . . . . 0.0 110.343 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.543 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.13 146.43 38.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.671 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.519 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 10.9 t90 -99.77 130.23 45.96 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.104 0.478 . . . . 0.0 110.148 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.65 153.88 39.31 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.133 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.412 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.2 Cg_endo -67.76 -18.05 47.51 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.663 2.242 . . . . 0.0 111.95 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -48.99 -18.57 0.3 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.405 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.519 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.96 165.11 25.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.543 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.22 -28.04 66.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.516 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.616 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.3 mt-30 -63.76 -41.21 98.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.669 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.12 -44.75 97.02 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.8 mt-30 -64.6 -38.71 91.94 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 120.99 0.424 . . . . 0.0 110.649 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.14 -41.15 98.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.11 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.81 -46.74 83.76 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.644 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.59 -31.73 57.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.089 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.88 -18.12 62.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.57 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.418 HD11 ' CD2' ' A' ' 299' ' ' LEU . 89.0 mt -88.25 -8.49 55.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.612 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.39 2.05 55.61 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -88.41 153.36 21.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.512 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.46 ' O ' HG12 ' A' ' 191' ' ' VAL . 7.9 p -116.09 128.72 55.91 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.055 0.455 . . . . 0.0 110.308 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.571 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.62 145.97 24.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.802 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.469 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.68 151.5 45.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.534 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.72 131.53 43.12 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.526 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.893 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.55 93.22 26.67 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.049 -179.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.679 ' C ' ' H ' ' A' ' 229' ' ' GLY . 47.6 Cg_exo -55.59 139.25 82.59 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.56 2.173 . . . . 0.0 111.612 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.04 -25.64 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.459 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.54 -49.78 29.2 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.8 mt -53.87 -37.01 63.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 0.0 110.197 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.92 36.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.777 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.85 86.85 0.01 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.861 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.3 p -79.42 -15.17 58.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.411 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.38 -41.12 10.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.616 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.8 t -66.06 -17.78 64.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.65 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.25 43.22 26.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.508 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.48 -147.27 7.21 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.96 143.01 50.19 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.955 0.407 . . . . 0.0 110.323 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -152.51 149.85 28.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.391 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -100.95 -151.75 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.398 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 66.9 t0 55.99 -91.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.555 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.459 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.96 175.25 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.54 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.459 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 93.0 mt -122.3 141.73 41.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.693 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.77 168.97 9.57 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.244 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.3 mt -147.73 150.9 35.16 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.154 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.53 -39.21 97.4 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.32 4.01 4.6 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.28 -58.06 3.49 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.011 0.434 . . . . 0.0 110.636 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.551 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.2 m-20 -62.2 -37.04 83.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.271 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.41 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.1 mp -52.14 -67.69 0.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.784 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.43 -42.07 66.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.145 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.16 17.96 0.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.724 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.92 48.13 0.26 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.83 -109.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.663 0.268 . . . . 0.0 110.675 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.469 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.71 -44.87 96.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.502 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.26 8.13 84.03 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -99.02 -13.19 19.98 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.672 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.6 t 176.8 142.45 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.079 0.466 . . . . 0.0 110.423 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.93 125.42 11.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.983 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.433 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -98.57 142.94 29.53 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 120.877 0.37 . . . . 0.0 110.88 177.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.9 mt -93.88 106.26 18.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.655 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.429 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.2 t80 -101.48 -12.27 18.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.215 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.4 -40.62 89.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.833 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.43 173.73 46.09 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.448 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -74.09 -112.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.811 0.339 . . . . 0.0 110.683 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.88 -28.74 67.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.689 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -58.85 -43.95 90.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.371 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.8 -44.32 93.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.357 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.48 -60.17 3.56 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.247 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.31 -43.55 61.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.084 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.16 -43.6 74.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.229 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.4 mt -64.62 -43.63 96.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.597 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -56.23 -37.48 69.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.211 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.87 1.25 18.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.277 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -114.94 91.33 26.13 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.213 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.31 -27.25 30.1 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.753 2.302 . . . . 0.0 111.841 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.38 -41.17 98.77 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.591 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.9 mp -95.07 5.12 52.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.362 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.87 -35.13 69.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.713 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.53 4.52 15.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.52 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.91 120.91 79.38 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.61 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -47.41 -37.43 25.4 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.478 2.119 . . . . 0.0 112.493 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -59.01 -43.84 91.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.758 0.313 . . . . 0.0 110.356 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.96 -43.7 92.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.344 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.81 -40.7 95.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.445 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.437 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.9 t-20 -89.42 -12.86 39.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.625 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.7 mtmt 62.18 32.36 17.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -89.15 43.87 1.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.074 0.464 . . . . 0.0 110.353 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.51 135.89 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.448 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.78 132.37 56.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.491 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.504 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.67 87.49 7.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.674 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.02 -40.69 96.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.971 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.429 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.72 168.85 35.0 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.51 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 77.8 p -76.13 -25.89 55.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 0.0 110.698 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.1 tp10 -67.27 -34.6 77.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.524 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.766 HG22 ' O ' ' A' ' 296' ' ' THR . 95.7 m -73.66 25.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.601 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.616 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 61.8 t80 -58.13 -51.13 70.99 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.402 HH12 ' HG3' ' A' ' 212' ' ' GLN . 64.4 mmt-85 -112.3 155.13 24.6 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.418 ' CD2' HD11 ' A' ' 219' ' ' LEU . 45.2 tp -115.88 124.77 51.48 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.766 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.49 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.7 t0 -147.79 165.79 29.5 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -49.13 -38.55 25.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.579 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -71.53 -65.31 0.77 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.267 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -60.79 -32.75 72.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.913 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.88 -25.19 27.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.549 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.1 mtt -63.08 -41.42 99.43 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.88 0.371 . . . . 0.0 110.857 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.18 -43.85 23.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.997 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.56 HG21 HG23 ' A' ' 296' ' ' THR . 76.6 t -66.04 -43.18 92.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.414 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 56.0 tp -60.55 -47.04 87.92 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.549 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -69.84 -39.85 76.18 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.546 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.504 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.3 ttt180 -62.06 -37.97 87.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.133 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.3 mt -87.19 4.32 42.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.795 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.631 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.5 tttt -112.59 -11.51 13.56 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.042 0.448 . . . . 0.0 110.263 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.9 84.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.66 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.02 -48.78 80.2 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.332 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.898 -1.048 . . . . 0.0 110.097 179.941 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.47 -2.1 57.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.298 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.94 179.09 1.23 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.991 0.424 . . . . 0.0 110.481 -179.65 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.6 Cg_exo -60.95 144.91 99.68 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.814 2.343 . . . . 0.0 112.149 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.96 -179.3 8.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.597 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.68 136.66 52.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.388 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.36 147.11 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.297 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.8 p -120.18 135.99 54.78 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.41 -143.38 0.32 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.233 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -63.52 -37.13 86.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.549 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.477 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.54 -66.12 0.22 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.546 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.48 141.99 45.68 Favored Glycine 0 CA--C 1.519 0.309 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.4 p -112.19 131.23 55.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.939 0.4 . . . . 0.0 110.4 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.21 128.9 54.65 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.532 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -85.49 130.3 34.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.227 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.453 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.0 mt -95.74 78.86 3.3 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.287 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.28 -32.31 73.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.55 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 175.88 110.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.075 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.453 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.5 pt20 -123.05 91.7 49.66 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.322 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.645 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.1 Cg_exo -56.95 148.82 65.44 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.769 2.313 . . . . 0.0 111.864 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.42 82.78 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 O-C-N 123.59 0.557 . . . . 0.0 111.017 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.645 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.45 67.07 0.89 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.133 0.492 . . . . 0.0 110.183 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.17 130.78 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.709 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.557 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.1 t -122.85 146.59 27.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.034 0.445 . . . . 0.0 110.015 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -136.38 143.91 44.28 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.693 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.1 p -99.31 -59.5 1.71 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.647 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.0 p -78.95 155.61 28.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.706 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 70' ' ' THR . 71.4 t -74.65 -21.84 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.55 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 94.7 m -60.36 -51.88 67.63 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.459 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.5 mt -66.3 -42.62 88.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.207 0.527 . . . . 0.0 110.85 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.15 -53.9 4.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.005 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.39 -38.12 70.24 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.7 m -62.21 -44.55 96.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 110.203 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.418 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.3 mt -66.27 -42.03 89.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.443 0.64 . . . . 0.0 110.756 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.59 -40.12 95.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.495 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.471 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.97 -35.91 76.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.183 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.537 HD11 HD12 ' A' ' 156' ' ' LEU . 32.7 pt -91.2 28.69 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.295 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.58 51.52 11.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.98 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.74 75.52 25.38 Favored Pre-proline 0 C--N 1.331 -0.208 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.34 151.15 86.64 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.793 2.328 . . . . 0.0 112.199 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.59 137.26 47.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.223 0.535 . . . . 0.0 110.208 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.447 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.0 pt -69.21 -43.65 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.326 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.483 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.02 131.07 53.46 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.964 0.411 . . . . 0.0 110.564 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.526 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.4 p -155.68 168.72 26.25 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.501 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.96 -176.97 21.59 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.627 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.37 172.54 12.56 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 121.01 0.433 . . . . 0.0 110.44 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.493 HG23 HG21 ' A' ' 51' ' ' VAL . 12.9 p -133.13 -111.84 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 110.349 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.49 179.68 0.94 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.348 -179.143 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.7 Cg_exo -61.34 57.89 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.975 2.45 . . . . 0.0 112.094 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.5 t-20 -64.19 -34.13 77.37 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 118.894 -0.574 . . . . 0.0 110.398 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.5 m-20 94.06 -36.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.103 0.877 . . . . 0.0 109.838 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -62.9 -39.84 95.73 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.179 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.49 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -74.27 -25.71 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.758 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.68 -171.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.575 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.26 -153.68 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.864 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.0 p-10 -52.72 -7.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.677 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.25 114.6 23.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.618 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.61 70.36 1.34 Allowed Glycine 0 C--O 1.225 -0.428 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -143.18 147.93 35.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.824 0.345 . . . . 0.0 110.961 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -85.94 -98.4 0.07 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.995 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.1 mtt-85 -64.28 -42.69 96.3 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.08 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.4 tt0 91.49 53.43 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.057 0.848 . . . . 0.0 110.954 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.38 -9.1 19.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.391 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.2 p -64.71 -33.99 77.27 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.165 0.507 . . . . 0.0 110.681 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.538 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.85 -24.27 1.39 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.59 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.4 t -69.13 -46.11 78.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.936 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.21 -48.49 81.26 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.964 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.69 -38.17 89.35 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.302 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.82 -32.28 52.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.095 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.593 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.7 mmt-85 -90.04 1.82 55.89 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.585 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.6 -49.34 0.18 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 124.102 0.876 . . . . 0.0 110.192 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.638 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.5 mt -46.42 154.88 0.25 Allowed 'General case' 0 CA--C 1.49 -1.345 0 CA-C-O 117.365 -1.302 . . . . 0.0 109.275 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.638 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 120.76 92.48 0.0 OUTLIER 'General case' 0 C--N 1.354 0.764 0 O-C-N 125.699 1.875 . . . . 0.0 110.464 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.526 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.34 143.54 42.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.098 0.475 . . . . 0.0 110.311 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.5 mt -132.52 27.2 4.4 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.147 -0.346 . . . . 0.0 110.428 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -140.6 138.46 34.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.015 0.436 . . . . 0.0 110.542 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.5 mt -137.37 164.99 28.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.418 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.34 -28.71 1.8 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -153.23 70.87 6.95 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.166 0.508 . . . . 0.0 110.288 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.22 145.58 98.22 Favored 'Trans proline' 0 C--N 1.301 -1.936 0 C-N-CA 122.719 2.279 . . . . 0.0 112.108 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.4 t -133.99 136.55 44.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.481 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.38 83.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.683 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.38 -42.17 96.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.52 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.53 98.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.581 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.6 t -63.68 -43.45 98.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.925 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.81 -35.12 77.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.233 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.55 -18.61 59.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.38 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -86.67 -6.85 58.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.562 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.409 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.6 mtp 48.1 56.09 17.47 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.627 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.0 Cg_endo -70.12 149.23 64.28 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.766 2.31 . . . . 0.0 112.122 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.04 -73.47 0.64 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.43 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 140' ' ' LEU . 38.4 tp -111.03 112.84 24.94 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.26 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.1 mt -101.13 126.19 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.556 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.5 mt -109.58 133.42 53.12 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.198 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.46 139.7 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.506 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 94.4 p -83.42 168.42 16.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.692 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.12 -37.41 79.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.402 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.2 t -139.38 159.07 43.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.932 0.396 . . . . 0.0 110.475 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.07 176.33 33.55 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.13 -33.84 87.14 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.7 151.53 44.88 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 110.523 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.9 t -63.06 140.82 58.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.359 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.7 10.44 11.0 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.607 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.08 -39.13 88.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.099 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.68 -35.86 24.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.59 0.709 . . . . 0.0 110.721 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.2 mt -70.8 -35.62 72.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.642 0.734 . . . . 0.0 110.738 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -42.84 -62.71 0.94 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.408 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.64 -42.66 91.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -62.1 -33.02 73.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.301 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.1 mt -73.3 -40.77 64.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.145 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.8 t -58.53 -48.58 80.36 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.013 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.8 m -52.9 -42.35 65.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.302 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.15 -43.03 92.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.082 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.4 154.15 5.58 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.659 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -39.37 107.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.639 2.226 . . . . 0.0 112.422 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.635 ' C ' HD12 ' A' ' 140' ' ' LEU . 93.8 m -110.13 120.88 43.85 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.037 0.446 . . . . 0.0 110.238 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.62 152.78 29.89 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.292 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.421 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.7 tt -128.75 131.04 68.82 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.268 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.81 127.79 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.504 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.9 t30 -101.79 103.53 14.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.302 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 147' ' ' LYS . 45.3 p90 -101.05 -11.29 19.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.862 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.74 -33.73 76.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.671 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -98.29 7.86 45.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.548 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.6 155.54 50.29 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.538 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.404 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.07 165.8 24.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.715 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.05 -48.69 80.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.152 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -53.7 -42.2 67.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.002 0.429 . . . . 0.0 110.063 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.2 t -62.49 -40.89 98.15 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.362 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.41 ' O ' HD23 ' A' ' 156' ' ' LEU . 47.4 tp -60.59 -43.95 96.79 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.261 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.501 HD22 HH21 ' A' ' 169' ' ' ARG . 45.0 tp -61.27 -43.43 98.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.139 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 m -55.03 -45.37 75.17 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.59 -40.58 97.36 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.891 0.377 . . . . 0.0 110.446 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.537 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.97 -42.29 98.96 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.343 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.19 -40.89 95.05 Favored Glycine 0 C--N 1.315 -0.587 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.72 -45.91 64.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.0 mt -64.61 -44.0 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.794 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.6 p -93.35 -8.56 41.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.587 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.85 25.37 71.85 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -102.06 52.26 0.82 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.769 0.319 . . . . 0.0 110.663 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.87 -39.23 76.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.575 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.15 -46.95 87.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.243 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -61.41 -39.12 89.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.35 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.27 -40.32 97.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.257 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.49 -27.51 69.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.545 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.95 -53.81 8.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.059 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.501 HH21 HD22 ' A' ' 153' ' ' LEU . 61.8 ttp180 -63.88 -43.24 96.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.47 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.9 mt -63.07 -43.86 99.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.726 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.18 -61.52 2.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.146 0.498 . . . . 0.0 110.403 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.65 -35.32 63.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.466 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.422 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.4 t80 -79.21 -35.19 42.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.963 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.1 m-20 -56.98 -40.1 75.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.146 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.08 -42.64 99.68 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.828 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.74 -37.76 87.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.285 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.422 HD11 ' CD2' ' A' ' 173' ' ' PHE . 80.4 mt -62.29 -42.33 99.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.715 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.07 -52.76 62.61 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.073 0.463 . . . . 0.0 110.639 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.41 -41.56 89.1 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.624 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.33 -39.65 94.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.671 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.29 -32.49 73.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.306 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.95 -21.99 18.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.657 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.633 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -65.02 -40.9 95.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.726 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.8 pt -78.1 136.47 24.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.727 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.37 109.31 11.65 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.214 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.8 125.66 0.3 Allowed Pre-proline 0 C--O 1.242 0.666 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.495 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.4 Cg_exo -43.88 152.36 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.786 2.324 . . . . 0.0 112.618 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.13 142.29 55.41 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.554 2.17 . . . . 0.0 112.504 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.3 147.07 2.11 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.626 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.91 154.6 70.64 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.75 2.3 . . . . 0.0 112.307 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.29 163.2 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.487 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -144.02 170.35 16.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.889 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.01 137.65 22.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.253 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.54 HG22 HD12 ' A' ' 205' ' ' LEU . 38.9 pt -134.37 146.75 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.65 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.46 132.26 57.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.168 0.509 . . . . 0.0 110.497 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -152.12 155.15 37.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.439 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.8 m -122.34 123.06 40.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.957 0.408 . . . . 0.0 110.364 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.51 -25.76 66.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.631 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.614 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.12 -49.18 20.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.084 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.12 -12.18 60.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.413 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.4 m80 49.47 41.95 21.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.496 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.1 t -135.97 144.76 45.57 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.328 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.5 113.97 27.02 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.258 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.474 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.8 133.33 55.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.039 0.447 . . . . 0.0 110.362 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.54 HD12 HG22 ' A' ' 194' ' ' ILE . 7.5 tt -111.92 146.32 37.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.483 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 12.5 t90 -99.11 129.74 45.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.175 0.512 . . . . 0.0 109.932 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.74 153.87 39.25 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.294 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.2 Cg_endo -67.59 -18.15 48.47 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.671 2.247 . . . . 0.0 111.957 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.37 -18.83 0.43 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.36 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.483 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.9 p -75.39 164.59 26.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.536 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.99 -27.84 65.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.559 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.623 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.2 mt-30 -63.99 -41.0 97.63 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.589 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.26 -44.54 97.36 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.6 mt-30 -64.59 -38.71 91.96 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.022 0.439 . . . . 0.0 110.557 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.2 mmm -62.18 -41.21 98.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.103 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.3 mt -63.7 -47.09 82.58 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.525 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.27 -31.84 54.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.355 . . . . 0.0 110.193 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.02 -18.32 62.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.472 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.422 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.5 mt -87.94 -8.67 55.38 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.626 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.57 2.13 55.42 Favored Glycine 0 N--CA 1.464 0.503 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -88.4 153.29 21.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.939 0.4 . . . . 0.0 110.464 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.448 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.3 p -115.93 128.7 55.97 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.143 0.497 . . . . 0.0 110.334 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.567 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.71 145.89 24.07 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.948 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.474 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.46 151.49 46.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.423 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.65 131.59 43.3 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.461 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.89 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.7 93.29 27.74 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.062 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.678 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.5 Cg_exo -55.52 139.13 82.15 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.556 2.171 . . . . 0.0 111.58 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.76 -25.69 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.477 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.13 -50.07 30.2 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.552 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.7 mt -54.17 -36.93 63.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.68 35.99 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.819 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.08 88.31 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.003 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 79.5 p -81.23 -14.15 57.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.31 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.8 -41.57 10.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.685 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.1 t -66.7 -16.92 64.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.647 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 55.94 43.76 26.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.439 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.74 -148.45 7.9 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.91 142.94 49.24 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.0 0.428 . . . . 0.0 110.327 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.14 149.56 28.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.278 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -101.19 -151.85 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.297 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.12 -92.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.624 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.463 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.67 175.24 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.596 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.463 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.5 mt -122.37 141.62 42.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.56 169.05 9.56 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.264 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.0 mt -147.63 150.86 35.21 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.224 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.69 -38.98 97.03 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.18 3.87 4.7 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -77.18 -58.04 3.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.958 0.409 . . . . 0.0 110.631 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.547 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.1 m-20 -62.25 -36.85 83.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.249 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.24 -67.74 0.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.67 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.68 -42.08 67.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.135 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.97 17.8 0.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.644 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.88 48.5 0.27 Allowed Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.45 -109.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.596 0.236 . . . . 0.0 110.754 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.474 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 12.0 m120 -61.12 -44.65 97.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.469 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.31 8.05 84.06 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -98.93 -13.25 20.07 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.668 -0.313 . . . . 0.0 110.697 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.8 t 176.96 142.53 0.08 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.087 0.47 . . . . 0.0 110.434 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -147.84 125.62 11.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.191 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.433 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -98.68 143.15 29.37 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 120.899 0.381 . . . . 0.0 110.778 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.1 mt -94.44 106.3 18.28 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.672 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.435 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.58 -11.69 19.05 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.171 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.14 -40.66 86.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.27 173.69 46.1 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.442 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.5 m-20 -74.02 -112.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.352 . . . . 0.0 110.856 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.76 -28.75 67.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.731 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.11 -44.01 91.95 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.147 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.68 -44.2 94.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.308 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.72 -59.93 3.88 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.201 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.32 -43.58 61.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.982 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.32 -43.63 75.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.181 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.7 mt -64.57 -43.62 96.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.581 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.4 -37.51 70.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.113 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.92 1.24 18.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.179 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -114.73 91.46 25.72 Favored Pre-proline 0 CA--C 1.528 0.11 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.179 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.33 -27.32 30.54 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.801 2.334 . . . . 0.0 111.811 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.538 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.42 -41.14 98.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.575 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.9 mp -95.14 5.04 52.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.346 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.58 -35.08 70.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.645 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.99 4.43 17.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.512 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.73 120.9 78.88 Favored Pre-proline 0 N--CA 1.441 -0.884 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.512 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.37 -37.47 25.19 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.41 2.074 . . . . 0.0 112.635 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.529 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -59.02 -43.65 91.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.75 0.31 . . . . 0.0 110.352 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.99 -43.75 92.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.301 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.89 -40.64 95.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.422 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.8 t-20 -89.51 -12.86 38.79 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.516 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.23 32.08 17.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.88 44.01 1.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.115 0.484 . . . . 0.0 110.367 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.78 135.63 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.529 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -116.64 132.51 56.67 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.386 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.506 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.5 87.31 7.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.834 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.97 -40.77 97.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.919 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.435 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.94 168.84 35.59 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.508 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 77.0 p -76.07 -25.88 55.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.901 0.382 . . . . 0.0 110.781 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.8 tp10 -67.37 -34.7 77.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.357 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.764 HG22 ' O ' ' A' ' 296' ' ' THR . 94.7 m -73.49 25.1 0.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.748 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.623 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 63.2 t80 -58.26 -51.07 71.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.413 HH12 ' HG3' ' A' ' 212' ' ' GLN . 63.5 mmt-85 -112.42 155.0 24.93 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.422 ' CD2' HD11 ' A' ' 219' ' ' LEU . 43.9 tp -115.72 124.92 52.04 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.491 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.2 t0 -148.04 165.89 29.42 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.533 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -49.08 -38.64 25.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.659 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -71.05 -65.61 0.72 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.54 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -60.61 -32.93 72.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.079 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.62 -24.97 23.75 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.811 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.9 mtt -63.23 -41.18 99.07 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 120.948 0.404 . . . . 0.0 111.105 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.54 -43.89 22.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.064 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.56 HG21 HG23 ' A' ' 296' ' ' THR . 77.3 t -65.81 -43.24 93.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.417 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 55.4 tp -60.82 -46.96 88.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.518 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -69.83 -39.65 76.33 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.663 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.506 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.5 ttt180 -62.09 -38.15 87.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.136 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.03 3.97 43.85 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.753 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.633 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.5 tttt -112.78 -11.06 13.54 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.114 0.483 . . . . 0.0 110.189 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.23 -36.95 85.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.549 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.95 -48.7 80.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.395 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.003 179.9 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.06 -2.63 58.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.415 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.72 179.16 1.22 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.498 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.3 Cg_exo -60.87 144.94 99.66 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.76 2.307 . . . . 0.0 112.203 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.613 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.78 -179.7 8.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.581 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.51 136.14 53.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.333 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -123.94 146.82 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.395 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.6 p -120.02 135.98 54.73 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.812 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.25 -143.61 0.32 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.259 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.65 -36.98 85.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.437 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.22 -66.96 0.22 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.523 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.27 142.3 44.93 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.3 p -112.18 131.24 55.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.934 0.397 . . . . 0.0 110.324 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.08 128.94 54.79 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.541 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.9 m -85.55 130.64 34.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.178 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.501 HD22 ' NE2' ' A' ' 42' ' ' GLN . 67.0 mt -95.83 78.63 3.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.271 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.04 -32.18 73.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.493 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.43 108.87 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.086 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.501 ' NE2' HD22 ' A' ' 39' ' ' LEU . 1.4 pt20 -122.25 91.56 49.09 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.194 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.644 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.1 Cg_exo -56.97 148.67 66.6 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.802 2.334 . . . . 0.0 111.827 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.79 82.67 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 O-C-N 123.57 0.544 . . . . 0.0 111.028 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.644 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.28 67.07 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.226 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.0 130.85 35.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.609 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.554 ' HA ' HG23 ' A' ' 64' ' ' VAL . 57.5 t -122.61 145.86 28.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.08 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -135.66 143.45 45.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.63 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.0 p -99.34 -59.54 1.7 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.594 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.7 p -79.07 155.12 28.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.668 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.492 HG21 HG23 ' A' ' 70' ' ' THR . 69.9 t -74.41 -21.72 17.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.569 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.5 m -60.36 -52.04 66.94 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.518 -178.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.5 mt -66.51 -42.37 87.43 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.363 0.601 . . . . 0.0 110.956 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -43.21 -53.63 4.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.083 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.3 -37.69 71.01 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -62.58 -44.48 96.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.893 0.378 . . . . 0.0 110.393 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.2 mt -66.25 -42.14 88.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.547 0.689 . . . . 0.0 110.769 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tp -62.62 -40.09 95.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.439 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.463 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.07 -35.75 75.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.006 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 156' ' ' LEU . 31.4 pt -91.6 28.92 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.16 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.35 51.65 11.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.816 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.86 75.71 24.32 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.98 151.5 85.61 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.775 2.317 . . . . 0.0 112.289 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.554 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.45 137.15 47.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.219 0.533 . . . . 0.0 110.251 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.442 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.1 pt -69.2 -43.63 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.243 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.08 130.92 53.24 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.97 0.414 . . . . 0.0 110.505 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.4 p -155.39 168.84 25.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.464 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.55 -177.53 21.83 Favored Glycine 0 N--CA 1.464 0.564 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.637 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -132.99 172.07 13.12 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.009 0.433 . . . . 0.0 110.458 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.492 HG23 HG21 ' A' ' 51' ' ' VAL . 14.2 p -133.49 -111.34 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.321 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.542 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.56 179.65 0.95 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.348 -179.044 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.2 Cg_exo -60.97 58.71 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.059 2.506 . . . . 0.0 112.108 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.543 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.2 t-20 -64.35 -34.94 79.31 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 118.669 -0.681 . . . . 0.0 110.521 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 45.8 m-20 95.07 -37.58 0.01 OUTLIER 'General case' 0 C--N 1.349 0.557 0 O-C-N 124.332 1.02 . . . . 0.0 109.857 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -62.54 -39.89 95.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.025 0.44 . . . . 0.0 110.261 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -73.93 -26.45 21.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.678 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.83 -172.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.518 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.2 p30 -73.77 -152.79 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.787 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.0 p-10 -54.61 -6.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.683 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.491 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.93 113.74 22.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.585 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.23 72.92 1.27 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.87 148.67 35.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.897 0.38 . . . . 0.0 110.825 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -86.0 -99.14 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.172 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.541 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.04 -43.28 96.02 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.143 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.554 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.8 tt0 91.8 52.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.117 0.886 . . . . 0.0 110.919 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -103.12 -8.9 20.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.347 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.2 p -65.05 -33.97 77.31 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.164 0.507 . . . . 0.0 110.727 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.554 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.49 -24.17 1.2 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.624 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.5 t -69.55 -45.84 77.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.1 -48.74 80.29 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.071 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.77 -38.2 89.66 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.348 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -53.7 -32.45 51.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.207 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.59 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.9 mmt-85 -90.02 1.71 56.0 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 119.19 -0.433 . . . . 0.0 110.579 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.85 -49.41 0.16 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.232 0.957 . . . . 0.0 110.351 179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.636 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.9 mt -46.32 154.01 0.31 Allowed 'General case' 0 CA--C 1.489 -1.39 0 CA-C-O 117.331 -1.319 . . . . 0.0 109.139 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.636 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.6 tt0 121.37 92.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 O-C-N 125.754 1.909 . . . . 0.0 110.538 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.48 143.09 42.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.115 0.483 . . . . 0.0 110.279 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 mt -131.91 26.81 4.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.8 0.333 . . . . 0.0 110.443 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.16 137.56 34.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.974 0.416 . . . . 0.0 110.525 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.9 mt -136.99 165.19 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.42 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.13 -28.44 1.84 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -153.32 70.85 6.89 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.192 0.52 . . . . 0.0 110.281 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.94 145.55 98.04 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.759 2.306 . . . . 0.0 112.135 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.3 t -134.06 136.72 44.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.981 0.42 . . . . 0.0 110.541 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.96 -38.3 82.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.642 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.27 -42.29 96.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.518 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.12 -41.44 98.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.561 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.67 -43.34 98.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.05 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.13 77.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.295 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -18.62 60.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.489 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.51 -6.6 58.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.524 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 78.7 mtp 47.91 55.98 17.3 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.596 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.31 149.27 63.1 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.755 2.303 . . . . 0.0 112.083 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.38 -72.56 0.68 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.498 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.476 HD22 HE22 ' A' ' 42' ' ' GLN . 38.7 tp -111.7 112.7 24.58 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.321 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.3 mt -101.09 126.37 54.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.567 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.2 mt -110.07 133.7 52.93 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.156 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -121.17 139.97 46.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.517 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.7 p -83.34 168.43 16.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.705 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -37.48 80.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.418 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -139.47 159.0 43.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.434 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.15 176.94 33.44 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.02 -34.0 87.49 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.88 151.56 45.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.927 0.394 . . . . 0.0 110.531 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.3 t -63.16 141.06 58.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.291 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.09 10.94 10.84 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.625 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.29 -38.93 88.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.007 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.632 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.81 -35.7 24.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.594 0.711 . . . . 0.0 110.605 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.0 mt -71.14 -35.42 71.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.52 0.676 . . . . 0.0 110.8 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.9 t80 -42.89 -62.95 0.88 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.19 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.632 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.3 p-10 -65.67 -42.64 91.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.988 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -62.24 -32.58 73.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.124 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.5 mt -73.94 -40.54 62.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.15 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.23 -48.87 79.03 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.221 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.6 m -52.69 -42.78 65.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.212 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.96 -43.07 92.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.221 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.04 152.63 5.27 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.66 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -39.02 107.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.627 2.218 . . . . 0.0 112.421 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.634 ' C ' HD12 ' A' ' 140' ' ' LEU . 94.2 m -109.43 121.02 44.27 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.239 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.634 HD12 ' C ' ' A' ' 139' ' ' THR . 10.9 mp -113.6 152.68 30.01 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.12 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.53 131.05 69.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.36 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.99 127.79 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.463 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.99 103.76 14.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.324 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.3 p90 -101.36 -11.42 19.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.772 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.4 p-10 -64.82 -33.48 76.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.673 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.1 p-10 -98.17 7.59 46.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.585 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.44 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.56 155.48 50.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.507 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -74.43 165.39 25.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.67 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.549 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 90.8 t90 -60.0 -48.52 81.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.255 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -53.95 -41.73 68.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.99 0.424 . . . . 0.0 110.061 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.9 t -62.55 -40.84 98.1 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.401 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.412 ' O ' HD23 ' A' ' 156' ' ' LEU . 47.4 tp -60.61 -43.93 96.87 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.338 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.541 HD22 HH21 ' A' ' 169' ' ' ARG . 45.0 tp -61.37 -42.97 99.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 0.0 110.261 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -55.79 -45.25 78.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.679 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.44 -40.6 97.13 Favored 'General case' 0 C--O 1.228 -0.044 0 CA-C-O 120.938 0.399 . . . . 0.0 110.388 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.93 -42.34 98.99 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.321 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.77 -40.72 95.8 Favored Glycine 0 C--N 1.316 -0.575 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.89 -45.85 63.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.937 0.399 . . . . 0.0 110.899 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.0 mt -64.49 -44.13 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.742 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.5 p -93.47 -8.15 42.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.538 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.65 25.0 71.47 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -101.35 52.24 0.84 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.817 0.341 . . . . 0.0 110.653 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.7 -39.02 77.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.668 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.47 -47.12 86.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.201 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -61.41 -39.02 89.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.357 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.4 97.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.068 0.461 . . . . 0.0 110.355 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.19 -27.71 69.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.541 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.71 -53.57 9.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.192 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.541 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -63.98 -43.26 96.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.461 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 174' ' ' ASP . 86.9 mt -63.08 -43.86 99.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.687 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.45 -61.72 2.33 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.173 0.511 . . . . 0.0 110.369 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.45 -34.99 62.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.448 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.4 ' CD2' HD11 ' A' ' 177' ' ' LEU . 23.2 t80 -79.66 -35.37 39.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.056 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.0 m-20 -56.0 -41.15 74.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.128 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.92 -42.25 99.73 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.756 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.3 -37.93 88.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.29 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 177' ' ' LEU . 82.0 mt -62.41 -42.26 99.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.752 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.8 -52.97 62.01 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.132 0.491 . . . . 0.0 110.704 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.45 -41.78 88.61 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.649 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.03 -40.0 95.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.7 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.32 -32.4 73.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.349 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.16 -21.69 18.93 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.684 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.0 tt0 -64.86 -41.36 95.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.642 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.0 pt -77.23 135.58 26.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.656 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.02 108.62 11.09 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.27 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.86 126.83 0.31 Allowed Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.548 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.9 Cg_exo -43.75 152.09 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.749 2.3 . . . . 0.0 112.609 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.2 142.09 54.42 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.598 2.198 . . . . 0.0 112.487 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.547 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.12 147.32 2.23 Favored Pre-proline 0 N--CA 1.446 -0.631 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.62 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.2 154.46 69.92 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.71 2.274 . . . . 0.0 112.293 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.58 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.42 163.14 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.417 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.58 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.75 170.46 15.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.905 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.64 137.65 21.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.961 0.41 . . . . 0.0 110.141 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.536 HG22 HD12 ' A' ' 205' ' ' LEU . 39.3 pt -134.08 146.46 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.623 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.9 131.74 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.182 0.515 . . . . 0.0 110.485 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -151.73 154.59 36.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.404 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 199' ' ' ALA . 84.8 m -121.86 122.54 39.66 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.996 0.427 . . . . 0.0 110.382 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.76 -25.5 66.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.551 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.611 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.45 -50.0 20.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.071 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.53 -10.74 60.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.398 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.3 m80 48.61 43.26 20.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.475 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.1 t -136.07 145.24 45.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.323 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.402 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -111.19 113.77 26.52 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.297 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.9 133.65 55.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.07 0.462 . . . . 0.0 110.301 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.23 146.43 38.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.72 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.495 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.8 t90 -99.36 129.86 45.6 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.152 0.501 . . . . 0.0 110.024 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.67 154.37 39.18 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.211 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.9 Cg_endo -67.64 -18.22 48.24 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.702 2.268 . . . . 0.0 111.925 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.2 -18.72 0.37 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.431 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.495 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.73 164.99 25.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.559 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.07 -27.94 66.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.529 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.52 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.8 mt-30 -63.56 -41.59 98.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.675 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.05 -44.87 96.85 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.38 -38.97 92.9 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.952 0.406 . . . . 0.0 110.642 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.549 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.4 mmm -62.23 -41.39 98.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.148 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 70.9 mt -63.78 -47.15 82.08 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.641 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.51 -31.97 57.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.075 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -70.7 -18.28 62.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.493 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.426 HD11 ' CD2' ' A' ' 299' ' ' LEU . 93.5 mt -88.61 -8.3 54.92 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.656 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.47 2.64 55.52 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -88.54 152.33 21.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.346 . . . . 0.0 110.543 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.446 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.2 p -115.15 128.12 55.99 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.117 0.484 . . . . 0.0 110.337 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.52 145.7 24.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.468 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.38 151.41 46.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.43 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.31 131.81 42.34 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.409 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.885 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.52 93.54 28.01 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.078 -179.57 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.68 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.4 Cg_exo -55.62 138.99 82.45 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.553 2.169 . . . . 0.0 111.493 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.77 -25.42 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.463 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.68 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.83 -49.55 28.42 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.56 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.8 mt -54.61 -37.18 65.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 0.0 110.098 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.29 35.8 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.837 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.56 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.38 88.35 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 82.6 p -81.83 -14.12 56.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.307 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.53 -40.89 11.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.582 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 24.7 t -66.86 -16.87 64.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.643 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.99 43.6 26.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.45 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.94 -147.44 7.43 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.02 142.95 49.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.035 0.445 . . . . 0.0 110.291 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.23 149.69 28.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.361 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -101.3 -151.35 0.41 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.294 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 55.76 -92.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.611 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.455 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.3 tt -126.56 174.8 9.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.604 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.455 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.7 mt -121.4 141.09 43.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.781 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.42 168.85 9.73 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.224 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.8 mt -147.57 150.85 35.26 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.191 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.75 -38.76 96.66 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.05 4.27 4.65 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.47 -58.03 3.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.94 0.4 . . . . 0.0 110.571 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.545 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.1 m-20 -62.42 -36.6 82.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.282 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.402 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.2 mp -52.29 -67.64 0.23 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.808 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.67 -42.11 67.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.072 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.84 17.97 0.15 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.698 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.77 48.32 0.26 Allowed Glycine 0 N--CA 1.464 0.564 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.36 -109.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.595 0.236 . . . . 0.0 110.741 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.74 -44.95 96.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.484 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.54 8.23 83.41 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -99.53 -12.24 20.31 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.751 -0.264 . . . . 0.0 110.732 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.7 t 176.2 142.47 0.07 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.096 0.474 . . . . 0.0 110.482 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.06 126.04 12.04 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.077 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 14.0 m-30 -99.06 142.89 29.97 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 120.893 0.378 . . . . 0.0 110.907 178.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.45 106.61 18.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.596 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.47 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.8 t80 -102.3 -12.1 18.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.203 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.66 -40.32 88.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.833 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.22 173.45 45.92 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.495 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.4 m-20 -74.49 -113.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.772 0.32 . . . . 0.0 110.77 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.27 -28.69 68.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.635 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.06 -44.19 91.81 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.306 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.64 -44.29 94.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.379 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.54 -60.09 3.66 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.174 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.21 -43.41 61.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.219 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.45 -43.87 75.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.159 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.6 mt -64.31 -43.62 97.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.651 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -56.84 -37.49 71.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.21 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.03 0.93 19.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.249 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -114.83 91.53 26.45 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.086 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.14 -27.26 28.91 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.743 2.295 . . . . 0.0 111.823 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.533 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.27 -41.37 99.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.63 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.8 mp -95.01 4.87 53.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.324 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.7 -35.24 70.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.667 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.72 4.59 15.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.51 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.82 121.51 81.6 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.563 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -47.72 -37.76 28.31 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.415 2.076 . . . . 0.0 112.553 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.535 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.94 -43.7 91.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.803 0.335 . . . . 0.0 110.266 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.7 -43.78 93.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.286 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.91 -40.6 95.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.43 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.4 -12.48 40.19 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.569 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.25 31.69 17.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.891 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -88.64 44.22 1.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.419 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.91 135.58 43.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.436 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.23 132.87 56.54 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.452 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.42 87.6 6.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.72 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.95 -41.33 97.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.983 0.421 . . . . 0.0 110.906 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.47 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.91 168.6 35.04 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 77.2 p -75.89 -25.79 56.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.834 0.35 . . . . 0.0 110.705 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -67.71 -34.55 77.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.484 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.759 HG22 ' O ' ' A' ' 296' ' ' THR . 98.5 m -72.96 19.38 0.09 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.596 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.52 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 52.0 t80 -57.36 -50.88 71.56 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.049 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 69.8 mmt-85 -108.15 148.98 29.11 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.426 ' CD2' HD11 ' A' ' 219' ' ' LEU . 40.1 tp -115.54 125.87 53.54 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.696 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.476 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.6 t0 -149.32 166.7 28.18 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.651 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -49.45 -38.22 28.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.597 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -72.6 -64.61 0.92 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.925 0.393 . . . . 0.0 111.381 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.26 -31.49 70.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.889 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -55.54 -25.05 35.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.523 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.7 mtt -63.08 -41.52 99.43 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 120.923 0.392 . . . . 0.0 110.809 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.16 -44.28 26.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.018 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.534 HG21 HG23 ' A' ' 296' ' ' THR . 78.6 t -66.16 -43.08 92.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.415 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.439 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.5 tp -60.37 -47.3 86.66 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.529 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -69.8 -39.69 76.4 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.675 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.498 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 70.6 ttt180 -61.76 -37.92 86.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.218 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.72 4.79 42.78 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.769 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -112.58 -12.09 13.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.045 0.45 . . . . 0.0 110.246 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.22 85.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.574 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.87 -48.63 80.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.328 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.025 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -90.16 -2.81 58.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.369 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.09 179.22 1.22 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.513 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.6 Cg_exo -60.92 145.16 99.46 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.815 2.343 . . . . 0.0 112.179 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.35 -179.38 8.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.571 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -116.33 137.15 52.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.98 0.419 . . . . 0.0 110.329 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -123.99 146.61 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.349 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -120.28 136.4 54.68 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.771 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 53.1 p30 -99.81 -143.16 0.33 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.133 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -62.87 -36.87 84.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.399 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.468 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -152.23 -59.76 0.15 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.446 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -60.75 140.27 48.06 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.1 p -111.78 130.21 55.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.925 0.393 . . . . 0.0 110.404 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -120.05 128.62 53.68 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.509 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.2 m -85.5 130.14 34.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.205 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.497 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.7 mt -96.29 78.61 3.08 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.343 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.46 -31.83 73.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.556 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.75 109.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.976 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.497 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -122.75 91.2 49.74 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.287 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.643 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -57.15 148.63 68.44 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.82 2.347 . . . . 0.0 111.876 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.28 82.77 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.653 0.595 . . . . 0.0 110.999 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.643 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.67 67.0 0.88 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.142 0.496 . . . . 0.0 110.229 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -77.07 130.93 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.752 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.575 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.6 t -122.58 147.72 26.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.047 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.0 t -136.55 143.97 43.97 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.666 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.408 ' OG1' ' N ' ' A' ' 50' ' ' SER . 18.2 p -99.71 -58.8 1.84 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.557 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.408 ' N ' ' OG1' ' A' ' 49' ' ' THR . 88.4 p -79.43 155.25 28.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.637 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.527 HG21 HG23 ' A' ' 70' ' ' THR . 69.0 t -74.05 -21.94 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.569 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.6 m -60.26 -51.92 67.48 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.516 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 mt -66.21 -42.68 88.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.172 0.511 . . . . 0.0 110.897 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.3 m -43.16 -53.96 4.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.959 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.0 -37.55 73.86 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 m -62.86 -44.22 96.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.87 0.366 . . . . 0.0 110.244 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 17.5 mt -65.86 -42.33 90.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.602 0.715 . . . . 0.0 110.679 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tp -62.93 -39.69 95.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.519 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.495 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.6 -36.0 77.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.235 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.51 HD11 HD12 ' A' ' 156' ' ' LEU . 34.2 pt -91.36 28.09 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.257 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.79 51.83 10.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.011 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.16 76.07 27.62 Favored Pre-proline 0 C--O 1.225 -0.189 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.02 149.6 90.14 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.742 2.294 . . . . 0.0 112.108 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.575 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.57 136.61 48.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-O 121.233 0.539 . . . . 0.0 110.256 179.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.434 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.3 pt -69.3 -43.73 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.369 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.16 131.15 53.27 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.989 0.423 . . . . 0.0 110.628 -178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.5 p -155.65 168.6 26.64 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.38 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.34 -177.24 21.98 Favored Glycine 0 N--CA 1.465 0.593 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.635 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.42 172.04 13.25 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 121.067 0.46 . . . . 0.0 110.434 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.527 HG23 HG21 ' A' ' 51' ' ' VAL . 12.8 p -133.38 -111.37 0.23 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.001 0.429 . . . . 0.0 110.346 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.94 179.73 0.93 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.356 -179.019 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.0 Cg_exo -61.02 58.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 123.032 2.488 . . . . 0.0 112.14 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.535 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.7 t-20 -64.38 -34.23 77.68 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 118.716 -0.659 . . . . 0.0 110.423 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.4 m-20 94.6 -37.27 0.01 OUTLIER 'General case' 0 C--N 1.348 0.543 0 O-C-N 124.156 0.91 . . . . 0.0 109.684 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -62.73 -40.07 96.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.029 0.442 . . . . 0.0 110.203 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -73.99 -26.16 20.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.714 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.75 -172.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.539 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.54 -153.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.79 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.3 p-10 -54.21 -6.85 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.707 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.01 114.19 23.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.647 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.42 72.06 1.3 Allowed Glycine 0 C--O 1.225 -0.446 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -143.58 148.13 35.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.913 0.387 . . . . 0.0 110.839 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -85.89 -98.77 0.07 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.076 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.86 -43.39 96.23 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.14 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.556 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.8 tt0 91.65 52.69 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 124.143 0.902 . . . . 0.0 110.919 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -103.33 -8.53 20.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.387 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -65.52 -33.31 75.63 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.198 0.523 . . . . 0.0 110.687 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.556 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.24 -24.26 1.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.629 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.8 t -69.57 -46.02 76.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.842 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.24 -48.51 81.12 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.984 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.61 -38.23 89.38 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.367 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.71 -32.86 53.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.144 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.588 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.79 1.71 55.8 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.554 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 83.03 -49.38 0.15 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.141 0.901 . . . . 0.0 110.275 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.628 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.1 mt -46.23 153.72 0.31 Allowed 'General case' 0 CA--C 1.486 -1.483 0 CA-C-O 117.127 -1.416 . . . . 0.0 109.257 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.628 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.35 92.06 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 O-C-N 125.896 1.998 . . . . 0.0 110.525 -178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.01 142.83 43.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.174 0.512 . . . . 0.0 110.212 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.8 mt -131.96 26.52 4.6 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.041 -0.412 . . . . 0.0 110.443 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -140.03 137.5 34.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.032 0.444 . . . . 0.0 110.516 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.7 mt -136.82 164.7 29.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.352 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.612 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.76 -28.76 1.74 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.08 70.67 7.77 Favored Pre-proline 0 N--CA 1.464 0.256 0 CA-C-O 121.195 0.521 . . . . 0.0 110.206 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.98 145.29 98.7 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.743 2.295 . . . . 0.0 112.087 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.1 t -135.03 137.11 42.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.507 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.0 -38.35 82.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.697 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.19 -42.23 96.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.512 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.91 -41.61 98.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.545 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.46 -43.35 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.96 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.04 -35.17 77.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.022 0.439 . . . . 0.0 110.216 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.58 -18.96 61.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.459 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.32 -6.55 58.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.537 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.413 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 68.9 mtp 47.65 55.87 17.11 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.661 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.5 Cg_endo -70.34 149.64 63.48 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.755 2.303 . . . . 0.0 112.132 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.48 -72.78 0.67 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.451 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.421 HD11 HD13 ' A' ' 140' ' ' LEU . 38.5 tp -111.61 113.93 26.65 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.348 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.0 mt -102.96 126.79 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 120.935 0.398 . . . . 0.0 110.566 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.2 mt -110.33 134.16 52.56 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.111 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.65 139.72 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.501 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.1 p -83.22 167.78 17.37 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.708 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.34 -37.25 80.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.43 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.6 t -139.57 158.6 43.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.439 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.59 176.64 33.87 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.68 86.88 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.34 151.38 44.41 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.919 0.39 . . . . 0.0 110.547 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.4 t -63.56 140.89 58.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.268 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.55 10.65 11.15 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.618 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.513 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.2 -39.07 88.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.171 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.628 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.75 -35.9 24.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.614 0.721 . . . . 0.0 110.667 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.8 mt -70.98 -35.26 72.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.525 0.678 . . . . 0.0 110.74 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.9 -62.98 0.87 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.339 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.628 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.72 -42.73 90.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -61.97 -32.64 73.1 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.509 0.506 . . . . 0.0 110.222 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.4 mt -73.75 -40.56 63.41 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.49 -49.03 78.82 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.137 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.8 m -52.98 -42.52 65.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.237 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.91 -43.08 93.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.991 0.424 . . . . 0.0 111.208 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.06 152.89 5.36 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.677 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -38.92 107.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.673 2.249 . . . . 0.0 112.488 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.637 ' C ' HD12 ' A' ' 140' ' ' LEU . 96.8 m -109.61 121.44 45.22 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.041 0.448 . . . . 0.0 110.181 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.637 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.83 152.68 30.33 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.254 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.2 tt -128.06 131.16 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.38 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.34 127.75 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.49 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 54.4 t30 -100.15 104.57 16.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.176 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -100.28 -12.02 19.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.014 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.8 p-10 -65.16 -34.08 77.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.81 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.581 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.8 p-10 -99.34 7.92 45.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.585 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -134.05 151.44 51.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.56 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.42 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.8 p -75.87 166.31 23.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.635 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.595 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.0 t90 -59.26 -48.76 80.43 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.101 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -54.24 -44.12 71.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.989 0.423 . . . . 0.0 110.04 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.3 t -63.05 -40.8 98.78 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.344 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.416 ' O ' HD23 ' A' ' 156' ' ' LEU . 62.7 tp -60.62 -44.52 96.23 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.287 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.6 tp -61.56 -42.51 98.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.192 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.9 m -55.55 -46.14 77.17 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.83 -40.6 95.87 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.962 0.41 . . . . 0.0 110.337 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.51 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -62.12 -42.51 99.3 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.41 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.27 -40.11 94.62 Favored Glycine 0 C--O 1.222 -0.608 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.34 -45.9 65.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.931 0.396 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.83 -44.1 96.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.2 p -92.95 -9.3 40.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.61 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.18 26.37 72.49 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -101.97 50.73 0.84 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.822 0.344 . . . . 0.0 110.694 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.63 -39.27 77.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.667 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.5 -47.21 86.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.223 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -59.84 -39.54 85.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.209 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.16 -40.82 98.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.059 0.457 . . . . 0.0 110.259 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.83 -29.03 70.42 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.966 0.412 . . . . 0.0 110.616 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -73.94 -54.39 8.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.076 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.495 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.6 ttp180 -64.67 -42.02 95.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.419 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.4 mt -62.3 -43.93 98.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.531 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.99 -59.67 4.76 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.136 0.493 . . . . 0.0 110.253 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -55.91 -34.15 65.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.48 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -80.17 -36.18 35.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.798 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.2 m-20 -54.66 -42.02 70.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.926 -178.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.98 -41.39 97.97 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.62 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -64.93 -38.21 90.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.322 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.1 mt -62.33 -42.45 99.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.804 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.84 -53.38 56.67 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.149 0.5 . . . . 0.0 110.685 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.22 -41.82 89.55 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.694 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.7 -40.31 96.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.697 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.03 -32.54 73.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.39 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.2 -21.53 19.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.736 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.63 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.2 tt0 -64.7 -41.93 95.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.763 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.1 pt -75.98 133.76 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.043 0.449 . . . . 0.0 110.723 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -127.51 106.11 8.95 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.317 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.3 128.27 0.35 Allowed Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.576 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.447 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.5 Cg_exo -43.44 151.3 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.812 2.342 . . . . 0.0 112.667 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.66 142.43 53.06 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.577 2.185 . . . . 0.0 112.517 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.544 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -170.97 147.29 2.28 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.672 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.9 153.96 71.77 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.761 2.308 . . . . 0.0 112.299 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.21 163.05 29.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.228 0.537 . . . . 0.0 110.415 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.578 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.52 169.82 16.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.949 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.03 137.59 22.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.987 0.422 . . . . 0.0 110.11 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.532 HG22 HD12 ' A' ' 205' ' ' LEU . 39.5 pt -134.22 146.34 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.76 131.9 59.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.198 0.523 . . . . 0.0 110.471 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -151.86 154.77 36.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.409 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.0 m -121.64 122.78 40.39 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 110.358 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.6 -25.61 66.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.638 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.611 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.95 -49.43 20.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.966 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.75 -12.03 60.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.34 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.7 m80 49.59 42.35 22.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.435 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.8 t -136.39 145.29 45.17 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.354 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.84 114.39 27.7 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.268 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.93 133.37 55.59 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.108 0.48 . . . . 0.0 110.289 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.532 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.07 146.4 38.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.793 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.476 ' N ' HD23 ' A' ' 205' ' ' LEU . 12.9 t90 -99.69 127.99 45.8 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.187 0.518 . . . . 0.0 109.86 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.46 153.67 41.35 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.401 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.74 -18.57 47.72 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.655 2.237 . . . . 0.0 111.977 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.13 -18.35 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.343 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.448 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.6 p -75.36 167.8 21.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.484 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.24 -35.62 75.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.429 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.5 mt-30 -56.74 -41.12 76.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.698 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.42 -42.99 97.77 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.503 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 73.1 mt-30 -63.91 -39.95 95.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 122.279 -0.541 . . . . 0.0 110.745 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.595 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.4 mmm -61.83 -41.54 97.91 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.196 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 77.5 mt -63.46 -49.79 72.26 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 121.16 0.505 . . . . 0.0 110.404 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.38 -32.66 50.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 0.0 110.076 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.18 -20.07 62.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.578 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 219' ' ' LEU . 67.1 mt -87.39 -6.53 58.42 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.58 3.89 57.24 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -88.63 149.81 23.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 0.0 110.527 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.447 ' O ' HG12 ' A' ' 191' ' ' VAL . 3.5 p -112.96 126.83 55.91 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.211 0.529 . . . . 0.0 110.191 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.87 145.61 24.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.061 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.48 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.9 150.51 46.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.398 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.61 131.29 44.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.385 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.888 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.67 92.97 26.18 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.996 -179.535 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.681 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.1 Cg_exo -55.6 139.13 82.53 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.542 2.161 . . . . 0.0 111.582 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.51 -24.62 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.483 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.681 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.07 -49.59 26.77 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.555 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -54.57 -36.91 64.88 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.63 36.06 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.82 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.555 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.68 87.4 0.01 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.879 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.5 p -80.81 -14.73 57.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.334 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.42 -41.11 11.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.668 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.2 t -66.85 -16.65 64.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.585 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.01 43.74 26.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.431 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.77 -146.87 7.22 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.57 143.42 49.75 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.026 0.441 . . . . 0.0 110.296 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -151.75 149.26 28.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.279 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -100.36 -152.83 0.43 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.317 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.6 t0 56.44 -91.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.671 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.471 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.67 175.39 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.594 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.471 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.8 mt -121.41 141.04 43.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.842 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.41 168.98 9.65 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.14 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.0 mt -147.3 150.69 35.27 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.278 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.69 -39.04 97.09 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.56 3.75 4.55 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.0 -58.31 3.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.959 0.409 . . . . 0.0 110.562 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.556 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.1 m-20 -62.06 -36.92 83.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.209 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.18 -67.66 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.79 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.6 -42.02 67.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.091 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.15 18.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.689 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.44 47.53 0.2 Allowed Glycine 0 N--CA 1.466 0.642 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 39.23 -109.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.569 0.223 . . . . 0.0 110.684 -178.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.48 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.5 m120 -60.98 -44.99 96.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.367 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.78 8.04 83.26 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -99.22 -12.47 20.38 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.709 -0.289 . . . . 0.0 110.687 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.4 t 176.38 142.65 0.07 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.085 0.469 . . . . 0.0 110.449 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.16 125.77 11.77 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.207 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.63 143.04 29.45 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 120.885 0.374 . . . . 0.0 110.958 178.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.0 mt -94.39 106.77 18.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.659 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.472 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 93.0 t80 -102.23 -12.95 17.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.117 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -65.87 -40.45 91.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.892 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.18 173.48 45.95 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.492 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -74.27 -112.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.76 0.314 . . . . 0.0 110.749 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.93 -28.77 67.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.673 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.2 -44.05 92.23 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.259 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.5 -44.49 94.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.327 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.45 -59.67 4.15 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.12 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.35 -43.41 61.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.069 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.74 74.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.194 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.3 -43.61 97.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.592 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -56.57 -37.77 71.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.074 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.32 0.99 20.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.168 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -115.07 91.28 26.48 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.094 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.05 -27.22 28.16 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.786 2.324 . . . . 0.0 111.897 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.531 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -41.27 98.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.536 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.9 mp -95.44 4.91 52.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.347 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.76 -35.31 70.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.644 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.82 4.77 15.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.489 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.525 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.68 121.2 80.22 Favored Pre-proline 0 N--CA 1.44 -0.937 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.587 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -47.55 -37.48 26.53 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.41 2.073 . . . . 0.0 112.628 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.72 -43.48 90.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.747 0.308 . . . . 0.0 110.245 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.85 -43.74 93.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.246 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.86 -40.62 95.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.335 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.46 -12.6 39.68 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.603 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 62.01 31.64 17.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.003 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.42 44.33 1.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.136 0.493 . . . . 0.0 110.327 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.4 135.82 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.439 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.65 132.42 56.69 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.4 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.49 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.83 88.39 6.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.77 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.431 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.9 mt -63.83 -41.74 97.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.983 0.42 . . . . 0.0 110.832 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.472 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.85 165.94 34.56 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 76.8 p -75.62 -25.99 57.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.846 0.355 . . . . 0.0 110.703 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.3 tp10 -68.4 -34.03 75.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.442 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.758 HG22 ' O ' ' A' ' 296' ' ' THR . 99.4 m -72.26 18.82 0.08 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.558 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.508 ' O ' ' NE2' ' A' ' 212' ' ' GLN . 48.1 t80 -56.93 -51.03 70.76 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.873 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -107.09 148.15 29.13 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 41.0 tp -115.52 126.11 53.86 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.842 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.477 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.0 t0 -149.55 166.83 28.04 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.672 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -49.28 -38.03 25.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.631 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -71.75 -64.91 0.84 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.47 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.9 -32.94 72.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.979 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.47 -25.52 25.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.66 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.2 mtt -63.56 -41.07 98.43 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 120.906 0.384 . . . . 0.0 111.06 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -77.65 -44.61 27.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.084 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.579 HG21 HG23 ' A' ' 296' ' ' THR . 79.6 t -66.12 -42.88 92.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.346 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.447 HD11 ' OE1' ' A' ' 183' ' ' GLN . 48.3 tp -59.92 -47.05 87.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.449 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -70.19 -39.55 75.15 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.134 0.492 . . . . 0.0 110.897 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.492 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 73.9 ttt180 -61.28 -37.79 84.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.197 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -88.06 5.06 42.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.689 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.63 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.0 tttt -112.23 -11.84 13.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.075 0.464 . . . . 0.0 110.303 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.26 85.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.53 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.97 -48.73 80.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.339 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.941 -179.964 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -89.89 -2.68 58.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.417 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.493 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.15 1.23 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.501 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.493 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.8 Cg_exo -60.81 144.89 99.64 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.86 2.373 . . . . 0.0 112.123 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.83 -179.48 8.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.592 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.77 137.0 52.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.371 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.71 146.99 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.383 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -120.03 136.14 54.67 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.791 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.36 -143.48 0.32 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.225 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.66 -37.08 86.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.458 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.21 -66.62 0.22 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.435 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.6 142.39 45.59 Favored Glycine 0 CA--C 1.519 0.294 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.6 p -112.17 131.36 55.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 110.443 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -119.1 129.1 54.88 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.485 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.9 m -85.76 130.37 34.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.225 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.486 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.3 mt -95.91 79.07 3.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.439 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.61 -31.96 73.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.71 109.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.986 0.422 . . . . 0.0 110.121 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.486 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.49 91.92 49.19 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.435 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.9 Cg_exo -56.7 148.67 63.9 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.804 2.336 . . . . 0.0 111.953 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.58 82.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.591 0.557 . . . . 0.0 110.979 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.5 66.84 0.89 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.271 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.06 130.58 36.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.812 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.561 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.7 t -122.61 146.71 27.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.061 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.0 t -135.96 143.96 45.16 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.77 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.5 p -99.5 -59.4 1.73 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.624 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.2 p -79.28 155.07 28.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.651 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.503 HG21 HG23 ' A' ' 70' ' ' THR . 73.3 t -74.05 -21.91 18.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.529 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.4 m -60.23 -52.07 66.85 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.536 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.38 -42.6 87.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.102 0.477 . . . . 0.0 110.787 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.9 m -43.14 -54.07 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.029 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.33 -37.05 70.53 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m -62.88 -44.71 95.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.867 0.365 . . . . 0.0 110.252 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.0 mt -66.37 -41.9 88.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.487 0.661 . . . . 0.0 110.75 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -62.61 -40.33 96.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.431 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.501 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.04 -35.61 75.48 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.202 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.529 HD11 HD12 ' A' ' 156' ' ' LEU . 32.6 pt -91.54 28.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.253 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.45 51.67 11.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.32 75.7 22.57 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.0 0.429 . . . . 0.0 109.919 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.61 151.35 85.96 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.825 2.35 . . . . 0.0 112.16 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.561 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.42 137.31 46.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.182 0.515 . . . . 0.0 110.274 179.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.445 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.4 pt -69.42 -43.4 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.359 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.03 131.17 53.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.96 0.41 . . . . 0.0 110.594 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.8 p -155.64 168.49 26.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.489 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.66 -177.16 21.78 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.649 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.92 172.85 12.24 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 110.449 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.503 HG23 HG21 ' A' ' 51' ' ' VAL . 14.9 p -133.16 -111.93 0.23 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.001 0.429 . . . . 0.0 110.428 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.43 179.68 0.94 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.509 -179.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.7 Cg_exo -60.97 58.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.965 2.443 . . . . 0.0 112.099 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.1 t-20 -64.43 -33.73 76.54 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.485 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 42.5 m-20 94.07 -36.96 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.875 0.734 . . . . 0.0 109.808 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -62.75 -39.73 95.06 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.188 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.35 -25.54 19.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.669 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.31 -171.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.428 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.14 -153.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.87 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.5 p-10 -52.72 -7.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.749 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.509 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.52 114.88 23.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.648 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.95 69.69 1.36 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -143.05 147.15 34.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 110.813 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -84.92 -98.58 0.06 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.11 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.556 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.06 -42.48 97.0 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.13 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.556 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 34.8 tt0 91.29 52.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.841 0.713 . . . . 0.0 111.076 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -102.8 -9.25 20.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.374 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.3 p -64.36 -34.11 77.39 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.138 0.494 . . . . 0.0 110.695 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.532 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.05 -23.61 1.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.677 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.92 -45.97 75.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.746 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.26 -48.55 80.9 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.009 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.37 -38.34 89.2 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.446 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.57 -32.74 52.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.175 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.611 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.4 mmt-85 -90.1 1.75 56.03 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.535 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.611 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 56.9 mttp 82.84 -49.38 0.17 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.838 0.711 . . . . 0.0 110.318 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.664 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.3 mt -45.86 154.01 0.25 Allowed 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 117.733 -1.127 . . . . 0.0 109.598 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.664 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.22 92.62 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 125.387 1.679 . . . . 0.0 110.521 -178.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.543 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.65 143.17 42.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.249 0.547 . . . . 0.0 110.244 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.9 mt -132.23 27.04 4.5 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 122.013 -0.429 . . . . 0.0 110.454 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.32 137.94 34.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.03 0.443 . . . . 0.0 110.559 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.2 mt -137.33 165.1 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.356 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.58 -28.48 1.91 Allowed Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.22 70.45 7.63 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.13 0.49 . . . . 0.0 110.172 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.93 145.23 98.83 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.751 2.301 . . . . 0.0 112.098 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.5 t -134.57 136.59 43.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.97 0.414 . . . . 0.0 110.544 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.37 83.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.63 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.14 -42.41 96.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.527 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.6 98.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.525 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.7 -43.41 98.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.03 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.23 -35.03 77.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.181 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.59 -18.73 60.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.407 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.61 -6.47 58.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.531 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 70.3 mtp 47.59 56.06 17.22 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.596 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.1 149.33 64.57 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.737 2.291 . . . . 0.0 112.12 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.24 -74.0 0.63 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.43 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.8 tp -110.22 112.91 25.17 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.268 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.4 mt -101.82 126.26 55.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.694 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 mt -109.51 133.7 52.77 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.276 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.54 139.44 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.594 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.5 p -83.43 168.58 16.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.793 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.24 -37.43 80.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.427 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.74 158.99 43.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.488 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.15 177.43 33.19 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.19 -33.9 87.38 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -125.12 151.98 45.01 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.9 0.381 . . . . 0.0 110.522 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.4 t -63.14 140.99 58.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.369 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.43 10.32 11.16 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.649 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.513 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.01 -38.79 87.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.244 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.638 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.2 -35.89 23.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.449 0.643 . . . . 0.0 110.628 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.1 mt -71.05 -35.51 71.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.504 0.668 . . . . 0.0 110.673 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -42.68 -62.71 0.92 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.356 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.638 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.91 -42.73 89.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.159 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -62.08 -32.69 73.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.338 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.3 mt -73.75 -40.98 63.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.898 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.27 -48.84 79.17 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.19 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.2 m -53.2 -42.48 66.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.182 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.81 -42.94 93.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.022 0.439 . . . . 0.0 111.158 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.64 154.57 5.53 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.657 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -39.39 106.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.647 2.232 . . . . 0.0 112.496 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.7 m -110.5 121.35 45.09 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.093 0.473 . . . . 0.0 110.199 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.22 153.28 29.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.286 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -129.29 131.55 67.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.404 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -115.16 128.03 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.056 0.455 . . . . 0.0 110.512 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.62 103.56 14.38 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.197 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.8 p90 -101.15 -11.21 19.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.872 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.2 p-10 -64.84 -33.41 75.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.703 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.571 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.3 p-10 -98.38 8.0 45.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.567 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.45 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.88 155.62 50.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.466 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.403 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.8 p -75.01 165.62 24.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.668 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.59 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.88 -48.62 80.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.217 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.54 -42.02 67.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.001 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.4 t -62.74 -41.06 99.01 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.37 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.409 ' CD1' HG21 ' A' ' 142' ' ' ILE . 45.6 tp -60.59 -44.41 96.29 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.406 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.37 -43.41 98.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.166 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.0 m -55.07 -44.93 75.26 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.35 -40.74 97.38 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.967 0.413 . . . . 0.0 110.507 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.529 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.94 -42.54 99.23 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.311 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.13 -40.85 95.16 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.57 -45.99 64.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.937 0.398 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.75 -43.98 96.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.837 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -93.07 -8.83 41.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.632 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.96 26.63 72.34 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.69 50.59 0.85 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.807 0.337 . . . . 0.0 110.678 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -69.44 -39.48 77.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.648 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.46 -47.2 86.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.274 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -60.13 -39.38 86.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.163 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.98 99.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.246 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.92 -28.5 70.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.591 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.29 -54.27 8.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.895 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.501 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.48 -42.28 92.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.366 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.9 mt -62.36 -43.84 98.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.566 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.57 -58.36 7.83 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.999 0.428 . . . . 0.0 110.356 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.13 -33.55 67.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.589 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.402 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.5 t80 -81.34 -36.5 29.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.774 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -55.63 -42.29 74.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.023 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.28 -42.23 99.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.74 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.27 -37.98 88.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.295 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.7 mt -62.51 -42.12 99.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.729 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.13 -52.98 61.69 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.045 0.45 . . . . 0.0 110.667 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.22 -41.91 89.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.665 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.7 -40.02 95.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.592 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.38 -31.91 73.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.434 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.77 -22.4 18.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.67 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.75 -41.27 96.03 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.668 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.0 pt -76.24 136.27 25.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.657 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.47 107.83 10.62 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.29 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -177.16 125.8 0.29 Allowed Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.472 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.4 Cg_exo -44.04 152.38 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.864 2.376 . . . . 0.0 112.509 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.8 141.91 55.85 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.612 2.208 . . . . 0.0 112.446 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.27 147.14 2.13 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.548 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.08 154.34 70.57 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.811 2.34 . . . . 0.0 112.312 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.05 162.99 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.235 0.54 . . . . 0.0 110.403 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.72 170.33 16.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.927 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.66 137.75 21.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 110.126 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.557 HG22 HD12 ' A' ' 205' ' ' LEU . 39.4 pt -134.54 147.2 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.661 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.02 132.15 58.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.115 0.483 . . . . 0.0 110.488 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -152.44 155.72 38.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.444 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.626 HG22 ' H ' ' A' ' 199' ' ' ALA . 88.8 m -123.25 123.48 40.85 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.945 0.402 . . . . 0.0 110.375 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.63 -25.64 66.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.626 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.626 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.69 -48.96 19.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.006 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.61 -12.06 60.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.497 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.1 m80 49.28 41.02 19.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.526 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.3 t -135.84 143.65 45.23 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.385 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.424 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -109.83 114.29 27.74 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.24 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.82 133.36 55.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.016 0.436 . . . . 0.0 110.488 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.557 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.87 146.62 37.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.834 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.497 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 10.0 t90 -99.97 129.65 46.06 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.186 0.517 . . . . 0.0 109.869 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.85 153.73 39.94 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.39 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.3 Cg_endo -67.77 -18.06 47.44 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.755 2.303 . . . . 0.0 111.975 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.27 -19.12 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.369 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.497 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.5 p -75.4 164.41 26.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.497 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.78 -27.66 65.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.526 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.61 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.0 mt-30 -63.88 -41.03 97.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.556 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.81 -44.48 97.96 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.45 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.1 mt-30 -64.49 -38.77 92.17 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 122.299 -0.53 . . . . 0.0 110.697 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.59 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.3 mmm -61.93 -41.24 97.72 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.209 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.56 -47.31 82.09 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.022 0.439 . . . . 0.0 110.437 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.91 -31.97 51.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.866 0.365 . . . . 0.0 110.268 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -70.9 -18.63 62.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.508 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.436 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.3 mt -87.65 -9.12 55.11 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.602 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.16 1.84 54.46 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -88.42 153.55 21.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.904 0.383 . . . . 0.0 110.468 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.434 ' O ' HG12 ' A' ' 191' ' ' VAL . 7.3 p -116.4 128.87 55.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.14 0.495 . . . . 0.0 110.41 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.48 146.3 23.79 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.916 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.486 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.93 151.5 45.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.488 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.49 131.51 43.51 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.428 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.888 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.72 93.44 28.53 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.05 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.676 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.2 Cg_exo -55.38 138.78 80.84 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.545 2.163 . . . . 0.0 111.679 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.98 -26.05 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.457 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.676 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.03 -50.11 30.57 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.56 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.5 mt -54.43 -37.07 64.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.45 36.24 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.74 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.56 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.3 86.31 0.02 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.878 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.5 p -79.2 -15.08 58.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.382 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -92.6 -41.01 10.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.603 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.9 t -66.13 -17.86 64.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.645 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 56.16 43.3 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.492 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.34 -148.34 7.72 Favored Glycine 0 CA--C 1.519 0.289 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.58 142.75 49.8 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 110.347 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -152.36 149.89 29.12 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.296 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -101.28 -151.33 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.348 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 55.81 -92.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.672 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.462 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.85 175.38 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.627 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.462 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.8 mt -122.5 141.81 41.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.65 169.32 9.35 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.23 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.3 mt -147.52 150.94 35.5 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.264 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.93 -38.85 96.67 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.35 3.77 4.65 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -77.34 -58.13 3.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.924 0.392 . . . . 0.0 110.538 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.546 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.0 m-20 -62.14 -36.34 81.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.308 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.424 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.1 mp -52.55 -67.51 0.25 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.86 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.75 -42.37 68.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.081 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.7 17.59 0.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.669 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.86 48.47 0.27 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.394 -0.683 . . . . 0.0 111.394 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 38.82 -109.98 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.593 0.235 . . . . 0.0 110.712 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.486 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.6 m120 -60.86 -44.93 96.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.475 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.47 7.99 83.87 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -98.91 -13.66 19.91 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.647 -0.325 . . . . 0.0 110.66 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.4 t 177.25 142.78 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.087 0.47 . . . . 0.0 110.42 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.13 125.34 11.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.165 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 14.0 m-30 -98.28 143.63 28.56 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 120.865 0.364 . . . . 0.0 110.83 178.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.7 mt -95.18 106.67 18.71 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.794 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.437 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.7 t80 -102.26 -12.1 18.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.158 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.44 -40.4 89.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.886 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.0 173.3 45.86 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.461 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.3 m-20 -74.07 -113.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.756 0.312 . . . . 0.0 110.704 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.72 -28.81 67.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.686 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.1 -43.86 91.9 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.225 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.32 -44.55 94.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.316 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.56 -59.98 3.8 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.189 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -51.02 -43.38 60.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.151 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.47 -43.41 75.51 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.19 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.53 -43.68 96.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.629 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.25 -37.55 69.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.098 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.48 0.79 18.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.131 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -115.21 91.7 28.81 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.148 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.35 -27.07 29.73 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.748 2.299 . . . . 0.0 111.95 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.538 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.55 -41.06 98.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.503 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.33 5.24 52.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.381 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.13 -35.08 69.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.585 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.93 4.53 16.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.51 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.64 121.25 80.33 Favored Pre-proline 0 N--CA 1.445 -0.7 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.549 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -47.14 -38.0 24.3 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.483 2.122 . . . . 0.0 112.529 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.529 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.8 -43.66 90.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.704 0.288 . . . . 0.0 110.37 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.0 -43.62 92.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.355 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.92 -40.78 95.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.415 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.6 t-20 -89.65 -12.41 39.7 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.588 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.2 mtmt 61.94 32.19 17.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.995 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.76 43.97 1.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.061 0.457 . . . . 0.0 110.307 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.68 135.67 41.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.503 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.78 132.69 56.63 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.447 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.15 89.16 7.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.732 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.403 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.8 mt -63.82 -41.05 97.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.021 0.438 . . . . 0.0 110.856 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.437 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.2 165.02 33.52 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.516 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 74.1 p -75.28 -25.71 58.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.94 0.4 . . . . 0.0 110.771 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.503 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.3 tp10 -68.42 -34.03 75.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.393 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 96.6 m -73.35 24.84 0.07 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.736 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.61 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 39.7 t80 -58.07 -50.66 72.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.433 ' CZ ' ' CE2' ' A' ' 297' ' ' PHE . 80.0 mmt-85 -111.19 154.01 24.99 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.436 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.8 tp -115.44 124.98 52.51 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.814 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.481 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.8 t0 -147.69 165.55 30.13 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.619 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -49.34 -37.88 26.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.57 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -71.12 -65.6 0.72 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.504 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -61.01 -32.91 72.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.975 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.19 -25.55 23.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.743 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.2 mtt -63.6 -40.9 98.11 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 120.829 0.347 . . . . 0.0 111.07 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.76 -43.94 24.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.195 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.578 HG21 HG23 ' A' ' 296' ' ' THR . 76.6 t -66.34 -42.85 91.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.357 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.1 tp -60.22 -46.96 87.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.464 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -70.07 -39.47 75.62 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.054 0.454 . . . . 0.0 110.759 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.9 ttt180 -61.75 -38.29 87.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.248 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.12 4.39 42.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.607 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -112.77 -11.01 13.55 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.091 0.472 . . . . 0.0 110.347 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.41 -37.09 85.95 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.487 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.84 -48.71 80.58 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.457 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.006 179.868 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.618 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.02 -2.52 58.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.464 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.8 179.03 1.25 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.552 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.96 144.97 99.69 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.84 2.36 . . . . 0.0 112.092 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.618 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.68 -179.58 8.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.601 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.73 136.84 52.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.358 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.0 tp -124.53 147.5 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.396 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -120.35 135.97 54.85 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 110.742 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.27 -143.5 0.32 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.194 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.54 -37.11 86.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.417 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.09 -67.21 0.22 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.507 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.54 142.72 45.18 Favored Glycine 0 C--O 1.228 -0.275 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.9 p -112.29 131.57 55.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.962 0.41 . . . . 0.0 110.481 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -118.94 128.92 54.86 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.507 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.2 m -85.41 130.35 34.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.247 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.481 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.3 mt -95.59 78.54 3.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.405 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.69 -32.17 73.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.52 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.5 109.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.121 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.481 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.74 91.47 49.59 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.326 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.94 148.67 66.31 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.818 2.345 . . . . 0.0 111.894 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -40.71 82.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 O-C-N 123.657 0.598 . . . . 0.0 111.008 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.44 66.85 0.89 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.266 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.22 130.74 35.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.752 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.567 ' HA ' HG23 ' A' ' 64' ' ' VAL . 56.2 t -122.61 146.95 27.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.041 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 t -136.23 143.62 44.42 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.718 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.8 p -99.38 -59.25 1.76 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.526 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.8 p -79.35 155.57 28.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.646 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.548 HG21 HG23 ' A' ' 70' ' ' THR . 69.5 t -74.46 -21.97 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.591 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.7 m -60.25 -52.15 66.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.575 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.35 -42.53 87.93 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.173 0.511 . . . . 0.0 110.939 177.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.4 m -42.92 -54.07 4.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.041 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.47 -37.69 69.39 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.2 m -62.36 -44.63 96.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 110.299 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.4 mt -66.3 -41.98 88.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.445 0.641 . . . . 0.0 110.756 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -62.55 -40.17 95.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.442 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.495 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.19 -35.83 76.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.133 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.538 HD11 HD12 ' A' ' 156' ' ' LEU . 32.0 pt -91.41 29.06 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.266 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.42 51.92 10.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.887 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.4 75.67 22.35 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.961 0.41 . . . . 0.0 109.906 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.73 151.45 85.65 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.837 2.358 . . . . 0.0 112.162 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.567 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.58 137.16 47.65 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-O 121.214 0.53 . . . . 0.0 110.255 179.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.442 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.7 pt -69.48 -43.38 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.305 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.9 131.08 53.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.603 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.535 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.1 p -155.54 168.66 26.42 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.422 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.68 -177.2 21.76 Favored Glycine 0 N--CA 1.463 0.496 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.637 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.8 172.66 12.48 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.954 0.407 . . . . 0.0 110.538 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.548 HG23 HG21 ' A' ' 51' ' ' VAL . 15.3 p -132.26 -113.17 0.23 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.421 . . . . 0.0 110.359 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.77 179.72 0.95 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.408 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.1 Cg_exo -61.31 57.48 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 123.069 2.513 . . . . 0.0 112.091 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 60.4 t-20 -64.3 -33.07 74.97 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.462 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.3 m-20 93.65 -35.55 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.962 0.789 . . . . 0.0 109.795 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HD3' HD21 ' A' ' 73' ' ' ASN . 77.4 mtp85 -63.23 -39.74 95.47 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.987 0.422 . . . . 0.0 110.173 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.79 -25.19 18.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.719 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -48.96 -171.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.555 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -73.72 -153.84 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.787 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 36.4 p-10 -52.34 -7.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.726 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -86.51 114.99 23.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.003 0.43 . . . . 0.0 110.59 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.07 70.2 1.34 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -143.57 147.46 34.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.825 0.345 . . . . 0.0 110.823 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.82 -98.58 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.136 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.551 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.82 -42.71 97.58 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.114 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.562 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.4 tt0 91.61 52.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.962 0.789 . . . . 0.0 110.907 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -102.53 -9.27 20.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.33 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -64.56 -34.17 77.63 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.043 0.449 . . . . 0.0 110.631 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.562 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.2 -24.36 1.71 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.614 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.42 -45.64 78.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.753 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.45 -48.3 81.76 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.037 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.52 -38.24 89.17 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.36 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.53 -32.98 52.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.155 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.601 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.86 1.46 56.15 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.493 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.98 -48.98 0.15 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.984 0.803 . . . . 0.0 110.208 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.651 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.5 153.83 0.34 Allowed 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 117.65 -1.167 . . . . 0.0 109.307 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.651 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.59 92.46 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 O-C-N 125.482 1.739 . . . . 0.0 110.491 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.52 143.19 42.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.138 0.494 . . . . 0.0 110.321 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.3 mt -132.24 27.1 4.5 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.122 -0.361 . . . . 0.0 110.362 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -140.31 137.83 34.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.045 0.45 . . . . 0.0 110.524 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.5 mt -136.99 165.02 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.447 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.97 -28.61 1.85 Allowed Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -152.61 70.79 7.39 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.153 0.501 . . . . 0.0 110.355 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.08 145.43 98.46 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.75 2.3 . . . . 0.0 112.06 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.7 t -134.56 136.77 43.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.514 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.37 82.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.635 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.11 -42.24 96.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.483 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.15 -41.62 98.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.48 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.59 -43.45 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.043 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.3 78.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.195 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.44 -18.7 60.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.413 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.52 -6.53 58.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.486 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 73.8 mtp 48.09 55.94 17.35 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.616 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.12 149.13 64.17 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.808 2.339 . . . . 0.0 112.129 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.32 -73.05 0.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.5 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.43 HD11 HD13 ' A' ' 140' ' ' LEU . 38.5 tp -111.35 113.48 25.98 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.313 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.4 mt -102.3 126.64 56.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.567 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 mt -110.19 133.94 52.72 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.262 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.98 139.95 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.474 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.6 p -83.5 168.67 16.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.741 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.46 80.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.442 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.1 t -139.94 159.21 42.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.423 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.31 177.29 33.4 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.28 -33.81 87.25 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.53 151.53 44.57 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.575 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.4 t -63.55 140.93 58.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.298 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.66 10.7 11.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.666 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.04 -39.05 88.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.187 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.01 -35.91 23.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.445 0.64 . . . . 0.0 110.576 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -70.8 -35.48 72.56 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.54 0.686 . . . . 0.0 110.784 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -42.91 -62.99 0.87 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.289 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.61 -42.84 91.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.132 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -61.95 -32.73 73.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.257 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.1 mt -73.82 -40.69 63.17 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.032 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.31 -48.98 78.78 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.186 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.5 m -53.0 -42.39 65.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.187 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.89 -43.04 93.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.089 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.43 153.61 5.33 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.633 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -39.15 106.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.687 2.258 . . . . 0.0 112.393 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.635 ' C ' HD12 ' A' ' 140' ' ' LEU . 93.4 m -109.94 121.35 45.04 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.191 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.71 152.82 29.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.269 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -129.13 131.17 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.326 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.411 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -115.16 128.17 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.073 0.463 . . . . 0.0 110.497 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.476 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.61 103.57 14.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.23 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.4 p90 -101.34 -11.35 19.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.832 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 48.9 p-10 -64.67 -33.52 76.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.639 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.566 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.2 p-10 -98.37 7.7 45.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.596 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.447 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.49 155.72 50.05 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.539 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.6 p -74.94 165.68 24.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.643 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.3 t90 -60.12 -48.76 80.38 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.256 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -53.42 -41.82 66.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.89 0.376 . . . . 0.0 110.064 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.1 t -62.82 -41.13 99.17 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.334 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.411 ' CD1' HG21 ' A' ' 142' ' ' ILE . 45.7 tp -60.7 -44.4 96.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.331 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.1 tp -61.4 -43.54 98.69 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.168 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -54.85 -45.03 74.48 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.44 -40.56 96.99 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.936 0.398 . . . . 0.0 110.492 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.538 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.96 -42.47 99.16 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.368 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.1 -40.85 95.22 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.59 -45.98 64.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.891 0.377 . . . . 0.0 110.842 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.8 mt -64.68 -43.96 96.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.893 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.3 p -92.99 -8.79 42.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.621 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.84 26.96 72.35 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -101.98 50.71 0.84 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 110.716 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.48 -39.23 77.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.635 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.66 -47.24 86.39 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.3 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -60.14 -39.47 86.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.225 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.96 99.31 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.292 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.92 -28.62 70.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.649 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.21 -54.3 8.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.048 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.495 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.4 ttp180 -65.47 -42.28 92.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.449 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.455 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.3 mt -62.52 -43.8 98.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.473 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.62 -59.08 5.43 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.067 0.46 . . . . 0.0 110.392 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -56.25 -34.2 66.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.568 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -80.87 -36.31 31.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.798 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.3 m-20 -54.98 -42.15 72.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.147 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.54 -41.92 99.2 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.639 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.08 -38.26 90.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.259 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 177' ' ' LEU . 81.4 mt -62.33 -42.19 99.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.692 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -52.81 62.52 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.135 0.493 . . . . 0.0 110.689 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.09 -41.99 89.94 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.673 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.87 -40.01 95.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.591 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.17 -32.27 73.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.379 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.3 -22.06 18.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.632 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.625 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.6 tt0 -64.75 -41.28 96.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.657 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 184' ' ' ILE . 32.8 pt -77.02 136.05 25.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.668 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.2 108.05 10.55 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.27 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.59 126.05 0.32 Allowed Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.458 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.7 152.23 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.796 2.331 . . . . 0.0 112.66 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.04 141.89 54.53 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.624 2.216 . . . . 0.0 112.479 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.42 147.24 2.1 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.605 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.32 155.1 68.35 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.772 2.315 . . . . 0.0 112.356 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.78 163.26 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.207 0.527 . . . . 0.0 110.371 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.61 170.05 16.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.894 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.17 137.47 22.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.067 0.46 . . . . 0.0 110.03 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.56 HG22 HD12 ' A' ' 205' ' ' LEU . 39.0 pt -134.28 146.67 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.637 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.55 131.75 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.348 0.594 . . . . 0.0 110.488 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -152.78 156.17 38.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.425 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 199' ' ' ALA . 88.4 m -122.17 122.88 40.21 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.878 0.37 . . . . 0.0 110.307 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.523 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.8 -26.32 67.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.591 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.599 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.68 -49.5 21.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.69 -10.44 59.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.449 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.523 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.9 m80 46.28 47.05 13.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.455 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -130.97 143.76 50.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.414 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.452 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -108.57 105.32 14.9 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.169 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.6 m-20 -115.95 128.79 56.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.148 0.499 . . . . 0.0 110.321 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.56 HD12 HG22 ' A' ' 194' ' ' ILE . 7.7 tt -111.84 146.32 37.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.47 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.2 t90 -99.55 128.55 45.66 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.131 0.491 . . . . 0.0 109.905 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.41 154.22 40.31 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.293 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.71 -18.09 47.81 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.726 2.284 . . . . 0.0 111.981 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.65 -19.26 0.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.472 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.434 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 87.0 p -74.76 164.44 26.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.483 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.98 -27.77 65.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.518 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.583 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.67 -41.45 98.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.634 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.07 -44.29 97.43 Favored Glycine 0 C--N 1.331 0.286 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.447 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.5 mt-30 -64.52 -38.77 92.16 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 122.4 -0.471 . . . . 0.0 110.683 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.3 mmm -62.12 -41.34 98.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.16 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.6 mt -63.59 -47.36 81.77 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.534 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.24 -31.83 54.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 0.0 110.113 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.97 -18.33 62.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.493 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.418 HD11 ' CD2' ' A' ' 299' ' ' LEU . 92.1 mt -88.37 -8.55 54.86 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.568 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.42 2.88 55.57 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -89.02 152.56 21.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 0.0 110.445 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.456 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.3 p -115.35 128.23 55.94 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.132 0.491 . . . . 0.0 110.334 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.16 146.75 23.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.038 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.46 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.4 151.28 45.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.487 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.07 131.69 42.65 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.39 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.884 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.38 93.78 28.46 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.095 -179.667 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.683 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.2 Cg_exo -55.47 138.73 81.11 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.607 2.205 . . . . 0.0 111.568 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.53 -25.49 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.471 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.68 -49.95 27.46 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.1 mt -55.15 -37.37 66.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.851 0.358 . . . . 0.0 110.086 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -65.54 35.53 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.84 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.573 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.45 88.3 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 86.2 p -82.26 -13.83 56.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.325 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.32 -40.67 11.35 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.611 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.2 t -66.71 -16.95 64.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.593 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.99 43.69 26.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.457 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.91 -148.08 7.81 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.61 142.25 49.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.998 0.427 . . . . 0.0 110.274 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.403 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.4 ttt-85 -152.0 149.54 29.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.342 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -102.02 -150.35 0.4 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.346 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.68 -93.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.616 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.0 tt -126.57 174.58 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.604 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.435 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 87.4 mt -121.7 140.94 44.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.902 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.28 170.33 8.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.169 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.5 mt -146.94 149.51 33.33 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.15 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.35 -39.25 97.58 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.19 3.06 4.01 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -78.33 -57.64 3.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.948 0.404 . . . . 0.0 110.583 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.617 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.8 m-20 -61.99 -36.89 82.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.245 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.452 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.7 mp -53.13 -67.42 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.022 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.488 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.72 -42.7 68.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.145 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.38 17.85 0.13 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.685 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.79 47.59 0.23 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 7.9 mp 39.71 -110.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.595 0.236 . . . . 0.0 110.651 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.46 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -60.92 -44.52 97.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.441 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.5 8.11 83.64 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -98.7 -13.31 20.32 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.779 -0.248 . . . . 0.0 110.712 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.0 t 176.85 142.84 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 110.478 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.89 125.49 11.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.108 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.83 143.64 28.93 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 120.92 0.391 . . . . 0.0 110.758 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.9 mt -94.91 106.31 18.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.724 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.451 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.9 -11.81 18.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.219 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.91 86.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.897 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.25 172.69 45.56 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.469 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -73.81 -113.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.0 110.72 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.44 -28.86 68.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.74 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.01 -43.9 91.6 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.275 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -63.53 -44.39 94.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.386 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.57 -59.81 4.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.187 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.21 -43.44 61.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.067 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.42 74.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.267 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.3 mt -64.66 -43.53 96.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.58 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -56.34 -37.61 70.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.133 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.75 0.85 19.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.149 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.08 91.17 26.08 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.127 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.21 -27.09 28.8 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.724 2.283 . . . . 0.0 111.912 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.538 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.46 -41.02 98.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.557 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.3 5.48 51.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.418 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.18 -35.21 68.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.658 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.55 4.5 15.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.495 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.6 121.46 81.02 Favored Pre-proline 0 N--CA 1.444 -0.764 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.541 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -47.46 -37.93 26.61 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.51 2.14 . . . . 0.0 112.556 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.66 -43.7 89.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.738 0.304 . . . . 0.0 110.292 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.04 -43.52 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.325 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.17 -40.86 97.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.441 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.413 ' ND2' ' CG ' ' A' ' 288' ' ' GLN . 58.0 t30 -90.99 -11.22 39.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.704 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.2 mtmt 61.1 32.66 19.68 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.481 0.488 . . . . 0.0 111.001 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . 0.413 ' CG ' ' ND2' ' A' ' 286' ' ' ASN . 97.1 mm-40 -88.11 43.9 1.16 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.361 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.5 135.83 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.534 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.88 132.15 56.77 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.373 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.6 88.65 7.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.762 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.441 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.1 mt -64.0 -41.13 97.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.003 0.43 . . . . 0.0 110.892 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.451 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.25 166.39 34.04 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 70.3 p -75.29 -25.53 58.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.835 0.35 . . . . 0.0 110.719 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.3 tp10 -68.33 -33.91 75.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.535 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 296' ' ' THR . 97.7 m -73.62 23.42 0.07 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.617 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.583 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 59.3 t80 -58.04 -51.23 70.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.428 HH12 ' HG3' ' A' ' 212' ' ' GLN . 66.1 mmt-85 -111.05 153.88 25.01 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.418 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.2 tp -116.13 125.6 52.57 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.494 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.7 t0 -147.43 165.43 30.27 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.561 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -49.37 -38.09 27.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.607 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -72.14 -64.86 0.86 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.52 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.32 -32.0 70.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.012 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.39 -25.36 24.13 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.614 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.8 mtt -63.37 -41.0 98.78 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 120.879 0.371 . . . . 0.0 110.782 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -78.23 -44.78 24.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.55 HG21 HG23 ' A' ' 296' ' ' THR . 79.3 t -65.9 -43.04 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.448 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.439 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 51.2 tp -60.36 -47.16 87.25 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.606 -178.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.11 -39.61 75.4 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.736 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.7 ttt180 -61.64 -38.13 86.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.154 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.2 mt -87.63 4.74 42.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.72 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.625 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.72 -11.87 13.45 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.004 0.431 . . . . 0.0 110.334 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.12 -37.24 86.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.522 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.01 -48.73 80.46 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.383 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 . . . . . 0 C--O 1.221 -0.408 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.008 179.899 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.25 -2.61 58.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.437 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.27 179.07 1.25 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.488 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.4 Cg_exo -60.78 145.29 99.18 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.794 2.329 . . . . 0.0 112.174 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.5 -179.36 8.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.585 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.3 137.01 52.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.405 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -123.99 147.09 28.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.366 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.7 p -119.98 135.95 54.72 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.78 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.39 -143.61 0.33 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.291 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.54 -37.29 86.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.456 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.477 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.82 -67.25 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.46 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.31 142.64 44.7 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.1 p -112.4 131.4 55.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.96 0.409 . . . . 0.0 110.397 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -119.01 129.16 54.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.442 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.7 m -85.63 130.78 34.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.289 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.484 HD22 ' OE1' ' A' ' 42' ' ' GLN . 70.3 mt -96.79 78.83 2.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.281 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.96 -31.84 72.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.561 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.56 107.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.148 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.484 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -120.74 91.19 47.11 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.414 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.658 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.3 Cg_exo -56.94 148.57 66.86 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.765 2.31 . . . . 0.0 111.842 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.62 82.41 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.577 0.548 . . . . 0.0 111.001 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.658 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.37 66.87 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.253 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -76.62 131.06 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.745 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.568 ' HA ' HG23 ' A' ' 64' ' ' VAL . 61.6 t -122.76 147.25 27.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.028 0.442 . . . . 0.0 110.066 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 t -136.33 144.12 44.48 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.654 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.404 ' OG1' ' N ' ' A' ' 50' ' ' SER . 19.7 p -100.09 -59.09 1.77 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.584 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.404 ' N ' ' OG1' ' A' ' 49' ' ' THR . 87.1 p -79.25 155.02 28.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.508 HG21 HG23 ' A' ' 70' ' ' THR . 71.4 t -74.07 -21.85 18.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.565 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.9 m -60.13 -52.07 66.92 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.542 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.6 mt -66.49 -42.4 87.51 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.131 0.491 . . . . 0.0 110.798 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -43.35 -53.9 5.01 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.074 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.04 -37.39 73.39 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 m -62.93 -44.28 96.5 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 110.38 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 17.8 mt -66.04 -42.05 90.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.396 0.617 . . . . 0.0 110.662 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 tp -62.88 -39.91 95.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.271 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.527 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.45 -36.1 77.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.177 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.45 HD11 HD12 ' A' ' 156' ' ' LEU . 32.8 pt -91.18 27.9 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.27 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.4 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 99.0 m-20 56.94 51.75 10.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.972 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.17 76.06 27.59 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.944 0.402 . . . . 0.0 110.001 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.87 149.56 90.37 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.811 2.341 . . . . 0.0 112.281 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.52 136.6 48.24 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-O 121.136 0.493 . . . . 0.0 110.281 179.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.3 pt -69.48 -43.4 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.32 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.51 131.39 52.82 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.946 0.403 . . . . 0.0 110.648 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.54 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.3 p -155.84 168.83 25.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.458 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.35 -177.39 21.97 Favored Glycine 0 N--CA 1.463 0.499 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.632 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.5 172.38 12.8 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.015 0.436 . . . . 0.0 110.482 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.508 HG23 HG21 ' A' ' 51' ' ' VAL . 13.7 p -133.33 -111.57 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 0.0 110.491 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.55 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.8 179.62 0.95 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.448 -179.221 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.4 Cg_exo -60.86 58.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.894 2.396 . . . . 0.0 112.076 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.4 t-20 -64.42 -33.98 77.12 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.5 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.6 m-20 94.29 -36.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.869 0.731 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.401 ' HD3' HD21 ' A' ' 73' ' ' ASN . 77.1 mtp85 -62.89 -39.96 96.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.937 0.398 . . . . 0.0 110.224 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -74.49 -26.0 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.675 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.59 -172.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.612 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.3 p30 -73.73 -152.75 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.771 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 36.9 p-10 -54.46 -6.6 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.726 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.495 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.59 114.19 23.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.548 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.53 71.73 1.31 Allowed Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.475 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.3 m-85 -143.19 148.21 36.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.74 0.305 . . . . 0.0 110.908 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -86.04 -98.64 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.961 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.558 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.08 -43.3 95.83 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.183 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.558 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 36.0 tt0 91.85 52.64 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.875 0.734 . . . . 0.0 110.961 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -103.47 -9.02 19.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.377 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.475 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -65.23 -33.25 75.56 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.02 0.438 . . . . 0.0 110.604 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.549 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 97.9 mttt -49.09 -24.51 1.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.619 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.6 t -69.67 -45.92 76.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.31 -48.47 81.22 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.111 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -38.38 90.17 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.364 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.8 -32.64 53.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.23 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.615 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.2 mmt-85 -89.91 1.72 55.89 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.468 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.615 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.95 -49.93 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.897 0.748 . . . . 0.0 110.294 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.668 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.1 mt -45.55 153.86 0.23 Allowed 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.456 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.668 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 121.01 92.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 125.218 1.574 . . . . 0.0 110.458 -178.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.54 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.28 142.72 43.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.201 0.524 . . . . 0.0 110.191 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.4 mt -131.71 26.75 4.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.467 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -140.11 137.52 34.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 110.51 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.632 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.0 mt -136.84 164.88 29.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.406 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.97 -28.4 1.86 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.469 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.71 70.62 7.29 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.101 0.477 . . . . 0.0 110.327 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.07 145.31 98.72 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.687 2.258 . . . . 0.0 112.215 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.7 t -133.8 136.11 44.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.527 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.74 -38.42 83.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.662 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.48 -41.99 96.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.52 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.11 -41.54 98.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.516 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -63.64 -43.29 98.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.976 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.1 77.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.284 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.76 -18.37 59.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.454 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.77 -6.39 58.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.508 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.416 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 75.2 mtp 47.93 55.79 17.17 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.614 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.6 Cg_endo -69.94 149.36 65.63 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.88 2.386 . . . . 0.0 112.114 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.76 -73.05 0.66 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.488 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.6 tp -111.43 114.21 27.18 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.267 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -103.49 126.97 57.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.525 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 mt -110.71 134.51 52.4 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.184 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.12 140.15 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.555 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.7 p -83.57 168.02 16.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.689 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.31 -37.26 80.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.472 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 t -139.19 158.4 44.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.486 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.3 177.0 33.54 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.71 86.99 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -125.28 151.7 45.64 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.913 0.387 . . . . 0.0 110.551 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.9 t -63.29 141.34 58.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.379 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.18 10.7 10.72 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.631 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.15 -38.97 88.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.15 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.7 -35.97 24.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.432 0.634 . . . . 0.0 110.633 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.2 mt -70.98 -35.1 71.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.486 0.66 . . . . 0.0 110.72 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -42.88 -62.94 0.88 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.285 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.61 -42.84 91.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.066 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -62.11 -32.29 72.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.242 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.4 mt -74.28 -40.64 62.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.969 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.44 -49.09 78.55 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.275 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.7 m -52.92 -42.85 65.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.157 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.18 -43.06 92.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -168.83 151.71 5.09 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.71 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -38.61 107.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.621 2.214 . . . . 0.0 112.387 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.643 ' C ' HD12 ' A' ' 140' ' ' LEU . 97.2 m -109.75 121.64 45.69 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.2 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.0 153.34 29.53 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.309 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -128.46 131.11 69.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.371 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.18 128.19 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.571 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 54.6 t30 -100.77 104.94 16.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.227 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.411 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.4 p90 -100.71 -11.94 19.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.893 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.0 p-10 -64.95 -33.69 76.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.742 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -99.29 7.91 45.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.542 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.411 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.8 mttm -134.57 151.84 51.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.869 0.366 . . . . 0.0 110.529 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.427 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.7 p -75.82 166.26 23.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.597 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.4 t90 -59.25 -48.62 80.94 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.276 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -54.44 -44.1 72.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.03 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.4 t -62.96 -40.7 98.5 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.202 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.436 ' O ' HD23 ' A' ' 156' ' ' LEU . 63.4 tp -60.92 -44.34 97.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.3 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 49.2 tp -61.49 -42.98 99.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.198 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.8 m -55.9 -45.7 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.741 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.23 -40.56 96.55 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.836 0.35 . . . . 0.0 110.394 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.45 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.03 -42.5 99.24 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.222 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.73 -40.06 95.56 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.42 -45.95 64.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.8 -44.0 96.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.5 p -92.77 -9.09 41.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.704 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.93 26.29 72.22 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -101.22 50.47 0.86 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.776 0.322 . . . . 0.0 110.629 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.48 -39.17 77.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.658 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.9 -47.45 85.73 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.213 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.4 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 88.0 mt-30 -59.97 -39.27 85.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.162 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.92 98.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.238 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.88 -29.13 70.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.558 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -73.86 -54.41 8.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.059 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.527 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.6 ttp180 -64.86 -42.13 95.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.455 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 174' ' ' ASP . 78.4 mt -62.43 -43.82 98.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.487 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.28 -58.71 6.72 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.009 0.433 . . . . 0.0 110.368 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -56.61 -33.57 66.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.37 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -81.1 -36.12 30.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.78 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.1 m-20 -54.84 -42.35 71.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.062 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.17 -41.77 98.64 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.696 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.0 -38.02 89.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.383 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.45 -42.48 99.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.653 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.75 -53.06 61.14 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.132 0.492 . . . . 0.0 110.752 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.48 -41.76 88.48 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.618 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.09 95.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.67 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.14 -32.63 74.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.418 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.06 -21.47 19.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.728 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.63 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.3 tt0 -64.87 -41.58 95.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.733 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.0 pt -76.5 133.9 30.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.675 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.71 106.46 9.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.4 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.59 128.37 0.34 Allowed Pre-proline 0 C--O 1.238 0.479 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.553 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.3 Cg_exo -43.65 151.42 0.4 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.839 2.359 . . . . 0.0 112.497 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.67 142.18 52.22 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.611 2.208 . . . . 0.0 112.421 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.542 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.72 147.17 2.39 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.542 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.15 153.93 70.93 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.787 2.325 . . . . 0.0 112.278 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.47 163.23 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.159 0.504 . . . . 0.0 110.45 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.75 169.93 16.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.832 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.68 137.4 22.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.3 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.53 HG22 HD12 ' A' ' 205' ' ' LEU . 39.2 pt -134.19 146.03 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.592 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -133.39 132.01 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.054 0.454 . . . . 0.0 110.517 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -151.82 154.45 36.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.48 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.0 m -121.56 122.69 40.23 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.955 0.407 . . . . 0.0 110.368 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.74 -25.59 66.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.595 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.96 -49.66 19.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.992 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.01 -11.53 60.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.403 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.6 m80 49.14 42.47 21.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.495 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.0 t -135.94 144.98 45.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.319 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.82 114.12 27.22 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.375 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -120.18 133.71 55.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.986 0.422 . . . . 0.0 110.399 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.18 146.53 37.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.74 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.48 ' N ' HD23 ' A' ' 205' ' ' LEU . 13.3 t90 -99.38 127.96 45.46 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.101 0.477 . . . . 0.0 109.987 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.7 153.42 41.14 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.264 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.9 -18.29 46.81 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.648 2.232 . . . . 0.0 111.962 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -18.75 0.59 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.368 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.443 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.1 p -75.21 167.7 21.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.476 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.11 -35.56 75.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.3 mt-30 -56.64 -41.19 76.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.763 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.37 -43.04 97.68 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.492 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.4 mt-30 -63.75 -40.08 95.84 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 122.549 -0.383 . . . . 0.0 110.542 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.597 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.2 mmm -61.56 -41.87 98.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.376 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.56 -49.88 71.67 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.473 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.11 -33.06 50.62 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -71.09 -20.21 62.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.558 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 219' ' ' LEU . 65.9 mt -87.28 -6.42 58.55 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.74 3.52 57.16 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -88.34 149.85 23.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.93 0.395 . . . . 0.0 110.507 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.441 ' O ' HG12 ' A' ' 191' ' ' VAL . 3.0 p -112.78 126.49 55.47 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.127 0.489 . . . . 0.0 110.355 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.79 145.84 24.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.999 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.489 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -70.06 150.77 46.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.438 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.86 131.21 44.43 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.502 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.896 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.69 93.25 27.51 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.118 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.679 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.6 Cg_exo -55.77 138.99 83.15 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.655 2.236 . . . . 0.0 111.561 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.75 -25.13 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.399 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.75 -49.91 27.2 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.56 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.1 mt -54.37 -37.01 64.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.54 35.92 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.801 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.56 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.58 87.92 0.01 OUTLIER 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.864 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 82.3 p -81.64 -14.28 56.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.351 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.51 -41.8 10.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.609 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.9 -16.91 64.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.587 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.91 43.69 27.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.504 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.21 -149.62 8.44 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -120.29 142.79 48.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.976 0.417 . . . . 0.0 110.36 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.24 149.76 29.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.366 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -101.21 -151.7 0.42 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.358 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 56.21 -91.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.688 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.479 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.3 tt -127.08 175.61 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.597 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.479 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.6 mt -122.23 141.68 41.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.81 169.26 9.36 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.255 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.3 mt -147.57 150.71 34.99 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.223 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.57 -39.06 97.21 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.33 3.74 4.67 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.11 -58.44 3.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.911 0.386 . . . . 0.0 110.568 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.55 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.9 m-20 -61.95 -36.57 81.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.29 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 9.9 mp -52.3 -67.8 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.757 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.42 -42.21 66.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.148 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.87 18.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.657 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.75 47.64 0.23 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 39.13 -110.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.521 0.201 . . . . 0.0 110.743 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.489 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.9 -44.98 96.37 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.473 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.78 8.1 83.17 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -99.14 -12.57 20.36 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.805 -0.232 . . . . 0.0 110.642 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.3 t 176.24 142.65 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.052 0.453 . . . . 0.0 110.493 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.432 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.1 125.47 11.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.156 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -98.37 143.03 29.27 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 120.848 0.356 . . . . 0.0 110.837 178.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.2 mt -94.41 106.52 18.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.674 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.469 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.87 -12.74 18.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.149 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.79 90.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.895 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.9 173.2 45.81 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.472 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 87.5 m-20 -74.07 -113.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 110.723 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.15 -28.91 68.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.765 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.08 -44.09 91.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.187 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.51 -44.45 94.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.318 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.32 -59.78 4.0 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.25 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.25 -43.47 61.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.111 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.2 -43.84 74.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.244 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.1 mt -64.39 -43.58 97.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.679 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -56.59 -37.67 70.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.163 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.28 1.17 19.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.212 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -115.04 91.47 27.13 Favored Pre-proline 0 C--O 1.231 0.114 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.17 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.14 -27.33 29.18 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.821 2.347 . . . . 0.0 111.864 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.4 -41.17 98.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.55 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.587 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.9 mp -95.24 4.75 53.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.396 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.71 -35.31 70.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.099 0.476 . . . . 0.0 110.673 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.76 4.62 15.8 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.624 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.79 121.15 80.26 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.565 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -47.64 -37.35 26.96 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.464 2.11 . . . . 0.0 112.472 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.528 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.88 -43.35 90.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.319 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.04 -43.8 92.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.303 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -64.95 -40.76 95.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.341 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.3 t-20 -89.15 -13.16 39.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.577 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.5 mtmt 62.66 32.05 16.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.93 44.51 1.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.292 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.68 135.4 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.551 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.6 132.41 56.69 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.398 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.49 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.83 88.69 6.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.786 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.425 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.4 mt -63.87 -41.72 97.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.78 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.469 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.82 165.9 34.41 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 75.5 p -75.61 -25.92 57.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.719 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -68.29 -33.97 75.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.552 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 296' ' ' THR . 98.7 m -72.62 19.85 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.668 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.508 ' O ' ' NE2' ' A' ' 212' ' ' GLN . 49.1 t80 -57.28 -51.01 71.1 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.014 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 70.9 mmt-85 -107.85 149.18 28.58 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 41.1 tp -115.67 126.26 53.9 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.862 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.475 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.6 t0 -149.74 166.67 28.71 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.611 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -49.21 -38.04 24.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.613 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.65 -65.11 0.8 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.454 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -60.71 -32.82 72.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.974 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.49 -25.21 24.1 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.3 mtt -63.67 -41.02 98.23 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 120.811 0.339 . . . . 0.0 110.945 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -78.37 -44.36 25.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.988 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.573 HG21 HG23 ' A' ' 296' ' ' THR . 79.7 t -65.97 -42.93 92.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.431 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.442 HD11 ' OE1' ' A' ' 183' ' ' GLN . 49.8 tp -60.01 -46.92 87.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.448 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -70.61 -39.48 73.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.988 0.423 . . . . 0.0 110.603 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.49 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 73.6 ttt180 -61.35 -38.0 85.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.319 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.8 mt -87.76 4.91 42.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.698 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.63 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.22 -11.71 13.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.041 0.448 . . . . 0.0 110.337 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.79 -37.1 85.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.489 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.96 -48.75 80.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.435 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.958 179.872 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.612 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -90.3 -2.39 58.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.441 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.93 179.04 1.25 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.525 -179.67 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.0 Cg_exo -60.74 144.81 99.61 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.802 2.334 . . . . 0.0 112.191 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.612 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.4 ptt-85 -156.09 -179.46 8.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.597 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.62 136.19 53.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.322 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.411 ' HA ' HD12 ' A' ' 30' ' ' ILE . 9.5 tp -123.78 146.53 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.432 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.8 p -119.78 135.99 54.63 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.719 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.1 p30 -99.28 -143.5 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.328 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.8 p -63.66 -37.0 85.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.42 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.31 -66.78 0.22 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.437 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.06 142.12 44.65 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.6 p -112.09 131.23 55.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.411 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -119.2 129.17 54.83 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.498 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.1 m -85.62 130.3 34.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.301 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' OE1' ' A' ' 42' ' ' GLN . 67.4 mt -95.69 78.58 3.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.399 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.82 -32.03 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.482 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.27 108.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.204 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.489 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -121.97 91.31 48.85 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.322 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.658 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.1 Cg_exo -56.94 148.8 65.48 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.782 2.321 . . . . 0.0 111.888 179.049 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.82 82.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.487 0.492 . . . . 0.0 110.922 -179.19 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.658 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.09 66.79 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.277 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.45 130.93 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.748 -179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.548 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.1 t -122.82 145.57 29.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.191 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.9 t -135.13 143.59 46.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.681 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.2 p -99.54 -59.26 1.75 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.576 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.4 p -79.74 155.11 28.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.593 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.482 HG21 HG23 ' A' ' 70' ' ' THR . 71.4 t -74.58 -21.9 17.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.46 179.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.2 m -59.9 -52.32 65.92 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.508 -178.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.0 mt -66.53 -42.35 87.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.129 0.49 . . . . 0.0 110.8 178.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.6 m -42.91 -53.73 4.55 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.169 -178.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.46 -37.34 69.42 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 178.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 m -62.79 -44.62 95.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.955 0.407 . . . . 0.0 110.484 -179.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.5 mt -66.37 -41.85 88.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.367 0.603 . . . . 0.0 110.683 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tp -62.5 -40.25 96.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.297 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.468 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.98 -35.75 75.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.033 -178.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.539 HD11 HD12 ' A' ' 156' ' ' LEU . 31.6 pt -91.57 28.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.163 -179.163 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.38 51.78 10.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.795 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.86 75.91 24.0 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.999 0.428 . . . . 0.0 110.05 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.19 151.27 86.03 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.739 2.293 . . . . 0.0 112.3 -178.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.548 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.51 137.48 46.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.156 0.503 . . . . 0.0 110.339 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.3 pt -69.41 -43.56 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.129 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.96 131.09 53.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.958 0.408 . . . . 0.0 110.613 -178.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.1 p -155.8 169.03 25.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.515 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.87 -177.43 21.63 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.628 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.01 172.19 12.96 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 120.979 0.418 . . . . 0.0 110.444 179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.482 HG23 HG21 ' A' ' 51' ' ' VAL . 11.9 p -133.76 -110.72 0.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.364 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.549 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.95 179.53 0.96 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.421 -179.202 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.7 Cg_exo -60.89 58.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.011 2.474 . . . . 0.0 112.079 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.4 t-20 -64.29 -35.03 79.52 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.52 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 47.2 m-20 94.96 -37.66 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.926 0.766 . . . . 0.0 110.031 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.64 -40.01 95.67 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.256 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.5 p -73.94 -26.44 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.697 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.9 -172.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.504 -179.402 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -73.88 -152.51 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.72 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.3 p-10 -54.78 -6.33 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.674 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.4 113.56 23.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.634 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.4 72.66 1.28 Allowed Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -143.68 148.56 35.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.919 0.39 . . . . 0.0 110.759 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.76 -99.15 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.136 178.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.564 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.28 -42.74 96.27 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.322 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.564 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.3 tt0 91.5 52.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.772 0.67 . . . . 0.0 110.951 178.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.45 -9.25 19.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.412 179.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.0 p -64.74 -33.78 76.78 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.112 0.482 . . . . 0.0 110.643 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.55 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 97.9 mttt -48.66 -23.35 1.0 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.591 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.8 t -70.05 -45.87 74.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.789 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.25 -48.65 80.49 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.183 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.61 -38.15 89.08 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.382 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.64 -32.39 51.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.237 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.617 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.5 mmt-85 -89.98 1.68 56.0 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.547 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.617 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.89 -49.1 0.16 Allowed 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.816 0.697 . . . . 0.0 110.342 179.141 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.683 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.9 mt -46.3 154.05 0.3 Allowed 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.557 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.683 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 121.12 92.26 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.029 1.456 . . . . 0.0 110.543 -178.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.537 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.3 143.3 43.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.078 0.466 . . . . 0.0 110.287 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 mt -131.92 26.97 4.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.847 0.356 . . . . 0.0 110.479 -179.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.48 138.15 34.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.004 0.431 . . . . 0.0 110.481 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.8 mt -137.19 165.15 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.429 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.62 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.11 -28.55 1.84 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.469 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -153.21 70.64 6.93 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.039 0.447 . . . . 0.0 110.391 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.15 145.53 98.28 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.801 2.334 . . . . 0.0 112.011 -179.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.1 t -134.04 136.81 44.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.57 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.33 82.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.656 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.42 -42.28 96.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.476 -179.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.71 98.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.484 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.4 t -63.66 -43.18 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.136 179.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.74 -35.23 77.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.249 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.82 -18.28 59.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.432 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.7 -6.53 58.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.523 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.413 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 66.9 mtp 48.04 55.96 17.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.623 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.9 Cg_endo -70.22 149.1 63.45 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.771 2.314 . . . . 0.0 112.134 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.36 -72.87 0.67 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.539 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.427 HD11 HD13 ' A' ' 140' ' ' LEU . 39.2 tp -111.42 112.4 24.12 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.377 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 75.6 mt -100.59 126.03 54.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.516 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.9 mt -109.38 133.0 53.6 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.287 -179.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.47 139.61 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.573 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.5 p -83.44 168.38 16.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.705 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.41 80.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.483 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.8 t -139.33 158.87 43.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.96 0.409 . . . . 0.0 110.446 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.16 177.04 33.41 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.91 87.39 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.97 151.62 45.25 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.906 0.384 . . . . 0.0 110.546 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.1 t -63.18 141.27 58.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.398 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.51 10.93 10.54 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.659 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.517 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.14 -38.83 87.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.099 -179.404 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.64 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.86 -35.79 23.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.377 0.608 . . . . 0.0 110.579 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.7 mt -71.06 -35.17 71.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.396 0.617 . . . . 0.0 110.691 179.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -42.94 -62.82 0.92 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.229 -178.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.64 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.87 -42.63 90.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.997 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.18 -32.28 72.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.266 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.4 mt -74.41 -40.54 61.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 178.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.93 -48.86 78.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.219 -179.08 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.5 m -52.66 -42.68 64.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.215 179.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.06 -43.05 92.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.173 179.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.36 153.21 5.22 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.622 -179.128 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -39.03 107.33 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.664 2.243 . . . . 0.0 112.435 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 93.8 m -108.72 121.01 44.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.287 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.03 152.52 30.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.343 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -129.0 131.51 68.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.42 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.11 127.68 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.55 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.8 t30 -101.83 103.86 14.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.359 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 147' ' ' LYS . 49.1 p90 -101.29 -11.31 19.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.801 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.7 p-10 -64.77 -33.52 76.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.728 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.577 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.8 p-10 -98.33 7.68 45.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.568 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.34 155.44 50.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.508 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.3 p -74.66 165.69 24.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.615 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.571 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 90.9 t90 -60.04 -48.7 80.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.38 -179.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.87 -41.87 67.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.005 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.9 t -62.6 -40.77 97.98 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.484 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 156' ' ' LEU . 48.4 tp -60.62 -43.94 96.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.417 -179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.5 HD23 HD11 ' A' ' 170' ' ' ILE . 46.1 tp -61.47 -42.96 99.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.21 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.5 m -55.75 -45.31 78.09 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.4 -40.69 97.32 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.881 0.372 . . . . 0.0 110.408 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.539 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.96 -42.38 99.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.158 179.233 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.65 -40.72 96.04 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.87 -46.04 63.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.853 0.359 . . . . 0.0 110.829 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.62 -44.03 96.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.795 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.5 p -93.01 -8.79 41.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.676 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.76 25.19 71.67 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -101.87 52.01 0.82 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.658 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.92 -39.03 76.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.685 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.28 -47.08 86.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.252 -179.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -61.4 -38.93 88.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.291 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.43 97.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.41 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.48 -27.54 69.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.507 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.92 -53.78 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.134 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.494 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -63.66 -43.49 96.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.441 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.0 mt -63.06 -43.85 99.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.7 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.3 -61.65 2.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.064 0.459 . . . . 0.0 110.392 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -54.61 -35.08 63.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.44 -179.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -79.75 -34.46 39.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.909 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 170' ' ' ILE . 50.2 m-20 -56.83 -40.14 75.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.805 -178.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.89 -42.45 99.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.937 0.399 . . . . 0.0 110.709 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.68 -37.96 87.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.292 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 177' ' ' LEU . 83.0 mt -62.33 -42.49 99.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.704 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.95 -53.29 57.76 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.081 0.467 . . . . 0.0 110.694 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.27 -41.66 89.56 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.633 179.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.76 94.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.68 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.22 -32.21 73.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.379 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -94.49 -21.67 18.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.615 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.631 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.94 -41.63 95.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.631 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.4 pt -77.52 136.09 25.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.745 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.24 108.95 11.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.338 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.74 126.38 0.31 Allowed Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.519 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.462 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.9 Cg_exo -43.88 152.13 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.76 2.307 . . . . 0.0 112.519 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.18 141.72 53.26 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.627 2.218 . . . . 0.0 112.354 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.37 147.22 2.11 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.497 179.402 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.21 154.46 69.88 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.764 2.31 . . . . 0.0 112.254 178.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.5 163.07 28.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.437 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.76 170.1 16.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.899 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.0 137.48 22.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.948 0.404 . . . . 0.0 110.315 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.535 HG22 HD12 ' A' ' 205' ' ' LEU . 38.9 pt -134.2 146.08 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.607 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.71 131.61 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.109 0.48 . . . . 0.0 110.497 178.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -151.94 154.8 36.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.406 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.62 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.0 m -122.05 122.82 40.17 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.945 0.402 . . . . 0.0 110.393 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.33 -25.64 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.618 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.62 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.39 -48.86 21.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.04 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.03 -11.73 60.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.414 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.4 m80 49.19 42.19 21.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.478 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.1 t -136.5 145.58 45.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.373 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.15 114.24 27.34 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.348 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.89 133.33 55.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.036 0.446 . . . . 0.0 110.376 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.535 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.03 146.38 38.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.713 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.488 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 12.2 t90 -99.37 130.01 45.61 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.121 0.486 . . . . 0.0 110.096 179.246 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.89 153.95 39.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.097 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.71 -18.22 47.84 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.796 2.33 . . . . 0.0 111.93 178.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.11 -18.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.405 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.488 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.5 p -75.97 164.98 25.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.497 179.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.96 -27.99 65.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.51 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.528 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.69 -41.56 98.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.763 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.91 -44.86 96.73 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.8 mt-30 -64.57 -38.81 92.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.957 0.408 . . . . 0.0 110.709 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.571 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.3 mmm -62.03 -41.44 98.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.229 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.4 mt -63.79 -47.25 81.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.912 0.387 . . . . 0.0 110.607 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.16 -32.07 54.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.154 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -70.79 -18.29 62.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.58 179.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.426 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.8 mt -88.7 -8.61 54.25 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.641 -179.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.67 2.75 55.32 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -88.48 151.91 22.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.509 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.448 ' O ' HG12 ' A' ' 191' ' ' VAL . 7.8 p -114.95 127.83 55.92 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.052 0.453 . . . . 0.0 110.427 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.566 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.35 146.13 23.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.962 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.472 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.56 151.07 46.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.524 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.65 131.65 43.34 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.487 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.894 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.62 93.73 29.37 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.139 -179.789 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.683 ' C ' ' H ' ' A' ' 229' ' ' GLY . 47.3 Cg_exo -55.63 138.72 81.74 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.673 2.249 . . . . 0.0 111.59 179.153 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.75 -25.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.444 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.47 -49.77 29.65 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.55 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -53.46 -36.43 61.61 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -67.16 36.57 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.725 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.55 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.63 86.67 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.831 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.3 p -78.83 -15.72 58.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.53 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.22 -40.77 10.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.626 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.9 t -66.2 -17.73 64.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.573 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.41 43.25 26.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.418 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.85 -146.6 6.98 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -123.39 143.21 50.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.96 0.409 . . . . 0.0 110.335 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.07 149.61 29.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.422 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -100.5 -152.17 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.391 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 55.9 -91.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.567 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.471 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.65 175.46 8.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.564 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.471 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.9 mt -122.16 141.76 41.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.734 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -100.0 169.12 9.41 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.328 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.5 mt -147.83 151.18 35.52 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.133 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.78 -39.01 97.01 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.19 4.1 4.63 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.23 -58.38 3.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.939 0.399 . . . . 0.0 110.573 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.546 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.0 m-20 -61.98 -36.97 83.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.313 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.19 -67.73 0.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.813 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.46 -42.09 66.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.153 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.12 18.06 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.637 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.92 48.34 0.27 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.57 -110.0 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.667 0.27 . . . . 0.0 110.717 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.472 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 12.3 m120 -60.62 -45.35 94.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.471 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.88 8.15 82.93 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.23 -12.61 20.24 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.799 -0.236 . . . . 0.0 110.631 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.6 t 176.2 142.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.063 0.459 . . . . 0.0 110.553 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.433 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.85 125.31 11.67 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.047 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.432 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -98.43 142.98 29.38 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 120.88 0.371 . . . . 0.0 110.781 178.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.3 mt -94.17 106.43 18.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.652 -179.169 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.468 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.2 t80 -101.96 -11.41 18.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.182 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.42 -40.33 85.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.788 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.39 173.75 46.11 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.499 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.5 m-20 -74.44 -113.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.756 0.312 . . . . 0.0 110.71 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.62 -28.57 67.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.685 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.01 -44.21 91.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.313 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.68 -44.4 93.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.354 179.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.38 -60.16 3.56 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.295 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.02 -43.34 60.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.227 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.39 -43.92 75.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.258 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.0 mt -64.55 -43.71 96.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.598 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -56.27 -37.72 70.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.268 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.94 1.22 18.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.316 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -115.04 91.14 25.77 Favored Pre-proline 0 CA--C 1.528 0.122 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.207 -179.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.98 -27.18 27.45 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.818 2.345 . . . . 0.0 111.879 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.45 -41.08 98.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.565 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.587 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.31 5.03 52.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.459 -179.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.95 -35.01 69.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.735 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.87 4.74 15.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.541 -178.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.533 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.88 121.39 81.27 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.561 179.918 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -47.53 -37.8 26.9 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.539 2.159 . . . . 0.0 112.427 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.533 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.72 -43.72 90.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.38 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.89 -43.69 92.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.335 179.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.67 -40.6 95.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.49 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.7 t-20 -89.84 -12.19 39.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.563 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.4 mtmt 61.85 31.85 18.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.959 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.47 44.15 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.34 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.18 135.82 41.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.465 -179.661 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.5 132.34 56.7 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.521 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.2 87.97 6.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.728 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.94 -41.35 97.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.885 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.468 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.21 167.89 34.44 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 75.5 p -75.89 -25.82 56.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.381 . . . . 0.0 110.797 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.6 tp10 -67.9 -34.18 76.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.489 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.768 HG22 ' O ' ' A' ' 296' ' ' THR . 97.0 m -73.24 19.9 0.09 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.69 -179.142 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.528 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 53.0 t80 -57.24 -51.14 70.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.018 -179.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -108.22 149.41 28.62 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.426 ' CD2' HD11 ' A' ' 219' ' ' LEU . 41.5 tp -115.26 125.26 53.1 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.672 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.468 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.5 t0 -149.08 166.29 29.18 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.624 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -49.08 -38.19 23.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.632 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -71.96 -64.99 0.83 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.262 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -60.81 -32.52 71.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.864 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.85 -25.6 29.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.617 -179.049 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.8 mtt -63.23 -41.23 99.09 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 120.9 0.381 . . . . 0.0 110.883 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.19 -44.4 25.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.994 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.568 HG21 HG23 ' A' ' 296' ' ' THR . 76.5 t -66.14 -42.88 92.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.397 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.443 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.4 tp -59.89 -47.46 85.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.451 -178.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -69.85 -39.72 76.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.047 0.451 . . . . 0.0 110.888 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.499 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 72.2 ttt180 -61.52 -38.19 86.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.29 -179.048 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.2 mt -87.48 5.04 41.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.658 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.631 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.66 -11.78 13.49 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.049 0.452 . . . . 0.0 110.259 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.84 -37.16 85.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.56 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.82 -48.88 79.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.427 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.022 179.786 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.45 -2.83 57.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.481 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.46 179.12 1.24 Allowed Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.477 -179.722 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.4 Cg_exo -60.52 144.42 99.52 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.79 2.326 . . . . 0.0 112.235 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.5 ptt-85 -155.75 -179.9 8.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.55 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.58 136.77 52.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.042 0.448 . . . . 0.0 110.312 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' HA ' HD12 ' A' ' 30' ' ' ILE . 9.1 tp -124.41 146.2 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.39 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -119.54 135.97 54.55 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.805 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.9 p30 -98.71 -144.11 0.32 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.17 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.65 -36.49 84.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.405 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -147.58 -70.27 0.23 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.43 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.81 144.12 41.77 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.263 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.8 p -112.8 129.84 56.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.914 0.387 . . . . 0.0 110.451 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -114.68 129.66 56.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.683 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.9 m -86.95 130.68 34.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.35 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.496 HD22 ' OE1' ' A' ' 42' ' ' GLN . 70.4 mt -97.61 78.87 2.67 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.434 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.8 -32.58 74.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.544 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 t 177.15 109.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.118 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.496 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.2 pt20 -124.52 91.5 49.4 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.39 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.62 149.27 59.46 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.865 2.377 . . . . 0.0 111.962 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -40.22 82.36 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.624 0.578 . . . . 0.0 110.998 -179.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.69 66.66 0.87 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.477 . . . . 0.0 110.18 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -77.28 131.23 35.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.555 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.4 t -122.65 147.86 26.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.104 0.478 . . . . 0.0 110.073 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.9 t -136.17 143.61 44.54 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.725 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 50' ' ' SER . 27.2 p -99.26 -59.96 1.62 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.618 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.401 ' N ' ' OG1' ' A' ' 49' ' ' THR . 87.1 p -79.07 156.14 28.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.64 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.575 HG21 HG23 ' A' ' 70' ' ' THR . 68.9 t -74.59 -21.55 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.572 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 100.0 m -60.15 -51.99 67.24 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.513 -178.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.0 mt -66.28 -42.44 88.41 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.817 177.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.23 -54.36 4.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.998 -178.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.11 -38.77 73.29 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.304 -0.719 . . . . 0.0 111.304 178.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.6 m -62.29 -43.67 98.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.934 0.397 . . . . 0.0 110.199 -179.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.7 mt -65.46 -42.41 92.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.502 0.668 . . . . 0.0 110.684 179.414 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.6 tp -63.08 -38.74 92.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.263 -179.348 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -61.59 -36.65 81.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.224 -178.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -91.22 27.6 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.148 -179.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.419 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 90.6 m-20 57.11 52.46 9.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.123 179.41 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.79 76.48 28.94 Favored Pre-proline 0 C--O 1.225 -0.223 0 CA-C-O 121.039 0.447 . . . . 0.0 109.891 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.67 148.2 92.32 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.733 2.289 . . . . 0.0 112.08 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -112.67 136.27 49.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.126 0.489 . . . . 0.0 110.395 179.724 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -70.11 -43.05 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.189 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.76 131.04 53.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.979 0.419 . . . . 0.0 110.637 -178.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.542 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.3 p -155.58 168.42 27.19 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.424 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.61 -177.26 21.81 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.646 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.57 172.43 12.75 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 121.081 0.467 . . . . 0.0 110.422 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.575 HG23 HG21 ' A' ' 51' ' ' VAL . 14.2 p -132.95 -112.09 0.23 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.452 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.63 179.7 0.93 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.497 -179.245 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.5 Cg_exo -60.83 57.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.966 2.444 . . . . 0.0 112.157 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.4 t-20 -64.42 -33.51 76.03 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.417 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.2 m-20 93.91 -36.17 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.779 0.675 . . . . 0.0 109.899 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.401 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.6 mtp85 -63.21 -39.72 95.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.203 179.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.33 -25.3 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.688 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.24 -170.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.468 -179.354 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.83 -154.91 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.878 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 38.3 p-10 -51.44 -7.92 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.823 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.516 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -85.68 114.99 23.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.693 179.59 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.38 70.87 1.32 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -144.87 148.07 33.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.924 0.392 . . . . 0.0 110.752 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.9 mp -85.92 -98.46 0.07 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.178 178.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.0 -42.53 97.13 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.176 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.4 tt0 91.47 53.03 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.868 0.73 . . . . 0.0 110.877 179.037 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -102.69 -9.55 19.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.331 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.5 p -63.88 -34.42 77.92 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.05 0.452 . . . . 0.0 110.703 -179.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.557 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.13 -23.86 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.59 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.0 t -70.11 -45.21 76.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.592 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.42 -48.53 80.79 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.923 -179.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.04 -38.38 88.49 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.436 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.31 -34.36 57.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.251 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.61 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.6 mmt-85 -88.43 1.08 55.48 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.608 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.5 mttp 83.17 -47.94 0.14 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.845 0.715 . . . . 0.0 110.315 179.163 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.668 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.4 mt -46.68 153.3 0.4 Allowed 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 117.817 -1.087 . . . . 0.0 109.606 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.668 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.6 tt0 122.03 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 O-C-N 125.318 1.636 . . . . 0.0 110.452 -178.573 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.84 142.85 44.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.204 0.526 . . . . 0.0 110.337 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.2 mt -131.95 26.61 4.6 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.096 -0.377 . . . . 0.0 110.49 -179.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.09 137.46 34.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.576 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.646 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.0 mt -136.99 164.86 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.411 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.48 -28.83 1.78 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.35 70.5 7.54 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 121.134 0.492 . . . . 0.0 110.219 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.15 145.32 98.74 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.783 2.322 . . . . 0.0 112.098 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.9 t -134.45 137.12 43.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.584 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.56 83.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.655 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.32 -42.0 96.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.485 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.08 -41.79 98.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.466 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.7 -43.21 97.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.063 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.23 -35.27 78.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.218 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.26 -18.3 57.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.433 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -87.09 -6.06 58.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.483 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 70.3 mtp 47.71 55.99 17.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.621 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.0 Cg_endo -70.08 149.26 64.57 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.784 2.323 . . . . 0.0 112.067 179.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.24 -72.39 0.68 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.579 179.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.403 HD11 HD13 ' A' ' 140' ' ' LEU . 38.2 tp -111.91 113.22 25.4 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.399 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.8 mt -102.0 126.9 55.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.0 0.429 . . . . 0.0 110.587 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.3 mt -110.74 133.72 53.1 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.212 -179.297 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.4 139.92 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.559 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.7 p -83.6 167.41 17.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.683 179.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.59 -36.85 79.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.455 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.4 t -138.2 157.78 45.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.456 -179.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.55 175.4 34.17 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.55 -33.61 87.03 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.38 151.42 44.42 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.97 0.414 . . . . 0.0 110.513 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.5 t -63.53 140.53 58.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.389 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.05 10.93 10.86 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.648 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -60.96 -38.92 87.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.219 -179.428 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.634 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.14 -35.58 23.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.445 0.641 . . . . 0.0 110.577 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.3 mt -71.16 -35.16 71.56 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.457 0.646 . . . . 0.0 110.654 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -43.02 -62.82 0.93 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.215 -178.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.634 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.5 p-10 -65.98 -42.93 89.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.021 -179.162 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.3 mt-30 -61.73 -32.38 72.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.343 -179.524 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.7 mt -74.38 -40.49 62.05 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.922 178.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.09 -49.09 78.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.277 -179.104 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 m -52.92 -42.56 65.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.211 179.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.83 -42.72 92.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.152 179.26 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.54 153.16 5.05 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.628 -179.335 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -39.04 106.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.679 2.253 . . . . 0.0 112.393 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.654 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.1 m -109.36 121.89 46.16 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.416 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.654 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.86 154.07 29.3 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.264 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.2 tt -130.38 129.23 64.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.409 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 92.9 mt -110.6 122.71 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.024 0.44 . . . . 0.0 110.614 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.544 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 54.2 t30 -101.17 106.91 18.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.256 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -100.76 0.25 38.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.847 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.4 p-10 -65.61 -34.77 78.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.959 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -101.88 10.22 39.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.728 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -133.99 148.31 51.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.909 0.385 . . . . 0.0 110.49 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.409 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 22.9 p -77.61 168.82 19.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.623 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.6 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.1 t90 -58.7 -49.87 75.99 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.064 -179.009 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -54.46 -46.17 73.26 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.944 0.402 . . . . 0.0 110.048 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 40.1 t -63.07 -40.77 98.67 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.14 0.495 . . . . 0.0 110.314 178.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.46 ' O ' HD23 ' A' ' 156' ' ' LEU . 52.0 tp -60.72 -44.54 96.48 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.309 -179.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.89 -43.5 98.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.113 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.9 m -54.51 -45.85 73.39 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.86 -40.1 94.2 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.853 0.358 . . . . 0.0 110.364 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 152' ' ' LEU . 2.3 mm? -61.59 -42.2 98.52 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.115 179.234 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.84 -38.8 94.68 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.148 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.52 -45.08 66.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.962 0.41 . . . . 0.0 110.712 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.69 -44.11 96.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.789 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.8 p -93.41 -8.69 41.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.533 -178.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.5 27.08 72.17 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -102.54 50.27 0.83 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.66 -179.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -69.31 -39.03 78.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.622 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.56 -47.26 86.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.31 -179.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.419 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 86.4 mt-30 -60.5 -39.33 87.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.213 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.51 -41.02 98.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.278 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.31 -29.28 70.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.607 179.334 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.18 -54.46 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.855 179.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.419 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.8 ttp180 -64.22 -42.89 96.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.431 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 174' ' ' ASP . 82.0 mt -62.59 -43.77 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.483 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.6 -61.11 2.76 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.2 0.524 . . . . 0.0 110.201 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.77 -34.51 62.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.521 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -80.33 -34.84 36.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.761 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -55.26 -41.71 72.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.059 -178.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.2 -41.8 98.7 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.662 179.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.14 -37.87 88.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.313 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.33 -42.39 99.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.756 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.8 -52.95 62.08 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.112 0.482 . . . . 0.0 110.59 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.34 -41.43 89.57 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.601 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.28 -39.78 94.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.615 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.64 -33.08 74.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.369 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.54 -21.49 19.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.612 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.628 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -65.18 -41.43 94.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.694 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 184' ' ' ILE . 30.9 pt -76.98 133.83 30.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.802 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -127.55 107.05 9.6 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.298 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.93 127.39 0.31 Allowed Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.483 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.78 151.99 0.38 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.865 2.377 . . . . 0.0 112.53 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.52 142.39 53.67 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.599 2.199 . . . . 0.0 112.368 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.545 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.78 146.86 2.3 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.548 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.0 153.9 71.65 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.855 2.37 . . . . 0.0 112.37 178.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.58 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.37 163.11 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 110.475 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.58 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.93 170.72 15.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.032 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.74 137.8 21.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.074 0.464 . . . . 0.0 110.098 179.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.55 HG22 HD12 ' A' ' 205' ' ' LEU . 39.9 pt -134.39 146.64 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.691 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.44 131.68 60.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.1 0.476 . . . . 0.0 110.472 178.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -152.09 154.84 36.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.431 179.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.5 m -122.02 122.71 39.93 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.921 0.391 . . . . 0.0 110.341 179.469 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.89 -25.34 66.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.662 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.613 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.12 -49.34 19.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.899 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.16 -11.49 60.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.345 -179.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.2 m80 49.21 42.57 21.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.483 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.0 t -136.42 144.56 44.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.33 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.79 114.54 27.96 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.293 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -120.41 133.95 55.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.048 0.451 . . . . 0.0 110.405 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.55 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.4 146.75 37.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.778 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.563 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 9.4 t90 -100.51 129.28 46.44 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.177 0.513 . . . . 0.0 109.962 179.335 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.27 153.75 41.53 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.164 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.406 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.8 Cg_endo -67.77 -18.05 47.44 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.685 2.256 . . . . 0.0 112.057 178.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -48.74 -18.92 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.468 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.563 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 84.8 p -74.84 163.89 27.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.551 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.5 -28.24 65.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.478 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.507 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.2 mt-30 -63.55 -42.86 98.35 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.577 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.0 -43.74 97.89 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.409 ' OE1' ' C ' ' A' ' 148' ' ' SER . 74.8 mt-30 -63.68 -38.52 91.42 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 122.271 -0.546 . . . . 0.0 110.629 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.6 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 85.6 mmm -61.99 -41.66 98.28 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.26 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 82.2 mt -63.83 -49.73 71.67 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.136 0.493 . . . . 0.0 110.257 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -51.96 -33.91 39.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.845 0.355 . . . . 0.0 110.241 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -70.88 -20.74 62.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.519 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 75.1 mt -87.61 -6.32 58.34 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 -179.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.87 -7.04 57.19 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -77.06 147.6 36.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.854 0.359 . . . . 0.0 110.614 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.423 ' O ' HG12 ' A' ' 191' ' ' VAL . 2.4 p -112.58 126.67 55.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.133 0.492 . . . . 0.0 110.284 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.558 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.41 145.49 24.43 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.995 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.501 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.23 150.59 47.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.448 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -129.98 130.81 45.51 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.379 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.895 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.96 92.79 27.08 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.192 -179.716 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.684 ' C ' ' H ' ' A' ' 229' ' ' GLY . 43.3 Cg_exo -55.61 139.11 82.55 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.581 2.188 . . . . 0.0 111.676 178.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.55 -25.42 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.485 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.684 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.14 -50.2 29.42 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.547 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -53.58 -35.89 61.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.892 0.377 . . . . 0.0 110.132 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -67.57 36.65 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.715 179.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.547 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.16 86.33 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.813 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.1 p -79.02 -16.07 57.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.4 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -91.66 -40.67 11.16 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.622 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -66.22 -17.35 64.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.594 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.56 43.22 26.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.462 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.78 -146.17 6.87 Favored Glycine 0 CA--C 1.519 0.292 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -123.39 143.37 50.17 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.961 0.41 . . . . 0.0 110.262 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -151.86 149.32 28.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -100.25 -152.35 0.42 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.43 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.86 -91.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.693 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.466 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.4 tt -126.31 175.1 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.617 -179.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.466 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.4 mt -121.7 141.22 43.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.698 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.58 169.35 9.35 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.256 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.7 mt -147.73 151.02 35.38 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.204 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.91 -38.76 96.56 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.96 4.14 4.73 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -77.3 -58.34 3.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.98 0.419 . . . . 0.0 110.522 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.537 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.3 m-20 -62.04 -36.81 82.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.314 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.42 -67.63 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.746 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.43 -42.2 66.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.149 -179.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.13 17.99 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.641 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.82 48.58 0.27 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.48 -109.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.516 0.198 . . . . 0.0 110.787 -178.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.501 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.3 m120 -60.58 -45.52 93.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.528 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 85.18 7.9 82.51 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -99.04 -12.66 20.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.598 0.237 . . . . 0.0 110.658 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.4 t 176.23 142.88 0.07 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.067 0.46 . . . . 0.0 110.44 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.36 125.35 11.33 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -98.29 143.14 29.09 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 120.873 0.368 . . . . 0.0 110.861 178.193 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.9 mt -94.35 106.75 18.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.762 -179.174 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.454 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.9 t80 -102.1 -12.63 17.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.173 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.36 89.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.88 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.74 173.19 45.86 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.493 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -74.06 -112.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 0.0 110.74 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.81 -28.97 68.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.693 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.81 -43.95 90.69 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.261 -178.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.44 -44.52 94.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.304 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.36 -60.05 3.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.198 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.96 -43.47 60.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.211 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.26 -43.58 74.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.247 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.3 mt -64.57 -43.53 96.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.548 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.45 -37.65 70.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.2 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.14 1.02 19.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.218 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -115.03 91.41 26.83 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.078 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.05 -27.27 28.27 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.769 2.312 . . . . 0.0 111.984 179.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.533 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.51 -41.09 98.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.584 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.9 mp -95.52 5.02 52.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.4 -179.269 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.9 -34.89 69.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.647 179.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -80.12 4.85 16.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.494 -178.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.526 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -69.04 121.23 80.98 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.511 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -47.38 -37.58 25.39 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.513 2.142 . . . . 0.0 112.562 -179.53 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.6 -43.38 89.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.759 0.314 . . . . 0.0 110.372 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.09 -43.51 92.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.309 179.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -65.06 -40.72 95.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.349 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 44.4 t-20 -89.31 -12.99 39.0 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.59 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 62.19 31.64 17.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.912 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.53 44.29 1.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.157 0.503 . . . . 0.0 110.366 179.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.79 135.69 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.446 -179.701 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.93 132.25 56.75 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.457 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.493 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.3 88.71 6.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.756 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.7 mt -63.87 -41.39 97.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.454 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.52 165.66 33.26 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.524 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 77.5 p -75.56 -25.83 57.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.885 0.374 . . . . 0.0 110.791 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.0 tp10 -68.43 -33.71 74.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.483 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.77 HG22 ' O ' ' A' ' 296' ' ' THR . 97.2 m -73.06 21.54 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.696 -179.174 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.507 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 51.7 t80 -57.41 -51.02 71.1 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.413 HH12 ' HG3' ' A' ' 212' ' ' GLN . 70.4 mmt-85 -109.35 151.15 27.0 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 39.0 tp -115.57 125.13 52.59 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.934 0.397 . . . . 0.0 110.69 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.481 ' CB ' HD23 ' A' ' 83' ' ' LEU . 40.6 t0 -147.94 165.75 29.75 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.631 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -49.35 -37.95 26.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.499 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -70.8 -65.67 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.235 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -61.11 -33.04 72.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -53.44 -25.6 16.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.575 -179.08 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.1 mtt -63.7 -40.85 97.82 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 120.874 0.368 . . . . 0.0 111.035 179.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -78.08 -44.69 25.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.115 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.576 HG21 HG23 ' A' ' 296' ' ' THR . 75.1 t -66.11 -42.76 91.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.383 179.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.431 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 48.6 tp -59.62 -47.31 86.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.465 -178.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -70.32 -39.26 74.89 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.016 0.436 . . . . 0.0 110.729 179.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.493 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 72.5 ttt180 -61.66 -38.05 86.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.251 -178.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.0 mt -87.74 5.16 41.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.624 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.628 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.88 -11.59 13.42 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.016 0.436 . . . . 0.0 110.333 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.08 -37.07 85.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.486 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.78 -48.89 79.77 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.396 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 C--O 1.222 -0.365 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.002 179.836 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.612 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.05 -2.32 58.1 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.371 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.489 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.8 179.15 1.23 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.502 -179.682 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.79 144.98 99.65 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.851 2.367 . . . . 0.0 112.197 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.612 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.99 -179.32 8.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.562 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -115.94 136.77 52.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.327 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.23 146.99 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.369 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.5 p -120.02 135.97 54.73 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.734 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.39 -143.34 0.32 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.259 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.65 -37.04 85.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.536 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.42 -66.48 0.22 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.393 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.52 142.33 45.47 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.331 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.5 p -112.2 131.54 55.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.917 0.389 . . . . 0.0 110.459 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -119.38 128.98 54.57 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.546 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.8 m -85.57 130.15 34.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.191 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.494 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.3 mt -95.62 78.69 3.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.496 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.73 -31.74 72.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.596 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 175.97 109.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.983 0.42 . . . . 0.0 110.109 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.494 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.58 91.41 49.46 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-O 120.752 0.311 . . . . 0.0 110.381 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.647 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.59 148.42 64.2 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.797 2.331 . . . . 0.0 112.067 178.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -40.64 82.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.634 0.584 . . . . 0.0 110.963 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.647 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.51 66.92 0.89 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.222 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.21 130.56 36.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.819 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.565 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.7 t -122.49 146.69 27.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.016 -179.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 t -135.97 143.7 44.98 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.742 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.5 p -99.35 -59.28 1.75 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.564 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.3 p -79.35 155.09 28.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.583 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.53 HG21 HG23 ' A' ' 70' ' ' THR . 72.4 t -74.1 -21.84 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.548 179.322 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.3 m -60.28 -52.09 66.76 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.499 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.4 mt -66.26 -42.76 88.06 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.8 177.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.1 m -42.87 -54.18 4.3 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.968 -178.521 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.23 -37.17 71.48 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 178.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.6 m -62.84 -44.79 95.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.915 0.388 . . . . 0.0 110.16 -179.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.2 mt -66.48 -41.91 88.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.521 0.677 . . . . 0.0 110.701 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 tp -62.75 -40.46 97.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.401 -179.264 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.99 -35.93 76.08 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.158 -179.043 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.524 HD11 HD12 ' A' ' 156' ' ' LEU . 32.6 pt -91.15 28.92 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.176 -179.289 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.54 51.74 10.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.971 179.409 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.56 76.05 21.3 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.614 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.07 151.66 84.96 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.74 2.293 . . . . 0.0 112.032 -178.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.565 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.44 137.48 46.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.242 0.544 . . . . 0.0 110.237 179.706 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.442 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.3 pt -69.47 -43.54 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.307 179.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.13 131.35 53.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.947 0.403 . . . . 0.0 110.526 -178.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.536 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.7 p -155.86 168.65 26.53 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.462 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.42 -177.32 21.93 Favored Glycine 0 N--CA 1.464 0.513 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.631 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.17 171.99 13.27 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.088 0.47 . . . . 0.0 110.36 179.383 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.53 HG23 HG21 ' A' ' 51' ' ' VAL . 14.7 p -131.94 -113.48 0.23 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.981 0.419 . . . . 0.0 110.269 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.99 179.82 0.93 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.407 -179.148 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.5 Cg_exo -60.7 57.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 123.031 2.488 . . . . 0.0 112.18 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.8 t-20 -64.42 -33.64 76.33 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 119.081 -0.485 . . . . 0.0 110.345 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.6 m-20 94.03 -36.74 0.02 OUTLIER 'General case' 0 C--N 1.346 0.448 0 O-C-N 123.832 0.707 . . . . 0.0 109.806 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.406 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.5 mtp85 -62.51 -39.7 94.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.191 179.315 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.499 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.25 -25.48 19.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.762 179.374 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.52 -171.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.456 -179.201 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.05 -154.08 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.815 -179.599 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 38.2 p-10 -52.49 -7.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.769 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.1 mm-40 -86.32 115.0 23.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.674 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.02 69.92 1.35 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -143.45 147.72 35.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.971 0.415 . . . . 0.0 110.768 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.66 -98.29 0.07 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.185 178.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.25 -42.42 96.52 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.036 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.547 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.17 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.988 0.805 . . . . 0.0 110.996 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -102.86 -8.79 20.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.322 179.306 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.6 p -64.87 -33.82 76.92 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.132 0.492 . . . . 0.0 110.763 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.537 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.36 -23.4 1.45 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.682 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 73.4 t -70.02 -45.86 74.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.688 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.64 80.4 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.891 -179.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.36 -38.29 88.96 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.927 0.394 . . . . 0.0 110.509 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.64 -32.34 51.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.185 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.596 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.7 mmt-85 -90.3 1.95 56.0 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.622 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.55 -49.58 0.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.942 0.776 . . . . 0.0 110.223 179.181 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.646 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.0 mt -45.81 154.65 0.21 Allowed 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 117.451 -1.262 . . . . 0.0 109.441 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.646 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 120.8 92.6 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 O-C-N 125.676 1.86 . . . . 0.0 110.471 -178.532 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.536 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.57 143.25 42.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.238 0.542 . . . . 0.0 110.294 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.7 mt -132.42 27.1 4.44 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.976 -0.453 . . . . 0.0 110.391 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.25 137.77 34.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.065 0.46 . . . . 0.0 110.516 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.1 mt -137.01 165.01 28.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.331 179.581 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.2 -28.57 1.82 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -152.98 71.08 7.13 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 121.203 0.525 . . . . 0.0 110.262 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.17 145.54 98.27 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.803 2.335 . . . . 0.0 112.027 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.9 t -134.56 136.85 43.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.597 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.22 81.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.651 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.14 -42.38 96.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.518 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.99 -41.65 98.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.5 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.71 -43.23 97.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.05 179.486 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.17 -35.09 77.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.994 0.426 . . . . 0.0 110.146 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.7 -18.8 61.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.451 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.63 -6.48 58.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.529 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 63.1 mtp 47.22 56.22 17.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.613 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.34 149.9 63.9 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.763 2.309 . . . . 0.0 112.106 179.413 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.14 -74.25 0.62 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.454 179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.448 HD11 HD13 ' A' ' 140' ' ' LEU . 38.4 tp -110.2 113.33 25.93 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.372 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.4 mt -102.04 126.26 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 120.955 0.407 . . . . 0.0 110.661 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.1 mt -109.58 133.95 52.5 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.22 -179.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.85 139.63 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.496 -179.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.4 p -83.38 168.5 16.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.799 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.13 -37.52 80.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.443 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.79 159.16 42.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.012 0.434 . . . . 0.0 110.381 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.22 176.96 33.49 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.71 86.99 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -124.82 151.51 45.12 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.925 0.393 . . . . 0.0 110.508 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.3 t -63.26 140.81 58.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.333 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.62 10.37 11.04 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.676 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.52 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -60.83 -38.87 86.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.258 -179.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.67 23.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.562 0.696 . . . . 0.0 110.613 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.9 mt -71.11 -35.44 71.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.587 0.708 . . . . 0.0 110.631 179.359 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -42.81 -62.84 0.9 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.353 -178.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.85 -42.84 89.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.7 mt-30 -61.99 -32.54 73.01 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.493 0.495 . . . . 0.0 110.427 -179.594 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.7 mt -73.91 -40.95 62.79 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.803 178.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.13 -48.86 78.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.153 -178.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.5 m -53.31 -42.38 66.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.036 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.12 -42.61 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.943 0.401 . . . . 0.0 111.199 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.64 154.24 5.39 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.665 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -39.48 106.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.622 2.215 . . . . 0.0 112.589 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.641 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.4 m -110.08 121.4 45.18 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.115 0.483 . . . . 0.0 110.264 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.99 152.84 30.32 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.2 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.91 131.55 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.353 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.402 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.8 mt -115.31 128.02 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.488 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.6 t30 -101.6 103.92 14.77 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.206 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.2 p90 -101.38 -11.18 19.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.823 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.5 p-10 -64.83 -33.5 76.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.704 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -98.45 7.59 45.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.531 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.31 155.45 50.58 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.467 -179.418 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.6 p -75.05 165.68 24.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.695 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.589 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.85 -48.85 80.01 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.166 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -53.5 -42.05 66.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.929 0.395 . . . . 0.0 110.132 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.1 t -62.73 -41.05 98.98 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.36 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.402 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.9 tp -60.5 -44.54 95.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.374 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.8 tp -61.34 -43.33 99.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.235 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.6 m -55.02 -44.94 75.03 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.34 -40.67 97.14 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 120.928 0.394 . . . . 0.0 110.488 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.524 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -62.02 -42.45 99.18 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.418 178.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.24 -40.86 94.94 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.68 -45.92 64.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.894 0.378 . . . . 0.0 110.781 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.78 -43.99 96.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.798 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.7 p -93.13 -8.7 41.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.581 -178.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.88 26.64 72.28 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -101.75 50.85 0.84 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 110.65 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -69.55 -39.75 77.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.591 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.16 -47.26 85.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.3 -179.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -60.22 -39.3 86.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.136 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.07 -40.87 98.96 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 121.064 0.459 . . . . 0.0 110.279 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.02 -28.31 70.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.685 179.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.35 -54.35 7.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.894 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.506 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.51 -42.17 92.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.366 -179.8 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.3 mt -62.4 -43.83 98.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.481 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.3 -58.32 8.15 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.026 0.441 . . . . 0.0 110.216 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.28 -33.1 67.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.689 -179.03 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.415 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.7 t80 -81.53 -36.71 28.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.676 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.1 m-20 -55.92 -41.99 75.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.933 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.49 -42.24 99.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.911 0.386 . . . . 0.0 110.774 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.28 -37.94 88.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.279 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.415 HD11 ' CD2' ' A' ' 173' ' ' PHE . 82.0 mt -62.37 -42.19 99.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.791 179.476 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.15 -52.91 61.93 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.169 0.509 . . . . 0.0 110.628 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.1 -41.81 90.11 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.75 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.99 95.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.652 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.26 -32.07 73.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.429 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.62 -22.38 18.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.679 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.79 -41.38 95.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.67 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 184' ' ' ILE . 33.0 pt -76.93 136.53 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.72 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.1 108.09 10.6 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.245 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.63 126.01 0.31 Allowed Pre-proline 0 C--O 1.241 0.611 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.562 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.451 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.94 152.46 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.823 2.349 . . . . 0.0 112.596 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.35 142.15 53.85 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.541 2.161 . . . . 0.0 112.428 179.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.38 147.32 2.13 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.573 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.19 154.82 69.38 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.81 2.34 . . . . 0.0 112.392 178.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.52 163.29 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.185 0.517 . . . . 0.0 110.484 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.62 170.34 16.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.955 179.457 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.2 137.44 22.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.946 0.403 . . . . 0.0 110.105 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.569 HG22 HD12 ' A' ' 205' ' ' LEU . 38.4 pt -134.14 146.51 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.726 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.71 131.77 59.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.257 0.551 . . . . 0.0 110.502 178.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -153.01 156.68 39.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.476 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.594 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.3 m -121.98 122.86 40.3 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.915 0.388 . . . . 0.0 110.358 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.517 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -61.06 -26.17 67.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.69 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.594 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.56 -49.25 22.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.872 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -77.42 -9.95 59.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.409 -179.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.9 m80 45.91 47.58 12.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.512 -179.635 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.2 t -130.76 143.0 50.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.968 0.413 . . . . 0.0 110.32 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.448 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -108.44 105.62 15.36 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.162 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.7 m-20 -116.39 129.2 56.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.159 0.504 . . . . 0.0 110.321 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.569 HD12 HG22 ' A' ' 194' ' ' ILE . 7.6 tt -111.92 146.46 37.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.806 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.472 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.5 t90 -99.61 128.73 45.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.207 0.527 . . . . 0.0 109.891 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.52 153.94 40.24 Favored Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.379 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.67 -17.74 47.95 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.682 2.254 . . . . 0.0 112.049 178.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -49.75 -18.89 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.342 -179.091 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.45 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.4 p -75.44 164.6 26.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.495 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.92 -27.88 65.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.496 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.574 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.7 mt-30 -63.73 -41.39 98.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.609 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.32 -44.45 97.52 Favored Glycine 0 C--N 1.332 0.337 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.49 -38.84 92.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 122.119 -0.636 . . . . 0.0 110.796 179.576 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.3 mmm -61.84 -41.27 97.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.279 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.3 mt -63.53 -47.63 80.84 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.055 0.455 . . . . 0.0 110.386 179.221 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.63 -32.07 49.87 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.872 0.368 . . . . 0.0 110.405 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.96 -17.91 62.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.473 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.431 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.7 mt -88.4 -9.14 53.62 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.575 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.1 2.37 54.65 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -88.72 153.0 21.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 110.453 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.457 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.2 p -115.86 128.44 55.81 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.149 0.499 . . . . 0.0 110.355 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.09 146.74 23.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.915 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.459 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.42 151.17 45.46 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.413 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.9 131.73 42.98 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.432 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.881 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.52 93.33 27.05 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.002 -179.453 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.684 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.2 Cg_exo -55.0 138.66 78.88 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.604 2.203 . . . . 0.0 111.71 178.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.38 -25.51 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.508 -179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.684 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.64 -49.93 27.79 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.1 mt -55.15 -37.05 66.47 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.034 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -65.66 35.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.816 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.573 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.45 88.34 0.01 OUTLIER 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 85.1 p -81.82 -13.65 57.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.297 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.73 -40.84 11.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.6 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 29.3 t -66.64 -17.03 64.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.591 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.8 43.86 27.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.444 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.93 -148.74 8.14 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.65 142.03 48.81 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.963 0.411 . . . . 0.0 110.288 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.416 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.3 ttt-85 -152.03 149.51 28.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.241 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -102.38 -149.86 0.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.307 179.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.41 -92.91 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.636 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.4 tt -126.68 174.43 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.56 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.435 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 88.2 mt -122.31 141.27 43.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.839 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.48 170.6 8.5 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.19 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 67.1 mt -146.71 149.61 33.77 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.12 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.26 -39.35 97.76 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.01 3.22 4.05 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -78.64 -57.46 3.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.949 0.404 . . . . 0.0 110.482 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.608 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.8 m-20 -62.14 -36.91 83.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.163 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.448 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.7 mp -52.88 -67.46 0.25 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.985 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.8 -42.49 68.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.094 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.67 17.45 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.666 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.15 48.33 0.29 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.1 mp 38.97 -109.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.505 0.193 . . . . 0.0 110.769 -178.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.459 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -60.79 -44.71 96.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.349 -179.572 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.46 8.07 83.77 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -98.8 -13.64 20.05 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 122.685 -0.303 . . . . 0.0 110.661 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.0 t 177.25 142.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.072 0.463 . . . . 0.0 110.445 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.98 125.45 11.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.14 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.55 143.84 28.53 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 120.902 0.382 . . . . 0.0 110.922 178.133 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.8 mt -95.24 106.38 18.41 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.73 -179.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.45 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.5 t80 -102.31 -11.4 18.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.114 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.61 -40.64 84.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.815 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.27 172.68 45.54 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.453 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 90.8 m-20 -73.72 -113.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.846 0.355 . . . . 0.0 110.794 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.35 -28.99 68.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.7 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.04 -43.71 91.68 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.251 -178.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -63.43 -44.48 94.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.31 179.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.6 -59.88 3.93 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.136 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.94 -43.55 60.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.233 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.32 -43.34 74.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.23 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.2 mt -64.68 -43.61 96.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.634 179.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -55.97 -37.75 69.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.135 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.5 1.03 17.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.241 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -114.93 91.11 25.16 Favored Pre-proline 0 N--CA 1.464 0.256 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.161 -179.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.96 -27.3 27.81 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.764 2.309 . . . . 0.0 112.02 179.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.536 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.69 -40.93 98.01 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.545 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.25 5.39 51.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.327 -179.187 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.36 -35.04 68.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.527 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.72 4.49 16.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.472 -178.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.62 121.1 79.76 Favored Pre-proline 0 N--CA 1.442 -0.868 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.566 -179.983 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.27 -37.74 24.87 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.503 2.135 . . . . 0.0 112.643 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.89 -43.84 91.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.803 0.335 . . . . 0.0 110.398 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.98 -43.48 92.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.356 179.345 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.07 -40.57 94.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.382 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.443 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.9 t-20 -89.73 -12.59 38.94 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.501 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.12 32.31 17.49 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.395 0.435 . . . . 0.0 110.992 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.04 43.69 1.16 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.126 0.489 . . . . 0.0 110.334 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.23 135.82 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.488 -179.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -116.87 132.44 56.7 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.469 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.19 88.93 7.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.709 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.88 -41.05 97.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.869 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.45 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.75 165.55 33.58 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 72.1 p -75.38 -25.75 57.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 110.824 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.2 tp10 -68.26 -33.94 75.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.414 -179.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 296' ' ' THR . 96.7 m -73.37 24.33 0.07 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.698 -179.026 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.574 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 43.0 t80 -58.28 -50.93 71.84 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.22 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.416 HH12 ' HG3' ' A' ' 212' ' ' GLN . 77.4 mmt-85 -110.4 152.9 25.71 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.085 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.431 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.1 tp -115.53 125.11 52.6 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 120.893 0.377 . . . . 0.0 110.723 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.49 ' CB ' HD23 ' A' ' 83' ' ' LEU . 40.9 t0 -148.04 165.76 29.81 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.652 179.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -49.32 -37.74 25.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.642 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -71.35 -65.6 0.73 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.487 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.88 -32.99 72.41 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.041 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.25 -25.49 23.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.703 -179.104 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.4 mtt -63.57 -40.8 97.91 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 120.892 0.377 . . . . 0.0 111.097 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.63 -44.27 24.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.188 179.524 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.581 HG21 HG23 ' A' ' 296' ' ' THR . 79.2 t -66.23 -42.82 91.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.308 179.645 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 51.0 tp -60.19 -47.11 87.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.464 -178.512 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -69.96 -39.24 76.13 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.593 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.5 ttt180 -61.89 -38.18 87.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.235 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.6 mt -87.26 4.67 41.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.625 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.9 -10.95 13.49 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.046 0.451 . . . . 0.0 110.221 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.29 86.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.432 179.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.81 -48.82 80.06 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.41 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.029 179.915 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.3 -2.46 58.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.43 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.493 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.05 1.25 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.537 -179.682 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.493 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.8 Cg_exo -60.75 144.93 99.63 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.806 2.337 . . . . 0.0 112.203 179.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.95 -179.53 8.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.635 -179.74 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.81 136.84 52.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.389 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.44 147.07 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.418 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 79.2 p -120.03 136.07 54.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.733 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.47 -143.34 0.33 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.266 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -63.67 -37.19 86.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.472 179.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.25 -66.53 0.22 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.416 179.637 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.43 142.22 45.36 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.0 p -112.17 131.53 55.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.949 0.404 . . . . 0.0 110.485 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -119.23 129.05 54.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.588 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.9 m -85.46 130.19 34.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.307 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.471 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.5 mt -95.51 78.75 3.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.373 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.73 -31.9 73.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.579 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.65 109.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.984 0.421 . . . . 0.0 110.119 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.471 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.35 91.81 49.12 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.416 -179.685 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.7 Cg_exo -56.68 148.35 65.63 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.826 2.35 . . . . 0.0 111.956 178.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.4 82.66 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.526 0.516 . . . . 0.0 110.961 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.6 mtm180 -151.41 66.87 0.89 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.062 0.458 . . . . 0.0 110.263 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.38 130.69 35.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.77 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.568 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.5 t -122.6 147.01 26.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.151 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.8 t -136.27 143.83 44.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.025 0.441 . . . . 0.0 110.639 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.4 ' OG1' ' N ' ' A' ' 50' ' ' SER . 26.1 p -99.53 -59.65 1.68 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.62 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.4 ' N ' ' OG1' ' A' ' 49' ' ' THR . 87.3 p -78.91 155.25 29.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.675 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.515 HG21 HG23 ' A' ' 70' ' ' THR . 73.8 t -74.42 -21.8 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.546 179.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.8 m -60.11 -52.28 66.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.506 -178.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.4 -42.59 87.62 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.723 177.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.0 m -42.91 -54.17 4.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.035 -178.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.31 -37.18 70.78 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.5 m -62.85 -44.69 95.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.906 0.384 . . . . 0.0 110.336 -179.358 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.407 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.9 mt -66.35 -41.84 88.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.426 0.632 . . . . 0.0 110.781 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.59 -40.44 96.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.333 -179.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.512 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.17 -35.76 76.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.185 -178.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.524 HD11 HD12 ' A' ' 156' ' ' LEU . 32.6 pt -91.27 28.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.237 -179.24 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.53 51.76 10.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.009 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.17 75.53 23.32 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.996 0.427 . . . . 0.0 109.995 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.36 150.98 87.27 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.794 2.329 . . . . 0.0 112.121 -178.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.17 137.27 46.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 CA-C-O 121.13 0.49 . . . . 0.0 110.356 179.814 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.445 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.0 pt -69.52 -43.49 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.219 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.06 131.25 53.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.522 -178.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.7 p -155.67 168.72 26.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.547 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.89 -177.21 21.62 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.636 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.33 172.55 12.54 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 121.043 0.449 . . . . 0.0 110.439 179.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.515 HG23 HG21 ' A' ' 51' ' ' VAL . 13.4 p -132.76 -112.43 0.23 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.991 0.424 . . . . 0.0 110.396 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.31 179.66 0.95 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.427 -179.185 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.3 Cg_exo -60.9 58.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.977 2.452 . . . . 0.0 112.07 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.572 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.0 t-20 -64.52 -33.84 76.83 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.438 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.3 m-20 93.92 -36.74 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.736 0.648 . . . . 0.0 109.926 -179.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.401 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.9 mtp85 -62.61 -39.58 94.24 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.256 179.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.499 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.9 p -74.55 -25.44 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.606 179.467 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.41 -171.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.449 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -74.03 -153.65 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.805 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.9 p-10 -52.82 -7.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.675 -179.405 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.5 114.8 23.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.623 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.03 70.0 1.35 Allowed Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -143.31 147.36 34.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.917 0.389 . . . . 0.0 110.769 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.33 -98.44 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.12 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.563 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.11 -42.81 96.74 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.123 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.563 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.55 53.0 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.771 0.669 . . . . 0.0 110.856 178.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -102.92 -9.63 19.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.407 179.239 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.4 p -64.05 -34.11 77.28 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.047 0.451 . . . . 0.0 110.683 -179.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.541 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.96 -23.38 1.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.668 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.1 t -70.12 -45.72 75.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.713 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.58 80.65 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.048 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.37 -38.26 88.86 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.431 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.66 -32.65 52.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.166 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.62 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.8 mmt-85 -89.91 1.5 56.16 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.587 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.94 -49.19 0.16 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.761 0.663 . . . . 0.0 110.213 179.122 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.682 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.6 mt -46.05 154.08 0.27 Allowed 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.69 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.682 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.6 tt0 121.26 92.57 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 125.115 1.509 . . . . 0.0 110.445 -178.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.65 143.35 42.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.0 110.337 179.345 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.8 mt -132.41 27.25 4.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.879 0.371 . . . . 0.0 110.426 -179.37 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.31 137.86 34.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.636 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.7 mt -137.16 165.13 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.369 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.62 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.16 -28.76 1.82 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -153.0 70.93 7.11 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.124 0.488 . . . . 0.0 110.333 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.96 145.41 98.4 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.792 2.328 . . . . 0.0 112.058 -179.494 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.0 t -134.37 136.96 43.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.573 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.28 82.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.576 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.02 -42.34 97.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.569 -179.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.88 -41.65 98.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.55 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -63.7 -43.32 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.107 179.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.91 -35.18 77.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.274 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.78 -18.68 60.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.42 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.65 -6.78 58.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.538 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 68.6 mtp 47.48 56.25 17.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.648 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.28 149.44 63.57 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.759 2.306 . . . . 0.0 112.064 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.09 -73.5 0.64 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.529 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.417 HD11 HD13 ' A' ' 140' ' ' LEU . 38.6 tp -111.01 113.57 26.21 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.271 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.0 mt -102.16 126.63 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.6 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.7 mt -109.84 133.91 52.63 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.278 -179.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.99 139.98 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.522 -179.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.1 p -83.68 168.62 16.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.71 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.25 -37.41 80.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.472 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.98 158.86 43.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.453 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -155.94 177.07 33.21 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.22 -33.71 86.83 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.84 151.4 45.3 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.891 0.376 . . . . 0.0 110.54 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -63.29 140.93 58.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.326 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.78 10.64 10.99 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.647 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.517 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -60.97 -38.89 87.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.168 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.2 -35.75 23.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.375 0.607 . . . . 0.0 110.538 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.3 mt -71.0 -35.21 71.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.41 0.624 . . . . 0.0 110.697 179.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -42.8 -63.03 0.85 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.319 -178.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.2 p-10 -65.67 -42.85 90.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.091 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.545 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -61.91 -32.62 73.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.314 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.5 mt -73.95 -40.79 62.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 178.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -57.99 -49.23 77.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.169 -179.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 75.2 m -52.46 -42.67 64.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.263 179.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.3 -42.87 91.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 111.022 179.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.4 153.48 5.3 Favored Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.676 -179.336 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -39.41 107.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.675 2.25 . . . . 0.0 112.435 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.646 ' C ' HD12 ' A' ' 140' ' ' LEU . 97.2 m -109.61 121.68 45.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.074 0.464 . . . . 0.0 110.258 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.646 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.05 152.55 30.84 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.299 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -128.87 131.24 68.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.474 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.408 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.8 mt -114.99 128.01 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.527 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.8 t30 -101.82 103.87 14.6 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.2 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.6 p90 -101.51 -10.85 19.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.888 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.77 -33.24 75.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.704 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.6 p-10 -98.8 8.05 45.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.583 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.442 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.87 155.56 50.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.534 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -75.08 165.93 24.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.69 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.596 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.3 t90 -60.01 -48.65 80.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.278 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.36 -42.41 66.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.116 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.8 t -62.84 -41.11 99.21 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.348 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.408 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.8 tp -60.5 -44.45 95.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.317 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.9 tp -61.26 -43.74 98.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.205 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 m -54.7 -45.22 73.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.708 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.14 -40.93 97.61 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.878 0.37 . . . . 0.0 110.455 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.524 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.68 -42.4 98.87 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.206 179.117 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.16 -40.6 95.0 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.508 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.75 -46.01 63.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.874 0.369 . . . . 0.0 110.847 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.74 -43.92 96.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.735 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -93.18 -8.66 41.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.632 -179.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.01 26.58 72.37 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.66 50.72 0.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 110.708 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.64 -39.47 77.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.584 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.45 -47.3 86.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.357 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -59.82 -39.56 85.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.317 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.88 -40.99 99.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.297 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.1 -28.66 70.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.601 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.29 -54.51 7.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.873 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.512 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.0 -42.43 94.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.533 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.454 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.1 mt -62.33 -43.91 98.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.53 -179.508 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.19 -60.8 3.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.967 0.413 . . . . 0.0 110.415 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.9 -34.0 62.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.619 -179.183 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -81.1 -35.84 31.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.762 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.7 m-20 -55.28 -41.95 72.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.124 -178.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.47 -42.04 99.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.643 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.04 -38.27 90.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.363 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.8 mt -62.36 -42.1 99.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.672 179.404 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.06 -53.27 57.84 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.068 0.461 . . . . 0.0 110.682 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.22 -41.85 89.53 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.635 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.0 95.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.615 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.42 -31.56 72.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.434 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -95.03 -22.68 17.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.611 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.666 ' NE2' ' HZ2' ' A' ' 312' ' ' LYS . 51.7 tt0 -64.85 -41.42 95.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.582 -179.55 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.2 pt -76.22 135.99 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.719 -179.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -126.1 108.1 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.292 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.6 pp -177.3 125.2 0.28 Allowed Pre-proline 0 C--O 1.239 0.502 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.497 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.5 Cg_exo -44.03 152.47 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.898 2.399 . . . . 0.0 112.429 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.8 141.73 55.2 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.622 2.215 . . . . 0.0 112.352 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.46 147.25 2.08 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.511 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.9 154.38 71.04 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.856 2.371 . . . . 0.0 112.328 178.661 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.581 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.14 162.91 30.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.134 0.492 . . . . 0.0 110.449 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.581 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -144.03 170.72 15.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.999 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.61 137.73 21.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.938 0.399 . . . . 0.0 110.245 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.565 HG22 HD12 ' A' ' 205' ' ' LEU . 39.5 pt -134.44 147.16 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.726 179.69 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -132.89 131.73 59.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 110.467 178.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -152.32 155.37 37.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.379 179.316 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.619 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.4 m -122.82 122.93 39.87 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.972 0.415 . . . . 0.0 110.425 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.79 -25.55 66.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.571 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.619 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.23 -48.88 21.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.925 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.81 -11.77 60.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.516 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.8 m80 49.4 41.63 21.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.582 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.8 t -136.29 144.76 44.92 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.408 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.431 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -110.96 114.47 27.81 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.393 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.9 133.56 55.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 0.0 110.347 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.565 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.27 146.91 37.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.771 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.544 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.6 t90 -100.42 131.14 46.5 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.196 0.522 . . . . 0.0 109.965 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.66 153.94 39.29 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.244 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.406 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.9 Cg_endo -67.87 -17.99 46.93 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.736 2.29 . . . . 0.0 111.985 178.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.19 -18.69 0.37 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.388 -179.148 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.544 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 84.1 p -75.5 164.66 26.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.518 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.11 -27.92 66.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.473 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.589 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.5 mt-30 -64.03 -41.22 97.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.605 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.24 -45.06 96.77 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.83 -38.86 92.4 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 122.438 -0.448 . . . . 0.0 110.731 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.596 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.1 mmm -62.03 -41.71 98.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.262 179.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.432 HD23 HD12 ' A' ' 219' ' ' LEU . 45.5 mt -63.43 -46.87 84.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.019 0.438 . . . . 0.0 110.325 179.488 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.94 -31.56 60.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.346 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.16 -17.52 63.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.496 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.453 HD11 ' CD2' ' A' ' 299' ' ' LEU . 88.4 mt -88.54 -9.34 52.68 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.576 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.58 1.78 50.01 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -88.46 154.42 20.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.843 0.354 . . . . 0.0 110.567 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.44 ' O ' HG12 ' A' ' 191' ' ' VAL . 6.2 p -116.35 128.7 55.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.132 0.492 . . . . 0.0 110.387 179.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.588 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.5 mm? -91.76 146.14 24.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.999 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.478 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -70.52 151.88 44.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.405 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.36 131.53 41.98 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.571 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.892 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.45 93.45 27.24 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.238 -179.815 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.678 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.9 Cg_exo -55.22 139.14 80.74 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.604 2.203 . . . . 0.0 111.758 178.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.0 -26.32 0.05 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.427 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.24 -50.3 28.27 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -53.65 -37.19 62.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.176 -179.385 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -66.77 36.09 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.709 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.02 88.32 0.01 OUTLIER 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.932 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 79.5 p -81.21 -14.18 57.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.36 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.9 -41.29 10.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.565 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.84 -16.98 64.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.633 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 55.72 43.68 27.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.539 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.5 -148.62 7.91 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.88 142.59 49.54 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.956 0.408 . . . . 0.0 110.382 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.416 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.0 ttt-85 -151.91 149.44 28.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.352 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -101.22 -151.49 0.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.316 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.75 -92.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.655 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.463 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.6 tt -126.58 175.18 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.532 -179.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.463 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -122.79 141.91 41.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.809 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.65 169.32 9.36 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.279 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.7 mt -147.96 150.97 35.0 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.176 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.91 -38.99 96.89 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.41 4.12 4.52 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -77.43 -58.25 3.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.485 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.551 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.0 m-20 -61.85 -36.89 82.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.518 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.431 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.1 mp -52.35 -67.86 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.635 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.36 -42.32 66.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.159 -179.515 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.04 17.56 0.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.635 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.71 49.13 0.27 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.5 mp 38.23 -109.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.565 0.222 . . . . 0.0 110.67 -178.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.478 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.9 m120 -60.37 -45.24 94.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.635 -179.742 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.55 7.87 83.89 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.338 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.95 -13.24 20.05 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.669 -0.312 . . . . 0.0 110.743 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.2 t 176.87 142.61 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.97 0.414 . . . . 0.0 110.465 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.2 125.09 11.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.094 179.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -98.27 143.34 28.86 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.841 0.353 . . . . 0.0 110.758 178.276 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.7 mt -94.91 106.78 18.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.807 -179.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.441 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.1 t80 -101.98 -12.52 18.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.209 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.07 -40.95 91.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.857 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.5 173.03 45.82 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.474 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 93.5 m-20 -73.7 -112.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.678 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -68.2 -28.83 67.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.614 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.96 -43.95 91.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.278 -178.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.39 -44.66 94.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.371 179.171 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.47 -60.16 3.57 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.378 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.83 -43.68 59.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.21 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.28 -43.38 74.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.205 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.75 -43.67 96.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.563 179.587 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -56.1 -37.51 69.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.182 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.23 0.84 17.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.238 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -115.17 91.13 26.37 Favored Pre-proline 0 N--CA 1.46 0.073 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.25 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.98 -27.07 27.11 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.847 2.365 . . . . 0.0 111.959 179.267 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.536 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.52 -40.94 98.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.513 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.1 mp -95.2 5.49 51.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.443 -179.143 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.19 -34.59 68.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.631 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -79.97 4.5 16.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.569 -178.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.96 121.1 80.4 Favored Pre-proline 0 N--CA 1.446 -0.645 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.462 -179.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -47.29 -37.65 24.83 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.463 2.108 . . . . 0.0 112.499 -179.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.53 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -59.06 -43.96 91.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.769 0.318 . . . . 0.0 110.446 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.08 -43.54 92.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.358 179.281 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.44 -40.99 96.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.428 -179.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -90.27 -11.54 40.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.69 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.62 32.8 18.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.965 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -89.0 43.85 1.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.096 0.474 . . . . 0.0 110.366 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.52 135.82 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.451 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -116.73 132.55 56.66 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.387 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.06 89.17 7.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.732 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.409 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.3 mt -63.9 -40.88 97.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.441 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.03 165.27 33.67 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.51 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 74.4 p -75.43 -25.72 57.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.878 0.37 . . . . 0.0 110.679 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.5 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.8 tp10 -68.53 -33.7 74.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.454 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 296' ' ' THR . 95.8 m -73.59 24.96 0.07 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.74 -179.148 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.589 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 40.2 t80 -58.32 -50.72 72.62 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.387 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.416 ' CZ ' ' CE2' ' A' ' 297' ' ' PHE . 79.3 mmt-85 -111.03 153.95 24.88 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.453 ' CD2' HD11 ' A' ' 219' ' ' LEU . 46.3 tp -115.77 125.17 52.4 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.757 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.486 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.5 t0 -147.93 165.68 29.94 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.656 179.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.26 -37.94 25.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.641 -179.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -71.36 -65.58 0.73 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.403 -179.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.84 -32.85 72.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.269 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.19 -25.58 23.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.797 -179.057 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.6 mtt -63.54 -40.91 98.24 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.05 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.0 -43.93 23.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.979 179.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.576 HG21 HG23 ' A' ' 296' ' ' THR . 79.8 t -66.35 -42.76 91.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.403 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.436 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.3 tp -60.17 -47.06 87.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.48 -178.737 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -70.07 -39.32 75.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.958 0.408 . . . . 0.0 110.584 179.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.7 ttt180 -61.87 -38.43 88.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.232 -178.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.09 4.49 41.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.622 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.666 ' HZ2' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.67 -11.2 13.57 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.103 0.478 . . . . 0.0 110.435 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.21 -37.28 86.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.51 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.68 -48.83 80.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.363 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.221 -0.405 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.069 179.769 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.11 -2.54 58.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.44 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.5 179.16 1.23 Allowed Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.49 -179.66 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.4 Cg_exo -60.72 145.07 99.52 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.84 2.36 . . . . 0.0 112.142 179.611 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.613 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.25 -179.44 8.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.631 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.19 136.95 52.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.362 179.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.05 147.17 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.402 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.4 p -120.18 136.05 54.76 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.062 0.458 . . . . 0.0 110.78 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.9 p30 -99.21 -143.8 0.32 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.244 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.52 -37.04 85.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.522 179.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.481 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.76 -67.69 0.23 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.422 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.12 142.71 44.21 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.2 p -112.51 131.22 55.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.895 0.378 . . . . 0.0 110.418 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -118.6 129.2 55.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.559 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.8 m -85.67 130.58 34.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.247 -179.808 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.475 HD22 ' OE1' ' A' ' 42' ' ' GLN . 70.0 mt -96.69 78.76 2.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 110.433 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.84 -31.68 72.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.603 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.51 107.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 110.089 -179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.475 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -121.13 91.32 47.95 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.42 -179.719 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.655 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.6 Cg_exo -56.73 148.54 64.95 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.801 2.334 . . . . 0.0 111.953 178.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.61 82.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.627 0.579 . . . . 0.0 110.951 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.655 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.41 66.85 0.89 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.071 0.462 . . . . 0.0 110.192 -179.465 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -76.83 130.98 35.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.803 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.571 ' HA ' HG23 ' A' ' 64' ' ' VAL . 58.9 t -122.63 147.33 26.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.028 -179.702 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.7 t -136.4 144.11 44.33 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.745 179.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 50' ' ' SER . 17.5 p -100.03 -59.04 1.78 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.549 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.415 ' N ' ' OG1' ' A' ' 49' ' ' THR . 87.3 p -79.2 155.07 28.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.612 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.523 HG21 HG23 ' A' ' 70' ' ' THR . 72.0 t -74.11 -21.83 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.472 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.2 m -60.31 -51.93 67.43 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.478 -178.433 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -66.4 -42.75 87.41 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.759 177.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.9 m -42.99 -54.07 4.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.911 -178.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.08 -37.46 73.0 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 178.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.5 m -62.89 -44.26 96.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.886 0.374 . . . . 0.0 110.164 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 17.5 mt -66.14 -42.21 89.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.544 0.687 . . . . 0.0 110.639 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.97 -39.78 95.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.379 -179.122 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.528 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.49 -35.81 76.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.231 -179.078 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.492 HD11 HD12 ' A' ' 156' ' ' LEU . 33.6 pt -91.5 27.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.317 -179.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.82 51.95 10.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.053 179.554 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.34 76.19 26.41 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 121.021 0.438 . . . . 0.0 109.839 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.24 149.63 89.88 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.8 2.333 . . . . 0.0 112.09 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.571 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.4 136.66 47.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 CA-C-O 121.127 0.489 . . . . 0.0 110.34 179.696 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -69.57 -43.45 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.358 179.317 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.49 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.35 131.35 53.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.032 0.444 . . . . 0.0 110.601 -179.008 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.536 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.4 p -155.94 168.68 26.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.47 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.32 -177.35 21.99 Favored Glycine 0 N--CA 1.463 0.456 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.639 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.35 172.07 13.19 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 121.04 0.448 . . . . 0.0 110.452 179.355 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.523 HG23 HG21 ' A' ' 51' ' ' VAL . 14.0 p -133.25 -111.39 0.23 Allowed 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.018 0.437 . . . . 0.0 110.453 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.94 179.62 0.94 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.44 -179.195 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.8 Cg_exo -60.89 58.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.926 2.418 . . . . 0.0 112.156 179.518 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.8 t-20 -64.42 -34.19 77.6 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.361 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 45.1 m-20 94.76 -37.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.824 0.703 . . . . 0.0 109.814 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HD3' HD21 ' A' ' 73' ' ' ASN . 77.3 mtp85 -62.76 -40.22 96.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.218 179.217 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.3 p -74.08 -25.98 20.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.758 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.84 -172.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.433 -179.219 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.87 -152.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.777 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.3 p-10 -54.36 -6.66 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.759 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.48 114.14 23.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.629 179.731 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.52 72.14 1.3 Allowed Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.2 m-85 -143.54 148.27 35.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.874 0.369 . . . . 0.0 110.899 179.236 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.96 -98.81 0.07 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.026 178.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.555 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.94 -43.26 96.39 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.177 179.291 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.555 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.8 tt0 91.66 52.55 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.913 0.758 . . . . 0.0 111.052 179.176 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -103.49 -8.63 19.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.335 179.267 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.465 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.3 p -65.33 -33.38 75.84 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.063 0.459 . . . . 0.0 110.672 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.552 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.12 -24.18 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.695 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.2 t -69.86 -45.93 75.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.765 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.14 -48.77 80.06 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.043 -179.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.48 -38.32 89.4 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.454 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.72 -32.62 52.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.136 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.607 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 83.7 mmt-85 -90.1 1.8 55.98 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.538 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.94 -49.79 0.16 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.865 0.728 . . . . 0.0 110.235 179.176 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.66 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.4 mt -45.54 153.75 0.23 Allowed 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 117.673 -1.156 . . . . 0.0 109.561 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.66 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 121.05 92.27 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 O-C-N 125.444 1.715 . . . . 0.0 110.456 -178.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.536 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.02 142.77 43.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.219 0.533 . . . . 0.0 110.262 179.34 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 mt -131.81 26.59 4.65 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.04 -0.413 . . . . 0.0 110.415 -179.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -139.97 137.27 34.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.045 0.45 . . . . 0.0 110.531 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.639 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.1 mt -136.72 164.89 29.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.361 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.614 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.22 -28.48 1.82 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.76 70.5 7.24 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.108 0.48 . . . . 0.0 110.259 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.1 145.32 98.72 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 122.768 2.312 . . . . 0.0 112.123 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.9 t -134.08 136.68 44.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.556 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.62 -38.54 84.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.665 179.652 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.35 -41.98 96.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.48 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.65 98.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.473 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.53 -43.22 98.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.077 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.01 -35.12 77.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.223 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.69 -18.69 60.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.401 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.66 -6.51 58.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.5 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.8 mtp 47.61 55.99 17.18 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.594 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.28 149.82 64.17 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.767 2.312 . . . . 0.0 112.126 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.9 -72.77 0.67 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.452 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.7 tp -111.67 114.19 27.05 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.388 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.3 mt -103.36 126.91 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 120.964 0.411 . . . . 0.0 110.608 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.0 mt -110.63 134.21 52.63 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.214 -179.401 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.86 140.12 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.572 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.0 p -83.48 168.25 16.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.788 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.5 -37.13 80.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.47 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 t -139.49 158.35 44.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.466 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.15 176.88 33.46 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.31 -34.0 87.87 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -179.541 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.82 151.52 45.11 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.91 0.386 . . . . 0.0 110.552 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.8 t -63.23 141.07 58.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.334 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.89 10.59 10.9 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.644 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -60.92 -38.98 87.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.235 -179.372 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.87 -35.74 23.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.479 0.657 . . . . 0.0 110.587 179.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.2 mt -71.16 -35.18 71.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.492 0.663 . . . . 0.0 110.614 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -42.95 -62.85 0.91 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.322 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.69 -42.96 90.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.058 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -61.86 -32.34 72.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.402 -179.607 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.2 mt -74.23 -40.64 62.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.869 178.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.42 -49.09 78.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.163 -178.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.9 m -53.04 -42.67 65.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.941 0.4 . . . . 0.0 110.142 179.6 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.53 -42.83 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 120.948 0.404 . . . . 0.0 111.218 179.023 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -168.6 151.4 5.18 Favored Pre-proline 0 N--CA 1.452 -0.369 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.726 -179.265 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -38.78 107.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.716 2.277 . . . . 0.0 112.493 179.717 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.4 m -109.35 121.71 45.77 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.047 0.451 . . . . 0.0 110.265 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.13 153.51 29.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.32 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -128.77 131.62 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.402 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.36 127.82 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 121.074 0.464 . . . . 0.0 110.535 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.2 t30 -100.99 105.1 16.28 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.149 179.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.9 p90 -101.28 -11.58 19.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.898 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.0 p-10 -64.82 -33.64 76.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.805 -179.656 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.2 p-10 -99.37 7.82 45.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.601 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.9 mttm -134.79 152.35 51.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.525 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.424 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.9 p -75.42 165.97 24.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.677 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.596 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.3 t90 -59.09 -48.49 81.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.23 -179.081 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -54.37 -43.68 71.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.043 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.1 t -62.9 -41.09 99.31 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.255 178.595 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.434 ' O ' HD23 ' A' ' 156' ' ' LEU . 54.8 tp -60.81 -44.53 96.74 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.185 -179.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.49 -42.75 99.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.153 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.8 m -55.63 -45.46 77.58 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.49 -40.13 95.7 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 120.892 0.377 . . . . 0.0 110.505 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.492 HD12 HD11 ' A' ' 60' ' ' ILE . 2.5 mm? -61.99 -42.51 99.22 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.324 179.058 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.16 -40.04 94.79 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.508 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.57 -45.9 64.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 110.849 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.87 -44.06 96.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.845 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.9 p -92.98 -9.1 41.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.643 -178.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.16 26.02 72.39 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -101.17 50.38 0.86 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.811 0.338 . . . . 0.0 110.649 -179.506 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -69.43 -39.56 77.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.628 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.53 -47.35 85.89 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.294 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -60.01 -39.16 84.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.099 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.04 -40.76 98.69 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.214 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.04 -28.86 70.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.56 179.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.12 -54.46 7.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.904 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.528 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.6 ttp180 -64.78 -42.23 95.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.406 -179.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.2 mt -62.48 -43.8 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.483 -179.508 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.95 -60.15 4.06 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.024 0.44 . . . . 0.0 110.311 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.22 -34.01 63.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.552 -179.229 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -80.7 -36.11 32.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.731 179.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.8 m-20 -54.79 -42.44 71.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.005 -178.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.01 -41.75 98.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.719 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -64.97 -38.02 89.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.355 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 177' ' ' LEU . 79.8 mt -62.53 -42.29 99.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.753 179.45 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.91 -52.97 61.91 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.066 0.46 . . . . 0.0 110.686 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.41 -41.79 88.75 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.711 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.74 -40.24 96.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.664 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.06 -32.81 74.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.477 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.07 -21.3 19.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.704 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.632 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.3 tt0 -64.89 -41.62 95.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.743 -179.56 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 184' ' ' ILE . 31.3 pt -76.47 133.93 29.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.071 0.462 . . . . 0.0 110.716 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -127.83 106.43 9.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.417 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.58 128.31 0.34 Allowed Pre-proline 0 C--O 1.24 0.553 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.521 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.49 151.37 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.869 2.38 . . . . 0.0 112.577 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.83 142.57 52.61 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.587 2.192 . . . . 0.0 112.411 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.542 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.89 147.19 2.3 Favored Pre-proline 0 N--CA 1.448 -0.555 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.574 179.395 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.99 153.8 71.85 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.879 2.386 . . . . 0.0 112.317 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.19 163.09 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.167 0.508 . . . . 0.0 110.454 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.578 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.5 169.76 17.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.958 179.462 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.84 137.48 22.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.147 179.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.538 HG22 HD12 ' A' ' 205' ' ' LEU . 39.8 pt -134.35 146.58 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.693 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -133.41 132.15 57.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.129 0.49 . . . . 0.0 110.43 178.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -152.05 154.85 36.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.398 179.158 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.615 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.8 m -121.95 122.88 40.39 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.961 0.41 . . . . 0.0 110.355 179.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.87 -25.34 66.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.656 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.615 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.19 -49.58 18.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.02 -10.9 60.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.416 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.0 m80 48.4 42.72 18.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.489 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.9 t -136.37 145.05 44.93 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.355 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.12 114.42 27.66 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.324 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -120.19 133.71 55.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.984 0.421 . . . . 0.0 110.387 179.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.538 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.24 146.68 37.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.052 0.453 . . . . 0.0 110.762 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.488 ' N ' HD23 ' A' ' 205' ' ' LEU . 12.4 t90 -99.73 127.93 45.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.195 0.521 . . . . 0.0 109.862 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.5 153.47 41.33 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.427 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.71 -18.56 47.92 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.629 2.219 . . . . 0.0 112.005 178.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.86 -18.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.419 -179.121 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.442 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.3 p -75.27 167.77 21.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.491 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.64 75.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.481 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.3 mt-30 -56.52 -41.38 76.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.722 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.22 -43.07 97.45 Favored Glycine 0 C--O 1.235 0.201 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.49 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.4 mt-30 -63.81 -39.87 95.26 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 122.231 -0.57 . . . . 0.0 110.82 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.596 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.3 mmm -61.77 -41.7 98.04 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.277 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 77.3 mt -63.31 -50.2 70.98 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.197 0.522 . . . . 0.0 110.328 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.69 -33.03 45.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.862 0.363 . . . . 0.0 110.227 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.15 -19.99 62.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.562 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 219' ' ' LEU . 66.2 mt -87.41 -6.44 58.44 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.819 -179.632 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.63 3.56 57.27 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -88.47 149.96 23.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.912 0.386 . . . . 0.0 110.519 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.438 ' O ' HG12 ' A' ' 191' ' ' VAL . 3.1 p -113.01 126.67 55.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.137 0.494 . . . . 0.0 110.332 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.63 145.91 24.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.078 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.489 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -70.05 150.5 46.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.44 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.52 131.25 45.0 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.466 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.895 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -114.02 92.94 27.87 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.004 -179.552 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.68 ' C ' ' H ' ' A' ' 229' ' ' GLY . 44.5 Cg_exo -55.52 139.12 82.11 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.544 2.162 . . . . 0.0 111.693 178.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.68 -25.05 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.448 -179.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.68 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.82 -49.79 27.37 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.558 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.1 mt -54.43 -36.97 64.6 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.62 36.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.804 179.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.52 87.85 0.01 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.93 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.1 p -80.88 -14.32 58.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.318 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.77 -41.41 10.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.616 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.1 t -66.99 -16.74 64.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.584 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.78 43.97 26.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.467 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.98 -148.58 8.03 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.81 143.19 48.98 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.971 0.415 . . . . 0.0 110.316 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -151.98 149.6 29.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.328 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -101.05 -152.21 0.43 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.299 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.3 -92.14 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.626 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.475 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.4 tt -126.81 175.58 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.612 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.475 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.0 mt -122.21 141.46 42.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 -179.431 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.61 169.29 9.39 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.243 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.6 mt -147.38 150.69 35.18 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.277 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.72 -38.96 96.99 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.53 3.62 4.6 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.07 -58.33 3.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.966 0.412 . . . . 0.0 110.518 -179.743 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.559 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.9 m-20 -61.95 -36.75 82.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.203 -179.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.24 -67.72 0.23 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.849 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.56 -42.32 67.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.109 -179.394 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.81 18.19 0.14 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.664 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.63 47.85 0.23 Allowed Glycine 0 N--CA 1.464 0.555 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 39.06 -110.07 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.501 0.191 . . . . 0.0 110.74 -178.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.489 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.84 -45.18 95.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.421 -179.482 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.95 8.05 82.96 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -99.16 -12.92 20.02 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.757 -0.261 . . . . 0.0 110.597 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.9 t 176.79 142.75 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.101 0.477 . . . . 0.0 110.417 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.17 125.6 11.65 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.137 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -98.52 143.33 29.05 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 120.915 0.388 . . . . 0.0 110.838 178.236 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.3 mt -94.65 106.55 18.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.782 -179.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.466 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.8 t80 -101.95 -12.52 18.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.13 179.582 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.7 90.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.87 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.02 173.36 45.9 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -179.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.496 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -74.01 -112.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.762 0.315 . . . . 0.0 110.768 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.74 -28.78 67.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.658 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.06 -44.06 91.81 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.236 -178.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.43 -44.49 94.42 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.288 179.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.47 -59.96 3.81 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.189 -179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.95 -43.52 60.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.159 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.31 -43.64 75.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.243 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.5 mt -64.49 -43.57 96.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.577 179.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -56.48 -37.72 70.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.152 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.22 1.02 19.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.199 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -114.83 91.49 26.25 Favored Pre-proline 0 N--CA 1.462 0.135 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.176 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.09 -27.32 28.79 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.715 2.277 . . . . 0.0 111.966 179.318 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.533 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.42 -41.08 98.7 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.545 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.591 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.9 mp -95.5 5.06 52.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.354 -179.14 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.83 -35.14 69.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.601 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -80.17 4.74 16.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.507 -178.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.73 121.11 80.0 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.57 -179.996 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.43 -37.71 26.0 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.492 2.128 . . . . 0.0 112.58 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.66 -43.4 89.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.765 0.317 . . . . 0.0 110.397 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.92 -43.67 92.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.357 179.204 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -65.1 -40.64 94.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.31 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 44.5 t-20 -89.08 -13.1 39.38 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.554 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 62.29 31.19 17.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.037 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.32 44.2 1.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.176 0.513 . . . . 0.0 110.346 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.93 135.75 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.514 -179.72 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -116.65 132.41 56.69 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.439 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.492 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.09 88.68 6.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.808 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.427 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.8 mt -63.93 -41.65 97.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.021 0.439 . . . . 0.0 110.781 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.466 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.79 165.87 34.28 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 71.2 p -75.47 -25.82 57.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.9 0.381 . . . . 0.0 110.756 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.503 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.1 tp10 -68.59 -33.82 74.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.478 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 99.0 m -72.65 19.67 0.08 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.129 0.49 . . . . 0.0 110.677 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.511 ' O ' ' NE2' ' A' ' 212' ' ' GLN . 49.6 t80 -57.1 -51.23 70.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.925 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 70.8 mmt-85 -107.65 149.05 28.56 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.7 tp -115.61 126.19 53.87 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.842 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.478 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.7 t0 -149.74 166.87 28.12 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.618 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -49.29 -38.05 26.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.649 -179.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -71.65 -65.21 0.79 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.462 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.61 -32.83 71.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.021 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.57 -25.42 26.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.735 -179.125 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.8 mtt -63.49 -41.15 98.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.827 0.346 . . . . 0.0 111.053 179.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.96 -44.48 26.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.102 179.563 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.575 HG21 HG23 ' A' ' 296' ' ' THR . 79.8 t -66.15 -42.73 91.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.365 179.643 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.45 HD11 ' OE1' ' A' ' 183' ' ' GLN . 49.3 tp -59.9 -47.09 87.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.514 -178.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -70.57 -39.23 74.01 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.73 179.151 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.496 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 73.3 ttt180 -61.5 -37.84 85.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.257 -178.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.3 mt -87.95 5.05 42.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.664 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.632 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.4 -11.71 13.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.03 0.443 . . . . 0.0 110.314 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.82 -37.29 86.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.394 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.92 -48.92 79.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.46 -179.653 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.992 179.886 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -90.1 -2.18 58.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.464 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.494 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.02 179.04 1.24 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.504 -179.638 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.81 145.01 99.64 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.827 2.351 . . . . 0.0 112.18 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.3 ptt-85 -156.37 -179.1 7.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.615 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.78 136.15 53.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.984 0.421 . . . . 0.0 110.371 179.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -123.41 146.64 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.409 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.8 p -119.72 135.87 54.66 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.818 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.5 p30 -99.4 -143.47 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.26 179.877 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -63.62 -37.11 86.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.526 179.58 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.36 -66.76 0.22 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.431 179.719 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.21 142.2 44.9 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.42 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.7 p -112.27 131.49 55.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 0.0 110.488 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -119.1 128.98 54.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.611 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -85.38 130.15 34.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.247 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.471 HD22 ' OE1' ' A' ' 42' ' ' GLN . 67.6 mt -95.67 78.51 3.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.39 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.73 -31.65 72.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.589 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.23 109.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.155 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.471 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.5 pt20 -122.18 91.08 49.11 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.414 -179.66 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.661 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.63 148.81 62.36 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.8 2.334 . . . . 0.0 112.049 178.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.92 82.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.506 0.504 . . . . 0.0 110.999 -179.252 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.661 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.1 66.86 0.91 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.292 -179.604 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.87 130.69 35.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.822 -179.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.556 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.7 t -122.73 146.23 28.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.061 -179.62 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.9 t -136.1 143.76 44.77 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.778 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.8 p -99.53 -59.05 1.79 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.579 179.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.9 p -79.29 155.11 28.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.627 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.501 HG21 HG23 ' A' ' 70' ' ' THR . 71.3 t -74.61 -21.72 17.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.514 179.377 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.8 m -60.28 -52.2 66.29 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.518 -178.537 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.34 -42.9 87.45 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.622 177.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.0 m -42.49 -54.04 4.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.985 -178.719 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.48 -37.36 69.18 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 178.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 m -62.67 -44.93 95.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.815 0.34 . . . . 0.0 110.107 -179.25 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.6 mt -66.41 -41.76 88.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.433 0.635 . . . . 0.0 110.714 179.697 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.56 -40.49 97.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.283 -179.284 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.468 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.77 -35.65 75.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.236 -178.909 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.533 HD11 HD12 ' A' ' 156' ' ' LEU . 32.2 pt -91.45 28.9 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.284 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.29 51.58 11.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.019 179.506 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.03 75.57 23.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 0.0 109.94 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.96 151.48 85.68 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.848 2.365 . . . . 0.0 112.064 -178.755 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.556 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.38 137.44 46.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-O 121.126 0.489 . . . . 0.0 110.319 179.826 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.448 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.9 pt -69.35 -43.49 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.263 179.597 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.09 131.22 53.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.044 0.45 . . . . 0.0 110.534 -179.049 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.3 p -155.91 168.8 26.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.522 -179.717 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.63 -177.18 21.8 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.635 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.03 171.92 13.34 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 121.094 0.473 . . . . 0.0 110.451 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.501 HG23 HG21 ' A' ' 51' ' ' VAL . 12.7 p -133.54 -110.86 0.23 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.004 0.43 . . . . 0.0 110.516 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.549 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.86 179.6 0.95 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.494 -179.312 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.0 Cg_exo -60.75 58.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.891 2.394 . . . . 0.0 112.082 179.557 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.3 t-20 -64.39 -35.19 80.11 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.445 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 47.4 m-20 94.93 -37.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.692 0.62 . . . . 0.0 109.889 -179.365 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.54 -39.86 94.95 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.199 179.109 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.6 p -73.96 -26.55 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.621 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.96 -172.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.383 -179.367 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -74.1 -152.63 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.765 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.8 p-10 -54.56 -6.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.724 -179.429 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.493 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.88 113.32 22.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.678 179.738 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.33 73.31 1.26 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.615 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.401 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.2 m-85 -144.24 148.33 34.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.817 0.342 . . . . 0.0 110.901 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.71 -99.38 0.07 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.022 178.836 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.564 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.17 -42.84 96.55 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.088 179.255 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.564 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.5 52.91 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.672 0.607 . . . . 0.0 111.042 179.025 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -103.57 -9.02 19.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.32 179.274 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.401 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.98 -33.74 76.77 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.097 0.475 . . . . 0.0 110.701 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.551 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 97.9 mttt -48.83 -23.22 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.72 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.5 t -70.18 -45.9 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.705 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.09 -48.82 79.92 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.978 -179.472 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.38 -38.34 89.2 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.379 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.67 -32.4 51.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.202 -179.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.621 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.91 1.61 56.02 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.49 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.621 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.99 -49.43 0.16 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.729 0.643 . . . . 0.0 110.229 179.209 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.686 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 79.5 mt -45.88 153.85 0.27 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 118.209 -0.901 . . . . 0.0 109.758 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.686 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.3 tt0 121.24 92.17 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.966 1.416 . . . . 0.0 110.472 -178.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.26 143.24 43.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.277 0.561 . . . . 0.0 110.269 179.416 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -131.97 27.03 4.59 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 122.053 -0.404 . . . . 0.0 110.443 -179.399 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.33 137.94 34.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.456 . . . . 0.0 110.514 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.7 mt -137.03 165.06 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.395 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.91 -28.44 1.87 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -152.85 70.69 7.19 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.06 0.457 . . . . 0.0 110.271 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.11 145.37 98.6 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 122.744 2.296 . . . . 0.0 112.114 -179.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.4 t -134.27 136.87 43.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.533 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.12 -38.33 82.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.547 179.725 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.25 -42.35 96.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.499 -179.45 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.67 98.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.544 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.4 t -63.68 -43.25 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.108 179.451 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.08 -35.08 77.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.137 -179.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.73 -18.49 59.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.376 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.75 -6.51 58.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.506 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.8 mtp 47.85 56.14 17.4 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.659 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.8 Cg_endo -70.28 149.29 63.35 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.8 2.334 . . . . 0.0 112.07 179.465 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -101.24 -73.38 0.65 Allowed 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.471 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.432 HD11 HD13 ' A' ' 140' ' ' LEU . 39.0 tp -111.02 112.39 24.18 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.269 179.632 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 75.9 mt -100.59 126.1 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.645 -179.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.9 mt -109.42 133.38 53.13 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.268 -179.428 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.56 139.61 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.585 -179.559 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.2 p -83.5 168.24 16.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.714 179.778 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.09 -37.43 79.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.488 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.59 159.0 43.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.442 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.27 177.22 33.41 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.2 -33.73 86.87 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 -179.684 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -125.07 151.7 45.31 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 110.519 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -63.12 141.2 58.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.334 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.72 10.03 10.89 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.666 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.7 mp -60.71 -38.97 86.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.305 -179.383 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.641 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.79 23.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.355 0.598 . . . . 0.0 110.568 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.9 mt -71.03 -35.29 71.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.482 0.658 . . . . 0.0 110.625 179.403 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.3 t80 -42.73 -62.72 0.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.355 -178.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.641 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.77 -42.83 90.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.176 -179.244 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -62.0 -32.57 73.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.417 -179.718 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 129' ' ' LEU . 71.2 mt -74.17 -40.79 62.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.792 178.745 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.1 -49.02 78.39 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.169 -179.094 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.3 m -53.06 -42.08 65.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.975 0.417 . . . . 0.0 110.155 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.56 -42.57 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 120.95 0.405 . . . . 0.0 111.081 179.241 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.78 153.61 5.01 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.661 -179.338 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -39.06 106.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.658 2.239 . . . . 0.0 112.491 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.1 m -109.37 121.32 44.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.129 0.49 . . . . 0.0 110.278 179.802 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.1 153.07 30.12 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.365 -179.757 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.6 tt -128.96 131.56 68.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.343 179.911 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.29 127.88 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.605 -179.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.9 t30 -101.9 103.67 14.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.174 179.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.9 p90 -101.15 -11.23 19.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.875 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.84 -33.26 75.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.731 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.5 p-10 -98.6 8.19 45.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.56 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.442 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.91 155.62 50.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.521 -179.413 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.408 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -74.86 165.83 24.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.626 -179.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.584 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -60.02 -48.95 79.61 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.264 -179.22 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -53.56 -42.06 67.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.17 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.0 t -62.47 -40.83 97.92 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.358 178.773 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.424 ' O ' HD23 ' A' ' 156' ' ' LEU . 48.0 tp -60.64 -43.97 96.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.275 -179.564 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.495 HD22 HH21 ' A' ' 169' ' ' ARG . 45.5 tp -61.32 -43.25 99.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.063 179.663 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -55.41 -45.58 76.69 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.32 -40.73 97.29 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.895 0.379 . . . . 0.0 110.509 179.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.533 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.8 -42.42 98.99 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.238 179.046 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.86 -40.88 95.72 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 179.522 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.93 -45.74 63.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 0.0 110.84 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.1 mt -64.78 -43.99 96.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.839 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -93.29 -8.55 41.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.633 -179.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.76 25.37 71.74 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -101.88 51.98 0.82 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.831 0.348 . . . . 0.0 110.673 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -69.74 -39.09 76.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.593 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.25 -47.2 86.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.34 -179.416 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -61.35 -39.15 89.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.232 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.23 -40.46 97.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.347 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.43 -27.17 68.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.567 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -75.32 -53.71 8.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.842 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.495 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -63.88 -43.26 96.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.422 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.3 mt -63.06 -43.89 99.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.73 -179.705 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.37 -61.76 2.32 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.062 0.458 . . . . 0.0 110.356 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -54.55 -35.05 62.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.565 -179.153 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -79.62 -34.99 40.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.822 179.694 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -56.6 -40.12 74.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.009 -178.642 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.88 -42.37 99.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.692 179.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.79 -37.75 87.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.315 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 177' ' ' LEU . 82.3 mt -62.45 -42.28 99.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.713 179.612 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.17 -53.32 56.99 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.017 0.436 . . . . 0.0 110.613 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.3 -41.4 89.81 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.633 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.24 -39.95 95.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.601 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.19 -32.16 73.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.471 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.52 -21.75 18.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.63 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.636 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.96 -41.57 95.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.717 -179.625 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -77.58 136.08 25.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.746 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.1 108.97 11.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.333 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.9 126.13 0.3 Allowed Pre-proline 0 C--O 1.238 0.473 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.501 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.461 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.7 Cg_exo -43.73 152.16 0.36 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.891 2.394 . . . . 0.0 112.483 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.99 141.68 54.11 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.579 2.186 . . . . 0.0 112.341 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.16 147.07 2.16 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.602 179.374 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.2 154.19 70.36 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.897 2.398 . . . . 0.0 112.269 178.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.584 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.4 163.24 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.151 0.501 . . . . 0.0 110.477 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -144.08 170.26 16.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.157 0.503 . . . . 0.0 110.851 179.68 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.82 137.4 22.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.213 179.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.547 HG22 HD12 ' A' ' 205' ' ' LEU . 38.9 pt -134.28 146.56 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.728 179.607 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.29 132.09 58.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.152 0.501 . . . . 0.0 110.418 178.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -152.09 154.73 36.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.377 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.628 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.6 m -122.15 123.01 40.54 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.904 0.383 . . . . 0.0 110.408 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.38 -25.43 65.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.679 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.628 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.53 -49.0 20.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.5 -9.85 59.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.499 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.6 m80 46.5 42.76 11.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.582 -179.602 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 t -135.89 145.77 46.69 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.421 179.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.406 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -111.33 113.92 26.73 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.393 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -120.06 133.58 55.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.438 . . . . 0.0 110.377 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.547 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.33 146.72 37.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.794 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.488 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.5 t90 -99.58 129.8 45.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.22 0.533 . . . . 0.0 109.864 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.62 153.85 39.34 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.292 179.935 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.1 Cg_endo -67.61 -18.3 48.41 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.705 2.27 . . . . 0.0 111.986 178.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.16 -18.72 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.414 -179.23 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.488 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.1 p -75.7 165.04 25.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.496 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.01 -28.3 66.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.508 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.543 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.47 -41.45 98.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.673 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.85 -44.89 96.66 Favored Glycine 0 C--N 1.331 0.276 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.43 -38.98 92.92 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 122.231 -0.57 . . . . 0.0 110.703 179.67 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.584 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.7 mmm -61.93 -41.41 97.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.246 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.58 -47.72 80.33 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.99 0.424 . . . . 0.0 110.44 179.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.73 -32.01 50.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.882 0.373 . . . . 0.0 110.379 179.715 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -70.89 -18.13 62.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.493 179.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.429 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.5 mt -88.62 -8.67 54.27 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.651 -179.494 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.61 2.64 55.37 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -88.59 152.26 21.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.929 0.395 . . . . 0.0 110.504 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.442 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.1 p -115.11 127.99 55.94 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.118 0.485 . . . . 0.0 110.397 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.566 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.36 146.15 23.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.943 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.474 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.84 151.66 45.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.529 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.1 131.74 42.65 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.546 179.811 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.896 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.79 93.53 29.27 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.099 -179.713 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.682 ' C ' ' H ' ' A' ' 229' ' ' GLY . 44.5 Cg_exo -55.14 138.95 80.18 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.61 2.207 . . . . 0.0 111.769 178.775 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.6 -25.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.481 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.682 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.79 -49.95 26.8 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.805 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -53.94 -37.21 63.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 -179.273 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -66.62 35.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.83 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.09 88.36 0.01 OUTLIER 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.913 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.2 p -81.94 -14.33 56.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.337 -179.672 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.34 -41.43 10.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.618 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.2 t -66.91 -16.67 64.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.616 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.09 43.47 26.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.495 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.56 -148.44 7.84 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.37 143.23 49.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.959 0.409 . . . . 0.0 110.358 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.1 ttt-85 -151.95 149.43 28.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.312 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -100.71 -152.09 0.42 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.372 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.4 t0 56.1 -91.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.469 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.0 tt -126.54 175.43 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.631 -179.508 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.469 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.0 mt -122.14 141.7 41.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 -179.44 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.79 169.33 9.32 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.266 -179.774 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.2 mt -147.9 150.76 34.7 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.183 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.75 -38.91 96.88 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.19 4.07 4.64 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.3 -58.24 3.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 110.539 -179.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.56 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.6 m-20 -62.1 -36.88 83.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.281 -179.757 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.406 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.0 mp -52.3 -67.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.736 -179.69 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.47 -42.23 67.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.19 -179.617 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.06 18.09 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.617 179.787 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.69 48.63 0.26 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.29 -109.91 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.485 0.183 . . . . 0.0 110.746 -178.664 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.474 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.9 m120 -60.78 -45.25 95.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.463 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.95 8.17 82.78 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 179.255 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.32 -12.75 20.05 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.725 -0.279 . . . . 0.0 110.673 -179.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.4 t 176.6 142.49 0.07 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.013 0.435 . . . . 0.0 110.446 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.0 tt -148.17 125.19 11.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.428 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -98.27 142.93 29.32 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 120.91 0.386 . . . . 0.0 110.694 178.313 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.3 mt -94.23 106.58 18.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.805 -179.323 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.463 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.3 t80 -101.91 -11.73 18.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.15 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.99 -40.2 87.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.84 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.81 173.97 46.17 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.459 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -74.39 -112.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.789 0.328 . . . . 0.0 110.798 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.83 -28.74 67.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.671 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.95 -44.18 91.4 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.24 -178.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.56 -44.4 94.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.317 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.47 -60.09 3.65 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.194 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.8 -43.74 58.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.143 179.763 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.91 75.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.242 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.1 mt -64.46 -43.62 96.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.587 179.56 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -56.57 -37.87 71.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.137 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.82 1.11 18.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.208 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.0 91.2 25.82 Favored Pre-proline 0 N--CA 1.461 0.104 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.164 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.86 -27.17 26.56 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.796 2.331 . . . . 0.0 112.034 179.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.537 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.58 -41.01 98.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.468 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.38 5.33 51.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.414 -179.21 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.06 -34.82 69.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.588 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -80.26 4.71 16.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.485 -178.819 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.91 121.11 80.36 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.555 179.921 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -47.15 -37.87 24.19 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.521 2.148 . . . . 0.0 112.533 -179.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.86 -43.77 90.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.469 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.98 -43.47 92.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.387 179.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -64.86 -40.67 95.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.439 -179.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -90.02 -12.25 39.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.504 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 62.16 32.54 17.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.989 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -89.08 43.97 1.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.079 0.466 . . . . 0.0 110.278 179.52 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.13 135.87 41.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.587 -179.752 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.6 132.56 56.65 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.37 179.618 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.499 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.56 87.86 7.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.762 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.97 -41.31 97.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.782 179.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.12 168.14 34.73 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.7 p -75.97 -25.89 56.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.756 179.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.491 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.3 tp10 -67.79 -33.92 75.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.471 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 296' ' ' THR . 97.4 m -73.47 19.9 0.1 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.076 0.465 . . . . 0.0 110.78 -179.148 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.543 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 55.3 t80 -57.26 -51.38 69.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.853 -179.369 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 67.4 mmt-85 -108.0 149.51 28.3 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.429 ' CD2' HD11 ' A' ' 219' ' ' LEU . 40.5 tp -115.34 125.39 53.18 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.851 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.474 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.4 t0 -149.06 166.41 28.79 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.567 179.537 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -49.29 -37.95 25.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.663 -179.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -71.89 -65.11 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.376 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.65 -32.74 71.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.983 -179.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.7 -25.51 27.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.786 -179.102 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.5 mtt -63.32 -40.79 98.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.851 0.358 . . . . 0.0 111.027 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.89 -44.03 23.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.982 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.563 HG21 HG23 ' A' ' 296' ' ' THR . 74.5 t -66.26 -42.79 91.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.381 179.605 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.441 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 51.7 tp -60.23 -47.1 87.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.495 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -70.17 -39.48 75.25 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.987 0.422 . . . . 0.0 110.672 179.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.499 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.3 ttt180 -61.67 -38.24 87.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.275 -179.043 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.4 4.75 41.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.61 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.636 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.3 tttt -112.82 -11.18 13.5 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.964 0.411 . . . . 0.0 110.264 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.15 -37.18 86.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.388 179.737 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.75 -48.91 79.66 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.465 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.157 179.66 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -89.94 -2.58 58.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.423 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.68 179.23 1.21 Allowed Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.524 -179.673 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.4 Cg_exo -60.87 145.0 99.67 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.818 2.345 . . . . 0.0 112.141 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.613 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.92 -179.56 8.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.639 -179.735 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.93 137.02 52.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.961 0.41 . . . . 0.0 110.313 179.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -124.43 147.05 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.346 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.5 p -120.03 136.11 54.68 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.779 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.46 -143.49 0.33 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.248 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.55 -37.39 87.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.453 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.476 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.93 -66.61 0.23 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.442 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.55 142.46 45.42 Favored Glycine 0 CA--C 1.518 0.277 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 -179.38 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.7 p -112.3 131.38 55.55 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.569 -0.371 . . . . 0.0 110.465 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -119.07 129.06 54.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.56 -179.832 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.5 m -85.6 130.43 34.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.223 -179.834 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.481 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.6 mt -95.95 78.82 3.22 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.388 179.679 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.71 -31.78 72.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.56 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 176.1 109.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.032 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.481 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.41 91.51 49.25 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.412 -179.753 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.647 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.3 Cg_exo -56.89 148.55 66.58 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.79 2.327 . . . . 0.0 111.956 178.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.48 82.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.679 0.612 . . . . 0.0 110.97 -179.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.647 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.6 66.93 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.055 0.455 . . . . 0.0 110.173 -179.389 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.23 130.69 35.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.561 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.3 t -122.42 146.55 27.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.046 0.451 . . . . 0.0 109.993 -179.664 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.2 t -135.81 143.77 45.36 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.038 0.447 . . . . 0.0 110.729 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.2 p -99.37 -59.53 1.7 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.619 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.5 p -79.25 155.22 28.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.654 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.524 HG21 HG23 ' A' ' 70' ' ' THR . 73.7 t -74.11 -21.92 18.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.486 179.355 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.1 m -60.33 -52.13 66.59 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.488 -178.406 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.9 mt -66.24 -42.72 88.2 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.759 177.823 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.1 m -43.24 -53.83 4.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.905 -178.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.37 -37.23 70.21 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 178.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m -62.75 -44.69 95.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.853 0.359 . . . . 0.0 110.141 -179.221 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.0 mt -66.46 -41.9 88.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.497 0.665 . . . . 0.0 110.739 179.688 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -62.56 -40.49 96.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.489 -179.392 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.92 -35.86 75.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.287 -179.084 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.529 HD11 HD12 ' A' ' 156' ' ' LEU . 32.5 pt -91.16 28.89 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.352 -179.465 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.45 51.75 10.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.058 179.56 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.49 76.04 21.51 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.584 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.03 151.53 85.46 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.836 2.357 . . . . 0.0 112.076 -178.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.561 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.37 137.46 46.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-O 121.176 0.512 . . . . 0.0 110.293 179.671 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.1 pt -69.46 -43.62 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.321 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.12 131.44 53.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.037 0.446 . . . . 0.0 110.569 -178.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.536 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.0 p -155.77 168.59 26.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.445 -179.715 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.47 -177.22 21.9 Favored Glycine 0 N--CA 1.463 0.471 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.638 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.97 172.77 12.35 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 121.078 0.466 . . . . 0.0 110.437 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.524 HG23 HG21 ' A' ' 51' ' ' VAL . 14.9 p -132.42 -112.92 0.23 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.104 0.478 . . . . 0.0 110.376 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.98 179.72 0.94 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.406 -179.198 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.5 Cg_exo -60.86 57.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.968 2.446 . . . . 0.0 112.145 179.554 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.1 t-20 -64.25 -33.16 75.16 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.382 -179.731 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 42.6 m-20 93.47 -36.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.757 0.661 . . . . 0.0 109.805 -179.524 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HD3' HD21 ' A' ' 73' ' ' ASN . 77.0 mtp85 -62.62 -39.64 94.45 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.216 179.271 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.34 -25.53 19.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.684 179.384 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.31 -170.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.436 -179.232 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.03 -154.35 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.856 -179.627 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.8 p-10 -52.31 -7.56 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.757 -179.567 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -85.95 114.92 23.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.676 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.97 70.4 1.34 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.625 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -143.84 147.99 34.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.844 0.354 . . . . 0.0 110.841 179.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -85.82 -98.46 0.07 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.082 178.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.551 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.18 -42.52 96.65 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.052 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.38 52.83 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.895 0.747 . . . . 0.0 111.024 179.205 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -102.88 -9.38 19.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.313 179.37 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.2 p -64.31 -33.91 76.93 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.139 0.495 . . . . 0.0 110.699 -179.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.55 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.21 -23.39 1.31 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.678 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.3 t -69.84 -45.95 75.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 179.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.23 -48.62 80.65 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.924 -179.324 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.4 -38.4 89.48 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.379 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.59 -33.07 53.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.134 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.606 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.5 mmt-85 -89.66 1.74 55.64 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.554 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.68 -49.34 0.18 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.862 0.726 . . . . 0.0 110.197 179.126 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.655 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.8 mt -45.9 154.4 0.24 Allowed 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 117.538 -1.22 . . . . 0.0 109.524 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.655 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.1 tt0 121.07 92.63 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 O-C-N 125.566 1.791 . . . . 0.0 110.443 -178.595 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.536 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.57 142.94 42.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.252 0.548 . . . . 0.0 110.312 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -131.94 26.98 4.6 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.0 -0.438 . . . . 0.0 110.437 -179.344 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.24 137.9 34.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.022 0.439 . . . . 0.0 110.589 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.638 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.5 mt -137.16 165.01 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.332 179.629 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.9 -28.43 1.87 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.58 70.51 7.37 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-O 121.079 0.466 . . . . 0.0 110.095 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.92 145.33 98.57 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 122.668 2.245 . . . . 0.0 112.133 -179.651 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.9 t -134.35 136.73 43.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.559 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.37 81.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.63 179.66 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.12 -42.23 96.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.51 -179.408 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.62 98.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.491 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.6 -43.35 98.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.004 179.479 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.08 77.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.132 -179.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.69 -18.75 60.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.362 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.66 -6.55 58.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.491 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.8 mtp 47.53 56.1 17.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.644 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.8 Cg_endo -70.03 149.46 65.19 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.791 2.327 . . . . 0.0 112.098 179.516 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.03 -73.61 0.64 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.519 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.435 HD11 HD13 ' A' ' 140' ' ' LEU . 38.6 tp -111.02 113.44 25.99 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.293 179.633 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -102.08 126.57 56.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 120.962 0.411 . . . . 0.0 110.64 -179.8 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.3 mt -109.92 133.96 52.6 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.266 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.73 139.6 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.558 -179.567 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.9 p -83.4 168.37 16.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.716 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.47 80.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.389 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.91 159.13 42.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.94 0.4 . . . . 0.0 110.432 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.23 176.82 33.54 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.29 -33.59 86.57 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.56 151.46 44.71 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.928 0.394 . . . . 0.0 110.507 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.0 t -63.33 140.78 58.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.331 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.55 10.35 11.08 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.591 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.01 -38.94 87.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.253 -179.283 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.97 -35.89 23.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.522 0.677 . . . . 0.0 110.605 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -70.96 -35.44 72.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.546 0.688 . . . . 0.0 110.659 179.394 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.83 -62.81 0.91 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.411 -178.756 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.65 -42.86 90.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.195 -179.402 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -61.98 -32.71 73.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.367 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.0 mt -73.58 -41.06 63.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.864 178.642 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.18 -48.87 78.98 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.122 -178.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.8 m -52.97 -42.5 65.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.961 0.41 . . . . 0.0 110.186 179.474 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.14 -42.84 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 120.934 0.397 . . . . 0.0 111.18 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.33 153.51 5.38 Favored Pre-proline 0 N--CA 1.452 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.655 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -39.29 107.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.682 2.255 . . . . 0.0 112.516 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.636 ' C ' HD12 ' A' ' 140' ' ' LEU . 97.0 m -109.73 121.4 45.14 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.116 0.484 . . . . 0.0 110.281 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.636 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.56 152.44 30.27 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.279 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -128.77 131.22 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.351 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -115.09 127.9 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.099 0.476 . . . . 0.0 110.52 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.8 t30 -101.43 103.81 14.74 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.161 179.822 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.0 p90 -101.35 -11.13 19.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.875 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.5 p-10 -64.89 -33.54 76.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.768 -179.718 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -98.4 7.72 45.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.503 -179.546 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.448 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.55 155.62 50.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.484 -179.358 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.2 p -75.02 165.75 24.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.675 -179.778 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.589 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.02 -48.8 80.22 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.188 -179.1 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -53.41 -42.0 66.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 110.094 -179.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.4 t -62.74 -41.04 99.0 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.366 178.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.409 ' CD1' HG21 ' A' ' 142' ' ' ILE . 45.6 tp -60.66 -44.42 96.48 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.325 -179.469 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.0 tp -61.47 -43.49 98.77 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.079 179.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.0 m -54.91 -45.04 74.69 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.18 -40.86 97.43 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.88 0.371 . . . . 0.0 110.46 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.529 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.86 -42.51 99.13 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.388 178.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.27 -40.78 94.86 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.51 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.54 -46.05 64.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.389 . . . . 0.0 110.842 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.79 -44.02 96.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.847 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.8 p -92.86 -8.89 42.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.622 -179.026 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.88 26.61 72.27 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -101.85 50.91 0.84 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.844 0.354 . . . . 0.0 110.693 -179.572 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.56 -39.59 77.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.622 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.37 -47.12 86.63 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.288 -179.293 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -60.07 -39.49 86.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.145 -179.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.97 99.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.247 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.88 -28.26 69.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.622 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.56 -54.18 7.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.898 179.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.506 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.54 -42.19 92.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.402 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.2 mt -62.43 -43.77 98.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.496 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.58 -58.15 8.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.984 0.421 . . . . 0.0 110.372 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.47 -33.35 67.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.597 -179.016 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.409 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.8 t80 -81.35 -36.72 29.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.756 179.558 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.7 m-20 -55.79 -42.01 74.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.867 -178.437 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.4 -42.19 99.24 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.919 0.39 . . . . 0.0 110.801 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.26 -38.06 89.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.237 179.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.409 HD11 ' CD2' ' A' ' 173' ' ' PHE . 82.4 mt -62.41 -42.2 99.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.718 179.569 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.19 -53.01 61.38 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.07 0.462 . . . . 0.0 110.67 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.02 -41.8 90.5 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.674 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.95 95.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.28 -32.09 73.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.382 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -94.62 -22.35 18.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.688 -179.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.635 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.76 -41.33 95.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.676 -179.554 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -76.45 136.37 24.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.69 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.72 107.91 10.59 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.246 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.73 125.95 0.31 Allowed Pre-proline 0 C--O 1.239 0.55 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.465 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.452 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.6 Cg_exo -44.02 152.35 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.872 2.381 . . . . 0.0 112.553 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.09 141.98 54.6 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.556 2.171 . . . . 0.0 112.385 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.35 147.33 2.14 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.52 179.301 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.28 154.62 69.37 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.813 2.342 . . . . 0.0 112.348 178.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.42 163.15 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.207 0.527 . . . . 0.0 110.42 179.799 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.56 170.11 16.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.008 179.453 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.75 137.32 22.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.949 0.404 . . . . 0.0 110.185 179.448 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.567 HG22 HD12 ' A' ' 205' ' ' LEU . 38.7 pt -134.16 146.55 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.682 179.528 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.95 132.04 59.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.261 0.553 . . . . 0.0 110.468 178.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -153.31 156.96 39.37 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.43 179.21 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.4 m -122.8 123.31 40.74 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.944 0.402 . . . . 0.0 110.418 179.383 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.474 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -61.09 -25.95 67.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.583 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.614 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.66 -50.0 19.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.972 179.708 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.24 -11.11 59.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.548 -179.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.474 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 80.6 m80 47.11 47.39 16.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.563 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.6 t -131.47 144.75 51.38 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.277 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.431 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -109.76 106.19 15.72 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.235 -179.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -116.76 129.61 56.21 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.177 0.513 . . . . 0.0 110.301 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.567 HD12 HG22 ' A' ' 194' ' ' ILE . 7.7 tt -112.1 146.54 37.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.813 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.472 ' N ' HD23 ' A' ' 205' ' ' LEU . 12.1 t90 -99.49 128.46 45.6 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.203 0.525 . . . . 0.0 109.851 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.41 153.88 40.37 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.37 179.758 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.5 Cg_endo -67.59 -18.08 48.43 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.651 2.234 . . . . 0.0 112.003 178.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -49.6 -18.55 0.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.332 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.421 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.9 p -75.56 164.15 26.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.474 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.71 -28.1 65.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.533 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.571 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.0 mt-30 -63.65 -41.25 98.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.656 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.57 -44.44 97.78 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -179.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.448 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.1 mt-30 -64.3 -38.81 92.35 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 122.212 -0.581 . . . . 0.0 110.712 179.588 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.2 mmm -61.99 -41.31 97.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.188 179.819 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 74.1 mt -63.49 -47.71 80.61 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.031 0.443 . . . . 0.0 110.392 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.66 -32.06 50.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.909 0.385 . . . . 0.0 110.273 179.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -71.01 -17.96 62.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.48 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.419 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.7 mt -88.77 -8.4 54.5 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.617 -179.477 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.44 2.58 55.55 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.811 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -88.68 152.2 21.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.953 0.406 . . . . 0.0 110.429 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.451 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.9 p -115.18 127.97 55.88 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.183 0.516 . . . . 0.0 110.356 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -91.94 146.63 23.59 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.011 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.457 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.38 151.18 45.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.477 179.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.1 131.77 42.67 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.5 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.881 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.54 93.53 28.01 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.079 -179.52 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.686 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.5 Cg_exo -55.31 138.77 80.5 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.599 2.199 . . . . 0.0 111.633 179.034 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.27 -25.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.478 -179.621 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.686 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.45 -50.11 28.07 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.819 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.4 mt -54.76 -36.67 65.08 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.122 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -65.95 36.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.783 179.431 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.569 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.51 86.25 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.953 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.2 p -79.27 -15.14 58.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.346 -179.809 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -92.4 -40.25 10.98 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.678 179.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -66.03 -18.03 65.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.598 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.16 43.44 26.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.41 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.89 -148.16 7.79 Favored Glycine 0 CA--C 1.518 0.262 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.97 142.31 49.89 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 110.316 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.406 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.4 ttt-85 -152.48 149.92 29.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.313 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -102.18 -149.95 0.4 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.3 179.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 55.29 -92.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.696 -179.782 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.441 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.1 tt -126.94 174.65 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.635 -179.495 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.441 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.0 mt -122.31 141.29 43.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.039 0.447 . . . . 0.0 110.899 -179.562 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.58 170.62 8.47 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.196 -179.787 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.3 mt -146.75 149.6 33.71 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.259 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.19 -39.38 97.86 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.07 3.14 4.04 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -78.5 -57.59 3.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.964 0.412 . . . . 0.0 110.517 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.613 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.6 m-20 -62.07 -36.88 82.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.203 -179.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.431 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.6 mp -52.98 -67.57 0.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.0 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.61 -42.53 67.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.112 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.74 17.74 0.15 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.656 179.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.0 48.05 0.27 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.1 mp 39.25 -109.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.534 0.207 . . . . 0.0 110.721 -178.623 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.457 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -60.83 -44.67 96.61 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.381 -179.57 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.6 7.96 83.69 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.336 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.93 -13.34 20.02 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.689 -0.301 . . . . 0.0 110.667 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.1 t 177.06 142.89 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.083 0.468 . . . . 0.0 110.427 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.431 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.2 125.3 11.41 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.197 179.521 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.47 143.65 28.68 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 120.892 0.377 . . . . 0.0 110.808 178.326 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.06 106.62 18.63 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.78 -179.264 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.2 t80 -102.3 -11.41 18.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.116 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.57 -40.55 84.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.875 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.28 172.71 45.57 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.599 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.472 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 94.8 m-20 -73.9 -113.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.784 0.326 . . . . 0.0 110.723 -179.745 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.67 -28.94 68.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.661 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.11 -43.62 91.91 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.104 -178.762 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.55 -44.4 94.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.299 179.299 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.63 -59.99 3.8 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.133 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -51.02 -43.58 60.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.115 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.31 -43.23 74.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.179 -179.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.67 -43.57 96.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.641 179.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -55.96 -37.61 69.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.149 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.76 1.0 18.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.158 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -114.96 91.41 26.49 Favored Pre-proline 0 N--CA 1.461 0.114 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.121 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.24 -27.29 29.81 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.798 2.332 . . . . 0.0 111.917 179.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.536 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.5 -40.98 98.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.484 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.37 5.22 52.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.349 -179.132 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.95 -35.12 69.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.622 179.557 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -80.06 4.69 16.34 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.521 -178.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.76 121.17 80.27 Favored Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.541 179.967 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -47.28 -37.68 24.8 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.427 2.085 . . . . 0.0 112.611 -179.582 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.53 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.84 -43.75 90.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.747 0.308 . . . . 0.0 110.404 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.01 -43.64 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.285 179.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.87 -40.66 95.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.376 -179.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.8 t-20 -89.78 -12.55 38.93 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.592 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 61.87 32.18 18.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.069 -179.743 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.78 43.84 1.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.136 0.493 . . . . 0.0 110.308 179.537 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.11 135.85 39.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.487 -179.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.9 132.19 56.76 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.412 179.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.02 89.12 7.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.796 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.05 -41.11 97.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.45 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.444 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.52 165.76 33.44 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.514 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 74.3 p -75.46 -25.87 57.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.887 0.375 . . . . 0.0 110.785 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.9 tp10 -68.27 -33.76 74.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.439 -179.737 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 296' ' ' THR . 95.8 m -73.59 23.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.751 -179.144 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.571 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 49.4 t80 -58.0 -50.86 71.95 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.102 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 75.0 mmt-85 -110.7 152.97 25.92 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.108 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.419 ' CD2' HD11 ' A' ' 219' ' ' LEU . 41.9 tp -115.48 125.54 53.2 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.989 179.767 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.492 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.3 t0 -148.03 165.55 30.44 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.581 179.46 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -49.35 -37.71 25.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.655 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.29 -65.54 0.73 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.58 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.96 -32.85 72.37 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.058 -179.536 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.13 -25.61 23.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.8 -179.166 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.7 mtt -63.55 -40.7 97.68 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 120.854 0.359 . . . . 0.0 111.135 179.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.64 -44.1 24.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.188 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.584 HG21 HG23 ' A' ' 296' ' ' THR . 77.2 t -66.37 -42.87 91.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.353 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.431 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.1 tp -60.24 -47.12 87.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.507 -178.488 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -69.67 -39.36 77.07 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.069 0.462 . . . . 0.0 110.796 179.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.7 ttt180 -61.89 -38.44 88.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.218 -178.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.01 4.29 42.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.594 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.635 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.3 tttt -112.84 -10.94 13.52 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.073 0.463 . . . . 0.0 110.314 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.35 86.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.427 179.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.86 -48.7 80.59 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.403 -179.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.064 179.86 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -90.22 -2.56 58.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.428 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.7 179.13 1.23 Allowed Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.588 -179.711 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.0 Cg_exo -60.86 144.79 99.63 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.81 2.34 . . . . 0.0 112.206 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.9 -179.56 8.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.562 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -115.7 136.44 53.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.355 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.28 147.63 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.386 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.3 p -120.65 136.26 54.88 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.814 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.32 -143.34 0.32 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.239 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.8 -36.95 85.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.484 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.0 -67.67 0.22 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.436 179.676 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.16 142.53 44.46 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.295 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.4 p -112.18 131.8 55.26 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.552 -0.381 . . . . 0.0 110.513 -179.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.12 128.9 54.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.591 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.3 m -85.39 130.14 34.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.223 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.8 mt -95.37 78.43 3.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.4 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.81 -32.27 73.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.532 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.61 108.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.993 0.425 . . . . 0.0 110.157 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.489 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.69 91.59 49.48 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-O 120.767 0.317 . . . . 0.0 110.404 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.655 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.6 Cg_exo -56.67 148.68 63.46 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.742 2.295 . . . . 0.0 111.993 178.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.26 82.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.677 0.61 . . . . 0.0 110.988 -179.196 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.655 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.57 66.88 0.88 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.261 -179.377 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.56 131.06 35.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.817 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.576 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.5 t -122.68 148.27 26.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.056 0.455 . . . . 0.0 110.077 -179.787 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.7 t -136.78 143.68 43.34 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.776 179.75 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.5 p -99.3 -59.03 1.8 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.572 179.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.0 p -79.16 155.43 28.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.587 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.548 HG21 HG23 ' A' ' 70' ' ' THR . 68.8 t -74.51 -21.72 17.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.484 179.357 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.1 m -60.4 -52.1 66.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.524 -178.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.37 -42.7 87.61 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.754 177.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.3 m -42.9 -53.89 4.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.948 -178.585 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.15 -37.41 72.29 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 178.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.8 m -62.8 -44.34 96.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.941 0.4 . . . . 0.0 110.152 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.6 mt -66.09 -42.05 89.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.505 0.669 . . . . 0.0 110.683 179.702 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.88 -40.04 96.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.393 -179.266 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.525 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.88 -36.1 78.34 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.348 -178.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.472 HD11 HD12 ' A' ' 156' ' ' LEU . 34.3 pt -90.92 27.81 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.27 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.89 52.03 9.91 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.391 0.432 . . . . 0.0 111.097 179.568 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.2 75.82 27.83 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.32 148.95 92.46 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.859 2.373 . . . . 0.0 112.12 -178.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.576 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.5 136.58 48.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-O 121.188 0.518 . . . . 0.0 110.308 179.807 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.442 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.68 -43.5 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.251 179.352 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.13 131.26 53.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.948 0.404 . . . . 0.0 110.605 -178.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.5 p -155.55 168.43 27.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.501 -179.796 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.81 -177.37 21.67 Favored Glycine 0 N--CA 1.463 0.453 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.638 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -134.04 173.16 11.88 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.062 0.458 . . . . 0.0 110.402 179.367 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.548 HG23 HG21 ' A' ' 51' ' ' VAL . 13.6 p -133.22 -111.79 0.23 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.982 0.42 . . . . 0.0 110.4 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.64 179.71 0.93 Allowed Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.466 -179.247 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.3 Cg_exo -60.93 58.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 123.018 2.479 . . . . 0.0 112.089 179.463 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.0 t-20 -64.45 -33.8 76.73 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.412 -179.647 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.2 m-20 93.85 -36.13 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.788 0.68 . . . . 0.0 109.769 -179.632 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.407 ' HD3' HD21 ' A' ' 73' ' ' ASN . 78.1 mtp85 -63.22 -40.09 96.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.235 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.3 p -74.42 -25.37 19.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.742 179.326 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.25 -171.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.463 -179.208 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.56 -153.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 38.0 p-10 -52.15 -7.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.751 -179.594 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.1 mm-40 -86.33 114.81 23.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.619 179.707 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.79 70.61 1.34 Allowed Glycine 0 CA--C 1.52 0.379 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -143.55 147.85 35.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.925 0.393 . . . . 0.0 110.802 179.233 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.98 -98.34 0.07 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.035 178.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.558 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.3 -42.49 96.35 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.132 179.354 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.561 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.3 tt0 91.55 53.29 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.851 0.719 . . . . 0.0 111.033 179.195 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -103.15 -9.43 19.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.345 179.261 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.5 p -64.06 -34.58 78.35 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.059 0.457 . . . . 0.0 110.732 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.561 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.71 -24.31 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.624 179.704 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.95 -45.62 76.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.58 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.89 -49.03 79.11 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.976 -179.368 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.44 -38.15 88.64 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.412 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.46 -32.8 51.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.135 -179.751 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.61 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.97 1.55 56.13 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.555 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 83.11 -48.98 0.15 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.743 0.652 . . . . 0.0 110.245 179.146 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.664 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.1 mt -46.51 153.64 0.35 Allowed 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 117.732 -1.128 . . . . 0.0 109.546 -179.872 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.664 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.3 tt0 121.64 92.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 125.359 1.662 . . . . 0.0 110.476 -178.634 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.42 143.16 42.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.245 0.545 . . . . 0.0 110.288 179.313 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.1 mt -132.42 26.95 4.44 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 122.02 -0.425 . . . . 0.0 110.479 -179.365 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.44 138.31 34.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 0.0 110.485 -179.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.638 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.1 mt -137.28 164.84 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.359 179.51 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.14 -29.0 1.82 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.2 70.64 7.67 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.17 0.51 . . . . 0.0 110.241 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.07 145.37 98.59 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 C-N-CA 122.795 2.33 . . . . 0.0 112.046 -179.53 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.2 t -134.66 136.68 42.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.574 179.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.63 83.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.619 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.01 -42.21 97.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.493 -179.415 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.07 -41.55 98.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.563 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.61 -43.43 98.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.994 179.487 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.15 77.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.174 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.31 -18.8 60.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.459 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.59 -6.62 58.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.523 -179.773 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 73.5 mtp 47.91 56.04 17.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.548 179.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.22 149.27 63.73 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.834 2.356 . . . . 0.0 112.1 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.31 -72.8 0.67 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.506 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.403 HD11 HD13 ' A' ' 140' ' ' LEU . 38.2 tp -111.56 113.9 26.62 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.386 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.9 mt -103.05 126.89 57.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 120.993 0.425 . . . . 0.0 110.572 -179.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.6 mt -110.11 134.29 52.33 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.251 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.84 139.92 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.499 -179.651 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.3 p -83.51 168.13 16.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.776 179.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.09 79.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.431 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.61 158.71 43.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.432 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.26 175.74 33.87 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.22 -33.62 86.54 Favored Glycine 0 CA--C 1.518 0.279 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -123.97 151.13 44.0 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.904 0.383 . . . . 0.0 110.585 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.4 t -63.52 140.08 58.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.389 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.1 10.82 11.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.656 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -60.99 -38.85 87.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.251 -179.394 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.633 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.32 -35.71 23.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.407 0.622 . . . . 0.0 110.587 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.4 mt -70.98 -35.42 72.1 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.51 0.671 . . . . 0.0 110.668 179.379 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -42.76 -63.0 0.86 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.348 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.633 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.7 p-10 -65.88 -42.83 89.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.114 -179.25 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.3 mt-30 -61.76 -32.8 73.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.362 -179.603 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.4 mt -73.62 -40.78 63.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 178.651 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.23 -49.2 77.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.165 -178.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.9 m -52.7 -42.7 65.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.186 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.09 -42.78 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 120.967 0.413 . . . . 0.0 111.144 179.165 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.58 153.36 5.09 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.632 -179.362 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -39.12 107.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.629 2.219 . . . . 0.0 112.538 179.65 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.639 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.3 m -110.04 121.35 45.06 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.095 0.474 . . . . 0.0 110.289 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.639 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -113.94 153.05 29.93 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.29 -179.729 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.456 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -130.36 129.25 64.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.398 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.5 mt -111.74 126.72 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.626 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.513 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 57.0 t30 -100.9 103.81 15.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.149 179.711 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -100.88 -6.31 24.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.956 -179.741 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.2 p-10 -65.34 -33.39 75.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.728 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.584 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -100.37 9.18 43.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.618 -179.366 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.436 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.7 mttm -135.48 153.31 51.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.461 -179.39 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.9 p -75.81 166.55 23.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.624 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.597 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.8 t90 -59.89 -48.93 79.7 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.194 -179.095 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.85 -43.41 69.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.88 0.371 . . . . 0.0 110.087 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.0 t -62.88 -41.02 99.24 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.28 178.573 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.421 ' O ' HD23 ' A' ' 156' ' ' LEU . 49.9 tp -60.68 -44.49 96.44 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.298 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.0 tp -61.04 -43.59 98.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.136 179.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -54.53 -45.02 73.28 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.37 -40.15 95.5 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.96 0.41 . . . . 0.0 110.398 179.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.472 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.79 -42.46 99.03 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.189 179.164 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.75 -40.09 95.54 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.362 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.43 -45.64 65.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.352 . . . . 0.0 110.762 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.84 -43.99 96.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.1 p -93.39 -8.95 40.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.632 -178.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.13 26.01 72.35 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -101.78 50.48 0.85 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.735 0.302 . . . . 0.0 110.65 -179.509 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.48 -39.29 77.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.625 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.39 -47.2 86.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.327 -179.452 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -60.23 -39.61 87.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.226 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.11 99.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.01 0.433 . . . . 0.0 110.245 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.03 -28.58 70.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.591 179.489 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.59 -54.12 8.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.885 179.407 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.525 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.5 ttp180 -65.26 -42.5 93.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.395 -179.764 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 174' ' ' ASP . 81.2 mt -62.61 -43.94 98.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.54 -179.388 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.11 -61.06 2.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.088 0.471 . . . . 0.0 110.403 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.8 -34.52 62.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.605 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -80.41 -35.9 34.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.812 179.576 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.8 m-20 -55.08 -42.07 72.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.997 -178.658 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.42 -41.94 99.07 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.746 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.0 -38.21 90.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.316 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.9 mt -62.46 -41.92 99.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.728 179.397 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.88 -52.81 62.61 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.097 0.475 . . . . 0.0 110.68 179.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.21 -41.75 89.69 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.674 179.408 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.92 95.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.592 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.36 -32.28 73.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.05 -22.16 18.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.589 -179.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.63 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.82 -41.06 96.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.698 -179.593 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -76.89 135.94 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.749 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -126.85 108.33 10.91 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.257 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.62 125.75 0.31 Allowed Pre-proline 0 C--O 1.239 0.551 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.495 179.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.6 Cg_exo -43.94 152.4 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.848 2.365 . . . . 0.0 112.585 -179.862 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.09 141.75 53.82 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.604 2.203 . . . . 0.0 112.382 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.3 147.31 2.16 Favored Pre-proline 0 N--CA 1.448 -0.528 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.563 179.315 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.11 154.22 70.63 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.839 2.36 . . . . 0.0 112.33 178.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.58 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.37 163.08 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.27 0.557 . . . . 0.0 110.42 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.58 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.77 170.39 15.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.97 179.593 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.17 137.6 22.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 0.0 110.182 179.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.542 HG22 HD12 ' A' ' 205' ' ' LEU . 40.6 pt -134.37 147.02 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.73 179.596 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.484 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -133.55 132.05 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.21 0.529 . . . . 0.0 110.436 178.772 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -152.1 155.04 37.1 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.382 179.14 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.7 m -122.26 122.89 40.16 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.952 0.406 . . . . 0.0 110.405 179.469 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.88 -25.36 66.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.678 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.614 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.45 -49.37 19.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.876 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.26 -9.81 59.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.393 -179.526 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.6 m80 46.85 43.39 13.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.544 -179.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -136.39 144.65 44.65 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.31 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.9 113.92 26.86 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.336 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.95 133.41 55.57 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.096 0.474 . . . . 0.0 110.405 179.824 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.542 HD12 HG22 ' A' ' 194' ' ' ILE . 7.5 tt -112.06 146.48 37.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.014 0.435 . . . . 0.0 110.728 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.459 ' N ' HD23 ' A' ' 205' ' ' LEU . 13.6 t90 -99.67 129.88 45.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.14 0.495 . . . . 0.0 109.919 179.434 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.64 154.02 39.29 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.333 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.8 Cg_endo -67.54 -18.3 48.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.752 2.302 . . . . 0.0 111.976 178.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -49.54 -18.38 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.344 -179.148 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.406 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.4 p -75.59 164.34 26.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.51 179.664 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.83 -27.95 65.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.45 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.575 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.1 mt-30 -63.98 -41.26 97.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.61 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.04 -45.05 96.62 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -179.52 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.436 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.63 -38.71 91.94 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 122.236 -0.567 . . . . 0.0 110.783 179.54 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.597 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.7 mmm -62.14 -41.78 98.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.312 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.405 HD23 HD12 ' A' ' 219' ' ' LEU . 48.5 mt -63.5 -47.14 82.96 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.143 0.497 . . . . 0.0 110.259 179.545 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -54.77 -31.64 58.97 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.894 0.378 . . . . 0.0 110.411 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -70.26 -17.7 63.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.451 179.573 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.423 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.5 mt -88.82 -9.23 52.52 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.585 -179.492 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.98 2.68 51.98 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.756 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.86 153.03 21.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.456 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.5 p -115.36 128.12 55.87 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.11 0.481 . . . . 0.0 110.323 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.5 mm? -91.75 146.6 23.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.032 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.456 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.81 151.62 44.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.41 179.709 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -133.06 132.1 41.4 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.465 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.887 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.42 93.96 29.42 Favored Pre-proline 0 C--O 1.235 0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.066 -179.633 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.684 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.3 Cg_exo -55.12 138.86 79.91 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.582 2.188 . . . . 0.0 111.662 178.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.6 -25.27 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.504 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.684 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.17 -49.58 26.24 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.729 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.563 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.8 mt -54.58 -37.34 65.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.093 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.33 35.75 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.767 179.376 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.563 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.48 88.02 0.01 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.926 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 81.1 p -81.0 -13.81 58.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.31 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.16 -40.71 10.86 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.604 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.7 t -67.04 -16.6 64.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.559 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.69 43.94 27.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.473 -179.589 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.61 -147.05 7.37 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.06 143.45 49.5 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.96 0.41 . . . . 0.0 110.343 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.08 149.61 29.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.338 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -101.02 -152.08 0.42 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.319 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.5 t0 56.02 -92.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.672 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.457 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.1 tt -126.49 175.13 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.661 -179.591 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.457 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -121.62 141.24 42.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.827 -179.392 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.48 168.8 9.75 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.16 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.3 mt -147.47 150.91 35.5 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.281 179.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.99 -38.74 96.48 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.09 4.3 4.63 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.63 -58.1 3.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.901 0.381 . . . . 0.0 110.466 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.567 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.1 m-20 -62.15 -36.45 81.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.332 -179.724 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.36 -67.8 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.842 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.32 -42.06 66.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.182 -179.362 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.29 18.03 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.629 179.816 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.59 48.46 0.24 Allowed Glycine 0 N--CA 1.465 0.591 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.62 -109.84 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.467 0.175 . . . . 0.0 110.745 -178.536 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.456 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 12.0 m120 -60.68 -45.18 95.12 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.534 -179.555 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.82 8.17 83.01 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.258 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.37 -12.71 20.04 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 122.744 -0.268 . . . . 0.0 110.7 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.5 t 176.44 142.44 0.07 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.077 0.465 . . . . 0.0 110.436 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.1 125.34 11.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.161 179.593 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.432 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.38 143.19 29.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 120.899 0.38 . . . . 0.0 110.944 178.153 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.8 mt -94.52 106.66 18.65 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.718 -179.257 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.446 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.82 -12.36 18.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.101 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.58 89.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.872 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.37 173.66 46.04 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.657 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.5 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -73.98 -112.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 110.798 -179.824 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.95 -28.61 67.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.707 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.98 -44.12 91.53 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.202 -178.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.75 -44.24 94.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.308 179.3 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.51 -60.24 3.48 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.167 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -50.9 -43.56 59.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.169 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.27 -43.72 74.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.211 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.7 mt -64.57 -43.56 96.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.635 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -56.39 -37.68 70.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.168 -179.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.8 1.07 18.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.19 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -115.25 91.1 26.64 Favored Pre-proline 0 N--CA 1.462 0.134 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.129 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.99 -26.99 26.88 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.746 2.297 . . . . 0.0 111.976 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.532 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.54 -41.09 98.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.495 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.598 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.43 5.28 52.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.401 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.17 -34.84 68.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.536 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -80.11 4.74 16.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.526 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.9 121.28 80.94 Favored Pre-proline 0 N--CA 1.445 -0.721 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.566 179.999 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -47.22 -37.79 24.51 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.446 2.097 . . . . 0.0 112.618 -179.569 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.88 -43.8 90.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.705 0.288 . . . . 0.0 110.403 179.764 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.93 -43.56 92.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.345 179.306 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.84 -40.68 95.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.327 -179.217 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -90.09 -12.06 39.5 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.572 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.69 32.84 18.29 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.393 0.433 . . . . 0.0 111.035 -179.801 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -89.3 43.87 1.17 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.17 0.509 . . . . 0.0 110.348 179.476 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.54 135.96 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.533 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -116.7 132.55 56.66 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.385 179.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.502 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.57 88.09 7.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.733 179.917 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.06 -40.82 97.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.446 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.64 167.54 34.82 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.515 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 73.8 p -75.55 -25.73 57.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.803 0.335 . . . . 0.0 110.689 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.503 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.4 tp10 -67.89 -34.56 76.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.491 -179.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.773 HG22 ' O ' ' A' ' 296' ' ' THR . 96.7 m -73.36 24.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.649 -179.106 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.575 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 56.7 t80 -58.04 -51.17 70.79 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.348 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.408 HH12 ' HG3' ' A' ' 212' ' ' GLN . 71.0 mmt-85 -111.77 154.54 24.9 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.073 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.423 ' CD2' HD11 ' A' ' 219' ' ' LEU . 45.0 tp -115.89 124.99 52.03 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.97 0.414 . . . . 0.0 110.824 179.688 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.488 ' CB ' HD23 ' A' ' 83' ' ' LEU . 44.4 t0 -147.22 165.37 30.27 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.59 179.552 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.4 -38.41 28.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.617 -179.463 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -71.81 -65.1 0.81 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.527 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -60.08 -32.27 70.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.926 -179.501 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.19 -25.27 21.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.684 -179.14 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.7 mtt -63.1 -41.27 99.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.975 0.417 . . . . 0.0 110.977 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.27 -44.52 25.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.207 179.427 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.546 HG21 HG23 ' A' ' 296' ' ' THR . 78.7 t -66.12 -42.88 92.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.465 179.703 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.443 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 52.1 tp -60.36 -47.25 86.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.524 -178.522 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -70.09 -39.54 75.49 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.696 179.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.502 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 70.2 ttt180 -61.89 -37.79 85.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.36 -178.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -87.8 4.81 42.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.723 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.63 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.6 tttt -113.2 -11.99 13.18 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.052 0.453 . . . . 0.0 110.357 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.3 86.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.449 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.91 -48.8 80.15 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.431 -179.644 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.059 179.8 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.608 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.86 -2.7 58.26 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.463 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.55 179.14 1.23 Allowed Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.561 -179.65 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.4 Cg_exo -60.75 145.0 99.64 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.799 2.333 . . . . 0.0 112.171 179.634 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.608 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.03 -179.52 8.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.596 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.97 136.94 52.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.013 0.435 . . . . 0.0 110.383 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.22 147.06 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.342 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.6 p -119.93 135.88 54.73 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.073 0.463 . . . . 0.0 110.699 179.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.42 -143.44 0.33 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.252 179.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.61 -37.11 86.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.485 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.4 -66.68 0.22 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.416 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.52 142.47 45.35 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -179.357 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 78.4 p -112.29 131.61 55.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 0.0 110.447 -179.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -119.2 129.03 54.76 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.526 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.1 m -85.56 130.18 34.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.217 -179.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.477 HD22 ' NE2' ' A' ' 42' ' ' GLN . 69.1 mt -95.7 78.5 3.3 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.463 179.646 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.64 -31.73 72.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.579 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.35 109.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.018 0.437 . . . . 0.0 110.089 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.478 HE22 HD22 ' A' ' 115' ' ' LEU . 1.4 pt20 -122.35 91.15 49.3 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.485 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.4 Cg_exo -56.74 148.48 65.36 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.831 2.354 . . . . 0.0 112.002 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.46 82.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.566 0.542 . . . . 0.0 110.975 -179.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.55 66.84 0.88 Allowed 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 121.094 0.473 . . . . 0.0 110.221 -179.422 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.4 130.74 35.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.803 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.565 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.4 t -122.42 146.61 27.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.057 -179.699 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.7 t -135.87 143.78 45.23 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.772 179.79 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.9 p -99.57 -59.36 1.73 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.588 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.1 p -79.22 155.17 28.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.66 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.524 HG21 HG23 ' A' ' 70' ' ' THR . 69.7 t -74.2 -21.89 17.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.474 179.355 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.3 m -60.28 -52.19 66.31 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.549 -178.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.34 -42.72 87.75 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.756 177.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.1 m -42.94 -53.83 4.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.9 -178.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.32 -37.19 70.68 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 178.564 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 m -62.78 -44.78 95.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.871 0.367 . . . . 0.0 110.141 -179.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.9 mt -66.45 -41.94 88.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.51 0.671 . . . . 0.0 110.711 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.65 -40.48 97.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.427 -179.363 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.9 -35.67 75.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.303 -179.046 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 156' ' ' LEU . 32.6 pt -91.34 28.65 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.314 -179.388 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.51 51.81 10.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.084 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.34 76.04 21.98 Favored Pre-proline 0 N--CA 1.463 0.199 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.624 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.77 151.21 86.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.864 2.376 . . . . 0.0 112.102 -178.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.565 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.18 137.47 46.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 121.155 0.502 . . . . 0.0 110.292 179.683 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.43 -43.55 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.395 179.344 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.25 131.48 53.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.033 0.444 . . . . 0.0 110.562 -179.008 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.6 p -155.7 168.51 26.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.437 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.36 -177.37 21.96 Favored Glycine 0 N--CA 1.463 0.475 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.634 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.52 172.25 12.98 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 121.165 0.507 . . . . 0.0 110.453 179.263 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.524 HG23 HG21 ' A' ' 51' ' ' VAL . 15.0 p -132.17 -113.14 0.23 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.037 0.446 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.64 179.58 0.97 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.399 -179.185 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.9 Cg_exo -61.04 57.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.997 2.465 . . . . 0.0 112.146 179.417 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.2 t-20 -64.1 -33.18 75.19 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.286 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.5 m-20 93.8 -36.62 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.674 0.609 . . . . 0.0 109.825 -179.527 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -62.51 -39.71 94.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.009 0.433 . . . . 0.0 110.225 179.279 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.505 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.26 -25.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.703 179.353 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.15 -171.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.444 -179.227 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.77 -154.15 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.843 -179.708 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 38.1 p-10 -52.46 -7.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.742 -179.557 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.13 114.87 23.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.679 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.23 70.05 1.34 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -143.59 147.45 34.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.866 0.365 . . . . 0.0 110.856 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -85.41 -98.2 0.07 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.126 178.859 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.3 -42.38 96.39 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.076 179.543 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.553 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.23 52.5 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.875 0.734 . . . . 0.0 111.027 179.205 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -102.6 -9.12 20.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.332 179.338 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.3 p -64.56 -33.86 76.9 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.183 0.515 . . . . 0.0 110.74 -179.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.539 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.29 -23.29 1.33 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 179.666 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.0 t -70.08 -45.83 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.689 179.698 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.29 -48.63 80.52 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.216 0.532 . . . . 0.0 109.963 -179.384 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.52 -38.2 89.01 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.425 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.71 -32.89 53.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.041 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.605 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.9 mmt-85 -89.87 1.77 55.8 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.453 -179.811 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.76 -49.38 0.17 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.903 0.752 . . . . 0.0 110.228 179.125 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.658 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.2 mt -45.97 154.3 0.25 Allowed 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 117.621 -1.181 . . . . 0.0 109.566 -179.768 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.658 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.9 tt0 121.16 92.65 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 O-C-N 125.461 1.726 . . . . 0.0 110.51 -178.511 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.69 142.93 42.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.242 0.544 . . . . 0.0 110.291 179.296 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.3 mt -132.05 27.15 4.55 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.973 -0.454 . . . . 0.0 110.44 -179.346 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.39 137.97 34.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.042 0.448 . . . . 0.0 110.583 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.9 mt -137.17 165.12 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.319 179.594 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.94 -28.51 1.86 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -152.96 70.89 7.14 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 121.119 0.485 . . . . 0.0 110.132 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.1 145.42 98.48 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 122.743 2.295 . . . . 0.0 112.126 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.9 t -134.27 136.75 43.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.543 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.27 81.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.643 179.652 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.25 -42.3 96.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.511 -179.385 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.92 -41.7 98.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.49 -179.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.56 -43.43 98.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.991 179.485 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.02 77.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.145 -179.636 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.62 -18.82 61.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.383 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.6 -6.68 58.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.461 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.41 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.4 mtp 47.57 56.3 17.39 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.568 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.8 Cg_endo -70.33 149.5 63.38 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.751 2.301 . . . . 0.0 112.098 179.5 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.04 -73.64 0.64 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.492 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.478 HD22 HE22 ' A' ' 42' ' ' GLN . 39.3 tp -111.07 113.6 26.25 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 110.295 179.648 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.6 mt -101.97 126.75 55.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 120.966 0.413 . . . . 0.0 110.714 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.5 mt -109.84 133.5 53.09 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.211 -179.43 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.5 139.43 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.55 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.4 p -83.32 168.39 16.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.851 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.4 -37.3 80.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.397 179.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.3 t -139.96 158.87 43.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.968 0.414 . . . . 0.0 110.415 -179.818 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.23 176.97 33.49 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.26 -33.81 87.2 Favored Glycine 0 CA--C 1.518 0.251 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -124.58 151.3 44.95 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 110.547 -179.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.0 t -63.24 140.88 58.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.333 -179.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.48 10.37 11.14 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.659 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.7 mp -60.92 -39.0 87.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.273 -179.374 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.84 23.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.469 0.652 . . . . 0.0 110.594 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.5 mt -70.99 -35.4 72.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.517 0.675 . . . . 0.0 110.613 179.398 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -42.77 -62.91 0.88 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.424 -178.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.7 p-10 -65.63 -42.92 90.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 -179.301 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -61.89 -32.6 72.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.399 -179.609 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.4 mt -73.9 -40.8 62.9 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.78 178.672 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.04 -49.0 78.39 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.114 -178.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.9 m -53.02 -42.37 65.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.955 0.407 . . . . 0.0 110.144 179.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.21 -42.7 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 120.909 0.385 . . . . 0.0 111.252 179.044 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.64 153.81 5.22 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.681 -179.401 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -39.25 107.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.702 2.268 . . . . 0.0 112.519 179.544 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.64 ' C ' HD12 ' A' ' 140' ' ' LEU . 96.2 m -109.56 121.08 44.4 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.152 0.501 . . . . 0.0 110.272 179.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.64 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.59 152.24 30.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.294 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.77 131.43 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.3 179.815 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.404 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.8 mt -115.27 127.97 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.553 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.51 103.85 14.74 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.151 179.766 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 147' ' ' LYS . 48.4 p90 -101.3 -11.11 19.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.895 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.92 -33.49 76.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.708 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.0 p-10 -98.21 7.57 46.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.589 -179.622 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.44 155.56 50.34 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.415 -179.38 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.2 p -74.9 165.82 24.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.63 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.589 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.05 -48.83 80.08 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.19 -179.073 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.46 -41.92 66.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.351 . . . . 0.0 110.082 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.6 t -62.69 -41.03 98.89 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.399 178.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.404 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.3 tp -60.74 -44.51 96.59 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.285 -179.472 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.33 -43.47 98.83 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.106 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.0 m -55.16 -44.99 75.67 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.17 -40.66 96.78 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 120.948 0.404 . . . . 0.0 110.545 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.521 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -61.94 -42.5 99.17 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.378 178.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.19 -40.8 95.03 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.548 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.76 -46.03 63.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.786 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.68 -44.05 96.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -92.95 -8.9 41.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.661 -179.023 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.41 26.39 72.71 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -101.74 50.32 0.85 Allowed 'General case' 0 N--CA 1.463 0.214 0 O-C-N 122.638 -0.331 . . . . 0.0 110.68 -179.576 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -69.46 -39.63 77.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.694 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.32 -47.08 86.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.301 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -60.2 -39.42 86.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.129 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.96 99.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.181 179.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.11 -28.39 70.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.67 179.476 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.3 -54.38 7.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.863 179.357 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.509 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.35 -42.22 93.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.376 -179.758 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.4 mt -62.31 -43.88 98.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.559 -179.418 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.48 -59.23 5.26 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.992 0.425 . . . . 0.0 110.308 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -56.28 -33.99 66.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.572 -179.085 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -80.73 -36.37 32.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.815 179.524 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.8 m-20 -55.45 -42.22 73.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.91 -178.419 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.17 -42.13 98.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.8 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.08 -38.15 89.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.306 179.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 177' ' ' LEU . 81.8 mt -62.44 -42.25 99.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.746 179.452 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.19 -52.84 62.17 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.026 0.441 . . . . 0.0 110.622 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.24 -41.85 89.44 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.641 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.95 95.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.641 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.34 -31.95 73.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.48 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.57 -22.26 18.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.635 -179.828 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.632 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.84 -41.35 95.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.597 -179.497 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.6 pt -76.73 136.13 25.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.741 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.87 107.98 10.59 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.265 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.71 125.87 0.31 Allowed Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.487 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.5 Cg_exo -43.8 152.42 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.794 2.33 . . . . 0.0 112.58 -179.804 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.18 141.95 54.0 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.536 2.157 . . . . 0.0 112.397 179.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.32 147.46 2.18 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.555 179.323 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.37 154.55 69.12 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.797 2.331 . . . . 0.0 112.272 178.52 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.57 163.3 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.232 0.539 . . . . 0.0 110.408 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.56 170.17 16.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.025 179.454 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.94 137.31 22.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.997 0.427 . . . . 0.0 110.127 179.484 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.554 HG22 HD12 ' A' ' 205' ' ' LEU . 38.0 pt -134.17 146.84 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.7 179.622 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -133.01 131.97 58.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.285 0.564 . . . . 0.0 110.439 178.775 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -152.98 156.42 38.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.362 179.202 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.607 HG22 ' H ' ' A' ' 199' ' ' ALA . 85.0 m -122.36 123.12 40.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.906 0.384 . . . . 0.0 110.418 179.416 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.522 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.78 -26.18 67.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.608 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.607 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.89 -49.23 21.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.68 -10.37 59.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.503 -179.703 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.522 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.5 m80 45.84 46.59 12.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 t -130.8 143.51 50.79 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.012 0.434 . . . . 0.0 110.334 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.456 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -108.23 105.62 15.42 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.18 -179.773 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -116.2 128.98 56.07 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.288 0.566 . . . . 0.0 110.29 179.714 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.554 HD12 HG22 ' A' ' 194' ' ' ILE . 7.7 tt -111.82 146.45 37.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.816 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.476 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.7 t90 -99.5 128.33 45.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.205 0.526 . . . . 0.0 109.795 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.22 153.8 40.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.434 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.62 -17.97 48.26 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.674 2.249 . . . . 0.0 112.018 178.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.84 -18.59 0.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.392 -179.189 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.422 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.7 p -75.49 164.7 26.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 179.577 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.96 -28.05 65.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.576 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.561 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.5 mt-30 -63.66 -41.4 98.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.59 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.36 -44.48 97.53 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.41 -38.89 92.61 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 122.167 -0.607 . . . . 0.0 110.739 179.67 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.0 mmm -61.83 -41.35 97.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.273 179.716 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.5 -47.75 80.44 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.095 0.474 . . . . 0.0 110.407 179.271 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.63 -32.07 49.83 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.913 0.387 . . . . 0.0 110.413 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -70.84 -18.22 62.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.501 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.414 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.7 mt -88.61 -8.7 54.23 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.558 -179.469 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.85 2.78 55.13 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.78 151.86 22.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.94 0.4 . . . . 0.0 110.432 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.449 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.3 p -114.87 127.8 55.92 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.178 0.513 . . . . 0.0 110.387 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.05 146.79 23.45 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.929 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.461 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -70.45 151.26 45.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.456 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.96 131.66 42.81 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.519 179.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.883 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.6 93.65 28.89 Favored Pre-proline 0 C--O 1.235 0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.055 -179.529 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.685 ' C ' ' H ' ' A' ' 229' ' ' GLY . 44.8 Cg_exo -55.17 138.55 79.38 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.618 2.212 . . . . 0.0 111.703 178.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.36 -25.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.521 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.685 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.44 -50.19 27.68 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 179.802 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.571 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -55.13 -36.93 66.28 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.101 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -65.77 35.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.806 179.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.571 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.14 88.66 0.01 OUTLIER 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.949 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 87.7 p -82.41 -13.6 56.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.331 -179.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.41 -40.95 11.15 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.633 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 31.9 t -66.65 -16.82 64.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.622 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.79 43.88 27.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.482 -179.599 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.95 -148.75 8.14 Favored Glycine 0 CA--C 1.518 0.245 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.82 142.17 48.86 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.916 0.389 . . . . 0.0 110.267 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.402 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.5 ttt-85 -151.93 149.47 28.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.349 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -102.11 -150.31 0.4 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.344 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.81 -93.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.64 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.439 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.0 tt -126.4 174.72 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.64 -179.589 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.439 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 89.5 mt -122.12 141.2 43.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -99.62 170.5 8.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.189 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 70.0 mt -146.69 149.69 33.93 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.229 179.743 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.22 -39.41 97.86 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.17 3.22 3.98 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -78.72 -57.42 3.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.937 0.399 . . . . 0.0 110.484 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.616 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.8 m-20 -62.03 -36.81 82.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.242 -179.67 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.456 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.7 mp -53.06 -67.45 0.25 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.014 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.8 -42.71 68.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.126 -179.297 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.31 17.64 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.701 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.9 47.81 0.25 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 7.9 mp 39.47 -110.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.532 0.206 . . . . 0.0 110.699 -178.677 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.461 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.7 m120 -60.76 -44.57 96.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.35 -179.563 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.4 7.92 84.09 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.413 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.87 -13.5 20.03 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.761 -0.258 . . . . 0.0 110.678 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.7 t 177.21 142.94 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 0.0 110.448 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.19 125.49 11.55 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.161 179.56 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.71 143.66 28.83 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 120.914 0.388 . . . . 0.0 110.847 178.269 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.9 mt -95.06 106.67 18.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.736 -179.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.442 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.1 t80 -101.91 -12.63 18.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.122 179.596 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.4 -41.04 89.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.82 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.36 172.86 45.69 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.469 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -73.59 -113.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.75 0.31 . . . . 0.0 110.815 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.6 -28.84 68.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.644 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.11 -43.64 91.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.16 -178.801 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.68 -44.28 94.18 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.267 179.248 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.6 -59.98 3.8 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.111 -179.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.96 -43.52 60.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.112 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.38 -43.33 75.06 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.199 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.2 mt -64.62 -43.61 96.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.674 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -55.94 -37.84 69.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.132 -179.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.48 0.78 18.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.182 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -115.04 90.99 25.21 Favored Pre-proline 0 N--CA 1.463 0.177 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.123 -179.564 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.09 -27.08 27.89 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.704 2.27 . . . . 0.0 111.979 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.538 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.48 -40.92 98.37 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.518 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.1 mp -95.53 5.59 51.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.343 -179.214 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.39 -34.84 68.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.612 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.86 4.59 16.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.495 -178.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.75 121.13 80.09 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.607 -179.979 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -47.28 -37.6 24.7 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.431 2.087 . . . . 0.0 112.635 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.84 -43.78 90.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.756 0.313 . . . . 0.0 110.4 179.724 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.03 -43.51 92.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.346 179.348 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.74 -40.64 95.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.383 -179.191 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -90.22 -12.19 38.77 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.1 mtmt 61.74 32.81 18.2 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.371 0.419 . . . . 0.0 111.024 -179.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -89.04 43.67 1.16 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.13 0.491 . . . . 0.0 110.295 179.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.22 136.02 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.44 -179.661 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -117.02 132.28 56.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.391 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.78 89.14 7.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.819 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.415 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.3 mt -63.97 -41.16 97.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.993 0.425 . . . . 0.0 110.811 179.521 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.02 165.22 33.58 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.511 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 67.6 p -75.26 -25.77 58.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.968 0.413 . . . . 0.0 110.822 179.778 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -68.39 -33.83 74.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.504 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.768 HG22 ' O ' ' A' ' 296' ' ' THR . 95.8 m -73.39 24.72 0.07 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.797 -179.076 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.561 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 44.0 t80 -58.71 -50.85 72.35 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.256 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.419 HH12 ' HG3' ' A' ' 212' ' ' GLN . 77.1 mmt-85 -110.64 153.09 25.7 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 179.135 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.414 ' CD2' HD11 ' A' ' 219' ' ' LEU . 42.7 tp -115.4 124.88 52.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.883 0.373 . . . . 0.0 110.816 179.759 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.489 ' CB ' HD23 ' A' ' 83' ' ' LEU . 40.6 t0 -147.73 165.53 30.22 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.592 179.572 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -49.4 -37.92 27.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.533 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.32 -65.45 0.75 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.871 0.367 . . . . 0.0 111.582 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.87 -32.76 72.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.013 -179.504 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.5 -25.66 26.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.724 -179.153 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.5 mtt -63.37 -40.83 98.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.874 0.369 . . . . 0.0 111.145 179.694 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.41 -44.24 25.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.103 179.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.585 HG21 HG23 ' A' ' 296' ' ' THR . 78.2 t -66.34 -42.89 91.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.347 179.652 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.438 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.3 tp -60.02 -47.22 86.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.446 -178.516 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -69.82 -39.28 76.59 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.07 0.462 . . . . 0.0 110.811 179.074 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.9 ttt180 -61.87 -38.33 87.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.219 -178.936 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.27 4.61 42.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.57 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.632 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -112.85 -11.25 13.48 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.066 0.46 . . . . 0.0 110.367 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.35 86.89 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.466 179.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.82 -48.81 80.12 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.39 -179.608 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.222 -0.379 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.012 179.912 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.36 -2.55 57.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.372 -179.81 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.493 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.62 179.05 1.25 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.521 -179.701 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.493 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.8 Cg_exo -60.73 144.74 99.59 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.814 2.343 . . . . 0.0 112.153 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.87 -179.57 8.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.632 -179.851 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.76 136.42 53.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.046 0.45 . . . . 0.0 110.364 179.765 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.08 147.26 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.382 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.9 p -120.3 136.1 54.79 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.813 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.21 -143.52 0.32 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.248 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.7 -37.03 85.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.47 179.623 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.482 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.15 -67.04 0.22 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.418 179.783 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.21 142.5 44.61 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.436 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.7 p -112.64 131.21 55.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.991 0.424 . . . . 0.0 110.463 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -118.96 129.14 55.0 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.54 -179.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.3 m -85.63 130.83 34.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.226 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.2 mt -96.24 78.7 3.11 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.343 179.678 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -65.93 -32.11 73.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.574 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.62 108.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.106 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.489 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -121.93 91.21 48.8 Favored Pre-proline 0 C--O 1.233 0.189 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.45 -179.729 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.663 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.2 Cg_exo -56.75 148.29 66.7 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.798 2.332 . . . . 0.0 111.982 178.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.18 82.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.695 0.622 . . . . 0.0 111.002 -179.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.663 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.47 66.72 0.89 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.263 -179.4 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.95 130.98 35.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.851 -179.742 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.569 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.1 t -122.75 147.7 26.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.062 0.458 . . . . 0.0 110.013 -179.678 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.2 t -136.62 144.03 43.86 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.753 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.1 p -99.45 -59.53 1.7 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.628 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.8 p -79.08 155.64 28.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.623 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.529 HG21 HG23 ' A' ' 70' ' ' THR . 70.1 t -74.26 -21.65 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.532 179.414 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -60.34 -52.01 67.08 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.547 -178.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.16 -42.7 88.61 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.718 177.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.8 m -43.26 -54.38 4.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.884 -178.54 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.88 -37.36 74.89 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 178.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m -62.91 -44.49 95.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.872 0.368 . . . . 0.0 110.163 -179.304 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 18.3 mt -66.07 -41.95 90.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.505 0.669 . . . . 0.0 110.663 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.04 -39.95 96.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.344 -179.251 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.541 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.48 -35.91 77.02 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.295 -178.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.445 HD11 HD12 ' A' ' 156' ' ' LEU . 33.9 pt -91.14 27.64 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.374 -179.381 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.403 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 98.8 m-20 57.08 51.93 9.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.084 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.48 76.39 25.25 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.66 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.98 149.46 90.49 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.877 2.385 . . . . 0.0 112.146 -178.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.43 136.71 47.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 121.115 0.483 . . . . 0.0 110.35 179.661 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.444 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.0 pt -69.67 -43.46 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.249 179.439 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.491 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.13 131.27 53.28 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.963 0.411 . . . . 0.0 110.608 -178.983 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.4 p -155.92 168.63 26.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.531 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.16 -177.43 22.09 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.644 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.26 171.92 13.38 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 121.102 0.477 . . . . 0.0 110.425 179.297 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.529 HG23 HG21 ' A' ' 51' ' ' VAL . 12.3 p -133.81 -110.51 0.22 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.008 0.432 . . . . 0.0 110.583 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.11 179.62 0.94 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.566 -179.323 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.4 Cg_exo -60.72 58.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.944 2.429 . . . . 0.0 112.126 179.512 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.3 t-20 -64.31 -34.88 79.15 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.48 -179.789 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.566 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 45.9 m-20 95.04 -38.07 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.671 0.607 . . . . 0.0 109.759 -179.436 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 -62.54 -39.88 95.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.99 0.424 . . . . 0.0 110.142 179.234 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -73.6 -26.55 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.693 179.326 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -50.04 -171.77 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.463 -179.381 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -74.38 -153.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 -179.785 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.3 p-10 -54.37 -6.77 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.675 -179.432 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.9 113.93 23.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.671 179.793 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.39 72.39 1.29 Allowed Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -143.8 148.1 35.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.862 0.363 . . . . 0.0 110.876 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.6 mp -85.99 -98.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.939 178.891 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.92 -43.38 96.11 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.113 179.395 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.37 52.53 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.794 0.684 . . . . 0.0 111.147 179.195 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.78 -8.63 19.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.347 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.0 p -65.45 -33.22 75.43 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.05 0.452 . . . . 0.0 110.65 -179.596 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.523 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.87 -23.24 1.02 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.717 179.639 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.4 t -70.13 -45.81 74.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.708 179.708 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.75 80.09 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.974 -179.441 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.41 -38.37 89.41 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.39 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.65 -32.78 52.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.208 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.618 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.5 mmt-85 -89.8 1.81 55.69 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.406 -179.802 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.618 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 82.68 -49.18 0.17 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.7 0.625 . . . . 0.0 110.246 179.152 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.673 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.3 mt -45.96 154.11 0.26 Allowed 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.542 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.673 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 121.2 92.05 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 125.17 1.543 . . . . 0.0 110.477 -178.683 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.543 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.92 142.56 44.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.282 0.563 . . . . 0.0 110.368 179.374 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.2 mt -131.6 26.59 4.72 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 122.016 -0.428 . . . . 0.0 110.379 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -139.8 136.96 34.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.06 0.457 . . . . 0.0 110.596 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.644 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.7 mt -136.52 164.69 30.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.393 179.592 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.613 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.19 -28.49 1.83 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.56 70.72 7.42 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 121.08 0.466 . . . . 0.0 110.182 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.08 145.41 98.5 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.705 2.27 . . . . 0.0 112.098 -179.481 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.5 t -134.59 136.91 43.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.509 179.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.35 82.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.57 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.2 -42.38 96.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.603 -179.439 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.91 -41.68 98.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.544 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.57 -43.35 98.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.987 179.487 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.17 -35.04 77.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.206 -179.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.81 -18.71 60.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.363 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.51 -6.4 58.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.457 -179.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.4 mtp 47.54 56.0 17.15 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.576 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.9 Cg_endo -70.33 149.61 63.5 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.816 2.344 . . . . 0.0 112.049 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.46 -73.72 0.64 Allowed 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.46 179.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.1 tp -110.61 113.72 26.55 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.27 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.3 mt -102.84 126.83 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.614 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.1 mt -110.57 134.18 52.63 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.275 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.68 140.05 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.57 -179.574 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.2 p -83.44 168.19 16.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.8 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.5 79.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.455 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.6 t -139.99 159.2 42.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.398 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.18 176.82 33.49 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.31 -33.67 86.83 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.49 151.67 44.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.858 0.361 . . . . 0.0 110.565 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.8 t -63.39 140.64 58.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.336 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.39 10.35 11.19 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.622 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.517 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -60.75 -39.0 87.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.253 -179.368 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.97 -35.9 23.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.358 0.599 . . . . 0.0 110.594 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.0 mt -70.89 -35.43 72.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.47 0.653 . . . . 0.0 110.607 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -42.78 -62.92 0.88 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.453 -178.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.82 -42.75 90.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.244 -179.395 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -61.83 -32.6 72.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.402 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.2 mt -73.88 -40.82 62.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.879 178.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -58.24 -49.18 77.99 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.231 -179.041 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.8 m -53.01 -42.49 65.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.896 0.379 . . . . 0.0 110.089 179.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.18 -42.82 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 120.927 0.394 . . . . 0.0 111.154 179.216 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.4 153.39 5.26 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.684 -179.395 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -39.08 107.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.666 2.244 . . . . 0.0 112.537 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.641 ' C ' HD12 ' A' ' 140' ' ' LEU . 94.1 m -109.68 121.08 44.4 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.115 0.483 . . . . 0.0 110.246 179.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.76 153.08 29.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.32 -179.841 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.6 tt -128.58 131.45 68.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.383 179.856 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.41 128.17 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.605 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.501 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 53.6 t30 -99.59 104.02 15.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.133 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.416 ' O ' ' O ' ' A' ' 147' ' ' LYS . 50.8 p90 -98.87 -12.39 20.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.969 -179.705 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.6 p-10 -64.93 -33.89 77.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.798 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.592 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.7 p-10 -99.23 6.89 46.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.596 -179.376 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.8 mttm -133.71 149.59 51.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.559 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.423 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -76.43 167.31 22.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.618 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.603 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.2 t90 -59.07 -48.3 82.1 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.166 -179.158 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -54.4 -45.99 73.04 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 40.4 t -63.42 -40.8 98.14 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.094 0.473 . . . . 0.0 110.2 178.429 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.434 ' O ' HD23 ' A' ' 156' ' ' LEU . 66.5 tp -61.04 -44.67 97.05 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.119 -179.353 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.49 -42.71 99.21 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.207 179.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.5 m -55.78 -45.61 78.14 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.39 -40.4 96.37 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.812 0.339 . . . . 0.0 110.445 179.766 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.445 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -61.81 -42.54 99.14 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.312 178.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.78 -40.0 95.45 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.425 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.36 -45.61 65.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.922 0.391 . . . . 0.0 110.843 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.9 mt -65.02 -43.88 96.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.82 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.3 p -92.89 -9.11 41.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.656 -179.049 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.96 26.42 72.28 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -101.72 50.76 0.84 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.883 0.373 . . . . 0.0 110.668 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.53 -39.31 77.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.608 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.37 -47.36 85.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.36 -179.448 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.403 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 87.3 mt-30 -60.3 -39.3 86.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.112 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.05 99.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.186 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.07 -28.39 70.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.607 179.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.21 -54.42 7.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.939 179.405 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.541 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.5 ttp180 -65.5 -41.98 92.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.561 -179.834 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 174' ' ' ASP . 78.9 mt -62.31 -43.92 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.549 -179.319 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.91 -57.85 9.39 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 120.995 0.426 . . . . 0.0 110.416 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -57.56 -33.83 68.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.619 -179.134 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -81.15 -36.43 30.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.774 179.648 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.4 m-20 -55.72 -41.64 74.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.095 -178.672 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.49 -42.1 99.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.631 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.19 -38.35 90.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.255 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 177' ' ' LEU . 83.0 mt -62.45 -42.02 99.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.76 179.498 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.18 -53.16 59.29 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.091 0.472 . . . . 0.0 110.628 179.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -65.87 -42.08 90.82 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.722 179.502 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.51 -39.45 94.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.669 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.7 -32.06 73.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.4 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -95.34 -21.96 18.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.617 -179.677 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.64 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.38 -41.77 96.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.685 -179.494 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.4 pt -74.53 135.55 27.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.016 0.436 . . . . 0.0 110.707 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.29 106.2 9.35 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.346 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -178.02 127.51 0.28 Allowed Pre-proline 0 C--O 1.239 0.53 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.513 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.447 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.7 Cg_exo -43.53 151.81 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.892 2.395 . . . . 0.0 112.53 -179.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.44 142.81 55.46 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.608 2.205 . . . . 0.0 112.343 179.672 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.545 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -171.66 147.14 1.99 Allowed Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.527 179.327 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.13 155.29 68.49 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.887 2.391 . . . . 0.0 112.34 178.676 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.59 163.14 28.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.201 0.524 . . . . 0.0 110.409 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.3 169.36 17.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.031 179.455 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.41 137.1 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.365 . . . . 0.0 110.177 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.57 HG22 HD12 ' A' ' 205' ' ' LEU . 38.0 pt -134.08 146.12 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.759 179.511 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.491 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -133.32 132.11 58.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.286 0.565 . . . . 0.0 110.431 178.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -153.07 156.55 38.94 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.403 179.193 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.605 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.4 m -121.84 122.93 40.57 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.41 179.556 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.467 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.94 -26.09 67.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.606 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.605 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.77 -49.56 20.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.974 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -75.79 -13.22 60.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.471 -179.65 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.467 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 78.4 m80 49.56 46.51 23.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.621 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.5 t -131.59 146.04 52.01 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.075 0.464 . . . . 0.0 110.247 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.426 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -110.21 106.05 15.33 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.234 -179.741 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -116.36 129.19 56.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.09 0.471 . . . . 0.0 110.276 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.57 HD12 HG22 ' A' ' 194' ' ' ILE . 7.7 tt -111.95 146.32 38.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.017 0.437 . . . . 0.0 110.889 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.464 ' N ' HD23 ' A' ' 205' ' ' LEU . 17.4 t90 -98.73 128.86 45.11 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.139 0.495 . . . . 0.0 109.912 179.442 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.05 153.55 39.12 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.229 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.8 -18.25 47.35 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.748 2.299 . . . . 0.0 111.981 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.9 -19.16 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.437 -179.273 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 86.7 p -75.86 167.63 21.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.449 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.46 74.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.453 -179.682 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.506 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.2 mt-30 -56.55 -40.68 75.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.756 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.31 -43.71 97.09 Favored Glycine 0 C--N 1.329 0.165 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.532 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.512 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.2 mt-30 -64.32 -40.57 96.16 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 122.341 -0.505 . . . . 0.0 110.796 -179.896 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.603 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.3 mmm -62.02 -42.46 99.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.499 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 39.7 mt -62.91 -49.21 75.69 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.049 0.452 . . . . 0.0 110.432 179.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.67 -31.52 62.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 110.441 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -69.48 -17.47 63.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.541 179.792 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.401 HD11 ' CD2' ' A' ' 299' ' ' LEU . 95.0 mt -87.3 -11.5 49.32 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.616 -179.569 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 105.19 1.32 41.43 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.723 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -88.2 156.1 19.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.923 0.392 . . . . 0.0 110.692 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.458 ' O ' HG12 ' A' ' 191' ' ' VAL . 7.1 p -116.39 128.59 55.65 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.183 0.516 . . . . 0.0 110.201 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.63 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.6 mm? -90.53 146.81 23.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.993 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.458 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -71.62 150.47 44.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.414 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.5 131.94 42.15 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.575 179.688 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.877 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.03 94.2 28.83 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.984 -179.579 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.687 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.8 Cg_exo -55.19 138.57 79.49 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.651 2.234 . . . . 0.0 111.602 178.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.28 -25.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.46 -179.59 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.687 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.07 -49.67 26.42 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.575 ' C ' ' H ' ' A' ' 232' ' ' ALA . 98.1 mt -54.89 -37.29 66.13 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.127 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -65.71 35.52 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.775 179.37 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.575 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.78 87.82 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.5 p -81.38 -13.86 57.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.382 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.73 -40.41 11.27 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.628 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 26.9 t -66.93 -16.62 64.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.573 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.83 43.82 27.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.488 -179.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.4 -146.52 7.16 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.23 142.98 49.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.947 0.404 . . . . 0.0 110.397 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.401 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.3 ttt-85 -151.82 149.37 28.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.034 0.445 . . . . 0.0 110.28 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -101.22 -151.3 0.41 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.348 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 55.67 -92.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.712 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.444 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.0 tt -126.57 174.63 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.618 -179.469 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.444 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -121.69 140.96 44.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.476 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.28 170.33 8.73 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.307 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.1 mt -146.82 149.55 33.53 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.191 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.42 -39.3 97.58 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.22 3.06 4.0 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -78.29 -57.73 3.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.935 0.398 . . . . 0.0 110.463 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.63 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.4 m-20 -62.06 -37.06 83.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.297 -179.649 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.426 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.7 mp -52.71 -67.78 0.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.74 -42.46 68.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.133 -179.283 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.39 17.69 0.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.668 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.05 48.0 0.27 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.1 mp 39.06 -110.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.493 0.187 . . . . 0.0 110.696 -178.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.458 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 12.0 m120 -60.66 -44.58 96.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.42 -179.639 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.32 7.85 84.33 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.329 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -98.67 -13.41 20.31 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.763 -0.257 . . . . 0.0 110.69 -179.795 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.5 t 177.03 142.72 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.132 0.492 . . . . 0.0 110.382 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.432 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -147.71 125.46 11.88 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.288 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 191' ' ' VAL . 14.0 m-30 -98.61 143.7 28.71 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 120.927 0.394 . . . . 0.0 110.731 178.405 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.2 mt -95.12 106.33 18.33 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.773 -179.255 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.481 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.8 t80 -102.45 -12.26 17.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.112 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.53 -40.04 88.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.883 179.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.16 173.61 46.07 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.463 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 96.5 m-20 -74.43 -113.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 0.0 110.769 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.5 -29.16 68.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.693 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.9 -43.81 91.1 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.112 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.36 -44.68 94.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.271 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.46 -59.95 3.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.197 -179.792 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -51.02 -43.64 60.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.082 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.12 -43.75 74.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.156 -179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.8 mt -64.41 -43.65 97.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.579 179.568 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -56.63 -37.9 71.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.144 -179.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.5 1.03 17.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.179 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -115.17 91.24 26.83 Favored Pre-proline 0 N--CA 1.461 0.089 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.176 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.12 -26.93 27.6 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.748 2.299 . . . . 0.0 111.975 179.329 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.55 -40.82 98.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.577 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.9 mp -95.16 5.57 51.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.381 -179.022 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.03 -35.14 69.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.618 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.63 4.27 16.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.492 -178.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.68 120.69 77.39 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.575 179.953 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -47.27 -37.66 24.7 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.446 2.097 . . . . 0.0 112.6 -179.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.535 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.93 -43.63 91.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.43 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.83 -43.61 93.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.337 179.241 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.9 -40.58 95.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.396 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.8 -12.28 39.65 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.508 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.81 31.66 18.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.051 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.44 44.04 1.17 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.128 0.49 . . . . 0.0 110.308 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.8 136.13 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.563 -179.704 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.66 132.5 56.67 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.361 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.496 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.35 88.66 6.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.794 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.82 -41.51 97.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.697 179.533 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.481 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.5 165.13 34.28 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.789 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.7 p -75.53 -26.09 57.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.4 tp10 -68.67 -33.77 74.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.394 -179.699 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.777 HG22 ' O ' ' A' ' 296' ' ' THR . 98.1 m -72.47 22.19 0.06 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.215 0.531 . . . . 0.0 110.761 -179.351 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.513 ' H ' ' C ' ' A' ' 295' ' ' GLU . 49.1 t80 -57.86 -51.0 71.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.851 -179.253 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.9 mmt-85 -108.02 150.03 27.66 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.401 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.7 tp -116.46 127.31 54.47 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.77 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.464 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.6 t0 -150.99 167.82 26.45 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.675 179.631 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.4 ' CE2' ' CE ' ' A' ' 305' ' ' MET . 91.4 t80 -49.3 -38.09 26.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.622 -179.54 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.16 -65.63 0.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.588 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.64 -33.03 72.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.028 -179.479 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.17 -25.31 21.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.782 -179.125 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . 0.4 ' CE ' ' CE2' ' A' ' 301' ' ' TYR . 61.3 mtt -63.57 -41.09 98.4 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.933 0.397 . . . . 0.0 111.158 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.96 -43.88 23.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.181 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.567 HG21 HG23 ' A' ' 296' ' ' THR . 77.9 t -66.21 -42.86 91.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.405 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.2 tp -60.34 -46.76 88.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.48 -178.555 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -70.47 -39.47 74.22 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.098 0.475 . . . . 0.0 110.805 179.162 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.496 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 73.6 ttt180 -61.56 -37.53 84.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.292 -179.029 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.6 mt -87.99 4.18 45.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.642 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.64 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 86.9 tttt -112.2 -11.26 13.77 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.003 0.43 . . . . 0.0 110.396 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.17 86.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.406 179.761 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.82 -48.89 79.75 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.474 -179.703 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.005 179.877 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.61 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.06 -2.34 58.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.373 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.481 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.5 179.18 1.22 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.469 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.5 Cg_exo -60.8 145.38 99.06 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.729 2.286 . . . . 0.0 112.166 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.61 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 34.9 ptt-85 -156.29 -179.47 8.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.579 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -116.18 137.44 52.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.323 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.69 146.88 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.322 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.5 p -119.93 135.81 54.76 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.807 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.16 -143.65 0.32 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.19 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.45 -37.14 86.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.445 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.481 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.31 -66.51 0.22 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.484 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.62 142.35 45.68 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 p -112.06 131.4 55.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.89 0.376 . . . . 0.0 110.391 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -118.98 128.81 54.74 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.499 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.0 m -85.62 130.28 34.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.143 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.486 HD22 ' OE1' ' A' ' 42' ' ' GLN . 70.0 mt -96.25 78.76 3.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.317 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.54 -32.15 73.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.471 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.6 109.77 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.044 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.486 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -123.3 91.37 49.85 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.199 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.636 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.2 Cg_exo -57.07 148.92 65.88 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.738 2.292 . . . . 0.0 111.773 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.28 83.11 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.631 0.582 . . . . 0.0 111.047 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.636 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.64 67.09 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.129 0.49 . . . . 0.0 110.261 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.45 130.82 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.515 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.563 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.9 t -122.84 147.01 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.085 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.9 t -136.24 143.8 44.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.644 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.3 p -99.08 -59.25 1.76 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.53 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.1 p -79.3 155.27 28.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.695 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.524 HG21 HG23 ' A' ' 70' ' ' THR . 71.4 t -74.22 -21.85 17.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.62 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.8 m -60.37 -51.98 67.21 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.486 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.8 mt -66.29 -42.52 88.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.502 0.668 . . . . 0.0 110.951 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.0 m -43.44 -53.76 5.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.076 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.13 -37.36 72.53 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.6 m -62.77 -44.63 95.68 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.367 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.412 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.0 mt -65.98 -42.17 90.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.43 0.633 . . . . 0.0 110.69 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 tp -62.59 -40.13 95.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.467 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.505 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.29 -36.16 77.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.05 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 156' ' ' LEU . 32.0 pt -90.75 28.61 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.177 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.59 51.39 11.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.825 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.72 75.14 26.12 Favored Pre-proline 0 C--N 1.333 -0.15 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.97 151.24 86.12 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.718 2.278 . . . . 0.0 112.16 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.563 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.63 137.29 47.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.306 0.574 . . . . 0.0 110.23 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.437 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.1 pt -69.06 -43.69 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.373 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.481 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.2 130.94 53.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.987 0.423 . . . . 0.0 110.597 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.525 ' O ' ' O ' ' A' ' 97' ' ' ARG . 30.8 p -155.41 168.88 25.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.346 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.77 -177.33 21.7 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.632 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.44 172.57 12.53 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.857 0.36 . . . . 0.0 110.556 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.524 HG23 HG21 ' A' ' 51' ' ' VAL . 14.7 p -132.47 -113.0 0.23 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.348 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.03 179.98 0.9 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.211 -178.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.7 Cg_exo -60.89 57.93 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 123.027 2.485 . . . . 0.0 112.187 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.4 t-20 -64.28 -34.13 77.41 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 118.606 -0.712 . . . . 0.0 110.584 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 45.1 m-20 93.91 -36.21 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.617 1.198 . . . . 0.0 109.753 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.411 ' HD3' HD21 ' A' ' 73' ' ' ASN . 78.1 mtp85 -62.7 -39.9 95.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.224 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.17 -25.83 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.804 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.32 -171.18 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.649 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -73.94 -153.88 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.833 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.8 p-10 -52.74 -7.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.658 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.3 114.89 23.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.556 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.88 70.11 1.35 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -143.25 147.91 35.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.941 0.4 . . . . 0.0 110.819 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.76 -98.62 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.125 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.1 mtt-85 -63.88 -42.71 97.43 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.236 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.5 tt0 91.72 53.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.286 0.991 . . . . 0.0 110.917 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -103.4 -9.0 19.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.404 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.5 p -64.66 -34.0 77.26 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.167 0.508 . . . . 0.0 110.777 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.531 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.79 -24.57 1.47 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.56 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.25 -46.04 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.048 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.27 -48.43 81.47 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.98 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.73 -38.21 89.62 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.347 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.95 -32.08 52.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.218 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.576 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.4 mmt-85 -90.09 1.9 55.85 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.686 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.36 -49.43 0.2 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 124.412 1.07 . . . . 0.0 110.366 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.613 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 83.2 mt -46.48 154.73 0.27 Allowed 'General case' 0 CA--C 1.485 -1.549 0 CA-C-O 117.068 -1.444 . . . . 0.0 108.966 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.613 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 120.82 92.68 0.0 OUTLIER 'General case' 0 C--N 1.359 1.001 0 O-C-N 125.958 2.036 . . . . 0.0 110.527 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.525 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.6 143.47 42.31 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.227 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.8 mt -132.47 27.03 4.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.692 0.282 . . . . 0.0 110.436 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.48 138.18 34.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.027 0.441 . . . . 0.0 110.491 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.632 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.6 mt -137.15 164.91 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.385 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.611 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.25 -28.59 1.81 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -152.54 70.99 7.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.193 0.521 . . . . 0.0 110.287 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.04 145.42 98.43 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.711 2.274 . . . . 0.0 112.075 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.1 t -134.78 136.59 42.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.035 0.445 . . . . 0.0 110.507 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.29 -38.17 81.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.702 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.25 -42.09 96.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.57 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.27 -41.48 98.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.515 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 64.9 t -63.67 -43.56 98.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.947 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.25 78.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.336 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.34 -18.67 59.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.502 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.76 -6.42 58.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.52 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 75.8 mtp 47.74 55.83 17.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.599 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.9 Cg_endo -70.49 150.02 63.11 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.841 2.361 . . . . 0.0 112.044 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -101.4 -75.9 0.58 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.404 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.4 HD11 HD13 ' A' ' 140' ' ' LEU . 38.6 tp -108.38 113.7 26.98 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.218 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.0 mt -102.64 126.77 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.404 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.5 mt -109.73 133.68 52.86 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.084 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.28 139.08 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.496 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.5 p -83.17 168.33 16.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.68 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -37.46 80.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.454 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -140.06 158.89 43.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.43 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.18 177.36 33.26 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.16 -33.82 87.11 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.61 151.84 44.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.874 0.369 . . . . 0.0 110.588 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.1 t -63.03 141.06 58.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.288 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.04 9.85 11.3 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.697 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.9 mp -61.22 -39.18 89.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.056 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.629 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.76 -36.01 23.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.647 0.737 . . . . 0.0 110.704 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -70.59 -35.61 73.1 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.488 0.661 . . . . 0.0 110.828 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -42.85 -63.03 0.86 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.332 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.629 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.89 -42.62 90.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.97 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.11 -33.18 73.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.083 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.2 mt -72.86 -40.74 65.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.24 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.51 -48.61 80.24 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.139 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 m -53.29 -42.25 66.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.105 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.78 -42.93 93.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.998 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.55 156.38 5.23 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.581 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -39.63 107.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.581 2.188 . . . . 0.0 112.347 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.642 ' C ' HD12 ' A' ' 140' ' ' LEU . 89.8 m -110.11 120.81 43.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.234 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.642 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.45 152.67 31.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.125 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -129.39 131.44 67.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.38 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.9 mt -115.17 128.12 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.384 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.2 t30 -101.6 103.61 14.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.262 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.5 p90 -100.96 -11.36 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.774 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.4 p-10 -64.79 -33.81 76.86 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.705 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.6 p-10 -98.08 7.8 45.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.63 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.7 155.41 50.44 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.543 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.404 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -74.93 165.68 24.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.668 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.598 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.84 -48.75 80.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.185 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -53.7 -41.96 67.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.918 0.39 . . . . 0.0 110.012 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.6 t -62.58 -41.14 98.76 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.391 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.406 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.8 tp -60.64 -44.13 96.75 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.315 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.7 tp -61.5 -43.42 98.9 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.226 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -54.99 -44.79 74.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.659 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.42 -40.68 97.35 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.893 0.377 . . . . 0.0 110.355 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.2 -42.35 99.21 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.387 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.05 -41.02 95.36 Favored Glycine 0 C--N 1.315 -0.587 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.42 -46.13 64.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.949 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.6 -44.05 96.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.816 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.4 p -93.02 -8.74 42.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.595 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.93 26.63 72.32 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -101.99 50.96 0.83 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.814 0.34 . . . . 0.0 110.721 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -69.67 -39.46 76.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.751 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.58 -47.08 86.98 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.268 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -60.02 -39.24 85.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.332 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.13 -40.87 98.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.277 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.91 -28.69 70.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.07 0.462 . . . . 0.0 110.571 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.03 -54.24 8.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.221 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.505 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.51 -42.1 92.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.439 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.9 mt -62.35 -43.78 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.434 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.72 -57.53 10.64 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.082 0.468 . . . . 0.0 110.509 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.89 -34.05 69.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.342 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.4 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.4 t80 -80.76 -37.15 30.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.075 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.5 m-20 -55.56 -41.45 73.31 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.245 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.75 -42.23 99.58 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.727 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.3 -37.83 88.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.227 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.4 HD11 ' CD2' ' A' ' 173' ' ' PHE . 82.6 mt -62.5 -42.24 99.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.737 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.04 -52.59 63.35 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.096 0.474 . . . . 0.0 110.7 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.37 -41.75 88.99 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.592 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.92 95.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.623 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.23 -32.43 73.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.381 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.09 -22.38 18.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.762 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.629 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.0 tt0 -64.85 -41.01 96.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.64 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.6 pt -77.16 136.6 24.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.623 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -127.15 108.22 10.71 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.218 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.08 126.0 0.34 Allowed Pre-proline 0 N--CA 1.446 -0.669 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.588 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.7 Cg_exo -44.04 152.61 0.37 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.664 2.242 . . . . 0.0 112.606 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.19 141.88 53.76 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.59 2.193 . . . . 0.0 112.456 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.547 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.16 147.2 2.19 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.648 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.46 155.23 67.5 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.745 2.297 . . . . 0.0 112.299 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.576 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.63 163.12 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.362 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.576 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.58 170.16 16.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.912 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.86 137.42 22.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.208 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.565 HG22 HD12 ' A' ' 205' ' ' LEU . 37.7 pt -134.26 146.51 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.603 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.92 131.98 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.305 0.574 . . . . 0.0 110.57 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -152.85 156.43 38.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.379 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.0 m -122.08 122.92 40.36 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.934 0.397 . . . . 0.0 110.329 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.486 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.78 -26.55 67.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.534 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.597 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.12 -50.02 21.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.079 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -75.75 -13.46 60.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.506 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.486 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 78.1 m80 49.94 46.21 24.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.529 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.6 t -131.14 144.86 51.7 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.317 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.428 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -109.4 106.08 15.71 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.204 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -116.46 129.69 56.35 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.14 0.495 . . . . 0.0 110.307 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.565 HD12 HG22 ' A' ' 194' ' ' ILE . 7.7 tt -112.36 146.19 38.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.719 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.466 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.9 t90 -99.34 128.68 45.48 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.141 0.496 . . . . 0.0 109.959 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.82 154.08 39.91 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.107 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.6 Cg_endo -67.71 -17.97 47.79 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.736 2.291 . . . . 0.0 111.897 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.43 -18.92 0.45 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.402 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.441 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.1 p -75.5 164.57 26.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.488 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.9 -27.89 65.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.532 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.61 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.8 mt-30 -63.76 -41.19 98.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.64 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.44 -44.28 97.82 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.55 -38.94 92.74 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 120.989 0.423 . . . . 0.0 110.461 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.28 -41.26 98.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.062 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 71.7 mt -63.6 -47.06 82.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.635 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.34 -31.75 55.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.91 -18.25 62.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.526 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.429 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.0 mt -88.11 -8.75 54.99 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.651 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.64 2.1 55.34 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -88.46 153.29 21.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.755 0.312 . . . . 0.0 110.436 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.462 ' O ' HG12 ' A' ' 191' ' ' VAL . 10.3 p -116.05 128.63 55.85 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.078 0.466 . . . . 0.0 110.384 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.33 146.33 23.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.901 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.456 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.24 151.36 45.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.432 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.37 131.88 42.32 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.394 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.877 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.3 93.71 27.73 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.002 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.678 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.1 Cg_exo -55.63 138.78 81.9 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.574 2.182 . . . . 0.0 111.435 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.56 -25.61 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.551 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.63 -49.89 28.03 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.9 mt -55.23 -37.16 66.8 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -65.54 35.65 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.909 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.569 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.47 88.32 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.773 0.32 . . . . 0.0 110.852 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.2 p -81.44 -13.4 58.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.377 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.86 -40.76 11.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.604 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.0 t -66.64 -17.02 64.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.644 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.01 44.0 26.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.485 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.29 -148.21 8.05 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.68 142.5 48.42 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.888 0.375 . . . . 0.0 110.352 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.422 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.3 ttt-85 -152.11 149.55 28.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.334 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -102.43 -150.12 0.4 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.26 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 55.48 -92.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.575 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.425 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.3 tt -127.2 174.13 11.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.498 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.425 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 88.2 mt -121.57 140.84 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.798 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.36 170.53 8.57 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.4 mt -146.88 149.53 33.44 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.253 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.19 -39.32 97.78 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.09 2.96 4.08 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -78.48 -57.32 3.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 110.621 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.618 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.2 m-20 -62.19 -36.81 83.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.084 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.428 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.8 mp -53.31 -67.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.05 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.482 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.84 -42.55 68.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.13 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.67 17.72 0.15 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.659 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.99 47.85 0.26 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 254' ' ' LEU . 7.8 mp 39.53 -110.17 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.601 0.238 . . . . 0.0 110.637 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.456 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -61.2 -44.15 97.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.326 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.15 8.14 84.19 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.86 -13.34 20.11 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.774 -0.251 . . . . 0.0 110.69 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.9 t 176.89 142.74 0.08 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.174 0.511 . . . . 0.0 110.51 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.3 tt -147.96 125.72 11.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.1 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.6 m-30 -98.92 143.42 29.24 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 120.917 0.389 . . . . 0.0 110.785 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.4 mt -94.7 106.26 18.23 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.55 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.436 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.0 t80 -101.98 -11.82 18.65 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.122 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.5 86.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.923 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.46 172.99 45.8 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.451 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.7 m-20 -73.9 -112.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.771 0.32 . . . . 0.0 110.701 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.05 -28.72 67.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.766 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.24 -43.59 92.4 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.159 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.48 -44.26 94.91 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.406 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.78 -59.77 4.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.158 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.29 -43.32 61.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.166 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.26 -43.42 74.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.163 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 93.2 mt -64.48 -43.63 96.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.651 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -56.43 -37.43 70.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.138 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.64 0.63 19.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.266 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -114.85 91.35 25.8 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.196 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.28 -27.22 29.78 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.773 2.315 . . . . 0.0 111.729 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.536 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.4 -41.2 98.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.585 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.25 5.12 52.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.291 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.79 -35.18 69.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.722 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -79.65 4.63 15.47 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.472 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.526 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.61 121.46 81.04 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.639 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -47.65 -37.48 27.3 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.349 2.032 . . . . 0.0 112.586 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -59.1 -43.71 91.89 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 63.0 t -65.87 -43.85 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.92 0.391 . . . . 0.0 110.287 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.68 -40.53 95.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.53 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.445 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 48.0 t-20 -89.84 -12.69 38.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.515 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 61.99 32.55 17.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.88 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.14 43.94 1.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.359 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.38 135.59 41.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.42 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.68 132.14 56.77 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.492 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.507 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.68 88.01 7.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.71 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.07 -40.64 96.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.96 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.436 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.33 167.99 34.93 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.51 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 75.7 p -75.93 -25.67 56.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 110.716 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.1 tp10 -67.45 -34.86 78.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.352 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.761 HG22 ' O ' ' A' ' 296' ' ' THR . 95.4 m -73.36 25.12 0.07 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.671 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.61 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 59.4 t80 -58.34 -51.15 71.03 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.431 HH12 ' HG3' ' A' ' 212' ' ' GLN . 68.6 mmt-85 -111.79 154.84 24.47 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.429 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.1 tp -115.92 125.2 52.27 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.484 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.6 t0 -147.79 165.67 29.85 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.585 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -48.99 -38.26 22.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.597 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -71.79 -65.17 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.458 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.6 p -60.84 -32.86 72.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.126 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.75 -25.19 26.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.585 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.8 mtt -63.54 -40.99 98.44 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 120.91 0.386 . . . . 0.0 111.01 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -79.03 -44.01 23.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.977 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.568 HG21 HG23 ' A' ' 296' ' ' THR . 77.5 t -65.94 -43.24 92.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.417 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.43 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 54.5 tp -60.66 -46.94 88.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.622 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -69.51 -39.62 77.47 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.466 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.507 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.0 ttt180 -61.94 -38.36 88.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.146 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.1 mt -86.82 4.09 42.54 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.834 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.629 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.3 tttt -112.71 -11.45 13.52 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.174 0.512 . . . . 0.0 110.29 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.04 85.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.624 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.02 -48.64 80.88 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.331 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.868 -1.063 . . . . 0.0 109.992 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.61 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.36 -2.63 57.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.383 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.476 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.09 179.03 1.26 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.452 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.9 Cg_exo -60.85 145.46 98.97 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.558 2.172 . . . . 0.0 112.171 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.61 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.29 -179.76 8.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.624 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.14 137.0 52.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.372 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -124.23 146.67 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.314 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -119.76 135.61 54.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.759 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.15 -143.98 0.32 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.143 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.21 -37.35 86.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.533 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.89 -66.99 0.23 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.532 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.47 142.56 45.14 Favored Glycine 0 C--O 1.224 -0.48 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.0 p -112.28 131.26 55.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.922 0.392 . . . . 0.0 110.26 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -118.7 128.86 54.9 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.545 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.1 m -85.44 130.43 34.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.198 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.487 HD22 ' OE1' ' A' ' 42' ' ' GLN . 71.1 mt -96.49 78.81 3.02 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.16 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.6 -32.06 73.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.501 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.75 108.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.024 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.487 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -122.11 90.79 48.98 Favored Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.245 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.636 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.0 Cg_exo -56.96 148.6 66.93 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.708 2.272 . . . . 0.0 111.652 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.13 82.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.574 0.546 . . . . 0.0 111.056 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.636 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.76 67.16 0.87 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.302 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.05 131.14 35.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.461 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.572 ' HA ' HG23 ' A' ' 64' ' ' VAL . 58.3 t -122.78 147.38 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.154 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.3 t -136.18 143.94 44.7 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.556 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 50' ' ' SER . 17.2 p -99.45 -59.39 1.73 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.492 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.42 ' N ' ' OG1' ' A' ' 49' ' ' THR . 86.6 p -79.4 155.06 28.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.93 0.395 . . . . 0.0 110.671 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.546 HG21 HG23 ' A' ' 70' ' ' THR . 68.9 t -73.47 -21.9 18.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.598 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.6 m -60.52 -51.74 68.13 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.384 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.9 mt -66.13 -42.62 88.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.496 0.665 . . . . 0.0 110.911 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.1 m -43.86 -54.16 5.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.996 -178.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.63 -37.11 77.01 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.0 m -63.2 -44.36 95.57 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.217 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.3 mt -65.73 -42.25 91.27 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.274 0.559 . . . . 0.0 110.544 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.93 -39.68 95.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.431 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.513 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.73 -36.2 78.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.078 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.511 HD11 HD12 ' A' ' 156' ' ' LEU . 33.5 pt -90.62 27.31 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.251 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 57.12 51.27 10.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.835 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -139.23 76.08 32.79 Favored Pre-proline 0 C--O 1.227 -0.081 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.66 149.42 90.93 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.634 2.223 . . . . 0.0 112.089 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -112.41 136.3 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.302 0.572 . . . . 0.0 110.161 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.431 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -68.97 -43.75 81.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.448 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.15 130.51 52.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.114 0.483 . . . . 0.0 110.613 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.6 p -155.28 168.83 25.78 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.305 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.6 -177.38 21.8 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.645 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.37 172.51 12.6 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.776 0.322 . . . . 0.0 110.601 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.546 HG23 HG21 ' A' ' 51' ' ' VAL . 12.9 p -133.81 -110.92 0.22 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.532 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.22 179.78 0.91 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.149 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.7 Cg_exo -60.91 58.88 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.892 2.395 . . . . 0.0 112.139 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.539 ' N ' ' O ' ' A' ' 71' ' ' THR . 57.7 t-20 -64.07 -34.44 78.03 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.693 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.5 m-20 94.34 -36.73 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 125.018 1.449 . . . . 0.0 109.778 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -63.06 -40.53 97.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.083 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -73.7 -26.56 21.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.933 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.68 -172.37 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.64 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.44 -152.91 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.809 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.3 p-10 -54.74 -6.54 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.684 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.486 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -87.37 114.11 23.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.956 0.408 . . . . 0.0 110.487 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.67 71.67 1.31 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -143.02 148.7 37.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.795 0.331 . . . . 0.0 110.968 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -86.5 -99.06 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.91 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.61 -43.55 96.55 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 119.027 -0.511 . . . . 0.0 110.141 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.529 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.8 tt0 91.77 52.37 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 124.487 1.117 . . . . 0.0 111.156 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -103.48 -8.58 20.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.449 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.5 p -65.29 -33.39 75.86 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.323 0.582 . . . . 0.0 110.819 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.529 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.1 mttt -48.86 -23.88 1.25 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.531 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.6 t -69.88 -45.78 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.299 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.49 -48.27 81.84 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.065 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.58 -38.5 90.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.303 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.84 -33.2 55.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.177 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.566 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.3 mmt-85 -88.88 1.86 54.68 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.619 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.43 -49.42 0.19 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.616 1.197 . . . . 0.0 110.347 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.598 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.8 mt -46.48 154.14 0.31 Allowed 'General case' 0 CA--C 1.485 -1.551 0 CA-C-O 117.082 -1.437 . . . . 0.0 108.67 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.598 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.1 91.89 0.0 OUTLIER 'General case' 0 C--N 1.363 1.16 0 O-C-N 125.944 2.028 . . . . 0.0 110.677 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.531 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.85 143.14 44.02 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.046 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.6 mt -132.15 26.47 4.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.492 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.03 137.6 34.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.942 0.401 . . . . 0.0 110.579 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.645 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.6 mt -136.82 164.63 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.383 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.606 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.88 -28.82 1.72 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -151.95 70.65 7.87 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.038 0.447 . . . . 0.0 110.26 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.14 145.41 98.54 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.686 2.257 . . . . 0.0 112.059 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.4 t -135.01 137.09 42.66 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.467 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.99 -38.1 82.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.701 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.44 -41.92 96.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.629 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.25 -41.38 98.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.386 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.75 -43.57 98.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.745 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.1 77.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.326 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.52 -18.85 60.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.489 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.63 -6.56 58.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.47 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.1 mtp 47.77 55.76 17.08 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.686 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.3 Cg_endo -70.0 149.56 65.51 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.927 2.418 . . . . 0.0 112.016 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.38 -72.81 0.67 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.42 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.418 HD11 HD13 ' A' ' 140' ' ' LEU . 38.2 tp -111.76 114.22 27.08 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.8 mt -103.16 126.87 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.344 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 mt -110.22 134.27 52.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.951 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.57 139.09 48.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.612 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.4 p -82.77 167.94 17.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.839 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.51 -37.27 80.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.38 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.91 158.6 43.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.457 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.45 177.12 33.6 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.15 -33.76 86.89 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.74 151.7 44.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.898 0.38 . . . . 0.0 110.58 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.4 t -63.48 141.14 58.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.284 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.51 10.44 11.13 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.654 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.513 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.7 mp -61.1 -39.48 90.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.994 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.63 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.44 -36.12 24.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.662 0.744 . . . . 0.0 110.681 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.8 mt -70.52 -35.61 73.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.83 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -43.04 -62.81 0.93 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.485 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.63 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.86 -42.63 90.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.932 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -62.09 -33.34 74.25 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.019 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.0 mt -72.57 -40.96 66.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.49 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.78 -48.27 81.83 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.131 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 65.7 m -53.61 -42.32 67.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.93 -43.12 92.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.889 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.42 153.39 5.25 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.591 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -39.05 107.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.519 2.146 . . . . 0.0 112.152 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.635 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.9 m -109.52 121.58 45.5 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.258 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 139' ' ' THR . 10.9 mp -113.85 152.58 30.51 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.182 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.34 131.03 69.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.287 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.28 128.02 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.441 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.0 t30 -100.7 104.75 16.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.221 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.419 ' O ' ' O ' ' A' ' 147' ' ' LYS . 45.7 p90 -100.77 -11.74 19.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.919 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.1 p-10 -64.79 -33.93 77.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.848 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -99.52 7.45 45.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.758 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.9 mttm -134.71 152.04 51.46 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.856 0.36 . . . . 0.0 110.637 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.424 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -75.75 166.31 23.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.658 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.594 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.5 t90 -59.32 -48.11 82.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.244 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -54.26 -43.88 71.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.897 0.38 . . . . 0.0 110.061 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.8 t -62.97 -41.06 99.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.126 0.489 . . . . 0.0 110.343 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.0 -43.92 98.17 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.008 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 53.3 tp -61.58 -42.97 99.63 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.14 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.5 m -55.29 -45.34 76.2 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.12 -40.71 96.83 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.181 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.511 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.31 -42.54 99.45 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.341 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.54 -40.73 94.3 Favored Glycine 0 C--N 1.315 -0.62 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.24 -46.16 65.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.982 0.42 . . . . 0.0 111.016 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.73 -43.98 96.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.942 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.8 p -92.89 -9.29 40.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.575 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.28 26.06 72.52 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -101.93 50.91 0.83 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.811 0.339 . . . . 0.0 110.809 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.51 -39.22 77.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.717 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.7 -46.87 87.76 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.414 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -60.03 -39.17 84.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.156 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.46 97.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.149 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.17 -29.15 70.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.149 0.499 . . . . 0.0 110.565 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -73.48 -54.44 8.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.149 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.513 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.6 ttp180 -64.86 -42.01 95.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.443 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 174' ' ' ASP . 81.0 mt -62.27 -43.84 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.527 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.34 -58.23 8.43 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.096 0.474 . . . . 0.0 110.738 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.08 -33.99 67.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.217 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -80.54 -36.3 33.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.123 0.487 . . . . 0.0 111.098 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.1 m-20 -55.34 -41.98 73.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.137 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.25 -41.98 98.92 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.785 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -64.88 -38.24 90.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.31 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.8 mt -62.49 -42.35 99.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.646 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.83 -53.23 58.74 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.729 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.3 -41.9 89.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.575 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.75 -40.0 95.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.616 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.3 -32.64 74.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.44 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.32 -21.89 18.71 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.843 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.636 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.2 tt0 -64.5 -41.68 96.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.757 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 184' ' ' ILE . 31.9 pt -76.07 134.82 28.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.22 106.91 9.56 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.4 pp -176.5 127.88 0.34 Allowed Pre-proline 0 N--CA 1.446 -0.637 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.527 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.2 Cg_exo -43.53 151.79 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.599 2.199 . . . . 0.0 112.594 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.41 142.21 53.69 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.655 2.237 . . . . 0.0 112.385 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.54 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -170.93 146.99 2.24 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.648 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.04 154.76 70.05 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.646 2.231 . . . . 0.0 112.153 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.577 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.59 162.93 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.416 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.577 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.45 169.93 16.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.919 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.88 137.37 22.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.154 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.535 HG22 HD12 ' A' ' 205' ' ' LEU . 39.5 pt -134.16 146.39 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.707 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.25 131.63 58.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.185 0.517 . . . . 0.0 110.49 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -151.65 154.62 36.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.32 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.608 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.7 m -121.75 122.64 39.97 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.014 0.435 . . . . 0.0 110.179 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.57 -25.73 66.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.463 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.608 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.11 -49.1 20.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.088 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.75 -9.05 58.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.38 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.0 m80 46.13 43.68 11.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.505 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.4 t -136.55 145.22 44.76 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.413 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.29 113.75 26.46 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.231 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.95 133.7 55.48 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.112 0.482 . . . . 0.0 110.304 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.535 HD12 HG22 ' A' ' 194' ' ' ILE . 7.6 tt -112.53 146.24 38.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.781 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.466 ' N ' HD23 ' A' ' 205' ' ' LEU . 13.6 t90 -99.3 128.19 45.39 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.38 153.36 40.47 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.174 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.51 -18.41 48.99 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.924 2.416 . . . . 0.0 111.829 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.07 -18.86 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.369 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.447 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.0 p -75.26 168.17 20.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.485 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.45 -35.77 76.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.419 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.496 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.3 mt-30 -56.62 -40.7 75.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.743 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.92 -43.3 98.2 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.4 mt-30 -63.98 -40.65 96.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.944 0.402 . . . . 0.0 110.373 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.594 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.1 mmm -61.74 -41.79 98.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.195 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 69.9 mt -63.33 -48.34 78.41 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.843 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -54.4 -32.07 56.39 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -70.63 -18.81 62.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.621 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.421 HD11 ' CD2' ' A' ' 299' ' ' LEU . 95.1 mt -87.96 -7.8 56.59 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.749 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.14 2.86 55.86 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -88.32 152.06 22.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.0 110.558 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.445 ' O ' HG12 ' A' ' 191' ' ' VAL . 6.6 p -114.73 127.81 55.95 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.099 0.476 . . . . 0.0 110.387 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.24 145.67 24.31 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.901 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.476 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.64 150.55 46.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.453 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.32 131.71 43.96 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.318 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.879 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.69 92.77 25.63 Favored Pre-proline 0 N--CA 1.464 0.275 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.049 -179.445 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.673 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.8 Cg_exo -55.58 139.4 82.67 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.534 2.156 . . . . 0.0 111.392 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.71 -25.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.588 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.11 -49.04 29.06 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.6 mt -55.16 -37.01 66.45 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -66.38 35.89 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.837 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.556 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.56 87.71 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.794 0.33 . . . . 0.0 110.778 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.4 p -81.53 -14.9 56.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.449 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -90.94 -41.33 11.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.612 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.81 -16.79 64.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.696 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 56.01 43.4 27.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.439 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.37 -147.7 7.4 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.58 142.94 50.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.969 0.414 . . . . 0.0 110.233 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.3 149.61 28.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.312 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -100.65 -152.0 0.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.255 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 56.31 -91.74 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.722 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.469 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.91 175.14 9.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.648 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.469 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.6 mt -121.44 140.79 44.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.816 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.16 168.59 9.96 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.303 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.0 mt -147.22 150.97 35.91 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.464 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.7 -39.0 97.05 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.11 4.3 4.61 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.51 -57.95 3.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.933 0.397 . . . . 0.0 110.594 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.551 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.8 m-20 -62.39 -37.18 84.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.109 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.0 -67.36 0.26 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.918 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -54.06 -41.77 68.52 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.06 18.12 0.15 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.684 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.98 47.72 0.26 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 39.07 -109.82 0.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.696 0.284 . . . . 0.0 110.664 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.9 m120 -61.21 -44.26 97.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.372 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 83.98 8.18 84.43 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -99.29 -12.58 20.22 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.739 -0.271 . . . . 0.0 110.671 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.8 t 176.48 142.31 0.07 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.097 0.475 . . . . 0.0 110.488 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.412 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.3 tt -147.79 126.16 12.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.201 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -99.25 142.95 30.08 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.035 0.445 . . . . 0.0 110.621 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.63 106.54 18.52 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.433 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.474 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 93.2 t80 -102.23 -12.55 17.92 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.007 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.4 90.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.813 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.29 173.8 46.18 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.452 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -74.59 -112.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.691 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.57 -28.45 67.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.753 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -59.81 -43.86 94.28 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.913 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -63.72 -44.1 94.6 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.318 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.69 -59.38 4.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.181 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.81 -43.1 62.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.054 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.51 -43.94 76.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.129 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.9 mt -64.05 -43.55 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.962 0.411 . . . . 0.0 110.707 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -57.1 -37.67 72.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.067 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.14 0.8 20.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.278 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -114.73 91.14 24.47 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.248 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.83 -27.35 27.02 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.824 2.35 . . . . 0.0 111.619 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -41.26 98.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.637 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.8 mp -95.18 4.8 53.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.314 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.49 -35.61 70.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.711 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.37 4.56 14.98 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.436 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.71 121.54 81.52 Favored Pre-proline 0 N--CA 1.438 -1.033 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.581 -179.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.56 -37.71 27.03 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.242 1.961 . . . . 0.0 112.542 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.91 -43.8 91.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.59 -43.77 93.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.351 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.67 -40.65 95.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.534 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.0 t-20 -89.59 -12.4 39.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.647 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 61.92 31.97 18.0 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.78 44.38 1.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.329 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.77 135.47 43.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.455 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -116.2 132.58 56.62 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.468 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.495 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.9 87.92 6.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.775 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.423 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.1 mt -63.68 -41.74 98.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.817 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.474 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.47 166.45 34.66 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.1 p -75.59 -26.07 57.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.879 0.371 . . . . 0.0 110.823 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.2 tp10 -68.04 -34.25 76.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.444 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.757 HG22 ' O ' ' A' ' 296' ' ' THR . 98.0 m -72.47 20.59 0.07 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.688 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.501 ' H ' ' C ' ' A' ' 295' ' ' GLU . 49.0 t80 -57.54 -51.12 70.77 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.951 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.1 mmt-85 -107.43 149.26 28.11 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.421 ' CD2' HD11 ' A' ' 219' ' ' LEU . 41.0 tp -115.91 126.23 53.63 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 123.411 0.444 . . . . 0.0 110.888 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.473 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.0 t0 -149.55 166.91 27.81 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.554 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.57 -37.99 29.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.435 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -71.71 -64.99 0.82 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.604 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.8 p -60.96 -32.66 72.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.973 0.416 . . . . 0.0 111.183 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.93 -25.37 28.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.6 mtt -63.61 -41.21 98.33 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 120.984 0.421 . . . . 0.0 110.999 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -77.92 -44.42 27.03 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.052 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.576 HG21 HG23 ' A' ' 296' ' ' THR . 78.8 t -65.85 -43.1 93.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.409 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.429 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.7 tp -60.36 -46.63 89.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.317 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -70.51 -39.22 74.22 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.559 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.495 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 73.4 ttt180 -61.42 -38.26 86.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.219 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.35 4.27 43.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.833 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.636 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.0 tttt -111.65 -11.84 13.96 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.136 0.493 . . . . 0.0 110.323 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.24 -37.25 84.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.68 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -61.15 -48.34 82.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.358 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.023 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.23 -2.71 58.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.395 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.481 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.67 178.91 1.29 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.468 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.9 Cg_exo -60.84 144.84 99.63 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.749 2.299 . . . . 0.0 112.204 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.4 ptt-85 -155.76 -179.48 8.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.57 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.74 136.5 53.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.34 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.35 147.32 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.452 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.2 p -120.5 136.01 54.9 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.7 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.1 p30 -98.97 -143.7 0.32 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.254 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.62 -37.27 86.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.509 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.53 -67.43 0.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.527 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.0 142.66 43.98 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.1 p -112.42 131.17 55.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.924 0.392 . . . . 0.0 110.397 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -118.99 129.31 55.08 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.547 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 m -86.16 131.24 34.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.982 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.48 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.3 mt -96.51 78.96 3.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.421 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.83 -32.67 74.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.491 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 t 176.78 110.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.103 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.48 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -123.79 91.11 50.04 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.228 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.3 Cg_exo -56.91 149.11 63.25 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.697 2.265 . . . . 0.0 111.765 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.22 81.99 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.602 0.564 . . . . 0.0 110.986 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.39 66.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.092 0.473 . . . . 0.0 110.236 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.2 mt -77.36 131.17 35.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.573 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.558 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.0 t -122.6 148.07 26.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.17 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 t -136.62 143.62 43.63 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.607 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.9 p -99.3 -59.31 1.75 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.557 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.3 p -79.52 156.37 27.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.63 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.558 HG21 HG23 ' A' ' 70' ' ' THR . 73.5 t -74.88 -21.51 16.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.636 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.7 m -60.2 -51.88 67.68 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.455 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.7 mt -66.46 -42.3 87.79 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.36 0.6 . . . . 0.0 110.906 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.22 -54.41 4.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.145 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.0 -38.78 74.45 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 m -62.38 -43.6 98.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.884 0.373 . . . . 0.0 110.357 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.1 mt -65.28 -42.65 92.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.403 0.621 . . . . 0.0 110.719 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 tp -63.07 -38.65 92.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.221 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.447 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -61.64 -36.52 81.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.948 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -91.58 27.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.027 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.419 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 98.6 m-20 57.22 52.45 8.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.253 0.345 . . . . 0.0 110.789 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.72 75.39 31.31 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.049 0.452 . . . . 0.0 109.989 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.96 148.49 93.42 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.735 2.29 . . . . 0.0 112.177 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -112.75 135.97 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.195 0.521 . . . . 0.0 110.275 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.85 -43.3 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.192 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.68 130.85 53.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 110.55 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.9 p -155.14 168.42 27.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.461 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.37 -177.71 21.94 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.653 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.46 172.46 12.68 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.878 0.371 . . . . 0.0 110.541 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.558 HG23 HG21 ' A' ' 51' ' ' VAL . 14.1 p -132.9 -112.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.269 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.31 179.91 0.9 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.274 -178.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.7 Cg_exo -61.16 57.87 0.1 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.015 2.476 . . . . 0.0 112.126 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.8 t-20 -64.36 -33.41 75.79 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.878 -0.582 . . . . 0.0 110.571 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 43.9 m-20 93.71 -35.5 0.02 OUTLIER 'General case' 0 C--N 1.345 0.383 0 O-C-N 124.322 1.014 . . . . 0.0 109.948 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.5 mtp85 -63.27 -39.97 96.09 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.283 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -74.31 -25.43 19.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.7 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.16 -170.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.65 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.66 -155.24 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.828 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.8 p-10 -51.57 -7.95 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.641 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.497 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -85.42 115.23 23.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.564 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.23 70.71 1.33 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -144.64 148.55 34.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 110.69 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.8 mp -86.29 -98.63 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.266 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.8 -42.97 97.59 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.179 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.555 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.7 tt0 91.88 52.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 124.136 0.898 . . . . 0.0 110.784 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -102.41 -8.92 20.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.446 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.9 p -64.78 -34.25 77.89 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.131 0.491 . . . . 0.0 110.648 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.555 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.57 -24.62 1.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.6 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 81.9 t -69.29 -45.55 78.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.925 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.31 81.76 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.155 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.33 -38.22 88.63 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.276 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.51 -33.87 56.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.292 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.591 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.2 mmt-85 -88.76 0.99 55.97 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.67 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 57.2 mttp 83.02 -47.61 0.14 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 124.25 0.968 . . . . 0.0 110.316 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.5 mt -47.2 153.18 0.5 Allowed 'General case' 0 CA--C 1.49 -1.359 0 CA-C-O 117.604 -1.189 . . . . 0.0 109.124 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.644 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 122.31 91.72 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 O-C-N 125.54 1.775 . . . . 0.0 110.469 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -74.81 142.59 44.21 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.963 0.411 . . . . 0.0 110.299 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 mt -131.65 26.41 4.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.741 0.305 . . . . 0.0 110.464 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.06 137.29 34.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.946 0.403 . . . . 0.0 110.479 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.653 HD12 ' O ' ' A' ' 69' ' ' ALA . 90.7 mt -137.17 164.94 28.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.354 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.613 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.21 -28.73 1.82 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.03 70.6 7.79 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.25 0.548 . . . . 0.0 110.348 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.97 145.25 98.8 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.808 2.339 . . . . 0.0 112.041 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.8 t -134.85 137.11 42.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.541 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.89 -38.44 83.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.665 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.28 -42.21 96.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.501 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.6 98.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.526 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.54 -43.36 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.037 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.07 -35.17 77.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.376 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.31 -18.74 60.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.495 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.6 -6.46 58.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.561 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.5 mtp 47.87 55.74 17.11 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.627 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.14 149.35 64.34 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.791 2.327 . . . . 0.0 112.121 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.41 -72.76 0.67 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.481 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.6 tp -111.33 113.15 25.41 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.367 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.8 mt -102.19 126.56 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.451 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.6 mt -110.57 134.0 52.79 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.173 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.55 140.22 45.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.446 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 94.8 p -83.61 167.2 17.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.665 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.58 -36.66 79.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.472 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 t -138.24 157.71 45.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.471 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.36 174.63 34.16 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.29 -33.98 87.77 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -123.57 150.98 43.41 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.92 0.391 . . . . 0.0 110.562 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.6 t -63.57 140.16 58.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.291 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.94 11.44 11.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.631 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.1 -39.25 89.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.098 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.627 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.82 -35.53 24.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.564 0.697 . . . . 0.0 110.705 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -71.11 -35.04 71.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.408 0.623 . . . . 0.0 110.787 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -43.07 -63.19 0.85 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.171 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.627 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.1 p-10 -65.89 -42.81 89.79 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.535 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -61.78 -32.6 72.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.114 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 129' ' ' LEU . 67.6 mt -73.83 -40.3 63.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.187 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.29 -49.31 77.59 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.195 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.5 m -52.62 -42.66 64.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.313 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.08 -42.97 92.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.993 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.31 152.61 5.03 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.623 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -38.58 107.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.677 2.252 . . . . 0.0 112.317 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.646 ' C ' HD12 ' A' ' 140' ' ' LEU . 94.2 m -109.35 120.95 44.08 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.293 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.646 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.54 153.64 29.69 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.225 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.456 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -130.49 128.93 64.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.376 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.1 mt -110.42 122.84 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.574 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.538 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 53.8 t30 -101.11 106.35 17.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.349 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -100.17 0.45 40.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.897 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -65.52 -34.93 79.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.585 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.0 p-10 -101.29 9.5 41.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -133.85 148.08 51.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.537 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.409 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 22.5 p -77.69 169.05 18.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.579 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.598 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.6 t90 -58.71 -49.74 76.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.087 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -54.41 -46.15 73.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.011 0.434 . . . . 0.0 110.144 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.9 t -63.24 -40.79 98.43 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.345 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.452 ' O ' HD23 ' A' ' 156' ' ' LEU . 51.4 tp -60.83 -44.37 97.03 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.367 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.2 -43.49 98.79 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.202 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -54.21 -45.8 72.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.772 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.8 -39.92 93.41 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.854 0.359 . . . . 0.0 110.268 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 152' ' ' LEU . 2.2 mm? -61.9 -42.25 98.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.059 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.8 -38.87 94.81 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.21 -45.75 65.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.963 0.411 . . . . 0.0 110.798 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.72 -44.15 96.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.715 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -92.86 -9.28 40.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.53 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.0 26.51 72.35 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -102.31 50.11 0.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.831 0.348 . . . . 0.0 110.704 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.21 -39.14 78.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.691 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.67 -47.4 85.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.256 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.419 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 86.6 mt-30 -59.99 -39.66 86.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.335 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.59 -40.89 98.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.328 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.15 -29.47 70.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.995 0.426 . . . . 0.0 110.542 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.09 -54.13 8.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.121 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.447 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.8 ttp180 -64.44 -42.79 95.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.474 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.9 mt -62.62 -43.72 98.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.499 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.71 -60.8 3.12 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.255 0.55 . . . . 0.0 110.402 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.23 -34.31 63.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.271 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -80.29 -34.96 36.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.937 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.2 m-20 -55.02 -41.53 71.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.185 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.18 -41.71 98.59 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.575 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.04 -37.74 88.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.269 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.23 -42.6 99.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.796 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.69 -53.04 61.46 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.19 0.519 . . . . 0.0 110.668 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.37 -41.45 89.44 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.544 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.28 -39.9 94.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.644 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.52 -33.23 74.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.365 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -93.21 -21.55 19.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.714 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.626 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -65.21 -41.44 94.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.667 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 184' ' ' ILE . 30.7 pt -77.48 133.94 29.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.05 0.452 . . . . 0.0 110.696 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -128.09 107.03 9.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.302 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.59 127.76 0.33 Allowed Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.556 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.445 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.3 Cg_exo -43.72 151.7 0.39 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.702 2.268 . . . . 0.0 112.598 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.63 142.51 53.49 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.629 2.219 . . . . 0.0 112.416 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.542 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.61 146.89 2.39 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.659 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.27 154.62 69.4 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.753 2.302 . . . . 0.0 112.29 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.584 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.98 163.4 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.42 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 191' ' ' VAL . 1.9 t -143.4 169.97 16.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.896 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.18 137.4 22.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.964 0.412 . . . . 0.0 110.159 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.523 HG22 HD12 ' A' ' 205' ' ' LEU . 38.0 pt -133.98 145.53 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.639 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -131.97 131.5 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.143 0.497 . . . . 0.0 110.548 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -152.62 156.04 38.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.418 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 199' ' ' ALA . 88.4 m -121.57 122.51 39.83 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.947 0.404 . . . . 0.0 110.331 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.496 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.41 -26.26 66.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.599 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.1 -48.74 22.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.014 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.83 -10.09 59.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.414 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.496 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.6 m80 45.88 46.65 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.563 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.0 t -132.16 143.09 49.73 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.402 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.404 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -108.08 107.26 17.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.296 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -116.96 130.1 56.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.099 0.476 . . . . 0.0 110.352 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.523 HD12 HG22 ' A' ' 194' ' ' ILE . 7.5 tt -112.03 145.77 39.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.603 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.487 ' N ' HD23 ' A' ' 205' ' ' LEU . 9.1 t90 -98.44 127.53 44.41 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.09 0.472 . . . . 0.0 110.043 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.08 153.18 43.26 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.156 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.04 -17.59 45.94 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.822 2.348 . . . . 0.0 111.923 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.19 -19.13 0.7 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.429 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.442 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.4 p -74.52 163.71 27.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.497 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.38 -27.73 64.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.458 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.492 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.5 mt-30 -63.37 -42.74 98.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.628 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.69 -43.58 98.9 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.409 ' OE1' ' C ' ' A' ' 148' ' ' SER . 74.7 mt-30 -63.75 -38.85 92.64 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.865 0.364 . . . . 0.0 110.46 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 85.9 mmm -62.27 -41.52 98.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.251 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.1 -49.25 72.96 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.628 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -52.36 -33.36 42.68 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -71.06 -20.43 62.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.491 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 75.0 mt -87.56 -6.45 58.32 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.63 -6.73 57.45 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -77.74 148.25 34.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.754 0.311 . . . . 0.0 110.622 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.47 ' O ' HG12 ' A' ' 191' ' ' VAL . 3.7 p -113.02 126.78 55.87 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.093 0.473 . . . . 0.0 110.331 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -91.94 145.86 24.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.925 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.472 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -69.88 150.26 46.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.462 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.17 131.4 44.02 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.396 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.883 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.53 93.48 27.75 Favored Pre-proline 0 C--O 1.235 0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.998 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.683 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.7 Cg_exo -55.25 138.37 79.27 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.652 2.234 . . . . 0.0 111.54 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.44 -24.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.537 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.62 -50.13 21.36 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 232' ' ' ALA . 98.5 mt -54.55 -35.98 63.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.769 0.318 . . . . 0.0 110.278 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.94 36.2 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.744 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.99 87.68 0.01 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.757 0.313 . . . . 0.0 110.873 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.3 p -81.61 -13.47 57.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.423 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -91.67 -39.48 11.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.544 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.7 t -66.63 -16.84 64.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.613 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.03 43.86 26.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.437 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 178.79 -146.45 7.3 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.22 142.21 50.13 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.925 0.393 . . . . 0.0 110.303 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.419 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.4 ttt-85 -152.18 149.58 28.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.384 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -102.41 -149.36 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.31 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 54.94 -93.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.648 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.436 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 13.0 tt -126.65 173.75 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.581 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 230' ' ' LEU . 95.1 mt -121.75 140.6 45.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.767 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.77 172.29 7.35 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.336 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 67.2 mt -146.82 149.08 32.61 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.09 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -62.89 -39.49 98.09 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.94 2.07 3.93 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -78.62 -57.54 3.71 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.93 0.395 . . . . 0.0 110.694 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.594 ' ND2' HD23 ' A' ' 226' ' ' LEU . 94.4 m-20 -62.36 -36.74 83.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.236 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.404 HD21 ' HB1' ' A' ' 203' ' ' ALA . 6.1 mp -53.84 -67.07 0.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.936 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.79 -42.24 68.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.215 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.01 18.09 0.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.652 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.07 46.91 0.24 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 254' ' ' LEU . 7.6 mp 39.83 -110.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.637 0.256 . . . . 0.0 110.608 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.472 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 10.8 m120 -60.77 -44.52 96.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.427 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.46 8.03 83.83 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -98.7 -12.54 20.91 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.778 -0.248 . . . . 0.0 110.636 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.1 t 175.75 143.06 0.06 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 110.487 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.99 125.9 11.99 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.051 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.93 143.44 29.22 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 120.882 0.372 . . . . 0.0 110.867 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.7 mt -94.62 106.3 18.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.584 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.453 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.1 t80 -101.86 -13.15 17.78 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.223 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.03 -40.39 91.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.821 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.64 173.15 45.86 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.457 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.9 m-20 -74.19 -112.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 0.0 110.74 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.76 -28.78 67.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.701 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.84 -44.13 90.89 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.314 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.56 -44.36 94.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.405 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.42 -59.81 3.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.223 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.35 -43.23 61.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.187 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.86 74.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.159 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.2 mt -64.35 -43.57 97.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.64 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.72 -37.58 71.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.246 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.06 0.88 19.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.27 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -114.99 91.13 25.51 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.179 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.01 -27.28 28.08 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.785 2.323 . . . . 0.0 111.81 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.533 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -41.24 98.9 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.559 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.9 mp -95.34 5.01 52.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.306 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.03 -35.28 69.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.679 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.21 4.62 14.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.516 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.82 121.17 80.38 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.618 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -47.53 -37.45 26.34 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.432 2.088 . . . . 0.0 112.46 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.89 -43.58 90.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.826 0.346 . . . . 0.0 110.235 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.89 -43.76 92.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.291 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.86 -40.53 95.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.494 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 48.0 t-20 -89.64 -12.87 38.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.607 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.39 32.43 16.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.801 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.98 44.03 1.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.409 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.03 135.56 42.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.429 -179.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.97 131.81 56.86 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.459 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.495 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.71 88.73 6.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.708 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.433 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.2 mt -63.95 -41.44 97.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.851 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.453 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.62 165.86 33.86 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.521 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 77.7 p -75.73 -25.62 56.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.831 0.348 . . . . 0.0 110.731 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.4 tp10 -68.29 -33.99 75.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.457 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 97.3 m -73.04 21.53 0.07 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.597 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.504 ' H ' ' C ' ' A' ' 295' ' ' GLU . 50.4 t80 -57.66 -50.86 71.78 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.994 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.402 HH12 ' HG3' ' A' ' 212' ' ' GLN . 71.3 mmt-85 -108.97 150.89 27.06 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.5 tp -115.48 125.03 52.57 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.765 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.488 ' CB ' HD23 ' A' ' 83' ' ' LEU . 40.7 t0 -148.04 165.85 29.54 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.569 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -49.36 -38.19 27.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.524 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -70.72 -65.63 0.71 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.212 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -61.04 -32.96 72.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.021 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -53.6 -25.7 18.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.495 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.6 mtt -63.7 -40.73 97.51 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 120.835 0.35 . . . . 0.0 110.979 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -78.01 -44.66 25.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.941 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.579 HG21 HG23 ' A' ' 296' ' ' THR . 79.2 t -66.2 -42.83 91.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.407 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.439 HD11 ' OE1' ' A' ' 183' ' ' GLN . 47.8 tp -59.57 -47.56 85.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.468 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -69.92 -39.32 76.22 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.606 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.495 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.1 ttt180 -61.77 -37.9 86.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.181 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.6 mt -87.76 4.82 42.85 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.626 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.58 -11.74 13.54 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.018 0.437 . . . . 0.0 110.288 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.95 -36.96 85.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.614 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -61.01 -49.11 78.73 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.434 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.099 179.875 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.614 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -90.37 -2.62 57.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.394 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.476 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.51 178.87 1.3 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.485 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.5 Cg_exo -60.79 145.11 99.47 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.556 2.17 . . . . 0.0 112.191 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.614 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.5 ptt-85 -155.99 -179.77 8.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.609 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -115.6 136.35 53.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.292 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -124.07 146.28 29.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.369 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.9 p -119.84 135.6 54.8 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.714 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.6 p30 -98.43 -144.41 0.31 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.296 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.36 -36.54 84.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.473 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.489 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -147.53 -70.4 0.23 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.593 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.77 144.09 41.68 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.0 p -112.58 130.05 56.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.783 0.325 . . . . 0.0 110.369 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -114.71 129.26 56.66 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.599 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -86.61 130.63 34.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.308 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.493 HD22 ' OE1' ' A' ' 42' ' ' GLN . 70.8 mt -97.84 78.71 2.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.2 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.03 -32.53 74.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.511 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.4 t 178.05 109.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.076 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.493 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -123.87 90.76 50.37 Favored Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.218 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.1 Cg_exo -56.66 149.3 59.68 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.709 2.272 . . . . 0.0 111.646 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.3 82.51 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.491 0.494 . . . . 0.0 110.997 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.57 66.84 0.88 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.303 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.2 mt -77.38 131.2 35.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.433 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.571 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.8 t -122.46 147.64 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.231 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.5 t -136.51 144.03 44.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.576 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 50' ' ' SER . 18.9 p -100.37 -58.9 1.81 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.46 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 49' ' ' THR . 87.5 p -79.43 155.49 28.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.901 0.381 . . . . 0.0 110.642 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.548 HG21 HG23 ' A' ' 70' ' ' THR . 72.6 t -74.2 -21.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.696 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.2 m -60.27 -51.7 68.41 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.456 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.4 mt -66.32 -42.62 87.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.532 0.682 . . . . 0.0 110.859 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.3 m -43.29 -54.58 4.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.198 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.91 -38.73 75.36 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.1 m -62.52 -43.73 98.09 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.172 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 48.2 mt -65.31 -42.57 92.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.052 0.453 . . . . 0.0 110.665 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.7 tp -62.95 -38.67 91.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.254 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.455 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -61.69 -36.45 80.92 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.068 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.4 pt -91.34 27.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.081 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 56.99 52.15 9.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.744 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.04 75.34 35.18 Favored Pre-proline 0 C--N 1.334 -0.081 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.34 148.66 92.67 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.596 2.197 . . . . 0.0 112.041 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.571 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.21 135.76 50.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 121.22 0.533 . . . . 0.0 110.229 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.441 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.4 pt -69.73 -43.38 80.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.219 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.8 130.41 52.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.013 0.435 . . . . 0.0 110.599 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.9 p -155.09 168.8 25.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.354 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.48 -177.73 21.86 Favored Glycine 0 N--CA 1.465 0.572 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.665 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -132.36 171.46 13.7 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.7 0.286 . . . . 0.0 110.575 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.548 HG23 HG21 ' A' ' 51' ' ' VAL . 13.0 p -133.82 -110.71 0.22 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.498 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.35 179.78 0.91 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.244 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.1 Cg_exo -60.94 58.51 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.912 2.408 . . . . 0.0 112.089 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.544 ' N ' ' O ' ' A' ' 71' ' ' THR . 56.7 t-20 -64.0 -35.23 80.02 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.699 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 48.0 m-20 95.31 -37.15 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.979 1.425 . . . . 0.0 109.986 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -62.69 -40.51 97.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.264 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -72.97 -26.53 23.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.815 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.86 -171.9 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.717 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -74.33 -153.13 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.805 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.6 p-10 -54.03 -6.86 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.608 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.77 114.06 23.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.962 0.41 . . . . 0.0 110.484 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.48 72.21 1.3 Allowed Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.449 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.4 m-85 -143.87 148.44 35.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 110.806 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.68 -99.24 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.065 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.67 -43.46 96.62 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.377 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.542 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 36.0 tt0 92.08 52.62 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.314 1.009 . . . . 0.0 111.016 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -103.01 -9.16 20.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.507 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.449 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.52 -34.06 77.36 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.136 0.493 . . . . 0.0 110.686 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.542 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.3 -24.67 1.27 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.491 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.94 -45.36 77.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.14 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.3 -48.69 80.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.224 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.49 -38.42 89.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.28 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.55 -32.95 52.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.292 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.583 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.51 1.19 56.25 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 118.868 -0.586 . . . . 0.0 110.681 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 83.16 -48.37 0.14 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.535 1.147 . . . . 0.0 110.348 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.629 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.1 mt -46.81 152.73 0.47 Allowed 'General case' 0 CA--C 1.49 -1.351 0 CA-C-O 117.632 -1.175 . . . . 0.0 108.951 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.629 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.0 tt0 122.25 91.32 0.0 OUTLIER 'General case' 0 C--N 1.358 0.967 0 O-C-N 125.515 1.76 . . . . 0.0 110.66 -178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.52 143.04 44.72 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.201 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.9 mt -132.08 26.25 4.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.427 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -139.69 136.52 34.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.577 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.665 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.5 mt -136.62 164.72 30.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.45 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.605 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.76 -28.88 1.73 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -151.46 70.72 8.25 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.053 0.454 . . . . 0.0 110.354 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.99 145.3 98.69 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.612 2.208 . . . . 0.0 112.016 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.9 t -135.69 137.65 41.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.537 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.08 -38.12 82.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.68 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.27 -42.26 96.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.576 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.07 -41.56 98.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.429 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.57 -43.47 98.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.935 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.09 -35.11 77.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.439 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.34 -19.0 61.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.554 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.54 -6.58 58.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.478 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.4 mtp 47.68 55.81 17.07 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.663 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.8 Cg_endo -70.05 149.4 64.98 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.919 2.412 . . . . 0.0 112.034 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.27 -71.68 0.7 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.43 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.408 HD11 HD13 ' A' ' 140' ' ' LEU . 38.0 tp -112.89 113.62 25.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.221 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.7 mt -102.17 126.85 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.289 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 mt -110.82 133.75 53.1 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.042 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.61 140.18 45.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.6 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.6 p -83.28 167.44 17.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.783 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.94 79.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.475 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.6 t -138.44 158.02 45.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.471 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.5 175.34 34.16 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.24 -33.91 87.5 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -124.09 150.95 44.43 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.593 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.5 t -63.71 140.68 58.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.306 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.56 11.63 10.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.674 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.7 mp -60.87 -39.58 89.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.165 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.633 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.6 -35.63 24.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.587 0.708 . . . . 0.0 110.596 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.4 mt -70.92 -35.12 72.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.867 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -43.28 -62.82 0.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.298 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.633 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.2 p-10 -65.91 -42.95 89.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.801 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -61.8 -32.85 73.18 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.06 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 129' ' ' LEU . 67.6 mt -73.4 -40.52 64.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.459 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.55 -48.45 80.85 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.278 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.1 m -53.24 -42.11 66.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.33 -42.81 91.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.612 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.11 152.27 5.06 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.673 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -39.11 106.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.572 2.182 . . . . 0.0 111.986 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.647 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.2 m -108.89 122.06 46.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.323 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.647 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.94 154.47 28.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.282 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.6 tt -130.23 129.22 65.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.474 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 93.1 mt -110.66 122.93 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.503 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.537 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 52.7 t30 -101.45 105.14 16.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.363 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.404 ' HB3' HD13 ' A' ' 152' ' ' LEU . 41.8 p90 -98.0 -0.19 45.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.004 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.2 p-10 -65.23 -35.04 79.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.028 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.594 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.1 p-10 -101.76 8.51 41.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -133.13 146.82 51.95 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.889 0.376 . . . . 0.0 110.565 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.427 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 21.1 p -78.61 170.41 16.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.545 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.597 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 88.1 t90 -58.31 -49.54 76.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.247 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -54.75 -47.39 73.91 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.22 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.8 t -63.33 -40.81 98.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.121 0.486 . . . . 0.0 110.264 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.459 ' O ' HD23 ' A' ' 156' ' ' LEU . 59.1 tp -61.01 -44.11 97.9 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.224 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.502 HD23 HD11 ' A' ' 170' ' ' ILE . 53.6 tp -61.1 -42.85 99.27 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.314 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.6 m -55.35 -46.39 76.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.666 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.44 -40.1 93.24 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.253 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 152' ' ' LEU . 2.1 mm? -61.84 -42.18 98.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.962 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.42 -38.92 95.42 Favored Glycine 0 C--N 1.317 -0.523 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.56 -45.02 66.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.402 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.64 -43.99 96.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.76 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -94.01 -8.48 39.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.563 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.83 25.83 71.97 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -102.81 51.17 0.81 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.787 0.327 . . . . 0.0 110.818 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.23 -38.73 78.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.117 0.484 . . . . 0.0 110.744 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.87 -46.99 87.55 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.392 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -61.37 -39.17 89.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.296 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.1 -40.57 98.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.309 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.73 -28.06 69.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.23 0.538 . . . . 0.0 110.458 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -75.2 -52.76 10.15 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.174 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.489 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -63.72 -42.92 97.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.45 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 174' ' ' ASP . 86.7 mt -62.83 -43.83 99.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.594 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.47 -61.09 2.78 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.15 0.5 . . . . 0.0 110.56 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.63 -35.4 63.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.228 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -79.59 -35.14 40.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.106 0.479 . . . . 0.0 111.265 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.4 m-20 -55.33 -40.67 71.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.297 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.45 -41.87 99.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.631 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.36 -38.08 88.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.31 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 177' ' ' LEU . 77.3 mt -62.27 -42.58 99.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.711 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.83 -53.25 58.44 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.053 0.454 . . . . 0.0 110.729 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.41 -41.39 89.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.587 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.72 94.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.624 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.08 -32.71 74.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.332 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -94.05 -21.88 18.87 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.764 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.63 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.1 tt0 -64.79 -41.88 95.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.72 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 184' ' ' ILE . 31.5 pt -76.33 134.43 28.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.684 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.58 106.52 9.22 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.184 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.5 127.92 0.34 Allowed Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.586 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.445 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.9 Cg_exo -43.57 151.69 0.36 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.615 2.21 . . . . 0.0 112.508 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.68 142.33 52.68 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.806 2.337 . . . . 0.0 112.299 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.39 146.68 2.46 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.664 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.02 154.01 71.38 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.716 2.277 . . . . 0.0 112.122 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.41 162.86 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.434 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.5 169.64 17.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.805 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.74 137.38 22.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.276 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.524 HG22 HD12 ' A' ' 205' ' ' LEU . 39.5 pt -134.24 146.25 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.652 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.47 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.88 131.52 59.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.081 0.467 . . . . 0.0 110.504 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -151.63 154.69 36.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.391 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.2 m -121.97 122.85 40.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.973 0.416 . . . . 0.0 110.268 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.42 -25.76 66.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.424 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.614 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.31 -49.15 20.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.105 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.23 -10.79 60.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.5 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.1 m80 47.93 42.95 17.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.495 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.1 t -136.47 145.35 45.07 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.386 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.412 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -111.22 113.92 26.76 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.296 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.89 133.62 55.52 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.359 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.524 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.41 146.18 38.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.721 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.48 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.4 t90 -99.69 127.93 45.8 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.021 0.438 . . . . 0.0 109.952 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.12 153.69 41.69 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.947 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.401 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.2 Cg_endo -67.58 -18.33 48.6 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.895 2.397 . . . . 0.0 111.931 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.6 -18.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.504 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.442 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.0 p -75.61 167.51 21.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.485 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.46 -35.13 75.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.447 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.2 mt-30 -56.42 -41.33 76.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.676 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.35 -42.89 97.63 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.483 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.7 mt-30 -63.59 -40.45 96.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.881 0.372 . . . . 0.0 110.302 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.597 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.2 mmm -61.87 -41.58 98.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.182 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.59 -49.95 71.34 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.661 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -52.92 -32.36 45.04 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -71.94 -19.89 61.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.54 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 64.4 mt -87.46 -6.45 58.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.57 3.94 57.24 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -89.28 151.39 22.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.711 0.291 . . . . 0.0 110.553 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.45 ' O ' HG12 ' A' ' 191' ' ' VAL . 2.6 p -114.44 127.63 55.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.994 0.426 . . . . 0.0 110.402 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.97 144.71 25.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.905 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.492 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.23 150.71 47.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.416 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.79 131.36 44.62 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.298 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.882 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.82 92.49 25.34 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.123 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.675 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.8 Cg_exo -55.24 138.9 80.52 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.603 2.202 . . . . 0.0 111.47 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.65 -25.03 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.662 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.92 -49.68 27.3 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.558 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -54.66 -36.76 64.94 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.59 35.82 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.845 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.02 87.47 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.837 0.351 . . . . 0.0 110.684 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.3 p -81.25 -14.23 57.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.486 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.45 -40.85 11.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.565 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.9 t -66.76 -16.52 64.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.639 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.1 43.64 26.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.518 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.31 -145.55 6.68 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -123.27 143.05 50.31 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 110.349 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.1 ttt-85 -151.49 148.82 28.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.36 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -100.24 -152.62 0.43 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.274 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 56.46 -92.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.593 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.464 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.56 175.09 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.635 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.464 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -120.72 140.29 45.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.769 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.01 169.03 9.71 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.406 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.8 mt -147.59 150.61 34.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.317 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.85 -38.82 96.68 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.39 3.81 4.62 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -77.24 -58.02 3.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.877 0.37 . . . . 0.0 110.678 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.538 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.1 m-20 -62.36 -36.62 82.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.255 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.412 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.0 mp -52.45 -67.44 0.25 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.828 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.74 -42.11 67.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.22 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.74 18.17 0.14 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.742 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.41 47.96 0.21 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 39.19 -110.22 0.09 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.734 0.302 . . . . 0.0 110.631 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.492 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.1 m120 -60.97 -44.87 96.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.467 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.61 8.39 83.06 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -99.4 -12.26 20.41 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.607 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.6 t 176.15 142.46 0.07 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.073 0.463 . . . . 0.0 110.555 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.17 125.74 11.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.058 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -98.97 142.9 29.88 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.024 0.44 . . . . 0.0 110.567 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.5 mt -94.47 106.62 18.61 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.533 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.477 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 93.0 t80 -102.66 -11.95 18.05 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.199 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.75 -39.89 88.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.8 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.13 173.82 46.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.456 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 96.3 m-20 -74.98 -112.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.799 0.333 . . . . 0.0 110.658 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.83 -28.44 67.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.753 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.55 -43.97 93.39 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.031 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.34 -44.47 94.8 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.433 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.53 -59.51 4.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.243 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.6 -43.19 62.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.128 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.39 -44.08 75.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.2 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.4 mt -64.19 -43.61 97.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.949 0.404 . . . . 0.0 110.735 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -56.8 -37.68 71.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.121 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.31 1.03 19.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.386 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -114.64 91.29 24.71 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.423 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.79 -27.54 27.38 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.836 2.357 . . . . 0.0 111.696 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.39 -41.32 98.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.63 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.8 mp -95.32 4.83 53.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.251 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.71 -35.58 70.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.697 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.62 4.68 15.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.428 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.533 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.74 121.71 82.2 Favored Pre-proline 0 N--CA 1.441 -0.916 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.575 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.34 -38.21 26.15 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.32 2.014 . . . . 0.0 112.446 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.533 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.83 -43.77 90.76 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.821 0.343 . . . . 0.0 110.077 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.96 -43.64 92.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.373 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.85 -40.75 95.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.576 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.446 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 48.6 t-20 -89.27 -12.59 40.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.648 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.3 mtmt 62.52 31.92 16.79 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -88.67 44.7 1.23 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.391 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -106.6 134.95 46.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.515 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -116.25 132.38 56.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.468 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.495 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.52 88.22 6.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.693 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.88 -41.61 97.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.772 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.477 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.83 167.15 34.51 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.2 p -75.6 -25.66 57.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.822 0.344 . . . . 0.0 110.711 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.6 tp10 -68.09 -34.54 76.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.512 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.742 HG22 ' O ' ' A' ' 296' ' ' THR . 98.6 m -72.5 17.68 0.11 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.598 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.513 ' O ' ' NE2' ' A' ' 212' ' ' GLN . 47.8 t80 -56.89 -51.28 69.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.115 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 -106.09 147.4 28.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.062 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.3 tp -115.27 125.61 53.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 123.461 0.476 . . . . 0.0 110.796 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.47 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.5 t0 -149.62 166.75 28.36 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.52 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -49.5 -38.13 29.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.476 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -71.51 -64.92 0.83 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.24 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -61.28 -32.53 72.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.948 0.404 . . . . 0.0 110.944 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.56 -25.8 28.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.393 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.7 mtt -63.57 -41.11 98.41 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.898 0.38 . . . . 0.0 110.811 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.6 -44.59 27.87 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.848 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.566 HG21 HG23 ' A' ' 296' ' ' THR . 77.4 t -66.12 -42.87 92.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.434 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 48.4 tp -59.88 -46.87 87.94 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.374 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -70.72 -39.12 73.58 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.463 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.495 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.2 ttt180 -61.56 -38.06 86.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.273 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.59 4.62 43.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.914 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.63 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.0 tttt -111.95 -12.27 13.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.118 0.485 . . . . 0.0 110.423 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.55 -37.01 84.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.678 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.02 -48.73 80.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.387 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.228 179.771 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -90.1 -2.69 58.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.406 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.04 1.25 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.489 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.2 Cg_exo -60.78 145.09 99.5 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.75 2.3 . . . . 0.0 112.168 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.04 -179.65 8.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.585 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.61 136.06 53.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.311 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' A' ' 30' ' ' ILE . 9.3 tp -123.34 146.24 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.358 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.0 p -120.35 136.42 54.71 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.767 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 53.1 p30 -100.03 -142.99 0.33 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.2 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -62.87 -37.19 85.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.513 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.464 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -152.01 -59.99 0.16 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.413 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -60.52 139.82 48.11 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.7 p -111.83 129.98 55.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.916 0.388 . . . . 0.0 110.461 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.97 128.84 53.94 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.523 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.8 m -85.45 130.62 34.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.222 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.468 HD22 ' OE1' ' A' ' 42' ' ' GLN . 67.9 mt -96.27 79.04 3.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.311 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.55 -32.03 73.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.485 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.01 109.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.063 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.468 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.5 pt20 -121.73 91.31 48.59 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.226 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.8 Cg_exo -57.05 148.95 65.58 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.759 2.306 . . . . 0.0 111.787 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.72 82.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 O-C-N 123.566 0.541 . . . . 0.0 110.983 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.24 66.95 0.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.111 0.482 . . . . 0.0 110.233 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.75 130.74 35.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.589 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.552 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.5 t -122.71 146.07 28.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.106 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 t -135.85 143.47 45.12 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.624 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.5 p -99.24 -59.31 1.75 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.51 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.8 p -79.37 154.62 28.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.638 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.5 HG21 HG23 ' A' ' 70' ' ' THR . 69.4 t -73.98 -21.72 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.573 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.8 m -60.28 -52.0 67.12 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.477 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.45 -42.34 87.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.368 0.604 . . . . 0.0 110.943 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.22 -53.93 4.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.099 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.1 -37.48 72.86 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.8 m -62.76 -44.6 95.77 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-O 120.848 0.356 . . . . 0.0 110.424 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.6 mt -66.19 -41.95 89.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.477 0.656 . . . . 0.0 110.728 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.57 -40.34 96.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.431 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.462 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.93 -35.71 75.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.976 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.538 HD11 HD12 ' A' ' 156' ' ' LEU . 31.7 pt -91.51 28.44 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.138 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.72 51.42 11.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.851 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.45 75.02 27.89 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.984 0.421 . . . . 0.0 109.941 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.17 151.3 85.94 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.765 2.31 . . . . 0.0 112.263 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.552 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.59 137.3 47.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.207 0.527 . . . . 0.0 110.235 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.445 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -69.13 -43.7 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.218 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.03 130.86 53.17 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.959 0.409 . . . . 0.0 110.548 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.529 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.1 p -155.59 168.96 25.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.408 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.86 -177.38 21.64 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.06 172.21 12.95 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.976 0.417 . . . . 0.0 110.498 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.5 HG23 HG21 ' A' ' 51' ' ' VAL . 12.8 p -134.05 -110.38 0.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.402 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.18 179.74 0.92 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.323 -179.018 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.5 Cg_exo -60.99 58.93 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 123.03 2.487 . . . . 0.0 112.088 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 56.7 t-20 -64.22 -35.16 79.92 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.586 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 46.2 m-20 94.91 -37.67 0.01 OUTLIER 'General case' 0 C--N 1.346 0.454 0 O-C-N 124.377 1.048 . . . . 0.0 109.938 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -62.7 -40.08 96.02 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.244 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -73.88 -26.77 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.724 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.76 -172.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.627 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.64 -152.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.742 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.6 p-10 -54.76 -6.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.681 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.49 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -87.06 113.68 23.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.609 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.25 73.06 1.27 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.94 148.58 35.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.825 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.84 -99.36 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.086 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.09 -42.95 96.76 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.142 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.548 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.2 tt0 91.6 53.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.088 0.867 . . . . 0.0 110.834 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -103.47 -9.21 19.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.453 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.2 p -64.9 -33.78 76.84 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.112 0.482 . . . . 0.0 110.664 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.548 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.62 -23.8 1.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.554 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.5 t -69.52 -46.0 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.978 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.35 81.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.117 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.72 -38.2 89.54 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.284 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.66 -32.16 50.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.226 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.591 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.5 mmt-85 -90.12 1.7 56.1 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 119.204 -0.426 . . . . 0.0 110.609 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 82.85 -49.11 0.16 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.212 0.945 . . . . 0.0 110.322 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.642 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.3 mt -46.49 153.96 0.33 Allowed 'General case' 0 CA--C 1.49 -1.34 0 CA-C-O 117.587 -1.197 . . . . 0.0 109.148 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.642 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.2 tt0 121.23 92.19 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 O-C-N 125.558 1.786 . . . . 0.0 110.529 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.529 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.21 143.46 43.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.218 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -132.12 26.95 4.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.733 0.301 . . . . 0.0 110.462 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.54 138.42 34.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.959 0.409 . . . . 0.0 110.469 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.63 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.6 mt -137.3 165.02 28.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.351 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.615 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.29 -28.59 1.81 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.95 70.95 7.15 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.188 0.518 . . . . 0.0 110.358 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.24 145.69 98.0 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 122.803 2.335 . . . . 0.0 112.032 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.2 t -134.38 136.64 43.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.568 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.14 82.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.716 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.5 -41.94 96.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.507 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.47 98.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.514 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.66 -43.35 98.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.06 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.99 -35.17 77.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.311 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -18.52 60.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.468 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.5 -6.34 58.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.526 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.0 mtp 48.0 55.74 17.17 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.651 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.15 149.12 63.94 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.777 2.318 . . . . 0.0 112.114 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -101.2 -73.37 0.65 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.46 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.418 HD11 HD13 ' A' ' 140' ' ' LEU . 38.3 tp -110.84 112.63 24.62 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.324 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -101.13 125.99 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.446 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.2 mt -109.5 133.27 53.28 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.149 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.22 139.48 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.484 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.9 p -83.42 168.41 16.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.648 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.56 80.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.44 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.51 159.18 42.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.424 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.2 177.01 33.46 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.94 87.5 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.77 151.98 44.42 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.962 0.41 . . . . 0.0 110.527 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.6 t -62.97 141.07 58.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.362 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.66 10.15 10.96 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.647 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.7 mp -60.98 -39.18 88.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.061 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.68 -35.91 24.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.54 0.686 . . . . 0.0 110.671 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.5 mt -70.83 -35.57 72.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.458 0.647 . . . . 0.0 110.774 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -42.78 -62.86 0.89 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.265 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.83 -42.61 90.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.994 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -62.33 -32.97 73.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.129 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.8 mt -73.48 -40.71 63.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.19 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.41 -48.66 79.96 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.206 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.7 m -53.28 -42.16 66.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.208 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.01 -43.04 92.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.002 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.62 154.08 5.34 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.625 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -39.13 107.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.666 2.244 . . . . 0.0 112.298 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.642 ' C ' HD12 ' A' ' 140' ' ' LEU . 94.5 m -109.75 121.4 45.14 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.252 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.642 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.28 152.82 30.75 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.252 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -128.27 131.42 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.359 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.29 127.42 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.397 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.88 103.6 14.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.364 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.9 p90 -101.12 -11.32 19.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.782 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.91 -33.47 76.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.622 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.2 p-10 -98.35 7.57 46.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.643 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.7 mttm -135.33 155.35 50.75 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.568 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.0 p -74.54 165.47 25.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.687 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.584 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -59.86 -48.7 80.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.298 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -53.86 -41.93 68.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.918 0.389 . . . . 0.0 110.081 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.4 t -62.42 -40.82 97.77 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.402 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.411 ' O ' HD23 ' A' ' 156' ' ' LEU . 47.4 tp -60.66 -43.87 97.12 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.355 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.516 HD22 HH21 ' A' ' 169' ' ' ARG . 44.0 tp -61.39 -43.07 99.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.861 0.363 . . . . 0.0 110.14 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.2 m -55.54 -45.3 77.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.716 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.49 -40.6 97.24 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 120.877 0.37 . . . . 0.0 110.395 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.538 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.02 -42.34 99.06 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.233 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.77 -41.05 95.93 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.72 -46.21 63.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.968 0.413 . . . . 0.0 110.894 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.6 mt -64.52 -44.05 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.819 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.8 p -93.23 -8.75 41.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.6 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.09 25.05 72.07 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -101.72 51.73 0.83 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.787 0.327 . . . . 0.0 110.681 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.79 -38.92 76.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.698 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.5 -46.92 87.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.187 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -61.37 -39.04 89.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.375 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.16 -40.45 97.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.362 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.3 -27.8 69.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.542 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.77 -53.71 8.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.171 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.516 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -63.75 -43.31 96.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.468 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 174' ' ' ASP . 86.7 mt -63.05 -43.9 99.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.676 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.33 -61.51 2.5 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.12 0.486 . . . . 0.0 110.484 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -54.81 -35.22 63.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.365 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -79.44 -34.72 41.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.114 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.3 m-20 -56.9 -40.01 75.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.926 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.83 -42.39 99.71 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.733 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.82 -37.74 87.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.294 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 177' ' ' LEU . 81.6 mt -62.41 -42.5 99.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.7 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.0 -53.14 59.79 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.128 0.489 . . . . 0.0 110.711 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.44 -41.41 89.16 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.548 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.26 -39.82 94.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.622 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.3 -32.33 73.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.338 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.21 -21.88 18.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.745 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.638 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -65.02 -41.42 95.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.698 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 pt -77.58 136.33 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.679 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.46 108.65 11.0 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.274 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.18 126.15 0.33 Allowed Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.89 152.18 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.724 2.283 . . . . 0.0 112.586 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.13 141.71 53.5 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.676 2.25 . . . . 0.0 112.469 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -170.96 147.07 2.24 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.669 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.13 154.5 70.15 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.734 2.289 . . . . 0.0 112.265 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.581 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.44 163.18 28.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.419 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.581 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.65 170.05 16.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.857 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.79 137.45 22.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.226 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.536 HG22 HD12 ' A' ' 205' ' ' LEU . 39.3 pt -134.03 146.01 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.603 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.72 131.68 59.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.133 0.492 . . . . 0.0 110.457 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -152.01 155.11 37.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.419 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.616 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.2 m -122.25 122.93 40.27 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.916 0.389 . . . . 0.0 110.382 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.37 -25.84 66.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.569 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.616 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.24 -49.17 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.086 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.59 -12.87 61.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.472 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.7 m80 50.43 41.55 25.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.439 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.9 t -136.27 144.79 44.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.339 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.401 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -110.5 114.31 27.62 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.35 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.1 m-20 -119.86 133.4 55.6 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.067 0.46 . . . . 0.0 110.372 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.98 146.32 38.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.756 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.484 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 12.3 t90 -99.29 129.54 45.52 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.062 0.458 . . . . 0.0 110.026 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.43 153.72 39.5 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.082 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.66 -18.29 48.12 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.791 2.328 . . . . 0.0 111.888 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.11 -18.71 0.35 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.45 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.484 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.1 p -75.65 165.23 25.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.496 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.14 -28.19 66.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.545 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.1 mt-30 -63.61 -41.43 98.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.17 -44.67 97.15 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.5 -38.92 92.7 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.981 0.42 . . . . 0.0 110.567 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.584 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.1 mmm -62.28 -41.36 98.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.114 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.5 mt -63.67 -47.05 82.8 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.648 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.48 -31.95 56.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.057 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -70.74 -18.14 62.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.543 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.427 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.4 mt -88.63 -8.67 54.24 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.692 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.85 2.52 55.12 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -88.57 152.46 21.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.768 0.318 . . . . 0.0 110.565 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.448 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.2 p -115.35 128.15 55.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.101 0.477 . . . . 0.0 110.378 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.46 146.02 24.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.852 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.47 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.64 151.16 46.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.463 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.9 131.59 42.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.408 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.89 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.56 93.4 27.59 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.061 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.677 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.0 Cg_exo -55.61 139.16 82.58 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.588 2.192 . . . . 0.0 111.519 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.86 -25.47 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.507 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.66 -49.88 27.9 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.553 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -53.99 -37.07 63.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.771 0.32 . . . . 0.0 110.19 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -66.71 35.96 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.815 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.553 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.32 88.13 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.4 p -81.72 -14.36 56.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.335 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -91.37 -41.41 10.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.564 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.7 t -66.88 -16.62 64.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.682 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.1 43.54 26.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.495 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.63 -147.99 7.63 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -121.75 143.11 49.57 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.953 0.406 . . . . 0.0 110.354 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -151.97 149.43 28.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.349 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -100.83 -151.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.313 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 55.87 -91.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.609 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.462 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.4 tt -126.67 175.12 9.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.559 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.462 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.8 mt -121.73 141.42 42.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.841 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.68 169.16 9.46 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.259 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.2 mt -147.73 150.83 35.02 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.181 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.58 -39.04 97.18 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.33 3.98 4.6 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -77.33 -58.03 3.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.001 0.429 . . . . 0.0 110.649 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.566 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.2 m-20 -62.15 -36.86 83.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.221 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.401 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.0 mp -52.36 -67.76 0.22 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.747 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.45 -42.17 66.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.248 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.11 17.92 0.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.672 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.99 48.59 0.29 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.42 -109.83 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.647 0.26 . . . . 0.0 110.744 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.47 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 12.0 m120 -60.96 -44.82 96.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.454 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.41 8.09 83.82 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -99.1 -12.95 20.05 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.783 -0.245 . . . . 0.0 110.646 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.0 t 176.69 142.57 0.07 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.121 0.486 . . . . 0.0 110.514 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.94 125.94 12.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.074 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -99.08 143.1 29.73 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 120.927 0.394 . . . . 0.0 110.79 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.4 mt -94.49 106.35 18.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.632 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.455 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.4 t80 -101.96 -12.29 18.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.163 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.22 -40.14 90.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.862 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.67 174.19 46.4 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.466 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.6 m-20 -74.67 -113.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 0.0 110.662 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.65 -28.61 67.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.743 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.04 -44.11 91.72 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.245 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.53 -44.28 94.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.398 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.56 -59.81 4.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.208 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.39 -43.34 61.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.151 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.34 -43.92 75.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.23 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.41 -43.6 97.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.682 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -56.55 -37.44 70.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.207 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.76 1.09 18.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.297 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -115.04 91.21 26.07 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.174 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.21 -27.11 28.86 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.803 2.336 . . . . 0.0 111.767 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.33 -41.06 98.87 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.641 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.22 4.93 53.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.371 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.63 -35.21 70.35 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.75 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.59 4.56 15.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.512 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.75 121.39 81.03 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.592 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -47.67 -37.67 27.77 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.46 2.107 . . . . 0.0 112.453 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.532 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -59.06 -43.75 91.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.788 0.328 . . . . 0.0 110.211 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.85 -43.75 93.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.251 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.72 -40.52 95.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.449 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.76 -12.43 39.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.534 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.2 mtmt 61.99 31.56 17.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.39 44.01 1.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.384 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.04 135.91 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.497 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.47 132.87 56.56 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.428 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.15 87.75 7.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.723 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.01 -41.25 97.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.92 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.455 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.98 168.45 34.97 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.0 p -76.05 -25.81 55.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.858 0.361 . . . . 0.0 110.731 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.1 tp10 -67.61 -34.18 76.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.465 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.762 HG22 ' O ' ' A' ' 296' ' ' THR . 97.0 m -73.52 20.47 0.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.648 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.557 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 57.0 t80 -57.63 -51.13 70.77 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.942 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.409 HH12 ' HG3' ' A' ' 212' ' ' GLN . 65.2 mmt-85 -108.28 149.72 28.26 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.427 ' CD2' HD11 ' A' ' 219' ' ' LEU . 40.4 tp -115.32 125.35 53.14 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.805 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.471 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.2 t0 -149.11 166.46 28.69 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.552 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -49.24 -38.16 25.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.61 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -71.54 -65.21 0.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.371 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -60.93 -32.86 72.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.47 -25.65 26.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.566 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.6 mtt -63.33 -40.87 98.5 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 120.865 0.364 . . . . 0.0 110.944 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.77 -44.22 23.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.562 HG21 HG23 ' A' ' 296' ' ' THR . 78.8 t -66.17 -43.03 92.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.403 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.3 tp -60.23 -47.06 87.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.466 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -69.83 -39.9 76.19 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.035 0.445 . . . . 0.0 110.744 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.498 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.2 ttt180 -61.61 -38.19 86.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.198 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.11 4.45 42.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.767 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.638 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -112.47 -11.51 13.62 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.045 0.45 . . . . 0.0 110.259 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.97 85.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.644 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.1 -48.87 79.67 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.339 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.042 179.947 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.44 -2.76 57.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.444 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.49 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.41 178.98 1.27 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.536 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.3 Cg_exo -60.75 144.82 99.61 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.652 2.235 . . . . 0.0 112.212 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.69 -179.75 8.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.608 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.58 136.69 52.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.392 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.1 tp -124.55 146.28 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.361 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.8 p -119.81 136.09 54.6 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.779 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.9 p30 -98.74 -144.17 0.32 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.273 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.56 -36.63 84.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.47 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.486 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.9 ttt85 -147.32 -70.59 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.565 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.81 144.07 41.81 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.2 p -112.68 130.08 56.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 0.0 110.397 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -114.8 129.65 56.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.686 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.9 m -86.83 130.6 34.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.342 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.493 HD22 ' OE1' ' A' ' 42' ' ' GLN . 71.1 mt -97.41 79.06 2.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.437 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -65.94 -32.55 74.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.53 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 t 177.09 109.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.155 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.493 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -123.36 91.59 49.64 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.324 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.3 Cg_exo -56.81 149.0 62.9 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.71 2.273 . . . . 0.0 111.82 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.69 83.05 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.933 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.48 67.27 0.89 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.316 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.59 130.69 35.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.637 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.552 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.4 t -123.04 146.31 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.108 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 t -136.16 143.84 44.68 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.626 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.7 p -99.35 -59.35 1.74 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.523 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.2 p -79.36 155.03 28.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.585 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.497 HG21 HG23 ' A' ' 70' ' ' THR . 72.5 t -74.36 -21.67 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.582 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.7 m -60.23 -52.09 66.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.537 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -66.62 -42.45 86.8 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.243 0.544 . . . . 0.0 110.759 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.8 m -42.88 -54.07 4.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.234 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.34 -37.24 70.51 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -62.85 -44.62 95.64 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 120.848 0.356 . . . . 0.0 110.428 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.422 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.9 mt -66.51 -41.93 88.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.306 0.574 . . . . 0.0 110.732 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.3 tp -62.5 -40.44 96.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.25 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.502 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.81 -36.05 75.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.928 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.527 HD11 HD12 ' A' ' 156' ' ' LEU . 30.7 pt -91.06 29.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.103 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 56.43 51.51 11.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.899 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.41 75.79 22.13 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.909 0.385 . . . . 0.0 109.98 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.15 152.11 83.35 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.783 2.322 . . . . 0.0 112.28 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.552 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.86 137.54 46.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.104 0.478 . . . . 0.0 110.33 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.5 pt -69.14 -43.65 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.241 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.1 131.21 53.33 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.948 0.404 . . . . 0.0 110.595 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.5 p -155.57 168.94 25.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.409 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.98 -177.28 21.56 Favored Glycine 0 N--CA 1.464 0.505 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.635 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.14 172.31 12.83 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.919 0.39 . . . . 0.0 110.507 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.497 HG23 HG21 ' A' ' 51' ' ' VAL . 15.0 p -132.35 -112.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.947 0.403 . . . . 0.0 110.462 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.18 179.76 0.93 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.344 -179.185 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.6 Cg_exo -60.8 57.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.962 2.441 . . . . 0.0 112.132 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.7 t-20 -64.41 -33.54 76.09 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.522 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.567 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.6 m-20 93.76 -36.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.08 0.862 . . . . 0.0 109.94 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.6 mtp85 -62.43 -39.48 93.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.265 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -74.69 -25.68 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.623 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.19 -171.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.86 -153.75 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.758 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.1 p-10 -52.78 -7.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.687 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.508 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.49 115.17 23.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.653 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.94 69.85 1.35 Allowed Glycine 0 CA--C 1.521 0.42 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -143.16 147.51 35.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.815 0.341 . . . . 0.0 110.832 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.61 -98.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.185 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.1 -42.64 96.84 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.122 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.0 tt0 91.51 53.14 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.866 0.729 . . . . 0.0 110.878 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -103.13 -9.05 19.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.447 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -64.79 -33.74 76.69 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.058 0.456 . . . . 0.0 110.65 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.55 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.18 -23.85 1.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.613 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.53 -46.0 76.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.936 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.41 -48.19 82.34 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.237 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.65 -38.26 89.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.292 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.78 -32.31 52.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.238 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.608 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.3 mmt-85 -90.19 1.65 56.21 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.57 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 56.9 mttp 82.64 -49.55 0.18 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.954 0.784 . . . . 0.0 110.29 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.671 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.7 mt -45.87 154.52 0.23 Allowed 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 118.16 -0.924 . . . . 0.0 109.453 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.671 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 120.77 92.68 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 O-C-N 125.066 1.479 . . . . 0.0 110.462 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.76 143.45 42.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.992 0.425 . . . . 0.0 110.249 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.5 mt -132.38 27.21 4.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 110.517 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.35 138.04 34.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.557 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.7 mt -137.25 164.96 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.386 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.02 -28.53 1.85 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.69 70.82 7.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.078 0.466 . . . . 0.0 110.36 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.89 145.19 98.9 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.754 2.303 . . . . 0.0 112.066 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.2 t -133.99 136.13 43.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.549 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.95 -38.17 82.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.673 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.25 -41.95 96.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.514 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.37 -41.41 98.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.527 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.0 t -63.84 -43.4 97.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.068 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.13 -35.05 77.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.323 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.75 -18.41 59.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.485 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.75 -6.39 58.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.498 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 68.0 mtp 47.57 56.06 17.21 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.584 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.13 149.43 64.51 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.786 2.324 . . . . 0.0 112.034 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.11 -73.88 0.63 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.433 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.502 HD11 HD13 ' A' ' 140' ' ' LEU . 37.9 tp -110.56 112.35 24.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.262 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.9 mt -100.72 126.33 54.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.022 0.439 . . . . 0.0 110.437 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.8 mt -109.16 132.83 53.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.272 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.0 139.3 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.511 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -83.55 168.38 16.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.579 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.1 -37.52 80.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.424 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -140.14 159.32 42.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.511 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.46 178.38 32.96 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.21 -33.74 86.92 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -125.6 152.67 44.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.899 0.381 . . . . 0.0 110.556 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 33.3 t -63.4 141.27 58.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.408 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.68 10.46 11.01 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.578 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -60.93 -38.97 87.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.113 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.88 -36.12 23.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.431 0.634 . . . . 0.0 110.629 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.1 mt -70.93 -35.57 72.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.373 0.606 . . . . 0.0 110.79 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -42.69 -62.8 0.9 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.201 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -66.17 -42.69 88.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.043 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.24 -32.58 73.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.267 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 129' ' ' LEU . 74.1 mt -73.9 -41.06 62.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.078 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -58.24 -48.98 78.69 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.301 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.0 m -52.95 -42.37 65.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.353 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.96 -42.65 92.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.985 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.44 153.97 5.47 Favored Pre-proline 0 N--CA 1.453 -0.281 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.581 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -39.74 106.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.669 2.246 . . . . 0.0 112.179 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.66 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.6 m -110.07 122.76 48.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.382 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.66 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -115.05 153.68 30.25 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.304 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -129.44 131.81 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.395 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.16 127.79 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.513 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.21 104.37 15.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.298 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.2 p90 -101.57 -11.17 19.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.805 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.576 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.73 -33.66 76.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.722 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.576 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.7 p-10 -98.41 8.03 45.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.573 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.61 155.18 50.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.582 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.409 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.45 165.94 24.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.64 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.595 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.8 t90 -59.72 -49.12 78.99 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.23 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -53.51 -42.39 67.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 110.109 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.8 t -62.85 -40.99 99.15 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.328 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.401 ' O ' HD23 ' A' ' 156' ' ' LEU . 48.9 tp -60.64 -44.19 96.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.366 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.37 -43.6 98.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.206 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.5 m -54.71 -44.64 73.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.875 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.79 -40.74 98.26 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.905 0.383 . . . . 0.0 110.379 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.527 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.03 -42.38 99.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.165 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.94 -41.21 95.5 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.66 -45.81 64.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.908 0.385 . . . . 0.0 110.831 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.55 -44.0 96.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.811 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -93.34 -8.34 42.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.583 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.5 26.67 71.95 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -101.76 51.41 0.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.818 0.342 . . . . 0.0 110.679 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.8 -39.38 76.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.707 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.61 -47.41 85.67 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.297 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -59.92 -39.47 85.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.35 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.9 -40.97 99.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.368 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.52 70.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.566 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.17 -54.37 7.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.1 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.502 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.5 ttp180 -65.57 -42.19 92.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.477 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.6 mt -62.36 -43.77 98.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.566 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.66 -57.16 12.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.931 0.396 . . . . 0.0 110.551 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -58.48 -32.76 69.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.345 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.423 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.9 t80 -82.1 -36.56 27.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.772 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.6 m-20 -56.13 -41.41 75.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.155 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.99 -42.25 99.79 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.595 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.45 -37.78 87.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.281 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.423 HD11 ' CD2' ' A' ' 173' ' ' PHE . 81.9 mt -62.5 -42.23 99.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.654 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.06 -52.91 62.03 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.013 0.435 . . . . 0.0 110.668 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.4 -41.77 88.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.565 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.98 95.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.563 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.31 -31.94 73.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.424 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.54 -22.51 18.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.766 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.65 -41.25 96.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.616 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 184' ' ' ILE . 33.0 pt -76.72 136.52 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.626 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.89 108.1 10.68 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.282 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.83 125.43 0.3 Allowed Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.505 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.451 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.7 Cg_exo -43.77 152.35 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.741 2.294 . . . . 0.0 112.484 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.89 141.81 55.06 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.634 2.223 . . . . 0.0 112.396 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.19 147.25 2.18 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.578 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.0 154.32 70.94 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.779 2.319 . . . . 0.0 112.324 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.585 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.27 163.15 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.42 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.585 ' N ' HG22 ' A' ' 191' ' ' VAL . 1.9 t -144.07 170.68 15.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.799 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.63 137.7 21.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.312 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.535 HG22 HD12 ' A' ' 205' ' ' LEU . 40.0 pt -134.31 146.96 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.675 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.28 131.83 58.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.102 0.477 . . . . 0.0 110.482 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -152.09 155.12 37.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.473 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.621 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.4 m -122.79 122.93 39.88 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.412 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.47 -25.67 66.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.579 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.621 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.33 -48.86 21.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.007 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.34 -9.41 58.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.467 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.2 m80 46.51 42.11 10.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.444 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -135.93 145.75 46.58 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.399 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.94 114.3 27.12 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.321 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.79 133.37 55.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 110.442 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.535 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.81 146.22 38.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.712 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.491 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.3 t90 -99.42 129.38 45.6 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.074 0.464 . . . . 0.0 110.056 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.02 153.42 39.84 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.073 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.85 -17.87 46.99 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.762 2.308 . . . . 0.0 111.962 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.14 -18.9 0.37 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.486 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.491 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.71 164.71 26.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.531 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.93 -27.95 65.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.504 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.6 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.9 mt-30 -63.65 -41.19 98.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.643 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.66 -44.37 97.95 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.45 -38.8 92.29 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.983 0.42 . . . . 0.0 110.464 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.595 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.0 mmm -62.14 -41.31 98.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.177 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.7 mt -63.63 -47.17 82.42 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.672 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.13 -31.95 53.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.114 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.85 -18.3 62.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.557 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.437 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.9 mt -87.87 -9.13 54.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.559 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.19 1.6 54.34 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -88.16 153.77 20.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.835 0.35 . . . . 0.0 110.519 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.455 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.0 p -116.31 128.74 55.82 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.071 0.463 . . . . 0.0 110.384 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.62 146.3 23.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.866 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.486 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.95 151.72 45.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.463 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.88 131.47 42.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.443 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.896 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.73 93.07 26.93 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.132 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.675 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.9 Cg_exo -55.43 139.21 81.77 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.597 2.198 . . . . 0.0 111.59 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.01 -26.07 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.486 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.36 -50.25 27.88 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.4 mt -53.71 -37.15 63.0 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -66.76 36.14 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.731 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.556 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 38.98 88.72 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.847 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.5 p -81.28 -13.87 58.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.377 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.98 -41.84 10.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.626 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.7 t -66.74 -16.94 64.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.636 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 55.74 44.01 26.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.453 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.67 -149.24 8.32 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.95 142.84 48.38 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.912 0.387 . . . . 0.0 110.369 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.01 149.56 29.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.391 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -101.31 -151.59 0.42 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.343 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 55.96 -92.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.631 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.466 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.4 tt -126.84 175.52 8.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.613 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.466 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.4 mt -122.72 142.04 40.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.759 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.86 169.65 9.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.329 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 58.7 mt -148.01 150.8 34.63 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.49 -39.05 97.26 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.1 4.03 4.69 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -77.55 -58.04 3.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.896 0.379 . . . . 0.0 110.596 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.56 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.4 m-20 -62.11 -36.61 82.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.264 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.36 -67.76 0.23 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.661 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.54 -42.48 67.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.264 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.63 17.42 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.56 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.02 48.83 0.3 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.53 -110.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.587 0.232 . . . . 0.0 110.704 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.486 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.9 m120 -60.8 -44.8 96.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.572 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.28 8.01 84.16 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.95 -13.58 19.89 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.628 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.1 t 177.25 142.55 0.08 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.007 0.432 . . . . 0.0 110.492 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.22 124.81 11.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.052 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.09 143.63 28.43 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 120.854 0.359 . . . . 0.0 110.699 178.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.5 mt -95.13 106.49 18.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.659 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.442 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.8 t80 -101.75 -12.27 18.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.279 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.37 -40.73 89.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.83 173.06 45.72 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.453 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -73.71 -113.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.814 0.34 . . . . 0.0 110.739 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.66 -28.62 67.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.715 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.9 -44.03 91.13 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.179 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.63 -44.22 94.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.336 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.71 -60.21 3.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.227 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.93 -43.54 60.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.165 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.27 -43.58 74.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.268 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.64 -43.63 96.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.648 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -56.28 -37.5 69.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.189 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.54 0.9 18.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.328 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -114.99 91.4 26.6 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.227 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.21 -27.28 29.54 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.809 2.34 . . . . 0.0 111.778 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.54 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -40.96 98.78 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.621 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.33 5.31 52.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.328 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.07 -35.37 69.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.009 0.433 . . . . 0.0 110.707 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.36 4.36 15.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.601 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.76 121.15 80.17 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.531 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -47.2 -37.89 24.53 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.479 2.119 . . . . 0.0 112.397 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.98 -43.74 91.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.846 0.355 . . . . 0.0 110.311 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.5 t -66.18 -43.68 91.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.337 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.89 -40.6 95.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.537 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.5 t-20 -89.64 -12.89 38.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.502 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 62.47 32.28 16.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.79 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.01 43.84 1.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.376 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.22 135.63 41.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.544 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.84 132.38 56.71 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.465 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.07 89.15 7.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.735 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.88 -40.98 97.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.784 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.79 165.34 33.26 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 71.7 p -75.47 -25.75 57.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 110.673 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.8 tp10 -68.36 -33.85 75.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.384 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 296' ' ' THR . 95.7 m -73.68 25.17 0.07 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.711 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.6 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 37.7 t80 -58.57 -50.75 72.68 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.413 HH12 ' HG3' ' A' ' 212' ' ' GLN . 79.4 mmt-85 -110.82 153.84 24.81 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.437 ' CD2' HD11 ' A' ' 219' ' ' LEU . 45.0 tp -115.67 125.1 52.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.721 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.487 ' CB ' HD23 ' A' ' 83' ' ' LEU . 44.7 t0 -147.98 165.66 30.05 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.531 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.16 -38.13 24.55 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.544 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.03 -65.83 0.69 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.29 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.91 -32.75 72.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.35 -25.25 23.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.627 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.5 mtt -63.72 -40.73 97.47 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 120.889 0.376 . . . . 0.0 111.01 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -79.1 -44.13 22.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.58 HG21 HG23 ' A' ' 296' ' ' THR . 79.0 t -66.15 -42.88 92.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.469 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.9 tp -60.1 -47.13 87.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.455 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.04 -39.31 75.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.58 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.2 ttt180 -61.85 -38.66 89.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.252 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -86.67 4.57 39.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.772 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.92 -11.16 13.46 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.048 0.451 . . . . 0.0 110.31 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.1 85.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.578 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.84 -48.88 79.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.422 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.178 179.701 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.612 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.68 -3.15 57.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.425 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.489 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -143.88 179.2 1.23 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.53 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 37.6 Cg_exo -60.55 144.57 99.54 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.779 2.32 . . . . 0.0 112.161 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.612 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.3 ptt-85 -155.85 179.96 8.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.571 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -116.03 137.22 52.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.346 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.83 146.17 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.46 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.8 p -119.9 136.27 54.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.744 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.7 p30 -98.33 -144.51 0.31 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.267 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.58 -36.39 83.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.481 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -147.04 -70.68 0.23 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.508 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.59 144.15 41.11 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.7 p -112.61 129.82 56.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 110.385 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -114.86 129.9 56.79 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.643 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 m -87.74 131.53 34.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.159 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.497 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.8 mt -99.02 79.64 2.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.655 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.16 -32.01 73.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.475 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 t 176.98 109.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.182 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.497 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -124.32 91.66 49.23 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.306 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.4 Cg_exo -56.64 149.04 61.05 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.792 2.328 . . . . 0.0 111.917 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.44 82.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.599 0.562 . . . . 0.0 110.923 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.0 mtm180 -151.62 67.23 0.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.24 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.84 130.99 35.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.667 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.567 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.6 t -123.16 147.74 27.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.149 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 t -136.22 143.96 44.63 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.703 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 50' ' ' SER . 16.9 p -99.65 -59.33 1.74 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.524 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.42 ' N ' ' OG1' ' A' ' 49' ' ' THR . 86.6 p -79.41 154.94 28.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.596 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.529 HG21 HG23 ' A' ' 70' ' ' THR . 70.5 t -73.72 -21.76 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.517 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.8 m -60.17 -52.03 67.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.535 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 mt -66.41 -42.32 87.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.208 0.527 . . . . 0.0 110.862 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.7 m -43.52 -54.27 4.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.091 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.63 -36.65 76.35 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 m -63.32 -44.38 95.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 0.0 110.423 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.7 mt -66.02 -42.13 90.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.484 0.659 . . . . 0.0 110.593 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tp -62.83 -40.17 96.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.367 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.534 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.52 -36.16 77.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.065 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.46 HD11 HD12 ' A' ' 156' ' ' LEU . 32.6 pt -90.99 27.66 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.168 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 57.02 51.51 10.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.944 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.81 75.92 29.86 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.036 0.446 . . . . 0.0 109.932 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -63.53 149.38 91.16 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.752 2.302 . . . . 0.0 112.214 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.567 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -112.71 137.11 46.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.198 0.523 . . . . 0.0 110.281 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.441 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.5 pt -69.51 -43.7 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.145 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.22 131.21 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.929 0.395 . . . . 0.0 110.59 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.2 p -155.78 168.67 26.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.467 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.7 -177.41 21.74 Favored Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.629 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.07 172.3 12.83 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.483 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.529 HG23 HG21 ' A' ' 51' ' ' VAL . 11.4 p -134.13 -110.27 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.396 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.545 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.43 179.6 0.94 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.348 -179.045 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.2 Cg_exo -60.79 58.87 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.996 2.464 . . . . 0.0 112.129 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 56.3 t-20 -64.37 -34.91 79.25 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.498 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 46.7 m-20 95.04 -38.14 0.01 OUTLIER 'General case' 0 C--N 1.346 0.448 0 O-C-N 124.016 0.822 . . . . 0.0 109.875 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.45 -39.84 94.67 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.018 0.437 . . . . 0.0 110.228 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.2 p -73.79 -26.5 21.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.693 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.97 -172.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.568 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.7 p30 -74.22 -152.88 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.757 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.7 p-10 -54.49 -6.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.701 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.493 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.94 113.66 22.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.589 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.48 72.74 1.28 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.99 148.62 35.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.885 0.374 . . . . 0.0 110.817 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.75 -99.16 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.139 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.04 -42.94 96.89 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.201 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.5 tt0 91.65 52.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.953 0.783 . . . . 0.0 110.925 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -103.43 -8.99 19.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.365 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -64.92 -33.58 76.35 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.108 0.48 . . . . 0.0 110.669 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.531 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 97.9 mttt -48.85 -23.55 1.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.671 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.7 t -70.02 -46.14 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.815 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.16 -48.63 80.7 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.107 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.63 -38.18 89.23 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.41 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.76 -32.31 51.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.261 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.6 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.9 mmt-85 -89.79 1.81 55.68 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.617 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.6 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 82.64 -49.5 0.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.015 0.822 . . . . 0.0 110.319 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.655 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.6 mt -46.06 154.48 0.25 Allowed 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 117.702 -1.142 . . . . 0.0 109.407 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.655 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 120.72 92.36 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 O-C-N 125.439 1.712 . . . . 0.0 110.479 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.533 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.11 143.02 43.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.084 0.468 . . . . 0.0 110.259 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -132.07 26.71 4.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.856 0.36 . . . . 0.0 110.533 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.33 138.14 34.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.013 0.435 . . . . 0.0 110.549 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.3 mt -137.16 164.79 29.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.398 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.613 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.63 -28.91 1.75 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -151.94 70.75 7.88 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.177 0.513 . . . . 0.0 110.258 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.87 145.29 98.64 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.777 2.318 . . . . 0.0 112.057 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.8 t -134.98 136.49 42.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.549 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.97 -38.17 82.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.657 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.51 -42.07 96.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.506 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.08 -41.59 98.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.516 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.77 -43.29 97.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.064 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.17 -35.09 77.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.263 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -18.29 59.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.506 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.72 -6.1 58.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.505 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.417 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 70.4 mtp 47.83 55.73 17.09 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.608 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.0 Cg_endo -70.25 149.16 63.4 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.744 2.296 . . . . 0.0 112.116 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.48 -72.99 0.66 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.429 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.448 HD11 HD13 ' A' ' 140' ' ' LEU . 37.6 tp -111.25 113.54 26.11 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.342 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.4 mt -102.67 126.95 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.576 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.5 mt -110.06 133.85 52.76 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.225 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.33 139.65 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.468 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.6 p -83.48 167.84 17.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.688 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -37.25 79.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.47 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.61 158.6 43.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.472 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.11 176.97 33.4 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.75 86.91 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.95 152.27 44.38 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.926 0.394 . . . . 0.0 110.505 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.0 t -63.47 140.93 58.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.355 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.62 10.5 11.07 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.611 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.513 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.04 -38.89 87.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.14 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.97 -35.86 23.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.542 0.687 . . . . 0.0 110.668 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.9 mt -70.98 -35.34 72.09 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.444 0.64 . . . . 0.0 110.733 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -42.81 -63.0 0.86 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.239 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.87 -42.71 90.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.049 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.07 -32.63 73.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.3 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.9 mt -73.9 -40.7 62.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.987 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.28 -49.22 77.92 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.21 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.3 m -52.89 -42.48 65.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.246 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.59 -42.87 93.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.131 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.73 153.94 5.19 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.65 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -39.38 106.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.661 2.241 . . . . 0.0 112.354 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.649 ' C ' HD12 ' A' ' 140' ' ' LEU . 97.1 m -109.97 122.22 47.06 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.332 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.649 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.5 153.44 29.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.225 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -129.04 131.5 68.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.393 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -114.88 127.6 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.475 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.496 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 55.3 t30 -100.65 104.45 15.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.311 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 147' ' ' LYS . 50.0 p90 -100.92 -11.18 19.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.809 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.0 p-10 -64.74 -33.53 76.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.728 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.1 p-10 -98.87 8.13 45.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.591 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.441 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.27 153.04 52.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.487 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.405 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.8 p -75.37 166.05 24.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.649 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.598 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.7 t90 -59.46 -48.91 79.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.127 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -54.28 -43.07 70.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.91 0.386 . . . . 0.0 110.114 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.1 t -62.78 -40.9 98.75 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.366 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.429 ' O ' HD23 ' A' ' 156' ' ' LEU . 55.5 tp -60.69 -44.37 96.62 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.241 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.35 -42.88 99.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.853 0.359 . . . . 0.0 110.192 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.0 m -55.86 -44.9 78.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.773 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.81 -40.3 96.93 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 120.908 0.385 . . . . 0.0 110.439 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.46 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.9 -42.27 98.88 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.287 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.81 -40.45 95.6 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.52 -45.54 65.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.908 0.385 . . . . 0.0 110.792 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.71 -44.03 96.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.742 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -93.44 -8.4 41.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.596 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.67 26.5 72.04 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -101.35 50.76 0.85 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.813 0.339 . . . . 0.0 110.589 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -69.65 -39.68 76.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.667 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.58 -47.59 84.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.208 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -59.62 -39.78 85.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.268 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.15 99.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.296 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.56 -28.59 69.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.604 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.47 -54.22 7.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.016 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.534 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.7 ttp180 -65.61 -42.36 91.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.458 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.8 mt -62.38 -43.9 98.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.522 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.67 -57.67 10.19 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.079 0.466 . . . . 0.0 110.377 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.91 -33.75 69.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.482 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -81.39 -36.35 29.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.755 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.4 m-20 -55.33 -41.87 73.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.982 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.54 -42.03 99.26 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.664 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.22 -38.23 89.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.348 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 177' ' ' LEU . 82.5 mt -62.5 -42.25 99.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.733 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.11 -53.06 60.72 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.12 0.486 . . . . 0.0 110.657 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.09 -42.0 89.91 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.642 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.71 -40.06 95.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.666 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.28 -31.9 73.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.37 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.92 -22.16 18.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.662 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.656 ' NE2' ' HZ2' ' A' ' 312' ' ' LYS . 51.7 tt0 -64.63 -41.33 96.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.599 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.5 pt -75.2 136.2 25.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.6 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -125.99 106.95 9.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.312 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -177.2 125.56 0.29 Allowed Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.57 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.8 Cg_exo -43.9 152.39 0.36 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.772 2.315 . . . . 0.0 112.56 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.87 141.93 55.54 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.658 2.239 . . . . 0.0 112.468 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.25 147.46 2.2 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.585 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.03 154.45 70.59 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.764 2.309 . . . . 0.0 112.362 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.47 163.12 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.194 0.521 . . . . 0.0 110.386 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.65 170.3 16.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.932 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.47 137.56 21.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.995 0.426 . . . . 0.0 110.111 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.536 HG22 HD12 ' A' ' 205' ' ' LEU . 39.6 pt -134.4 147.14 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.657 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.56 132.04 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.157 0.503 . . . . 0.0 110.492 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -151.95 154.84 36.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.423 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.7 m -121.82 122.62 39.87 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.947 0.403 . . . . 0.0 110.344 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.93 -25.48 66.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.646 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.86 -49.65 19.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.91 -9.53 58.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.409 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.8 m80 46.97 43.74 14.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.436 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.7 t -135.78 145.11 46.2 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.347 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.47 113.49 25.96 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.26 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.1 m-20 -119.86 133.26 55.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.384 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 194' ' ' ILE . 7.5 tt -112.02 146.35 38.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.757 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.482 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.1 t90 -99.35 128.85 45.51 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.104 0.478 . . . . 0.0 110.067 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.65 154.04 40.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.174 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.68 -17.98 47.91 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.662 2.241 . . . . 0.0 111.94 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.35 -18.79 0.42 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.405 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.482 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 84.6 p -75.42 164.73 26.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.507 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.89 -28.14 65.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.461 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.556 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.4 mt-30 -63.67 -41.74 98.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.669 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.65 -44.67 96.67 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.441 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.1 mt-30 -64.45 -38.9 92.63 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 122.448 -0.442 . . . . 0.0 110.672 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.06 -41.19 97.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.276 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.61 -47.42 81.47 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.997 0.427 . . . . 0.0 110.502 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -53.82 -32.15 51.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.193 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -70.92 -19.0 62.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.555 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' A' ' 299' ' ' LEU . 92.6 mt -87.48 -8.89 55.9 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.63 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.83 2.72 55.15 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.9 152.67 21.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.339 . . . . 0.0 110.532 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.438 ' O ' HG12 ' A' ' 191' ' ' VAL . 7.8 p -115.57 128.19 55.78 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.063 0.459 . . . . 0.0 110.305 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.41 146.52 23.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.959 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.478 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -70.07 151.1 45.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.447 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.64 131.56 43.28 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.475 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.891 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.57 93.42 27.67 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.073 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.679 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.3 Cg_exo -55.52 138.99 82.02 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.629 2.219 . . . . 0.0 111.617 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.82 -25.51 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.482 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.57 -49.82 28.78 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.553 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.1 mt -54.05 -36.97 63.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.71 36.09 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.72 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.553 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.14 86.73 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.9 p -79.61 -15.04 58.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.34 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -92.37 -41.4 10.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.59 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -65.98 -17.72 64.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.621 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 56.18 43.32 26.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.466 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.23 -148.31 7.67 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.87 142.81 49.88 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.958 0.408 . . . . 0.0 110.336 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.06 149.57 28.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.328 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -100.79 -151.86 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.308 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.5 t0 55.9 -92.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.673 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.463 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.48 175.41 8.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.601 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.463 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.7 mt -122.32 141.72 41.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.766 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.7 169.17 9.45 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.226 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.8 mt -147.66 150.86 35.17 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.191 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.64 -38.82 96.83 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.82 4.2 4.78 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -77.45 -58.22 3.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.945 0.402 . . . . 0.0 110.558 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.528 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.1 m-20 -62.17 -36.64 82.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.416 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.17 -67.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.777 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.72 -42.27 67.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.102 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.72 17.38 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.645 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.34 49.13 0.34 Allowed Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.411 -0.675 . . . . 0.0 111.411 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 37.85 -109.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.635 0.255 . . . . 0.0 110.825 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.478 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.7 m120 -60.65 -45.2 95.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.493 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.82 7.85 83.48 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.04 -13.04 20.04 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.745 -0.268 . . . . 0.0 110.696 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.4 t 176.86 142.89 0.08 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.063 0.458 . . . . 0.0 110.458 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.35 125.43 11.4 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.087 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.76 143.43 29.12 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 120.916 0.389 . . . . 0.0 110.837 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.6 mt -94.88 106.47 18.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.674 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.9 t80 -101.88 -12.02 18.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.261 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.24 89.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.834 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.54 173.86 46.16 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.443 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.5 m-20 -74.44 -113.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.759 0.314 . . . . 0.0 110.734 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.74 -28.4 67.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.66 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.96 -44.14 91.44 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.27 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.68 -44.14 94.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.341 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.48 -60.38 3.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.273 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.92 -43.53 60.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.174 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.47 -43.81 75.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.252 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.1 mt -64.54 -43.6 96.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.629 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -56.52 -37.66 70.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.2 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.66 1.19 17.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.272 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -115.0 91.28 26.16 Favored Pre-proline 0 CA--C 1.528 0.134 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.118 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.97 -27.17 27.38 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.768 2.312 . . . . 0.0 111.875 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.533 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.41 -41.26 98.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.526 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.15 5.12 52.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.407 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.96 -35.38 69.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.595 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.58 4.35 16.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.516 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.66 121.51 81.33 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.615 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -47.31 -38.13 25.82 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.487 2.125 . . . . 0.0 112.533 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.535 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.86 -43.95 90.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.812 0.339 . . . . 0.0 110.391 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.73 -43.63 93.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.293 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.83 -40.64 95.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.454 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 44.8 t-20 -89.73 -12.14 40.27 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.549 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.4 mtmt 61.73 31.3 18.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.965 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -88.17 43.78 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.435 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.43 136.09 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.453 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.59 132.8 56.59 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.452 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.1 88.49 7.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.752 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.0 -41.41 97.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.891 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.46 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.42 167.26 33.76 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.4 p -75.71 -25.97 57.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.852 0.358 . . . . 0.0 110.747 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -67.77 -33.91 75.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.533 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 296' ' ' THR . 97.1 m -73.72 20.41 0.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.674 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.556 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 55.0 t80 -57.26 -51.19 70.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.939 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 68.4 mmt-85 -108.38 150.12 27.79 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.417 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.1 tp -115.54 125.78 53.43 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.811 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.468 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.7 t0 -149.56 166.72 28.36 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.598 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -49.16 -37.97 24.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.631 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.83 -65.21 0.79 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.388 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -60.92 -32.76 72.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.7 -25.22 25.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.688 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.3 mtt -63.66 -40.98 98.2 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.871 0.367 . . . . 0.0 111.057 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.85 -43.94 24.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.03 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.572 HG21 HG23 ' A' ' 296' ' ' THR . 78.9 t -66.34 -42.85 91.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.328 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.6 tp -60.06 -47.13 87.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.505 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.99 -39.4 75.95 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.578 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.9 ttt180 -61.96 -38.24 87.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.208 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -87.14 4.31 42.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.68 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.656 ' HZ2' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -113.07 -11.06 13.39 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.025 0.441 . . . . 0.0 110.283 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.3 86.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.559 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.66 -48.66 80.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.361 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 117.885 -1.055 . . . . 0.0 110.038 179.907 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.14 -2.36 58.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.442 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.488 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.06 1.24 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.533 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.93 145.26 99.32 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.774 2.316 . . . . 0.0 112.165 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.15 -179.1 7.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.6 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.0 137.0 52.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.323 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -124.57 146.73 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.443 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.4 p -119.97 135.99 54.7 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.704 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.28 -143.53 0.32 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.309 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.49 -37.15 86.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.487 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.476 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.1 ttt85 -149.31 -66.26 0.22 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.533 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.5 142.16 45.57 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 p -112.07 131.3 55.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 0.0 110.409 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -119.06 129.09 54.91 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.547 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -85.62 130.26 34.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.273 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.486 HD22 ' OE1' ' A' ' 42' ' ' GLN . 67.1 mt -95.97 78.86 3.21 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.353 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.51 -32.07 73.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.479 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 175.97 109.78 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.143 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.486 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -122.72 91.53 49.54 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.277 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.654 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.5 Cg_exo -56.97 148.92 65.0 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.818 2.345 . . . . 0.0 111.816 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.52 82.78 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.654 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.38 67.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.097 0.475 . . . . 0.0 110.279 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.19 130.73 35.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.582 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.564 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.7 t -122.78 146.91 27.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.202 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.2 t -136.26 143.48 44.28 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.62 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.6 p -99.18 -59.5 1.71 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.618 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.0 p -79.18 155.13 28.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.611 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.497 HG21 HG23 ' A' ' 70' ' ' THR . 74.0 t -74.23 -21.83 17.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.571 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.9 m -60.13 -52.25 66.13 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.553 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.8 mt -66.63 -42.33 86.93 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.249 0.547 . . . . 0.0 110.877 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.6 m -42.88 -54.06 4.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.265 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.47 -37.48 69.32 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.2 m -62.48 -44.68 95.81 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.82 0.343 . . . . 0.0 110.443 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.8 mt -66.2 -41.99 89.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.385 0.612 . . . . 0.0 110.703 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.2 tp -62.68 -40.34 96.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.284 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.17 -35.82 76.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.899 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 156' ' ' LEU . 30.6 pt -91.36 28.85 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.021 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 56.57 51.61 10.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.798 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.2 75.58 23.14 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.984 0.421 . . . . 0.0 110.054 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.53 151.41 85.67 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.723 2.282 . . . . 0.0 112.256 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.56 137.32 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.121 0.486 . . . . 0.0 110.335 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.9 pt -69.42 -43.45 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.178 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.1 131.17 53.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 110.522 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.0 p -155.77 168.98 25.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.481 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.24 -177.12 21.43 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.54 172.91 12.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 110.56 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.497 HG23 HG21 ' A' ' 51' ' ' VAL . 13.1 p -132.9 -112.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.29 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.26 179.76 0.93 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.328 -179.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.5 Cg_exo -60.93 57.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 123.032 2.488 . . . . 0.0 112.151 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.7 t-20 -64.43 -33.69 76.47 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.606 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 43.4 m-20 93.6 -36.27 0.02 OUTLIER 'General case' 0 C--N 1.344 0.332 0 O-C-N 124.014 0.822 . . . . 0.0 109.993 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.406 ' HD3' HD21 ' A' ' 73' ' ' ASN . 78.1 mtp85 -62.64 -39.38 93.67 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.299 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.88 -25.29 18.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.73 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.38 -171.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.597 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.46 -153.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.752 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.1 p-10 -52.36 -7.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.706 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.36 114.86 23.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.531 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.85 69.98 1.35 Allowed Glycine 0 CA--C 1.522 0.469 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -143.23 147.39 34.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.968 0.414 . . . . 0.0 110.673 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.49 -98.3 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.205 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.36 -42.57 96.15 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.205 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.64 53.65 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.894 0.746 . . . . 0.0 110.791 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -103.9 -8.77 19.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.429 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -65.18 -33.79 76.85 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.175 0.512 . . . . 0.0 110.649 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.548 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.84 -24.24 1.37 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.568 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.9 t -69.5 -45.68 77.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.876 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.23 -48.57 80.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.117 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.73 -38.09 89.13 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.379 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.82 -32.42 52.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.281 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.607 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.5 mmt-85 -89.87 1.77 55.8 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.588 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.54 -49.51 0.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 124.036 0.835 . . . . 0.0 110.412 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.669 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.17 154.92 0.23 Allowed 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.443 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.669 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 120.66 92.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 125.133 1.521 . . . . 0.0 110.501 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.531 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.61 143.56 42.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.291 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.8 mt -132.58 27.15 4.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.494 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.55 138.39 34.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.541 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.63 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.6 mt -137.5 165.14 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.427 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.618 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.22 -28.71 1.82 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -152.59 70.87 7.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.121 0.486 . . . . 0.0 110.396 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.97 145.38 98.49 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.789 2.326 . . . . 0.0 112.048 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.8 t -134.47 136.37 43.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.036 0.446 . . . . 0.0 110.522 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.26 -38.17 81.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.673 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.45 -42.29 96.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.511 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.94 -41.73 98.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.481 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.51 -43.19 98.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.146 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.04 -35.07 77.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.345 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.5 -18.4 58.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.476 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.96 -6.33 58.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.486 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.418 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 75.9 mtp 47.76 55.77 17.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.66 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.14 149.4 64.4 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.807 2.338 . . . . 0.0 112.093 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.16 -74.01 0.63 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.503 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.434 HD11 HD13 ' A' ' 140' ' ' LEU . 37.8 tp -110.45 113.09 25.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.368 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -101.68 126.39 55.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.5 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.2 mt -109.7 133.53 53.02 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.248 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.56 140.02 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.587 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.8 p -83.62 168.68 16.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.641 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.08 -37.61 80.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.432 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.96 159.38 42.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.476 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.2 177.49 33.2 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.14 -33.77 86.93 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -124.87 151.93 44.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.822 0.344 . . . . 0.0 110.603 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.5 t -63.14 141.01 58.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.307 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.46 10.46 11.17 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.559 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.07 -39.03 88.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.072 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.04 -35.99 23.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.361 0.6 . . . . 0.0 110.696 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.8 mt -70.83 -35.45 72.47 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.428 0.632 . . . . 0.0 110.72 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.76 -63.28 0.81 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.158 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.6 p-10 -65.89 -42.72 89.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.4 mt-30 -62.01 -32.66 73.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.164 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.3 mt -74.01 -40.35 62.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.051 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.23 -49.12 78.2 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.208 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.1 m -52.59 -42.56 64.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.216 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.77 -42.98 93.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.08 154.81 5.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.632 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.29 106.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.709 2.273 . . . . 0.0 112.339 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.644 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.0 m -110.07 121.19 44.67 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.31 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.644 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.0 153.03 30.06 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.296 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -129.09 131.22 68.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.413 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -114.92 127.85 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.443 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.477 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.8 t30 -101.38 103.62 14.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.34 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.3 p90 -101.14 -11.37 19.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.769 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.2 p-10 -64.77 -33.63 76.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.66 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.8 p-10 -98.12 7.79 45.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.603 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.449 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.64 155.6 50.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.564 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.3 p -74.96 165.71 24.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.664 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.592 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.4 t90 -59.85 -48.88 79.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.286 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.51 -41.95 66.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.088 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.2 t -62.73 -41.01 98.96 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.406 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.409 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.6 tp -60.59 -44.28 96.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.376 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.36 -43.56 98.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.211 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.0 m -54.87 -44.93 74.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.837 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.39 -40.94 98.12 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.837 0.351 . . . . 0.0 110.331 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -61.89 -42.48 99.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.157 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.9 -40.89 95.64 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.41 -46.16 64.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.899 0.381 . . . . 0.0 110.816 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.74 -44.02 96.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.735 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -92.97 -8.69 42.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.553 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.8 26.62 72.2 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -101.8 51.07 0.84 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 110.667 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -69.91 -39.38 76.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.644 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.57 -47.26 86.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.248 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -59.88 -39.36 85.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.341 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.14 99.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.322 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.71 -28.52 70.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.974 0.416 . . . . 0.0 110.576 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.39 -54.25 7.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.058 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.506 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.4 ttp180 -65.55 -42.17 92.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.518 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.466 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.3 mt -62.35 -43.86 98.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.488 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.75 -57.73 9.93 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.021 0.439 . . . . 0.0 110.453 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.78 -33.86 68.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.35 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -81.46 -36.28 29.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.811 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.2 m-20 -55.6 -41.59 73.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.238 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.64 -42.42 99.59 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.688 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.29 -38.01 88.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.366 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 177' ' ' LEU . 81.6 mt -62.25 -42.23 99.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.68 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.8 62.53 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.044 0.45 . . . . 0.0 110.66 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.19 -41.92 89.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.559 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.86 95.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.56 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.42 -31.99 73.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.379 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.63 -22.21 18.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.729 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.633 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.83 -41.16 95.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.651 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.8 pt -77.01 136.73 23.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.574 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.01 108.29 10.81 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.291 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.76 125.5 0.3 Allowed Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.512 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.6 Cg_exo -43.81 152.18 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.775 2.316 . . . . 0.0 112.499 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.79 141.82 55.61 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.61 2.206 . . . . 0.0 112.461 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.33 147.08 2.1 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.592 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.02 154.58 70.43 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.741 2.294 . . . . 0.0 112.292 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.35 163.13 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.4 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 1.9 t -143.97 170.76 15.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.817 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.12 137.99 21.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.237 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.533 HG22 HD12 ' A' ' 205' ' ' LEU . 39.4 pt -134.45 146.9 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.639 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 204' ' ' ASN . 3.0 p -133.08 131.76 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.145 0.498 . . . . 0.0 110.505 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -151.99 155.13 37.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.466 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.5 m -121.95 122.65 39.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.938 0.399 . . . . 0.0 110.392 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.25 -25.96 66.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.6 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.37 -48.69 21.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.066 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.7 -12.2 60.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.387 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.0 m80 49.74 41.69 22.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.491 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.3 t -136.45 144.97 44.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.407 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.403 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -110.88 114.38 27.67 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.295 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.73 133.24 55.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.064 0.459 . . . . 0.0 110.352 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.533 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.74 146.16 38.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.686 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.503 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 10.0 t90 -99.62 129.56 45.78 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.082 0.468 . . . . 0.0 110.089 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.01 153.76 39.78 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.144 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.407 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.4 Cg_endo -67.82 -18.11 47.22 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.741 2.294 . . . . 0.0 111.972 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.01 -18.83 0.33 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.507 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.503 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.61 165.05 25.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.521 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.15 -27.95 66.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.472 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.605 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.3 mt-30 -63.78 -41.28 97.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.642 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.55 -44.64 97.53 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.449 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.25 -38.9 92.69 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.004 0.43 . . . . 0.0 110.633 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.592 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.0 mmm -61.99 -41.21 97.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.159 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 74.8 mt -63.6 -47.22 82.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.949 0.404 . . . . 0.0 110.645 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.94 -32.09 52.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.049 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.94 -18.62 62.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.518 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.433 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.9 mt -88.01 -8.49 55.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.659 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.42 2.3 55.58 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -88.57 153.18 21.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.513 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.463 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.1 p -116.13 128.62 55.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.049 0.452 . . . . 0.0 110.421 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.74 146.14 23.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.831 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.476 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.65 151.65 45.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.526 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.68 131.4 43.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.347 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.896 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.57 93.3 27.15 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.121 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.678 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.6 Cg_exo -55.55 139.05 82.21 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.629 2.219 . . . . 0.0 111.635 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.05 -25.73 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.474 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.55 -50.11 27.46 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.554 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.8 mt -53.82 -37.31 63.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 0.0 110.252 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -66.73 36.06 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.769 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.554 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.1 88.46 0.01 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.829 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 86.7 p -81.02 -13.62 58.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.393 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -92.39 -41.49 10.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.548 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.92 -16.91 64.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.669 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.75 43.95 27.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.504 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.78 -148.67 8.03 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.63 142.98 48.92 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.996 0.426 . . . . 0.0 110.331 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.19 149.64 28.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.35 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -101.46 -151.69 0.42 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.305 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 56.19 -92.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.635 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.464 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.83 175.23 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.629 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.464 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.2 mt -122.4 141.79 41.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.676 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.98 169.55 9.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.285 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.7 mt -148.01 151.11 35.2 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.106 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.52 -39.05 97.23 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.97 4.21 4.7 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -77.57 -58.07 3.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.903 0.382 . . . . 0.0 110.577 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.552 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.9 m-20 -62.1 -36.71 82.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.301 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.403 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.0 mp -52.26 -67.75 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.748 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.31 -42.49 66.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.231 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.02 17.66 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.678 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.1 49.03 0.31 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.28 -109.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.609 0.242 . . . . 0.0 110.715 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.68 -45.06 95.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.47 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.4 7.96 84.02 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.85 -13.6 20.0 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.821 -0.223 . . . . 0.0 110.617 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.0 t 177.2 142.57 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.996 0.427 . . . . 0.0 110.5 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.05 125.34 11.54 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.998 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.432 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -98.66 143.31 29.18 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.8 178.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.6 mt -94.5 106.38 18.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.626 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.439 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.2 t80 -101.4 -12.5 18.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.254 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.66 90.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.749 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.32 173.63 46.03 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.46 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -73.91 -112.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.797 0.332 . . . . 0.0 110.72 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -68.02 -28.52 67.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.666 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -58.76 -44.12 90.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.386 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.64 -44.29 94.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.333 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.54 -60.31 3.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.267 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -50.95 -43.36 60.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.229 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.56 75.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.267 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.5 mt -64.56 -43.67 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.607 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -56.27 -37.34 69.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.241 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.54 0.79 18.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.28 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -115.22 91.24 27.05 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.242 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.26 -26.87 28.42 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.814 2.343 . . . . 0.0 111.84 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.5 -40.95 98.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.564 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.591 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.35 5.21 52.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.435 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.1 -35.07 69.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.717 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.6 4.65 15.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.538 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.99 120.99 80.03 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.559 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -47.24 -37.53 24.26 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.501 2.134 . . . . 0.0 112.451 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -59.1 -43.74 91.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.818 0.342 . . . . 0.0 110.323 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.91 -43.7 92.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.377 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.85 -40.54 95.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.483 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.437 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 44.3 t-20 -89.54 -12.72 39.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.601 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 62.03 31.37 17.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.809 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.37 43.72 1.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.417 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -103.95 136.02 38.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.489 -179.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -116.77 132.36 56.71 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.466 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.41 88.24 7.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.668 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.83 -40.85 97.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.821 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.439 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.6 167.24 34.14 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.51 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 76.3 p -75.68 -25.76 57.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.854 0.359 . . . . 0.0 110.746 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.0 tp10 -67.8 -34.62 77.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.427 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 94.6 m -73.53 25.44 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.714 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.605 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 60.8 t80 -58.18 -51.2 70.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.342 -0.39 . . . . 0.0 109.986 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.417 HH12 ' HG3' ' A' ' 212' ' ' GLN . 66.4 mmt-85 -112.02 155.24 24.11 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.433 ' CD2' HD11 ' A' ' 219' ' ' LEU . 45.5 tp -116.01 125.14 52.08 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.748 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.491 ' CB ' HD23 ' A' ' 83' ' ' LEU . 45.2 t0 -147.58 165.52 30.14 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.551 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -49.07 -38.1 23.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.512 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.71 -65.28 0.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.232 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -61.01 -32.79 72.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.51 -25.48 25.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.601 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.5 mtt -63.38 -41.09 98.77 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 120.924 0.392 . . . . 0.0 110.918 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.17 -43.91 22.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.978 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.569 HG21 HG23 ' A' ' 296' ' ' THR . 76.0 t -66.29 -42.88 91.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.417 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 52.1 tp -60.31 -47.23 86.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.546 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -69.74 -39.6 76.66 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.516 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.6 ttt180 -62.06 -38.24 88.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.217 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.6 mt -87.12 4.5 42.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.741 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.633 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.3 tttt -112.86 -11.23 13.48 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.038 0.447 . . . . 0.0 110.355 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.03 85.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.638 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.94 -48.82 80.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.366 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.134 179.804 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -89.63 -2.49 58.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.391 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.2 179.01 1.25 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.521 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.6 Cg_exo -60.66 145.13 99.39 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.718 2.279 . . . . 0.0 112.171 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.82 -179.4 8.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.655 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.91 137.4 52.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.39 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -125.05 147.11 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.437 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 79.1 p -120.24 136.26 54.71 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.788 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.18 -143.83 0.32 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.199 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -63.53 -37.23 86.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.441 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.57 -67.19 0.23 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.475 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.44 142.59 45.05 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.2 p -112.16 131.45 55.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 110.377 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -119.13 129.51 55.07 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.517 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 m -86.64 131.33 34.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.871 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.478 HD22 ' OE1' ' A' ' 42' ' ' GLN . 66.3 mt -96.96 79.37 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.496 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.75 -31.79 72.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.521 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.77 109.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.117 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.478 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.06 92.18 48.87 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.386 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 37.3 Cg_exo -57.08 148.72 67.28 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.724 2.283 . . . . 0.0 111.782 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.85 83.0 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 O-C-N 123.491 0.495 . . . . 0.0 110.927 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.49 67.11 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.293 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.09 130.75 35.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.604 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.559 ' HA ' HG23 ' A' ' 64' ' ' VAL . 56.1 t -122.62 146.47 27.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.067 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 t -135.88 143.47 45.05 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.679 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.6 p -99.06 -59.77 1.66 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.599 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.3 p -79.25 155.33 28.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.659 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.496 HG21 HG23 ' A' ' 70' ' ' THR . 70.8 t -74.06 -22.07 18.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.488 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.2 m -60.27 -52.05 66.92 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.484 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.6 mt -66.43 -42.18 88.09 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.312 0.577 . . . . 0.0 110.881 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.0 m -43.7 -53.78 5.56 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.19 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.22 -37.28 71.63 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.5 m -62.77 -44.61 95.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.826 0.346 . . . . 0.0 110.517 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.412 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.0 mt -66.22 -42.05 89.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.397 0.617 . . . . 0.0 110.652 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.57 -40.44 96.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.354 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.09 -35.77 75.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.066 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 156' ' ' LEU . 32.4 pt -91.36 28.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.256 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.53 51.68 10.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.875 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.4 75.83 22.13 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.924 0.393 . . . . 0.0 109.962 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.67 151.46 85.55 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.733 2.289 . . . . 0.0 112.382 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.48 136.87 48.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.185 0.517 . . . . 0.0 110.267 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.441 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -69.06 -43.58 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.299 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.03 131.18 53.42 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.025 0.44 . . . . 0.0 110.598 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.8 p -155.7 168.82 25.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.433 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.98 -177.07 21.57 Favored Glycine 0 N--CA 1.464 0.524 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.631 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.53 172.68 12.4 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 110.527 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.496 HG23 HG21 ' A' ' 51' ' ' VAL . 15.3 p -132.8 -112.52 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.96 0.41 . . . . 0.0 110.36 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.28 179.69 0.94 Allowed Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.368 -179.103 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.8 Cg_exo -60.91 58.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.978 2.452 . . . . 0.0 112.094 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.3 t-20 -64.57 -33.66 76.43 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.526 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.2 m-20 93.8 -36.76 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.064 0.852 . . . . 0.0 109.923 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -62.57 -39.48 93.81 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.24 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.1 p -74.35 -25.66 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.715 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.16 -171.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.617 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.86 -154.2 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.76 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 38.0 p-10 -52.53 -7.54 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.669 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.16 115.17 23.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.545 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.99 69.54 1.36 Allowed Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -143.12 147.37 34.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.937 0.399 . . . . 0.0 110.752 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.15 -98.47 0.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.204 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.0 -42.73 97.08 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.16 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.553 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.0 tt0 91.62 53.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.97 0.794 . . . . 0.0 110.907 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -103.27 -8.7 20.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.369 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.8 p -65.06 -33.85 77.03 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.1 0.476 . . . . 0.0 110.589 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.542 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.1 mttt -48.88 -24.05 1.32 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.644 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.45 -46.0 77.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.921 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.4 -48.42 81.31 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.071 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.57 -38.24 89.33 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.272 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.83 -32.52 53.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.272 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.605 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.7 mmt-85 -89.98 1.57 56.13 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.566 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.8 -49.24 0.17 Allowed 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.999 0.812 . . . . 0.0 110.3 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.659 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.28 154.21 0.29 Allowed 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.259 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.659 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 121.01 92.39 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 125.287 1.617 . . . . 0.0 110.476 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.7 mtp180 -75.47 143.43 42.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.057 0.456 . . . . 0.0 110.354 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.2 mt -132.44 27.07 4.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.461 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.36 138.23 34.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.548 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.7 mt -137.43 165.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.358 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.618 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.5 -28.81 1.77 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.55 70.96 7.46 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.15 0.5 . . . . 0.0 110.373 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.89 145.27 98.71 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.714 2.276 . . . . 0.0 112.075 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.9 t -134.4 136.37 43.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.485 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.81 -38.22 83.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.669 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.37 -42.28 96.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.496 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.49 98.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.494 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.3 t -63.65 -43.4 98.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.029 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.07 77.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.32 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.66 -18.69 60.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.464 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.36 -6.42 58.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.566 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 77.9 mtp 47.74 55.82 17.11 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.56 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.12 149.18 64.26 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.768 2.312 . . . . 0.0 112.109 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.28 -74.05 0.63 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.406 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.422 HD11 HD13 ' A' ' 140' ' ' LEU . 38.5 tp -110.3 113.13 25.55 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.264 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.3 mt -101.93 126.19 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.481 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.7 mt -109.19 133.28 53.22 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.202 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.16 139.31 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.533 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.9 p -83.57 168.54 16.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.677 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.21 -37.42 80.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.437 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -139.85 158.89 43.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.477 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.16 177.67 33.08 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.89 87.36 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -125.15 152.03 45.0 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.954 0.407 . . . . 0.0 110.555 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.3 t -63.34 141.24 58.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.36 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.84 10.54 10.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.684 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.9 mp -61.27 -39.02 88.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.973 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.74 -36.09 23.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.467 0.651 . . . . 0.0 110.612 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.2 mt -70.93 -35.34 72.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.447 0.641 . . . . 0.0 110.756 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -42.81 -62.68 0.94 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.27 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.7 p-10 -65.98 -42.59 89.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.067 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.4 -32.81 73.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.14 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.7 mt -73.44 -40.91 63.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.136 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.43 -48.78 79.58 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.167 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.0 m -53.01 -42.7 65.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.241 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.7 -43.2 93.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.106 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.47 154.27 5.56 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.599 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -39.24 106.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.624 2.216 . . . . 0.0 112.377 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 94.3 m -110.22 121.4 45.18 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.983 0.421 . . . . 0.0 110.218 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.37 152.89 30.78 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.233 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -129.09 131.38 68.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.428 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -115.01 127.9 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.553 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.2 t30 -101.74 103.65 14.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.278 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.2 p90 -101.19 -11.22 19.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.797 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.7 -33.74 76.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.631 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.571 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.6 p-10 -98.09 7.96 45.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.661 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.94 155.6 50.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.503 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.401 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.0 165.7 24.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.689 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.59 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.91 -48.52 81.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.244 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.79 -42.02 67.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.1 t -62.6 -41.17 98.81 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.356 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.406 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.4 tp -60.58 -44.35 96.32 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.441 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.45 -43.42 98.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.164 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -54.99 -44.87 74.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.797 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.67 -40.63 97.66 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.837 0.351 . . . . 0.0 110.289 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -62.03 -42.53 99.27 Favored 'General case' 0 CA--C 1.51 -0.558 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.245 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.01 -41.1 95.4 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.3 -46.17 64.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.953 0.406 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.66 -44.06 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.826 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.7 p -93.01 -8.86 41.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.567 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.93 26.9 72.4 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -102.06 50.65 0.84 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.849 0.357 . . . . 0.0 110.694 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -69.57 -39.44 77.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.677 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.78 -47.23 86.54 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.292 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -59.78 -39.57 85.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.275 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.94 -40.91 99.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.259 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.68 -28.89 70.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.522 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.04 -54.24 8.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.197 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.506 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.5 ttp180 -65.49 -42.16 92.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.494 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.4 mt -62.43 -43.77 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.524 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.62 -57.61 10.44 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.971 0.415 . . . . 0.0 110.515 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.66 -33.34 68.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.366 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.409 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.2 t80 -81.58 -36.52 28.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.856 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 170' ' ' ILE . 58.0 m-20 -55.46 -41.95 73.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.411 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.72 -42.17 99.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.646 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.34 -37.89 88.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.222 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.409 HD11 ' CD2' ' A' ' 173' ' ' PHE . 81.5 mt -62.43 -42.31 99.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.715 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.93 62.0 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.078 0.466 . . . . 0.0 110.677 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.36 -41.72 89.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.519 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.05 95.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.55 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.26 -32.15 73.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.409 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.65 -22.38 18.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.681 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.56 -41.23 96.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.651 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 184' ' ' ILE . 32.6 pt -76.95 136.46 24.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.659 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -126.83 108.27 10.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.291 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -177.04 125.81 0.3 Allowed Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.492 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.1 Cg_exo -44.02 152.44 0.38 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.806 2.337 . . . . 0.0 112.468 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.85 141.83 55.31 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.68 2.253 . . . . 0.0 112.48 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.55 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.16 146.98 2.14 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.602 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.06 154.57 70.3 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.817 2.345 . . . . 0.0 112.272 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.38 163.22 29.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.472 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -144.03 170.75 15.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.829 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.61 137.71 21.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.225 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.537 HG22 HD12 ' A' ' 205' ' ' LEU . 39.0 pt -134.45 147.14 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.617 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.43 132.05 57.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.148 0.499 . . . . 0.0 110.482 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -151.95 154.87 36.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.398 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.0 m -122.31 122.94 40.24 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.64 -25.83 66.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.623 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.22 -48.99 20.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.035 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.99 -11.03 60.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.373 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 76.8 m80 48.59 41.74 17.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.467 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.6 t -136.31 144.97 44.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.391 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.19 114.36 27.54 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.278 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.6 m-20 -119.79 133.41 55.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 110.376 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.537 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.81 146.24 37.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.79 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.498 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.6 t90 -99.26 129.94 45.52 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.083 0.468 . . . . 0.0 109.997 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.55 153.72 39.42 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.126 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.4 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.9 Cg_endo -67.95 -17.97 46.47 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.811 2.341 . . . . 0.0 111.852 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.24 -19.16 0.44 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.397 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.498 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.1 p -75.44 164.72 26.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.502 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.95 -27.72 65.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.504 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.585 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.0 mt-30 -63.85 -41.22 97.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.582 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.69 -44.52 97.81 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.41 -38.86 92.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.995 0.426 . . . . 0.0 110.578 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.59 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.1 mmm -62.24 -41.18 98.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.063 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.1 mt -63.78 -46.65 84.25 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.646 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.7 -31.84 58.58 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.7 -18.77 62.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.537 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.443 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.4 mt -87.39 -9.4 54.86 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.664 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.51 1.71 53.36 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -88.34 153.84 20.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.884 0.373 . . . . 0.0 110.469 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.444 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.0 p -116.41 128.84 55.86 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.071 0.462 . . . . 0.0 110.471 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.65 146.33 23.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.864 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.479 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.82 151.41 45.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.516 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.56 131.41 43.32 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.43 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.892 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.61 93.53 28.35 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.095 -179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.675 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.0 Cg_exo -55.85 139.07 83.62 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.556 2.171 . . . . 0.0 111.521 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.1 -26.05 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.503 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.18 -50.03 30.11 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.553 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.7 mt -53.99 -37.05 63.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -66.73 36.09 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.794 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.553 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.0 88.38 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.949 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 81.5 p -80.98 -14.08 58.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.398 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.85 -41.82 10.41 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.597 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.2 t -66.64 -16.96 64.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.621 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.76 44.01 26.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.507 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.75 -149.21 8.32 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.09 142.75 48.61 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.013 0.435 . . . . 0.0 110.339 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -151.95 149.61 29.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.368 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -101.32 -151.67 0.42 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.319 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.03 -92.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.689 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.468 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.85 175.38 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.596 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.468 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.2 mt -122.69 141.85 41.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.815 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.87 169.61 9.1 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.31 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.4 mt -147.82 150.9 35.04 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.21 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.65 -38.98 97.06 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.1 3.97 4.71 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -77.49 -57.98 3.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.897 0.38 . . . . 0.0 110.651 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.55 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.4 m-20 -62.09 -36.73 82.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.196 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 9.9 mp -52.38 -67.59 0.24 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.725 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.66 -42.24 67.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.154 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.92 17.42 0.17 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.649 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.37 48.76 0.33 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.31 -109.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.621 0.248 . . . . 0.0 110.753 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.479 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.7 m120 -60.94 -44.58 97.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.521 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.15 7.89 84.56 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.92 -13.54 19.94 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.748 -0.266 . . . . 0.0 110.732 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.5 t 177.08 142.52 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.131 0.491 . . . . 0.0 110.504 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.95 125.47 11.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.106 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 191' ' ' VAL . 14.0 m-30 -98.42 143.72 28.56 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 120.937 0.399 . . . . 0.0 110.711 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.2 mt -95.22 106.28 18.29 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.727 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.442 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.0 t80 -101.79 -11.81 18.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.221 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.96 -40.75 87.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.831 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.9 173.2 45.81 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.472 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -74.06 -113.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 110.709 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.28 -28.76 68.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.725 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.01 -43.89 91.61 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.27 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -63.62 -44.33 94.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.31 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.65 -60.02 3.75 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.266 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.09 -43.38 61.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.102 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.43 -43.57 75.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.161 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.56 -43.66 96.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.615 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -56.22 -37.59 69.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.156 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.5 0.93 18.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.259 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -115.12 91.51 27.63 Favored Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.167 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.4 -27.09 30.13 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.846 2.364 . . . . 0.0 111.717 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.536 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.41 -41.2 98.72 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.558 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.9 mp -95.1 4.9 53.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.432 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.08 70.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.703 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -79.97 4.53 16.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.615 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.64 121.29 80.49 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.536 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -47.49 -37.65 26.38 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.408 2.072 . . . . 0.0 112.424 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.527 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -59.03 -43.63 91.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.792 0.329 . . . . 0.0 110.289 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.05 -43.86 92.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.279 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.82 -40.65 95.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.519 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.9 t-20 -89.54 -12.92 38.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.541 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.35 32.7 16.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.49 43.87 1.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.341 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.48 135.67 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.539 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.72 132.62 56.64 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.469 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.32 89.01 7.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.7 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.411 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.1 mt -63.9 -41.11 97.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.783 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.95 165.57 34.09 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.52 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 76.5 p -75.44 -25.74 57.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.865 0.364 . . . . 0.0 110.665 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -68.35 -34.49 76.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.345 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 296' ' ' THR . 95.3 m -72.98 25.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.722 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.585 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 39.6 t80 -58.53 -50.36 74.05 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.408 HH12 ' HG3' ' A' ' 212' ' ' GLN . 79.1 mmt-85 -111.05 153.48 25.56 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.443 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.9 tp -115.53 125.03 52.51 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.691 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.482 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.4 t0 -147.88 165.71 29.81 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.614 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -49.3 -38.16 26.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.509 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -71.23 -65.47 0.74 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.421 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -60.96 -32.73 72.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.962 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.4 -25.61 25.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.634 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.6 mtt -63.5 -41.02 98.55 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 120.905 0.383 . . . . 0.0 111.003 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -78.7 -44.03 24.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.067 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.58 HG21 HG23 ' A' ' 296' ' ' THR . 76.6 t -66.18 -42.99 92.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.352 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.9 tp -60.14 -47.27 86.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.481 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -69.7 -39.66 76.79 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.634 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.4 ttt180 -61.63 -38.67 88.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.19 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -86.84 4.42 41.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.759 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.59 -11.19 13.61 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.018 0.437 . . . . 0.0 110.28 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.83 -37.12 85.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.632 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.19 -48.63 80.65 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.326 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.975 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.618 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.75 -2.4 58.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.38 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.484 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.12 179.06 1.24 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.047 0.451 . . . . 0.0 110.514 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.6 Cg_exo -60.98 145.1 99.57 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.773 2.316 . . . . 0.0 112.169 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.618 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.77 -179.31 8.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.553 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.7 136.88 52.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.355 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.0 tp -124.64 147.44 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.372 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.4 p -120.39 136.1 54.83 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.767 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.5 -143.47 0.33 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.25 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.41 -37.3 86.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.477 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.1 -66.85 0.22 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.467 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.64 142.48 45.61 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.2 p -112.2 131.71 55.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.951 0.405 . . . . 0.0 110.401 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.15 128.89 54.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.53 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.2 m -85.49 130.36 34.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.237 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.472 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.8 mt -95.71 78.75 3.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.306 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.6 -32.19 73.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.493 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 176.03 109.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.099 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.472 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -122.55 91.59 49.35 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.28 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.2 Cg_exo -56.95 148.54 67.19 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.794 2.329 . . . . 0.0 111.869 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.15 82.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.595 0.56 . . . . 0.0 111.022 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.43 66.82 0.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.227 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.85 130.83 35.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.697 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.572 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.7 t -122.57 147.43 26.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.079 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 t -136.62 143.74 43.69 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.65 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.7 p -99.22 -59.48 1.72 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.572 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.0 p -79.01 155.46 28.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.688 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.538 HG21 HG23 ' A' ' 70' ' ' THR . 70.3 t -74.43 -21.9 17.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.557 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.2 m -60.22 -51.87 67.72 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.503 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.4 mt -66.56 -42.4 87.15 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.319 0.58 . . . . 0.0 110.905 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.5 m -43.37 -53.83 5.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.065 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.27 -37.84 71.35 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.7 m -62.5 -44.45 96.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.846 0.355 . . . . 0.0 110.34 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.408 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.5 mt -65.99 -42.14 90.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.464 0.65 . . . . 0.0 110.714 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tp -62.57 -40.13 95.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.453 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.517 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.48 -36.11 77.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.134 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 156' ' ' LEU . 33.3 pt -90.9 28.29 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.208 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.81 51.82 10.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.939 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.83 75.75 24.45 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.974 0.416 . . . . 0.0 109.889 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.18 150.63 87.93 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.781 2.32 . . . . 0.0 112.213 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.36 136.88 48.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.198 0.523 . . . . 0.0 110.282 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.25 -43.55 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.307 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.11 131.19 53.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.006 0.431 . . . . 0.0 110.553 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.6 p -155.46 168.61 26.54 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.399 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.69 -177.42 21.75 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.637 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.77 172.86 12.2 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 120.881 0.372 . . . . 0.0 110.518 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.538 HG23 HG21 ' A' ' 51' ' ' VAL . 14.7 p -132.41 -113.16 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.374 . . . . 0.0 110.312 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.87 179.85 0.92 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.353 -179.02 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.8 Cg_exo -61.23 57.74 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.988 2.458 . . . . 0.0 112.137 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.545 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 60.4 t-20 -64.37 -33.38 75.71 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.468 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 42.7 m-20 93.76 -35.68 0.02 OUTLIER 'General case' 0 C--N 1.345 0.403 0 O-C-N 124.182 0.926 . . . . 0.0 109.804 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.6 mtp85 -63.05 -39.86 95.98 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.989 0.423 . . . . 0.0 110.267 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -74.73 -25.33 18.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.738 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.03 -171.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.599 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -73.3 -154.16 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.787 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.2 p-10 -52.11 -7.71 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.684 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -86.34 115.1 23.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.594 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.18 70.06 1.34 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -143.57 147.46 34.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.931 0.396 . . . . 0.0 110.784 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.57 -98.48 0.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.137 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.87 -42.74 97.44 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.129 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.569 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.6 tt0 91.68 53.13 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.066 0.854 . . . . 0.0 110.892 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -102.95 -9.31 19.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.419 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -64.54 -34.26 77.82 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.173 0.511 . . . . 0.0 110.664 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.569 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.1 mttt -48.91 -24.79 1.61 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.597 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.2 -45.66 79.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.792 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.25 -48.47 81.28 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.038 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.48 -38.35 89.52 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.364 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.67 -33.0 53.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.176 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.592 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.1 mmt-85 -89.72 1.47 56.03 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.598 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.92 -49.13 0.16 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 124.159 0.912 . . . . 0.0 110.288 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.64 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.1 mt -46.52 153.79 0.34 Allowed 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 117.403 -1.284 . . . . 0.0 109.264 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.64 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 121.62 92.62 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 O-C-N 125.625 1.828 . . . . 0.0 110.431 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.533 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.7 143.29 42.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.122 0.487 . . . . 0.0 110.276 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.3 mt -132.42 27.06 4.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.453 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.37 138.07 34.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.036 0.446 . . . . 0.0 110.512 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.9 mt -137.17 164.98 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.401 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.614 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.13 -28.63 1.83 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -153.01 70.93 7.1 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.167 0.508 . . . . 0.0 110.232 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.12 145.48 98.37 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.715 2.277 . . . . 0.0 112.089 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.5 t -134.2 136.61 43.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.563 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.35 82.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.649 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.31 -42.18 96.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.512 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.57 98.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.478 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.66 -43.31 98.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.961 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.2 77.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.26 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.48 -18.7 60.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.438 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.39 -6.44 58.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.523 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 72.4 mtp 47.94 55.85 17.23 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.617 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.16 148.99 63.72 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.798 2.332 . . . . 0.0 112.098 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.15 -73.04 0.66 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.501 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 140' ' ' LEU . 37.9 tp -111.32 113.64 26.26 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.313 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.4 mt -102.6 126.37 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.537 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.3 mt -109.77 134.06 52.44 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.143 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.77 139.87 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.496 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.4 p -83.4 168.45 16.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.707 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.16 -37.4 80.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.41 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -139.99 159.21 42.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.433 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.27 177.28 33.37 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.24 -33.87 87.36 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.57 151.74 44.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.904 0.383 . . . . 0.0 110.543 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -63.39 140.85 58.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.32 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.54 10.66 11.16 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.657 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.18 -39.04 88.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.092 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.633 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.86 23.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.586 0.708 . . . . 0.0 110.611 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.0 mt -70.76 -35.65 72.72 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.531 0.681 . . . . 0.0 110.764 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.88 -62.96 0.88 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.273 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.633 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.89 -42.64 90.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.046 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -62.17 -32.77 73.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.177 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.5 mt -73.48 -40.9 63.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.24 -48.85 79.11 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.16 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.3 m -52.9 -42.58 65.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.199 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.74 -43.05 93.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.107 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.75 153.89 5.15 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.62 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -39.12 106.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.664 2.243 . . . . 0.0 112.406 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.64 ' C ' HD12 ' A' ' 140' ' ' LEU . 96.8 m -110.33 121.52 45.47 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.244 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.64 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.02 152.96 30.19 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.26 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.9 131.0 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.309 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -114.79 127.78 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.432 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.3 103.75 14.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.278 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 147' ' ' LYS . 45.5 p90 -101.45 -11.2 19.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.783 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.69 -33.61 76.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.666 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -98.21 7.79 45.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.525 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.76 155.46 50.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.527 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.7 p -74.89 165.71 24.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.709 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -60.05 -48.65 80.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.197 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.79 -42.02 67.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.923 0.392 . . . . 0.0 110.027 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.8 t -62.63 -41.11 98.83 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.358 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.409 ' CD1' HG21 ' A' ' 142' ' ' ILE . 47.4 tp -60.7 -44.17 96.89 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.353 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.4 tp -61.5 -43.22 99.26 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.101 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -55.31 -44.88 76.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.52 -40.65 97.44 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.894 0.378 . . . . 0.0 110.327 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -61.95 -42.46 99.14 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.31 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.88 -40.62 95.54 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.58 -45.86 64.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.926 0.393 . . . . 0.0 110.855 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.67 -44.04 96.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.85 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.3 p -93.19 -8.61 41.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.588 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.78 26.34 72.08 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -101.47 50.75 0.85 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.768 0.318 . . . . 0.0 110.67 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.58 -39.36 77.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.659 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.5 -47.17 86.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.234 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -60.19 -39.45 86.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.308 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.1 99.37 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.307 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.94 -28.69 70.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.994 0.426 . . . . 0.0 110.602 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.19 -54.24 8.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.15 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.517 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.4 ttp180 -65.55 -42.25 92.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.477 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.454 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.3 mt -62.45 -43.94 98.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.492 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.48 -58.96 5.71 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.14 0.495 . . . . 0.0 110.48 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -56.51 -34.16 66.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.448 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -80.79 -36.21 32.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.886 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.7 m-20 -55.1 -42.26 72.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.095 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.42 -41.82 98.98 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.686 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.05 -38.19 90.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.285 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.7 mt -62.38 -42.11 99.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.771 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.47 63.87 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.084 0.469 . . . . 0.0 110.677 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.35 -41.79 89.02 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.601 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.06 -39.94 95.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.566 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.12 -32.43 73.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.361 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.24 -21.97 18.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.668 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.625 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.67 -41.35 96.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.64 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 pt -76.59 135.92 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.677 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.93 107.79 10.39 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.273 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.67 125.97 0.31 Allowed Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.541 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 73.9 Cg_exo -43.72 152.24 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.781 2.32 . . . . 0.0 112.601 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.87 141.98 55.75 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.573 2.182 . . . . 0.0 112.484 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.547 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.22 147.32 2.19 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.628 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.34 154.85 68.79 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.735 2.29 . . . . 0.0 112.284 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.56 163.27 28.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.419 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.84 170.8 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.959 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.92 137.92 21.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.93 0.395 . . . . 0.0 110.195 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.542 HG22 HD12 ' A' ' 205' ' ' LEU . 40.1 pt -134.47 147.37 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.692 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -133.2 131.95 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.098 0.475 . . . . 0.0 110.501 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -151.99 155.08 37.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.442 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.615 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.6 m -122.33 122.84 40.0 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.96 0.41 . . . . 0.0 110.366 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.2 -25.78 65.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.613 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.615 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.49 -48.46 22.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.069 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.07 -11.21 60.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.386 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.6 m80 48.25 41.55 16.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.485 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.3 t -135.89 145.22 46.08 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.42 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.406 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -110.94 114.02 27.03 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.233 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.63 133.13 55.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 110.351 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.542 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.77 146.24 37.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.772 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.468 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 10.3 t90 -99.36 129.77 45.59 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.096 0.475 . . . . 0.0 109.973 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.59 153.81 39.37 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.306 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.414 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.8 Cg_endo -67.76 -18.39 47.56 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.716 2.277 . . . . 0.0 111.954 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.1 -18.44 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.4 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.468 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.3 p -76.42 164.69 25.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.508 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.78 -27.64 65.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.514 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.603 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.1 mt-30 -63.75 -41.1 98.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.77 -44.48 97.93 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.63 -38.63 91.68 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.961 0.41 . . . . 0.0 110.575 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.3 mmm -62.16 -41.35 98.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.082 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.71 -46.91 83.28 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.534 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.5 -31.91 56.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.073 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.79 -18.68 62.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.449 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.414 HD11 ' CD2' ' A' ' 299' ' ' LEU . 92.1 mt -87.61 -9.31 54.64 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.61 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.29 1.9 54.04 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -88.34 153.77 20.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 110.516 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.458 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.3 p -116.56 129.02 55.94 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.119 0.485 . . . . 0.0 110.331 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -93.02 146.21 23.79 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.927 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.477 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.41 151.48 46.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.49 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.39 131.41 43.63 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.397 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.891 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.54 93.3 27.01 Favored Pre-proline 0 C--O 1.234 0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.077 -179.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.677 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.6 Cg_exo -55.75 138.96 82.94 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.569 2.179 . . . . 0.0 111.527 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.84 -25.59 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.46 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.26 -49.96 29.96 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.552 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.0 mt -54.0 -36.8 63.34 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.85 36.42 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.814 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.75 86.94 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.905 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.1 p -79.4 -15.39 57.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.405 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -92.19 -41.29 10.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.627 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -66.03 -17.94 65.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.605 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.17 43.37 26.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.468 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.49 -147.76 7.46 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.97 142.66 50.08 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.026 0.441 . . . . 0.0 110.294 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.43 149.82 28.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.353 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -101.3 -151.55 0.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.347 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.4 t0 56.16 -91.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.652 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.471 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.85 175.35 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.559 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.471 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 93.4 mt -122.29 141.76 41.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.833 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.81 169.02 9.53 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.221 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.5 mt -147.68 151.07 35.53 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.266 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.69 -39.0 97.06 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.06 4.0 4.72 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.27 -58.06 3.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.996 0.426 . . . . 0.0 110.578 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.541 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.8 m-20 -62.22 -36.93 83.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.212 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.406 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.1 mp -52.21 -67.61 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.778 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.71 -42.13 67.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.132 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.0 17.71 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.607 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.25 48.46 0.31 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.47 -109.79 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.605 0.24 . . . . 0.0 110.7 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.9 -44.59 96.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.42 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.21 7.95 84.38 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -98.91 -13.33 20.05 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.713 -0.286 . . . . 0.0 110.693 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.6 t 177.03 142.71 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.089 0.471 . . . . 0.0 110.498 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.06 125.49 11.64 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.176 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.6 m-30 -98.65 143.26 29.23 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 120.923 0.392 . . . . 0.0 110.809 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.9 mt -94.42 106.32 18.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.678 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.451 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.9 t80 -101.58 -11.55 19.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.108 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.43 87.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.874 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.74 174.12 46.32 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.475 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.4 m-20 -74.35 -113.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.741 0.305 . . . . 0.0 110.772 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.78 -28.69 67.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.708 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.03 -43.93 91.68 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.271 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.72 -44.26 94.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.377 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.52 -60.14 3.59 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.247 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.11 -43.26 61.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.17 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.53 -43.68 75.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.2 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.2 mt -64.47 -43.65 96.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.664 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -56.31 -37.39 69.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.162 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.77 0.95 18.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.197 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -115.05 91.31 26.5 Favored Pre-proline 0 CA--C 1.529 0.147 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.148 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.29 -27.2 29.76 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.796 2.33 . . . . 0.0 111.832 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.36 -41.02 98.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.569 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.45 5.22 52.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.349 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.97 -35.21 69.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.695 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.58 4.56 15.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.527 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.58 121.33 80.51 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.566 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -47.6 -37.69 27.25 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.397 2.065 . . . . 0.0 112.558 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.53 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.94 -43.57 91.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.856 0.36 . . . . 0.0 110.305 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.88 -43.89 92.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.285 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.91 -40.59 95.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.444 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.437 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.7 t-20 -89.32 -12.93 39.13 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.529 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.5 mtmt 62.32 31.94 17.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.893 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -89.01 43.87 1.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.046 0.45 . . . . 0.0 110.313 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.51 135.87 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.444 -179.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -116.61 132.55 56.65 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.485 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.1 87.84 7.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.769 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.86 -41.23 97.83 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.866 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.451 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.46 167.65 34.58 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.516 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 71.2 p -75.53 -25.69 57.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.845 0.355 . . . . 0.0 110.763 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.4 tp10 -67.84 -34.86 77.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.452 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 95.7 m -73.27 24.59 0.06 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.65 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.603 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 65.5 t80 -58.23 -51.18 70.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.421 HH12 ' HG3' ' A' ' 212' ' ' GLN . 58.9 mmt-85 -112.17 155.1 24.5 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.414 ' CD2' HD11 ' A' ' 219' ' ' LEU . 46.1 tp -116.3 125.64 52.43 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.49 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.0 t0 -147.29 165.3 30.52 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.573 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -49.41 -38.2 28.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.548 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -72.23 -64.8 0.87 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.509 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.3 -32.11 70.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.984 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.66 -25.3 26.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.571 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.6 mtt -63.08 -41.18 99.35 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 120.965 0.412 . . . . 0.0 110.953 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -78.33 -44.79 24.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.095 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.554 HG21 HG23 ' A' ' 296' ' ' THR . 73.6 t -66.0 -43.06 92.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.435 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.441 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 52.7 tp -60.26 -47.37 86.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.548 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.94 -39.39 76.11 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.635 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.1 ttt180 -61.96 -38.07 87.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.233 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.8 mt -87.38 4.61 42.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.794 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.625 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.3 tttt -112.87 -11.7 13.4 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.045 0.45 . . . . 0.0 110.284 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.04 -37.31 86.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.539 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.95 -48.69 80.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.379 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.022 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.56 -2.53 57.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.43 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.488 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.61 179.03 1.25 Allowed Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.457 -179.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.7 Cg_exo -60.81 144.7 99.6 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.796 2.331 . . . . 0.0 112.183 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.98 -179.65 8.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.596 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.61 136.27 53.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.317 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -123.91 146.65 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.333 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.3 p -119.91 136.0 54.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.77 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.1 p30 -99.42 -143.62 0.33 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.225 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -63.4 -37.19 86.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.593 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.9 ttt85 -149.3 -66.62 0.22 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.501 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.29 142.1 45.16 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.8 p -112.15 131.03 55.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.934 0.397 . . . . 0.0 110.437 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -118.92 129.08 54.99 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.542 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.6 m -85.67 130.64 34.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.214 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.1 mt -96.0 78.77 3.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.343 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.81 -32.0 73.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.473 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.12 108.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.164 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.489 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.5 pt20 -121.65 91.4 48.52 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.304 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.652 ' O ' ' N ' ' A' ' 45' ' ' ARG . 37.1 Cg_exo -57.0 148.59 67.44 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.738 2.292 . . . . 0.0 111.824 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.69 82.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.556 0.535 . . . . 0.0 111.018 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.14 66.85 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.046 0.45 . . . . 0.0 110.251 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.44 131.0 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.614 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.544 ' HA ' HG23 ' A' ' 64' ' ' VAL . 56.7 t -122.89 145.54 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.146 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -135.52 143.32 45.7 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.623 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.0 p -99.26 -59.19 1.77 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.552 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.9 p -79.52 154.97 28.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.647 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 70' ' ' THR . 70.8 t -74.58 -21.79 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.57 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.5 m -60.12 -52.18 66.45 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.434 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.6 -42.4 86.94 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.245 0.545 . . . . 0.0 110.873 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -42.82 -53.64 4.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.153 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.45 -37.75 69.56 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.9 m -62.56 -44.62 95.88 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.884 0.373 . . . . 0.0 110.459 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.418 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.8 mt -66.19 -41.94 89.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.38 0.61 . . . . 0.0 110.739 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.65 -40.15 96.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.324 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.466 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.03 -35.91 76.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.94 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 156' ' ' LEU . 31.4 pt -91.31 28.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.118 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.54 51.64 10.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.819 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.02 75.93 23.12 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.95 0.405 . . . . 0.0 110.003 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.4 151.77 84.06 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.746 2.298 . . . . 0.0 112.265 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.544 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.85 137.42 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.149 0.499 . . . . 0.0 110.316 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.447 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.5 pt -69.26 -43.61 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.219 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.78 130.96 53.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.926 0.393 . . . . 0.0 110.547 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.5 p -155.75 168.99 25.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.44 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.75 -177.44 21.71 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -132.67 171.86 13.3 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 120.943 0.402 . . . . 0.0 110.531 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.493 HG23 HG21 ' A' ' 51' ' ' VAL . 12.4 p -133.45 -111.02 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.426 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.91 179.61 0.95 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.303 -179.171 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.6 Cg_exo -60.88 58.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.953 2.436 . . . . 0.0 112.129 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.1 t-20 -64.24 -35.21 80.09 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.483 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 48.3 m-20 95.26 -37.65 0.01 OUTLIER 'General case' 0 C--N 1.345 0.401 0 O-C-N 124.113 0.883 . . . . 0.0 110.008 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -62.61 -39.87 95.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.2 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.9 p -73.81 -26.41 21.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.689 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -50.06 -172.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.547 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.05 -152.79 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.711 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.7 p-10 -54.37 -6.66 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.685 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.493 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -86.92 113.82 23.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.559 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.15 72.73 1.28 Allowed Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.84 148.05 34.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 0.0 110.809 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.25 -99.47 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.109 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.554 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.86 -43.11 97.09 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.252 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.4 tt0 91.74 52.8 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.916 0.76 . . . . 0.0 110.861 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -103.32 -9.21 19.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.457 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.3 p -64.79 -33.86 76.98 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.049 0.452 . . . . 0.0 110.679 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.554 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.66 -23.67 1.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.516 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.3 t -69.7 -45.88 76.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.889 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.23 -48.6 80.74 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.165 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.67 -38.12 89.11 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.337 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.63 -32.51 51.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.218 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.605 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.3 mmt-85 -89.76 1.62 55.88 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.575 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.84 -49.08 0.16 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 124.045 0.841 . . . . 0.0 110.331 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.662 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.7 mt -46.49 154.3 0.3 Allowed 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 117.89 -1.053 . . . . 0.0 109.349 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.662 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 121.17 92.36 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 125.313 1.633 . . . . 0.0 110.502 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.39 143.26 42.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.251 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.9 mt -131.77 26.83 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.758 0.313 . . . . 0.0 110.481 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.42 138.08 34.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.969 0.414 . . . . 0.0 110.506 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.63 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.0 mt -137.17 165.19 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.432 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.615 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.04 -28.51 1.85 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -153.01 70.65 7.07 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.178 0.513 . . . . 0.0 110.362 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.12 145.52 98.28 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.772 2.315 . . . . 0.0 112.053 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.5 t -134.1 137.0 44.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.59 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.2 -38.17 81.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.666 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.41 -42.23 96.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.529 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.7 98.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.503 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 64.2 t -63.72 -43.33 97.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.066 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.65 -35.32 77.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.332 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.8 -18.36 59.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.484 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.52 -6.44 58.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.508 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.413 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.9 mtp 48.15 55.78 17.26 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.588 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.05 148.98 64.39 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.844 2.363 . . . . 0.0 112.133 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.28 -73.1 0.66 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.424 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 140' ' ' LEU . 38.7 tp -111.33 112.42 24.18 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.305 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.4 mt -100.55 126.07 54.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.476 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.4 mt -109.36 133.16 53.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.203 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.55 139.55 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.526 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.9 p -83.43 168.25 16.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.673 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.23 -37.48 80.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.494 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -139.03 158.96 43.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.502 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.44 176.8 33.71 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.83 87.16 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.93 151.55 45.28 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.876 0.369 . . . . 0.0 110.604 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.2 t -62.93 141.17 58.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.291 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.05 10.51 10.77 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.664 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.07 -39.07 88.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.031 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.83 -35.7 24.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.452 0.644 . . . . 0.0 110.654 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.3 mt -71.11 -35.31 71.73 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.437 0.637 . . . . 0.0 110.772 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -42.87 -62.93 0.89 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.185 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.76 -42.82 90.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -62.12 -32.65 73.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.204 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.8 mt -74.03 -40.46 62.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.054 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.16 -48.81 79.13 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.209 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.3 m -52.88 -42.44 65.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.194 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.15 -43.05 92.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.103 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.35 153.37 5.3 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.632 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -39.18 107.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.643 2.229 . . . . 0.0 112.326 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.3 m -109.09 121.38 45.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.285 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.36 152.89 30.76 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.26 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.95 131.45 68.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.365 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.07 127.72 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.493 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.4 t30 -101.86 103.67 14.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.324 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 49.6 p90 -101.23 -11.27 19.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.751 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.9 p-10 -64.78 -33.44 76.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.652 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.577 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.1 p-10 -98.31 7.41 46.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.584 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.14 155.35 50.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.572 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.408 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.2 p -74.65 165.7 24.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.664 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.588 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -59.99 -48.86 79.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.281 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -53.84 -41.99 68.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.104 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.2 t -62.49 -40.82 97.92 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.451 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 156' ' ' LEU . 48.7 tp -60.61 -43.75 97.1 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.297 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.507 HD22 HH21 ' A' ' 169' ' ' ARG . 44.6 tp -61.4 -43.2 99.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.826 0.346 . . . . 0.0 110.213 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.7 m -55.63 -45.37 77.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.833 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.35 -40.76 97.43 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-O 120.847 0.356 . . . . 0.0 110.377 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -61.88 -42.38 98.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.184 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.63 -40.76 96.1 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.77 -46.15 63.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.941 0.401 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.52 -43.98 96.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.766 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.2 p -93.21 -8.49 42.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.585 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.69 25.32 71.63 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -101.8 52.09 0.83 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.779 0.323 . . . . 0.0 110.623 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.84 -39.07 76.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.629 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.3 -47.17 86.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.262 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -61.33 -38.97 88.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.413 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.4 97.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.324 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.41 -27.69 69.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.491 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.77 -53.75 8.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.207 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.507 HH21 HD22 ' A' ' 153' ' ' LEU . 61.8 ttp180 -63.78 -43.51 96.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.458 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.1 mt -63.08 -43.88 99.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.654 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.35 -61.62 2.41 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.118 0.485 . . . . 0.0 110.377 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.66 -35.08 63.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.457 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -79.6 -34.77 40.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.004 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.6 m-20 -56.49 -40.12 74.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.112 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.95 -42.41 99.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.686 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.79 -37.72 87.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.309 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 177' ' ' LEU . 82.0 mt -62.44 -42.45 99.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.737 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.09 -53.17 59.18 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.059 0.457 . . . . 0.0 110.679 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.12 -41.77 90.08 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.562 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.93 95.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.647 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.17 -32.26 73.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.419 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.3 -21.97 18.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.719 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.637 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.94 -41.4 95.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.68 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 pt -77.48 136.14 24.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.666 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.26 108.69 11.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.351 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.5 126.14 0.32 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.559 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.457 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.4 Cg_exo -43.68 152.02 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.742 2.295 . . . . 0.0 112.598 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.03 141.66 53.81 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.605 2.203 . . . . 0.0 112.465 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.12 147.34 2.23 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.62 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.28 154.62 69.37 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.74 2.293 . . . . 0.0 112.26 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.52 163.2 28.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.446 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.82 170.1 16.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.853 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.51 137.75 21.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.238 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.546 HG22 HD12 ' A' ' 205' ' ' LEU . 39.7 pt -134.29 146.71 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.288 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.654 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.76 131.77 59.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.099 0.476 . . . . 0.0 110.53 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -152.05 155.11 37.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.369 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.624 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.5 m -122.62 122.92 39.98 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.924 0.393 . . . . 0.0 110.401 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.11 -25.71 65.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.601 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.624 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.42 -48.97 20.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.091 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.62 -13.25 61.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.442 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.3 m80 50.72 41.36 26.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.503 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 43.3 t -136.32 144.68 44.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.344 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.14 114.18 27.47 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.315 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.1 m-20 -119.74 133.35 55.65 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.972 0.415 . . . . 0.0 110.372 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.546 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.07 146.32 38.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.735 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.478 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.2 t90 -99.5 129.8 45.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.108 0.48 . . . . 0.0 110.059 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.48 154.14 39.37 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.086 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.7 Cg_endo -67.8 -17.93 47.26 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.742 2.295 . . . . 0.0 111.933 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.56 -18.43 0.43 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.457 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.478 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.83 165.26 25.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.523 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.26 -28.17 66.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.491 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.526 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.51 -41.63 98.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.705 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.84 -44.95 96.59 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.44 -39.01 93.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.949 0.404 . . . . 0.0 110.612 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.588 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.4 mmm -62.08 -41.31 98.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.226 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.71 -47.14 82.33 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.64 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.33 -32.05 55.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.095 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.71 -18.3 62.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.496 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.43 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.1 mt -88.53 -8.6 54.53 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.691 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.74 2.43 55.25 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -88.55 152.63 21.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.0 110.499 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.448 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.2 p -115.5 128.32 55.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.077 0.465 . . . . 0.0 110.42 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.563 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.52 146.1 23.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.899 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.469 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.37 151.05 46.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.49 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.76 131.47 43.0 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.463 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.893 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.62 93.41 27.93 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.142 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.679 ' C ' ' H ' ' A' ' 229' ' ' GLY . 47.5 Cg_exo -55.65 139.16 82.79 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.62 2.213 . . . . 0.0 111.558 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.99 -25.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.445 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.71 -49.81 27.97 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.0 mt -53.97 -37.14 63.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.56 35.99 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.782 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.2 88.18 0.01 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.844 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.9 p -81.33 -14.31 57.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.356 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.64 -41.19 10.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.567 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.8 t -66.84 -16.72 64.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.607 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.06 43.53 26.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.469 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.91 -147.1 7.25 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -122.49 143.16 49.88 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.994 0.426 . . . . 0.0 110.389 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -151.97 149.47 28.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.453 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -100.72 -151.94 0.42 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.392 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 55.92 -92.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.648 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.464 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.54 175.08 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.565 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.464 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.5 mt -121.83 141.43 42.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.726 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.75 169.22 9.4 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.281 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.4 mt -147.83 150.85 34.95 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.182 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.65 -38.95 97.01 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.15 4.13 4.64 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.37 -58.15 3.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.922 0.392 . . . . 0.0 110.579 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.552 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.1 m-20 -62.13 -36.86 83.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.271 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.28 -67.81 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.722 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.33 -42.11 66.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.185 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.14 18.12 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.64 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.79 48.61 0.27 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.41 -109.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.6 0.238 . . . . 0.0 110.726 -178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.469 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 12.0 m120 -60.89 -44.72 96.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.425 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.41 8.13 83.76 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -99.13 -12.74 20.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.58 0.229 . . . . 0.0 110.715 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.8 t 176.37 142.42 0.07 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.062 0.458 . . . . 0.0 110.533 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.88 125.39 11.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.03 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 191' ' ' VAL . 14.0 m-30 -98.6 143.03 29.44 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 120.85 0.357 . . . . 0.0 110.817 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.1 mt -94.33 106.5 18.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.675 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.463 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.3 t80 -102.28 -11.65 18.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.25 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.08 -40.15 86.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.804 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.11 173.68 46.14 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.5 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.0 m-20 -74.45 -112.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.347 . . . . 0.0 110.618 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.13 -28.72 67.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.728 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.85 -44.17 90.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.296 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -63.35 -44.54 94.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.353 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.34 -59.92 3.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.29 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.16 -43.32 61.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.221 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.38 -43.92 75.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.216 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.4 mt -64.42 -43.63 97.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.589 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -56.71 -37.43 70.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.172 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.96 1.03 18.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.251 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.0 91.35 26.43 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.195 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.01 -27.19 27.75 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.743 2.296 . . . . 0.0 111.87 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.34 -41.19 98.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.634 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.9 mp -95.21 5.11 52.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.41 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.72 -35.09 70.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.683 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.8 4.7 15.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.528 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.95 121.08 80.32 Favored Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.556 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -47.27 -37.8 24.94 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.507 2.138 . . . . 0.0 112.487 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.9 -43.82 91.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.294 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.82 -43.72 93.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.303 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.6 -40.52 95.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.539 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -90.32 -11.94 39.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.53 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.86 32.38 18.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.884 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.77 44.0 1.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.385 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.34 135.74 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.566 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.44 133.03 56.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.435 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.497 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.69 87.95 7.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.686 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.91 -41.47 97.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.834 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.16 167.93 34.42 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.8 p -75.9 -25.82 56.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.84 0.352 . . . . 0.0 110.691 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.4 tp10 -67.84 -34.32 76.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.39 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.763 HG22 ' O ' ' A' ' 296' ' ' THR . 97.1 m -73.14 19.7 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.631 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.526 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 53.1 t80 -57.25 -51.08 70.8 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.058 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.401 HH12 ' HG3' ' A' ' 212' ' ' GLN . 68.5 mmt-85 -108.05 149.36 28.53 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.43 ' CD2' HD11 ' A' ' 219' ' ' LEU . 42.3 tp -115.46 125.57 53.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.756 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.47 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.6 t0 -149.37 166.61 28.52 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.632 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -49.15 -38.14 24.47 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.588 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.82 -65.15 0.8 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.231 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.86 -32.79 72.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.44 -26.01 28.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.659 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.6 mtt -63.36 -41.04 98.8 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 120.851 0.357 . . . . 0.0 110.908 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.26 -44.41 25.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.914 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.565 HG21 HG23 ' A' ' 296' ' ' THR . 74.9 t -66.17 -42.89 92.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.425 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.436 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.3 tp -59.86 -47.49 85.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.505 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -69.64 -39.56 77.05 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.027 0.441 . . . . 0.0 110.723 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.5 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 72.2 ttt180 -61.7 -38.43 87.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.203 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -87.14 4.9 40.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.785 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.637 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.65 -11.77 13.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.04 0.448 . . . . 0.0 110.266 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.74 -37.08 85.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.642 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.99 -48.78 80.24 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.386 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.057 179.855 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.85 -2.46 58.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.413 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.9 179.08 1.24 Allowed Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.556 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.1 Cg_exo -60.9 145.11 99.52 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.781 2.321 . . . . 0.0 112.165 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.03 -179.21 7.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.589 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.81 136.67 52.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.342 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.39 147.29 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.362 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.9 p -120.39 136.12 54.82 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.27 -143.57 0.32 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.191 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -63.46 -37.18 86.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.526 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.05 -66.96 0.22 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.412 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.32 142.4 44.96 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.7 p -112.24 131.44 55.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.907 0.384 . . . . 0.0 110.435 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -119.22 129.06 54.76 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.518 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.0 m -85.68 130.36 34.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.225 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.48 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.8 mt -95.94 78.88 3.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.32 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.9 -31.91 73.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.491 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 176.06 108.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.05 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.48 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -121.89 91.56 48.77 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.312 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.646 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.3 Cg_exo -56.94 148.77 65.7 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.787 2.325 . . . . 0.0 111.862 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.64 82.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.607 0.567 . . . . 0.0 111.044 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.646 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.16 66.71 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.229 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.7 130.65 36.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.63 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.553 ' HA ' HG23 ' A' ' 64' ' ' VAL . 57.9 t -122.91 146.34 28.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.027 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -135.96 144.3 45.32 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 50' ' ' SER . 20.8 p -100.13 -59.28 1.74 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.619 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.406 ' N ' ' OG1' ' A' ' 49' ' ' THR . 86.5 p -79.21 154.78 28.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.653 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.516 HG21 HG23 ' A' ' 70' ' ' THR . 72.2 t -74.0 -22.01 18.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.578 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.4 m -60.24 -51.89 67.62 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.559 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -66.45 -42.42 87.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.196 0.522 . . . . 0.0 110.855 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.1 m -43.38 -53.74 5.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.048 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.41 -37.64 69.88 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.5 m -62.51 -44.66 95.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.896 0.379 . . . . 0.0 110.324 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.0 mt -66.16 -42.01 89.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.535 0.683 . . . . 0.0 110.704 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.63 -40.21 96.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.398 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.508 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.05 -35.79 75.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.07 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 156' ' ' LEU . 31.8 pt -91.36 28.91 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.229 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.5 51.66 10.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.881 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.35 75.55 22.71 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.91 151.88 84.22 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.742 2.295 . . . . 0.0 112.136 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.553 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.82 137.48 46.86 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 CA-C-O 121.172 0.51 . . . . 0.0 110.236 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.22 -43.63 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.317 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.483 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.97 131.12 53.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.051 0.453 . . . . 0.0 110.552 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.53 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.0 p -155.62 168.84 25.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.493 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.82 -177.25 21.67 Favored Glycine 0 N--CA 1.464 0.544 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.64 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.72 172.76 12.32 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.0 0.428 . . . . 0.0 110.486 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.516 HG23 HG21 ' A' ' 51' ' ' VAL . 14.6 p -132.59 -112.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.339 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.17 179.9 0.91 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.359 -179.131 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.8 Cg_exo -60.89 57.59 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.973 2.449 . . . . 0.0 112.154 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.6 t-20 -63.87 -33.36 75.52 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.407 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 43.6 m-20 93.42 -36.64 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.014 0.821 . . . . 0.0 109.855 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.7 mtp85 -62.65 -39.51 94.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.019 0.438 . . . . 0.0 110.145 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 77' ' ' ALA . 15.0 p -74.29 -25.65 19.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.758 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.36 -171.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.545 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -74.12 -154.13 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.845 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.2 p-10 -52.52 -7.4 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.665 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.19 115.02 23.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.977 0.418 . . . . 0.0 110.631 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.82 70.16 1.35 Allowed Glycine 0 CA--C 1.52 0.39 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 3.3 m-85 -143.47 148.18 35.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 110.793 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -86.08 -98.42 0.07 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.135 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.89 -42.84 97.37 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.183 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.547 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.3 tt0 91.53 52.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.991 0.807 . . . . 0.0 110.858 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -102.86 -9.48 19.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.429 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.419 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.3 p -64.24 -33.85 76.75 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.149 0.5 . . . . 0.0 110.691 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.546 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.12 -23.96 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.66 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.39 -45.99 77.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.27 -48.33 81.9 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.043 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.65 -38.11 89.0 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.374 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.82 -32.72 53.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.161 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.594 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.94 1.71 55.93 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.523 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.65 -49.38 0.18 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.115 0.884 . . . . 0.0 110.265 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.5 mt -46.16 154.65 0.25 Allowed 'General case' 0 CA--C 1.49 -1.336 0 CA-C-O 117.475 -1.25 . . . . 0.0 109.343 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.644 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.0 tt0 120.95 92.57 0.0 OUTLIER 'General case' 0 C--N 1.353 0.735 0 O-C-N 125.563 1.79 . . . . 0.0 110.46 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.53 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.7 mtp180 -75.7 143.36 42.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.14 0.495 . . . . 0.0 110.265 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.5 mt -132.43 27.12 4.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 0.0 110.461 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.21 137.7 34.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.003 0.43 . . . . 0.0 110.49 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.8 mt -137.29 165.09 28.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.391 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.08 -28.46 1.84 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.35 70.84 7.59 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.191 0.52 . . . . 0.0 110.208 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -60.0 145.3 98.71 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 C-N-CA 122.751 2.3 . . . . 0.0 112.066 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.7 t -134.73 136.81 42.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.553 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.12 81.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.711 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.26 -42.33 96.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.52 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.86 -41.61 98.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.546 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.4 t -63.5 -43.42 98.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.99 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.06 77.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.23 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.76 -18.9 61.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.478 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.38 -6.57 58.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 81.9 mtp 47.8 55.97 17.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.59 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.3 Cg_endo -70.37 149.36 62.87 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.807 2.338 . . . . 0.0 112.101 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.22 -72.94 0.66 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.454 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.456 HD11 HD13 ' A' ' 140' ' ' LEU . 38.2 tp -111.56 113.01 25.14 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.324 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.1 mt -101.27 126.46 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.584 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.7 mt -109.52 133.47 53.05 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.225 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.68 139.65 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.493 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.4 p -83.45 168.56 16.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.671 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.42 80.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.381 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.8 t -139.53 158.94 43.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.943 0.402 . . . . 0.0 110.453 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.29 176.92 33.56 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.21 -33.71 86.82 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.77 151.52 45.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.925 0.393 . . . . 0.0 110.507 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.1 t -63.06 140.98 58.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.339 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.69 10.42 11.0 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.642 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.09 -39.16 88.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.081 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.79 -35.98 23.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.588 0.709 . . . . 0.0 110.705 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.4 mt -70.83 -35.54 72.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.528 0.68 . . . . 0.0 110.732 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -42.81 -62.83 0.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.317 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.81 -42.78 90.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.06 -179.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -62.03 -32.73 73.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.24 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.3 mt -73.77 -40.64 63.31 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.102 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.29 -48.76 79.47 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.153 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.1 m -53.05 -42.5 65.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.097 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.88 -43.09 93.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.937 0.399 . . . . 0.0 111.099 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.32 153.47 5.36 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.674 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -39.25 107.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.65 2.233 . . . . 0.0 112.445 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.641 ' C ' HD12 ' A' ' 140' ' ' LEU . 97.8 m -109.65 121.64 45.67 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.24 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.96 152.6 30.64 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.256 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.98 131.4 68.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.321 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.403 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -115.14 127.89 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.491 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.472 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 57.0 t30 -101.56 103.8 14.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.265 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.6 p90 -101.38 -11.21 19.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.816 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.75 -33.65 76.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.682 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.9 p-10 -98.3 7.66 45.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.612 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.448 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.46 155.39 50.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.51 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.403 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.8 p -74.86 165.64 24.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.641 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.86 -48.77 80.35 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.247 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.66 -41.95 67.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.028 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.3 t -62.65 -41.08 98.86 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.385 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.403 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.5 tp -60.61 -44.38 96.36 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.393 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.3 tp -61.41 -43.43 98.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.145 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -55.07 -44.88 75.2 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.43 -40.78 97.68 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.943 0.402 . . . . 0.0 110.469 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -62.03 -42.47 99.2 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.305 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.21 -40.91 95.02 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.5 -45.96 64.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.832 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.75 -44.04 96.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.794 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.4 p -93.03 -8.81 41.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.622 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.01 26.58 72.38 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -101.54 50.63 0.85 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.807 0.337 . . . . 0.0 110.703 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.45 -39.61 77.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.617 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.4 -47.26 86.13 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.252 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -59.94 -39.55 85.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.314 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.77 98.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.278 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.0 -28.61 70.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.614 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.18 -54.26 8.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.067 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.508 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.4 ttp180 -65.49 -42.27 92.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.456 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.459 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.6 mt -62.35 -43.98 98.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.502 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.66 -58.35 7.8 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.037 0.446 . . . . 0.0 110.344 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.05 -34.05 67.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.471 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.4 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.2 t80 -81.01 -36.35 30.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.875 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -55.61 -41.84 74.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.03 -178.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.7 -42.1 99.47 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.684 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.29 -38.05 89.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.288 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 177' ' ' LEU . 82.3 mt -62.47 -42.23 99.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.674 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.08 -52.79 62.48 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.091 0.472 . . . . 0.0 110.664 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.32 -41.75 89.23 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.588 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.89 95.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.611 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.34 -32.13 73.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.426 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.62 -22.26 18.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.693 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.636 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.77 -41.26 96.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.652 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.3 pt -76.56 136.45 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.698 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.72 107.91 10.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.224 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.82 125.69 0.3 Allowed Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.45 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.452 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.2 Cg_exo -43.96 152.38 0.37 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.757 2.305 . . . . 0.0 112.623 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.75 141.85 55.88 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.589 2.193 . . . . 0.0 112.466 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.01 147.44 2.29 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.622 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.31 154.32 69.71 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.782 2.321 . . . . 0.0 112.303 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.581 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.39 163.15 29.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.438 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.581 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.91 170.73 15.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.915 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.36 137.75 22.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.238 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.551 HG22 HD12 ' A' ' 205' ' ' LEU . 40.1 pt -134.24 146.89 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.672 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.03 131.87 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.168 0.508 . . . . 0.0 110.488 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -152.12 155.25 37.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.388 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.621 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.6 m -122.69 123.16 40.49 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.917 0.389 . . . . 0.0 110.341 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.5 -25.66 66.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.649 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.621 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.59 -48.94 20.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.038 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.18 -13.62 61.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.435 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 76.5 m80 51.05 40.92 26.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.518 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.9 t -136.48 143.96 44.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.422 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -109.56 114.54 28.25 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.287 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.3 m-20 -119.8 133.32 55.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.128 0.49 . . . . 0.0 110.346 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.551 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.97 146.41 37.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.787 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.478 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.6 t90 -99.47 129.61 45.66 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.142 0.496 . . . . 0.0 109.996 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.14 153.89 39.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.225 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.7 Cg_endo -67.8 -18.04 47.3 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.647 2.231 . . . . 0.0 111.958 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.29 -18.7 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.441 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.478 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.63 164.65 26.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.486 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.91 -27.94 65.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.503 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.579 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.9 mt-30 -63.82 -41.33 97.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.586 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.37 -44.61 97.4 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.448 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.2 mt-30 -64.51 -38.75 92.11 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 122.524 -0.398 . . . . 0.0 110.575 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.2 mmm -62.16 -41.08 97.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.167 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.3 mt -63.59 -47.02 83.18 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.464 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.31 -31.91 55.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.155 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -70.84 -18.24 62.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.558 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.437 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.6 mt -88.17 -9.11 54.16 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.617 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.18 1.97 54.41 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -88.43 153.22 21.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 110.467 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.447 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.0 p -116.12 128.73 55.91 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.129 0.49 . . . . 0.0 110.348 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.562 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.66 146.24 23.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.897 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.476 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.75 151.26 46.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.402 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.43 131.44 43.57 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.425 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.893 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.62 93.37 27.72 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.032 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.677 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.7 Cg_exo -55.65 139.0 82.62 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.575 2.183 . . . . 0.0 111.518 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.84 -25.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.483 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -69.94 -50.1 31.18 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.552 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.5 mt -53.94 -36.92 63.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.814 0.34 . . . . 0.0 110.123 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -66.7 36.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.829 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.88 86.81 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.948 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.3 p -79.09 -15.24 58.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.325 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.58 -41.04 10.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.616 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.1 t -66.21 -18.0 65.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.546 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.14 43.48 26.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.435 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.52 -148.22 7.71 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.68 142.79 49.81 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.002 0.429 . . . . 0.0 110.294 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.41 149.93 29.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.317 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -101.21 -151.55 0.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.369 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 56.0 -91.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.646 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.471 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.84 175.42 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.648 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.471 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.1 mt -122.54 141.78 41.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.83 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.76 169.29 9.35 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.327 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.5 mt -147.65 151.01 35.46 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.289 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.63 -38.95 97.02 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.95 4.13 4.74 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -77.37 -58.1 3.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.986 0.422 . . . . 0.0 110.595 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.549 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.1 m-20 -62.11 -36.69 82.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.232 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.44 -67.53 0.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.55 -42.21 67.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.1 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.29 17.67 0.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.62 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.17 48.62 0.31 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.5 mp 38.65 -109.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.6 0.238 . . . . 0.0 110.736 -178.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.9 m120 -60.95 -44.75 96.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.427 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.42 7.97 83.98 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.88 -13.51 20.0 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.743 -0.269 . . . . 0.0 110.65 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.7 t 176.97 142.7 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.122 0.487 . . . . 0.0 110.479 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.13 125.21 11.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.14 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.6 m-30 -98.31 143.52 28.7 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 120.898 0.38 . . . . 0.0 110.763 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.87 106.55 18.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.688 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.4 t80 -101.79 -12.21 18.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.157 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.47 -40.86 89.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.853 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.79 173.22 45.87 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.009 -0.837 . . . . 0.0 111.009 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.461 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.4 m-20 -73.85 -113.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 110.758 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.89 -28.69 67.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.711 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.9 -43.9 91.11 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.237 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.57 -44.17 94.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.408 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.73 -60.09 3.68 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.217 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.08 -43.34 61.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.142 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.48 -43.62 75.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.144 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.6 mt -64.59 -43.66 96.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.6 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -56.07 -37.49 69.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.16 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.72 0.94 18.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.185 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -114.98 91.14 25.49 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.147 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.19 -27.09 28.69 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.756 2.304 . . . . 0.0 111.848 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.536 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.45 -40.97 98.55 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.592 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.35 5.11 52.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.352 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.87 -35.19 69.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.687 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.65 4.5 15.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.53 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.67 121.17 80.07 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -47.32 -37.66 25.12 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.469 2.113 . . . . 0.0 112.512 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.532 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -59.05 -43.82 91.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.804 0.335 . . . . 0.0 110.273 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.5 t -65.86 -43.77 93.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.299 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -65.03 -40.66 95.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.428 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.9 t-20 -89.49 -12.73 39.22 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.575 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.7 mtmt 62.16 32.07 17.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -88.9 43.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.101 0.477 . . . . 0.0 110.332 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.13 135.81 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.419 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.8 132.3 56.73 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.403 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.13 89.05 7.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.765 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.9 -41.23 97.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.877 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.444 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.79 165.64 33.84 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 69.0 p -75.47 -25.83 57.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.888 0.375 . . . . 0.0 110.813 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.0 tp10 -68.23 -33.84 75.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.439 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 96.7 m -73.53 24.45 0.07 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.67 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.579 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 43.7 t80 -58.28 -50.7 72.66 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.409 HH12 ' HG3' ' A' ' 212' ' ' GLN . 76.9 mmt-85 -110.8 153.17 25.75 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.437 ' CD2' HD11 ' A' ' 219' ' ' LEU . 43.6 tp -115.49 125.34 52.94 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.819 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.488 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.1 t0 -148.16 165.77 29.89 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.605 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -49.38 -38.05 27.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.567 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -70.92 -65.76 0.7 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.449 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -60.97 -32.72 72.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.056 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.22 -25.58 23.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.678 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.7 mtt -63.51 -40.83 98.08 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 120.872 0.368 . . . . 0.0 111.081 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.75 -44.24 23.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.108 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.581 HG21 HG23 ' A' ' 296' ' ' THR . 78.6 t -66.14 -42.91 92.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.409 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.3 tp -60.29 -47.01 87.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.48 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -70.0 -39.33 75.93 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.598 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.498 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.7 ttt180 -61.79 -38.29 87.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.166 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.5 mt -87.07 4.45 42.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.71 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.636 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.78 -11.3 13.5 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 110.264 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.12 85.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.552 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.85 -48.61 81.01 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.296 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.964 179.971 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.614 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.34 -2.46 57.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.412 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.89 179.04 1.25 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.0 Cg_exo -60.73 144.61 99.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.71 2.273 . . . . 0.0 112.194 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.614 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.58 -179.87 8.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.621 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.63 136.52 52.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.318 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.12 147.07 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.368 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.6 p -120.25 136.08 54.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 110.745 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.6 -143.43 0.33 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.269 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.41 -37.27 86.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.504 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.474 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.17 -66.84 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.486 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.62 142.38 45.65 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.0 p -112.26 131.41 55.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.908 0.385 . . . . 0.0 110.45 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -118.8 128.96 54.96 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.561 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.5 m -85.35 130.33 34.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.237 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.473 HD22 ' OE1' ' A' ' 42' ' ' GLN . 67.7 mt -95.68 78.9 3.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.324 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.53 -31.94 73.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.493 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.79 109.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.073 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.473 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.5 pt20 -122.05 91.66 48.9 Favored Pre-proline 0 C--O 1.233 0.203 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.296 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.646 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.2 Cg_exo -56.94 148.76 65.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.766 2.311 . . . . 0.0 111.874 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.61 82.75 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 O-C-N 123.587 0.554 . . . . 0.0 110.991 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.646 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.45 67.03 0.89 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.244 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.14 130.66 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.665 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.56 ' HA ' HG23 ' A' ' 64' ' ' VAL . 55.2 t -122.66 146.68 27.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.047 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.9 t -136.28 143.87 44.45 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.697 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.2 p -99.26 -59.2 1.77 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.584 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.2 p -79.46 155.39 28.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.632 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.525 HG21 HG23 ' A' ' 70' ' ' THR . 70.6 t -74.3 -21.86 17.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.567 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.4 m -60.28 -52.01 67.11 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.456 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.29 -42.54 88.23 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.375 0.607 . . . . 0.0 110.879 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.0 m -43.38 -53.93 5.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.086 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.31 -37.75 70.89 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.7 m -62.51 -44.67 95.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.805 0.336 . . . . 0.0 110.277 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.2 mt -66.14 -41.98 89.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.464 0.649 . . . . 0.0 110.761 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.53 -40.19 95.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.476 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.467 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.14 -36.0 76.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.135 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.535 HD11 HD12 ' A' ' 156' ' ' LEU . 32.9 pt -91.07 28.7 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.239 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.72 51.48 10.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.861 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.94 75.66 23.97 Favored Pre-proline 0 C--N 1.332 -0.167 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.68 151.44 85.64 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.743 2.295 . . . . 0.0 112.17 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.56 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.61 137.18 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.191 0.519 . . . . 0.0 110.25 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.444 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.7 pt -69.09 -43.69 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.339 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.95 130.97 53.43 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.933 0.396 . . . . 0.0 110.581 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.53 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.8 p -155.51 168.79 25.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.429 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.78 -177.45 21.69 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.631 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.54 172.88 12.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.944 0.402 . . . . 0.0 110.523 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.525 HG23 HG21 ' A' ' 51' ' ' VAL . 13.6 p -133.03 -112.11 0.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.404 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.36 179.79 0.92 Allowed Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.346 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.3 Cg_exo -61.2 57.86 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.943 2.428 . . . . 0.0 112.117 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.8 t-20 -63.97 -33.98 76.95 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.51 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.3 m-20 94.01 -36.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.176 0.923 . . . . 0.0 109.808 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.2 mtp85 -62.99 -40.1 96.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.258 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 77' ' ' ALA . 15.0 p -74.43 -25.92 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.744 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.21 -171.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.608 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -73.69 -153.87 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.819 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.1 p-10 -52.79 -7.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.751 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.504 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.22 114.59 23.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.619 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.81 71.04 1.33 Allowed Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -143.75 148.23 35.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.861 0.362 . . . . 0.0 110.812 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -86.07 -98.66 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.031 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.99 -42.83 97.06 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.227 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.561 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.7 tt0 91.7 53.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.994 0.809 . . . . 0.0 110.887 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -103.12 -9.22 19.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.36 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -64.49 -34.19 77.64 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.079 0.466 . . . . 0.0 110.625 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.561 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.1 mttt -48.91 -23.76 1.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.562 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.9 t -69.53 -45.93 77.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.41 -48.38 81.46 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.055 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.63 -38.21 89.35 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.276 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.71 -32.25 51.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.173 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.595 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 83.2 mmt-85 -90.16 1.67 56.17 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.575 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.76 -49.18 0.17 Allowed 'General case' 0 N--CA 1.465 0.305 0 O-C-N 124.169 0.918 . . . . 0.0 110.288 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.1 mt -46.54 154.21 0.31 Allowed 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 117.503 -1.237 . . . . 0.0 109.274 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.644 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.32 92.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 O-C-N 125.569 1.793 . . . . 0.0 110.431 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.53 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.59 143.51 42.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.123 0.487 . . . . 0.0 110.228 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 mt -132.37 27.18 4.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.769 0.319 . . . . 0.0 110.471 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.48 138.25 34.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.015 0.436 . . . . 0.0 110.495 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.1 mt -137.3 165.04 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.367 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.0 -28.57 1.85 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -153.16 70.93 7.01 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.13 0.49 . . . . 0.0 110.292 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.08 145.48 98.34 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.724 2.282 . . . . 0.0 112.075 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.7 t -134.05 136.37 43.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.05 -38.29 82.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.63 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.28 -42.03 96.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.53 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.4 98.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.523 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -63.74 -43.54 98.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.946 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.13 77.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.237 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.68 -18.6 60.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.427 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.6 -6.61 58.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.509 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.5 mtp 47.93 56.02 17.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.609 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.4 Cg_endo -70.23 149.09 63.35 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.834 2.356 . . . . 0.0 112.112 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -100.75 -74.11 0.62 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.564 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.436 HD11 HD13 ' A' ' 140' ' ' LEU . 38.1 tp -110.45 113.32 25.87 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.296 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.9 mt -101.78 126.38 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.508 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.1 mt -109.79 133.55 53.02 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.183 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.26 139.62 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.563 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.2 p -83.45 168.41 16.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.701 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.42 80.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.459 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.2 t -139.58 158.97 43.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.436 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.01 176.65 33.41 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.33 -33.82 87.34 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.48 151.57 44.43 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.881 0.372 . . . . 0.0 110.537 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.5 t -63.1 140.57 58.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.316 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.39 10.5 11.23 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.677 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.52 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.06 -38.97 88.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.049 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.637 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.99 -35.92 23.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.554 0.692 . . . . 0.0 110.645 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' LEU . 90.9 mt -70.69 -35.65 72.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.495 0.664 . . . . 0.0 110.726 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -42.8 -62.93 0.88 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.375 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.637 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.74 -42.65 90.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.102 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -62.14 -32.97 73.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.209 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.5 mt -73.29 -40.95 64.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.038 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.42 -48.85 79.32 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.145 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.4 m -52.94 -42.32 65.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.247 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.11 -42.93 92.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.928 0.394 . . . . 0.0 111.043 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.53 154.37 5.55 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.621 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -39.63 107.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.621 2.214 . . . . 0.0 112.335 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.637 ' C ' HD12 ' A' ' 140' ' ' LEU . 93.8 m -110.09 121.13 44.54 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.255 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.637 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.88 152.74 30.31 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.223 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.6 tt -128.8 131.39 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.391 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.404 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.5 mt -115.13 127.75 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.469 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.9 t30 -101.52 103.23 14.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.243 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 147' ' ' LYS . 44.5 p90 -100.96 -11.09 20.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.812 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.5 p-10 -64.8 -33.56 76.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.703 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.7 p-10 -98.47 8.12 45.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.601 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.443 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.8 155.51 50.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.51 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.404 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.8 p -74.99 165.85 24.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.705 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.4 t90 -60.01 -48.8 80.22 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.246 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.5 -42.19 67.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.921 0.391 . . . . 0.0 110.103 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.7 t -62.54 -40.81 97.99 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.406 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.408 ' O ' HD23 ' A' ' 156' ' ' LEU . 46.3 tp -60.62 -43.91 96.93 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.282 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.505 HD22 HH21 ' A' ' 169' ' ' ARG . 44.8 tp -61.45 -43.25 99.2 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.111 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.5 m -55.01 -45.27 75.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.53 -40.67 97.52 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.855 0.359 . . . . 0.0 110.338 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.535 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.02 -42.37 99.09 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.302 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.07 -41.18 95.25 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.61 -46.03 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.952 0.406 . . . . 0.0 110.975 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.53 -44.05 96.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.887 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.8 p -93.31 -8.54 41.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.597 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.89 25.46 71.92 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -102.12 51.83 0.82 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.8 0.333 . . . . 0.0 110.699 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.76 -39.23 76.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.664 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.28 -46.94 87.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.173 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -61.36 -39.02 89.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.315 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.4 -40.46 97.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.311 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.62 69.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.018 0.437 . . . . 0.0 110.545 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.77 -53.61 8.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.158 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.505 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -64.11 -43.25 95.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.406 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.2 mt -62.98 -43.89 99.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.717 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.46 -61.38 2.57 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.128 0.489 . . . . 0.0 110.461 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.71 -35.11 63.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.451 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -79.6 -35.24 39.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.957 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 170' ' ' ILE . 56.4 m-20 -56.29 -40.66 74.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.255 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.01 -42.37 99.81 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.684 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.64 -37.83 87.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.287 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 177' ' ' LEU . 81.7 mt -62.42 -42.16 99.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.736 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.05 -52.78 62.56 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.128 0.489 . . . . 0.0 110.694 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.46 -41.47 89.02 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.609 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.8 94.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.633 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.01 -32.53 73.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.43 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.03 -21.93 18.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.696 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -65.11 -41.03 95.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.734 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -77.45 136.32 24.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.74 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.28 108.56 10.97 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.258 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.44 125.96 0.32 Allowed Pre-proline 0 C--O 1.24 0.555 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.529 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.1 Cg_exo -43.92 152.21 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.824 2.349 . . . . 0.0 112.533 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.26 142.12 54.16 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.678 2.252 . . . . 0.0 112.472 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.44 147.26 2.09 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.607 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.85 154.29 71.3 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.726 2.284 . . . . 0.0 112.293 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.12 162.99 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.452 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.578 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.83 170.57 15.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.948 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.77 137.84 21.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.0 110.166 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.549 HG22 HD12 ' A' ' 205' ' ' LEU . 40.0 pt -134.33 146.99 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.695 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.94 131.86 59.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.161 0.505 . . . . 0.0 110.468 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -152.22 155.45 37.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.363 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.616 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.6 m -123.05 123.23 40.39 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.939 0.4 . . . . 0.0 110.331 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.78 66.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.635 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.616 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.23 -49.28 19.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.1 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.89 -11.65 60.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.403 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.5 m80 48.84 41.98 19.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.485 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.9 t -136.16 143.48 44.49 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.363 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -109.86 114.18 27.53 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.29 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.94 133.63 55.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.05 0.452 . . . . 0.0 110.445 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.549 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.05 146.45 37.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.787 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.481 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.4 t90 -99.8 129.78 45.94 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.127 0.489 . . . . 0.0 109.939 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.54 153.82 39.41 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.281 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.417 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.0 Cg_endo -67.62 -18.37 48.39 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.72 2.28 . . . . 0.0 111.912 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -48.92 -18.28 0.27 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.401 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.481 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.4 p -76.2 165.35 25.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.499 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.35 -28.34 66.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.484 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.613 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.0 mt-30 -63.57 -41.13 98.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.617 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.31 -44.52 97.43 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.443 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.8 mt-30 -64.57 -39.05 93.05 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.886 0.374 . . . . 0.0 110.496 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.19 -41.31 98.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.107 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 70.5 mt -63.59 -47.05 83.03 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.588 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -54.63 -31.77 57.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.112 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.7 -18.38 62.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.539 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.0 mt -87.94 -9.1 54.62 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.609 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.27 2.34 54.14 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -88.59 153.43 21.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.359 . . . . 0.0 110.549 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.442 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.0 p -115.98 128.52 55.8 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.154 0.502 . . . . 0.0 110.307 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.4 145.88 24.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.944 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.474 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.66 151.59 45.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.503 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.17 131.72 42.5 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.385 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.887 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.73 93.36 28.19 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.063 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.677 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.5 Cg_exo -55.38 138.91 81.15 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.571 2.181 . . . . 0.0 111.539 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.78 -25.78 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.505 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.18 -50.16 29.42 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.562 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.7 mt -54.48 -37.11 64.86 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.18 35.89 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.898 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.562 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.3 88.24 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.909 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.3 p -81.68 -13.91 57.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.323 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.64 -41.45 10.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.577 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.4 t -67.02 -16.66 64.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.649 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.95 43.81 26.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.461 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 180.0 -148.5 8.0 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.55 143.02 48.82 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.001 0.429 . . . . 0.0 110.313 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -151.95 149.48 28.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.273 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -101.14 -151.86 0.42 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.33 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.06 -91.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.664 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.459 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.8 tt -127.08 175.29 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.545 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.459 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.1 mt -122.17 141.63 41.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.84 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.55 169.13 9.51 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.207 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.3 mt -147.69 150.72 34.87 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.241 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.67 -39.01 97.08 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.21 4.07 4.63 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.49 -57.98 3.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.949 0.404 . . . . 0.0 110.566 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.546 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.1 m-20 -62.25 -36.27 81.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.326 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.52 -67.72 0.23 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.735 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.4 -42.29 66.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.241 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.06 17.85 0.16 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.681 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.76 48.59 0.26 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.62 -109.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.59 0.233 . . . . 0.0 110.728 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.474 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -61.08 -44.57 97.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.406 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.25 8.15 84.01 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -99.2 -13.05 19.9 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.75 -0.265 . . . . 0.0 110.69 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.3 t 176.79 142.34 0.08 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.112 0.482 . . . . 0.0 110.454 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.423 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.9 125.4 11.69 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.165 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.434 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.67 143.02 29.51 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 120.894 0.378 . . . . 0.0 110.775 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.9 mt -94.15 106.29 18.27 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.664 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.441 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.3 t80 -101.48 -11.88 18.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.129 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.3 87.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.84 174.14 46.32 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.451 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -74.41 -113.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.799 0.333 . . . . 0.0 110.786 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.45 -28.61 68.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.702 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.1 -44.1 91.91 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.172 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.89 -44.02 94.28 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.383 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.81 -60.27 3.47 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.233 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.15 -43.39 61.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.13 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.57 75.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.139 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.7 mt -64.45 -43.67 96.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.657 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -56.46 -37.5 70.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.139 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.82 0.91 18.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.223 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -114.9 91.35 26.04 Favored Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.164 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.2 -27.19 29.11 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.802 2.335 . . . . 0.0 111.786 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.536 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.36 -41.25 98.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.545 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.15 4.99 53.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.343 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.75 -35.16 70.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.719 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.83 4.73 15.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.558 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.89 121.32 81.04 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.6 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -47.58 -37.44 26.68 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.411 2.074 . . . . 0.0 112.523 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -59.12 -43.73 91.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.777 0.323 . . . . 0.0 110.244 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.89 -43.79 92.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.33 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -64.81 -40.65 95.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.424 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.8 t-20 -89.54 -12.78 38.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.588 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.8 mtmt 62.11 32.27 17.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.96 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -89.07 43.87 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.072 0.463 . . . . 0.0 110.352 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.44 135.85 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.453 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -116.53 132.45 56.68 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.44 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.503 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.79 87.22 7.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.751 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.04 -40.77 97.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.441 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.58 169.35 35.54 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.508 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 72.4 p -76.35 -25.78 55.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.819 0.343 . . . . 0.0 110.699 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.7 tp10 -67.24 -34.82 78.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.398 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.763 HG22 ' O ' ' A' ' 296' ' ' THR . 93.2 m -73.59 25.01 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.758 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.613 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 64.2 t80 -58.27 -51.25 70.55 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.418 HH12 ' HG3' ' A' ' 212' ' ' GLN . 61.2 mmt-85 -112.16 154.96 24.72 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.417 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.3 tp -115.54 124.4 50.95 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.494 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.9 t0 -147.42 165.58 29.81 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.583 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -49.0 -38.51 23.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.624 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -71.5 -65.37 0.76 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.523 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.73 -32.87 72.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.082 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.64 -25.29 25.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.697 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.7 mtt -63.35 -41.0 98.83 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 120.894 0.378 . . . . 0.0 111.018 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.34 -43.99 22.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.987 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.564 HG21 HG23 ' A' ' 296' ' ' THR . 75.1 t -65.81 -43.22 93.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.398 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 56.5 tp -60.65 -47.28 86.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.494 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -69.39 -39.64 77.87 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.725 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.503 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.2 ttt180 -62.13 -38.39 88.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.207 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.2 mt -86.86 3.88 43.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.84 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -112.57 -11.29 13.6 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.064 0.459 . . . . 0.0 110.315 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.07 -37.0 85.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.515 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.01 -48.74 80.4 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.414 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.09 179.829 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.618 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.15 -2.05 58.02 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.369 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.484 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.08 179.04 1.24 Allowed Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.499 -179.625 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.0 Cg_exo -61.04 145.2 99.33 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.769 2.313 . . . . 0.0 112.226 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.618 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.4 ptt-85 -156.41 -178.95 7.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.601 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.91 136.68 52.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.281 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -123.97 146.68 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.378 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.8 p -119.8 135.94 54.66 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.736 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.41 -143.53 0.33 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.295 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -63.28 -37.06 85.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.598 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.88 -65.56 0.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.518 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.84 141.95 46.47 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 p -112.02 131.19 55.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.922 0.392 . . . . 0.0 110.36 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -119.08 128.87 54.73 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.51 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.1 m -85.45 130.13 34.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.201 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.471 HD22 ' NE2' ' A' ' 42' ' ' GLN . 69.0 mt -96.03 78.67 3.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.432 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.52 -31.69 72.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.466 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.28 109.98 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.172 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.471 ' NE2' HD22 ' A' ' 39' ' ' LEU . 1.4 pt20 -122.99 91.35 49.91 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.196 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.645 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.9 Cg_exo -57.01 148.99 64.96 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.756 2.304 . . . . 0.0 111.784 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.79 82.89 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 O-C-N 123.603 0.564 . . . . 0.0 110.928 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.645 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.28 67.09 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.289 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.1 130.69 35.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.549 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.554 ' HA ' HG23 ' A' ' 64' ' ' VAL . 56.5 t -122.79 146.51 27.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.124 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.4 t -136.04 144.16 45.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.63 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 p -100.48 -58.87 1.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.564 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.2 p -79.43 154.78 28.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.598 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.547 HG21 HG23 ' A' ' 70' ' ' THR . 72.8 t -74.07 -21.81 18.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.629 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 94.7 m -60.31 -52.1 66.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.474 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.3 mt -66.5 -42.2 87.74 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.347 0.594 . . . . 0.0 111.003 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.2 m -43.32 -54.06 4.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.143 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.26 -37.84 71.42 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.7 m -62.28 -44.5 96.37 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.956 0.407 . . . . 0.0 110.645 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.9 mt -66.2 -42.18 89.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.459 0.647 . . . . 0.0 110.737 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.63 -40.25 96.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.371 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.464 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.21 -36.03 76.76 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.914 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.535 HD11 HD12 ' A' ' 156' ' ' LEU . 31.6 pt -91.2 28.89 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.042 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.6 51.63 10.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.777 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.0 75.34 24.23 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.949 0.404 . . . . 0.0 109.998 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.44 151.57 85.0 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.743 2.295 . . . . 0.0 112.246 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.554 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.77 137.37 47.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.181 0.515 . . . . 0.0 110.245 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.4 pt -69.34 -43.61 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.163 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.482 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.9 130.87 53.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.915 0.388 . . . . 0.0 110.544 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.53 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.0 p -155.64 168.98 25.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.456 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.98 -177.04 21.58 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.627 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.58 172.65 12.46 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 120.934 0.397 . . . . 0.0 110.513 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.547 HG23 HG21 ' A' ' 51' ' ' VAL . 13.6 p -132.68 -112.49 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.276 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.41 179.84 0.91 Allowed Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.326 -179.115 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.3 Cg_exo -60.93 57.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 123.054 2.503 . . . . 0.0 112.214 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.1 t-20 -64.41 -33.82 76.75 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.487 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.8 m-20 93.85 -36.09 0.02 OUTLIER 'General case' 0 C--N 1.346 0.435 0 O-C-N 124.08 0.862 . . . . 0.0 109.966 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.405 ' HD3' HD21 ' A' ' 73' ' ' ASN . 77.9 mtp85 -63.1 -39.39 94.55 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.218 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 77' ' ' ALA . 15.0 p -74.71 -25.29 18.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.692 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.35 -171.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.588 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.7 p30 -74.08 -153.66 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.765 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.0 p-10 -52.77 -7.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.639 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.508 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.37 115.06 23.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.582 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.85 69.69 1.36 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -142.96 147.53 35.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.958 0.409 . . . . 0.0 110.704 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.29 -98.4 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.313 178.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.548 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.4 -42.5 96.06 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.108 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.548 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.5 tt0 91.69 53.05 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.075 0.859 . . . . 0.0 110.79 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.24 -9.09 19.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.466 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.0 p -64.64 -34.04 77.35 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.118 0.485 . . . . 0.0 110.653 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.532 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.66 -23.9 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.553 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.53 -46.02 76.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.881 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.24 -48.49 81.24 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.073 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.68 -38.09 89.0 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.357 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.68 -32.58 52.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.248 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.594 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.1 mmt-85 -89.69 1.67 55.75 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.695 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 56.9 mttp 82.69 -49.05 0.17 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 124.115 0.885 . . . . 0.0 110.31 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.649 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.71 154.79 0.29 Allowed 'General case' 0 CA--C 1.49 -1.327 0 CA-C-O 117.592 -1.194 . . . . 0.0 109.253 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.649 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 120.85 92.47 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 O-C-N 125.462 1.726 . . . . 0.0 110.542 -178.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.53 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.39 143.44 42.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.108 0.48 . . . . 0.0 110.244 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.4 mt -132.4 26.95 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.0 110.47 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -140.52 138.15 34.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.441 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.4 mt -137.31 165.01 28.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.391 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.15 -28.8 1.82 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.408 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -152.18 70.13 7.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.201 0.524 . . . . 0.0 110.348 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.03 145.44 98.39 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 122.663 2.242 . . . . 0.0 112.126 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.0 t -134.81 137.35 43.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.521 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.22 -38.07 81.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.716 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.27 -42.29 96.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.547 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.52 98.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.558 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.2 t -63.58 -43.41 98.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.057 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.13 77.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.294 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.52 -18.62 59.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.463 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.58 -6.62 58.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.576 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.415 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 64.3 mtp 48.17 55.87 17.34 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.609 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.37 149.23 62.66 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.716 2.277 . . . . 0.0 112.111 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.13 -73.21 0.65 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.468 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.469 HD22 HE22 ' A' ' 42' ' ' GLN . 38.0 tp -111.02 112.65 24.62 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.44 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.8 mt -101.11 126.06 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.469 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.6 mt -109.59 133.64 52.87 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.294 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -121.01 140.17 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.472 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.6 p -83.5 168.68 16.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.64 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.43 80.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.433 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.1 t -140.15 159.09 42.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.963 0.411 . . . . 0.0 110.416 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.3 177.66 33.2 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.26 -33.79 87.15 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -124.84 151.72 44.9 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.904 0.383 . . . . 0.0 110.567 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.2 t -63.36 141.2 58.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.355 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.74 10.67 11.02 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.577 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.31 -39.07 89.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.071 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.634 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.9 -35.72 23.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.516 0.675 . . . . 0.0 110.709 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.5 mt -71.0 -35.42 72.06 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.473 0.654 . . . . 0.0 110.727 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -42.74 -63.19 0.82 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.132 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.634 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.83 -42.64 90.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -61.99 -32.91 73.42 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.424 0.453 . . . . 0.0 110.17 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.9 mt -73.8 -40.24 63.53 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.22 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.17 -49.13 78.08 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.15 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 78.9 m -52.36 -42.74 64.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.314 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.37 -43.26 94.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.141 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.99 154.85 5.3 Favored Pre-proline 0 N--CA 1.453 -0.285 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.646 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -39.19 106.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.696 2.264 . . . . 0.0 112.356 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.643 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.4 m -110.09 121.5 45.41 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.169 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.26 152.93 30.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.257 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -129.01 129.11 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.382 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.4 mt -112.54 127.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.498 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.11 103.34 14.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.3 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 147' ' ' LYS . 44.0 p90 -101.04 -11.17 19.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.703 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.2 p-10 -64.72 -33.77 76.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.619 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.7 p-10 -98.27 8.1 45.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.597 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.83 155.62 50.05 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.499 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.1 165.91 24.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.594 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.09 -48.62 80.94 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.22 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.76 -42.03 67.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.992 0.425 . . . . 0.0 110.084 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.0 t -62.63 -40.63 97.58 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.435 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.406 ' CD1' HG21 ' A' ' 142' ' ' ILE . 45.9 tp -60.62 -43.88 96.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.417 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.514 HD22 HH21 ' A' ' 169' ' ' ARG . 43.9 tp -61.45 -43.19 99.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.188 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.2 m -54.94 -45.17 74.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.806 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.5 -40.72 97.62 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-O 120.889 0.376 . . . . 0.0 110.381 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.535 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.95 -42.33 98.99 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.249 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.05 -41.03 95.36 Favored Glycine 0 C--N 1.316 -0.533 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.85 -46.0 63.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.94 0.4 . . . . 0.0 110.807 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.61 -44.03 96.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.741 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.6 p -93.27 -8.64 41.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.546 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.8 25.16 71.71 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -102.15 52.49 0.81 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.72 0.295 . . . . 0.0 110.593 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -70.04 -39.11 75.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.696 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.16 -47.01 86.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.165 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -61.38 -38.91 88.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.434 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.38 97.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.413 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.45 -27.67 69.15 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.537 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.82 -53.77 8.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.17 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.514 HH21 HD22 ' A' ' 153' ' ' LEU . 61.8 ttp180 -63.55 -43.56 96.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.448 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 174' ' ' ASP . 85.7 mt -63.01 -43.78 99.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.658 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.08 -61.65 2.42 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.112 0.482 . . . . 0.0 110.383 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.54 -35.09 62.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.425 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.411 ' CD2' HD11 ' A' ' 177' ' ' LEU . 23.3 t80 -79.6 -35.05 40.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.891 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.3 m-20 -56.68 -40.43 75.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.96 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.94 -42.61 99.86 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.769 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.85 -37.52 86.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.303 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.411 HD11 ' CD2' ' A' ' 173' ' ' PHE . 80.9 mt -62.26 -42.36 99.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.702 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -53.0 61.77 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.168 0.509 . . . . 0.0 110.645 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.25 -41.69 89.6 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.597 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.31 -39.68 94.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.5 -32.36 73.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.302 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.93 -22.12 18.79 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.647 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.631 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -65.22 -40.91 94.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.632 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.1 pt -78.45 136.45 23.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.568 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.53 109.45 11.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.277 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.48 125.8 0.32 Allowed Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.518 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.4 Cg_exo -43.92 152.29 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.713 2.276 . . . . 0.0 112.598 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.16 142.0 54.28 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.612 2.208 . . . . 0.0 112.461 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.37 147.4 2.14 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.602 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.15 154.74 69.67 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.805 2.337 . . . . 0.0 112.296 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.27 163.23 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.405 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -144.1 170.41 16.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.793 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.83 137.89 21.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.017 0.437 . . . . 0.0 110.226 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.543 HG22 HD12 ' A' ' 205' ' ' LEU . 38.9 pt -134.44 146.72 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.574 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.98 131.73 58.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.128 0.49 . . . . 0.0 110.474 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -151.92 154.89 36.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.357 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.2 m -122.08 122.62 39.68 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.961 0.41 . . . . 0.0 110.371 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.32 -25.98 66.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.613 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.72 -49.02 22.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.007 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.38 -11.04 60.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.285 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.8 m80 48.6 42.47 19.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.452 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.6 t -136.43 145.7 45.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.386 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.41 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -111.44 114.18 27.12 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.311 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.72 133.32 55.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.08 0.467 . . . . 0.0 110.343 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.543 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.13 146.43 38.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.671 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.519 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 10.9 t90 -99.77 130.23 45.96 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.104 0.478 . . . . 0.0 110.148 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.65 153.88 39.31 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.133 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.412 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.2 Cg_endo -67.76 -18.05 47.51 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.663 2.242 . . . . 0.0 111.95 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -48.99 -18.57 0.3 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.405 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.519 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.96 165.11 25.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.543 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.22 -28.04 66.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.516 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.616 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.3 mt-30 -63.76 -41.21 98.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.669 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.12 -44.75 97.02 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.8 mt-30 -64.6 -38.71 91.94 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 120.99 0.424 . . . . 0.0 110.649 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.9 mmm -62.14 -41.15 98.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.11 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.81 -46.74 83.76 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.644 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.59 -31.73 57.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.089 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.88 -18.12 62.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.57 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.418 HD11 ' CD2' ' A' ' 299' ' ' LEU . 89.0 mt -88.25 -8.49 55.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.612 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.39 2.05 55.61 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -88.41 153.36 21.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.512 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.46 ' O ' HG12 ' A' ' 191' ' ' VAL . 7.9 p -116.09 128.72 55.91 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.055 0.455 . . . . 0.0 110.308 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.571 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.62 145.97 24.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.802 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.469 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.68 151.5 45.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.534 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.72 131.53 43.12 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.526 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.893 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.55 93.22 26.67 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.049 -179.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.679 ' C ' ' H ' ' A' ' 229' ' ' GLY . 47.6 Cg_exo -55.59 139.25 82.59 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.56 2.173 . . . . 0.0 111.612 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.04 -25.64 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.459 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.54 -49.78 29.2 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.8 mt -53.87 -37.01 63.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 0.0 110.197 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.92 36.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.777 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.85 86.85 0.01 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.861 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.3 p -79.42 -15.17 58.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.411 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.38 -41.12 10.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.616 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.8 t -66.06 -17.78 64.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.65 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.25 43.22 26.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.508 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.48 -147.27 7.21 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.96 143.01 50.19 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.955 0.407 . . . . 0.0 110.323 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -152.51 149.85 28.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.391 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -100.95 -151.75 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.398 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 66.9 t0 55.99 -91.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.555 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.459 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.96 175.25 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.54 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.459 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 93.0 mt -122.3 141.73 41.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.693 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.77 168.97 9.57 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.244 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.3 mt -147.73 150.9 35.16 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.154 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.53 -39.21 97.4 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.32 4.01 4.6 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.28 -58.06 3.49 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.011 0.434 . . . . 0.0 110.636 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.551 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.2 m-20 -62.2 -37.04 83.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.271 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.41 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.1 mp -52.14 -67.69 0.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.784 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.43 -42.07 66.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.145 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.16 17.96 0.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.724 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.92 48.13 0.26 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.83 -109.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.663 0.268 . . . . 0.0 110.675 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.469 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.71 -44.87 96.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.502 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.26 8.13 84.03 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -99.02 -13.19 19.98 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.672 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.6 t 176.8 142.45 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.079 0.466 . . . . 0.0 110.423 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.93 125.42 11.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.983 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.433 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -98.57 142.94 29.53 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 120.877 0.37 . . . . 0.0 110.88 177.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.9 mt -93.88 106.26 18.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.655 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.429 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.2 t80 -101.48 -12.27 18.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.215 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.4 -40.62 89.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.833 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.43 173.73 46.09 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.448 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -74.09 -112.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.811 0.339 . . . . 0.0 110.683 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.88 -28.74 67.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.689 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -58.85 -43.95 90.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.371 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.8 -44.32 93.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.357 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.48 -60.17 3.56 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.247 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.31 -43.55 61.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.084 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.16 -43.6 74.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.229 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.4 mt -64.62 -43.63 96.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.597 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -56.23 -37.48 69.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.211 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.87 1.25 18.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.277 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -114.94 91.33 26.13 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.213 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.31 -27.25 30.1 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.753 2.302 . . . . 0.0 111.841 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.38 -41.17 98.77 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.591 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.9 mp -95.07 5.12 52.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.362 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.87 -35.13 69.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.713 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.53 4.52 15.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.52 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.91 120.91 79.38 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.61 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -47.41 -37.43 25.4 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.478 2.119 . . . . 0.0 112.493 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -59.01 -43.84 91.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.758 0.313 . . . . 0.0 110.356 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.96 -43.7 92.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.344 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.81 -40.7 95.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.445 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.437 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.9 t-20 -89.42 -12.86 39.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.625 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.7 mtmt 62.18 32.36 17.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -89.15 43.87 1.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.074 0.464 . . . . 0.0 110.353 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.51 135.89 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.448 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.78 132.37 56.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.491 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.504 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.67 87.49 7.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.674 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.02 -40.69 96.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.971 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.429 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.72 168.85 35.0 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.51 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 77.8 p -76.13 -25.89 55.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 0.0 110.698 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.1 tp10 -67.27 -34.6 77.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.524 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.766 HG22 ' O ' ' A' ' 296' ' ' THR . 95.7 m -73.66 25.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.601 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.616 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 61.8 t80 -58.13 -51.13 70.99 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.402 HH12 ' HG3' ' A' ' 212' ' ' GLN . 64.4 mmt-85 -112.3 155.13 24.6 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.418 ' CD2' HD11 ' A' ' 219' ' ' LEU . 45.2 tp -115.88 124.77 51.48 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.766 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.49 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.7 t0 -147.79 165.79 29.5 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -49.13 -38.55 25.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.579 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -71.53 -65.31 0.77 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.267 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -60.79 -32.75 72.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.913 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.88 -25.19 27.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.549 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.1 mtt -63.08 -41.42 99.43 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.88 0.371 . . . . 0.0 110.857 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.18 -43.85 23.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.997 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.56 HG21 HG23 ' A' ' 296' ' ' THR . 76.6 t -66.04 -43.18 92.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.414 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 56.0 tp -60.55 -47.04 87.92 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.549 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -69.84 -39.85 76.18 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.546 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.504 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.3 ttt180 -62.06 -37.97 87.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.133 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.3 mt -87.19 4.32 42.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.795 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.631 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.5 tttt -112.59 -11.51 13.56 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.042 0.448 . . . . 0.0 110.263 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.9 84.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.66 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.02 -48.78 80.2 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.332 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.898 -1.048 . . . . 0.0 110.097 179.941 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.47 -2.1 57.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.298 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.94 179.09 1.23 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.991 0.424 . . . . 0.0 110.481 -179.65 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.6 Cg_exo -60.95 144.91 99.68 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.814 2.343 . . . . 0.0 112.149 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.96 -179.3 8.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.597 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.68 136.66 52.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.388 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.36 147.11 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.297 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.8 p -120.18 135.99 54.78 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.41 -143.38 0.32 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.233 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -63.52 -37.13 86.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.549 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.477 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.54 -66.12 0.22 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.546 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.48 141.99 45.68 Favored Glycine 0 CA--C 1.519 0.309 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.4 p -112.19 131.23 55.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.939 0.4 . . . . 0.0 110.4 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.21 128.9 54.65 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.532 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -85.49 130.3 34.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.227 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.453 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.0 mt -95.74 78.86 3.3 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.287 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.28 -32.31 73.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.55 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 175.88 110.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.075 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.453 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.5 pt20 -123.05 91.7 49.66 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.322 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.645 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.1 Cg_exo -56.95 148.82 65.44 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.769 2.313 . . . . 0.0 111.864 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.42 82.78 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 O-C-N 123.59 0.557 . . . . 0.0 111.017 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.645 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.45 67.07 0.89 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.133 0.492 . . . . 0.0 110.183 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.17 130.78 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.709 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.557 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.1 t -122.85 146.59 27.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.034 0.445 . . . . 0.0 110.015 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -136.38 143.91 44.28 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.693 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.1 p -99.31 -59.5 1.71 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.647 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.0 p -78.95 155.61 28.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.706 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 70' ' ' THR . 71.4 t -74.65 -21.84 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.55 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 94.7 m -60.36 -51.88 67.63 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.459 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.5 mt -66.3 -42.62 88.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.207 0.527 . . . . 0.0 110.85 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.15 -53.9 4.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.005 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.39 -38.12 70.24 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.7 m -62.21 -44.55 96.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 110.203 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.418 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.3 mt -66.27 -42.03 89.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.443 0.64 . . . . 0.0 110.756 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.59 -40.12 95.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.495 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.471 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.97 -35.91 76.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.183 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.537 HD11 HD12 ' A' ' 156' ' ' LEU . 32.7 pt -91.2 28.69 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.295 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.58 51.52 11.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.98 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.74 75.52 25.38 Favored Pre-proline 0 C--N 1.331 -0.208 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.34 151.15 86.64 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.793 2.328 . . . . 0.0 112.199 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.59 137.26 47.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.223 0.535 . . . . 0.0 110.208 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.447 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.0 pt -69.21 -43.65 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.326 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.483 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.02 131.07 53.46 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.964 0.411 . . . . 0.0 110.564 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.526 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.4 p -155.68 168.72 26.25 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.501 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.96 -176.97 21.59 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.627 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.37 172.54 12.56 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 121.01 0.433 . . . . 0.0 110.44 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.493 HG23 HG21 ' A' ' 51' ' ' VAL . 12.9 p -133.13 -111.84 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 110.349 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.49 179.68 0.94 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.348 -179.143 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.7 Cg_exo -61.34 57.89 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.975 2.45 . . . . 0.0 112.094 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.5 t-20 -64.19 -34.13 77.37 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 118.894 -0.574 . . . . 0.0 110.398 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.5 m-20 94.06 -36.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.103 0.877 . . . . 0.0 109.838 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -62.9 -39.84 95.73 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.179 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.49 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -74.27 -25.71 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.758 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.68 -171.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.575 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.26 -153.68 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.864 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.0 p-10 -52.72 -7.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.677 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.25 114.6 23.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.618 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.61 70.36 1.34 Allowed Glycine 0 C--O 1.225 -0.428 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -143.18 147.93 35.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.824 0.345 . . . . 0.0 110.961 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -85.94 -98.4 0.07 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.995 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.1 mtt-85 -64.28 -42.69 96.3 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.08 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.4 tt0 91.49 53.43 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.057 0.848 . . . . 0.0 110.954 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.38 -9.1 19.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.391 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.2 p -64.71 -33.99 77.27 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.165 0.507 . . . . 0.0 110.681 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.538 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.85 -24.27 1.39 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.59 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.4 t -69.13 -46.11 78.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.936 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.21 -48.49 81.26 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.964 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.69 -38.17 89.35 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.302 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.82 -32.28 52.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.095 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.593 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.7 mmt-85 -90.04 1.82 55.89 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.585 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.6 -49.34 0.18 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 124.102 0.876 . . . . 0.0 110.192 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.638 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.5 mt -46.42 154.88 0.25 Allowed 'General case' 0 CA--C 1.49 -1.345 0 CA-C-O 117.365 -1.302 . . . . 0.0 109.275 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.638 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 120.76 92.48 0.0 OUTLIER 'General case' 0 C--N 1.354 0.764 0 O-C-N 125.699 1.875 . . . . 0.0 110.464 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.526 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.34 143.54 42.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.098 0.475 . . . . 0.0 110.311 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.5 mt -132.52 27.2 4.4 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.147 -0.346 . . . . 0.0 110.428 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -140.6 138.46 34.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.015 0.436 . . . . 0.0 110.542 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.5 mt -137.37 164.99 28.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.418 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.34 -28.71 1.8 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -153.23 70.87 6.95 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.166 0.508 . . . . 0.0 110.288 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.22 145.58 98.22 Favored 'Trans proline' 0 C--N 1.301 -1.936 0 C-N-CA 122.719 2.279 . . . . 0.0 112.108 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.4 t -133.99 136.55 44.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.481 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.38 83.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.683 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.38 -42.17 96.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.52 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.53 98.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.581 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.6 t -63.68 -43.45 98.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.925 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.81 -35.12 77.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.233 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.55 -18.61 59.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.38 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -86.67 -6.85 58.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.562 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.409 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.6 mtp 48.1 56.09 17.47 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.627 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.0 Cg_endo -70.12 149.23 64.28 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.766 2.31 . . . . 0.0 112.122 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.04 -73.47 0.64 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.43 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 140' ' ' LEU . 38.4 tp -111.03 112.84 24.94 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.26 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.1 mt -101.13 126.19 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.556 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.5 mt -109.58 133.42 53.12 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.198 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.46 139.7 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.506 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 94.4 p -83.42 168.42 16.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.692 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.12 -37.41 79.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.402 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.2 t -139.38 159.07 43.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.932 0.396 . . . . 0.0 110.475 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.07 176.33 33.55 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.13 -33.84 87.14 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.7 151.53 44.88 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 110.523 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.9 t -63.06 140.82 58.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.359 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.7 10.44 11.0 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.607 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.08 -39.13 88.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.099 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.68 -35.86 24.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.59 0.709 . . . . 0.0 110.721 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.2 mt -70.8 -35.62 72.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.642 0.734 . . . . 0.0 110.738 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -42.84 -62.71 0.94 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.408 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.64 -42.66 91.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -62.1 -33.02 73.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.301 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.1 mt -73.3 -40.77 64.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.145 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.8 t -58.53 -48.58 80.36 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.013 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.8 m -52.9 -42.35 65.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.302 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.15 -43.03 92.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.082 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.4 154.15 5.58 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.659 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -39.37 107.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.639 2.226 . . . . 0.0 112.422 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.635 ' C ' HD12 ' A' ' 140' ' ' LEU . 93.8 m -110.13 120.88 43.85 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.037 0.446 . . . . 0.0 110.238 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.62 152.78 29.89 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.292 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.421 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.7 tt -128.75 131.04 68.82 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.268 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.81 127.79 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.504 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.9 t30 -101.79 103.53 14.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.302 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 147' ' ' LYS . 45.3 p90 -101.05 -11.29 19.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.862 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.74 -33.73 76.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.671 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -98.29 7.86 45.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.548 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.6 155.54 50.29 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.538 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.404 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -75.07 165.8 24.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.715 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.05 -48.69 80.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.152 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -53.7 -42.2 67.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.002 0.429 . . . . 0.0 110.063 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.2 t -62.49 -40.89 98.15 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.362 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.41 ' O ' HD23 ' A' ' 156' ' ' LEU . 47.4 tp -60.59 -43.95 96.79 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.261 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.501 HD22 HH21 ' A' ' 169' ' ' ARG . 45.0 tp -61.27 -43.43 98.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.139 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 m -55.03 -45.37 75.17 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.59 -40.58 97.36 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.891 0.377 . . . . 0.0 110.446 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.537 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.97 -42.29 98.96 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.343 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.19 -40.89 95.05 Favored Glycine 0 C--N 1.315 -0.587 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.72 -45.91 64.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.0 mt -64.61 -44.0 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.794 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.6 p -93.35 -8.56 41.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.587 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.85 25.37 71.85 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -102.06 52.26 0.82 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.769 0.319 . . . . 0.0 110.663 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.87 -39.23 76.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.575 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.15 -46.95 87.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.243 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -61.41 -39.12 89.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.35 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.27 -40.32 97.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.257 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.49 -27.51 69.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.545 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.95 -53.81 8.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.059 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.501 HH21 HD22 ' A' ' 153' ' ' LEU . 61.8 ttp180 -63.88 -43.24 96.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.47 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.9 mt -63.07 -43.86 99.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.726 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.18 -61.52 2.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.146 0.498 . . . . 0.0 110.403 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.65 -35.32 63.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.466 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.422 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.4 t80 -79.21 -35.19 42.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.963 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.1 m-20 -56.98 -40.1 75.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.146 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.08 -42.64 99.68 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.828 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.74 -37.76 87.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.285 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.422 HD11 ' CD2' ' A' ' 173' ' ' PHE . 80.4 mt -62.29 -42.33 99.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.715 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.07 -52.76 62.61 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.073 0.463 . . . . 0.0 110.639 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.41 -41.56 89.1 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.624 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.33 -39.65 94.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.671 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.29 -32.49 73.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.306 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.95 -21.99 18.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.657 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.633 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -65.02 -40.9 95.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.726 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.8 pt -78.1 136.47 24.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.727 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.37 109.31 11.65 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.214 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.8 125.66 0.3 Allowed Pre-proline 0 C--O 1.242 0.666 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.495 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.4 Cg_exo -43.88 152.36 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.786 2.324 . . . . 0.0 112.618 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.13 142.29 55.41 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.554 2.17 . . . . 0.0 112.504 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.3 147.07 2.11 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.626 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.91 154.6 70.64 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.75 2.3 . . . . 0.0 112.307 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.29 163.2 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.487 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -144.02 170.35 16.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.889 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.01 137.65 22.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.253 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.54 HG22 HD12 ' A' ' 205' ' ' LEU . 38.9 pt -134.37 146.75 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.65 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.46 132.26 57.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.168 0.509 . . . . 0.0 110.497 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -152.12 155.15 37.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.439 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.8 m -122.34 123.06 40.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.957 0.408 . . . . 0.0 110.364 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.51 -25.76 66.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.631 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.614 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.12 -49.18 20.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.084 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.12 -12.18 60.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.413 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.4 m80 49.47 41.95 21.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.496 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.1 t -135.97 144.76 45.57 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.328 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.5 113.97 27.02 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.258 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.474 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.8 133.33 55.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.039 0.447 . . . . 0.0 110.362 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.54 HD12 HG22 ' A' ' 194' ' ' ILE . 7.5 tt -111.92 146.32 37.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.483 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 12.5 t90 -99.11 129.74 45.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.175 0.512 . . . . 0.0 109.932 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.74 153.87 39.25 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.294 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.2 Cg_endo -67.59 -18.15 48.47 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.671 2.247 . . . . 0.0 111.957 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.37 -18.83 0.43 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.36 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.483 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.9 p -75.39 164.59 26.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.536 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.99 -27.84 65.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.559 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.623 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.2 mt-30 -63.99 -41.0 97.63 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.589 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.26 -44.54 97.36 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.6 mt-30 -64.59 -38.71 91.96 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.022 0.439 . . . . 0.0 110.557 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.2 mmm -62.18 -41.21 98.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.103 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.3 mt -63.7 -47.09 82.58 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.525 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.27 -31.84 54.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.355 . . . . 0.0 110.193 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.02 -18.32 62.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.472 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.422 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.5 mt -87.94 -8.67 55.38 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.626 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.57 2.13 55.42 Favored Glycine 0 N--CA 1.464 0.503 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -88.4 153.29 21.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.939 0.4 . . . . 0.0 110.464 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.448 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.3 p -115.93 128.7 55.97 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.143 0.497 . . . . 0.0 110.334 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.567 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.71 145.89 24.07 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.948 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.474 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.46 151.49 46.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.423 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.65 131.59 43.3 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.461 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.89 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.7 93.29 27.74 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.062 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.678 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.5 Cg_exo -55.52 139.13 82.15 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.556 2.171 . . . . 0.0 111.58 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.76 -25.69 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.477 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.13 -50.07 30.2 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.552 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.7 mt -54.17 -36.93 63.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.68 35.99 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.819 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.08 88.31 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.003 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 79.5 p -81.23 -14.15 57.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.31 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.8 -41.57 10.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.685 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.1 t -66.7 -16.92 64.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.647 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 55.94 43.76 26.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.439 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.74 -148.45 7.9 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.91 142.94 49.24 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.0 0.428 . . . . 0.0 110.327 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.14 149.56 28.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.278 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -101.19 -151.85 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.297 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.12 -92.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.624 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.463 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.67 175.24 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.596 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.463 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.5 mt -122.37 141.62 42.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.56 169.05 9.56 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.264 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.0 mt -147.63 150.86 35.21 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.224 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.69 -38.98 97.03 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.18 3.87 4.7 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -77.18 -58.04 3.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.958 0.409 . . . . 0.0 110.631 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.547 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.1 m-20 -62.25 -36.85 83.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.249 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.24 -67.74 0.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.67 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.68 -42.08 67.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.135 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.97 17.8 0.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.644 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.88 48.5 0.27 Allowed Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.45 -109.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.596 0.236 . . . . 0.0 110.754 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.474 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 12.0 m120 -61.12 -44.65 97.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.469 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.31 8.05 84.06 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -98.93 -13.25 20.07 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.668 -0.313 . . . . 0.0 110.697 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.8 t 176.96 142.53 0.08 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.087 0.47 . . . . 0.0 110.434 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -147.84 125.62 11.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.191 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.433 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -98.68 143.15 29.37 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 120.899 0.381 . . . . 0.0 110.778 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.1 mt -94.44 106.3 18.28 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.672 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.435 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.58 -11.69 19.05 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.171 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.14 -40.66 86.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.27 173.69 46.1 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.442 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.5 m-20 -74.02 -112.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.352 . . . . 0.0 110.856 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.76 -28.75 67.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.731 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.11 -44.01 91.95 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.147 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.68 -44.2 94.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.308 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.72 -59.93 3.88 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.201 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -51.32 -43.58 61.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.982 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.32 -43.63 75.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.181 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.7 mt -64.57 -43.62 96.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.581 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.4 -37.51 70.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.113 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.92 1.24 18.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.179 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -114.73 91.46 25.72 Favored Pre-proline 0 CA--C 1.528 0.11 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.179 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.33 -27.32 30.54 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.801 2.334 . . . . 0.0 111.811 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.538 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.42 -41.14 98.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.575 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.9 mp -95.14 5.04 52.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.346 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.58 -35.08 70.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.645 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.99 4.43 17.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.512 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.73 120.9 78.88 Favored Pre-proline 0 N--CA 1.441 -0.884 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.512 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.37 -37.47 25.19 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.41 2.074 . . . . 0.0 112.635 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.529 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -59.02 -43.65 91.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.75 0.31 . . . . 0.0 110.352 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.99 -43.75 92.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.301 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.89 -40.64 95.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.422 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.8 t-20 -89.51 -12.86 38.79 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.516 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.23 32.08 17.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.88 44.01 1.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.115 0.484 . . . . 0.0 110.367 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.78 135.63 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.529 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -116.64 132.51 56.67 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.386 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.506 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.5 87.31 7.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.834 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.97 -40.77 97.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.919 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.435 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.94 168.84 35.59 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.508 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 77.0 p -76.07 -25.88 55.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.901 0.382 . . . . 0.0 110.781 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.8 tp10 -67.37 -34.7 77.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.357 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.764 HG22 ' O ' ' A' ' 296' ' ' THR . 94.7 m -73.49 25.1 0.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.748 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.623 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 63.2 t80 -58.26 -51.07 71.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.413 HH12 ' HG3' ' A' ' 212' ' ' GLN . 63.5 mmt-85 -112.42 155.0 24.93 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.422 ' CD2' HD11 ' A' ' 219' ' ' LEU . 43.9 tp -115.72 124.92 52.04 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.491 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.2 t0 -148.04 165.89 29.42 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.533 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -49.08 -38.64 25.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.659 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -71.05 -65.61 0.72 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.54 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -60.61 -32.93 72.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.079 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.62 -24.97 23.75 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.811 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.9 mtt -63.23 -41.18 99.07 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 120.948 0.404 . . . . 0.0 111.105 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.54 -43.89 22.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.064 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.56 HG21 HG23 ' A' ' 296' ' ' THR . 77.3 t -65.81 -43.24 93.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.417 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 55.4 tp -60.82 -46.96 88.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.518 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -69.83 -39.65 76.33 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.663 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.506 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.5 ttt180 -62.09 -38.15 87.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.136 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.03 3.97 43.85 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.753 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.633 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.5 tttt -112.78 -11.06 13.54 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.114 0.483 . . . . 0.0 110.189 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.23 -36.95 85.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.549 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.95 -48.7 80.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.395 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.003 179.9 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.06 -2.63 58.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.415 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.72 179.16 1.22 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.498 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.3 Cg_exo -60.87 144.94 99.66 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.76 2.307 . . . . 0.0 112.203 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.613 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.78 -179.7 8.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.581 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.51 136.14 53.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.333 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -123.94 146.82 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.395 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.6 p -120.02 135.98 54.73 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.812 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.25 -143.61 0.32 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.259 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.65 -36.98 85.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.437 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.22 -66.96 0.22 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.523 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.27 142.3 44.93 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.3 p -112.18 131.24 55.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.934 0.397 . . . . 0.0 110.324 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.08 128.94 54.79 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.541 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.9 m -85.55 130.64 34.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.178 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.501 HD22 ' NE2' ' A' ' 42' ' ' GLN . 67.0 mt -95.83 78.63 3.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.271 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.04 -32.18 73.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.493 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.43 108.87 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.086 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.501 ' NE2' HD22 ' A' ' 39' ' ' LEU . 1.4 pt20 -122.25 91.56 49.09 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.194 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.644 ' O ' ' N ' ' A' ' 45' ' ' ARG . 36.1 Cg_exo -56.97 148.67 66.6 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.802 2.334 . . . . 0.0 111.827 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.79 82.67 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 O-C-N 123.57 0.544 . . . . 0.0 111.028 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.644 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.28 67.07 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.226 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.0 130.85 35.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.609 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.554 ' HA ' HG23 ' A' ' 64' ' ' VAL . 57.5 t -122.61 145.86 28.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.08 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.1 t -135.66 143.45 45.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.63 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.0 p -99.34 -59.54 1.7 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.594 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.7 p -79.07 155.12 28.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.668 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.492 HG21 HG23 ' A' ' 70' ' ' THR . 69.9 t -74.41 -21.72 17.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.569 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.5 m -60.36 -52.04 66.94 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.518 -178.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.5 mt -66.51 -42.37 87.43 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.363 0.601 . . . . 0.0 110.956 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -43.21 -53.63 4.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.083 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.3 -37.69 71.01 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -62.58 -44.48 96.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.893 0.378 . . . . 0.0 110.393 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.2 mt -66.25 -42.14 88.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.547 0.689 . . . . 0.0 110.769 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tp -62.62 -40.09 95.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.439 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.463 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.07 -35.75 75.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.006 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 156' ' ' LEU . 31.4 pt -91.6 28.92 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.16 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.35 51.65 11.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.816 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.86 75.71 24.32 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.98 151.5 85.61 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.775 2.317 . . . . 0.0 112.289 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.554 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.45 137.15 47.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.219 0.533 . . . . 0.0 110.251 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.442 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.1 pt -69.2 -43.63 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.243 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.08 130.92 53.24 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.97 0.414 . . . . 0.0 110.505 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.4 p -155.39 168.84 25.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.464 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.55 -177.53 21.83 Favored Glycine 0 N--CA 1.464 0.564 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.637 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -132.99 172.07 13.12 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.009 0.433 . . . . 0.0 110.458 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.492 HG23 HG21 ' A' ' 51' ' ' VAL . 14.2 p -133.49 -111.34 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.321 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.542 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.56 179.65 0.95 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.348 -179.044 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.2 Cg_exo -60.97 58.71 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.059 2.506 . . . . 0.0 112.108 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.543 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.2 t-20 -64.35 -34.94 79.31 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 118.669 -0.681 . . . . 0.0 110.521 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 45.8 m-20 95.07 -37.58 0.01 OUTLIER 'General case' 0 C--N 1.349 0.557 0 O-C-N 124.332 1.02 . . . . 0.0 109.857 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -62.54 -39.89 95.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.025 0.44 . . . . 0.0 110.261 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -73.93 -26.45 21.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.678 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.83 -172.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.518 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.2 p30 -73.77 -152.79 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.787 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.0 p-10 -54.61 -6.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.683 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.491 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.93 113.74 22.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.585 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.23 72.92 1.27 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.87 148.67 35.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.897 0.38 . . . . 0.0 110.825 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -86.0 -99.14 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.172 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.541 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.04 -43.28 96.02 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.143 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.554 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.8 tt0 91.8 52.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.117 0.886 . . . . 0.0 110.919 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -103.12 -8.9 20.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.347 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.2 p -65.05 -33.97 77.31 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.164 0.507 . . . . 0.0 110.727 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.554 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.49 -24.17 1.2 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.624 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.5 t -69.55 -45.84 77.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.1 -48.74 80.29 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.071 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.77 -38.2 89.66 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.348 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -53.7 -32.45 51.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.207 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.59 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.9 mmt-85 -90.02 1.71 56.0 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 119.19 -0.433 . . . . 0.0 110.579 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.85 -49.41 0.16 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.232 0.957 . . . . 0.0 110.351 179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.636 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.9 mt -46.32 154.01 0.31 Allowed 'General case' 0 CA--C 1.489 -1.39 0 CA-C-O 117.331 -1.319 . . . . 0.0 109.139 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.636 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.6 tt0 121.37 92.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 O-C-N 125.754 1.909 . . . . 0.0 110.538 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.48 143.09 42.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.115 0.483 . . . . 0.0 110.279 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 mt -131.91 26.81 4.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.8 0.333 . . . . 0.0 110.443 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -140.16 137.56 34.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.974 0.416 . . . . 0.0 110.525 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.9 mt -136.99 165.19 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.42 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.13 -28.44 1.84 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -153.32 70.85 6.89 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.192 0.52 . . . . 0.0 110.281 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.94 145.55 98.04 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.759 2.306 . . . . 0.0 112.135 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.3 t -134.06 136.72 44.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.981 0.42 . . . . 0.0 110.541 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.96 -38.3 82.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.642 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.27 -42.29 96.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.518 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.12 -41.44 98.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.561 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.67 -43.34 98.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.05 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.13 77.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.295 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -18.62 60.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.489 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.51 -6.6 58.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.524 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 78.7 mtp 47.91 55.98 17.3 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.596 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.31 149.27 63.1 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.755 2.303 . . . . 0.0 112.083 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.38 -72.56 0.68 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.498 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.476 HD22 HE22 ' A' ' 42' ' ' GLN . 38.7 tp -111.7 112.7 24.58 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.321 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.3 mt -101.09 126.37 54.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.567 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.2 mt -110.07 133.7 52.93 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.156 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -121.17 139.97 46.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.517 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.7 p -83.34 168.43 16.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.705 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -37.48 80.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.418 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -139.47 159.0 43.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.434 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.15 176.94 33.44 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.02 -34.0 87.49 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.88 151.56 45.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.927 0.394 . . . . 0.0 110.531 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.3 t -63.16 141.06 58.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.291 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.09 10.94 10.84 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.625 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.29 -38.93 88.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.007 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.632 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.81 -35.7 24.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.594 0.711 . . . . 0.0 110.605 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.0 mt -71.14 -35.42 71.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.52 0.676 . . . . 0.0 110.8 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.9 t80 -42.89 -62.95 0.88 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.19 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.632 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.3 p-10 -65.67 -42.64 91.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.988 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.543 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -62.24 -32.58 73.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.124 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.5 mt -73.94 -40.54 62.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.15 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.23 -48.87 79.03 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.221 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.6 m -52.69 -42.78 65.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.212 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.96 -43.07 92.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.221 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.04 152.63 5.27 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.66 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -39.02 107.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.627 2.218 . . . . 0.0 112.421 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.634 ' C ' HD12 ' A' ' 140' ' ' LEU . 94.2 m -109.43 121.02 44.27 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.239 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.634 HD12 ' C ' ' A' ' 139' ' ' THR . 10.9 mp -113.6 152.68 30.01 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.12 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.53 131.05 69.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.36 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.99 127.79 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.463 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.99 103.76 14.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.324 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.3 p90 -101.36 -11.42 19.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.772 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.4 p-10 -64.82 -33.48 76.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.673 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.1 p-10 -98.17 7.59 46.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.585 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.44 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.56 155.48 50.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.507 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -74.43 165.39 25.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.67 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.549 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 90.8 t90 -60.0 -48.52 81.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.255 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -53.95 -41.73 68.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.99 0.424 . . . . 0.0 110.061 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.9 t -62.55 -40.84 98.1 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.401 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.412 ' O ' HD23 ' A' ' 156' ' ' LEU . 47.4 tp -60.61 -43.93 96.87 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.338 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.541 HD22 HH21 ' A' ' 169' ' ' ARG . 45.0 tp -61.37 -42.97 99.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 0.0 110.261 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -55.79 -45.25 78.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.679 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.44 -40.6 97.13 Favored 'General case' 0 C--O 1.228 -0.044 0 CA-C-O 120.938 0.399 . . . . 0.0 110.388 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.93 -42.34 98.99 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.321 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.77 -40.72 95.8 Favored Glycine 0 C--N 1.316 -0.575 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.89 -45.85 63.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.937 0.399 . . . . 0.0 110.899 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.0 mt -64.49 -44.13 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.742 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.5 p -93.47 -8.15 42.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.538 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.65 25.0 71.47 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -101.35 52.24 0.84 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.817 0.341 . . . . 0.0 110.653 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.7 -39.02 77.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.668 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.47 -47.12 86.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.201 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -61.41 -39.02 89.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.357 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.4 97.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.068 0.461 . . . . 0.0 110.355 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.19 -27.71 69.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.541 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.71 -53.57 9.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.192 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.541 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -63.98 -43.26 96.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.461 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 174' ' ' ASP . 86.9 mt -63.08 -43.86 99.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.687 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.45 -61.72 2.33 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.173 0.511 . . . . 0.0 110.369 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -54.45 -34.99 62.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.448 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.4 ' CD2' HD11 ' A' ' 177' ' ' LEU . 23.2 t80 -79.66 -35.37 39.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.056 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.0 m-20 -56.0 -41.15 74.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.128 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.92 -42.25 99.73 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.756 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.3 -37.93 88.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.29 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 177' ' ' LEU . 82.0 mt -62.41 -42.26 99.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.752 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.8 -52.97 62.01 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.132 0.491 . . . . 0.0 110.704 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.45 -41.78 88.61 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.649 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.03 -40.0 95.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.7 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.32 -32.4 73.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.349 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.16 -21.69 18.93 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.684 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.0 tt0 -64.86 -41.36 95.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.642 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.0 pt -77.23 135.58 26.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.656 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.02 108.62 11.09 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.27 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.86 126.83 0.31 Allowed Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.548 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.9 Cg_exo -43.75 152.09 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.749 2.3 . . . . 0.0 112.609 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.2 142.09 54.42 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.598 2.198 . . . . 0.0 112.487 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.547 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.12 147.32 2.23 Favored Pre-proline 0 N--CA 1.446 -0.631 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.62 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.2 154.46 69.92 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.71 2.274 . . . . 0.0 112.293 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.58 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.42 163.14 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.417 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.58 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.75 170.46 15.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.905 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.64 137.65 21.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.961 0.41 . . . . 0.0 110.141 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.536 HG22 HD12 ' A' ' 205' ' ' LEU . 39.3 pt -134.08 146.46 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.623 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.9 131.74 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.182 0.515 . . . . 0.0 110.485 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -151.73 154.59 36.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.404 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 199' ' ' ALA . 84.8 m -121.86 122.54 39.66 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.996 0.427 . . . . 0.0 110.382 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.76 -25.5 66.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.551 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.611 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.45 -50.0 20.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.071 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.53 -10.74 60.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.398 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.3 m80 48.61 43.26 20.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.475 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.1 t -136.07 145.24 45.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.323 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.402 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -111.19 113.77 26.52 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.297 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.9 133.65 55.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.07 0.462 . . . . 0.0 110.301 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.23 146.43 38.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.72 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.495 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.8 t90 -99.36 129.86 45.6 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.152 0.501 . . . . 0.0 110.024 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.67 154.37 39.18 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.211 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.9 Cg_endo -67.64 -18.22 48.24 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.702 2.268 . . . . 0.0 111.925 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.2 -18.72 0.37 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.431 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.495 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.6 p -75.73 164.99 25.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.559 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.07 -27.94 66.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.529 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.52 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.8 mt-30 -63.56 -41.59 98.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.675 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.05 -44.87 96.85 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.38 -38.97 92.9 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.952 0.406 . . . . 0.0 110.642 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.549 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.4 mmm -62.23 -41.39 98.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.148 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 70.9 mt -63.78 -47.15 82.08 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.641 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.51 -31.97 57.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.075 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -70.7 -18.28 62.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.493 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.426 HD11 ' CD2' ' A' ' 299' ' ' LEU . 93.5 mt -88.61 -8.3 54.92 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.656 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.47 2.64 55.52 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -88.54 152.33 21.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.346 . . . . 0.0 110.543 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.446 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.2 p -115.15 128.12 55.99 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.117 0.484 . . . . 0.0 110.337 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.52 145.7 24.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.468 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.38 151.41 46.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.43 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.31 131.81 42.34 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.409 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.885 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.52 93.54 28.01 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.078 -179.57 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.68 ' C ' ' H ' ' A' ' 229' ' ' GLY . 48.4 Cg_exo -55.62 138.99 82.45 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.553 2.169 . . . . 0.0 111.493 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.77 -25.42 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.463 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.68 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.83 -49.55 28.42 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.56 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.8 mt -54.61 -37.18 65.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 0.0 110.098 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.29 35.8 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.837 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.56 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.38 88.35 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 82.6 p -81.83 -14.12 56.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.307 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.53 -40.89 11.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.582 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 24.7 t -66.86 -16.87 64.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.643 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.99 43.6 26.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.45 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.94 -147.44 7.43 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.02 142.95 49.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.035 0.445 . . . . 0.0 110.291 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -152.23 149.69 28.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.361 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -101.3 -151.35 0.41 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.294 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 55.76 -92.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.611 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.455 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.3 tt -126.56 174.8 9.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.604 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.455 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.7 mt -121.4 141.09 43.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.781 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.42 168.85 9.73 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.224 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.8 mt -147.57 150.85 35.26 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.191 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.75 -38.76 96.66 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.05 4.27 4.65 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.47 -58.03 3.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.94 0.4 . . . . 0.0 110.571 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.545 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.1 m-20 -62.42 -36.6 82.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.282 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.402 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.2 mp -52.29 -67.64 0.23 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.808 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.67 -42.11 67.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.072 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.84 17.97 0.15 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.698 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.77 48.32 0.26 Allowed Glycine 0 N--CA 1.464 0.564 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.36 -109.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.595 0.236 . . . . 0.0 110.741 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.74 -44.95 96.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.484 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.54 8.23 83.41 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -99.53 -12.24 20.31 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.751 -0.264 . . . . 0.0 110.732 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.7 t 176.2 142.47 0.07 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.096 0.474 . . . . 0.0 110.482 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.06 126.04 12.04 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.077 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 14.0 m-30 -99.06 142.89 29.97 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 120.893 0.378 . . . . 0.0 110.907 178.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.45 106.61 18.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.596 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.47 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.8 t80 -102.3 -12.1 18.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.203 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.66 -40.32 88.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.833 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.22 173.45 45.92 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.495 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.4 m-20 -74.49 -113.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.772 0.32 . . . . 0.0 110.77 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.27 -28.69 68.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.635 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.06 -44.19 91.81 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.306 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.64 -44.29 94.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.379 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.54 -60.09 3.66 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.174 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -51.21 -43.41 61.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.219 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.45 -43.87 75.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.159 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.6 mt -64.31 -43.62 97.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.651 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -56.84 -37.49 71.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.21 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.03 0.93 19.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.249 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -114.83 91.53 26.45 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.086 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.14 -27.26 28.91 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.743 2.295 . . . . 0.0 111.823 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.533 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.27 -41.37 99.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.63 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.8 mp -95.01 4.87 53.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.324 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.7 -35.24 70.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.667 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.72 4.59 15.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.51 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.82 121.51 81.6 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.563 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -47.72 -37.76 28.31 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.415 2.076 . . . . 0.0 112.553 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.535 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.94 -43.7 91.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.803 0.335 . . . . 0.0 110.266 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.7 -43.78 93.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.286 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.91 -40.6 95.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.43 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.4 -12.48 40.19 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.569 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.25 31.69 17.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.891 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -88.64 44.22 1.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.419 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.91 135.58 43.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.436 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.23 132.87 56.54 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.452 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.42 87.6 6.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.72 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.95 -41.33 97.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.983 0.421 . . . . 0.0 110.906 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.47 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 78.91 168.6 35.04 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 77.2 p -75.89 -25.79 56.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.834 0.35 . . . . 0.0 110.705 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -67.71 -34.55 77.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.484 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.759 HG22 ' O ' ' A' ' 296' ' ' THR . 98.5 m -72.96 19.38 0.09 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.596 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.52 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 52.0 t80 -57.36 -50.88 71.56 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.049 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 69.8 mmt-85 -108.15 148.98 29.11 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.426 ' CD2' HD11 ' A' ' 219' ' ' LEU . 40.1 tp -115.54 125.87 53.54 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.696 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.476 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.6 t0 -149.32 166.7 28.18 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.651 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -49.45 -38.22 28.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.597 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -72.6 -64.61 0.92 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.925 0.393 . . . . 0.0 111.381 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.26 -31.49 70.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.889 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -55.54 -25.05 35.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.523 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.7 mtt -63.08 -41.52 99.43 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 120.923 0.392 . . . . 0.0 110.809 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.16 -44.28 26.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.018 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.534 HG21 HG23 ' A' ' 296' ' ' THR . 78.6 t -66.16 -43.08 92.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.415 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.439 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.5 tp -60.37 -47.3 86.66 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.529 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -69.8 -39.69 76.4 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.675 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.498 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 70.6 ttt180 -61.76 -37.92 86.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.218 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.72 4.79 42.78 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.769 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -112.58 -12.09 13.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.045 0.45 . . . . 0.0 110.246 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.22 85.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.574 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.87 -48.63 80.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.328 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.025 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -90.16 -2.81 58.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.369 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.09 179.22 1.22 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.513 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 29.6 Cg_exo -60.92 145.16 99.46 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.815 2.343 . . . . 0.0 112.179 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.35 -179.38 8.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.571 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -116.33 137.15 52.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.98 0.419 . . . . 0.0 110.329 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -123.99 146.61 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.349 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -120.28 136.4 54.68 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.771 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 53.1 p30 -99.81 -143.16 0.33 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.133 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -62.87 -36.87 84.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.399 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.468 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -152.23 -59.76 0.15 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.446 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -60.75 140.27 48.06 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.1 p -111.78 130.21 55.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.925 0.393 . . . . 0.0 110.404 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -120.05 128.62 53.68 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.509 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.2 m -85.5 130.14 34.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.205 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.497 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.7 mt -96.29 78.61 3.08 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.343 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.46 -31.83 73.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.556 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.75 109.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.976 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.497 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -122.75 91.2 49.74 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.287 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.643 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -57.15 148.63 68.44 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.82 2.347 . . . . 0.0 111.876 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.28 82.77 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.653 0.595 . . . . 0.0 110.999 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.643 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.67 67.0 0.88 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.142 0.496 . . . . 0.0 110.229 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -77.07 130.93 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.752 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.575 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.6 t -122.58 147.72 26.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.047 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.0 t -136.55 143.97 43.97 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.666 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.408 ' OG1' ' N ' ' A' ' 50' ' ' SER . 18.2 p -99.71 -58.8 1.84 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.557 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.408 ' N ' ' OG1' ' A' ' 49' ' ' THR . 88.4 p -79.43 155.25 28.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.637 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.527 HG21 HG23 ' A' ' 70' ' ' THR . 69.0 t -74.05 -21.94 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.569 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.6 m -60.26 -51.92 67.48 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.516 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 mt -66.21 -42.68 88.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.172 0.511 . . . . 0.0 110.897 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.3 m -43.16 -53.96 4.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.959 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.0 -37.55 73.86 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 m -62.86 -44.22 96.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.87 0.366 . . . . 0.0 110.244 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 17.5 mt -65.86 -42.33 90.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.602 0.715 . . . . 0.0 110.679 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tp -62.93 -39.69 95.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.519 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.495 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.6 -36.0 77.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.235 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.51 HD11 HD12 ' A' ' 156' ' ' LEU . 34.2 pt -91.36 28.09 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.257 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.79 51.83 10.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.011 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.16 76.07 27.62 Favored Pre-proline 0 C--O 1.225 -0.189 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.02 149.6 90.14 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.742 2.294 . . . . 0.0 112.108 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.575 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.57 136.61 48.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-O 121.233 0.539 . . . . 0.0 110.256 179.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.434 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.3 pt -69.3 -43.73 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.369 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.16 131.15 53.27 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.989 0.423 . . . . 0.0 110.628 -178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.5 p -155.65 168.6 26.64 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.38 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.34 -177.24 21.98 Favored Glycine 0 N--CA 1.465 0.593 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.635 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.42 172.04 13.25 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 121.067 0.46 . . . . 0.0 110.434 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.527 HG23 HG21 ' A' ' 51' ' ' VAL . 12.8 p -133.38 -111.37 0.23 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.001 0.429 . . . . 0.0 110.346 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.94 179.73 0.93 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.356 -179.019 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.0 Cg_exo -61.02 58.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 123.032 2.488 . . . . 0.0 112.14 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.535 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.7 t-20 -64.38 -34.23 77.68 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 118.716 -0.659 . . . . 0.0 110.423 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.4 m-20 94.6 -37.27 0.01 OUTLIER 'General case' 0 C--N 1.348 0.543 0 O-C-N 124.156 0.91 . . . . 0.0 109.684 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -62.73 -40.07 96.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.029 0.442 . . . . 0.0 110.203 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.5 p -73.99 -26.16 20.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.714 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.75 -172.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.539 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.54 -153.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.79 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.3 p-10 -54.21 -6.85 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.707 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.01 114.19 23.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.647 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.42 72.06 1.3 Allowed Glycine 0 C--O 1.225 -0.446 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -143.58 148.13 35.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.913 0.387 . . . . 0.0 110.839 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -85.89 -98.77 0.07 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.076 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -63.86 -43.39 96.23 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.14 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.556 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.8 tt0 91.65 52.69 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 124.143 0.902 . . . . 0.0 110.919 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -103.33 -8.53 20.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.387 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -65.52 -33.31 75.63 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.198 0.523 . . . . 0.0 110.687 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.556 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.24 -24.26 1.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.629 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.8 t -69.57 -46.02 76.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.842 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.24 -48.51 81.12 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.984 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.61 -38.23 89.38 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.367 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.71 -32.86 53.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.144 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.588 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.79 1.71 55.8 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.554 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 83.03 -49.38 0.15 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.141 0.901 . . . . 0.0 110.275 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.628 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.1 mt -46.23 153.72 0.31 Allowed 'General case' 0 CA--C 1.486 -1.483 0 CA-C-O 117.127 -1.416 . . . . 0.0 109.257 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.628 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.35 92.06 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 O-C-N 125.896 1.998 . . . . 0.0 110.525 -178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.534 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.01 142.83 43.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.174 0.512 . . . . 0.0 110.212 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.8 mt -131.96 26.52 4.6 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.041 -0.412 . . . . 0.0 110.443 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -140.03 137.5 34.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.032 0.444 . . . . 0.0 110.516 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.7 mt -136.82 164.7 29.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.352 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.612 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.76 -28.76 1.74 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -152.08 70.67 7.77 Favored Pre-proline 0 N--CA 1.464 0.256 0 CA-C-O 121.195 0.521 . . . . 0.0 110.206 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.98 145.29 98.7 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.743 2.295 . . . . 0.0 112.087 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.1 t -135.03 137.11 42.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.507 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.0 -38.35 82.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.697 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.19 -42.23 96.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.512 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.91 -41.61 98.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.545 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.46 -43.35 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.96 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.04 -35.17 77.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.022 0.439 . . . . 0.0 110.216 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.58 -18.96 61.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.459 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.32 -6.55 58.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.537 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.413 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 68.9 mtp 47.65 55.87 17.11 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.661 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.5 Cg_endo -70.34 149.64 63.48 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.755 2.303 . . . . 0.0 112.132 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.48 -72.78 0.67 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.451 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.421 HD11 HD13 ' A' ' 140' ' ' LEU . 38.5 tp -111.61 113.93 26.65 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.348 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.0 mt -102.96 126.79 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 120.935 0.398 . . . . 0.0 110.566 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.2 mt -110.33 134.16 52.56 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.111 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.65 139.72 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.501 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.1 p -83.22 167.78 17.37 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.708 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.34 -37.25 80.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.43 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.6 t -139.57 158.6 43.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.439 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.59 176.64 33.87 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.68 86.88 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.34 151.38 44.41 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.919 0.39 . . . . 0.0 110.547 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.4 t -63.56 140.89 58.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.268 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.55 10.65 11.15 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.618 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.513 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.2 -39.07 88.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.171 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.628 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.75 -35.9 24.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.614 0.721 . . . . 0.0 110.667 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.8 mt -70.98 -35.26 72.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.525 0.678 . . . . 0.0 110.74 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.9 -62.98 0.87 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.339 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.628 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.72 -42.73 90.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.8 mt-30 -61.97 -32.64 73.1 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.509 0.506 . . . . 0.0 110.222 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.4 mt -73.75 -40.56 63.41 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.49 -49.03 78.82 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.137 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.8 m -52.98 -42.52 65.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.237 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.91 -43.08 93.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.991 0.424 . . . . 0.0 111.208 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.06 152.89 5.36 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.677 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -38.92 107.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.673 2.249 . . . . 0.0 112.488 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.637 ' C ' HD12 ' A' ' 140' ' ' LEU . 96.8 m -109.61 121.44 45.22 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.041 0.448 . . . . 0.0 110.181 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.637 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.83 152.68 30.33 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.254 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.2 tt -128.06 131.16 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.38 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.34 127.75 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.49 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 54.4 t30 -100.15 104.57 16.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.176 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -100.28 -12.02 19.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.014 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.8 p-10 -65.16 -34.08 77.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.81 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.581 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.8 p-10 -99.34 7.92 45.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.585 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -134.05 151.44 51.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.56 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.42 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.8 p -75.87 166.31 23.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.635 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.595 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.0 t90 -59.26 -48.76 80.43 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.101 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -54.24 -44.12 71.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.989 0.423 . . . . 0.0 110.04 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.3 t -63.05 -40.8 98.78 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.344 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.416 ' O ' HD23 ' A' ' 156' ' ' LEU . 62.7 tp -60.62 -44.52 96.23 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.287 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.6 tp -61.56 -42.51 98.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.192 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.9 m -55.55 -46.14 77.17 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.83 -40.6 95.87 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.962 0.41 . . . . 0.0 110.337 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.51 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -62.12 -42.51 99.3 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.41 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.27 -40.11 94.62 Favored Glycine 0 C--O 1.222 -0.608 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.34 -45.9 65.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.931 0.396 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.83 -44.1 96.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.2 p -92.95 -9.3 40.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.61 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.18 26.37 72.49 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -101.97 50.73 0.84 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.822 0.344 . . . . 0.0 110.694 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.63 -39.27 77.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.667 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.5 -47.21 86.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.223 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -59.84 -39.54 85.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.209 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.16 -40.82 98.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.059 0.457 . . . . 0.0 110.259 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.83 -29.03 70.42 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.966 0.412 . . . . 0.0 110.616 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -73.94 -54.39 8.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.076 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.495 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.6 ttp180 -64.67 -42.02 95.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.419 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.4 mt -62.3 -43.93 98.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.531 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.99 -59.67 4.76 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.136 0.493 . . . . 0.0 110.253 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -55.91 -34.15 65.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.48 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -80.17 -36.18 35.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.798 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.2 m-20 -54.66 -42.02 70.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.926 -178.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.98 -41.39 97.97 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.62 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -64.93 -38.21 90.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.322 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.1 mt -62.33 -42.45 99.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.804 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.84 -53.38 56.67 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.149 0.5 . . . . 0.0 110.685 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.22 -41.82 89.55 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.694 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.7 -40.31 96.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.697 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.03 -32.54 73.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.39 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.2 -21.53 19.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.736 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.63 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.2 tt0 -64.7 -41.93 95.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.763 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.1 pt -75.98 133.76 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.043 0.449 . . . . 0.0 110.723 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -127.51 106.11 8.95 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.317 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.3 128.27 0.35 Allowed Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.576 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.447 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 74.5 Cg_exo -43.44 151.3 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.812 2.342 . . . . 0.0 112.667 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.66 142.43 53.06 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.577 2.185 . . . . 0.0 112.517 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.544 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -170.97 147.29 2.28 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.672 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.9 153.96 71.77 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.761 2.308 . . . . 0.0 112.299 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.21 163.05 29.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.228 0.537 . . . . 0.0 110.415 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.578 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.52 169.82 16.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.949 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.03 137.59 22.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.987 0.422 . . . . 0.0 110.11 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.532 HG22 HD12 ' A' ' 205' ' ' LEU . 39.5 pt -134.22 146.34 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.76 131.9 59.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.198 0.523 . . . . 0.0 110.471 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -151.86 154.77 36.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.409 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.0 m -121.64 122.78 40.39 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 110.358 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.6 -25.61 66.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.638 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.611 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.95 -49.43 20.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.966 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.75 -12.03 60.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.34 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.7 m80 49.59 42.35 22.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.435 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.8 t -136.39 145.29 45.17 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.354 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.84 114.39 27.7 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.268 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -119.93 133.37 55.59 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.108 0.48 . . . . 0.0 110.289 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.532 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.07 146.4 38.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.793 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.476 ' N ' HD23 ' A' ' 205' ' ' LEU . 12.9 t90 -99.69 127.99 45.8 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.187 0.518 . . . . 0.0 109.86 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.46 153.67 41.35 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.401 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.74 -18.57 47.72 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.655 2.237 . . . . 0.0 111.977 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.13 -18.35 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.343 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.448 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.6 p -75.36 167.8 21.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.484 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.24 -35.62 75.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.429 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.5 mt-30 -56.74 -41.12 76.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.698 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.42 -42.99 97.77 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.503 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 73.1 mt-30 -63.91 -39.95 95.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 122.279 -0.541 . . . . 0.0 110.745 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.595 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.4 mmm -61.83 -41.54 97.91 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.196 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 77.5 mt -63.46 -49.79 72.26 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 121.16 0.505 . . . . 0.0 110.404 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.38 -32.66 50.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 0.0 110.076 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.18 -20.07 62.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.578 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 219' ' ' LEU . 67.1 mt -87.39 -6.53 58.42 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.58 3.89 57.24 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -88.63 149.81 23.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 0.0 110.527 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.447 ' O ' HG12 ' A' ' 191' ' ' VAL . 3.5 p -112.96 126.83 55.91 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.211 0.529 . . . . 0.0 110.191 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.87 145.61 24.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.061 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.48 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.9 150.51 46.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.398 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.61 131.29 44.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.385 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.888 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.67 92.97 26.18 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.996 -179.535 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.681 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.1 Cg_exo -55.6 139.13 82.53 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.542 2.161 . . . . 0.0 111.582 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.51 -24.62 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.483 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.681 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.07 -49.59 26.77 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.555 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -54.57 -36.91 64.88 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -66.63 36.06 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.82 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.555 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.68 87.4 0.01 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.879 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.5 p -80.81 -14.73 57.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.334 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.42 -41.11 11.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.668 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.2 t -66.85 -16.65 64.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.585 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.01 43.74 26.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.431 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.77 -146.87 7.22 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.57 143.42 49.75 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.026 0.441 . . . . 0.0 110.296 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -151.75 149.26 28.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.279 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -100.36 -152.83 0.43 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.317 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.6 t0 56.44 -91.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.671 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.471 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.6 tt -126.67 175.39 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.594 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.471 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.8 mt -121.41 141.04 43.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.842 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.41 168.98 9.65 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.14 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.0 mt -147.3 150.69 35.27 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.278 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.69 -39.04 97.09 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.56 3.75 4.55 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.0 -58.31 3.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.959 0.409 . . . . 0.0 110.562 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.556 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.1 m-20 -62.06 -36.92 83.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.209 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.18 -67.66 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.79 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.6 -42.02 67.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.091 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.15 18.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.689 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.44 47.53 0.2 Allowed Glycine 0 N--CA 1.466 0.642 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 39.23 -109.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.569 0.223 . . . . 0.0 110.684 -178.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.48 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.5 m120 -60.98 -44.99 96.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.367 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.78 8.04 83.26 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -99.22 -12.47 20.38 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.709 -0.289 . . . . 0.0 110.687 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.4 t 176.38 142.65 0.07 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.085 0.469 . . . . 0.0 110.449 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.16 125.77 11.77 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.207 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.63 143.04 29.45 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 120.885 0.374 . . . . 0.0 110.958 178.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.0 mt -94.39 106.77 18.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.659 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.472 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 93.0 t80 -102.23 -12.95 17.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.117 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -65.87 -40.45 91.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.892 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.18 173.48 45.95 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.492 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -74.27 -112.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.76 0.314 . . . . 0.0 110.749 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.93 -28.77 67.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.673 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.2 -44.05 92.23 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.259 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.5 -44.49 94.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.327 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.45 -59.67 4.15 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.12 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.35 -43.41 61.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.069 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.74 74.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.194 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.3 -43.61 97.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.592 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -56.57 -37.77 71.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.074 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.32 0.99 20.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.168 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -115.07 91.28 26.48 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.094 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.05 -27.22 28.16 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.786 2.324 . . . . 0.0 111.897 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.531 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.32 -41.27 98.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.536 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.9 mp -95.44 4.91 52.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.347 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.76 -35.31 70.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.644 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.82 4.77 15.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.489 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.525 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.68 121.2 80.22 Favored Pre-proline 0 N--CA 1.44 -0.937 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.587 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -47.55 -37.48 26.53 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.41 2.073 . . . . 0.0 112.628 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.72 -43.48 90.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.747 0.308 . . . . 0.0 110.245 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.85 -43.74 93.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.246 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.86 -40.62 95.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.335 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.46 -12.6 39.68 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.603 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 62.01 31.64 17.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.003 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.42 44.33 1.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.136 0.493 . . . . 0.0 110.327 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.4 135.82 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.439 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.65 132.42 56.69 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.4 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.49 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.83 88.39 6.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.77 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.431 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.9 mt -63.83 -41.74 97.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.983 0.42 . . . . 0.0 110.832 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.472 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.85 165.94 34.56 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 76.8 p -75.62 -25.99 57.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.846 0.355 . . . . 0.0 110.703 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.3 tp10 -68.4 -34.03 75.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.442 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.758 HG22 ' O ' ' A' ' 296' ' ' THR . 99.4 m -72.26 18.82 0.08 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.558 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.508 ' O ' ' NE2' ' A' ' 212' ' ' GLN . 48.1 t80 -56.93 -51.03 70.76 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.873 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -107.09 148.15 29.13 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 41.0 tp -115.52 126.11 53.86 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.842 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.477 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.0 t0 -149.55 166.83 28.04 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.672 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -49.28 -38.03 25.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.631 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -71.75 -64.91 0.84 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.47 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.9 -32.94 72.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.979 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.47 -25.52 25.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.66 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.2 mtt -63.56 -41.07 98.43 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 120.906 0.384 . . . . 0.0 111.06 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -77.65 -44.61 27.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.084 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.579 HG21 HG23 ' A' ' 296' ' ' THR . 79.6 t -66.12 -42.88 92.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.346 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.447 HD11 ' OE1' ' A' ' 183' ' ' GLN . 48.3 tp -59.92 -47.05 87.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.449 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -70.19 -39.55 75.15 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.134 0.492 . . . . 0.0 110.897 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.492 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 73.9 ttt180 -61.28 -37.79 84.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.197 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -88.06 5.06 42.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.689 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.63 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.0 tttt -112.23 -11.84 13.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.075 0.464 . . . . 0.0 110.303 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.26 85.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.53 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.97 -48.73 80.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.339 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.941 -179.964 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -89.89 -2.68 58.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.417 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.493 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.15 1.23 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.501 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.493 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.8 Cg_exo -60.81 144.89 99.64 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.86 2.373 . . . . 0.0 112.123 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.83 -179.48 8.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.592 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.77 137.0 52.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.371 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.71 146.99 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.383 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -120.03 136.14 54.67 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.791 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.36 -143.48 0.32 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.225 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.66 -37.08 86.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.458 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.21 -66.62 0.22 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.435 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.6 142.39 45.59 Favored Glycine 0 CA--C 1.519 0.294 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.6 p -112.17 131.36 55.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 110.443 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -119.1 129.1 54.88 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.485 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.9 m -85.76 130.37 34.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.225 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.486 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.3 mt -95.91 79.07 3.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.439 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.61 -31.96 73.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.71 109.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.986 0.422 . . . . 0.0 110.121 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.486 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.49 91.92 49.19 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.435 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.9 Cg_exo -56.7 148.67 63.9 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.804 2.336 . . . . 0.0 111.953 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.58 82.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.591 0.557 . . . . 0.0 110.979 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.5 66.84 0.89 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.271 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.06 130.58 36.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.812 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.561 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.7 t -122.61 146.71 27.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.061 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.0 t -135.96 143.96 45.16 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.77 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.5 p -99.5 -59.4 1.73 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.624 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.2 p -79.28 155.07 28.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.651 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.503 HG21 HG23 ' A' ' 70' ' ' THR . 73.3 t -74.05 -21.91 18.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.529 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.4 m -60.23 -52.07 66.85 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.536 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.38 -42.6 87.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.102 0.477 . . . . 0.0 110.787 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.9 m -43.14 -54.07 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.029 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.33 -37.05 70.53 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m -62.88 -44.71 95.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.867 0.365 . . . . 0.0 110.252 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.0 mt -66.37 -41.9 88.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.487 0.661 . . . . 0.0 110.75 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -62.61 -40.33 96.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.431 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.501 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.04 -35.61 75.48 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.202 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.529 HD11 HD12 ' A' ' 156' ' ' LEU . 32.6 pt -91.54 28.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.253 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.45 51.67 11.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.32 75.7 22.57 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.0 0.429 . . . . 0.0 109.919 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.61 151.35 85.96 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.825 2.35 . . . . 0.0 112.16 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.561 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.42 137.31 46.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.182 0.515 . . . . 0.0 110.274 179.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.445 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.4 pt -69.42 -43.4 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.359 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.03 131.17 53.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.96 0.41 . . . . 0.0 110.594 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.8 p -155.64 168.49 26.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.489 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.66 -177.16 21.78 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.649 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.92 172.85 12.24 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 110.449 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.503 HG23 HG21 ' A' ' 51' ' ' VAL . 14.9 p -133.16 -111.93 0.23 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.001 0.429 . . . . 0.0 110.428 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.43 179.68 0.94 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.509 -179.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.7 Cg_exo -60.97 58.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.965 2.443 . . . . 0.0 112.099 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.1 t-20 -64.43 -33.73 76.54 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.485 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 42.5 m-20 94.07 -36.96 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.875 0.734 . . . . 0.0 109.808 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -62.75 -39.73 95.06 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.188 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.35 -25.54 19.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.669 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.31 -171.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.428 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.14 -153.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.87 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.5 p-10 -52.72 -7.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.749 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.509 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.52 114.88 23.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.648 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.95 69.69 1.36 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -143.05 147.15 34.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 110.813 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -84.92 -98.58 0.06 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.11 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.556 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.06 -42.48 97.0 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.13 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.556 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 34.8 tt0 91.29 52.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.841 0.713 . . . . 0.0 111.076 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -102.8 -9.25 20.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.374 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.3 p -64.36 -34.11 77.39 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.138 0.494 . . . . 0.0 110.695 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.532 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.05 -23.61 1.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.677 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.92 -45.97 75.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.746 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.26 -48.55 80.9 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.009 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.37 -38.34 89.2 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.446 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.57 -32.74 52.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.175 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.611 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.4 mmt-85 -90.1 1.75 56.03 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.535 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.611 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 56.9 mttp 82.84 -49.38 0.17 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.838 0.711 . . . . 0.0 110.318 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.664 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.3 mt -45.86 154.01 0.25 Allowed 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 117.733 -1.127 . . . . 0.0 109.598 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.664 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.22 92.62 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 125.387 1.679 . . . . 0.0 110.521 -178.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.543 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.65 143.17 42.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.249 0.547 . . . . 0.0 110.244 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.9 mt -132.23 27.04 4.5 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 122.013 -0.429 . . . . 0.0 110.454 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.32 137.94 34.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.03 0.443 . . . . 0.0 110.559 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.2 mt -137.33 165.1 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.356 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.58 -28.48 1.91 Allowed Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.22 70.45 7.63 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.13 0.49 . . . . 0.0 110.172 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.93 145.23 98.83 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.751 2.301 . . . . 0.0 112.098 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.5 t -134.57 136.59 43.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.97 0.414 . . . . 0.0 110.544 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.37 83.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.63 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.14 -42.41 96.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.527 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.6 98.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.525 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.7 -43.41 98.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.03 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.23 -35.03 77.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.181 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.59 -18.73 60.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.407 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.61 -6.47 58.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.531 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 70.3 mtp 47.59 56.06 17.22 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.596 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.1 149.33 64.57 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.737 2.291 . . . . 0.0 112.12 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.24 -74.0 0.63 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.43 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.8 tp -110.22 112.91 25.17 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.268 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.4 mt -101.82 126.26 55.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.694 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 mt -109.51 133.7 52.77 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.276 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.54 139.44 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.594 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.5 p -83.43 168.58 16.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.793 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.24 -37.43 80.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.427 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.74 158.99 43.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.488 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.15 177.43 33.19 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.19 -33.9 87.38 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -125.12 151.98 45.01 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.9 0.381 . . . . 0.0 110.522 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.4 t -63.14 140.99 58.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.369 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.43 10.32 11.16 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.649 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.513 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.01 -38.79 87.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.244 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.638 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.2 -35.89 23.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.449 0.643 . . . . 0.0 110.628 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.1 mt -71.05 -35.51 71.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.504 0.668 . . . . 0.0 110.673 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -42.68 -62.71 0.92 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.356 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.638 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.91 -42.73 89.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.159 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -62.08 -32.69 73.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.338 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 70.3 mt -73.75 -40.98 63.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.898 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.27 -48.84 79.17 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.19 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.2 m -53.2 -42.48 66.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.182 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.81 -42.94 93.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.022 0.439 . . . . 0.0 111.158 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.64 154.57 5.53 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.657 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -39.39 106.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.647 2.232 . . . . 0.0 112.496 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.7 m -110.5 121.35 45.09 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.093 0.473 . . . . 0.0 110.199 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.22 153.28 29.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.286 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -129.29 131.55 67.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.404 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -115.16 128.03 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.056 0.455 . . . . 0.0 110.512 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.62 103.56 14.38 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.197 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.8 p90 -101.15 -11.21 19.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.872 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.2 p-10 -64.84 -33.41 75.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.703 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.571 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.3 p-10 -98.38 8.0 45.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.567 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.45 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.88 155.62 50.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.466 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.403 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.8 p -75.01 165.62 24.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.668 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.59 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.88 -48.62 80.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.217 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.54 -42.02 67.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.001 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.4 t -62.74 -41.06 99.01 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.37 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.409 ' CD1' HG21 ' A' ' 142' ' ' ILE . 45.6 tp -60.59 -44.41 96.29 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.406 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.37 -43.41 98.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.166 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.0 m -55.07 -44.93 75.26 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.35 -40.74 97.38 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.967 0.413 . . . . 0.0 110.507 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.529 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.94 -42.54 99.23 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.311 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.13 -40.85 95.16 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.57 -45.99 64.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.937 0.398 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.75 -43.98 96.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.837 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -93.07 -8.83 41.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.632 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.96 26.63 72.34 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.69 50.59 0.85 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.807 0.337 . . . . 0.0 110.678 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -69.44 -39.48 77.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.648 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.46 -47.2 86.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.274 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -60.13 -39.38 86.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.163 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.98 99.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.246 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.92 -28.5 70.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.591 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.29 -54.27 8.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.895 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.501 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.48 -42.28 92.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.366 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.9 mt -62.36 -43.84 98.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.566 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.57 -58.36 7.83 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.999 0.428 . . . . 0.0 110.356 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.13 -33.55 67.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.589 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.402 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.5 t80 -81.34 -36.5 29.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.774 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -55.63 -42.29 74.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.023 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.28 -42.23 99.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.74 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.27 -37.98 88.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.295 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.7 mt -62.51 -42.12 99.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.729 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.13 -52.98 61.69 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.045 0.45 . . . . 0.0 110.667 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.22 -41.91 89.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.665 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.7 -40.02 95.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.592 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.38 -31.91 73.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.434 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.77 -22.4 18.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.67 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.75 -41.27 96.03 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.668 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.0 pt -76.24 136.27 25.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.657 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.47 107.83 10.62 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.29 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -177.16 125.8 0.29 Allowed Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.472 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.4 Cg_exo -44.04 152.38 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.864 2.376 . . . . 0.0 112.509 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.8 141.91 55.85 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.612 2.208 . . . . 0.0 112.446 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.27 147.14 2.13 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.548 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.08 154.34 70.57 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.811 2.34 . . . . 0.0 112.312 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.05 162.99 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.235 0.54 . . . . 0.0 110.403 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.72 170.33 16.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.927 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.66 137.75 21.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 110.126 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.557 HG22 HD12 ' A' ' 205' ' ' LEU . 39.4 pt -134.54 147.2 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.661 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.02 132.15 58.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.115 0.483 . . . . 0.0 110.488 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -152.44 155.72 38.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.444 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.626 HG22 ' H ' ' A' ' 199' ' ' ALA . 88.8 m -123.25 123.48 40.85 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.945 0.402 . . . . 0.0 110.375 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.63 -25.64 66.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.626 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.626 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.69 -48.96 19.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.006 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.61 -12.06 60.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.497 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.1 m80 49.28 41.02 19.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.526 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.3 t -135.84 143.65 45.23 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.385 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.424 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -109.83 114.29 27.74 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.24 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.82 133.36 55.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.016 0.436 . . . . 0.0 110.488 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.557 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -111.87 146.62 37.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.834 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.497 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 10.0 t90 -99.97 129.65 46.06 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.186 0.517 . . . . 0.0 109.869 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.85 153.73 39.94 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.39 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.3 Cg_endo -67.77 -18.06 47.44 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.755 2.303 . . . . 0.0 111.975 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.27 -19.12 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.369 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.497 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 85.5 p -75.4 164.41 26.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.497 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.78 -27.66 65.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.526 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.61 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 84.0 mt-30 -63.88 -41.03 97.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.556 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.81 -44.48 97.96 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.45 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.1 mt-30 -64.49 -38.77 92.17 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 122.299 -0.53 . . . . 0.0 110.697 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.59 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.3 mmm -61.93 -41.24 97.72 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.209 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.56 -47.31 82.09 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.022 0.439 . . . . 0.0 110.437 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.91 -31.97 51.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.866 0.365 . . . . 0.0 110.268 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -70.9 -18.63 62.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.508 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.436 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.3 mt -87.65 -9.12 55.11 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.602 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.16 1.84 54.46 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -88.42 153.55 21.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.904 0.383 . . . . 0.0 110.468 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.434 ' O ' HG12 ' A' ' 191' ' ' VAL . 7.3 p -116.4 128.87 55.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.14 0.495 . . . . 0.0 110.41 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.48 146.3 23.79 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.916 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.486 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.93 151.5 45.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.488 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.49 131.51 43.51 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.428 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.888 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.72 93.44 28.53 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.05 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.676 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.2 Cg_exo -55.38 138.78 80.84 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.545 2.163 . . . . 0.0 111.679 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.98 -26.05 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.457 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.676 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.03 -50.11 30.57 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.56 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.5 mt -54.43 -37.07 64.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.45 36.24 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.74 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.56 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.3 86.31 0.02 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.878 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.5 p -79.2 -15.08 58.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.382 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -92.6 -41.01 10.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.603 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.9 t -66.13 -17.86 64.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.645 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 56.16 43.3 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.492 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.34 -148.34 7.72 Favored Glycine 0 CA--C 1.519 0.289 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.58 142.75 49.8 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 110.347 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -152.36 149.89 29.12 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.296 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -101.28 -151.33 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.348 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 55.81 -92.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.672 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.462 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.9 tt -126.85 175.38 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.627 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.462 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.8 mt -122.5 141.81 41.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.65 169.32 9.35 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.23 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.3 mt -147.52 150.94 35.5 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.264 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.93 -38.85 96.67 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.35 3.77 4.65 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -77.34 -58.13 3.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.924 0.392 . . . . 0.0 110.538 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.546 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.0 m-20 -62.14 -36.34 81.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.308 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.424 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.1 mp -52.55 -67.51 0.25 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.86 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.75 -42.37 68.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.081 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.7 17.59 0.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.669 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.86 48.47 0.27 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.394 -0.683 . . . . 0.0 111.394 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 38.82 -109.98 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.593 0.235 . . . . 0.0 110.712 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.486 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.6 m120 -60.86 -44.93 96.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.475 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.47 7.99 83.87 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -98.91 -13.66 19.91 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.647 -0.325 . . . . 0.0 110.66 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.4 t 177.25 142.78 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.087 0.47 . . . . 0.0 110.42 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.13 125.34 11.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.165 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 14.0 m-30 -98.28 143.63 28.56 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 120.865 0.364 . . . . 0.0 110.83 178.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.7 mt -95.18 106.67 18.71 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.794 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.437 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.7 t80 -102.26 -12.1 18.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.158 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.44 -40.4 89.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.886 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.0 173.3 45.86 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.461 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 95.3 m-20 -74.07 -113.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.756 0.312 . . . . 0.0 110.704 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.72 -28.81 67.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.686 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.1 -43.86 91.9 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.225 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.32 -44.55 94.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.316 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.56 -59.98 3.8 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.189 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -51.02 -43.38 60.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.151 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.47 -43.41 75.51 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.19 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.53 -43.68 96.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.629 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.25 -37.55 69.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.098 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.48 0.79 18.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.131 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -115.21 91.7 28.81 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.148 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.35 -27.07 29.73 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.748 2.299 . . . . 0.0 111.95 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.538 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.55 -41.06 98.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.503 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.33 5.24 52.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.381 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.13 -35.08 69.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.585 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.93 4.53 16.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.51 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.64 121.25 80.33 Favored Pre-proline 0 N--CA 1.445 -0.7 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.549 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -47.14 -38.0 24.3 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.483 2.122 . . . . 0.0 112.529 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.529 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.8 -43.66 90.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.704 0.288 . . . . 0.0 110.37 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.0 -43.62 92.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.355 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.92 -40.78 95.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.415 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.6 t-20 -89.65 -12.41 39.7 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.588 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.2 mtmt 61.94 32.19 17.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.995 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.76 43.97 1.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.061 0.457 . . . . 0.0 110.307 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.68 135.67 41.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.503 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.78 132.69 56.63 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.447 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.15 89.16 7.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.732 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.403 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.8 mt -63.82 -41.05 97.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.021 0.438 . . . . 0.0 110.856 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.437 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.2 165.02 33.52 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.516 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 74.1 p -75.28 -25.71 58.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.94 0.4 . . . . 0.0 110.771 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.503 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.3 tp10 -68.42 -34.03 75.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.393 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 96.6 m -73.35 24.84 0.07 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.736 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.61 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 39.7 t80 -58.07 -50.66 72.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.433 ' CZ ' ' CE2' ' A' ' 297' ' ' PHE . 80.0 mmt-85 -111.19 154.01 24.99 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.436 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.8 tp -115.44 124.98 52.51 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.814 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.481 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.8 t0 -147.69 165.55 30.13 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.619 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -49.34 -37.88 26.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.57 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -71.12 -65.6 0.72 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.504 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -61.01 -32.91 72.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.975 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.19 -25.55 23.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.743 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.2 mtt -63.6 -40.9 98.11 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 120.829 0.347 . . . . 0.0 111.07 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.76 -43.94 24.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.195 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.578 HG21 HG23 ' A' ' 296' ' ' THR . 76.6 t -66.34 -42.85 91.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.357 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.1 tp -60.22 -46.96 87.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.464 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -70.07 -39.47 75.62 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.054 0.454 . . . . 0.0 110.759 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.9 ttt180 -61.75 -38.29 87.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.248 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.12 4.39 42.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.607 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -112.77 -11.01 13.55 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.091 0.472 . . . . 0.0 110.347 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.41 -37.09 85.95 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.487 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.84 -48.71 80.58 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.457 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.006 179.868 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.618 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.02 -2.52 58.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.464 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.8 179.03 1.25 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.552 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.96 144.97 99.69 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.84 2.36 . . . . 0.0 112.092 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.618 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.68 -179.58 8.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.601 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.73 136.84 52.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.358 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.0 tp -124.53 147.5 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.396 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -120.35 135.97 54.85 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 110.742 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.27 -143.5 0.32 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.194 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.54 -37.11 86.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.417 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.1 ttt85 -149.09 -67.21 0.22 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.507 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.54 142.72 45.18 Favored Glycine 0 C--O 1.228 -0.275 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.9 p -112.29 131.57 55.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.962 0.41 . . . . 0.0 110.481 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -118.94 128.92 54.86 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.507 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.2 m -85.41 130.35 34.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.247 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.481 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.3 mt -95.59 78.54 3.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.405 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.69 -32.17 73.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.52 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.5 109.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.121 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.481 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.74 91.47 49.59 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.326 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.94 148.67 66.31 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.818 2.345 . . . . 0.0 111.894 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -40.71 82.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 O-C-N 123.657 0.598 . . . . 0.0 111.008 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.44 66.85 0.89 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.266 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.22 130.74 35.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.752 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.567 ' HA ' HG23 ' A' ' 64' ' ' VAL . 56.2 t -122.61 146.95 27.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.041 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 t -136.23 143.62 44.42 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.718 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.8 p -99.38 -59.25 1.76 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.526 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.8 p -79.35 155.57 28.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.646 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.548 HG21 HG23 ' A' ' 70' ' ' THR . 69.5 t -74.46 -21.97 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.591 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.7 m -60.25 -52.15 66.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.575 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.35 -42.53 87.93 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.173 0.511 . . . . 0.0 110.939 177.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.4 m -42.92 -54.07 4.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.041 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.47 -37.69 69.39 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.2 m -62.36 -44.63 96.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 110.299 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.4 mt -66.3 -41.98 88.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.445 0.641 . . . . 0.0 110.756 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -62.55 -40.17 95.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.442 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.495 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.19 -35.83 76.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.133 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.538 HD11 HD12 ' A' ' 156' ' ' LEU . 32.0 pt -91.41 29.06 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.266 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.42 51.92 10.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.887 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.4 75.67 22.35 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.961 0.41 . . . . 0.0 109.906 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.73 151.45 85.65 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.837 2.358 . . . . 0.0 112.162 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.567 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.58 137.16 47.65 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-O 121.214 0.53 . . . . 0.0 110.255 179.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.442 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.7 pt -69.48 -43.38 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.305 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.9 131.08 53.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.603 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.535 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.1 p -155.54 168.66 26.42 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.422 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.68 -177.2 21.76 Favored Glycine 0 N--CA 1.463 0.496 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.637 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.8 172.66 12.48 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.954 0.407 . . . . 0.0 110.538 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.548 HG23 HG21 ' A' ' 51' ' ' VAL . 15.3 p -132.26 -113.17 0.23 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.421 . . . . 0.0 110.359 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.77 179.72 0.95 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.408 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.1 Cg_exo -61.31 57.48 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 123.069 2.513 . . . . 0.0 112.091 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 60.4 t-20 -64.3 -33.07 74.97 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.462 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.3 m-20 93.65 -35.55 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.962 0.789 . . . . 0.0 109.795 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HD3' HD21 ' A' ' 73' ' ' ASN . 77.4 mtp85 -63.23 -39.74 95.47 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.987 0.422 . . . . 0.0 110.173 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.79 -25.19 18.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.719 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -48.96 -171.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.555 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -73.72 -153.84 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.787 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 36.4 p-10 -52.34 -7.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.726 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.4 mm-40 -86.51 114.99 23.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.003 0.43 . . . . 0.0 110.59 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.07 70.2 1.34 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -143.57 147.46 34.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.825 0.345 . . . . 0.0 110.823 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.82 -98.58 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.136 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.551 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.82 -42.71 97.58 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.114 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.562 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.4 tt0 91.61 52.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.962 0.789 . . . . 0.0 110.907 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -102.53 -9.27 20.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.33 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.1 p -64.56 -34.17 77.63 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.043 0.449 . . . . 0.0 110.631 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.562 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.2 -24.36 1.71 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.614 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.42 -45.64 78.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.753 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.45 -48.3 81.76 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.037 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.52 -38.24 89.17 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.36 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.53 -32.98 52.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.155 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.601 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.86 1.46 56.15 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.493 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.98 -48.98 0.15 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.984 0.803 . . . . 0.0 110.208 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.651 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.3 mt -46.5 153.83 0.34 Allowed 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 117.65 -1.167 . . . . 0.0 109.307 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.651 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.7 tt0 121.59 92.46 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 O-C-N 125.482 1.739 . . . . 0.0 110.491 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.52 143.19 42.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.138 0.494 . . . . 0.0 110.321 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.3 mt -132.24 27.1 4.5 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.122 -0.361 . . . . 0.0 110.362 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -140.31 137.83 34.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.045 0.45 . . . . 0.0 110.524 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.5 mt -136.99 165.02 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.447 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.97 -28.61 1.85 Allowed Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -152.61 70.79 7.39 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.153 0.501 . . . . 0.0 110.355 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.08 145.43 98.46 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.75 2.3 . . . . 0.0 112.06 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.7 t -134.56 136.77 43.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.514 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.37 82.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.635 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.11 -42.24 96.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.483 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.15 -41.62 98.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.48 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.59 -43.45 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.043 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.3 78.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.195 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.44 -18.7 60.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.413 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.52 -6.53 58.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.486 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 73.8 mtp 48.09 55.94 17.35 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.616 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.7 Cg_endo -70.12 149.13 64.17 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.808 2.339 . . . . 0.0 112.129 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.32 -73.05 0.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.5 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.43 HD11 HD13 ' A' ' 140' ' ' LEU . 38.5 tp -111.35 113.48 25.98 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.313 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.4 mt -102.3 126.64 56.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.567 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 mt -110.19 133.94 52.72 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.262 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.98 139.95 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.474 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.6 p -83.5 168.67 16.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.741 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.46 80.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.442 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.1 t -139.94 159.21 42.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.423 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.31 177.29 33.4 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.28 -33.81 87.25 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.53 151.53 44.57 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.575 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.4 t -63.55 140.93 58.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.298 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.66 10.7 11.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.666 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.04 -39.05 88.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.187 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.01 -35.91 23.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.445 0.64 . . . . 0.0 110.576 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -70.8 -35.48 72.56 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.54 0.686 . . . . 0.0 110.784 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -42.91 -62.99 0.87 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.289 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.61 -42.84 91.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.132 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -61.95 -32.73 73.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.257 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.1 mt -73.82 -40.69 63.17 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.032 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.31 -48.98 78.78 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.186 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.5 m -53.0 -42.39 65.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.187 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.89 -43.04 93.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.089 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.43 153.61 5.33 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.633 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -39.15 106.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.687 2.258 . . . . 0.0 112.393 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.635 ' C ' HD12 ' A' ' 140' ' ' LEU . 93.4 m -109.94 121.35 45.04 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.191 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.71 152.82 29.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.269 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -129.13 131.17 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.326 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.411 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -115.16 128.17 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.073 0.463 . . . . 0.0 110.497 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.476 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.3 t30 -101.61 103.57 14.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.23 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.4 p90 -101.34 -11.35 19.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.832 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 48.9 p-10 -64.67 -33.52 76.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.639 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.566 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 41.2 p-10 -98.37 7.7 45.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.596 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.447 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.49 155.72 50.05 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.539 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.406 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.6 p -74.94 165.68 24.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.643 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.593 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.3 t90 -60.12 -48.76 80.38 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.256 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -53.42 -41.82 66.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.89 0.376 . . . . 0.0 110.064 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.1 t -62.82 -41.13 99.17 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.334 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.411 ' CD1' HG21 ' A' ' 142' ' ' ILE . 45.7 tp -60.7 -44.4 96.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.331 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.1 tp -61.4 -43.54 98.69 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.168 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -54.85 -45.03 74.48 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.44 -40.56 96.99 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.936 0.398 . . . . 0.0 110.492 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.538 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.96 -42.47 99.16 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.368 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.1 -40.85 95.22 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.59 -45.98 64.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.891 0.377 . . . . 0.0 110.842 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.8 mt -64.68 -43.96 96.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.893 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.3 p -92.99 -8.79 42.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.621 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.84 26.96 72.35 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -101.98 50.71 0.84 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 110.716 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.48 -39.23 77.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.635 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.66 -47.24 86.39 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.3 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -60.14 -39.47 86.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.225 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.96 99.31 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.292 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.92 -28.62 70.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.649 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.21 -54.3 8.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.048 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.495 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.4 ttp180 -65.47 -42.28 92.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.449 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.455 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.3 mt -62.52 -43.8 98.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.473 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.62 -59.08 5.43 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.067 0.46 . . . . 0.0 110.392 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -56.25 -34.2 66.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.568 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -80.87 -36.31 31.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.798 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 170' ' ' ILE . 55.3 m-20 -54.98 -42.15 72.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.147 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.54 -41.92 99.2 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.639 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.08 -38.26 90.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.259 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 177' ' ' LEU . 81.4 mt -62.33 -42.19 99.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.692 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -52.81 62.52 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.135 0.493 . . . . 0.0 110.689 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.09 -41.99 89.94 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.673 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.87 -40.01 95.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.591 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.17 -32.27 73.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.379 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.3 -22.06 18.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.632 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.625 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.6 tt0 -64.75 -41.28 96.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.657 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 184' ' ' ILE . 32.8 pt -77.02 136.05 25.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.668 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.2 108.05 10.55 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.27 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.59 126.05 0.32 Allowed Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.458 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.7 152.23 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.796 2.331 . . . . 0.0 112.66 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.04 141.89 54.53 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.624 2.216 . . . . 0.0 112.479 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.42 147.24 2.1 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.605 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.32 155.1 68.35 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.772 2.315 . . . . 0.0 112.356 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.78 163.26 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.207 0.527 . . . . 0.0 110.371 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.61 170.05 16.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.894 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.17 137.47 22.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.067 0.46 . . . . 0.0 110.03 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.56 HG22 HD12 ' A' ' 205' ' ' LEU . 39.0 pt -134.28 146.67 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.637 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.55 131.75 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.348 0.594 . . . . 0.0 110.488 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -152.78 156.17 38.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.425 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 199' ' ' ALA . 88.4 m -122.17 122.88 40.21 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.878 0.37 . . . . 0.0 110.307 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.523 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.8 -26.32 67.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.591 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.599 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.68 -49.5 21.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.69 -10.44 59.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.449 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.523 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.9 m80 46.28 47.05 13.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.455 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -130.97 143.76 50.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.414 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.452 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -108.57 105.32 14.9 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.169 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.6 m-20 -115.95 128.79 56.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.148 0.499 . . . . 0.0 110.321 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.56 HD12 HG22 ' A' ' 194' ' ' ILE . 7.7 tt -111.84 146.32 37.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.47 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.2 t90 -99.55 128.55 45.66 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.131 0.491 . . . . 0.0 109.905 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.41 154.22 40.31 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.293 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.71 -18.09 47.81 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.726 2.284 . . . . 0.0 111.981 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.65 -19.26 0.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.472 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.434 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 87.0 p -74.76 164.44 26.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.483 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.98 -27.77 65.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.518 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.583 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.67 -41.45 98.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.634 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.07 -44.29 97.43 Favored Glycine 0 C--N 1.331 0.286 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.447 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.5 mt-30 -64.52 -38.77 92.16 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 122.4 -0.471 . . . . 0.0 110.683 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.593 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.3 mmm -62.12 -41.34 98.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.16 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 72.6 mt -63.59 -47.36 81.77 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.534 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.24 -31.83 54.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 0.0 110.113 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.97 -18.33 62.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.493 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.418 HD11 ' CD2' ' A' ' 299' ' ' LEU . 92.1 mt -88.37 -8.55 54.86 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.568 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.42 2.88 55.57 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -89.02 152.56 21.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 0.0 110.445 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.456 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.3 p -115.35 128.23 55.94 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.132 0.491 . . . . 0.0 110.334 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.16 146.75 23.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.038 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.46 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.4 151.28 45.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.487 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.07 131.69 42.65 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.39 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.884 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.38 93.78 28.46 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.095 -179.667 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.683 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.2 Cg_exo -55.47 138.73 81.11 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.607 2.205 . . . . 0.0 111.568 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.53 -25.49 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.471 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.68 -49.95 27.46 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.1 mt -55.15 -37.37 66.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.851 0.358 . . . . 0.0 110.086 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -65.54 35.53 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.84 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.573 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.45 88.3 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 86.2 p -82.26 -13.83 56.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.325 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.32 -40.67 11.35 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.611 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.2 t -66.71 -16.95 64.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.593 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.99 43.69 26.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.457 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.91 -148.08 7.81 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.61 142.25 49.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.998 0.427 . . . . 0.0 110.274 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.403 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.4 ttt-85 -152.0 149.54 29.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.342 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -102.02 -150.35 0.4 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.346 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.68 -93.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.616 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.0 tt -126.57 174.58 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.604 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.435 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 87.4 mt -121.7 140.94 44.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.902 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.28 170.33 8.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.169 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.5 mt -146.94 149.51 33.33 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.15 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.35 -39.25 97.58 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.19 3.06 4.01 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -78.33 -57.64 3.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.948 0.404 . . . . 0.0 110.583 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.617 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.8 m-20 -61.99 -36.89 82.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.245 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.452 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.7 mp -53.13 -67.42 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.022 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.488 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.72 -42.7 68.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.145 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.38 17.85 0.13 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.685 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.79 47.59 0.23 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 7.9 mp 39.71 -110.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.595 0.236 . . . . 0.0 110.651 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.46 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -60.92 -44.52 97.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.441 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.5 8.11 83.64 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -98.7 -13.31 20.32 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.779 -0.248 . . . . 0.0 110.712 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.0 t 176.85 142.84 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 110.478 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.89 125.49 11.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.108 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.83 143.64 28.93 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 120.92 0.391 . . . . 0.0 110.758 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.9 mt -94.91 106.31 18.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.724 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.451 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.9 -11.81 18.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.219 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.91 86.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.897 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.25 172.69 45.56 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.469 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -73.81 -113.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.0 110.72 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.44 -28.86 68.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.74 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.01 -43.9 91.6 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.275 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -63.53 -44.39 94.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.386 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.57 -59.81 4.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.187 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.21 -43.44 61.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.067 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.42 74.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.267 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.3 mt -64.66 -43.53 96.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.58 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -56.34 -37.61 70.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.133 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.75 0.85 19.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.149 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.08 91.17 26.08 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.127 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.21 -27.09 28.8 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.724 2.283 . . . . 0.0 111.912 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.538 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.46 -41.02 98.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.557 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.3 5.48 51.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.418 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.18 -35.21 68.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.658 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.55 4.5 15.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.495 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.6 121.46 81.02 Favored Pre-proline 0 N--CA 1.444 -0.764 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.541 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -47.46 -37.93 26.61 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.51 2.14 . . . . 0.0 112.556 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.66 -43.7 89.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.738 0.304 . . . . 0.0 110.292 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.04 -43.52 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.325 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.17 -40.86 97.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.441 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.413 ' ND2' ' CG ' ' A' ' 288' ' ' GLN . 58.0 t30 -90.99 -11.22 39.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.704 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.2 mtmt 61.1 32.66 19.68 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.481 0.488 . . . . 0.0 111.001 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.413 ' CG ' ' ND2' ' A' ' 286' ' ' ASN . 97.1 mm-40 -88.11 43.9 1.16 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.361 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.5 135.83 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.534 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.88 132.15 56.77 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.373 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.6 88.65 7.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.762 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.441 ' O ' ' OG1' ' A' ' 296' ' ' THR . 87.1 mt -64.0 -41.13 97.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.003 0.43 . . . . 0.0 110.892 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.451 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.25 166.39 34.04 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 70.3 p -75.29 -25.53 58.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.835 0.35 . . . . 0.0 110.719 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.3 tp10 -68.33 -33.91 75.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.535 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 296' ' ' THR . 97.7 m -73.62 23.42 0.07 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.617 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.583 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 59.3 t80 -58.04 -51.23 70.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.428 HH12 ' HG3' ' A' ' 212' ' ' GLN . 66.1 mmt-85 -111.05 153.88 25.01 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.418 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.2 tp -116.13 125.6 52.57 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.494 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.7 t0 -147.43 165.43 30.27 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.561 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -49.37 -38.09 27.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.607 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -72.14 -64.86 0.86 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.52 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.32 -32.0 70.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.012 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.39 -25.36 24.13 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.614 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.8 mtt -63.37 -41.0 98.78 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 120.879 0.371 . . . . 0.0 110.782 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -78.23 -44.78 24.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.55 HG21 HG23 ' A' ' 296' ' ' THR . 79.3 t -65.9 -43.04 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.448 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.439 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 51.2 tp -60.36 -47.16 87.25 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.606 -178.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.11 -39.61 75.4 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.736 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 71.7 ttt180 -61.64 -38.13 86.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.154 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.2 mt -87.63 4.74 42.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.72 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.625 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.72 -11.87 13.45 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.004 0.431 . . . . 0.0 110.334 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.12 -37.24 86.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.522 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.01 -48.73 80.46 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.383 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 . . . . . 0 C--O 1.221 -0.408 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.008 179.899 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.25 -2.61 58.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.437 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.27 179.07 1.25 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.488 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.4 Cg_exo -60.78 145.29 99.18 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.794 2.329 . . . . 0.0 112.174 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.616 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -156.5 -179.36 8.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.585 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.3 137.01 52.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.405 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -123.99 147.09 28.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.366 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.7 p -119.98 135.95 54.72 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.78 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.39 -143.61 0.33 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.291 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -63.54 -37.29 86.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.456 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.477 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.82 -67.25 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.46 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.31 142.64 44.7 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.1 p -112.4 131.4 55.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.96 0.409 . . . . 0.0 110.397 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -119.01 129.16 54.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.442 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.7 m -85.63 130.78 34.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.289 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.484 HD22 ' OE1' ' A' ' 42' ' ' GLN . 70.3 mt -96.79 78.83 2.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.281 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.96 -31.84 72.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.561 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.56 107.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.148 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.484 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -120.74 91.19 47.11 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.414 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.658 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.3 Cg_exo -56.94 148.57 66.86 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.765 2.31 . . . . 0.0 111.842 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -40.62 82.41 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.577 0.548 . . . . 0.0 111.001 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.658 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.37 66.87 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.253 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -76.62 131.06 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.745 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.568 ' HA ' HG23 ' A' ' 64' ' ' VAL . 61.6 t -122.76 147.25 27.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.028 0.442 . . . . 0.0 110.066 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 t -136.33 144.12 44.48 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.654 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.404 ' OG1' ' N ' ' A' ' 50' ' ' SER . 19.7 p -100.09 -59.09 1.77 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.584 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.404 ' N ' ' OG1' ' A' ' 49' ' ' THR . 87.1 p -79.25 155.02 28.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.508 HG21 HG23 ' A' ' 70' ' ' THR . 71.4 t -74.07 -21.85 18.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.565 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.9 m -60.13 -52.07 66.92 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.542 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.6 mt -66.49 -42.4 87.51 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.131 0.491 . . . . 0.0 110.798 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -43.35 -53.9 5.01 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.074 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.04 -37.39 73.39 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 m -62.93 -44.28 96.5 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 110.38 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 17.8 mt -66.04 -42.05 90.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.396 0.617 . . . . 0.0 110.662 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 tp -62.88 -39.91 95.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.271 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.527 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.45 -36.1 77.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.177 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.45 HD11 HD12 ' A' ' 156' ' ' LEU . 32.8 pt -91.18 27.9 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.27 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.4 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 99.0 m-20 56.94 51.75 10.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.972 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.17 76.06 27.59 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.944 0.402 . . . . 0.0 110.001 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.87 149.56 90.37 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.811 2.341 . . . . 0.0 112.281 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.52 136.6 48.24 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-O 121.136 0.493 . . . . 0.0 110.281 179.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.3 pt -69.48 -43.4 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.32 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.51 131.39 52.82 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.946 0.403 . . . . 0.0 110.648 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.54 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.3 p -155.84 168.83 25.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.458 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.35 -177.39 21.97 Favored Glycine 0 N--CA 1.463 0.499 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.632 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.5 172.38 12.8 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.015 0.436 . . . . 0.0 110.482 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.508 HG23 HG21 ' A' ' 51' ' ' VAL . 13.7 p -133.33 -111.57 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 0.0 110.491 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.55 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.8 179.62 0.95 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.448 -179.221 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.4 Cg_exo -60.86 58.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.894 2.396 . . . . 0.0 112.076 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.4 t-20 -64.42 -33.98 77.12 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.5 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.6 m-20 94.29 -36.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.869 0.731 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.401 ' HD3' HD21 ' A' ' 73' ' ' ASN . 77.1 mtp85 -62.89 -39.96 96.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.937 0.398 . . . . 0.0 110.224 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.7 p -74.49 -26.0 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.675 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.59 -172.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.612 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.3 p30 -73.73 -152.75 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.771 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 36.9 p-10 -54.46 -6.6 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.726 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.495 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.59 114.19 23.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.548 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.53 71.73 1.31 Allowed Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.475 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.3 m-85 -143.19 148.21 36.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.74 0.305 . . . . 0.0 110.908 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -86.04 -98.64 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.961 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.558 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.08 -43.3 95.83 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.183 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.558 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 36.0 tt0 91.85 52.64 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.875 0.734 . . . . 0.0 110.961 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -103.47 -9.02 19.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.377 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.475 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -65.23 -33.25 75.56 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.02 0.438 . . . . 0.0 110.604 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.549 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 97.9 mttt -49.09 -24.51 1.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.619 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.6 t -69.67 -45.92 76.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.31 -48.47 81.22 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.111 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -38.38 90.17 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.364 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.8 -32.64 53.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.23 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.615 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.2 mmt-85 -89.91 1.72 55.89 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.468 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.615 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.95 -49.93 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.897 0.748 . . . . 0.0 110.294 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.668 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.1 mt -45.55 153.86 0.23 Allowed 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.456 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.668 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 121.01 92.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 125.218 1.574 . . . . 0.0 110.458 -178.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.54 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.28 142.72 43.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.201 0.524 . . . . 0.0 110.191 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.4 mt -131.71 26.75 4.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.467 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -140.11 137.52 34.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 110.51 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.632 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.0 mt -136.84 164.88 29.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.406 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.97 -28.4 1.86 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.469 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.71 70.62 7.29 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.101 0.477 . . . . 0.0 110.327 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.07 145.31 98.72 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.687 2.258 . . . . 0.0 112.215 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.7 t -133.8 136.11 44.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.527 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.74 -38.42 83.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.662 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.48 -41.99 96.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.52 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.11 -41.54 98.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.516 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -63.64 -43.29 98.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.976 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.1 77.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.284 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.76 -18.37 59.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.454 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.77 -6.39 58.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.508 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.416 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 75.2 mtp 47.93 55.79 17.17 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.614 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.6 Cg_endo -69.94 149.36 65.63 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.88 2.386 . . . . 0.0 112.114 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.76 -73.05 0.66 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.488 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.6 tp -111.43 114.21 27.18 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.267 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -103.49 126.97 57.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.525 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.7 mt -110.71 134.51 52.4 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.184 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.12 140.15 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.555 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.7 p -83.57 168.02 16.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.689 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.31 -37.26 80.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.472 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 t -139.19 158.4 44.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.486 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.3 177.0 33.54 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.71 86.99 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -125.28 151.7 45.64 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.913 0.387 . . . . 0.0 110.551 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.9 t -63.29 141.34 58.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.379 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.18 10.7 10.72 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.631 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.15 -38.97 88.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.15 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.7 -35.97 24.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.432 0.634 . . . . 0.0 110.633 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.2 mt -70.98 -35.1 71.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.486 0.66 . . . . 0.0 110.72 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -42.88 -62.94 0.88 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.285 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.61 -42.84 91.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.066 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -62.11 -32.29 72.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.242 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.4 mt -74.28 -40.64 62.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.969 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.44 -49.09 78.55 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.275 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.7 m -52.92 -42.85 65.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.157 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.18 -43.06 92.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -168.83 151.71 5.09 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.71 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -38.61 107.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.621 2.214 . . . . 0.0 112.387 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.643 ' C ' HD12 ' A' ' 140' ' ' LEU . 97.2 m -109.75 121.64 45.69 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.2 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.0 153.34 29.53 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.309 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -128.46 131.11 69.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.371 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.18 128.19 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.571 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.473 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 54.6 t30 -100.77 104.94 16.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.227 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.411 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.4 p90 -100.71 -11.94 19.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.893 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.0 p-10 -64.95 -33.69 76.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.742 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -99.29 7.91 45.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.542 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.411 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.8 mttm -134.57 151.84 51.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.869 0.366 . . . . 0.0 110.529 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.427 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.7 p -75.82 166.26 23.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.597 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.4 t90 -59.25 -48.62 80.94 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.276 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -54.44 -44.1 72.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.03 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.4 t -62.96 -40.7 98.5 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.202 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.436 ' O ' HD23 ' A' ' 156' ' ' LEU . 63.4 tp -60.92 -44.34 97.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.3 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 49.2 tp -61.49 -42.98 99.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.198 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.8 m -55.9 -45.7 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.741 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.23 -40.56 96.55 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.836 0.35 . . . . 0.0 110.394 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.45 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -62.03 -42.5 99.24 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.222 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.73 -40.06 95.56 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.42 -45.95 64.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.8 -44.0 96.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.5 p -92.77 -9.09 41.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.704 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.93 26.29 72.22 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -101.22 50.47 0.86 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.776 0.322 . . . . 0.0 110.629 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.48 -39.17 77.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.658 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.9 -47.45 85.73 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.213 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.4 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 88.0 mt-30 -59.97 -39.27 85.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.162 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.92 98.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.238 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.88 -29.13 70.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.558 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -73.86 -54.41 8.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.059 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.527 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.6 ttp180 -64.86 -42.13 95.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.455 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 174' ' ' ASP . 78.4 mt -62.43 -43.82 98.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.487 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.28 -58.71 6.72 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.009 0.433 . . . . 0.0 110.368 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -56.61 -33.57 66.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.37 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -81.1 -36.12 30.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.78 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.1 m-20 -54.84 -42.35 71.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.062 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.17 -41.77 98.64 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.696 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.0 -38.02 89.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.383 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.45 -42.48 99.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.653 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.75 -53.06 61.14 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.132 0.492 . . . . 0.0 110.752 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.48 -41.76 88.48 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.618 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.09 95.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.67 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.14 -32.63 74.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.418 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -94.06 -21.47 19.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.728 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.63 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.3 tt0 -64.87 -41.58 95.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.733 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.0 pt -76.5 133.9 30.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.675 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.71 106.46 9.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.4 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.59 128.37 0.34 Allowed Pre-proline 0 C--O 1.238 0.479 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.553 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.3 Cg_exo -43.65 151.42 0.4 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.839 2.359 . . . . 0.0 112.497 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.67 142.18 52.22 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.611 2.208 . . . . 0.0 112.421 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.542 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.72 147.17 2.39 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.542 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.15 153.93 70.93 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.787 2.325 . . . . 0.0 112.278 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.47 163.23 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.159 0.504 . . . . 0.0 110.45 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.75 169.93 16.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.832 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.68 137.4 22.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.3 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.53 HG22 HD12 ' A' ' 205' ' ' LEU . 39.2 pt -134.19 146.03 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.592 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -133.39 132.01 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.054 0.454 . . . . 0.0 110.517 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -151.82 154.45 36.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.48 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.0 m -121.56 122.69 40.23 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.955 0.407 . . . . 0.0 110.368 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.74 -25.59 66.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.595 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.96 -49.66 19.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.992 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.01 -11.53 60.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.403 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.6 m80 49.14 42.47 21.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.495 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.0 t -135.94 144.98 45.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.319 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.82 114.12 27.22 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.375 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -120.18 133.71 55.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.986 0.422 . . . . 0.0 110.399 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.18 146.53 37.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.74 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.48 ' N ' HD23 ' A' ' 205' ' ' LEU . 13.3 t90 -99.38 127.96 45.46 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.101 0.477 . . . . 0.0 109.987 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.7 153.42 41.14 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.264 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.9 -18.29 46.81 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.648 2.232 . . . . 0.0 111.962 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -18.75 0.59 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.368 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.443 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.1 p -75.21 167.7 21.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.476 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.11 -35.56 75.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.3 mt-30 -56.64 -41.19 76.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.763 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.37 -43.04 97.68 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.492 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.4 mt-30 -63.75 -40.08 95.84 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 122.549 -0.383 . . . . 0.0 110.542 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.597 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.2 mmm -61.56 -41.87 98.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.376 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.56 -49.88 71.67 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.473 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.11 -33.06 50.62 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -71.09 -20.21 62.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.558 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 219' ' ' LEU . 65.9 mt -87.28 -6.42 58.55 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.74 3.52 57.16 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -88.34 149.85 23.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.93 0.395 . . . . 0.0 110.507 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.441 ' O ' HG12 ' A' ' 191' ' ' VAL . 3.0 p -112.78 126.49 55.47 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.127 0.489 . . . . 0.0 110.355 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.79 145.84 24.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.999 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.489 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -70.06 150.77 46.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.438 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.86 131.21 44.43 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.502 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.896 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.69 93.25 27.51 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.118 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.679 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.6 Cg_exo -55.77 138.99 83.15 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.655 2.236 . . . . 0.0 111.561 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.75 -25.13 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.399 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.75 -49.91 27.2 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.56 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.1 mt -54.37 -37.01 64.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.54 35.92 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.801 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.56 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.58 87.92 0.01 OUTLIER 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.864 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 82.3 p -81.64 -14.28 56.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.351 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.51 -41.8 10.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.609 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.9 -16.91 64.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.587 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.91 43.69 27.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.504 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.21 -149.62 8.44 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -120.29 142.79 48.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.976 0.417 . . . . 0.0 110.36 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.24 149.76 29.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.366 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -101.21 -151.7 0.42 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.358 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.0 t0 56.21 -91.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.688 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.479 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.3 tt -127.08 175.61 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.597 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.479 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.6 mt -122.23 141.68 41.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.81 169.26 9.36 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.255 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.3 mt -147.57 150.71 34.99 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.223 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.57 -39.06 97.21 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.33 3.74 4.67 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.11 -58.44 3.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.911 0.386 . . . . 0.0 110.568 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.55 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.9 m-20 -61.95 -36.57 81.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.29 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 9.9 mp -52.3 -67.8 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.757 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.42 -42.21 66.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.148 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.87 18.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.657 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.75 47.64 0.23 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 39.13 -110.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.521 0.201 . . . . 0.0 110.743 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.489 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.9 -44.98 96.37 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.473 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.78 8.1 83.17 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -99.14 -12.57 20.36 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.805 -0.232 . . . . 0.0 110.642 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.3 t 176.24 142.65 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.052 0.453 . . . . 0.0 110.493 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.432 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.1 125.47 11.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.156 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -98.37 143.03 29.27 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 120.848 0.356 . . . . 0.0 110.837 178.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.2 mt -94.41 106.52 18.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.674 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.469 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.87 -12.74 18.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.149 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.79 90.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.895 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.9 173.2 45.81 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.472 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 87.5 m-20 -74.07 -113.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 110.723 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.15 -28.91 68.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.765 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.08 -44.09 91.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.187 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.51 -44.45 94.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.318 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.32 -59.78 4.0 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.25 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -51.25 -43.47 61.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.111 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.2 -43.84 74.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.244 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.1 mt -64.39 -43.58 97.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.679 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -56.59 -37.67 70.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.163 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.28 1.17 19.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.212 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -115.04 91.47 27.13 Favored Pre-proline 0 C--O 1.231 0.114 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.17 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.14 -27.33 29.18 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.821 2.347 . . . . 0.0 111.864 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.4 -41.17 98.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.55 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.587 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.9 mp -95.24 4.75 53.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.396 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.71 -35.31 70.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.099 0.476 . . . . 0.0 110.673 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.76 4.62 15.8 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.624 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.79 121.15 80.26 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.565 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -47.64 -37.35 26.96 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.464 2.11 . . . . 0.0 112.472 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.528 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.88 -43.35 90.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.319 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.04 -43.8 92.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.303 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -64.95 -40.76 95.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.341 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.3 t-20 -89.15 -13.16 39.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.577 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.5 mtmt 62.66 32.05 16.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.93 44.51 1.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.292 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.68 135.4 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.551 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.6 132.41 56.69 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.398 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.49 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -82.83 88.69 6.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.786 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.425 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.4 mt -63.87 -41.72 97.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.78 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.469 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.82 165.9 34.41 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 75.5 p -75.61 -25.92 57.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.719 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -68.29 -33.97 75.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.552 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 296' ' ' THR . 98.7 m -72.62 19.85 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.668 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.508 ' O ' ' NE2' ' A' ' 212' ' ' GLN . 49.1 t80 -57.28 -51.01 71.1 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.014 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 70.9 mmt-85 -107.85 149.18 28.58 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 41.1 tp -115.67 126.26 53.9 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.862 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.475 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.6 t0 -149.74 166.67 28.71 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.611 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -49.21 -38.04 24.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.613 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.65 -65.11 0.8 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.454 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.2 p -60.71 -32.82 72.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.974 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.49 -25.21 24.1 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.3 mtt -63.67 -41.02 98.23 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 120.811 0.339 . . . . 0.0 110.945 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -78.37 -44.36 25.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.988 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.573 HG21 HG23 ' A' ' 296' ' ' THR . 79.7 t -65.97 -42.93 92.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.431 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.442 HD11 ' OE1' ' A' ' 183' ' ' GLN . 49.8 tp -60.01 -46.92 87.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.448 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -70.61 -39.48 73.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.988 0.423 . . . . 0.0 110.603 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.49 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 73.6 ttt180 -61.35 -38.0 85.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.319 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.8 mt -87.76 4.91 42.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.698 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.63 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.22 -11.71 13.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.041 0.448 . . . . 0.0 110.337 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.79 -37.1 85.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.489 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.96 -48.75 80.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.435 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.958 179.872 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.612 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -90.3 -2.39 58.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.441 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.93 179.04 1.25 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.525 -179.67 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 33.0 Cg_exo -60.74 144.81 99.61 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.802 2.334 . . . . 0.0 112.191 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.612 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.4 ptt-85 -156.09 -179.46 8.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.597 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.62 136.19 53.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.322 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.411 ' HA ' HD12 ' A' ' 30' ' ' ILE . 9.5 tp -123.78 146.53 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.432 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.8 p -119.78 135.99 54.63 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.719 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.1 p30 -99.28 -143.5 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.328 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.8 p -63.66 -37.0 85.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.42 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.31 -66.78 0.22 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.437 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.06 142.12 44.65 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.6 p -112.09 131.23 55.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.411 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -119.2 129.17 54.83 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.498 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.1 m -85.62 130.3 34.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.301 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' OE1' ' A' ' 42' ' ' GLN . 67.4 mt -95.69 78.58 3.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.399 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.82 -32.03 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.482 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.27 108.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.204 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.489 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -121.97 91.31 48.85 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.322 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.658 ' O ' ' N ' ' A' ' 45' ' ' ARG . 35.1 Cg_exo -56.94 148.8 65.48 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.782 2.321 . . . . 0.0 111.888 179.049 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.82 82.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.487 0.492 . . . . 0.0 110.922 -179.19 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.658 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.3 mtm180 -151.09 66.79 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.277 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.45 130.93 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.748 -179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.548 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.1 t -122.82 145.57 29.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.191 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.9 t -135.13 143.59 46.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.681 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.2 p -99.54 -59.26 1.75 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.576 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.4 p -79.74 155.11 28.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.593 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.482 HG21 HG23 ' A' ' 70' ' ' THR . 71.4 t -74.58 -21.9 17.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.46 179.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.2 m -59.9 -52.32 65.92 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.508 -178.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.0 mt -66.53 -42.35 87.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.129 0.49 . . . . 0.0 110.8 178.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.6 m -42.91 -53.73 4.55 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.169 -178.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.46 -37.34 69.42 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 178.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 m -62.79 -44.62 95.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.955 0.407 . . . . 0.0 110.484 -179.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.5 mt -66.37 -41.85 88.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.367 0.603 . . . . 0.0 110.683 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tp -62.5 -40.25 96.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.297 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.468 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.98 -35.75 75.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.033 -178.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.539 HD11 HD12 ' A' ' 156' ' ' LEU . 31.6 pt -91.57 28.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.163 -179.163 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.38 51.78 10.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.795 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.86 75.91 24.0 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.999 0.428 . . . . 0.0 110.05 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.19 151.27 86.03 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.739 2.293 . . . . 0.0 112.3 -178.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.548 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.51 137.48 46.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.156 0.503 . . . . 0.0 110.339 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.3 pt -69.41 -43.56 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.129 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.96 131.09 53.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.958 0.408 . . . . 0.0 110.613 -178.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.1 p -155.8 169.03 25.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.515 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.87 -177.43 21.63 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.628 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.01 172.19 12.96 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 120.979 0.418 . . . . 0.0 110.444 179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.482 HG23 HG21 ' A' ' 51' ' ' VAL . 11.9 p -133.76 -110.72 0.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.364 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.549 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.95 179.53 0.96 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.421 -179.202 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.7 Cg_exo -60.89 58.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.011 2.474 . . . . 0.0 112.079 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.4 t-20 -64.29 -35.03 79.52 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.52 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 47.2 m-20 94.96 -37.66 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.926 0.766 . . . . 0.0 110.031 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.64 -40.01 95.67 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.256 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.5 p -73.94 -26.44 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.697 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.9 -172.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.504 -179.402 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -73.88 -152.51 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.72 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.3 p-10 -54.78 -6.33 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.674 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.4 113.56 23.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.634 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.4 72.66 1.28 Allowed Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -143.68 148.56 35.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.919 0.39 . . . . 0.0 110.759 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.3 mp -85.76 -99.15 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.136 178.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.564 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.28 -42.74 96.27 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.322 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.564 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.3 tt0 91.5 52.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.772 0.67 . . . . 0.0 110.951 178.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.45 -9.25 19.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.412 179.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.0 p -64.74 -33.78 76.78 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.112 0.482 . . . . 0.0 110.643 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.55 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 97.9 mttt -48.66 -23.35 1.0 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.591 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.8 t -70.05 -45.87 74.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.789 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.25 -48.65 80.49 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.183 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.61 -38.15 89.08 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.382 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.64 -32.39 51.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.237 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.617 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.5 mmt-85 -89.98 1.68 56.0 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.547 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.617 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.89 -49.1 0.16 Allowed 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.816 0.697 . . . . 0.0 110.342 179.141 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.683 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.9 mt -46.3 154.05 0.3 Allowed 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.557 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.683 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 121.12 92.26 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.029 1.456 . . . . 0.0 110.543 -178.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.537 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.3 143.3 43.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.078 0.466 . . . . 0.0 110.287 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 mt -131.92 26.97 4.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.847 0.356 . . . . 0.0 110.479 -179.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.48 138.15 34.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.004 0.431 . . . . 0.0 110.481 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.8 mt -137.19 165.15 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.429 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.62 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.11 -28.55 1.84 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.469 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -153.21 70.64 6.93 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.039 0.447 . . . . 0.0 110.391 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.15 145.53 98.28 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.801 2.334 . . . . 0.0 112.011 -179.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.1 t -134.04 136.81 44.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.57 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.33 82.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.656 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.42 -42.28 96.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.476 -179.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.71 98.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.484 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.4 t -63.66 -43.18 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.136 179.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.74 -35.23 77.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.249 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.82 -18.28 59.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.432 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.7 -6.53 58.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.523 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.413 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 66.9 mtp 48.04 55.96 17.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.623 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.9 Cg_endo -70.22 149.1 63.45 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.771 2.314 . . . . 0.0 112.134 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.36 -72.87 0.67 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.539 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.427 HD11 HD13 ' A' ' 140' ' ' LEU . 39.2 tp -111.42 112.4 24.12 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.377 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 75.6 mt -100.59 126.03 54.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.516 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.9 mt -109.38 133.0 53.6 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.287 -179.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.47 139.61 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.573 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.5 p -83.44 168.38 16.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.705 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.41 80.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.483 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.8 t -139.33 158.87 43.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.96 0.409 . . . . 0.0 110.446 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.16 177.04 33.41 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.17 -33.91 87.39 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.97 151.62 45.25 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.906 0.384 . . . . 0.0 110.546 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.1 t -63.18 141.27 58.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.398 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.51 10.93 10.54 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.659 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.517 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.14 -38.83 87.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.099 -179.404 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.64 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.86 -35.79 23.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.377 0.608 . . . . 0.0 110.579 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.7 mt -71.06 -35.17 71.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.396 0.617 . . . . 0.0 110.691 179.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -42.94 -62.82 0.92 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.229 -178.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.64 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.87 -42.63 90.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.997 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.2 mt-30 -62.18 -32.28 72.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.266 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.4 mt -74.41 -40.54 61.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 178.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.93 -48.86 78.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.219 -179.08 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.5 m -52.66 -42.68 64.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.215 179.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.06 -43.05 92.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.173 179.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.36 153.21 5.22 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.622 -179.128 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -39.03 107.33 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.664 2.243 . . . . 0.0 112.435 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 93.8 m -108.72 121.01 44.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.287 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.03 152.52 30.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.343 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -129.0 131.51 68.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.42 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.11 127.68 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.55 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.8 t30 -101.83 103.86 14.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.359 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 147' ' ' LYS . 49.1 p90 -101.29 -11.31 19.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.801 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.7 p-10 -64.77 -33.52 76.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.728 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.577 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.8 p-10 -98.33 7.68 45.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.568 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.34 155.44 50.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.508 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.3 p -74.66 165.69 24.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.615 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.571 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 90.9 t90 -60.04 -48.7 80.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.38 -179.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.87 -41.87 67.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.005 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.9 t -62.6 -40.77 97.98 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.484 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 156' ' ' LEU . 48.4 tp -60.62 -43.94 96.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.417 -179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.5 HD23 HD11 ' A' ' 170' ' ' ILE . 46.1 tp -61.47 -42.96 99.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.21 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.5 m -55.75 -45.31 78.09 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.4 -40.69 97.32 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.881 0.372 . . . . 0.0 110.408 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.539 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.96 -42.38 99.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.158 179.233 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.65 -40.72 96.04 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.87 -46.04 63.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.853 0.359 . . . . 0.0 110.829 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.62 -44.03 96.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.795 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.5 p -93.01 -8.79 41.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.676 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.76 25.19 71.67 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -101.87 52.01 0.82 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.658 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.92 -39.03 76.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.685 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.28 -47.08 86.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.252 -179.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -61.4 -38.93 88.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.291 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.43 97.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.41 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.48 -27.54 69.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.507 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.92 -53.78 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.134 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.494 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -63.66 -43.49 96.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.441 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.0 mt -63.06 -43.85 99.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.7 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.3 -61.65 2.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.064 0.459 . . . . 0.0 110.392 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -54.61 -35.08 63.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.44 -179.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -79.75 -34.46 39.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.909 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 170' ' ' ILE . 50.2 m-20 -56.83 -40.14 75.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.805 -178.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.89 -42.45 99.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.937 0.399 . . . . 0.0 110.709 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.68 -37.96 87.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.292 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 177' ' ' LEU . 83.0 mt -62.33 -42.49 99.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.704 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.95 -53.29 57.76 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.081 0.467 . . . . 0.0 110.694 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.27 -41.66 89.56 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.633 179.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.76 94.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.68 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.22 -32.21 73.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.379 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -94.49 -21.67 18.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.615 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.631 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.94 -41.63 95.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.631 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.4 pt -77.52 136.09 25.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.745 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.24 108.95 11.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.338 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.74 126.38 0.31 Allowed Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.519 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.462 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.9 Cg_exo -43.88 152.13 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.76 2.307 . . . . 0.0 112.519 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.18 141.72 53.26 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.627 2.218 . . . . 0.0 112.354 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.37 147.22 2.11 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.497 179.402 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.21 154.46 69.88 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.764 2.31 . . . . 0.0 112.254 178.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.5 163.07 28.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.437 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.76 170.1 16.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.899 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.0 137.48 22.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.948 0.404 . . . . 0.0 110.315 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.535 HG22 HD12 ' A' ' 205' ' ' LEU . 38.9 pt -134.2 146.08 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.607 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.71 131.61 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.109 0.48 . . . . 0.0 110.497 178.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -151.94 154.8 36.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.406 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.62 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.0 m -122.05 122.82 40.17 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.945 0.402 . . . . 0.0 110.393 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.33 -25.64 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.618 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.62 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.39 -48.86 21.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.04 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.03 -11.73 60.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.414 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.4 m80 49.19 42.19 21.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.478 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.1 t -136.5 145.58 45.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.373 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.15 114.24 27.34 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.348 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.89 133.33 55.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.036 0.446 . . . . 0.0 110.376 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.535 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.03 146.38 38.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.713 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.488 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 12.2 t90 -99.37 130.01 45.61 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.121 0.486 . . . . 0.0 110.096 179.246 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.89 153.95 39.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.097 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.3 Cg_endo -67.71 -18.22 47.84 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.796 2.33 . . . . 0.0 111.93 178.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.11 -18.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.405 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.488 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.5 p -75.97 164.98 25.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.497 179.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.96 -27.99 65.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.51 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.528 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.69 -41.56 98.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.763 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.91 -44.86 96.73 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.8 mt-30 -64.57 -38.81 92.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.957 0.408 . . . . 0.0 110.709 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.571 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.3 mmm -62.03 -41.44 98.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.229 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.4 mt -63.79 -47.25 81.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.912 0.387 . . . . 0.0 110.607 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.16 -32.07 54.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.154 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -70.79 -18.29 62.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.58 179.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.426 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.8 mt -88.7 -8.61 54.25 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.641 -179.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.67 2.75 55.32 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -88.48 151.91 22.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.509 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.448 ' O ' HG12 ' A' ' 191' ' ' VAL . 7.8 p -114.95 127.83 55.92 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.052 0.453 . . . . 0.0 110.427 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.566 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.35 146.13 23.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.962 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.472 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.56 151.07 46.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.524 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.65 131.65 43.34 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.487 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.894 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.62 93.73 29.37 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.139 -179.789 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.683 ' C ' ' H ' ' A' ' 229' ' ' GLY . 47.3 Cg_exo -55.63 138.72 81.74 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.673 2.249 . . . . 0.0 111.59 179.153 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.75 -25.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.444 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.47 -49.77 29.65 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.55 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -53.46 -36.43 61.61 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -67.16 36.57 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.725 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.55 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.63 86.67 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.831 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.3 p -78.83 -15.72 58.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.53 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.22 -40.77 10.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.626 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.9 t -66.2 -17.73 64.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.573 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.41 43.25 26.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.418 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.85 -146.6 6.98 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -123.39 143.21 50.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.96 0.409 . . . . 0.0 110.335 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -152.07 149.61 29.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.422 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -100.5 -152.17 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.391 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 55.9 -91.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.567 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.471 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.7 tt -126.65 175.46 8.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.564 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.471 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.9 mt -122.16 141.76 41.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.734 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -100.0 169.12 9.41 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.328 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.5 mt -147.83 151.18 35.52 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.133 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.78 -39.01 97.01 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.19 4.1 4.63 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.23 -58.38 3.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.939 0.399 . . . . 0.0 110.573 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.546 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.0 m-20 -61.98 -36.97 83.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.313 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.19 -67.73 0.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.813 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.46 -42.09 66.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.153 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.12 18.06 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.637 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.92 48.34 0.27 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.57 -110.0 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.667 0.27 . . . . 0.0 110.717 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.472 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 12.3 m120 -60.62 -45.35 94.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.471 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.88 8.15 82.93 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.23 -12.61 20.24 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.799 -0.236 . . . . 0.0 110.631 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.6 t 176.2 142.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.063 0.459 . . . . 0.0 110.553 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.433 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.85 125.31 11.67 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.047 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.432 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -98.43 142.98 29.38 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 120.88 0.371 . . . . 0.0 110.781 178.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.3 mt -94.17 106.43 18.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.652 -179.169 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.468 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.2 t80 -101.96 -11.41 18.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.182 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.42 -40.33 85.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.788 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.39 173.75 46.11 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.499 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.5 m-20 -74.44 -113.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.756 0.312 . . . . 0.0 110.71 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.62 -28.57 67.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.685 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.01 -44.21 91.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.313 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -63.68 -44.4 93.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.354 179.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.38 -60.16 3.56 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.295 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -51.02 -43.34 60.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.227 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.39 -43.92 75.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.258 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.0 mt -64.55 -43.71 96.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.598 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -56.27 -37.72 70.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.268 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.94 1.22 18.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.316 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -115.04 91.14 25.77 Favored Pre-proline 0 CA--C 1.528 0.122 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.207 -179.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.98 -27.18 27.45 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.818 2.345 . . . . 0.0 111.879 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.45 -41.08 98.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.565 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.587 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.31 5.03 52.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.459 -179.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.95 -35.01 69.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.735 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.87 4.74 15.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.541 -178.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.533 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.88 121.39 81.27 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.561 179.918 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -47.53 -37.8 26.9 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.539 2.159 . . . . 0.0 112.427 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.533 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.72 -43.72 90.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.38 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.89 -43.69 92.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.335 179.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.67 -40.6 95.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.49 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.7 t-20 -89.84 -12.19 39.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.563 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.4 mtmt 61.85 31.85 18.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.959 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.47 44.15 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.34 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.18 135.82 41.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.465 -179.661 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.5 132.34 56.7 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.521 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.498 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.2 87.97 6.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.728 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.94 -41.35 97.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.885 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.468 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.21 167.89 34.44 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 75.5 p -75.89 -25.82 56.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.381 . . . . 0.0 110.797 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.6 tp10 -67.9 -34.18 76.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.489 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.768 HG22 ' O ' ' A' ' 296' ' ' THR . 97.0 m -73.24 19.9 0.09 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.69 -179.142 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.528 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 53.0 t80 -57.24 -51.14 70.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.018 -179.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -108.22 149.41 28.62 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.426 ' CD2' HD11 ' A' ' 219' ' ' LEU . 41.5 tp -115.26 125.26 53.1 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.672 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.468 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.5 t0 -149.08 166.29 29.18 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.624 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -49.08 -38.19 23.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.632 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -71.96 -64.99 0.83 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.262 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -60.81 -32.52 71.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.864 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.85 -25.6 29.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.617 -179.049 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.8 mtt -63.23 -41.23 99.09 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 120.9 0.381 . . . . 0.0 110.883 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.19 -44.4 25.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.994 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.568 HG21 HG23 ' A' ' 296' ' ' THR . 76.5 t -66.14 -42.88 92.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.397 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.443 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.4 tp -59.89 -47.46 85.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.451 -178.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -69.85 -39.72 76.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.047 0.451 . . . . 0.0 110.888 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.499 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 72.2 ttt180 -61.52 -38.19 86.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.29 -179.048 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.2 mt -87.48 5.04 41.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.658 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.631 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.66 -11.78 13.49 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.049 0.452 . . . . 0.0 110.259 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.84 -37.16 85.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.56 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.82 -48.88 79.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.427 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.022 179.786 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.45 -2.83 57.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.481 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.46 179.12 1.24 Allowed Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.477 -179.722 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.4 Cg_exo -60.52 144.42 99.52 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.79 2.326 . . . . 0.0 112.235 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.5 ptt-85 -155.75 -179.9 8.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.55 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.58 136.77 52.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.042 0.448 . . . . 0.0 110.312 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' HA ' HD12 ' A' ' 30' ' ' ILE . 9.1 tp -124.41 146.2 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.39 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -119.54 135.97 54.55 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.805 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.9 p30 -98.71 -144.11 0.32 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.17 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.65 -36.49 84.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.405 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -147.58 -70.27 0.23 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.43 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -57.81 144.12 41.77 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.263 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.8 p -112.8 129.84 56.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.914 0.387 . . . . 0.0 110.451 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -114.68 129.66 56.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.683 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.9 m -86.95 130.68 34.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.35 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.496 HD22 ' OE1' ' A' ' 42' ' ' GLN . 70.4 mt -97.61 78.87 2.67 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.434 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.8 -32.58 74.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.544 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 t 177.15 109.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.118 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.496 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.2 pt20 -124.52 91.5 49.4 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.39 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.62 149.27 59.46 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.865 2.377 . . . . 0.0 111.962 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -40.22 82.36 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.624 0.578 . . . . 0.0 110.998 -179.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.1 mtm180 -151.69 66.66 0.87 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.477 . . . . 0.0 110.18 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -77.28 131.23 35.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.555 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.4 t -122.65 147.86 26.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.104 0.478 . . . . 0.0 110.073 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.9 t -136.17 143.61 44.54 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.725 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 50' ' ' SER . 27.2 p -99.26 -59.96 1.62 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.618 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.401 ' N ' ' OG1' ' A' ' 49' ' ' THR . 87.1 p -79.07 156.14 28.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.64 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.575 HG21 HG23 ' A' ' 70' ' ' THR . 68.9 t -74.59 -21.55 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.572 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 100.0 m -60.15 -51.99 67.24 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.513 -178.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.0 mt -66.28 -42.44 88.41 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.817 177.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -43.23 -54.36 4.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.998 -178.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.11 -38.77 73.29 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.304 -0.719 . . . . 0.0 111.304 178.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.6 m -62.29 -43.67 98.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.934 0.397 . . . . 0.0 110.199 -179.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.7 mt -65.46 -42.41 92.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.502 0.668 . . . . 0.0 110.684 179.414 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.6 tp -63.08 -38.74 92.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.263 -179.348 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -61.59 -36.65 81.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.224 -178.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -91.22 27.6 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.148 -179.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.419 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 90.6 m-20 57.11 52.46 9.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.123 179.41 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.79 76.48 28.94 Favored Pre-proline 0 C--O 1.225 -0.223 0 CA-C-O 121.039 0.447 . . . . 0.0 109.891 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.67 148.2 92.32 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.733 2.289 . . . . 0.0 112.08 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -112.67 136.27 49.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.126 0.489 . . . . 0.0 110.395 179.724 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -70.11 -43.05 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.189 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -124.76 131.04 53.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.979 0.419 . . . . 0.0 110.637 -178.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.542 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.3 p -155.58 168.42 27.19 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.424 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.61 -177.26 21.81 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.646 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.57 172.43 12.75 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 121.081 0.467 . . . . 0.0 110.422 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.575 HG23 HG21 ' A' ' 51' ' ' VAL . 14.2 p -132.95 -112.09 0.23 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.452 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.63 179.7 0.93 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.497 -179.245 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 37.5 Cg_exo -60.83 57.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.966 2.444 . . . . 0.0 112.157 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.4 t-20 -64.42 -33.51 76.03 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.417 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.2 m-20 93.91 -36.17 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.779 0.675 . . . . 0.0 109.899 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.401 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.6 mtp85 -63.21 -39.72 95.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.203 179.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.33 -25.3 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.688 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.24 -170.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.468 -179.354 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.83 -154.91 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.878 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 38.3 p-10 -51.44 -7.92 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.823 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.516 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -85.68 114.99 23.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.693 179.59 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.38 70.87 1.32 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -144.87 148.07 33.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.924 0.392 . . . . 0.0 110.752 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.9 mp -85.92 -98.46 0.07 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.178 178.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.0 -42.53 97.13 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.176 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.4 tt0 91.47 53.03 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.868 0.73 . . . . 0.0 110.877 179.037 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -102.69 -9.55 19.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.331 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.5 p -63.88 -34.42 77.92 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.05 0.452 . . . . 0.0 110.703 -179.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.557 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.13 -23.86 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.59 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.0 t -70.11 -45.21 76.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.592 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.42 -48.53 80.79 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.923 -179.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.04 -38.38 88.49 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.436 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.31 -34.36 57.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.251 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.61 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.6 mmt-85 -88.43 1.08 55.48 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.608 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.5 mttp 83.17 -47.94 0.14 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.845 0.715 . . . . 0.0 110.315 179.163 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.668 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.4 mt -46.68 153.3 0.4 Allowed 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 117.817 -1.087 . . . . 0.0 109.606 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.668 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.6 tt0 122.03 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 O-C-N 125.318 1.636 . . . . 0.0 110.452 -178.573 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.84 142.85 44.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.204 0.526 . . . . 0.0 110.337 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.2 mt -131.95 26.61 4.6 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.096 -0.377 . . . . 0.0 110.49 -179.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.09 137.46 34.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.576 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.646 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.0 mt -136.99 164.86 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.411 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.48 -28.83 1.78 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.35 70.5 7.54 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 121.134 0.492 . . . . 0.0 110.219 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.15 145.32 98.74 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.783 2.322 . . . . 0.0 112.098 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.9 t -134.45 137.12 43.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.584 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.56 83.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.655 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.32 -42.0 96.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.485 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.08 -41.79 98.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.466 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.7 -43.21 97.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.063 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.23 -35.27 78.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.218 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.26 -18.3 57.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.433 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -87.09 -6.06 58.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.483 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 70.3 mtp 47.71 55.99 17.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.621 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.0 Cg_endo -70.08 149.26 64.57 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.784 2.323 . . . . 0.0 112.067 179.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.24 -72.39 0.68 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.579 179.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.403 HD11 HD13 ' A' ' 140' ' ' LEU . 38.2 tp -111.91 113.22 25.4 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.399 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.8 mt -102.0 126.9 55.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.0 0.429 . . . . 0.0 110.587 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.3 mt -110.74 133.72 53.1 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.212 -179.297 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.4 139.92 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.559 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.7 p -83.6 167.41 17.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.683 179.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.59 -36.85 79.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.455 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.4 t -138.2 157.78 45.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.456 -179.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.55 175.4 34.17 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.55 -33.61 87.03 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.38 151.42 44.42 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.97 0.414 . . . . 0.0 110.513 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.5 t -63.53 140.53 58.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.389 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.05 10.93 10.86 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.648 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -60.96 -38.92 87.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.219 -179.428 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.634 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.14 -35.58 23.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.445 0.641 . . . . 0.0 110.577 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.3 mt -71.16 -35.16 71.56 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.457 0.646 . . . . 0.0 110.654 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -43.02 -62.82 0.93 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.215 -178.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.634 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.5 p-10 -65.98 -42.93 89.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.021 -179.162 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.3 mt-30 -61.73 -32.38 72.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.343 -179.524 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.7 mt -74.38 -40.49 62.05 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.922 178.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.09 -49.09 78.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.277 -179.104 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 m -52.92 -42.56 65.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.211 179.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.83 -42.72 92.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.152 179.26 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.54 153.16 5.05 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.628 -179.335 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -39.04 106.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.679 2.253 . . . . 0.0 112.393 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.654 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.1 m -109.36 121.89 46.16 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.416 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.654 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.86 154.07 29.3 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.264 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.2 tt -130.38 129.23 64.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.409 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 92.9 mt -110.6 122.71 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.024 0.44 . . . . 0.0 110.614 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.544 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 54.2 t30 -101.17 106.91 18.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.256 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -100.76 0.25 38.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.847 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.4 p-10 -65.61 -34.77 78.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.959 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -101.88 10.22 39.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.728 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -133.99 148.31 51.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.909 0.385 . . . . 0.0 110.49 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.409 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 22.9 p -77.61 168.82 19.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.623 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.6 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.1 t90 -58.7 -49.87 75.99 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.064 -179.009 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -54.46 -46.17 73.26 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.944 0.402 . . . . 0.0 110.048 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 40.1 t -63.07 -40.77 98.67 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.14 0.495 . . . . 0.0 110.314 178.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.46 ' O ' HD23 ' A' ' 156' ' ' LEU . 52.0 tp -60.72 -44.54 96.48 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.309 -179.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.89 -43.5 98.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.113 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.9 m -54.51 -45.85 73.39 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.86 -40.1 94.2 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.853 0.358 . . . . 0.0 110.364 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 152' ' ' LEU . 2.3 mm? -61.59 -42.2 98.52 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.115 179.234 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.84 -38.8 94.68 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.148 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.52 -45.08 66.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.962 0.41 . . . . 0.0 110.712 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.69 -44.11 96.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.789 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.8 p -93.41 -8.69 41.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.533 -178.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.5 27.08 72.17 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -102.54 50.27 0.83 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.66 -179.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -69.31 -39.03 78.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.622 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.56 -47.26 86.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.31 -179.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.419 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 86.4 mt-30 -60.5 -39.33 87.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.213 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.51 -41.02 98.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.278 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.31 -29.28 70.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.607 179.334 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.18 -54.46 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.855 179.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.419 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.8 ttp180 -64.22 -42.89 96.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.431 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 174' ' ' ASP . 82.0 mt -62.59 -43.77 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.483 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.6 -61.11 2.76 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.2 0.524 . . . . 0.0 110.201 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.77 -34.51 62.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.521 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -80.33 -34.84 36.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.761 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -55.26 -41.71 72.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.059 -178.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.2 -41.8 98.7 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.662 179.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.14 -37.87 88.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.313 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.33 -42.39 99.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.756 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.8 -52.95 62.08 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.112 0.482 . . . . 0.0 110.59 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.34 -41.43 89.57 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.601 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.28 -39.78 94.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.615 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.64 -33.08 74.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.369 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.54 -21.49 19.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.612 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.628 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -65.18 -41.43 94.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.694 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 184' ' ' ILE . 30.9 pt -76.98 133.83 30.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.802 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -127.55 107.05 9.6 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.298 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.93 127.39 0.31 Allowed Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.483 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.78 151.99 0.38 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.865 2.377 . . . . 0.0 112.53 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.52 142.39 53.67 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.599 2.199 . . . . 0.0 112.368 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.545 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.78 146.86 2.3 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.548 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.0 153.9 71.65 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.855 2.37 . . . . 0.0 112.37 178.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.58 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.37 163.11 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 110.475 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.58 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.0 t -143.93 170.72 15.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.032 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.74 137.8 21.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.074 0.464 . . . . 0.0 110.098 179.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.55 HG22 HD12 ' A' ' 205' ' ' LEU . 39.9 pt -134.39 146.64 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.691 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.44 131.68 60.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.1 0.476 . . . . 0.0 110.472 178.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -152.09 154.84 36.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.431 179.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.5 m -122.02 122.71 39.93 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.921 0.391 . . . . 0.0 110.341 179.469 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.89 -25.34 66.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.662 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.613 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.12 -49.34 19.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.899 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.16 -11.49 60.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.345 -179.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.2 m80 49.21 42.57 21.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.483 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.0 t -136.42 144.56 44.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.33 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.79 114.54 27.96 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.293 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -120.41 133.95 55.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.048 0.451 . . . . 0.0 110.405 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.55 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.4 146.75 37.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.778 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.563 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 9.4 t90 -100.51 129.28 46.44 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.177 0.513 . . . . 0.0 109.962 179.335 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.27 153.75 41.53 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.164 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.406 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.8 Cg_endo -67.77 -18.05 47.44 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.685 2.256 . . . . 0.0 112.057 178.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -48.74 -18.92 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.468 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.563 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 84.8 p -74.84 163.89 27.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.551 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.5 -28.24 65.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.478 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.507 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.2 mt-30 -63.55 -42.86 98.35 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.577 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.0 -43.74 97.89 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.409 ' OE1' ' C ' ' A' ' 148' ' ' SER . 74.8 mt-30 -63.68 -38.52 91.42 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 122.271 -0.546 . . . . 0.0 110.629 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.6 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 85.6 mmm -61.99 -41.66 98.28 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.26 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 82.2 mt -63.83 -49.73 71.67 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.136 0.493 . . . . 0.0 110.257 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -51.96 -33.91 39.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.845 0.355 . . . . 0.0 110.241 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -70.88 -20.74 62.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.519 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 75.1 mt -87.61 -6.32 58.34 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 -179.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.87 -7.04 57.19 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -77.06 147.6 36.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.854 0.359 . . . . 0.0 110.614 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.423 ' O ' HG12 ' A' ' 191' ' ' VAL . 2.4 p -112.58 126.67 55.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.133 0.492 . . . . 0.0 110.284 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.558 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.41 145.49 24.43 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.995 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.501 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.23 150.59 47.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.448 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -129.98 130.81 45.51 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.379 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.895 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.96 92.79 27.08 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.192 -179.716 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.684 ' C ' ' H ' ' A' ' 229' ' ' GLY . 43.3 Cg_exo -55.61 139.11 82.55 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.581 2.188 . . . . 0.0 111.676 178.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.55 -25.42 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.485 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.684 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.14 -50.2 29.42 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.547 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -53.58 -35.89 61.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.892 0.377 . . . . 0.0 110.132 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -67.57 36.65 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.715 179.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.547 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.16 86.33 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.813 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.1 p -79.02 -16.07 57.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.4 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -91.66 -40.67 11.16 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.622 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -66.22 -17.35 64.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.594 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.56 43.22 26.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.462 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.78 -146.17 6.87 Favored Glycine 0 CA--C 1.519 0.292 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -123.39 143.37 50.17 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.961 0.41 . . . . 0.0 110.262 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -151.86 149.32 28.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -100.25 -152.35 0.42 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.43 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.86 -91.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.693 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.466 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.4 tt -126.31 175.1 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.617 -179.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.466 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.4 mt -121.7 141.22 43.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.698 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.58 169.35 9.35 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.256 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.7 mt -147.73 151.02 35.38 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.204 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.91 -38.76 96.56 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 129.96 4.14 4.73 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -77.3 -58.34 3.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.98 0.419 . . . . 0.0 110.522 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.537 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.3 m-20 -62.04 -36.81 82.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.314 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.42 -67.63 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.746 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.43 -42.2 66.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.149 -179.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.13 17.99 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.641 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.82 48.58 0.27 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.48 -109.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.516 0.198 . . . . 0.0 110.787 -178.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.501 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.3 m120 -60.58 -45.52 93.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.528 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 85.18 7.9 82.51 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -99.04 -12.66 20.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.598 0.237 . . . . 0.0 110.658 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.4 t 176.23 142.88 0.07 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.067 0.46 . . . . 0.0 110.44 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.36 125.35 11.33 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.8 m-30 -98.29 143.14 29.09 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 120.873 0.368 . . . . 0.0 110.861 178.193 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.9 mt -94.35 106.75 18.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.762 -179.174 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.454 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.9 t80 -102.1 -12.63 17.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.173 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.36 89.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.88 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.74 173.19 45.86 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.493 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.6 m-20 -74.06 -112.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 0.0 110.74 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.81 -28.97 68.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.693 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.81 -43.95 90.69 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.261 -178.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.44 -44.52 94.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.304 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.36 -60.05 3.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.198 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.96 -43.47 60.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.211 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.26 -43.58 74.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.247 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.3 mt -64.57 -43.53 96.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.548 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -56.45 -37.65 70.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.2 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.14 1.02 19.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.218 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -115.03 91.41 26.83 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.078 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.05 -27.27 28.27 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.769 2.312 . . . . 0.0 111.984 179.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.533 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.51 -41.09 98.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.584 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.9 mp -95.52 5.02 52.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.4 -179.269 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.9 -34.89 69.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.647 179.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -80.12 4.85 16.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.494 -178.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.526 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -69.04 121.23 80.98 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.511 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -47.38 -37.58 25.39 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.513 2.142 . . . . 0.0 112.562 -179.53 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.6 -43.38 89.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.759 0.314 . . . . 0.0 110.372 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.09 -43.51 92.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.309 179.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -65.06 -40.72 95.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.349 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 44.4 t-20 -89.31 -12.99 39.0 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.59 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 62.19 31.64 17.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.912 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.53 44.29 1.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.157 0.503 . . . . 0.0 110.366 179.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.79 135.69 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.446 -179.701 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.93 132.25 56.75 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.457 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.493 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.3 88.71 6.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.756 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.7 mt -63.87 -41.39 97.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.454 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.52 165.66 33.26 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.524 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 77.5 p -75.56 -25.83 57.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.885 0.374 . . . . 0.0 110.791 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.0 tp10 -68.43 -33.71 74.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.483 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.77 HG22 ' O ' ' A' ' 296' ' ' THR . 97.2 m -73.06 21.54 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.696 -179.174 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.507 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 51.7 t80 -57.41 -51.02 71.1 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.413 HH12 ' HG3' ' A' ' 212' ' ' GLN . 70.4 mmt-85 -109.35 151.15 27.0 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 39.0 tp -115.57 125.13 52.59 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.934 0.397 . . . . 0.0 110.69 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.481 ' CB ' HD23 ' A' ' 83' ' ' LEU . 40.6 t0 -147.94 165.75 29.75 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.631 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -49.35 -37.95 26.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.499 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -70.8 -65.67 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.235 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.1 p -61.11 -33.04 72.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -53.44 -25.6 16.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.575 -179.08 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.1 mtt -63.7 -40.85 97.82 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 120.874 0.368 . . . . 0.0 111.035 179.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -78.08 -44.69 25.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.115 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.576 HG21 HG23 ' A' ' 296' ' ' THR . 75.1 t -66.11 -42.76 91.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.383 179.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.431 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 48.6 tp -59.62 -47.31 86.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.465 -178.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -70.32 -39.26 74.89 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.016 0.436 . . . . 0.0 110.729 179.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.493 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 72.5 ttt180 -61.66 -38.05 86.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.251 -178.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.0 mt -87.74 5.16 41.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.624 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.628 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.88 -11.59 13.42 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.016 0.436 . . . . 0.0 110.333 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.08 -37.07 85.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.486 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.78 -48.89 79.77 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.396 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 C--O 1.222 -0.365 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.002 179.836 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.612 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.05 -2.32 58.1 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.371 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.489 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.8 179.15 1.23 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.502 -179.682 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.79 144.98 99.65 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.851 2.367 . . . . 0.0 112.197 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.612 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.99 -179.32 8.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.562 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -115.94 136.77 52.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.327 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.23 146.99 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.369 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.5 p -120.02 135.97 54.73 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.734 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.39 -143.34 0.32 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.259 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.65 -37.04 85.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.536 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.42 -66.48 0.22 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.393 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.52 142.33 45.47 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.331 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.5 p -112.2 131.54 55.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.917 0.389 . . . . 0.0 110.459 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -119.38 128.98 54.57 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.546 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.8 m -85.57 130.15 34.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.191 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.494 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.3 mt -95.62 78.69 3.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.496 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.73 -31.74 72.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.596 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 175.97 109.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.983 0.42 . . . . 0.0 110.109 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.494 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.58 91.41 49.46 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-O 120.752 0.311 . . . . 0.0 110.381 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.647 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.59 148.42 64.2 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.797 2.331 . . . . 0.0 112.067 178.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -40.64 82.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.634 0.584 . . . . 0.0 110.963 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.647 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.51 66.92 0.89 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.222 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.21 130.56 36.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.819 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.565 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.7 t -122.49 146.69 27.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.016 -179.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 t -135.97 143.7 44.98 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.742 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.5 p -99.35 -59.28 1.75 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.564 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.3 p -79.35 155.09 28.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.583 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.53 HG21 HG23 ' A' ' 70' ' ' THR . 72.4 t -74.1 -21.84 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.548 179.322 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.3 m -60.28 -52.09 66.76 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.499 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.4 mt -66.26 -42.76 88.06 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.8 177.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.1 m -42.87 -54.18 4.3 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.968 -178.521 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.23 -37.17 71.48 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 178.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.6 m -62.84 -44.79 95.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.915 0.388 . . . . 0.0 110.16 -179.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.2 mt -66.48 -41.91 88.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.521 0.677 . . . . 0.0 110.701 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 tp -62.75 -40.46 97.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.401 -179.264 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.99 -35.93 76.08 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.158 -179.043 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.524 HD11 HD12 ' A' ' 156' ' ' LEU . 32.6 pt -91.15 28.92 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.176 -179.289 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.54 51.74 10.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.971 179.409 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.56 76.05 21.3 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.614 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.07 151.66 84.96 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.74 2.293 . . . . 0.0 112.032 -178.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.565 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.44 137.48 46.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.242 0.544 . . . . 0.0 110.237 179.706 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.442 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.3 pt -69.47 -43.54 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.307 179.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.13 131.35 53.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.947 0.403 . . . . 0.0 110.526 -178.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.536 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.7 p -155.86 168.65 26.53 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.462 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.42 -177.32 21.93 Favored Glycine 0 N--CA 1.464 0.513 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.631 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.17 171.99 13.27 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.088 0.47 . . . . 0.0 110.36 179.383 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.53 HG23 HG21 ' A' ' 51' ' ' VAL . 14.7 p -131.94 -113.48 0.23 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.981 0.419 . . . . 0.0 110.269 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.99 179.82 0.93 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.407 -179.148 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.5 Cg_exo -60.7 57.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 123.031 2.488 . . . . 0.0 112.18 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 58.8 t-20 -64.42 -33.64 76.33 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 119.081 -0.485 . . . . 0.0 110.345 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.6 m-20 94.03 -36.74 0.02 OUTLIER 'General case' 0 C--N 1.346 0.448 0 O-C-N 123.832 0.707 . . . . 0.0 109.806 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.406 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.5 mtp85 -62.51 -39.7 94.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.191 179.315 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.499 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.25 -25.48 19.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.762 179.374 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.52 -171.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.456 -179.201 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.05 -154.08 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.815 -179.599 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 38.2 p-10 -52.49 -7.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.769 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.1 mm-40 -86.32 115.0 23.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.674 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.02 69.92 1.35 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -143.45 147.72 35.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.971 0.415 . . . . 0.0 110.768 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.66 -98.29 0.07 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.185 178.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.25 -42.42 96.52 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.036 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.547 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.17 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.988 0.805 . . . . 0.0 110.996 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -102.86 -8.79 20.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.322 179.306 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.6 p -64.87 -33.82 76.92 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.132 0.492 . . . . 0.0 110.763 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.537 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.36 -23.4 1.45 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.682 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 73.4 t -70.02 -45.86 74.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.688 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.64 80.4 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.891 -179.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.36 -38.29 88.96 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.927 0.394 . . . . 0.0 110.509 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.64 -32.34 51.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.185 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.596 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.7 mmt-85 -90.3 1.95 56.0 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.622 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.55 -49.58 0.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.942 0.776 . . . . 0.0 110.223 179.181 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.646 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 82.0 mt -45.81 154.65 0.21 Allowed 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 117.451 -1.262 . . . . 0.0 109.441 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.646 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 120.8 92.6 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 O-C-N 125.676 1.86 . . . . 0.0 110.471 -178.532 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.536 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.57 143.25 42.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.238 0.542 . . . . 0.0 110.294 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.7 mt -132.42 27.1 4.44 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.976 -0.453 . . . . 0.0 110.391 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.25 137.77 34.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.065 0.46 . . . . 0.0 110.516 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.1 mt -137.01 165.01 28.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.331 179.581 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.2 -28.57 1.82 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -152.98 71.08 7.13 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 121.203 0.525 . . . . 0.0 110.262 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.17 145.54 98.27 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.803 2.335 . . . . 0.0 112.027 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.9 t -134.56 136.85 43.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.597 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.22 81.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.651 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.14 -42.38 96.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.518 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.99 -41.65 98.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.5 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.71 -43.23 97.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.05 179.486 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.17 -35.09 77.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.994 0.426 . . . . 0.0 110.146 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.7 -18.8 61.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.451 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.63 -6.48 58.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.529 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 63.1 mtp 47.22 56.22 17.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.613 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.34 149.9 63.9 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.763 2.309 . . . . 0.0 112.106 179.413 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.14 -74.25 0.62 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.454 179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.448 HD11 HD13 ' A' ' 140' ' ' LEU . 38.4 tp -110.2 113.33 25.93 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.372 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.4 mt -102.04 126.26 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 120.955 0.407 . . . . 0.0 110.661 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.1 mt -109.58 133.95 52.5 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.22 -179.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.85 139.63 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.496 -179.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.4 p -83.38 168.5 16.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.799 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.13 -37.52 80.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.443 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.79 159.16 42.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.012 0.434 . . . . 0.0 110.381 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.22 176.96 33.49 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.71 86.99 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -124.82 151.51 45.12 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.925 0.393 . . . . 0.0 110.508 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.3 t -63.26 140.81 58.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.333 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.62 10.37 11.04 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.676 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.52 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -60.83 -38.87 86.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.258 -179.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.67 23.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.562 0.696 . . . . 0.0 110.613 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.9 mt -71.11 -35.44 71.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.587 0.708 . . . . 0.0 110.631 179.359 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -42.81 -62.84 0.9 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.353 -178.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.9 p-10 -65.85 -42.84 89.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.7 mt-30 -61.99 -32.54 73.01 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.493 0.495 . . . . 0.0 110.427 -179.594 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.7 mt -73.91 -40.95 62.79 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.803 178.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.13 -48.86 78.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.153 -178.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.5 m -53.31 -42.38 66.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.036 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.12 -42.61 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.943 0.401 . . . . 0.0 111.199 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.64 154.24 5.39 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.665 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -39.48 106.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.622 2.215 . . . . 0.0 112.589 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.641 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.4 m -110.08 121.4 45.18 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.115 0.483 . . . . 0.0 110.264 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.99 152.84 30.32 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.2 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.91 131.55 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.353 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.402 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.8 mt -115.31 128.02 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.488 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.6 t30 -101.6 103.92 14.77 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.206 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.2 p90 -101.38 -11.18 19.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.823 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.5 p-10 -64.83 -33.5 76.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.704 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -98.45 7.59 45.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.531 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.31 155.45 50.58 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.467 -179.418 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.6 p -75.05 165.68 24.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.695 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.589 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -59.85 -48.85 80.01 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.166 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -53.5 -42.05 66.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.929 0.395 . . . . 0.0 110.132 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.1 t -62.73 -41.05 98.98 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.36 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.402 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.9 tp -60.5 -44.54 95.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.374 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.8 tp -61.34 -43.33 99.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.235 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.6 m -55.02 -44.94 75.03 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.34 -40.67 97.14 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 120.928 0.394 . . . . 0.0 110.488 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.524 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -62.02 -42.45 99.18 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.418 178.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.24 -40.86 94.94 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.68 -45.92 64.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.894 0.378 . . . . 0.0 110.781 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.78 -43.99 96.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.798 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.7 p -93.13 -8.7 41.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.581 -178.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.88 26.64 72.28 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -101.75 50.85 0.84 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 110.65 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -69.55 -39.75 77.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.591 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.16 -47.26 85.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.3 -179.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -60.22 -39.3 86.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.136 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.07 -40.87 98.96 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 121.064 0.459 . . . . 0.0 110.279 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.02 -28.31 70.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.685 179.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.35 -54.35 7.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.894 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.506 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.51 -42.17 92.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.366 -179.8 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.3 mt -62.4 -43.83 98.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.481 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.3 -58.32 8.15 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.026 0.441 . . . . 0.0 110.216 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -57.28 -33.1 67.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.689 -179.03 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.415 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.7 t80 -81.53 -36.71 28.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.676 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.1 m-20 -55.92 -41.99 75.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.933 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.49 -42.24 99.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.911 0.386 . . . . 0.0 110.774 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.28 -37.94 88.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.279 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.415 HD11 ' CD2' ' A' ' 173' ' ' PHE . 82.0 mt -62.37 -42.19 99.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.791 179.476 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.15 -52.91 61.93 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.169 0.509 . . . . 0.0 110.628 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.1 -41.81 90.11 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.75 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.99 95.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.652 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.26 -32.07 73.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.429 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.62 -22.38 18.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.679 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.634 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.79 -41.38 95.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.67 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 184' ' ' ILE . 33.0 pt -76.93 136.53 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.72 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.1 108.09 10.6 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.245 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.63 126.01 0.31 Allowed Pre-proline 0 C--O 1.241 0.611 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.562 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.451 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.94 152.46 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.823 2.349 . . . . 0.0 112.596 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.35 142.15 53.85 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.541 2.161 . . . . 0.0 112.428 179.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.38 147.32 2.13 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.573 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.19 154.82 69.38 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.81 2.34 . . . . 0.0 112.392 178.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.52 163.29 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.185 0.517 . . . . 0.0 110.484 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.62 170.34 16.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.955 179.457 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.2 137.44 22.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.946 0.403 . . . . 0.0 110.105 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.569 HG22 HD12 ' A' ' 205' ' ' LEU . 38.4 pt -134.14 146.51 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.726 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -132.71 131.77 59.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.257 0.551 . . . . 0.0 110.502 178.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -153.01 156.68 39.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.476 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.594 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.3 m -121.98 122.86 40.3 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.915 0.388 . . . . 0.0 110.358 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.517 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -61.06 -26.17 67.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.69 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.594 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.56 -49.25 22.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.872 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -77.42 -9.95 59.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.409 -179.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.9 m80 45.91 47.58 12.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.512 -179.635 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.2 t -130.76 143.0 50.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.968 0.413 . . . . 0.0 110.32 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.448 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -108.44 105.62 15.36 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.162 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.7 m-20 -116.39 129.2 56.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.159 0.504 . . . . 0.0 110.321 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.569 HD12 HG22 ' A' ' 194' ' ' ILE . 7.6 tt -111.92 146.46 37.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.806 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.472 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.5 t90 -99.61 128.73 45.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.207 0.527 . . . . 0.0 109.891 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.52 153.94 40.24 Favored Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.379 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.67 -17.74 47.95 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.682 2.254 . . . . 0.0 112.049 178.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -49.75 -18.89 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.342 -179.091 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.45 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.4 p -75.44 164.6 26.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.495 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.92 -27.88 65.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.496 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.574 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.7 mt-30 -63.73 -41.39 98.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.609 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.32 -44.45 97.52 Favored Glycine 0 C--N 1.332 0.337 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.49 -38.84 92.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 122.119 -0.636 . . . . 0.0 110.796 179.576 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.3 mmm -61.84 -41.27 97.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.279 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.3 mt -63.53 -47.63 80.84 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.055 0.455 . . . . 0.0 110.386 179.221 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.63 -32.07 49.87 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.872 0.368 . . . . 0.0 110.405 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -70.96 -17.91 62.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.473 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.431 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.7 mt -88.4 -9.14 53.62 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.575 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.1 2.37 54.65 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -88.72 153.0 21.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 110.453 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.457 ' O ' HG12 ' A' ' 191' ' ' VAL . 9.2 p -115.86 128.44 55.81 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.149 0.499 . . . . 0.0 110.355 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.09 146.74 23.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.915 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.459 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.42 151.17 45.46 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.413 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.9 131.73 42.98 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.432 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.881 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.52 93.33 27.05 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.002 -179.453 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.684 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.2 Cg_exo -55.0 138.66 78.88 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.604 2.203 . . . . 0.0 111.71 178.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.38 -25.51 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.508 -179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.684 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.64 -49.93 27.79 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.1 mt -55.15 -37.05 66.47 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.034 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -65.66 35.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.816 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.573 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.45 88.34 0.01 OUTLIER 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 85.1 p -81.82 -13.65 57.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.297 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.73 -40.84 11.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.6 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 29.3 t -66.64 -17.03 64.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.591 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.8 43.86 27.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.444 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.93 -148.74 8.14 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.65 142.03 48.81 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.963 0.411 . . . . 0.0 110.288 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.416 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.3 ttt-85 -152.03 149.51 28.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.241 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -102.38 -149.86 0.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.307 179.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.41 -92.91 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.636 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.4 tt -126.68 174.43 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.56 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.435 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 88.2 mt -122.31 141.27 43.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.839 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -99.48 170.6 8.5 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.19 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 67.1 mt -146.71 149.61 33.77 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.12 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.26 -39.35 97.76 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.01 3.22 4.05 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -78.64 -57.46 3.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.949 0.404 . . . . 0.0 110.482 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.608 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.8 m-20 -62.14 -36.91 83.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.163 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.448 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.7 mp -52.88 -67.46 0.25 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.985 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.8 -42.49 68.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.094 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.67 17.45 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.666 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.15 48.33 0.29 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.1 mp 38.97 -109.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.505 0.193 . . . . 0.0 110.769 -178.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.459 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -60.79 -44.71 96.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.349 -179.572 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.46 8.07 83.77 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -98.8 -13.64 20.05 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 122.685 -0.303 . . . . 0.0 110.661 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.0 t 177.25 142.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.072 0.463 . . . . 0.0 110.445 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -147.98 125.45 11.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.14 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.55 143.84 28.53 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 120.902 0.382 . . . . 0.0 110.922 178.133 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.8 mt -95.24 106.38 18.41 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.73 -179.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.45 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.5 t80 -102.31 -11.4 18.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.114 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.61 -40.64 84.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.815 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.27 172.68 45.54 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.453 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 90.8 m-20 -73.72 -113.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.846 0.355 . . . . 0.0 110.794 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.35 -28.99 68.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.7 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.04 -43.71 91.68 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.251 -178.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -63.43 -44.48 94.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.31 179.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.6 -59.88 3.93 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.136 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.94 -43.55 60.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.233 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.32 -43.34 74.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.23 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.2 mt -64.68 -43.61 96.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.634 179.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -55.97 -37.75 69.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.135 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.5 1.03 17.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.241 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -114.93 91.11 25.16 Favored Pre-proline 0 N--CA 1.464 0.256 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.161 -179.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.96 -27.3 27.81 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.764 2.309 . . . . 0.0 112.02 179.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.536 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.69 -40.93 98.01 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.545 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.25 5.39 51.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.327 -179.187 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.36 -35.04 68.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.527 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -79.72 4.49 16.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.472 -178.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.62 121.1 79.76 Favored Pre-proline 0 N--CA 1.442 -0.868 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.566 -179.983 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.27 -37.74 24.87 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.503 2.135 . . . . 0.0 112.643 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.89 -43.84 91.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.803 0.335 . . . . 0.0 110.398 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.98 -43.48 92.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.356 179.345 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.07 -40.57 94.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.382 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.443 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 47.9 t-20 -89.73 -12.59 38.94 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.501 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.6 mtmt 62.12 32.31 17.49 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.395 0.435 . . . . 0.0 110.992 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -89.04 43.69 1.16 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.126 0.489 . . . . 0.0 110.334 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.23 135.82 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.488 -179.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -116.87 132.44 56.7 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.469 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.19 88.93 7.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.709 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.88 -41.05 97.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.869 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.45 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.75 165.55 33.58 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 72.1 p -75.38 -25.75 57.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 110.824 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.2 tp10 -68.26 -33.94 75.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.414 -179.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 296' ' ' THR . 96.7 m -73.37 24.33 0.07 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.698 -179.026 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.574 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 43.0 t80 -58.28 -50.93 71.84 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.22 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.416 HH12 ' HG3' ' A' ' 212' ' ' GLN . 77.4 mmt-85 -110.4 152.9 25.71 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.085 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.431 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.1 tp -115.53 125.11 52.6 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 120.893 0.377 . . . . 0.0 110.723 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.49 ' CB ' HD23 ' A' ' 83' ' ' LEU . 40.9 t0 -148.04 165.76 29.81 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.652 179.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -49.32 -37.74 25.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.642 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -71.35 -65.6 0.73 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.487 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.88 -32.99 72.41 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.041 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.25 -25.49 23.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.703 -179.104 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.4 mtt -63.57 -40.8 97.91 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 120.892 0.377 . . . . 0.0 111.097 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.63 -44.27 24.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.188 179.524 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.581 HG21 HG23 ' A' ' 296' ' ' THR . 79.2 t -66.23 -42.82 91.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.308 179.645 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 51.0 tp -60.19 -47.11 87.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.464 -178.512 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -69.96 -39.24 76.13 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.593 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.5 ttt180 -61.89 -38.18 87.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.235 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.6 mt -87.26 4.67 41.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.625 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.634 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.9 -10.95 13.49 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.046 0.451 . . . . 0.0 110.221 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.29 86.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.432 179.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.81 -48.82 80.06 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.41 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.029 179.915 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.3 -2.46 58.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.43 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.493 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.73 179.05 1.25 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.537 -179.682 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.493 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.8 Cg_exo -60.75 144.93 99.63 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.806 2.337 . . . . 0.0 112.203 179.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.95 -179.53 8.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.635 -179.74 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.81 136.84 52.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.389 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.44 147.07 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.418 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 79.2 p -120.03 136.07 54.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.733 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.47 -143.34 0.33 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.266 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -63.67 -37.19 86.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.472 179.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.25 -66.53 0.22 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.416 179.637 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.43 142.22 45.36 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.0 p -112.17 131.53 55.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.949 0.404 . . . . 0.0 110.485 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -119.23 129.05 54.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.588 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.9 m -85.46 130.19 34.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.307 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.471 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.5 mt -95.51 78.75 3.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.373 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.73 -31.9 73.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.579 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 t 175.65 109.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.984 0.421 . . . . 0.0 110.119 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.471 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.35 91.81 49.12 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.416 -179.685 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.7 Cg_exo -56.68 148.35 65.63 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.826 2.35 . . . . 0.0 111.956 178.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.4 82.66 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.526 0.516 . . . . 0.0 110.961 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.6 mtm180 -151.41 66.87 0.89 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.062 0.458 . . . . 0.0 110.263 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.38 130.69 35.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.77 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.568 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.5 t -122.6 147.01 26.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.151 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.8 t -136.27 143.83 44.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.025 0.441 . . . . 0.0 110.639 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.4 ' OG1' ' N ' ' A' ' 50' ' ' SER . 26.1 p -99.53 -59.65 1.68 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.62 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.4 ' N ' ' OG1' ' A' ' 49' ' ' THR . 87.3 p -78.91 155.25 29.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.675 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.515 HG21 HG23 ' A' ' 70' ' ' THR . 73.8 t -74.42 -21.8 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.546 179.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.8 m -60.11 -52.28 66.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.506 -178.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.4 -42.59 87.62 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.723 177.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.0 m -42.91 -54.17 4.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.035 -178.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.31 -37.18 70.78 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.5 m -62.85 -44.69 95.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.906 0.384 . . . . 0.0 110.336 -179.358 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.407 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.9 mt -66.35 -41.84 88.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.426 0.632 . . . . 0.0 110.781 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.59 -40.44 96.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.333 -179.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.512 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.17 -35.76 76.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.185 -178.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.524 HD11 HD12 ' A' ' 156' ' ' LEU . 32.6 pt -91.27 28.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.237 -179.24 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.53 51.76 10.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.009 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.17 75.53 23.32 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.996 0.427 . . . . 0.0 109.995 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.36 150.98 87.27 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.794 2.329 . . . . 0.0 112.121 -178.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.17 137.27 46.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 CA-C-O 121.13 0.49 . . . . 0.0 110.356 179.814 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.445 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.0 pt -69.52 -43.49 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.219 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.06 131.25 53.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.522 -178.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.7 p -155.67 168.72 26.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.547 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.89 -177.21 21.62 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.636 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.33 172.55 12.54 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 121.043 0.449 . . . . 0.0 110.439 179.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.515 HG23 HG21 ' A' ' 51' ' ' VAL . 13.4 p -132.76 -112.43 0.23 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.991 0.424 . . . . 0.0 110.396 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.31 179.66 0.95 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.427 -179.185 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.3 Cg_exo -60.9 58.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.977 2.452 . . . . 0.0 112.07 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.572 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.0 t-20 -64.52 -33.84 76.83 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.438 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.3 m-20 93.92 -36.74 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.736 0.648 . . . . 0.0 109.926 -179.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.401 ' HD3' HD21 ' A' ' 73' ' ' ASN . 76.9 mtp85 -62.61 -39.58 94.24 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.256 179.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.499 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.9 p -74.55 -25.44 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.606 179.467 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.41 -171.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.449 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -74.03 -153.65 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.805 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 37.9 p-10 -52.82 -7.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.675 -179.405 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.5 114.8 23.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.623 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.03 70.0 1.35 Allowed Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -143.31 147.36 34.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.917 0.389 . . . . 0.0 110.769 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.33 -98.44 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.12 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.563 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.11 -42.81 96.74 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.123 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.563 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.55 53.0 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.771 0.669 . . . . 0.0 110.856 178.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -102.92 -9.63 19.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.407 179.239 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.4 p -64.05 -34.11 77.28 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.047 0.451 . . . . 0.0 110.683 -179.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.541 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.96 -23.38 1.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.668 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.1 t -70.12 -45.72 75.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.713 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.58 80.65 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.048 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.37 -38.26 88.86 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.431 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.66 -32.65 52.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.166 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.62 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.8 mmt-85 -89.91 1.5 56.16 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.587 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.94 -49.19 0.16 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.761 0.663 . . . . 0.0 110.213 179.122 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.682 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.6 mt -46.05 154.08 0.27 Allowed 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.69 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.682 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.6 tt0 121.26 92.57 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 125.115 1.509 . . . . 0.0 110.445 -178.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.65 143.35 42.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.0 110.337 179.345 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.8 mt -132.41 27.25 4.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.879 0.371 . . . . 0.0 110.426 -179.37 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.31 137.86 34.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.636 HD12 ' O ' ' A' ' 69' ' ' ALA . 91.7 mt -137.16 165.13 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.369 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.62 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.16 -28.76 1.82 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -153.0 70.93 7.11 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.124 0.488 . . . . 0.0 110.333 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.96 145.41 98.4 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.792 2.328 . . . . 0.0 112.058 -179.494 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.0 t -134.37 136.96 43.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.573 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.28 82.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.576 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.02 -42.34 97.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.569 -179.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.88 -41.65 98.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.55 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -63.7 -43.32 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.107 179.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.91 -35.18 77.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.274 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.78 -18.68 60.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.42 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.65 -6.78 58.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.538 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 68.6 mtp 47.48 56.25 17.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.648 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.28 149.44 63.57 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.759 2.306 . . . . 0.0 112.064 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.09 -73.5 0.64 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.529 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.417 HD11 HD13 ' A' ' 140' ' ' LEU . 38.6 tp -111.01 113.57 26.21 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.271 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.0 mt -102.16 126.63 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.6 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.7 mt -109.84 133.91 52.63 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.278 -179.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.99 139.98 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.522 -179.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.1 p -83.68 168.62 16.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.71 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.25 -37.41 80.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.472 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.98 158.86 43.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.453 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -155.94 177.07 33.21 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.22 -33.71 86.83 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.84 151.4 45.3 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.891 0.376 . . . . 0.0 110.54 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -63.29 140.93 58.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.326 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.78 10.64 10.99 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.647 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.517 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -60.97 -38.89 87.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.168 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.639 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.2 -35.75 23.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.375 0.607 . . . . 0.0 110.538 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.3 mt -71.0 -35.21 71.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.41 0.624 . . . . 0.0 110.697 179.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -42.8 -63.03 0.85 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.319 -178.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.639 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.2 p-10 -65.67 -42.85 90.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.091 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.545 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -61.91 -32.62 73.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.314 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.5 mt -73.95 -40.79 62.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 178.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -57.99 -49.23 77.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.169 -179.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 75.2 m -52.46 -42.67 64.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.263 179.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.3 -42.87 91.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 111.022 179.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.4 153.48 5.3 Favored Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.676 -179.336 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -39.41 107.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.675 2.25 . . . . 0.0 112.435 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.646 ' C ' HD12 ' A' ' 140' ' ' LEU . 97.2 m -109.61 121.68 45.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.074 0.464 . . . . 0.0 110.258 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.646 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.05 152.55 30.84 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.299 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -128.87 131.24 68.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.474 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.408 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.8 mt -114.99 128.01 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.527 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.8 t30 -101.82 103.87 14.6 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.2 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.6 p90 -101.51 -10.85 19.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.888 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.77 -33.24 75.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.704 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.6 p-10 -98.8 8.05 45.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.583 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.442 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.8 mttm -135.87 155.56 50.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.534 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.4 p -75.08 165.93 24.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.69 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.596 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 91.3 t90 -60.01 -48.65 80.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.278 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.36 -42.41 66.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.116 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.8 t -62.84 -41.11 99.21 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.348 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.408 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.8 tp -60.5 -44.45 95.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.317 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.9 tp -61.26 -43.74 98.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.205 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 m -54.7 -45.22 73.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.708 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.14 -40.93 97.61 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.878 0.37 . . . . 0.0 110.455 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.524 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.68 -42.4 98.87 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.206 179.117 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.16 -40.6 95.0 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.508 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.75 -46.01 63.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.874 0.369 . . . . 0.0 110.847 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.74 -43.92 96.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.735 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -93.18 -8.66 41.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.632 -179.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.01 26.58 72.37 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.66 50.72 0.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 110.708 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -69.64 -39.47 77.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.584 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.45 -47.3 86.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.357 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -59.82 -39.56 85.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.317 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.88 -40.99 99.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.297 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.1 -28.66 70.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.601 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.29 -54.51 7.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.873 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.512 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.0 -42.43 94.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.533 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.454 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.1 mt -62.33 -43.91 98.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.53 -179.508 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.19 -60.8 3.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.967 0.413 . . . . 0.0 110.415 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.9 -34.0 62.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.619 -179.183 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -81.1 -35.84 31.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.762 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.7 m-20 -55.28 -41.95 72.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.124 -178.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.47 -42.04 99.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.643 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.04 -38.27 90.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.363 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.8 mt -62.36 -42.1 99.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.672 179.404 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.06 -53.27 57.84 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.068 0.461 . . . . 0.0 110.682 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.22 -41.85 89.53 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.635 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.0 95.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.615 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.42 -31.56 72.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.434 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -95.03 -22.68 17.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.611 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.666 ' NE2' ' HZ2' ' A' ' 312' ' ' LYS . 51.7 tt0 -64.85 -41.42 95.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.582 -179.55 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.2 pt -76.22 135.99 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.719 -179.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -126.1 108.1 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.292 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.6 pp -177.3 125.2 0.28 Allowed Pre-proline 0 C--O 1.239 0.502 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.497 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.5 Cg_exo -44.03 152.47 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.898 2.399 . . . . 0.0 112.429 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.8 141.73 55.2 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.622 2.215 . . . . 0.0 112.352 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.46 147.25 2.08 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.511 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.9 154.38 71.04 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.856 2.371 . . . . 0.0 112.328 178.661 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.581 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.14 162.91 30.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.134 0.492 . . . . 0.0 110.449 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.581 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -144.03 170.72 15.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.999 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.61 137.73 21.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.938 0.399 . . . . 0.0 110.245 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.565 HG22 HD12 ' A' ' 205' ' ' LEU . 39.5 pt -134.44 147.16 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.726 179.69 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -132.89 131.73 59.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 110.467 178.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -152.32 155.37 37.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.379 179.316 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.619 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.4 m -122.82 122.93 39.87 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.972 0.415 . . . . 0.0 110.425 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.79 -25.55 66.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.571 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.619 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.23 -48.88 21.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.925 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.81 -11.77 60.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.516 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 77.8 m80 49.4 41.63 21.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.582 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.8 t -136.29 144.76 44.92 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.408 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.431 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -110.96 114.47 27.81 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.393 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -119.9 133.56 55.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 0.0 110.347 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.565 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.27 146.91 37.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.771 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.544 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.6 t90 -100.42 131.14 46.5 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.196 0.522 . . . . 0.0 109.965 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.66 153.94 39.29 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.244 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.406 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.9 Cg_endo -67.87 -17.99 46.93 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.736 2.29 . . . . 0.0 111.985 178.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.19 -18.69 0.37 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.388 -179.148 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.544 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 84.1 p -75.5 164.66 26.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.518 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.11 -27.92 66.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.473 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.589 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.5 mt-30 -64.03 -41.22 97.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.605 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.24 -45.06 96.77 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.9 mt-30 -64.83 -38.86 92.4 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 122.438 -0.448 . . . . 0.0 110.731 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.596 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 88.1 mmm -62.03 -41.71 98.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.262 179.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.432 HD23 HD12 ' A' ' 219' ' ' LEU . 45.5 mt -63.43 -46.87 84.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.019 0.438 . . . . 0.0 110.325 179.488 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.94 -31.56 60.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.346 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -70.16 -17.52 63.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.496 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.453 HD11 ' CD2' ' A' ' 299' ' ' LEU . 88.4 mt -88.54 -9.34 52.68 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.576 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.58 1.78 50.01 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -88.46 154.42 20.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.843 0.354 . . . . 0.0 110.567 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.44 ' O ' HG12 ' A' ' 191' ' ' VAL . 6.2 p -116.35 128.7 55.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.132 0.492 . . . . 0.0 110.387 179.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.588 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.5 mm? -91.76 146.14 24.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.999 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.478 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -70.52 151.88 44.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.405 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.36 131.53 41.98 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.571 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.892 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.45 93.45 27.24 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.238 -179.815 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.678 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.9 Cg_exo -55.22 139.14 80.74 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.604 2.203 . . . . 0.0 111.758 178.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 62.0 -26.32 0.05 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.427 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.24 -50.3 28.27 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -53.65 -37.19 62.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.176 -179.385 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -66.77 36.09 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.709 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.02 88.32 0.01 OUTLIER 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.932 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 79.5 p -81.21 -14.18 57.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.36 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.9 -41.29 10.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.565 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -66.84 -16.98 64.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.633 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 55.72 43.68 27.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.539 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.5 -148.62 7.91 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.88 142.59 49.54 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.956 0.408 . . . . 0.0 110.382 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.416 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.0 ttt-85 -151.91 149.44 28.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.352 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -101.22 -151.49 0.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.316 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.75 -92.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.655 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.463 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.6 tt -126.58 175.18 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.532 -179.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.463 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -122.79 141.91 41.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.809 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.65 169.32 9.36 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.279 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 59.7 mt -147.96 150.97 35.0 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.176 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.91 -38.99 96.89 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.41 4.12 4.52 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -77.43 -58.25 3.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.485 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.551 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.0 m-20 -61.85 -36.89 82.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.518 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.431 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.1 mp -52.35 -67.86 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.635 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.36 -42.32 66.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.159 -179.515 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.04 17.56 0.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.635 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.71 49.13 0.27 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.5 mp 38.23 -109.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.565 0.222 . . . . 0.0 110.67 -178.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.478 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.9 m120 -60.37 -45.24 94.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.635 -179.742 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.55 7.87 83.89 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.338 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.95 -13.24 20.05 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.669 -0.312 . . . . 0.0 110.743 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.2 t 176.87 142.61 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.97 0.414 . . . . 0.0 110.465 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.2 125.09 11.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.094 179.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -98.27 143.34 28.86 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.841 0.353 . . . . 0.0 110.758 178.276 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.7 mt -94.91 106.78 18.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.807 -179.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.441 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.1 t80 -101.98 -12.52 18.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.209 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.07 -40.95 91.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.857 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.5 173.03 45.82 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.474 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 93.5 m-20 -73.7 -112.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.678 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -68.2 -28.83 67.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.614 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.96 -43.95 91.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.278 -178.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.39 -44.66 94.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.371 179.171 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.47 -60.16 3.57 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.378 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.83 -43.68 59.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.21 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.28 -43.38 74.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.205 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.75 -43.67 96.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.563 179.587 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -56.1 -37.51 69.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.182 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.23 0.84 17.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.238 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -115.17 91.13 26.37 Favored Pre-proline 0 N--CA 1.46 0.073 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.25 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.98 -27.07 27.11 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.847 2.365 . . . . 0.0 111.959 179.267 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.536 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.52 -40.94 98.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.513 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.1 mp -95.2 5.49 51.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.443 -179.143 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.19 -34.59 68.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.631 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -79.97 4.5 16.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.569 -178.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.96 121.1 80.4 Favored Pre-proline 0 N--CA 1.446 -0.645 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.462 -179.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -47.29 -37.65 24.83 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.463 2.108 . . . . 0.0 112.499 -179.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.53 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -59.06 -43.96 91.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.769 0.318 . . . . 0.0 110.446 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.08 -43.54 92.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.358 179.281 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.44 -40.99 96.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.428 -179.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -90.27 -11.54 40.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.69 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.62 32.8 18.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.965 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -89.0 43.85 1.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.096 0.474 . . . . 0.0 110.366 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.52 135.82 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.451 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -116.73 132.55 56.66 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.387 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.501 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.06 89.17 7.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.732 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.409 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.3 mt -63.9 -40.88 97.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.441 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.03 165.27 33.67 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.51 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 74.4 p -75.43 -25.72 57.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.878 0.37 . . . . 0.0 110.679 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.5 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.8 tp10 -68.53 -33.7 74.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.454 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 296' ' ' THR . 95.8 m -73.59 24.96 0.07 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.74 -179.148 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.589 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 40.2 t80 -58.32 -50.72 72.62 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.387 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.416 ' CZ ' ' CE2' ' A' ' 297' ' ' PHE . 79.3 mmt-85 -111.03 153.95 24.88 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.453 ' CD2' HD11 ' A' ' 219' ' ' LEU . 46.3 tp -115.77 125.17 52.4 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.757 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.486 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.5 t0 -147.93 165.68 29.94 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.656 179.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.26 -37.94 25.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.641 -179.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -71.36 -65.58 0.73 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.403 -179.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.84 -32.85 72.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.269 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.19 -25.58 23.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.797 -179.057 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.6 mtt -63.54 -40.91 98.24 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.05 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.0 -43.93 23.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.979 179.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.576 HG21 HG23 ' A' ' 296' ' ' THR . 79.8 t -66.35 -42.76 91.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.403 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.436 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.3 tp -60.17 -47.06 87.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.48 -178.737 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -70.07 -39.32 75.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.958 0.408 . . . . 0.0 110.584 179.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.501 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.7 ttt180 -61.87 -38.43 88.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.232 -178.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.09 4.49 41.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.622 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.666 ' HZ2' ' NE2' ' A' ' 183' ' ' GLN . 87.2 tttt -112.67 -11.2 13.57 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.103 0.478 . . . . 0.0 110.435 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.21 -37.28 86.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.51 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.68 -48.83 80.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.363 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.221 -0.405 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.069 179.769 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -90.11 -2.54 58.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.44 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.5 179.16 1.23 Allowed Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.49 -179.66 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.4 Cg_exo -60.72 145.07 99.52 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.84 2.36 . . . . 0.0 112.142 179.611 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.613 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.25 -179.44 8.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.631 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -116.19 136.95 52.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.362 179.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -124.05 147.17 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.402 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.4 p -120.18 136.05 54.76 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.062 0.458 . . . . 0.0 110.78 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 51.9 p30 -99.21 -143.8 0.32 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.244 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.52 -37.04 85.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.522 179.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.481 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.76 -67.69 0.23 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.422 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.12 142.71 44.21 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.2 p -112.51 131.22 55.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.895 0.378 . . . . 0.0 110.418 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -118.6 129.2 55.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.559 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.8 m -85.67 130.58 34.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.247 -179.808 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.475 HD22 ' OE1' ' A' ' 42' ' ' GLN . 70.0 mt -96.69 78.76 2.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 110.433 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.84 -31.68 72.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.603 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t 176.51 107.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 110.089 -179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.475 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -121.13 91.32 47.95 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.42 -179.719 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.655 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.6 Cg_exo -56.73 148.54 64.95 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.801 2.334 . . . . 0.0 111.953 178.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.61 82.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.627 0.579 . . . . 0.0 110.951 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.655 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.41 66.85 0.89 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.071 0.462 . . . . 0.0 110.192 -179.465 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -76.83 130.98 35.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.803 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.571 ' HA ' HG23 ' A' ' 64' ' ' VAL . 58.9 t -122.63 147.33 26.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.028 -179.702 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.7 t -136.4 144.11 44.33 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.745 179.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 50' ' ' SER . 17.5 p -100.03 -59.04 1.78 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.549 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.415 ' N ' ' OG1' ' A' ' 49' ' ' THR . 87.3 p -79.2 155.07 28.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.612 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.523 HG21 HG23 ' A' ' 70' ' ' THR . 72.0 t -74.11 -21.83 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.472 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.2 m -60.31 -51.93 67.43 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.478 -178.433 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -66.4 -42.75 87.41 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.759 177.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.9 m -42.99 -54.07 4.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.911 -178.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.08 -37.46 73.0 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 178.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.5 m -62.89 -44.26 96.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.886 0.374 . . . . 0.0 110.164 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 17.5 mt -66.14 -42.21 89.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.544 0.687 . . . . 0.0 110.639 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.97 -39.78 95.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.379 -179.122 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.528 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.49 -35.81 76.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.231 -179.078 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.492 HD11 HD12 ' A' ' 156' ' ' LEU . 33.6 pt -91.5 27.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.317 -179.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.82 51.95 10.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.053 179.554 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.34 76.19 26.41 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 121.021 0.438 . . . . 0.0 109.839 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.24 149.63 89.88 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.8 2.333 . . . . 0.0 112.09 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.571 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.4 136.66 47.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 CA-C-O 121.127 0.489 . . . . 0.0 110.34 179.696 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.8 pt -69.57 -43.45 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.358 179.317 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.49 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.35 131.35 53.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.032 0.444 . . . . 0.0 110.601 -179.008 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.536 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.4 p -155.94 168.68 26.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.47 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.32 -177.35 21.99 Favored Glycine 0 N--CA 1.463 0.456 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.639 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.35 172.07 13.19 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 121.04 0.448 . . . . 0.0 110.452 179.355 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.523 HG23 HG21 ' A' ' 51' ' ' VAL . 14.0 p -133.25 -111.39 0.23 Allowed 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.018 0.437 . . . . 0.0 110.453 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.94 179.62 0.94 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.44 -179.195 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.8 Cg_exo -60.89 58.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.926 2.418 . . . . 0.0 112.156 179.518 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.8 t-20 -64.42 -34.19 77.6 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.361 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 45.1 m-20 94.76 -37.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.824 0.703 . . . . 0.0 109.814 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HD3' HD21 ' A' ' 73' ' ' ASN . 77.3 mtp85 -62.76 -40.22 96.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.218 179.217 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.3 p -74.08 -25.98 20.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.758 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.84 -172.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.433 -179.219 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.8 p30 -73.87 -152.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.777 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.3 p-10 -54.36 -6.66 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.759 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -87.48 114.14 23.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.629 179.731 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.52 72.14 1.3 Allowed Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.2 m-85 -143.54 148.27 35.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.874 0.369 . . . . 0.0 110.899 179.236 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.96 -98.81 0.07 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.026 178.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.555 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.94 -43.26 96.39 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.177 179.291 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.555 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.8 tt0 91.66 52.55 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.913 0.758 . . . . 0.0 111.052 179.176 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -103.49 -8.63 19.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.335 179.267 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.465 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.3 p -65.33 -33.38 75.84 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.063 0.459 . . . . 0.0 110.672 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.552 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.12 -24.18 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.695 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.2 t -69.86 -45.93 75.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.765 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.14 -48.77 80.06 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.043 -179.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.48 -38.32 89.4 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.454 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.72 -32.62 52.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.136 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.607 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 83.7 mmt-85 -90.1 1.8 55.98 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.538 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.94 -49.79 0.16 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.865 0.728 . . . . 0.0 110.235 179.176 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.66 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.4 mt -45.54 153.75 0.23 Allowed 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 117.673 -1.156 . . . . 0.0 109.561 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.66 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.8 tt0 121.05 92.27 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 O-C-N 125.444 1.715 . . . . 0.0 110.456 -178.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.536 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.9 mtp180 -75.02 142.77 43.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.219 0.533 . . . . 0.0 110.262 179.34 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 mt -131.81 26.59 4.65 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.04 -0.413 . . . . 0.0 110.415 -179.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -139.97 137.27 34.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.045 0.45 . . . . 0.0 110.531 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.639 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.1 mt -136.72 164.89 29.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.361 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.614 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.22 -28.48 1.82 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.76 70.5 7.24 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.108 0.48 . . . . 0.0 110.259 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.1 145.32 98.72 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 122.768 2.312 . . . . 0.0 112.123 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.9 t -134.08 136.68 44.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.556 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.62 -38.54 84.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.665 179.652 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.35 -41.98 96.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.48 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.65 98.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.473 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.53 -43.22 98.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.077 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.01 -35.12 77.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.223 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.69 -18.69 60.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.401 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.66 -6.51 58.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.5 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.411 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.8 mtp 47.61 55.99 17.18 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.594 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.1 Cg_endo -70.28 149.82 64.17 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.767 2.312 . . . . 0.0 112.126 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -101.9 -72.77 0.67 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.452 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.7 tp -111.67 114.19 27.05 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.388 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.3 mt -103.36 126.91 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 120.964 0.411 . . . . 0.0 110.608 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.0 mt -110.63 134.21 52.63 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.214 -179.401 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.86 140.12 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.572 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.0 p -83.48 168.25 16.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.788 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.5 -37.13 80.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.47 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 t -139.49 158.35 44.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.466 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.15 176.88 33.46 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.31 -34.0 87.87 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -179.541 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.82 151.52 45.11 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.91 0.386 . . . . 0.0 110.552 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.8 t -63.23 141.07 58.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.334 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.89 10.59 10.9 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.644 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -60.92 -38.98 87.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.235 -179.372 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.87 -35.74 23.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.479 0.657 . . . . 0.0 110.587 179.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.2 mt -71.16 -35.18 71.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.492 0.663 . . . . 0.0 110.614 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -42.95 -62.85 0.91 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.322 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.8 p-10 -65.69 -42.96 90.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.058 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -61.86 -32.34 72.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.402 -179.607 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.2 mt -74.23 -40.64 62.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.869 178.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.42 -49.09 78.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.163 -178.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.9 m -53.04 -42.67 65.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.941 0.4 . . . . 0.0 110.142 179.6 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.53 -42.83 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 120.948 0.404 . . . . 0.0 111.218 179.023 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -168.6 151.4 5.18 Favored Pre-proline 0 N--CA 1.452 -0.369 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.726 -179.265 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -38.78 107.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.716 2.277 . . . . 0.0 112.493 179.717 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.4 m -109.35 121.71 45.77 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.047 0.451 . . . . 0.0 110.265 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -114.13 153.51 29.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.32 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -128.77 131.62 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.402 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.36 127.82 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 121.074 0.464 . . . . 0.0 110.535 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 55.2 t30 -100.99 105.1 16.28 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.149 179.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 147' ' ' LYS . 46.9 p90 -101.28 -11.58 19.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.898 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.0 p-10 -64.82 -33.64 76.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.805 -179.656 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 38.2 p-10 -99.37 7.82 45.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.601 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.9 mttm -134.79 152.35 51.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.525 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.424 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.9 p -75.42 165.97 24.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.677 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.596 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.3 t90 -59.09 -48.49 81.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.23 -179.081 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -54.37 -43.68 71.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.043 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.1 t -62.9 -41.09 99.31 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.255 178.595 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.434 ' O ' HD23 ' A' ' 156' ' ' LEU . 54.8 tp -60.81 -44.53 96.74 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.185 -179.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.49 -42.75 99.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.153 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.8 m -55.63 -45.46 77.58 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.49 -40.13 95.7 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 120.892 0.377 . . . . 0.0 110.505 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.492 HD12 HD11 ' A' ' 60' ' ' ILE . 2.5 mm? -61.99 -42.51 99.22 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.324 179.058 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.16 -40.04 94.79 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.508 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.57 -45.9 64.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 110.849 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.87 -44.06 96.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.845 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.9 p -92.98 -9.1 41.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.643 -178.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.16 26.02 72.39 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -101.17 50.38 0.86 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.811 0.338 . . . . 0.0 110.649 -179.506 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -69.43 -39.56 77.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.628 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.53 -47.35 85.89 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.294 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -60.01 -39.16 84.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.099 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.04 -40.76 98.69 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.214 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.04 -28.86 70.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.56 179.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.12 -54.46 7.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.904 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.528 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.6 ttp180 -64.78 -42.23 95.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.406 -179.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.2 mt -62.48 -43.8 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.483 -179.508 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.95 -60.15 4.06 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.024 0.44 . . . . 0.0 110.311 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -55.22 -34.01 63.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.552 -179.229 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -80.7 -36.11 32.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.731 179.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.8 m-20 -54.79 -42.44 71.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.005 -178.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.01 -41.75 98.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.719 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -64.97 -38.02 89.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.355 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 177' ' ' LEU . 79.8 mt -62.53 -42.29 99.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.753 179.45 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.91 -52.97 61.91 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.066 0.46 . . . . 0.0 110.686 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.41 -41.79 88.75 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.711 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.74 -40.24 96.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.664 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.06 -32.81 74.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.477 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.07 -21.3 19.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.704 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.632 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 52.3 tt0 -64.89 -41.62 95.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.743 -179.56 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 184' ' ' ILE . 31.3 pt -76.47 133.93 29.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.071 0.462 . . . . 0.0 110.716 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -127.83 106.43 9.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.417 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.58 128.31 0.34 Allowed Pre-proline 0 C--O 1.24 0.553 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.521 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.448 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.0 Cg_exo -43.49 151.37 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.869 2.38 . . . . 0.0 112.577 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.83 142.57 52.61 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.587 2.192 . . . . 0.0 112.411 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.542 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -170.89 147.19 2.3 Favored Pre-proline 0 N--CA 1.448 -0.555 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.574 179.395 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.99 153.8 71.85 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.879 2.386 . . . . 0.0 112.317 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.19 163.09 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.167 0.508 . . . . 0.0 110.454 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.578 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.5 169.76 17.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.958 179.462 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.84 137.48 22.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.147 179.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.538 HG22 HD12 ' A' ' 205' ' ' LEU . 39.8 pt -134.35 146.58 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.693 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -133.41 132.15 57.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.129 0.49 . . . . 0.0 110.43 178.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -152.05 154.85 36.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.398 179.158 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.615 HG22 ' H ' ' A' ' 199' ' ' ALA . 89.8 m -121.95 122.88 40.39 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.961 0.41 . . . . 0.0 110.355 179.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.87 -25.34 66.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.656 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.615 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.19 -49.58 18.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.02 -10.9 60.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.416 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.0 m80 48.4 42.72 18.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.489 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.9 t -136.37 145.05 44.93 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.355 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -111.12 114.42 27.66 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.324 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.9 m-20 -120.19 133.71 55.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.984 0.421 . . . . 0.0 110.387 179.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.538 HD12 HG22 ' A' ' 194' ' ' ILE . 7.4 tt -112.24 146.68 37.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.052 0.453 . . . . 0.0 110.762 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.488 ' N ' HD23 ' A' ' 205' ' ' LEU . 12.4 t90 -99.73 127.93 45.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.195 0.521 . . . . 0.0 109.862 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.5 153.47 41.33 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.427 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.71 -18.56 47.92 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.629 2.219 . . . . 0.0 112.005 178.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.86 -18.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.419 -179.121 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.442 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.3 p -75.27 167.77 21.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.491 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.64 75.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.481 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 297' ' ' PHE . 82.3 mt-30 -56.52 -41.38 76.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.722 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.22 -43.07 97.45 Favored Glycine 0 C--O 1.235 0.201 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.49 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.4 mt-30 -63.81 -39.87 95.26 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 122.231 -0.57 . . . . 0.0 110.82 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.596 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.3 mmm -61.77 -41.7 98.04 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.277 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 77.3 mt -63.31 -50.2 70.98 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.197 0.522 . . . . 0.0 110.328 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.69 -33.03 45.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.862 0.363 . . . . 0.0 110.227 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.15 -19.99 62.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.562 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 219' ' ' LEU . 66.2 mt -87.41 -6.44 58.44 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.819 -179.632 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.63 3.56 57.27 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -88.47 149.96 23.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.912 0.386 . . . . 0.0 110.519 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.438 ' O ' HG12 ' A' ' 191' ' ' VAL . 3.1 p -113.01 126.67 55.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.137 0.494 . . . . 0.0 110.332 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.3 mm? -91.63 145.91 24.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.078 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.489 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -70.05 150.5 46.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.44 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.52 131.25 45.0 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.466 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.895 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -114.02 92.94 27.87 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.004 -179.552 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.68 ' C ' ' H ' ' A' ' 229' ' ' GLY . 44.5 Cg_exo -55.52 139.12 82.11 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.544 2.162 . . . . 0.0 111.693 178.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.68 -25.05 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.448 -179.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.68 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.82 -49.79 27.37 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.558 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.1 mt -54.43 -36.97 64.6 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -66.62 36.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.804 179.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.52 87.85 0.01 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.93 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.1 p -80.88 -14.32 58.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.318 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.77 -41.41 10.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.616 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.1 t -66.99 -16.74 64.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.584 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.78 43.97 26.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.467 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.98 -148.58 8.03 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.81 143.19 48.98 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.971 0.415 . . . . 0.0 110.316 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -151.98 149.6 29.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.328 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -101.05 -152.21 0.43 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.299 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 56.3 -92.14 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.626 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.475 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 10.4 tt -126.81 175.58 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.612 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.475 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 91.0 mt -122.21 141.46 42.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 -179.431 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.61 169.29 9.39 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.243 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.6 mt -147.38 150.69 35.18 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.277 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.72 -38.96 96.99 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.53 3.62 4.6 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -77.07 -58.33 3.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.966 0.412 . . . . 0.0 110.518 -179.743 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.559 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.9 m-20 -61.95 -36.75 82.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.203 -179.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.24 -67.72 0.23 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.849 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.56 -42.32 67.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.109 -179.394 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.81 18.19 0.14 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.664 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.63 47.85 0.23 Allowed Glycine 0 N--CA 1.464 0.555 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.3 mp 39.06 -110.07 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.501 0.191 . . . . 0.0 110.74 -178.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.489 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.8 m120 -60.84 -45.18 95.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.421 -179.482 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.95 8.05 82.96 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -99.16 -12.92 20.02 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.757 -0.261 . . . . 0.0 110.597 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.9 t 176.79 142.75 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.101 0.477 . . . . 0.0 110.417 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.17 125.6 11.65 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.137 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -98.52 143.33 29.05 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 120.915 0.388 . . . . 0.0 110.838 178.236 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.3 mt -94.65 106.55 18.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.782 -179.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.466 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.8 t80 -101.95 -12.52 18.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.13 179.582 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.7 90.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.87 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.02 173.36 45.9 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -179.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.496 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -74.01 -112.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.762 0.315 . . . . 0.0 110.768 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.74 -28.78 67.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.658 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.06 -44.06 91.81 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.236 -178.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.43 -44.49 94.42 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.288 179.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.47 -59.96 3.81 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.189 -179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.95 -43.52 60.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.159 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.31 -43.64 75.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.243 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.5 mt -64.49 -43.57 96.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.577 179.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -56.48 -37.72 70.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.152 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -77.22 1.02 19.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.199 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -114.83 91.49 26.25 Favored Pre-proline 0 N--CA 1.462 0.135 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.176 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.09 -27.32 28.79 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.715 2.277 . . . . 0.0 111.966 179.318 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.533 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.42 -41.08 98.7 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.545 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.591 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.9 mp -95.5 5.06 52.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.354 -179.14 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.83 -35.14 69.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.601 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -80.17 4.74 16.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.507 -178.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.73 121.11 80.0 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.57 -179.996 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.43 -37.71 26.0 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.492 2.128 . . . . 0.0 112.58 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.66 -43.4 89.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.765 0.317 . . . . 0.0 110.397 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.92 -43.67 92.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.357 179.204 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -65.1 -40.64 94.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.31 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 44.5 t-20 -89.08 -13.1 39.38 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.554 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 283' ' ' ALA . 53.9 mtmt 62.29 31.19 17.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.037 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.32 44.2 1.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.176 0.513 . . . . 0.0 110.346 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.93 135.75 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.514 -179.72 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -116.65 132.41 56.69 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.439 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.492 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.09 88.68 6.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.808 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.427 ' O ' ' OG1' ' A' ' 296' ' ' THR . 86.8 mt -63.93 -41.65 97.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.021 0.439 . . . . 0.0 110.781 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.466 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.79 165.87 34.28 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 71.2 p -75.47 -25.82 57.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.9 0.381 . . . . 0.0 110.756 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.503 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.1 tp10 -68.59 -33.82 74.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.478 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 296' ' ' THR . 99.0 m -72.65 19.67 0.08 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.129 0.49 . . . . 0.0 110.677 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.511 ' O ' ' NE2' ' A' ' 212' ' ' GLN . 49.6 t80 -57.1 -51.23 70.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.925 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 70.8 mmt-85 -107.65 149.05 28.56 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.7 tp -115.61 126.19 53.87 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.842 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.478 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.7 t0 -149.74 166.87 28.12 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.618 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -49.29 -38.05 26.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.649 -179.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -71.65 -65.21 0.79 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.462 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.61 -32.83 71.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.021 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.57 -25.42 26.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.735 -179.125 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 62.8 mtt -63.49 -41.15 98.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.827 0.346 . . . . 0.0 111.053 179.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.96 -44.48 26.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.102 179.563 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.575 HG21 HG23 ' A' ' 296' ' ' THR . 79.8 t -66.15 -42.73 91.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.365 179.643 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.45 HD11 ' OE1' ' A' ' 183' ' ' GLN . 49.3 tp -59.9 -47.09 87.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.514 -178.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -70.57 -39.23 74.01 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.73 179.151 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.496 ' NH2' ' OD1' ' A' ' 265' ' ' ASP . 73.3 ttt180 -61.5 -37.84 85.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.257 -178.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.3 mt -87.95 5.05 42.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.664 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.632 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.1 tttt -112.4 -11.71 13.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.03 0.443 . . . . 0.0 110.314 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.82 -37.29 86.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.394 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.92 -48.92 79.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.46 -179.653 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.992 179.886 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -90.1 -2.18 58.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.464 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.494 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.02 179.04 1.24 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.504 -179.638 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 30.5 Cg_exo -60.81 145.01 99.64 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.827 2.351 . . . . 0.0 112.18 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.3 ptt-85 -156.37 -179.1 7.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.615 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -115.78 136.15 53.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.984 0.421 . . . . 0.0 110.371 179.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -123.41 146.64 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.409 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.8 p -119.72 135.87 54.66 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.818 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.5 p30 -99.4 -143.47 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.26 179.877 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -63.62 -37.11 86.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.526 179.58 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.36 -66.76 0.22 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.431 179.719 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.21 142.2 44.9 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.42 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.7 p -112.27 131.49 55.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 0.0 110.488 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -119.1 128.98 54.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.611 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.4 m -85.38 130.15 34.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.247 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.471 HD22 ' OE1' ' A' ' 42' ' ' GLN . 67.6 mt -95.67 78.51 3.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.39 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.73 -31.65 72.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.589 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.23 109.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.155 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.471 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.5 pt20 -122.18 91.08 49.11 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.414 -179.66 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.661 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.5 Cg_exo -56.63 148.81 62.36 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.8 2.334 . . . . 0.0 112.049 178.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.92 82.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.506 0.504 . . . . 0.0 110.999 -179.252 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.661 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.5 mtm180 -151.1 66.86 0.91 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.292 -179.604 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.87 130.69 35.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.822 -179.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.556 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.7 t -122.73 146.23 28.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.061 -179.62 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.9 t -136.1 143.76 44.77 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.778 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.8 p -99.53 -59.05 1.79 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.579 179.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.9 p -79.29 155.11 28.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.627 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.501 HG21 HG23 ' A' ' 70' ' ' THR . 71.3 t -74.61 -21.72 17.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.514 179.377 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.8 m -60.28 -52.2 66.29 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.518 -178.537 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.34 -42.9 87.45 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.622 177.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.0 m -42.49 -54.04 4.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.985 -178.719 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.48 -37.36 69.18 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 178.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 m -62.67 -44.93 95.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.815 0.34 . . . . 0.0 110.107 -179.25 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.6 mt -66.41 -41.76 88.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.433 0.635 . . . . 0.0 110.714 179.697 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.56 -40.49 97.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.283 -179.284 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.468 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.77 -35.65 75.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.236 -178.909 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.533 HD11 HD12 ' A' ' 156' ' ' LEU . 32.2 pt -91.45 28.9 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.284 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.29 51.58 11.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.019 179.506 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.03 75.57 23.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 0.0 109.94 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.96 151.48 85.68 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.848 2.365 . . . . 0.0 112.064 -178.755 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.556 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -113.38 137.44 46.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-O 121.126 0.489 . . . . 0.0 110.319 179.826 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.448 HG13 ' N ' ' A' ' 66' ' ' ALA . 15.9 pt -69.35 -43.49 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.263 179.597 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.09 131.22 53.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.044 0.45 . . . . 0.0 110.534 -179.049 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.3 p -155.91 168.8 26.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.522 -179.717 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.63 -177.18 21.8 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.635 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.03 171.92 13.34 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 121.094 0.473 . . . . 0.0 110.451 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.501 HG23 HG21 ' A' ' 51' ' ' VAL . 12.7 p -133.54 -110.86 0.23 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.004 0.43 . . . . 0.0 110.516 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.549 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.86 179.6 0.95 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.494 -179.312 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.0 Cg_exo -60.75 58.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.891 2.394 . . . . 0.0 112.082 179.557 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.3 t-20 -64.39 -35.19 80.11 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.445 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 47.4 m-20 94.93 -37.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.692 0.62 . . . . 0.0 109.889 -179.365 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.54 -39.86 94.95 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.199 179.109 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 77' ' ' ALA . 13.6 p -73.96 -26.55 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.621 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.96 -172.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.383 -179.367 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -74.1 -152.63 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.765 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.8 p-10 -54.56 -6.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.724 -179.429 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.493 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.88 113.32 22.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.678 179.738 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.33 73.31 1.26 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.615 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.401 ' CZ ' ' OG ' ' A' ' 87' ' ' SER . 2.2 m-85 -144.24 148.33 34.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.817 0.342 . . . . 0.0 110.901 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.71 -99.38 0.07 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.022 178.836 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.564 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.3 mtt-85 -64.17 -42.84 96.55 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.088 179.255 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.564 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.5 52.91 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.672 0.607 . . . . 0.0 111.042 179.025 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -103.57 -9.02 19.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.32 179.274 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.401 ' OG ' ' CZ ' ' A' ' 82' ' ' PHE . 78.1 p -64.98 -33.74 76.77 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.097 0.475 . . . . 0.0 110.701 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.551 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 97.9 mttt -48.83 -23.22 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.72 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.5 t -70.18 -45.9 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.705 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.09 -48.82 79.92 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.978 -179.472 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.38 -38.34 89.2 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.379 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.67 -32.4 51.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.202 -179.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.621 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.91 1.61 56.02 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.49 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.621 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.99 -49.43 0.16 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.729 0.643 . . . . 0.0 110.229 179.209 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.686 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 79.5 mt -45.88 153.85 0.27 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 118.209 -0.901 . . . . 0.0 109.758 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.686 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.3 tt0 121.24 92.17 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.966 1.416 . . . . 0.0 110.472 -178.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.26 143.24 43.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.277 0.561 . . . . 0.0 110.269 179.416 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -131.97 27.03 4.59 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 122.053 -0.404 . . . . 0.0 110.443 -179.399 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.33 137.94 34.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.456 . . . . 0.0 110.514 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.7 mt -137.03 165.06 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.395 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.91 -28.44 1.87 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -152.85 70.69 7.19 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.06 0.457 . . . . 0.0 110.271 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.11 145.37 98.6 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 122.744 2.296 . . . . 0.0 112.114 -179.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.4 t -134.27 136.87 43.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.533 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.12 -38.33 82.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.547 179.725 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.25 -42.35 96.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.499 -179.45 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.67 98.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.544 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.4 t -63.68 -43.25 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.108 179.451 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.08 -35.08 77.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.137 -179.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.73 -18.49 59.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.376 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.75 -6.51 58.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.506 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.8 mtp 47.85 56.14 17.4 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.659 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.8 Cg_endo -70.28 149.29 63.35 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.8 2.334 . . . . 0.0 112.07 179.465 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -101.24 -73.38 0.65 Allowed 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.471 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.432 HD11 HD13 ' A' ' 140' ' ' LEU . 39.0 tp -111.02 112.39 24.18 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.269 179.632 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 75.9 mt -100.59 126.1 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.645 -179.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.9 mt -109.42 133.38 53.13 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.268 -179.428 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.56 139.61 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.585 -179.559 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.2 p -83.5 168.24 16.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.714 179.778 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.09 -37.43 79.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.488 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.59 159.0 43.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.442 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.27 177.22 33.41 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.2 -33.73 86.87 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 -179.684 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -125.07 151.7 45.31 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 110.519 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -63.12 141.2 58.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.334 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.72 10.03 10.89 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.666 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.7 mp -60.71 -38.97 86.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.305 -179.383 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.641 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.79 23.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.355 0.598 . . . . 0.0 110.568 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.9 mt -71.03 -35.29 71.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.482 0.658 . . . . 0.0 110.625 179.403 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.3 t80 -42.73 -62.72 0.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.355 -178.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.641 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.77 -42.83 90.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.176 -179.244 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.544 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -62.0 -32.57 73.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.417 -179.718 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 129' ' ' LEU . 71.2 mt -74.17 -40.79 62.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.792 178.745 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -58.1 -49.02 78.39 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.169 -179.094 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 73.3 m -53.06 -42.08 65.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.975 0.417 . . . . 0.0 110.155 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.56 -42.57 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 120.95 0.405 . . . . 0.0 111.081 179.241 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.78 153.61 5.01 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.661 -179.338 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -39.06 106.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.658 2.239 . . . . 0.0 112.491 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 140' ' ' LEU . 95.1 m -109.37 121.32 44.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.129 0.49 . . . . 0.0 110.278 179.802 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -114.1 153.07 30.12 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.365 -179.757 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.6 tt -128.96 131.56 68.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.343 179.911 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.29 127.88 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.605 -179.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.9 t30 -101.9 103.67 14.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.174 179.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.9 p90 -101.15 -11.23 19.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.875 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.6 p-10 -64.84 -33.26 75.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.731 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.5 p-10 -98.6 8.19 45.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.56 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.442 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.91 155.62 50.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.521 -179.413 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.408 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -74.86 165.83 24.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.626 -179.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.584 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.1 t90 -60.02 -48.95 79.61 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.264 -179.22 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -53.56 -42.06 67.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.17 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.0 t -62.47 -40.83 97.92 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.358 178.773 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.424 ' O ' HD23 ' A' ' 156' ' ' LEU . 48.0 tp -60.64 -43.97 96.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.275 -179.564 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.495 HD22 HH21 ' A' ' 169' ' ' ARG . 45.5 tp -61.32 -43.25 99.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.063 179.663 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.3 m -55.41 -45.58 76.69 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.32 -40.73 97.29 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.895 0.379 . . . . 0.0 110.509 179.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.533 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.8 -42.42 98.99 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.238 179.046 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.86 -40.88 95.72 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 179.522 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.93 -45.74 63.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 0.0 110.84 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.1 mt -64.78 -43.99 96.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.839 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.4 p -93.29 -8.55 41.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.633 -179.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.76 25.37 71.74 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -101.88 51.98 0.82 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.831 0.348 . . . . 0.0 110.673 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -69.74 -39.09 76.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.593 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.25 -47.2 86.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.34 -179.416 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -61.35 -39.15 89.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.232 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.23 -40.46 97.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.347 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.43 -27.17 68.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.567 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -75.32 -53.71 8.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.842 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.495 HH21 HD22 ' A' ' 153' ' ' LEU . 61.7 ttp180 -63.88 -43.26 96.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.422 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 174' ' ' ASP . 87.3 mt -63.06 -43.89 99.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.73 -179.705 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.37 -61.76 2.32 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.062 0.458 . . . . 0.0 110.356 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -54.55 -35.05 62.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.565 -179.153 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -79.62 -34.99 40.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.822 179.694 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.6 m-20 -56.6 -40.12 74.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.009 -178.642 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.88 -42.37 99.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.692 179.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.79 -37.75 87.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.315 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 177' ' ' LEU . 82.3 mt -62.45 -42.28 99.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.713 179.612 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.17 -53.32 56.99 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.017 0.436 . . . . 0.0 110.613 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.3 -41.4 89.81 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.633 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.24 -39.95 95.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.601 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.19 -32.16 73.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.471 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -94.52 -21.75 18.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.63 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.636 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.96 -41.57 95.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.717 -179.625 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -77.58 136.08 25.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.746 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.1 108.97 11.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.333 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.9 126.13 0.3 Allowed Pre-proline 0 C--O 1.238 0.473 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.501 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.461 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.7 Cg_exo -43.73 152.16 0.36 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.891 2.394 . . . . 0.0 112.483 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.99 141.68 54.11 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.579 2.186 . . . . 0.0 112.341 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.16 147.07 2.16 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.602 179.374 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.2 154.19 70.36 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.897 2.398 . . . . 0.0 112.269 178.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.584 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.4 163.24 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.151 0.501 . . . . 0.0 110.477 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -144.08 170.26 16.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.157 0.503 . . . . 0.0 110.851 179.68 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.82 137.4 22.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.213 179.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.547 HG22 HD12 ' A' ' 205' ' ' LEU . 38.9 pt -134.28 146.56 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.728 179.607 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -133.29 132.09 58.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.152 0.501 . . . . 0.0 110.418 178.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -152.09 154.73 36.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.377 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.628 HG22 ' H ' ' A' ' 199' ' ' ALA . 87.6 m -122.15 123.01 40.54 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.904 0.383 . . . . 0.0 110.408 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.38 -25.43 65.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.679 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.628 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.53 -49.0 20.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.5 -9.85 59.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.499 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.6 m80 46.5 42.76 11.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.582 -179.602 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 t -135.89 145.77 46.69 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.421 179.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.406 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -111.33 113.92 26.73 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.393 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -120.06 133.58 55.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.438 . . . . 0.0 110.377 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.547 HD12 HG22 ' A' ' 194' ' ' ILE . 7.3 tt -112.33 146.72 37.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.794 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.488 ' HE1' ' HG ' ' A' ' 210' ' ' SER . 11.5 t90 -99.58 129.8 45.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.22 0.533 . . . . 0.0 109.864 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.62 153.85 39.34 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.292 179.935 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 41.1 Cg_endo -67.61 -18.3 48.41 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.705 2.27 . . . . 0.0 111.986 178.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.16 -18.72 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.414 -179.23 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.488 ' HG ' ' HE1' ' A' ' 206' ' ' TRP . 86.1 p -75.7 165.04 25.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.496 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.01 -28.3 66.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.508 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.543 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.9 mt-30 -63.47 -41.45 98.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.673 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.85 -44.89 96.66 Favored Glycine 0 C--N 1.331 0.276 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.43 -38.98 92.92 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 122.231 -0.57 . . . . 0.0 110.703 179.67 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.584 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.7 mmm -61.93 -41.41 97.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.246 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.58 -47.72 80.33 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.99 0.424 . . . . 0.0 110.44 179.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.73 -32.01 50.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.882 0.373 . . . . 0.0 110.379 179.715 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -70.89 -18.13 62.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.493 179.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.429 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.5 mt -88.62 -8.67 54.27 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.651 -179.494 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.61 2.64 55.37 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -88.59 152.26 21.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.929 0.395 . . . . 0.0 110.504 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.442 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.1 p -115.11 127.99 55.94 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.118 0.485 . . . . 0.0 110.397 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.566 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.36 146.15 23.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.943 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.474 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -69.84 151.66 45.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.529 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.1 131.74 42.65 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.546 179.811 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.896 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -113.79 93.53 29.27 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.099 -179.713 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.682 ' C ' ' H ' ' A' ' 229' ' ' GLY . 44.5 Cg_exo -55.14 138.95 80.18 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.61 2.207 . . . . 0.0 111.769 178.775 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.6 -25.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.481 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.682 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.79 -49.95 26.8 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.805 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.6 mt -53.94 -37.21 63.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 -179.273 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -66.62 35.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.83 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.09 88.36 0.01 OUTLIER 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.913 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 80.2 p -81.94 -14.33 56.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.337 -179.672 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.34 -41.43 10.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.618 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.2 t -66.91 -16.67 64.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.616 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.09 43.47 26.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.495 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.56 -148.44 7.84 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -121.37 143.23 49.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.959 0.409 . . . . 0.0 110.358 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.1 ttt-85 -151.95 149.43 28.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.312 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -100.71 -152.09 0.42 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.372 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.4 t0 56.1 -91.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.469 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.0 tt -126.54 175.43 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.631 -179.508 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.469 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 92.0 mt -122.14 141.7 41.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 -179.44 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.79 169.33 9.32 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.266 -179.774 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.2 mt -147.9 150.76 34.7 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.183 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.75 -38.91 96.88 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.19 4.07 4.64 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.3 -58.24 3.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 110.539 -179.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.56 ' ND2' HD23 ' A' ' 226' ' ' LEU . 92.6 m-20 -62.1 -36.88 83.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.281 -179.757 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.406 HD21 ' HB1' ' A' ' 203' ' ' ALA . 10.0 mp -52.3 -67.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.736 -179.69 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.47 -42.23 67.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.19 -179.617 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.06 18.09 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.617 179.787 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.69 48.63 0.26 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.29 -109.91 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.485 0.183 . . . . 0.0 110.746 -178.664 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.474 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.9 m120 -60.78 -45.25 95.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.463 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.95 8.17 82.78 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 179.255 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.32 -12.75 20.05 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.725 -0.279 . . . . 0.0 110.673 -179.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.4 t 176.6 142.49 0.07 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.013 0.435 . . . . 0.0 110.446 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.0 tt -148.17 125.19 11.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.428 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.9 m-30 -98.27 142.93 29.32 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 120.91 0.386 . . . . 0.0 110.694 178.313 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.3 mt -94.23 106.58 18.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.805 -179.323 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.463 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.3 t80 -101.91 -11.73 18.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.15 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.99 -40.2 87.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.84 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.81 173.97 46.17 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.459 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.2 m-20 -74.39 -112.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.789 0.328 . . . . 0.0 110.798 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.83 -28.74 67.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.671 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -58.95 -44.18 91.4 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.24 -178.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.56 -44.4 94.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.317 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.47 -60.09 3.65 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.194 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.8 -43.74 58.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.143 179.763 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.91 75.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.242 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.1 mt -64.46 -43.62 96.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.587 179.56 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -56.57 -37.87 71.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.137 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.82 1.11 18.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.208 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.0 91.2 25.82 Favored Pre-proline 0 N--CA 1.461 0.104 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.164 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.86 -27.17 26.56 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.796 2.331 . . . . 0.0 112.034 179.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.537 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.58 -41.01 98.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.468 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.38 5.33 51.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.414 -179.21 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.06 -34.82 69.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.588 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -80.26 4.71 16.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.485 -178.819 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.91 121.11 80.36 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.555 179.921 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -47.15 -37.87 24.19 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.521 2.148 . . . . 0.0 112.533 -179.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.86 -43.77 90.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.469 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.98 -43.47 92.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.387 179.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -64.86 -40.67 95.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.439 -179.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -90.02 -12.25 39.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.504 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 62.16 32.54 17.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.989 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -89.08 43.97 1.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.079 0.466 . . . . 0.0 110.278 179.52 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.13 135.87 41.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.587 -179.752 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.6 132.56 56.65 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.37 179.618 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.499 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.56 87.86 7.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.762 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.97 -41.31 97.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.782 179.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.12 168.14 34.73 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.7 p -75.97 -25.89 56.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.756 179.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.491 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.3 tp10 -67.79 -33.92 75.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.471 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 296' ' ' THR . 97.4 m -73.47 19.9 0.1 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.076 0.465 . . . . 0.0 110.78 -179.148 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.543 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 55.3 t80 -57.26 -51.38 69.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.853 -179.369 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 67.4 mmt-85 -108.0 149.51 28.3 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.429 ' CD2' HD11 ' A' ' 219' ' ' LEU . 40.5 tp -115.34 125.39 53.18 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.851 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.474 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.4 t0 -149.06 166.41 28.79 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.567 179.537 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -49.29 -37.95 25.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.663 -179.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -71.89 -65.11 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.376 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.65 -32.74 71.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.983 -179.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.7 -25.51 27.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.786 -179.102 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.5 mtt -63.32 -40.79 98.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.851 0.358 . . . . 0.0 111.027 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.89 -44.03 23.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.982 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.563 HG21 HG23 ' A' ' 296' ' ' THR . 74.5 t -66.26 -42.79 91.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.381 179.605 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.441 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 51.7 tp -60.23 -47.1 87.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.495 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -70.17 -39.48 75.25 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.987 0.422 . . . . 0.0 110.672 179.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.499 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.3 ttt180 -61.67 -38.24 87.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.275 -179.043 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.4 4.75 41.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.61 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.636 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.3 tttt -112.82 -11.18 13.5 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.964 0.411 . . . . 0.0 110.264 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.15 -37.18 86.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.388 179.737 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.75 -48.91 79.66 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.465 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.157 179.66 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -89.94 -2.58 58.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.423 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.68 179.23 1.21 Allowed Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.524 -179.673 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.4 Cg_exo -60.87 145.0 99.67 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.818 2.345 . . . . 0.0 112.141 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.613 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.1 ptt-85 -155.92 -179.56 8.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.639 -179.735 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.93 137.02 52.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.961 0.41 . . . . 0.0 110.313 179.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -124.43 147.05 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.346 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.5 p -120.03 136.11 54.68 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.779 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.46 -143.49 0.33 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.248 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.55 -37.39 87.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.453 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.476 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -148.93 -66.61 0.23 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.442 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.55 142.46 45.42 Favored Glycine 0 CA--C 1.518 0.277 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 -179.38 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.7 p -112.3 131.38 55.55 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.569 -0.371 . . . . 0.0 110.465 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -119.07 129.06 54.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.56 -179.832 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.5 m -85.6 130.43 34.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.223 -179.834 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.481 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.6 mt -95.95 78.82 3.22 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.388 179.679 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.71 -31.78 72.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.56 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t 176.1 109.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.032 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.481 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.41 91.51 49.25 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.412 -179.753 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.647 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.3 Cg_exo -56.89 148.55 66.58 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.79 2.327 . . . . 0.0 111.956 178.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.48 82.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.679 0.612 . . . . 0.0 110.97 -179.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.647 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.6 66.93 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.055 0.455 . . . . 0.0 110.173 -179.389 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.23 130.69 35.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.561 ' HA ' HG23 ' A' ' 64' ' ' VAL . 54.3 t -122.42 146.55 27.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.046 0.451 . . . . 0.0 109.993 -179.664 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.2 t -135.81 143.77 45.36 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.038 0.447 . . . . 0.0 110.729 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.2 p -99.37 -59.53 1.7 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.619 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.5 p -79.25 155.22 28.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.654 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.524 HG21 HG23 ' A' ' 70' ' ' THR . 73.7 t -74.11 -21.92 18.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.486 179.355 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 98.1 m -60.33 -52.13 66.59 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.488 -178.406 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.9 mt -66.24 -42.72 88.2 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.759 177.823 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.1 m -43.24 -53.83 4.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.905 -178.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.37 -37.23 70.21 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 178.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m -62.75 -44.69 95.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.853 0.359 . . . . 0.0 110.141 -179.221 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.0 mt -66.46 -41.9 88.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.497 0.665 . . . . 0.0 110.739 179.688 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -62.56 -40.49 96.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.489 -179.392 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.92 -35.86 75.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.287 -179.084 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.529 HD11 HD12 ' A' ' 156' ' ' LEU . 32.5 pt -91.16 28.89 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.352 -179.465 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.45 51.75 10.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.058 179.56 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.49 76.04 21.51 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.584 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.03 151.53 85.46 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.836 2.357 . . . . 0.0 112.076 -178.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.561 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.37 137.46 46.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-O 121.176 0.512 . . . . 0.0 110.293 179.671 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.1 pt -69.46 -43.62 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.321 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.12 131.44 53.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.037 0.446 . . . . 0.0 110.569 -178.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.536 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.0 p -155.77 168.59 26.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.445 -179.715 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.47 -177.22 21.9 Favored Glycine 0 N--CA 1.463 0.471 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.638 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.97 172.77 12.35 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 121.078 0.466 . . . . 0.0 110.437 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.524 HG23 HG21 ' A' ' 51' ' ' VAL . 14.9 p -132.42 -112.92 0.23 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.104 0.478 . . . . 0.0 110.376 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.98 179.72 0.94 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.406 -179.198 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 38.5 Cg_exo -60.86 57.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.968 2.446 . . . . 0.0 112.145 179.554 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.1 t-20 -64.25 -33.16 75.16 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.382 -179.731 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 42.6 m-20 93.47 -36.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.757 0.661 . . . . 0.0 109.805 -179.524 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HD3' HD21 ' A' ' 73' ' ' ASN . 77.0 mtp85 -62.62 -39.64 94.45 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.216 179.271 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -74.34 -25.53 19.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.684 179.384 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.31 -170.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.436 -179.232 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.0 p30 -74.03 -154.35 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.856 -179.627 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.8 p-10 -52.31 -7.56 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.757 -179.567 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -85.95 114.92 23.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.676 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.97 70.4 1.34 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.625 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -143.84 147.99 34.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.844 0.354 . . . . 0.0 110.841 179.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -85.82 -98.46 0.07 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.082 178.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.551 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.18 -42.52 96.65 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.052 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.38 52.83 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.895 0.747 . . . . 0.0 111.024 179.205 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -102.88 -9.38 19.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.313 179.37 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.2 p -64.31 -33.91 76.93 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.139 0.495 . . . . 0.0 110.699 -179.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.55 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.21 -23.39 1.31 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.678 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.3 t -69.84 -45.95 75.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 179.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.23 -48.62 80.65 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.924 -179.324 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.4 -38.4 89.48 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.379 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.59 -33.07 53.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.134 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.606 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.5 mmt-85 -89.66 1.74 55.64 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.554 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.3 mttp 82.68 -49.34 0.18 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.862 0.726 . . . . 0.0 110.197 179.126 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.655 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.8 mt -45.9 154.4 0.24 Allowed 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 117.538 -1.22 . . . . 0.0 109.524 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.655 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 59.1 tt0 121.07 92.63 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 O-C-N 125.566 1.791 . . . . 0.0 110.443 -178.595 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.536 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.57 142.94 42.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.252 0.548 . . . . 0.0 110.312 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.6 mt -131.94 26.98 4.6 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.0 -0.438 . . . . 0.0 110.437 -179.344 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -140.24 137.9 34.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.022 0.439 . . . . 0.0 110.589 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.638 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.5 mt -137.16 165.01 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.332 179.629 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.616 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.9 -28.43 1.87 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.58 70.51 7.37 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-O 121.079 0.466 . . . . 0.0 110.095 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.92 145.33 98.57 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 122.668 2.245 . . . . 0.0 112.133 -179.651 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.9 t -134.35 136.73 43.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.559 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.37 81.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.63 179.66 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.12 -42.23 96.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.51 -179.408 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.62 98.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.491 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.6 -43.35 98.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.004 179.479 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.08 77.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.132 -179.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.69 -18.75 60.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.362 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.66 -6.55 58.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.491 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.8 mtp 47.53 56.1 17.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.644 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.8 Cg_endo -70.03 149.46 65.19 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.791 2.327 . . . . 0.0 112.098 179.516 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.03 -73.61 0.64 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.519 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.435 HD11 HD13 ' A' ' 140' ' ' LEU . 38.6 tp -111.02 113.44 25.99 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.293 179.633 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.7 mt -102.08 126.57 56.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 120.962 0.411 . . . . 0.0 110.64 -179.8 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.3 mt -109.92 133.96 52.6 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.266 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.73 139.6 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.558 -179.567 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.9 p -83.4 168.37 16.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.716 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.47 80.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.389 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.91 159.13 42.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.94 0.4 . . . . 0.0 110.432 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.23 176.82 33.54 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.29 -33.59 86.57 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.56 151.46 44.71 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.928 0.394 . . . . 0.0 110.507 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.0 t -63.33 140.78 58.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.331 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.55 10.35 11.08 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.591 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -61.01 -38.94 87.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.253 -179.283 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.97 -35.89 23.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.522 0.677 . . . . 0.0 110.605 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 133' ' ' LEU . 91.6 mt -70.96 -35.44 72.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.546 0.688 . . . . 0.0 110.659 179.394 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -42.83 -62.81 0.91 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.411 -178.756 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.65 -42.86 90.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.195 -179.402 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.0 mt-30 -61.98 -32.71 73.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.367 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.0 mt -73.58 -41.06 63.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.864 178.642 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.18 -48.87 78.98 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.122 -178.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.8 m -52.97 -42.5 65.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.961 0.41 . . . . 0.0 110.186 179.474 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.14 -42.84 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 120.934 0.397 . . . . 0.0 111.18 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.33 153.51 5.38 Favored Pre-proline 0 N--CA 1.452 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.655 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -39.29 107.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.682 2.255 . . . . 0.0 112.516 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.636 ' C ' HD12 ' A' ' 140' ' ' LEU . 97.0 m -109.73 121.4 45.14 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.116 0.484 . . . . 0.0 110.281 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.636 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.56 152.44 30.27 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.279 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.4 tt -128.77 131.22 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.351 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.7 mt -115.09 127.9 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.099 0.476 . . . . 0.0 110.52 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.8 t30 -101.43 103.81 14.74 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.161 179.822 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 147' ' ' LYS . 47.0 p90 -101.35 -11.13 19.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.875 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.5 p-10 -64.89 -33.54 76.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.768 -179.718 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.4 p-10 -98.4 7.72 45.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.503 -179.546 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.448 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.55 155.62 50.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.484 -179.358 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.2 p -75.02 165.75 24.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.675 -179.778 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.589 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.02 -48.8 80.22 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.188 -179.1 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -53.41 -42.0 66.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 110.094 -179.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.4 t -62.74 -41.04 99.0 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.366 178.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.409 ' CD1' HG21 ' A' ' 142' ' ' ILE . 45.6 tp -60.66 -44.42 96.48 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.325 -179.469 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.0 tp -61.47 -43.49 98.77 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.079 179.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.0 m -54.91 -45.04 74.69 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.18 -40.86 97.43 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.88 0.371 . . . . 0.0 110.46 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.529 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.86 -42.51 99.13 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.388 178.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.27 -40.78 94.86 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.51 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.54 -46.05 64.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.389 . . . . 0.0 110.842 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.79 -44.02 96.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.847 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.8 p -92.86 -8.89 42.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.622 -179.026 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.88 26.61 72.27 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -101.85 50.91 0.84 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.844 0.354 . . . . 0.0 110.693 -179.572 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.56 -39.59 77.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.622 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.37 -47.12 86.63 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.288 -179.293 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -60.07 -39.49 86.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.145 -179.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.97 99.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.247 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.88 -28.26 69.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.622 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.56 -54.18 7.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.898 179.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.506 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.54 -42.19 92.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.402 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 174' ' ' ASP . 80.2 mt -62.43 -43.77 98.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.496 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.58 -58.15 8.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.984 0.421 . . . . 0.0 110.372 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.47 -33.35 67.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.597 -179.016 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.409 ' CD2' HD11 ' A' ' 177' ' ' LEU . 22.8 t80 -81.35 -36.72 29.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.756 179.558 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.7 m-20 -55.79 -42.01 74.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.867 -178.437 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.4 -42.19 99.24 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.919 0.39 . . . . 0.0 110.801 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.26 -38.06 89.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.237 179.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.409 HD11 ' CD2' ' A' ' 173' ' ' PHE . 82.4 mt -62.41 -42.2 99.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.718 179.569 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.19 -53.01 61.38 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.07 0.462 . . . . 0.0 110.67 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.02 -41.8 90.5 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.674 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.95 95.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.28 -32.09 73.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.382 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -94.62 -22.35 18.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.688 -179.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.635 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.9 tt0 -64.76 -41.33 95.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.676 -179.554 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -76.45 136.37 24.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.69 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.72 107.91 10.59 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.246 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.73 125.95 0.31 Allowed Pre-proline 0 C--O 1.239 0.55 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.465 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.452 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.6 Cg_exo -44.02 152.35 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.872 2.381 . . . . 0.0 112.553 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.09 141.98 54.6 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.556 2.171 . . . . 0.0 112.385 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.35 147.33 2.14 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.52 179.301 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.28 154.62 69.37 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.813 2.342 . . . . 0.0 112.348 178.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.42 163.15 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.207 0.527 . . . . 0.0 110.42 179.799 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.56 170.11 16.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.008 179.453 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.75 137.32 22.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.949 0.404 . . . . 0.0 110.185 179.448 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.567 HG22 HD12 ' A' ' 205' ' ' LEU . 38.7 pt -134.16 146.55 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.682 179.528 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.8 p -132.95 132.04 59.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.261 0.553 . . . . 0.0 110.468 178.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -153.31 156.96 39.37 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.43 179.21 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.4 m -122.8 123.31 40.74 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.944 0.402 . . . . 0.0 110.418 179.383 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.474 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -61.09 -25.95 67.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.583 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.614 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.66 -50.0 19.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.972 179.708 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.24 -11.11 59.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.548 -179.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.474 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 80.6 m80 47.11 47.39 16.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.563 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.6 t -131.47 144.75 51.38 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.277 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.431 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -109.76 106.19 15.72 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.235 -179.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -116.76 129.61 56.21 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.177 0.513 . . . . 0.0 110.301 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.567 HD12 HG22 ' A' ' 194' ' ' ILE . 7.7 tt -112.1 146.54 37.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.813 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.472 ' N ' HD23 ' A' ' 205' ' ' LEU . 12.1 t90 -99.49 128.46 45.6 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.203 0.525 . . . . 0.0 109.851 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.41 153.88 40.37 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.37 179.758 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.5 Cg_endo -67.59 -18.08 48.43 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.651 2.234 . . . . 0.0 112.003 178.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -49.6 -18.55 0.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.332 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.421 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.9 p -75.56 164.15 26.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.474 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.71 -28.1 65.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.533 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.571 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.0 mt-30 -63.65 -41.25 98.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.656 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.57 -44.44 97.78 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -179.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.448 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.1 mt-30 -64.3 -38.81 92.35 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 122.212 -0.581 . . . . 0.0 110.712 179.588 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.2 mmm -61.99 -41.31 97.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.188 179.819 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 74.1 mt -63.49 -47.71 80.61 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.031 0.443 . . . . 0.0 110.392 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.66 -32.06 50.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.909 0.385 . . . . 0.0 110.273 179.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -71.01 -17.96 62.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.48 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.419 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.7 mt -88.77 -8.4 54.5 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.617 -179.477 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.44 2.58 55.55 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.811 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -88.68 152.2 21.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.953 0.406 . . . . 0.0 110.429 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.451 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.9 p -115.18 127.97 55.88 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.183 0.516 . . . . 0.0 110.356 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -91.94 146.63 23.59 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.011 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.457 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.38 151.18 45.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.477 179.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.1 131.77 42.67 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.5 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.881 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.54 93.53 28.01 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.079 -179.52 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.686 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.5 Cg_exo -55.31 138.77 80.5 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.599 2.199 . . . . 0.0 111.633 179.034 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.27 -25.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.478 -179.621 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.686 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.45 -50.11 28.07 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.819 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.4 mt -54.76 -36.67 65.08 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.122 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -65.95 36.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.783 179.431 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.569 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 40.51 86.25 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.953 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.2 p -79.27 -15.14 58.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.346 -179.809 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -92.4 -40.25 10.98 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.678 179.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.0 t -66.03 -18.03 65.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.598 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 56.16 43.44 26.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.41 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -179.89 -148.16 7.79 Favored Glycine 0 CA--C 1.518 0.262 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.97 142.31 49.89 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 110.316 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.406 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.4 ttt-85 -152.48 149.92 29.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.313 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -102.18 -149.95 0.4 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.3 179.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.2 t0 55.29 -92.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.696 -179.782 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.441 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.1 tt -126.94 174.65 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.635 -179.495 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.441 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.0 mt -122.31 141.29 43.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.039 0.447 . . . . 0.0 110.899 -179.562 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.58 170.62 8.47 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.196 -179.787 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.3 mt -146.75 149.6 33.71 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.259 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.19 -39.38 97.86 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.07 3.14 4.04 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -78.5 -57.59 3.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.964 0.412 . . . . 0.0 110.517 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.613 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.6 m-20 -62.07 -36.88 82.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.203 -179.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.431 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.6 mp -52.98 -67.57 0.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.0 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.61 -42.53 67.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.112 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.74 17.74 0.15 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.656 179.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.0 48.05 0.27 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.1 mp 39.25 -109.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.534 0.207 . . . . 0.0 110.721 -178.623 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.457 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 11.4 m120 -60.83 -44.67 96.61 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.381 -179.57 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.6 7.96 83.69 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.336 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.93 -13.34 20.02 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.689 -0.301 . . . . 0.0 110.667 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.1 t 177.06 142.89 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.083 0.468 . . . . 0.0 110.427 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.431 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.2 125.3 11.41 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.197 179.521 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.47 143.65 28.68 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 120.892 0.377 . . . . 0.0 110.808 178.326 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.06 106.62 18.63 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.78 -179.264 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 91.2 t80 -102.3 -11.41 18.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.116 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -67.57 -40.55 84.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.875 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.28 172.71 45.57 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.599 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.472 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 94.8 m-20 -73.9 -113.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.784 0.326 . . . . 0.0 110.723 -179.745 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.67 -28.94 68.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.661 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.11 -43.62 91.91 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.104 -178.762 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -63.55 -44.4 94.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.299 179.299 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.63 -59.99 3.8 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.133 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -51.02 -43.58 60.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.115 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.31 -43.23 74.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.179 -179.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.67 -43.57 96.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.641 179.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -55.96 -37.61 69.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.149 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.76 1.0 18.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.158 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -114.96 91.41 26.49 Favored Pre-proline 0 N--CA 1.461 0.114 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.121 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.24 -27.29 29.81 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.798 2.332 . . . . 0.0 111.917 179.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.536 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.5 -40.98 98.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.484 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.37 5.22 52.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.349 -179.132 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -71.95 -35.12 69.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.622 179.557 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -80.06 4.69 16.34 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.521 -178.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.76 121.17 80.27 Favored Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.541 179.967 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -47.28 -37.68 24.8 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.427 2.085 . . . . 0.0 112.611 -179.582 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.53 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.84 -43.75 90.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.747 0.308 . . . . 0.0 110.404 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.01 -43.64 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.285 179.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.87 -40.66 95.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.376 -179.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.8 t-20 -89.78 -12.55 38.93 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.592 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.0 mtmt 61.87 32.18 18.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.069 -179.743 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -88.78 43.84 1.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.136 0.493 . . . . 0.0 110.308 179.537 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.11 135.85 39.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.487 -179.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.9 132.19 56.76 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.412 179.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.02 89.12 7.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.796 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.05 -41.11 97.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.45 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.444 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 80.52 165.76 33.44 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.514 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 74.3 p -75.46 -25.87 57.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.887 0.375 . . . . 0.0 110.785 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.9 tp10 -68.27 -33.76 74.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.439 -179.737 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 296' ' ' THR . 95.8 m -73.59 23.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.751 -179.144 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.571 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 49.4 t80 -58.0 -50.86 71.95 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.102 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 75.0 mmt-85 -110.7 152.97 25.92 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.108 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.419 ' CD2' HD11 ' A' ' 219' ' ' LEU . 41.9 tp -115.48 125.54 53.2 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.989 179.767 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.492 ' CB ' HD23 ' A' ' 83' ' ' LEU . 41.3 t0 -148.03 165.55 30.44 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.581 179.46 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -49.35 -37.71 25.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.655 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.29 -65.54 0.73 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.58 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.96 -32.85 72.37 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.058 -179.536 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.13 -25.61 23.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.8 -179.166 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.7 mtt -63.55 -40.7 97.68 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 120.854 0.359 . . . . 0.0 111.135 179.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.64 -44.1 24.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.188 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.584 HG21 HG23 ' A' ' 296' ' ' THR . 77.2 t -66.37 -42.87 91.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.353 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.431 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.1 tp -60.24 -47.12 87.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.507 -178.488 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -69.67 -39.36 77.07 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.069 0.462 . . . . 0.0 110.796 179.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.7 ttt180 -61.89 -38.44 88.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.218 -178.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.01 4.29 42.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.594 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.635 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.3 tttt -112.84 -10.94 13.52 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.073 0.463 . . . . 0.0 110.314 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.35 86.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.427 179.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.86 -48.7 80.59 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.403 -179.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.064 179.86 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -90.22 -2.56 58.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.428 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.7 179.13 1.23 Allowed Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.588 -179.711 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 32.0 Cg_exo -60.86 144.79 99.63 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.81 2.34 . . . . 0.0 112.206 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.617 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.9 -179.56 8.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.562 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -115.7 136.44 53.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.355 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.28 147.63 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.386 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.3 p -120.65 136.26 54.88 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.814 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.4 p30 -99.32 -143.34 0.32 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.239 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.8 -36.95 85.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.484 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.0 -67.67 0.22 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.436 179.676 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.16 142.53 44.46 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.295 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.4 p -112.18 131.8 55.26 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.552 -0.381 . . . . 0.0 110.513 -179.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -119.12 128.9 54.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.591 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.3 m -85.39 130.14 34.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.223 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' OE1' ' A' ' 42' ' ' GLN . 68.8 mt -95.37 78.43 3.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.4 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.81 -32.27 73.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.532 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.61 108.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.993 0.425 . . . . 0.0 110.157 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.489 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.3 pt20 -122.69 91.59 49.48 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-O 120.767 0.317 . . . . 0.0 110.404 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.655 ' O ' ' N ' ' A' ' 45' ' ' ARG . 34.6 Cg_exo -56.67 148.68 63.46 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.742 2.295 . . . . 0.0 111.993 178.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.26 82.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.677 0.61 . . . . 0.0 110.988 -179.196 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.655 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.2 mtm180 -151.57 66.88 0.88 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.261 -179.377 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.56 131.06 35.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.817 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.576 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.5 t -122.68 148.27 26.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.056 0.455 . . . . 0.0 110.077 -179.787 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.7 t -136.78 143.68 43.34 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.776 179.75 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.5 p -99.3 -59.03 1.8 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.572 179.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.0 p -79.16 155.43 28.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.587 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.548 HG21 HG23 ' A' ' 70' ' ' THR . 68.8 t -74.51 -21.72 17.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.484 179.357 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.1 m -60.4 -52.1 66.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.524 -178.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.37 -42.7 87.61 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.754 177.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.3 m -42.9 -53.89 4.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.948 -178.585 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.15 -37.41 72.29 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 178.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.8 m -62.8 -44.34 96.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.941 0.4 . . . . 0.0 110.152 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.6 mt -66.09 -42.05 89.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.505 0.669 . . . . 0.0 110.683 179.702 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.88 -40.04 96.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.393 -179.266 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.525 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.88 -36.1 78.34 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.348 -178.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.472 HD11 HD12 ' A' ' 156' ' ' LEU . 34.3 pt -90.92 27.81 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.27 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.89 52.03 9.91 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.391 0.432 . . . . 0.0 111.097 179.568 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.2 75.82 27.83 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.32 148.95 92.46 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.859 2.373 . . . . 0.0 112.12 -178.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.576 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.5 136.58 48.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-O 121.188 0.518 . . . . 0.0 110.308 179.807 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.442 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.68 -43.5 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.251 179.352 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.13 131.26 53.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.948 0.404 . . . . 0.0 110.605 -178.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.5 p -155.55 168.43 27.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.501 -179.796 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.81 -177.37 21.67 Favored Glycine 0 N--CA 1.463 0.453 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.638 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -134.04 173.16 11.88 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.062 0.458 . . . . 0.0 110.402 179.367 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.548 HG23 HG21 ' A' ' 51' ' ' VAL . 13.6 p -133.22 -111.79 0.23 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.982 0.42 . . . . 0.0 110.4 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -102.64 179.71 0.93 Allowed Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.466 -179.247 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.3 Cg_exo -60.93 58.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 123.018 2.479 . . . . 0.0 112.089 179.463 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.0 t-20 -64.45 -33.8 76.73 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.412 -179.647 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.2 m-20 93.85 -36.13 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.788 0.68 . . . . 0.0 109.769 -179.632 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.407 ' HD3' HD21 ' A' ' 73' ' ' ASN . 78.1 mtp85 -63.22 -40.09 96.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.235 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.3 p -74.42 -25.37 19.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.742 179.326 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.25 -171.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.463 -179.208 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.56 -153.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 38.0 p-10 -52.15 -7.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.751 -179.594 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.1 mm-40 -86.33 114.81 23.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.619 179.707 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.79 70.61 1.34 Allowed Glycine 0 CA--C 1.52 0.379 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -143.55 147.85 35.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.925 0.393 . . . . 0.0 110.802 179.233 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.4 mp -85.98 -98.34 0.07 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.035 178.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.558 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.3 -42.49 96.35 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.132 179.354 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.561 ' NE2' ' NZ ' ' A' ' 88' ' ' LYS . 35.3 tt0 91.55 53.29 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.851 0.719 . . . . 0.0 111.033 179.195 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -103.15 -9.43 19.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.345 179.261 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.5 p -64.06 -34.58 78.35 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.059 0.457 . . . . 0.0 110.732 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.561 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.71 -24.31 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.624 179.704 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.95 -45.62 76.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.58 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.89 -49.03 79.11 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.976 -179.368 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.44 -38.15 88.64 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.412 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.46 -32.8 51.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.135 -179.751 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.61 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.0 mmt-85 -89.97 1.55 56.13 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.555 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 83.11 -48.98 0.15 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.743 0.652 . . . . 0.0 110.245 179.146 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.664 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 80.1 mt -46.51 153.64 0.35 Allowed 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 117.732 -1.128 . . . . 0.0 109.546 -179.872 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.664 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.3 tt0 121.64 92.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 125.359 1.662 . . . . 0.0 110.476 -178.634 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.42 143.16 42.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.245 0.545 . . . . 0.0 110.288 179.313 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.1 mt -132.42 26.95 4.44 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 122.02 -0.425 . . . . 0.0 110.479 -179.365 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.44 138.31 34.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 0.0 110.485 -179.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.638 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.1 mt -137.28 164.84 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.359 179.51 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.14 -29.0 1.82 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.2 70.64 7.67 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.17 0.51 . . . . 0.0 110.241 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.07 145.37 98.59 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 C-N-CA 122.795 2.33 . . . . 0.0 112.046 -179.53 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.2 t -134.66 136.68 42.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.574 179.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.63 83.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.619 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.01 -42.21 97.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.493 -179.415 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.07 -41.55 98.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.563 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.61 -43.43 98.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.994 179.487 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.15 77.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.174 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.31 -18.8 60.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.459 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.59 -6.62 58.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.523 -179.773 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.412 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 73.5 mtp 47.91 56.04 17.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.548 179.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 112' ' ' MET . 56.2 Cg_endo -70.22 149.27 63.73 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.834 2.356 . . . . 0.0 112.1 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -101.31 -72.8 0.67 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.506 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.403 HD11 HD13 ' A' ' 140' ' ' LEU . 38.2 tp -111.56 113.9 26.62 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.386 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.9 mt -103.05 126.89 57.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 120.993 0.425 . . . . 0.0 110.572 -179.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.6 mt -110.11 134.29 52.33 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.251 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.84 139.92 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.499 -179.651 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.3 p -83.51 168.13 16.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.776 179.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.09 79.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.431 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -139.61 158.71 43.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.432 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.26 175.74 33.87 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.22 -33.62 86.54 Favored Glycine 0 CA--C 1.518 0.279 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -123.97 151.13 44.0 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.904 0.383 . . . . 0.0 110.585 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.4 t -63.52 140.08 58.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.389 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.1 10.82 11.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.656 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -60.99 -38.85 87.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.251 -179.394 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.633 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.32 -35.71 23.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.407 0.622 . . . . 0.0 110.587 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.4 mt -70.98 -35.42 72.1 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.51 0.671 . . . . 0.0 110.668 179.379 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -42.76 -63.0 0.86 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.348 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.633 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.7 p-10 -65.88 -42.83 89.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.114 -179.25 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.3 mt-30 -61.76 -32.8 73.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.362 -179.603 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.4 mt -73.62 -40.78 63.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 178.651 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.23 -49.2 77.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.165 -178.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.9 m -52.7 -42.7 65.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.186 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.09 -42.78 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 120.967 0.413 . . . . 0.0 111.144 179.165 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.58 153.36 5.09 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.632 -179.362 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -39.12 107.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.629 2.219 . . . . 0.0 112.538 179.65 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.639 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.3 m -110.04 121.35 45.06 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.095 0.474 . . . . 0.0 110.289 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.639 HD12 ' C ' ' A' ' 139' ' ' THR . 11.1 mp -113.94 153.05 29.93 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.29 -179.729 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.456 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.3 tt -130.36 129.25 64.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.398 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.5 mt -111.74 126.72 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.626 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.513 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 57.0 t30 -100.9 103.81 15.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.149 179.711 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -100.88 -6.31 24.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.956 -179.741 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.2 p-10 -65.34 -33.39 75.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.728 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.584 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.5 p-10 -100.37 9.18 43.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.618 -179.366 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.436 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.7 mttm -135.48 153.31 51.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.461 -179.39 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.407 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 23.9 p -75.81 166.55 23.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.624 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.597 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 90.8 t90 -59.89 -48.93 79.7 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.194 -179.095 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.85 -43.41 69.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.88 0.371 . . . . 0.0 110.087 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.0 t -62.88 -41.02 99.24 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.28 178.573 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.421 ' O ' HD23 ' A' ' 156' ' ' LEU . 49.9 tp -60.68 -44.49 96.44 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.298 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.0 tp -61.04 -43.59 98.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.136 179.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.7 m -54.53 -45.02 73.28 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.37 -40.15 95.5 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.96 0.41 . . . . 0.0 110.398 179.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.472 HD12 HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -61.79 -42.46 99.03 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.189 179.164 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.75 -40.09 95.54 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.362 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.43 -45.64 65.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.352 . . . . 0.0 110.762 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.84 -43.99 96.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.1 p -93.39 -8.95 40.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.632 -178.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.13 26.01 72.35 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -101.78 50.48 0.85 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.735 0.302 . . . . 0.0 110.65 -179.509 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.48 -39.29 77.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.625 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.39 -47.2 86.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.327 -179.452 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -60.23 -39.61 87.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.226 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.11 99.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.01 0.433 . . . . 0.0 110.245 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.03 -28.58 70.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.591 179.489 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.59 -54.12 8.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.885 179.407 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.525 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.5 ttp180 -65.26 -42.5 93.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.395 -179.764 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 174' ' ' ASP . 81.2 mt -62.61 -43.94 98.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.54 -179.388 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.11 -61.06 2.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.088 0.471 . . . . 0.0 110.403 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -54.8 -34.52 62.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.605 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -80.41 -35.9 34.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.812 179.576 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 170' ' ' ILE . 53.8 m-20 -55.08 -42.07 72.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.997 -178.658 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.42 -41.94 99.07 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.746 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.0 -38.21 90.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.316 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 177' ' ' LEU . 80.9 mt -62.46 -41.92 99.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.728 179.397 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.88 -52.81 62.61 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.097 0.475 . . . . 0.0 110.68 179.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.21 -41.75 89.69 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.674 179.408 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.92 95.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.592 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.36 -32.28 73.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.05 -22.16 18.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.589 -179.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.63 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.82 -41.06 96.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.698 -179.593 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.2 pt -76.89 135.94 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.749 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -126.85 108.33 10.91 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.257 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.62 125.75 0.31 Allowed Pre-proline 0 C--O 1.239 0.551 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.495 179.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.6 Cg_exo -43.94 152.4 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.848 2.365 . . . . 0.0 112.585 -179.862 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.09 141.75 53.82 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.604 2.203 . . . . 0.0 112.382 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.3 147.31 2.16 Favored Pre-proline 0 N--CA 1.448 -0.528 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.563 179.315 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.11 154.22 70.63 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.839 2.36 . . . . 0.0 112.33 178.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.58 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.37 163.08 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.27 0.557 . . . . 0.0 110.42 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.58 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.1 t -143.77 170.39 15.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.97 179.593 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -148.17 137.6 22.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 0.0 110.182 179.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.542 HG22 HD12 ' A' ' 205' ' ' LEU . 40.6 pt -134.37 147.02 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.73 179.596 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.484 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -133.55 132.05 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.21 0.529 . . . . 0.0 110.436 178.772 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -152.1 155.04 37.1 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.382 179.14 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 199' ' ' ALA . 91.7 m -122.26 122.89 40.16 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.952 0.406 . . . . 0.0 110.405 179.469 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.88 -25.36 66.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.678 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.614 ' H ' HG22 ' A' ' 197' ' ' THR . . . -75.45 -49.37 19.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.876 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -73.26 -9.81 59.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.393 -179.526 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.6 m80 46.85 43.39 13.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.544 -179.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 t -136.39 144.65 44.65 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.31 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -110.9 113.92 26.86 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.336 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 195' ' ' VAL . 98.0 m-20 -119.95 133.41 55.57 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.096 0.474 . . . . 0.0 110.405 179.824 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.542 HD12 HG22 ' A' ' 194' ' ' ILE . 7.5 tt -112.06 146.48 37.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.014 0.435 . . . . 0.0 110.728 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.459 ' N ' HD23 ' A' ' 205' ' ' LEU . 13.6 t90 -99.67 129.88 45.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.14 0.495 . . . . 0.0 109.919 179.434 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.64 154.02 39.29 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.333 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' A' ' 210' ' ' SER . 40.8 Cg_endo -67.54 -18.3 48.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.752 2.302 . . . . 0.0 111.976 178.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -49.54 -18.38 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.344 -179.148 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.406 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 85.4 p -75.59 164.34 26.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.51 179.664 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.83 -27.95 65.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.45 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.575 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.1 mt-30 -63.98 -41.26 97.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.61 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.04 -45.05 96.62 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -179.52 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.436 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 74.7 mt-30 -64.63 -38.71 91.94 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 122.236 -0.567 . . . . 0.0 110.783 179.54 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.597 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 87.7 mmm -62.14 -41.78 98.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.312 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.405 HD23 HD12 ' A' ' 219' ' ' LEU . 48.5 mt -63.5 -47.14 82.96 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.143 0.497 . . . . 0.0 110.259 179.545 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -54.77 -31.64 58.97 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.894 0.378 . . . . 0.0 110.411 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -70.26 -17.7 63.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.451 179.573 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.423 HD11 ' CD2' ' A' ' 299' ' ' LEU . 90.5 mt -88.82 -9.23 52.52 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.585 -179.492 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.98 2.68 51.98 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.756 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.86 153.03 21.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.456 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.5 p -115.36 128.12 55.87 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.11 0.481 . . . . 0.0 110.323 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.5 mm? -91.75 146.6 23.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.032 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.456 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -70.81 151.62 44.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.41 179.709 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -133.06 132.1 41.4 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.465 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.887 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.42 93.96 29.42 Favored Pre-proline 0 C--O 1.235 0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.066 -179.633 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.684 ' C ' ' H ' ' A' ' 229' ' ' GLY . 46.3 Cg_exo -55.12 138.86 79.91 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.582 2.188 . . . . 0.0 111.662 178.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.6 -25.27 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.504 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.684 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.17 -49.58 26.24 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.729 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.563 ' C ' ' H ' ' A' ' 232' ' ' ALA . 97.8 mt -54.58 -37.34 65.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.093 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -66.33 35.75 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.767 179.376 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.563 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.48 88.02 0.01 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.926 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 81.1 p -81.0 -13.81 58.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.31 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -92.16 -40.71 10.86 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.604 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.7 t -67.04 -16.6 64.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.559 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.69 43.94 27.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.473 -179.589 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.61 -147.05 7.37 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.06 143.45 49.5 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.96 0.41 . . . . 0.0 110.343 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -152.08 149.61 29.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.338 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -101.02 -152.08 0.42 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.319 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.5 t0 56.02 -92.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.672 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.457 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 11.1 tt -126.49 175.13 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.661 -179.591 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.457 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -121.62 141.24 42.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.827 -179.392 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.48 168.8 9.75 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.16 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.3 mt -147.47 150.91 35.5 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.281 179.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.99 -38.74 96.48 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 130.09 4.3 4.63 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -77.63 -58.1 3.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.901 0.381 . . . . 0.0 110.466 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.567 ' ND2' HD23 ' A' ' 226' ' ' LEU . 99.1 m-20 -62.15 -36.45 81.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.332 -179.724 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 10.0 mp -52.36 -67.8 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.842 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.32 -42.06 66.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.182 -179.362 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -74.29 18.03 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.629 179.816 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.59 48.46 0.24 Allowed Glycine 0 N--CA 1.465 0.591 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.4 mp 38.62 -109.84 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.467 0.175 . . . . 0.0 110.745 -178.536 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.456 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 12.0 m120 -60.68 -45.18 95.12 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.534 -179.555 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.82 8.17 83.01 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.258 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.37 -12.71 20.04 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 122.744 -0.268 . . . . 0.0 110.7 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.5 t 176.44 142.44 0.07 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.077 0.465 . . . . 0.0 110.436 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -148.1 125.34 11.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.161 179.593 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.432 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.38 143.19 29.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 120.899 0.38 . . . . 0.0 110.944 178.153 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.8 mt -94.52 106.66 18.65 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.718 -179.257 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.446 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.5 t80 -101.82 -12.36 18.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.101 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.58 89.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.872 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.37 173.66 46.04 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.657 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.5 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -73.98 -112.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 110.798 -179.824 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.95 -28.61 67.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.707 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.98 -44.12 91.53 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.202 -178.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.75 -44.24 94.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.308 179.3 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.51 -60.24 3.48 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.167 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -50.9 -43.56 59.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.169 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.27 -43.72 74.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.211 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.7 mt -64.57 -43.56 96.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.635 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -56.39 -37.68 70.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.168 -179.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.8 1.07 18.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.19 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -115.25 91.1 26.64 Favored Pre-proline 0 N--CA 1.462 0.134 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.129 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.99 -26.99 26.88 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.746 2.297 . . . . 0.0 111.976 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.532 ' N ' HD22 ' A' ' 277' ' ' LEU . 3.9 mm? -63.54 -41.09 98.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.495 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.598 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.0 mp -95.43 5.28 52.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.401 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.17 -34.84 68.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.536 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -80.11 4.74 16.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.526 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.9 121.28 80.94 Favored Pre-proline 0 N--CA 1.445 -0.721 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.566 179.999 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -47.22 -37.79 24.51 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.446 2.097 . . . . 0.0 112.618 -179.569 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.88 -43.8 90.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.705 0.288 . . . . 0.0 110.403 179.764 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.93 -43.56 92.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.345 179.306 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.84 -40.68 95.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.327 -179.217 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -90.09 -12.06 39.5 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.572 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.69 32.84 18.29 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.393 0.433 . . . . 0.0 111.035 -179.801 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -89.3 43.87 1.17 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.17 0.509 . . . . 0.0 110.348 179.476 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.54 135.96 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.533 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -116.7 132.55 56.66 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.385 179.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.502 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -84.57 88.09 7.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.733 179.917 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.06 -40.82 97.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.446 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 79.64 167.54 34.82 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.515 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 73.8 p -75.55 -25.73 57.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.803 0.335 . . . . 0.0 110.689 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.503 ' C ' ' H ' ' A' ' 297' ' ' PHE . 48.4 tp10 -67.89 -34.56 76.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.491 -179.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.773 HG22 ' O ' ' A' ' 296' ' ' THR . 96.7 m -73.36 24.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.649 -179.106 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.575 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 56.7 t80 -58.04 -51.17 70.79 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.348 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.408 HH12 ' HG3' ' A' ' 212' ' ' GLN . 71.0 mmt-85 -111.77 154.54 24.9 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.073 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.423 ' CD2' HD11 ' A' ' 219' ' ' LEU . 45.0 tp -115.89 124.99 52.03 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.97 0.414 . . . . 0.0 110.824 179.688 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.488 ' CB ' HD23 ' A' ' 83' ' ' LEU . 44.4 t0 -147.22 165.37 30.27 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.59 179.552 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -49.4 -38.41 28.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.617 -179.463 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -71.81 -65.1 0.81 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.527 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.5 p -60.08 -32.27 70.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.926 -179.501 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.19 -25.27 21.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.684 -179.14 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 63.7 mtt -63.1 -41.27 99.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.975 0.417 . . . . 0.0 110.977 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.27 -44.52 25.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.207 179.427 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.546 HG21 HG23 ' A' ' 296' ' ' THR . 78.7 t -66.12 -42.88 92.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.465 179.703 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.443 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 52.1 tp -60.36 -47.25 86.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.524 -178.522 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -70.09 -39.54 75.49 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.696 179.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.502 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 70.2 ttt180 -61.89 -37.79 85.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.36 -178.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 98.1 mt -87.8 4.81 42.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.723 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.63 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.6 tttt -113.2 -11.99 13.18 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.052 0.453 . . . . 0.0 110.357 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.3 86.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.449 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.91 -48.8 80.15 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.431 -179.644 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.059 179.8 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.608 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.86 -2.7 58.26 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.463 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.55 179.14 1.23 Allowed Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.561 -179.65 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.4 Cg_exo -60.75 145.0 99.64 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.799 2.333 . . . . 0.0 112.171 179.634 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.608 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -156.03 -179.52 8.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.596 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.97 136.94 52.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.013 0.435 . . . . 0.0 110.383 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.22 147.06 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.342 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.6 p -119.93 135.88 54.73 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.073 0.463 . . . . 0.0 110.699 179.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.3 p30 -99.42 -143.44 0.33 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.252 179.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -63.61 -37.11 86.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.485 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.4 -66.68 0.22 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.416 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.52 142.47 45.35 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -179.357 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 78.4 p -112.29 131.61 55.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 0.0 110.447 -179.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -119.2 129.03 54.76 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.526 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.1 m -85.56 130.18 34.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.217 -179.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.477 HD22 ' NE2' ' A' ' 42' ' ' GLN . 69.1 mt -95.7 78.5 3.3 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.463 179.646 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.64 -31.73 72.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.579 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 t 176.35 109.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.018 0.437 . . . . 0.0 110.089 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.478 HE22 HD22 ' A' ' 115' ' ' LEU . 1.4 pt20 -122.35 91.15 49.3 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.485 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.65 ' O ' ' N ' ' A' ' 45' ' ' ARG . 32.4 Cg_exo -56.74 148.48 65.36 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.831 2.354 . . . . 0.0 112.002 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -40.46 82.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.566 0.542 . . . . 0.0 110.975 -179.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.65 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.55 66.84 0.88 Allowed 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 121.094 0.473 . . . . 0.0 110.221 -179.422 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.4 130.74 35.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.803 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.565 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.4 t -122.42 146.61 27.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.057 -179.699 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.7 t -135.87 143.78 45.23 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.772 179.79 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.9 p -99.57 -59.36 1.73 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.588 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.1 p -79.22 155.17 28.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.66 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.524 HG21 HG23 ' A' ' 70' ' ' THR . 69.7 t -74.2 -21.89 17.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.474 179.355 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.3 m -60.28 -52.19 66.31 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.549 -178.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.34 -42.72 87.75 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.756 177.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.1 m -42.94 -53.83 4.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.9 -178.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.32 -37.19 70.68 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 178.564 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 m -62.78 -44.78 95.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.871 0.367 . . . . 0.0 110.141 -179.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 15.9 mt -66.45 -41.94 88.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.51 0.671 . . . . 0.0 110.711 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.65 -40.48 97.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.427 -179.363 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -59.9 -35.67 75.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.303 -179.046 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 156' ' ' LEU . 32.6 pt -91.34 28.65 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.314 -179.388 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.51 51.81 10.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.084 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -141.34 76.04 21.98 Favored Pre-proline 0 N--CA 1.463 0.199 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.624 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.77 151.21 86.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.864 2.376 . . . . 0.0 112.102 -178.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.565 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.6 OUTLIER -113.18 137.47 46.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 121.155 0.502 . . . . 0.0 110.292 179.683 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.2 pt -69.43 -43.55 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.395 179.344 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.25 131.48 53.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.033 0.444 . . . . 0.0 110.562 -179.008 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 97' ' ' ARG . 31.6 p -155.7 168.51 26.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.437 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.36 -177.37 21.96 Favored Glycine 0 N--CA 1.463 0.475 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.634 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.52 172.25 12.98 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 121.165 0.507 . . . . 0.0 110.453 179.263 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.524 HG23 HG21 ' A' ' 51' ' ' VAL . 15.0 p -132.17 -113.14 0.23 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.037 0.446 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -101.64 179.58 0.97 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.399 -179.185 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 36.9 Cg_exo -61.04 57.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.997 2.465 . . . . 0.0 112.146 179.417 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.557 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 59.2 t-20 -64.1 -33.18 75.19 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.286 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 44.5 m-20 93.8 -36.62 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.674 0.609 . . . . 0.0 109.825 -179.527 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -62.51 -39.71 94.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.009 0.433 . . . . 0.0 110.225 179.279 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.505 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.9 p -74.26 -25.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.703 179.353 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -49.15 -171.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.444 -179.227 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 80' ' ' GLN . 56.1 p30 -73.77 -154.15 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.843 -179.708 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 38.1 p-10 -52.46 -7.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.742 -179.557 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.2 mm-40 -86.13 114.87 23.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.679 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.23 70.05 1.34 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -143.59 147.45 34.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.866 0.365 . . . . 0.0 110.856 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.5 mp -85.41 -98.2 0.07 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.126 178.859 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -64.3 -42.38 96.39 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.076 179.543 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.553 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.23 52.5 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.875 0.734 . . . . 0.0 111.027 179.205 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -102.6 -9.12 20.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.332 179.338 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.3 p -64.56 -33.86 76.9 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.183 0.515 . . . . 0.0 110.74 -179.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.539 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -49.29 -23.29 1.33 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 179.666 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.0 t -70.08 -45.83 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.689 179.698 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.29 -48.63 80.52 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.216 0.532 . . . . 0.0 109.963 -179.384 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.52 -38.2 89.01 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.425 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -53.71 -32.89 53.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.041 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.605 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 86.9 mmt-85 -89.87 1.77 55.8 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.453 -179.811 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.2 mttp 82.76 -49.38 0.17 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.903 0.752 . . . . 0.0 110.228 179.125 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.658 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.2 mt -45.97 154.3 0.25 Allowed 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 117.621 -1.181 . . . . 0.0 109.566 -179.768 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.658 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.9 tt0 121.16 92.65 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 O-C-N 125.461 1.726 . . . . 0.0 110.51 -178.511 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -75.69 142.93 42.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.242 0.544 . . . . 0.0 110.291 179.296 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.3 mt -132.05 27.15 4.55 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.973 -0.454 . . . . 0.0 110.44 -179.346 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -140.39 137.97 34.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.042 0.448 . . . . 0.0 110.583 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 69' ' ' ALA . 92.9 mt -137.17 165.12 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.319 179.594 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 144.94 -28.51 1.86 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -152.96 70.89 7.14 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 121.119 0.485 . . . . 0.0 110.132 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.1 145.42 98.48 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 122.743 2.295 . . . . 0.0 112.126 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.9 t -134.27 136.75 43.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.543 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.27 81.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.643 179.652 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.25 -42.3 96.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.511 -179.385 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.92 -41.7 98.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.49 -179.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.56 -43.43 98.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.991 179.485 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.02 77.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.145 -179.636 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.62 -18.82 61.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.383 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.6 -6.68 58.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.461 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.41 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 71.4 mtp 47.57 56.3 17.39 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.568 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.8 Cg_endo -70.33 149.5 63.38 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.751 2.301 . . . . 0.0 112.098 179.5 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -101.04 -73.64 0.64 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.492 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.478 HD22 HE22 ' A' ' 42' ' ' GLN . 39.3 tp -111.07 113.6 26.25 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 110.295 179.648 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.6 mt -101.97 126.75 55.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 120.966 0.413 . . . . 0.0 110.714 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.5 mt -109.84 133.5 53.09 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.211 -179.43 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.5 139.43 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.55 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.4 p -83.32 168.39 16.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.851 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.4 -37.3 80.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.397 179.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.3 t -139.96 158.87 43.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.968 0.414 . . . . 0.0 110.415 -179.818 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.23 176.97 33.49 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.26 -33.81 87.2 Favored Glycine 0 CA--C 1.518 0.251 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -124.58 151.3 44.95 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 110.547 -179.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.0 t -63.24 140.88 58.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.333 -179.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.48 10.37 11.14 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.659 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.7 mp -60.92 -39.0 87.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.273 -179.374 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.635 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.05 -35.84 23.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.469 0.652 . . . . 0.0 110.594 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.5 mt -70.99 -35.4 72.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.517 0.675 . . . . 0.0 110.613 179.398 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -42.77 -62.91 0.88 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.424 -178.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.635 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 39.7 p-10 -65.63 -42.92 90.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 -179.301 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 84.9 mt-30 -61.89 -32.6 72.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.399 -179.609 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.4 mt -73.9 -40.8 62.9 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.78 178.672 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -58.04 -49.0 78.39 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.114 -178.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.9 m -53.02 -42.37 65.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.955 0.407 . . . . 0.0 110.144 179.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.21 -42.7 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 120.909 0.385 . . . . 0.0 111.252 179.044 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.64 153.81 5.22 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.681 -179.401 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -39.25 107.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.702 2.268 . . . . 0.0 112.519 179.544 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.64 ' C ' HD12 ' A' ' 140' ' ' LEU . 96.2 m -109.56 121.08 44.4 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.152 0.501 . . . . 0.0 110.272 179.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.64 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.59 152.24 30.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.294 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.5 tt -128.77 131.43 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.3 179.815 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.404 HG21 ' CD1' ' A' ' 152' ' ' LEU . 96.8 mt -115.27 127.97 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.553 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' CG ' ' A' ' 146' ' ' ASP . 56.5 t30 -101.51 103.85 14.74 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.151 179.766 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 147' ' ' LYS . 48.4 p90 -101.3 -11.11 19.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.895 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 49.3 p-10 -64.92 -33.49 76.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.708 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 39.0 p-10 -98.21 7.57 46.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.589 -179.622 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 214' ' ' GLN . 68.9 mttm -135.44 155.56 50.34 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.415 -179.38 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.402 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.2 p -74.9 165.82 24.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.63 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.589 ' CD2' ' SD ' ' A' ' 215' ' ' MET . 91.2 t90 -60.05 -48.83 80.08 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.19 -179.073 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -53.46 -41.92 66.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.351 . . . . 0.0 110.082 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.6 t -62.69 -41.03 98.89 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.399 178.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.404 ' CD1' HG21 ' A' ' 142' ' ' ILE . 46.3 tp -60.74 -44.51 96.59 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.285 -179.472 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.33 -43.47 98.83 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.106 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.0 m -55.16 -44.99 75.67 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.17 -40.66 96.78 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 120.948 0.404 . . . . 0.0 110.545 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.521 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -61.94 -42.5 99.17 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.378 178.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -66.19 -40.8 95.03 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.548 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.76 -46.03 63.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.786 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.68 -44.05 96.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.0 p -92.95 -8.9 41.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.661 -179.023 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 66.41 26.39 72.71 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -101.74 50.32 0.85 Allowed 'General case' 0 N--CA 1.463 0.214 0 O-C-N 122.638 -0.331 . . . . 0.0 110.68 -179.576 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -69.46 -39.63 77.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.694 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.32 -47.08 86.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.301 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -60.2 -39.42 86.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.129 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.96 99.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.181 179.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.11 -28.39 70.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.67 179.476 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.3 -54.38 7.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.863 179.357 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.509 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.3 ttp180 -65.35 -42.22 93.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.376 -179.758 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 174' ' ' ASP . 79.4 mt -62.31 -43.88 98.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.559 -179.418 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.48 -59.23 5.26 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.992 0.425 . . . . 0.0 110.308 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -56.28 -33.99 66.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.572 -179.085 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -80.73 -36.37 32.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.815 179.524 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 170' ' ' ILE . 52.8 m-20 -55.45 -42.22 73.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.91 -178.419 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.17 -42.13 98.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.8 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.08 -38.15 89.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.306 179.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 177' ' ' LEU . 81.8 mt -62.44 -42.25 99.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.746 179.452 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.19 -52.84 62.17 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.026 0.441 . . . . 0.0 110.622 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -66.24 -41.85 89.44 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.641 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.95 95.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.641 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.34 -31.95 73.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.48 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -94.57 -22.26 18.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.635 -179.828 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.632 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.84 -41.35 95.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.597 -179.497 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.6 pt -76.73 136.13 25.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.741 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.87 107.98 10.59 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.265 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.71 125.87 0.31 Allowed Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.487 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.453 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.5 Cg_exo -43.8 152.42 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.794 2.33 . . . . 0.0 112.58 -179.804 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.18 141.95 54.0 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.536 2.157 . . . . 0.0 112.397 179.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.2 pm0 -171.32 147.46 2.18 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.555 179.323 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.37 154.55 69.12 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.797 2.331 . . . . 0.0 112.272 178.52 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 192' ' ' THR . 2.6 p -138.57 163.3 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.232 0.539 . . . . 0.0 110.408 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.56 170.17 16.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.025 179.454 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.94 137.31 22.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.997 0.427 . . . . 0.0 110.127 179.484 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.554 HG22 HD12 ' A' ' 205' ' ' LEU . 38.0 pt -134.17 146.84 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.7 179.622 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.9 p -133.01 131.97 58.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.285 0.564 . . . . 0.0 110.439 178.775 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -152.98 156.42 38.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.362 179.202 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.607 HG22 ' H ' ' A' ' 199' ' ' ALA . 85.0 m -122.36 123.12 40.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.906 0.384 . . . . 0.0 110.418 179.416 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.522 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.78 -26.18 67.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.608 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.607 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.89 -49.23 21.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.68 -10.37 59.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.503 -179.703 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.522 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 79.5 m80 45.84 46.59 12.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 t -130.8 143.51 50.79 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.012 0.434 . . . . 0.0 110.334 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.456 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -108.23 105.62 15.42 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.18 -179.773 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -116.2 128.98 56.07 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.288 0.566 . . . . 0.0 110.29 179.714 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.554 HD12 HG22 ' A' ' 194' ' ' ILE . 7.7 tt -111.82 146.45 37.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.816 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.476 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.7 t90 -99.5 128.33 45.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.205 0.526 . . . . 0.0 109.795 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.22 153.8 40.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.434 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.62 -17.97 48.26 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.674 2.249 . . . . 0.0 112.018 178.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.84 -18.59 0.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.392 -179.189 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.422 ' OG ' ' NE1' ' A' ' 206' ' ' TRP . 86.7 p -75.49 164.7 26.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 179.577 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -58.96 -28.05 65.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.576 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.561 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 83.5 mt-30 -63.66 -41.4 98.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.59 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.36 -44.48 97.53 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 147' ' ' LYS . 75.0 mt-30 -64.41 -38.89 92.61 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 122.167 -0.607 . . . . 0.0 110.739 179.67 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 149' ' ' TRP . 88.0 mmm -61.83 -41.35 97.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.273 179.716 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.5 -47.75 80.44 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.095 0.474 . . . . 0.0 110.407 179.271 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.63 -32.07 49.83 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.913 0.387 . . . . 0.0 110.413 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -70.84 -18.22 62.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.501 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.414 HD11 ' CD2' ' A' ' 299' ' ' LEU . 91.7 mt -88.61 -8.7 54.23 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.558 -179.469 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.85 2.78 55.13 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.78 151.86 22.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.94 0.4 . . . . 0.0 110.432 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.449 ' O ' HG12 ' A' ' 191' ' ' VAL . 8.3 p -114.87 127.8 55.92 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.178 0.513 . . . . 0.0 110.387 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.4 mm? -92.05 146.79 23.45 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.929 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.461 ' HB2' ' OD1' ' A' ' 255' ' ' ASN . . . -70.45 151.26 45.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.456 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.96 131.66 42.81 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.519 179.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.883 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.6 93.65 28.89 Favored Pre-proline 0 C--O 1.235 0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.055 -179.529 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.685 ' C ' ' H ' ' A' ' 229' ' ' GLY . 44.8 Cg_exo -55.17 138.55 79.38 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.618 2.212 . . . . 0.0 111.703 178.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.36 -25.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.521 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.685 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -70.44 -50.19 27.68 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 179.802 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.571 ' C ' ' H ' ' A' ' 232' ' ' ALA . 96.9 mt -55.13 -36.93 66.28 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.101 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -65.77 35.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.806 179.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.571 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.14 88.66 0.01 OUTLIER 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.949 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 87.7 p -82.41 -13.6 56.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.331 -179.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -91.41 -40.95 11.15 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.633 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 31.9 t -66.65 -16.82 64.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.622 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 55.79 43.88 27.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.482 -179.599 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.95 -148.75 8.14 Favored Glycine 0 CA--C 1.518 0.245 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.82 142.17 48.86 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.916 0.389 . . . . 0.0 110.267 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.402 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.5 ttt-85 -151.93 149.47 28.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.349 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -102.11 -150.31 0.4 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.344 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.1 t0 55.81 -93.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.64 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.439 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.0 tt -126.4 174.72 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.64 -179.589 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.439 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 89.5 mt -122.12 141.2 43.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -99.62 170.5 8.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.189 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 70.0 mt -146.69 149.69 33.93 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.229 179.743 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.22 -39.41 97.86 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.17 3.22 3.98 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -78.72 -57.42 3.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.937 0.399 . . . . 0.0 110.484 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.616 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.8 m-20 -62.03 -36.81 82.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.242 -179.67 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.456 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.7 mp -53.06 -67.45 0.25 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.014 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.8 -42.71 68.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.126 -179.297 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.31 17.64 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.701 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 31.9 47.81 0.25 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 254' ' ' LEU . 7.9 mp 39.47 -110.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.532 0.206 . . . . 0.0 110.699 -178.677 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.461 ' OD1' ' HB2' ' A' ' 224' ' ' ALA . 11.7 m120 -60.76 -44.57 96.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.35 -179.563 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.4 7.92 84.09 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.413 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -98.87 -13.5 20.03 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.761 -0.258 . . . . 0.0 110.678 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.7 t 177.21 142.94 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 0.0 110.448 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.2 tt -148.19 125.49 11.55 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.161 179.56 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 191' ' ' VAL . 13.7 m-30 -98.71 143.66 28.83 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 120.914 0.388 . . . . 0.0 110.847 178.269 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 54.9 mt -95.06 106.67 18.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.736 -179.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.442 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.1 t80 -101.91 -12.63 18.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.122 179.596 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.4 -41.04 89.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.82 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -177.36 172.86 45.69 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.469 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 88.3 m-20 -73.59 -113.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.75 0.31 . . . . 0.0 110.815 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.6 -28.84 68.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.644 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.11 -43.64 91.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.16 -178.801 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.68 -44.28 94.18 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.267 179.248 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.6 -59.98 3.8 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.111 -179.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -50.96 -43.52 60.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.112 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.38 -43.33 75.06 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.199 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 92.2 mt -64.62 -43.61 96.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.674 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -55.94 -37.84 69.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.132 -179.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.48 0.78 18.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.182 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -115.04 90.99 25.21 Favored Pre-proline 0 N--CA 1.463 0.177 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.123 -179.564 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.09 -27.08 27.89 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.704 2.27 . . . . 0.0 111.979 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.538 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.48 -40.92 98.37 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.518 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 278' ' ' LEU . 10.1 mp -95.53 5.59 51.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.343 -179.214 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.39 -34.84 68.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.612 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.86 4.59 16.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.495 -178.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.75 121.13 80.09 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.607 -179.979 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -47.28 -37.6 24.7 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.431 2.087 . . . . 0.0 112.635 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 287' ' ' LYS . . . -58.84 -43.78 90.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.756 0.313 . . . . 0.0 110.4 179.724 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.03 -43.51 92.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.346 179.348 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.74 -40.64 95.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.383 -179.191 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -90.22 -12.19 38.77 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.1 mtmt 61.74 32.81 18.2 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.371 0.419 . . . . 0.0 111.024 -179.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -89.04 43.67 1.16 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.13 0.491 . . . . 0.0 110.295 179.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.22 136.02 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.44 -179.661 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -117.02 132.28 56.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.391 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.5 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.78 89.14 7.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.819 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.415 ' O ' ' OG1' ' A' ' 296' ' ' THR . 88.3 mt -63.97 -41.16 97.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.993 0.425 . . . . 0.0 110.811 179.521 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.02 165.22 33.58 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.511 ' OG1' ' ND2' ' A' ' 74' ' ' ASN . 67.6 p -75.26 -25.77 58.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.968 0.413 . . . . 0.0 110.822 179.778 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.5 tp10 -68.39 -33.83 74.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.504 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.768 HG22 ' O ' ' A' ' 296' ' ' THR . 95.8 m -73.39 24.72 0.07 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.797 -179.076 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.561 ' CD1' ' NE2' ' A' ' 212' ' ' GLN . 44.0 t80 -58.71 -50.85 72.35 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.256 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.419 HH12 ' HG3' ' A' ' 212' ' ' GLN . 77.1 mmt-85 -110.64 153.09 25.7 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 179.135 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.414 ' CD2' HD11 ' A' ' 219' ' ' LEU . 42.7 tp -115.4 124.88 52.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.883 0.373 . . . . 0.0 110.816 179.759 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.489 ' CB ' HD23 ' A' ' 83' ' ' LEU . 40.6 t0 -147.73 165.53 30.22 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.592 179.572 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -49.4 -37.92 27.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.533 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -71.32 -65.45 0.75 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.871 0.367 . . . . 0.0 111.582 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.3 p -60.87 -32.76 72.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.013 -179.504 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.5 -25.66 26.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.724 -179.153 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 61.5 mtt -63.37 -40.83 98.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.874 0.369 . . . . 0.0 111.145 179.694 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.41 -44.24 25.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.103 179.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.585 HG21 HG23 ' A' ' 296' ' ' THR . 78.2 t -66.34 -42.89 91.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.347 179.652 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.438 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 49.3 tp -60.02 -47.22 86.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.446 -178.516 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -69.82 -39.28 76.59 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.07 0.462 . . . . 0.0 110.811 179.074 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.5 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 72.9 ttt180 -61.87 -38.33 87.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.219 -178.936 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.27 4.61 42.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.57 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.632 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 87.4 tttt -112.85 -11.25 13.48 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.066 0.46 . . . . 0.0 110.367 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.35 86.89 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.466 179.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.82 -48.81 80.12 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.39 -179.608 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.222 -0.379 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.012 179.912 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' NH1' ' A' ' 28' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -90.36 -2.55 57.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.372 -179.81 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.493 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -144.62 179.05 1.25 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.521 -179.701 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.493 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 31.8 Cg_exo -60.73 144.74 99.59 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.814 2.343 . . . . 0.0 112.153 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' NH1' ' N ' ' A' ' 24' ' ' ALA . 35.2 ptt-85 -155.87 -179.57 8.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.632 -179.851 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -115.76 136.42 53.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.046 0.45 . . . . 0.0 110.364 179.765 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.08 147.26 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.382 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.9 p -120.3 136.1 54.79 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.813 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 52.2 p30 -99.21 -143.52 0.32 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.248 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -63.7 -37.03 85.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.47 179.623 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.482 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 61.0 ttt85 -149.15 -67.04 0.22 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.418 179.783 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -58.21 142.5 44.61 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.436 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.7 p -112.64 131.21 55.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.991 0.424 . . . . 0.0 110.463 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -118.96 129.14 55.0 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.54 -179.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.3 m -85.63 130.83 34.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.226 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' OE1' ' A' ' 42' ' ' GLN . 69.2 mt -96.24 78.7 3.11 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.343 179.678 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -65.93 -32.11 73.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.574 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 176.62 108.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.106 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.489 ' OE1' HD22 ' A' ' 39' ' ' LEU . 4.4 pt20 -121.93 91.21 48.8 Favored Pre-proline 0 C--O 1.233 0.189 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.45 -179.729 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.663 ' O ' ' N ' ' A' ' 45' ' ' ARG . 33.2 Cg_exo -56.75 148.29 66.7 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.798 2.332 . . . . 0.0 111.982 178.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -40.18 82.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.695 0.622 . . . . 0.0 111.002 -179.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.663 ' N ' ' O ' ' A' ' 43' ' ' PRO . 86.4 mtm180 -151.47 66.72 0.89 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.263 -179.4 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.95 130.98 35.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.851 -179.742 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.569 ' HA ' HG23 ' A' ' 64' ' ' VAL . 53.1 t -122.75 147.7 26.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.062 0.458 . . . . 0.0 110.013 -179.678 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.2 t -136.62 144.03 43.86 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.753 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.1 p -99.45 -59.53 1.7 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.628 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.8 p -79.08 155.64 28.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.623 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.529 HG21 HG23 ' A' ' 70' ' ' THR . 70.1 t -74.26 -21.65 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.532 179.414 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -60.34 -52.01 67.08 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.547 -178.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.16 -42.7 88.61 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.718 177.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.8 m -43.26 -54.38 4.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.884 -178.54 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.88 -37.36 74.89 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 178.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m -62.91 -44.49 95.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.872 0.368 . . . . 0.0 110.163 -179.304 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 18.3 mt -66.07 -41.95 90.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.505 0.669 . . . . 0.0 110.663 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.04 -39.95 96.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.344 -179.251 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.541 ' HB1' ' NH1' ' A' ' 169' ' ' ARG . . . -60.48 -35.91 77.02 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.295 -178.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.445 HD11 HD12 ' A' ' 156' ' ' LEU . 33.9 pt -91.14 27.64 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.374 -179.381 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.403 ' CB ' ' NE2' ' A' ' 165' ' ' GLN . 98.8 m-20 57.08 51.93 9.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.084 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -140.48 76.39 25.25 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.66 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.98 149.46 90.49 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.877 2.385 . . . . 0.0 112.146 -178.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -112.43 136.71 47.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 121.115 0.483 . . . . 0.0 110.35 179.661 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.444 HG13 ' N ' ' A' ' 66' ' ' ALA . 16.0 pt -69.67 -43.46 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.249 179.439 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.491 ' O ' ' CG2' ' A' ' 64' ' ' VAL . . . -125.13 131.27 53.28 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.963 0.411 . . . . 0.0 110.608 -178.983 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 97' ' ' ARG . 32.4 p -155.92 168.63 26.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.531 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -108.16 -177.43 22.09 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.644 ' O ' HD12 ' A' ' 100' ' ' ILE . . . -133.26 171.92 13.38 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 121.102 0.477 . . . . 0.0 110.425 179.297 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.529 HG23 HG21 ' A' ' 51' ' ' VAL . 12.3 p -133.81 -110.51 0.22 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.008 0.432 . . . . 0.0 110.583 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -103.11 179.62 0.94 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.566 -179.323 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 71' ' ' THR . 39.4 Cg_exo -60.72 58.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.944 2.429 . . . . 0.0 112.126 179.512 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 57.3 t-20 -64.31 -34.88 79.15 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.48 -179.789 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.566 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 45.9 m-20 95.04 -38.07 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.671 0.607 . . . . 0.0 109.759 -179.436 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 -62.54 -39.88 95.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.99 0.424 . . . . 0.0 110.142 179.234 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 77' ' ' ALA . 14.8 p -73.6 -26.55 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.693 179.326 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -50.04 -171.77 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.463 -179.381 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 80' ' ' GLN . 55.9 p30 -74.38 -153.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 -179.785 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 38.3 p-10 -54.37 -6.77 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.675 -179.432 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 78' ' ' ASP . 99.3 mm-40 -86.9 113.93 23.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.671 179.793 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.39 72.39 1.29 Allowed Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -143.8 148.1 35.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.862 0.363 . . . . 0.0 110.876 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 83' ' ' LEU . 7.6 mp -85.99 -98.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.939 178.891 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 95.2 mtt-85 -63.92 -43.38 96.11 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.113 179.395 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.559 ' CB ' ' O ' ' A' ' 84' ' ' ARG . 35.2 tt0 91.37 52.53 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.794 0.684 . . . . 0.0 111.147 179.195 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -103.78 -8.63 19.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.347 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.0 p -65.45 -33.22 75.43 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.05 0.452 . . . . 0.0 110.65 -179.596 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.523 ' NZ ' ' NE2' ' A' ' 85' ' ' GLN . 98.0 mttt -48.87 -23.24 1.02 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.717 179.639 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 76.4 t -70.13 -45.81 74.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.708 179.708 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.75 80.09 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.974 -179.441 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.41 -38.37 89.41 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.39 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -53.65 -32.78 52.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.208 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.618 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 87.5 mmt-85 -89.8 1.81 55.69 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.406 -179.802 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.618 ' HB2' ' O ' ' A' ' 93' ' ' ARG . 62.4 mttp 82.68 -49.18 0.17 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.7 0.625 . . . . 0.0 110.246 179.152 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.673 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 81.3 mt -45.96 154.11 0.26 Allowed 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.542 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.673 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 58.5 tt0 121.2 92.05 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 125.17 1.543 . . . . 0.0 110.477 -178.683 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.543 ' O ' ' O ' ' A' ' 67' ' ' SER . 85.8 mtp180 -74.92 142.56 44.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.282 0.563 . . . . 0.0 110.368 179.374 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.2 mt -131.6 26.59 4.72 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 122.016 -0.428 . . . . 0.0 110.379 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -139.8 136.96 34.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.06 0.457 . . . . 0.0 110.596 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.644 HD12 ' O ' ' A' ' 69' ' ' ALA . 93.7 mt -136.52 164.69 30.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.393 179.592 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.613 ' N ' HG22 ' A' ' 100' ' ' ILE . . . 145.19 -28.49 1.83 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 1.7 pm0 -152.56 70.72 7.42 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 121.08 0.466 . . . . 0.0 110.182 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.08 145.41 98.5 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.705 2.27 . . . . 0.0 112.098 -179.481 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.5 t -134.59 136.91 43.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.509 179.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.35 82.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.57 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.2 -42.38 96.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.603 -179.439 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.91 -41.68 98.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.544 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.57 -43.35 98.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.987 179.487 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.17 -35.04 77.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.206 -179.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.81 -18.71 60.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.363 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.51 -6.4 58.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.457 -179.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.414 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 74.4 mtp 47.54 56.0 17.15 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.576 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 112' ' ' MET . 55.9 Cg_endo -70.33 149.61 63.5 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.816 2.344 . . . . 0.0 112.049 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -101.46 -73.72 0.64 Allowed 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.46 179.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.1 tp -110.61 113.72 26.55 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.27 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.3 mt -102.84 126.83 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.614 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.1 mt -110.57 134.18 52.63 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.275 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.68 140.05 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.57 -179.574 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.2 p -83.44 168.19 16.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.8 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.5 79.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.455 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.6 t -139.99 159.2 42.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.398 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -156.18 176.82 33.49 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.31 -33.67 86.83 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -124.49 151.67 44.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.858 0.361 . . . . 0.0 110.565 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.8 t -63.39 140.64 58.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.336 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.39 10.35 11.19 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.622 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.517 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.8 mp -60.75 -39.0 87.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.253 -179.368 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.636 ' O ' ' OD1' ' A' ' 131' ' ' ASP . . . -83.97 -35.9 23.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.358 0.599 . . . . 0.0 110.594 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' LEU . 92.0 mt -70.89 -35.43 72.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.47 0.653 . . . . 0.0 110.607 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -42.78 -62.92 0.88 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.453 -178.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.636 ' OD1' ' O ' ' A' ' 128' ' ' ALA . 40.0 p-10 -65.82 -42.75 90.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.244 -179.395 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.541 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.1 mt-30 -61.83 -32.6 72.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.402 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 129' ' ' LEU . 69.2 mt -73.88 -40.82 62.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.879 178.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -58.24 -49.18 77.99 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.231 -179.041 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.8 m -53.01 -42.49 65.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.896 0.379 . . . . 0.0 110.089 179.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.18 -42.82 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 120.927 0.394 . . . . 0.0 111.154 179.216 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.4 153.39 5.26 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.684 -179.395 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -39.08 107.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.666 2.244 . . . . 0.0 112.537 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.641 ' C ' HD12 ' A' ' 140' ' ' LEU . 94.1 m -109.68 121.08 44.4 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.115 0.483 . . . . 0.0 110.246 179.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 139' ' ' THR . 11.0 mp -113.76 153.08 29.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.32 -179.841 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 141' ' ' ILE . 19.6 tt -128.58 131.45 68.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.383 179.856 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.41 128.17 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.605 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.501 ' ND2' ' OD1' ' A' ' 145' ' ' ASP . 53.6 t30 -99.59 104.02 15.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.133 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.416 ' O ' ' O ' ' A' ' 147' ' ' LYS . 50.8 p90 -98.87 -12.39 20.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.969 -179.705 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 146' ' ' ASP . 50.6 p-10 -64.93 -33.89 77.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.798 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.592 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 40.7 p-10 -99.23 6.89 46.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.596 -179.376 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 144' ' ' TYR . 68.8 mttm -133.71 149.59 51.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.559 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.423 ' C ' ' OE1' ' A' ' 214' ' ' GLN . 24.1 p -76.43 167.31 22.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.618 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.603 ' CD1' ' SD ' ' A' ' 215' ' ' MET . 89.2 t90 -59.07 -48.3 82.1 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.166 -179.158 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -54.4 -45.99 73.04 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 40.4 t -63.42 -40.8 98.14 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.094 0.473 . . . . 0.0 110.2 178.429 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.434 ' O ' HD23 ' A' ' 156' ' ' LEU . 66.5 tp -61.04 -44.67 97.05 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.119 -179.353 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.49 -42.71 99.21 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.207 179.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.5 m -55.78 -45.61 78.14 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.39 -40.4 96.37 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.812 0.339 . . . . 0.0 110.445 179.766 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.445 HD12 HD11 ' A' ' 60' ' ' ILE . 2.3 mm? -61.81 -42.54 99.14 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.312 178.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 161' ' ' GLY . . . -65.78 -40.0 95.45 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.425 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.36 -45.61 65.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.922 0.391 . . . . 0.0 110.843 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.9 mt -65.02 -43.88 96.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.82 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.3 p -92.89 -9.11 41.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.656 -179.049 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 157' ' ' GLY . . . 65.96 26.42 72.28 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -101.72 50.76 0.84 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.883 0.373 . . . . 0.0 110.668 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.53 -39.31 77.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.608 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.37 -47.36 85.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.36 -179.448 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.403 ' NE2' ' CB ' ' A' ' 61' ' ' ASP . 87.3 mt-30 -60.3 -39.3 86.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.112 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.05 99.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.186 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.07 -28.39 70.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.607 179.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.21 -54.42 7.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.939 179.405 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.541 ' NH1' ' HB1' ' A' ' 59' ' ' ALA . 61.5 ttp180 -65.5 -41.98 92.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.561 -179.834 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 174' ' ' ASP . 78.9 mt -62.31 -43.92 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.549 -179.319 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.91 -57.85 9.39 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 120.995 0.426 . . . . 0.0 110.416 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -57.56 -33.83 68.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.619 -179.134 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -81.15 -36.43 30.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.774 179.648 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' ILE . 54.4 m-20 -55.72 -41.64 74.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.095 -178.672 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.49 -42.1 99.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.631 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.19 -38.35 90.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.255 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 177' ' ' LEU . 83.0 mt -62.45 -42.02 99.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.76 179.498 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.18 -53.16 59.29 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.091 0.472 . . . . 0.0 110.628 179.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 183' ' ' GLN . . . -65.87 -42.08 90.82 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.722 179.502 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.51 -39.45 94.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.669 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.7 -32.06 73.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.4 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -95.34 -21.96 18.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.617 -179.677 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.64 ' NE2' ' NZ ' ' A' ' 312' ' ' LYS . 51.8 tt0 -64.38 -41.77 96.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.685 -179.494 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.4 pt -74.53 135.55 27.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.016 0.436 . . . . 0.0 110.707 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.29 106.2 9.35 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.346 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 pp -178.02 127.51 0.28 Allowed Pre-proline 0 C--O 1.239 0.53 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.513 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.447 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 75.7 Cg_exo -43.53 151.81 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.892 2.395 . . . . 0.0 112.53 -179.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.44 142.81 55.46 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.608 2.205 . . . . 0.0 112.343 179.672 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.545 ' OE1' ' N ' ' A' ' 189' ' ' GLN . 1.3 pm0 -171.66 147.14 1.99 Allowed Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.527 179.327 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.13 155.29 68.49 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.887 2.391 . . . . 0.0 112.34 178.676 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 192' ' ' THR . 2.7 p -138.59 163.14 28.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.201 0.524 . . . . 0.0 110.409 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 191' ' ' VAL . 2.2 t -143.3 169.36 17.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.031 179.455 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.41 137.1 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.365 . . . . 0.0 110.177 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.57 HG22 HD12 ' A' ' 205' ' ' LEU . 38.0 pt -134.08 146.12 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.759 179.511 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.491 ' O ' ' O ' ' A' ' 204' ' ' ASN . 2.7 p -133.32 132.11 58.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.286 0.565 . . . . 0.0 110.431 178.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -153.07 156.55 38.94 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.403 179.193 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.605 HG22 ' H ' ' A' ' 199' ' ' ALA . 90.4 m -121.84 122.93 40.57 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.41 179.556 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.467 ' O ' ' CE1' ' A' ' 201' ' ' HIS . . . -60.94 -26.09 67.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.606 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.605 ' H ' HG22 ' A' ' 197' ' ' THR . . . -74.77 -49.56 20.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.974 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -75.79 -13.22 60.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.471 -179.65 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.467 ' CE1' ' O ' ' A' ' 198' ' ' ALA . 78.4 m80 49.56 46.51 23.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.621 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.5 t -131.59 146.04 52.01 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.075 0.464 . . . . 0.0 110.247 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.426 ' HB1' HD21 ' A' ' 250' ' ' LEU . . . -110.21 106.05 15.33 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.234 -179.741 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 195' ' ' VAL . 97.8 m-20 -116.36 129.19 56.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.09 0.471 . . . . 0.0 110.276 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.57 HD12 HG22 ' A' ' 194' ' ' ILE . 7.7 tt -111.95 146.32 38.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.017 0.437 . . . . 0.0 110.889 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.464 ' N ' HD23 ' A' ' 205' ' ' LEU . 17.4 t90 -98.73 128.86 45.11 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.139 0.495 . . . . 0.0 109.912 179.442 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.05 153.55 39.12 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.229 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.8 -18.25 47.35 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.748 2.299 . . . . 0.0 111.981 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.9 -19.16 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.437 -179.273 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 86.7 p -75.86 167.63 21.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.449 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.46 74.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.453 -179.682 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.506 ' NE2' ' CD1' ' A' ' 297' ' ' PHE . 82.2 mt-30 -56.55 -40.68 75.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.756 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.31 -43.71 97.09 Favored Glycine 0 C--N 1.329 0.165 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.532 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.512 ' OE1' ' N ' ' A' ' 149' ' ' TRP . 74.2 mt-30 -64.32 -40.57 96.16 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 122.341 -0.505 . . . . 0.0 110.796 -179.896 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.603 ' SD ' ' CD1' ' A' ' 149' ' ' TRP . 97.3 mmm -62.02 -42.46 99.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.499 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 39.7 mt -62.91 -49.21 75.69 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.049 0.452 . . . . 0.0 110.432 179.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.67 -31.52 62.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 110.441 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -69.48 -17.47 63.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.541 179.792 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.401 HD11 ' CD2' ' A' ' 299' ' ' LEU . 95.0 mt -87.3 -11.5 49.32 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.616 -179.569 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 105.19 1.32 41.43 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.723 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -88.2 156.1 19.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.923 0.392 . . . . 0.0 110.692 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.458 ' O ' HG12 ' A' ' 191' ' ' VAL . 7.1 p -116.39 128.59 55.65 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.183 0.516 . . . . 0.0 110.201 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.63 HD22 ' N ' ' A' ' 223' ' ' LEU . 3.6 mm? -90.53 146.81 23.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.993 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.458 ' CB ' ' OD1' ' A' ' 255' ' ' ASN . . . -71.62 150.47 44.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.414 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.5 131.94 42.15 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.575 179.688 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.877 ' N ' HD12 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -113.03 94.2 28.83 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.984 -179.579 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.687 ' C ' ' H ' ' A' ' 229' ' ' GLY . 45.8 Cg_exo -55.19 138.57 79.49 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.651 2.234 . . . . 0.0 111.602 178.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 61.28 -25.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.46 -179.59 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.687 ' H ' ' C ' ' A' ' 227' ' ' PRO . . . -71.07 -49.67 26.42 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.575 ' C ' ' H ' ' A' ' 232' ' ' ALA . 98.1 mt -54.89 -37.29 66.13 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.127 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -65.71 35.52 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.775 179.37 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.575 ' H ' ' C ' ' A' ' 230' ' ' LEU . . . 39.78 87.82 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.5 p -81.38 -13.86 57.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.382 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -91.73 -40.41 11.27 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.628 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 26.9 t -66.93 -16.62 64.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.573 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 55.83 43.82 27.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.488 -179.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 179.4 -146.52 7.16 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.23 142.98 49.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.947 0.404 . . . . 0.0 110.397 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.401 HH12 ' H ' ' A' ' 242' ' ' ILE . 76.3 ttt-85 -151.82 149.37 28.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.034 0.445 . . . . 0.0 110.28 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -101.22 -151.3 0.41 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.348 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.3 t0 55.67 -92.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.712 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.444 ' CG1' ' H ' ' A' ' 243' ' ' ILE . 12.0 tt -126.57 174.63 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.618 -179.469 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.444 ' H ' ' CG1' ' A' ' 242' ' ' ILE . 90.3 mt -121.69 140.96 44.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.476 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -99.28 170.33 8.73 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.307 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.1 mt -146.82 149.55 33.53 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.191 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -63.42 -39.3 97.58 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 132.22 3.06 4.0 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -78.29 -57.73 3.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.935 0.398 . . . . 0.0 110.463 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.63 ' ND2' HD23 ' A' ' 226' ' ' LEU . 93.4 m-20 -62.06 -37.06 83.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.297 -179.649 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.426 HD21 ' HB1' ' A' ' 203' ' ' ALA . 7.7 mp -52.71 -67.78 0.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 253' ' ' GLY . . . -53.74 -42.46 68.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.133 -179.283 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 253' ' ' GLY . . . -73.39 17.69 0.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.668 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 251' ' ' ALA . . . 32.05 48.0 0.27 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 254' ' ' LEU . 8.1 mp 39.06 -110.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.493 0.187 . . . . 0.0 110.696 -178.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.458 ' OD1' ' CB ' ' A' ' 224' ' ' ALA . 12.0 m120 -60.66 -44.58 96.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.42 -179.639 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 253' ' ' GLY . . . 84.32 7.85 84.33 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.329 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -98.67 -13.41 20.31 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.763 -0.257 . . . . 0.0 110.69 -179.795 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.5 t 177.03 142.72 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.132 0.492 . . . . 0.0 110.382 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.432 HD23 ' C ' ' A' ' 259' ' ' LEU . 9.1 tt -147.71 125.46 11.88 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.288 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 191' ' ' VAL . 14.0 m-30 -98.61 143.7 28.71 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 120.927 0.394 . . . . 0.0 110.731 178.405 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.2 mt -95.12 106.33 18.33 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.773 -179.255 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.481 ' CE1' ' O ' ' A' ' 293' ' ' GLY . 92.8 t80 -102.45 -12.26 17.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.112 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -66.53 -40.04 88.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.883 179.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -178.16 173.61 46.07 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.463 ' OD1' ' NH2' ' A' ' 310' ' ' ARG . 96.5 m-20 -74.43 -113.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 0.0 110.769 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.5 -29.16 68.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.693 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.9 -43.81 91.1 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.112 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.36 -44.68 94.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.271 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -52.46 -59.95 3.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.197 -179.792 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -51.02 -43.64 60.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.082 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.12 -43.75 74.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.156 -179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 91.8 mt -64.41 -43.65 97.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.579 179.568 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -56.63 -37.9 71.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.144 -179.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -76.5 1.03 17.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.179 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -115.17 91.24 26.83 Favored Pre-proline 0 N--CA 1.461 0.089 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.176 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.12 -26.93 27.6 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.748 2.299 . . . . 0.0 111.975 179.329 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 277' ' ' LEU . 4.0 mm? -63.55 -40.82 98.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.577 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 278' ' ' LEU . 9.9 mp -95.16 5.57 51.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.381 -179.022 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -72.03 -35.14 69.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.618 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -79.63 4.27 16.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.492 -178.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -68.68 120.69 77.39 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.575 179.953 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -47.27 -37.66 24.7 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.446 2.097 . . . . 0.0 112.6 -179.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.535 ' HB3' HD22 ' A' ' 281' ' ' LEU . . . -58.93 -43.63 91.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.43 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.83 -43.61 93.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.337 179.241 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -64.9 -40.58 95.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.396 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 46.6 t-20 -89.8 -12.28 39.65 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.508 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 283' ' ' ALA . 54.3 mtmt 61.81 31.66 18.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.051 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.44 44.04 1.17 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.128 0.49 . . . . 0.0 110.308 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -104.8 136.13 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.563 -179.704 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.66 132.5 56.67 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.361 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.496 ' O ' ' CZ ' ' A' ' 310' ' ' ARG . . . -83.35 88.66 6.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.794 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.82 -41.51 97.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.697 179.533 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.481 ' O ' ' CE1' ' A' ' 262' ' ' PHE . . . 81.5 165.13 34.28 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.789 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 74.7 p -75.53 -26.09 57.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' A' ' 297' ' ' PHE . 47.4 tp10 -68.67 -33.77 74.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.394 -179.699 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.777 HG22 ' O ' ' A' ' 296' ' ' THR . 98.1 m -72.47 22.19 0.06 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.215 0.531 . . . . 0.0 110.761 -179.351 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.513 ' H ' ' C ' ' A' ' 295' ' ' GLU . 49.1 t80 -57.86 -51.0 71.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.851 -179.253 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 71.9 mmt-85 -108.02 150.03 27.66 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.401 ' CD2' HD11 ' A' ' 219' ' ' LEU . 44.7 tp -116.46 127.31 54.47 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.77 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.464 ' CB ' HD23 ' A' ' 83' ' ' LEU . 42.6 t0 -150.99 167.82 26.45 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.675 179.631 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.4 ' CE2' ' CE ' ' A' ' 305' ' ' MET . 91.4 t80 -49.3 -38.09 26.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.622 -179.54 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.16 -65.63 0.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.588 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.4 p -60.64 -33.03 72.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.028 -179.479 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 300' ' ' ASP . . . -54.17 -25.31 21.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.782 -179.125 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . 0.4 ' CE ' ' CE2' ' A' ' 301' ' ' TYR . 61.3 mtt -63.57 -41.09 98.4 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.933 0.397 . . . . 0.0 111.158 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.96 -43.88 23.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.181 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.567 HG21 HG23 ' A' ' 296' ' ' THR . 77.9 t -66.21 -42.86 91.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.405 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 304' ' ' ALA . 50.2 tp -60.34 -46.76 88.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.48 -178.555 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -70.47 -39.47 74.22 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.098 0.475 . . . . 0.0 110.805 179.162 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.496 ' CZ ' ' O ' ' A' ' 291' ' ' ALA . 73.6 ttt180 -61.56 -37.53 84.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.292 -179.029 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.6 mt -87.99 4.18 45.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.642 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.64 ' NZ ' ' NE2' ' A' ' 183' ' ' GLN . 86.9 tttt -112.2 -11.26 13.77 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.003 0.43 . . . . 0.0 110.396 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.17 86.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.406 179.761 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.82 -48.89 79.75 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.474 -179.703 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.005 179.877 . . . . . . . . 0 0 . 1 stop_ save_